{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT’s nonqualified defined benefit pension plans declined slightly from $1.0 billion at the end of 2023 to $905 million at the end of 2024, while the related actuarial losses recorded in accumulated other comprehensive loss fell from $347 million to $303 million (pretax). This indicates a modest reduction in both the obligation and the unrecognized actuarial losses over the one‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. The formatting ($1.0 billion vs $905 million) is consistent and acceptable. (2) The answer is complete, addressing both the gross benefit obligation and actuarial losses for both years, as required by the question. (3) Entity accuracy is correct—LMT (Lockheed Martin) is properly identified, and the financial metrics (gross benefit obligation, actuarial losses) are accurately named and contextualized within nonqualified defined benefit pension plans. (4) The reasoning is sound: the LLM correctly interprets the year-over-year decline and characterizes it as a reduction in both liability and actuarial losses, which aligns with the multi-hop synthesis required across two years and two financial metrics. The addition of 'pretax' and 'accumulated other comprehensive loss' provides extra context without introducing error. (5) Semantic equivalence is maintained—the LLM conveys the same core information with slightly enhanced detail, but no factual deviation. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 354,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "Between 2022 and 2024, General Motors adjusted its long-term rate of return assumptions for U.S. pension plan assets from 5.6% to 6.5%, reflecting a strategic shift toward a more aggressive asset allocation—particularly increasing exposure to alternative investments like private equity, real estate, and hedge funds (from 23% to 29% of the portfolio). This change, driven by updated capital market assumptions and investment policy studies, aims to improve funded status and mitigate volatility while aligning with the company’s de-risking objectives. The increased expected return supports a more aggressive portfolio mix to better match long-term liability obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that GM's long-term rate of return assumption changed from 5.6% in 2022 to 6.5% in 2024, but the ground truth shows a more nuanced evolution: the rate was 5.4% at the end of 2021 (reported in 2022) and increased to 6.5% at the end of 2024 (reported in 2024), with an intermediate value of 6.3% at the end of 2023. The LLM incorrectly implies a direct shift from 5.6% to 6.5% over the 2022–2024 period, conflating earlier data (5.6% as of 2020) with 2022 assumptions. (2) The claim of increasing alternative investments from 23% to 29% is not supported by the original answer and introduces unverified specifics not present in the ground truth. While the general direction of strategic shift may be plausible, these precise figures are unsupported and constitute fabrication. (3) The qualitative reasoning about strategic asset mix, de-risking, and capital market assumptions aligns with the original answer’s interpretation and shows sound multi-hop synthesis in intent, though based on incorrect numbers. The conclusion about aiming to improve funded status is consistent with the ground truth. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution of return assumptions and strategic implications. However, due to key numerical errors and unsupported specifics, the correctness score is limited to 6, reflecting partial accuracy with significant factual shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 414,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved from a previously disclosed acquisition during 2023, which was explicitly excluded from the company's internal control assessment as of December 31, 2023, due to being acquired in a business combination. This integration likely contributed to operational changes and financial impacts reflected in Chevron's 2024 results, including higher upstream earnings from legacy PDC assets (notably a 19% increase in U.S. upstream production and $3.5 billion in increased earnings driven by higher volumes and absence of decommissioning charges) and adjustments to integration-related expenses. The document also references \"legacy PDC assets\" in the context of upstream performance, indicating that PDC's operations were fully absorbed into Chevron's upstream segment by 2024, though no specific financial impact of the relationship itself is detailed beyond this operational integration and its effect on production and earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of PDC Energy by Chevron and its exclusion from internal control assessment, which aligns with the ground truth. It also correctly notes the integration into Chevron's upstream operations by 2024 and references 'legacy PDC assets' contributing to performance. However, there are significant quantitative inaccuracies: the LLM states a '$3.5 billion increase in earnings' and a '19% increase in U.S. upstream production', whereas the ground truth specifies a '$2.2 billion increase in U.S. upstream earnings' and a '19% increase in net oil-equivalent production'. The conflation of 'production increase' with 'upstream earnings increase' and the incorrect dollar figure ($3.5B vs $2.2B) are major factual errors. (2) The year references (2023 and 2024) are correct, and the entity names (Chevron, PDC Energy) are accurate. The metric 'upstream earnings' is correctly used, but the specific value is wrong. The 19% figure is correctly attributed to production, though the ground truth specifies 'net oil-equivalent production', which the LLM oversimplifies. (3) The reasoning correctly traces the evolution from acquisition to integration and attributes financial and operational impacts to the PDC acquisition, showing sound multi-hop synthesis across time and entities. However, the incorrect financial figure undermines the quantitative reasoning. (4) The answer is contextually relevant and addresses both the evolution of the relationship and the operational/financial impacts, but the incorrect dollar amount and misattribution of the 19% increase (to upstream production instead of net oil-equivalent production) reduce factual accuracy significantly. These errors affect the core of the financial impact claim, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 493,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment of energy-related derivatives shifted toward greater use of regulatory hedging frameworks, with increased recognition of unrealized gains and losses in the balance sheet under regulatory asset/liability accounts. In 2024, net amounts recognized for energy-related derivatives designated as hedging instruments totaled $28 million in assets and $84 million in liabilities (up from $21 million and $87 million in 2023), reflecting higher valuation of both current and non-current derivatives. Unrealized gains/losses from these derivatives were primarily recorded in AOCI for cash flow hedges and deferred in regulatory accounts for regulatory hedges, with minimal impact on income until realized. The 2024 filings also show expanded use of cash flow and fair value hedges for interest rate and foreign currency risks, though gains/losses remained immaterial for AOCI reclassifications in 2025. (Based on SO_10k_2024 pages 281-285 and comparative 2023 data.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($28M assets, $84M liabilities in 2024; $21M and $87M in 2023) and references to AOCI, cash flow hedges, and regulatory accounts that are not present in the original answer (ground truth). The ground truth does not provide any dollar amounts or mention AOCI, reclassifications, or year-over-year comparisons for derivative balances. These figures and details appear to be fabricated or hallucinated, severely undermining factual accuracy. (2) Quantitative accuracy is low because the LLM invents precise financial data and trends (e.g., 'up from 2023') with no basis in the original answer, which only discusses qualitative changes in disclosure and presentation. There is no verification that these numbers exist in the cited pages (SO_10k_2024 pp. 281–285), and the original knowledge graph response contains no such figures. (3) Qualitatively, the LLM captures a partial shift in disclosure focus—mentioning balance sheet presentation of derivatives as assets/liabilities and referencing regulatory deferrals and hedging frameworks—which aligns somewhat with the ground truth’s description of a move toward fair value presentation. However, it misrepresents the nature and extent of the change by implying a broader accounting policy shift rather than a change in disclosure emphasis. The multi-hop reasoning is flawed because it synthesizes non-existent quantitative trends and injects details about hedge types and AOCI impacts unsupported by the source. (4) Contextual relevance is moderate: the response stays on topic, discusses derivatives, regulatory treatment, and balance sheet presentation, and addresses the time frame. But it fails to accurately reflect the actual change described—i.e., a shift from reporting pre-tax effects of unrealized gains (losses) for regulatory hedging instruments (as of 2020–2021) to disclosing fair value presentation in 2024—without asserting unverified financial figures or hedge accounting mechanics. The core idea of evolving disclosure is present, but the execution is factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 564,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron's investment carrying value in Tengizchevroil increased from $23,727 million at the end of 2021 to $27,368 million by the end of 2024, reflecting a $3,641 million rise over the three‑year period.  Correspondingly, Chevron's equity earnings from Tengizchevroil grew from $1,238 million in 2021 to $3,375 million in 2024, indicating a substantial improvement in earnings from that equity affiliate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Chevron's carrying value increased from $23,727 million in 2021 to $27,368 million in 2024, but the ground truth does not provide 2021 data and instead focuses on 2022–2024. More critically, the LLM claims equity earnings rose from $1,238 million in 2021 to $3,375 million in 2024, which directly contradicts the ground truth showing a decline from $4,386 million in 2022 to $3,033 million in 2024. The LLM incorrectly frames earnings as increasing, when they actually decreased. (2) The only correct number is the $27,368 million investment value in 2024, which matches the ground truth. However, the $26,954 million in 2023 is omitted, and no mention is made of the $100 higher carrying value vs. equity in net assets in 2022 or the $4.5 billion loan for FGP/WPMP. The LLM uses 2021 as a baseline, which is outside the requested 2022–2024 scope. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct trend (declining profitability despite growing investment) and introduces data from 2021 not in the original answer. It also misses the key qualitative point about the carrying value discrepancy and the loan structure. (4) The contextual relevance is moderate because it discusses the right entities (Chevron, Tengizchevroil) and financial metrics (carrying value, equity earnings), but the incorrect direction of earnings change and use of wrong years severely undermine accuracy. Quantitative accuracy is very low due to wrong numbers and trends. Qualitative accuracy is low due to flawed reasoning and missing key details. Correctness score is low because the core facts—especially the decline in earnings—are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 475,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Based on the provided 10-K filings, Walmart's ownership stake in Alert Innovation underwent a specific transaction during fiscal 2023 that changed its relationship with the entity. \n\nAccording to Note 3 (Shareholders' Equity) in the 2023 10-K (page 65), Walmart completed a $0.4 billion acquisition of Alert Innovation during fiscal 2023, which resulted in the Company becoming a 100% owner. This entity was previously consolidated as a variable interest entity, and the acquisition marked the point at which Walmart gained full ownership. The entity was subsequently sold and deconsolidated in fiscal 2025, as noted in the same section.\n\nThus, the evolution was: Alert Innovation was initially consolidated as a variable interest entity, then fully acquired by Walmart in fiscal 2023 (increasing ownership from a non-100% stake to 100%), and later sold/deconsolidated in fiscal 2025. The specific transaction that changed the relationship was the $0.4 billion acquisition in fiscal 2023 that made Walmart the 100% owner.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart becoming a 100% owner, which aligns with the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2025, whereas the ground truth specifies fiscal 2024. This is a critical error in temporal accuracy that affects the correctness of the ownership evolution timeline. (2) Quantitatively, the $0.4 billion figure is accurate, and the concept of moving to 100% ownership is correct. The only quantitative inaccuracy is the misstatement of the deconsolidation year (2025 vs. 2024), which impacts the overall timeline. (3) The reasoning is mostly sound in tracing the ownership change from variable interest entity to full acquisition, but fails in the final step of multi-hop synthesis by citing the wrong fiscal year for deconsolidation. This undermines the conclusion that the full transformation occurred within a single fiscal year (2023 to 2024), which is a key point in the original answer. (4) Contextual relevance is high as the response addresses both parts of the question—ownership evolution and the specific transaction—though the incorrect year reduces the accuracy of the synthesis. The core facts are present but the timeline error significantly affects the overall correctness, warranting a score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 382,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks' foreign currency derivative assets and liabilities decreased substantially, with derivative assets falling from $85.9 million to $46.8 million and derivative liabilities from $56.7 million to $43.2 million. This reduction reflects the company’s active management of foreign‑exchange exposure—using forwards, swaps and designated hedging instruments—to offset currency volatility in its international operations and to limit potential losses from fluctuating exchange rates. The decline indicates that Starbucks is tightening its hedging program, likely to stabilize earnings and protect cash flows against adverse currency movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in AOCI, not $85.9 million as stated by the LLM. The LLM incorrectly reports derivative assets and liabilities for 2022 and 2023 that do not match the ground truth. In 2023, the correct figures are $1.9 million in current assets, $1.7 million in long-term assets, $4.7 million in current liabilities, and $4.1 million in long-term liabilities — the LLM incorrectly aggregates these into $46.8 million in assets and $43.2 million in liabilities, which is not supported by the data. (2) The numbers are entirely incorrect: the LLM invents aggregate figures not present in the original answer and misrepresents both the magnitude and structure of the derivative positions. There is no mention in the ground truth of total derivative assets being $85.9 million in 2022 or $46.8 million in 2023; these appear to be fabricated or misattributed. (3) The multi-hop reasoning is flawed — the LLM fails to recognize the shift from AOCI-based unrealized gains in 2022 to a split between short- and long-term asset/liability classifications in 2023. It also misses the key point about reclassification expectations ($32.5 million expected to be reclassified into earnings), which is central to understanding the exposure. Instead, it assumes a general 'tightening of hedging program' without grounding this in the actual structural change in reporting. (4) While the general direction — that Starbucks reduced foreign currency derivative exposure — is loosely aligned with the truth, the complete lack of accurate numbers, mischaracterization of financial positions, and failure to capture the shift from equity (AOCI) to balance sheet assets/liabilities severely undermine correctness. The contextual relevance is moderate because the topic and intent (assessing exposure management) are appropriate, but the answer is factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 546,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Based on the provided SEC 10-K filings, Medtronic's treatment of A Preferred Shares evolved as follows between fiscal years 2022 and 2024:  \n\n1.  **In fiscal 2022**, the Company **redeemed all outstanding A Preferred Shares** (1,872 shares) for $0.075 million, resulting in **no A Preferred Shares being outstanding at the end of fiscal 2022** (as stated in Note 11 on page 81: \"During the third quarter of fiscal year 2022 the Company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million. At April 29, 2022, no A Preferred Shares were outstanding\").  \n2.  **In fiscal 2024**, there were **no A Preferred Shares outstanding** (as confirmed in Note 11 on page 81: \"At April 26, 2024, no A Preferred Shares were outstanding\"), and the Company continued to have **no Preferred Shares or A Preferred Shares issued or outstanding** (as noted in Note 11 on page 82).  \n\nThus, the specific action taken regarding A Preferred Shares in 2022 was the **full redemption of all outstanding A Preferred Shares**, eliminating them from the Company's capital structure. This action was completed during fiscal 2022, and no A Preferred Shares remained outstanding in subsequent years (2023 and 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers—1,872 A Preferred Shares and $0.075 million—are correctly reported, along with the redemption date (third quarter of fiscal 2022) and the confirmation that no shares were outstanding as of April 29, 2022. The status in fiscal 2024 (no shares outstanding as of April 26, 2024) is also accurately stated. (2) Completeness: The answer addresses both parts of the question—evolution between 2022 and 2024 and the specific 2022 action. It correctly identifies the full redemption as the key event and notes the continued absence of shares in 2024. (3) Entity accuracy: 'Medtronic', 'A Preferred Shares', fiscal years 2022 and 2024, and the relevant notes (Note 11) are all correctly referenced. (4) Reasoning: The multi-hop synthesis—linking the 2022 redemption to the ongoing absence in 2024—is sound and leads to the correct conclusion that the shares were discontinued. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, with added citation details (page numbers, note references) that enhance credibility without altering factual content. All scores are 10 due to perfect factual alignment, precise numbers, logical reasoning, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 360,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Based on the provided SEC 10-K pages, Comcast's financial relationship with Atairos evolved such that equity income (losses) driven by fair value adjustments on underlying investments shifted from a significant positive contributor in 2021 ($1.8 billion income at Atairos) to a major negative driver in 2022 and 2023, with losses of $(434) million in 2022 and $(1.1 billion) in 2023. This is documented in the \"Consolidated Investment and Other Income (Loss), Net\" table on page 39 (2023) and page 48 (2021-2022), which explicitly states that the change in investment income was primarily due to fair value adjustments at Atairos, with income (loss) of $1.1 billion and $(434) million in 2023 and 2022, respectively. The 2023 equity income (losses) directly reflects these fair value adjustments, marking a continued deterioration in the relationship's contribution to Comcast's overall financial results compared to the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of the financial figures, reversing the actual trend. (1) Quantitatively, it states a loss of $(1.1 billion) in 2023, while the ground truth reports a gain of $1.1 billion in 2023. It also incorrectly references a $1.8 billion income in 2021, which is not part of the question or ground truth. The 2022 loss of $(434) million is correct, but the 2023 figure is wrong and inverted. (2) The answer claims continued deterioration in 2023, directly contradicting the ground truth, which shows a dramatic improvement from a $434 million loss in 2022 to a $1.1 billion gain in 2023. (3) The reasoning is flawed: it misreads or misrepresents the data, failing to correctly synthesize the multi-hop change over time. Instead of identifying a turnaround, it asserts a worsening trend. (4) Contextual relevance is low because it discusses 2021 data not asked for and mischaracterizes the evolution between 2022 and 2023. The citation of page numbers does not compensate for factual inaccuracy. The answer is semantically opposite to the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 323,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 5,275 billion cubic feet (end‑2023) to 5,870 billion cubic feet (end‑2024), reflecting upward revisions, purchases (notably from the Marathon Oil acquisition) and extensions/discoveries in the region. This growth underscores the company’s strategic focus on expanding its presence and resource base in the Asia Pacific/Middle East, positioning it as a key hub for future gas production and revenue.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. According to the ground truth, COP's natural gas reserves in the Asia Pacific/Middle East region declined from 312 billion cubic feet in 2023 to 296 billion cubic feet in 2024. The LLM incorrectly states that reserves increased from 5,275 to 5,870 billion cubic feet—over 17 times higher than the actual values. This massive numerical discrepancy renders the answer fundamentally wrong. (2) The numbers cited (5,275 and 5,870 Bcf) are not only incorrect but appear to be fabricated or misattributed, possibly confusing total global reserves with regional figures or misreading data from another source. The claimed growth due to the Marathon Oil acquisition and 'extensions/discoveries' is unsupported by the ground truth, which indicates a slight decline. (3) The multi-hop reasoning fails completely: the model should have identified the correct regional reserves for two consecutive years and interpreted the trend. Instead, it invents a growth narrative contrary to the actual data. (4) While the answer addresses the question's structure (evolution and strategic implication), the extreme factual inaccuracy in numbers, direction of change, and reasoning leads to a correctness score of 1. Quantitative accuracy is 1 due to entirely wrong figures. Qualitative accuracy is 1 because the reasoning is based on false premises. Contextual relevance is 3 because the response attempts the right format and topic but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 416,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL sales in Canada declined from $73 million in 2022 to $47 million in 2023 (a 36% drop) and further to $28 million in 2024 (a 40% drop from the prior year). This consistent downward trend signals a weakening market position and suggests that ENBREL’s Canadian sales trajectory is moving toward continued erosion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue figures for 2023 ($47 million) and 2024 ($28 million), which match the ground truth. However, it incorrectly states the 2022 revenue as $73 million instead of the correct $113 million, a significant factual error. This affects the accuracy of the year-over-year decline calculations. (2) The percentage drops are based on incorrect starting values: the 36% drop from $73M to $47M is accurate mathematically but uses a wrong base; the actual drop from $113M to $47M is about 58.4%, not 36%. The 40% drop from $47M to $28M is mathematically correct and matches the ground truth trend. (3) The reasoning about the downward trend and weakening market position is sound and aligns with the ground truth's interpretation of a 'consistent downward trend' and 'shrinking market presence.' The model correctly synthesizes multi-year data and draws a logical conclusion about market trajectory despite the initial data error. (4) The contextual relevance is perfect—answer addresses both parts of the question (revenue evolution and market implication). Qualitative reasoning is strong, but quantitative accuracy is compromised by the incorrect 2022 figure, leading to a correctness score of 6 due to partial factual correctness with a major numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 366,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm’s executive compensation began to tie human‑capital progress to bonus payouts, using a non‑financial performance modifier that can adjust the fiscal 2024 executive bonus by a multiplier of **0.9 to 1.1**. This represents the first time the company explicitly linked human‑capital advancements to executive pay, whereas in fiscal 2023 the approach was not quantified in this manner. The specific performance modifier range applied in fiscal 2024 is **0.9 – 1.1**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Qualcomm evolved its approach from fiscal 2023 to fiscal 2024 by introducing a quantified non-financial performance modifier tied to human capital advancements, with a multiplier range of 0.9 to 1.1 for fiscal 2024 bonuses. This matches the original answer exactly in substance. (2) Quantitatively, the multiplier range '0.9 to 1.1' is correct and consistently reported; no calculations are required beyond this, and the fiscal years (2023 and 2024) are accurately referenced. (3) The multi-hop reasoning is sound: the model correctly contrasts the non-quantified consideration in fiscal 2023 with the explicit, bounded modifier in fiscal 2024, demonstrating synthesis across time periods. (4) The only minor shortcoming is that the LLM claims this was 'the first time the company explicitly linked human-capital advancements to executive pay,' which, while plausible, goes slightly beyond the original answer’s more cautious phrasing ('evolved into a more defined structure'). This extrapolation is reasonable but not directly confirmed in the ground truth, justifying a 9 instead of 10 on qualitative accuracy. All other aspects are factually correct, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 361,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Based on the provided SEC 10-K filings, Breyanzi's therapeutic scope expanded significantly between 2022 and 2024 through multiple new approvals. In 2022, it was approved for relapsed/refractory DLBCL (as noted in the Phase III table on page 18), but by 2024 it received FDA accelerated approvals for three additional B-cell malignancies: relapsed/refractory CLL/SLL (page 45), relapsed/refractory FL (page 45), and relapsed/refractory MCL (page 44). This broadened its indication from a single DLBCL approval to a portfolio covering multiple hematologic cancers, with the 2024 approvals specifically extending its use to CLL/SLL, FL, and MCL after prior systemic therapies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Breyanzi was approved for relapsed/refractory DLBCL in 2022, which contradicts the ground truth: the original answer makes no mention of an approval in 2022, only that trials were ongoing for CLL and FL with expected timing in 2023/24. The LLM fabricates a DLBCL approval not present in the ground truth. (2) It claims three new approvals in 2024 including MCL (Mantle Cell Lymphoma), but the ground truth only confirms two FDA accelerated approvals: for FL (May 2024) and CLL/SLL (March 2024). The MCL indication is not mentioned in the original answer and appears to be hallucinated. (3) The ground truth emphasizes a shift from late-stage trials in 2022 to accelerated approvals in 2024 for specific populations, whereas the LLM misrepresents the 2022 status as an existing approval and overstates the 2024 expansion. (4) The reasoning is flawed because it fails to accurately reflect the multi-hop progression from trial phase (2022) to approval (2024), instead inventing prior approvals and additional indications. While the mention of CLL/SLL and FL approvals in 2024 aligns partially with the truth, the inclusion of MCL and the erroneous DLBCL approval severely compromise accuracy. Quantitative accuracy is low due to wrong years and fabricated indications. Qualitative accuracy suffers from incorrect entity relationships and flawed synthesis. Contextual relevance is moderate because the answer addresses therapeutic evolution but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 432,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "From 2023 to 2024, the Resorts and Vacations subsegment within Experiences grew revenue by 5% (from $7,949 M to $8,375 M), driven by higher cruise ticket prices, modest hotel rate increases, and increased occupancy, while overall Parks & Experiences revenue rose 5% to $34,151 M, reflecting broader park attendance and spending gains. This segment’s growth contributed to the Experiences segment’s operating income increasing 4% to $9,272 M, outpacing the modest 5% overall revenue growth of the segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the Resorts and Vacations revenue increase from $7,949M to $8,375M, which is a 5% growth, matching the ground truth. It also correctly states that overall Parks & Experiences revenue grew to $34,151M in 2024. The 2023 Parks & Experiences revenue is not explicitly mentioned but can be inferred from the 5% growth claim, which aligns with the ground truth ($32,549M to $34,151M is indeed ~5%). However, the LLM incorrectly states that the Resorts and Vacations growth 'outpaced' the overall segment growth, when in fact both grew at 5%—this misrepresents the comparison. Additionally, the mention of operating income increasing 4% to $9,272M is not part of the original answer and introduces unverified data, which undermines accuracy. (2) All provided numbers are quantitatively accurate, and the 5% growth calculation is correct. The $8,375M / $7,949M ≈ 1.053, which rounds to 5%, and $34,151M / $32,549M ≈ 1.049, also ~5%. The operating income figure, while possibly factual, is not in the ground truth and was not asked for, making it extraneous. (3) The multi-hop reasoning is partially sound—revenue trends are correctly synthesized across segments and years. However, the conclusion that Resorts and Vacations 'outpaced' overall growth is logically flawed since both grew at the same rate. This indicates a failure in comparative reasoning. (4) The answer is contextually relevant and addresses the evolution of Resorts and Vacations and its comparison to overall Parks & Experiences growth. The core facts are present, but the erroneous comparative claim and introduction of unsupported operating income data reduce qualitative accuracy. Hence, correctness is scored 7 due to mostly accurate data but flawed synthesis and extra, unverified information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 488,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, CVS's forward contracts tied to accelerated share repurchase (ASR) transactions evolved from a $1.5 billion ASR with Barclays Bank PLC in January 2022 (accounted as a $1.2 billion treasury‑stock transaction and a $0.3 billion equity‑classified forward) to a $3.0 billion ASR with Morgan Stanley in January 2024 (initially recorded as a $2.6 billion treasury‑stock transaction and a $0.4 billion equity‑classified forward, later reclassified to treasury stock in March 2024). The company also executed a $2.0 billion ASR with Citibank in January 2023, similarly structured as an initial treasury‑stock entry with a forward equity component. These transactions progressively increased the notional amounts and share volumes repurchased, while the forward contracts remained classified as equity instruments initially recorded in capital surplus before being re‑classified to treasury stock upon final settlement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that CVS executed a $1.5 billion ASR with Barclays Bank PLC in January 2022, which is not mentioned in the ground truth and outside the requested 2023–2024 timeframe. The 2023 ASR was with Citibank, N.A. for $2.0 billion (correctly noted later in the answer), but the breakdown is wrong—LLM says $1.2B treasury and $0.3B forward, while ground truth is $1.6B and $0.4B respectively. The 2024 ASR with Morgan Stanley for $3.0B is correct, as is the $2.6B/$0.4B split. However, the claim that the forward was 'reclassified to treasury stock in March 2024' is misleading—the ground truth says the final 15% of shares were received then, not that the contract was reclassified. (2) Quantitative accuracy is poor: the $1.5B, $1.2B, and $0.3B figures are all incorrect. Only the 2024 numbers ($3.0B total, $2.6B/$0.4B split) are accurate. The constant $0.4B forward value is correctly noted in both years, but the LLM fails to highlight the key insight that forward value remained unchanged despite larger ASR size. (3) Reasoning is partially sound—LLM recognizes the structure of ASRs and the equity classification of forwards, and attempts to compare across years. However, inclusion of an incorrect 2022 transaction and misattribution of amounts undermine the multi-hop synthesis. The evolution is misrepresented due to wrong data. (4) Contextual relevance is high—the answer addresses forward contracts in ASRs, their accounting treatment, and changes over time. But due to major factual and quantitative errors, the correctness score is low. Semantic equivalence fails on core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 457,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "From 2023 to 2024, Duke Energy’s disclosure for the Master Retirement Trust became more transparent regarding fair value categorization. In 2023, the trust’s fair value hierarchy table clearly separated Level 1, Level 2, Level 3, and “Not Categorized” assets, with Level 3 assets explicitly defined as those measured using significant unobservable inputs. By 2024, the disclosure retained this structure but added clearer context in the accompanying narrative, specifying that certain investments measured using net asset value per share were excluded from the hierarchy (as noted in footnote (b)), and the reconciliation of Level 3 balances (from $62M to $76M) was explicitly detailed. This evolution improved clarity on how assets were classified, particularly for Level 3 items like partnership interests and hedge funds, while maintaining consistent categorization across periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased transparency in Duke Energy's 2024 disclosures regarding the Master Retirement Trust, particularly the addition of a Level 3 reconciliation, which aligns with the ground truth. However, it introduces specific dollar amounts—'Level 3 balances (from $62M to $76M)'—that are not present in the original answer and cannot be verified from the provided ground truth, making this a significant quantitative inaccuracy. The original answer mentions the addition of a reconciliation but does not specify any figures, so including these numbers reduces factual reliability. (2) The LLM also adds details not present in the ground truth, such as the structure of the fair value hierarchy table separating Level 1, 2, 3, and 'Not Categorized' assets in 2023 and the mention of footnote (b), which are absent from the original. While plausible, these specifics were not confirmed in the ground truth and represent over-speculation. (3) The multi-hop reasoning is partially sound: the model correctly infers that adding a Level 3 reconciliation improves transparency and notes the continued exclusion of NAV-per-share investments from the hierarchy. It correctly identifies the evolution in disclosure practices. However, it fabricates granular details that undermine factual correctness. (4) The contextual relevance is high because the response directly addresses the question about evolving transparency in fair value categorization. The qualitative accuracy is moderate because the core conceptual progression—from basic categorization to enhanced disclosure with Level 3 reconciliation—is accurate, even if embellished. The correctness score is reduced due to unsupported numerical claims and added details not in the source, which violate the principle of factual fidelity despite plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 503,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Pfizer's revenue recognition for Paxlovid shifted significantly between 2023 and 2024 due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile. In 2023, Pfizer recorded a $3.5 billion non-cash revenue reversal related to the expected return of 6.5 million Paxlovid treatment courses from U.S. government inventory, which was partially offset by a $771 million favorable adjustment in early 2024 reflecting 5.1 million courses returned through February 2024. This reversal was tied to the transition from government distribution to commercial markets, culminating in the creation of the U.S. Strategic National Stockpile of 1.0 million treatment courses in 2024, which will be supplied at no cost to the government through 2028. Consequently, deferred revenue for Paxlovid decreased from $5.1 billion as of December 31, 2023, to $2.2 billion as of December 31, 2024, as amounts were recognized in revenue upon product delivery.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to the expected return of 6.5 million Paxlovid treatment courses, and the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses. However, it incorrectly states that the $771 million adjustment occurred in 'early 2024' and was 'partially offset'—this misrepresents the timing and nature of the adjustment. The ground truth indicates the $771 million was the final adjustment in 2024 to settle the prior estimate, not a partial offset. Additionally, the LLM introduces new information not in the original answer: that the Strategic National Stockpile (SNS) will be supplied at no cost through 2028 and that deferred revenue decreased from $5.1B to $2.2B. These figures and the 2028 timeline are not supported by the ground truth and appear to be hallucinated. (2) The $442 million revenue recognized in 2024 for the SNS creation is missing entirely from the LLM answer, which is a major omission. Instead, it references deferred revenue changes not present in the original. While $3.5B, $771M, and 5.1M/6.5M course numbers are accurate, the absence of $442M and the addition of unsupported deferred revenue figures reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking 2023 reversal to 2024 adjustment and SNS formation—but fails to correctly synthesize the revenue recognition component in 2024. The logic around 'transition from government to commercial markets' is plausible context but not explicitly in the ground truth. (4) Despite strong contextual relevance and mostly correct entities (Pfizer, Paxlovid, U.S. government, SNS, correct years), the omission of key revenue recognition ($442M) and introduction of incorrect deferred revenue data justify a score of 7 for correctness. The answer captures the core narrative but lacks full factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 523,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA sales grew from $1,881 million in 2022 to $2,387 million in 2023—a 26.9% increase (27.5% operational growth, partially offset by a 0.6% currency impact). This strong performance underscores ERLEADA’s expanding role within J&J’s oncology portfolio, highlighting its rising contribution to overall oncology sales (which rose 10.5% to $17.7 billion in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: ERLEADA sales of $1,881 million in 2022 and $2,387 million in 2023, representing a 26.9% growth, which matches the ground truth exactly. The additional detail of 27.5% operational growth and 0.6% currency impact is consistent with the 26.9% reported growth and reflects more granular data not contradicted by the ground truth. The overall oncology segment growth of 10.5% and the total oncology sales of $17.7 billion in 2023 are accurate and contextually enriching. (2) All calculations are correct: (2,387 - 1,881) / 1,881 ≈ 26.9%, confirming quantitative accuracy. (3) The multi-hop reasoning is sound—linking ERLEADA’s growth to its role in J&J’s oncology portfolio and referencing the broader segment performance demonstrates appropriate synthesis. While the LLM does not explicitly contrast ERLEADA’s performance with declining products like IMBRUVICA and ZYTIGA (a minor omission), it still correctly infers ERLEADA’s expanding role based on strong growth and portfolio context. (4) The answer is semantically equivalent and highly relevant, with only a slight reduction in completeness due to the missing contrast with other products. Scores reflect high accuracy, with a 9 in qualitative accuracy due to this partial omission in comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 372,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA (apalutamide) sales grew sharply from $297 million in 2022 to $813 million in 2023 in the United States and from $35 million to $478 million internationally, driving worldwide sales up from $332 million to $1.291 billion—a 70 % increase in the U.S. and a 70 % rise globally. This rapid acceleration indicates that ERLEADA is gaining market share and expanding its footprint, suggesting a positive trajectory as it captures additional patients with metastatic castration‑resistant prostate cancer.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in numbers and misrepresents the sales data. According to the ground truth, ERLEADA had worldwide sales of $1,291 million in 2022 and $2,387 million in 2023, with a 26.9% growth from 2022 to 2023. However, the LLM claims worldwide sales were $332 million in 2022 and $1.291 billion in 2023, stating this is a 70% increase—this is incorrect. The 70% growth actually refers to the prior year (2021 to 2022), not 2022 to 2023. The LLM incorrectly assigns the 70% growth rate to the 2022–2023 period, which contradicts the ground truth that shows a 26.9% growth in that period. (2) The LLM fabricates U.S. and international sales figures not present in the original answer ($297M U.S. in 2022, $813M in 2023, etc.), which are unsupported by the ground truth. The original answer does not break down sales by region, so these numbers are speculative and incorrect. Additionally, the LLM incorrectly states that $1.291 billion is the 2023 sales figure, when in fact that was the 2022 figure. (3) The multi-hop reasoning is flawed: the model fails to correctly track the year-over-year progression and misattributes growth rates. It also invents a regional breakdown that wasn't in the source, indicating a failure to synthesize accurately across time points. (4) While the general sentiment about positive market trajectory is directionally aligned, the severe numerical inaccuracies and incorrect growth rates undermine the factual basis. The contextual relevance is moderate because it addresses sales evolution and market trajectory, but the qualitative and quantitative inaccuracies severely limit correctness. Scores reflect major factual errors in core data and calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 472,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVIDIA repaid the 0.584% Notes Due 2024 during fiscal year 2025, as indicated by the updated debt table showing a zero balance for that tranche in the Jan 26 2025 column and a note stating “In fiscal year 2025, we repaid the 0.584% Notes Due 2024.” This repayment reduced the short‑term portion of long‑term debt and left no outstanding balance for those notes as of the latest reporting date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the repayment occurred in fiscal year 2025, the balance is zero as of January 26, 2025, and the instrument is correctly identified as the 0.584% Notes Due 2024. The mention of a zero balance and explicit quote from the filing support factual precision. (2) The LLM correctly captures the evolution in debt strategy—repayment rather than rollover—though it omits the specific $1,250 million balance in fiscal 2023 and the 0.66% effective interest rate, which were part of the original answer. These omissions are minor in terms of overall correctness but slightly reduce completeness. (3) Reasoning is sound: the model correctly infers that repayment indicates a strategic choice to retire debt, and it synthesizes information across time points (pre- and post-repayment). (4) The answer is fully relevant, directly addressing how NVDA's debt management evolved. The omission of the 2023 balance and interest rate prevents a perfect score, but the core multi-hop insight—debt was repaid in FY2025, leading to zero outstanding balance—is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 330,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Based on the provided 10-K pages, Honeywell's investment in Mortgage/Asset-backed securities declined from **$31 million in 2022 to $10 million in 2023**, a reduction of **$21 million (approximately a 68% decrease)**. This change is reflected in the “Mortgage/Asset‑backed securities” line item under Fixed Income in the Level 2 and Level 3 tables for both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Honeywell's investment in Mortgage/Asset-backed securities was $982 million in 2022 under U.S. Plans, not $31 million as stated by the LLM. The 2023 value of $10 million is correct and correctly attributed to Non-U.S. Plans. The calculated reduction is therefore $972 million (98%), not $21 million (68%) as claimed. These numerical inaccuracies severely undermine the correctness of the response. (2) Quantitative accuracy is very low: the 2022 figure is off by over $950 million, leading to a completely incorrect magnitude of change. The percentage decrease is also wrong due to incorrect base values. Only the 2023 amount is accurate. (3) The reasoning is partially sound in that the model identifies the need to compare two years and calculate a change, but it fails at multi-hop synthesis—specifically, it does not correctly identify that the 2022 amount was under U.S. Plans and the 2023 under Non-U.S. Plans, nor does it reflect the major strategic shift implied by the shift in plan type and drastic reduction. The model appears to have pulled data from a different part of the filing or misread the tables. (4) Contextual relevance is moderate—the answer addresses the right metric and time frame and attempts the correct type of analysis (year-over-year change), but due to severe factual inaccuracies, the conclusion about the magnitude and significance of the change is misleading. A 68% decrease is substantial, but pales in comparison to the actual 98%+ reduction, which the LLM fails to capture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 441,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One’s use of securitized debt obligations shifted toward greater reliance on them within its long‑term funding mix, as evidenced by the increase in securitized debt issuances (from $1.25 billion in 2020 to $6.25 billion in 2021 and continued growth reflected in the 2023 disclosures) and the corresponding reduction in other long‑term debt maturities. These obligations are consistently classified as Level 3 in the fair‑value hierarchy, with fair‑value measurements relying on significant unobservable inputs such as discount rates, prepayment rates, and loss severity. Consequently, while securitized debt remains a key component of the company’s funding strategy, its fair‑value classification remains at Level 3, reflecting the use of internally derived valuation techniques rather than quoted market prices.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that securitized debt obligations are classified as Level 3 in the fair value hierarchy, while the ground truth explicitly states they are classified under Level 2 in 2023. This is a critical error in both entity and classification accuracy. Additionally, the LLM references securitized debt issuances increasing from $1.25 billion in 2020 to $6.25 billion in 2021 and claims continued growth into 2023, but this data is not present in the original answer and contradicts the focus on 2022–2023 evolution. The original answer provides no issuance figures for those years, nor any trend suggesting increased reliance. Instead, it emphasizes enhanced disclosure and valuation transparency in 2023, not a strategic shift toward greater reliance. (2) Quantitatively, the LLM fails to report the actual carrying value ($18,043 million) and fair value ($18,067 million) disclosed in 2023, which are central to the original answer. These numbers are entirely omitted, and instead, irrelevant issuance figures from prior years are introduced without support. (3) The multi-hop reasoning is flawed: the model incorrectly infers an increase in reliance based on outdated issuance data and mischaracterizes the fair value classification, failing to synthesize the correct evolution in funding mix and disclosure practices. The original answer highlights continuity in use but improved transparency, not increased reliance or Level 3 classification. (4) Contextual relevance is moderate because the answer addresses securitized debt in Capital One’s funding mix and fair value classification, but the incorrect data and reasoning severely undermine factual correctness. The qualitative error in fair value hierarchy level and unsupported claims about issuance trends result in a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 511,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024, JPMorgan’s CECL capital transition benefit declined from a $1.4 billion benefit reflected in CET1 capital at the end of 2023 to a $720 million benefit by the end of 2024. Consequently, the quantitative CECL‑related capital benefit fell by roughly $680 million over the one‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figures: JPMorgan's CECL capital benefit was $1.4 billion in 2023 and decreased to $720 million in 2024, matching the ground truth exactly. The calculated reduction of $680 million ($1.4B - $720M) is accurate. (2) All numeric values are correct and properly formatted; the calculation of the change in benefit is precise and logically derived. (3) The reasoning is sound: the answer captures the evolution of the CECL treatment as a phased reduction over time, which aligns with the ground truth's mention of a phased transition culminating on January 1, 2025. While the LLM does not explicitly mention the full phase-in by 2025, it correctly implies an ongoing reduction consistent with regulatory transition rules. (4) The answer is contextually complete and highly relevant, addressing both the evolution and the quantitative change. The only minor omission is the forward-looking detail about full phase-in by 2025, which slightly affects completeness but does not detract from the core factual accuracy. Hence, the correctness score is 9 rather than 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 321,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "The Revolving Loan Credit Agreement was expanded in fiscal 2024: the prior $3 billion facility (maturing December 2025) was replaced by a $5 billion unsecured revolving facility that now matures in October 2029, providing greater borrowing capacity and extending the maturity horizon. No borrowings were outstanding under either facility as of the respective fiscal‑year ends.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $3 billion facility in fiscal 2023 maturing in December 2025 was replaced by a $5 billion facility maturing in October 2029. These numbers and dates match the original answer exactly, with acceptable formatting variations (e.g., $3 billion = $3.0 billion). (2) Quantitative accuracy is perfect: both dollar amounts and maturity dates are correct, and the comparison (increase from $3B to $5B, extension of maturity) is accurately described. (3) The multi-hop reasoning is sound—information from two fiscal years is correctly synthesized to show the evolution of the credit agreement. (4) The LLM adds a relevant detail not in the original answer—'No borrowings were outstanding under either facility as of the respective fiscal-year ends'—which does not contradict the ground truth and may reflect additional data from the filings; this enhances completeness without introducing error. The answer addresses all aspects of the question: terms (unsecured revolving, maturity dates) and capacity changes. Wording differs slightly but meaning is preserved. All entities (Salesforce, Revolving Loan Credit Agreement, fiscal 2023 and 2024) are correctly identified. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 366,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS's relationship with Coyote evolved from a strategic partnership to a divestiture. The company completed the sale of Coyote in the third quarter of 2024, recording a pre-tax gain of $156 million ($152 million after tax) from the transaction. This change impacted UPS's 2024 financial results by contributing to the overall gains and adjustments reflected in the non-GAAP financial measures reported in the 2024 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the pre-tax gain of $156 million and after-tax gain of $152 million match the original answer exactly. The timing reference to the 'third quarter of 2024' is consistent with the 2024 divestiture, though the original answer does not specify the quarter—this is a minor addition but not incorrect. (2) The financial impact is correctly stated, noting the gain's effect on 2024 financial results and its inclusion in non-GAAP measures per the 10-K, which adds appropriate context. (3) Qualitatively, the evolution from an operational subsidiary to a divested asset is accurately captured as a 'divestiture,' though the LLM refers to it as a 'strategic partnership,' which slightly understates the depth of integration described in the original (Coyote was a branded subsidiary, not just a partner). This is a minor mischaracterization but doesn't invalidate the core accuracy. (4) The answer addresses both parts of the question: the evolution of the relationship and the financial impact in 2024. Multi-hop reasoning is sound—linking the divestiture to the financial gain and its reporting in 2024 filings. (5) Semantic equivalence is strong; the LLM conveys the same key facts with only slight variation in framing. No calculation errors. One point deducted from correctness and qualitative accuracy for the slight mislabeling of the relationship nature, but all critical facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 413,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific’s chassis fleet declined from 48,340 total units (30,635 owned + 17,705 leased) in 2023 to 48,340 total units (30,635 owned + 17,705 leased) in 2024, with ownership remaining stable at 30,635 units and leased units unchanged at 17,705. The company maintained its chassis fleet size and structure, focusing on operational efficiency and buffer capacity for equipment needs without significant changes to ownership or leasing arrangements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims that Union Pacific's chassis fleet remained unchanged from 2023 to 2024 at 48,340 total units (30,635 owned + 17,705 leased), but the ground truth shows a dramatic reduction to only 5,553 total units in 2024 (4,356 owned + 1,197 leased). This misrepresents the core fact of a significant strategic shift. (2) Quantitative accuracy is extremely low: all 2024 numbers are wrong. The LLM repeats 2023 figures for 2024, failing to report the correct totals, owned, or leased units. Calculations such as the total (4,356 + 1,197 = 5,553) are not reflected at all. The claimed stability contradicts the actual 88.5% reduction in total chassis. (3) Qualitative reasoning is flawed: the LLM concludes that Union Pacific 'maintained its chassis fleet size and structure' and focused on 'operational efficiency,' which is unsupported and opposite to the truth. The actual shift—from nearly 48k to under 6k units—indicates a major strategic divestment or outsourcing, not stability. The model fails to perform the basic multi-hop comparison across years and misinterprets the relationship evolution. (4) Contextual relevance is low but not zero because the answer addresses the right topic (chassis units, ownership structure, years), so some framing is relevant. However, the factual foundation is completely wrong, rendering the response misleading. Correctness and quantitative accuracy are near zero due to total failure in reporting updated figures and detecting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 422,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing's treatment of aluminum agreements evolved from being classified as derivatives not receiving hedge accounting treatment (as noted in 2022 disclosures) to continuing this classification in 2024, with no change in their hedge accounting status. The time horizon for these agreements remains tied to the contract terms, with the aluminum agreements and other non-hedge derivatives having notional amounts and maturities extending through 2028, as disclosed in the 2024 derivative disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Boeing classified aluminum agreements as derivatives without hedge accounting in 2022 and maintains this classification in 2024. It also correctly notes the extension of maturities through 2028, which aligns with the ground truth. However, it misses a key evolution: in 2024, these agreements were incorporated into a broader hedging program for forecasted transactions, indicating a strategic shift—even if hedge accounting designation did not change. The LLM incorrectly implies no change in treatment, while the ground truth emphasizes a shift toward structured hedging despite unchanged hedge accounting status. (2) Quantitatively, the time horizon 'through 2028' is accurately reported, and no incorrect numbers are present—minor phrasing like 'maturities extending through 2028' is acceptable and consistent with the original. (3) The multi-hop reasoning is partially sound: the model connects disclosures across years and recognizes derivative classification continuity and maturity timeline. However, it fails to synthesize the qualitative shift from strategic sourcing to hedging forecasted transactions, which is central to the question about 'evolution in treatment and disclosure.' This represents a failure in deeper contextual synthesis. (4) Scores reflect that core facts (dates, classification, time horizon) are correct (supporting 5/10), but the answer lacks the critical insight about Boeing’s evolving rationale and integration into hedging strategy, which diminishes qualitative accuracy. Contextual relevance remains high as the response stays focused on the topic with appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 455,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk has remained stable between fiscal 2023 and 2024, with the company maintaining its hedging strategy of using forward contracts and currency swaps with maturities under 18 months to manage exchange rate volatility. The company continues to express confidence that near-term currency fluctuations will not materially impact its financial statements, as evidenced by its 95% confidence level assessments based on historical movements. While the company acknowledges currency devaluation as a potential risk factor for goodwill and intangible asset impairments (particularly for the Gillette indefinite-lived intangible asset), it has not altered its hedging instruments or reduced its confidence in mitigating near-term exchange rate risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: P&G's currency risk exposure remained stable between FY2023 and FY2024; the company used forward contracts and currency swaps with maturities under 18 months; and it maintained a 95% confidence level that near-term exchange rate fluctuations would not materially affect financial statements. (2) Quantitative elements—'95% confidence level', 'less than 18 months' maturities—are accurately reported with no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly infers continuity in hedging strategy and risk assessment across both fiscal years. (4) The only minor deviation is the addition of context about goodwill and intangible asset impairments (e.g., Gillette), which, while not in the original answer, is consistent with P&G's disclosures and does not contradict the ground truth. This extra detail enhances context without introducing inaccuracy. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 334,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Adobe has progressively expanded Frame.io’s functional scope and deepened its integration with other Adobe products between 2022 and 2024. Initially positioned as a cloud‑native collaboration platform for video and creative asset review, Frame.io is now tightly embedded within the Creative Cloud ecosystem, offering native frame‑accurate commenting and annotation workflows that are directly accessible from Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Adobe Express. The platform also supports Camera‑to‑Cloud uploads and integrates with Adobe Stock, Adobe Firefly Services, and Adobe GenStudio, enabling end‑to‑end content creation, editing, and publishing pipelines. This evolution reflects Adobe’s strategy of treating Frame.io as a core collaboration layer that unifies video, design, and generative AI workflows across its suite of Creative Cloud and Document Cloud offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io evolved from a trademarked asset in 2022 to a core collaboration platform by 2024, described as cloud-native with real-time review, frame-accurate commenting, and Camera to Cloud functionality. The integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront (implied via Creative Cloud and GenStudio context) are correctly identified. The mention of Adobe GenStudio, Adobe Firefly, and Adobe Stock integration is consistent with the 2024 positioning. (2) There are no numeric values, dates, or calculations to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly inferring evolution in functional scope and integration depth between 2022 and 2024. The only minor gap is that Workfront is not explicitly named in the LLM answer, though its inclusion under broader ecosystem terms like GenStudio may be semantically acceptable. (4) The answer is contextually excellent, directly addressing the evolution in positioning, functional scope, and product integration. Wording differs slightly but meaning is equivalent. One point deducted from qualitative accuracy due to slight overstatement of integration breadth (e.g., 'Document Cloud offerings' is not supported in the original answer).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 375,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between fiscal years 2022 and 2023, AMD's investment in the ATMP joint venture remained relatively stable, with the carrying value of its equity interest increasing from approximately $83 million to $99 million. The company continues to account for this investment using the equity method, recognizing gains from the JV (e.g., $16 million in 2023 and $14 million in 2022) and reporting related party balances such as payables of $363 million and receivables of $9 million as of December 30 2023. This consistent accounting treatment reflects AMD's unchanged 15 % ownership and lack of funding obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content and misrepresents the evolution of AMD's financial relationship with the ATMP JV between 2022 and 2023. (1) Quantitative Accuracy: The reported carrying values of $83 million and $99 million are false; the ground truth states the carrying values were $69 million as of December 25, 2021, and $63 million as of December 26, 2020 — no carrying value was disclosed for 2023. The LLM incorrectly claims an increase, when in fact the 2023 filing omitted the carrying value entirely. The reported gains of $16 million (2023) and $14 million (2022) are not supported by the original answer and contradict the trend of reduced disclosure. The related party balances (payables of $363 million, receivables of $9 million) are fabricated and not mentioned in the ground truth. (2) Completeness: While the question asks about changes in carrying value and nature of disclosures, the LLM fails to note the critical fact that AMD stopped disclosing the carrying value and transaction amounts in 2023 — a central point in the original answer. Instead, it invents new data. (3) Entity Accuracy: The entities (AMD, ATMP JV, 15% equity interest) are correctly identified, and the equity method of accounting is correctly noted. Fiscal years are referenced approximately correctly (though exact dates differ slightly). (4) Reasoning: The multi-hop reasoning is flawed. The original answer hinges on a comparison of disclosure depth between years — a qualitative change in reporting transparency — but the LLM incorrectly assumes continuity and invents quantitative trends. It fails to recognize that the absence of data in 2023 is itself a significant change. (5) Semantic Equivalence: The LLM answer conveys the opposite of the ground truth — stability and continued disclosure — when the actual situation is reduced transparency. Despite addressing the same topic, the factual inaccuracies and invented numbers render the response highly misleading. The contextual relevance is moderate because it discusses the right companies and relationship, but the substance is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 568,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Based on the provided financial data, Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline indicates a reduction in the company's aerospace segment sales, suggesting a potential weakening in its position within the aerospace sector, possibly due to market dynamics or industry-specific challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, though not explicitly quantified (e.g., by percentage or dollar difference), which is acceptable given the question did not require it. (2) All numeric values are correct and properly formatted; no calculation errors. (3) The reasoning correctly identifies the decline as indicating reduced sales in the aerospace segment and links it to potential market or industry challenges. While the LLM answer suggests a weakening in Honeywell's position in the aerospace sector broadly, the ground truth nuances this by noting overall growth in the Aerospace Technologies division, implying the weakness is isolated to the original equipment segment rather than the entire sector position. This subtle but important distinction is slightly underdeveloped in the LLM response, hence a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addresses both parts of the question (revenue evolution and implications), and conveys semantically equivalent information with only slight simplification in the interpretation. Overall, the response is factually sound and well-aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 376,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, reflecting a 10.2 % total change (or 10.3 % when excluding exchange‑rate effects). This represents the percentage change in the segment’s total revenue for Heart Failure Devices between 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the global revenue figures for Heart Failure Devices in 2023 ($1,161 million) and 2024 ($1,279 million), matching the ground truth exactly. The percentage change is stated as 10.2%, which is accurate and matches the ground truth calculation: ((1,279 - 1,161) / 1,161) ≈ 0.1016 or 10.2% when rounded. (2) The only discrepancy is the mention of '10.3% when excluding exchange-rate effects', which introduces a nuance not present in the original answer. While the original acknowledges minimal impact from exchange rates, it does not provide an alternative percentage, making this addition speculative. However, this does not contradict the core calculation and may reflect a reasonable interpretation. (3) The reasoning is sound: the model correctly synthesized the two-year revenue data and computed the percentage change accurately. It also addressed both parts of the question—evolution of revenue and percentage change—demonstrating proper multi-hop understanding. (4) The answer is contextually complete and relevant, with only a minor over-specification on exchange-rate adjustment. Given that all key facts and calculations are correct, and the extra detail does not materially mislead, the score is reduced by only one point for slight overprecision not supported in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 370,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Based on the provided document pages, IBM's treatment of the 0.300% Notes due 2028 has evolved from being classified as a liability on the balance sheet in the 2022 filing (page 28 of IBM_10k_2022.pdf) to being explicitly disclosed as a registered debt security in the 2023 filing (page 1 of IBM_10k_2023.pdf), where it is listed among the company’s outstanding notes with its specific terms and maturity. This shift reflects a more prominent presentation of the notes in the 2023 Form 10‑K, highlighting the issuance details and market‑wide registration, whereas the 2022 filing only referenced the notes within the broader debt disclosures without the same level of explicit enumeration.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the evolution in IBM's treatment of the 0.300% Notes due 2028 between the 2022 and 2023 filings: from a more general reference in 2022 to explicit disclosure as a registered security in 2023. The mention of the 2022 balance sheet classification (page 28) and the 2023 explicit listing (page 1) matches the document evidence. (2) There are no numeric values (e.g., interest rate, maturity year) in dispute—0.300%, 2028 maturity, and correct years (2022 vs 2023 filings) are all accurately used. No calculations are required, so quantitative accuracy is perfect. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers a shift in disclosure practice from incorporation by reference (2022) to formal registration and enumeration (2023), even if it doesn't mention the specific Exhibit 4.1 or the trading symbol IBM 28B. However, the omission of the New York Stock Exchange registration and the specific trading symbol—key details in the ground truth—prevents a full 10 on qualitative accuracy. (4) The answer remains highly relevant and factually consistent with the question, clearly addressing how the treatment evolved. Minor lack of specificity on the registration mechanism (NYSE, trading symbol) results in a correctness score of 8 rather than 9 or 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 383,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region improved from 2022 to 2023, with net sales increasing from $29.375 billion to $30.658 billion and operating income rising from $11.569 billion to $13.062 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values. According to the ground truth, Apple's 2023 net sales in the Rest of Asia Pacific were $29,615 million ($29.615 billion), but the LLM reports $30.658 billion—overstating by approximately $1.043 billion. Similarly, the reported 2023 operating income is $13.062 billion in the LLM answer, whereas the correct figure is $12.066 billion, an overstatement of nearly $1 billion. These errors severely undermine the quantitative accuracy. (2) Calculations based on the LLM's numbers would imply a net sales increase of $1.283 billion (from $29.375B to $30.658B) and an operating income increase of $1.493 billion (from $11.569B to $13.062B), which are vastly different from the actual increases of $240 million (0.8%) and $497 million (4.3%). The model fails to report these correct deltas or percentages. (3) While the qualitative direction of change (improvement in performance) is correct, and the model correctly identifies the relevant financial metrics (net sales, operating income) and region (Rest of Asia Pacific), it fails in multi-hop synthesis by using incorrect data points—likely due to hallucination or retrieval error. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing the evolution of financial performance over the specified period and focusing on the right region and metrics. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 420,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "Based on the disclosures in the 2022 and 2024 10-K filings, the vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed from a five-year pro rata schedule (for grants prior to 2022) to a four-year pro rata schedule (for grants after December 31, 2021), as explicitly stated in the stock-based compensation notes in both filings. This change applies to options granted under the amended and restated 2007 Omnibus Incentive Plan after 2021, while executive officers and certain other employees may still have different vesting terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitatively, all key numbers and dates are accurate: the vesting period for grants prior to 2022 is correctly stated as five years, and for grants after December 31, 2021, as four years. These match the original answer and are consistent across the 2022 and 2024 10-K disclosures. (2) The answer is complete, addressing the evolution of vesting periods between pre- and post-2021 grants under the 2007 Omnibus Incentive Plan, and correctly references the amended and restated plan. (3) Entity accuracy is strong: the plan name, time periods, and context (10-K disclosures) are all correct. (4) Reasoning is sound—LLM correctly infers a structural change in vesting terms and notes the continuity in both 2022 and 2024 filings, though it does not explicitly reconfirm the 2024 continuation as clearly as the original answer. The minor deduction in qualitative accuracy is due to the omission of explicit confirmation from the 2024 10-K that the vesting terms remained unchanged, which slightly weakens the multi-hop synthesis. However, the core conclusion about the shift from five to four years is accurate and well-supported. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 355,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS Health's approach to validating fair value estimates for Level 2 debt securities remained consistent from 2022 to 2023, relying on observable market inputs such as quoted prices for similar assets and discounted cash flows. The company maintained its quarterly validation process, comparing Level 2 prices to secondary sources and internal estimates, and did not adjust any Level 2 prices during 2023 or 2022. However, Level 2 debt securities decreased significantly from $20,812 million in 2022 to $19,671 million in 2023, reflecting a net transfer out of Level 3 assets (50 million in 2023 vs. 29 million in 2022), though the validation methodology itself did not change.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CVS maintained a consistent validation approach for Level 2 debt securities from 2022 to 2023, with no price adjustments and continued quarterly comparisons to secondary sources—this aligns with the ground truth. However, the LLM introduces financial figures ($20,812 million and $19,671 million) and Level 3 transfer amounts (50 million vs. 29 million) that are not present in the original answer and were not part of the question about validation methodology. These numbers, while possibly factual, are extraneous and not supported by the provided ground truth, raising concerns about sourcing or hallucination. (2) The quantitative inaccuracies stem from including unsupported dollar amounts and transfers; the ground truth does not mention portfolio size changes or Level 3 transfers, so these cannot be verified and appear irrelevant to the validation process evolution. (3) The multi-hop reasoning is partially sound—the model correctly infers that the methodology did not change between years, which is the core of the answer. However, it adds unrelated financial data and asset transfer details that distract from the focus on price validation, adjustments, and secondary source use. (4) The correctness score is 7 because the key qualitative point—unchanged validation methodology—is accurate and well-articulated. Quantitative accuracy is lower (6) due to unsupported numbers. Qualitative accuracy is high (8) as the reasoning about process consistency is valid. Contextual relevance is strong (9) since the main thrust addresses the question, despite the extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 447,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS Health’s classification and valuation methodology for privately-placed equity securities remained consistent, continuing to classify these securities as Level 3 due to the absence of an active market and reliance on internal valuation using unobservable inputs such as earnings multiples and discount rates for lack of marketability. The fair value determination for these securities was based on internal analysis of financial statements and cash flow projections, with no material changes observed in the methodology. Additionally, Level 3 financial assets, including privately placed equity securities, saw a net decrease of $50 million in transfers out of Level 3 during 2023, reflecting reduced holdings in such instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023 and used internal analysis of financial statements and cash flow projections for fair value determination. It accurately notes the use of unobservable inputs such as earnings multiples and discount for lack of marketability. However, it omits a key qualitative evolution mentioned in the ground truth: in 2023, CVS placed increased emphasis on the sensitivity of fair value to changes in unobservable inputs, indicating enhanced scrutiny or more detailed sensitivity analysis. This is a significant point in the evolution of the methodology and its absence reduces completeness. (2) The LLM introduces a quantitative claim not present in the ground truth: a $50 million net decrease in Level 3 transfers in 2023. While this may be factually correct from the filing, it is not part of the original answer and does not directly address the question about methodology evolution. This adds extraneous information but does not contradict known facts, so quantitative accuracy is still high. (3) The reasoning is logically sound and synthesizes information consistently across years, but fails to capture the nuanced shift in 2023 regarding sensitivity analysis, which represents a multi-hop insight about methodological refinement beyond just input usage. (4) Correctness is scored 7 because core facts are accurate and the overall consistency of methodology is correctly conveyed, but the missing detail about enhanced scrutiny in 2023 prevents a higher score. Quantitative accuracy is 8 due to correct use of numbers where provided and no errors in calculation. Qualitative accuracy is 7 due to omission of a key qualitative development. Contextual relevance is 9 as the response stays focused on the topic with only minor inclusion of peripheral data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 510,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "Based on the provided financial data from both 2023 and 2024 Form 10-K filings:\n\n1.  **Total Net Revenue Change (Alphagan/Combigan):** The total net revenue for Alphagan/Combigan decreased by **21.4%** in 2024 compared to 2023 (from $272M in 2023 to $272M in 2024, with a 21.4% decline at actual currency rates and 19.1% at constant currency rates).\n\n2.  **International Revenue Trend:** International revenue for Alphagan/Combigan increased by **4.9%** in 2024 (from $144M in 2023 to $151M in 2024 at actual currency rates, and 10.4% at constant currency rates), showing growth internationally despite the overall decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both total net revenue change and international revenue trend. According to the ground truth, total net revenue decreased from $272M in 2023 to $248M in 2024 (an 8.8% decline), but the LLM incorrectly states that revenue remained at $272M in both years and reports a 21.4% decline, which is mathematically impossible given those inputs. The international revenue trend is also incorrect: the ground truth shows an increase from $151M to $153M (1.5% growth), but the LLM claims it rose from $144M to $151M (4.9% growth), using incorrect base figures. (2) Calculations are flawed: a drop from $272M to $248M is a (272-248)/272 ≈ 8.8% decline, not 21.4%. The LLM’s own stated numbers ($272M to $272M) contradict any decline. Similarly, an increase from $144M to $151M is about 4.9%, but these figures do not match the ground truth. (3) Multi-hop reasoning is partially present—the model attempts to compare two years and calculate trends—but fails due to incorrect data extraction from the source documents. It likely misread or misaligned the financial figures across filings. (4) Despite incorrect numbers, the answer addresses both parts of the question and interprets the general trend direction correctly (overall decline, international growth), preserving some contextual relevance. However, severe quantitative inaccuracies severely undermine factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 406,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy shifted from a standalone entity in 2023 to a fully integrated subsidiary after Chevron's acquisition of PDC in 2023, which was completed during 2023 and became fully operational in 2024. This integration directly contributed to Chevron's 2024 production growth, as evidenced by the \"full-year of legacy PDC Energy, Inc. (PDC) production\" cited in the 2024 production summary (page 29), which drove a 7% increase in worldwide oil-equivalent production to 3.3 million barrels per day compared to 2023. The acquisition also expanded Chevron's operational footprint, particularly in the Permian Basin, where PDC's assets were incorporated into Chevron's development strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of PDC Energy by Chevron and the resulting integration into Chevron's operations by 2024. It accurately states that the full-year contribution from legacy PDC operations contributed to a 7% increase in Chevron's worldwide oil-equivalent production, which aligns with the ground truth. The production figure of 3.3 million barrels per day is consistent with public disclosures and adds contextual detail not in the original answer but does not contradict it. (2) Quantitatively, all numbers are correct: the 7% production increase and the reference to full-year PDC contribution match the ground truth. The mention of 3.3 million barrels per day is accurate per Chevron's 2024 reporting and enhances the answer without introducing error. (3) The multi-hop reasoning is sound—linking the 2023 acquisition to 2024 production impact shows proper synthesis across time and entities. The addition of operational expansion in the Permian Basin is a reasonable inference from PDC's asset base and Chevron's strategy, though not explicitly stated in the ground truth; this adds value without inaccuracy. (4) The answer is highly relevant, fully addressing both the evolution of the relationship and the operational impact on production. The only minor gap is the absence of the detail about PDC being excluded from internal control assessment in 2023, but this is a secondary point and not central to the operational impact focus of the question. Overall, the answer matches the ground truth in substance and enhances it with accurate, relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 443,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS expanded its cold‑chain logistics capabilities primarily through the acquisition of healthcare‑focused logistics firms. In 2023, it bought MNX Global Logistics and Happy Returns, both of which added temperature‑sensitive and returns‑management expertise to its Supply Chain Solutions segment. Building on that foundation, in January 2025 UPS completed the purchase of Frigo‑Trans and Biotech & Pharma Logistics—a leading European complex healthcare logistics provider—for roughly $440 million, further strengthening its international cold‑chain network. These acquisitions collectively broadened UPS’s specialized logistics offerings and reinforced its strategy to deepen cold‑chain capabilities worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the 2024 acquisition of Frigo-Trans and Biotech & Pharma Logistics for approximately $440 million, it incorrectly states the acquisition occurred in January 2025 instead of 2024, which misaligns with the timeline in the question. Additionally, it includes 'Happy Returns' as a 2023 acquisition contributing to cold-chain logistics, which is not supported by the ground truth—UPS did acquire Happy Returns, but it is a reverse logistics company focused on e-commerce returns, not cold-chain or healthcare logistics. The ground truth specifies Bomi Group and MNX Global Logistics as the 2023 cold-chain-related acquisitions, but Bomi Group is omitted in the LLM answer. (2) The $440 million figure is correctly reported, but the date of the transaction is wrong (January 2025 vs. 2024), which is a significant error in temporal accuracy. The inclusion of Happy Returns introduces a false entity in the context of cold-chain capabilities. (3) The multi-hop reasoning is partially sound—the model connects acquisitions to cold-chain expansion and recognizes the international strategic shift—but fails in entity synthesis by substituting Happy Returns for Bomi Group and misdating the European acquisition. This undermines the accuracy of the evolution narrative from 2023 to 2024. (4) Despite these errors, the answer is contextually relevant and captures the overall strategic direction of UPS’s cold-chain investment. The qualitative accuracy is moderate because core elements (MNX, Frigo-Trans, Biotech & Pharma, $440M) are present, but key facts are incorrect or missing, reducing overall correctness. Hence, a score of 6/10 reflects partial correctness with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 485,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program was updated through amendments to its 2021 Long-Term Incentive Plan, which introduced a dedicated RSU award form for directors and added performance-based metrics to align compensation with shareholder interests. The 2024 filing (Exhibit 10.16) confirms the adoption of a formal Director Deferral Program and updated RSU award terms, reinforcing governance by tying director equity to long-term performance metrics such as Return on Capital and Total Shareholder Return, thereby enhancing shareholder alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Linde plc's non-employee director RSU program from 2022 to 2024, noting the initial framework under the 2021 Long-Term Incentive Plan and the 2024 introduction of the Director Deferral Program, adopted on July 30, 2024 (implied in the original answer and confirmed in Exhibit 10.16). (2) There are no numeric inaccuracies—dates and program names are correct, and while the LLM adds specific performance metrics (Return on Capital and Total Shareholder Return), these are plausible and consistent with shareholder alignment goals; however, the original answer does not explicitly name these metrics, so this is a minor addition not contradicted by ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and programs, correctly linking governance enhancements to long-term shareholder alignment. (4) The answer is contextually precise, addressing both governance structure and shareholder alignment. The only minor gap is that the LLM emphasizes performance-based metrics more than the original, which focuses on deferral as the key 2024 enhancement. Still, this does not detract from factual correctness. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 369,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors’ financial and legal relationship with Stellantis remained anchored by the 2017 sale of Opel/Vauxhall, which included Stellantis’ indemnification of GM for certain post‑sale liabilities such as emissions claims, product liabilities and recalls, with those indemnification obligations extending through 2025‑2029 or until specific events occur.  While GM cannot quantify any material loss from these indemnities, the company notes that ongoing consumer lawsuits in Europe alleging emissions violations could trigger payments under the indemnity, though it presently considers such exposure remote.  Separately, GM’s 2024 financial disclosures highlight a $2.6 billion accrual and $1.6 billion receivable related to the Chevrolet Bolt recall and associated costs, reflecting the company’s estimate of recall expenses net of expected reimbursements from LG Energy Solution.  This recall matter is distinct from the Stellantis indemnity but illustrates how GM’s post‑sale financial exposures are being managed through accruals and receivables.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and misrepresents the core financial and legal evolution between GM and Stellantis. The original answer states that GM reported a $0.2 billion gain in 2022 from Stellantis warrants, which is a key positive financial event. However, the LLM answer omits this entirely and instead fabricates a $2.6 billion accrual and $1.6 billion receivable related to the Chevrolet Bolt recall—information that is not only unrelated to Stellantis but also not mentioned in the ground truth. This introduces major incorrect financial figures and shifts focus to a different issue (Bolt recall) involving LG Energy Solution, which has no connection to Stellantis. (2) Quantitatively, the numbers are entirely wrong: $0.2 billion gain in 2022 (correct) vs. fabricated $2.6B and $1.6B figures (incorrect). The LLM also incorrectly states that Stellantis indemnifies GM, while the truth is that GM indemnifies Stellantis for pre-sale liabilities—this reverses the direction of liability and is a critical error. The time frame of indemnification (2025–2029) is not in the original and appears speculative. (3) The multi-hop reasoning fails: the model does not connect GM’s 2022 warrant gain to its later legal exposure in 2024. Instead, it invents a narrative around GM being indemnified and introduces an unrelated recall. The synthesis between financial gains and evolving legal obligations is missing. (4) Contextual relevance is moderate because the answer discusses post-sale liabilities related to Opel/Vauxhall, which is relevant, but it distorts the nature of the indemnity and introduces irrelevant financial data. The core transformation from financial benefit (2022) to contingent liability (2024) is not accurately conveyed, leading to a fundamentally incorrect overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 499,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "Southern Company’s 2024 10‑K shows energy‑related derivatives now presented separately as “Risk Management Activities” with detailed line‑item balances for current and non‑current assets and liabilities, and they are categorized into regulatory hedges, cash‑flow hedges and non‑designated contracts; in contrast, the 2022 filing (pages 325‑329) only disclosed a summary table of “Energy‑related derivatives” without the same segment‑specific breakdown or explicit classification of cash‑flow versus fair‑value hedges. Consequently, the 2024 presentation provides a more granular, disaggregated view of derivative categorization and financial statement placement, while the 2022 filing relied on aggregated “Other” balances and less explicit hedge‑type labeling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Southern Company's derivative disclosures from 2022 to 2024: in 2022, disclosures were aggregated under 'Other' with limited breakdown, while in 2024, they are more granular, categorized under 'Risk Management Activities' with clear classification into hedge types and balance sheet placement. This matches the ground truth's claim of a shift from income-focused to balance sheet-oriented reporting. (2) There are no numeric values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound—comparing disclosure practices across two filings, identifying changes in categorization and presentation. The LLM adds detail not in the original (e.g., breakdown into regulatory hedges, cash-flow hedges, non-designated contracts; current vs non-current classification), which is consistent with plausible 2024 enhancements and does not contradict the ground truth. (4) The only reason for not scoring a 10 is that the original emphasizes the shift from income statement (pre-tax effects) to balance sheet (fair value) focus, while the LLM focuses more on disaggregation and labeling improvements. However, this is a difference in emphasis, not factual inaccuracy. The LLM answer captures the essence and direction of change accurately. Thus, correctness is 9 due to slightly different framing, but all facts and reasoning are sound and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 429,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, Gilead’s strategic relationship with Arcus evolved through a series of amendments and equity actions that deepened Gilead’s ownership and governance influence. In May 2023 Gilead amended the Collaboration Agreement to add up to four new inflammatory‑disease targets, paid a $35 million upfront fee, and secured the right to license each program at two predetermined points; exercising the earlier option for the first two targets would make Arcus eligible for up to $420 million in option and milestone payments plus tiered royalties, while later exercises would involve shared development costs and U.S. profit‑sharing. In January 2024 Gilead made an additional $320 million equity investment in Arcus, raising its stake to roughly 33 % and increasing its board representation to three designees, thereby enhancing its governance role. These moves built on the 2021 option exercise that had already generated a $725 million collaboration payment and a $625 million in‑process R&D charge, and they set the stage for future cost‑sharing and profit‑sharing arrangements under the amended agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the January 2024 $320 million equity investment, the resulting 33% ownership stake, and the increase in board designees from two to three, which aligns with the ground truth. However, it omits the specific 2023 ownership percentage (19.9%) mentioned in the original answer, instead focusing on other collaboration details not directly tied to equity or governance. The inclusion of the $35 million upfront fee and $420 million in potential payments, while factually possibly accurate, are not part of the equity ownership or governance evolution and distract from the core question. (2) The $320 million investment and 33% ownership are correctly stated and match the ground truth. However, the absence of the 19.9% figure from 2023 is a significant quantitative omission, weakening the comparative analysis between years. The $725 million and $625 million figures from 2021 are contextually relevant to the broader relationship but not directly responsive to the 2023–2024 equity and governance focus. (3) The reasoning is logically structured and shows multi-hop synthesis by connecting equity investment to governance changes (board seats) and linking to broader strategic moves. However, it overemphasizes ancillary collaboration amendments (e.g., new targets, option rights) that, while related, are not central to the question about equity and governance. The core evolution in ownership and control is partially captured but not fully isolated or contrasted between the two years. (4) The answer is contextually relevant and well-informed, but the inclusion of extraneous financial details reduces precision. The omission of the 19.9% stake in 2023 prevents a complete before-and-after picture, which is critical for assessing the 'evolution' asked in the question. Thus, while the 2024 facts are correct and the direction of change is accurate, the lack of full quantitative baseline data from 2023 limits the correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 536,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 28 2024 to July 1 2026 in the June 29 2023 amendment, and the borrowing capacity under that facility remained unchanged at $6.0 billion (subject to sublimits). Additionally, the facility’s interest‑rate benchmark was switched from LIBOR to SOFR.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the initial maturity date: it states June 28, 2024, while the ground truth specifies June 30, 2025, for the 2022 period. This is a significant factual discrepancy affecting the core of the question. The 2023 maturity date (July 1, 2026) and unchanged $6.0 billion borrowing capacity are correctly reported. (2) Quantitative accuracy is partially correct: the $6.0 billion capacity matches, and the 2023 maturity date is accurate, but the incorrect 2022 maturity date undermines the comparison. The mention of LIBOR to SOFR transition, while potentially true, is extraneous and not part of the original question or answer, adding irrelevant detail. (3) Multi-hop reasoning is partially sound—the model identifies changes between two years and correctly notes no change in capacity—but fails in synthesizing the correct starting maturity date, leading to flawed evolution analysis. (4) Contextual relevance is high as the answer addresses maturity date evolution and borrowing capacity, but the inclusion of the interest-rate benchmark shift distracts from the core query. The correctness score is 6 due to one major factual error in a key data point (maturity date in 2022), despite correct reporting of other elements and overall structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 363,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s U.S. refinery crude inputs were about 60 % imported in both 2023 and 2024, and the company continued to rely on that imported mix to run its refineries.  Refinery capacity utilization fell from roughly 90 % in 2023 to about 87 % in 2024, reflecting the lower utilization noted for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's imported crude oil reliance was about 60% in both 2023 and 2024, matching the ground truth. The refinery capacity utilization figures are slightly rounded (90% vs 90.8% in 2023, 87% vs 86.6% in 2024), but these approximations are reasonable and do not materially misrepresent the trend. (2) Quantitatively, the original values are 90.8% and 86.6%, while the LLM reports 'roughly 90%' and 'about 87%'. These are acceptable rounding for qualitative summary, though not exact. No calculations were required beyond comparison, which is handled appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct data points (import dependency and capacity utilization) across two years and links them to show stable import reliance alongside declining operational intensity. (4) The answer is contextually complete and relevant, addressing both parts of the question. The minor rounding of percentages prevents a perfect score, but overall accuracy and synthesis are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 304,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS reduced its notional exposure to British Pound Sterling hedging instruments from $856 million in 2022 to $663 million in 2023, and further to $536 million in 2024, reflecting a deliberate scaling back of its foreign‑currency hedge program. This contraction, coupled with the shift in AOCI gains from a $199 million gain on designated net‑investment hedges in 2022 to a $127 million gain in 2024, indicates that UPS is tightening its currency‑risk management—relying more on cash‑flow hedges and natural hedges rather than maintaining large designated investment hedges—while still using forward contracts to protect forecasted GBP‑denominated cash flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 and 2024 GBP hedge positions as $663 million and $536 million, matching the ground truth. However, it introduces a 2022 value of $856 million and AOCI gains data ($199M in 2022, $127M in 2024) not present in the original answer or required by the question, which risks misleading the user. While the core 2023–2024 reduction is accurate, the additional numbers are unverified and not part of the ground truth, affecting quantitative accuracy. (2) The reduction from 663M to 536M is correctly implied (127M decrease), though the LLM does not explicitly calculate the 19.15% drop mentioned in the original. The use of dollar units (e.g., $663 million) is acceptable as equivalent to '663 million units' assuming the context implies USD notional value. (3) The reasoning is sound in interpreting the reduction as a strategic move to reduce GBP exposure, and the LLM adds nuanced insight about a shift toward cash-flow and natural hedges, which is plausible and contextually consistent with UPS's risk management, though not explicitly confirmed in the ground truth. This shows strong qualitative reasoning but goes beyond the provided data. (4) The answer is highly relevant to the question, addressing both the evolution of the hedge position and its strategic implications. However, the inclusion of unrequested and unverified data from 2022 and AOCI gains introduces inaccuracies that reduce quantitative precision. Overall, the core facts are correct, but the addition of unsupported details prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 433,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Based on the provided 2023 and 2024 data, Bank of America's money market investments (classified as time deposits and other short-term investments) held at fair value increased slightly from **$1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024**. This modest shift indicates a relatively stable short-term investment strategy, with minimal reallocation between years, likely reflecting a conservative approach to preserve liquidity and capital preservation amid market conditions. The near-identical figures suggest the company maintained its short-term investment position without significant strategic adjustments during the transition from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of money market investments for both years—$1.2 billion at December 31, 2023, and $1.3 billion at December 31, 2024—matching the ground truth exactly. These figures are reported with correct dates and dollar amounts, satisfying quantitative accuracy. (2) All numeric values are accurate and properly formatted; the increase of $0.1 billion (or $100 million) is implied and consistent with the ground truth. No calculations are required beyond this simple comparison, and the model correctly reflects the direction and magnitude of change. (3) The multi-hop reasoning is sound: the model synthesizes data across two time points and draws a reasonable conclusion about short-term investment strategy. While the original answer interprets the increase as indicating 'a slight expansion in liquidity management or short-term capital deployment,' the LLM characterizes it as 'relatively stable' and 'minimal reallocation,' which is slightly more conservative in tone but still logically defensible given the small absolute change. This difference in interpretation does not constitute a factual error but reflects nuanced reasoning. (4) The answer fully addresses both parts of the question—evolution of fair value and strategic implication—and uses correct entities (Bank of America, money market investments, fair value, correct years). The slight divergence in qualitative emphasis (stability vs. modest growth) prevents a perfect 10, but the core facts, synthesis, and relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 428,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell‑back options is 26 million mmBtu for Southern Company in 2021, which is broken down as 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power and 8 million mmBtu for Southern Power. In the 2024 filing, this figure is reduced to 15 million mmBtu for Southern Company, comprising 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power and 3 million mmBtu for Southern Power. Thus, the maximum expected sell‑back volume declined from 26 million mmBtu in 2021 to 15 million mmBtu in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 volume (15 million mmBtu) and its subsidiary breakdown, which matches the ground truth. It also accurately states the 2022 (ground truth) volume of 26 million mmBtu and correct subsidiary allocations. However, it incorrectly references the year 2021 instead of 2022 for the initial volume, which is a factual error in temporal attribution. (2) All numeric values — both company-wide and subsidiary-specific — are accurate and consistent with the ground truth. The calculation of the decline from 26 to 15 million mmBtu is correct, and the subsidiary reductions are properly represented. The only quantitative issue is the mislabeling of the year, not the numbers themselves. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across Southern Company and its subsidiaries for two time points, compares them, and draws the correct conclusion about a decline. The synthesis across entities and years is logically valid. (4) Despite the year error, the core financial and operational data are correct, and the overall trend is accurately described. The mistake in the year reduces quantitative accuracy slightly but does not invalidate the key conclusion. Contextual relevance is perfect — the answer directly addresses the question’s focus on changes over time and across subsidiaries.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 379,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, Adobe integrated Firefly’s generative AI capabilities more deeply across its Creative Cloud suite, introducing features like Generative Fill, Expand, and Background in Photoshop, as well as Generative Recolor in Illustrator, all powered by the Firefly Vector Model for editable vector graphics. The Firefly web app and its AI-driven tools (including vector and design model APIs) became central to products like Express, Acrobat, and Stock, with paid Generative Credits and enterprise-focused Firefly Services/Custom Models expanding access for commercial use cases. This evolution emphasized native, commercially safe AI integration across Adobe’s ecosystem, from creative workflows to document management.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in entity identification and multi-hop reasoning. (1) Correctly identifies the expansion of Firefly's capabilities into Adobe Illustrator by 2024, specifically mentioning Generative Recolor, which aligns with the ground truth. It also correctly notes integration into Adobe Express. However, it incorrectly attributes Photoshop features like Generative Fill, Expand, and Background to the 'Firefly Vector Model,' which is factually wrong—these are powered by Firefly's image model, not the vector-specific model. The Firefly Vector Model is specifically for vector graphics (e.g., Generative Recolor in Illustrator), not raster image editing in Photoshop. (2) Quantitatively, there are no explicit numbers, dates, or calculations in either answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) The reasoning is partially sound in recognizing broader integration across Creative Cloud and commercialization via Generative Credits and enterprise services, but it fails the multi-hop requirement by conflating different Firefly models (image vs. vector), leading to incorrect attribution of functionality. The original question specifically asks about the 'Firefly Vector Model,' which has a narrow scope, but the LLM generalizes to all Firefly AI features. (4) Despite this conflation, the answer remains contextually relevant, discussing the evolution of Firefly in Adobe's suite, and captures the directional trend of expanded integration and commercial use. However, due to the core error in model-specific functionality, the qualitative accuracy is low, pulling down the overall correctness score. Semantic equivalence is partially achieved but undermined by technical inaccuracy in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 491,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, Biktarvy’s commercial significance has declined markedly within Gilead’s HIV portfolio. In 2023, Biktarvy generated $9.69 billion in U.S. sales (26 % of total revenue) and $1.25 billion in Europe, but by 2024 its share of total product revenue fell to roughly 21 % of U.S. sales and 19 % of European sales, reflecting growing competition and the impact of pricing pressures and reimbursement reforms. This erosion of Biktarvy’s contribution forces Gilead to accelerate the launch of newer HIV regimens and expand its oncology and cell‑therapy pipelines to offset the loss of revenue and maintain growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. The ground truth states that Biktarvy generated $11,850 million ($11.85 billion) in total global product sales in 2023, whereas the LLM claims $9.69 billion in U.S. sales alone and $1.25 billion in Europe—implying a global total of about $10.94 billion, which is both numerically incorrect and misattributed by region. There is no support in the original answer for regional breakdowns or percentage shares of revenue (e.g., 26% of total revenue in 2023 or 21% in 2024), nor for the claim that Biktarvy’s commercial significance 'declined markedly'—the original answer states it remained central to GILD’s HIV portfolio. (2) The LLM invents specific percentages (26%, 21%, 19%) and regional sales figures not present in the ground truth, and incorrectly frames the trend as a marked decline, while the original emphasizes continued centrality despite growing risks. (3) The reasoning is partially sound in identifying strategic implications—such as the need to innovate or diversify due to generic competition and shifting treatment paradigms—but this is based on incorrect premises. The multi-hop synthesis fails because it uses fabricated numbers rather than accurately reflecting the reported global sales growth from $10.39B (2022) to $11.85B (2023). (4) The contextual relevance is moderate because the answer addresses the strategic implications question and mentions relevant themes (competition, pipeline expansion), but the foundation of the argument is factually unsound. Correctness score is low due to major quantitative and factual errors, despite some alignment in qualitative directionality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 468,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "Based on the provided document pages, the Series 2018-1A Securities (a specific tranche of the 2018 securitization) had an outstanding principal balance of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022. The interest rate for this tranche was 3.652% (as noted in the \"Series 2018-1A Securities (11)\" entry on page 108). This indicates minimal change in outstanding principal between the two years, with the interest rate remaining fixed at 3.652% for the tranche. The document does not specify any significant structural changes to the interest rate or principal repayment schedule between 2022 and 2023 for this particular series.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated in the LLM answer. In 2023, the principal was $496.8 million, which the LLM correctly reports. This means the LLM underreports the 2022 principal by $3.9 million, leading to an incorrect assessment of the change in principal over the year. The interest rate of 3.652% is correctly reported. (2) The calculation of principal reduction is therefore flawed: ground truth shows a decrease from $500.0M to $496.8M (a $3.2M reduction), while the LLM reports a change from $496.1M to $496.8M, which would imply an increase, not a decrease—though the LLM still describes it as 'minimal change,' missing the direction and magnitude of the actual amortization. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that the interest rate remained fixed and that there were no structural changes, which aligns with the ground truth. It also correctly identifies the security and time frame, showing proper entity recognition and contextual understanding. However, it fails in multi-hop synthesis by using an incorrect 2022 principal value, possibly from misreading or misextracting data from the source document. (4) The contextual relevance is high because the answer addresses the right security, years, and metrics. However, due to the critical error in the 2022 principal amount, the correctness and quantitative accuracy scores are low, as financial analysis hinges on precise figures, especially for principal balances in securitizations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 451,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS’s relationship with Coyote shifted from a core growth contributor to a divested asset, resulting in a $156 million gain on divestiture and a $111 million goodwill impairment charge in 2023 that was later reversed with an additional $108 million impairment in 2024. The exit reduced Supply Chain Solutions revenue by $806 million and lowered operating expenses, but the company expects modest revenue growth in 2025 from remaining Logistics and freight‑forwarding businesses. Strategically, UPS is refocusing on its core U.S. package network and expanding high‑margin logistics (e.g., MNX acquisition) while exiting the underperforming truckload brokerage segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS recorded a $111 million impairment charge in 2023 related to the Coyote trade name, and then fully divested Coyote in September 2024, which led to a decline in Supply Chain Solutions revenue. However, the LLM claims a $156 million gain on divestiture, a reversal of the 2023 impairment, and an additional $108 million impairment in 2024—none of which are supported by the original answer. There is no mention of a gain on divestiture or impairment reversal in the ground truth. The $806 million revenue decrease is fabricated and not present in the original. (2) Quantitatively, only the $111 million impairment charge in 2023 is correct. All other figures—$156 million gain, $108 million 2024 impairment, $806 million revenue drop—are incorrect and unsupported. Calculations and financial impacts are therefore invalid. (3) The multi-hop reasoning is partially sound in that the model identifies a strategic shift from 2023 to 2024 and links Coyote’s exit to revenue impact and strategic refocusing. It correctly infers that UPS is moving away from underperforming segments toward core logistics, which aligns with the strategic direction. However, the reasoning is based on false financial data, undermining the conclusion. (4) The contextual relevance is moderate because the answer addresses both financial impact and strategic direction as asked, and correctly identifies the evolution from impairment to divestiture. However, due to major quantitative errors and invented figures, the overall correctness score is low. The answer creates a plausible narrative but with incorrect financial specifics, leading to a misleading portrayal of the actual events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 480,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "The Performance Share Unit Awards under Linde plc’s 2009 Long‑Term Incentive Plan were first introduced for grants beginning in 2019, with two distinct performance metrics used: Return on Capital (as set out in Exhibit 10.11k) and Total Shareholder Return (as set out in Exhibit 10.11l). Subsequent amendments—most recently the First Amendment effective January 29 2024 (Exhibit 10.03e)—updated the plan’s structure but did not change the 2019‑era performance‑metric framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a subtle inaccuracy regarding the timeline and structure of the Performance Share Unit Awards. (1) It correctly identifies the two performance metrics—Return on Capital (Exhibit 10.11k) and Total Shareholder Return (Exhibit 10.11l)—used for grants beginning in 2019, which aligns with the original answer. (2) The mention of the First Amendment effective January 29, 2024 (Exhibit 10.03e) is factually plausible but not directly tied to the evolution of the performance metrics for the 2019 grants; the original answer emphasizes continuity evidenced by Exhibits 10.10l and 10.10m in 2024, which the LLM omits. This weakens the multi-hop synthesis between 2022 and 2024 structures. (3) The LLM incorrectly implies that the awards were 'first introduced' for grants beginning in 2019, while the original answer does not make this claim and focuses instead on the persistence of the structure through 2024. This misrepresents the evolution aspect of the question. (4) Despite these issues, the core factual elements—correct exhibits, correct metrics, correct plan name, and the conclusion that the framework remained unchanged—are present, supporting a score of 7 for correctness. Quantitative accuracy is high (8) due to correct dates and exhibit references. Qualitative accuracy is slightly lower (7) due to flawed reasoning about the introduction and evolution timeline. Contextual relevance is strong (9) as the response directly addresses the performance metrics and plan structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 418,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy’s regulatory trajectory accelerated with two key milestones: it received FDA Breakthrough Therapy designation for extensive-stage small cell lung cancer (2023) and subsequently gained FDA approval for treating unresectable locally advanced or metastatic HR+/HER2- breast cancer (2024), followed by EU approval as monotherapy for the same indication. This progression—from designation to expanded approvals—demonstrates a clear development trajectory toward broader therapeutic applications, particularly in oncology, while reinforcing its strategic focus on high-unmet-need areas.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the Breakthrough Therapy designation for extensive-stage small cell lung cancer was granted in 2024, not 2023 as stated by the LLM. Additionally, the LLM incorrectly claims that Trodelvy received FDA approval for HR+/HER2- breast cancer in 2024 and EU approval for the same indication—this information is not present in the original answer and is therefore unsupported. The original answer only states that HR+/HER2- breast cancer was an existing indication in 2023, with no mention of new approvals in 2024. (2) The dates are quantitatively incorrect: assigning the Breakthrough Therapy designation to 2023 instead of 2024 misrepresents the timeline. There are no numerical values to verify beyond years, but the year error is critical. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that expansion into new indications reflects a strategic development trajectory in high-unmet-need oncology areas, which aligns with the original conclusion. However, it fabricates regulatory milestones (approvals in US and EU) not present in the source, undermining the validity of the synthesis. (4) While the overall intent and contextual relevance are strong—addressing regulatory evolution and development trajectory—the inclusion of false approvals and misassigned dates reduces factual reliability. The core idea of expansion is correct, but execution contains major factual errors, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 422,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, Vertex AI’s role within Google Cloud shifted from a primarily infrastructure‑focused platform for training and deploying custom models to a more integrated, generative‑AI‑centric hub. In 2023 the platform chiefly offered tools for training, tuning, and serving traditional AI models, but by 2024 it was expanded to host Gemini‑based generative models (e.g., Gemini 1.5/2.0) and pre‑packaged AI agents such as Duet AI for Cloud, enabling developers to more easily build, augment, and deploy multimodal generative applications directly on Google Cloud. This evolution reflects Google’s broader push to make Vertex AI the primary gateway for enterprises to leverage the company’s latest generative‑AI capabilities at scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Vertex AI from 2023 to 2024. It accurately captures the shift toward generative AI centrality, including support for Gemini models (e.g., Gemini 1.5/2.0), which matches the original answer's mention of 'support for Gemini and other leading generative AI models.' The addition of services like pre-packaged AI agents (e.g., Duet AI for Cloud) and multimodal application support reflects the expanded capabilities in 2024. However, the LLM answer omits specific services mentioned in the ground truth such as 'vector search, grounding, and distillation,' which are key technical enhancements that improve model cost and quality. While it correctly identifies the platform’s expanded role, it does not explicitly mention 'testing' as a new capability introduced in 2024. There are no numerical values to verify, so quantitative accuracy is 10 by default. The reasoning is sound and contextually appropriate, showing a clear understanding of the platform’s strategic evolution. The answer is semantically close to the original but lacks a few specific technical details, justifying a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 348,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment of weather derivatives in Southern Company’s disclosures shifted from being treated as immaterial and excluded from derivative valuations (as noted in the 2022 discussion of “immaterial premium and intrinsic value associated with weather derivatives” on page 124) to being explicitly included in the fair‑value tables and regulatory‑hedge accounting disclosures for 2023‑2024 (pages 283‑287). The 2024 notes now present detailed balances of energy‑related derivatives—including weather‑related components—within regulatory assets and liabilities, showing amounts such as $‑61 million in current regulatory assets and $8 million in net derivative gains, whereas the 2022 filing only referenced weather derivatives in passing without quantifying them. Consequently, the amounts deemed immaterial and excluded from derivative valuations in 2022 are no longer treated as immaterial; they are now measured, disclosed, and incorporated into the Registrants’ risk‑management and regulatory frameworks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that weather derivatives were 'explicitly included' in fair-value tables and regulatory-hedge accounting disclosures in 2023–2024, with specific amounts like '$-61 million' and '$8 million', but the original answer states that weather derivatives remained immaterial and excluded from valuation in both 2022 and 2024. The $17 million and $62 million figures in the ground truth refer to cash collateral in broker margin accounts, not weather derivative values, and are unrelated to the $-61M or $8M cited by the LLM—these numbers do not appear in the ground truth at all. (2) Quantitative accuracy is very low: the LLM invents specific figures for weather derivatives that are not supported by the original answer, and misattributes disclosed collateral amounts to derivative valuations. There are no calculations in the question, but the use of false numbers severely undermines accuracy. (3) The reasoning is flawed: the LLM incorrectly infers a shift in treatment from 'immaterial' to 'material and disclosed', when the ground truth indicates consistency in immateriality treatment, with only added context on collateral. The multi-hop synthesis fails—instead of recognizing that weather derivatives remained immaterial, it fabricates a narrative of increased inclusion. (4) Contextual relevance is moderate because the answer discusses derivative disclosures and attempts to compare years, but it misrepresents the core facts. Overall, the answer reflects a fundamental misunderstanding of the original data and introduces hallucinated details, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 453,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Based on GILD's 2023 and 2024 disclosures, Biktarvy's regulatory and market positioning evolved through an expanded HIV indication (FDA approval for patients with M184V/I resistance and use in pregnancy) and maintained strong patent protection through 2033 in both the U.S. and EU, with no generic competition anticipated before then. The company also reinforced its manufacturing strategy by expanding cell therapy capabilities and securing proprietary process patents, while regulatory exclusivity in the U.S. is projected to last until 2032.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the expanded FDA indication in 2024 for Biktarvy to include patients with M184V/I resistance and use in pregnancy, which aligns with the ground truth. It also correctly notes the U.S. patent protection through 2033. However, it incorrectly states that regulatory exclusivity in the U.S. is projected to last until 2032, which contradicts both the ground truth (2033) and its own mention of 2033 patent expiration. Additionally, the mention of EU patent protection through 2033 and proprietary process patents is not present in the original answer and cannot be verified from the provided ground truth, suggesting potential hallucination. (2) The key numeric discrepancy is the U.S. exclusivity end date: ground truth and correct data is 2033, but LLM states 2032 in one instance, which is factually incorrect. The rest of the numbers (patent expiration in 2033) are correctly cited. (3) The multi-hop reasoning is mostly sound—LLM synthesizes regulatory developments (2024 label expansion) and market positioning (patent protection)—but introduces unverified information about EU patents and manufacturing strategy not present in the original answer, weakening the qualitative accuracy. (4) The answer is contextually relevant and captures the core evolution from patent protection to expanded indications. However, due to the incorrect 2032 exclusivity date and unsupported claims about EU and manufacturing, the quantitative and overall correctness scores are reduced. The core facts are mostly right, but with notable errors in precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 435,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "Between 2022 and 2023, AMT's utilization of the 2021 Multicurrency Credit Facility shifted from net borrowing to net repayment. In 2022 (as of December 31, 2021), the facility had $1.6 billion available, and subsequent to that date, AMT borrowed an additional $850 million under the facility (as noted in the 2021 filing for 2021 usage). However, in 2023, AMT borrowed $3.0 billion under the facility but repaid $6.1 billion in aggregate, resulting in a net reduction of $3.1 billion in outstanding borrowings under the facility during the year ended December 31, 2023. This repayment was used to settle existing indebtedness, including the 2021 USD Two-Year Delayed Draw Term Loan. The facility was subsequently amended in June 2023 to extend its maturity to July 2026 and replace LIBOR with SOFR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the shift in AMT's utilization of the 2021 Multicurrency Credit Facility from net borrowing in 2022 to net repayment in 2023. All key financial figures are accurate: $850 million in additional borrowings in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023. The net reduction of $3.1 billion is correctly calculated. The amendment details—maturity extended to July 2026 and replacement of LIBOR with SOFR—are factually correct and match the ground truth. However, the mention of 'as of December 31, 2021' and referencing the '2021 filing for 2021 usage' introduces a minor temporal confusion, as the $850 million borrowing is part of 2022 activity, not 2021. This does not affect the numerical accuracy but slightly muddies the timeline. (2) Quantitative accuracy is perfect: $850 million, $3.0 billion, $6.1 billion, and the derived net repayment of $3.1 billion are all correct. The EUR-to-USD conversion of 842.6 million EUR = $919.1 million is not mentioned in the LLM answer, which is a minor omission, but since the total repayment of $6.1 billion is correctly stated and includes this amount, it does not constitute a major error. (3) The multi-hop reasoning is sound—LLM correctly synthesizes changes in borrowing behavior and facility amendments across years. The connection between repayment and the retirement of the 2021 USD Two-Year Delayed Draw Term Loan adds useful context not in the original but is consistent with plausible inference. (4) The answer is highly relevant, directly addressing both borrowing amounts and facility amendments. The only reason for not scoring a 10 is the slight misstatement around timing and the omission of the EUR conversion detail, which is present in the ground truth but not critical to the core conclusion. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 518,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "The role of Google Ad Manager in Alphabet’s advertising revenue recognition strategy has shifted from being treated as a distinct revenue stream to being integrated under broader advertising revenue categories. In 2023, Ad Manager’s revenue was included within \"Advertising revenues\" alongside Google Search, YouTube, and Google Network properties, with recognition occurring on a gross basis when Alphabet acts as the principal (i.e., controls ad inventory before transferring it to customers). By 2024, the strategy emphasized that advertising revenue from Ad Manager is recognized when control transfers to customers, with gross reporting for network inventory and variable consideration (e.g., incentives) estimated and reduced from revenue. This integration reflects a streamlined approach where Ad Manager’s revenue is no longer isolated but part of Alphabet’s consolidated advertising revenue model, consistent with its gross basis reporting for network placements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and timeline. (1) It accurately identifies that in 2023, Google Ad Manager revenue was recognized on a gross basis as part of Alphabet's advertising revenue, particularly when Alphabet acts as principal, which matches the original answer. In 2024, it correctly notes a shift toward emphasizing control-based criteria (control of inventory, responsibility, pricing discretion) for gross revenue recognition, though it frames this as part of a broader consolidation into advertising revenue rather than a strategic evolution in justification. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financial terms. (3) The multi-hop reasoning is sound: the model correctly synthesizes the role of Ad Manager in revenue recognition across two years and links it to accounting principles (principal vs agent, control transfer). However, it slightly mischaracterizes the evolution—not as a shift from transactional to control-based justification per se, but as a consolidation of reporting categories, which downplays the strategic refinement in narrative and accounting rationale emphasized in the ground truth. (4) The answer remains contextually precise, addressing both years and the integration with revenue reporting models. While the core facts are correct, the nuance about Google Ad Manager becoming more central due to a control-based justification is underemphasized, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 429,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "UPS recorded $56 million of goodwill impairment in 2023 related to the Roadie reporting unit and $61 million in 2022, but no goodwill impairments were recorded in 2024. The company’s 2024 goodwill testing identified Roadie, Global Freight Forwarding and Global Logistics and Distribution as units with limited excess fair value, indicating heightened risk of future impairment, yet the fair values still exceeded carrying amounts, so no impairment was recognized this year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $56 million goodwill impairment in 2023 related to Roadie, which matches the ground truth. However, it introduces a $61 million impairment in 2022 that is not mentioned in the original answer and is irrelevant to the question’s focus on 2023–2024 evolution. This incorrect addition affects quantitative accuracy. The statement that no impairment was recorded in 2024 aligns with the ground truth. (2) The LLM accurately states that in 2024, Roadie was among the reporting units with limited excess fair value over carrying value, indicating ongoing risk—this matches the original answer’s emphasis on continued financial sensitivity. However, it adds two other units (Global Freight Forwarding and Global Logistics and Distribution) not mentioned in the ground truth, which, while possibly true, dilutes focus on Roadie specifically. (3) The multi-hop reasoning is partially sound: the model connects impairment in 2023 to risk monitoring in 2024, capturing the shift from active impairment to caution. But the inclusion of extraneous data (2022 impairment, other units) suggests incomplete filtering of relevant information. (4) Despite these issues, the core message about Roadie’s evolving risk profile—impairment in 2023, no new impairment but ongoing risk in 2024—is preserved, warranting a correctness score of 7. Quantitative accuracy is penalized due to the unsupported 2022 figure. Qualitative and contextual scores remain high because the reasoning and relevance to strategic positioning are largely intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 430,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's helium-related business, primarily within the \"Other\" segment (which includes global helium wholesale), underwent a strategic shift from 2022 to 2024, marked by a significant reduction in helium-related costs and a notable improvement in profitability. This change directly contributed to a $19 million (44%) increase in operating profit for the \"Other\" segment in 2024 compared to 2023, driven explicitly by \"insurance recovery for LAMT partially offset by higher costs due to helium\" (page 28). While the provided financial data (e.g., sales and operating profit figures for segments like APAC, Americas, and EMEA) does not quantify helium's standalone impact on total company sales or operating profit, the segment-level improvement confirms that the resolution of helium-related cost pressures positively affected the company's overall operating performance, with the \"Other\" segment's operating profit rising to $43 million in 2024 from $62 million in 2023 (though the segment's sales declined slightly by 2%). The document does not provide specific dollar figures for helium's contribution to total sales or operating profit, but the qualitative shift and segment-level profit increase indicate a positive evolution in Linde's helium strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude. The ground truth states that helium had a negative impact on Linde's performance in 2024, contributing to a 2% underlying sales decrease and increased operating costs in the 'Other' segment. However, the LLM claims a 'positive evolution' with a $19M (44%) increase in operating profit due to resolution of helium cost pressures—this is factually wrong. The LLM incorrectly states that the 'Other' segment operating profit rose to $43M in 2024 from $62M in 2023, which is a decrease, not an increase, and contradicts its own claim. The $19M figure and 44% change appear fabricated or miscalculated. (2) Quantitative inaccuracies are severe: the LLM misrepresents the direction of profit change (claims increase when it decreased), misstates the actual figures (wrong values for 2023 and 2024 operating profit), and incorrectly attributes a positive impact to helium when the truth is negative. The 2% sales decline is correctly cited, but it is falsely framed as part of an improvement. (3) Multi-hop reasoning fails: the model incorrectly infers that 'insurance recovery partially offset by higher helium costs' implies a net positive outcome, when the ground truth emphasizes increased costs and negative impact. It also fails to recognize that helium shifted from a neutral/supply role in 2022 to a cost pressure in 2024. (4) Contextual relevance is moderate—the answer addresses Linde, helium, the 'Other' segment, and cites LAMT and insurance recovery, showing some alignment with the topic—but the conclusions are inverted from the truth. Due to major factual and directional errors, especially in quantitative claims, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 474,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long‑term credit protection agreements with FNMA and FHLMC rose from $8.0 billion at the end of 2023 to $8.7 billion at the end of 2024. This increase reflects a larger pool of residential‑mortgage loans that are fully insured and thus receive complete credit protection, indicating that the Corporation’s exposure to credit losses on its residential‑mortgage portfolio is limited – the insured loans are not subject to allowance for credit losses, so the growth in protected loans suggests the Corporation’s direct credit‑risk exposure on residential mortgages remains relatively low.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the trend in loan values. The ground truth states that the value decreased from $8.7 billion in 2023 to $8.0 billion in 2024, but the LLM claims it increased from $8.0 billion to $8.7 billion — a complete inversion of the correct direction. This fundamental error undermines the entire response. (2) Quantitatively, the dollar amounts are correct in isolation ($8.7B and $8.0B), but their assignment to years is swapped, making the comparison invalid. No calculations are required beyond the comparison of change, which is incorrect. (3) The reasoning is internally logical but based on false premises. The LLM correctly understands that loans under credit protection agreements are fully insured and not subject to allowance for credit losses, and that this limits credit risk exposure. However, because the trend is reversed, the conclusion — that growing protected loans suggest low risk — misinterprets the actual situation. The correct interpretation, per the original answer, is that the decline suggests reduced reliance on full credit protection and potentially fewer high-risk loans. (4) Contextual relevance is fair because the LLM addresses both parts of the question — the evolution of loan values and the implication for credit risk — and uses appropriate financial logic. However, due to the critical error in trend direction, the qualitative and quantitative accuracy scores are low. Correctness is severely penalized because the core factual claim is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 419,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly has evolved from a standalone generative AI app (2023) to a deeply integrated, commercially safe AI capability embedded across Creative Cloud, Express, and Experience Cloud (2024), emphasizing native integration and enterprise indemnification to differentiate from competitors. However, this expansion introduces significant regulatory risks, as new AI-specific regulations like the EU AI Act (2024) could impose inconsistent compliance costs, liability exposure, and potential restrictions on AI development or deployment, directly threatening Adobe's monetization strategies and market position if regulatory frameworks conflict with its responsible AI approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Adobe Firefly's strategic positioning from 2023 to 2024: starting with competitive differentiation via native integration and commercial safety (2023), then shifting toward a more risk-aware stance in 2024 due to regulatory pressures like the EU AI Act. The mention of integration across Creative Cloud, Express, and Experience Cloud adds contextual detail not in the original but is consistent with Adobe’s actual product strategy and enhances completeness without introducing error. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) and the reference to the EU AI Act in 2024 are correct. (3) The multi-hop reasoning is sound: the model synthesizes Firefly’s competitive differentiation (integration, commercial use indemnification) with emerging regulatory risks, correctly identifying how these factors jointly shape strategic positioning over time. (4) The only minor deviation from the original answer is the emphasis on 'enterprise indemnification' and 'liability exposure'—while plausible and contextually relevant—these specifics are not explicitly stated in the ground truth, slightly reducing qualitative precision. However, this does not constitute an error, just a nuanced expansion. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 422,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Based on the provided SEC 10-K filings, Trodelvy's financial performance and regulatory trajectory between 2023 and 2024 show significant growth and regulatory expansion. Trodelvy product sales increased 56% year-over-year in 2023 to $1.063 billion, driven by higher demand across new and existing geographies, and received a second Breakthrough Therapy designation from the FDA in 2024 for treating adult patients with extensive-stage small cell lung cancer after platinum-based chemotherapy. Regulatory exclusivity for Trodelvy is projected to expire in 2028 (U.S.) and 2029 (EU), with pediatric exclusivity extending protection until 2031, while its patent expiration is listed as 2028 in the U.S. and 2029 in the EU. The drug also gained expanded FDA approval in 2023 for unresectable or metastatic HR+/HER2- breast cancer after prior endocrine therapy and systemic treatments, and received accelerated approval for liver cancer (Livdelzi) in 2024, further solidifying its oncology portfolio momentum.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2023 financial performance of Trodelvy with a 56% year-over-year increase to $1.063 billion (equivalent to $1,063 million), which matches the ground truth. It also accurately states the 2024 FDA second Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy. However, the LLM introduces several pieces of information not present in the original answer and potentially not supported by the knowledge graph used: the expanded FDA approval in 2023 for HR+/HER2- breast cancer, the 2024 accelerated approval for liver cancer (Livdelzi), and detailed patent/regulatory exclusivity timelines (2028 U.S., 2029 EU, pediatric until 2031). These additions suggest overreach or hallucination, especially since Livdelzi is a different drug (not Trodelvy) and conflating it with Trodelvy is a significant factual error. (2) Quantitative accuracy is high for the core numbers: $1.063 billion = $1,063 million, 56% increase is correct. However, the additional dates (2028, 2029, 2031) are unverified in the context of the ground truth and thus cannot be considered accurate. (3) Multi-hop reasoning is partially sound—linking financial growth and regulatory milestones is appropriate—but the model fails to restrict its synthesis to the provided knowledge graph, introducing extraneous and incorrect entities (e.g., Livdelzi) and approvals not mentioned in the original answer. (4) The correctness score is 6 due to correct core facts but significant overstatement and inclusion of likely false or irrelevant information. Quantitative accuracy is 8 because the key numbers are correct, but extra numbers lack verification. Qualitative accuracy is 5 due to entity confusion and unsupported claims. Contextual relevance is 7 because the answer addresses the question’s intent but drifts into unrelated oncology developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 515,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "From 2022 to 2024 Chevron’s stake in Angola LNG Limited remained a 36.4 % equity interest, but the company’s financial exposure grew through larger net loans to the project ($4.731 bn in 2024 versus $4.278 bn in 2022) and increased equity‑method accounting disclosures.  In its 2024 10‑K (pages 83‑87) Chevron reports $1.665 bn of Angola LNG Limited investments and notes that its share of equity‑affiliate earnings rose to $4.272 bn in 2023, reflecting stronger upstream realizations and the absence of prior impairments.  The 2022 filing (pages 40‑44) shows a $73 million carrying‑value premium on the Angola LNG investment and highlights that the project’s net loan balance was $4.494 bn at year‑end 2022, indicating a steady expansion of Chevron’s capital commitment and strategic positioning in the Angolan LNG value chain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that Chevron's stake in Angola LNG Limited was 36.4% in both 2022 and 2024 is incorrect: the original answer states that the 36.4% stake was specifically disclosed in 2024, while in 2022 the company only generally referenced earnings contributions from Angola LNG without specifying ownership percentage. (2) The financial figures are largely fabricated or misstated: the original answer reports total income from equity affiliates as $5,657 million in 2022, but the LLM claims $4.272 billion in equity-earnings specifically from Angola LNG in 2023 — a figure not present in the ground truth and implausibly large for a single affiliate. (3) The LLM cites specific investment amounts ($1.665 billion in Angola LNG Limited investments in 2024) and net loan balances ($4.731 billion in 2024 vs $4.278 billion in 2022) that do not appear in the original answer and contradict it — the original makes no mention of net loans or carrying values. (4) Page references (e.g., 2024 10-K pages 83–87) and granular disclosures (e.g., $73 million carrying-value premium) are not supported by the ground truth and appear hallucinated. (5) While the LLM attempts multi-hop reasoning by comparing years and inferring strategic positioning, it does so using incorrect data, leading to invalid conclusions about 'steady expansion' and 'larger net loans.' The only correct element is the 36.4% ownership stake in 2024, which aligns with the original. However, the synthesis is flawed due to incorrect temporal attribution and unsupported financial details. The answer is contextually relevant to the question’s focus on evolution, equity, and strategy, but its factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 480,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, META’s Fixed-Rate Senior Unsecured Notes increased from $18.5 billion (as of Dec 31 2023) to $29.0 billion (as of Dec 31 2024), reflecting the issuance of $10.5 billion of new notes in August 2024 in addition to the existing $18.5 billion of outstanding notes. The Notes, which mature between 2027 and 2064 and carry stated rates of 3.50%–5.55%, now represent the company’s primary long‑term debt, with $28.8 billion recorded as long‑term debt on the balance sheet after adjusting for unamortized discounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the increase in total value of Fixed-Rate Senior Unsecured Notes from $18.5 billion (end of 2023) to $29.0 billion (end of 2024), and the $10.5 billion issuance in August 2024. These figures match the ground truth exactly. The net proceeds from 2023 ($8.46 billion in May) are not mentioned in the LLM answer, which is a minor omission but does not affect the overall correctness of the evolution described. (2) All numbers, dates, and calculations are accurate. The $10.5 billion issuance aligns with the $10.50 billion in the original answer, and the starting and ending totals are correct. The final balance sheet amount of $28.8 billion (after adjustments) is an additional detail not in the ground truth but is plausible and consistent with accounting practices; it does not contradict the core facts. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change over time, links the increase to a specific issuance event in 2024, and contextualizes the notes as a primary debt instrument. The omission of the 2023 issuance details slightly weakens completeness but does not impair the core narrative of growth in debt value and issuance activity. (4) The answer is semantically equivalent to the ground truth in conveying the evolution of value and issuance, with slightly more detail on maturity and interest rates (3.50%–5.55%, maturities to 2064), which enhances context without introducing error. Scores reflect high accuracy with a minor deduction in qualitative accuracy due to incomplete coverage of 2023 issuance activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 447,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "Based on the provided SEC 10-K filings, LIN's financial exposure to helium as a raw material shifted from being categorized as a \"supply\" in 2023 to a \"dependency\" in 2024, as evidenced by specific cost and sourcing disclosures in the documents. The 2024 filing (page 60) explicitly references helium in the context of \"cost reduction programs and other charges\" (Note 3), where helium-related costs were materially included in the $175 million accrued liability for such programs, and the company's reliance on helium as a critical raw material for its core industrial gas operations was underscored by its inclusion in the \"Other Current Liabilities\" line item. This transition reflects a strategic shift from treating helium as a manageable supply to recognizing it as a key dependency requiring close monitoring due to its impact on operational costs and supply chain resilience.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that helium costs were 4.2% of total raw material expenses in 2023 and increased to 6.8% in 2024, but the LLM answer does not mention these percentages at all. Instead, it introduces a $175 million accrued liability from Note 3 on page 60 of the 2024 filing, which is not present in the ground truth and appears to be fabricated or misattributed. There is no mention in the original answer of cost reduction programs, accrued liabilities, or 'Other Current Liabilities' related to helium. (2) Quantitatively, the LLM fails to report the correct metrics (4.2% and 6.8%) and invents a dollar amount ($175 million) not supported by the ground truth, making the quantitative accuracy very low. (3) While the LLM correctly identifies the shift from 'supply' to 'dependency' as a strategic change in categorization, it fails to support this with the correct multi-hop evidence—namely, the increase in cost percentage from 4.2% to 6.8%. The reasoning is partially sound in interpreting the shift in categorization but is undermined by reliance on incorrect or unverified disclosures. (4) The contextual relevance is moderate because the answer addresses the general topic of helium exposure and the shift in classification, but it introduces irrelevant and unsupported financial figures, reducing its overall accuracy and trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 395,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s European customer balances were progressively expanded for credit use: the Luxembourg regulator allowed up to 35 % of European balances to be designated for credit in 2018, and by the end of 2021 the cumulative amount approved for credit had risen to $2.7 billion (≈27 % of European balances). In 2023 the company further increased the authorized pool, with management designating additional funds that brought the total approved for credit to $3.0 billion, representing roughly 39 % of European customer balances. Consequently, the amount approved for credit activities grew from $2.7 billion in 2021 to $3.0 billion in 2023, a $0.3 billion increase, which corresponds to an approximate 11 % rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that PayPal increased the approved amount from $2.7B in 2021 to $3.0B in 2023, implying growth, while the ground truth states that the approved amount decreased from $3.8B in 2022 to $3.0B in 2023. The LLM incorrectly references 2021 data not asked in the question and omits the correct 2022 figure entirely. The percentage figures for 2023 (39%) are correct, but the 2022 percentage is stated as 37% in the truth versus not being directly compared in the LLM response. (2) The calculation of an 11% increase is based on incorrect base values ($2.7B to $3.0B), whereas the correct change is from $3.8B to $3.0B, a $0.8B decrease, or approximately a -21% change. The LLM’s quantitative assertions are therefore fundamentally wrong. (3) The multi-hop reasoning fails because the model does not correctly synthesize the evolution between 2022 and 2023 as required; instead, it introduces irrelevant 2018 and 2021 data and misrepresents the trend as increasing when it was actually decreasing. The core dynamic—reduction in absolute funding despite a slight rise in percentage—was missed. (4) While the LLM discusses the right topic and mentions correct entities (PayPal, European balances, credit activities, percentages), the incorrect data and direction of change severely undermine factual correctness. Contextual relevance is moderate due to topical alignment, but accuracy scores are low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 417,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Between 2023 and 2024, Starbucks' exposure to foreign currency derivatives designated as cash flow hedges shifted significantly: the fair value of foreign currency - other designated derivative assets decreased from $32.0 million (Oct 1 2023) to $1.9 million (Sep 29 2024), while the corresponding liability in accrued liabilities fell from $2.0 million to $2.5 million, reflecting a net reduction in the hedged foreign‑currency positions. This reduction is mirrored in the AOCI reclassification schedule, where the cumulative amount of gains/(losses) expected to be reclassified from AOCI to earnings within 12 months dropped from $9.5 million (Oct 1 2023) to $60.1 million (Sep 29 2024) for coffee‑related hedges and from $39.6 million to $11.5 million for other foreign‑currency hedges, indicating a smaller pool of gains to be recognized in earnings. Consequently, the expected reclassification impact on earnings from these foreign‑currency hedges is now lower, with the net gains/(losses) anticipated to be reclassified decreasing from $9.5 million to $60.1 million for coffee and from $39.6 million to $11.5 million for other foreign‑currency positions, resulting in a net reduction of approximately $30 million in earnings‑impacting gains compared with the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Starbucks' fair value for foreign currency - other instruments was $1,164 million in 2023 and $920 million in 2024. However, the LLM incorrectly reports the fair value as $32.0 million and $1.9 million, which are off by orders of magnitude and likely refer to a subset or misinterpretation of the data. Additionally, the LLM claims the expected reclassification from AOCI dropped from $9.5 million to $60.1 million for coffee-related hedges, which reverses the direction and misstates the numbers—ground truth shows a drop from $55.3 million to $9.5 million for the total expected reclassification, not split as described. The only correct numbers are the AOCI net gains: $39.6 million in 2023 and $11.5 million in 2024, which the LLM correctly identifies for 'other foreign-currency hedges'. (2) Calculations are flawed: the LLM suggests a net reduction of $30 million in earnings-impacting gains, but this is based on incorrect values and misattribution (e.g., claiming reclassification increases from $9.5M to $60.1M, which is opposite to the truth). (3) Multi-hop reasoning is partially present—LLM attempts to link fair value changes to AOCI and reclassification impact—but fails due to incorrect entity mapping (e.g., conflating coffee-related hedges with overall foreign currency instruments). (4) Contextual relevance is moderate: the answer addresses the right topic (foreign currency exposure, AOCI, reclassification), but misrepresents the scope and magnitude. The mention of 'other instruments' is partially accurate, but the focus on coffee-related hedges introduces irrelevant detail not in the question. Overall, major factual and quantitative errors severely undermine correctness despite some correct elements in AOCI gains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 499,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "Based on the provided pages, the fair value of energy-related derivatives held by Alabama Power and Georgia Power increased from $15 million (assets) and $61 million (liabilities) at December 31 2022 to $15 million (assets) and $110 million (liabilities) at December 31 2023. This represents a directional shift from a net liability position in 2022 to a larger net liability position in 2023, with the liability amount more than doubling.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly aggregates Alabama Power and Georgia Power's 2022 derivative positions into a single figure of $15M assets and $61M liabilities, which does not match the ground truth. In reality, in 2022, Alabama Power had $55M in assets and $11M in liabilities, while Georgia Power had $75M in assets and $8M in liabilities—totaling $130M in assets and $19M in liabilities, not $15M and $61M. The 2023 figures are partially correct for liabilities ($110M) but only reflect Alabama Power’s liability, not a combined total. Georgia Power’s 2023 liability was $124M, so the combined liability would be $234M, not $110M. The LLM also incorrectly states that asset value remained at $15M in both years, when only Alabama Power reported $15M in assets in 2023—Georgia Power reported $13M, totaling $28M, not $15M. (2) Calculations and comparisons are flawed: the claim that liabilities increased from $61M to $110M is incorrect, as is the assertion that liability more than doubled—this misrepresents the actual directional shift. (3) Multi-hop reasoning failed: the model did not correctly distinguish between the two companies or track their individual and combined positions over time. Instead, it conflated figures and misrepresented the data. (4) Despite these errors, the answer correctly identifies a directional shift toward greater liability exposure, which is contextually relevant, but the severe quantitative and entity-level inaccuracies severely undermine correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate relevance due to correct general trend mention.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 459,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "Based on the provided 10-K filings, the U.S. Retiree Health Care Plan's asset allocation strategy evolved from 2022 to 2023 with fixed income securities increasing from 65% to 80% of total plan assets, while equity securities decreased from 35% to 20%. This shift aligns with the stated target allocation ranges (65%-80% fixed income, 20%-35% equity) and reflects a deliberate move toward greater fixed income exposure to better match liability sensitivity. The 2023 weighted average allocation shows 80% fixed income and 20% equity, compared to 65% fixed income and 35% equity in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages and years are accurate: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These numbers exactly match the original answer. (2) The answer is complete, addressing the evolution of asset allocation between the two years and the shift in distribution between fixed income and equity securities. (3) Entity accuracy is correct—'U.S. Retiree Health Care Plan' is properly identified, and the years 2022 and 2023 are correctly referenced. (4) The reasoning is sound and adds contextual insight by referencing the target allocation ranges and the rationale for increased fixed income exposure to match liability sensitivity, which enhances the explanation without contradicting the ground truth. The multi-hop synthesis—comparing allocations across two years and interpreting the strategic shift—is logically and factually correct. (5) The semantic meaning is equivalent to the original answer, with slightly more detail but no factual deviation. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 317,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's regulatory approval expanded with a new indication granted by the European Commission for monotherapy treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have previously received endocrine therapy and at least two systemic therapies. Additionally, the FDA approved Trodelvy for the same HR+/HER2- breast cancer indication, while earlier in 2023 the company noted that the Phase 3 EVOKE-01 trial of Trodelvy versus docetaxel in previously treated metastatic non-small cell lung cancer did not meet its primary survival endpoint, though it observed a potential trend in a subgroup of patients who were non-responsive to prior anti-PD-(L)1 immunotherapy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the 2023 expansion of Trodelvy's regulatory approvals, including both the European Commission (EC) and FDA approvals for the treatment of adult patients with unresectable or metastatic HR+/HER2-negative breast cancer who have received prior endocrine-based therapy and at least two additional systemic therapies. The indication details match the original answer in substance, with only minor rephrasing (e.g., 'endocrine therapy' vs 'endocrine-based therapy'). The mention of the EVOKE-01 trial in metastatic non-small cell lung cancer is factually correct and contextually relevant as it pertains to Trodelvy's regulatory and clinical development landscape in 2023, though it was not part of the original answer. This additional information does not detract from correctness but adds context beyond the scope of the question. All entities (FDA, EC, HR+/HER2- breast cancer) and timeframes (2023) are accurate. There are no numerical inaccuracies (no incorrect dates or figures), so quantitative accuracy is perfect. The reasoning is sound, demonstrating multi-hop synthesis of approval changes across regions and indications. The answer fully addresses both parts of the question: evolution of approval status and new indications in 2023. The only reason for not scoring a 10 is the inclusion of slightly tangential information about the failed lung cancer trial, which, while true, is not directly asked for and slightly distracts from the core focus on approved indications. However, this does not compromise factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 443,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta’s disclosure regarding user perception as a risk factor evolved from a general warning about declining user engagement and platform trust (e.g., risks tied to user behavior changes, competition, and platform integrity in 2023 filings) to a more specific emphasis on how regulatory actions and data privacy laws directly undermine user trust and platform utility. In 2024, the focus shifted to concrete threats like the invalidation of EU-U.S. data transfer mechanisms (DPF), which could legally restrict data flows and force Meta to limit product availability in Europe—potentially reducing ad revenue and user engagement. Additionally, 2024 disclosures highlighted how evolving privacy regulations (e.g., GDPR, DMA, CCPA/CPRA) and proposed digital services taxes (e.g., \"digital advertising taxes\") could force Meta to alter its core advertising model, directly impacting its ability to monetize user data and deliver targeted ads. This marks a shift from broad user retention risks to legally driven, structural threats to Meta’s revenue model tied to global regulatory compliance.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the LLM misrepresents the evolution of Meta's risk disclosures. The ground truth states that in 2024, Meta reduced its emphasis on user perception risks and shifted focus to operational and financial risks like acquisition integration, tax liabilities, and investor sentiment. In contrast, the LLM claims the 2024 focus intensified on regulatory threats to user trust and data flows (e.g., EU-U.S. DPF, GDPR, DMA), framing them as an evolution of user perception risks. This is incorrect: the actual shift was away from user perception as a central risk factor, not toward a more detailed version of it. The LLM invents specific regulatory mechanisms (e.g., 'invalidation of EU-U.S. data transfer mechanisms') and links them directly to user perception and ad revenue impacts that are not supported by the ground truth. While the answer is contextually relevant—addressing risk factor evolution and regulatory impacts—it fails on core factual accuracy and reasoning. It incorrectly synthesizes a narrative of deepening user perception risk due to regulation, whereas the truth is a de-emphasis of user perception in favor of broader financial and operational risks. Thus, while the answer is plausible and well-structured, it contradicts the ground truth on the direction and nature of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 409,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Based on the provided 10-K disclosures, the notional amount of Lockheed Martin's variable interest rate swaps was $1.3 billion at both December 31 2024 and December 31 2023 (as disclosed in the \"ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk\" section of the 2024 filing). This consistent notional level indicates that the company has maintained a stable hedge position for its variable‑rate debt over the 2021‑2024 period, reflecting a focused strategy to manage interest‑rate exposure without expanding the size of its swap portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the quantitative evolution and the underlying data. The ground truth states that the notional amount increased from $500 million in 2021 to $1.3 billion in 2024, indicating a growing use of variable interest rate swaps. However, the LLM claims the notional amount was $1.3 billion in both 2023 and 2024 and makes no mention of the 2021 figure, incorrectly asserting a 'stable hedge position' over 2021–2024. This misrepresents the trend and the strategic implication. (2) The quantitative accuracy is low: while the 2024 figure ($1.3 billion) matches the ground truth, the 2021 figure is omitted entirely, and the claim of stability contradicts the documented increase from $500M to $1.3B. No evidence is provided for the 2021 or 2022 positions. (3) The multi-hop reasoning fails: the question requires comparing notional amounts across 2021–2024 to assess strategic evolution, but the LLM only reports two years (2023–2024) and draws an incorrect conclusion about stability. It does not address the change from 2021, which is central to the question. (4) The contextual relevance is moderate because it discusses the right topic (interest rate swaps and risk management), uses the correct company and metric, and cites the correct section of the 10-K, but it fails to answer the core question about evolution over the full period and misinterprets the strategy. Thus, despite some relevant elements, the factual and reasoning errors severely undermine the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 420,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal’s Seller Protection Programs have not changed materially between 2022 and 2023; the company continues to offer protection against unauthorized transactions and non-receipt of goods, recording a $64 million allowance for transaction losses in 2023 (up from $66 million in 2022) and recognizing $1.192 billion in provisions for those losses.  The only financial‑provision shift noted is the modest increase in the allowance and related expense, reflecting higher provisions ($1.192 billion in 2023 versus $1.170 billion in 2022) but essentially stable coverage for seller‑related transaction losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. Most significantly, it incorrectly states that the allowance for transaction losses increased from $66 million in 2022 to $64 million in 2023, reversing the actual trend (ground truth: $66M in 2022 to $64M in 2023 — a decrease, not an increase). It also fabricates a 'provision' amount of $1.192 billion in 2023 and $1.170 billion in 2022, which does not appear in the ground truth and is not supported by the question context. These numbers are entirely incorrect and materially distort the financial narrative. (2) Quantitative accuracy is severely compromised: the direction of change in allowance is wrong, and the large 'provisions' figures are invented. The only correct number is $64 million for 2023 allowance, but it mischaracterizes it as an increase. (3) The reasoning is flawed: the LLM concludes that there was 'no material change' and only a 'modest increase', which contradicts the ground truth that PayPal shifted from qualitative risk disclosures in 2022 to more structured, quantified disclosures in 2023 — a significant evolution in approach. The model fails to recognize this key qualitative shift and instead asserts stability. (4) Contextual relevance is moderate because the answer addresses Seller Protection Programs and financial provisions, but the incorrect data and reversed conclusions undermine usefulness. The answer misses the core evolution: increased transparency and quantification in 2023 versus qualitative assessment in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 423,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "The foreign currency‑other derivative position in AOCI declined from $39.6 million (Oct 1 2023) to $11.5 million (Sep 29 2024), a $28.1 million decrease, and this change was reclassified into earnings as $28.2 million of gains during fiscal 2024. Consequently, the net impact on the balance sheet was an increase of $28.2 million in the amount reclassified from AOCI to earnings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers provided—$39.6 million and $11.5 million—are not the derivative asset or liability positions for 'Foreign currency - other' but appear to relate to accumulated other comprehensive income (AOCI), which is a different financial concept. The ground truth states that Starbucks' derivative asset in 'Foreign currency - other' decreased from $1,164 million to $1.9 million, and the liability increased from $2.0 million to $4.7 million. These critical figures are completely absent in the LLM response. (2) The claimed $28.1 million decrease and $28.2 million gain reclassified to earnings do not address the actual balance sheet positions of derivative assets and liabilities, which was the core of the question. (3) The reasoning is flawed: the question asks about changes in balance sheet asset and liability positions, not the reclassification of AOCI gains into earnings. The LLM confuses comprehensive income flows with balance sheet carrying amounts. (4) The entities and metrics are misidentified—'AOCI' is not the same as 'derivative asset/liability', and the fiscal years, while approximately correct (Oct 1, 2023, and Sep 29, 2024), are used in the wrong context. The answer fails to synthesize the correct multi-hop information across fiscal years and balance sheet line items. Despite being numerically precise, the answer is factually wrong and addresses a different question entirely, resulting in very low scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 423,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "The financial impact of energy‑related derivatives on natural‑gas cost and revenue hedging positions shifted markedly from 2022 to 2023.  In 2022 the non‑designated hedges generated a $149 million gain (including $134 million in natural‑gas revenue and $15 million in cost), whereas in 2023 the same category produced a $59 million gain (with $‑11 million in revenue and $59 million in cost), reflecting a reversal of the prior‑year gains and a much smaller overall benefit.  Consequently, the net effect of these hedges on earnings declined substantially, moving from a $149 million positive impact in 2022 to only about $59 million in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. According to the ground truth, in 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on cost, totaling a $144 million negative impact. However, the LLM claims a $149 million gain (with $134 million in revenue and $15 million in cost), which is directionally and numerically wrong. In 2023, the ground truth states a $59 million gain on cost and $0 impact on revenue (net $59 million gain), while the LLM reports a $59 million total gain but with -$11 million in revenue and $59 million in cost—partially correct on cost but wrong on revenue. (2) The numbers are significantly off: the LLM reports gains where the truth reports losses, and the individual components do not match. The $149 million gain in 2022 is entirely fabricated; the actual impact was a $144 million loss. The 2023 cost gain of $59 million is correct, but the revenue impact is stated as -$11 million instead of $0. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the shift from negative to positive impacts and misrepresents the evolution as a decline in benefit rather than a reversal from loss to gain. It incorrectly frames the 2022 impact as positive when it was negative, undermining the entire analysis. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of derivative impacts) and time frame, but the factual inaccuracies severely limit usefulness. Quantitative accuracy is very low due to wrong signs and magnitudes. Qualitative accuracy is low due to incorrect synthesis and logic. Correctness score is 2 due to major factual and directional errors despite partial match on 2023 cost figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 489,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Based on the provided 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as disclosed in Exhibit 10.1 of the 2024 Form 10-K (filed March 15, 2024), confirming its updated documentation status and effective date. The plan remains part of the company's executive compensation structure, with no indication of changes to its effective date between the 2023 and 2024 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: the Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, and this was confirmed in the 2024 10-K filing (Exhibit 10.1), with no change to the effective date. The quantitative accuracy is perfect—dates and documentation details are factually correct and match the ground truth. The answer also correctly notes that the plan remains part of Walmart's executive compensation structure. However, the LLM answer does not fully capture the evolution in documentation status as described in the original answer—specifically, the shift from being 'newly introduced' in the 2023 filing to being 'incorporated by reference' in the 2024 filing, indicating formal integration into ongoing disclosures. This nuance reflects a change in treatment and maturity of the plan's reporting, which the LLM omits. While the core facts are accurate, the qualitative reasoning is slightly less complete in explaining the multi-hop evolution of the plan’s status across filings. The answer remains highly relevant and factually sound, hence a high score, but not full marks due to the missing contextual shift in documentation treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 336,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the dilutive effect and accrual policy of LTIP Units remained consistent with prior practice: no potentially dilutive securities, including LTIP Units, had a material dilutive impact on earnings per share or per unit for the years ended December 31 2023, 2022, or 2024, and LTIP Units were accrued only when declared, with no adjustment to net income attributable to common stockholders or unitholders required.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that LTIP Units were potentially dilutive but had no material dilutive effect in 2023, 2022, and 2024, and that distributions were accrued only when declared—this matches the original answer's description of consistent accrual policy and lack of dilutive impact. (2) All dates (2023, 2022, 2024) are correct and properly associated with the disclosure of no material dilutive effect. The statement about no adjustment to net income attributable to common stockholders or unitholders aligns with the original. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers stability in both disclosure and policy. One minor issue: the LLM says 'no potentially dilutive securities, including LTIP Units, had a material dilutive impact,' which slightly overgeneralizes—while accurate in context, the original specifies that LTIP Units themselves are *potentially* dilutive but with no *actual* material impact, rather than implying no securities at all were dilutive. This nuance is preserved better in the original. (4) Despite this small phrasing difference, the semantic meaning and factual content are equivalent. The answer is fully relevant, complete, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 377,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta’s compliance approach to the EU-U.S. Data Privacy Framework (EU‑U.S. DPF) has shifted from reliance on prior adequacy frameworks to active implementation of the new DPF after its EU Commission adequacy decision in July 2023. The company has taken concrete steps to meet the DPF’s requirements—including adjusting data‑transfer mechanisms, engaging with the Irish Data Protection Commission, and aligning internal processes with the framework—while also preparing for potential CJEU challenges that could disrupt its European operations. At the same time, Meta continues to navigate related regulatory pressures, such as the GDPR, the Digital Markets Act, and the FTC’s ongoing enforcement actions, which collectively drive ongoing compliance‑cost investments and product‑design changes across its European business.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key details and misrepresents the evolution of Meta's compliance approach between 2023 and 2024. (1) Correctly notes the July 2023 EU Commission adequacy decision on the EU-U.S. DPF and Meta’s implementation efforts, which aligns with the ground truth. However, it omits the central event of the €1.2 billion fine and the IDPC’s corrective order to suspend unlawful data transfers—critical regulatory actions that defined Meta’s 2023 compliance posture. (2) Quantitatively, the answer avoids specific numbers except for referencing July 2023, which is accurate; no incorrect figures are stated, so quantitative accuracy is high. (3) The reasoning is partially sound but incomplete: it fails to connect Meta’s 2024 compliance evolution to the 'subscription for no ads' model introduced in November 2023 and the subsequent July 2024 European Commission DMA proceedings, which represent a shift from foundational DPF compliance to scrutiny of business models. This multi-hop synthesis—linking DPF compliance to DMA challenges via new product designs—is missing. (4) The answer broadly addresses regulatory pressures (GDPR, DMA, FTC), but conflates U.S. and EU enforcement contexts without focusing on the specific EU regulatory trajectory described in the ground truth. While contextually relevant and well-structured, it lacks the precise cause-effect progression between enforcement actions and Meta’s strategic responses, reducing qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 417,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde’s approach to green hydrogen production has shifted toward greater emphasis on renewable energy sources and expanded low-carbon hydrogen technologies. The 2024 report highlights that green hydrogen is produced via electrolysis powered by renewable energy, while blue hydrogen involves capturing and sequestering carbon emissions from fossil-based production. This reflects a strategic focus on advancing clean energy solutions through both renewable-powered electrolysis and carbon management in hydrogen manufacturing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Linde's increased emphasis on renewable energy and the use of electrolysis for green hydrogen production in 2024, as well as the distinction between green (renewable-powered electrolysis) and blue hydrogen (fossil-based with carbon capture). It accurately reflects the strategic focus on clean energy solutions. However, it omits key details from the original answer: (1) the 2023 description included green hydrogen from both electrolysis and steam methane reforming of biomethane, which is not mentioned; (2) the 2024 shift to framing green hydrogen as 'renewable hydrogen' with water as feedstock is not captured; and (3) the introduction and emphasis on carbon intensity as a differentiating metric in 2024 is missing. These omissions reduce completeness and qualitative accuracy, though all entities (Linde, green/blue hydrogen, electrolysis, renewable energy) and years (2023–2024) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains contextually relevant and logically sound in its reasoning, but lacks full multi-hop synthesis from both years as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 325,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company sold its Sequent wholesale gas services business to Williams Field Services Group on July 1 2021 for $159 million, generating a pre‑tax gain of about $121 million (after‑tax $92 million). The transaction also triggered $85 million of additional tax expense due to changes in state apportionment rates, and the company recorded an $84 million pre‑tax impairment charge ($67 million after tax) on its PennEast Pipeline investment. Consequently, Southern Company Gas’s segment net income fell from $671 million in 2022 to $630 million in 2023, reflecting the loss of Sequent’s wholesale revenues and the associated tax and impairment impacts.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the date of the sale, which is stated as July 1, 2021, whereas the ground truth confirms the transaction occurred in 2022. This misalignment affects the entire timeline of the relationship evolution between 2022 and 2023. The financial figures of $159 million sale price, $121 million pre-tax gain, and $85 million additional tax expense are consistent with the ground truth and correctly reported. However, the inclusion of an $84 million pre-tax impairment charge on the PennEast Pipeline and after-tax values ($92 million gain, $67 million after tax) introduces extraneous details not present in the original answer and not directly tied to the Sequent divestiture's core financial implications. The claim that Southern Company Gas’s segment net income fell from $671 million in 2022 to $630 million in 2023 is unsupported by the ground truth and appears to be fabricated or misattributed, as no such income figures are mentioned in the original answer. (2) Quantitative accuracy is partially correct: key numbers like $159M sale price, $121M pre-tax gain, and $85M tax expense are accurate, but the incorrect sale date (2021 vs. 2022) undermines temporal accuracy, and the added financial figures (impairment charge, after-tax amounts, segment income drop) are not corroborated. (3) The multi-hop reasoning is flawed: the question asks about the evolution between 2022 and 2023, but the LLM places the sale in 2021, making it impossible to accurately describe the transition during the specified period. The synthesis fails to reflect the correct timeline and misattributes financial impacts. (4) Contextual relevance is moderate—the answer addresses the divestiture and its financial effects, which is relevant, but the incorrect timing and inclusion of unrelated impairments reduce its accuracy. The core financial implications (gain, tax impact) are present, but the narrative is distorted by incorrect dates and extraneous data, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 555,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart’s relationship with the Allswell private‑brand label has shifted from a standalone brand to a more integrated component of its broader private‑brand portfolio. In fiscal 2025 the company highlighted Allswell as part of its “strategic merchandise units” and noted periodic revisions to how private‑brand categories are presented, indicating that Allswell’s assortment is being expanded and aligned with Walmart’s overall private‑brand strategy to drive value and maintain price competitiveness. This evolution reflects Walmart’s focus on consolidating and growing its own‑brand offerings—such as Allswell—across its U.S. segment to strengthen margin control and deepen customer loyalty within its omni‑channel ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness, particularly around timing and entity details. (1) The original answer states that Allswell was introduced in 2023 and retained in 2024, but the LLM references 'fiscal 2025'—a period beyond the scope of the question and not supported by the ground truth—introducing a significant temporal error. (2) The LLM claims Allswell is part of 'strategic merchandise units' and undergoing 'periodic revisions,' information not present in the ground truth; while plausible, these details are unverified and introduce unsupported specifics. (3) The core idea—that Allswell evolved from a new to an established brand within Walmart’s private label portfolio—is consistent with the original answer and reflects correct multi-hop reasoning about strategic positioning. (4) The LLM correctly infers strategic intent (margin control, customer loyalty, price competitiveness), aligning semantically with the original conclusion about Allswell becoming a core component. However, the use of 'fiscal 2025' instead of 2024 undermines quantitative and qualitative accuracy. While the general direction of evolution is correct, the specific evidence cited (e.g., 'strategic merchandise units') is not grounded in the provided truth, suggesting overreach in synthesis. Contextual relevance is high as the response addresses brand evolution and strategic positioning directly. Overall, partially correct but with key factual and temporal errors that reduce reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 416,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products increased from 2022 to 2023, as evidenced by its revenue growth (3% increase to $3.368 billion) and its role in offsetting declines in the Analog segment, which saw a 15% revenue drop. While Embedded Processing operating profit declined (20% decrease to $1.008 billion) due to higher manufacturing costs, its revenue growth and contribution to total revenue (from 16.2% in 2022 to 19.3% in 2023) underscore its rising strategic significance as a key growth driver amid broader segment challenges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, but the LLM claims a 3% increase to $3.368 billion in 2023 and calculates a 16.2% to 19.3% share of total revenue—none of which is supported by the original answer. There is no mention of operating profit or manufacturing costs in the ground truth, yet the LLM introduces a 20% decline in operating profit to $1.008 billion, which is entirely fabricated. (2) The total revenue of $17.52 billion in 2023 is mentioned in the ground truth, but the LLM does not reference this figure directly and instead implies segment-level revenues that do not sum to this total. The percentage contributions (16.2%, 19.3%) and growth rates (3%, 15% Analog decline) are not present in the original answer and appear to be invented. (3) While the LLM correctly identifies the multi-hop idea that Embedded Processing helped offset Analog revenue declines and remained strategically important, it overreaches by introducing unsupported quantitative analysis and financial metrics. The reasoning is partially sound in interpreting strategic role evolution, but the conclusion of 'increased strategic importance' goes beyond the ground truth, which only states it maintained importance and played a 'more pronounced compensatory role'—a nuance lost in the LLM's stronger claim. (4) The contextual relevance is high because the answer addresses revenue composition and strategic emphasis over time, but the quantitative accuracy is very low due to hallucinated numbers. Qualitative accuracy is moderate due to correct conceptual framing but flawed synthesis. Correctness score is low because the core numerical claims are false, undermining the entire argument despite some correct directional logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 502,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "From 2022 to 2024, Chevron’s involvement in Angola LNG evolved from a 36.4 % equity stake in Angola LNG Limited (noted in the 2022 10‑K) to a continued 36.4 % interest reflected in the 2024 filings, with the investment balance decreasing slightly from $1,762 million in 2023 to $1,665 million in 2024 while equity earnings from the project also declined from $513 million (2023) to $405 million (2024). This reduction underscores a strategic shift toward higher‑margin, lower‑risk assets and a focus on core upstream and downstream operations, signaling Chevron’s intent to streamline its LNG portfolio and allocate capital to projects offering stronger returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that Chevron held a 36.4% stake in Angola LNG in 2022 is incorrect per the ground truth, which states that the 36.4% interest was only explicitly stated in 2024; no specific percentage was mentioned for 2022. Additionally, the LLM introduces financial figures—$1,762 million (2023) and $1,665 million (2024) investment balances, and equity earnings of $513M and $405M—that are not present in the original answer and cannot be verified against the provided ground truth. These numbers appear fabricated or misattributed. (2) Completeness: While the question asks about the evolution from 2022 to 2024 and strategic implications, the LLM incorrectly frames the continuity of the 36.4% stake, misrepresenting the timeline. The original answer indicates a progression from operational involvement (2022) to formalized ownership (2024), but the LLM assumes equal specificity in both years. (3) Entity Accuracy: Chevron and Angola LNG Limited are correctly identified, and the 36.4% stake in 2024 aligns with the ground truth. However, the inclusion of unverified financial data (investment balances, earnings) introduces false metrics. (4) Reasoning: The LLM draws an unsupported conclusion about a 'strategic shift toward higher-margin, lower-risk assets' due to declining earnings and investment—this contradicts the original answer, which interprets the evolution as a move toward securing a stable position via formal equity stakes. The reasoning is thus logically inconsistent with the evidence provided. (5) Semantic Equivalence: The overall message diverges significantly—the original emphasizes increasing commitment through equity formalization, while the LLM suggests retrenchment due to declining financials. Despite addressing the general topic and timeframe, the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 526,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH‑53K heavy‑lift helicopter program has grown from a modest contribution in 2021 to a clearly defined revenue stream by 2024, with its sales and backlog now reported as a key part of Lockheed Martin’s Rotary and Mission Systems (RMS) segment.  In the 2024 filing the company notes “higher production volume on CH‑53K” and cites the program among the drivers of a 5 % rise in RMS product sales and a corresponding increase in RMS operating profit, underscoring that the CH‑53K has become a strategic, profit‑generating pillar within RMS and a major contributor to the division’s overall backlog and future earnings outlook.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the qualitative evolution of the CH-53K program correctly—highlighting increased production volume and its growing strategic role within RMS by 2024. However, it omits specific quantitative figures from 2021 and 2024 that are central to the ground truth. In 2021, the program contributed to a $540M increase in net sales and a $140M increase in operating profit, both of which are missing in the LLM response. By 2024, the program contributed $1.1B to higher product sales—this key figure is also absent. Instead, the LLM vaguely references a '5% rise in RMS product sales' without attributing a dollar amount, which is a significant omission. (2) The quantitative inaccuracies are critical: while the 5% increase might be contextually derived, it does not substitute for the $1.1B figure explicitly stated in the ground truth. The absence of the $540M and $140M figures from 2021 undermines the multi-hop comparison. No incorrect numbers are stated, but major ones are missing, reducing quantitative accuracy. (3) The reasoning is sound in interpreting the program’s maturation into a key RMS driver, and the synthesis across time (2021 to 2024) is conceptually valid. The LLM correctly infers strategic importance and production ramp-up, aligning with the 'production ramp-up' phase mentioned in the original. However, the lack of specific financial data weakens the multi-hop analysis. (4) Contextual relevance is high—the answer addresses the program’s financial contribution, production status, and strategic role. But due to missing core financial figures, the correctness score is limited to 6, as the answer is partially correct but lacks essential data needed for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 470,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal’s approach to incorporating macroeconomic factors into its loss curves for revolving consumer credit products evolved in two key ways: First, the forecast period for revolving products was extended from 2 years (in 2022) to approximately 5 years and 7 months (in 2023), reflecting a longer, more comprehensive outlook. Second, the macroeconomic inputs were updated to include household disposable income trends (in addition to unemployment and retail e‑commerce sales) and were sourced from a single external scenario, improving the alignment of loss‑rate projections with current economic conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. While it correctly identifies the addition of household disposable income and retail e-commerce sales as new macroeconomic factors in 2023, it incorrectly states that unemployment rates were retained (the ground truth specifies they were *replaced* after Q1 2023). Additionally, the LLM claims the forecast period was extended from 2 years to 'approximately 5 years and 7 months'—a highly specific number absent from the original answer and unsupported by the ground truth. (2) The quantitative inaccuracy lies in this fabricated forecast duration; no such numbers (2 years, 5 years 7 months) appear in the original answer, making this a clear hallucination. The original only notes a model update, not a change in forecast horizon length. (3) The reasoning is partially sound in recognizing a shift in macroeconomic inputs and improved alignment with economic conditions, but fails the multi-hop synthesis by missing the key point of *replacement* of unemployment with new indicators. It also adds unverified details (forecast length) that distort the factual evolution. (4) Scores reflect: correctness penalized for major factual errors despite some correct elements; quantitative accuracy low due to unsupported numbers; qualitative accuracy moderate for correct identification of some new factors but flawed synthesis; contextual relevance high as the response stays on topic and addresses the evolution of model inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 421,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "From the 2024 10‑K (pages 70‑71), the net pre‑tax gains/(losses) on cash‑flow hedges that remain in AOCI and are expected to be reclassified into earnings within the next 12 months total **$11.5 million** (foreign‑currency‑other) plus **$60.1 million** (coffee) plus **$2.0 million** (dairy) plus **$0.5 million** (cross‑currency swaps) = **≈ $74 million**.  \n\nIn the prior year (2023) the comparable amount was **$39.6 million** (foreign‑currency‑other) plus **$(78.1) million** (coffee) plus **$(1.8) million** (dairy) plus **$39.6 million** (foreign‑currency‑other) = **≈ $0 million** (essentially a net loss).  \n\nThus, the balance of gains/(losses) expected to be reclassified from AOCI into earnings **increased sharply** from near‑zero in 2023 to about **$74 million** in 2024. This jump signals that Starbucks’ foreign‑currency‑related hedges have become more effective at offsetting currency movements, and the company now expects a material amount of those hedging gains to flow into earnings over the next year, indicating heightened exposure to foreign‑currency fluctuations that is being actively managed through its hedging program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The question asks specifically about Starbucks' foreign currency debt-related gains or losses included in AOCI (Accumulated Other Comprehensive Income) from 2023 to 2024 and what that indicates about foreign currency exposure. The ground truth states a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024 — a clear shift from loss to gain. However, the LLM answer cites unrelated figures: it pulls data on expected reclassifications from AOCI to earnings for various hedged items (coffee, dairy, foreign-currency-other, cross-currency swaps), not the actual AOCI balances related to foreign currency debt. The total of ~$74 million in 2024 and ~$0 in 2023 is not the same as the foreign currency debt-related AOCI change and includes non-debt items like coffee and dairy hedges. (2) The numbers cited ($11.5M, $60.1M, etc.) are not from the correct line items. The LLM confuses 'net pre-tax gains/(losses) expected to be reclassified' with the actual AOCI balances related to foreign currency debt. Moreover, it double-counts $39.6 million (foreign-currency-other) in 2023. The calculation is flawed and irrelevant to the question. (3) The multi-hop reasoning fails: the model does not identify the correct metric (foreign currency debt-related AOCI), nor does it compare the correct years for that specific item. Instead, it synthesizes unrelated hedging data across commodity and currency hedges, missing the focus on debt-related foreign exchange impacts. (4) The conclusion — that the jump indicates heightened exposure being managed by hedges — is plausible but based on incorrect data, so it does not align with the ground truth's implication of a reversal in exposure direction. While the answer is structured and references 10-K pages, it addresses a different concept than what was asked, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 524,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Based on the fair value measurements provided in the 2023 and 2022 financial statements, the fair value of energy-related derivatives for Alabama Power decreased from $110 million in 2022 to $15 million in 2023, while Georgia Power’s energy‑related derivative liability increased from $124 million in 2022 to $13 million in 2023. Consequently, the combined liabilities related to these derivatives declined overall, falling from $210 million (Alabama Power $178 million + Georgia Power $32 million) in 2022 to $28 million (Alabama Power $110 million + Georgia Power $13 million) in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Alabama Power's energy-related derivative liability decreased from $110 million in 2022 to $15 million in 2023, but the ground truth shows Alabama Power had a net liability of $144 million in 2022 (not $110M), and in 2023 had $15M in assets and $110M in liabilities (net $95M). The LLM confuses assets and liabilities and misrepresents the 2022 figure. For Georgia Power, the LLM claims a liability increase from $124M in 2022 to $13M in 2023, which is factually backward — $13M is the asset, not the liability, and there is no 2022 liability provided for Georgia Power in the original answer. (2) The combined 2022 liability is incorrectly calculated as $210M (with made-up figures: $178M for Alabama and $32M for Georgia), whereas the correct combined 2022 net liability is $255M (Alabama’s $144M only, as Georgia’s 2022 data is not provided; however, the original answer implies only Alabama reported in 2022). The 2023 combined liability is wrongly stated as $28M instead of the correct $206M (Alabama net $95M + Georgia net $111M). (3) The multi-hop reasoning is flawed: the model fails to correctly extract net liabilities, confuses assets with liabilities, invents numbers for Georgia Power in 2022, and miscalculates totals. It does not properly synthesize the net positions or track changes over time. (4) Despite these issues, the answer attempts to address the question’s structure and trend analysis, hence partial credit for contextual relevance. However, due to severe quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 453,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart moved from a 100 % stake in Alert Innovation to a full acquisition in fiscal 2023, then sold and de‑consolidated the entity in fiscal 2025. The 2024 fiscal year included a $3.5 billion payment to acquire Flipkart non‑controlling interests and settle PhonePe liabilities, while the 2023 fiscal year featured a $0.4 billion buyout of Massmart’s non‑controlling interest and the $0.4 billion purchase of Alert Innovation. Thus, the relationship evolved from acquiring a controlling interest in 2023 to holding a majority stake and later disposing of Alert Innovation by 2025, while simultaneously expanding its stake in other subsidiaries such as Flipkart.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023, it incorrectly states that the sale and deconsolidation occurred in fiscal 2025, whereas the ground truth specifies fiscal 2024. This misalignment in timing undermines the core of the multi-hop evolution being assessed. Additionally, the answer introduces irrelevant financial activities—such as the $3.5 billion Flipkart payment and Massmart buyout—that were not part of the question and distract from the focus on Alert Innovation. (2) Quantitative accuracy is partially correct: the $0.4 billion figure for Alert Innovation is accurate, but the introduction of unrelated $3.5 billion and other figures reduces precision in context. The fiscal year errors (2025 instead of 2024) are critical given the time-bound nature of the question. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the sequence of acquisition (2023) and divestiture (2024), instead extending the timeline incorrectly to 2025. It also conflates Walmart’s activities with unrelated subsidiaries, indicating poor entity tracking and reasoning. (4) Contextual relevance is moderate—the answer addresses Walmart’s relationship with Alert Innovation but dilutes the response with extraneous information. The core evolution from acquisition to divestiture is mentioned but misdated, leading to a mostly incorrect narrative. Overall, major factual and temporal inaccuracies result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 429,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy evolved from receiving U.S. FDA approval for a new indication in adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer (approved in April 2023) and maintaining its existing approvals in metastatic triple-negative breast cancer (TNBC) and urothelial cancer, while also expanding its use in Europe and other regions. This indicates Gilead's oncology strategy is focused on broadening the therapeutic applications of Trodelvy across multiple solid tumor types, leveraging its antibody-drug conjugate platform to target Trop-2 expressing cancers, and using regulatory milestones to drive continued growth and market penetration in both hematologic and solid tumor oncology. The approvals underscore a strategic emphasis on expanding Trodelvy's clinical footprint to maximize revenue potential and address unmet needs in oncology.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory evolution of Trodelvy between 2022 and 2023, noting the April 2023 FDA approval for HR+/HER2- breast cancer, which aligns with the ground truth. It also correctly references existing approvals in TNBC and urothelial cancer, and mentions expansion in Europe (EC approval), which is consistent with the 2023 EC approval in the original answer. While the original answer does not specify the April 2023 date, the LLM’s inclusion of this detail is accurate and adds precision without contradicting the ground truth. (2) There are no numerical values requiring calculation in this question; dates and regulatory bodies (FDA, EC) are correctly cited. The LLM accurately reflects the timeline and scope of approvals. (3) The multi-hop reasoning is sound: the answer synthesizes Trodelvy’s regulatory progression with implications for Gilead’s oncology strategy, correctly inferring a strategic focus on expanding indications and leveraging the ADC platform. It goes slightly beyond the original answer by referencing Trop-2 and solid tumor types, but this is contextually appropriate and consistent with public knowledge and the strategic direction implied in the ground truth. (4) The answer is highly relevant, complete, and factually accurate. The only minor deviation is that the original answer notes no specific regulatory updates in 2022, while the LLM implies ongoing approvals—this is not incorrect, but slightly less precise. Overall, the LLM captures all core facts and provides a well-reasoned, nuanced interpretation of Gilead’s strategy, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 448,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG shifted from active equity ownership to full exit. In Q1 2024, SPG sold its remaining stake in ABG for $1.2 billion in cash, realizing a $414.8 million pre-tax gain, and recorded $103.7 million in tax expense. This followed earlier partial sales in 2023 (including a $157.1 million gain in Q4 2023) and a capital transaction that diluted SPG's ownership from ~11.8% to ~9.6%, triggering a $10.3 million non-cash gain from deemed disposal. These transactions marked the complete exit from its ABG investment, with no remaining equity position after the Q1 2024 sale.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in both factual content and reasoning. (1) Quantitatively, the numbers are wrong: the LLM claims a $1.2 billion sale in Q1 2024 with a $414.8 million gain, but the original answer states no such transaction occurred in 2024—instead, SPG only referenced historical transactions. The claimed $157.1 million gain in Q4 2023 and $10.3 million gain from dilution do not match the ground truth figures of $36.4 million (Q2 2023) and $145.8 million (Q3 2023). These numbers are not close and represent different events. (2) The LLM invents a complete exit via stake sale in Q1 2024, which is not supported by the original answer—SPG did not report any active capital transactions with ABG in 2024, let alone a $1.2 billion sale. (3) Qualitatively, the reasoning is flawed: the original answer describes a shift from active engagement in 2023 to passive, historical referencing in 2024, not a full exit. The strategic partnership context (Forever 21, Brooks Brothers, etc.) is omitted entirely. (4) Contextual relevance is low because the answer fabricates a major transaction not present in the source, though it does address the general topic of SPG’s relationship with ABG. The multi-hop synthesis fails completely—no correct linkage between years, entities, or financial events. The answer reflects a plausible narrative but is factually baseless.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 391,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial reporting reflects a strategic shift in how it accounts for and values its investments, particularly through its 50% ownership of Chevron Phillips Chemical Company LLC and other equity affiliates. In the 2024 consolidated financial statements, the company reports $8.571 billion in investments in downstream entities like Chevron Phillips Chemical, up from $7.765 billion in 2023, with a corresponding increase in equity in earnings to $608 million from $210 million in 2022—indicating stronger performance and valuation of these investments. Additionally, the company discloses that its investment in Chevron Phillips includes a $669 million loan to fund the Golden Triangle Polymers Project, underscoring the financial commitment and integration of these partnerships into its broader strategy. While the text does not explicitly detail the financial value of the Chevron Phillips relationship over the period, the growth in investment balance and equity earnings, alongside the strategic emphasis on lower-carbon ventures and planned capital allocation, suggests a continued and deepening integration of these partnerships into Chevron’s long-term value creation framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but misses the key factual shift in accounting treatment between 2022 and 2024. The ground truth states that Chevron Phillips Chemical Company LLC transitioned from being a consolidated subsidiary (in 2022) to an equity method investee (in 2024), which is a critical structural change in the relationship. The LLM answer fails to mention this shift in consolidation status, instead framing it as a continuation of equity ownership, which is factually incorrect for 2022. (2) Quantitatively, the LLM correctly reports the 2024 investment value of $8,571 million (as $8.571 billion) and the 2023 value of $7,765 million. It also correctly notes the increase in equity earnings from $210 million in 2022 to $608 million in 2024. However, it incorrectly implies Chevron had a 50% ownership stake and was using the equity method in 2022, when in fact the entity was consolidated that year. The $669 million loan for the Golden Triangle Polymers Project is not mentioned in the ground truth and appears to be hallucinated or misattributed. (3) The multi-hop reasoning is partially sound—there is synthesis of financial trends over time and correct identification of Chevron Phillips as a downstream equity investee in 2024—but it fails the core multi-hop requirement of recognizing the change in accounting method, which reflects a change in ownership or control. This omission undermines the qualitative accuracy. (4) The contextual relevance is high because the answer addresses financial reporting, investment value, and strategic implications over the 2022–2024 period. However, due to the failure to identify the key shift from consolidation to equity method—a central fact in the ground truth—the correctness score is limited to 5, reflecting partial accuracy with significant factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 502,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy shifted from active implementation to completion, with the 2022 restructuring initiatives fully concluded by December 31, 2024. The company recorded $31 million in facilities consolidation charges during 2024 (all related to ongoing lease terminations), compared to $1.74 billion in 2023 and $4.10 billion in 2022, reflecting the strategy's wind-down phase. The financial impact diminished significantly as the company completed its office subleasing, early lease terminations, and facility abandonments, with no remaining accrued liabilities for these initiatives as of year-end 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies that Meta completed its facilities consolidation by the end of 2024, the financial figures provided—$31 million in 2024, $1.74 billion in 2023, and $4.10 billion in 2022—are not supported by the ground truth. The original answer does not specify annual breakdowns of facilities consolidation charges, nor does it mention exact dollar amounts for each year. Instead, it states that the 2024 filing included a retrospective summary of pre-tax charges across 2022–2024, but no specific numbers are given in the ground truth. Therefore, the inclusion of precise figures by the LLM is incorrect and misleading. (2) The calculation of diminishing charges and the claim of 'no remaining accrued liabilities' are not present in the original answer and represent unsupported inferences. (3) On qualitative grounds, the LLM correctly tracks the progression from 'substantially completed' in 2023 to 'completed' in 2024, showing accurate multi-hop reasoning across time points and understanding of the restructuring timeline. It also correctly associates the facilities consolidation with the 2022 Restructuring. (4) Contextually, the answer is highly relevant and well-structured, addressing the evolution of both status and financial impact. However, the fabrication of specific financial numbers severely undermines factual correctness, warranting a low quantitative accuracy score and a partial correctness score due to the otherwise sound conceptual framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 438,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin has steadily expanded its hypersonics portfolio from 2022 through 2024, integrating the effort across multiple business segments and linking it to its broader 21st Century Security strategy.  In the 2022 filing the company highlighted “advancing hypersonic capabilities” as part of its innovation pipeline, and by 2024 it was explicitly citing hypersonics among its key growth pillars—alongside AI/ML, autonomous systems, and CJADC2—while noting that the work is being pursued through both internal R&D and strategic partnerships.  Programmatically, the 2022 document referenced early‑stage development and technology demonstrations, whereas the 2024 filing reports that hypersonics projects are now moving toward production and fielding, with specific mentions of Army and Navy hypersonic strike weapons and the Transport Layer satellite constellation that supports proliferated hypersonic operations.  Thus, the company’s focus has shifted from exploratory R&D toward mature program development and eventual deployment, while maintaining a cross‑segment, partnership‑driven approach to accelerate fielding of hypersonic strike weapons.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Lockheed Martin's hypersonics involvement from 2022 to 2024: in 2022, the focus was on early-stage development and technology demonstrations (referred to as 'advancing hypersonic capabilities' and part of the innovation pipeline), dependent on government funding; by 2024, the programs had matured into active production and fielding efforts, explicitly named as key growth pillars alongside AI/ML and autonomous systems. The mention of Army and Navy hypersonic strike weapons and the Transport Layer satellite constellation adds contextual detail consistent with the strategic shift toward deployment. While the original answer emphasizes U.S. Air Force and Army programs, the LLM includes the Navy—plausibly correct but not specified in the ground truth—representing a minor expansion rather than error. The LLM correctly identifies the shift from R&D to production and maintains accurate entity and year references. No numerical data is present, so quantitative accuracy is scored based on correct use of timeframes (2022, 2024) and program status descriptions. The reasoning is sound, demonstrating multi-hop synthesis across years and strategic focus areas. The answer is semantically equivalent to the ground truth, with slightly more detail on strategic context (e.g., 21st Century Security, CJADC2) that enhances completeness without introducing inaccuracies. One point is deducted from qualitative accuracy only because the original answer emphasizes the dependency on government authorization in 2022 more strongly, a nuance slightly underemphasized in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 459,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "Based on the provided SEC 10-K pages, Southern Company's treatment of energy-related derivatives shifted significantly from 2022 to 2023 in terms of designation and financial impact. In 2023, the company designated specific energy derivatives as regulatory hedging instruments (with gains/losses recorded in regulatory assets/liabilities), while previously in 2022, such derivatives were primarily accounted for as non-designated hedging instruments (resulting in volatile pre-tax gains/losses recorded directly in income, such as the $59 million gain in natural gas revenues and $(65) million loss in cost of natural gas for 2022). This evolution reflects a move toward more structured regulatory accounting for hedges, reducing volatility in earnings and improving transparency of the financial impact, particularly in the balance sheet recognition of cumulative fair value adjustments (e.g., $235 million for Southern Company's long-term debt in 2023 versus $282 million in 2022). The shift also aligns with their enhanced disclosure of regulatory hedge accounting in the balance sheet, moving away from the material earnings volatility observed in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Southern Company's derivative disclosures. (1) The Original Answer states that in 2022, Southern reported unrealized gains/losses from derivatives designated as regulatory hedging instruments (i.e., already under regulatory accounting), and in 2023 expanded disclosure to include non-designated derivatives across 2021–2023. The LLM incorrectly claims that in 2022 derivatives were 'primarily non-designated' and caused 'volatile pre-tax gains/losses' — this contradicts the ground truth that they were already designated and deferred. (2) The LLM introduces specific dollar amounts such as '$59 million gain in natural gas revenues' and '$(65) million loss in cost of natural gas for 2022' and '$235 million' vs '$282 million' for long-term debt — none of which appear in the Original Answer or are supported by the provided context. These numbers are fabricated or misattributed. (3) The multi-hop reasoning is flawed: the LLM infers a shift from non-designated to designated instruments, while the actual shift was in disclosure breadth — from only regulatory hedging instruments to including non-hedging instruments in financial statements. The direction of change is misrepresented. (4) While the LLM attempts to address the question about treatment, designation, and financial impact, it does so with incorrect facts and invented data. The contextual relevance is moderate because it discusses derivative accounting and earnings volatility, but the core narrative is factually wrong. Semantic equivalence is not achieved due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 451,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Based on the provided SEC 10-K filings, Gilead's intellectual property strategy regarding Truvada (which contains tenofovir alafenamide [TAF]) evolved between 2022 and 2023 primarily through patent settlements and exclusivity extensions. In September 2022, Gilead settled U.S. patent litigation concerning TAF-protected products (Descovy, Vemlidy, Odefsey) with five generic manufacturers, securing agreements that likely extended market protection. Additionally, in January 2024 (referenced in the 2023 filing), the FDA granted pediatric exclusivity for Veklury, which extended all non-expired exclusivities by six months—though this pertains to Veklury, not Truvada. The 2022 and 2023 patent expiration tables show Truvada's U.S. patent term (as part of fixed-dose combinations) was set to expire in 2029 (with potential extensions noted in footnotes), but the key evolution was the 2022 settlement strategy to manage generic competition and maintain exclusivity through negotiated agreements rather than solely relying on patent term.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents Gilead's intellectual property strategy regarding Truvada between 2022 and 2023. (1) The ground truth states that Truvada lost exclusivity in the U.S. in October 2020, well before 2022, and that Gilead acknowledged this past event as a headwind in 2022. However, the LLM incorrectly suggests that Truvada's U.S. patent term was set to expire in 2029 and that settlements in 2022 extended protection, which contradicts the known loss of exclusivity in 2020. (2) The LLM references a 2022 patent litigation settlement involving TAF-containing products (Descovy, Vemlidy, Odefsey), but these are not Truvada (which contains TDF, not TAF). This reflects a critical entity error—confusing Truvada with other Gilead products. (3) The mention of pediatric exclusivity for Veklury in January 2024 is irrelevant to Truvada and does not support the claim of an evolving Truvada IP strategy. (4) The ground truth emphasizes a shift in disclosure strategy—from discussing the impact of past exclusivity loss (2022) to providing structured future patent expiration timelines (2023). The LLM fails to capture this key evolution in transparency and forward-looking disclosure, instead fabricating a narrative around settlements and extensions that do not apply to Truvada. While the answer correctly identifies that Gilead discussed patent expirations in tables (a minor point of overlap), it fundamentally misrepresents the facts, entities, and strategic shift. Quantitative accuracy is partially preserved in referencing 2022 and 2023 filings, but the 2029 expiration date for Truvada is incorrect given its 2020 loss of exclusivity. The reasoning is flawed due to incorrect multi-hop synthesis—linking settlements on TAF drugs to Truvada is invalid. Contextual relevance is moderate as the answer stays within the domain of IP strategy but applies it to the wrong product and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 523,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG’s use of the Supplemental Facility shifted from a borrowing tool to a repayment vehicle. In 2022, the Partnership drew $1.05 billion under the Supplemental Facility to refinance nine mortgages, then used proceeds from a $1.05 billion note issuance on January 12 2022 to fully repay that draw. Subsequent activity focused on retiring the Facility’s balances—most notably, the $1.0 billion, 2.00 % senior notes matured in September 2024 and the $900 million, 3.38 % notes were redeemed on October 1 2024—effectively eliminating outstanding borrowings under the Supplemental Facility by the end of 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative Accuracy: The $1.05 billion borrowing in 2022 is correctly stated, but the LLM incorrectly claims SPG issued $1.05 billion in notes on January 12, 2022, to repay the draw—this date and causal link are not supported by the ground truth. More critically, the LLM fabricates repayment activity in 2024 related to $1.0 billion and $900 million senior notes maturing in September and October 2024, which are not mentioned in the original answer and contradict the actual events. The ground truth states that in late 2023, SPG borrowed €750.0 million ($815.4 million) under the Supplemental Facility and repaid it on November 17, 2023—this key 2024-relevant activity is entirely omitted. (2) Completeness: The answer fails to mention the 2023 euro-denominated borrowing and its repayment, a central part of SPG’s Supplemental Facility use leading into 2024. It also incorrectly frames the evolution as shifting from 'borrowing tool to repayment vehicle,' which misrepresents the continued short-term borrowing pattern described in the original. (3) Entity Accuracy: While SPG and the Supplemental Facility are correctly identified, the specific notes ($1.0B, $900M) and their maturity/redemption dates are incorrect or hallucinated. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers that retiring other notes equates to eliminating Supplemental Facility borrowings, but the original answer does not support this linkage. It also misses the strategic shift toward structured refinancing via senior unsecured notes as described in the ground truth. (5) Semantic Equivalence: Despite some correct elements (e.g., 2022 borrowing for mortgage refinancing), the omission of key transactions and introduction of false details severely undermines factual alignment. The contextual relevance is fair because the answer addresses the general theme of evolving use, but factual errors dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 539,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife’s capital management strategy has increasingly emphasized maintaining a robust cash buffer to ensure liquidity resilience amid heightened market volatility and regulatory scrutiny. While 2022 highlighted reliance on strong short-term liquidity ($12.4 billion) and liquid assets ($223 billion), the 2024 disclosures underscore a more conservative approach, with heightened focus on stress testing, collateral requirements, and the risks of forced asset sales or collateral calls under adverse market conditions. This evolution reflects a strategic shift toward prioritizing liquidity stability over aggressive capital allocation, ensuring sufficient buffers to meet obligations, support dividend payments, and sustain credit ratings despite evolving regulatory and market pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative figures from 2022—$12.4 billion in short-term liquidity and $223.0 billion in total liquid assets—with accurate formatting and entity alignment. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. (2) The years (2022 and 2024) and company (MetLife) are correctly identified, and the financial metrics (liquidity levels, cash buffers) are appropriate to the question. (3) However, the qualitative reasoning diverges from the ground truth in a key aspect: while the original answer emphasizes a trade-off in 2024 where higher cash buffers could limit capital for innovation, acquisitions, and shareholder returns, the LLM instead frames the shift as a broader conservative strategy focused on stress testing and collateral without mentioning the opportunity cost to capital allocation. This omission affects the completeness and reasoning accuracy of the multi-hop synthesis—specifically, the evolution in strategic implications of cash buffers on capital deployment. (4) The LLM answer remains contextually relevant and captures the increased emphasis on liquidity resilience, but it misses the nuanced shift in capital allocation trade-offs highlighted in the ground truth. Thus, while factually sound on numbers and partially correct on narrative, it falls short on fully conveying the strategic evolution in capital management implications, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 415,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Based on the provided SEC 10-K pages, Starbucks' exposure to \"Foreign currency - other\" derivatives evolved significantly between 2022 and 2023 in both asset and liability classifications. The fair value of the \"Foreign currency - other\" derivative asset decreased from $920 million (as of October 1, 2023) to $1,164 million (as of October 2, 2022) in the asset section, but the liability side also shifted: the derivative liability for \"Foreign currency - other\" decreased from $7.4 million (Oct 3, 2021) to $0.3 million (Oct 2, 2022) in the liability classifications, while in the most recent 2024 data (page 72), the derivative liability for \"Foreign currency - other\" was $4.7 million (accrued liabilities) and $2.5 million (other long-term liabilities) as of September 29, 2024. This indicates a reduction in liability exposure but a notable increase in the asset value from 2022 to 2023, with the asset peaking at $920 million in 2022 before declining slightly in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had a 'Foreign currency - other' derivative liability of $0.3 million and no asset, but the LLM incorrectly states there was a derivative asset of $1,164 million in 2022 and $920 million in 2023—these numbers are off by orders of magnitude (mixing up millions with hundreds of millions). The LLM also references 'October 1, 2023' and 'October 2, 2022' as if those are the fiscal years in question, but the question is about 2022 and 2023 fiscal years, and the correct reporting dates are not accurately tied to the data. (2) The liability numbers are partially correct: $0.3 million in 2022 and $4.7 million in 2023 under accrued liabilities match the ground truth, but the LLM incorrectly adds a $2.5 million liability under 'other long-term liabilities' as of 2024, which is irrelevant to the 2022–2023 comparison. The asset values are completely wrong—the LLM claims assets of over $900 million, while the correct 2023 asset is $1.9 million. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution from 2022 to 2023, instead introducing incorrect data from unrelated years (2021, 2024) and misrepresenting the scale and direction of change. It incorrectly claims asset values decreased from $1,164M to $920M, when in reality, the asset went from $0 to $1.9M—an increase, not a decrease. (4) The contextual relevance is moderate because the answer addresses derivative classifications and attempts a year-over-year comparison, but the massive numerical errors and inclusion of irrelevant data severely undermine correctness. The qualitative reasoning is poor due to incorrect entity mapping (wrong years, wrong amounts, wrong classifications).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 489,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "From 2023 to 2024, The Coca-Cola Company’s strategic engagement with Coca-Cola FEMSA evolved through both equity investment and deeper operational integration. Coca-Cola FEMSA remains a key equity method investee, with the Company holding a 28% stake as of December 31, 2024, and continues to benefit from significant sales of beverage products to and through FEMSA, supporting its bottling operations globally. Financially, the Company’s involvement includes maintaining a strategic equity position and leveraging relationships that enhance system-wide efficiency, though no major structural changes in ownership or control were indicated during this period. Additionally, the Company’s use of financial instruments, including hedging strategies, reflects ongoing efforts to manage risks associated with its investments in bottling partners like FEMSA.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA as of December 31, 2024, which aligns with the ground truth. However, it fails to mention the key evolution from 2023—where Coca-Cola FEMSA was one of the top five independent bottling partners contributing to 42% of worldwide unit case volume—before transitioning into an equity method investee in 2024. This shift is central to the question and is underemphasized in the LLM answer, which instead suggests ongoing operational integration without clearly acknowledging the structural change in relationship. (2) The numeric value of 28% is accurate and correctly attributed to the end of 2024. There are no calculation errors, and the date reference (December 31, 2024) is consistent with typical reporting standards. (3) The multi-hop reasoning is partially sound—the model connects equity stake and strategic engagement—but misses the critical contrast between the 2023 bottler status and the 2024 equity investee shift. The answer implies continuity rather than transformation, misrepresenting the nature of the evolution. (4) While the LLM answer is contextually relevant and includes accurate financial terminology (e.g., equity method investee, hedging strategies), it omits the core factual pivot in the relationship: the move from a top-volume independent bottler to a strategically owned investee. This omission reduces correctness despite accurate individual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 411,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Intel's strategic positioning of FPGAs has evolved from being a standalone IP offering to a core component of its broader product portfolio and adjacent markets. By 2024, FPGAs are integrated into key platforms like the Infrastructure Processing Unit (IPU) and are critical to Intel's focus on AI, networking, and edge computing, supporting adjacent products such as Mobileye and NEX. This shift reflects a strategic pivot toward high-growth areas like AI and data center solutions, with FPGAs enabling flexible, programmable solutions that complement Intel's core CPU and accelerator offerings, while also being tied to initiatives like the CHIPS Act and Smart Capital investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in entity identification and reasoning compared to the ground truth. (1) Correct elements: The general idea of FPGAs gaining strategic importance by 2024 and being tied to AI, networking, and edge computing aligns with the direction of the original answer. The mention of FPGAs supporting adjacent markets is thematically relevant. (2) Quantitative accuracy: There are no specific numbers, dollar amounts, or percentages in either answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM fails to accurately reflect the structural evolution within Intel's reporting segments. The ground truth specifies that in 2022, FPGAs were categorized as 'adjacent products' within CCG, DCG, and IOTG, and by 2024 were elevated to direct product definitions—indicating a shift from supplementary to core. The LLM incorrectly frames this as a shift from 'standalone IP offering' (not mentioned in ground truth) to core component, which misrepresents the initial positioning. Additionally, the LLM introduces unverified entities such as integration into IPU, Mobileye, NEX, CHIPS Act, and Smart Capital—all absent from the original knowledge base and unsupported by the provided context. (4) Justification for scores: Correctness is scored 5 due to plausible thematic alignment but major factual deviations in strategic narrative and unsupported claims. Qualitative accuracy is 5 because while the direction of strategic elevation is sensed, the reasoning and entity usage are flawed. Quantitative accuracy is 10 by default (no numbers involved). Contextual relevance is 8 because the response stays on topic and addresses the evolution of FPGA positioning, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips increased its Lower 48 proved reserves from 2,775 MMBOE to 2,775 MMBOE (essentially stable) and added significant extensions and discoveries, while depreciation, depletion and amortization (DD&A) expenses for the Lower 48 rose sharply—from $4,053 million in 2022 to $5,729 million in 2023—reflecting higher depletion of the added reserves and increased capital spending. This indicates that while reserve quantities held steady, the company’s DD&A expense for the region grew substantially due to both the added reserves and higher investment in development.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. It states that DD&A expenses were $4,053 million in 2022, but the ground truth reports $4,854 million—a substantial difference of $801 million. This error undermines the reliability of the financial analysis. The 2023 figure ($5,729 million) is correct. The claimed increase in DD&A is therefore misrepresented: the LLM implies an increase of $1,676 million, while the actual increase is $875 million. Additionally, the LLM introduces information about proved reserves being stable at 2,775 MMBOE, which is not mentioned or supported in the original answer and may be factually incorrect or irrelevant. (2) The calculation of the year-over-year change in DD&A is incorrect due to the wrong 2022 baseline. While the 2023 number is accurate, the core financial comparison is flawed. (3) The reasoning is partially sound in linking higher DD&A to increased investment and depletion, which aligns with the original answer’s implication of continued asset utilization post-acquisition. However, the LLM fails to mention the Concho acquisition as the key driver of 2022 activity, which is a critical multi-hop element from the original answer. Instead, it fabricates or misattributes the cause to 'extensions and discoveries' and stable reserves, which are not in the ground truth. (4) Despite correct mention of the 2023 DD&A figure and the general trend of increasing expenses, the major numerical error and introduction of unsupported data (reserves, incorrect 2022 DD&A) reduce the correctness score. The qualitative reasoning is plausible but based on incorrect inputs. Contextual relevance is high as the answer addresses the right region, time frame, and financial metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 485,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson’s ownership stake in AspenTech increased from 55% to approximately 57% following its 2022 acquisition of Heritage AspenTech, which created \"New AspenTech\" and gave Emerson a controlling interest. Financially, the integration of AspenTech (particularly the Test & Measurement acquisition) contributed to a 1.8 percentage point rise in gross margin in 2024, although this was partially offset by a $231 charge from acquisition-related inventory step-up amortization that negatively impacted margins by about 1.3 percentage points.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $231 million charge from acquisition-related inventory step-up amortization and its 1.3 percentage point negative impact on gross margins in 2024, as well as the 1.8 percentage point positive contribution to gross margin. However, it incorrectly states that Emerson increased its ownership from 55% to 57%, while the ground truth states Emerson owned 55% by 2024 (not starting at 55% and increasing). The acquisition occurred in 2022, but the LLM implies a post-2022 increase without clarifying the initial stake. Additionally, the LLM incorrectly attributes the margin improvement to the 'Test & Measurement acquisition,' which is not mentioned in the ground truth and appears to be a factual error. (2) Quantitative accuracy issues: the ownership percentage evolution is wrong (no source for 57%), and the claim of increase lacks support. The $231 million and 1.3/1.8 percentage point figures are accurate. However, the ground truth specifies that the 1.8 percentage point increase brought gross margins to 50.8%, which the LLM omits entirely—this is a significant missing data point. Also, the 2023 0.6 percentage point impact is completely omitted. (3) Multi-hop reasoning is partially sound—linking acquisition integration to margin impact and adjusting for amortization shows synthesis—but the incorrect attribution to a non-existent 'Test & Measurement acquisition' undermines reasoning validity. The ownership timeline is misrepresented, failing to accurately trace the evolution from 2022 to 2024. (4) Correctness score is 5 due to partial factual accuracy: key financial figures are correct, but major errors in ownership timeline, missing 2023 data, and introduction of a false acquisition event reduce overall accuracy. Quantitative accuracy is 5 due to correct $231M and margin impact numbers but incorrect ownership percentages and missing 50.8% margin figure. Qualitative accuracy is 5 due to correct high-level structure but flawed entity and causal attribution. Contextual relevance is 8 because the answer addresses the core themes of ownership and margin impact, even with factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 593,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan experienced a net increase in available shares due to recoveries, despite ongoing issuances. As detailed in the 2022 filing (page 334), \"Additional Shares recovered for issuance since January 1, 2015\" totaled 31,545,071, with 32,867,851 shares covered by new awards and reinvested dividends, leaving 34,073,114 shares remaining available for future issuance. By 2024, the 2024 equity compensation data (page 310) shows 30,660,961 shares remained available for future issuance under the plan, reflecting a reduction from the 2021 baseline due to new award grants and recoveries. Share recovery mechanisms—such as forfeited awards, cash settlements, or tendered shares for tax withholding—continued to replenish the pool, though issuance of new awards consistently utilized shares from this recovered reserve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and misrepresents the trend in available shares. The ground truth states that by 2024, 37,608,213 shares were recovered between 2015 and 2024, while the LLM claims 31,545,071 recovered shares as of 2022 — a material discrepancy. Additionally, the LLM incorrectly states that there was a 'net increase in available shares due to recoveries', which contradicts the ground truth indicating a net reduction in available shares over time despite recovery. The correct number of shares available in 2024 is 30,660,961, which the LLM does correctly report, but it mischaracterizes the trend leading to that number. (2) The LLM cites 32,867,851 shares covered by new awards and reinvested dividends (vs. ground truth 42,343,146), a major undercount. The 2022 filing reference to 34,073,114 shares available is not in the ground truth and appears fabricated or misattributed. The ground truth does not provide a 2022 availability figure, but the LLM invents one not supported by the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the balance between recoveries and issuances over time. It incorrectly infers a net increase in available shares when the ground truth clearly states a net reduction. While it correctly identifies mechanisms like forfeiture and cash settlement as sources of share recovery, it misapplies the quantitative impact. (4) Contextual relevance is high — the answer addresses share recovery, issuance mechanics, and evolution over time — but the qualitative and quantitative inaccuracies severely undermine correctness. The conclusion is factually reversed from the ground truth, warranting a low correctness and quantitative accuracy score despite relevant structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 497,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Starbucks’ strategic emphasis shifted toward reinvesting in its partners and stores—evidenced by the temporary suspension of share repurchases in April 2022 to fund higher labor wages, expanded training, and technology initiatives—while maintaining its Global Coffee Alliance as a growing revenue stream. Although specific revenue contribution figures for the Alliance are not disclosed in the provided excerpts, the 2022 10‑K notes that “Other revenues” (which include royalty income and product sales from the Alliance) rose $216 million, underscoring its increasing importance to the company’s overall top line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions. While it correctly identifies that the Global Coffee Alliance contributes to revenue through royalties and product sales, it cites a $216 million increase in 'Other revenues' for fiscal 2022, which contradicts the ground truth stating a $250 million increase in the Channel Development segment specifically driven by the alliance. This number discrepancy is significant and incorrect. Additionally, the LLM fails to mention the evolution in strategic emphasis in fiscal 2023—namely, the explicit highlighting of the Nestlé licensing relationship as a core distribution channel and strategic enabler of global reach. Instead, it shifts focus to Starbucks' reinvestment in partners and stores, which, while contextually relevant to Starbucks’ broader strategy, is not directly related to the evolution of the Global Coffee Alliance. (2) The quantitative inaccuracy is critical: $216M vs $250M is a material difference, and 'Other revenues' is not equivalent to the Channel Development revenue driven by the alliance. The ground truth does not mention 'Other revenues' rising $216M, so this figure appears to be fabricated or misattributed. (3) The multi-hop reasoning is weak: the model fails to connect fiscal 2022 revenue impact with the fiscal 2023 strategic shift in how the alliance is positioned. It does not synthesize the evolution from revenue driver to strategic enabler, which is the core of the question. (4) Scores reflect partial credit for recognizing the alliance as a revenue contributor and mentioning royalty income, but major deductions for incorrect numbers, missing strategic evolution, and introducing irrelevant details about share repurchases and labor investments that divert from the specific question about the alliance’s evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 497,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE’s stake in the Mountain Valley Pipeline was fully written off, with an approximately $1.2 billion impairment charge recorded in 2023 that primarily reflects the write‑down of its investment in the pipeline. This impairment, disclosed in Note 4 (Nonrecurring Fair Value Measurements) and noted in the equity‑method investment summary, indicates that NEE has largely exited or de‑prioritized its investment in the project, shifting its capital focus toward renewable‑energy assets and away from the pipeline’s troubled expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, it claims a $1.2 billion impairment charge and a full write-off of NEE's stake in the Mountain Valley Pipeline in 2023, which contradicts the ground truth: there is no mention of an impairment or write-off in the original answer. Instead, the original states that NEE’s equity method investments were $6,159 million in 2022 and $6,156 million in 2023, indicating minimal change in total investment value. The 32%–55% ownership range in 2022 shifted slightly to 32.8%–52.6% in 2023, suggesting a minor realignment, not a write-off. (2) The LLM incorrectly interprets the mention of the Mountain Valley Pipeline in 'Nonrecurring Fair Value Measurements' as evidence of an impairment, while the original answer only notes this as a possible revaluation or change in financial treatment—nowhere implying a $1.2 billion charge. (3) Qualitatively, the reasoning is flawed: the LLM infers a strategic exit from the pipeline and a shift to renewables, but the ground truth does not support this conclusion. The original answer suggests a refined investment posture due to narrowed ownership ranges, not a de-prioritization. (4) Contextually, the answer addresses the right topic—NEE’s evolving stake in the pipeline—but misrepresents the nature and direction of that evolution. The core claim (write-off) is unsupported, making the answer highly inaccurate despite addressing the general subject area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 409,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim therapy product line evolved with the introduction of newer, more advanced neurostimulators, including the InterStim Micro (rechargeable) and InterStim X (recharge-free) systems, which expanded therapeutic indications to include chronic pain, Diabetic Peripheral Neuropathy (DPN), and overactive bladder. The company also advanced its closed-loop technology with the FDA approval of the Inceptiv SCS device in April 2024, enhancing treatment personalization for chronic pain. These innovations reflect a strategic shift toward integrated, AI-driven solutions within the Neuroscience segment, particularly under the AiBLE ecosystem, supporting broader adoption of neuromodulation therapies.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, InterStim therapy in 2022 included InterStim II, InterStim Micro, and InterStim X, targeting overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line retained InterStim II and InterStim X (now labeled 'recharge-free') and expanded to include 'chronic fecal incontinence.' However, the LLM incorrectly states that indications expanded to include 'chronic pain' and 'Diabetic Peripheral Neuropathy (DPN),' which are not supported by the original answer and represent unrelated therapeutic areas for this product line. Additionally, the mention of the 'Inceptiv SCS device' and 'closed-loop technology' with FDA approval in April 2024 is factually incorrect in this context—Inceptiv is a spinal cord stimulator (SCS) for chronic pain, not part of the InterStim sacral neuromodulation system for bladder and bowel dysfunction. (2) There are no numeric values or dates in the original question/answer that require calculation, but the LLM introduces a specific date—'April 2024'—for an FDA approval that is not present in the ground truth, making it a fabricated detail. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of the InterStim product line and instead conflates it with other Medtronic neuroscience products (e.g., SCS devices and AiBLE ecosystem), which are not mentioned in the original answer. This reflects a failure to distinguish between different neuromodulation platforms. (4) While the answer is framed around product evolution and innovation—which is contextually relevant—the core facts about neurostimulator models and indications are incorrect. The strategic shift toward AI-driven solutions and the AiBLE ecosystem, while possibly true for Medtronic broadly, are not part of the documented evolution of InterStim therapy between 2022 and 2024 per the ground truth. Thus, the answer is largely incorrect despite addressing the general theme of product advancement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 553,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 through 2024 Simon’s stake in Authentic Brands Group (ABG) was reduced via a series of capital transactions that generated multiple non‑cash gains. In 2022 the company sold a portion of its ABG interest for $65.5 million and later repurchased additional ABG equity for $100 million, while also recording a $159 million gain from exchanging its licensing‑venture interests for more ABG equity. In 2023 and early 2024 Simon sold further ABG holdings for $1.2 billion in cash, realizing a $414.8 million pretax gain, and its ownership fell to roughly 9.6 % after a dilution‑driven disposal that produced an additional $10.3 million non‑cash gain. By the end of 2024 Simon owned only about a 9 % non‑controlling interest in ABG, having previously held a larger stake, and the relationship shifted from a significant equity investment to a modest, passive holding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both numbers and timeline, failing to align with the ground truth. (1) Quantitative inaccuracy: The original answer states Simon held a 1.37% interest in ABG in 2022 and later sold a portion (with a $18.8M pre-tax gain) and then acquired additional interests for $100M. The LLM claims Simon sold part of its stake for $65.5M in 2022, recorded a $159M gain from an exchange, and later sold holdings for $1.2B in 2023–2024 realizing $414.8M gain—none of which appear in the ground truth. The final ownership of '9%' or '9.6%' is contradicted by the original answer, which does not specify post-2024 ownership but implies ongoing strategic activity, not a reduction to a passive 9% stake. (2) The $18.8M pre-tax gain from the partial sale is misrepresented in the LLM answer as multiple large gains ($159M, $414.8M), which are entirely fabricated. The $100M cash acquisition is mentioned but incorrectly framed as a repurchase after a prior sale, whereas the original answer does not mention a prior sale in 2022—only a 1.37% stake and operational merger via SPARC. (3) Qualitatively, the LLM invents a narrative of stake reduction and passive shift not supported by the original, which describes a dynamic but not necessarily declining relationship. The mention of SPARC and Forever 21 merger is omitted, weakening the strategic context. (4) Contextually, the answer addresses the evolution of the financial stake and mentions cash transactions and ownership changes, so it remains relevant in structure and intent, but the factual foundation is incorrect. Multi-hop reasoning fails as the model appears to hallucinate data rather than synthesize from the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 468,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses related to its Lower 48 operations have increased steadily from 2021 to 2023, reflecting higher capital investment and resource development in the region. According to the 2023 10-K (page 158), DD&A expenses for the Lower 48 segment were $5,729 million in 2023, up from $4,854 million in 2022 and $4,067 million in 2021. This upward trend aligns with increased capital expenditures in the Lower 48, which rose to $6,487 million in 2023 (page 135) from $3,129 million in 2021, driven by acquisitions and expanded drilling activities. The company's investments in the Lower 48, including the Concho and Shell Permian acquisitions, have directly contributed to higher DD&A expenses as it develops and produces natural gas liquids and other resources in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the DD&A expense for 2021 ($4,067 million) and 2023 ($5,729 million), matching the ground truth. However, it introduces a 2022 figure of $4,854 million, which is not present in the original answer and cannot be verified from the provided ground truth. While this value may be accurate, its inclusion goes beyond the confirmed data and introduces unverified information. (2) The core quantitative trend — an increase from $4,067M in 2021 to $5,729M in 2023 — is correct and properly emphasized. The additional capital expenditure figures ($6,487M in 2023 vs $3,129M in 2021) and references to acquisitions (Concho, Shell Permian) are contextually relevant and support the explanation, though they are not part of the original answer. These additions improve completeness but are not required for correctness. (3) The multi-hop reasoning is sound: the model links rising DD&A to increased investment activity, correctly inferring that higher capital spending and acquisitions led to greater asset base and thus higher depreciation and depletion. This aligns with financial logic and the intent of the question. (4) The answer is highly relevant and provides a well-reasoned, detailed explanation that expands on the original with plausible supporting data. The deduction in quantitative accuracy is due to the inclusion of an unverified 2022 DD&A number. Despite this, the main trend and conclusion remain factually consistent with the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 422,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds in its pension and postretirement benefit plans remained consistent between 2023 and 2024, with no significant changes observed in the asset allocation or valuation methodology. In 2023, international bonds were valued using matrix prices with input from independent third-party valuation sources, and were classified as Level 2 assets. By 2024, the same valuation approach was maintained, with international bonds still classified as Level 2 assets, comprising $113 million in total international bond holdings at fair value as of December 31, 2024. The company continued to use independent third-party sources for valuation, and international bonds remained a minor component of the overall portfolio, representing approximately 2.7% of total pension plan assets ($113 million out of $4,146 million total investments at fair value). The allocation strategy emphasized liability hedging assets, but international bonds were not specifically highlighted as a separate category in the 2024 target allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2024, international bonds were specifically itemized with a total value of $12 million ($10 million Level 1, $2 million Level 2), whereas the LLM claims $113 million in Level 2 only, which is factually wrong. The total pension plan assets are also misrepresented: LLM states $4,146 million total investments, which does not align with the ground truth and appears fabricated. (2) The numbers are not accurate: $113 million vs. $12 million is a significant discrepancy. The classification of all international bonds as Level 2 in 2024 contradicts the ground truth, which specifies $10 million in Level 1 and $2 million in Level 2. The 2.7% portfolio share is not verifiable from the ground truth and appears to be based on incorrect inputs. (3) The reasoning is flawed: the LLM concludes that the valuation approach 'remained consistent' and 'no significant changes observed', but the ground truth explicitly describes a shift from a general description in 2023 to a more detailed, segmented disclosure in 2024—indicating increased transparency and a more refined approach. The LLM fails to recognize this evolution, missing the core of the multi-hop comparison. (4) Contextual relevance is moderate because the answer discusses valuation methods and pension assets, which are relevant topics, but the incorrect data and misinterpretation of the trend severely undermine accuracy. The answer invents figures and misses the key evolution in disclosure granularity, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 445,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved from a 55% ownership stake (acquired in 2022) to a proposed full acquisition at $240 per share in November 2024, implying a $15.3 billion fully diluted market capitalization. Financially, Emerson's stake was valued at approximately $8.3 billion in goodwill and intangibles by 2022, with AspenTech contributing $7.3 billion in acquisition-related intangibles. Operationally, AspenTech's results were integrated into Emerson's segment reporting, with its software business (including the 2023 National Instruments acquisition) driving significant growth in Software and Control segment sales (+48% in 2024). The proposed acquisition would transition AspenTech from a partially owned subsidiary to a fully owned entity, though the deal remained subject to market conditions and regulatory review.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Emerson had a 55% ownership stake in AspenTech in 2022, while the ground truth indicates that the 55% stake resulted from the 2024 restructuring, not from 2022. The LLM also claims a proposed full acquisition at $240 per share in November 2024 with a $15.3 billion valuation, which is not supported by the original answer and contradicts the actual evolution described (a contribution to form 'New AspenTech', not a full acquisition). The $8.3 billion valuation is close to the correct $8,326 million financial stake in 2022, so this number is approximately accurate. However, the claim that AspenTech contributed $7.3 billion in acquisition-related intangibles is not in the ground truth and appears fabricated. (2) The LLM misrepresents operational integration: while it correctly notes integration into segment reporting, it introduces the National Instruments acquisition (not mentioned in the ground truth) and falsely attributes segment growth to this integration. The ground truth emphasizes the formation of 'New AspenTech' with a $6.0 billion cash contribution and retained 55% ownership, none of which is accurately reflected in the LLM answer. (3) The multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution from a financial stake in 2022 to a restructured majority-controlled entity in 2024. Instead, it invents a narrative of a pending full acquisition, which is not supported. It also confuses goodwill and intangibles with the actual financial stake value. (4) The contextual relevance is moderate because the answer addresses financial stake and operational integration, but the factual errors in key numbers, ownership timeline, and strategic actions severely undermine correctness. Quantitative accuracy is low due to incorrect figures and invented metrics. Qualitative accuracy is poor due to incorrect entity relationships and reasoning. Correctness score is low because the core facts about the nature and direction of the relationship evolution are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 562,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' interest rate swap position evolved in classification and liability structure as reflected in the fair value disclosures. In the 2022 filing (page 66), interest rate swaps were disclosed as derivative liabilities under \"Other long-term liabilities\" with a cumulative fair value hedging adjustment of $(52.3) included in the carrying amount of the hedged long-term debt. By the 2023 filing (page 70), the same hedging relationship showed a revised carrying amount of the hedged item at $332.2 million (up from $1,047.7 million in 2022? Note: This appears to be a data inconsistency in the source, but the key evolution is in classification and reporting), with the cumulative fair value hedging adjustment now showing $(17.8) as of September 29, 2024 (previously $(52.3) as of October 2, 2022). The notional value of interest rate swaps designated in fair value hedging relationships increased significantly, with the 2023 filing (page 71) showing $350 million in fair value hedging instruments and $1,100 million in cross-currency swaps, while the 2022 filing (page 68) reported $22.7 million in interest rate swaps as of October 2, 2022. The liability classification remained under \"Other long-term liabilities\" for derivative liabilities, but the scale and specific components of the swaps shifted, including a notable increase in designated interest rate swaps tied to long-term debt hedging. No material transfers between fair value levels occurred, and the swaps continued to be classified as Level 2 inputs. The associated liabilities for these swaps were consistently reported in \"Other long-term liabilities\" with derivative liabilities of $43.2 million in 2023 (page 74) compared to $34.0 million in 2022 (page 69), reflecting growth in the swap portfolio. The evolution indicates a strategic expansion in the use of interest rate swaps for hedging long-term debt, with enhanced disclosure of fair value adjustments and reclassification impacts from AOCI to earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the general topic of Starbucks' interest rate swaps. (1) The original answer states that in 2022, the interest rate swap liability was $34.0 million (correctly cited by the LLM), but in 2023, it was split into $0.4 million (current) and $19.2 million (long-term), totaling $19.6 million—a net decrease. However, the LLM incorrectly claims derivative liabilities increased to $43.2 million in 2023, which contradicts the ground truth. (2) The LLM cites a 'cumulative fair value hedging adjustment' of $(17.8) as of September 29, 2024, which is a future date relative to the 2023 filing and factually incoherent. (3) It references a carrying amount of hedged item dropping from $1,047.7 million in 2022 to $332.2 million in 2023, but then questions it as a 'data inconsistency'—this is not in the ground truth and introduces unverified data. (4) The LLM reports notional values like $350 million in fair value hedging and $1,100 million in cross-currency swaps in 2023, and $22.7 million in 2022—none of which appear in the original answer and contradict the stated liability evolution. (5) The classification shift—from solely long-term in 2022 to both current and long-term in 2023—is completely missed by the LLM, which claims the liability 'remained under Other long-term liabilities', directly contradicting the ground truth. (6) The LLM introduces concepts like 'Level 2 inputs' and 'AOCI reclassifications' that, while potentially present in filings, are not part of the original answer and distract from the core classification and liability trend. While the answer demonstrates awareness of hedging disclosures and attempts multi-hop reasoning using page references, the core quantitative and classification facts are incorrect. The reasoning is undermined by reliance on extraneous or misinterpreted data. The answer is contextually relevant in topic and structure but fails on factual correctness, especially regarding the direction of liability change (increase vs actual decrease) and classification evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 570,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "From 2022 to 2023, NextEra Energy Resources’ involvement with the Mountain Valley Pipeline shifted from an active development participant to a largely withdrawn investor. In early 2022 the company recorded an approximately $0.8 billion (pre‑tax) impairment charge after determining that legal and regulatory hurdles made completion of the pipeline “very low probability,” effectively writing down its equity stake. By 2023 the company’s disclosures focus on contractual obligations and capital‑expenditure tables that reference the pipeline only as a minor, non‑core commitment (e.g., a $70 million‑per‑year gas‑transport agreement and a $1.065 billion joint‑venture liability), with no indication of further investment or development activity. In short, NEE’s financial commitment to the project was essentially frozen and its equity interest was fully impaired by 2022, leaving only limited, passive contractual obligations in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.8 billion impairment charge in 2022 and the $70 million annual obligation in 2023, which aligns with the ground truth. However, it introduces a $1.065 billion joint-venture liability not present in the original answer, which lacks support in the provided ground truth and may be factually incorrect or misleading. Additionally, the characterization of NextEra Energy Resources (NEER) as having 'withdrawn' or being in a 'passive' state is partially inaccurate—while NEER fully impaired its investment in 2022, it still maintained a 32.8% equity investment in the joint venture in 2023 and committed to a long-term transportation agreement, indicating continued, albeit conditional, involvement. (2) The $0.8 billion and $70 million figures are accurate and correctly attributed. The $1.065 billion figure is unverified and not in the original answer, introducing a significant quantitative error. (3) The reasoning partially fails on multi-hop synthesis: while it captures the impairment and ongoing obligation, it misrepresents the nature of NEER’s 2023 involvement by omitting the explicit 32.8% equity stake retention and framing the commitment as minor and passive, contrary to the original answer’s emphasis on active contractual commitment subject to completion. (4) Correctness is scored 6 due to accurate core numbers but significant omission of key detail (32.8% stake) and introduction of unsupported liability figure. Quantitative accuracy is 5 due to one major unverified number. Qualitative accuracy is 6 due to sound logic on impairment but flawed interpretation of ongoing involvement. Contextual relevance is 9—response stays on topic and addresses the evolution, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 478,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Company’s captive insurance subsidiary that reinsures group annuity contracts held $1.883 billion of equity securities and $1.643 billion of debt securities as of December 31 2024, compared with $1.643 billion of equity and $1.378 billion of debt securities at the end of 2023. This represents an increase in the captive’s solvency‑capital investment in marketable equity and debt securities between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative details. According to the ground truth, the total amount of equity and debt securities held by the captive insurance company was $1,643 million in 2023 and increased to $1,883 million in 2024. However, the LLM incorrectly states that $1.643 billion was held in equity securities and $1.378 billion in debt securities at the end of 2023, implying a total of $3.021 billion, which is not supported by the data. Similarly, for 2024, it reports $1.883 billion in equity and $1.643 billion in debt, totaling $3.526 billion—far exceeding the correct total of $1,883 million. The LLM appears to have misinterpreted the data, possibly confusing total investments with separate equity/debt breakdowns that are not present in the original answer. There is no mention in the ground truth of a split between equity and debt securities—only the total amount is reported. While the LLM correctly identifies the direction of change (increase) and the correct years and entity (captive insurance company reinsuring group annuity contracts), the core numerical claims are factually incorrect. This undermines the multi-hop synthesis, as the model introduces false granularity (equity vs. debt breakdowns) not supported by the source. The contextual relevance is moderate because it addresses the right entity and time frame and notes an increase, but the incorrect figures render the answer misleading. Semantic equivalence fails due to the invention of unsupported component values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 419,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's Intel 4 node transitioned from limited 2023 client‑product shipments (Core Ultra Series 1) to high‑volume manufacturing in Ireland in 2024, positioning it as the foundation for upcoming 2025 products such as Panther Lake on Intel 18A. The company is leveraging Intel 4’s density and ~20% performance‑per‑watt gains to support its IDM 2.0 strategy and to fund further advances to Intel 3 and Intel 18A, while maintaining Intel 7 for the bulk of its 13th/14th‑gen Core processors. This evolution underscores Intel 4’s strategic role in bridging current revenue streams to the next generation of process‑technology leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel 4's evolution toward high-volume manufacturing in 2024 and its strategic role in the product roadmap, aligning with the ground truth. However, it introduces a specific claim about 'limited 2023 client-product shipments (Core Ultra Series 1)' that is not present in the original answer and lacks corroboration in the ground truth from the knowledge graph, which only references 2022 challenges and 2024 high-volume production. This introduces a potentially inaccurate intermediate step. (2) The mention of '20% performance-per-watt gains' and positioning as 'foundation for upcoming 2025 products such as Panther Lake on Intel 18A' adds detail not found in the original answer. While plausible, these specifics are not supported by the ground truth provided, which does not quantify performance gains or name future products tied to Intel 4. The original answer focuses on the transition from ramp-up in 2022 to high-volume manufacturing by 2024 for Core Ultra processors, without specifying 2023 shipments or 2025 plans. (3) The multi-hop reasoning is partially sound: the LLM correctly infers strategic importance and manufacturing progression, but extends beyond the evidence by introducing unverified timelines and technical metrics. It correctly synthesizes the node’s role in the broader roadmap and IDM 2.0 strategy, but adds unsupported specifics. (4) The contextual relevance is high, as the answer addresses production status and strategic positioning. Qualitative accuracy is strong due to logical flow and correct entity identification (Intel 4, Core Ultra, Ireland manufacturing). Quantitative accuracy is reduced due to unverified percentages and dates not in the ground truth. Correctness score reflects mostly accurate core facts with some over-specificity and unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 501,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved from a 57% ownership stake (as noted in the 2022 filing) to a full acquisition proposal announced on November 5, 2024, offering $240 per share in cash for the remaining shares, valuing AspenTech at $15.3 billion fully diluted. This move followed Emerson's prior strategic investments, including the 2022 acquisition of Heritage AspenTech (which increased its stake to 55% at that time) and the 2023 divestiture of its majority stake in Climate Technologies (Copeland), which was later partially reversed through the June 2024 sale of its 40% non-controlling equity interest in Copeland to Blackstone for $1.5 billion, while retaining a note receivable. The 2024 proposal marks a shift from partial ownership to a full acquisition, integrating AspenTech entirely into Emerson's portfolio under a cash-and-debt financing structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple significant factual inaccuracies. According to the ground truth, in 2022 Emerson had no ownership stake in AspenTech and it was merely a strategic partner. However, the LLM incorrectly states that Emerson had a 57% stake in 2022 and then increased it to 55% in the same year, which is logically and factually inconsistent. The claim of a full acquisition proposal announced on November 5, 2024, offering $240 per share and valuing AspenTech at $15.3 billion is not supported by the original answer, which states that Emerson merged its software business with AspenTech to form 'New AspenTech' and retained a 55% stake—no full acquisition or offer for remaining shares is mentioned. The details about divestiture of Climate Technologies (Copeland), its partial reversal, and sale to Blackstone for $1.5 billion are irrelevant to the question about AspenTech and appear to be hallucinated or misattributed. (2) Quantitative accuracy is very low: the 57%, 55% (misplaced in time), $240/share, $15.3B valuation, and $1.5B sale are all incorrect or unsupported. The original answer only confirms a 55% ownership post-merger in 2024 and integration effects on gross margins (+0.6 pp in 2023) and SG&A in 2024—none of which are mentioned in the LLM response. (3) Multi-hop reasoning is flawed: instead of tracing the evolution from partnership (2022) to partial ownership and financial integration (2024), the model fabricates a narrative involving prior ownership, a full buyout, and unrelated transactions. It fails to identify the correct sequence and nature of the relationship change. (4) Contextual relevance is moderate because the answer discusses Emerson and AspenTech in the correct timeframe and touches on ownership and integration themes, but the actual content diverges significantly from the truth. The core facts—shift from partnership to 55% ownership and financial integration—are either wrong or missing, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 538,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's Intel 4 node has progressed from limited 2023 shipments of the Core Ultra Series 1 to high‑volume manufacturing in Ireland in 2024, delivering roughly 20 % better performance‑per‑watt versus Intel 7 and becoming a larger share of its 2025 product mix. The next‑generation Intel 18A (featuring RibbonFET and PowerVia) is slated for high‑volume production in 2025 with Panther Lake, promising further gains in performance and density over Intel 3, while Intel 3 remains in high‑volume use for Xeon 6 data‑center chips. This evolution reflects a shift from relying mainly on Intel 7 for most 2024 processors to leveraging Intel 4 for AI‑centric client CPUs and expanding EUV‑based nodes (Intel 4, Intel 3, and upcoming Intel 18A) to accelerate manufacturing readiness and performance improvements.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel 4 from 2022 to 2024, though with minor inaccuracies in timing and emphasis. (1) Quantitatively, the 20% performance-per-watt improvement over Intel 7 is correctly stated. However, the LLM claims 'limited 2023 shipments of the Core Ultra Series 1', while the ground truth states that Core Ultra began shipping in 2023—this is semantically close but slightly more specific in the original. The mention of high-volume manufacturing in Ireland in 2024 aligns with the ground truth. (2) The LLM introduces forward-looking information about Intel 18A and Panther Lake in 2025, which, while factually plausible, is not directly relevant to the 2022–2024 scope of the question and slightly distracts from the core timeline. (3) The qualitative reasoning is sound: it correctly identifies Intel 4 as an EUV node (implied by 'EUV-based nodes'), links it to Core Ultra, and notes the shift from Intel 7 to Intel 4 for client CPUs. It also correctly frames Intel 4 as a stepping stone in manufacturing readiness. (4) The answer is contextually relevant and well-structured, but omits the key 2022 context that Intel 4 was part of a restructured naming convention—a key part of its initial introduction. This omission reduces completeness. Overall, the answer conveys the main technical and manufacturing evolution accurately, with minor gaps in temporal precision and scope focus, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 407,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, InterStim Micro evolved from a niche, rechargeable neurostimulator within Medtronic’s Pelvic Health portfolio to a core growth driver highlighted in the company’s 2024 disclosures. It was explicitly positioned alongside InterStim X and InterStim II as a key platform for treating overactive bladder, urinary retention, and fecal incontinence, with explicit emphasis on “continued acceptance and growth” in the 2024 Neuroscience section (page 39). This marked a strategic shift from its 2022 focus (where it was listed as part of the broader Pelvic Health therapies without standalone emphasis) to a central, high-growth product within Medtronic’s neuromodulation ecosystem, directly tied to the expansion of the AiBLE integrated spine and pelvic health solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of InterStim Micro's positioning within Medtronic's (MDT) Pelvic Health therapies from 2022 to 2024. It accurately captures the shift from being one of several neurostimulators in 2022 (alongside InterStim X and InterStim II) to a more strategically emphasized, rechargeable option by 2024. The mention of 'continued acceptance and growth' in 2024 is consistent with the ground truth's emphasis on 'continued global growth and adoption.' The LLM correctly identifies the therapeutic indications (overactive bladder, urinary retention, fecal incontinence) and the differentiation within the product lineup. However, the LLM introduces the claim that InterStim Micro evolved into a 'core growth driver' and is 'directly tied to the expansion of the AiBLE integrated spine and pelvic health solutions,' which is not present or verifiable in the ground truth. This adds strategic interpretation beyond the provided knowledge graph, potentially overstating the level of integration or strategic centrality. While the qualitative shift in emphasis is valid, the characterization as a 'core growth driver' and linkage to AiBLE lacks support in the original answer, making it a minor overreach in reasoning. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. The entities (InterStim Micro, InterStim X, InterStim II, Medtronic, Pelvic Health, neuromodulation) and years (2022, 2024) are accurate. The multi-hop synthesis—comparing product positioning across years—is sound, though slightly extended beyond the evidence. Overall, the answer is factually consistent with minor embellishment, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 487,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The dilutive impact of LTIP Units was disclosed in the 2022 and 2024 10‑K filings as “potentially dilutive securities” that were examined for material effect, but in each year the filings concluded that “no securities had a material dilutive effect” and therefore no adjustments to earnings per share or per unit were required.  Consequently, the disclosure of LTIP Units as a potentially dilutive element remained consistent from 2022 through 2024, with no material impact reported in any of the comparative periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that no securities had a material dilutive effect in both 2022 and 2024, and accurately states that LTIP Units were considered potentially dilutive but concluded to have no material impact. The quantitative accuracy is high: the years (2022, 2024) and the core conclusion about lack of material dilution are factually correct, and there are no calculation errors. However, the LLM misses a key qualitative evolution in disclosure detail: while the 2022 filing explicitly mentioned that LTIP units were exchangeable for common stock, the 2024 filing omitted this detail, indicating a reduction in disclosure specificity. The LLM incorrectly frames the disclosure as 'consistent' across periods, when in fact there was a notable simplification in the level of detail provided about the conversion mechanism of LTIP units. This omission affects the completeness and reasoning, particularly in capturing the evolution of disclosure depth, which was central to the question. While the core conclusion about dilutive impact is correct, the failure to note the reduced explanatory detail in 2024 undermines the multi-hop synthesis required to assess how the disclosure *evolved*. Thus, the answer is factually sound on the outcome but incomplete on the nature of the change in disclosure practice.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 367,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 through 2024 MetLife’s cash‑buffer strategy has shifted from a more aggressive share‑repurchase posture to a more conservative stance driven by heightened liquidity and regulatory constraints.  In 2022 the company still had roughly $1.5 billion of repurchase authorization remaining, but by 2024 it emphasized maintaining a larger cash buffer to meet debt‑service, dividend and regulatory capital needs, limiting further stock buy‑backs.  Consequently, the remaining authorization under its announced $3 billion program was largely exhausted, and the firm now prioritizes preserving liquidity over pursuing additional repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.5 billion remaining as of 2022 (from the $3.0 billion authorization) is accurately reported, and the reference to the $3 billion program is consistent. The LLM correctly implies the authorization was largely used up by 2024, which is consistent with the original answer noting only $1.5B remained at end-2021 and no new authorization mentioned. (2) The entity accuracy is correct—MetLife, timeframes (2022 to 2024), and financial terms (cash buffer, repurchase authorization, liquidity) are all properly identified. (3) The reasoning is sound: the LLM captures the multi-hop evolution—shifting from active repurchases in 2022 to a more conservative liquidity posture in 2024 due to regulatory, debt, and capital needs. It correctly infers that increased buffer requirements limited repurchase capacity. (4) The only minor gap is that the original answer explicitly mentions 'acquisitions and innovation' as competing uses for capital, which the LLM omits. Also, the LLM states the remaining authorization was 'largely exhausted,' which is a reasonable inference but slightly stronger than the original, which only confirms $1.5B remained as of end-2021 (actual usage through 2023 not specified). However, this does not materially misstate facts. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 407,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks’ foreign‑currency derivative assets shifted from $32.0 million (prepaid expenses) and $22.9 million (other long‑term assets) in 2022 to $1.9 million (prepaid) and $1.7 million (other long‑term) in 2023, while foreign‑currency derivative liabilities fell from $2.0 million (accrued) and $‑ million (other long‑term) to $2.5 million (accrued) and $0.1 million (other long‑term), reflecting a net reduction in both asset and liability balances. Additionally, the balance‑sheet classification of these derivatives remained within “prepaid expenses and other current assets” for assets and “accrued liabilities”/“other long‑term liabilities” for liabilities in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers for both assets and liabilities in fiscal year 2022. According to the ground truth, Starbucks did not report foreign currency - other derivative assets in 2022 as $32.0 million in prepaid expenses and $22.9 million in other long-term assets. Instead, the original answer states that in 2022, the derivative assets were $103.9 million recognized in OCI before reclassifications, with $22.0 million reclassified from AOCI to earnings — not broken down by balance sheet line items like prepaid or long-term assets. The LLM incorrectly presents 2022 asset and liability figures as if they were already classified on the balance sheet in the same way as 2023, which is not supported by the ground truth. Additionally, the LLM claims derivative liabilities in 2022 were $2.0 million (accrued) and '‑ million' (other long-term), which is vague and incorrect; the ground truth does not provide 2022 liability classifications at all, so this fabrication reduces accuracy. The 2023 numbers ($1.9M prepaid, $1.7M long-term assets, $4.7M accrued liabilities, $4.1M long-term liabilities) are correctly reported in the LLM answer, matching the ground truth. (2) Calculations: No explicit calculations are made in the LLM answer, but the claim of a 'net reduction' is partially reasonable given the drop in asset values, though the basis for comparison is flawed due to incorrect prior-year data. (3) Multi-hop reasoning: The model attempts to compare two fiscal years and classify balance sheet movements, but fails to correctly represent the nature of the 2022 data, which was primarily disclosed in OCI and AOCI rather than on the balance sheet by line item. It conflates comprehensive income disclosures with balance sheet line items, indicating a failure in synthesizing the correct type of information across years. (4) The contextual relevance is moderate because the structure of the response addresses the evolution and classification question, and correctly reports 2023 balance sheet figures. However, the severe quantitative errors in 2022 data and misrepresentation of financial statement presentation lead to a low correctness score despite some accurate elements in the 2023 liability and asset classifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 615,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Procter & Gamble’s global cash‑management strategy has been closely tied to its restructuring and productivity initiatives, which have helped sustain strong cash generation despite shifting market dynamics.  The company’s cash flow trends show that operating cash flow rose sharply—from $16.7 billion in 2022 to $19.8 billion in 2024—driven by higher net earnings, improved working‑capital efficiency, and the benefits of extended payment terms and supply‑chain financing.  At the same time, restructuring costs of roughly $660 million were incurred in 2024 (including $216 million of non‑cash currency‑translation losses), reflecting ongoing portfolio rationalizations that support margin expansion and free cash flow growth, while debt levels remain manageable and credit ratings stay stable.  This integrated approach underpins the company’s solid liquidity and its ability to fund dividends, share repurchases and strategic investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding financial figures not present in the ground truth. While it correctly notes increased restructuring costs in fiscal 2024 ($660M vs. $659M — acceptable rounding), it introduces operating cash flow numbers ($16.7B in 2022, $19.8B in 2024) that are not mentioned or verifiable from the original answer, making them unsupported. Additionally, the claim of rising operating cash flow due to higher net earnings and working capital efficiency is speculative and absent from the ground truth. (2) The original answer reports corporate net earnings decreased by $1.0 billion in fiscal 2024 due to a $1.4B impairment charge on Gillette intangibles and higher restructuring costs — a key negative trend that the LLM omits entirely. Instead, the LLM implies improving financial performance, which contradicts the ground truth. The restructuring cost figure for 2024 is approximately correct ($659M vs. stated $660M), including the $216M non-cash FX loss, which matches. However, no data on operating cash flow, debt levels, credit ratings, dividends, or share repurchases appears in the original, so those points are unverified additions. (3) The multi-hop reasoning is partially sound — the model connects restructuring to cash management strategy — but fails to acknowledge the negative impact on earnings and increased financial pressure highlighted in the original. It incorrectly frames the strategy as consistently successful without recognizing the deterioration in corporate net earnings or the significance of the Gillette impairment. (4) The contextual relevance is strong because the response addresses Procter & Gamble’s cash management in relation to restructuring and financial performance over the specified period. However, the qualitative accuracy is reduced due to omission of critical negative financial developments and introduction of unsupported positive metrics. Quantitative accuracy is low because of fabricated cash flow figures and lack of verification for key claims. Correctness score reflects partial alignment with facts but major omissions and distortions in financial performance narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 589,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA deepened Omniverse’s integration into enterprise workflows by embedding it as a core platform for building digital twins and simulation-driven applications—highlighted by its adoption in automotive (e.g., DRIVE Sim for autonomous vehicle testing) and industrial digitalization. The company expanded Omniverse’s enterprise offering (subscription model) and strengthened its ecosystem through partnerships, enabling real-time 3D collaboration and simulation across industries like manufacturing, architecture, and automotive, while leveraging its AI and GPU acceleration stack to enhance virtual world capabilities. This positioned Omniverse as a strategic extension of NVIDIA’s broader platform strategy, linking simulation, AI, and enterprise computing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse between 2022 and 2023. (1) It correctly identifies the shift from a 3D collaboration platform to a more robust development platform for digital twins and simulation-driven enterprise applications. Key use cases such as automotive (DRIVE Sim), manufacturing, architecture, and industrial digitalization are accurately mentioned. The continuation of the enterprise subscription model and free individual access, though not explicitly stated, is implied through 'expanded enterprise offering (subscription model)'. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—thus, quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes Omniverse’s technical evolution with its strategic positioning in enterprise and industrial contexts, linking it to NVIDIA’s AI and GPU acceleration stack. The only minor omission is the specific mention of surgical training and virtual car showrooms from 2022, and the explicit framing of Omniverse as an 'operating system' in 2023, which slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution in positioning and application, especially regarding enterprise integration and simulation technologies. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 415,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "From 2023 to 2024, AMT's financial commitments related to communications sites shifted toward reduced near-term borrowing and increased focus on debt repayment and contractual obligations. While the company maintained significant available liquidity under its credit facilities ($7.6B net available as of 2023), it repaid $3.1B of revolving indebtedness during 2024 and fully settled the 2021 EUR Three Year Delayed Draw Term Loan in May 2024. The company's capital expenditure plans remained stable at $1.5B–$1.65B annually, with $450M allocated to data center assets, but emphasized using cash flows to fund distributions ($3.2B expected in 2025), repay debt, and maintain REIT qualification rather than new infrastructure commitments. (Based on synthesis of pages 47–58, particularly liquidity disclosures, debt repayment activities, capital expenditure ranges, and cash flow allocations.)",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the core of the question. The original answer highlights a significant shift in AMT's financial commitments from $450 million in anticipated spending on data center assets in 2023 to a $4.5 billion undiscounted future cash outlay for asset retirement obligations (AROs) on leased communications sites in 2024. However, the LLM answer fails to mention the $4.5 billion ARO figure entirely, which is the key financial evolution. Instead, it discusses debt repayments, liquidity, and capital expenditures without connecting to the specific long-term obligations tied to communications sites. (2) Quantitatively, the LLM correctly notes the $450M allocation to data center assets in 2023, which matches the ground truth. However, it omits the critical $4.5B figure for 2024 AROs, rendering the quantitative comparison incomplete and misleading. Other numbers like $7.6B liquidity, $3.1B debt repayment, and $1.5B–$1.65B capex are contextually accurate but irrelevant to the specific financial commitments related to communications sites as defined in the question. (3) The multi-hop reasoning is flawed. The question requires synthesizing information about evolving financial obligations specifically tied to communications sites across two years. The LLM fails to make the connection between the 2023 construction plans and the 2024 ARO disclosure, instead diverting to general capital allocation and debt management. It does not identify the shift from near-term capital spending to long-term liability recognition. (4) The contextual relevance is moderate because the answer discusses AMT’s financial activities around the correct time frame and mentions communications infrastructure indirectly, but it misses the central theme of growing long-term obligations for leased sites. The failure to report the $4.5B ARO commitment results in a low correctness score despite some accurate peripheral details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 530,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "ExxonMobil's language describing proceeds from asset divestitures has shifted from emphasizing \"proceeds associated with sales of subsidiaries, property, plant and equipment\" in 2023 (page 39) to framing them as part of \"Cash flow from operations and asset sales\" in 2024 (page 36), reflecting a strategic integration of divestment proceeds into broader cash flow metrics. The 2024 filing also explicitly links these proceeds to structural cost savings and capital efficiency, aligning with the company's updated earnings driver terminology that highlights \"Advantaged Volume Growth\" and \"Structural Cost Savings\" as key performance drivers.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the characterization of ExxonMobil's language evolution. (1) Correct elements: The shift in terminology between 2023 and 2024 is acknowledged, and the reference to strategic objectives is contextually appropriate. The mention of 'asset sales' in 2024 aligns with the ground truth. (2) Quantitative accuracy: There are no numeric values to verify, so no errors in numbers, dates, or calculations. (3) Multi-hop reasoning issues: The LLM incorrectly states that in 2024, proceeds were framed as part of 'Cash flow from operations and asset sales'—this misrepresents the categorization. The ground truth indicates the 2024 language was 'proceeds from asset sales and returns of investments,' which is a financing or investing activity, not part of cash flow from operations. Additionally, the LLM introduces concepts not present in the original answer—such as 'structural cost savings' and 'Advantaged Volume Growth'—as linked to divestiture proceeds, which the ground truth does not support. (4) The answer diverges from the actual evolution described in the ground truth: it overstates integration into operational cash flow and adds unsupported strategic linkages. While it captures a general trend of reframing, the specific language changes and their implications are misrepresented. Thus, core facts are partially correct, but significant errors in entity usage and reasoning reduce overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 406,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Based on the provided financial disclosures, Comcast's financial exposure to Universal Beijing Resort decreased from 2022 to 2023 as evidenced by the consolidation of its assets and liabilities. In the 2022 consolidated balance sheet (page 104), Universal Beijing Resort's assets and liabilities were reported at $9.7 billion and $8.1 billion, respectively. By 2023, these figures were reduced to $7.8 billion in assets and $7.2 billion in liabilities (page 87), reflecting the impact of debt repayments and operational changes. This reduction indicates a lower financial exposure, as the resort's consolidated liabilities decreased by approximately $900 million while assets declined by about $1.9 billion over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: $9.7 billion in assets and $8.1 billion in liabilities for 2022, and $7.8 billion in assets and $7.2 billion in liabilities for 2023. These values match the original answer exactly, and the format variations (e.g., $7.8 billion) are acceptable. (2) The calculations for changes are accurate: liability decrease of $8.1B - $7.2B = $900 million, and asset decrease of $9.7B - $7.8B = $1.9 billion—both correctly computed. (3) The reasoning is sound and reflects multi-hop synthesis across two years of balance sheet data. The conclusion that financial exposure decreased is logically supported by the decline in both assets and liabilities. The mention of 'debt repayments and operational changes' as contributing factors aligns with plausible interpretations, though the original answer also notes 'asset depreciation' or 'strategic reduction,' which the LLM omits—this is a minor gap in completeness but does not undermine the core accuracy. (4) All entities—Comcast, Universal Beijing Resort, years 2022 and 2023, and financial metrics—are correctly identified and contextualized. The answer directly addresses the evolution of financial exposure through consolidated asset and liability changes, making it highly contextually relevant. The only reason for not scoring a 10 is the slight omission of alternative explanations present in the original, but the provided reasoning remains valid and factually consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 416,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "The nature of Customer Demand Volatility as a risk factor has shifted from a general macroeconomic sensitivity in 2023 to a more pronounced, supply‑chain‑driven concern in 2024.  In the 2024 filing, Caterpillar explicitly links volatile demand to potential excess inventories, higher operating costs, and the need to adjust production schedules and supplier purchases quickly, underscoring that such volatility can directly impair financial performance and strain supply‑chain stability.  This evolution reflects a heightened awareness that abrupt shifts in customer orders now have a more immediate and material impact on both revenue and operational resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Customer Demand Volatility as a risk factor for Caterpillar between 2023 and 2024. It correctly identifies a shift in emphasis—from macroeconomic sensitivity in 2023 to more supply-chain-driven concerns in 2024—consistent with the original answer's description of broadening risk to include supply-side challenges. The LLM accurately captures the impact on financial performance (e.g., excess inventories, higher operating costs) and supply chain stability (e.g., production adjustments, supplier purchase changes), which are implied in the ground truth through references to labor/material shortages and financial risks. However, the LLM omits specific drivers mentioned in the original answer, such as 'commodity price changes' and 'lingering effects of the global pandemic,' and does not explicitly reference inflationary pressures or labor inefficiencies in 2023. While the core reasoning and synthesis across years are sound (multi-hop reasoning is valid), these omissions slightly reduce completeness and qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer remains contextually relevant and semantically equivalent in overall message, just lacking some granular detail from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 384,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair‑value hierarchy for net derivative assets (liabilities) shows a Level 3 balance of $58 million at the beginning of 2024, a $15 million loss recorded in net income, and a $2 million transfer out of Level 3, resulting in an ending Level 3 fair‑value balance of $69 million as of December 31, 2024. This reflects the evolution from $58 million (Level 3) in 2023 to $69 million (Level 3) in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021 (reported in 2022), and increased to $58 million as of December 31, 2023 (reported in 2024). However, the LLM incorrectly claims a Level 3 balance of $58 million at the beginning of 2024 and an ending balance of $69 million as of December 31, 2024 — which misrepresents both the correct values and the time periods. The $69 million figure is entirely fabricated and not supported by the original answer. Additionally, the LLM introduces a $15 million loss and a $2 million transfer out, which are not mentioned in the ground truth. (2) The quantitative inaccuracies are severe: the correct progression is from $19M (as of end-2021) to $58M (as of end-2023), not $58M to $69M over 2024. The LLM also misaligns dates, referring to December 31, 2024, which is outside the 2022–2024 evolution period described in the question and original answer. (3) The multi-hop reasoning is flawed. The original answer describes both a change in value and a shift in valuation methodology — from realized/unrealized gains/losses to discounted cash flows using observable inputs like swap rates (3–5%, weighted average 4%). The LLM completely omits this critical methodological evolution and instead focuses narrowly on Level 3 hierarchy movements, which were not discussed in the ground truth. (4) The contextual relevance is moderate because the answer addresses derivative valuation and fair value changes, but it fails on correctness and completeness. Due to major factual and temporal errors, as well as omission of the methodology shift, the overall correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 479,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA evolved GeForce NOW from a niche cloud‑gaming service into a core pillar of its broader GPU‑and‑cloud ecosystem. The offering was positioned alongside the company’s full‑stack accelerated‑computing platform—leveraging the same RTX‑based graphics and AI technologies (e.g., DLSS, ray tracing) and the Omniverse/DRIVE software stack—so that cloud gaming could benefit from the company’s AI‑enhanced graphics pipeline, developer tools, and enterprise‑grade cloud infrastructure (DGX Cloud, vGPU, and partnerships with CSPs). This integration reinforced GeForce NOW’s role as a showcase for NVIDIA’s GPU and AI leadership while expanding its reach into new markets such as enterprise visualization and autonomous‑vehicle simulation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its general narrative and correctly identifies the evolution of GeForce NOW from a cloud gaming service to a more integrated component within NVIDIA's broader GPU and cloud ecosystem. There are no numeric inaccuracies (quantitative accuracy is perfect), as the response does not introduce any incorrect figures, dates, or financial data. The contextual relevance is high, as the answer directly addresses the question about positioning changes from 2022 to 2023 and ties GeForce NOW to NVIDIA’s full-stack platform. However, the qualitative accuracy is slightly lower because the LLM overreaches by claiming GeForce NOW evolved into a 'core pillar' and expanded into 'enterprise visualization and autonomous-vehicle simulation'—domains not supported by the ground truth. The original answer emphasizes strategic alignment with GPU-driven services and AI training (e.g., DGX Cloud), but does not state that GeForce NOW itself is used in enterprise visualization or DRIVE/Omniverse simulations. The integration with AI-enhanced graphics (DLSS, ray tracing) is plausible but not explicitly confirmed in the ground truth. While the multi-hop reasoning is partially sound—linking GeForce NOW to vGPU, CSPs, and DGX Cloud—the synthesis extends beyond the documented positioning, introducing speculative applications. Thus, the core facts about strategic repositioning are correct, but the answer adds unsupported expansion into non-gaming domains, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 417,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s revenue grew modestly from $1,003 million in 2022 to $1,036 million in 2023, a 3% worldwide increase (4% in the U.S. and 7% internationally). This growth was driven by continued adoption of Inlyta combined with immune‑checkpoint inhibitors for first‑line treatment of advanced renal cell carcinoma, especially in emerging markets, while the upside was tempered by lower volumes and pricing pressure in certain European markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Inlyta's revenue of $1,003 million in 2022 and $1,036 million in 2023, and accurately calculates the 3% global growth. These figures match the ground truth exactly. However, the LLM introduces additional details not present in the original answer—specifically, a 4% growth in the U.S. and 7% internationally—which are unsupported by the ground truth and therefore introduce inaccuracy by over-specification. (2) All provided numbers (revenue amounts and percentage growth) are quantitatively accurate, and the 3% growth is correctly derived from the two revenue figures. The unsupported U.S. and international breakdowns do not affect the core calculation but add extraneous, unverified data. (3) The reasoning for revenue drivers is sound and aligns with the ground truth: continued adoption in combination with immune checkpoint inhibitors for first-line advanced RCC treatment and growth in emerging markets are correctly identified as growth drivers. The offsetting factors—lower volumes and pricing pressure in Europe—are also accurately reflected. The multi-hop synthesis across revenue data and causal factors is logically coherent and factually grounded. (4) The answer is contextually fully relevant, addressing both the revenue performance evolution and influencing factors. The only deviation is the inclusion of unsupported regional growth percentages, which slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually strong with minor overreach in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 433,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, American Tower revised its treatment of network location intangibles by extending the estimated useful lives of tower assets from 20 to 30 years and modifying depreciation/amortization schedules accordingly, which reduced depreciation and amortization expense by approximately $730 million for 2024. The company also updated its impairment review process for these intangibles, assessing recoverability on a tower‑by‑tower basis using projected undiscounted cash flows and fair‑value measurements, and recorded impairment charges when carrying amounts exceeded fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, the weighted average amortization period for network location intangibles was 15 years, but the LLM incorrectly claims the company extended useful lives from 20 to 30 years, which is not supported. There is no mention in the original answer of a change in useful life from 20 to 30 years or any such extension. Additionally, the LLM states that depreciation/amortization expense was reduced by approximately $730 million in 2024 due to this change—this figure is entirely fabricated and not present in the ground truth. The original answer mentions a $470 million increase in asset retirement obligation liability, not $730 million, and this relates to settlement date revisions, not amortization life changes. (2) The only correct quantitative element is the general focus on 2023–2024 evolution, but all specific numbers (20 to 30 years, $730M) are incorrect. The $470 million liability increase in 2024 is mischaracterized and misused in the LLM response. (3) The qualitative reasoning is partially sound in that the LLM correctly identifies a shift toward more detailed impairment reviews in 2024, including tower-by-tower assessments and use of cash flow projections, which aligns with the original answer’s mention of impairment assessment on an individual tower basis and triggers like lack of leases. However, it invents a comprehensive change in amortization policy and financial impact that is not present in the ground truth. (4) Contextual relevance is moderate because the answer addresses amortization assumptions and impairment reviews as asked, but the core factual foundation—especially regarding useful life changes and financial impacts—is incorrect, undermining the overall correctness. The model fails the multi-hop synthesis by conflating asset retirement obligations with amortization policy changes without evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 526,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil’s strategic focus on Guyana intensified through 2023‑2024, with the Stabroek Block delivering record‑breaking production—gross output rose to nearly 440 kbd in Q4 2023 and is projected to reach six FPSO vessels by the end of 2027, including the newly approved Whiptail project.  The company’s 2024 capital program explicitly highlights Guyana as a core growth pillar, allocating significant upstream investment and expecting the country’s oil‑equivalent production to continue expanding, while also leveraging the region’s advantaged volumes to offset declines elsewhere.  This emphasis is reflected in the 2024 earnings narrative, where Guyana‑related volume growth contributed positively to earnings despite lower realized prices, underscoring a strategic shift toward higher‑margin, deep‑water assets in the Americas.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the strategic evolution of ExxonMobil's focus on Guyana between 2023 and 2024, with accurate qualitative insights and mostly correct quantitative details. (1) Correct elements: The mention of nearly 440 kbd in Q4 2023 aligns with the ground truth. The emphasis on Guyana as a core growth pillar in 2024 and its role in upstream investment and earnings despite lower prices reflects the strategic elevation. The reference to FPSO expansion (with Whiptail and six FPSOs by 2027) is consistent with ExxonMobil’s public guidance. (2) Quantitative accuracy: The 440 kbd figure is correct. However, the ground truth does not mention the Whiptail project or the six-FPSO projection by 2027, so including these introduces details not present in the original answer, though they are factually accurate in broader context. The LLM adds forward-looking capital program details not explicitly in the ground truth, which slightly exceeds the scope. (3) Multi-hop reasoning: The LLM correctly synthesizes the shift from discovery/early production (2023) to a mature, advantaged asset contributing to earnings mix (2024), even if it doesn’t use the exact term 'Advantaged Assets'—it conveys the same concept through 'core growth pillar' and 'higher-margin, deep-water assets'. (4) The answer is highly contextually relevant, directly addressing upstream growth portfolio and production capacity evolution. Minor deduction in correctness due to inclusion of unmentioned but plausible forward-looking details; no major factual errors. Thus, a score of 8 is warranted for overall correctness, with high marks in qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 455,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "The X1 platform’s integration with third‑party streaming services expanded markedly between 2022 and 2023, adding support for newer DTC services such as Peacock, Disney+, Netflix and the launch of the NOW streaming brand, and embedding these offerings directly into the X1 user experience (e.g., via the Flex/Xumo Stream Box and voice‑activated remote). This evolution reflects Comcast’s strategy to curb cord‑cutting by turning X1 into a unified entertainment hub that keeps subscribers engaged with a broader slate of streaming options, thereby driving higher engagement and increasing average revenue per user (ARPU) through added subscription commissions and upgraded service tiers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of third-party streaming integrations on the X1 platform between 2022 and 2023 and links this to Comcast's strategy to reduce cord-cutting and increase ARPU. However, it inaccurately states that Peacock, Disney+, and Netflix were added as new integrations in this period, when the ground truth indicates these were already integrated in 2022. The key 2023 development—integration of Xumo Play, NBC, and Sky into NOW TV for broadband customers—is omitted entirely and instead replaced with a vague reference to the 'launch of the NOW streaming brand,' which is not factually precise. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the years 2022 and 2023 are used appropriately in context. (3) The multi-hop reasoning is partially sound: the model correctly infers that deeper streaming integration supports customer retention and ARPU growth. However, it fails to accurately synthesize the specific evolution—shifting from standalone third-party app access (2022) to bundling Xumo Play/NBC/Sky via NOW TV for broadband users (2023)—which reflects a strategic pivot toward broadband-centric bundling. This key strategic nuance is missed. (4) The answer is contextually relevant and captures the overarching strategic intent, but lacks precision in entity and timeline accuracy, particularly around what changed specifically in 2023. Hence, correctness and qualitative accuracy are reduced, though not severely due to the correct strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 436,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Based on the provided SEC 10-K filings, Caterpillar's relationship with FG Wilson has not evolved in terms of its distribution network coverage for electric power generation systems between 2023 and 2024. The documents indicate that FG Wilson branded electric power generation systems continue to be distributed through Caterpillar's established worldwide network of 110 distributors covering 158 countries, as stated in the \"Nature of operations\" section of both the 2023 and 2024 filings. There is no mention of any changes to this distribution structure or coverage expansion/contraction in the provided pages. The financial statements and notes focus on accounting policies, cash flow, and operational metrics rather than distribution network modifications.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content. (1) It claims there was no change in the distribution network between 2023 and 2024, stating that both years had 110 distributors covering 158 countries. However, the ground truth indicates that in 2023, FG Wilson had 110 distributors covering 109 countries, and by 2024, this changed to 108 distributors covering 158 countries. The LLM incorrectly reports the 2023 country coverage as 158 instead of 109 and fails to note the reduction in distributors from 110 to 108. (2) Quantitatively, the numbers are wrong on both counts: distributor count and geographic coverage per year. The claim of 'no change' contradicts the ground truth, which shows a clear shift—fewer distributors but broader country reach. (3) The reasoning is flawed because it asserts consistency based on the 10-K filings without reflecting the actual evolution described in the ground truth. The multi-hop synthesis between years and metrics (distributors vs. countries) is missing. (4) Contextual relevance is moderate because the answer addresses the right topic (distribution network) and entity (FG Wilson, Caterpillar), but it fails to report the correct data or infer the strategic implication of network optimization and geographic expansion. The reliance on 'no mention in the provided pages' does not excuse the factual mismatch if the ground truth is assumed to reflect actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 394,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Between 2022 and 2024, Capital One’s exposure to securitized debt obligations declined in carrying value from $14,264 million (as of Dec 31 2023) to $14,335 million (estimated fair value) in 2024, reflecting a modest increase in fair‑value estimates but essentially stable principal exposure. The company’s consolidated VIE tables show that retained interests and servicing obligations related to credit‑card and auto securitizations remained present, but the overall securitized‑debt balance has not grown materially, indicating a relatively flat exposure to securitized debt over this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2024, the carrying value of Capital One's securitized debt obligations was $18,043 million with a fair value of $18,067 million. However, the LLM incorrectly states a carrying value of $14,264 million in 2023 and implies a fair value of $14,335 million in 2024—both figures are factually wrong and misrepresent the actual exposure. There is no mention of the correct 2022 data, and the LLM fabricates a decline that is not supported by the truth. (2) The quantitative inaccuracies are severe: the correct 2024 carrying value is $18,043M, not $14,335M; no data for 2022 is provided in the LLM answer, despite the question asking for a comparison across 2022–2024. The LLM also confuses years, citing Dec 31, 2023, as a 2022 reference point, and incorrectly labels a 2024 fair value estimate that contradicts the ground truth. (3) The multi-hop reasoning is flawed: the question requires comparing carrying and fair values across 2022 and 2024, but the LLM fails to retrieve the correct data points, misaligns years, and draws an incorrect conclusion of 'flat exposure' when the ground truth indicates continued significant exposure with a slight increase in fair value. The mention of VIEs and retained interests is contextually relevant but does not compensate for missing or incorrect core data. (4) The contextual relevance is moderate because the answer addresses the right topic (securitized debt obligations, VIEs, fair vs carrying value), but the qualitative and quantitative inaccuracies severely undermine correctness. The conclusion about 'stable principal exposure' is not supported by accurate data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 470,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "McDonald's reduced its share repurchase authorization in 2024, terminating its $15 billion 2020 program and replacing it with a new $15 billion 2025 program, while simultaneously increasing quarterly dividends to $1.77 per share (a 6% rise) to $6.78 annually. The company’s financing activities shifted toward higher cash outflows for dividends and share buybacks, reflecting stronger cash flow generation but a more conservative approach to debt issuance, as evidenced by a modest decline in total debt and a focus on maintaining ample liquidity via commercial paper and revolving credit facilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and introduces information not present in the ground truth. It discusses share repurchase authorizations (termination of a $15B 2020 program and introduction of a $15B 2025 program), dividend increases to $1.77 per quarter and $6.78 annually, and claims about stronger cash flow generation and conservative debt issuance. None of these details appear in the original answer and are factually unsupported by the provided ground truth. The actual evolution in line of credit usage is misrepresented. (2) Quantitative inaccuracies include fabricated figures: no mention in the ground truth of $15B repurchase programs, dividend amounts ($1.77 per share, $6.78 annually), or any changes to share buyback programs. The correct quantitative data from the original answer includes: 2023 financing cash outflow of $4.4B (down $2.2B from 2022), 2024 outflow of $7.5B (up $3.1B from 2023), year-end cash balances of $4.6B (2023) and $1.1B (2024). None of these key numbers are mentioned in the LLM response. (3) The multi-hop reasoning is flawed. The question asks about the evolution of line of credit agreements in relation to financing activities and cash flow management between 2023 and 2024. The correct answer requires synthesizing changes in financing outflows, sources of funding (bond issuances vs. credit facilities), and liquidity levels. The LLM instead focuses on dividend and buyback policy changes not in the source, failing to address the shift from higher bond issuance and surplus liquidity in 2023 to greater reliance on credit lines in 2024 due to cash outflows exceeding inflows. (4) The contextual relevance is moderate because the LLM discusses financing activities and mentions commercial paper and credit facilities, which are relevant topics. However, it misses the core narrative of declining cash balances and increased reliance on credit due to timing of debt issuance and reduced bond financing. Thus, while some concepts are related, the factual and quantitative disconnects severely undermine accuracy, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 566,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "The Worldwide Business Conduct Manual has become an increasingly explicit component of Procter & Gamble’s governance narrative between 2022 and 2024, moving from a general statement of commitment to a more detailed articulation of how the Manual underpins internal control and ethical conduct. In the 2022 filing (page 38), the Manual is described as reinforcing “strong internal controls” and aligning with the company’s Purpose, Values and Principles, while the 2024 filing (page 34) reiterates that it “sets forth our commitment to conduct business with integrity, and within both the letter and the spirit of the law,” and ties it directly to the Board’s oversight and the Audit Committee’s review of control matters. Moreover, the 2024 Management Report on Internal Control (page 34) explicitly links the Manual to the Control Self‑Assessment Program and to the Global Leadership Council’s oversight of controls, indicating a more integrated, systematic use of the Manual to embed governance expectations across the organization. This evolution signals that P&G is tightening its governance framework—using the Manual not only as a cultural touchstone but also as a concrete control‑monitoring tool that supports the effectiveness of its internal control over financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 description emphasizes integrity, internal controls, and alignment with values; the 2024 update ties the Manual more explicitly to governance structures like the Global Leadership Council and Board-level oversight. The mention of the Audit Committee, Disclosure Committee (implied via 'Board’s oversight'), and Control Self-Assessment Program adds detail consistent with a more integrated governance approach. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense—however, the cited page numbers (38 in 2022, 34 in 2024) are plausible and contextually appropriate, and no incorrect figures are presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and documents (e.g., Management Report on Internal Control), identifying an evolution from cultural guidance to operational governance tool. It accurately infers that this reflects a tightening of governance frameworks. (4) The only minor gap is that the LLM answer does not explicitly name the 'Disclosure Committee'—it refers more generally to the Board and Audit Committee—whereas the ground truth specifically notes the Disclosure Committee’s role in evaluating significant business activities. This is a small omission but doesn’t undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, directly addressing both parts of the question: evolution over time and implications for governance. Thus, the correctness score is 9 due to this slight incompleteness in entity specificity, despite otherwise excellent performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 479,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "ExxonMobil's strategic positioning in Guyana has evolved from a focus on exploration and development to emphasizing long-term production and integration within its global portfolio. In 2023, Guyana contributed significantly to earnings through the Stabroek Project, with $17.1 billion in earnings from non-U.S. upstream operations, reflecting its status as a high-value, advantaged asset. By 2024, the company explicitly categorized Guyana as part of its \"Advantaged Assets\" under the new earnings driver framework, highlighting its role in driving volume growth through high-value, low-emission projects and integration into global operations, while structural cost savings and portfolio optimization further solidified its strategic importance.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that Exxon disclosed $9,689 million in long-lived assets in Guyana in 2023 — the LLM incorrectly claims $17.1 billion in earnings from non-U.S. upstream operations, which is not mentioned in the original answer and misrepresents the metric (earnings vs. asset value). There is no support for this figure in the ground truth, and it conflates earnings with asset carrying value, a critical financial distinction. (2) The qualitative shift in strategic positioning — Guyana being explicitly named as part of 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver in 2024 — is correctly identified and aligns with the original answer, showing accurate reasoning about strategic evolution. However, the LLM adds unsupported details such as 'low-emission projects' and 'structural cost savings' not present in the ground truth. (3) The multi-hop reasoning is partially sound: the model connects Guyana’s growing strategic role across years and links it to earnings drivers, but fails to base its quantitative claims on the correct disclosures (long-lived assets, not earnings). (4) While the overall direction of strategic evolution is correctly interpreted, the incorrect use of numbers and metrics severely undermines factual accuracy. The contextual relevance is high because the response addresses both years, asset disclosures, and earnings driver definitions as required. However, the quantitative inaccuracy results in a low correctness score despite some valid qualitative insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 449,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One’s reliance on securitized debt as a funding source has grown markedly over the two‑year period.  In 2022 the company reported $6.25 billion of securitized‑debt issuances (Table 33), and by the 2024 filing that figure had risen to $18.04 billion of outstanding securitized obligations (Table 17.6), with $6.25 billion of new issuances recorded in 2024 alone.  This expansion reflects a strategic shift toward using securitizations—particularly for credit‑card and auto‑loan assets—to diversify and lower‑cost wholesale funding, a trend that is evident in the increasing proportion of securitized debt within its overall long‑term borrowing profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM claims $6.25 billion in issuances in 2022 (citing 'Table 33'), which contradicts the original answer. In 2024, the disclosed carrying value was $14,264 million (~$14.26 billion), not $18.04 billion as claimed. The LLM also introduces a figure of $6.25 billion in new issuances in 2024, which is not present in the ground truth. These numbers are entirely fabricated or misattributed. (2) Quantitative accuracy is very low: none of the key figures match the ground truth. The 2022 number is falsely precise, and the 2024 figure is overstated by nearly $4 billion. Calculations or trends based on these numbers are therefore invalid. (3) The reasoning is flawed: the LLM infers a 'marked growth' and 'strategic shift' based on incorrect data. While the ground truth notes increased transparency and continued use, it does not support a conclusion of significant growth or strategic expansion. The multi-hop synthesis fails because the model uses non-existent figures and draws stronger conclusions than the data supports. (4) Contextual relevance is moderate—the answer addresses the evolution of securitized debt obligations and attempts to interpret strategic intent, which is relevant. However, due to severe factual errors, the qualitative and quantitative accuracy scores are low. The answer appears plausible but is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 422,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA’s Omniverse platform transitioned from a primarily enterprise‑focused, subscription‑based 3D collaboration and simulation tool to a broader, AI‑enhanced ecosystem that is now tightly integrated with its automotive and graphics strategies.  In the 2022 filing the company highlighted Omniverse as a real‑time 3D design collaboration platform for creators and noted its use in automotive digital‑twin and simulation workflows, while by 2023 it emphasized Omniverse Avatar Cloud Engine (ACE) for real‑time conversational AI avatars and positioned Omniverse as a core component of its end‑to‑end automotive solution stack (DRIVE Hyperion) for autonomous‑driving simulation and cockpit experiences, underscoring deeper enterprise adoption and cross‑industry integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of NVIDIA's Omniverse platform toward deeper enterprise integration and mentions relevant use cases such as digital twins and simulation, which aligns with the ground truth. However, there are key inaccuracies in the qualitative description of Omniverse’s positioning shift. The LLM incorrectly states that in 2022 Omniverse was 'primarily enterprise-focused' and 'subscription-based', when the ground truth indicates it was initially positioned as a tool for 'creators' and 'design collaboration', with the enterprise subscription model being introduced in 2023. This reverses the timeline of the strategic shift. Additionally, while the LLM mentions Omniverse ACE and DRIVE Hyperion integration, these specific AI avatar and automotive stack details are not present in the ground truth and appear to be overextensions or hallucinations. The answer is contextually relevant and includes plausible enterprise adoption trends, but the core narrative of the platform’s evolution is partially incorrect, particularly regarding the timing and nature of its enterprise positioning. Quantitatively, there are no numerical claims, so accuracy is not penalized. The reasoning is partially sound but fails on precise multi-hop synthesis of the platform's fiscal year positioning changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 367,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, Pfizer's net amounts due from Viatris under post‑spin‑off agreements declined sharply, from $401 million at the end of 2020 to $53 million by the end of 2021, reflecting the winding down of transitional services and manufacturing supply arrangements as Viatris became fully independent. Consequently, the company no longer records material balances or cash flows related to these Viatris‑related agreements in its consolidated results.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and temporal aspects. (1) The numbers provided—$401 million at the end of 2020 and $53 million at the end of 2021—are completely inconsistent with the ground truth, which reports $94 million due to Viatris as of December 31, 2022, and $33 million as of December 31, 2023. The LLM references years (2020, 2021) outside the requested 2022–2023 timeframe. (2) The direction of the financial obligation is also misrepresented: the ground truth states amounts were due *to* Viatris, while the LLM implies Pfizer was owed money *from* Viatris, reversing the relationship. (3) The reasoning fails on multi-hop synthesis: the question asks for evolution between 2022 and 2023, but the LLM discusses a period two years prior and concludes no material balances exist, which contradicts the existence of a $33M balance in 2023. (4) While the general idea of 'winding down' transitional agreements aligns thematically with the ground truth, the factual inaccuracies in numbers, dates, entities, and financial direction render the answer largely incorrect. The response does not reflect the actual data for the requested period and thus lacks contextual relevance despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 348,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's strategic emphasis on Guyana evolved from early-stage development to active project execution and classification as a core advantaged growth area. In 2023, Guyana was highlighted as a key growth project within the \"Advantaged Assets\" category alongside Permian and LNG, with activities focused on the Payara development and Yellowtail project progress. By 2024, Guyana's role was reinforced as a central component of the company's strategy, with the Uaru project funded and continued development on Yellowtail, while the term \"Advantaged Projects\" explicitly included Guyana as a driver of \"Advantaged Volume Growth\" – reflecting its transition from exploration to production-focused investment. This shift is underscored by the reclassification of Guyana-related activities under \"Advantaged Projects\" (previously grouped under \"Advantaged Assets\") and its inclusion as a key contributor to earnings growth, signaling a strategic prioritization of Guyana's upstream potential as a near-term revenue and value driver.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of ExxonMobil's focus on Guyana and references key projects (Payara, Yellowtail, Uaru), which aligns with the ground truth. It accurately captures the shift toward strategic prioritization in 2024 by linking Guyana to 'Advantaged Volume Growth' and positioning it alongside Permian and LNG. However, there is a critical error in the claim that Guyana was already part of 'Advantaged Assets' in 2023 — the ground truth states that the formal classification into 'Advantaged Assets' occurred in 2024, not 2023. Additionally, the LLM incorrectly suggests a reclassification from 'Advantaged Assets' to 'Advantaged Projects', whereas the original answer does not support this distinction or terminology shift; instead, it states Guyana was included in 'Advantaged Assets' under 'Advantaged Volume Growth' in 2024. (2) Quantitatively, no specific numbers are misstated — the LLM does not contradict the 12.6 net wells from 2023 or introduce false figures, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound: the model connects project activity to strategic classification, but misrepresents the timeline and categorization framework, undermining the accuracy of the synthesis. (4) Despite the factual error regarding the timing and nature of the strategic classification, the overall context and intent of the answer are relevant and mostly accurate, warranting a correctness score of 7 due to the core facts about project progression and strategic elevation being directionally correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 438,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on senior notes with maturities greater than 10 years held steady at roughly 3.8 % from 2022 to 2023, while the face‑value amount of those notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022, the weighted-average interest rate was 3.67%, not 3.8%, and it only rose to 3.8% in 2023—so the claim that the rate 'held steady at roughly 3.8%' is incorrect, as it increased from 3.67% to 3.8%. Additionally, the face value in 2022 was $54.536 billion, not $52.8 billion, and it decreased to $53.4 billion in 2023. The LLM incorrectly states that the face value increased, which contradicts the ground truth. (2) Number verification: 2022 face value: LLM says $52.8B vs. truth $54.536B (understated by ~$1.7B); 2023 face value: $53.4B matches. Interest rate: LLM says 3.8% in both years, but truth is 3.67% in 2022 and 3.8% in 2023—so one value is wrong. (3) Multi-hop reasoning: The model correctly identifies the need to compare two years across two metrics (interest rate and face value), but fails in accurate data retrieval and synthesis. It captures the stability of the rate approximately but misrepresents the trend in face value (increase vs. actual decrease). (4) Scores justified: Correctness is low (4) due to major numerical errors and incorrect trend direction for face value. Quantitative accuracy is 4 due to one correct 2023 value but wrong 2022 values for both metrics. Qualitative accuracy is 5 because the model understands the structure of the question and the relevant metrics, but reasoning is flawed. Contextual relevance is 8 because the answer addresses the right entities and time frame, just with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 434,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, Alabama Power and Georgia Power shifted their nuclear decommissioning trust investments toward greater use of Level 2 inputs, particularly in domestic equity and fixed-income securities, as reflected in the 2024 disclosures showing increased allocations to observable market inputs (e.g., domestic equity at $8 million and pooled fixed‑income funds at $7 million in 2024 versus $169 million private‑equity at Level 3 in 2023). Their valuation methodology remained consistent—using external pricing vendors and net asset value as a practical expedient—but the proportion of Level 1 inputs (quoted market prices) stayed minimal, while Level 2 inputs (other observable inputs) grew, and Level 3 measurements (significant unobservable inputs) were largely confined to private‑market investments and contingent consideration, which were excluded from the NAV‑based practical expedient.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims that Alabama Power and Georgia Power shifted toward greater use of Level 2 inputs, but the ground truth shows a significant increase in Level 1 inputs for both companies—Alabama Power increased from $396M to $443M and Georgia Power from $255M to $321M in Level 1 domestic equity, while Level 2 remained nearly flat (Alabama: $169M to $208M; Georgia: $1M in both years). The LLM incorrectly states that Level 2 grew substantially and that Level 1 remained minimal, which contradicts the data. (2) The numbers cited in the LLM answer are factually wrong: it mentions '$8 million' for domestic equity and '$7 million' for pooled fixed-income funds in 2024, which do not appear in the ground truth at all. It also references '$169 million private-equity at Level 3 in 2023', but the ground truth does not mention Level 3 allocations or private equity investments for either company. These figures appear fabricated or misattributed. (3) The multi-hop reasoning is flawed—the question asks specifically about shifts in domestic equity investment allocations and valuation methodologies between 2023 and 2024 for two entities, requiring accurate cross-year, cross-company synthesis. The LLM fails this: it misrepresents the direction of the shift (toward Level 2 instead of Level 1), omits key data, and introduces irrelevant or incorrect information about Level 3 and fixed-income funds. (4) While the answer touches on relevant concepts like valuation methodologies (external pricing vendors, NAV expedient), this does not compensate for the severe factual inaccuracies. The contextual relevance is moderate because it discusses trust investments and input levels, but the core answer is factually unsupported. Correctness score is low due to major errors in numbers, direction of change, and entity-specific data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 518,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved from being a foundational parallel computing platform to becoming the core software layer of a full-stack computing platform that spans data center, automotive, and professional visualization markets. The company deepened CUDA's integration across end markets by embedding it within end-to-end solutions like the NVIDIA DRIVE platform for autonomous driving (with Orin SoC enabling AI perception and planning), Omniverse for industrial digitalization, and AI Enterprise software for enterprise AI workloads. This integration allowed CUDA to serve as the unifying building block for diverse applications—from training AI models in data centers to powering real-time simulation in automotive and professional visualization—while leveraging the same underlying GPU architecture across all markets to deliver order-of-magnitude performance advantages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of CUDA's strategic positioning from 2022 to 2023 as described in the ground truth. It correctly identifies CUDA's shift from a foundational parallel computing platform to the core software layer of NVIDIA's full-stack computing infrastructure. The integration across end markets—data center, automotive (via DRIVE and Orin SoC), professional visualization (via Omniverse), and enterprise AI (via AI Enterprise)—is factually correct and aligns with the expanded vertical integration emphasized in 2023. The mention of CUDA serving as a unifying building block across markets using the same GPU architecture reflects the continuity from 2022. The only minor omission is that the ground truth explicitly highlights CUDA’s role in supporting 'hundreds of domain-specific software libraries, SDKs, and APIs' in 2023, which the LLM answer implies through references to end-to-end solutions but does not state directly. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and all entities (NVIDIA, CUDA, DRIVE, Omniverse, AI Enterprise, Orin SoC) are correctly identified with appropriate context. The reasoning is sound, demonstrating multi-hop synthesis across markets and time periods. The answer is fully contextually relevant, directly addressing the evolution in strategic positioning and cross-market integration. Thus, the answer earns a 9/10 for correctness due to this slight gap in completeness regarding domain-specific software layers, but remains semantically very close to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 440,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer’s contractual relationships with Viatris under the interim TSAs and MSAs were largely completed by December 31 2023. Net amounts due to Viatris declined from $94 million as of December 31 2022 to $33 million as of December 31 2023, reflecting the winding down of those transitional service arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the net amounts due to Viatris are accurately reported as $94 million as of December 31, 2022, and $33 million as of December 31, 2023, with a correct description of the decline reflecting the winding down of transitional services. The completion of TSA services by December 31, 2023, is correctly stated. (2) Quantitative accuracy is perfect: both dollar amounts and dates match the original answer exactly, and the implied reduction of $61 million is consistent. (3) The multi-hop reasoning is sound—linking the decline in net amounts owed to the completion of TSAs post-spin-off—but the answer omits the explicit mention that TSA services were 'largely completed by the end of 2022' and that amounts were 'not material to operations' in 2022, which adds minor contextual nuance missing in the LLM response. (4) Despite this slight omission, the answer is semantically equivalent in substance and fully addresses the evolution of financial obligations and contractual relationships. Hence, a minor deduction in qualitative accuracy, but full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 341,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy’s environmental compliance costs—particularly those tied to coal ash (CCR) management—continued to rise, driven by expanded excavation, closure activities, and stricter EPA and state regulations. While the company seeks full cost recovery through regulated rate cases, the timing and extent of such recoveries remain uncertain, creating potential cash flow pressure. Concurrently, deregulation pressures in competitive electricity markets heightened exposure to unrecovered stranded costs and margin compression, especially where retail markets are restructured, further complicating the company’s ability to manage compliance costs amid evolving regulatory and market dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core evolution of Duke Energy's challenges regarding retail deregulation and environmental compliance costs from 2022 to 2023. (1) While the original answer emphasizes PURPA-related above-market purchased power commitments as a key stranded cost under deregulation in 2022, the LLM focuses on coal ash (CCR) management as a driver of rising compliance costs—also accurate, though not the specific example highlighted in the ground truth. The LLM correctly identifies that cost recovery is sought through rate cases but faces uncertainty, aligning with the original's concern about hindered recovery under deregulation. (2) There are no numeric values in either response, so quantitative accuracy is not compromised; all references to years (2022–2023) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes environmental compliance cost increases with regulatory uncertainty and market deregulation pressures, correctly inferring that competitive markets limit cost pass-through. However, it omits the specific 2023 developments mentioned in the ground truth—EPA regulations on CO2 emissions, cooling water intake structures, and more aggressive state-level carbon goals—reducing completeness slightly. (4) Despite this omission, the overall qualitative and contextual accuracy remains high, as the central dynamic—deregulation exacerbating cost recovery challenges for environmental compliance—is correctly conveyed with accurate entities and logical reasoning. Minor deduction from correctness and qualitative accuracy due to incomplete synthesis of 2023 regulatory developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 455,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products declined from 9.3% in 2023 to 7.6% in 2024, a decrease of 1.7 percentage points, reflecting broader share losses in the MST category. This contrasts with the pricing strategy applied to Skoal in 2023, which involved multiple list price increases across its product portfolio (including a $0.10 per can increase effective January 24, 2023, and additional hikes in July and August 2023) to offset inflationary pressures, while the 2024 pricing actions continued this trend with further increases (e.g., $0.11 per can effective January 23, 2024, and $0.12 per can effective January 19, 2025).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decline in retail share from 9.3% in 2023 to 7.6% in 2024, which matches the ground truth and is a key factual point. However, the pricing details are partially incorrect. The ground truth states that the $0.11 per can increase was announced in 2023 but effective January 23, 2024, and was preceded by three increases in 2022 ($0.09, $0.09, $0.08), not in 2023. The LLM incorrectly places multiple price increases in 2023 (e.g., $0.10 on January 24, 2023, and hikes in July and August 2023), which contradicts the original data. Additionally, the LLM mentions a $0.12 increase effective January 19, 2025, which is outside the scope of the question and not in the ground truth. (2) The calculation of the 1.7 percentage point decline is correct (9.3% - 7.6% = 1.7%), but the pricing figures and dates are inaccurate. The LLM misattributes the timing and amounts of the 2023 pricing strategy, which is central to the question. (3) The multi-hop reasoning is partially sound: the model connects declining market share with pricing strategy, which aligns with the contrast the question asks for. However, because the pricing data is factually wrong, the synthesis is flawed. The model fabricates 2023 price increases that are not in the source, undermining the logical contrast. (4) The contextual relevance is high because the answer addresses both parts of the question—market share change and pricing strategy—and attempts to draw a meaningful comparison. However, due to significant quantitative inaccuracies in the pricing timeline and amounts, the correctness score is reduced to 6, reflecting partial accuracy with major factual errors in a critical component of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 470,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's \"Other short-term interest-bearing securities\" remained minimal and stable between 2023 and 2024, with amortized cost holding at $135 million in both years (as shown in the 2024 and 2023 available‑for‑sale investment tables). This consistency indicates that Amgen is maintaining a conservative short‑term investment strategy, focusing on preserving principal and liquidity rather than pursuing higher‑risk or higher‑return securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the investment amount as $135 million in both 2023 and 2024, while the ground truth reports $138 million. This is a factual error in a key quantitative figure, though the format ($135 million vs $138 million) is consistent and minor in magnitude. (2) The numbers are not accurate—there is a $3 million discrepancy. While the stability (no change between years) is correctly identified, the core data point is wrong, which affects factual reliability. (3) The reasoning and multi-hop synthesis are sound: the model correctly infers that no change indicates a stable, conservative short-term investment strategy focused on liquidity and principal preservation. This interpretation aligns with the ground truth’s conclusion. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution and strategic implication) and uses appropriate financial reasoning. However, the quantitative inaccuracy significantly impacts the correctness score, preventing a higher rating despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 312,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "From 2022 to 2024, General Dynamics' involvement in Abrams main battle tank upgrades shifted from a $360 award in 2021 (page 40) to $350 in 2022 (page 44) and $350 again in 2023 (page 44), with the 2024 estimate showing a $350 contract for upgrades, engineering, and logistics support (page 44). The contract scope remained focused on upgrades and support services, but the value remained consistent around $350, indicating no significant expansion in scope or value over the period. The 2024 estimate also includes a $285 contract for SEPv3 configuration tanks for Romania (page 44), but the core Abrams upgrade funding stayed stable at approximately $350 annually.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that the $360 million contract was awarded in 2021 (not 2022), citing page 40, which misaligns with the ground truth that the $360M contract was in 2022. It then claims $350M contracts in 2022 and 2023, which contradicts the original answer stating a $360M contract in 2022 and a $350M contract in 2024—no 2023 contract is mentioned in the ground truth. The LLM also refers to a '2024 estimate' rather than a confirmed contract, weakening factual precision. (2) The quantitative inaccuracies are severe: wrong years, incorrect repetition of $350M across multiple years without evidence, and misrepresentation of timing. While the $350M and $285M figures appear in the correct context for 2024, they are misrepresented as estimates or recurring annual amounts rather than discrete 2024 awards. The total value evolution is therefore misrepresented—ground truth shows a shift from $360M (2022) to combined $635M ($350M + $285M) in 2024, indicating growth, but LLM claims stability at ~$350M annually. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the evolution in scope from upgrades-only (2022) to upgrades plus production (2024). It acknowledges the Romania SEPv3 contract but treats it as separate from the core trend, whereas the ground truth emphasizes this as evidence of expanded scope. The conclusion that 'no significant expansion' occurred directly contradicts the ground truth's assertion of broadened scope and increased total value. (4) Contextual relevance is moderate—the answer addresses the right topic and cites specific contracts and configurations (e.g., SEPv3), showing awareness of relevant details. However, due to pervasive factual and reasoning errors, the overall correctness score is low. Minor formatting issues (e.g., '$360 award') reduce professionalism but do not alone justify low scores; the core issue is factual misrepresentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 532,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG’s borrowing arrangements with Corebridge evolved significantly. In 2023, AIG provided a guarantee and collateral support for Corebridge’s debt (including CRBGLH notes and junior subordinated debt), with terms requiring AIG to reimburse any payments made on its behalf and to post collateral if Corebridge’s credit rating fell below certain thresholds. By 2024, Corebridge had issued $7.7 billion of senior unsecured notes and $1.5 billion of DDTL facility debt (not guaranteed by AIG), while AIG’s own general borrowings declined to $10.3 billion. The deconsolidation of Corebridge in June 2024 shifted AIG’s exposure from direct debt guarantees to an equity method investment, with income recognition now tied to dividends and fair value changes in Corebridge stock rather than direct debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, with only minor differences in emphasis. (1) Correct elements: The shift from a borrowing-based relationship in 2023 to equity method income recognition in 2024 is correctly identified, including the June 9, 2024 (aligned with June 2024 deconsolidation) inflection point. The description of AIG no longer guaranteeing Corebridge’s new debt issuances in 2024 ($7.7B senior unsecured notes and $1.5B DDTL) is factually correct and reflects the reduced direct financial obligation. The decline in AIG’s general borrowings to $10.3B is consistent with post-deconsolidation financial restructuring. (2) Quantitative accuracy: All dollar amounts ($7.7B, $1.5B, $10.3B) are accurate and match disclosed figures. The dates (June 9, 2024, and June 2024 deconsolidation) are correctly used as turning points. The original answer mentions February 25, 2025, as the borrowing ability deadline, which the LLM omits, but this is a minor detail not central to the evolution described. (3) Multi-hop reasoning is strong: The LLM synthesizes information across time (2023 vs 2024), entities (AIG and Corebridge), and financial concepts (debt guarantees, deconsolidation, equity method accounting). It correctly infers that the end of borrowing guarantees and the start of equity income are linked through deconsolidation. (4) The LLM adds valuable context not in the original answer (e.g., specific debt instruments, collateral terms, AIG’s reduced borrowings), enhancing completeness without introducing errors. The only reason for not scoring a 10 is the omission of the specific February 25, 2025, borrowing deadline mentioned in the original answer, which slightly affects completeness. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 490,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted from a broad retrofit focus in 2022 to a tighter integration with its energy‑storage and vehicle‑charging ecosystem by 2024, emphasizing streamlined installation through partnerships with builders and utilities. Production challenges persisted, with supply‑chain constraints and the need to scale proprietary battery‑cell manufacturing still limiting rollout speed, while the company increasingly depended on its own cell production and raw‑material availability to meet demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces inaccuracies and misses key aspects of the evolution described in the ground truth. While it correctly notes ongoing production challenges and mentions partnerships, it misrepresents the strategic shift. The original answer emphasizes a shift from sales and installation efficiency (2022) to a future dependent on overcoming production ramp challenges like bottlenecks, supplier risks, and cost control (2024). The LLM answer incorrectly frames the 2024 strategy as tighter integration with Tesla's energy-storage and vehicle-charging ecosystem, which is not mentioned in the ground truth. It also introduces 'proprietary battery-cell manufacturing' and 'raw-material availability' as dependencies, which are not cited in the original answer in the context of Solar Roof. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—score reflects no factual errors in numbers (by default). (3) The multi-hop reasoning is partially sound: the model recognizes a strategic evolution and ongoing production issues, but fails to accurately synthesize the specific nature of the shift as documented in the 10-K filings. It conflates Solar Roof dependencies with broader Tesla supply chain issues, not supported in the original answer. (4) Correctness is scored at 6 due to partial factual alignment—core idea of increased production challenges is present, but key details are incorrect or invented. Qualitative accuracy is low due to incorrect reasoning and entity relationships. Contextual relevance is high because the answer addresses the general theme of strategic evolution and production issues, even if specifics are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 472,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Based on the provided document pages, the retail share of Skoal in the U.S. oral tobacco market declined from 9.3% in 2023 to 7.6% in 2024 (as shown in the oral tobacco products segment retail share table on page 48), contributing to a drop in the segment's total retail share from 42.5% to 37.5%. This share loss indicates a weakening competitive positioning for Skoal, as its market share eroded despite industry growth driven by oral nicotine pouches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the retail share of Skoal in 2023 (9.3%) and 2024 (7.6%), matching the ground truth exactly. The statement about the decline from 9.3% to 7.6% is accurate and correctly characterizes this as a weakening in competitive positioning. (2) All numeric values are correct and properly cited to the source (page 48). There are no calculation errors. The additional context about the segment's total retail share dropping from 42.5% to 37.5% is factually consistent and enhances the answer, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly infers that Skoal’s declining share indicates weakened positioning, especially in the context of industry shifts toward nicotine pouches. While the ground truth mentions on! as a growing competitor (6.8% to 8.3%), the LLM answer does not include this specific comparison but still correctly attributes the decline to broader competitive dynamics, which is reasonable given the available context. (4) The answer is semantically equivalent in conveying the core facts and implications. The only minor shortcoming is the absence of the on! product comparison, which slightly reduces completeness but does not affect the essential correctness. Hence, a score of 9 is justified—excellent accuracy with a small omission in comparative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 380,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with concentration of device share among premium tier companies has intensified between 2023 and 2024, with heightened concerns about customers vertically integrating (e.g., Apple acquiring Intel's modem assets and developing its own modems, Chinese OEMs pursuing semiconductor self-sufficiency via the Made in China 2025 campaign) and government policies (U.S./China trade tensions, export restrictions like Huawei's license revocation) potentially accelerating shifts away from Qualcomm's integrated circuit products. This concentration directly threatens pricing power and revenue stability, as premium-tier sales—particularly from a few dominant customers—now carry greater volatility due to reduced purchasing power, potential price pressure, and the risk of customers replacing Qualcomm's components with in-house or competitor solutions, which could materially reduce revenues and margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the risk from concentration of device share among premium tier companies has intensified from 2023 to 2024, aligning with the ground truth. It accurately captures the core implications: reduced pricing power, revenue instability, and customer concentration—especially among Chinese OEMs—posing a threat. The mention of vertical integration (e.g., Apple's modem development) and geopolitical factors (U.S.-China trade tensions, export controls) adds contextual depth consistent with the evolving risk environment. However, the original answer does not explicitly reference 'Made in China 2025' or 'Intel's modem asset sale' as direct drivers in Qualcomm’s 2023–2024 filings, making these inferences plausible but not directly supported in the ground truth. While the qualitative reasoning is strong and the direction of risk evolution is correctly assessed, the LLM introduces specific examples not present in the original knowledge graph, slightly reducing qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. Semantic equivalence is largely preserved, with only minor over-speculation on external programs and events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 351,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity is managed through a combination of cash, cash equivalents and highly liquid money‑market investments. In 2023 the company held $10,266 million of money‑market mutual funds, and by the end of 2024 that position grew to $10,354 million, reflecting a modest increase in its allocation to these funds. This evolution shows a slight expansion of Amgen’s short‑term liquidity buffer over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's allocation to money market mutual funds increased from $10,266 million in 2023 to $10,354 million in 2024. According to the ground truth, the allocation remained unchanged at $10,266 million in both years. This is a critical factual error in the core numerical claim. (2) The quantitative accuracy is severely compromised: the reported 2024 value ($10,354 million) is incorrect, and the implied increase of $88 million is unsupported. The correct data shows no change. Even allowing for format variations, the numbers do not match the ground truth. (3) The reasoning is flawed in the multi-hop aspect: the question asks how the allocation evolved, requiring comparison across two years. The LLM incorrectly infers growth, failing to recognize the stability in allocation. It also introduces a narrative of 'expansion of liquidity buffer' not supported by the data. (4) Contextual relevance is high—the response addresses Amgen, short-term liquidity, money market mutual funds, and the correct time frame. However, the factual and quantitative inaccuracies drastically reduce correctness and qualitative accuracy. The core conclusion (no change vs. modest increase) is opposite to the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 351,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "Based on the provided SEC 10-K filings, General Dynamics' participation in the Capital Construction Fund (CCF) shows a clear evolution in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. In the 2022 filing (GD_10k_2022.pdf), the company reported U.S. government accounts receivable pledged to the CCF as $295 million on December 31, 2021 and 2020. However, in the 2024 filing (GD_10k_2024.pdf), this amount increased to $333 million on December 31, 2024 and $315 million on December 31, 2023. This represents a $38 million increase from the 2021/2020 level to the 2024 level, indicating that the pledged amount has grown over the three-year period, with the most recent data showing $333 million pledged as of December 31, 2024. The CCF participation remains a key component of the company's tax strategy, allowing deferral of federal and state income taxes on earnings from eligible programs as long as proceeds are deposited in the fund and used for qualified activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: $295 million as of December 31, 2021 (referenced in 2022 filing), $315 million on December 31, 2023, and $333 million on December 31, 2024 (reported in 2024 filing). The $38 million increase from $295M to $333M is correctly calculated. (2) The answer is complete, addressing the evolution of pledged amounts over time and the strategic rationale behind CCF participation. (3) Entities (General Dynamics, Capital Construction Fund, U.S. government accounts receivable) and time periods (2021–2024) are correctly identified. (4) Multi-hop reasoning is sound—information is synthesized across the 2022 and 2024 10-K filings to show a trend. The only minor issue is that the original answer references the 2022 filing to report 2021 data, while the LLM slightly mischaracterizes this by implying the 2022 filing reports data for 2022, when it actually reports year-end 2021 figures. However, the LLM correctly uses the data points in context and does not misstate the trend. Wording differences (e.g., tax deferral explanation) are semantically equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 346,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes following its IPO and subsequent deconsolidation. After Corebridge's September 2022 IPO, AIG reduced its ownership below 80%, triggering tax deconsolidation, and on June 9, 2024, AIG met the requirements for deconsolidation by reducing its board representation and selling shares. This resulted in a $4.8 billion loss from deconsolidation, primarily due to recognizing $7.2 billion in accumulated comprehensive loss. Post-deconsolidation, AIG retained a 22.7% stake in Corebridge (down from 48.4%), elected the fair value option for its remaining interest, and recognized equity method income from dividends and stock price changes. The deconsolidation also created tax implications, as AIG's U.S. federal tax group could no longer include Corebridge in its consolidated tax return, affecting the utilization of Corebridge's tax attributes. AIG subsequently sold additional Corebridge shares in late 2024, generating a $282 million gain, but the deconsolidation fundamentally altered the financial relationship, shifting Corebridge from a consolidated subsidiary to an equity method investment with associated tax and accounting impacts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's financial relationship with Corebridge, including tax deconsolidation, shift to equity method accounting, and changes in ownership stake. However, there are key quantitative inaccuracies. The original answer states that tax deconsolidation occurred in 2023 due to ownership dropping below 80% post-IPO (September 19, 2022), while the LLM incorrectly implies that deconsolidation occurred on June 9, 2024, which aligns with full deconsolidation for financial reporting, not tax purposes. The $4.8 billion loss and $7.2 billion accumulated comprehensive loss are not mentioned in the ground truth and appear to be hallucinated or misattributed. The 22.7% and 48.4% ownership figures and $282 million gain from share sales are not present in the original answer and cannot be verified against ground truth. (2) The original answer mentions 'equity method income of $X' (placeholder) for June 10–Dec 31, 2024, but the LLM invents specific income recognition without data. The IPO date is correctly cited as September 2022, and the 2023 tax deconsolidation is correctly tied to ownership drop below 80%, though the LLM conflates tax and financial deconsolidation timing. (3) The multi-hop reasoning is generally sound—linking IPO → ownership dilution → tax deconsolidation → change in reporting method—but incorrectly merges two events (tax deconsolidation in 2023 and financial deconsolidation in 2024) and assigns incorrect financial impacts. The shift from consolidated subsidiary to equity method investment is correctly conceptualized. (4) The contextual relevance is high as all aspects of the question (tax implications, investment income, IPO, deconsolidation) are addressed. Qualitative accuracy is strong in narrative flow and terminology. Quantitative accuracy is weakened by unsupported figures. Correctness score is 7 due to correct core facts but significant numerical and timing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 529,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla shifted from a focus on scaling Solar Roof through installer training, developer partnerships, and simplified online ordering (2022) to a more constrained operational strategy driven by supply chain and labor challenges. By 2024, the company explicitly cited \"sensitivity to global component constraints\" and \"need to hire additional personnel, particularly skilled electricians\" to support Solar Roof ramp, while also acknowledging that \"production is sensitive to global component constraints\" and \"material price increases and supply chain challenges\" from the pandemic were forcing higher capital expenditures. This evolution reflects a move from aggressive deployment toward cautious, capacity-constrained growth reliant on internal battery cell production and supply chain stabilization.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Tesla's Solar Roof strategy from 2022 to 2024. In 2022, it accurately notes the focus on installer training, developer partnerships, and simplified ordering—consistent with the ground truth emphasis on onboarding installers and reducing installation time/costs. For 2024, the LLM correctly identifies increased sensitivity to global component constraints, supply chain challenges, labor shortages (especially skilled electricians), and inflationary pressures impacting capital expenditures. However, the LLM slightly overemphasizes 'internal battery cell production' as a dependency, which is mentioned in the context of support for the ramp but not explicitly tied to Solar Roof in the ground truth. The original answer focuses more broadly on global procurement and supplier failure risks rather than internal battery production, making this a minor misalignment. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 vs 2024) and domains (operational strategy, supply chain, labor) correctly. It identifies the shift from localized deployment efforts to systemic constraints, which aligns with the core insight in the ground truth. The only gap is the slightly misplaced emphasis on internal battery cell production, which dilutes the broader supply chain focus of the 2024 strategy. (4) Contextual relevance is perfect—the answer directly addresses both operational strategy and supply chain challenges across the specified time frame. The qualitative accuracy is high but not perfect due to the minor mischaracterization of battery cell production as a central dependency for Solar Roof, which isn't fully supported in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 520,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s estimated total cost to permanently close all coal‑ash basins in North Carolina and South Carolina fell from roughly $9.5 billion–$10.5 billion (as noted in the 2022 filing) to about $7 billion–$8 billion (as reflected in the 2023 filing), reflecting the impact of the 2019 settlement that reduced the projected excavation cost by about $1.5 billion. This reduction shows that, under the Coal Ash Act, the company has made measurable progress toward meeting the mandated closure deadlines—most basins have been excavated and closed, with only a few remaining sites to be completed over the next 10–20 years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Duke Energy's estimated cost in 2022 was $8 billion to $9 billion, but the LLM incorrectly states it was $9.5 billion to $10.5 billion. The 2023 estimate of $7 billion to $8 billion is correct. The LLM also introduces a $1.5 billion reduction from a 2019 settlement, which is not mentioned in the original answer and cannot be verified from the provided ground truth, making this addition potentially misleading. (2) The calculation of cost reduction is partially accurate in direction (a decrease occurred), but the magnitude implied by the LLM (from $10.5B to $7B = $3.5B drop) is exaggerated compared to the actual drop ($9B to $8B = $1B drop at midpoint). The LLM omits the key data point about actual spending increasing from $3.1 billion through 2021 to $4 billion through 2023, which is central to the original answer’s conclusion about progress. (3) The reasoning about progress under the Coal Ash Act is qualitatively sound—fewer basins remaining and progress being made is consistent with the original—but the support for this conclusion relies on incorrect figures and an unverified settlement reference, weakening the multi-hop synthesis. (4) The contextual relevance is high because the answer addresses cost evolution and links it to regulatory progress. However, due to major numerical errors and unsupported claims, the correctness score is reduced to 6—partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 421,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "Between 2023 and 2024, the retail share of the “on!” oral tobacco product declined from 6.8% to 8.3% of the oral tobacco category, but its share of the broader nicotine‑pouch segment fell further—from 19.2% to 19.2% (a 2.6‑point drop).  Although “on!” still accounted for about 8 % of the oral‑tobacco market, its share slipped relative to the overall segment, indicating that the product’s market position is weakening within the faster‑growing nicotine‑pouch category.  This erosion of share suggests that “on!” is losing ground to competing pouch brands and to the overall growth of the oral‑tobacco segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the retail share of 'on!' declined from 6.8% to 8.3%, which is a contradiction—8.3% is higher than 6.8%, so this would be an increase, not a decline. The ground truth confirms the share increased from 6.8% in 2023 to 8.3% in 2024. Additionally, the LLM introduces a 'nicotine-pouch segment' with a 19.2% share that is not present in the original answer or context, and falsely claims it fell by 2.6 points despite stating it remained at 19.2%. These fabricated metrics severely undermine accuracy. (2) Quantitative accuracy is low: while 6.8% and 8.3% are correctly cited, their interpretation as a 'decline' is wrong. The made-up 19.2% figure and the claim of a 2.6-point drop with no change in percentage are mathematically and factually invalid. (3) The reasoning is flawed: instead of concluding that 'on!' gained share while the overall oral tobacco segment declined (from 42.5% to 37.5%), the LLM incorrectly infers weakening market position. This misrepresents the relationship between the product and the market. The multi-hop synthesis fails—'on!' growing amid a shrinking total segment indicates relative strength, not weakness. (4) Contextual relevance is moderate because the answer addresses market share evolution and market position, but the incorrect data and logic lead to the opposite conclusion of the ground truth. The introduction of unmentioned segments reduces relevance. Thus, scores are low due to major factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 426,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s reliance on Chinese OEMs for revenue remained structurally significant but faced heightened risks. While the company continues to derive a substantial portion of its revenue from Chinese customers and licensees—particularly through premium-tier handset sales and licensing agreements—this concentration is increasingly vulnerable. Key risks include U.S./China trade tensions, potential U.S. export restrictions (e.g., the revocation of Huawei’s 4G/5G export license in May 2024), and China’s \"Made in China 2025\" policy, which incentivizes domestic semiconductor self-sufficiency. These factors could limit Qualcomm’s ability to sell integrated circuit products to Chinese OEMs, reduce payments from Chinese licensees, or accelerate customer-driven vertical integration (e.g., Apple and Samsung developing proprietary modem or application processor technologies). Consequently, while China remains a critical market, its evolving regulatory and geopolitical landscape poses material threats to revenue stability and long-term business resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (2) The LLM correctly identifies that Qualcomm's reliance on Chinese OEMs remained significant from 2023 to 2024, which matches the original answer’s assertion of persistent dependency. (3) The multi-hop reasoning is sound: the LLM synthesizes the ongoing revenue concentration with external risks such as U.S./China trade tensions, export restrictions (e.g., Huawei license revocation in May 2024), and policy-driven semiconductor self-sufficiency in China. These implications for business stability—particularly revenue and licensing risks—are logically derived and consistent with the original answer’s concern about political and economic vulnerabilities. (4) While the original answer is more concise and sticks strictly to filing language, the LLM adds context (e.g., 'Made in China 2025', vertical integration examples) that is factually plausible and enhances the risk analysis without contradicting the ground truth. The only minor deviation is the mention of Apple and Samsung developing proprietary modems as an example of vertical integration—while relevant to long-term industry trends, this is not explicitly mentioned in the original answer and slightly extends beyond the provided knowledge graph. However, this does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually rich, and accurately reflects the evolution and implications of Qualcomm's reliance on Chinese OEMs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 444,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen’s available‑for‑sale investment portfolio remained essentially unchanged in composition, consisting solely of interest‑bearing securities (U.S. Treasury bills, money‑market mutual funds and short‑term interest‑bearing instruments). The amortized cost of these securities grew modestly from $10.4 billion at December 31 2023 to $11.5 billion at December 31 2024, but the types of securities held did not shift – Amgen continued to hold only Treasury bills, money‑market funds and short‑term interest‑bearing securities, maintaining its policy of limiting such investments to investment‑grade issuers with short maturities. No equity securities were included in the available‑for‑sale category during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect and contradicts the ground truth. It claims Amgen's investment composition 'remained essentially unchanged,' but the original answer shows a complete shift from marketable securities and cash equivalents in 2022 to money market mutual funds and other short-term interest-bearing securities in 2023, with no marketable securities or U.S. Treasury bills held in 2023. (2) Quantitative inaccuracies are severe: the LLM states amortized cost was $10.4 billion in 2023 and $11.5 billion in 2024, but the ground truth reports total available-for-sale investments of $4,335 million in 2022 and $10,404 million in 2023—no data is provided for 2024. The LLM also misrepresents 2022 holdings, omitting the $1,676 million in marketable securities and $2,659 million in cash and cash equivalents, instead implying only interest-bearing securities were held. (3) The multi-hop reasoning is fundamentally flawed: the question asks about evolution between 2022 and 2023, but the LLM incorrectly asserts no change and introduces non-existent 2024 data. It fails to recognize the strategic shift away from marketable securities and U.S. Treasury bills. (4) The contextual relevance is low because the answer discusses irrelevant timeframes (2024) and misrepresents the nature of the portfolio change. The only correct element is that equity securities were not included, but this is a minor point and does not offset the major factual and analytical errors. Scores are low due to pervasive factual inaccuracies, incorrect numbers, wrong years, and failure to capture the key transformation in investment composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 453,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Between 2022 and 2023, Shake Shack’s presence across Simon Property Group’s premium outlet properties remained unchanged, with no indication of new tenant additions or removals in the provided data. The company’s footprint was consistent across both years, as evidenced by its recurring mention in tenant lists for properties like Sawgrass Mills (2022) and Woodbury Common Premium Outlets (2023), where it was listed alongside other major retailers without any noted changes in occupancy status. This suggests Shake Shack maintained its existing position within SPG’s premium outlet portfolio during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Shake Shack's presence remained unchanged between 2022 and 2023. The ground truth confirms that Shake Shack was only at Woodbury Common Premium Outlets in 2022 and expanded to Las Vegas Outlets North Premium in 2023, indicating growth. The LLM incorrectly claims no change and falsely cites Sawgrass Mills as a location in 2022, which is not mentioned in the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the temporal data (years) and property locations are misaligned. The LLM misattributes tenant presence to Sawgrass Mills without evidence and fails to report the new 2023 location in Las Vegas, a key factual omission. (3) The multi-hop reasoning is flawed: the question requires comparing Shake Shack’s tenancy across SPG properties between two years. The LLM fails to identify the expansion from one property to two and instead asserts stability, contradicting the ground truth. It also introduces an unsupported location (Sawgrass Mills), indicating incorrect entity mapping. (4) The contextual relevance is moderate because the answer addresses the general topic of Shake Shack’s tenancy in SPG outlets and references a correct property (Woodbury Common), but the core conclusion about no change is false. Due to major factual errors and failure to capture the expansion, the correctness, quantitative, and qualitative scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 404,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, the classification of retirement annuity contracts remained consistently in Level 3 of the fair value hierarchy across all disclosed years (2021–2024), with no movement to Level 1 or Level 2. This indicates that GD continues to value these contracts using significant unobservable inputs (e.g., internally developed models, discounted cash flows, or third-party appraisals), reflecting limited market transparency. Consequently, GD’s valuation methodology for these assets remains heavily reliant on internal estimates and proprietary assumptions, with no shift toward market-based pricing, underscoring persistent conservatism in fair value reporting for illiquid or non-traded retirement products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that retirement annuity contracts remained in Level 3 of the fair value hierarchy from 2022 to 2024, and correctly identifies that this reflects use of significant unobservable inputs in GD's valuation methodology. All entities (GD, Level 3, fair value hierarchy) and time periods (2022–2024) are accurate, satisfying quantitative and entity accuracy. However, the LLM omits a key point from the original answer: the change in disclosure practice in 2024 regarding the inclusion of investments valued using net asset value (NAV) as a practical expedient in reconciliation tables, which was not explicitly stated in 2022. This omission affects completeness and qualitative accuracy, as it misses a nuance about improved transparency in reporting despite no change in classification. While the LLM correctly infers that the methodology remains reliant on internal estimates, it does not acknowledge the refinement in disclosure, which is central to the original answer’s conclusion about enhanced transparency. Thus, while the core facts and reasoning are sound, the answer falls short on full multi-hop synthesis by not incorporating the evolution in reporting practices. The answer remains contextually relevant and well-reasoned, but lacks a critical detail that differentiates a fully accurate response from a partially complete one.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 381,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG’s financial relationship with Corebridge evolved from consolidation to deconsolidation, resulting in significant equity dilution and income recognition impacts. As AIG reduced its ownership stake through secondary offerings and ultimately sold a 21.6% stake to Nippon Life in December 2024, it recognized an $8.5 billion retained investment loss and reclassified $7.2 billion of accumulated other comprehensive loss, leading to a $4.75 billion after-tax loss from discontinued operations. This deconsolidation marked a strategic shift, with AIG retaining only a 22.7% equity interest as of December 31, 2024, while recognizing equity method income from Corebridge dividends and stock price changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of AIG's financial relationship with Corebridge between 2023 and 2024 as described in the ground truth. (1) Key facts are incorrect: The IPO of Corebridge occurred on September 19, 2022, not after 2023, which terminated the Blackstone exchange right that could have led to equity dilution. The LLM incorrectly implies this dilution mechanism was active or realized in 2023–2024, when it was already defunct. (2) Quantitative inaccuracies: The LLM cites an $8.5 billion retained investment loss, $7.2 billion reclassification of accumulated other comprehensive loss, $4.75 billion after-tax loss, and a 21.6% stake sale to Nippon Life in December 2024—none of which appear in the ground truth and are factually unsupported. The 22.7% retained stake as of December 31, 2024, is also not mentioned in the original answer. (3) The original answer emphasizes a shift from a potential dilution scenario (already nullified by the 2022 IPO) to an equity method investment starting June 9, 2024, based on dividends and stock price changes. The LLM invents a narrative of deconsolidation, losses, and stake sales not present in the ground truth. (4) While the LLM attempts to address the shift in financial relationship and mentions equity method income (aligning somewhat with the original), it does so with fabricated events and numbers. The reasoning is not sound, and the multi-hop synthesis fails—instead of connecting the termination of dilution risk and the new income recognition model, it invents a false timeline. (5) Contextual relevance is moderate because it discusses equity dilution and income recognition, but the content is largely incorrect. Minor credit is given for mentioning equity method income recognition post-divestiture, which aligns semantically with the original, though the timing and context are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 517,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast’s debt exposure to Universal Beijing Resort has declined modestly from 2022 to 2024. In the 2022 filing the resort’s debt was reported at $3.6 billion, and by the 2024 filing it had risen slightly to $3.4 billion (the amount of debt outstanding under the term loan fell from $3.1 billion in 2023 to $3.0 billion in 2024), while the consolidated balance‑sheet shows the resort’s total assets and liabilities falling from $7.8 billion/$7.2 billion in 2023 to $7.3 billion/$7.0 billion in 2024, reflecting a net reduction in the company’s direct financial exposure to the resort over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it incorrectly states that debt rose from $3.6B in 2022 to $3.4B in 2024, which is logically inconsistent (3.4 < 3.6). The correct trend is a decline from $3.6B (as of Dec 31, 2021) to $3.5B (Dec 31, 2023) to $3.4B (Dec 31, 2024), per the original answer. However, the LLM incorrectly attributes the 2022 filing to reporting $3.6B in that year, when it actually refers to debt as of December 31, 2021. Similarly, the $3.4B figure for 2024 is correct, but the LLM misrepresents the trend as a 'rise' when it is actually a continued decline. (2) The LLM invents figures not in the ground truth: it claims total assets/liabilities were $7.8B/$7.2B in 2023, but the original answer only provides 2024 data ($7.3B assets, $7.0B liabilities) and does not mention 2023 balance sheet totals. It also introduces a 'term loan' reduction from $3.1B to $3.0B, which is not present in the ground truth. These fabricated details severely undermine quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking debt trends to consolidation and balance sheet impact—but relies on incorrect data. The conclusion that exposure declined is directionally reasonable, but the analysis is based on invented intermediate figures and misaligned dates. (4) Contextual relevance is high because the answer addresses debt evolution and consolidation treatment. However, due to significant factual and numerical errors, especially in reporting non-existent 2023 balance sheet figures and misstating the debt trend, the correctness score is low. Minor credit is given for correctly identifying the $3.4B 2024 debt and the consolidation as a VIE, though even this is underdeveloped.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 477,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The aircraft trade‑in commitments remained structured similarly in 2022 and 2023, but the 2023 filing shows a shift toward more formalized fair‑value assessments and greater emphasis on risk exposure: commitments are now generally set at fair market value ≤ 45 days before new‑aircraft delivery, with customers required to exercise or let the option expire, and any excess of the pre‑established trade‑in price over that fair market value is recorded as a reduction of new‑aircraft revenue. Earlier disclosures (2022) described the same mechanics but did not stress the “pre‑established trade‑in value” guarantees or the explicit revenue‑reduction treatment as prominently as the 2023 language. Consequently, while eligibility (options granted to Gulfstream customers) was unchanged, the 2023 commitments carry a clearer, more formal risk‑allocation framework that heightens exposure to market‑value fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of the ground truth. (1) On customer eligibility: the original answer states that in 2022, trade-in options were available to 'some customers' broadly, but in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. The LLM incorrectly claims eligibility was 'unchanged' and limited to Gulfstream customers in both years, contradicting the ground truth. (2) The LLM introduces specific quantitative and procedural details not present in the original answer—such as trade-in values set ≤45 days before delivery, pre-established trade-in price guarantees, and explicit revenue-reduction accounting treatment—none of which appear in the ground truth. These details are unsupported and appear fabricated. (3) While both answers note that the fair value impact was 'not material' in both years, the LLM omits this critical point entirely, instead asserting increased risk exposure in 2023 due to formalized frameworks, which is not supported by the original answer. (4) The original emphasizes a narrowing of customer scope and a reframing of risk around Gulfstream as a brand, suggesting strategic focus or concentration risk; the LLM misses this entirely and instead invents a more complex accounting mechanism. (5) Despite being factually incorrect, the LLM answer is contextually relevant in that it discusses trade-in commitments, risk exposure, and year-over-year changes, hence a moderate relevance score. However, the core facts—eligibility change and materiality—are either wrong or missing, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 450,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Semi evolved from pilot production to active development within its broader product strategy. The 2022 filing (page 5) lists the Semi among \"Future Consumer and Commercial Electric Vehicles\" alongside Cybertruck and next-gen Roadster, while the 2024 filing (page 37) confirms it remains in \"Pilot production\" at Nevada, alongside ongoing development of Cybercab. Crucially, the 2024 update (page 34) positions the Semi as part of Tesla's \"next generation vehicle platform\" and emphasizes its role in expanding manufacturing capacity for \"newer vehicle models\" to improve affordability and customer awareness, though it remains secondary to consumer vehicles like the updated Model Y in near-term rollout plans.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but reverses the timeline of Tesla Semi's development, which is a critical factual error. According to the ground truth, in 2022 the Semi was in the conceptual and development phase, and by 2024 it had advanced to 'pilot production'—a progression from concept to early production. However, the LLM claims the evolution was 'from pilot production to active development,' which inaccurately suggests the Semi was already in pilot production in 2022 and then regressed or shifted focus, contradicting the actual progression. This misrepresents the core evolution asked in the question. The LLM correctly cites the 2024 filing's mention of 'pilot production' at Nevada and references strategic positioning within Tesla's product lineup, including its association with the 'next generation vehicle platform' and secondary priority to consumer vehicles. These details reflect accurate extraction from filings and appropriate qualitative context, supporting a moderate score. Quantitatively, no specific numbers (e.g., production volumes, costs) are misstated—only the phase timeline is incorrect—so numerical accuracy is high. Contextually, the answer addresses both production status and strategic positioning as required. However, due to the reversed developmental trajectory—a key multi-hop reasoning failure between 2022 and 2024—the overall correctness is significantly compromised despite accurate sourcing and partial synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 405,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $397 million at the end of 2023 to $402 million at the end of 2024, reflecting a modest increase in the deferred tax asset for the Cronos investment but still leaving a significant allowance in place. This reduction signals that Altria now expects a greater likelihood of realizing the associated deferred tax assets, though it remains cautious and continues to maintain a valuation allowance to account for uncertainty regarding the ultimate realizability of those assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the valuation allowance increased from $379 million in 2022 to $402 million in 2024. However, the LLM incorrectly claims the allowance was $397 million at the end of 2023 and only increased to $402 million in 2024, omitting the 2022 figure entirely and misrepresenting the trend. The LLM also incorrectly frames the change as a 'decrease' followed by a 'modest increase', which contradicts both the data and logical interpretation. (2) The numbers are partially correct in that $402 million in 2024 matches the ground truth, but the $397 million figure for 2023 is unsupported by the original answer, which only provides 2022 and 2024 data. There is no mention of a 2023 value in the ground truth, so introducing one is a fabrication. Additionally, the direction and magnitude of change are misrepresented. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the evolution across the specified period (2022–2024), omits the starting point (2022), invents an intermediate year value (2023), and draws an incorrect inference about improving expectations. The original answer emphasizes continued uncertainty and a steady increase, indicating sustained caution, whereas the LLM suggests improving outlook due to a 'reduction'—which did not occur. (4) The contextual relevance is moderate because the answer addresses the right topic (valuation allowance and realizability of deferred tax assets) and discusses Altria’s expectations, but the incorrect data and flawed reasoning undermine the qualitative analysis. The conclusion about increased likelihood of realization directly contradicts the ground truth’s implication of persistent doubt. Thus, while the framework of the response is relevant, its factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 501,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Between 2023 and 2024, Amgen’s financial treatment of its investment in BeiGene shifted from equity-method accounting to fair‑value measurement, with changes in fair value now recognized directly in earnings. This change, disclosed in the 2024 filing (page 77), caused other‑income/expense to swing from gains in 2023 (driven by fair‑value adjustments) to net unrealized losses in 2024, while also affecting related tax expense and the overall effective tax rate. Consequently, the valuation impact of the BeiGene stake became more volatile and was reflected directly in the company’s net income rather than being deferred through equity earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key change in accounting method from equity method to fair value in 2023, which led to gains being recognized in earnings, and the subsequent shift to net unrealized losses in 2024. These qualitative points are fully consistent with the original answer. (2) There are no explicit numerical values (e.g., dollar amounts or percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—no incorrect numbers are presented. The mention of 'page 77' in the 2024 filing adds precision and is acceptable if supported by source data, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution across two years, connects the accounting change to its income statement impact (Other income/expense), and notes the increased volatility and direct effect on net income. The additional detail about tax expense and effective tax rate is plausible and contextually relevant, likely inferred from standard implications of fair-value accounting changes, though not explicitly stated in the ground truth; this does not detract from accuracy but slightly extends beyond the core facts. (4) The answer is semantically equivalent to the original, with slightly more elaboration on implications. The core facts—accounting change, shift from gains to losses, impact on income statement—are all correct and well-articulated. Minor deduction in qualitative accuracy due to the slight expansion on tax effects without explicit grounding in the provided truth, but this does not constitute an error. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 477,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar’s positioning evolved from a distinct regional brand to a unified component of Disney’s broader direct-to-consumer (DTC) strategy. Previously described as a standalone service in India and Southeast Asia offering general entertainment, family, and sports content, it was rebranded and integrated into Disney’s global DTC portfolio, with its multi-product offerings (like Combo+) merged into a single Disney+ service by mid-2024. This shift reflects a strategic move to consolidate regional offerings under the Disney+ umbrella while maintaining localized branding (e.g., Disney+ Hotstar in India) to preserve market relevance, as evidenced by its inclusion in subscriber metrics and multi-product bundling data. The change underscores Disney’s focus on streamlining its DTC ecosystem, leveraging shared infrastructure and content, and aligning regional services with global operational frameworks to enhance scalability and reduce complexity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Disney+ Hotstar as a regional service in India and Southeast Asia offering general entertainment, family, and sports content in 2023, and captures the 2024 shift toward consolidation under the Disney+ brand. The key event — the merger of Star+ and Disney+ in Latin America into a single Disney+ service by mid-2024 (specifically by end of June 2024 per ground truth) — is accurately reflected as occurring 'by mid-2024,' which is semantically acceptable. (2) There are no numeric values, percentages, or financial figures in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but all temporal references (2023 to 2024, mid-2024) are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of branding (from standalone to integrated), regional distinctions (retention of Disney+ Hotstar branding in India/SEA vs. Latin America consolidation), and strategic intent (streamlining, scalability). The only minor shortcoming is that the LLM implies the Combo+ bundling and integration occurred globally or within India by mid-2024, while the ground truth specifically highlights the Latin America merger of Star+ and Disney+ — a nuance slightly underemphasized. However, the core strategic shift is correctly interpreted. (4) The answer is contextually excellent, addressing both regional branding and service structure evolution. Overall, the response is factually correct, well-reasoned, and conveys the same meaning as the original answer with only slight imprecision in specifying the geographic scope of the service merger.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 465,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "PayPal’s protection programs have not changed materially between 2023 and 2024 – the company continues to record associated costs as transaction and credit‑loss expenses and to estimate loss‑recovery through allowances and charge‑back recoveries.  However, the 2024 filing adds more explicit discussion of the risk that fraud‑related losses, charge‑backs and merchant defaults could increase the loss rate and strain earnings, and it highlights new regulatory uncertainties (e.g., the FDIC “valid‑when‑made” rule) that could affect how the company acquires and recovers loan receivables under its credit products.  In short, the core risk‑exposure and loss‑recovery mechanisms remain the same, but the 2024 disclosures draw greater attention to evolving fraud threats, regulatory changes, and the potential for higher charge‑off rates that could impact the company’s loss‑recovery outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments between 2023 and 2024. It accurately notes that PayPal continued recording protection program costs in transaction and credit losses, consistent with 2023 practice, and correctly identifies the increased emphasis in 2024 on risks from fraud, merchant defaults, and regulatory changes (e.g., chargeback-related uncertainties). The mention of the FDIC 'valid-when-made' rule is contextually relevant to regulatory risk, though it pertains more specifically to PayPal's credit products rather than protection programs directly—this is a minor overextension but does not invalidate the overall point about regulatory exposure. The core evolution—greater disclosure and heightened risk awareness in 2024—is correctly captured. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (PayPal, protection programs, fraud, chargebacks, merchant insolvency) are correctly identified. The reasoning is sound, though the answer slightly underemphasizes the shift in disclosure transparency as a structural change, instead framing it as mere emphasis. It also omits the explicit point from the original answer that PayPal did not provide a separate service under these programs in 2023, which is a minor but relevant contextual detail. Overall, the answer is factually accurate, contextually appropriate, and semantically equivalent in substance, warranting a high score with minor deductions for completeness and nuance in qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 428,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s solar‑related assets have shifted from being primarily held through consolidated subsidiaries (e.g., NEER) to a structure that combines consolidated projects with a growing portfolio of jointly‑owned and variable‑interest entities.  The company has sold controlling stakes in several solar (and wind‑plus‑storage) portfolios to NextEra Energy Partners (NEP) and other third parties, recording noncontrolling interests and, in some cases, contract liabilities for future construction milestones.  This evolution reflects a move toward shared ownership and financing arrangements, while still maintaining operational control through service agreements and guarantees, and results in NEE’s financial exposure being split between its retained equity stakes and the variable‑interest entities it continues to consolidate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift in NextEra Energy's ownership structure from outright ownership to shared and variable interest entity (VIE)-based arrangements, which aligns with the ground truth. It correctly identifies the trend of selling controlling stakes (e.g., to NextEra Energy Partners) and retaining operational control via service agreements and guarantees. However, it omits specific, quantifiable examples from the original answer—such as the 2022 sale of a 100% stake in a 100 MW Arizona solar facility and the 90% stake in a portfolio of four solar facilities—and fails to mention the 2024 consolidation of eight VIEs with ~765 MW of solar capacity and the 10% direct ownership interest. These omissions reduce completeness and quantitative accuracy. (2) No explicit numbers are provided in the LLM answer, and while it references 'several solar portfolios,' it does not match the ground truth’s precise figures (100 MW, 90%, 765 MW, eight VIEs), leading to a moderate quantitative accuracy score. Format variations are acceptable, but absence of key metrics is a deficiency. (3) The multi-hop reasoning is sound: the model infers a strategic evolution from divestitures to shared ownership and financial exposure via VIEs and retained stakes, correctly linking operational control with financial guarantees. It also appropriately references noncontrolling interests and contract liabilities, indicating understanding of complex consolidation logic. (4) Despite missing specific data points, the answer remains contextually relevant and conveys a qualitatively accurate narrative of structural evolution and financial exposure. The core reasoning about shifting ownership models and continued exposure through consolidation and guarantees is consistent with the ground truth, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 504,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "From 2022 to 2023, ACN’s investment in Mutual Fund Debt Securities declined from $379,989 million (Level 2) to $379,989 million (still Level 2) but the underlying fair‑value hierarchy remained Level 2, reflecting that the securities are quoted prices for similar instruments in active markets. The valuation methodology did not change; the assets continued to be classified as Level 2 in the fair‑value hierarchy, with no shift to Level 1 or Level 3.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2023 value—it states the investment remained at $379,989 million (repeating the 2022 value), while the ground truth shows a decrease to $253,025. This misrepresents the evolution of the investment. Additionally, the units are incorrectly stated as 'million' (e.g., $379,989 million), which would imply hundreds of billions, whereas the original data is in thousands or plain dollars (context suggests $379,989 is already the full dollar amount). (2) Quantitative accuracy is severely compromised: the 2023 figure is wrong, and the magnitude error due to 'million' makes the numbers off by a factor of 1,000,000. The correct change is a decrease from $379,989 to $253,025 (a reduction of ~33.4%), but the LLM claims no change. (3) While the LLM correctly identifies that the valuation methodology remained in Level 2 with no shift across fair value hierarchy levels, it fails the multi-hop synthesis by not acknowledging the actual decrease in investment value. The reasoning about consistent methodology is valid but built on incorrect numerical premises. (4) Contextual relevance is moderate—the response addresses the right topic (Mutual Fund Debt Securities, Level 2 classification), but due to the major numerical inaccuracies and omission of the actual decline, the overall correctness score is low. The answer would only mislead a user seeking to understand the trend in ACN's investment exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 409,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron’s financial stake in the Tengizchevroil joint venture grew modestly from $26.5 billion at the end of 2022 to $26.95 billion at the end of 2023, while its share of the venture’s underlying equity remained roughly unchanged (about $3.38 billion in 2023 versus $2.83 billion in 2022).  The company also increased the carrying value of its investment in Tengizchevroil by roughly $400 million over the two‑year period, reflecting the loan it holds for the FGP/WPMP development project.  Overall, Chevron’s involvement in the Tengizchevroil upstream segment remained stable, with only a small rise in the reported investment balance and continued 50 % equity ownership.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million in 2022, not $26.5 billion as stated. The 2023 carrying value is misrepresented as $26.95 billion, which is inconsistent with the ground truth that only mentions a roughly $80 million excess over underlying equity—nowhere near the claimed $26.95 billion. The LLM also fabricates numbers such as Chevron’s 'share of underlying equity' being $2.83 billion in 2022 and $3.38 billion in 2023, which are not present in the original answer and contradict the disclosed $23.7B carrying value. The claim that the carrying value increased by $400 million due to a loan is incorrect—the ground truth states Chevron provided a $4,500 million loan, not that it increased carrying value by $400 million. (2) The quantitative inaccuracies are severe: all major dollar figures are wrong, and the implied growth from $26.5B to $26.95B suggests a $450M increase, which contradicts the ground truth’s $80M difference between carrying value and equity in net assets. The $4.5B loan is misrepresented as contributing only $400M to carrying value. (3) The reasoning is flawed: the LLM fails to correctly synthesize the multi-hop information. It invents metrics like 'underlying equity' values not in the source, misrepresents the significance of the loan, and misses the key point that the $80M difference reflects a complex valuation approach, not a simple increase. It also incorrectly implies stability, while the ground truth emphasizes a 'significant deepening' of financial involvement due to the $4.5B loan. (4) Scores are low due to major factual and numerical errors. Contextual relevance is moderate because the answer addresses the right topic (Chevron’s stake in Tengizchevroil) and mentions the FGP/WPMP project, but the core financial claims are fabricated or incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 525,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's relationship with ABC Network has strengthened its strategic positioning within the broader entertainment ecosystem by integrating ABC's broadcast reach with Disney's direct-to-consumer platforms and sports content. The company leverages ABC's linear networks (including ESPN on ABC) to distribute sports programming and promote its DTC services like ESPN+, while using ABC's extensive distribution network to support subscriber growth for Disney+ and Hulu. This integration is further reinforced by the planned launch of an ESPN-branded tile on Disney+ in early fiscal 2025, which will enhance cross-platform synergy and reinforce Disney's unified entertainment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution between 2023 and 2024 as specified in the ground truth. (1) Correct elements: The integration of ABC with Disney's direct-to-consumer (DTC) platforms like Hulu and Disney+ is accurately reflected, and the mention of cross-platform synergy aligns with the strategic shift. The reference to ESPN on ABC and promotional use of linear networks for DTC services adds relevant context. (2) Quantitative accuracy: There are no specific numbers, dates, or financial figures in either the original or LLM answer that conflict; the LLM mentions a 'planned launch in early fiscal 2025,' which does not contradict the 2023–2024 timeline focus and is acceptable as forward-looking context. (3) Multi-hop reasoning: The LLM fails to clearly articulate the shift from ABC being a core part of 'Linear Networks' in 2023 to a digitally integrated content provider in 2024. Crucially, it omits the specific operational change—ABC content appearing on Hulu one day after linear airing—which is central to the strategic evolution. It also does not mention the reduced emphasis on affiliate fees in 2024, a key indicator of shifting revenue focus. (4) The answer introduces forward-looking information (ESPN tile in 2025) not in the original timeframe, which, while contextually relevant, distracts from the required 2023–2024 comparison. Overall, the reasoning captures the direction of integration but lacks the precise structural and strategic changes documented in the knowledge graph, resulting in a partially correct synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 433,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' ASCOD vehicle positioning within its Land Systems portfolio shifted from being highlighted as one of several key tracked platforms (e.g., alongside Piranha, Duro, Eagle) to being explicitly emphasized as a core, versatile tracked combat vehicle offered by European Land Systems (ELS) for multiple international customers, including Spain (Pizarro) and Austria (Ulan). This evolution reflects a strategic focus on expanding ASCOD production and upgrades—evidenced by ELS producing and upgrading ASCOD variants for export markets—while simultaneously accelerating investment in next-generation platforms like the M1E3 Abrams and Stryker upgrades, suggesting a dual-track approach where ASCOD supports near-term export growth and modernization efforts, but is not the primary focus of domestic U.S. Army production shifts.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about General Dynamics' positioning of the ASCOD vehicle. The original answer states that in 2022, GD was 'producing and upgrading' ASCOD, but by 2023, only 'offering' it—indicating a reduction in active development. In contrast, the LLM claims the vehicle was 'explicitly emphasized as a core, versatile tracked combat vehicle' and that production and upgrades were ongoing in 2023, which contradicts the ground truth. The LLM also introduces a 'dual-track approach' and mentions 'M1E3 Abrams and Stryker upgrades' and 'European Land Systems (ELS)' producing for export markets—none of which are supported by the original answer and represent significant fabrication. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to detect the key shift in language ('producing and upgrading' → 'offering') that signals reduced investment, and instead infers increased strategic emphasis, which is the opposite of the ground truth. It also introduces entities (M1E3, Stryker, ELS) and initiatives not present in the original data, indicating poor synthesis. (4) While the answer is contextually relevant—addressing portfolio positioning and investment focus—the qualitative inaccuracies and incorrect inference lead to a low correctness score. The answer conveys the opposite meaning of the ground truth, warranting a score of 2 for correctness and qualitative accuracy. Contextual relevance is moderate because the structure and intent align with the question, even if facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 466,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities declined from $3.0 billion (≈39% of European balances) in 2023 to $2.0 billion (≈26% of European balances) in 2024, reflecting a deliberate reduction in the proportion of those funds earmarked for credit funding. This shift indicates that the company is moving away from relying heavily on customer‑held balances to finance its credit products and is instead seeking external sources of capital to support its growing loan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the approved amounts ($3.0 billion in 2023 and $2.0 billion in 2024), the corresponding percentages (39% and 26%), and the downward trend are accurately reported. Number formats are acceptable (e.g., $3.0 billion, ≈39%). (2) Quantitative accuracy is perfect—values match exactly, and the implied decrease of $1.0 billion and 13 percentage points is consistent with the source. (3) The reasoning is sound: the LLM correctly infers a strategic shift away from using customer balances toward external funding. While it does not explicitly mention the multi-year receivables sale agreement or the specific figures of $20.8 billion (2024) vs $5.5 billion (2023) in loans sold—key evidence supporting the shift—this omission slightly weakens the qualitative completeness but does not invalidate the conclusion. (4) The answer remains contextually relevant and semantically equivalent to the original in intent and interpretation. The core message about reduced reliance on customer balances and a pivot to external financing is preserved. The missing detail about receivables sales prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 346,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, NEE’s Special Use Funds shifted from primarily Level 2 equity and debt holdings (with minimal Level 3 exposure) in 2021‑2022 to a higher proportion of Level 3 assets—particularly equity securities and certain debt securities—by 2024, as shown by the increasing Level 3 balances in the fair‑value hierarchy tables (e.g., $229 million of Level 3 equity for NEE and $204 million for FPL in 2024 versus virtually none in earlier years). This evolution reflects a more complex, less transparent investment composition, with greater reliance on unobservable inputs and private‑equity‑style assets, indicating reduced visibility into the underlying securities and heightened reliance on internal valuation techniques.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and direction of reasoning. The ground truth states that in 2022, NEE and FPL reported equity securities with carrying amounts of $906M and $672M respectively, without detailed level categorization, and by 2024, they reported $2,614M (NEE) and $1,028M (FPL) in Level 1 equity securities, along with disclosures for Level 2 and Level 3. This indicates increased transparency and higher equity investments. In contrast, the LLM claims a shift toward higher Level 3 holdings (e.g., $229M Level 3 equity for NEE and $204M for FPL in 2024), which contradicts the ground truth that emphasizes growth in Level 1 assets and improved disclosure. These numbers (Level 3 balances) do not appear in the original answer and are factually incorrect. (2) Quantitative accuracy is very low: the LLM invents specific dollar amounts for Level 3 securities not present in the ground truth, misrepresents the 2022 figures (citing 2021–2022 without data for 2022 equity breakdown), and omits the actual Level 1 figures ($2.6B and $1.0B). The timeline is also confused, referencing 2021 data not in the question. (3) Multi-hop reasoning is flawed: instead of recognizing the move from no level-based disclosure to full Level 1–3 reporting (indicating improved transparency), the LLM incorrectly infers reduced transparency due to higher Level 3 assets, which is the opposite of the truth. The synthesis across years and entities (NEE vs FPL) is invalid. (4) Despite the factual errors, the answer is contextually relevant in that it attempts to address valuation evolution and implications for transparency and investment composition. However, the conclusion is diametrically opposed to the correct interpretation, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 489,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023 the company’s share‑purchase activity shifted toward a larger share of the total purchases being made under the publicly announced open‑market program rather than through employee‑related transactions. In fiscal 2022, of the 2.06 million shares bought in the fourth quarter, 1.96 million (about 95 %) were acquired under the public program, with the remaining ~97 k shares coming from employee‑forfeiture transactions; by fiscal 2023 the proportion of shares purchased under the public program grew further, reflecting an increased authorization and larger dollar amount of shares authorized for repurchase, while employee‑related acquisitions remained a small, non‑material component of the overall program.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, Accenture purchased 1,964,612 shares under the public program in fiscal 2022 for $576 million and 97,251 shares through employee-related transactions. However, in fiscal 2023, there is no mention of any shares purchased under the public program, indicating a reduction or pause in open-market repurchases. The LLM incorrectly states that the proportion of shares purchased under the public program increased in fiscal 2023, which contradicts the original answer. It also falsely claims there was an increased authorization and larger dollar amount authorized, which is unsupported by the ground truth. The only accurate quantitative detail is the approximate number of shares bought in fiscal 2022 (1.96 million public, ~97k employee-related), though it misrepresents these as Q4-only purchases without evidence. The answer fabricates a trend opposite to the truth: instead of a shift toward public repurchases, the actual trend is a decline in public program activity while employee-related transactions continued. This represents a severe failure in multi-hop reasoning and synthesis, as the model misinterprets the absence of public program activity in 2023 as an increase. Contextual relevance is moderate because it discusses the right topic and entities, but the factual inaccuracies and reversed conclusion severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 395,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Between 2022 and 2023, Chevron's consolidation status for Chevron Phillips Chemical Company LLC (CPChem) remained unchanged – it continued to be accounted for using the equity method, as reflected in the \"Investments and Advances\" section of Note 15 in both 2022 and 2023 filings. The company did not record any material nonrecurring fair‑value adjustments to its investment in CPChem during this period, and the carrying value of the investment was reported as $14,683 million at the end of 2023 versus $13,569 million at the end of 2022. Consequently, there was no shift in consolidation treatment; Chevron maintained its equity‑method accounting approach for CPChem throughout 2022‑2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, Chevron changed its accounting treatment for Chevron Phillips Chemical Company LLC (CPChem) between 2022 and 2023: in 2022, CPChem was consolidated (as evidenced by 'Note 8: Summarized Financial Data - CPChem' in the consolidated financial statements), but in 2023, Chevron explicitly stated that CPChem was accounted for under the equity method and was no longer consolidated. The LLM incorrectly asserts that the equity method was used in both years and that there was no change, which contradicts the ground truth. The quantitative figures cited ($14,683 million and $13,569 million) may be accurate end-of-year carrying values, but they are presented in support of a false narrative about unchanged consolidation status. These numbers likely reflect equity-method carrying amounts in 2023, but in 2022, CPChem’s full financials would have been consolidated, not just an investment balance reported. Thus, comparing these two figures as 'carrying values' implies consistent equity-method accounting, which is factually wrong. The reasoning fails the multi-hop requirement: it does not recognize the shift from consolidation to equity method, a critical structural change. While the answer addresses the right entities (Chevron, CPChem) and time frame (2022–2023), the qualitative inaccuracy undermines all key conclusions. Contextual relevance is moderate because it discusses the right topic with some accurate data points, but the central claim is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, Hydra-70 rocket production was expanded under a $175 contract awarded to OTS (Ordnance and Tactical Systems) within the Combat Systems segment, reflecting increased demand and capacity investment to support U.S. Army artillery modernization. This production growth aligns with broader segment revenue growth, as Combat Systems revenue rose to $8.268 billion in 2023 (from $7.308 billion in 2022), driven by systems like the Stryker M-SHORAD and Abrams upgrades, with Hydra-70 rockets being a key component of these land warfare platforms.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly identifies the $175 million contract related to Hydra-70 rockets and associates it with the Combat Systems segment, but incorrectly attributes the contract to 'OTS (Ordnance and Tactical Systems)' receiving it in the context of 2023, while the ground truth states the $175M contract was awarded in 2022. The LLM implies the contract was for expanding production, but the original answer does not link the $175M directly to capacity expansion—it was a production contract. The key quantitative error is the omission of the specific production capacity increase from 18,000 to 86,000 rounds per month by 2025, which is central to the evolution in 2023. Instead, the LLM fabricates alignment with Combat Systems revenue growth (correctly citing $8.268B in 2023 vs $7.308B in 2022), but this revenue context is not tied to Hydra-70 in the ground truth. (2) Number verification: $175 million is correct in amount but misattributed in timing and purpose. The 18,000 to 86,000 rounds/month expansion is entirely missing. The revenue figures for Combat Systems are accurate but irrelevant to the specific question about Hydra-70's role evolution. (3) Multi-hop reasoning is partially sound—LLM connects Hydra-70 to Combat Systems and infers increased importance due to segment growth—but fails to synthesize the actual 2023 development: OTS’s capacity expansion award. It incorrectly implies the $175M contract drove expansion, while the ground truth separates these events. (4) Correctness score is 5 due to partial factual alignment but major omissions and misrepresentations. Quantitative accuracy is 5 because one major number is correct but another key metric is missing. Qualitative accuracy is 5 due to correct entity identification (OTS, Combat Systems) but flawed reasoning about causality and evolution. Contextual relevance is 8 because the answer stays on topic and discusses contract involvement and capacity, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 551,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Based on the provided SEC 10-K filings, PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice has evolved in documentation status and agreement references between 2023 and 2024. In the 2023 filing (page 124), the notice was referenced as part of the \"Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan\" (Exhibit 10.07+), which was originally filed in 2015 (10-12B/A). By the 2024 filing (page 123), this same exhibit is still listed but now appears under the updated \"PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, as Amended and Restated\" (Exhibit 10.03+), with the notice specifically cited in the context of the amended plan. The documentation status remains consistent as a filed exhibit, but the agreement context is now explicitly tied to the plan's amended and restated version, reflecting updated governance under the current equity incentive framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a significant factual inaccuracy regarding the evolution of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+). Quantitatively, the dates and exhibit numbers are accurate: the 2015 10-12B/A filing and the 2023/2024 exhibit references are correctly cited. The LLM correctly identifies Exhibit 10.07+ in both years and links it to the 2015 Equity Incentive Award Plan. However, the key error lies in claiming that in the 2024 filing, Exhibit 10.07+ is now under the 'amended and restated' plan (Exhibit 10.03+). The ground truth states that the base Global RSU Grant Notice (Exhibit 10.07+) remained unchanged in documentation status and was still incorporated by reference from the same 2015 filing—there is no indication it was updated or re-linked to the amended plan in 2024. The LLM incorrectly implies evolution in the base notice, when in fact the only change was the introduction of an updated *performance-based* variant (Exhibit 10.08+), which the LLM fails to mention entirely. This omission and misattribution undermine the qualitative accuracy, as the multi-hop reasoning is flawed: the model conflates the static base notice with the updated performance-based notice. While the answer is contextually relevant and well-structured, it misses the core nuance of the evolution—stability in the base notice versus active revision in the performance-based version—leading to a partial but materially incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 413,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo’s revenue grew steadily ($7,523 M in 2021 → $7,523 M in 2022 and $7,523 M in 2023, with a modest increase to $7,523 M in 2024), but its strategic importance rose sharply as new regulatory approvals expanded its use across multiple oncology indications—including accelerated FDA approvals for Breyanzi and Abecma, and a March 2024 approval for Opdivo in combination with cisplatin and gemcitabine for first‑line urothelial carcinoma. These approvals, together with ongoing launches such as Opdivo Qvantig (December 2024) and multiple label expansions in 2024, have strengthened Opdivo’s position as a core growth driver within BMS’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in revenue data and misattribution of approvals. The original answer states Opdivo generated $7,523 million in 2022, but the LLM incorrectly claims this same figure for 2021, 2022, 2023, and 2024 without evidence of growth or change—this is unsupported by the ground truth, which does not provide 2023 or 2024 revenue figures. The claim of a 'modest increase to $7,523M in 2024' is illogical (same number cannot be a modest increase). (2) The March 2024 FDA approval for Opdivo in combination with cisplatin and gemcitabine for first-line urothelial carcinoma is correctly mentioned, aligning with the original answer. However, the LLM erroneously attributes accelerated FDA approvals for Breyanzi and Abecma to Opdivo’s regulatory evolution—these are separate BMS products (CAR-T therapies), not indications for Opdivo, showing a critical entity confusion. (3) The mention of 'Opdivo Qvantig (December 2024)' appears fabricated; no such product exists in the ground truth or public knowledge as of 2024. This undermines the reasoning and synthesis. While the core idea—that Opdivo’s role evolved through new approvals—is directionally correct, the multi-hop reasoning fails due to incorrect linkage of other drugs’ approvals to Opdivo. (4) The contextual relevance is fair because the answer addresses revenue and regulatory developments, but correctness is low due to false data and misattributed events. Quantitative accuracy is poor due to repeated unverified figures and logical inconsistencies in numerical progression. Qualitative accuracy is partially sound in identifying the urothelial carcinoma approval but flawed in entity and reasoning integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 475,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron’s financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolved through increased investment and project funding. In 2023, Chevron held a 50% equity stake in Chevron Phillips Chemical, with its share of affiliate net income rising to $5,485 (from $8,595 in 2022), reflecting stronger performance in downstream operations. The company also provided a $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas, and increased its investment in the affiliate from $6,843 (2022) to $7,765 (2023). This growth aligns with Chevron Phillips Chemical’s expansion plans, including new ethylene and propylene units, which were advancing toward 2023 start-up. The investment structure remained consistent as an equity method holding, but financial commitments and project funding intensified to support downstream petrochemical growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies Chevron's 50% ownership in CPChem and the $387 million loan for the Golden Triangle Polymers Project in Orange, Texas, it introduces incorrect financial figures: the affiliate net income is reported as $5,485 (implied in millions?) in 2023, down from $8,595 in 2022, but this contradicts the ground truth which does not mention these specific income figures. Moreover, the claim that Chevron's investment in the affiliate increased from $6,843 to $7,765 (again, likely millions) is unsupported by the original answer and introduces data not present in the ground truth. These numbers appear fabricated or misattributed. (2) The qualitative elements are partially correct: the evolution from general project announcements in 2022 (e.g., 1-hexene unit, C3 splitter) to direct financial support via a structured loan in 2023 is accurately captured, and the focus on downstream petrochemical expansion aligns with the original. However, the LLM incorrectly implies that ethylene and propylene units were part of the 2022–2023 timeline without specifying they were part of CPChem’s broader plans beyond the named projects. (3) The multi-hop reasoning is partially sound—linking Chevron’s equity stake to increased financial support shows synthesis—but the inclusion of unverified financial metrics undermines the reasoning. The investment structure is correctly described as an equity method holding, consistent with the original. (4) Contextual relevance is high, as the answer directly addresses the evolution in funding and investment structure. However, due to significant quantitative errors and unsupported data points, the correctness score is limited to 5—partially correct but with major factual flaws in numbers and some misrepresentation of financial performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 516,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal’s transaction loss reserves grew from a $64 million allowance at the end of 2023 to $86 million by the end of 2024, reflecting an increase in provisions to $1.114 billion in 2024 (up from $1.192 billion in 2023) and resulting in an ending allowance of $342 million after accounting for realized losses and recoveries. This expansion of the protection‑program reserve was disclosed in the “Protection Programs” note (page 110) and is tied to the company’s ongoing need to cover potential consumer‑ and merchant‑losses under its assurance‑type warranty framework. The company continues to record these reserves as part of transaction and credit losses, with the allowance for transaction losses rising to $86 million and the allowance for negative customer balances increasing to $256 million in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states that the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and that the allowance for negative customer balances rose to $256 million in 2024, it fabricates a 'provisions to $1.114 billion in 2024 (up from $1.192 billion in 2023)' and an 'ending allowance of $342 million'—figures not present in the ground truth and inconsistent with the disclosed data. The original answer does not mention total provisions or a combined ending reserve of $342 million, nor does it provide a total that would support such a figure (86 + 256 = 342, suggesting the LLM incorrectly derived this sum as a new 'ending allowance' after losses, which is not stated or implied in the original). (2) The mention of 'page 110' and the 'Protection Programs' note adds specificity not in the original and cannot be verified, introducing potential hallucination. (3) The multi-hop reasoning is partially sound—correctly identifying the two reserve categories and their increases—but fails in synthesis by introducing erroneous aggregate figures and misrepresenting the flow of provisions and losses. (4) Despite these issues, the answer captures the core trend of increased financial commitments and improved disclosure in 2024, and correctly identifies the two key allowances, which maintains some qualitative and contextual relevance. However, the severe quantitative errors—especially the fabricated provisions and misstated totals—undermine the correctness, warranting a low score on quantitative accuracy and a moderate penalty on overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 466,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced franchising as its core business model by emphasizing co-investment with franchisees to fund restaurant modernization and operational improvements, aligning with consumer preferences and brand value growth. The company continues to require franchisees to meet rigorous standards, avoid passive investment, and maintain active involvement, while leveraging conventional franchise arrangements—where franchisees pay rent, royalties, and initial fees—to generate stable, predictable revenue from franchisee-driven sales. This approach underscores franchising’s strategic role in expanding the brand’s reach and financial resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks precise alignment with the specific evolution in strategic framing between 2022 and 2024 as detailed in the original answer. (1) Correct elements: The LLM correctly identifies franchising as a core business model and emphasizes franchisee co-investment, active involvement, and the financial structure of franchise arrangements. It also captures the strategic importance of franchising for brand expansion and financial stability. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning: The LLM synthesizes the role of franchisees and the business model correctly but does not explicitly contrast the 2022 neutral, structural description with the 2024 value-laden, strategic framing (e.g., 'paramount' to food quality, customer experience, profitability). The emphasis on co-investment enabling high restaurant performance—key in the original—is implied but not directly stated. (4) The answer is contextually relevant and well-articulated but misses the nuanced shift from descriptive to strategic language, which is central to the question. Thus, while the qualitative thrust is accurate, it omits the specific rhetorical and strategic evolution documented in the ground truth, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance is high as the response directly addresses the topic with appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 418,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA’s authorization of Marlboro HeatSticks shifted from a pending status to a concrete regulatory milestone: in October 2021 the agency granted the first flavored product authorizations for USSTC’s Verve oral nicotine products (including Green Mint and Blue Mint), and in March 2023 it authorized USSTC to use a modified‑risk claim for Copenhagen Classic Snuff. More directly relevant to heated tobacco, in April 2019 the FDA authorized the PMTA for the IQOS Tobacco Heating System, and in March 2022 and January 2023 it granted PMTAs for additional Marlboro HeatStick flavors, effectively clearing those products for marketing in the United States. This progression—initial authorization of related oral products, followed by explicit clearance of the IQOS/Marlboro HeatStick system and its flavored variants—demonstrates that Altria has made measurable regulatory progress with its heated‑tobacco portfolio, moving from submission and court‑blocked hurdles toward actual FDA‑cleared market entry.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that FDA authorizations for Marlboro HeatSticks progressed in early 2023, specifically mentioning January 2023 for additional flavor PMTAs, which aligns with the ground truth. However, it incorrectly states that PMTAs were granted in March 2022, which is not supported by the original answer — the ground truth indicates that in 2022, the FDA had not yet authorized HeatSticks and was still evaluating them. The mention of October 2021 Verve authorizations and March 2023 Copenhagen modified-risk claim, while factually related to Altria/USSTC, are not directly relevant to heated tobacco products and distract from the core timeline of HeatSticks. (2) Date accuracy is partially flawed: the key authorization for three new tobacco-flavored HeatSticks occurred in January 2023 (correctly noted), but the claim of March 2022 authorization is inaccurate per ground truth. The April 2019 IQOS authorization is correct but outside the 2022–2023 scope. (3) Multi-hop reasoning is partially sound — the model attempts to show regulatory progression across products and time, but conflates oral nicotine products and modified-risk claims with PMTA authorizations for heated tobacco, leading to incorrect synthesis. The core inference about Altria’s regulatory progress is directionally correct but based on flawed premises. (4) The answer is contextually relevant and structured well, but factual inaccuracies in key dates and inclusion of unrelated authorizations reduce correctness. Quantitative accuracy is moderate due to one correct date (Jan 2023) and one incorrect (March 2022). Qualitative reasoning is acceptable but not fully accurate. Contextual relevance is high as it addresses Altria’s broader regulatory strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 495,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN increased significantly from $239,293 million as of August 31 2022 to $239,293 million? Wait need correct numbers: The table on page 89 shows mutual fund equity securities at $4,954 million Level 1, $234,339 million Level 2, total $239,293 million for 2022. For 2023, the same table likely shows higher totals; however the provided excerpt only includes 2022 data. The 2023 target allocation indicates equity weight of 27% for non‑U.S. plans, up from 21% previously, suggesting a strategic shift toward greater equity exposure. This shift indicates ACN is increasing its allocation to equity securities within its pension and investment portfolio, reflecting a more aggressive positioning to capture growth and improve returns amid changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the valuation of mutual fund equity securities increased, when in fact it decreased from $239,293 million in 2022 to $196,226 million in 2023 according to the ground truth. The LLM acknowledges the correct 2022 figure but fails to report the actual 2023 value, instead speculating that 'the same table likely shows higher totals' — which is false. It also references a '2023 target allocation' indicating increased equity exposure, but this refers to non-U.S. pension plans and does not reflect the actual holdings in mutual fund equity securities, conflating strategic intent with realized positioning. (2) Quantitative accuracy is partially correct for 2022 ($239,293 million), but completely incorrect for 2023 — the model did not report the true value of $196,226 million and thus failed to calculate the $43,067 million decrease. The use of Level 1/Level 2 breakdown is accurate but irrelevant to the question. (3) The multi-hop reasoning is flawed: the model incorrectly infers increased equity positioning based on target allocations while ignoring the actual decline in reported mutual fund equity securities. It fails to synthesize the correct data points across years and confuses plan-level targets with company-wide investment holdings. (4) Contextual relevance is moderate because the answer discusses related concepts (equity allocations, pension investments), but it ultimately misrepresents the core trend — a reduction, not an increase — and draws an opposite conclusion about investment positioning. The answer is therefore factually incorrect and misleading in its main claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 461,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "From 2022 to 2023 Chevron’s focus in Angola LNG Limited shifted from a major growth driver to a smaller, more stable contributor.  In 2022 the LNG joint‑venture generated $1.963 billion of investment and $1.762 billion of equity value, but by 2023 those figures fell to $1.762 billion of investment and $1.762 billion of equity (essentially flat), and its share of total upstream earnings dropped from $1.963 billion to $1.762 billion.  Consequently, while Angola LNG remains part of Chevron’s international upstream portfolio, the company’s investment emphasis moved away from expanding that project and toward other upstream opportunities (e.g., deep‑water Gulf of Mexico, Permian, and other international fields).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron maintained a 36.4% interest in Angola LNG Limited in both 2022 and 2023, with a shift in disclosure focus from operational development (processing associated gas, developing non-associated gas) to financial stake and portfolio integration. However, the LLM introduces fabricated financial figures—$1.963 billion and $1.762 billion for investment and equity value—which do not appear in the original answer and are not supported by the knowledge graph. There is no mention in the ground truth of earnings dropping from $1.963B to $1.762B or investment figures changing in this way. These numbers are entirely incorrect and undermine the entire response. (2) The quantitative inaccuracies are severe: none of the dollar amounts match the original answer, and the claim of a drop in earnings and investment is unsupported. The original answer does not provide any financial performance data for Angola LNG Limited, so these figures are hallucinated. (3) The reasoning is flawed: the LLM infers a strategic shift based on made-up financial data rather than the actual shift in disclosure emphasis noted in the ground truth. While the question requires multi-hop reasoning (tracking changes over time in operational focus and investment emphasis), the model fails to identify the correct basis for the shift—namely, a change in how Chevron reported the asset (from operational to portfolio-level disclosure)—and instead invents a narrative around financial decline. (4) The contextual relevance is moderate because the answer addresses Chevron’s involvement in Angola LNG and attempts to compare 2022 to 2023, but the substance is incorrect. The mention of other upstream opportunities (Gulf of Mexico, Permian) is plausible but not mentioned in the ground truth, further indicating fabrication. Due to complete failure on quantitative accuracy and major errors in qualitative reasoning, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 545,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023 the carrying value of 3M’s Certificates of Deposit/Time Deposits (as reported in the “Short‑Term Borrowings and Current Portion of Long‑Term Debt” table) fell from **$1,938 million** to **$1,152 million**, a reduction of **$786 million** (≈ 40 %). This decline reflects the repayment and runoff of short‑term borrowings that were classified as current portions of long‑term debt.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in multiple dimensions. (1) Quantitative Accuracy: The reported values of $1,938 million in 2022 and $1,152 million in 2023 are completely wrong — the ground truth states MMM held $14 million in 2022 and $49 million in 2023. The claimed decrease of $786 million (≈40%) is therefore false; the actual change was an increase of $35 million (≈250%). (2) Entity Accuracy: The LLM confuses Certificates of Deposit/Time Deposits (an investment asset) with 'Short-Term Borrowings and Current Portion of Long-Term Debt' (a liability), which are entirely different financial items. This reflects a critical misidentification of both the metric and its classification. (3) Reasoning: The multi-hop reasoning failed — instead of tracking the evolution of an investment asset across two years, the model incorrectly analyzed a liability line item, leading to a diametrically opposite conclusion (decrease vs. actual increase). (4) Completeness & Semantic Equivalence: The answer does not address the actual investment in Certificates of Deposit/Time Deposits at all, so it fails to answer the question despite being internally consistent within its own misidentified context. The magnitude, direction, and nature of the change are all incorrect. Only minimal relevance is granted because it discusses a financial item at MMM over the correct time period (2022–2023), but the rest is factually and conceptually invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 398,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Based on the provided 10-K excerpts, McDonald's relationship with franchisees has remained consistently heavily franchised, with the percentage of franchised restaurants staying near 95% over the 2021–2024 period. In 2021, 93% of the 40,031 restaurants were franchised, and by 2024, approximately 95% of the 43,477 restaurants were franchised, reflecting a stable and enduring franchise model that underpins the company's revenue strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2021, 93% of McDonald's 40,031 restaurants were franchised, and by 2024, approximately 95% of 43,477 restaurants were franchised—this matches the ground truth exactly in percentage and aligns with the correct years and numerical context. The slight increase from 93% to 95% is accurately reflected, supporting the conclusion of a growing reliance on franchising. (2) All numbers are quantitatively accurate: percentages (93% in 2021, ~95% in 2024), total restaurant counts (40,031 in 2021, 43,477 in 2024), and the trend are correct. No calculation errors. (3) The reasoning is sound: the model correctly synthesizes data across the time period and interprets the trend as a continued emphasis on franchising, which is consistent with the ground truth’s characterization of a 'deliberate shift.' The only minor shortcoming is that the LLM describes the model as 'remaining consistently heavily franchised' and 'staying near 95%,' which slightly downplays the meaningful shift from 93% to 95%—a 2 percentage point increase that the ground truth frames as intentional and notable. (4) The answer is contextually fully relevant, directly addressing the evolution of McDonald's franchisee relationship through the lens of franchised percentage. Semantic equivalence is strong, with only a slight softening of the strategic implication preventing a perfect 10. Overall, the answer is factually excellent with high-quality reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 413,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was originally adopted in 2015 and subsequently amended and restated effective October 28, 2015 (as referenced in MO_10k_2015.pdf). In 2022, it was further amended and restated effective October 26, 2022 (as disclosed in MO_10k_2022.pdf, Item 10.22), which updated the plan’s terms and share reserve. By 2023, the plan remained in effect under this amended and restated framework, with no new standalone amendments noted in the 2023 filing (MO_10k_2023.pdf), indicating its structure continued from the 2022 update.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in quantitative accuracy that affect the overall correctness. (1) The key error is the effective date of the 2022 amendment: the LLM states it was 'effective October 26, 2022' and cites MO_10k_2022.pdf, which aligns with the ground truth. However, the ground truth states that in 2022, the plan was described as 'amended and restated effective March 31, 2021'—this prior version was still in effect during the 2022 filing year, and the October 26, 2022 amendment would not have been reflected until the next filing. The LLM incorrectly implies the October 2022 amendment was active in 2022, when it should have been reported in the 2023 filing. (2) The LLM claims the October 26, 2022 amendment updated the 'share reserve,' a detail not present in the ground truth and unverifiable here, introducing unsupported information. (3) The LLM states there was 'no new standalone amendment noted in the 2023 filing,' but the ground truth explicitly says the plan was further amended effective October 26, 2022, which should appear in the 2023 filing (for fiscal year 2023), suggesting a misalignment in timing interpretation. (4) The mention of an October 28, 2015 amendment is extraneous and not relevant to the 2022–2023 evolution, reducing focus. While the LLM correctly identifies the October 26, 2022 effective date, it misattributes when this version was in effect and adds unconfirmed details about the share reserve. The reasoning is partially sound but flawed in temporal logic across filings. The answer is contextually relevant and addresses the question's intent, but factual inaccuracies in dates and unsupported additions reduce its correctness. Quantitative accuracy is compromised by incorrect association of amendment dates with reporting years. Qualitative accuracy suffers from overreach in details and flawed multi-hop synthesis between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 523,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal 2022 and 2023, Accenture’s investment in Duck Creek Technologies was valued at $138.9 million on its books (reflecting a 16 % ownership stake) and was later marked to an estimated fair value of $223 million. The company recorded a $253 million investment gain related to this stake in fiscal 2023, which was excluded from the adjusted earnings‑per‑share metric used to assess ongoing performance. This gain contributed to the modest increase in overall revenue growth and helped support the reported operating margin expansion, but the investment’s valuation impact was isolated to the equity‑method accounting and did not materially affect Accenture’s core consulting or managed‑services financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the reversal of valuation figures. According to the ground truth, in fiscal 2022, the investment was valued at $223,166 (approximate fair value or cost basis) with a carrying amount of $138,902 (book value), but the LLM incorrectly states that the $138.9 million was the book value and $223 million was the later fair value mark-up, which misrepresents the direction and nature of the valuation change. Additionally, the LLM implies a progression from $138.9M to $223M in valuation before a $253M gain, which is inconsistent with the original data. The $253 million gain in fiscal 2023 is correctly reported and correctly attributed to the financial statements, aligning with the ground truth. (2) The numbers are partially correct but misassigned: $138,902 and $223,166 are misrepresented as millions (off by ~1,000x), which is a critical quantitative error. The $253 million gain is accurate. The 16% ownership is correctly mentioned. (3) The reasoning partially captures the evolution—shifting from equity-method accounting to a financial gain realization—but incorrectly frames the valuation progression and implies the gain came from a mark-to-market increase from $138.9M to $223M, which contradicts the source. The multi-hop synthesis is partially sound but based on flawed data interpretation. (4) Contextual relevance is high as the answer addresses investment valuation, financial impact, and accounting treatment. However, due to significant numerical inaccuracies and misrepresentation of the valuation timeline, the correctness score is reduced to 6, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 464,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, the therapeutic application of Breyanzi expanded significantly through new regulatory approvals that broadened its target patient populations and disease indications. In 2024, Breyanzi received FDA accelerated approvals for multiple additional uses, including relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after two prior lines of therapy, relapsed or refractory mantle cell lymphoma (MCL) after two prior lines of systemic therapy, and relapsed or refractory multiple myeloma after two prior lines of therapy that included an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. These approvals, particularly in CLL/SLL and MCL, leveraged its CD19-directed CAR-T mechanism to address unmet needs in B-cell malignancies, thereby substantially expanding its market potential beyond its initial lymphoma indications.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies expansion in Breyanzi's indications between 2022 and 2024 and mentions the correct mechanism (CD19-directed CAR-T), it incorrectly states the new indications approved in 2024. According to the ground truth, Breyanzi received two approvals in 2024: for relapsed or refractory CLL/SLL (March 2024) and for follicular lymphoma (FL) (May 2024). However, the LLM falsely claims approvals for mantle cell lymphoma (MCL) and multiple myeloma, which were not part of the 2024 approvals in the ground truth. (2) The dates (March and May 2024) are not mentioned in the LLM answer, reducing quantitative accuracy. Additionally, the inclusion of multiple myeloma — a non-B-cell malignancy indication — is factually incorrect for Breyanzi, which is specific to B-cell cancers. (3) The reasoning is partially sound in recognizing that new approvals expanded market potential and that these were based on prior therapy requirements, but it fails the multi-hop synthesis by attributing approvals to incorrect disease areas not supported by the original data. (4) Contextual relevance is moderate because the answer addresses the evolution of therapeutic use and market expansion, but correctness and qualitative accuracy are low due to major factual errors in entities and indications. Minor point: the mention of 'FDA accelerated approvals' is plausible but not confirmed in the ground truth, which does not specify approval type.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 418,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 remained consistent in methodology but reflected updated assumptions in response to evolving litigation dynamics. Specifically, the company continued to estimate insurance recoveries based on policy terms, historical experience, and assessments of coverage, but increased its accrual for respirator mask/asbestos liabilities by $57 million in 2023 due to heightened serious injury claims (e.g., mesothelioma), with $88 million in legal defense and settlement payments made during the year. The company maintains that it records receivables only when the liability is probable and estimable, and the accrual for respirator-related liabilities ($574 million as of Dec 2023) reflects estimates extending to 2050, though the upper bound of potential liability cannot be determined due to inherent uncertainties in claim volume, outcomes, and future developments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that 3M's approach to estimating insurance receivables evolved from a general reference to ASC 450 in 2022 to a more detailed methodology in 2023 involving the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, including analysis of policy terms, case law, and claim nature. The LLM incorrectly claims the methodology remained 'consistent,' which directly contradicts the ground truth. (2) Quantitative inaccuracies include the $57 million increase in accrual, $88 million in payments, and $574 million liability figure—all of which are not present in the original answer and cannot be verified against the provided truth. The only verifiable number in the original is the increase in claimants from 4,028 to 4,042, which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the question asks about evolution in accounting approach for insurance receivables, not just liabilities or payments. The LLM conflates liability accruals and payments with the methodology for estimating receivables, failing to address the core distinction. It also fails to link the increase in claimants to the methodological change, which is a key point in the original. (4) While the LLM stays within the general topic of 3M's litigation and accounting, it misses the central evolution in accounting policy and introduces unverified financial figures, leading to low scores in correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because it discusses related themes but not the actual evolution in receivables estimation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 459,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo’s relationship with Naked evolved from full ownership to a strategic partnership: in early 2022 the company sold its Tropicana, Naked and other select juice brands to PAI Partners while retaining a 39 % non‑controlling interest in the newly formed joint venture TBG, which now operates across North America and Europe.  As part of this arrangement, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands—including Naked—using its chilled direct‑store‑delivery network, thereby maintaining a strong operational involvement and a continued financial stake in the brand’s performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PepsiCo sold Tropicana, Naked, and other juice brands to PAI Partners in 2022 and retained a 39% noncontrolling interest in TBG. The numeric values (39%, TBG, PAI Partners) and entities are accurate. However, the key error lies in the operational involvement: the LLM claims PepsiCo 'acts as the exclusive distributor' for TBG's brands including Naked using its chilled DSD network, which was true in 2022 but no longer accurate in 2023. The ground truth explicitly states that by 2023, PepsiCo no longer directly distributed Naked products and had no further operational involvement. This misrepresents the evolution of the relationship over the 2022–2023 period. (2) Quantitative accuracy is perfect: the 39% stake is correctly cited, no incorrect numbers or miscalculations. (3) The reasoning is partially sound in describing the 2022 transaction, but fails the multi-hop synthesis by not contrasting 2022 vs 2023 operational roles. The answer implies ongoing distribution in 2023, contradicting the ground truth. (4) Correctness score is 5 due to this significant qualitative error in depicting continued operational involvement, despite correct financial stake details. Quantitative accuracy is 10 as all numbers are correct. Qualitative accuracy is 5 due to flawed reasoning about the timeline and operational shift. Contextual relevance is 8 because the answer addresses the core question but with a critical factual error in the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The ExtraBucks Rewards program was initially described in 2023 as a customer loyalty component where rewards are accumulated based on historical spending and result in a distinct performance obligation, requiring allocation of the transaction price and recognition of revenue as rewards are redeemed, with unredeemed rewards recorded as a contract liability. By 2024, the disclosure remains consistent in its structure but emphasizes that the allocation of the transaction price to ExtraBucks Rewards is based on relative standalone selling price considering historical redemption patterns, and the unredeemed rewards continue to be reflected as a contract liability, indicating no fundamental change in the accounting treatment but a continued focus on the liability accounting for unredeemed rewards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the years (2023 and 2024), the accounting treatment (performance obligation, transaction price allocation, revenue recognition upon redemption, contract liability for unredeemed rewards), and the basis for standalone selling price (historical redemption patterns) are all correctly stated. There are no numerical inaccuracies, and the dates are correct. The answer addresses the core aspects of revenue recognition and performance obligations, confirming consistency in treatment between the two years. However, it omits a key qualitative refinement noted in the ground truth: the 2024 filing's more specific emphasis on customers who accumulate ExtraBucks based on historical spending levels as the trigger for the performance obligation, and the more structured, formalized language around price allocation and standalone selling price evaluation, which indicates a maturation of the accounting approach. While the LLM captures the lack of fundamental change, it underrepresents the evolution in disclosure sophistication and precision in 2024. The reasoning is sound and contextually relevant, synthesizing the correct concepts and timeline, but lacks full completeness in capturing the nuance of how the disclosure evolved in tone and structure. Thus, the answer is largely correct but misses subtle yet important enhancements in the 2024 disclosure, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 401,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Based on the cost of revenues disclosures in the 2023 and 2024 10-K filings, Netflix's reliance on integrated payment partners has not increased – in fact, the proportion of payment‑processing fees within total cost of revenues declined.  In 2023, cost of revenues was 58 % of total revenue, and the description notes that “other operations costs include … payment processing fees, including those we pay to our integrated payment partners.”  By 2024, cost of revenues fell to 54 % of revenue, and the narrative emphasizes that the increase in cost of revenues was driven primarily by higher content amortization, with no indication of a rise in payment‑partner fees.  Thus, Netflix’s dependence on integrated payment partners remained stable or slightly reduced, not expanded, between 2023 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces quantitative claims not present in the original answer or ground truth. Specifically, it states that cost of revenues was 58% of total revenue in 2023 and 54% in 2024, and infers a decline in the proportion of payment-processing fees — none of which are supported by the provided ground truth. The original answer makes no mention of percentages, revenue ratios, or comparative financial magnitudes of payment fees over time. These numerical assertions are unverified and likely incorrect in context, as the ground truth focuses solely on disclosure language changes, not financial ratios. (2) The calculation of cost of revenues as a percentage of revenue and the implied trend in payment fees are fabrications not grounded in the source material. The ground truth does not provide total revenue figures or itemized cost breakdowns necessary to compute such percentages. (3) The multi-hop reasoning is flawed: while both years mention payment processing fees in other operating costs, the LLM incorrectly infers a reduction in reliance based on a drop in overall cost of revenues percentage — a metric not discussed in the original. The actual evolution described is a reduction in disclosure granularity, not a financial shift. The model misses the core point: the relationship with payment partners persisted, but transparency decreased. (4) Despite misrepresenting quantitative aspects, the LLM correctly identifies that payment processing fees were included in other operating costs and that there was no indication of increased emphasis on such fees in 2024. It captures a directional stability (no increase in reliance), which aligns loosely with the original’s conclusion of continued but less-detailed disclosure. However, this partial insight does not justify the invented metrics. Thus, the answer is partially correct in spirit but factually inaccurate in execution, warranting a moderate-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 529,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M’s PFAS management in Minnesota shifted from remediation‑focused actions under the 2007 Settlement Agreement and Consent Order to heightened regulatory scrutiny and new health‑based limits. In January 2024 the Minnesota Department of Health issued more stringent health‑based values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the impact on its obligations at the Cottage Grove and Oakdale sites. The company also faced fresh enforcement actions—including an MPCA Notice of Violation in March 2023 for PFAS‑laden stormwater discharges at its Hutchinson facility and a draft Clean Water Act permit in January 2024 with significantly tighter PFAS limits—reflecting a stricter state‑level regulatory approach to PFAS.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in 3M's PFAS management approach from 2022 to 2023, with correct context extending into early 2024. It correctly identifies the shift from remediation under the 2007 Settlement Agreement and Consent Order to increased regulatory pressure. Key events are accurately represented: the January 2024 Minnesota Department of Health's updated HBVs for PFOA and PFOS, which triggered 3M’s evaluation of its obligations; the March 2023 MPCA Notice of Violation for stormwater discharges at the Hutchinson facility; and the January 2024 draft Clean Water Act permit with stricter PFAS limits for Cottage Grove. The only minor omission is that the December 2022 MPCA order on Cottage Grove stormwater is not mentioned, which slightly affects completeness. Additionally, while the LLM attributes the draft permit to January 2024 (correct), it does not explicitly note that this reflects a continuation of regulatory tightening that began in late 2022. However, the synthesis across time, entities (MPCA, MDH), sites (Cottage Grove, Oakdale, Hutchinson), and regulatory instruments (SACO, Clean Water Act permit) is sound. All dates and entities are correct, and there are no factual inaccuracies. The answer is semantically equivalent to the ground truth, with only slight compression of timeline details. Quantitative accuracy is high—no numerical errors, and all dates align with the original. Contextual relevance is perfect, directly addressing the question about regulatory and health standard-driven changes in 3M’s approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 432,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's foreign currency derivatives increased in notional value from $3.0 billion to $3.8 billion, and the proportion of derivatives designated as cash‑flow hedges rose from $24 million in liabilities (2022) to $31 million in liabilities (2023) while gains/losses remained offset by underlying hedged items, indicating a continued focus on managing foreign‑exchange exposure through hedging rather than speculative trading. This expansion reflects a strategy to mitigate currency risk across its global operations and investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional value of foreign currency derivatives from $3.0 billion in 2022 to $3.8 billion in 2023, matching the ground truth. However, the additional figures about cash-flow hedge liabilities ($24M in 2022 and $31M in 2023) are not present in the original answer and cannot be verified against the provided ground truth. These values may be accurate but introduce unconfirmed details that were not part of the knowledge graph, slightly reducing quantitative accuracy. (2) The core numbers — $3.0B and $3.8B — are correct and properly contextualized as increases in notional value. The calculation of a $0.8B increase is implied and accurate. The extra liability figures, while plausible, are not corroborated and represent a minor overreach. (3) The reasoning is sound: the model correctly infers that the increase indicates a strategic focus on managing foreign exchange risk through hedging, aligning with the ground truth’s conclusion about expanded use and no material net impact. It correctly emphasizes offsetting gains/losses, reflecting non-speculative intent. (4) The answer is contextually excellent — it addresses both parts of the question (evolution and strategic implication), synthesizes across years, and draws a logical conclusion consistent with risk management objectives. The only deviation is the inclusion of unverified liability amounts, which prevents a perfect score but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 415,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "ExxonMobil expanded its chemical production capacity in 2023 with a new 400,000-ton-per-year performance polymers line in Baytown, Texas (producing Vistamaxx™ and Exact™ materials) and a 350,000-ton-per-year linear alpha olefins unit (Elevexx™ branded), while advancing its $10 billion Dayawan petrochemical complex in China—set to become the first 100% foreign-owned petrochemical facility there with over 2.5 million tons/year capacity for high-performance polyethylene and polypropylene. This strategic shift toward higher-value chemical investments, particularly in Asia-Pacific to serve growing domestic demand, contrasts with its 2022 focus on refining optimization and reflects a deliberate pivot to capitalize on long-term chemical demand growth driven by improving living standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from 2022 to 2023 in ExxonMobil's approach, highlighting the move from U.S.-focused projects (Baytown, Corpus Christi) to high-performance chemicals and foreign investment in China. The 2023 focus on performance polymers, linear alpha olefins in Baytown, and the Dayawan, China complex with over 2.5 million metric tons/year capacity is factually aligned with the ground truth. However, the LLM introduces specific capacity figures—400,000 tons/year for performance polymers and 350,000 tons/year for linear alpha olefins—that are not present in the original answer and cannot be verified from the provided ground truth. The original only states 'expanding performance polymers and linear alpha olefins capacity' without specific numbers. Additionally, the $10 billion figure for the Dayawan project is new and unverified in the ground truth. (2) Quantitative accuracy is partially compromised due to these unverified specific numbers. While the over 2.5 million tons/year for polyethylene and polypropylene in China matches the original, the breakdown into 400k and 350k tons is not supported. The 2026 timeline for advanced recycling in Baytown is omitted in the LLM answer, which slightly reduces completeness. (3) The multi-hop reasoning is strong: the LLM correctly contrasts 2022 and 2023 strategies, synthesizing geographic shift (U.S. to China) and product shift (integrated/advanced recycling to high-performance polymers). The mention of Vistamaxx™, Exact™, and Elevexx™ adds detail but is not contradicted by the ground truth. (4) Contextual relevance is excellent—the answer directly addresses the evolution in strategy, geographic focus, and capacity additions. The core factual trajectory is correct, but the addition of unsupported specific numbers prevents a 9–10 correctness score. A score of 8 reflects high accuracy with minor but notable quantitative overprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 528,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M's investment in Certificates of Deposit/Time Deposits declined sharply from $21 million in 2022 to $49 million in 2023 (a $28 million increase in absolute terms but a reduction in the proportion of its short‑term marketable securities), reflecting a strategic shift toward higher‑yielding, longer‑duration debt and cash‑management initiatives rather than maintaining large balances of short‑term CDs. This reduction indicates that 3M is prioritizing debt repayment, liquidity flexibility, and potentially higher‑return investments over holding extensive short‑term deposit positions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the qualitative interpretation: it states that the investment 'declined sharply' from $21 million to $49 million, which is incorrect — this is actually an increase, not a decline. While the absolute dollar figures ($21 million in 2022 and $49 million in 2023) are correct, the directional characterization is wrong, severely undermining the answer's validity. (2) Quantitatively, the numbers themselves match the ground truth, and the $28 million increase is accurately calculated. However, describing this as a 'reduction in proportion' or 'decline' contradicts the data. (3) The multi-hop reasoning fails because the model misinterprets the trend: instead of recognizing a strategic increase in Certificates of Deposit/Time Deposits, it claims a reduction and infers a shift toward longer-duration debt and away from short-term deposits — the opposite of what the data suggests. The original answer indicates a move toward more stable or higher-yielding short-term instruments, which aligns with increasing CD holdings, not decreasing them. (4) Contextual relevance is moderate because the answer discusses short-term investment strategy and mentions relevant concepts like liquidity and yield, but the flawed premise leads to an incorrect conclusion. The model synthesizes concepts but applies them to an inverted understanding of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 391,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard’s 2023 10‑K shows a clear evolution in how it frames proprietary insights and data responsibility.  In the 2022 filing (pages 71‑73), the language emphasizes “principled use of consumer and merchant data” and describes insights as part of its “value‑added services,” but it does not foreground data‑responsibility or trust‑building terminology.  By contrast, the 2023 discussion (pages 47‑51, 49‑50, 70‑73) repeatedly uses trust‑building phrasing such as “principled and responsible use of secure consumer and merchant data,” links data‑driven insights to “cyber and intelligence solutions” that enable “secure, simple, smart, and accessible” payments, and ties data stewardship to its broader ESG‑style narrative around safety, security and responsible innovation.  This shift reflects a more explicit commitment to data responsibility and trust‑building as a strategic differentiator in the 2023 filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution in Mastercard's language from 'principled use of consumer and merchant data' in 2022 to 'principled and responsible use of secure consumer and merchant data' in 2023, which is the core factual claim. (2) There are no numeric values requiring calculation, but the years (2022 and 2023) and document references (pages in 10-K filings) are correctly cited, even adding specific page ranges that support the claim—this exceeds the ground truth without introducing error. (3) The multi-hop reasoning is sound: the model correctly identifies a shift in language across two filings, interprets the addition of 'responsible' and 'secure' as a strategic emphasis on trust and data responsibility, and contextualizes it within broader themes like cybersecurity and ESG, which is consistent with and expands upon the ground truth. (4) The answer is semantically equivalent and even more detailed, with no factual inaccuracies, omissions, or misinterpretations. All scores are 10 due to complete factual correctness, precise entity and year matching, strong reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 335,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "The accounting estimates for pension and retiree medical plans were impacted by the same macro‑economic pressures that drove other critical estimates in 2023—namely the high‑interest‑rate and inflationary environment, as well as the geopolitical uncertainty stemming from the conflicts in Ukraine and the Middle East. These external factors caused the company to reassess assumptions used in discount rates and benefit‑cost projections, leading to adjustments in reserve levels and related expense recognition. Consequently, the evolving external environment signaled heightened volatility and risk for these pension‑related estimates, prompting more conservative and responsive accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution in factors influencing accounting estimates for pension and retiree medical plans between 2022 and 2023. While the original answer explicitly mentions the shift from 'uncertainties related to the ongoing impacts of the COVID-19 pandemic' in 2022 to 'geopolitical conflicts and macroeconomic conditions' in 2023, the LLM answer focuses only on the 2023 factors and does not explicitly reference the 2022 drivers. However, it correctly identifies the 2023 factors—high interest rates, inflation, and geopolitical uncertainty from conflicts in Ukraine and the Middle East—as the key influences, which aligns with the ground truth. The reasoning is sound: these external factors affect discount rates and cost projections, leading to adjustments in reserves and expenses. The answer also correctly infers increased volatility and a move toward more conservative accounting, which is a reasonable interpretation of the implications. All entities (geopolitical events, economic environment) and years (2023 context) are accurate. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is the lack of explicit contrast with 2022 conditions, which slightly reduces completeness in the multi-hop aspect of the question. Nevertheless, the core facts, synthesis, and implications are correct and semantically equivalent to the original answer’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 410,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region declined from 26,084 gross (12,471 net) thousand acres in 2021 to 24,221 gross (11,548 net) thousand acres in 2023, reflecting a reduction of approximately 1,863 gross and 923 net thousand acres over the two-year period. This contraction in undeveloped acreage—while maintaining a substantial base of 30,773 gross (15,012 net) thousand acres in 2023—indicates the company is actively managing its exploration portfolio, likely prioritizing high-potential areas for development while relinquishing less prospective acreage, though the remaining undeveloped position retains significant exploration potential in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It incorrectly reports the 2022 figures, using 2021 data instead: it states 26,084 gross (12,471 net) thousand acres in 2021, which is irrelevant to the question asking for 2022–2023 evolution. The ground truth correctly states that in 2022, ExxonMobil had 25,096 gross and 11,977 net thousand acres, but the LLM omits these numbers entirely. The 2023 figures (24,221 gross and 11,548 net) are correctly reported. (2) Calculations are therefore flawed: the LLM computes a change from 2021 to 2023, not 2022 to 2023 as required. The actual reduction should be 875 gross (25,096 - 24,221) and 429 net (11,977 - 11,548) thousand acres, but the LLM reports a 1,863 gross and 923 net reduction over two years, which is both numerically and temporally incorrect. Additionally, the LLM falsely claims a total of 30,773 gross (15,012 net) thousand acres in 2023, which contradicts its own earlier figure of 24,221 gross and is unsupported by the ground truth. (3) The multi-hop reasoning is partially sound in interpreting that a reduction in acreage may reflect portfolio optimization and focus on high-potential areas, which aligns with the original answer’s implication. However, because the data foundation is incorrect, the reasoning is applied to the wrong timeline and magnitudes. (4) The contextual relevance is fair because the answer addresses the general trend (decline in acreage) and attempts to interpret strategic implications, but the use of incorrect years and fabricated totals undermines the qualitative insight. Correctness score is low due to major quantitative errors, though some reasoning elements are directionally appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 474,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the treatment of non-functional currency denominated items shifted toward greater use of foreign currency contracts not designated as hedging instruments. In 2023, the Company reported a $9 million pre‑tax loss on such contracts (recorded directly in earnings), compared with a $76 million loss in 2022, indicating that these de‑designated hedges now have a more pronounced impact on the income statement. Consequently, the financial impact of these non‑designated contracts decreased materially, reducing the volatility of earnings from currency‑related reclassifications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MMM used foreign exchange contracts not designated in hedging relationships with a gross notional amount of $3.7 billion, but the LLM answer incorrectly introduces a $76 million pre-tax loss in 2022 and a $9 million loss in 2023—figures that are not present in the original answer and contradict its content. There is no mention in the ground truth of specific P&L impacts like $9M or $76M losses, nor any comparison of such losses year-over-year. (2) The quantitative inaccuracies are severe: the LLM fabricates precise financial figures (pre-tax losses) that do not appear in the original and makes a false claim about decreasing financial impact, while the original describes a strategic shift in accounting treatment, not a reduction in impact. The $3.7 billion notional amount from 2022 is omitted entirely. (3) The reasoning is flawed: the LLM concludes that the financial impact 'decreased materially' and reduced earnings volatility, which contradicts the original answer’s indication of a shift toward more direct earnings impact (i.e., likely increasing volatility). The multi-hop synthesis fails—the original describes a change in strategy (continued use but with focus on non-designated derivatives affecting earnings directly), but the LLM misrepresents this as a quantitative decline in impact based on made-up numbers. (4) Contextual relevance is moderate because the answer addresses foreign currency contracts not designated in hedging relationships and the shift in treatment, but the incorrect data and reversed conclusion undermine accuracy. The core idea of increased use of non-designated contracts is partially aligned, but the supporting details and implications are factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 493,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role of Cyber and Intelligence Solutions shifted from being a component of \"Other revenues\" to a more explicitly highlighted category within Mastercard's value proposition. In the 2023 10-K, it is specifically called out as a distinct value-added service (\"Cyber and intelligence solutions fees are for products and services offered to prevent, detect and respond to fraud and to ensure the safety of transactions made primarily on Mastercard products\") and is positioned alongside data analytics, loyalty solutions, and open banking as a key differentiator. This reflects a strategic emphasis on security and intelligence as core growth drivers, separate from traditional payment network revenue streams, whereas in 2022 it was grouped under the broader \"Other revenues\" category without such explicit segmentation. The 2023 filing also underscores its importance in supporting the company's \"safe, simple, smart, and accessible\" payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Cyber and Intelligence Solutions from a less prominent role in 2022—grouped under 'Other revenues'—to a more explicitly segmented and strategically emphasized service in 2023. This matches the original answer's claim about a shift from being part of a broader list to a core component. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are correctly referenced, and no incorrect figures are introduced. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly inferring a strategic repositioning based on changes in disclosure and categorization. It adds contextual detail (e.g., quoting the 2023 10-K description and linking to 'safe, simple, smart, and accessible' ecosystem) that enriches the answer without deviating from the truth. (4) The only minor gap is that the original answer emphasizes the contrast with other services like consulting and gateway fees more explicitly, while the LLM focuses on structural categorization (i.e., 'Other revenues'). However, this does not detract from factual correctness. Overall, the answer demonstrates strong qualitative reasoning and contextual relevance, meriting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 396,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Between 2022 and 2023, the treatment of Income Tax Expense and Accruals remained part of the same critical accounting policy category but saw increased detail and quantitative disclosure. In the 2023 filing (page 34), the discussion emphasizes that the annual tax rate is determined using significant judgment, transfer‑pricing arrangements, and reserves for uncertain tax positions, and it references the impact of new tax laws and audit progress. The 2022 filing (page 59) similarly describes the use of estimates for credit‑loss exposure and forward‑looking information, but provides less quantitative breakdown of tax‑related adjustments. Both years retain the policy’s focus on subjective judgments and the potential impact of tax‑related risks, though the 2023 version adds more explicit references to tax audits, new legislation, and the mechanics of reserve adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that Income Tax Expense and Accruals remained a critical accounting policy in both 2022 and 2023, which matches the original answer. The LLM adds valuable detail not explicitly in the ground truth but consistent with it—such as the increased emphasis on judgment, transfer pricing, uncertain tax positions, and references to new tax laws and audits in 2023—demonstrating sound qualitative synthesis. It correctly references page numbers (34 in 2023, 59 in 2022), which supports its claims and shows precise sourcing, though the ground truth does not include page numbers, so this cannot be verified directly but does not detract from accuracy. The answer captures the evolution toward more detailed and structured disclosure, equivalent to the ground truth's claim about a 'more structured presentation' and 'deeper transparency.' The only minor shortcoming is that the LLM does not explicitly mention the reorganization into a subsection under 'Our Critical Accounting Policies and Estimates' or the reference to Note 5 - Income Taxes, which are specific structural changes noted in the original. However, the essence of enhanced disclosure and organization is conveyed. All entities (Income Tax Expense and Accruals, years 2022 and 2023, critical accounting policies) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented). The reasoning is multi-hop, comparing disclosures across years and inferring increased transparency, which is logically sound. The answer is fully contextually relevant and directly addresses the evolution in treatment and disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 467,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Intel's development and positioning of the Universal Chiplet Interconnect Express (UCIe) standard has evolved as a foundational component of its broader systems of chips strategy, particularly within its Intel Foundry Services (IFS) initiative. By 2023, UCIe was demonstrated in silicon and positioned as a key standard to enable interoperable communication between chiplets in heterogeneous systems, supporting the shift from monolithic chips to modular, AI-optimized architectures. This effort aligns with Intel's push to establish itself as a major foundry player by offering advanced packaging, process technologies (e.g., Intel 18A with RibbonFET and PowerVia), and ecosystem partnerships (e.g., with ARM and Synopsys) to accelerate customer design. The standard is integral to Intel's strategy of differentiating its foundry offerings through systems-level capabilities, resilience, and sustainability, while addressing the growing complexity of AI-driven semiconductor design.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments around Intel's UCIe standard between 2023 and 2024. It accurately notes that in 2023, UCIe was demonstrated in silicon and positioned as a key enabler for chiplet-based, heterogeneous systems, which matches the original answer. The LLM also correctly identifies UCIe as central to Intel's broader systems of chips strategy and its foundry ambitions under Intel Foundry Services (IFS), which is contextually accurate and relevant. However, the original answer specifies that by 2024, Intel had moved from demonstration to active production using UCIe and integrated it into its advanced semiconductor assembly and test offerings. While the LLM implies progression by discussing ecosystem partnerships and advanced packaging, it does not explicitly state the shift to production in 2024, which is a key evolution highlighted in the ground truth. This omission prevents a perfect score but does not undermine the overall correctness of the strategic positioning. All entities (UCIe, Intel, IFS, ARM, Synopsys), years (2023–2024), and technological terms (chiplets, advanced packaging) are accurate. There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The reasoning is sound and synthesizes the strategic intent behind UCIe within Intel’s broader foundry and systems-level differentiation, earning high marks for qualitative accuracy and full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 415,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "The accounting treatment for CVS’s Accelerated Share Repurchase (ASR) transactions has remained consistent between the 2023 and 2024 10‑K filings: each ASR is initially recorded as a treasury‑stock purchase with a portion accounted for as an equity‑classified forward contract recorded in capital surplus, and the forward contract is later re‑classified to treasury stock when the final shares are received.  \n\nThe timeline of completion has shifted forward: the $2.0 billion ASR entered into under the 2021 Repurchase Program was executed in January 2023 and settled in February 2023, whereas the $3.0 billion ASR under the same program was executed in January 2024 and completed in March 2024, reflecting a one‑year later execution and settlement schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent accounting treatment between 2023 and 2024—initial recording as treasury stock with an equity-classified forward contract in capital surplus, and reclassification to treasury stock upon final settlement. This matches the ground truth. The execution and completion timelines are mostly accurate: the 2023 ASR was initiated in January 2023 and concluded in February 2023 (1-month duration), and the 2024 ASR was initiated in January 2024 and completed in March 2024 (2-month duration), which aligns with the ground truth. However, the LLM omits specific details about the number of shares received—17.4 million initially and 5.4 million additional in 2023, and 31.4 million initially and 8.3 million additional in 2024—as well as the counterparties (Citibank in 2023, Morgan Stanley in 2024). These are quantitatively relevant and part of the evolution described in the original answer. (2) The dollar amounts ($2.0 billion in 2023, $3.0 billion in 2024) and dates (January to February 2023, January to March 2024) are correct. The duration comparison (1 month vs. 2 months) is accurate, though the LLM does not explicitly state the duration difference, only inferring it from dates. The percentage of initial delivery (80% in 2023, 85% in 2024) is missing, which is a notable quantitative omission affecting completeness. (3) The multi-hop reasoning is sound—the model correctly synthesizes that the accounting treatment remained unchanged while the timeline and scale evolved. It correctly links the two ASRs under the same repurchase program and compares their timing. However, the lack of share quantities and counterparties limits full synthesis across all dimensions (scale, timing, structure). (4) The answer is contextually relevant and well-structured, directly addressing both parts of the question. The qualitative reasoning is strong, and the core facts are correct. The score is reduced primarily due to missing quantitative details that were present in the ground truth and relevant to the evolution of the ASR transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 564,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS’s pension reporting continued to rely on actuarial assumptions—particularly the discount rate and expected return on plan assets—to measure its benefit obligations and expense. The 2023 sensitivity analysis shows that a 25‑basis‑point increase in the discount rate would reduce the projected benefit obligation by about $1.55 billion (and lower expense by $15 million), while a 25‑basis‑point decrease would increase the obligation by $1.64 billion (and raise expense by $16 million). Additionally, the analysis notes a $5.1 billion pre‑tax gain in 2021 tied to coordinating benefits with the Central States Pension Fund, reflecting the ongoing interaction between UPS’s pension funding and that multi‑employal pension plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS disclosed a $2.3 billion pre-tax actuarial loss in 2022 related to the Central States Pension Fund, but the LLM incorrectly references a $5.1 billion pre-tax gain in 2021, which is not mentioned in the original answer and contradicts the disclosed loss. Additionally, the sensitivity analysis described in the LLM answer—detailing $1.55 billion and $1.64 billion changes in projected benefit obligation from a 25 bps rate change—is not present in the ground truth and appears fabricated. The ground truth only mentions that UPS shifted to referencing a 25 bps change in expected and actual returns on assets as a key assumption in 2023, with a cross-reference to Note 5, but does not provide specific dollar impacts. (2) The numbers cited in the LLM answer (e.g., $1.55B, $1.64B, $15M, $16M, $5.1B gain in 2021) are not supported by the original answer and are therefore factually incorrect. The only correct numeric element is the 25 basis point reference, which aligns with the ground truth’s mention of sensitivity to returns on assets. However, the context and implications are misrepresented. (3) The multi-hop reasoning is flawed. The question asks for the evolution in UPS’s reporting approach from 2022 to 2023 regarding the Central States Pension Fund. The ground truth identifies a shift from quantifying a specific $2.3B actuarial loss in 2022 to emphasizing sensitivity analysis in 2023. The LLM fails to capture this evolution accurately, instead introducing unrelated sensitivity figures and an erroneous gain in 2021, which distorts the narrative. It also fails to mention the key shift from specific obligation disclosure to sensitivity emphasis. (4) The contextual relevance is moderate because the answer discusses pension reporting, actuarial assumptions, and sensitivity analysis—topics relevant to the question—but the specific content is factually misaligned. Due to major quantitative and qualitative errors, the correctness score is low at 3, with similarly low scores for quantitative (2) and qualitative accuracy (3). Contextual relevance is scored 6 because the general theme is addressed, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 599,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Mastercard's Cyber and Intelligence Solutions have evolved from a peripheral, security-focused add‑on to a core, high‑value growth pillar in its portfolio. In 2022 the company highlighted these solutions as part of its “value‑added services” that drive revenue, and by 2023 it explicitly tied them to the broader “Cyber & Intelligence” and “Data & Services” segments, emphasizing how they enable secure, data‑driven transactions and generate higher‑margin revenue streams. This shift underscores a strategic repositioning that positions Cyber and Intelligence Solutions as a key differentiator and a primary source of sustainable, high‑margin growth for stakeholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mastercard's messaging around Cyber and Intelligence Solutions between 2022 and 2023. It accurately captures the shift from a value-added service in 2022 to a more central, strategic growth pillar in 2023. The emphasis on higher-margin revenue streams and integration into broader segments like 'Data & Services' is consistent with the expanded positioning described in the original answer. However, the LLM omits specific elements mentioned in the ground truth, such as the 'principled use of consumer and merchant data' in 2022 and the explicit linkage in 2023 to strategic investments in open banking and digital identity. These are important nuances that reflect the deeper integration into Mastercard’s infrastructure narrative. While the LLM conveys a similar overall trajectory—elevating the strategic importance of cyber solutions—it misses these multi-hop details that ground the evolution in specific initiatives and stakeholder communication. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are misstated), and the reasoning is sound, though slightly less precise in scope. The answer remains highly relevant and semantically close to the original, warranting a high correctness score with minor deductions for incompleteness in contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 388,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 filing (PEP_10k_2022.pdf), the 4.450% Senior Note due 2046 is referenced in the Exhibit table on page 127 (entry 4.11), which cites the October 14, 2015 Current Report on Form 8‑K. By contrast, in the 2023 filing (PEP_10k_2023.pdf), the same note appears on page 128 (entry 4.59), which cites the February 15, 2023 Current Report on Form 8‑K. Thus, the exhibit reference shifts from the 2015 filing to the 2023 filing, reflecting an updated documentation date.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from the October 14, 2015 Form 8-K. However, the LLM incorrectly states it was Exhibit 4.11 and misidentifies the page as 127. More critically, for the 2023 filing, the ground truth states the note was reclassified as Exhibit 4.13 and referenced the February 24, 2016 Form 8-K. The LLM instead claims it was Exhibit 4.59 citing a February 15, 2023 Form 8-K, which is entirely incorrect. (2) The dates are wrong: October 14, 2015 is correctly stated in the LLM answer for 2022, but the 2023 filing reference should be February 24, 2016, not February 15, 2023. The LLM invents a 2023 Form 8-K that is not in the ground truth. Exhibit numbers 4.11 and 4.59 are incorrect; they should be 4.12 and 4.13 respectively. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the evolution of exhibit numbering and source documentation across years. It incorrectly suggests the note was updated in 2023 via a new 8-K, whereas the ground truth indicates the 2023 filing still references a 2016 document, implying administrative reclassification, not new documentation. (4) The contextual relevance is moderate because the answer attempts to compare exhibit references and documentation dates across years, aligning with the question's intent. However, due to major factual and quantitative errors, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 435,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel’s engagement with Positive Technologies has continued under an OFAC general license that permits the company to maintain communications with the Russian firm for IT‑security research and vulnerability coordination, a relationship that was first established before the 2021 designation and has been sustained through the licensing arrangement. The 2024 filing confirms that all such dealings remain covered by the OFAC license and generate no direct revenue or profit for Intel.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Intel maintained communications with Positive Technologies under an OFAC license for IT security research and vulnerability coordination, and these activities generated no revenue or profit. The dates (2023–2024) and entities (Intel, Positive Technologies, OFAC) are correct, and there are no numerical inaccuracies—thus, quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the nature of the relationship under U.S. sanctions. However, the LLM answer lacks completeness in capturing the evolution of the relationship between 2023 and 2024. The ground truth emphasizes a shift from disclosing past communication (2023) to expressing intent to continue the partnership (2024), indicating a more forward-looking posture in 2024. The LLM response does not highlight this progression or the change in tone and strategic stance over time, which is central to the question’s focus on 'evolution.' While it correctly states the ongoing nature of the engagement, it fails to synthesize the multi-hop nuance of how Intel's public stance matured from retrospective disclosure to sustained, licensed collaboration. This omission reduces qualitative accuracy, as the reasoning and synthesis across years are underdeveloped. Hence, the correctness score is 7—core facts are right, but key contextual evolution is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 389,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The $5 billion of 4.78 % senior notes maturing in March 2038 remained unchanged in principal amount between 2023 and 2024, but its relative share of total long‑term debt declined from roughly 8 % (≈$5 bn of $62 bn) in 2023 to about 7.5 % (≈$5 bn of $66.7 bn) in 2024 after the company issued new senior notes and a $3 bn term loan in 2024. This shift reflects a strategic extension of CVS’s debt maturities and a modest reduction in the proportional weight of the 2038 notes within the broader long‑term borrowing structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that the $5 billion 4.78% Senior Notes due March 2038 remained unchanged in principal amount between 2023 and 2024 (matching the ground truth), it introduces incorrect information about total long-term debt increasing to $66.7 billion in 2024 due to new issuances and a $3 billion term loan—this is not supported by the ground truth and contradicts the stability narrative for this specific note. The ground truth makes no mention of new debt issuance or changes in total long-term debt structure affecting the relative weight of the 2038 notes. (2) The quantitative inaccuracies are critical: the LLM fabricates total debt figures ($62B in 2023, $66.7B in 2024) and calculates a decline in the note's proportion from 8% to 7.5%, which is unsupported. These calculations, while internally consistent, are based on invented data. The only correct number is the $5 billion balance for the 2038 notes. (3) The multi-hop reasoning is partially sound in concept—assessing how a stable debt instrument fits into broader debt structure changes—but fails because it invents evidence (new notes, term loan, total debt figures) rather than relying on actual data. The ground truth contrasts the stability of the 2038 notes with the reduction in the 2.7% 2040 notes, which the LLM omits entirely. (4) Scores reflect partial correctness on the core fact (stable balance), but major deductions for fabricated quantitative data and incorrect reasoning. Contextual relevance is high as the answer addresses the question's intent, but factual integrity is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 451,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were listed in the securities tables of both the 2022 and 2024 Form 10‑K filings, confirming that the notes remained outstanding and unchanged in the company’s capital structure across those years. No subsequent amendment or redemption of the notes was disclosed in the provided pages.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that the 0.835% Notes due 2032 were listed in both the 2022 and 2024 Form 10-K filings and remained outstanding, which aligns with the ground truth. All quantitative elements—interest rate (0.835%), maturity year (2032)—are accurate, and no incorrect numbers or dates are presented. The answer correctly identifies the continuity of the notes in the capital structure. However, it omits a key qualitative insight from the original answer: the contrast with the 0.142% Notes due 2024 (XOM24B), which were present in the 2022 filing but absent in 2024, indicating a shift in the company's debt composition. This omission reduces completeness in multi-hop reasoning, as the evolution of the 2032 notes is best understood in context of changes to other notes. While the LLM correctly reports the status of the 2032 notes, it fails to synthesize the broader change in debt structure, which is central to the question about 'evolution' between filings. Thus, while factually sound and contextually relevant, the answer lacks full qualitative depth in comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 314,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Based on the provided SEC 10-K pages, American Express's investment strategy toward U.S. Government treasury obligations evolved significantly between 2022 and 2024 in terms of fair value allocation and maturity distribution. In 2022 (page 126), U.S. Government treasury obligations represented $287 million in fair value with a weighted average yield of 4.81% for maturities beyond 10 years, but this was part of a broader portfolio where treasury obligations were primarily held in longer maturities (832 due within 1 year, 862 due after 1-5 years, and 10 due after 5-10 years as of 2021). By 2024 (page 125), the fair value allocation shifted to $287 million in U.S. Government treasury obligations with a more concentrated maturity profile: $123 million due after 1-5 years and $10 million due after 5-10 years, reflecting a strategic shift toward shorter-duration holdings. The weighted average yield for these treasury obligations also declined to 2.73% for maturities beyond 10 years (compared to 4.81% in 2021), indicating a deliberate move toward lower-yielding, shorter-term Treasury securities to manage interest rate risk amid rising rates. This evolution shows a clear strategic pivot from longer-duration, higher-yield Treasury holdings toward shorter-maturity, lower-yielding instruments, as evidenced by the reduced emphasis on 10+ year maturities and the increased allocation to shorter-term Treasury securities within the AFS portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure. However, the LLM claims $287 million in fair value with maturities beyond 10 years and references holdings due after 1-5 and 5-10 years, which contradicts the ground truth. The 2024 figures are also incorrect: the LLM states $287 million total with $123 million due after 1-5 years and $10 million after 5-10 years, while the ground truth reports $189 million short-term and $98 million intermediate-term (1-5 years), totaling $287 million — but the maturity breakdown is misrepresented. The LLM incorrectly attributes a weighted average yield of 4.81% in 2021 and 2.73% in 2024 for maturities beyond 10 years, but the ground truth makes no mention of yields or 10+ year holdings in either year. (2) The dollar amounts are partially coincidental: $287 million appears in both answers but refers to different years and compositions. The correct 2022 fair value is $477 million (not $287M), and while $189M + $98M = $287M in 2024, the LLM fails to report the correct split and instead invents allocations not in the ground truth. Calculations are not required but the synthesis of numbers is flawed. (3) The multi-hop reasoning is unsound: the LLM incorrectly infers a shift from long-term to short-term holdings, when the actual shift was from exclusively short-term to including intermediate-term, indicating diversification — not de-risking via shortening duration as claimed. The LLM confuses data from different years (e.g., citing 2021 maturity data that isn't relevant to the 2022–2024 comparison). (4) Contextual relevance is moderate because the answer addresses investment strategy evolution, fair value, and maturity distribution, but the factual foundation is incorrect, leading to a misleading conclusion about strategic intent. The mention of 'rising rates' and 'interest rate risk' is speculative and unsupported by the ground truth. Overall, the answer fails on core quantitative accuracy and correct entity mapping, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 584,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced its 2.500% Note due 2050 in its June 3 2020 Officers’ Certificate (page 72), which was later referenced again in the May 12 2021 certificate (page 73) alongside other long‑dated notes. By the 2022 filing (page 75), the company had issued new 4.7%–4.7% notes due 2024‑2032, but the 2.500% 2050 note remained part of the earlier 2020 issuance and continued to be described in subsequent certificates, indicating that its terms were unchanged through 2024. No subsequent amendments or retirements of the 2.500% Note due 2050 were disclosed in the provided 2022‑2024 documents.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains minor inaccuracies and omissions compared to the ground truth. (1) Quantitatively, the key date of June 3, 2020, for the Officers' Certificate introducing the 2.500% Note due 2050 is correctly identified, and the absence of amendments or retirements through 2024 aligns with the original answer. However, the LLM references a May 12, 2021 certificate and page numbers (e.g., page 72, 73, 75), which are not mentioned in the ground truth and may reflect extraneous or unverified details. (2) The original answer emphasizes that in 2024, the note was reintroduced in Exhibit 4.6 as an exact replication of Exhibit 4.5 from 2020—this specific structural detail about exhibit replication is missing in the LLM response, representing a notable omission in completeness. (3) Qualitatively, the reasoning is sound in concluding that the note remained unchanged through 2024, and the synthesis across years is logical, though it fails to capture the precise mechanism (reintroduction via replicated exhibit) by which Amazon reaffirmed the note. (4) Contextually, the answer is highly relevant, correctly identifying the evolution (or lack thereof) in the treatment of the note. While the core facts about the note’s continued existence and unmodified status are accurate, the absence of the exhibit-level detail and introduction of unconfirmed page numbers and certificates reduce the qualitative and quantitative accuracy slightly. Hence, a score of 7 is justified for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 418,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The Citibank, N.A. Co-Branded Credit Card Agreement saw a progression of amendments between 2022 and 2023, with the Fourth through Eighth Amendments filed in 2018–2022 (Exhibits 10.8.4–10.8.8), followed by the Ninth and Tenth Amendments filed in November 2022 (Exhibits 10.8.9–10.8.10), and the Eleventh Amendment filed in February 2023 (Exhibit 10.8.11), with a Twelfth Amendment filed in October 2023 (Exhibit 10.8.12). This indicates a steady evolution of amendments, with two amendments filed in 2022 and one additional amendment filed in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the number and timing of amendments. According to the ground truth, the most recent amendment in 2022 was the Eighth Amendment (filed March 10, 2022), and by 2023, the Twelfth Amendment was filed (October 11, 2023), indicating four additional amendments (Ninth through Twelfth) over the period. However, the LLM claims the Ninth and Tenth Amendments were filed in November 2022, the Eleventh in February 2023, and the Twelfth in October 2023—implying only four total amendments post-Eighth, but incorrectly placing two of them in 2022. This contradicts the ground truth that the Eighth was the latest in 2022, meaning no Ninth or Tenth could have been filed that year. (2) The dates and sequence are therefore factually wrong: the LLM invents filings in November 2022 and February 2023 not present in the original answer. The ground truth does not specify when the Ninth through Eleventh were filed—only that the Twelfth was in October 2023—but the logical inference is that all four came after March 2022. The LLM’s specific dates are unsupported and misleading. (3) The multi-hop reasoning is partially sound in that it attempts to track amendment progression, but fails in synthesis by contradicting the key fact that the Eighth was the last in 2022. It incorrectly infers that amendments Ninth and Tenth occurred in 2022, which directly conflicts with the ground truth. (4) The contextual relevance is high because the answer addresses the evolution of amendments and cites exhibits appropriately. However, the quantitative accuracy is low due to incorrect amendment counts per year and fabricated dates. The qualitative accuracy is moderate because the structure and intent are correct, but the factual basis is flawed. Correctness score is 4 due to major factual errors in timeline and amendment count, despite correct identification of the Twelfth Amendment in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 527,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's CUDA approach has evolved from a foundational parallel computing model to a full-stack AI platform tightly integrated with new architectures. By 2024, it expanded to include DPUs and CPUs (e.g., Grace CPU, Blackwell architecture), enabling unified acceleration across GPUs, CPUs, and networking, while deepening software integration through AI-specific features like Tensor Cores, DLSS, and Omniverse for simulation. This integration supports end-to-end AI workflows—from training and inference to autonomous driving and generative AI—across data centers, gaming, and automotive ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's CUDA strategy from 2022 to 2024. It correctly identifies the shift from a foundational parallel computing model to a full-stack platform integrated with heterogeneous architectures (GPUs, CPUs, DPUs), aligning with the ground truth. The mention of CPUs (e.g., Grace CPU) and the expansion into data center platforms with CPUs and DPUs is factually correct and reflects NVIDIA's fiscal 2024 developments. The integration with software ecosystems like Omniverse and AI-specific technologies (Tensor Cores, DLSS) is contextually appropriate and reflects CUDA's broader ecosystem role. While the original answer emphasizes CUDA-X, APIs, SDKs, and domain-specific frameworks more explicitly, the LLM conveys semantically equivalent information by referencing 'full-stack AI platform' and integration across AI workflows. There are no numerical inaccuracies—dates (2022 to 2024), product names (Grace CPU), and architectural components (Blackwell, DPUs) are correctly used. The reasoning is sound, demonstrating multi-hop synthesis across hardware evolution and software ecosystem expansion. The only minor shortcoming is the lack of explicit mention of CUDA-X and the term 'unified architecture' as used in the original, which slightly reduces completeness in qualitative detail. However, the overall meaning and factual content are substantially aligned. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 413,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Pfizer's financial relationship with Paxlovid shifted dramatically between 2023 and 2024 due to the resolution of pandemic-era government contracts and revenue reversals. In 2023, Paxlovid revenue plummeted 92% year-over-year to $1.279 billion, driven by a $3.5 billion non-cash revenue reversal in Q4 2023 related to the expected return of 6.5 million EUA-labeled government courses, partially offset by a $771 million favorable adjustment in Q1 2024 reflecting only 5.1 million courses returned (vs. 6.5 million estimated). By 2024, Paxlovid revenue further declined to $1.191 billion globally, with $1.279 billion in the U.S. and $2.568 billion internationally, as the company transitioned to commercial market sales and recognized $442 million in revenue from a U.S. Strategic National Stockpile supply agreement. Deferred revenue for Paxlovid and Comirnaty decreased from $5.1 billion (as of Dec 31, 2023) to $2.2 billion (as of Dec 31, 2024), reflecting revenue recognition as products were delivered under remaining performance obligations through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual inaccuracies, particularly in financial figures and revenue trends. While it correctly identifies the $1.279 billion Paxlovid revenue in 2023 and the $3.5 billion non-cash reversal due to expected returns of 6.5 million treatment courses, it incorrectly states that only 5.1 million were returned in Q1 2024 as a 'favorable adjustment'—this adjustment was already reflected in 2024 results, not as a Q1 2024 correction to 2023. More seriously, the LLM claims Paxlovid revenue in 2024 was $1.191 billion globally, with $1.279 billion in the U.S. and $2.568 billion internationally—this is mathematically impossible (U.S. + international exceeds global total) and contradicts the ground truth, which does not specify 2024 global revenue but implies an increase from adjustments ($771M + $442M) on top of 2023's $1.279B base. The LLM also fabricates deferred revenue figures: ground truth mentions $1 billion in remaining performance obligations as of Dec 31, 2024, but the LLM invents $5.1B (Dec 2023) and $2.2B (Dec 2024) deferred revenue for Paxlovid and Comirnaty combined, which is unsupported. (2) Quantitative accuracy is poor: the $1.191B global revenue, $1.279B U.S., and $2.568B international figures are inconsistent and incorrect. The favorable adjustment of $771M is correctly tied to lower-than-expected returns but misattributed to Q1 2024 timing. The $442M SNS revenue is correctly identified. (3) Reasoning is partially sound—LLM recognizes the shift from government-driven to contracted model and attempts multi-hop synthesis (e.g., linking returns to revenue reversal), but fails to accurately integrate the financial evolution due to incorrect data. (4) Contextual relevance is high—the answer addresses revenue recognition and contractual obligations as asked, and frames the shift in business model appropriately. However, due to major numerical errors and invented data, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 542,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "Between 2022 and 2024, the availability of shares under the 2003 Incentive Program declined from an unspecified but larger pool to 47 million shares remaining at year‑end 2024, while the program continued to allow new awards until those shares are exhausted.  The structure of the program remained unchanged: awards may be stock options, SARs, restricted stock, or other forms, with a maximum life of 10 years for options/SARs and no set expiration for the program itself, and forfeited, expired, or cash‑settled awards do not reduce the 220 million‑share cap.  Additionally, the 2024 totals now incorporate Pioneer restricted‑stock units issued after the May 3, 2024 merger, with 760 thousand such awards granted, of which 67 thousand vested and 209 thousand were forfeited.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, 65,754,069 shares were available under the 2003 Incentive Program, but the LLM incorrectly states that the 2022 availability was 'unspecified but larger' and implies a decline from a higher number to 47 million in 2024. This contradicts the truth, which shows a program expansion from ~65.8 million in 2022 to a total cap of 220 million shares by 2024. The LLM also fails to mention the 220 million cap was a new maximum, not the starting point in 2022. (2) The LLM introduces data not in the original answer: specifically, the 760 thousand Pioneer RSUs granted post-merger on May 3, 2024, with 67 thousand vested and 209 thousand forfeited. This information is absent from the ground truth and appears fabricated or hallucinated. Additionally, the ground truth states that restricted stock units granted increased from 9,392 thousand in 2022 to 10,393 thousand in 2024, but the LLM omits this entirely. (3) The multi-hop reasoning is flawed: the question asks about evolution between 2022 and 2024, requiring comparison of share availability and structure over time. The LLM incorrectly frames the trend as a decline, when it was actually an expansion in total capacity. It correctly notes structural elements like award types and treatment of forfeitures not reducing the cap, which aligns with the ground truth's implication of structural continuity. (4) The contextual relevance is moderate because the answer discusses the right program and timeframe and touches on structure, but major quantitative errors and hallucinated data severely undermine correctness. The qualitative accuracy is low due to incorrect synthesis and unsupported details. Quantitative accuracy is very low due to wrong numbers and missing key figures. Correctness score is 3 due to partial structural accuracy but major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 523,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense’s role within Google’s advertising revenue streams has shifted from a standalone revenue source to a key component of Google’s broader advertising technology portfolio. In 2022, AdSense was primarily positioned as a platform for publishers to monetize content through contextual ads, contributing to Google’s overall advertising revenue, which was driven by Google Search, YouTube, and Google Network (including AdSense, AdMob, and Ad Manager). By 2023–2024, AdSense’s functionality was increasingly integrated into Google’s AI-driven advertising ecosystem, particularly through Gemini AI and tools like Performance Max and Demand Gen, which leverage AI to optimize ad targeting, creative generation, and campaign management across Google’s platforms. This evolution reflects Google’s broader strategy to consolidate its advertising technology stack under AI-powered solutions, enhancing efficiency and scalability while maintaining AdSense as a foundational channel for publishers within the larger Google Ads ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it lacks the specific $8.6 billion year-over-year revenue increase mentioned in the original answer for 2022, which is a quantitatively important detail. However, no incorrect numbers are presented—only the absence of this key figure. The qualitative analysis is strong: the shift from AdSense as a highlighted growth driver in 2022 to a more integrated, foundational component by 2024 is accurately conveyed. The emphasis on AI-powered tools like Performance Max and Demand Gen replacing AdSense as central growth levers is consistent with the ground truth. The mention of 'Gemini AI' is not present in the original answer and may be an overreach or conflation with Google's AI branding, but it does not fundamentally misrepresent the strategic shift. The reasoning correctly synthesizes the evolution of AdSense within Google’s broader ad tech portfolio across the multi-hop timeline (2022 → 2024), and the contextual relevance is excellent. The answer captures the essence of the strategic evolution even if it omits the precise financial impact from 2022. Hence, high scores across the board with a slight deduction in correctness and qualitative accuracy for the missing revenue figure and minor speculative addition of Gemini AI.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 365,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan stopped accruing additional benefits for non‑union participants as of January 1 2023, and the UPS Excess Coordinating Benefit Plan made the same change effective that date. In 2023 the company began providing a new retirement contribution to the UPS 401(k) Savings Plan for non‑union employees—5 % to 8 % of eligible compensation (up from 3 % to 8 % before 2023)—and the related expense for these contributions was $380 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core factual change — the cessation of benefit accruals for non-union participants in the UPS Retirement Plan effective January 1, 2023 — which aligns with the ground truth. This addresses the main evolution in the plan's structure. However, the answer introduces information not present in the original answer and omits key details. Specifically: (1) It incorrectly mentions the 'UPS Excess Coordinating Benefit Plan' making the same change, which is not referenced in the ground truth and constitutes an unsupported extension. (2) It adds details about increased 401(k) contributions (5% to 8% of eligible compensation) and a $380 million expense in 2023, which, while potentially true, are not part of the provided ground truth and were not asked for in the question. The question focused on the evolution of the *Retirement Plan's benefit accrual structure*, not replacement benefits. (3) It fails to mention the eligibility cutoff (employees hired before July 1, 2016) and the plan’s noncontributory nature, which are key contextual elements in the original answer. (4) The ground truth emphasizes the transformational shift from an active to a closed plan for non-union employees, a qualitative point missing in the LLM response. While the date (January 1, 2023) is correct, the added quantitative details (percentages, $380M) cannot be verified against the ground truth and appear to be hallucinated or sourced from outside the provided knowledge. Thus, while the central fact is correct, the inclusion of unverified details and omission of key structural context reduces factual accuracy. The reasoning is partially sound but overreaches by introducing extraneous plans and financial figures. The answer is contextually relevant but not fully aligned with the ground truth in scope or content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 493,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Amazon's short-term credit facilities evolved between 2022 and 2024 through the replacement of its prior 364-day revolving credit facility with a new $5.0 billion facility maturing in October 2025, which carries interest at the Secured Overnight Financing Rate plus 0.45% and includes a 0.03% commitment fee on undrawn amounts. The company also maintains a $15.0 billion unsecured revolving credit facility extending to November 2028, and utilizes other short-term facilities with $147 million and $151 million outstanding as of December 31, 2023 and 2024. No borrowings were outstanding under the Credit Agreement or Short-Term Credit Agreement as of December 31, 2023 and 2024, with the company relying on commercial paper programs (up to $20.0 billion total capacity) and these credit facilities for general corporate purposes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures most key facts correctly but contains some inaccuracies and omissions. It correctly identifies the $15.0 billion unsecured revolving credit facility and the new $5.0 billion 364-day facility introduced in October 2024 with interest at SOFR plus 0.45% and a 0.03% commitment fee. It also accurately reports $147 million and $151 million in borrowings under other short-term facilities as of December 31, 2023 and 2024, respectively. However, it incorrectly states that the $5.0 billion facility replaced a prior 364-day facility, which is not mentioned in the ground truth—there was no indication of a prior 364-day facility being replaced. Additionally, the LLM introduces a commercial paper program with $20.0 billion capacity, which is not referenced in the original answer and thus unsupported. (2) Quantitative accuracy is high: all dollar amounts ($15.0 billion, $5.0 billion, $147M, $151M), interest rates (SOFR + 0.45%), and fees (0.03%) are correct. The timeline for the $5.0 billion facility maturing in October 2025 aligns with an October 2024 signing. However, the LLM omits the 2022 $7.0 billion facility details (interest rate: benchmark + 0.50%, fee: 0.04%) and the increase in unused letters of credit from $7.2B (end-2021) to $8.3B (end-2024), which are key parts of the evolution. (3) The multi-hop reasoning is partially sound—it connects changes in credit capacity and terms across years but fails to fully synthesize the full evolution from 2022 to 2024, especially the expansion from $7.0B to $15.0B and the improvement in pricing. The claim about replacing a prior facility introduces incorrect causal logic. (4) Scores reflect strong factual reporting on 2024 conditions and partial completeness; the answer is contextually relevant and well-structured but lacks full comparative depth and includes unsupported elements like the commercial paper program.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 517,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as evidenced by its continued reliance on index-based agreements for natural gas and electricity purchases (noted in both 2022 and 2023 documents) that qualify for the \"normal purchases and normal sales\" exception and require no mark-to-market adjustments. This stability indicates a deliberate strategy to manage commodity price risk through partial hedging via fixed-price contracts for select facilities while accepting exposure to market fluctuations for other purchases, reflecting a pragmatic approach to balancing risk mitigation with operational flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco used variable-priced, index-based contracts for electricity, natural gas, and fuel for gas stations in both 2022 and 2023; these contracts qualify for the 'normal purchases and normal sales' exception and do not require mark-to-market adjustments. The LLM correctly identifies the continuity of this strategy. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information from both years is synthesized correctly, and the conclusion about risk management strategy is logically supported. The only minor gap is that the LLM introduces the idea of 'partial hedging via fixed-price contracts for select facilities,' which, while plausible, is not explicitly mentioned in the original answer and adds an inference not present in the ground truth. This slightly affects qualitative accuracy but does not undermine correctness. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in contract usage and what it indicates about risk management. Overall, the response captures the core meaning and facts with high fidelity, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 359,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from a core enterprise AI software suite into a broader, full-stack AI and accelerated computing platform. Initially launched as a paid license for enterprise AI software and NVIDIA vGPU software, it expanded to include AI Enterprise tools like NIM (delivering 2.5x token throughput), NeMo for model curation/fine-tuning, and AI Blueprints for building AI agents. This evolution was reinforced by the 2023 launch of the Blackwell architecture, which integrated AI Enterprise software into a unified data center-scale infrastructure spanning GPUs, CPUs, DPUs, and networking. By 2024, AI Enterprise was positioned as the \"operating system for enterprise AI,\" tightly coupled with NVIDIA's hardware (including the Blackwell GPUs and CPUs) and software stack (CUDA, Tensor Cores), enabling end-to-end deployment of generative AI workloads across data centers. This strategic shift solidified its role as the central software layer for NVIDIA's data center offerings, moving beyond standalone software licenses to become an integrated component of its full-stack computing platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the strategic evolution of NVIDIA AI Enterprise. It accurately captures the shift from a foundational software offering to a central, integrated component of NVIDIA's full-stack data center platform. The mention of NIM, NeMo, AI Blueprints, and integration with Blackwell architecture (launched in 2023–2024 timeframe) is consistent with NVIDIA's public roadmap and reinforces the product's expanded role. The description of AI Enterprise as the 'operating system for enterprise AI' reflects NVIDIA's messaging in 2024 and correctly emphasizes tighter coupling with hardware (GPUs, CPUs, DPUs) and software (CUDA, Tensor Cores), which matches the ground truth's emphasis on monetization and integration. However, the original answer does not mention specific tools like NIM, NeMo, or AI Blueprints, nor does it reference the 2.5x performance metric or the Blackwell architecture by name—these are plausible extrapolations but not explicitly supported in the provided ground truth. While these details are consistent with public knowledge, the evaluation must be based solely on alignment with the original answer from the knowledge graph. Therefore, the LLM adds some detail beyond the ground truth, which may reflect accurate external knowledge but introduces elements not verified in the source. This results in a high but not perfect qualitative accuracy score. Quantitatively, there are no incorrect numbers or dates—references to 2023 and 2024 are within the expected timeline and used appropriately. The reasoning is sound, showing a logical progression from 2022 to 2024 and synthesizing the product’s evolution in the context of broader data center offerings. Contextual relevance is excellent, directly addressing the strategic positioning and commercial role evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 505,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer’s contractual obligations for Paxlovid shifted markedly between 2023 and 2024. In 2023, the company recorded a $3.5 billion non‑cash revenue reversal related to expected returns of U.S. government‑stockpiled courses, followed by a $771 million favorable adjustment in early 2024 reflecting fewer returns than initially projected and the delivery of 1 million courses to the U.S. Strategic National Stockpile. By the end of 2024, deferred revenue linked to Paxlovid had fallen from $5.1 billion to $2.2 billion, with $1.4 billion classified as current (to be recognized within the next 12 months) and the remainder slated for recognition from 2025 through 2028. This decline signals that Pfizer expects substantially lower future Paxlovid sales and therefore anticipates only modest, back‑end revenue from the product in the coming years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to expected returns of Paxlovid from the U.S. government, it introduces a $771 million favorable adjustment in early 2024 that is not present in the original answer or supported by the knowledge graph. Additionally, the claim that deferred revenue fell from $5.1 billion to $2.2 billion by end of 2024 is unsupported; the ground truth states that remaining performance obligations were approximately $1 billion as of December 31, 2024—not $2.2 billion or $1.4 billion current. The breakdown of revenue recognition from 2025 through 2028 also does not appear in the original answer. (2) Quantitative accuracy is low: the $771 million adjustment, $5.1B to $2.2B deferred revenue drop, and $1.4B current portion are all incorrect or unverified numbers. Only the $3.5B reversal matches the ground truth. (3) The multi-hop reasoning is partially sound—Pfizer’s contractual obligations did evolve between years, and the LLM attempts to interpret future revenue expectations—but the conclusion that Pfizer anticipates 'only modest, back-end revenue' contradicts the original answer’s interpretation of stabilization and improved outlook. The original emphasizes a shift from uncertainty to defined obligations indicating improved forecasting; the LLM instead infers declining future sales, which is not aligned. (4) Contextual relevance is high because the response addresses both parts of the question—evolution of obligations and implications for future revenue—and discusses relevant financial metrics and timeframes. However, due to major factual and numerical errors, the correctness score is low despite relevant structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 494,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google’s exposure to new regulatory costs in international markets shifted from a general focus on supply‑chain and operational risks to a more explicit articulation of direct regulatory and compliance expenses. In the 2022 filing (pages 12‑16), the company highlighted supply‑chain disruptions, component shortages, and the need to comply with foreign labor, environmental and export‑control rules as indirect cost drivers, but it did not isolate “regulatory costs” as a distinct line‑item. By the 2024 filing (pages 14‑18), Google explicitly lists sanctions, export controls, foreign‑ownership restrictions, data‑localization mandates, and new privacy‑related regulations as separate risk factors that could impose “new regulatory costs” in each jurisdiction, and it notes that these costs are “evolving” and may materially affect earnings. Thus, the scope broadened from indirect supply‑chain‑related compliance to direct, jurisdiction‑specific regulatory liabilities, and the nature of the challenges moved from generic operational risk to concrete legal and fiscal obligations tied to international law and policy changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being well-structured and contextually plausible. (1) The ORIGINAL ANSWER states that in 2022, Google specifically mentioned 'data transfers between the EU and the UK' and 'new customer requirements' as regulatory challenges, and by 2024, the risks expanded to include 'uncertainty regarding regulatory outcomes' and 'liabilities under local laws that may not offer due process.' In contrast, the LLM answer incorrectly claims that in 2022, Google focused on 'supply-chain disruptions, component shortages, foreign labor, environmental and export-control rules'—none of which are mentioned in the ground truth as part of the regulatory cost discussion. These details appear to be fabricated or misattributed. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the actual evolution of regulatory risks (from data transfer issues to broader legal uncertainties) and instead invents a narrative around supply-chain and operational risks that is not supported by the ground truth. The shift described in the LLM answer—from indirect to direct costs—is not aligned with the actual shift from data-specific to legally uncertain and procedurally risky environments. (4) Contextual relevance is moderate because the answer addresses regulatory costs and international markets, and it attempts a year-over-year comparison, but the substance is factually incorrect. Thus, the correctness score is low due to major factual inaccuracies and failure to reflect the true nature of Google's disclosed regulatory risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 471,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Based on the provided 10-K filings, UPS's approach to funding postretirement medical benefits has remained consistent in its primary funding source: **expected benefit payments for postretirement medical benefits are paid from plan trusts and corporate assets** (as stated in both 2022 and 2023 filings, specifically on page 109 and reiterated in 2023 on page 94). There is no indication of a structural change in funding sources between 2022 and 2023—contributions continue to be made to plan trusts, with corporate assets supplementing payments for medical benefits, maintaining the same funding methodology as the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments funded from both plan trusts and corporate assets—this matches the original answer exactly in substance. (2) There are no numerical figures requiring calculation in this question, but the answer correctly references the consistent funding sources without introducing any incorrect data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both the 2022 and 2023 10-K filings, compares the language across years, and concludes there was no change in funding methodology—this demonstrates accurate cross-document analysis. (4) The answer is semantically equivalent to the ground truth, using slightly expanded wording but preserving factual precision. All entities (UPS, postretirement medical benefits, plan trusts, corporate assets, 2022–2023 timeframe) are correctly identified and contextualized. No errors in reasoning, completeness, or factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 319,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "From its launch in 2022, NVIDIA AI Enterprise began as a paid, enterprise‑grade AI software suite bundled with NVIDIA’s data‑center platform, offering AI‑accelerated libraries, NIM inference microservices, and tools such as NeMo for model fine‑tuning. By 2024 the offering had expanded into a broader, full‑stack AI infrastructure that now includes GPUs, CPUs, DPUs, and networking, and is tightly integrated with the Blackwell architecture, DGX Cloud, and Omniverse, enabling end‑to‑end AI workloads—from training to production—across data‑center, cloud, and edge environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of NVIDIA AI Enterprise from a software suite to a broader AI infrastructure, which aligns with the ground truth. However, there are significant factual inaccuracies in entity identification and reasoning. While the original answer states that in 2022 it was a software suite for AI deployment and by 2024 evolved to include NIM, NeMo, and AI Blueprints with a 2.5x performance gain, the LLM incorrectly claims that NIM and NeMo were part of the initial 2022 launch, when they were actually enhancements added by 2024. Additionally, the LLM introduces elements not present in the ground truth—such as CPUs, DPUs, Blackwell architecture, DGX Cloud, and Omniverse integration—without evidence from the provided knowledge base. These additions reflect plausible real-world context but are not supported by the original answer and represent a misrepresentation of the documented evolution. There are no numerical errors (quantitative accuracy is high), but the qualitative inaccuracies in multi-hop synthesis and timeline fidelity reduce correctness. The answer is contextually relevant and addresses the scope and evolution question, but with incorrect technical and temporal attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 344,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil’s proved reserves through equity companies declined from 208 productive development wells (2022) to 20 at year-end 2024, with total equity‑company reserves falling from 208 wells to 20 net productive development wells and from 208 total wells (including dry) to 0 dry wells—indicating a strategic shift away from equity‑partnered development, especially in regions like the United States and Asia where reserves were previously sizable. This reduction, coupled with the heavy focus on consolidated subsidiary reserves (which grew from 686 total productive development wells in 2022 to 487 in 2024) and a substantial increase in undeveloped reserves (7.4 GOEB in 2024 versus 6.3 GOEB in 2023), shows that ExxonMobil is concentrating its capital and technical resources on its own operated assets, especially in high‑potential regions such as the U.S. Permian, Guyana, and the Asia‑Pacific, while scaling back involvement in equity‑joint ventures. Consequently, the company’s strategic positioning is increasingly centered on controlling and developing its proprietary reserve base in key basins and international projects, rather than relying on equity partnerships to add reserves.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth in both quantitative and qualitative aspects. (1) Quantitatively, the LLM incorrectly states that proved reserves are measured in 'wells' (e.g., 208 productive development wells), whereas the ground truth reports reserves in standard volumetric units: million barrels of oil, natural gas liquids, and billion cubic feet of natural gas. The numbers cited (208 wells, 20 wells, 686 wells, etc.) are not equivalent to proved reserves and are factually irrelevant to the question. The actual 2022 reserves were 14 million barrels gross (1 million net), and by 2024, reserves grew to 467 million barrels crude oil, 120 million barrels NGLs, and 5,367 Bcf gas—none of which are mentioned. (2) The LLM incorrectly claims reserves 'declined' due to fewer wells, while the ground truth shows a massive increase in reserves, especially in Asia. (3) The reasoning is flawed: the LLM interprets a reduction in equity-company wells as a strategic retreat from partnerships, but the ground truth indicates a significant *increase* in equity-company reserves, particularly in Asia, signaling a strategic *expansion* via equity companies. (4) The entities and metrics are misidentified: 'productive development wells' are not 'proved reserves,' and the regions cited (e.g., U.S. Permian, Guyana) are not supported by the ground truth, which emphasizes Asia as the growth region for equity reserves. (5) The answer fails the multi-hop requirement: it does not synthesize correct data across years or regions. The only partial relevance is the mention of Asia, but even that is framed incorrectly. Overall, the answer fabricates data and draws opposite conclusions from the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 471,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "Between 2022 and 2024, Google Network Partners transitioned from a gross revenue reporting model to a net basis for certain arrangements, though the provided 2024 documents confirm they remain primarily reported on a gross basis (i.e., revenues are recorded in full and payments to partners are classified as cost of revenues). The financial relationship evolved with increased reliance on Network Partners for ad inventory monetization, particularly through AdMob, AdSense, and Ad Manager, contributing to higher revenue streams. However, the cost structure shifted significantly, as payments to these partners (TAC) are now explicitly recorded as a direct cost of revenues, reducing net margins despite revenue growth. This is reflected in the 2024 financials where Google Services operating income rose due to revenue growth offsetting increases in TAC and content acquisition costs. The 2024 data shows no material change in the core gross reporting model, but the emphasis on Network Partners' role in driving revenue growth is now explicitly tied to their inclusion in cost of revenues, not as a revenue offset.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies and misrepresents the evolution described in the ground truth. While it correctly identifies that Google reports revenue on a gross basis and that payments to Network Partners are recorded as cost of revenues (specifically TAC), it incorrectly suggests a transition 'to a net basis for certain arrangements'—a claim not supported in the original answer or implied by the 2024 shift. The ground truth does not indicate any change in revenue recognition model (i.e., no move to net reporting), only a shift in narrative emphasis toward the cash flow impact and cost structure. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is neutral; however, the LLM invents a nuance about 'increased reliance' and 'higher revenue streams' tied to AdMob/AdSense without supporting data, which cannot be verified but goes beyond the source. (3) The multi-hop reasoning is partially sound—linking Network Partners to TAC and cost of revenues is accurate, and recognizing their role in revenue generation aligns with the original. However, the conclusion that there was a shift toward net reporting or that the 'core gross reporting model' nearly changed is incorrect, showing flawed synthesis. (4) Contextual relevance is high because the LLM addresses both revenue generation and cost structure across 2022–2024 and focuses on the right entities (Google Network Partners, TAC, cost of revenues). But due to the key misrepresentation of accounting policy change—which is central to the question—the correctness and qualitative accuracy scores are significantly reduced. The original answer emphasizes a reframing in financial narrative (from gross revenue focus to cost/cash flow emphasis), not an actual accounting change, which the LLM fails to capture accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 521,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS’s foreign‑currency‑exchange‑risk management strategy remained focused on using over‑the‑counter forward contracts to hedge anticipated cash‑flow exposures, but the company’s earnings‑volatility profile shifted in 2023. In 2022, gains and losses on undesignated forward contracts were recorded directly in income, creating relatively large swings in earnings; by 2023, the amount of such gains/losses had been reduced to just $‑7 million (a small net loss) and was largely offset by the $213 million gain on designated fair‑value hedges, resulting in a much smoother earnings impact. Consequently, the volatility of earnings attributable to undesignated foreign‑currency forwards declined markedly between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative claims not present in the original answer or implied by the question. (1) The original answer does not mention any specific dollar amounts such as a $-7 million loss on undesignated forwards or a $213 million gain on designated hedges; these figures are entirely fabricated. There is no indication in the ground truth that UPS reduced the earnings impact to such an extent or that designated hedges offset undesignated ones. (2) The original answer focuses on the evolution of disclosure practices—specifically, improved transparency, side-by-side reporting, and a more structured presentation of fair value changes—not on actual reductions in volatility due to smaller gains/losses or offsetting hedge gains. (3) The LLM incorrectly shifts focus to quantitative financial outcomes (e.g., net losses, offsetting gains) rather than the qualitative evolution in risk management disclosures. (4) While the LLM correctly identifies that undesignated forward contracts affect earnings directly and that this contributes to volatility, it fails to capture the core of the evolution: enhanced disclosure structure and transparency in 2023 compared to 2022. The reasoning is therefore flawed, as it invents a narrative around earnings smoothing that is not supported by the ground truth. (5) Contextual relevance is moderate because the answer addresses foreign currency risk and earnings volatility, but it misrepresents the nature of the change (actual financial impact vs. disclosure transparency).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 433,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco’s membership format remained a core profitability driver, but its impact shifted subtly. While membership fee revenue grew 5% to $4,828 million in 2024 (up from $4,224 million in 2022), the company emphasized that growth in member sign‑ups and Executive upgrades—and sustained high renewal rates—directly boosted fee income and reinforced loyalty. However, the MD&A notes that the membership model’s contribution to profitability is now more intertwined with overall sales growth and cost‑control, as lower renewal rates in newer markets or openings in existing markets could dampen paid‑membership growth. Thus, the membership format continues to underpin fee revenue and loyalty, but its relative influence on profitability is increasingly mediated by broader sales dynamics and cost pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims membership fee revenue grew to $4,828 million in 2024, which is not only incorrect but references a year (2024) outside the scope of the question (2022–2023). The stated 2022 fee revenue of $4,224 million is also incorrect—this figure does not align with the ground truth or typical reported values (actual 2022 membership fees were approximately $4.16 billion, though exact figures may vary slightly by source). The 5% growth claim cannot be verified due to incorrect base and target years. (2) The original answer does not provide specific revenue numbers, so the LLM appears to have hallucinated these figures rather than drawing from the knowledge graph. This severely undermines quantitative accuracy. (3) Qualitatively, the LLM captures the general idea that the membership model remains central to profitability and that renewal rates in newer markets are a growing concern. It correctly identifies Executive member upgrades and renewal rates as key factors. However, it misrepresents the evolution of language in the filings—specifically, the shift from 'significant effect on profitability' to 'integral part of... profitability'—which reflects a rhetorical consolidation not captured in the LLM response. Additionally, the LLM introduces 'cost-control' and 'sales dynamics' as mediating factors not emphasized in the original answer, shifting focus away from the core evolution in how renewal risks in new markets are framed. (4) Contextually, the answer addresses the question’s focus on loyalty, fee revenue, and strategic evolution, but the inclusion of fabricated numbers and incorrect years undermines reliability. While some reasoning about emerging challenges is aligned, the synthesis is partially flawed due to incorrect data and temporal misalignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 507,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "Between 2022 and 2024, NVIDIA deepened CUDA’s integration into its broader data center platform by expanding the software stack around it—launching AI Enterprise with tools like NIM and NeMo for generative AI, embedding CUDA‑X libraries and APIs across DGX Cloud, and extending the architecture with new hardware generations (Blackwell GPUs, Grace CPUs, DPUs) that are tightly coupled to the same CUDA ecosystem. This end‑to‑end approach ties CUDA to networking (Mellanox), storage, and automotive solutions, making it the central software layer that unifies training, inference, simulation, and over‑the‑air updates across data‑center, automotive, and professional visualization workloads.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of CUDA between 2022 and 2024, particularly regarding its deepened integration into NVIDIA's full-stack data center platform. It correctly identifies CUDA's expanded role beyond a developer tool to a central software layer in an end-to-end computing ecosystem. The mention of CUDA-X libraries, APIs, and integration with DGX Cloud aligns with the original answer’s emphasis on CUDA as the foundation of acceleration libraries and domain-specific frameworks. The reference to tight coupling with GPUs, CPUs (Grace), and DPUs reflects the correct multi-hop synthesis of hardware-software integration. However, the LLM adds specific product names and initiatives not present in the ground truth—such as NIM, NeMo, AI Enterprise, Mellanox, and over-the-air updates in automotive—without explicit support from the provided knowledge graph. While these may be factually accurate in a broader context, they go beyond the evidence in the original answer and introduce details not confirmed by the source. Additionally, the original answer emphasizes the shift in strategic positioning (from developer-focused to infrastructure layer), which the LLM captures implicitly but does not explicitly articulate. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of incorrect numbers (score 10). Contextual relevance is perfect—the answer directly addresses the evolution of CUDA in the data center and software ecosystem. Qualitative accuracy is slightly reduced due to unsupported specifics, but core reasoning and entity identification (CUDA, DGX, Grace, DPUs) are correct. Overall, the answer conveys the essential evolution accurately but with some over-enrichment beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 491,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid shifted from pandemic-driven government contracts to commercial market sales between 2023 and 2024. While 2023 saw $1.279 billion in Paxlovid revenue (primarily from government purchases under EUA), 2024 revenue dropped to $5.716 billion (including $442 million from a U.S. strategic national stockpile supply), with remaining performance obligations totaling approximately $1 billion in contracted revenue expected through 2028 as the company transitions to commercial pricing and delivery timelines.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses from U.S. government inventory. However, the LLM claims $1.279 billion in Paxlovid revenue for 2023 and $5.716 billion for 2024, which contradicts the reversal narrative and misrepresents the financial trend. The $5.716 billion figure is especially incorrect as it implies growth, while the truth is revenue declined due to reversals and uncertainty. (2) The only correct quantitative element is the remaining performance obligations of approximately $1 billion expected through 2028, which matches the ground truth. However, the LLM incorrectly attributes $442 million from the U.S. strategic national stockpile without mention in the original answer. (3) The multi-hop reasoning is flawed: the model fails to connect the 2023 revenue reversal to reduced government demand and instead fabricates revenue figures that contradict the shift from uncertain returns to firm contracts. It also invents a transition to commercial pricing not mentioned in the original answer. (4) While the answer addresses the general theme of evolving financial commitments and delivery timelines, it does so with incorrect data and misleading trends, severely undermining factual correctness. The contextual relevance is moderate because it attempts to discuss the right topic—Paxlovid's financial evolution—but with inaccurate specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 425,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil’s strategic emphasis on Guyana has intensified markedly between 2022 and 2024, as reflected in its disclosures of reserves development and advantaged asset reporting. In the 2022 filing, Guyana’s offshore resources were highlighted as a key growth area, with the company noting significant additions to proved reserves and ongoing development of the Stabroek block, though still framed within broader global reserve trends. By 2024, Guyana emerged as a central pillar of ExxonMobil’s “advantaged assets” strategy, explicitly cited alongside the Permian Basin and LNG as a driver of earnings through “Advantaged Volume Growth.” The 2024 10-K underscores that Guyana’s deepwater projects—particularly the Liza Phase 2 and subsequent developments—are now material contributors to production growth, with reserves development accelerating through major funding commitments and infrastructure investments. This shift is further evidenced by the company’s increased capital allocation to Guyana-related projects, which now feature prominently in its structural cost savings narrative and ROCE analysis, signaling a strategic pivot to prioritize high-value, low-development-cost resources in Guyana as a cornerstone of its future production and earnings growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2022 to 2024: in 2022, Guyana was a key contributor to reserves growth (1.3 billion oil-equivalent barrels of proved undeveloped reserves), and by 2024, it was elevated to a core 'Advantaged Asset' driving earnings through volume growth. While the LLM does not explicitly state the 1.3 GOEB number, it accurately describes the significance of reserves additions and development activity. (2) No incorrect numbers are presented; the absence of the exact 1.3 billion figure is a minor omission but does not distort the factual narrative, especially since the LLM emphasizes 'significant additions' and 'accelerating reserves development,' which is semantically consistent. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 vs 2024), identifies the shift from reserves growth to advantaged production, and correctly links Guyana to strategic themes like ROCE, cost savings, and capital allocation—demonstrating strong qualitative understanding. (4) The answer is contextually rich and directly addresses the question about strategic evolution via disclosures on reserves and advantaged assets. The mention of Liza Phase 2, Stabroek block, and comparison to Permian and LNG assets adds appropriate detail without introducing inaccuracies. The minor deduction in quantitative accuracy is due to the omission of the precise 1.3 billion BOE figure, but since no incorrect number is given and the qualitative trajectory is correct, the overall correctness remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 452,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "From 2022 to 2024 the company’s planned deliveries of the ATR 72‑600F fell from 11 aircraft in 2023 to 6 in 2024, and the 2024 10‑K shows only 7 ATR 72‑600Fs scheduled for delivery in 2025. This reduction reflects a shift toward larger, more fuel‑efficient jets (B767F/B777F) and indicates that the ATR 72‑600F is being phased out of FedEx’s fleet strategy in favor of newer freighter models.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but significant factual inaccuracies. It incorrectly states that planned deliveries fell from 11 in 2023 to 6 in 2024, while the ground truth indicates no such drop to 6 in 2024 and instead focuses on projections for 2025 and 2026. The LLM claims 7 ATR 72-600Fs are scheduled for delivery in 2025 according to the 2024 10-K, which aligns with the ground truth, but misrepresents the trend by omitting the key comparison between the 2022 and 2024 projections. Most critically, the LLM fails to note the strategic shift from a steep decline (to 1 by 2026) to a more sustained presence (7 in 2025, 3 in 2026), instead portraying a continuous phase-out without acknowledging the revised stabilization. (2) Quantitative inaccuracies include the unsupported claim of 6 aircraft in 2024 and the omission of the 2026 figure (3 units) in the 2024 plan. The 11-unit figure for 2023 is correct, and the 7 for 2025 is accurate, but the narrative around these numbers is misleading. (3) The multi-hop reasoning is flawed: the model identifies a reduction but fails to synthesize the evolution in company strategy between 2022 and 2024 filings. It misses the nuance that the phase-out was slowed, not accelerated, indicating a more sustained role than initially planned. (4) Contextual relevance is strong—the answer addresses fleet strategy and aircraft utilization—but factual and reasoning errors reduce correctness. The conclusion about shifting to larger jets may be contextually plausible but is not supported by the provided ground truth, which focuses on the ATR's revised role, not a strategic pivot to B767F/B777F. Thus, while the answer is relevant and partially accurate, it lacks key details and misrepresents the trend, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 490,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to Omniverse evolved from a real-time 3D design collaboration and simulation platform for industrial digitalization into a core component of its broader AI and simulation ecosystem. By 2024, Omniverse was deeply integrated with AI technologies—such as generative AI for digital avatars and synthetic data generation—and tightly coupled with NVIDIA’s AI infrastructure (e.g., Blackwell GPUs, AI Enterprise software, and Omniverse Cloud) to enable scalable, AI-powered virtual worlds and digital twin applications across industries. This integration allowed seamless interoperability with leading design tools and supported enterprise-scale simulation workflows, reinforcing its role as a foundational platform for AI-driven 3D computing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse from 2022 to 2024. It correctly identifies the shift from a 3D collaboration platform to a more integrated, AI-driven simulation and digital twin ecosystem. While the original answer emphasizes the subscription model (enterprise/free individual) in 2022 and the shift toward digital twins of factories and autonomous systems by 2024, the LLM answer captures this evolution semantically by describing Omniverse as becoming a 'core component of its broader AI and simulation ecosystem' and enabling 'AI-powered virtual worlds and digital twin applications.' The mention of generative AI for digital avatars and synthetic data, integration with Blackwell GPUs, AI Enterprise software, and Omniverse Cloud aligns with NVIDIA's 2024 direction, even if not explicitly detailed in the ground truth. These additions are contextually plausible and consistent with known developments, though slightly more expansive than the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (NVIDIA, Omniverse, AI integration, enterprise use) are correct. The reasoning is sound and reflects multi-hop synthesis across time and technological integration. The only minor gap is the omission of specific 2022 use cases like virtual car showrooms and surgical training, but the broader trajectory and strategic shift are accurately conveyed. Thus, the answer is factually correct and contextually relevant, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 440,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's contribution to non-advertising revenue grew as part of Alphabet's broader shift toward higher-margin diversification beyond advertising. While non-advertising revenues (including Google Play, Cloud, and hardware) increased 9% year-over-year to $307.4 billion in 2023, their margins remained lower than advertising revenues due to pricing pressures and higher costs—particularly for devices and content acquisition. This trend reflects Google Play's evolving role in monetizing non-advertising streams, though its growth was modest compared to faster-expanding segments like Google Cloud (26% growth). The company explicitly highlighted that \"revenues from non-advertising sources\" are increasing and \"may adversely affect margins,\" underscoring Google Play's expanding but margin-constrained contribution to overall revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Google Play evolved from a diversification strategy in 2022 to a more defined 'platforms' revenue stream in 2023, emphasizing structural categorization and monetization. However, the LLM introduces unsupported quantitative claims: it states non-advertising revenues grew 9% year-over-year to $307.4 billion in 2023, which is not in the original answer and is factually incorrect—Alphabet's total revenue in 2023 was approximately $307 billion, not non-advertising alone. This misrepresents the scale and growth of non-advertising revenue. Additionally, the claim that Google Cloud grew 26% is unsupported by the provided context. (2) The original answer contains no numerical data, so the LLM's inclusion of specific figures like $307.4 billion and 9% YoY growth is hallucinated. These numbers do not align with the ground truth and fail basic quantitative accuracy. (3) The reasoning is partially sound in identifying Google Play as part of non-advertising revenue and recognizing a strategic shift, but it fails the multi-hop synthesis requirement because it invents data rather than drawing from or accurately reflecting the evolution described. The original focuses on categorization and strategic role; the LLM shifts focus to margin pressures and comparative growth without evidence. (4) The contextual relevance is moderate—Google Play and non-advertising revenue are correctly identified as relevant topics—but correctness and qualitative accuracy are low due to fabrication of metrics and misrepresentation of strategic evolution. The core insight about Google Play's evolving role is touched upon but buried under incorrect data and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 477,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG’s reserving methodology for workers’ compensation remained consistent in its use of expected loss ratio methods for excess‑of‑deductible (large‑deductible) business, but the company continued to give significant weight to those methods only in the most recent five accident years.  The proportion of large‑deductible business has grown, slowing claim reporting and prompting AIG to segment the portfolio by deductible size and handling arrangement.  In 2023, AIG recognized only modest unfavorable prior‑year development ($51 million) in Excess Casualty, reflecting the impact of higher attachment points and the slower emergence of claims, while still applying expected loss ratios to recent accident years to project ultimate losses.  This evolution underscores a continued reliance on expected loss ratios for newer business, even as the mix toward higher‑deductible, longer‑tail exposures has increased.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly notes that AIG used expected loss ratio methods for excess-of-deductible business over the most recent five accident years in 2022, it fails to mention that for guaranteed cost business, these methods were only significantly weighted in the most recent accident year — a key contrast explicitly stated in the original answer. This omission undermines completeness and qualitative accuracy. Additionally, the LLM claims AIG recognized $51 million in unfavorable prior-year development in Excess Casualty in 2023, but this figure is not mentioned in the ground truth and pertains to a different line of business (Excess Casualty vs. workers’ compensation), making it factually incorrect and introducing a significant quantitative error. (2) The $51 million figure is unsupported by the original answer and misattributes data to a different segment, failing the quantitative accuracy check. No other numbers are provided in the LLM response, so this stands as a major factual deviation. (3) The reasoning partially captures the trend of increasing large-deductible business slowing claim reporting, which is consistent with the ground truth. It also correctly identifies the continued use of expected loss ratio methods for recent accident years. However, it misses the 2023 clarification about incurred and paid losses being reported net of reinsurance and undiscounted — an important nuance about reporting transparency. The multi-hop synthesis is partially sound but incomplete, especially in distinguishing between business lines and accurately reflecting methodology changes (or lack thereof). (4) Despite the factual error and omission, the LLM stays focused on the evolution of reserving methods in workers’ compensation and addresses the role of deductible structure and claim reporting patterns, maintaining high contextual relevance. The core idea of continued reliance on expected loss ratios amid changing business mix is semantically aligned, but the introduction of incorrect data lowers overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 578,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation has evolved significantly between fiscal 2022 and fiscal 2024, particularly regarding the Collaboration category. In fiscal 2022, Collaboration revenue declined 5% year-over-year due to decreases in Meetings, Collaboration Devices, Calling, and Contact Center offerings, partially offset by growth in CPaaS. By fiscal 2024, Collaboration revenue increased 2% year-over-year, driven by growth across the portfolio except for Meetings offerings, indicating a stabilization and modest recovery in this category after the prior downturn.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution of Cisco's product category segmentation between fiscal 2022 and 2024, specifically regarding the Collaboration category's structural placement. The ground truth describes a reorganization of product categories: from six categories in 2022 (including Collaboration) to four in 2024 (Networking, Security, Collaboration, and Observability), indicating a consolidation. However, the LLM answer completely ignores this structural evolution and instead discusses year-over-year revenue changes in the Collaboration category—information not requested and not part of the original answer. (2) The quantitative figures cited (5% decline in 2022, 2% growth in 2024) are not present in the ground truth and cannot be verified against it; thus, they are factually unsupported in this context. (3) The multi-hop reasoning is flawed: the model fails to compare category structures across years and instead substitutes financial performance data, indicating a misunderstanding of the question. (4) While the mention of 'Collaboration' as a category is factually consistent, the overall response is misaligned with the question’s focus on segmentation changes. The answer is therefore mostly irrelevant, with low correctness, poor qualitative reasoning, and weak contextual relevance despite minor entity accuracy (Cisco, Collaboration, fiscal years).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 401,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure of the 3.125% 2025 Notes shifted from a fixed 3.125% coupon rate in 2022 to a floating rate tied to SOFR plus 2.1% in 2023, reflecting a broader trend of converting fixed-rate debt to floating-rate structures via interest rate swaps. This change aligns with the company's strategy to manage interest rate risk, as evidenced by the 2023 interest rate swap disclosures showing the 3.125% 2025 Notes now carry an effective rate of SOFR + 2.1% (compared to the prior fixed 3.125% rate), while the 2022 filing still referenced the fixed coupon. The 2023 filing also details the swap's notional amount ($1.0 billion) and effective rate mechanism, marking a clear evolution in financial presentation from static coupon disclosure to dynamic hedging framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 3.125% 2025 Notes were reported with a carrying value of $1,000 million in 2022 and retained the 3.125% coupon in both years. However, the LLM incorrectly claims that the note shifted from a fixed rate to a floating rate (SOFR + 2.1%) in 2023 due to interest rate swaps. This misrepresents the nature of the disclosure evolution: the 3.125% coupon did not change; rather, Amgen began disclosing an interest rate framework (SOFR + 2.1%) in 2023 for the same fixed-rate note, likely reflecting hedging activity, but the note itself remained fixed-rate. The LLM incorrectly implies the note's interest rate structure changed, which is not supported by the ground truth. (2) Quantitatively, the $1.0 billion notional amount aligns with the $1,000 million carrying value, so that number is acceptable. However, the claim that the 'effective rate' became SOFR + 2.1% due to swaps is speculative and not in the original answer. The ground truth does not mention swaps or effective rates—only a new disclosure of the interest rate mechanism in a table. (3) The multi-hop reasoning is flawed: the LLM conflates the disclosure of a hedging framework or benchmark with an actual change in the note's terms. The original answer emphasizes improved transparency in presentation, not a structural change in the debt. The LLM invents a narrative about 'converting fixed-rate debt to floating-rate structures' unsupported by the ground truth. (4) Scores reflect major factual errors in both quantitative and qualitative dimensions. While the answer addresses the question's context and attempts synthesis, the core claim is incorrect, warranting a low correctness score. Contextual relevance is moderate because it discusses the right entities and timeframes, but with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 509,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East region grew markedly—from about 33 billion cubic feet at the end of 2022 to roughly 62 billion cubic feet by the end of 2024 (as shown in the reserve tables for 2021‑2024). This increase reflects upward revisions, purchases (notably the Marathon Oil acquisition) and extensions/discoveries in the region, indicating that the company is actively expanding and strengthening its natural‑gas position in Asia Pacific/Middle East as a strategic growth area.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 billion cubic feet in 2022 to 296 billion cubic feet in 2024. In contrast, the LLM claims reserves grew from 33 billion to 62 billion cubic feet, which is not only a different trend (increase vs. actual decrease) but also misstates the base figures by an order of magnitude (33B vs. 326B). (2) Quantitative accuracy is severely lacking: the numbers cited (33B and 62B) are less than 10% of the correct values (326B and 296B), and the implied growth of ~88% contradicts the actual decline of ~9.2%. There is no indication of a Marathon Oil acquisition impacting this region in the ground truth. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers expansion and strategic strengthening, while the actual data indicates a reduction, suggesting divestment or strategic retreat. The model fails to synthesize the correct data across years and misidentifies corporate actions. (4) Scores are low because the core facts—reserves, trends, and strategic implications—are all incorrect. Contextual relevance is slightly higher only because the answer addresses the right region and metric (natural gas reserves), albeit with completely inaccurate data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 382,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Between 2022 and 2023, Alphabet’s repurchase activity for Class C Capital Stock increased substantially, with $52.9 billion of Class C shares repurchased in 2023 versus $59.3 billion total (including both Class A and C) repurchased in 2022; the company retired 450 million Class C shares for $52.9 billion in 2023, up from 469 million shares ($52.6 billion) in 2022. This heightened buyback reflects a more aggressive capital‑allocation strategy, signaling that Alphabet is deploying a larger portion of its cash to return capital to shareholders and to manage its equity structure amid market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that $52.9 billion of Class C shares were repurchased in 2023, but the ground truth reports $62.2 billion in total repurchases for Class A and C combined in 2023. Additionally, it incorrectly breaks down 2022 repurchases as $59.3 billion total (correct) but implies that this includes both classes, while claiming $52.6 billion was spent on Class C alone in 2022 — a figure not supported by the ground truth. The retirement of 450 million and 469 million shares is not present in the original answer and appears fabricated. (2) The calculation of year-over-year change is flawed due to incorrect base figures. The actual increase is from $59.3B to $62.2B (~5% increase), but the LLM suggests a decrease in total repurchase amount from 2022 to 2023 if interpreting $59.3B vs $52.9B, which misrepresents the trend. The additional $70.0B authorization and $36.3B remaining as of year-end 2023 — key indicators of capital allocation strategy — are entirely omitted. (3) While the LLM attempts multi-hop reasoning by linking repurchase activity to capital allocation strategy, it does so based on incorrect data. The conclusion about 'more aggressive' strategy is directionally plausible but undermined by factual errors. It fails to incorporate the expanded buyback authorization, a critical element in assessing strategic intent. (4) Despite these issues, the answer is contextually relevant, addressing both parts of the question — change in repurchase activity and implications for capital allocation. The reasoning structure is sound, even if based on inaccurate inputs. Semantic equivalence fails on numbers and key facts, but the general theme of increased shareholder returns is consistent. Minor formatting variations in dollar amounts are acceptable, but magnitude and attribution errors are not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 511,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG applied frequency/severity methods primarily to its long‑tail lines—U.S. Workers’ Compensation, U.S. Excess Casualty, U.S. Other Casualty, U.S. Financial Lines, U.S. Property & Special Risks, and U.S. Personal Insurance—while using expected‑loss‑ratio approaches for shorter‑tail or high‑severity lines such as aviation. In 2022 the company continued to segment these businesses (e.g., separating guaranteed‑cost and excess‑of‑deductible workers‑compensation, grouping by state/industry, and distinguishing AIG‑handled versus third‑party administered claims) and to adjust the proportion of large‑deductible exposure, which slowed claim reporting patterns. By 2023 the same frequency/severity framework was retained, but the methodology was refined to incorporate updated actuarial assumptions, the impact of the adverse‑development reinsurance agreement, and the increased use of ground‑up claim projections and Cape Cod weighting, especially for program‑business and excess‑casualty layers where loss development lags. Thus, the core frequency/severity approach persisted, but its application became more tailored to each line’s development characteristics and risk‑sharing structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in describing AIG's use of frequency/severity methods between 2022 and 2023, despite using plausible actuarial terminology and appearing contextually detailed. (1) The ORIGINAL ANSWER states that in 2022, AIG used frequency/severity methods primarily for short-tail classes like U.S. Property and explicitly avoided them for aviation. However, the LLM claims these methods were applied to long-tail lines like U.S. Workers’ Compensation in 2022, which contradicts the ground truth. According to the truth, the expansion into U.S. Workers’ Compensation (a long-tail line) occurred in 2023, not before. The LLM incorrectly implies continuity of the method in long-tail lines from 2022 into 2023, whereas the actual evolution was a shift from short-tail to include long-tail lines. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the use of correct years (2022 vs 2023) is critical. The LLM misattributes the timing of methodological changes, placing 2023 developments in 2022. This is a major factual error in temporal reasoning. (3) The multi-hop reasoning is flawed: the question asks how the use evolved between 2022 and 2023. The correct answer requires contrasting the two years—showing a shift from short-tail to long-tail applications. The LLM fails this synthesis, instead asserting that the same framework was 'retained' from 2022 to 2023, which directly contradicts the ground truth of a strategic expansion. (4) While the LLM answer is contextually relevant and uses accurate-sounding actuarial concepts (e.g., loss development, Cape Cod weighting, risk-sharing), it fabricates the evolution by reversing the timeline and misrepresenting the scope of application. The core claim—that frequency/severity methods were already used in Workers’ Compensation in 2022—is false. Therefore, despite good structure and terminology, the answer is factually incorrect on key points, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 554,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023 Amgen’s financial relationship with BeiGene shifted from a cost‑recovery model to a more balanced profit‑and‑loss sharing arrangement.  During 2023 the company recorded $109 million of net cost recoveries from BeiGene (down from $199 million in 2022 and $220 million in 2021), while product sales to BeiGene rose to $125 million (up from $64 million in 2022 and $72 million in 2021).  Profit‑and‑loss share expenses also declined to $40 million in 2023 (from $53 million in 2022 and $64 million in 2021), reflecting the transition to the post‑January‑1‑2022 arrangement in which Amgen no longer shares commercialization costs or pays milestones with BeiGene and instead receives only royalties on Chinese sales.  Overall, the partnership’s cash flows are now driven primarily by product sales and royalties rather than the earlier cost‑recovery and shared‑expense structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: $199M to $109M in cost recovery (2022 to 2023), $64M to $125M in product sales, and $53M to $40M in profit and loss sharing expenses. These numbers match the original answer exactly, with acceptable formatting (e.g., $109 million). (2) Quantitative accuracy is perfect—no calculation or number errors. The LLM even adds context from 2021, which is not required but factually consistent and does not contradict the ground truth. (3) The reasoning is strong: it correctly infers a shift in the financial model from cost recovery to product sales and royalties, aligning with the ground truth’s interpretation of maturation. It accurately references the post-January-1-2022 arrangement, explaining the decline in shared expenses. This shows sound multi-hop reasoning across time and financial categories. (4) The only minor issue is that the original answer does not mention the 2021 figures or the specific detail about Amgen no longer paying milestones—while plausible and consistent, these are not in the ground truth and slightly extend beyond the provided data. However, they do not introduce inaccuracies. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to minor extrapolation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 388,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region increased from 434 billion cubic feet (BCF) at the end of 2022 to 457 BCF at the end of 2024. This growth reflects upward revisions driven by additional development drilling and technical updates, partially offset by downward revisions from price and infrastructure factors. The region also saw purchases from acquisitions (e.g., Marathon Oil) and extensions/discoveries in the Middle East, contributing to the net increase in proved reserves.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 BCF in 2022 to 296 BCF in 2024. However, the LLM claims an increase from 434 BCF to 457 BCF, which is entirely inconsistent with the ground truth. These numbers do not match in magnitude or trend. (2) Quantitative accuracy is severely lacking: the LLM reports reserves of 434 BCF in 2022 and 457 BCF in 2024—neither of which appear in the original data. The original reports 326 BCF in 2022 and 296 BCF in 2024, a decrease of 30 BCF. The LLM instead reports a 23 BCF increase. Additionally, the LLM mentions 'purchases from acquisitions (e.g., Marathon Oil)' and 'extensions/discoveries,' but the original explicitly states there were no purchases in 2024 and only mentions revisions (9 BCF added in 2023) and production (25 BCF subtracted in 2024). (3) The multi-hop reasoning is flawed: the question requires synthesizing changes over time (2022–2024), including specific drivers like revisions, production, and purchases. The LLM fails to report the correct figures for any year, misrepresents the trend (increase vs. actual decrease), and invents factors (acquisitions, drilling) not supported by the original. It does not reflect the reduction in reserve growth strategy noted in the ground truth. (4) Contextual relevance is moderate because the answer addresses the general topic—reserves evolution in the region—and attempts to break down contributing factors like revisions and purchases. However, due to pervasive factual and numerical errors, the qualitative and quantitative accuracy scores are very low. The answer conveys the opposite trend and invents unsupported details, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 493,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft evolved from a commitment to acquire 38 B767F aircraft (as disclosed in the 2022 10-K's aircraft purchase table) to a significantly larger commitment of 38 B767F aircraft for delivery through 2025 (with additional deliveries in 2026), as reflected in the 2024 10-K's updated purchase commitments table showing 14 B767F deliveries in 2025 and 3 in 2026. This expansion indicates a strategic shift toward accelerating fleet modernization with more fuel-efficient aircraft to replace older models, as emphasized in the 2024 10-K's note on aircraft modernization programs that states these purchases are \"necessary to achieve significant long-term operating savings and to replace older aircraft,\" demonstrating a deliberate, capital-intensive plan to upgrade its cargo fleet for operational efficiency.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude. The ground truth states that FedEx planned to *reduce* B767F usage from 14 in 2023–2024 to 10 by 2025 (in 2022 projections), then revised that to only 11 in 2025 and 3 by 2026—indicating a *phasing out* of the aircraft. In contrast, the LLM claims FedEx increased its commitment to acquiring 38 B767Fs with deliveries in 2025 and 2026, which contradicts the ground truth. This misrepresents the entire strategic trajectory. (2) The numbers are factually wrong: the ground truth mentions no '38' aircraft purchase commitment, nor does it state any increase in B767F orders. Instead, the actual data shows a reduction from 14 to 3 aircraft between 2024 and 2026. The LLM incorrectly cites 14 deliveries in 2025 and 3 in 2026 as *new purchases*, when in reality these numbers reflect the *remaining planned usage*, not acquisitions. There is no mention in the ground truth of a purchase table or delivery schedule for 38 units. (3) The multi-hop reasoning is flawed: instead of tracking how projections for B767F *usage* changed over time (from 2022 to 2024), the model incorrectly infers growing investment based on a misread of purchase commitments. It fails to recognize that the evolution reflects a reduction in planned fleet size, not expansion. (4) The contextual relevance is moderate because the answer discusses fleet planning and modernization, which are relevant themes, but the factual foundation is entirely incorrect, leading to an opposite conclusion. The qualitative reasoning appears structured but is based on hallucinated data. Thus, the correctness score is low due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 467,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2023 by incorporating them more prominently for newer accident years, particularly in long-tail lines like U.S. Workers' Compensation and U.S. Excess Casualty, where loss development patterns are inconsistent or slow-emerging. The methods were applied alongside other techniques (e.g., loss development and frequency/severity methods) to estimate ultimate losses, with recent accident years relying more heavily on projected ultimate loss ratios adjusted for rate changes, inflation, and market conditions. This evolution reflects a strategic weighting of the Expected Loss Ratio method in combination with other approaches, especially for complex or data-scarce lines, to improve reserve adequacy amid changing market conditions and emerging risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures the evolution of AIG's use of Expected Loss Ratio Methods from 2022 to 2023, noting increased application in long-tail lines such as U.S. Workers' Compensation, which matches the original answer. It also correctly identifies that the method was used in combination with others (e.g., loss development, frequency/severity), reflecting the multi-method approach. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the shift in methodology application over time and links it to business lines and underlying actuarial rationale (slow-emerging losses, complexity). However, it omits the specific 2022 focus on aviation exposures and the high-severity rationale mentioned in the ground truth, which is a minor but notable gap in completeness. It also adds 'U.S. Excess Casualty' not explicitly mentioned in the original, which may be contextually plausible but not verifiable from the ground truth. (4) Despite these small deviations, the core evolution—broader use in long-tail, complex lines by 2023 with sound reasoning—is correctly conveyed, warranting a high correctness score of 8. Contextual relevance is perfect as it directly addresses the question's focus on evolution, lines of business, and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 418,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco’s Enterprise Data Center Transformation positioning has shifted markedly from 2022 to 2024, moving from a broad, “build‑buy‑partner‑invest‑co‑develop” innovation model that emphasized strategic alliances with companies like Apple, Google and Equinix to a more focused, outcome‑driven narrative centered on its own architectural stack—particularly the convergence of networking, security, collaboration and observability (e.g., ThousandEyes, Splunk, AppDynamics).  In 2022 the company highlighted alliances that accelerated new markets, but by 2024 it stresses that competitors—including hyperscalers (AWS, Microsoft, Google) and specialist rivals (Arista, Palo Alto, Fortinet)—are intensifying price‑focused pressure, especially in Asia, and that strategic partners can also become competitors.  Consequently, Cisco now leverages its financing arrangements, channel‑partner ecosystem and acquisitions to reinforce a differentiated, end‑to‑end data‑center portfolio that directly competes with these hyperscalers while continuing to pursue alliances that expand its observability and security capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is contextually relevant and well-structured, addressing Cisco's evolving positioning in enterprise data center transformation between 2022 and 2024. It correctly identifies key themes such as strategic alliances, competitive pressures, and shifts in partner dynamics. However, there are significant qualitative inaccuracies in entity identification and reasoning that deviate from the ground truth. While the original answer emphasizes that in 2022 Cisco noted partners aligning with or acquiring competitors (hurting Cisco’s business), and by 2024 expanded alliances to create new markets while adding Nvidia as a new competitive entrant, the LLM response introduces unsupported specifics: alliances with Apple and Equinix are not mentioned in the ground truth, nor is the 'build-buy-partner-invest-co-develop' model. Additionally, the LLM incorrectly frames hyperscalers (AWS, Google, Microsoft) as central competitors in 2024 without mention of Nvidia, which is a key differentiator in the original answer. The LLM also adds details about regional pricing pressure in Asia and specific acquisitions (Splunk, AppDynamics, ThousandEyes) that are not in the ground truth. While these may be factually true in broader context, they are not part of the knowledge graph's supported answer and represent over-inference. The reasoning is partially sound in identifying a shift toward end-to-end differentiation and partner-to-competitor dynamics, but fails to accurately synthesize the multi-hop elements around alliance evolution and competitive landscape changes as defined in the original. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is semantically related but not equivalent due to these factual divergences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 486,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "Based on the provided pages, the effective interest rate for the 3.125% 2025 Notes was SOFR + 2.1% with a notional amount of $1,000 million as of December 31 2023 (page 144). This represents the evolution of the rate and notional amount for that specific tranche between 2022 and 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 notional amount ($1.0 billion or $1,000 million) and the effective interest rate (SOFR + 2.1%) for the 3.125% 2025 Notes, which matches the ground truth. However, it fails to provide any information about the 2022 state beyond implying a change occurred, omitting the key fact that the notional amount hedged in 2022 was $5.2 billion and that new swaps were entered after termination of prior ones. (2) Quantitatively, the numbers reported for 2023 are accurate and correctly formatted ($1,000 million = $1.0 billion), but the absence of the 2022 notional amount and context (e.g., $5.2 billion) results in incomplete quantitative comparison. (3) The reasoning is partially sound in recognizing evolution, but the answer lacks multi-hop synthesis—specifically, connecting the 2022 hedging activity and notional amount to the 2023 figures to explain the evolution. The original answer emphasizes a dynamic hedging strategy and reduced exposure, which the LLM omits entirely, indicating a failure to fully synthesize across years. (4) Contextual relevance is high because the response addresses the specific notes and time frame, but the lack of comparative analysis across 2022–2023 limits completeness. Correctness score is 6 due to partial factual accuracy but significant omission of key 2022 data and strategic context required for full multi-hop understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 393,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "From 2022 to 2024 Cisco’s strategic positioning of AppDynamics evolved from a standalone observability solution to a core component of its broader observability and Application Experience portfolio. In the 2022 “Reimagine Applications” section, Cisco highlighted adding AppDynamics to its full‑stack observability stack alongside Intersight, ThousandEyes and security innovations. By 2024, the company explicitly grouped AppDynamics under the “Observability” product category, reporting a 27 % revenue increase (driven by ThousandEyes and the Splunk‑derived Observability Suite) and emphasizing its role in delivering “greater insights that enable faster, better decision making.” This shows Cisco has deepened its emphasis on observability—particularly application performance monitoring—within its portfolio, integrating AppDynamics more tightly with its networking, security and collaboration offerings to support multicloud and hybrid‑work environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of AppDynamics' strategic positioning from 2022 to 2024: in 2022, AppDynamics was introduced as part of Cisco's full-stack observability strategy alongside Intersight and ThousandEyes, and by 2024, it was formally grouped under a new 'Observability' product category. (2) The 27% revenue increase mentioned is consistent with the 2024 reporting shift, though the ground truth does not specify the percentage—this detail appears to be correctly pulled from external context (e.g., Cisco's 2024 earnings report), so it does not constitute an error but adds value. The mention of Splunk-derived Observability Suite is contextually accurate given Cisco's 2023-2024 acquisition timeline, even if not in the original answer. (3) Multi-hop reasoning is sound: the model synthesizes changes in product categorization, strategic emphasis, and revenue reporting across years, correctly inferring tighter integration within Cisco’s portfolio. (4) Minor deduction in quantitative accuracy only because the 27% figure, while plausible and likely correct, is not present in the ground truth provided, making it an unverifiable addition. However, it does not contradict the truth and supports the narrative. Overall, the answer captures the core strategic shift accurately, with excellent contextual and semantic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 392,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes was SOFR + 4.3% in both 2022 and 2023, and the associated notional amount remained $1,500 million throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the effective interest rate timeline and the notional amount evolution. According to the ground truth, in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio, with swaps terminated and replaced at current rates—no mention of SOFR + 4.3% being in effect then. The $1.5 billion notional amount and SOFR + 4.3% rate are explicitly stated only for 2023. The LLM incorrectly asserts both metrics were unchanged from 2022 to 2023, contradicting the original answer which implies a change due to swap replacement. (2) Quantitative inaccuracies: the $1,500 million notional is correct for 2023 but falsely claimed for 2022; the $5.2 billion figure from 2022 is entirely omitted. The effective interest rate is misattributed to 2022 without support. (3) Multi-hop reasoning failure: the question asks how the rate and notional evolved, requiring comparison across years and understanding of hedging changes. The LLM fails to recognize the swap termination and reset in 2022 as a pivotal change, instead assuming stability. It does not synthesize the updated terms in 2023 as a continuation of strategy with new terms, missing the evolution. (4) Contextual relevance is moderate—the answer addresses the right note series and metrics—but correctness and reasoning are severely compromised by factual and temporal inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 388,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG’s reserving methodology for loss development remained consistent in its core approaches—using paid and incurred development methods, expected loss ratios, and Bornhuetter-Ferguson/Cape Cod hybrids—but the application refined segmentation and criteria. In 2023, the company continued to segment U.S. Excess Casualty by deductible size and whether claims were handled internally or by third parties, and expanded grouping by state and industry subset for Workers’ Compensation, while maintaining the use of expected loss ratio methods for long-tail lines like U.S. Excess Casualty and Workers’ Compensation. The 2023 tables show updated accident year development data through 2023, with prior year development excluding ADC impacts now reflecting more granular segmentation (e.g., separating guaranteed cost and excess of deductible business) and adjusted reporting patterns due to increased large deductible business. This evolution reflects a more detailed application of the same methods, particularly in how loss development factors and expected loss ratios are applied across refined business subsets and segmentation criteria.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that AIG used expected loss ratio methods in both 2022 and 2023, with a more refined and granular application in 2023. The answer accurately notes the continuation of methods like Bornhuetter-Ferguson and the use of expected loss ratios for long-tail lines such as U.S. Workers’ Compensation and U.S. Excess Casualty—consistent with the ground truth’s focus on Workers’ Compensation as a key line. The LLM correctly highlights enhanced segmentation in 2023 by state, industry subset, deductible size, and claim handling (internal vs. third party), which matches the ground truth’s mention of risk-sharing features, state/industry subsets, deductible size, and claim handling entities. It also adds value by referencing updated accident year data and distinctions between guaranteed cost and excess of deductible business, which are consistent with increased granularity. The only minor shortcoming is that the ground truth emphasizes that in 2022, the use of expected loss ratios was part of a general sensitivity analysis without detailed segmentation—this contrast is somewhat downplayed in the LLM answer, which focuses more on continuity than evolution from a general to a specific application. However, the core facts, entities, years, and methodological evolution are correctly conveyed. No numerical inaccuracies are present, and all qualitative details are factually sound and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 412,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo’s engagement with the 2.850% Senior Notes due 2026 shifted from being referenced as a floating‑rate note issuance in 2023 (Form 4.57) to being explicitly authorized as part of a broader 2024 debt issuance slate in the Board resolutions dated February 28, 2024 (Form 4.64). This reflects a strategic expansion of its senior note program, incorporating the 2.850% 2026 tranche alongside a suite of new notes (e.g., 3.600% 2024, 2.625% 2026, 4.250% 2044, etc.) to diversify maturities and funding costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The claim that the 2.850% Senior Notes due 2026 were a 'floating-rate note' in 2023 is incorrect — the ground truth and SEC filings confirm it is a fixed-rate note. Additionally, the LLM invents specific new notes such as '3.600% 2024', '2.625% 2026', and '4.250% 2044', which are not mentioned in the ground truth and lack support from the referenced knowledge graph. The forms cited (4.57, 4.64) appear fabricated or misreferenced, as no standard SEC forms match these numbers. (2) COMPLETENESS: While the question asks about the evolution of PepsiCo's engagement with the 2.850% Senior Notes due 2026 and broader debt strategy, the LLM fails to mention the key 2024 introductions highlighted in the ground truth: the 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035. Instead, it substitutes unverified examples, missing the emphasis on higher-yielding, long-term instruments. (3) REASONING: The multi-hop synthesis is flawed — while the LLM correctly infers a broadening debt strategy, it bases this on incorrect instruments and mischaracterized data. The progression from 2023 to 2024 is partially valid in intent (expansion of debt program), but the evidence used is inaccurate. (4) SEMANTIC EQUIVALENCE: The overall message of diversification is partially aligned, but due to incorrect notes, rates, and form references, the factual foundation is unsound. The answer introduces hallucinated details rather than reflecting the actual strategic shift toward higher-yielding, longer-term debt. Thus, while contextually relevant and attempting qualitative reasoning, the answer scores low on quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 476,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s exposure to channel‑partner financing guarantees remained modest but grew slightly over the period.  In fiscal 2022 the maximum potential future payments under these guarantees were about $188 million (with $9 million of deferred revenue), and by fiscal 2024 the corresponding figures rose to roughly $188 million in potential payments and $0.9 million of deferred revenue – essentially unchanged in absolute terms but reflecting a small increase in the underlying exposure.  This limited growth indicates that Cisco’s risk‑management strategy continues to rely on modest guarantees while shifting most financing risk to the channel partners themselves, using hedging and contractual protections rather than large balance‑sheet commitments.  Consequently, the company’s overall financial‑risk profile remains low, with risk concentrated in its core product and service contracts rather than in extensive financing guarantees.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, Cisco's channel partner financing volume was $27.9 billion, with $1.4 billion subject to guarantees. The LLM incorrectly states that the maximum potential future payments were only $188 million, which is off by more than an order of magnitude. Additionally, the LLM claims deferred revenue of $9 million and $0.9 million in 2022 and 2024 respectively, which are not mentioned or supported in the original answer. By 2024, the ground truth states that Cisco no longer disclosed specific figures, but the LLM fabricates updated numbers ($188 million potential payments and $0.9 million deferred revenue), which are not present in the source data. (2) The quantitative inaccuracies are severe: the actual guaranteed balance was $1.4 billion in 2022, not $188 million. The LLM's numbers are less than 14% of the correct value, representing a major error. There are no calculations in the LLM response that align with the disclosed data. (3) The multi-hop reasoning is flawed. The original answer emphasizes a reduction in disclosure transparency from 2022 to 2024, indicating a strategic shift in risk communication. The LLM instead asserts continued disclosure with stable exposure, contradicting the core insight about reduced transparency. It fails to recognize that the absence of 2024 figures prevents definitive conclusions, thus missing the key qualitative point. (4) The contextual relevance is moderate because the LLM addresses the general topic of Cisco’s risk management and channel financing, but due to severe factual and quantitative errors, the conclusion about 'modest growth' and 'low risk profile' is unsupported and misleading. The reasoning about shifting risk to partners may be plausible but is not substantiated by the provided data. Therefore, the correctness score is low at 2 due to major factual and numerical discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 532,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "Between 2022 and 2023, the 2.45% 2030 Notes maintained a notional amount of $1,000 million, but their effective interest rate structure shifted from a LIBOR‑plus‑1.0% spread (as shown for 2021) to a SOFR‑plus‑1.3% spread (reflecting the 2023 table). This change reflects the transition from LIBOR‑based swaps to SOFR‑based swaps for that tranche.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy regarding the timing and basis of the interest rate structure change. (1) Quantitatively, the notional amount ($1.0 billion or $1,000 million) is correct, and the shift to SOFR + 1.3% in 2023 is accurate. However, the LLM incorrectly references a 'LIBOR-plus-1.0%' spread 'as shown for 2021', which is not part of the original question or ground truth—no 2021 data was provided, and the ground truth states that in 2022, Amgen entered into swaps converting the fixed rate to a floating rate based on LIBOR (without specifying the exact spread). The 1.0% spread is not confirmed in the ground truth. (2) The transition from LIBOR to SOFR by 2023 is correctly identified, and the continuation of the $1.0 billion notional amount is accurate. (3) The multi-hop reasoning is sound: the model correctly infers that the interest rate structure evolved due to benchmark transitions (LIBOR to SOFR) while the underlying note remained outstanding. (4) Despite the minor error in attributing a specific LIBOR spread and referencing 2021 (outside the question scope), the core facts—status (outstanding), notional amount, and rate benchmark transition—are correct. Wording is semantically equivalent and relevant. Hence, a score of 8 is justified: core accuracy is strong, but with a notable detail error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 376,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Based on the provided 10-K filings, FedEx's relationship with Pass-Through Certificates remained consistent in structure but evolved in scale and context between 2022 and 2023. The company continues to fully and unconditionally guarantee the $970 million Series 2020-1AA Pass-Through Certificates issued by FedEx Express, which are secured by aircraft (net book value of $1.7 billion as of May 2024) and carry a fixed 1.875% interest rate due in February 2034. While the 2022 filing notes the certificates were issued to fund general corporate purposes, the 2023 filing confirms the same structure with updated aircraft valuations and no material changes to the guarantee obligation, though the company's overall debt profile shifted toward longer-term unsecured debt (e.g., $1.75 billion New Five-Year Credit Agreement replacing prior facilities).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its core claim. The ground truth states that in 2023, FedEx clarified that pass-through certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express, marking a clear shift from 2022 when they were fully and unconditionally guaranteed. However, the LLM claims the guarantee 'remained consistent' and that FedEx 'continues to fully and unconditionally guarantee' the certificates, which directly contradicts the ground truth. This is a major factual error. (2) Quantitative inaccuracies include: the net book value cited as $1.7 billion 'as of May 2024' — a date not relevant to the 2022–2023 comparison — whereas the ground truth reports $1.8 billion in 2022; the interest rate (1.875%) and maturity date (February 2034) are not present in the ground truth and appear fabricated. The $970 million amount is correct, but the context is wrong. (3) The multi-hop reasoning is flawed: the model fails to recognize the critical evolution from guaranteed obligation in 2022 to disavowal of obligation in 2023. Instead, it asserts continuity, missing the key shift entirely. It also introduces unrelated details (e.g., New Five-Year Credit Agreement) that do not address the specific evolution of pass-through certificates. (4) The contextual relevance is moderate because the answer discusses pass-through certificates and FedEx, but it misrepresents the central financial relationship. Due to the severity of the factual and reasoning errors, especially on the guarantee status, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 436,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard’s risk‑mitigation framework for settlement exposure has remained anchored in its rule‑based guarantee of customer settlement obligations, but the company has progressively refined how it quantifies and offsets that exposure.  In 2023 the firm recorded a gross settlement exposure of roughly $75 million and applied risk‑mitigation arrangements that reduced net exposure to about $63 million; by the end of 2024 the gross exposure had risen to roughly $78 million and net exposure to about $65 million, reflecting higher daily payment volumes and tighter collateral requirements.  This evolution shows that Mastercard is tightening its risk‑management methodology—updating exposure estimates, expanding collateral and credit‑enhancement requirements, and revising its methodology as market conditions change—while still relying on a disciplined, short‑term settlement‑risk model to protect against customer failures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. It reports gross settlement exposure as 'roughly $75 million' in 2023 and '$78 million' in 2024, which is off by a factor of 1,000—the correct values are $75,023 million and $78,385 million, respectively. Similarly, the implied mitigated amounts are incorrect: the LLM suggests net exposure was $63 million in 2023 (implying $12 million mitigated), which aligns numerically with the correct mitigation amount ($12,167 million), but due to the misstatement of gross exposure in millions instead of thousands of millions, the scale is completely wrong. This fundamental error undermines the entire quantitative foundation of the response. (2) Calculations are conceptually correct (e.g., inferring mitigation by subtracting net from gross), but because the base numbers are wrong by orders of magnitude, all derived conclusions are invalid. The LLM also fails to explicitly state the actual amount of risk mitigation used ($12,167M in 2023, $13,466M in 2024), instead only implying it indirectly through net exposure. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing gross and net exposure indicates rising volumes and tighter risk controls, and it correctly identifies the continuity of Mastercard’s rule-based guarantee model. It draws a reasonable qualitative conclusion about tightening risk management, which aligns with the ground truth’s interpretation of a more robust strategy. However, it misses the explicit point that the amount of mitigation *increased* in absolute terms, which is a key indicator of proactive risk management. (4) Contextual relevance is strong—the answer addresses both parts of the question (evolution over time and strategic implication) and uses appropriate financial risk terminology. However, due to the severe numerical inaccuracies, the correctness score is low. Quantitative accuracy is very poor (score 2) due to the magnitude errors. Qualitative accuracy is moderate (score 5) because reasoning and entity identification (Mastercard, settlement exposure, risk mitigation) are correct, but key details are misrepresented. Contextual relevance is good (score 7) as the structure and intent match the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 609,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased significantly—from $426 million in 2022 to $48 million in 2024—reflecting a reduction in the notional amount of outstanding cash‑flow hedges (from $18.2 billion to $16.2 billion) and the associated deferred gains in accumulated other comprehensive income. This decline indicates that Nike is either unwinding or scaling back its hedge program, shifting exposure management toward other mechanisms (e.g., internal netting or unhedged positions), and suggests a lower reliance on formal hedging of foreign‑currency cash‑flow risks during that period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, Nike's liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. The LLM claims a decrease from $426 million to $48 million, which is factually wrong on all counts—both the starting and ending values are incorrect, and the direction of change is opposite. (2) Specific number verification: Ground truth reports $37M (accrued liabilities) + $11M (deferred taxes) = $48M total in 2022; LLM reports $426M in 2022—no match. In 2024, ground truth is $110M + $5M = $115M; LLM reports $48M—again incorrect. The LLM introduces unrelated figures like notional amounts ($18.2B to $16.2B) and deferred gains in AOCI, which are not mentioned or supported in the original answer. (3) Multi-hop reasoning assessment: The question requires comparing two years’ liability disclosures across two balance sheet categories and interpreting the change. The LLM fails this synthesis entirely—it pulls numbers not present in the source and constructs a narrative based on false premises. (4) Justification for scores: Correctness is 1 due to complete factual inaccuracy. Quantitative accuracy is 1 because all numbers are wrong. Qualitative accuracy is 1 because the reasoning is based on fabricated data. Contextual relevance is 3 because the answer addresses the general topic (hedging strategy) but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 421,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "The representation of Bounty within P&G’s Baby, Feminine & Family Care segment remained consistent in both the 2022 and 2023 10‑K filings, continuing to be listed under the “Baby, Feminine & Family Care” reportable segment with its major brands highlighted as “Always, Always Discreet, Tampax Bounty, Charmin, Puffs.” The segment’s net‑sales and earnings percentages (24%/25% in 2022 and 25%/23% in 2023) show that Bounty’s business is still a core component of the segment, but the lack of any growth or specific mention of Bounty suggests its brand visibility has not materially increased; it remains a stable, though not expanding, contributor to the segment’s overall performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Bounty was explicitly listed among the key brands in both 2022 and 2023. According to the ground truth, Bounty was *not* explicitly listed as a key brand in the 2022 10-K, but *was* included in 2023—this is a critical distinction that the LLM missed. The answer falsely claims consistency in representation when in fact there was a change, which directly contradicts the ground truth. (2) The percentages cited (24%/25% in 2022 and 25%/23% in 2023) are not supported by the original answer or context; these figures are introduced without verification and appear to be fabricated or misattributed. There is no mention in the ground truth of net sales or earnings percentages for the segment in either year, so these numbers fail the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the question requires comparing the presence/visibility of Bounty across two filings, but the LLM incorrectly assumes consistent mention and then draws a conclusion about stable brand visibility, which contradicts the ground truth that indicates an *increase* in visibility due to the 2023 explicit mention. The model fails to recognize the evolution in disclosure. (4) The contextual relevance is moderate because the answer addresses the right segment and company, and attempts to discuss brand visibility, but the core factual error about Bounty’s listing and the invented financial data severely undermine correctness. The conclusion about 'no material increase' is directly opposite to the ground truth’s implication of increased visibility. Thus, despite relevant framing, the answer is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 458,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle’s hardware business revenue recognition remained unchanged between fiscal 2022 and fiscal 2023 – hardware products and support are recognized at the point of delivery when ownership transfers, and support services are recognized ratably over the contract term. However, the company’s strategic emphasis shifted markedly toward its cloud and license segment, with cloud services and license support revenues rising to $30.174 billion in fiscal 2022 (up from $28.700 billion in fiscal 2021) and now representing the majority of total revenue, while hardware’s share fell to 6 % of total revenue. This strategic shift is reflected in the increased focus on cloud‑based offerings and the corresponding growth in cloud services and license support margins.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and misses key aspects of the original answer. While it correctly notes that hardware revenue is recognized at the point of delivery, it incorrectly claims that revenue recognition remained 'unchanged' between fiscal 2022 and 2023. The ground truth states that in 2023, Oracle introduced a more detailed explanation of hardware and software as a combined performance obligation, indicating an evolution in revenue recognition treatment, which the LLM fails to acknowledge. Additionally, the LLM introduces specific dollar figures for 'cloud services and license support' ($30.174 billion in 2022) and a comparison to 2021, which are not present in the original answer and cannot be verified from the provided ground truth. The 6% hardware revenue share is also not mentioned in the original and appears to be fabricated or inferred incorrectly. (2) Quantitative accuracy is partially correct in that the general structure of revenue recognition (point-in-time for products, ratable for support) aligns with typical accounting practices, but the specific numbers cited (e.g., $30.174B, 6%) are not supported by the ground truth and appear to be hallucinated. There is no mention in the original answer of year-over-year cloud revenue comparisons or hardware’s percentage of total revenue. (3) The multi-hop reasoning is flawed. The question asks about evolution in both revenue recognition and strategic emphasis in the hardware business. The LLM incorrectly concludes no change in revenue recognition and shifts focus to cloud growth, which is contextually related but not directly responsive to the hardware business’s strategic evolution. The original answer highlights increased R&D investment and integration of hardware and software in 2023—a key strategic shift the LLM omits entirely. Instead, it infers a strategic shift away from hardware toward cloud, which contradicts the ground truth’s indication of renewed strategic emphasis on hardware innovation. (4) The contextual relevance is moderate because the answer discusses Oracle’s financial segments and revenue recognition, but it misrepresents the nature of the evolution by focusing on cloud growth rather than the internal strategic and accounting changes within the hardware business. Due to major factual inaccuracies, omission of key points, and introduction of unsupported data, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 649,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Based on the provided SEC 10-K filings, ERLEADA (apalutamide) sales grew from $1,881 million in 2021 to $2,387 million in 2022, representing a 26.9% year-over-year increase (with operational growth of 27.5% and a minor currency impact of -0.6%). This growth continued into 2023, where ERLEADA sales reached $2,387 million (consistent with 2022 levels) but showed a 26.9% total change from 2022 (with operational growth of 27.5% and a -0.6% currency impact), indicating sustained market momentum and expansion in key regions like Europe and the U.S., despite broader oncology market pressures. This trajectory suggests ERLEADA is maintaining strong, growing market share in metastatic castration-resistant prostate cancer, driven by continued clinical adoption and competitive positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dates and sales trends. It incorrectly states that ERLEADA sales grew from $1,881 million in 2021 to $2,387 million in 2022, while the ground truth shows the $1,881M → $2,387M growth occurred between 2022 and 2023. Furthermore, it claims 2023 sales were 'consistent with 2022 levels' at $2,387 million, implying no growth in 2023, which contradicts the ground truth showing $2,387M as the 2023 figure representing growth from $1,881M in 2022. The percentage growth (26.9%) is correctly calculated but applied to the wrong years. (2) The calculation of 26.9% growth is accurate ((2387 - 1881) / 1881 ≈ 0.269), but the LLM misattributes this change to the 2021–2022 period instead of 2022–2023. Additionally, the mention of 'operational growth of 27.5%' and 'currency impact of -0.6%' introduces details not present in the ground truth and potentially hallucinated or misattributed from another context. (3) The multi-hop reasoning fails because the model incorrectly sequences the time series data, undermining the core of the question about evolution between 2022 and 2023. It also adds unsupported details about regional performance and market pressures without grounding in the provided truth. (4) Despite the incorrect timeline, the LLM does recognize the significance of the growth and infers positive market trajectory, which aligns qualitatively with the conclusion in the ground truth. However, the factual inaccuracies in timing and figures severely undermine the correctness. Thus, the correctness and quantitative accuracy scores are low; qualitative accuracy is moderate due to partial reasoning; contextual relevance is acceptable as it addresses the product and market trajectory conceptually.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 482,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA’s relationship with local broadcast television stations has shifted from a reliance on traditional affiliation agreements to a more competitive, market‑driven dynamic. While the company still depends on local stations to carry its broadcast networks and to secure carriage on multichannel video providers, it now faces heightened competition for audience share and advertising revenue as viewers fragment across DTC streaming and other platforms. This evolving landscape has increased the pressure on CMCSA to negotiate retransmission consent and affiliation terms that reflect the declining linear‑TV audience, making the company more vulnerable to the financial and distribution risks associated with these local station relationships.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of the evolution of CMCSA's relationship with local broadcast television stations from 2023 to 2024. According to the ground truth, the relationship shifted from competition in 2023 to dependency in 2024, with CMCSA's linear networks becoming reliant on local broadcast stations for retransmission consent. However, the LLM answer incorrectly states that the shift was from 'reliance on traditional affiliation agreements' to a 'more competitive, market-driven dynamic,' which inverts the actual direction of change. This is a critical factual and logical error in multi-hop reasoning, as it misrepresents the nature of the relationship evolution. While the LLM correctly references relevant concepts such as retransmission consent, affiliation agreements, and audience fragmentation, and uses appropriate terminology (e.g., linear-TV audience, multichannel video providers), the core conclusion contradicts the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is not applicable but scored as 10 by default. Contextual relevance is moderate because the answer discusses pertinent themes but draws the wrong inference. The qualitative accuracy is low due to the incorrect synthesis of the relationship shift, undermining the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 374,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of MA's Held-to-Maturity (HTM) securities declined sharply from $306 million at the end of 2023 to $38 million at the end of 2024. This reduction reflects a strategic shift away from low‑yielding time‑deposit holdings toward higher‑return assets such as available‑for‑sale securities and equity investments, indicating that the company is reallocating its cash portfolio to improve earnings and manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the quantitative change in HTM securities: from $306 million in 2023 to $38 million in 2024, matching the ground truth exactly. The direction and magnitude of the decline are accurately reported. 2) All numeric values and years are correct. The drop of $268 million is implied and accurate, though not explicitly calculated—this is acceptable as the question does not require a difference computation. 3) The entity (MA) and financial metric (HTM securities) are correctly identified, and the time periods (2023 to 2024) are accurate. 4) The reasoning is sound and adds value: while the original answer states the shift indicates a move toward more liquid or short-term positions, the LLM elaborates with plausible strategic rationale—reallocating from low-yielding deposits to higher-return assets like AFS and equities, aiming to improve earnings and manage interest-rate risk. This is a reasonable inference consistent with the observed data and common financial strategy, though slightly more specific than the original. It does not contradict the ground truth but enriches it. 5) Semantic equivalence is maintained: the core factual content matches, and the added interpretation is contextually appropriate and logically grounded. The only minor limitation is that the LLM introduces 'time-deposit holdings' and 'equity investments' not explicitly mentioned in the ground truth, but these are plausible components of such a strategy and do not introduce factual errors. Overall, the answer is factually correct, complete, and contextually relevant with strong multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 442,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, continuing to be categorized under Feminine Care sub-categories alongside Tampax and other menstrual and incontinence products. The brand maintained its positioning in the feminine care space, with market share and strategic focus consistent with prior years, though specific changes in categorization or sub-category structure were not indicated. The segment as a whole showed stable net sales and earnings contributions, with no major restructuring or reclassification of Always mentioned in the provided disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative evolution in the categorization of the Always brand. (1) Correctly identifies that Always remained within the Baby, Feminine & Family Care segment and under Feminine Care in both years, and no incorrect numbers are present (hence high quantitative accuracy). However, it fails to report the specific 2023 repositioning of Always under the updated 'Menstrual Care' sub-category within Feminine Care, which is a central point in the ground truth. (2) There are no numeric inaccuracies—no figures were misrepresented because the answer avoided specific financials or metrics. (3) The multi-hop reasoning is weak: while the model correctly tracks the brand across years and segments, it does not synthesize the nuanced shift in sub-category structure (from general Feminine Care to more targeted Menstrual Care), which reflects a strategic repositioning. (4) Contextually, the response is relevant and addresses the general positioning, but the omission of the specific reclassification significantly reduces factual completeness. The claim that 'no major restructuring or reclassification... was mentioned' directly contradicts the ground truth, indicating a failure in information synthesis. Thus, while not factually wrong in what it states, it omits a critical detail necessary for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 376,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's positioning of Engineered Systems shifted from a revenue driver to a lower-margin, strategic hardware component, with its revenue share declining from 6% of total revenue in fiscal 2023 to 6% in fiscal 2024, while the company emphasized cloud and license growth as the primary margin drivers. Financially, Engineered Systems revenue recognition follows standard hardware accounting (recognized at delivery), but its contribution to overall revenue and margins has diminished, reflecting a strategic pivot toward cloud services and license support as the core growth engines, with cloud services now representing 37% of total revenue (up from 25% in 2022). The company's financial disclosures highlight that Engineered Systems' revenue is increasingly less central to growth, with margin pressures and lower revenue share compared to the higher-margin cloud and license segments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Engineered Systems' revenue share declined from 6% in fiscal 2023 to 6% in fiscal 2024, implying a decline when the percentage is identical. The ground truth states that hardware (including Engineered Systems) represented 6% of total revenue in both fiscal 2023 and 2024, with no decline. Additionally, the claim that cloud services rose from 25% in 2022 to 37% in 2023 is unsupported by the original answer, which does not mention cloud revenue percentages at all. (2) Quantitative accuracy is low: the 25% and 37% figures are fabricated; the 6% figure is correct but misinterpreted as a decline. The original answer does not provide hardware revenue percentages for 2022, so any comparison of change from 2022 to 2023 is speculative. (3) The reasoning is partially sound in identifying a strategic shift toward cloud, but it misrepresents the evolution of Engineered Systems' financial contribution. The original answer emphasizes improved disclosure and consistent measurement in 2023, not a decline in strategic importance. The LLM incorrectly infers a strategic demotion and margin pressure not present in the ground truth. (4) Contextual relevance is high—the answer addresses revenue recognition, strategic emphasis, and financial contribution—but the factual errors undermine correctness. The synthesis fails on key multi-hop elements: it misuses the 6% figure and invents cloud revenue data, leading to an incorrect narrative of decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 425,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast’s advertising‑sales strategy has remained anchored in using its own sales force and representation firms to sell ad inventory, but the 2024 filing shows a modest shift in how those relationships are structured.  The 2023 10‑K notes that “we also enter into representation agreements under which we sell advertising on behalf of third parties… we record the advertising that is sold in advertising revenue and the fees paid to the third parties in other operating and administrative expenses,” and that “in some cases, we work with representation firms as an extension of our sales force to sell a portion of the advertising units allocated to us and record the revenue net of agency commissions.”  By contrast, the 2024 10‑K (page 73) emphasizes that “we have determined that a contract exists for our advertising sales arrangements once all terms and conditions are agreed upon… Revenue from these arrangements is recognized in the period in which advertisements are aired or delivered,” with no substantive change to the role of external representation firms—only a clarification of the timing and accounting of the revenue.  Thus, between 2023 and 2024 the evolution is one of refined accounting language and tighter integration of representation‑firm commissions into expense reporting, rather than a strategic overhaul of the advertising‑sales model.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing accurate excerpts from the 10-K filings. While it correctly quotes language from both years and identifies that representation agreements exist, it misinterprets the evolution between 2023 and 2024. The ground truth states that Comcast shifted from using representation firms as an extension of its sales force (co-selling model, revenue recorded net of commissions) in 2023 to formal representation agreements where they sell on behalf of third parties with expanded strategic alignment in 2024. However, the LLM claims there was 'no substantive change' and characterizes the shift as merely 'refined accounting language' and 'tighter integration of commissions into expense reporting'—which contradicts the ground truth. This represents a failure in multi-hop reasoning: the model did not correctly synthesize the strategic shift implied by the change in business model (from co-selling to formal representation). There are no numerical errors (hence high quantitative accuracy), and the response is contextually relevant, but the qualitative misinterpretation of the strategic evolution severely undermines correctness. The LLM also incorrectly suggests that the 2023 description includes selling on behalf of third parties, which blurs the distinction—the key point being that in 2023 the firm acted as an extension of Comcast’s sales force, whereas in 2024 the relationship evolved into a formalized structure where Comcast sells for third parties. Thus, the answer misses the central strategic transformation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 434,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle’s industry‑specific hardware offerings continued to represent a small, relatively stable portion of total revenue (about 6 % in both fiscal 2023 and fiscal 2022), with modest revenue declines from $3.359 billion in 2022 to $3.183 billion in 2023 and corresponding margin pressure.  The company’s accounting treatment for hardware‑related revenue remains point‑in‑time recognition upon delivery, and the hardware segment’s operating margin fell from $1.878 billion (≈ 59 % of its revenue) in 2022 to $1.878 billion (≈ 59 % of its revenue) in 2023 after adjusting for fixed‑cost structure, indicating that strategic emphasis on hardware has not shifted dramatically between the two years.  Overall, the evolution is characterized more by modest revenue contraction and margin stability than by a fundamental change in how hardware revenue is recognized or reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces numerical data not present in the ground truth. The ground truth does not mention specific revenue figures ($3.359 billion, $3.183 billion), margins ($1.878 billion), percentages (6%), or trends in revenue decline and margin stability. These numbers are either fabricated or hallucinated, severely undermining factual correctness. (2) Quantitative accuracy is low because none of the financial figures in the LLM answer can be verified against the original answer; the original makes no mention of revenue amounts, margins, or percentages. The claim of '6% of total revenue' and exact dollar declines are unsupported. (3) The qualitative reasoning is flawed: the original answer emphasizes a shift in Oracle’s strategic emphasis toward R&D and innovation in 2023 and a more detailed revenue recognition policy, but the LLM incorrectly concludes that 'strategic emphasis has not shifted dramatically,' contradicting the ground truth. The LLM fails to report Oracle’s increased focus on R&D and more detailed disclosure of performance obligations in 2023. (4) Contextual relevance is moderate—the answer addresses hardware revenue recognition and strategic emphasis as asked, but misrepresents both due to hallucinated data and incorrect synthesis. While it correctly notes point-in-time recognition, it misses the multi-hop nuance of evolving disclosure around combined performance obligations (hardware + software) in 2023. Overall, the answer is factually incorrect in both quantitative and qualitative dimensions despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 448,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA (ibrutinib) sales declined 13.7% from $3,784 million in 2022 to $3,264 million in 2023, with operational growth of 13.2% offset by a 0.5% negative currency impact. This decrease was primarily driven by global competitive pressures affecting the drug's market position.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the sales figures ($3,784 million in 2022 and $3,264 million in 2023) and the 13.7% decline, which matches the ground truth exactly. The numerical values and percentage change are accurate, and formatting variations (e.g., $3.784 billion vs $3,784 million) are acceptable. (2) Quantitatively, all numbers are correct, including the implied calculation of the percentage drop: (3,784 - 3,264) / 3,784 ≈ 13.7%. However, the LLM introduces 'operational growth of 13.2%' and '0.5% negative currency impact', which are not present in the original answer and contradict the narrative of a sales decline due to competitive and market pressures—these figures suggest underlying growth, which is inconsistent with the ground truth. (3) The reasoning is partially flawed: while the LLM identifies 'global competitive pressures' as a factor—aligning with the original answer—it omits key contextual factors such as pandemic-related delays in new patient starts (noted in 2022) and the continuation of downward trends into 2023 due to market saturation or treatment shifts in oncology. Additionally, the introduction of operational growth and currency effects appears fabricated or misattributed, indicating a failure in multi-hop synthesis or source integration. (4) The correctness score is 7 because core quantitative facts are accurate and the main contributing factor (competition) is mentioned, but the answer includes misleading qualitative information and omits important context from the ground truth. Quantitative accuracy is perfect (10), but qualitative accuracy is reduced (6) due to incorrect reasoning elements. Contextual relevance remains high (9) as the response stays focused on the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 474,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort has evolved from 2023 to 2024 with no material change in debt levels or ownership structure, as the resort remains a consolidated VIE with $3.5 billion of debt outstanding as of December 31, 2024 (up slightly from $3.5 billion in 2023), and Comcast maintains its 30% equity interest without any new financing commitments or structural changes to its risk exposure. The company continues to report the resort's assets and liabilities on its balance sheet ($7.3 billion in assets and $7.0 billion in liabilities as of December 31, 2024), while its maximum financial risk remains limited to its 30% equity stake, with no additional guarantees or liquidity arrangements beyond its existing contractual obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, with the term loan reducing from $3.1 billion to $3.0 billion. However, the LLM claims debt remained unchanged at $3.5 billion in both years and even states it 'increased slightly'—which is incorrect. Additionally, the LLM introduces specific balance sheet figures ($7.3 billion in assets and $7.0 billion in liabilities as of December 31, 2024) that are not present in the original answer and cannot be verified against the ground truth, making them potentially misleading or fabricated. (2) The ownership structure (30% stake) and consolidation as a VIE are correctly identified, as is the point that Comcast’s maximum financial risk remains limited to its equity interest—this part is accurate and aligns with the original answer. However, the claim of 'no material change in debt levels' contradicts the ground truth, which notes a clear reduction from $3.5B to $3.4B. (3) The reasoning is partially sound in recognizing that Comcast consolidates the resort as a VIE and that risk exposure is capped at equity, but it fails the multi-hop synthesis by not acknowledging the actual debt reduction trend across years. The model appears to conflate the years or misreport the data, undermining the quantitative comparison. (4) While the answer is contextually relevant and addresses all three aspects of the question (debt, ownership, risk), the core numerical inaccuracies—especially the misrepresentation of stable debt when there was a decrease—severely impact correctness. The introduction of unverified asset/liability figures further reduces quantitative accuracy. Thus, the answer is partially correct in structure and qualitative elements but fails on key facts, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 523,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "The financial commitment related to future lease payments for build-to-suit facilities and equipment increased from approximately $3.4 billion in 2022 to about $0.9 billion in undiscounted future payments for 2024‑2027 commitments reported in 2023, and is projected to reach roughly $3.4 billion in undiscounted payments for 2025‑2027 as disclosed in the 2024 lease schedule. This growth indicates that FedEx is expanding its build‑to‑suit leasing strategy, adding significant new lease obligations as it secures additional facilities and equipment for future operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that financial commitments increased from $3.4 billion in 2022 to $0.9 billion in 2023, when in fact they decreased significantly—from $3.4 billion in 2022 to $0.9 billion in 2023. The direction of change is completely reversed, which is a major factual error. Additionally, the LLM introduces a non-existent projection of $3.4 billion in undiscounted payments for 2025–2027 'as disclosed in the 2024 lease schedule,' which is not mentioned in the original answer and contradicts the trend. (2) The numbers themselves are partially accurate—$3.4 billion for 2022 and $0.9 billion for 2023 appear in the ground truth—but their interpretation is wrong. The LLM misrepresents the $0.9 billion as an increase rather than a decrease. Dates are also distorted: the original states 2023–2024 commencement in 2022, and 2025–2027 in 2023; the LLM incorrectly frames this as evidence of expansion and projects future growth not present in the source. (3) The multi-hop reasoning fails: instead of recognizing a strategic reduction in long-term lease commitments, the LLM concludes an expansion of leasing strategy, which is the opposite of the correct inference. It does not synthesize the reduction and timeline extension into a coherent strategic shift. (4) Contextual relevance is moderate—the response addresses lease payments and strategy—but due to fundamental errors in directionality, magnitude, and unsupported projections, the overall correctness is very low. The conclusion is diametrically opposed to the truth, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 435,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard completed its acquisition of Dynamic Yield Ltd. in April 2022, finalizing the purchase accounting in 2023 and reporting $200 million of goodwill and $125 million of other intangible assets acquired. In 2024 the company expanded its strategic focus on digital identity and cyber‑security by acquiring Recorded Future for $2.7 billion, adding threat‑intelligence capabilities, and continued to invest in value‑added services. These moves signal Mastercard’s deliberate shift toward broadening its high‑margin, data‑driven solutions and strengthening its technology platform beyond core payment‑network revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard acquired Dynamic Yield Ltd. in April 2022, with $200 million of goodwill and $125 million of other intangible assets, which aligns with the ground truth that the total acquisition cost was $325 million and $200 million was attributed to goodwill. The 2024 strategic shift toward cybersecurity via the $2.7 billion acquisition of Recorded Future is accurately reported and contextually relevant. (2) All numeric values—$200 million goodwill, $125 million other intangibles (summing to $325 million total), and $2.7 billion for Recorded Future—are quantitatively accurate and consistent with the ground truth, allowing for format variation. Dates (April 2022 acquisition, accounting finalized in 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly infers from the lack of new Dynamic Yield activity and the new acquisition of Recorded Future that Mastercard shifted strategic focus from personalization (via Dynamic Yield) to cybersecurity and threat intelligence. It synthesizes information across two acquisitions and time periods (2022–2023 vs. 2024). (4) The only minor omission is that the original answer explicitly notes the 'stable' relationship with Dynamic Yield in 2024 due to completed integration, which the LLM implies but does not state directly. However, the core facts, numbers, and strategic interpretation are correct and semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 437,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers was most recently amended and restated effective May 26 2022, as reflected in Exhibit 10.28 of Lowe’s 2022 Form 10‑Q (filed November 27 2024). This amendment supersedes the prior plan and is the latest version referenced in the company’s SEC filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor filing document error. Quantitatively, all key dates and amendment details are accurate: the most recent amendment date (May 26, 2022) and filing date (November 27, 2024) match the ground truth. The exhibit number (10.28) is also correct. However, the LLM incorrectly identifies the filing as a 2022 Form 10-Q, while the ground truth specifies it was filed on November 27, 2024 — which would be part of a 2024 filing (likely a 10-K or 10-Q for Q3 2024), not a 2022 form. This is a factual inconsistency in the document type and year. The answer correctly captures the evolution by noting the 2022 amendment as the latest, but does not mention the prior version (amended May 29, 2020, filed August 26, 2020, Exhibit 10.29), which is relevant to the multi-hop aspect of how the plan evolved between 2022 and 2024. While the core update is accurately described, the omission of the earlier plan version and the incorrect form type slightly reduce completeness and qualitative accuracy. Contextual relevance is strong as the response directly addresses the amendment history and current status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 322,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million at the end of 2022 to $872 million at the end of 2023, reflecting a modest rise in market perception of the company's debt value over that period. This upward shift suggests that investors’ expectations of the company’s creditworthiness and the notes’ attractiveness improved slightly between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the fair value decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. The LLM incorrectly reports a starting value of $830 million at the end of 2022, which is not only numerically wrong but also shifts the time frame, omitting the 2021 data point entirely. The LLM claims an increase in fair value, while the truth is a decrease. (2) The numbers are incorrect: $830M vs $999M (2021), and the LLM skips 2021 entirely, using 2022 instead. The $872M figure for 2023 is correct. However, the calculation of change is flawed due to wrong inputs. The LLM implies a positive change, but the actual change is negative: $872M - $999M = -$127M. (3) The multi-hop reasoning is unsound. The question asks for the change between 2021 and 2023, requiring synthesis across two years and interpretation of market perception. The LLM fails to retrieve the 2021 value and misrepresents the trend. It incorrectly infers improving market perception when the decline in fair value suggests the opposite—potentially deteriorating confidence or higher required yields. (4) Scores are low due to major factual and quantitative errors. Correctness is 2 because only the 2023 value is right, and the overall conclusion is inverted. Quantitative accuracy is 2 due to wrong dollar amounts and time periods. Qualitative accuracy is 3 because the logic of linking fair value to market perception is sound in theory, but applied to incorrect data. Contextual relevance is 6 because the answer addresses the right topic and metric but with wrong data and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 454,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA sales declined 13.7% from $3.784 billion in 2022 to $3.264 billion in 2023, reflecting global competitive pressures and loss of exclusivity, which signals a weakening market position for the drug within J&J’s oncology portfolio despite overall oncology segment growth of 10.5%.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, IMBRUVICA sales were $4,369 million in 2022, not $3.784 billion as stated in the LLM answer. The 2023 sales figure of $3,264 million is correct. The calculated decline is therefore (4,369 - 3,264) / 4,369 = 25.2%, not 13.7% as claimed. The LLM underreports both the 2022 sales and the percentage decline. (2) The calculation error is substantial: using $3.784 billion as the 2022 base leads to (3.784 - 3.264) / 3.784 ≈ 13.7%, which is factually incorrect due to the wrong starting value. (3) Qualitatively, the LLM correctly identifies the declining trend and attributes it to competitive pressures and loss of exclusivity, which aligns with the weakening market position conclusion in the ground truth. It also correctly contextualizes the decline within J&J’s oncology portfolio and notes overall segment growth, adding relevant context not in the original but plausibly consistent. However, it fails to mention the comparative performance of other oncology drugs like DARZALEX and ERLEADA, which the ground truth uses to support the weakening position claim. (4) The contextual relevance is high because the answer addresses both parts of the question—sales evolution and market position—and provides a reasonable interpretation. However, the correctness score is low due to the critical error in the 2022 sales figure and resulting miscalculation of the decline, which undermines the factual foundation of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 422,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "LOW's inventory reserves declined modestly from 2022 to 2024, with the LCNRV reserve falling from $222 million to $222 million (essentially stable) and the shrink reserve rising from $414 million to $427 million; however, a 10 % shift in either reserve would alter net earnings by roughly $17–$32 million, meaning the reserves have a limited but material impact on earnings volatility. The company’s overall earnings were primarily driven by share‑repurchase spending and dividend increases rather than inventory reserve adjustments.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the LCNRV reserve was $222 million in 2022 and remained at $222 million in 2024, implying no change, whereas the ground truth shows it increased from $168 million in 2022 to $222 million in 2024—a substantial increase of $54 million. This misrepresents the trend. The shrink reserve increase from $414M to $427M is correctly stated. (2) The sensitivity figures—$17 million for a 10% change in LCNRV-related assumptions and $32 million for a 10% change in shrinkage rate—are accurately reported, which supports partial quantitative credit. However, the claim that reserves 'declined modestly' is factually wrong, as both reserves increased. (3) The reasoning is flawed: the LLM incorrectly infers stability in LCNRV and an overall decline in reserves, undermining the multi-hop synthesis. It also introduces irrelevant information about 'share-repurchase spending and dividend increases' as primary earnings drivers, which was not part of the original answer and is unsupported in context. (4) While the answer addresses the question's structure (evolution and implications), the core quantitative misstatement of the LCNRV trend and the erroneous conclusion about reserve direction significantly reduce correctness. The contextual relevance is moderate because it discusses the right concepts but distorts key facts and adds off-topic commentary.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 400,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta evolved from a newly launched product to a commercially established asset, with its net revenues increasing by more than 100% in 2023, driven by strong market share uptake, market growth, and regulatory approvals for chronic migraine prevention in both the U.S. (April 2023) and Europe (August 2023). This growth contributed to AbbVie’s overall net revenue expansion and was highlighted as a key driver in the company’s neuroscience portfolio performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, it claims Qulipta received regulatory approvals in April 2023 (U.S.) and August 2023 (Europe), which contradicts the ground truth stating that regulatory approval occurred in 2022 (implied by the $1.0 billion reclassification of R&D assets upon approval). The ground truth does not mention European approval or any 2023 regulatory events. Additionally, the LLM claims net revenues increased by 'more than 100%' in 2023, but no such calculation is supported by the original answer, which only provides 2023 revenue figures ($405M U.S., $3M international) without 2022 revenue for comparison. The actual 2022 revenue for Qulipta is not in the ground truth, so asserting a percentage increase is speculative. (2) Quantitative accuracy is low: the only correct numbers in the original are the 2023 revenues, but these are not mentioned in the LLM response at all—instead, a fabricated growth percentage and incorrect approval dates are introduced. The $1.0 billion reclassification event in 2022, a key financial milestone, is omitted. (3) The reasoning is partially sound in that it recognizes a transition from development to commercialization, and correctly identifies Qulipta as a revenue driver in AbbVie’s portfolio. However, it fails the multi-hop synthesis: it does not connect the 2022 regulatory approval to the intangible asset reclassification, nor does it reference the shift from developmental asset (2022) to revenue generator (2023) using the correct financial and regulatory timeline. (4) Contextual relevance is high because the answer addresses the evolution of Qulipta’s status and financial role. However, due to major factual and quantitative errors—especially incorrect dates, invented growth metrics, and omission of key financial events—the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 507,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023 Honeywell’s environmental‑liability exposure shifted markedly from being largely dependent on Resideo’s reimbursements to a more self‑contained funding model.  In 2022 the company recorded a $140 million receivable from Resideo for 90 % of its environmental costs, and the indemnification agreement capped annual payments at $140 million with a 2043 expiry.  By 2023 the same $140 million quarterly reimbursement was still being collected, but the company’s own accrued environmental liability had risen to $641 million (up from $615 million in 2022), reflecting higher accruals and payments, while the Resideo receivable remained unchanged at $140 million.  This indicates that Honeywell’s risk exposure is now primarily borne by its own balance‑sheet provisions rather than by external reimbursements, increasing its direct financial risk for future environmental remediation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Honeywell's financial dependency on Resideo remained consistent between 2022 and 2023, with Resideo still obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year. However, the LLM incorrectly claims that there was a 'marked shift' toward a self-contained funding model, implying reduced dependency, which contradicts the ground truth. (2) Quantitative inaccuracies include the claim of a '$140 million quarterly reimbursement' — this is false; the $140 million is an annual cap, not quarterly. This misrepresents the financial arrangement and exaggerates Resideo's payments by a factor of four. Additionally, while the LLM cites Honeywell's accrued environmental liabilities increasing from $615M to $641M, this information is not present in the ground truth and cannot be verified as relevant or correct in context. (3) The multi-hop reasoning is flawed: the model infers increased risk exposure due to higher internal accruals and unchanged Resideo payments, but the ground truth emphasizes consistency in the indemnification agreement and no change in risk mitigation strategy. The LLM fabricates a narrative of shifting dependency unsupported by the source. (4) Despite incorrect facts and reasoning, the answer is contextually relevant — it addresses the right companies, topic (environmental liabilities), and time frame. It attempts multi-hop analysis and discusses risk exposure, which aligns with the question’s intent, warranting a moderate relevance score. However, the core conclusion is factually wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 465,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent across both filings, specifying \"highly liquid investments with an original maturity of three months or less from the time of purchase\" (2022 Form 10-K, page 49; 2024 Form 10-K, page 52). However, the 2024 filing explicitly includes \"short-term investments\" within cash and cash equivalents (page 52), whereas the 2022 filing treated these as a separate line item under cash equivalents (page 49). This evolution indicates a strategic shift toward consolidating short-term investments into the cash equivalent category for presentation simplicity, not a change in the underlying maturity definition. The core criterion—original maturity of three months or less—remains unchanged, reflecting stable cash management practices with no material shift in risk profile or liquidity strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Target's definition of 'original maturity' for cash equivalents remained at 'three months or less' in both 2022 and 2024, which aligns with the ground truth. This aspect is factually accurate. However, the LLM introduces a claim not present in the original answer or supported by the provided context: that in 2024, Target included 'short-term investments' within cash and cash equivalents, whereas in 2022 they were separate. This specific detail about classification changes is not mentioned in the ground truth and represents an unsupported inference or potential misinterpretation of the filings. The ground truth emphasizes a broader discussion of fair value measurements in 2024, not a reclassification of short-term investments. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond consistency in referencing fiscal years (2022 and 2024), which the LLM handles correctly. (3) The multi-hop reasoning is partially sound—comparing disclosures across years—but the conclusion about a 'strategic shift toward consolidating short-term investments' is not supported by the ground truth and misrepresents the nature of the evolution. The actual evolution noted is increased discussion around fair value, not presentation consolidation. (4) The correctness score is 5 due to the accurate retention of the maturity threshold but significant deviation in interpreting the strategic implication and introducing unverified structural changes. Qualitative accuracy is low due to flawed reasoning, though contextual relevance remains high as the response addresses the question's intent regarding definition evolution and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 479,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "Between 2023 and 2024, NVIDIA reclassified its 3.50% Notes Due 2040 from a Level 2 liability (carrying amount $870 million) in 2023 to a Level 2 liability with a slightly lower carrying amount of $851 million in 2024, reflecting routine fair‑value adjustments and the amortization of discount and issuance costs. This modest change indicates that the company’s long‑term debt strategy remains focused on maintaining a stable ladder of senior unsecured notes with staggered maturities, while continuing to manage debt at relatively low yields and preserving flexibility for future capital needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. According to the ground truth, the carrying value of the 3.50% Notes Due 2040 increased from $851 million in 2023 (as of Jan 28, 2024) to $1,000 million in 2024 (as of Jan 26, 2025). However, the LLM incorrectly states that the value decreased from $870 million to $851 million, reversing the trend and misreporting both figures. The $870 million figure does not appear in the ground truth and is therefore erroneous. (2) The LLM correctly identifies the valuation level as Level 2 in both years, which matches the ground truth. However, it omits the 2024 enhancements: the effective interest rate of 3.54% and remaining term of 15.2 years, which are important for understanding the evolution of the debt classification. (3) The reasoning about NVIDIA’s long-term debt strategy being stable and focused on low-yield senior unsecured notes is plausible and contextually reasonable, but the conclusion is based on incorrect data. The ground truth indicates growth in long-term debt valuation, suggesting increased reliance or market revaluation, not stability or amortization-driven decline. Thus, the multi-hop synthesis fails because it draws an opposite inference from inaccurate numbers. (4) While the answer addresses the question's structure and attempts to interpret strategic implications, the core factual foundation is flawed. The contextual relevance is high because it discusses the right entities and concepts, but correctness is severely undermined by incorrect financial figures and a reversed trend. Minor note: fiscal dates (Jan 2024 vs Jan 2025) are correctly implied as reporting dates for 2023 and 2024 fiscal years, so entity and time mapping is acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 482,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Based on the provided financial data, Venclexta's total global revenue increased by 13.9% in 2023 compared to 2022 (from $2,009 million to $2,288 million), with the growth rate reported as 13.9% at actual currency rates and 15.0% at constant currency rates. This represents a clear acceleration in revenue growth from the prior year, driven by continued market share gains and favorable pricing across key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2022 revenue ($2,009 million) and 2023 revenue ($2,288 million), and accurately calculates the growth rate as 13.9%, matching the ground truth. The mention of 15.0% at constant currency is an additional detail not present in the original answer but does not contradict it and may reflect supplementary data; however, since the ground truth only specifies 13.9%, this extra information slightly deviates from the provided facts but does not make the answer incorrect. (2) All numeric values—$2,009M, $2,288M, and 13.9%—are factually correct and consistent with the original answer. The year-over-year growth calculation is accurate: (2,288 - 2,009) / 2,009 ≈ 13.9%. (3) The multi-hop reasoning is sound: the model correctly identifies Venclexta, compares its financial performance across two years, synthesizes revenue and growth rate data, and concludes an acceleration in growth, which aligns with the upward trend in both revenue and growth rate (from 10.4% to 13.9%) in the ground truth. (4) The answer is highly relevant and mostly complete, though it omits the explicit mention of the 2022 growth rate (10.4%), which was part of the original answer and directly responsive to the question about evolution between 2022 and 2023. Despite this minor omission, the core quantitative facts and trend interpretation are correct, warranting a high score. The omission prevents a perfect 10, but the answer remains factually strong and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 415,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Netflix amended its Executive Severance and Retention Incentive Plan in September 2021 (effective September 10, 2021) and, in December 2023, replaced it with an amended and restated version that took effect on January 1, 2024. The 2023 filing (Exhibit 10.16† in the 2023 10‑K) details this amendment and its January 1, 2024 effective date, marking the evolution of the plan between the 2022 and 2023 SEC filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key dates and events are correct: the September 10, 2021 amendment and the December 8, 2023 filing of the plan amended and restated effective January 1, 2024. The LLM correctly identifies the forward-looking effective date of the 2024 amendment, consistent with the 2023 filing. (2) Quantitative accuracy is perfect: all dates (September 10, 2021; December 8, 2023; January 1, 2024) match the original answer. (3) The reasoning correctly synthesizes the evolution between the 2022 and 2023 filings—showing that the 2022 filing referenced the 2021 amendment, while the 2023 filing introduced a new amendment effective in 2024. The mention of Exhibit 10.16† adds precision not in the original but is contextually appropriate. (4) The only minor shortcoming is that the LLM does not explicitly note that the 2022 filing itself did not contain a new amendment but referenced the 2021 version, which could slightly affect clarity on the timeline of filings vs. effective dates. However, this is implied. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong multi-hop understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 336,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "The Benefit Restoration Plan’s documentation and structure remained consistent between 2022 and 2024, with no substantive changes to its design or provisions noted in the filings. The company continued to use the plan to supplement 401(k) benefits for employees affected by IRS contribution limits, maintaining the same eligibility rules and employer matching structure. This consistency suggests Lowe’s takes a stable, long-term approach to retirement benefits, prioritizing continuity and predictability for participants rather than frequent revisions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims there were 'no substantive changes' to the Benefit Restoration Plan between 2022 and 2024, which directly contradicts the ground truth: in 2024, Lowe's filed an updated and restated version of the plan (Exhibit 10.3) effective January 1, 2025, indicating a formal structural revision. This is a critical factual error. (2) While there are no numerical figures (e.g., dollar amounts, percentages) to verify for quantitative accuracy, the key date of the plan update (effective 2025, filed in 2024) is omitted, and the absence of any mention of the restated filing (Exhibit 10.3) in the 2024 10-K undermines the answer’s factual basis. (3) The multi-hop reasoning fails: the question requires synthesizing information across years (2022 vs 2024 filings) to detect evolution in documentation and structure. The LLM incorrectly infers stability when the evidence shows deliberate formalization and likely enhancement. (4) The conclusion that Lowe's prioritizes 'continuity and predictability' misinterprets the signal from the updated plan, which instead indicates a strategic, forward-looking approach to retirement benefits. The answer is contextually relevant in discussing the plan’s purpose (supplementing 401(k) limits) but fails on core accuracy and synthesis, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 383,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "Between fiscal years 2023 and 2024, the outstanding balance of NVDA’s 0.584% Notes Due 2024 fell from $1,250 million to $‑ (reflecting the full repayment of the issue in fiscal 2025), while the total long‑term debt net carrying amount declined from $8,459 million to $8,463 million (the slight increase is attributable to the unamortized discount and issuance costs being removed after repayment). In short, the company retired the 0.584% Notes Due 2024 during FY 2025, eliminating that $1.25 billion liability from its long‑term obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The original answer states that NVDA reported a liability of $1,185 million in fiscal year 2023 for the 0.584% Notes Due 2024, but the LLM claims it was $1,250 million — this is incorrect. Additionally, the LLM states the notes were repaid in fiscal year 2025, while the ground truth explicitly says the obligation was fully repaid by fiscal year 2024, as per the 2024 10-K. This misalignment in both amount and timing undermines the core accuracy. (2) The quantitative inaccuracies are critical: the $1,185M figure is misrepresented as $1,250M, and the repayment is incorrectly attributed to FY2025 instead of FY2024. The mention of total long-term debt changing from $8,459M to $8,463M is irrelevant to the specific question about the 0.584% Notes and appears to be extraneous or misattributed data. (3) The multi-hop reasoning fails because the model incorrectly infers the repayment occurred in FY2025, contradicting the source that confirms repayment in FY2024. It also introduces unrelated financial details (unamortized discount, total long-term debt) not mentioned in the ground truth, suggesting possible confusion with another filing or debt instrument. (4) Despite these issues, the answer is contextually relevant in that it addresses the evolution of the debt obligation and correctly concludes that the notes were retired. However, due to major factual and temporal inaccuracies, the correctness score is low. Quantitative accuracy is severely compromised, qualitative reasoning is flawed, and while the topic is relevant, precision is lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 445,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret’s global net revenue declined by 7.2% at constant currency, driven by a 12.7% drop in the United States and a 1.9% decrease internationally. In the U.S., sales fell to $659 million from $755 million in 2022, while international revenues slipped to $771 million from $786 million, reflecting ongoing competition and market pressures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values match: 2022 U.S. revenue was $755M, 2023 U.S. revenue $659M (12.7% decrease); 2022 international revenue $786M, 2023 international $771M (1.9% decrease); total 2022 revenue $1,541M and 2023 $1,430M (7.2% decline at constant currency, consistent with the data). (2) Calculations are accurate: (755 - 659)/755 ≈ 12.7%, (786 - 771)/786 ≈ 1.9%, and (1541 - 1430)/1541 ≈ 7.2%. (3) Multi-hop reasoning is sound: the model correctly synthesized data across U.S. and international markets and compared performance across 2022 and 2023, identifying both the overall trend and regional differences. (4) The answer addresses all parts of the question: global revenue evolution, U.S. trends, and international trends. Minor addition of 'constant currency' and 'market pressures' adds context without contradicting facts. All entities (Mavyret, U.S., international, years) are correct. Scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 303,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix’s covenant limitations under its senior notes remained consistent in scope—restricting liens, sale‑lease‑back transactions, additional subsidiary indebtedness, and the consolidation or merger of substantially all assets—but the company’s repayment obligations evolved. In 2022 it still had $400 million of 5.750% notes maturing in March 2024; by 2024 those notes had been fully repaid upon maturity, and the company added newer long‑dated issues (e.g., $1 billion 4.900% notes due 2034 and $800 million 5.400% notes due 2054). Consequently, while the covenant framework did not change materially, the composition of outstanding notes shifted toward later‑maturity debt, reducing near‑term repayment pressure and maintaining compliance with all covenants through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Netflix's compliance with covenants in both 2022 and 2024 and accurately describes the core restrictions (liens, sale-lease-back, subsidiary indebtedness, mergers). It correctly notes the $400 million repayment of 5.750% Senior Notes upon maturity in March 2024, aligning with the ground truth. However, it incorrectly claims the covenant scope 'remained consistent'—the ground truth specifies that by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions, indicating a narrowing of covenant scope. This is a significant qualitative omission. (2) Quantitatively, all numbers are accurate: $400 million repayment, 5.750% rate, and the new issuances of $1 billion 4.900% notes due 2034 and $800 million 5.400% notes due 2054 are correctly reported (though these new issuances are not in the ground truth and thus cannot be verified; their inclusion may reflect plausible inference but introduces unconfirmed detail). The euro-denominated tranches totaling €5,170 million in 2022 are omitted, which is a completeness gap. (3) The multi-hop reasoning is partially sound—linking repayment to debt composition shift is logical and relevant. However, the failure to recognize the evolution in covenant scope (removal of sale-lease-back restrictions for some notes) undermines the qualitative accuracy. The model synthesizes repayment and compliance correctly but misses a key nuance in covenant evolution. (4) Scores reflect high quantitative accuracy and full contextual relevance, but correctness and qualitative accuracy are reduced due to the misrepresentation of covenant scope stability and the omission of euro-denominated tranches. The answer is mostly correct but misses a critical detail about covenant evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 490,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell’s Safety and Productivity Solutions segment underwent a structural reorganization that combined the Safety and Retail business unit with the Advanced Sensing Technologies unit to form the new Sensing and Safety Technologies unit. This realignment was reflected in the 2023 financial disclosures, where the segment’s revenue declined to $5,489 million (down from $6,907 million in 2022), and the company explicitly noted the recasting of historical periods to reflect the new structure. The evolution culminated in a strategic acquisition in 2023: Honeywell agreed to acquire Carrier Global’s Global Access Solutions business for $5.0 billion, which will be reported within the Honeywell Building Technologies segment, signaling a shift toward expanding its building technologies portfolio through targeted acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the merger of Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies, it introduces incorrect financial data: the Safety and Productivity Solutions segment revenue declined from $6,907M to $5,489M. However, the ground truth states that Safety and Retail alone generated $2,387M in 2022, not the entire segment. The LLM incorrectly uses segment-level revenue changes to support its point, which is not in the original answer. Additionally, the claim about Honeywell acquiring Carrier Global’s Global Access Solutions for $5.0 billion in 2023 is factually incorrect in this context—this acquisition is unrelated to the Safety and Retail evolution and belongs to a different segment (Building Technologies), and there is no evidence in the ground truth that this reflects the evolution of the Safety and Retail line. (2) Quantitative accuracy is low: the $5,489M and $6,907M figures are not supported by the ground truth, and the $5.0 billion acquisition figure, while potentially real, is misattributed in context. The correct revenue figure for Safety and Retail in 2022 ($2,387M) is omitted. (3) The multi-hop reasoning is partially sound—the model correctly identifies the structural change and the integration of two units. However, it fails to accurately reflect that the reorganization was introduced in July 2022 but reported in the 2023 filing, and incorrectly ties an unrelated acquisition to the evolution of the Safety and Retail product line, showing flawed synthesis. (4) Contextual relevance is moderate—the answer addresses the structural change but veers off into unrelated financials and an acquisition that does not reflect the evolution of Safety and Retail. Correctness score is low due to major factual and contextual errors in numbers and strategic interpretation, despite capturing the core structural change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 531,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, Class B‑2 common stock transitioned from having no outstanding shares to being issued (49 million shares) and began participating in the company’s capital structure, while its conversion rights were aligned with those of Class B‑1 and the broader series A convertible preferred stock. The conversion of Class B‑1, B‑2 and C common stock (and the series A, B and C preferred stock) into Class A common stock would increase the number of Class A shares outstanding, leading to voting dilution and potentially pressuring the market price of the existing Class A shares. Moreover, holders of these non‑Class A securities have limited but distinct voting rights on certain corporate actions, which can create divergent interests from Class A shareholders and affect governance dynamics.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that Class B-2 Common Stock went from 'no outstanding shares' to being issued with 49 million shares in 2024, which is the opposite of the truth: the Original Answer states that by 2024, *no shares of Class B-2 were outstanding*, indicating they were eliminated, not newly issued. This fundamental reversal of fact invalidates the core of the response. (2) The 49 million shares figure is not present in the ground truth and appears to be fabricated or misattributed; there is no mention of share count for Class B-2 in the Original Answer, so this number fails quantitative accuracy. (3) The multi-hop reasoning is flawed: instead of recognizing the phase-out of Class B-2 stock and its diminishing role, the model incorrectly infers an expansion of its role in 2024. It also conflates Class B-2 with other classes (B-1, C, Series A/B/C preferred), which are not mentioned in the Original Answer, introducing irrelevant and inaccurate entities. (4) While the general concept of conversion leading to dilution and governance impact is thematically relevant, the directionality of the evolution—active in 2023, then eliminated by 2024—is completely misrepresented. The answer is contextually relevant in topic but fails on factual correctness, making it misleading despite using plausible financial language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 383,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "The Home Depot has evolved its shopping experience between 2023 and 2024 by deepening its interconnected digital and in-store capabilities. It expanded omnichannel fulfillment (BOPIS, BODFS, BORIS, curbside pickup, and same-day/next-day delivery) and enhanced store navigation tools, mobile app features, and electronic shelf labels to streamline the customer journey. Simultaneously, it invested in associate productivity—through AI-powered inventory tools like Sidekick and Computer Vision, upgraded hdPhone devices, and labor optimization—to improve in-store service speed and product availability. These efforts collectively aim to create a seamless, personalized experience across all touchpoints, from online research to in-store checkout and delivery.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies The Home Depot and the relevant time frame (2023–2024), and accurately describes enhancements in digital and in-store capabilities. It correctly notes investments in mobile app features, electronic shelf labels, and store navigation, which aligns with the 2023 initiatives in the ground truth. The mention of omnichannel fulfillment options (BOPIS, BODFS, etc.) and delivery improvements adds relevant context, though these are not explicitly highlighted in the original answer. However, the LLM introduces specific technologies like 'Sidekick' and 'Computer Vision' and 'hdPhone devices' that are not present in the ground truth, which may be accurate but go beyond the provided information. More critically, the LLM omits the 2024 shift toward personalized digital experiences—specifically customer product review summaries, enhanced product content, and leveraging customer data for personalization—which is a key evolution emphasized in the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; no errors here. (3) The reasoning is partially sound: the LLM correctly synthesizes improvements in digital and in-store experiences across years, but fails to capture the core multi-hop shift from operational improvements (2023) to data-driven personalization (2024). This weakens the qualitative accuracy. (4) The answer is contextually relevant and well-structured, but the omission of the strategic pivot to personalization in 2024—central to the original answer—prevents a higher correctness score. The added detail on associate tools, while plausible, is not in the ground truth and slightly distracts from the customer-facing evolution described in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 490,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan expanded its equity award types to include performance share units, performance-based restricted stock units, and cliff-vested restricted stock unit agreements, reflecting an evolution in the specific forms of equity compensation offered under the plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of equity award types from 2022 to 2024 and notes the inclusion of performance share units, performance-based restricted stock units, and cliff-vested restricted stock unit agreements, which aligns with the ground truth. However, it omits several equity forms that were already present in 2022 (e.g., Non-Qualified Stock Options, Price-Vested Stock Options, Non-Employee Director awards), making the evolution appear more additive than comparative. The introduction of the Cliff-Vested Restricted Stock Unit Agreement and Performance Award Performance Share Unit Agreement in 2024 is partially correct, but the LLM merges 'Performance Award Performance Share Unit Agreement' simply into 'performance share units', losing specificity. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly infers evolution in the plan and identifies some new forms, but fails to fully contrast the 2022 baseline with the 2024 updates, leading to an incomplete synthesis. It does not clarify which awards were pre-existing versus newly introduced. (4) The answer is contextually relevant and factually aligned in direction, but lacks completeness in representing the full scope of award types and changes. Hence, correctness and qualitative accuracy are reduced due to omissions and oversimplification, though core elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 424,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Based on AbbVie's financial disclosures in the provided 10-K filings, Qulipta's commercial performance evolved as follows from its 2021 FDA approval through 2023:  \n- **2021**: Qulipta generated no revenue (as indicated by \"$ -\" in the 2021 column for both U.S. and total net revenues).  \n- **2022**: U.S. net revenues surged to $158 million (>100% growth from 2021), with international revenues reaching $158 million (also >100% growth), reflecting strong market uptake following its 2021 approval for chronic migraine prevention.  \n- **2023**: Total net revenues exploded to over $100 million (exceeding 100% growth from 2022), driven by continued market share expansion, favorable pricing, and regulatory approvals in additional regions (e.g., EU approval in August 2023). This growth was explicitly cited as \"greater than 100%\" in AbbVie's 2023 financial disclosures, underscoring accelerating adoption post-launch.  \n\nThus, Qulipta transitioned from zero revenue in 2021 to becoming a rapidly growing, high-performing product within AbbVie's portfolio by 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Qulipta had no revenue in 2021, it incorrectly reports 2022 international revenue as $158 million (same as U.S.), whereas the ground truth shows no international revenue in 2022 and only $3 million in 2023. The 2023 revenue is wildly underreported as 'over $100 million' when the actual total was $408 million. The claim of 'greater than 100% growth' in 2023 is misleading—while growth from $158M to $408M is about 158%, the LLM incorrectly frames it as 'over $100 million' in total, suggesting a much smaller base. (2) Calculations and numbers are largely wrong: 2022 international revenue is falsely equated to U.S. revenue; 2023 total revenue is off by nearly $300 million; growth percentages are applied to incorrect bases. The FDA approval date (September 2021) is omitted, and the indication is incorrectly stated as 'chronic migraine' instead of 'episodic migraine'. (3) Multi-hop reasoning is partially present—revenue trends over time are acknowledged—but synthesis is flawed due to incorrect data extraction from financial disclosures. The model fails to accurately pull and compare the correct figures across years and geographies. (4) Despite incorrect numbers, the answer attempts to address the evolution of commercial performance and references AbbVie's disclosures, maintaining some contextual relevance. However, the severe quantitative errors undermine the factual foundation, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 422,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix’s equity compensation disclosures show a clear evolution between the 2022 and 2024 filings. The 2022 filing (2020 Stock Plan) described stock option and RSU grants under the plan, but the 2024 filing expands this to detail both RSU and performance‑based PSU awards, outlines the specific vesting conditions, and provides a more granular schedule of option activity, exercises, and remaining contractual terms. Additionally, the 2024 filing includes updated tables on granted options, vested shares, and the intrinsic value of exercised options, reflecting a more comprehensive disclosure of the equity compensation activities and the plan’s structural changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increased disclosure between 2022 and 2024, which aligns with the ground truth. It correctly identifies that the 2024 filing includes more detailed information on equity compensation activities such as vesting conditions, option activity, and updated tables—this reflects a qualitatively accurate direction. However, it misrepresents the 2022 filing: the ground truth states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list without any detailed description of stock option or RSU grants, whereas the LLM claims the 2022 filing 'described stock option and RSU grants,' which is factually incorrect. This is a significant error in multi-hop reasoning, as it mischaracterizes the starting point of the evolution. The mention of PSUs (performance-based stock units) in 2024 is consistent with the ground truth’s reference to performance-based criteria, so that detail is acceptable. Dates and document types (e.g., Def 14A) are not mentioned but not required for core correctness. The answer is contextually relevant and uses appropriate terminology, but the factual inaccuracy about the 2022 disclosure level reduces both correctness and qualitative accuracy. Quantitative accuracy scores higher because there are no explicit numerical errors—just absence of specific numbers (which aren't central here).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 378,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company's approach to aluminum purchase agreements remained consistent in that these agreements are classified as derivative instruments not receiving hedge accounting treatment, as explicitly stated in Note 19 and reiterated in Note 121. While the company continued to use aluminum derivative contracts for strategic sourcing and non-U.S. business requirements, the classification and accounting treatment did not change—these instruments were still not designated as hedges and were recorded at fair value through earnings, with no hedge accounting applied in either period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that aluminum purchase agreements were classified as derivative instruments without hedge accounting treatment in both 2022 and 2023, and that they were used for strategic sourcing and non-U.S. business needs. It correctly references Note 19 and Note 121 for this classification, which aligns with typical SEC filing disclosures. However, the LLM fails to capture the key evolution highlighted in the ground truth: in 2023, the company added new information that the quantities in these contracts offset each other and are priced at prevailing market prices—indicating a refinement in strategy toward market pricing alignment and risk mitigation. This omission represents a significant gap in addressing the 'evolution' aspect of the question, which is central to the multi-hop reasoning required. While the LLM correctly notes consistency in accounting treatment, it does not acknowledge the qualitative strategic evolution described in the original answer. Thus, although entities, years, and classifications are accurate (hence high quantitative and contextual scores), the qualitative reasoning is incomplete, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 336,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "The Directors' Code of Conduct was accessible via a dedicated URL on the company's website in both 2023 and 2024, with no indication of removal or relocation. However, the 2024 filing (page 13) explicitly states it will disclose amendments or waivers to the Directors' Code of Conduct on its website, whereas the 2023 filing (page 13) only mentioned such disclosures for the Code of Conduct relating to executive officers, not specifically for the Directors' Code of Conduct. The scope of the Directors' Code of Conduct remained consistent, applying to all directors, but its accessibility details were slightly more explicit in the 2024 filing regarding future disclosure practices.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some accurate contextual information, such as the mention of website disclosure practices in both years and referencing page 13 of the filings. However, it fundamentally misrepresents the key facts regarding the evolution of the Directors' Code of Conduct. The ground truth states that the URL changed between 2023 and 2024, reflecting a reorganization of the document's location and categorization (e.g., domain shift from 'bnymellon.com' to 'bny.com', path changes including 'investor-relations' and updated file naming). The LLM incorrectly claims there was 'no indication of removal or relocation,' which directly contradicts the documented URL change. Additionally, the ground truth identifies a significant expansion in scope in 2024 with the addition of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which the LLM fails to mention entirely. Instead, the LLM asserts that the 'scope remained consistent,' which is factually incorrect. While the LLM correctly notes increased explicitness about future disclosure of amendments, this is a minor point compared to the actual structural and substantive changes. The answer misses the multi-hop synthesis of both accessibility (URL change) and scope (new insider trading section), leading to a major deficiency in qualitative accuracy. Quantitative accuracy is scored higher because there are no numerical errors—dates (2023, 2024) and page numbers (13) align—but the absence of calculation errors does not compensate for factual omissions. Contextual relevance is moderate because the answer addresses disclosure practices but fails to capture the true evolution in accessibility and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 457,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the company issued a new tranche of 4.95% senior notes due June 25 2034 (the “2034 notes”) as part of its June 2024 debt issuance, adding $1.75 billion of long‑term debt at that fixed rate. This addition, together with the broader 2024 issuance of nine senior‑note tranches (including floating‑rate and longer‑dated fixed‑rate notes), reflects a strategic shift toward a more diversified and longer‑dated debt profile, extending maturities out to 2064 and reducing reliance on near‑term borrowings. Consequently, the company’s long‑term debt balance grew from $44.1 billion at the end of 2023 to $53.1 billion at the end of 2024, indicating a deliberate move to fund growth initiatives—such as the SRS acquisition—while managing interest‑rate risk through a mix of floating and fixed‑rate securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that HD issued $750 million of 4.95% senior notes due September 30, 2026, in 2023, and by 2024, the carrying amount was $747 million for those 2026 notes, plus a new $980 million issuance of 4.95% senior notes due 2052. In contrast, the LLM claims a $1.75 billion issuance of 4.95% notes due June 25, 2034, which is not supported by the ground truth. The dates (2034 vs. 2026 and 2052), amounts ($1.75B vs. $750M and $980M), and maturities are all factually wrong. (2) Quantitative accuracy is very low: none of the key numbers match—neither the issuance amounts nor the maturity dates. The LLM also cites total long-term debt increasing from $44.1B to $53.1B, which is not in the original answer and cannot be verified from the provided truth. (3) The reasoning is flawed: the LLM invents a '2034 note' and a nine-tranche issuance including floating-rate debt and a 2064 maturity, which are not mentioned in the ground truth. It fails to identify the actual multi-hop evolution: the continuation of the 2026 notes and the addition of a long-dated 2052 tranche at the same coupon rate, indicating a strategy of maturity extension at a fixed rate. Instead, it fabricates a broader refinancing strategy. (4) Contextual relevance is moderate because it discusses debt strategy and long-term maturities, which aligns thematically with the question, but the factual foundation is incorrect, undermining the analysis. The conclusion about extending maturities has partial alignment, but the evidence cited is false. Overall, the answer does not reflect the actual structure and value evolution of HD's 4.95% notes as described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 475,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Based on the provided SEC 10-K pages, Intel's investment in Beijing Unisoc Technology Ltd. (Unisoc) was accounted for as a non-marketable equity security. In 2021, Intel recognized $471 million in observable price adjustments to its investment in Unisoc, and as of December 30, 2023, the net book value of this investment was $1.1 billion (matching the $1.1 billion reported as of December 31, 2022). The document confirms no significant changes in the investment's valuation between 2022 and 2023, with the net book value remaining stable at $1.1 billion despite ongoing market conditions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the $471 million observable price adjustment in 2021 is correctly cited, and the net book value of $1.1 billion as of December 30, 2023 (matching December 31, 2022) is precisely reported. Format variations (e.g., $1.1 billion vs $1.1B) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the 2021 observable price adjustment and the 2023 net book value, while also noting the stability of valuation between 2022 and 2023—key to showing the evolution of Intel's financial treatment. (3) Entity accuracy is perfect: 'Beijing Unisoc Technology Ltd.' is correctly named, and the accounting treatment as a 'non-marketable equity security' is accurately described. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the 2021 adjustment event with the subsequent stable valuation in 2022 and 2023, concluding that despite earlier adjustments, the investment's book value remained unchanged, indicating stable financial treatment. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity (e.g., 'no significant changes' and 'despite ongoing market conditions') that do not introduce inaccuracies. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 378,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "AbbVie’s engagement with Qulipta evolved from a regulatory milestone in 2023 to commercial launch later that year. In April 2023 the FDA approved Qulipta for the preventive treatment of chronic migraine, and by August 2023 the EC followed with a similar approval; the product then entered the market in January 2024 after the company submitted a Complete Response Resubmission for its NDA in December 2023. This progression reflects a shift from seeking regulatory clearance to actively commercializing Qulipta.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the FDA approval in April 2023 and EC approval in August 2023 for Qulipta, which aligns with the ground truth. However, it introduces a significant factual error by stating that the product entered the market in January 2024 after a 'Complete Response Resubmission' in December 2023—this detail is not present in the original answer and contradicts the timeline implied by the ground truth, which emphasizes regulatory and commercial advancement in 2023, not a 2024 launch. Additionally, the original answer highlights a key 2022 development: the reclassification of $1.0 billion in R&D intangible assets due to regulatory approvals, which the LLM answer omits entirely. This omission undermines the multi-hop aspect of the question, which asks about evolution from 2022 to 2023. (2) Quantitatively, the $1.0 billion asset reclassification in 2022 is missing, a major numerical and factual gap. The dates of FDA and EC approvals (April and August 2023) are correct. The mention of a December 2023 resubmission and January 2024 launch is unsupported and likely incorrect. (3) The reasoning is partially sound in tracing a regulatory-to-commercial trajectory, but fails to synthesize the full evolution from 2022 to 2023 because it ignores the 2022 asset reclassification, a critical indicator of AbbVie’s engagement shift. The multi-hop synthesis is incomplete. (4) The contextual relevance is high as the answer addresses regulatory and commercial development, but the inclusion of unverified post-2023 events and omission of key 2022 information reduces factual accuracy. Correctness score is 6 due to correct identification of 2023 approvals but major omissions and an unsupported claim about the launch timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 480,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing’s framing of “upgrades and conversions” within Global Services shifted from a general acknowledgment of its role in sustaining platforms to a more strategic emphasis on leveraging these capabilities to drive market share growth amid heightened competition. In the 2022 filing, the segment was described as providing services including “upgrades and conversions” as part of a broader service portfolio, while the 2023 filing explicitly tied these activities to competitive differentiation, stating BGS intends to “grow market share by leveraging a high level of customer satisfaction and productivity” through such offerings. This evolution reflects a deliberate strategic emphasis on upgrades and conversions as a key growth lever within Global Services, moving from operational description to a core competitive strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Boeing's evolving strategic emphasis on 'upgrades and conversions' within the Global Services segment between 2022 and 2023, and the framing aligns with the ground truth. It correctly identifies that in 2022, 'upgrades and conversions' were mentioned as part of a broader list of services without strategic emphasis. The 2023 shift toward a more strategic positioning is also accurately captured. However, the LLM introduces a claim not present in the original answer: that Boeing explicitly tied 'upgrades and conversions' to 'growing market share' and 'competitive differentiation' through customer satisfaction and productivity. While the 2023 framing does suggest a more integrated and strategic role, the specific language about market share growth and competitive differentiation is not supported by the ground truth and represents an overinterpretation or addition not present in the source. This affects qualitative accuracy, as the reasoning extrapolates beyond the provided evidence. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default (scored 10). Contextual relevance is high, as the response directly addresses the evolution in language and strategic framing. The core facts are correct, but the added strategic narrative reduces qualitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 389,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Between 2021 and 2023, Intel’s investment in Beijing Unisoc Technology Ltd. remained classified as a non‑marketable equity security. In 2021 the company recorded a $471 million observable price adjustment to the investment, and by the end of 2023 the net book value of the holding was $1.1 billion (up from $1.1 billion as of Dec 31 2022, having been $658 million as of Dec 26 2020). The investment is accounted for under the cost method, with no market‑based valuation adjustments reported beyond the initial price adjustment; consequently, its valuation is reflected only through the carrying amount on Intel’s balance sheet, which remained at $1.1 billion throughout 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeline. While it correctly states that Intel recorded a $471 million observable price adjustment in 2021 and that the net book value was $1.1 billion as of the end of 2023, it incorrectly claims the value was $1.1 billion as of Dec 31, 2022 and $658 million as of Dec 26, 2020 — none of which are supported by the ground truth. The ground truth only confirms the $1.1 billion value for 2021 (Dec 25, 2021) and 2023 (Dec 30, 2023), with no mention of 2020 or 2022 values. This introduces false precision and incorrect trend implications (e.g., 'up from $1.1 billion' suggests no change, but then cites a lower prior value). (2) The quantitative inaccuracies are significant: the $658 million figure for 2020 and the repeated $1.1 billion for 2022 are not in the original answer and contradict the limited data provided. The ground truth does not support any claim about movement in value over time beyond the two data points, both of which are $1.1 billion. (3) The reasoning is partially sound — the LLM correctly identifies the $471 million adjustment in 2021 and the stable $1.1 billion book value in 2023, and correctly notes the absence of similar adjustments in 2023. However, it overreaches by implying a trend and inserting unsupported intermediate values, failing the multi-hop synthesis test by fabricating data points. (4) Contextual relevance is high — the answer addresses the evolution of the investment, valuation, and recognition — but correctness is undermined by invented numbers. The qualitative accuracy is moderate because the core concepts (cost method, observable price adjustment, no 2023 adjustment) are plausible, but not fully verifiable from the ground truth provided. Overall, the answer is partially correct but contains critical quantitative errors that distort the financial narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 514,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, Self-Service Lockers evolved from a convenience feature into a core component of Home Depot’s interconnected shopping experience, enabling seamless online order pickup and curbside service that bridges digital and physical channels. This integration supports the company’s broader strategy of unifying in-store, online, and job-site interactions—enhancing customer satisfaction, driving sales growth, and reinforcing the frictionless journey from inspiration to post-purchase support.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Self-Service Lockers from a convenience feature in 2023 to a core component of Home Depot's omnichannel strategy in 2024, aligning with the ground truth's central theme. However, it omits key quantitative and programmatic details present in the original answer. Specifically, the LLM fails to mention that approximately 50% of U.S. online orders were fulfilled through stores in 2024—a critical data point demonstrating operational scale. It also does not reference the specific interconnected retail programs (BOSS, BOPIS, BODFS, BORIS) that contextualize the lockers' integration into fulfillment workflows. (2) There are no numerical inaccuracies because the LLM answer avoids citing specific numbers, thus not contradicting the ground truth. This absence prevents a lower quantitative score, but the lack of inclusion of the 50% fulfillment statistic limits completeness. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift based on implied integration across channels, but it does not explicitly connect the locker evolution to the broader fulfillment network leveraging stores for pickup, returns, and delivery as stated in the 2024 data. The synthesis across years is reasonable but lacks grounding in the specific evidence provided in the original answer. (4) The correctness score is 7 because the core conceptual shift is accurately conveyed, but significant factual omissions reduce completeness. Quantitative accuracy is 10 because no numbers are misstated (none are given). Qualitative accuracy is 7 due to correct reasoning but missing entity and program references. Contextual relevance is 9 as the response stays focused and relevant to the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 482,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "The level of detail and specificity in Costco’s disclosures regarding estimation methods for Insurance/Self‑insurance Liabilities remained essentially consistent between 2023 and 2024. Both years describe the use of historical claims experience, demographic and severity factors, and other actuarial assumptions to estimate retained risk, noting that adjustments have historically been immaterial and that the methodology has not changed materially.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Costco significantly increased the detail and specificity of its disclosures from 2023 to 2024, whereas the LLM claims the level of detail remained 'essentially consistent'—this is a direct contradiction. In 2023, Costco did not disclose the specific factors (e.g., demographic and severity factors, actuarial assumptions) used in estimating liabilities, but in 2024 it did, which represents a meaningful enhancement. The LLM incorrectly attributes these detailed disclosures to both years. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires comparing disclosure depth across two years, but the LLM fails to recognize the evolution and instead asserts consistency, missing the key progression in transparency. It incorrectly projects 2024-level detail back into 2023, failing to synthesize the correct contrast. (4) Correctness is severely compromised due to the incorrect conclusion about consistency. While the answer uses relevant terminology (e.g., 'actuarial assumptions'), it misattributes the timing and evolution of disclosures, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right topic and companies but with incorrect comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 419,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory‑related costs shifted from a $59 million increase in cost of sales in 2021 (driven by fair‑value adjustments to inventory) to an $87 million charge in 2023 related to excess inventory, while the 2022 cost of sales rose primarily due to higher volumes and incremental acquisition‑related expenses. Consequently, inventory‑related cost pressures eased in 2023 compared with the prior two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the $59 million fair-value adjustment occurred in 2021, while the ground truth specifies 2022. This misalignment in timing undermines the entire analysis. Additionally, the LLM claims that the $87 million charge in 2023 was related to the Aldevron acquisition, but the original answer clarifies that this new charge was due to excess inventory from reduced demand in the Biotechnology segment and was not acquisition-related. The LLM also incorrectly implies that inventory-related cost pressures eased in 2023, whereas the original answer shows a shift to a larger $87 million charge, indicating increased, not decreased, pressure. (2) Quantitatively, the $59 million and $87 million figures are correct in amount but are assigned to incorrect contexts and years. The $59 million is wrongly placed in 2021 instead of 2022, and the $87 million is mischaracterized as a continuation of acquisition costs rather than a new operational issue. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from acquisition-driven costs (2022) to their absence in 2023 and the emergence of a separate inventory challenge. Instead, it conflates the two charges and misattributes causality and timing. (4) Contextual relevance is moderate because the answer discusses inventory-related costs and the Aldevron acquisition, but the incorrect timeline and misattribution of causes severely reduce factual accuracy. Due to major errors in dates, causality, and interpretation, the correctness score is low despite some correct dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 452,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "The treatment of shop card liabilities remained consistent between 2023 and 2024, with the Company continuing to record outstanding shop card balances as a liability net of estimated breakage in other current liabilities. This consistent approach reflects Costco's disciplined accounting for unclaimed balances, recognizing revenue only upon redemption while systematically estimating and accounting for breakage based on historical redemption patterns. The lack of material changes indicates a stable, conservative approach to handling unclaimed shop card balances that aligns with their overall conservative financial reporting practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: it correctly states that Costco treated shop card liabilities as a liability net of estimated breakage in both 2023 and 2024, recognized revenue upon redemption, and used historical redemption patterns to estimate breakage. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Costco, shop card liabilities, breakage, redemption) are correctly identified. The answer is contextually relevant and addresses the core question about treatment and recognition. However, it misses a key qualitative nuance emphasized in the original answer: the increased emphasis on 'estimated breakage' and methodology refinement in 2024. While the LLM describes a 'consistent' and 'stable' approach, the ground truth highlights an evolution—greater emphasis and refinement in 2024—suggesting progress rather than stasis. This omission reduces qualitative accuracy, as the reasoning downplays the shift toward a more formalized estimation process. Thus, while the core facts are correct, the synthesis of change over time is less precise, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 325,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved from a nascent offering into a strategically scaled business, marked by significant customer commitments and expanded partnerships. In 2022, IFS secured foundational agreements like the ARM and Synopsys collaborations and expanded its RAMP-C program with DoD, while 2023 saw accelerated momentum with four design wins on Intel 18A (including a major high-performance computing customer), five new advanced packaging design wins, and the commercial agreement with Tower for New Mexico analog manufacturing. This growth was underpinned by a doubling of the IFS Accelerator Ecosystem to over 40 partners and the culmination of its first phase of the RAMP-C program, positioning IFS as a differentiated foundry provider focused on advanced packaging and US/European capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel's Foundry Services from 2022 to 2023 with accurate qualitative insights and mostly correct quantitative details. It correctly identifies the 2023 milestones: four design wins on Intel 18A (including a major HPC customer) and five new advanced packaging design wins, which aligns with the ground truth. It also accurately notes the expansion of the IFS Accelerator Ecosystem to over 40 partners. However, there is a factual inaccuracy regarding the timing of the ARM and Synopsys agreements—these were part of 2023 developments (multigenerational agreements to enable SoC design on Intel 18A), not 2022, as the LLM incorrectly states. Additionally, the mention of the Tower agreement for New Mexico analog manufacturing and the DoD RAMP-C program expansion, while contextually relevant to IFS growth, are not present in the ground truth and appear to be extraneous or incorrectly attributed details. The reasoning is sound in showing a progression from foundational steps to customer traction, and the answer addresses both strategic partnerships and customer engagement. Despite minor factual errors and inclusion of unsupported specifics, the overall narrative matches the ground truth’s intent. Hence, minor deductions in quantitative and qualitative accuracy, but high marks for contextual relevance and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 386,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Based on the provided document pages, the financial impact of DHR's relationship with Aldevron evolved as follows:  \n- In 2023, DHR recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition (Page 83), with net cash consideration of $5.61 billion (Page 83).  \n- This contrasts with 2021, where DHR recorded $6.1 billion of goodwill and $9.56 billion of net cash consideration for the Aldevron Acquisition (Page 83), indicating a significant increase in both goodwill and cash outlay in 2023 compared to the 2021 transaction.  \n- The 2023 goodwill ($6.1 billion) and net cash consideration ($5.61 billion) reflect the acquisition's scale, though the 2023 transaction was financed primarily through cash on hand (Page 73), while the 2021 transaction utilized a mix of cash, debt, and equity (Page 73).  \n\n(Note: The document does not explicitly detail a *change* in the relationship between 2022 and 2023 beyond the 2023 acquisition activity, but the 2023 goodwill and cash consideration figures are directly contrasted with the 2021 data for context.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that in 2023, DHR recorded $6.1 billion of goodwill and $5.61 billion of net cash consideration, while the ground truth indicates that in 2023, the net cash consideration was $9.561 billion—over $3.95 billion more than stated. Additionally, the LLM falsely references a 2021 transaction with $9.56 billion net cash consideration and $6.1 billion goodwill, but the original answer and context focus on 2022 and 2023, not 2021. There is no mention of 2021 in the ground truth. (2) Quantitative accuracy is severely compromised: the $5.61 billion figure for 2023 net cash consideration is incorrect (should be $9.561 billion), and the comparison to 2021 introduces non-existent data. The goodwill amount of $6.1 billion is correctly attributed to the acquisition but misassigned to 2023 as if it were newly recorded then, whereas the ground truth states it was preliminarily recorded in 2022. (3) The multi-hop reasoning is flawed: instead of showing the evolution from 2022 (goodwill of $6.1B) to 2023 (net cash consideration of $9.561B), the model fabricates a comparison with 2021 and misrepresents the timeline and financial progression. It fails to recognize that goodwill was initially recorded in 2022 and that 2023 reflects a revised or finalized cash consideration. (4) Contextual relevance is moderate because the answer discusses the right companies (DHR, Aldevron) and relevant financial concepts (goodwill, net cash consideration, financing methods), but the incorrect years and figures undermine the analysis. The mention of financing via cash on hand vs. debt/equity may be document-based but distracts from the core question about financial evolution between 2022 and 2023. Overall, major factual and temporal inaccuracies result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 503,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of AT&T's 1.800% Global Notes shifted from September 5, 2026 in the 2022 filing to September 14, 2039 in the 2024 filing, reflecting a longer‑dated debt issuance. This extension indicates AT&T is deliberately lengthening the average maturity of its outstanding notes to better match financing needs and reduce near‑term refinancing pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maturity dates from the 2022 and 2024 filings: September 5, 2026, and September 14, 2039, respectively. These match the ground truth exactly. The shift of over 13 years is accurately implied, though not explicitly calculated. (2) All numeric values—dates and interest rate (1.800%)—are correct and match the original answer. No calculation errors; the extension from 2026 to 2039 is a 13-year increase, which the model captures in spirit by noting a 'longer-dated debt issuance' and 'extension'. (3) The multi-hop reasoning is sound: the model synthesizes data across two filings (2022 and 2024) for the same class of notes and infers a strategic shift in debt management. The conclusion about reducing near-term refinancing pressure is a reasonable and contextually appropriate interpretation of the maturity extension, aligning with financial best practices. (4) The answer is semantically equivalent to the ground truth, with slightly more interpretive insight (e.g., 'match financing needs'), which enhances rather than distorts. The only minor shortcoming is not explicitly stating the magnitude of the extension (e.g., 'over 13 years'), which slightly reduces completeness. Hence, a 9/10 on correctness and qualitative accuracy, but full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 376,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target's compliance with its debt‑leverage covenant remained strong throughout 2023‑2024, and the company continued to meet the covenant without triggering any breach.  The only structural change that could affect future compliance is the replacement of the prior 364‑day revolving credit facility with a new $1.0 billion facility (expiring October 2025) and the retention of the $3.0 billion facility expiring in October 2028; these facilities provide a liquidity backstop for the commercial‑paper program and support the company’s overall debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the essential information from the ground truth. (1) All key facts are correct: Target maintained compliance with its debt leverage covenant in both 2023 and 2024; the $1.0 billion 364-day facility was renewed with an expiration extended to October 2025 (from October 2024); the $3.0 billion five-year facility remains unchanged, expiring in October 2028. These numbers, dates, and dollar amounts match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the model correctly links the renewal of the credit facility to Target’s ongoing compliance, recognizing that the renewal supports liquidity and debt management, which in turn supports covenant compliance. (4) The only minor shortcoming is that the LLM does not explicitly state that Target 'expected to remain' in compliance in 2023, nor does it directly mention that the renewal 'likely provided continued flexibility'—phrasing present in the original that adds nuance to the causal relationship. However, the implication is preserved. The answer is semantically equivalent and fully relevant to the question, with excellent synthesis of financial structure and compliance status across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 359,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "From 2022 to 2023 Intel’s RISE strategy evolved from a broad sustainability framework into a more targeted, measurable agenda that explicitly ties digital‑readiness initiatives to its RISE goals.  The 2022 filing highlighted the expansion of supplier engagement and responsible‑minerals collaboration as part of RISE, while the 2023 report shows a concrete scaling‑up of those efforts—e.g., a larger supplier‑audit and capacity‑building program, new spending targets for women‑ and minority‑owned suppliers, and the launch of the Intel RISE Technology Initiative that funds projects on inclusive technology, carbon‑neutral computing, and AI‑driven health‑and‑safety solutions.  This progression reflects a shift from describing RISE as a strategic pillar to operationalizing it through expanded external collaborations (such as the Alliance for Global Inclusion and green‑bond funding) and linking its milestones to specific performance metrics like renewable‑energy use, Scope 3 emissions reductions, and digital‑readiness volunteer hour targets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and fails to correctly represent the core evolution of Intel's digital readiness initiatives as described in the ground truth. (1) The answer incorrectly shifts focus to supplier engagement, responsible minerals, green bonds, and the Intel RISE Technology Initiative—none of which are mentioned in the original answer and not directly tied to digital readiness or the Alliance for Global Inclusion. (2) Quantitatively, the LLM introduces unverified metrics such as 'spending targets for women- and minority-owned suppliers', 'renewable-energy use', 'Scope 3 emissions', and 'volunteer hour targets' that do not appear in the ground truth and are not supported by the provided context. There are no numbers in the LLM answer that match the specific 50% benchmark, 18 recognized organizations out of 27 respondents, or the publication of the third global inclusion index—key quantitative facts in the original. (3) The multi-hop reasoning is flawed: while the question asks about evolution in digital readiness via the RISE strategy and external collaboration (specifically the Alliance for Global Inclusion), the LLM conflates broader ESG/sustainability efforts under RISE with digital inclusion. The actual evolution—from forming a collaborative framework in 2022 to publishing a performance-based inclusion index in 2023 with formal recognition for high scorers—is missed entirely. (4) Despite this, the answer is contextually relevant in discussing RISE and external collaborations, and it correctly identifies a strategic shift toward measurable outcomes, which aligns thematically with the ground truth. However, the absence of key facts, incorrect emphasis, and invented details significantly reduce factual accuracy. Minor formatting flexibility is allowed, but the lack of alignment with documented initiatives results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 510,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson sold its 40 % non‑controlling equity stake in Copeland to Blackstone for $1.5 billion in August 2024, generating a $539 pre‑tax gain ($435 after‑tax) that is reported in discontinued operations. The transaction also included the sale of the $2.25 billion note receivable for $1.9 billion, providing additional cash proceeds and eliminating the equity‑method losses that had been recorded in Other deductions. This divestiture marked the final exit from the Climate Technologies business and resulted in a substantial one‑time gain and cash inflow for the company.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and irrelevant to the question. (1) It discusses Emerson's sale of its stake in Copeland to Blackstone, which is unrelated to the Micromine transaction. The original question asks about Emerson's relationship with Micromine in 2023–2024, but the LLM response addresses a different company (Copeland), a different transaction (divestiture of Climate Technologies), and a different year (August 2024 sale). (2) None of the numbers match the ground truth: the $1.5 billion sale price, $539 million pre-tax gain, $435 million after-tax gain, $2.25 billion note, and $1.9 billion proceeds are all incorrect in this context. The actual financial implication was a $24 million mark-to-market gain in 2023 from foreign currency forwards, not a multi-billion-dollar divestiture gain. (3) The multi-hop reasoning is entirely flawed—the LLM failed to identify the correct entities (Micromine, AspenTech, foreign currency contracts) and instead fabricated a narrative about a Copeland divestiture. (4) The answer lacks any contextual relevance: it does not mention Micromine, the acquisition attempt, its termination due to Russian regulatory issues, or the termination of hedging contracts in 2024. The entire response is factually and contextually disconnected from the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 363,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) had approximately 15 million shares available at the end of fiscal 2023, compared with about 17 million shares available at the end of fiscal 2022.  During fiscal 2023, roughly 1 million shares were purchased under the ESPP at an average price of $277.19, whereas in fiscal 2022 the company reported about 1 million shares purchased at an average price of $305.14.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 17 million shares available in 2022 and 15 million in 2023; approximately 1 million shares purchased each year; average purchase prices of $305.14 in 2022 and $277.19 in 2023. These values exactly match the original answer, with acceptable formatting (e.g., using '1 million' instead of 'one million', and thin spaces in numbers). (2) The answer is complete, addressing both parts of the question: changes in share availability and average purchase price from 2022 to 2023. (3) Entity accuracy is correct—The Home Depot, U.S. ESPP, and proper fiscal years (2022 and 2023) are correctly referenced. (4) The reasoning is sound and demonstrates multi-hop synthesis by comparing availability and purchase price across two fiscal years using accurate data points from each. (5) The semantic meaning is equivalent to the original answer, clearly conveying the reduction in available shares and the decrease in average purchase price. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 313,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "The pattern of impairment triggers and associated charges shifted notably between 2022 and 2023, reflecting evolving risks in Danaher’s intangible asset portfolio. In 2022, impairment charges totaled $77 million, primarily triggered in the second quarter of 2023 across the Biotechnology, Diagnostics and Biotechnology segments, whereas in 2021 the Company recorded only $10 million of impairment charges, linked to triggers in the first quarter of 2021 within the Diagnostics segment. This increase indicates a heightened risk of asset overvaluation, especially in finite‑lived intangibles such as technology and customer relationships, prompting more frequent testing and larger write‑downs as market conditions and segment performance changed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the timeline and attribution of impairment charges. It incorrectly states that the $77 million impairment charge occurred in 2022 and was triggered in the second quarter of 2023, which is contradictory and false. According to the ground truth, the $77 million charge was in 2023 (reported in the 2023 filing), not in 2022. The 2022 filing only reported a $10 million charge from Q1 2021 in the Diagnostics segment. The LLM conflates reporting year with event year and misattributes the timing of the $77 million charge. (2) Quantitatively, while the $10 million and $77 million figures are both mentioned, their assignment to years is reversed: the $10 million was in 2021 (reported in 2022), and $77 million was in 2023 (reported in 2023). The LLM incorrectly states that $77 million was in 2022. Additionally, it misrepresents the segments involved: it says 'Biotechnology, Diagnostics and Biotechnology' (redundant and unclear), while the ground truth specifies Biotechnology in Q2 2023, both Diagnostics and Biotechnology in Q4 2023, and Diagnostics again in Q1 2021 (for comparison). (3) The multi-hop reasoning is partially sound in that it identifies a trend of increasing impairment charges and links it to risks in intangible assets, but it fails to correctly synthesize the evolution across filings. It misses the key point that Biotechnology was not previously impaired before 2023, which is a critical shift. The conclusion about heightened risk is reasonable but based on incorrect premises. (4) Contextual relevance is high because the answer addresses the question's intent—evolution of impairment triggers and implications for intangible asset risk—but the factual foundation is flawed. Due to major quantitative and temporal errors, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 512,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The outstanding letters of credit related to trade contracts decreased from $362 million in 2022 to $598 million in 2023, reflecting an increase in the company’s exposure to trade‑related commitments. This rise suggests that Home Depot is becoming more involved in business transactions tied to trade contracts, likely to support its expanded supply‑chain and distribution activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that letters of credit 'decreased' from $362 million to $598 million, when in fact the value increased. This misrepresents the core quantitative fact. However, the actual dollar amounts ($362 million in 2022 and $598 million in 2023) are correct, which supports partial credit for number accuracy. (2) Quantitative accuracy is low because while the values themselves are correct, the comparison (decrease vs. increase) is factually wrong, and no correct calculation of the change (an increase of $236 million) is implied. The direction of change is a fundamental part of the quantitative claim. (3) The reasoning is partially sound in interpreting the rise (though mislabeled as a decrease) as indicating greater involvement in trade-related transactions, which aligns with the ground truth. The mention of supply-chain and distribution activities adds plausible context, though the company name 'Home Depot' is incorrectly introduced (not mentioned in the original question or answer), which is an entity error. (4) Despite correct numbers and reasonable interpretation of implications, the reversal of the trend severely undermines factual correctness. Contextual relevance is high because the answer addresses both parts of the question—change in value and its implication—and attempts multi-hop reasoning, but the flawed premise weakens the conclusion. Thus, correctness is scored low due to the inversion of the key fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 420,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were listed among IBM’s outstanding debt securities in both the 2023 and 2024 Form 10‑K filings, confirming that the issue remains part of IBM’s capital structure and continues to be disclosed in the company’s periodic reports. This consistent inclusion indicates that IBM maintains transparent, ongoing disclosures of its long‑term debt instruments across filing periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that the 0.300% Notes due 2028 were included in both the 2023 and 2024 filings, which aligns with the ground truth. However, it fails to capture the key evolution in the status of the notes between the two years. The ground truth specifies a significant shift: in 2023, the notes were disclosed only as part of instruments defining holders’ rights with reference to Exhibit 4.1 filed in 2020, while in 2024, they are explicitly listed as actively issued and traded under the symbol IBM28B on the NYSE. This indicates a progression from passive disclosure to active market recognition, which the LLM answer omits entirely. (2) There are no numeric values, dates, or calculations in the response that contradict the ground truth; thus, quantitative accuracy is high. The percentage (0.300%) and maturity year (2028) are correctly referenced. (3) The multi-hop reasoning is flawed: the question asks for how the *status* evolved and what this indicates about disclosure practices. The LLM fails to synthesize the change in disclosure nature—from legal documentation reference to active trading status—missing the core analytical point. It instead defaults to a generic observation about consistent disclosure, which does not reflect the nuanced evolution. (4) While the response is relevant to IBM’s debt disclosures, it lacks the depth and precision required for full credit. The correctness score is low due to missing the central transformation in the instrument’s status and its implications for financial transparency and market engagement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 440,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "Between 2023 and 2024 IBM’s disclosure and registration of the 1.750% Notes due 2031 shifted from being referenced only in the 2023 10‑K’s “Exhibits” section (where the 1.750% Notes due 2031 were listed among the debt instruments incorporated by reference in 2022‑2023 filings) to being explicitly included in the 2024 registration table of securities on page 1 of the 2024 10‑K, where it appears alongside other IBM notes with their ticker symbols (e.g., IBM31 for the 1.750% Notes due 2031) and is identified as being listed on the New York Stock Exchange. This change reflects a more prominent disclosure of the 2031 notes in the 2024 filing, moving them from a generic exhibit reference to a specific, exchange‑listed security.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: in 2023, the 1.750% Notes due 2031 were disclosed via incorporation by reference in exhibits (specifically referencing a January 30, 2019 filing, though the LLM generalizes this as 2022–2023 filings, which is contextually acceptable given the ongoing relevance), and by 2024, the notes were explicitly registered with a ticker symbol (IBM31) on the New York Stock Exchange. (2) There are no numeric or date inaccuracies—percentages (1.750%), maturity year (2031), and ticker (IBM31) are correct. The LLM correctly identifies the shift in disclosure format without introducing false data. (3) The multi-hop reasoning is sound: it synthesizes changes in disclosure practices between two annual filings (2023 vs 2024 10-Ks), correctly interpreting the evolution from passive exhibit reference to active listing in a registration table. (4) The answer addresses all parts of the question—disclosure changes and registration status—while maintaining high contextual relevance and precise qualitative and quantitative accuracy. Minor phrasing differences (e.g., 'registration table of securities on page 1' vs ground truth's broader 'explicitly registered') do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 364,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Based on the provided SEC 10-K filings, Eli Lilly's financial relationship with Zyprexa (an olanzapine-based product) evolved significantly between 2023 and 2024, particularly concerning revenue recognition and business model shifts. In 2023, revenue from Zyprexa was primarily driven by the sale of the olanzapine portfolio rights (including Zyprexa) to a third party, resulting in a one-time revenue recognition of $1.69 billion outside the U.S. (page 47), which was explicitly noted as part of collaboration and other revenue. This transaction, along with the sale of rights to other products like Baqsimi, contributed to a 23% increase in gross margin in 2023, as the absence of COVID-19 antibody revenue and the olanzapine rights sale improved realized pricing and margin structure (page 49). By 2024, Zyprexa itself no longer generated revenue as a product; instead, its revenue was fully replaced by the one-time gain from the portfolio rights sale in 2023, and subsequent revenue recognition for related products (like Olumiant, which includes baricitinib sales under the olanzapine portfolio framework) was reported under \"Other products\" with no specific Zyprexa revenue line item. The company's revenue model shifted from recognizing product sales of Zyprexa to recognizing one-time gains from intellectual property asset sales, with no ongoing product revenue from Zyprexa itself. Revenue recognition for such collaborations and IP sales was governed by the company's policy of recognizing revenue when control transfers or when the product has no alternative use, and the 2023 rights sale was treated as a collaboration arrangement revenue component (page 63). Thus, the financial relationship with Zyprexa transitioned from ongoing product sales to a one-time revenue event, with no material revenue from Zyprexa in 2024, and the business model moved toward leveraging IP rights sales as a strategic revenue source rather than product sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key quantitative details. The ground truth states that Eli Lilly generated $1.45 billion from the sale of the olanzapine portfolio (including Zyprexa) outside the U.S. in 2023, but the LLM incorrectly reports this figure as $1.69 billion, which is a material error. Additionally, the LLM claims that the sale contributed to a 23% increase in gross margin and references 'page 49' of a filing, but this specific impact and citation are not supported by the ground truth and appear fabricated or misattributed. (2) The LLM incorrectly implies that Olumiant or baricitinib is part of the olanzapine portfolio, which is factually wrong—olanzapine is an antipsychotic, while baricitinib (Olumiant) is a JAK inhibitor; there is no known therapeutic or portfolio linkage between them. This reflects a serious entity and conceptual error. (3) While the LLM correctly identifies the shift from product sales to collaboration/IP-based revenue recognition, it mischaracterizes the nature of the transition: the ground truth describes an ongoing shift to royalty or profit-sharing arrangements post-sale, whereas the LLM frames it as a one-time gain with no further revenue, missing the nuance of potential ongoing collaboration revenue. (4) The contextual relevance is high—the response directly addresses the evolution of the financial relationship, revenue recognition changes, and business model implications. However, due to major quantitative errors and incorrect multi-hop reasoning (e.g., linking unrelated drugs, misstating revenue figures), the overall correctness is significantly compromised. The qualitative reasoning appears structured but is built on incorrect premises, reducing its validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 485,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased in April 2023, eliminating any outstanding redemption obligations; consequently, no liability for these interests remained on the balance sheet at December 31 2023, and they had no impact on earnings‑per‑share calculations thereafter. Prior to the repurchase, the interests were re‑classified from equity to a liability at fair value, with the redemption price paid in cash (or AT&T stock) and recorded as a current liability, and the difference between fair value and carrying value was charged to additional paid‑in capital, which affected diluted EPS only while the interests were outstanding.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core timeline—reclassification and full repurchase of Mobility Preferred Interests in April 2023—and correctly notes the elimination of redemption obligations and balance sheet liabilities by year-end 2023. However, it omits key quantitative details from the ground truth: the specific liability split of $2,670 million in current and $2,670 million in noncurrent liabilities in 2023, and the total repurchase cost of $5,414 million. These omissions affect completeness and quantitative accuracy. (2) The LLM incorrectly implies that no liability remained at year-end 2023 without acknowledging that the reclassification and liability recognition occurred earlier in the year before repurchase, which is a material detail. Also, the statement that the difference between fair value and carrying value was charged to additional paid-in capital is not supported in the ground truth, which does not specify the accounting treatment of the revaluation. This introduces a factual inaccuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that repurchase eliminates future EPS impact and connects the prior existence of the instrument to diluted EPS. However, it fails to mention the specific role of ASU 2020-06 in allowing stock settlement treatment for diluted EPS in periods prior to repurchase—a key accounting nuance in the original answer. (4) While the LLM answer is contextually relevant and addresses the evolution from 2023 to 2024, the missing numbers, incorrect accounting detail, and omission of the ASU 2020-06 impact reduce correctness and qualitative accuracy. The answer is directionally correct but lacks precision and completeness on critical financial and accounting points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 479,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's treatment and disclosure of the 0.875% Notes due 2030 shows a consistent pattern of listing and registration across multiple filings. The notes are explicitly identified in the 2024 Form 10-K (page 1) as part of the \"Securities registered pursuant to Section 12(b) of the Act\" table, where they are listed as \"0.875% Notes due 2030\" with the trading symbol \"IBM30A\" on the New York Stock Exchange. This confirms their active listing and registration status. The 2023 filing (page 21) references the \"instruments defining the rights of the holders of the 0.875% Notes due 2030\" as part of a February 8, 2022 Form 8-K filing, indicating the registration was previously established and remains referenced in ongoing disclosures. Thus, there is no evidence of a change in listing status or registration between 2023 and 2024; the notes have been consistently listed and registered as part of IBM's long-term debt instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key facts such as the 0.875% Notes due 2030, the February 8, 2022 Form 8-K reference in the 2023 filing, and the explicit listing in the 2024 Form 10-K with trading symbol IBM30A on the NYSE. These details are factually accurate and match the ground truth. However, the core of the question asks about the *evolution* of treatment and disclosure between 2023 and 2024, specifically the shift from incorporation by reference to explicit listing. The LLM incorrectly concludes that there is 'no evidence of a change,' which directly contradicts the ground truth that there *was* a meaningful evolution in disclosure practice. (2) Quantitatively, all dates (2022-02-08), percentages (0.875%), maturity year (2030), and trading symbol (IBM30A) are correct. No calculations were required. (3) The multi-hop reasoning is partially sound—information is drawn from both 2023 and 2024 filings—but the synthesis is flawed because it fails to recognize the significance of the shift from referenced disclosure to explicit registration in the table. This is a critical misinterpretation of the regulatory disclosure context. (4) While the answer is contextually relevant and well-structured, the incorrect conclusion about the lack of change undermines the overall correctness. The answer should have highlighted the progression from indirect reference to full listing, not denied it. Hence, correctness is scored low despite accurate individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 411,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "The Telco LLC preferred interests evolved from a 2020 issuance of $2 billion of cumulative preferred equity (Telco Class A‑1) that paid a 4.25 % distribution and reset every seven years, to a 2023 expansion adding $5.25 billion of Class A‑2 and A‑3 interests at a 6.85 % rate with a reset in 2027, and then in October 2024 AT&T authorized an additional $2.25 billion of Class A‑4 interests paying a higher 5.94 % distribution that resets in 2028. This progression shows AT&T’s strategy of layering preferred equity with escalating distribution rates and staggered reset periods to fund subsidiary growth while retaining flexibility to call or redeem the securities, indicating a deliberate use of preferred equity as a financing tool that can be adjusted to market conditions and capital‑allocation priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, the Telco Preferred Interests consisted of $2,000 (not $2 billion) of Class A-1 and $5,250 (not $5.25 billion) of Class A-2/A-3, totaling $7,250 by 2024. The LLM incorrectly scales the amounts by a factor of 1 million (e.g., $2,000 vs $2 billion), which is a critical error. Additionally, the LLM fabricates an October 2024 issuance of $2.25 billion of Class A-4 interests at 5.94%, which is not present in the original answer. The original states that the structure remained the same in 2024 with no new classes issued—only a clarification on distribution payment flexibility. (2) The quantitative inaccuracies are severe: dollar amounts are off by orders of magnitude, and a non-existent issuance is introduced. The original answer reports no increase in total value beyond the 2023 issuance, with the 2024 total remaining at $7,250 (implied sum of $2,000 + $5,250), whereas the LLM claims an additional $2.25 billion was authorized, which is unsupported. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a pattern of 'layering' with escalating rates and staggered resets, but the ground truth shows only two issuances (2020 and 2023) and no 2024 issuance. The conclusion about 'escalating distribution rates' is misleading—Class A-4 at 5.94% is lower than the 6.85% on A-2/A-3. The correct inference from the original is that AT&T expanded the instrument in 2023 and clarified distribution flexibility in 2024, indicating continued reliance on preferred equity, not a new issuance. (4) The contextual relevance is moderate because the answer addresses the general theme of AT&T's financing strategy, but the factual foundation is incorrect. Due to major errors in numbers, entities, and invented events, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 521,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One’s exposure to multifamily commercial real‑estate loans is managed through loss‑sharing agreements with government‑sponsored enterprises (GSEs).  Under these agreements the company originated multifamily loans that it subsequently sells to GSEs and shares any credit losses that may arise.  In 2022 the company recorded a liability of $82 million related to these loss‑sharing arrangements, and by the end of 2023 that liability had increased to $137 million, reflecting higher expected losses and the adoption of a fair‑value option for new loss‑sharing agreements entered into after January 1 2020.  The liability is recognized in other non‑interest income (or amortized into income as risk is released), and the amount of exposure has grown modestly from 2022 to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Capital One's liability for loss sharing agreements was $82 million in 2022 and increased to $137 million in 2023, reflecting increased risk exposure in multifamily commercial real estate loans. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The explanation includes additional context—specifically, the adoption of a fair-value option for agreements after January 1, 2020—which is factually consistent with Capital One’s accounting policies and adds depth without contradicting the ground truth. While this detail isn't in the original answer, it does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly links loan origination, sale to GSEs, loss sharing, liability recognition, and year-over-year change in exposure. (4) The only minor shortcoming is that the LLM characterizes the increase as 'modest,' whereas a rise from $82M to $137M (~67% increase) could be seen as significant, making 'modest' a slight understatement. However, this is a qualitative interpretation rather than a factual error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 352,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023 Amazon’s co‑branded credit‑card programs moved from a peripheral revenue stream to a more strategically significant source of payment‑related income, but this shift also introduced heightened regulatory exposure.  In the 2023 filing the company explicitly warns that renewal or continuation of these programs on less‑favorable terms—or their termination—could “adversely affect our operating results,” and it highlights new compliance obligations tied to payment‑card rules, data‑security standards, and evolving tax‑collection requirements for marketplace sellers.  Consequently, the programs now carry material compliance costs and potential liabilities that could materially dent Amazon’s earnings if regulatory pressures or contract renegotiations force unfavorable changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the increased strategic significance of Amazon's co-branded credit card programs from 2022 to 2023 and acknowledges the heightened regulatory risks and potential impact on operating results, which aligns with the ground truth. It accurately reflects that in 2023, Amazon emphasized risks related to renewal on less favorable terms or termination affecting operating results—a point also present in 2022 per the original answer, though the LLM implies this warning was new in 2023, which is a minor inaccuracy. The LLM correctly notes expanded compliance obligations but misattributes the new requirements: it mentions 'evolving tax-collection requirements for marketplace sellers,' which is not mentioned in the ground truth. Instead, the original answer specifies 'data localization rules' and 'cross-border data transfers' as new in 2023—key regulatory shifts the LLM omits entirely. While the LLM captures the general trend of increasing compliance costs and operational risks, it fails to identify the specific nature of the new obligations (data localization), which is a significant omission in the multi-hop synthesis across years and regulatory domains. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is contextually relevant and well-structured. However, the substitution of tax-collection rules for data governance issues reduces qualitative accuracy, as it misrepresents the type of regulatory evolution. Thus, the answer is partially correct with core facts right but missing a key factual component of the regulatory shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 439,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PMI's financial relationship with RBH shifted from consolidation to deconsolidation following RBH's entry into Court‑Protection under Canada's Companies' Creditors Arrangement Act (CCAA) in March 2019, with RBH's results removed from PMI's consolidated balance sheets thereafter. The 2024 10‑K confirms that RBH remains under CCAA protection, its financial statements are no longer consolidated, and PMI recorded a $2.3 billion impairment charge on its equity investment in RBH after a court‑ordered objection to the proposed restructuring plan indicated potential impairment, reflecting the deconsolidated and uncertain valuation of RBH in PMI's financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the deconsolidation of RBH due to CCAA proceedings initiated in March 2019 and that RBH's financial results were no longer consolidated in PM's (or PMI's) financial statements by 2022 and 2024. However, it introduces a $2.3 billion impairment charge in 2024, which is not present in the ground truth; the original answer mentions a CAD 3.1 billion allocation of compensatory damages against RBH in Canadian tobacco litigation, not an impairment charge recorded by PM. This is a significant factual discrepancy. Additionally, the LLM refers to 'PMI' (Philip Morris International), while the correct entity is 'PM' (Philip Morris Inc., likely referring to Altria or the domestic U.S. operations), which is a critical entity error. (2) Quantitative accuracy is compromised: the $2.3B impairment is incorrect and not supported by the ground truth, which does not specify any impairment charge amount recorded by PM in 2024, but rather emphasizes the need for 'impairment analysis' and 'fair value estimate' involving judgment on assumptions. The CAD 3.1B litigation liability is entirely omitted. (3) The multi-hop reasoning is partially sound—LLM correctly traces the timeline from CCAA filing to deconsolidation and recognizes the shift to an equity investment requiring valuation judgment. However, it fails to mention the evolution to an equity investment requiring ongoing impairment evaluation based on discount rates, sales volumes, margins, and tax treatment of a potential global settlement, which is a key qualitative point in the original. Instead, it cites a court objection triggering a specific charge, which is not in the ground truth. (4) Contextual relevance is high as the response addresses the evolution of the financial relationship, consolidation status, and valuation considerations. However, due to incorrect entity (PMI vs PM), wrong financial figure ($2.3B vs no specified charge), and omission of key details (CAD 3.1B litigation, specific valuation assumptions), the correctness score is limited to 6—partially correct but with significant factual and entity errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 574,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi’s revenue grew from $677.6 million (total) in 2023 to $645.7 million in U.S. sales plus $31.9 million outside the U.S. in 2023, reflecting its contribution as part of Lilly’s broader portfolio expansion; however, its standalone revenue share remains modest relative to blockbuster products such as Jardiance, Verzenio, and Mounjaro. Strategically, Baqsimi is positioned as a niche, high‑margin respiratory asset that bolsters Lilly’s diversified product mix, supporting overall revenue growth while complementing the company’s focus on high‑value, high‑impact therapies within its portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Baqsimi had $645.7 million in U.S. sales and $31.9 million outside the U.S. in 2024, when in fact these figures are from 2023 and represent the last year of direct reporting. The model fails to note that Baqsimi was no longer reported as a direct revenue contributor in 2024 due to the divestiture of rights. Instead, it falsely implies continued growth and presence in the product portfolio. (2) Quantitatively, the numbers themselves ($677.6M total, $645.7M U.S., $31.9M ex-U.S.) are accurate but misattributed to 2024 instead of 2023. There is no evidence of growth into 2024; the model incorrectly frames the 2023 data as if it reflects 2024 performance. No actual calculation errors, but temporal misplacement invalidates the quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the key event—the 2023 sale of rights—that fundamentally changed Baqsimi’s role. It does not recognize the shift from direct product revenue to collaboration income, missing a critical strategic transition. The mention of other products (Jardiance, Verzenio, Mounjaro) adds context but is not supported by the ground truth and distracts from the core change in Baqsimi’s status. (4) Scores reflect major factual error in both time period and strategic interpretation: while some numbers are correct, their application is wrong, leading to a misleading conclusion. The answer is contextually relevant in discussing revenue and strategy but fundamentally incorrect in its core claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 440,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Total Highway Revenue Equipment composition shifted toward greater ownership of containers and chassis. In 2022, owned containers were 48,962 and leased were 1,856 (≈96% owned); by 2024, owned containers rose to 46,375 and leased dropped to 288 (≈99% owned), while owned chassis increased from 29,875 to 4,356 and leased fell from 14,148 to 1,197 (≈78% owned). This indicates a clear trend of increasing ownership and decreasing reliance on leased equipment across both container and chassis categories.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Union Pacific's owned Total Highway Revenue Equipment dropped from 78,837 in 2022 to 50,731 in 2024, and leased units fell from 16,004 to 1,485. However, the LLM incorrectly states that owned containers were 48,962 in 2022 and rose to 46,375 in 2024—this contradicts the ground truth that does not break out containers by ownership in those exact terms and shows an overall decline in owned units. The LLM also misrepresents the chassis leasing data: it claims leased chassis fell from 14,148 to 1,197, but the ground truth indicates total leased units were 16,004 in 2022 (with chassis heavily leased), and specifically notes leased containers dropped from 1,856 to 288, and owned chassis decreased from 29,875 to 4,356—meaning chassis ownership declined, not increased as the LLM claims. (2) The LLM incorrectly states that owned chassis increased from 29,875 to 4,356, which is a decrease, not an increase. It also miscalculates the percentage ownership for chassis (claiming ~78% owned in 2024 when 4,356 owned vs 1,197 leased would be about 78%, but the actual leased chassis number in 2024 is not 1,197—the ground truth says total leased units are 1,485, and chassis-specific leased numbers are not fully provided, but the trend is a massive reduction). The container ownership percentages are fabricated based on incorrect base numbers. (3) The multi-hop reasoning is flawed: the LLM infers increasing ownership, while the ground truth shows a strategic reduction in both owned and leased assets, especially in chassis. The conclusion of 'increasing ownership' is the opposite of the true trend. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the question about changes in owned vs leased composition and attempts to analyze trends in containers and chassis. However, due to major quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 540,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s use of securitized debt obligations grew modestly from 2022 to 2023, with the carrying value of securitized debt rising from $16.9 billion to $18.0 billion and its share of total funding increasing from roughly 4% to 5% of overall funding. This reflects continued reliance on securitizations as a source of liquidity, but the proportion remains small relative to the company’s dominant deposit base, which still provides the majority of funding.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct quantitative information but introduces data not present in the ground truth. The $18.0 billion carrying value in 2023 aligns closely with the ground truth value of $18.043 billion, which is acceptable within rounding. However, the claimed 2022 value of $16.9 billion is not supported by the original answer, which does not provide a specific dollar amount for 2022—only a qualitative description of securitized debt as a key funding source. The percentages (4% to 5% of total funding) are entirely absent from the ground truth and appear to be speculative or derived from external data, making them factually unsupported. (2) Calculations such as the increase from $16.9B to $18.0B and the implied total funding base are not verifiable against the original answer and introduce inaccuracies. The ground truth does not support any calculation of proportion within total funding. (3) The multi-hop reasoning is partially sound in that it attempts to compare two years and assess the role of securitized debt in funding structure, but it misses the key qualitative evolution highlighted in the original answer: the reclassification of securitized debt obligations under Level 2 of the fair value hierarchy in 2023, indicating a shift toward standardized valuation methods. This is a critical omission, as it reflects a structural change in how these instruments were accounted for, which the LLM answer fails to mention. (4) While the LLM correctly identifies that securitized debt remains a component of funding and is secondary to deposits, it substitutes unsupported numerical analysis for the actual qualitative shift documented in the filings. Thus, while contextually relevant and addressing the general theme of funding role evolution, the answer prioritizes unverified quantitative claims over the actual documented change in classification and valuation approach, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 530,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The nature of LLY's revenue from Zyprexa evolved such that in 2023 it was included under \"collaboration and other revenue\" as part of the sale of the olanzapine portfolio rights, and by 2024 it was reclassified into \"net product revenue\" as part of the broader product sales, reflecting a shift from being treated as a one-time portfolio sale to ongoing product revenue. This transition is documented in Note 2 of the 2024 10-K, which states that revenue from Zyprexa (referenced as \"sale of the rights for the olanzapine portfolio\") was initially recorded in collaboration and other revenue in 2023, but by 2024 it was integrated into net product revenue as part of regular product sales. The revenue recognition method remained consistent as point-in-time sales at shipment, with no material changes to the underlying accounting policy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its description of how Zyprexa revenue was classified in 2023 and 2024, reversing the actual evolution. According to the ground truth, in 2023, Zyprexa revenue came from the sale of rights to the olanzapine portfolio and was recognized as part of product sales (or potentially as a one-time gain), but by 2024, it shifted to being recognized under collaboration and other arrangements as ongoing collaboration revenue. The LLM incorrectly states that in 2023 the revenue was in 'collaboration and other revenue' and then moved to 'net product revenue' in 2024—this is the opposite of the truth. This misrepresentation invalidates the core of the answer. The citation to Note 2 of the 2024 10-K is plausible but used to support an incorrect narrative. There are no numeric values (e.g., dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the directional and categorical error is severe. The reasoning is flawed as it fails to correctly synthesize the multi-hop change in revenue recognition nature over time. While the answer addresses the question's structure (source and recognition method), it does so with incorrect information, leading to low correctness and qualitative accuracy scores. Contextual relevance is moderate because the response discusses the right topic and cites a relevant note, but with wrong substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 387,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities remained consistent as Level 2 fair‑value measurements using a bid‑evaluation process with independent pricing sources, but the classification and target allocation shifted as the plan’s overall strategy evolved. In 2022 the plan targeted a 45%–55% split between equity and debt, with debt representing about 42% of assets and Federal Government Securities held at roughly 742 million (Level 2). By 2024 the target allocation moved to a 70%–80% debt weighting, and the debt portfolio’s average credit rating improved to AA‑ while the expected long‑term return on assets was lowered from 6.25% to 5.25%, reflecting a more conservative, de‑risking approach that increased the relative importance of Federal Government Securities within the plan.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $742 million value of Federal Government Securities in 2022 and maintains their Level 2 classification, which aligns with the ground truth. However, it introduces several pieces of information not present in the original answer or implied by the question, such as target allocation ranges (45%–55%, 70%–80%), debt portfolio credit rating (AA-), and expected long-term return changes (6.25% to 5.25%). These details, while plausible in context, are not part of the ground truth and were not asked for in the question. (2) The only verified numeric value from the ground truth is $742 million in 2022, which is accurately reported. The other numbers (percentages, returns, ratings) cannot be verified and appear to be hallucinated or inferred beyond available data. (3) The multi-hop reasoning is partially sound in that it connects valuation methodology (Level 2, bid evaluation) across years, but it overreaches by inferring strategic shifts like de-risking and allocation changes that were not mentioned in the original answer. The core evolution—continued Level 2 classification with added methodological clarity in 2024—is overshadowed by extraneous details. (4) The contextual relevance is high because the response addresses valuation methodology and classification over time, but correctness and qualitative accuracy are reduced due to unsupported additions. The answer captures the continuity in Level 2 classification and mentions bid evaluation, which matches the 2024 clarification, but fails to clearly state that the classification did not change—only the explanation became more specific. Thus, while some facts are correct, significant portions are unverified, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 481,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023 Capital One shifted from using refreshed FICO scores (69% > 660 in 2022) to a slightly lower share of high‑score cards (68% > 660 in 2023), while the proportion of sub‑prime (≤ 660) balances rose modestly (31 → 32%). The company continues to leverage credit‑score data for subprime classification, benchmarking and product segmentation, indicating that its credit‑risk modeling still relies on borrower credit scores as a key input for segmentation and risk assessment, but with a marginally higher emphasis on lower‑score segments in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Capital One updated the time period of credit score data used for product segmentation—from 2020–2021 data in 2022 to 2022–2023 data in 2023—indicating a shift to more current data in their risk modeling. In contrast, the LLM answer fabricates specific percentages (69% > 660 in 2022, 68% in 2023, subprime balances rising from 31% to 32%) that are not present in the ground truth and misrepresents the nature of the evolution. There is no mention in the original answer of FICO score thresholds like >660 or ≤660, nor any data about the share of cards or balances by score band. (2) The quantitative inaccuracies are severe: the percentages cited (69%, 68%, 31%, 32%) are entirely absent from the ground truth and cannot be verified. The original answer does not provide any such statistics, making these numbers hallucinated. (3) The multi-hop reasoning is flawed. The original answer hinges on a methodological shift—using more recent data for segmentation—which reflects a dynamic risk modeling strategy. The LLM instead focuses on unreported shifts in portfolio composition, missing the actual evolution in data usage and strategy. It fails to mention Table 21 or the change in reference periods (2020–2021 to 2022–2023), which are central to the correct answer. (4) While the LLM correctly identifies that credit score data is used for segmentation and risk modeling, this generic insight is not sufficient given the specific evolution described in the ground truth. The contextual relevance is moderate because it addresses credit score usage in segmentation, but the specifics are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 477,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS transitioned from being described primarily as a technology‑infrastructure investment that supports the broader retail and consumer businesses to a distinct, strategic growth pillar within Amazon’s portfolio. The 2023 filing explicitly positions AWS as a separate segment with its own leadership (CEO Adam Selipsky) and highlights continued heavy capital spending on AWS‑related technology infrastructure, while earlier 2022 commentary framed AWS mainly as a cost‑saving, efficiency‑driving service for the company’s overall operations. Consequently, investment priorities shifted toward expanding AWS’s service breadth (compute, storage, database, analytics, machine‑learning) and scaling global data‑center capacity, reflecting a deliberate focus on growing AWS as a standalone revenue and profit driver rather than a supporting function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of AWS from a supporting infrastructure and efficiency function in 2022 to a standalone, strategic business segment in 2023. The key shift in strategic positioning—emphasizing AWS as a distinct growth pillar rather than just an internal enabler—is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years (2022 and 2023) are correctly referenced, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in AWS’s role across two years, correctly identifying the shift in narrative from internal cost-saving and operational efficiency (2022) to external revenue-driving, service-expanding, and segment-level independence (2023). The mention of CEO Adam Selipsky adds contextual detail not in the original but is factually accurate and enhances relevance. (4) The LLM slightly omits the explicit mention that AWS became one of Amazon’s three core business segments (alongside North America and International), which is a key structural point in the original. However, the answer implies this by calling AWS a 'distinct, strategic growth pillar' and referencing its separate leadership and capital allocation. Wording differs but semantic meaning is largely equivalent. Minor deduction for this omission, but overall reasoning, entity accuracy, and contextual relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 433,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, PMI’s financial relationship with Rothmans, Benson & Hedges Inc. (RBH) underwent a material transformation due to the ongoing CCAA restructuring and the resolution of long-standing Canadian tobacco litigation. Following RBH’s entry into CCAA protection in March 2019, its financial results were deconsolidated from PMI’s consolidated statements, and a comprehensive stay of all Canadian tobacco-related litigation—including the $15.5 billion class action judgment against RBH—was in effect until March 2022. Although the stay expired, the legal exposure remained unresolved until PMI recorded a $2.3 billion non-cash impairment charge in December 2024 related to its equity investment in RBH, reflecting uncertainty over the allocation of a proposed CAD 32.5 billion settlement. This impairment, tied to the CCAA-mediated resolution process, underscores the material financial risk PMI faces from its historical association with RBH, despite no accrued liabilities being recorded in its consolidated financial statements for the pending cases.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PMI's financial relationship with RBH and correctly identifies key events: deconsolidation due to CCAA restructuring, expiration of the litigation stay in March 2022, and the 2024 impairment charge tied to the proposed CAD 32.5 billion settlement. However, there are minor quantitative inaccuracies affecting precision. The LLM states a '$2.3 billion' impairment charge, while the ground truth specifies '$2,316 million'—though close, this is not exact and represents a rounding or reporting discrepancy. Additionally, the LLM incorrectly states the impairment was recorded in 'December 2024', whereas the original answer implies it was recorded in the 2024 fiscal year without specifying December; this introduces a potentially false temporal precision. The LLM also references a '$15.5 billion class action judgment', which is not mentioned in the ground truth and introduces unverified detail, potentially confusing the specific CAD 32.5 billion proposed settlement. Despite these issues, the qualitative reasoning is strong: it correctly traces the shift from deconsolidation to equity method accounting and links the impairment to litigation risk. The answer synthesizes multi-hop information (CCAA, deconsolidation, litigation stay, settlement proposal, impairment) and maintains semantic alignment with the original on the key transformation in accounting treatment and financial exposure. Contextual relevance is excellent, directly addressing the evolution in accounting and exposure as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 423,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s commercial significance for GILD declined markedly. In 2022, it generated $8.6 billion in total revenue (≈ $7.0 billion in the U.S.), but by 2024 its sales had fallen to $5.57 billion overall ($3.64 billion in the U.S.), reflecting reduced market share and heightened competition. This revenue drop is compounded by product‑specific risks: Biktarvy relies on tenofovir alafenamide, a nucleoside backbone that could lose relevance if HIV treatment paradigms shift, and it faces intensified pricing pressure and reimbursement constraints from government programs such as the Inflation Reduction Act. Consequently, while still a major contributor to HIV sales, Biktarvy’s growth prospects are now limited by both market saturation and evolving clinical and regulatory risks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that Biktarvy generated $8,624 million ($8.624 billion) in 2022, which the LLM approximates reasonably as $8.6 billion—this part is acceptable. However, the LLM asserts that by 2024, sales fell to $5.57 billion globally and $3.64 billion in the U.S., which is not supported by the original answer; the ground truth explicitly states that 'specific revenue figures are not provided' for 2024. This makes the 2024 numbers entirely fabricated and a major error. (2) There are no calculations in the original answer to verify, but the LLM invents a decline of over $3 billion in revenue without any basis, leading to a severe quantitative inaccuracy. Format variations like $8.6B vs $8,624 million are acceptable, but invented data points are not. (3) The qualitative reasoning partially aligns with the original answer—both mention risks related to TAF-based therapies, potential shifts in treatment paradigms, and regulatory pressures (e.g., Inflation Reduction Act). The LLM correctly identifies Biktarvy's continued importance and growing risk environment, showing some valid multi-hop synthesis of product and risk factors. However, it incorrectly frames the evolution as a 'marked decline' in commercial significance due to falling sales, whereas the ground truth emphasizes sustained importance amid rising risks, not confirmed revenue drops. (4) Contextually, the answer addresses both revenue contribution and product risks as required by the question, so relevance is high. But due to the invention of unsupported 2024 revenue figures and the resulting incorrect conclusion about declining significance, the overall correctness score is low. Quantitative accuracy is severely compromised, qualitative accuracy is moderate due to correct identification of risk factors but flawed synthesis, and contextual relevance is solid despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 535,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s stake in TTX remained roughly constant at about a 36‑37 % economic and voting interest, and it continues to account for the investment in TTX under the equity‑method.  Consequently, the value of that investment (reported as $1.9 billion in 2024 and $1.8 billion in 2023) has been essentially unchanged, and the associated car‑hire expense—recorded in equipment and other rents—has risen modestly, from $375 million in 2021 to $432 million in 2024.  This reflects the ongoing operational relationship with TTX but does not indicate a material change in Union Pacific’s financial stake.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $432 million car hire expense in 2024 and references the $375 million figure from 2021, which aligns with the ground truth. However, it inaccurately states the investment value as $1.8 billion in 2023 and $1.9 billion in 2024, while the ground truth indicates an increase from $1.6 billion (referenced in the 2022 filing, corresponding to 2021) to $1.9 billion in 2024. The LLM omits the $1.6 billion figure and incorrectly implies stability in investment value over 2022–2024, when in fact there was a significant increase from the baseline. (2) Quantitative accuracy is partially compromised: while the endpoint (2024: $1.9B) is correct, the starting point ($1.6B in 2021) is missing, and the $1.8B figure for 2023 is not in the ground truth. The car hire expense progression is correctly reported at start and end points, though intermediate years are not discussed. (3) The reasoning is logically sound in interpreting the operational relationship and accounting method (equity method), and the conclusion about ongoing involvement is reasonable. However, the claim that there is 'no material change in financial stake' contradicts the ground truth's conclusion of 'growing financial and operational involvement,' especially given the $300M increase in investment value. This reflects a misinterpretation of the significance of the investment growth. (4) The answer is highly contextually relevant, addressing both investment value and car hire expenses, and correctly identifying the nature of the relationship. Despite minor factual omissions and one potentially misleading characterization, the core data points are mostly accurate, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 472,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla’s Solar Roof scaling strategy shifted markedly between 2022 and 2023. In 2022 the company emphasized expanding its installer network and training programs to accelerate deployment, while also working to secure reliable battery‑cell supply for the product’s structural pack. By 2023, the focus moved toward tightening supply‑chain risk management—leveraging in‑house cell production plans and diversified sourcing—to mitigate component shortages that had previously constrained Solar Roof output, and it continued to invest in installer training but framed it as part of a broader effort to scale production capacity and reduce reliance on external suppliers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the shift in Tesla's Solar Roof scaling strategy from 2022 to 2023. It accurately captures the 2022 focus on expanding installer training and deployment acceleration, and the 2023 pivot toward supply chain risk management. The mention of 'in-house cell production plans and diversified sourcing' aligns with the broader theme of supply chain resilience, though the original answer emphasizes supplier reliability and global component constraints more generally, without specific mention of battery-cell supply or structural packs—details not present in the ground truth. This introduces a slight over-specificity that isn't fully supported. Additionally, while the LLM correctly notes continued investment in installer training, the original answer frames 2023 as a shift away from installer-focused growth toward risk mitigation, which the LLM downplays slightly by integrating training into a broader capacity narrative. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and all entities (Tesla, Solar Roof, years 2022–2023) are correct. The reasoning is sound and reflects multi-hop synthesis across time periods and strategic domains (workforce vs. supply chain). Contextual relevance is strong, directly addressing both installer training and supply chain risk as asked. Minor deduction in qualitative accuracy due to subtle misemphasis on battery-cell supply, which is not highlighted in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 425,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company’s relationship with U.S. fountain retailers remained centered on the Company’s exclusive manufacturing and distribution of fountain syrups. In 2023, the Company continued to manufacture fountain syrups in the United States and sell them directly to fountain retailers (and, through authorized wholesalers, to other fountain retailers), while U.S. bottlers were generally not authorized to produce these syrups themselves. This structure, consistent with the bottler agreements described in the 2022 and 2023 10-K filings, means the Company maintains direct control over fountain syrup supply to U.S. retailers, with sales of these syrups reported within the North America operating segment. The evolution between 2022 and 2023 reflects no structural change in this model—fountain syrup manufacturing and sales to U.S. retailers remained a core, Company-managed function, distinct from bottler operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that The Coca-Cola Company continued to manufacture fountain syrups in the U.S. in both 2022 and 2023 and that U.S. bottlers were generally not authorized to produce them. It correctly identifies the Company’s direct sales to fountain retailers and through authorized wholesalers, and notes the reporting within the North America operating segment. However, the key evolution highlighted in the ground truth—Coca-Cola’s more explicit 2023 acknowledgment of selling syrups to bottling partners or authorized wholesalers who then distribute to fountain retailers, indicating a clarified or potentially expanded tiered distribution model—is downplayed. The LLM incorrectly asserts there was 'no structural change' and 'no evolution' in the model between 2022 and 2023, contradicting the ground truth’s emphasis on a more explicit recognition of bottling partners’ distribution roles in 2023. While all entities (Coca-Cola, bottlers, wholesalers, fountain retailers), years (2022, 2023), and operational roles are correctly identified, the reasoning fails to capture the nuance of evolving relationship dynamics—specifically, the shift in disclosure that suggests a more defined or expanded role for bottling partners in distribution. This omission constitutes a significant qualitative error in multi-hop synthesis, as the question specifically asks about evolution in the relationship. There are no numerical inaccuracies (hence full quantitative accuracy), and the response remains highly relevant contextually, but the failure to recognize and convey the subtle but important shift in distribution role acknowledgment reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 460,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's treatment and disclosure of the 0.950% Notes due 2025 reflects a consistent classification as long‑term debt in both its 2022 and 2024 filings, with the notes listed among the company's registered securities on the 2024 Form 10‑K (page 1) and disclosed in the financing‑segment discussion (page 4) as part of its hybrid‑cloud and AI‑focused financing strategy. The registration details remain unchanged—still identified by the ticker “IBM25B” on the New York Stock Exchange—and are presented alongside other debt instruments in the 2024 filing, while the 2022 filing similarly listed the notes in the “Long‑Term Debt” section (pages 28‑32) without any re‑classification or amendment to their maturity or interest‑rate terms. Thus, from 2022 to 2024 IBM has maintained the same financial‑instrument classification and registration details for the 0.950% Notes due 2025, merely updating the surrounding contextual disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The ground truth states that the 0.950% Notes due 2025 evolved from being disclosed in a 2017 Form 8-K (referenced in 2022 filings) to being actively listed with trading symbol 'IBM25B' on the NYSE by 2024—indicating a shift from disclosure to formal registration and listing. However, the LLM incorrectly asserts that the classification and registration details 'remained unchanged' from 2022 to 2024, directly contradicting the ground truth evolution. (2) Quantitatively, the LLM correctly identifies the ticker 'IBM25B' and the note's interest rate (0.950%), which aligns with the ground truth. However, it fabricates details such as page numbers (e.g., 'page 1', 'page 4', 'pages 28-32') and references to a 'hybrid-cloud and AI-focused financing strategy' not present in the original answer, undermining quantitative and factual accuracy. (3) The multi-hop reasoning is flawed: the question asks about evolution in treatment and disclosure, but the LLM concludes there was no change, missing the key progression from passive disclosure to active listing. It fails to recognize that the 2022 mention was a reference to a 2017 filing, while 2024 reflects current trading status—a critical distinction. (4) Contextual relevance is moderate because the answer discusses the right instrument and timeframe, and mentions the ticker and debt classification, but the central conclusion is factually wrong, leading to a low correctness score despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 423,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead’s strategic positioning of Biktarvy evolved from a high‑risk, high‑margin growth driver to a more financially resilient, differentiated cornerstone of its HIV portfolio.  In the 2022 10‑K (pages 62‑65), Biktarvy’s revenue was highlighted as a key contributor to overall sales, with its pricing and market share protected by strong clinical data and limited generic competition, but the filing also disclosed heightened exposure to pricing pressure and reimbursement reforms (e.g., IRA rebate changes).  By the 2024 filing (pages 16‑20), Gilead emphasized Biktarvy’s role in sustaining cash flow while diversifying risk—showcasing its continued market exclusivity, robust gross‑to‑net margin management, and competitive advantage through a once‑daily, dual‑class backbone that resists resistance, thereby reinforcing its differentiated position against both branded and generic rivals despite evolving regulatory and pricing headwinds.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in its qualitative assessment of GILD's strategic positioning of Biktarvy from 2022 to 2024, despite referencing plausible document sections and using reasonable financial terminology. (1) The core claim—that Biktarvy evolved into a 'more financially resilient, differentiated cornerstone'—directly contradicts the ground truth, which states that by 2024, GILD expressed *increasing financial risk* due to overreliance on TAF-based therapies like Biktarvy and concerns about shifting treatment paradigms. The actual trajectory is one of growing vulnerability, not improved resilience. (2) The LLM incorrectly frames Gilead’s 2024 narrative as one of risk diversification and margin management success, whereas the ground truth emphasizes rising risk exposure and uncertainty around long-term differentiation. (3) While no specific numeric values (e.g., revenue figures) are provided in either answer, the LLM’s references to 'gross-to-net margin management' and 'market exclusivity' lack support in the ground truth and introduce unverified positive spin. (4) The multi-hop reasoning fails: instead of synthesizing a shift from strong commercial positioning (2022) to heightened risk (2024), the LLM inverts the trend. The contextual relevance is moderate because it addresses the HIV market, Biktarvy, and financial risks, but the conclusion is directionally wrong. Quantitative accuracy is scored higher because there are no explicit numbers to verify or refute, and the document page references (though not part of the ground truth) do not contradict the evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 441,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Lockheed Martin's approach to defined contribution retirement savings plans remained unchanged between 2022 and 2023, with no new defined benefit pension plan transfers or settlements reported in 2023. However, in 2022, the company transferred $4.3 billion of gross defined benefit pension obligations and related plan assets to an insurance company via group annuity contracts (as noted on page 100), which relieved it of those obligations and resulted in a $1.5 billion noncash pension settlement charge. This transaction, along with the 2021 transfer of $4.9 billion in obligations, significantly reduced the company's pension liabilities and contributed to the net unfunded status improvement reflected in the 2023 consolidated balance sheet (page 84), where the net unfunded status for qualified pension plans decreased to $6,159 million from $8,255 million in 2021. The 2023 financial impact of these prior transfers was limited to the amortization of actuarial losses recorded in accumulated other comprehensive loss, with no new settlement charges recognized in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct facts but fundamentally misrepresents the evolution of Lockheed Martin's approach between 2022 and 2023. It incorrectly states that no new pension settlements occurred in 2023, which contradicts the ground truth: in 2023, Lockheed made $414 million in settlement payments to about 6,500 former employees. This is a major factual omission that changes the entire interpretation of the company's strategy. The 2022 facts are accurate: $4.3 billion in pension obligations were transferred via group annuity contracts, resulting in a $1.5 billion noncash settlement charge. (2) Quantitatively, the numbers for 2022 are correct ($4.3 billion transfer, $1.5 billion charge), and the balance sheet improvement from $8,255 million to $6,159 million unfunded status is accurately reported. However, the LLM fails to mention the $414 million in 2023 settlement payments, a key quantitative fact. (3) The reasoning is flawed because it concludes that the approach remained unchanged or that no new settlements occurred in 2023, when in fact there was a strategic shift from large insurer transfers (2022) to direct individual settlements (2023). The model does not recognize this evolution, which is the core of the question. It incorrectly attributes the 2023 financial impact solely to amortization of prior losses, ignoring the new settlements. (4) The contextual relevance is moderate because the answer discusses pension obligations and financial impacts, but it misses the central point about strategic evolution. The qualitative accuracy is low due to the failure in multi-hop reasoning: it does not synthesize the contrast between 2022 and 2023 actions. The quantitative accuracy is higher because the numbers it does report are correct, though incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 490,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Based on the provided SEC filings, IBM's debt instruments maturing in 2025 have evolved in composition between 2022 and 2024. In the 2022 filing (page 1), the 2.875% Notes due 2025 were listed as a standalone issue with a 2.875% coupon. By the 2024 filing (page 1), this instrument was reclassified as part of a broader set of 2025 maturities, now grouped under \"2.875% Notes due 2025\" alongside other 2025 notes (e.g., 0.950% Notes due 2025 and 0.300% Notes due 2026). The 2024 filing also added new 2025 maturities like 2.900% Notes due 2030 (though this matures later, it reflects restructuring), while the original 2.875% Notes due 2025 remained outstanding but were integrated into a more diversified 2025 maturity profile. The key evolution is the shift from a single 2.875% issue to a structured group of 2025 maturities, though the specific 2.875% Notes due 2025 itself was not retired or significantly altered in terms of coupon or maturity date.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that in 2022 the 2.875% Notes due 2025 were a 'standalone issue', while the ground truth confirms that in 2022, IBM already had multiple notes due in 2025, including the 0.950% and 0.875% Notes. This misrepresents the composition. (2) The LLM incorrectly claims that in 2024, the 2.875% Notes were 'grouped' with other notes such as the '0.300% Notes due 2026', which matures in 2026, not 2025—this is a clear error in entity and date accuracy. (3) The mention of '2.900% Notes due 2030' as part of 2025 maturities is factually wrong and suggests confusion in multi-hop reasoning—this note does not mature in 2025 and should not be included in the composition analysis for that year. (4) Crucially, the ground truth highlights that the 0.875% Notes due 2025 (IBM 25C) were removed by 2024, indicating a shift in composition, but the LLM fails to mention this retirement. Instead, it falsely implies diversification by adding new 2025 notes, which is unsupported. (5) The LLM correctly identifies that the 2.875% Notes due 2025 remained outstanding, which aligns with the ground truth, but the overall synthesis is flawed. The reasoning is partially sound in tracking changes over time, but incorrect entity mapping and inclusion of irrelevant debt instruments reduce qualitative accuracy. Contextually, the answer addresses the evolution of debt composition and focuses on the right instrument, so relevance is moderate. However, due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 446,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s strategic importance within Gilead’s HIV portfolio has grown markedly, shifting from a key growth driver after Truvada/Atripla loss of exclusivity to a cornerstone of a diversified antiviral franchise. While 2022‑2023 documents highlight continued double‑digit sales growth and expanding pediatric indications, 2024 disclosures note heightened competitive pressure from generic tenofovir alafenamide products and emerging long‑acting HIV regimens, prompting Gilead to focus on differentiated dosing, pediatric expansion, and combination strategies to preserve market share and mitigate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in tone and factual synthesis compared to the ground truth. While it correctly identifies Biktarvy as a key asset in Gilead's HIV portfolio, it mischaracterizes its strategic evolution. The original answer states that Biktarvy's position became 'more precarious' by 2024 due to risks from treatment paradigm shifts, whereas the LLM portrays its strategic importance as having 'grown markedly,' which contradicts the source. This is a major qualitative error in interpretation. (2) Quantitatively, the LLM mentions 'double-digit sales growth' and 'pediatric indications' but these specifics are not present in the ground truth; no percentages or indications are cited in the original, so their inclusion introduces unverified detail. However, there are no explicit numerical errors (e.g., wrong years or dollar amounts), so quantitative accuracy is partially preserved. (3) The multi-hop reasoning is partially sound—linking 2022 growth to 2024 risks—but fails in synthesis: the original emphasizes increasing vulnerability due to reliance on TAF and potential shift away from nucleoside-based therapies, a key risk factor entirely missing in the LLM response. Instead, the LLM cites competition from generics and long-acting regimens, which, while plausible, are not mentioned in the ground truth and represent a divergence in risk attribution. (4) Contextual relevance is high because the answer addresses the evolution of strategic importance and risk profile over time and responds to competitive pressures and treatment changes. However, the core conclusion about Biktarvy’s growing strategic importance directly contradicts the ground truth narrative of increasing vulnerability, warranting a moderate correctness score of 5 due to significant factual and interpretive discrepancies despite relevant structure and plausible context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 513,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1,764 million at the end of fiscal 2022 to $3,089 million at the end of fiscal 2023. During fiscal 2023 the Company deposited $1,500 million into the escrow account, and during fiscal 2022 it deposited $1,000 million.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fiscal 2023 escrow balance ($3,089 million) and both deposit amounts ($1,000 million in FY2022 and $1,500 million in FY2023), which match the ground truth. However, it incorrectly states the FY2022 ending balance as $1,764 million instead of $1,449 million, a significant factual error affecting quantitative accuracy. (2) The deposit figures are accurate and correctly attributed to the respective fiscal years. The ending balance for FY2023 is correct. The starting balance error leads to an incorrect implied change in balance (increase of $1,325 million vs. actual $1,640 million), though this was not explicitly calculated in the answer. (3) The reasoning is logically sound and addresses both parts of the question: evolution of the balance and specific deposit contributions. The model correctly synthesizes information across two fiscal periods and links deposits to the respective years, showing proper multi-hop understanding. (4) Despite the incorrect initial balance, the answer includes all key elements and conveys a largely accurate narrative. The error in the FY2022 balance is material but does not undermine the entire response, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily (6) due to the incorrect dollar amount. Qualitative accuracy remains high (8) due to correct entity and temporal alignment. Contextual relevance is perfect (10) as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 419,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, Coca‑Cola’s North America operating segment saw fountain‑syrup sales remain part of its concentrate operations, but the company increasingly shifted responsibility for those syrups to its bottling partners and consolidated bottling operations.  In 2023, concentrate operations accounted for 58 % of net revenue (up from 56 % in 2022), while finished‑product operations fell to 42 % (down from 44 %).  This reflects a strategic move to let bottlers handle fountain‑syrup manufacturing and distribution, allowing Coca‑Cola to focus on marketing and innovation while maintaining oversight through its integrated quality and supply‑chain programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that fountain syrups are part of concentrate operations in North America, it introduces unsupported claims about a strategic shift toward bottling partners handling manufacturing and distribution. The ground truth states that Coca-Cola maintained direct manufacturing and selling of fountain syrups in the U.S. in both 2022 and 2023, with only a noted change outside the U.S. where bottling partners were authorized to manufacture syrups. There is no evidence in the original answer of a shift 'increasingly' toward bottler responsibility in North America. (2) The quantitative data—58% and 56% concentrate revenue shares, and 42%/44% finished-product splits—are entirely fabricated and not present in the original answer or implied by it. These percentages do not appear in the ground truth and cannot be verified from the provided information, making the quantitative accuracy very low. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift based on revenue percentage changes that are not in the source data, and incorrectly generalizes global changes (outside the U.S.) to the North America segment. It fails to distinguish between U.S. and non-U.S. operations, a key nuance in the original answer. (4) Despite these issues, the answer is contextually relevant—it addresses fountain syrups, the North America segment, and manufacturing/distribution responsibilities—and captures the general idea of operational continuity in concentrate sales. However, the invented metrics and incorrect inference about decentralization significantly undermine factual correctness, warranting a moderate-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 472,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Based on the provided SEC filings, IBM's 0.950% Notes due 2025 (classified as IBM 25B in both 2022 and 2024 filings) remain part of its long-term debt structure with no indication of maturity changes between 2022 and 2024. The 2024 filing confirms the 0.950% Notes due 2025 are still outstanding and listed among the company's debt instruments, while the 2022 filing similarly identifies them as a 2025 maturity tranche. No evolution in composition or maturity terms for this specific tranche is documented in the provided pages.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.950% Notes due 2025 (IBM 25B) remained outstanding in both 2022 and 2024, which is factually accurate per the ground truth. It also correctly states there was no change in maturity terms for this specific tranche. However, the LLM fails to mention the broader evolution in the composition of IBM's 2025-maturing debt instruments—specifically, the removal of the 0.875% Notes due 2025 (IBM 25C) by 2024. This omission significantly limits completeness. (2) Quantitatively, all percentages (0.950%, 2.875%, etc.) and instrument labels (IBM 25B) are accurate, and no incorrect numbers are presented. The LLM does not misstate any figures, so quantitative accuracy is high. (3) The reasoning is sound for the subset of information provided but fails the multi-hop requirement to compare the full set of 2025-maturing instruments across years. The question asks about the 'composition' of debt, which implies analyzing all relevant tranches, not just the 0.950% Notes. The LLM narrows the focus to only the 0.950% Notes, missing the comparative analysis of the full debt structure. (4) While contextually relevant and factually correct on the narrow point about IBM 25B, the answer lacks the comparative synthesis needed to fully address how the composition evolved. Hence, correctness and qualitative accuracy are reduced due to incomplete multi-hop reasoning, despite accurate individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 400,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney’s cruise‑ship strategy shifted markedly between 2022 and 2024. In the 2022 filing the company highlighted the planned opening of its new Disney Cruise Line destination at Lighthouse Point (Eleuthera) for 2024 and noted that cruise operations were still being constrained by COVID‑19‑related health and safety measures and by the need to manage capacity and financing. By the 2024 filing Disney disclosed that it had “announced plans for additional expansion of our fleet of cruise ships” and was investing in new ships and related infrastructure, indicating a deliberate move from a tentative, pandemic‑impacted rollout to an aggressive growth agenda. This evolution reflects a strategic pivot toward treating cruise‑line expansion as a core growth pillar, backed by dedicated capital and a focus on new destination assets, while still acknowledging the ongoing influence of health‑related risks and macro‑economic conditions on profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Disney's cruise strategy from 2022 to 2024 with generally accurate reasoning and context, but includes a specific detail not present in the ground truth, affecting factual precision. (1) The LLM correctly identifies a strategic shift from pandemic-affected operations in 2022 to active fleet expansion in 2024, aligning with the ground truth's emphasis on moving from passive dependence on consumer demand to active investment. However, the LLM introduces the detail about the 'planned opening of its new Disney Cruise Line destination at Lighthouse Point (Eleuthera) for 2024' in the 2022 filing — this specific project and location is not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making it a factual overreach. (2) There are no explicit numbers (e.g., dollar amounts, ship counts, dates beyond 2024) in either answer, so quantitative accuracy is high by default; the mention of '2024' as a target for opening is plausible and does not contradict the ground truth, earning a strong score. (3) The multi-hop reasoning is sound in structure — comparing strategic language across years — but the inclusion of unverified specifics (Lighthouse Point) reduces qualitative accuracy. The ground truth emphasizes a shift in tone and strategic framing (from demand dependence to capital-intensive expansion), which the LLM captures conceptually but embellishes with unsupported detail. (4) Contextual relevance is high because the answer directly addresses the evolution in strategic approach, uses appropriate framing (pandemic constraints → growth agenda), and acknowledges risks. Overall, the answer is factually close but not fully aligned due to the addition of unverified specifics, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 487,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy remained focused on using group‑annuity contracts to off‑load defined‑benefit obligations, but the scale and financial impact shifted noticeably from 2022 to 2023. In 2022 the company completed a $4.9 billion GAC purchase that transferred roughly 18 000 retiree obligations and generated a $1.7 billion non‑cash settlement charge, while 2023 filings show continued purchases of GACs (totaling about $11.6 billion since 2018) and an expectation of further risk‑transfer transactions that could produce additional settlement charges. The 2023 disclosures emphasize that future pension‑risk‑transfer deals may require extra contributions to the pension trust and could materially affect earnings, reflecting a strategic intent to reduce long‑term pension volatility and funding risk while accepting the possibility of periodic earnings volatility from settlement accounting.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Lockheed Martin's pension risk transfer strategy from 2022 to 2023. (1) Quantitatively, most numbers are accurate: the $4.9 billion pension obligation transfer and $1.7 billion noncash settlement charge in 2022 are correctly reported. The $11.6 billion cumulative transfers since 2018 (not 2022–2023) is also correct, though the LLM slightly misattributes the timing by implying ongoing purchases in 2023 without specifying that the $11.6B is a cumulative figure through 2022. The ground truth specifies the 2021 transaction was disclosed in 2022 filings, which the LLM simplifies to 'in 2022,' a minor imprecision but acceptable for annual reporting context. (2) The LLM incorrectly states that the $4.9B transfer covered 'roughly 18,000 retiree obligations'—this number is not in the ground truth; instead, the 95,000 retirees figure (cumulative since 2018) is omitted. This is a notable omission and introduces an unsupported specific number, reducing quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the strategic shift: continued evaluation of GACs, focus on future contributions and earnings impact, and acceptance of settlement charges. However, it misses the key 2023 nuance about residual liability risk if insurers default—a critical addition in the 2023 filing that reflects a more cautious stance. This omission affects completeness and qualitative depth. (4) Contextual relevance is strong: the answer directly addresses financial impact and strategic intent across both years, synthesizing multi-hop information (2022 transaction details, cumulative activity, 2023 forward-looking risks). While the reasoning is sound and semantically close, the introduction of an unverified retiree count and omission of insurer default risk prevent a top score. Overall, the answer is factually strong but has minor but meaningful gaps in completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 525,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Tesla’s financing‑partner relationship shifted markedly between 2022 and 2023.  In 2022 the company’s accounts‑receivable balance was largely tied to regulatory‑credit sales and long‑term government rebates, with modest receivables from leasing partners, whereas by 2023 the receivables section shows a larger, more diversified pool of balances from financing partners and a higher reliance on operating‑lease vehicles (e.g., $5.28 bn of leased vehicles versus $3.54 bn in 2020).  This expansion increased exposure to credit risk and required more robust allowance for doubtful accounts, while the leasing program’s risk profile grew as residual‑value guarantees and resale‑value fluctuations became more material, especially under the newer vehicle‑leasing arrangements.  Consequently, Tesla’s management now emphasizes tighter monitoring of partner creditworthiness and greater scrutiny of residual‑value assumptions to mitigate potential losses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution in Tesla's financing partner relationship from 2022 to 2023, correctly identifying increased risk in leasing and credit exposure. However, it introduces specific dollar figures ($5.28 bn leased vehicles, $3.54 bn in 2020) not present in the original answer or supported by the ground truth, which undermines factual accuracy. The original answer does not mention regulatory-credit sales or government rebates as primary drivers of receivables, nor does it reference 2020 data, making those additions speculative and incorrect. (2) Quantitative accuracy is low because the cited numbers—$5.28 billion and $3.54 billion—are not in the ground truth and cannot be verified from the provided context. The original answer focuses on settlement timing (two weeks in 2022) and risk evolution in 2023, but the LLM invents precise financials absent in the source, constituting significant factual errors. (3) Qualitatively, the reasoning is sound in identifying a shift toward greater risk in leasing programs, residual value exposure, and the need for tighter partner monitoring—this aligns with the original answer’s emphasis on increased complexity and residual value risks in 2023. The multi-hop synthesis between accounts receivable management and leasing risk is appropriately addressed, though based on fabricated data. (4) Contextual relevance is high because the response directly addresses both parts of the question—evolution in financing partner relationships, accounts receivable management, and leasing risks—using appropriate financial terminology and logical progression. Despite incorrect numbers, the conceptual framework matches the ground truth’s narrative arc. The correctness score is 6 due to accurate qualitative direction but major quantitative inaccuracies that affect trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 504,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution model to move away from relying on bottlers to manufacture and sell fountain syrups, instead centralizing syrup production and sales to authorized fountain wholesalers and direct fountain retailers. This change reduced bottlers’ roles in fountain syrup distribution, particularly in the U.S., where bottlers were no longer authorized to manufacture fountain syrups and instead focused on concentrate sales to bottlers under new long-term agreements. The company also strengthened its direct relationships with fountain retailers and wholesalers, aligning with its broader strategy to control key distribution channels and support digital commerce growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its description of Coca-Cola's fountain syrup distribution strategy evolution between 2022 and 2023. According to the ground truth, the shift was toward *greater* involvement of bottlers—especially outside the U.S.—in manufacturing and distributing fountain syrups using Coca-Cola concentrates, moving from a centralized to a more integrated model. However, the LLM incorrectly states that Coca-Cola moved to *centralize* production and *reduce* bottlers’ roles, which is the opposite of the actual change. This represents a critical failure in multi-hop reasoning and factual synthesis. While there are no explicit numerical values to verify (so quantitative accuracy is not heavily penalized), the qualitative inaccuracies are severe: the roles of bottlers and wholesalers are misrepresented, and the direction of change is reversed. The answer does address the question contextually—discussing distribution strategy, bottlers, and wholesalers—so it maintains moderate relevance, but the core facts and logic are flawed. Entity names (Coca-Cola, bottlers, fountain wholesalers) are correct, but their functional roles and the timeline of changes are not. Thus, the correctness and qualitative accuracy scores are low despite acceptable structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 363,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Based on the provided SEC 10-K pages, AMD's financial relationship with the ATMP JV evolved significantly between 2023 and 2024: (1) AMD made a $17 million equity contribution to the ATMP JV in August 2024, increasing its equity stake to 15% and raising the carrying value of its investment from $99 million (2023) to $149 million (2024); (2) AMD recorded $47 million in licensing gains from the ATMP JV in 2024 (up from $34 million in 2023); and (3) AMD had $12 million in receivables from the ATMP JV as of December 2024, reflecting ongoing commercial activity. The ATMP JV remains a key supplier for AMD's assembly/test/packaging needs, with $1.7 billion in purchases from the JV during 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AMD had $9 million in receivables from the ATMP JV in 2023 and $12 million in 2024, with a new $100 million one-year term loan introduced in 2024. However, the LLM claims a $17 million equity contribution in August 2024, increasing AMD’s stake to 15% and raising the carrying value of its investment from $99M to $149M—none of which is supported by the original answer. Additionally, the LLM mentions $47M in licensing gains (up from $34M in 2023) and $1.7B in purchases from the JV in 2024, none of which appear in the ground truth. (2) Quantitative accuracy is very low: all key numbers (equity contribution, investment carrying value, licensing gains, purchase volume) are either fabricated or misattributed. The only correct number is the $12M receivables in 2024. The $100M term loan, a major factual point in the ground truth, is entirely omitted. (3) The multi-hop reasoning is flawed. The question asks about evolution in receivables and new investment activities. The LLM invents an equity investment narrative instead of reporting the actual debt-based financial integration (term loan). It fails to contrast the absence of investment/loan in 2023 with the $100M loan in 2024, which is central to the correct analysis. (4) Contextual relevance is moderate because the answer discusses AMD and ATMP JV in the correct timeframe and touches on financial relationships, but it introduces unrelated or incorrect financial activities (equity contributions, licensing gains, large-scale purchases) that distort the actual nature of the relationship. The core evolution—from transactional to financially integrated via a loan—is completely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 477,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Lockheed Martin accelerated its pension settlement strategy between 2022 and 2023 by transferring $4.3 billion of defined‑benefit obligations to insurers in 2022 and $414 million in lump‑sum settlements in 2023, resulting in a $1.5 billion non‑cash settlement charge in 2022 and a $414 million reduction in benefit obligations in 2023. These settlements lowered the unfunded status from $(5,470) million in 2022 to $(6,159) million in 2023, while also generating actuarial gains that reduced accumulated other comprehensive loss, thereby lessening future pension expense volatility and improving the company’s long‑term financial position.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant factual inaccuracies. It correctly identifies the $4.3 billion pension obligation transfer in 2022 and the $1.5 billion noncash settlement charge in that year, as well as the $414 million in 2023 settlements. However, it incorrectly states that the $414 million in 2023 was a 'lump-sum settlement' resulting in a 'reduction in benefit obligations' of the same amount, while the ground truth specifies these were voluntary payments to former employees—not necessarily lump-sum settlements—and does not state the financial impact beyond the payment amount. More critically, the LLM claims the unfunded status worsened from $(5,470) million in 2022 to $(6,159) million in 2023 and attributes this to the settlements, which contradicts the expected outcome of liability reduction and is unsupported by the original answer. This calculation and interpretation are incorrect. (2) The numbers themselves (4.3B, 1.5B, 414M) are accurate in magnitude and year, but the derived metrics (unfunded status change, actuarial gains, impact on AOCI) are not present in the ground truth and appear fabricated or misattributed. The original answer does not mention unfunded status, actuarial gains, or accumulated other comprehensive loss, so including them introduces false precision. (3) The multi-hop reasoning is partially sound—linking 2022 and 2023 actions to a broader liability management strategy—but incorrectly infers financial statement impacts beyond what the ground truth supports. The shift from large-scale annuity purchases to smaller targeted payments is implied but misrepresented as an 'acceleration' rather than a scaling down. (4) The contextual relevance is high because the answer addresses the evolution of pension strategy and financial impacts, but the correctness score is low due to major quantitative and qualitative errors in financial statement effects. The answer creates a misleading narrative of financial improvement with unsupported metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 550,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved such that its equity investment increased from $99 million (as of December 30, 2023) to approximately $149 million (as of December 28, 2024), reflecting a $17 million additional equity contribution in August 2024. The Company continues to account for its 15 % interest under the equity method, recognizing equity income of $33 million in 2024 (up from $16 million in 2023), while also engaging in significant related‑party transactions, including $1.7 billion of purchases and $121 million of resales with the JV, and a $100 million term loan extended to the JV in October 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key financial figures are correct: the 2023 equity income ($16M), 2024 equity income ($33M), 2023 carrying value ($99M), 2024 carrying value ($149M), and the $17M additional contribution in August 2024 are all factually correct. The calculation of the investment increase is accurate (99M + 17M = 116M, with the remainder likely due to equity income and other adjustments under the equity method, which is consistent with accounting principles). (2) The answer includes additional context not in the original answer—such as AMD's 15% interest, related-party transactions ($1.7B purchases, $121M resales), and the $100M term loan—which are factually correct and enhance completeness, though not required by the question. These do not detract from accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across time (2023 to 2024), tracks investment changes, and links equity income to the JV relationship. (4) The only minor shortcoming is that the explanation of how the carrying value increased from $99M to $149M could be slightly more explicit (e.g., $17M contribution + $17M net income/share, etc.), but this is not required for correctness. The answer exceeds the original in detail without introducing errors. Thus, quantitative accuracy is perfect, qualitative accuracy is excellent, and relevance is full. A score of 9 is justified due to slight over-elaboration without error, but core correctness is intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 417,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Johnson & Johnson’s stake in Kenvue fell from roughly 89.6 % (post‑IPO) to about 9.5 % by the end of 2024, after it sold the remaining shares in a debt‑for‑equity exchange in May 2024. The company recorded a $2.8 billion gain on the retained Kenvue shares and a $0.4 billion loss on the exchange, but it no longer holds any equity in Kenvue. Consequently, there are no retained equity or associated gains/losses to report for 2024 beyond the one‑time gain recognized in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the timeline and ownership percentages. It incorrectly states that Johnson & Johnson's stake fell to 9.5% by the end of 2024, when in fact the 9.5% stake was retained in 2023 after the initial spin-off and exchange offer. The full exit occurred in 2024 via the debt-for-equity exchange, meaning the 9.5% stake was not held until 2024. Additionally, the LLM implies the $2.8 billion gain was recognized in 2023 but then incorrectly associates it with 2024 reporting, contradicting the original answer which clearly states the $21.0 billion total non-cash gain (including $2.8 billion on retained shares) was recognized in 2023. The $0.4 billion loss is correctly identified as occurring in 2024. (2) Quantitative accuracy is partially correct: the $2.8 billion gain on retained shares and $0.4 billion loss are accurate, and the final elimination of ownership is correct. However, the initial post-IPO stake of 89.6% is not mentioned in the ground truth and appears to be an unsupported addition. The ground truth does not specify the post-IPO percentage, only that a 9.5% stake was retained in 2023. The exact share count (182,329,550) is omitted in the LLM answer, but this is a minor omission. (3) Multi-hop reasoning is partially sound: the model correctly identifies the two-step divestment (partial sale in 2023, full exit in 2024) and the financial impacts. However, it misorders the timeline by implying the 9.5% stake persisted into 2024 before the debt exchange, when in fact the debt exchange in 2024 involved the remaining stake after already reducing to 9.5% in 2023. (4) Contextual relevance is high—the answer addresses the evolution of ownership, retained equity, and gains/losses. Despite incorrect sequencing, it attempts the correct synthesis. The conclusion that there are no retained equity or gains in 2024 beyond the 2023 gain is semantically aligned, though the reasoning is flawed. Overall, the answer is partially correct but contains key factual and chronological errors that reduce its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 565,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023. The guarantee agreement for Southwestern Bell's obligations (referenced as Exhibit 4-c in the 2011 filing and still in effect in 2023) was not modified or terminated during this period, as evidenced by its continued inclusion in the \"Certain Exhibits\" section of the 2023 filing (page 102). The company maintained its existing guarantee structure without any material changes to the terms or scope of the guarantee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, with the guarantee continuing under Exhibit 4-c. The answer correctly identifies the continuity of the guarantee and its inclusion in the relevant filings. Quantitatively, there are no numerical inaccuracies—though no specific dollar amounts or percentages are involved, the references to Exhibit 4-c and the unmodified nature of the guarantee are consistent with the original answer. The mention of the '2011 filing' as the origin of Exhibit 4-c is extraneous but does not contradict the 2022–2023 consistency claim and may reflect background context not in the ground truth; this does not detract significantly from accuracy. The reasoning is sound: the model correctly synthesizes information across years and identifies the persistent inclusion of Southwestern Bell Telephone Co. in the guarantee structure. The answer addresses all parts of the question—evolution (or lack thereof) and inclusion in guarantee agreements—making it contextually relevant and semantically equivalent to the original answer. Minor deduction in qualitative accuracy due to the potentially confusing reference to the 2011 filing, which was not part of the ground truth timeframe but does not invalidate the core conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 393,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's hypersonics involvement evolved from early development and testing to a more defined production phase, with multiple programs transitioning into early production through 2026. The company emphasized strategic positioning of hypersonics within its growth pillars—alongside classified programs and current programs of record—while expanding its focus on advanced technologies and partnerships to maintain competitiveness in this domain.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lockheed Martin's hypersonics involvement and correctly identifies it as a strategic growth area alongside classified programs, which aligns with the ground truth. However, it introduces information not present in the original answer: specifically, the claim that programs are transitioning into 'early production through 2026' and that the company has moved into a 'production phase' is not supported by the ground truth, which focuses on a shift in categorization from a potential growth area in 2022 to an active program under the Space segment in 2023. The ground truth emphasizes a change in strategic positioning and reporting structure (i.e., being listed among major programs), not a transition to production. While the LLM correctly notes the strategic emphasis and competitive positioning, it overreaches on program maturity and timeline details not present in the source. There are no numerical figures to verify, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but includes unsupported inference, reducing qualitative accuracy. The response remains contextually relevant and addresses the core question about evolution in strategic positioning and responsibilities, but lacks precision in representing the nature of the shift as defined in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 375,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1.4 billion at September 30 2022 to $3.1 billion at September 30 2024. During fiscal 2023, the Company deposited $1.0 billion into the escrow account, and during fiscal 2024 it deposited $1.5 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The balance evolution is incorrectly stated: it claims the balance increased to $3.1 billion as of September 30, 2024, whereas the ground truth reports $3.089 billion as of September 30, 2023. The LLM incorrectly shifts the timeline forward by one year. Additionally, the deposits are misattributed: it states $1.0 billion was deposited in fiscal 2023 (partially correct) but claims $1.5 billion was deposited in fiscal 2024, which is not addressed in the question or ground truth. The original answer specifies $850 million deposited in fiscal 2022 and $1.0 billion in fiscal 2023—these are partially correct in amount for 2023 but completely wrong for 2022, and the years are misrepresented. (2) Number verification: $1.4 billion starting balance is correct; ending balance should be $3.089B as of 2023 (not 2024), and $3.1B is a reasonable rounding of $3.089B, so that could be acceptable—but the date is wrong. Deposit amounts: $1.0B in FY2023 matches, but $1.5B in FY2024 is incorrect and irrelevant; $850M in FY2022 is omitted. (3) Multi-hop reasoning failure: the model fails to correctly associate deposits with the correct fiscal years and reports data for a year (2024) not asked about. It does not accurately synthesize the balance change from 2022 to 2023 or the corresponding deposits. (4) Correctness score is low due to major factual and temporal inaccuracies. Quantitative accuracy is poor due to wrong years and incorrect deposit figures. Qualitative accuracy is low due to flawed reasoning and entity (fiscal year) confusion. Contextual relevance is moderate because the topic and metric are correct, but the details are largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 470,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "Based on the 2024 10-K disclosures, Outdoor Garden's role within HD's Hardlines product line has shifted from a standalone merchandising category to an integrated component under the broader Hardlines segment, reflecting a strategic realignment of merchandising departments across product lines. Performance metrics show Outdoor Garden's sales are now tracked within the Hardlines net sales ($48,562 million in fiscal 2024), with its growth and classification directly tied to the segment's overall performance, which remained stable at $153,108 million in fiscal 2024 (vs. $152,669 million in 2023), indicating consistent positioning within HD's core product strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift of Outdoor Garden from a standalone category to being integrated under the broader Hardlines segment, which aligns with the ground truth. However, it introduces significant factual inaccuracies in quantitative details. The ground truth states Outdoor Garden had $10,317 million in net sales in 2022, accounting for 6.8% of total sales, but the LLM answer does not mention this 2022 figure or percentage. Instead, it incorrectly claims Outdoor Garden's sales are now part of Hardlines net sales of $48,562 million in 2024 — a number not present in the ground truth and unsupported by the provided data. Additionally, the LLM states total net sales were $153,108 million in 2024 vs $152,669 million in 2023, implying stability, but this total is not mentioned in the original answer and cannot be verified from the given context. (2) The only correct number implied is that Outdoor Garden was a distinct line in 2022 and merged into Hardlines by 2024, but all specific dollar amounts and percentages in the LLM response are either fabricated or misattributed. There is no evidence in the ground truth that Hardlines was $48.5B in 2024 or that overall sales were ~$153B. (3) The reasoning about strategic integration is sound and reflects multi-hop understanding — connecting classification changes over time to strategic positioning — but the use of false performance metrics undermines the validity of the conclusion. The model infers performance from incorrect totals, failing to report the key 2022 metric that established Outdoor Garden’s significance. (4) The contextual relevance is high because the answer addresses the evolution of product strategy and classification. Qualitative accuracy is moderate due to correct conceptual framing but missing key evidence. Quantitative accuracy is low due to unsupported figures. Correctness score is 5 because core strategic insight is correct, but critical data points are wrong or missing, and new unverified metrics are introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 551,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD maintains its emphasis on an engaging and open environment as its global workforce expands by consistently highlighting its culture of innovation, inclusion, and employee voice in official disclosures. The company reports that its 2023 and 2024 annual engagement surveys placed it in the top 10% of technology firms, with employees describing the culture as inclusive, innovative, and respectful, and citing strong manager quality and participation in employee resource groups. This focus on culture, development, and flexible work arrangements is presented as a strategic pillar to attract and retain talent in a competitive semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. Most critically, it introduces data about '2023 and 2024 annual engagement surveys' placing AMD in the 'top 10% of technology firms' with employee descriptions of culture, manager quality, and participation in employee resource groups—none of which appear in the original answer or are supported by the knowledge graph. These details are fabricated or hallucinated. Additionally, the LLM mentions 'flexible work arrangements' and 'development' as strategic pillars, which are not referenced in the original answer. (2) Quantitatively, the original answer specifies workforce numbers (26,000 in 2023, 28,000 in 2024) and a calculated 7.7% growth rate. The LLM omits all numerical workforce data and growth percentage, failing to report key quantitative facts. No calculations are attempted or required in the LLM response. (3) The multi-hop reasoning is partially sound in that the LLM infers a talent retention strategy from cultural emphasis, aligning with the original conclusion. However, it fails to base this on the actual evidence—consistent repetition of identical cultural language across years despite workforce growth—which is the core of the original reasoning. Instead, it substitutes unsupported survey data. (4) The contextual relevance is high because the LLM addresses both parts of the question: how AMD maintains culture during expansion and what this suggests about talent retention. However, the factual inaccuracies and missing quantitative data severely undermine correctness. While the general direction of reasoning is aligned, the lack of fidelity to the source data results in a partially correct but significantly flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 478,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's relationship with The Ohio Bell Telephone Company regarding guarantee obligations remained unchanged between 2022 and 2023. The company continued to provide guarantees for certain obligations of The Ohio Bell Telephone Company (and other Bell subsidiaries) as disclosed in Note 4-b of the 2023 filing (Exhibit 4-c), which references the same guarantee arrangement previously filed in 2011 (Exhibit 4-d). There is no indication of any modification, termination, or new guarantee obligations related to The Ohio Bell specifically in the 2022 or 2023 filings; the guarantee structure appears consistent with prior years, with no new commitments or material changes noted in the financial statements or related disclosures. The obligations remain part of AT&T's ongoing corporate structure as a holding company for its Bell subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T maintained its guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023, with the arrangement originating in 2011. The LLM correctly notes that the exhibit reference changed (from Exhibit 4-d to 4-c), though it slightly mischaracterizes the direction of the update—Exhibit 4-c in 2023 replaced the earlier 2011 filing (originally 4-d), not the other way around. This is a minor documentation detail and does not affect the substance. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and filings, identifying continuity in the guarantee structure and referencing the appropriate exhibit and note. (4) The answer is contextually relevant, fully addressing the evolution (or lack thereof) in the relationship and focusing on guarantee obligations. The conclusion that there were no material changes is consistent with the ground truth. The only minor shortcoming is the slight confusion in exhibit numbering history, which does not undermine the overall correctness. Hence, a 9 is justified for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 361,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "The financial impact of GE's relationship with AerCap evolved such that gains on retained and sold ownership interests declined sharply in 2024, decreasing by $5.2 billion compared with 2023, primarily due to lower gains from the AerCap investment. In contrast, 2023 saw a substantial increase in those gains—$5.7 billion—driven largely by AerCap and GE HealthCare investments, which contributed to a $8.1 billion rise in continuing earnings that year. Thus, the trend moved from a strong gain‑driven earnings boost in 2023 to a notable reduction in gains on AerCap‑related interests in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.7 billion gain in 2023 and the $5.2 billion decrease in gains in 2024 compared to 2023, both of which match the ground truth. The entities—GE, AerCap, and GE HealthCare—are accurately referenced, and the years 2023 and 2024 are correctly used. (2) All numeric values are accurate: $5.7 billion increase in 2023 and $5.2 billion decrease in gains on ownership interests in 2024. The LLM adds that these gains contributed to an $8.1 billion rise in continuing earnings in 2023, which is not contradicted by the ground truth but is an additional detail not present in the original answer. This does not make it incorrect but slightly extends beyond the provided information. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in financial impact from 2023 to 2024, noting the reversal from strong gains to a significant decline, primarily tied to AerCap and GE HealthCare. The conclusion about a 'notable reduction' in 2024 aligns with the ground truth’s emphasis on a $5.2 billion drop. (4) The answer is highly factually accurate and contextually relevant. The only minor deviation is the inclusion of the $8.1 billion continuing earnings figure, which, while plausible and consistent, is not in the ground truth and could be seen as a slight overextension. However, it does not distort the core facts. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 421,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot’s strategic use of HD Supply has evolved from a legacy acquisition (completed in 2020) to a core growth engine focused on professional customers and MRO services. By integrating SRS—acquired in 2024, which carries the HD Supply brand and a network of 780 branches—the company has expanded its Pro‑focused product assortment, dedicated sales force, and enhanced credit and fulfillment options, reinforcing its ecosystem for contractors, remodelers, and specialty trades. This evolution underscores a deliberate shift toward deepening professional‑customer engagement and MRO capabilities as a driver of future sales and shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that SRS was acquired in 2024 and that it 'carries the HD Supply brand and a network of 780 branches.' This is false: HD Supply was acquired in 2020, not 2024, and SRS is not mentioned in the ground truth; the 780-branch figure does not appear in the original answer and cannot be verified from the provided context. (2) The timeline is distorted: the original answer emphasizes a shift *between 2022 and 2024* from integration challenges to strategic maturity, but the LLM implies a 2024 acquisition, which contradicts the 2020 acquisition date. (3) While the LLM correctly identifies HD Supply’s role in serving professional customers and MRO services, it fabricates a key event (the 2024 SRS acquisition) and misattributes the evolution to this fictional event, undermining the reasoning. (4) The qualitative insight about HD Supply becoming a 'core growth engine' and supporting Pro customers aligns broadly with the original answer’s claim about it becoming a 'core component' of Pro-focused strategy by 2024, so some conceptual understanding is present. (5) Contextually, the answer addresses the focus on professional customers and MRO services, fulfilling the question's intent, but does so with incorrect supporting facts. Quantitative accuracy is low due to the incorrect date (2024 vs 2020) and unsupported numeric claim (780 branches). Qualitative accuracy is partially met due to correct thematic elements but penalized for fabricated entities and events. Contextual relevance is fair because the overall direction of the response matches the question’s focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 460,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Based on the provided 2023 and 2024 SEC 10-K filings, AMD's reliance on cross-licensing agreements has remained consistent in structure but evolved in strategic emphasis. While the 2023 filing (p. 15) notes approximately 18,800 global patent matters (including 13,200 issued patents) and references \"numerous cross-licensing and technology exchange agreements\" as typical in the semiconductor industry, the 2024 filing (p. 13) updates the patent portfolio to approximately 18,500 global matters (12,800 issued patents, 5,600 pending) and emphasizes that these agreements enable continued use of licensed technologies critical to product development. Crucially, the 2024 filing explicitly states that no individual patent or its expiration is material to the business, underscoring that cross-licensing serves as a stable, non-disruptive mechanism for technology exchange rather than a focal point of strategic evolution. The patent portfolio size contraction (from ~18,800 to ~18,500 matters) reflects routine patent management, not a shift in cross-licensing dependence. (298 characters)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly swaps the patent portfolio numbers between 2023 and 2024. According to the ground truth, in 2023 AMD had ~18,500 patent matters (12,800 issued, 5,600 pending), and in 2024 it grew to ~18,800 (13,200 issued, 5,600 pending). The LLM reverses this, claiming 18,800 in 2023 and 18,500 in 2024, which is a critical error. It also misattributes the 13,200 issued patents to 2023 when it belongs to 2024. (2) The quantitative inaccuracies are severe: the direction of change (growth vs. contraction) is wrong, and the year-by-year breakdown is inverted. This leads to an incorrect conclusion about 'portfolio contraction,' which contradicts the actual growth. (3) The reasoning is flawed due to incorrect data synthesis. While the LLM correctly identifies that cross-licensing remains important and cites relevant language about technology exchange, the core multi-hop analysis—comparing patent portfolio evolution and its strategic implications—fails because it is based on swapped data. The conclusion that reliance hasn't evolved is partially reasonable, but the supporting evidence is factually wrong. (4) Contextual relevance is fair because the answer addresses patent portfolio size, cross-licensing, and technology exchange as asked. However, the quantitative inaccuracy undermines correctness, warranting a low score. The qualitative reasoning would score higher if based on correct data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 408,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson retained a roughly 9% stake in Kenvue following the IPO and subsequent exchange offer, which reduced its ownership from ~89.6% to 9.5%. In May 2024, the company completed a debt-for-equity exchange, surrendering its remaining 182.3 million shares of Kenvue stock in exchange for commercial paper, thereby divesting its entire equity stake. This transaction resulted in a $0.4 billion loss recorded in other income/expense and marked the end of J&J's financial stake in Kenvue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth with only minor deviations. (1) Quantitatively, the LLM correctly states the 9.5% stake (rounded to 'roughly 9%'), the May 2024 debt-for-equity exchange, the surrender of 182.3 million shares (accurate rounding from 182,329,550), the $0.4 billion loss, and the complete divestiture. The only minor imprecision is the reference to the 'IPO'—the original answer specifies an 'exchange offer' in August 2023, not an IPO, though Kenvue's public listing was via spin-off, so this is a nuanced point. (2) The dollar value of the initial stake ($4.3 billion) and the $3.6 billion commercial paper offset are omitted, which slightly reduces completeness but do not undermine the core financial narrative. (3) The reasoning is sound: the LLM correctly traces the reduction from majority ownership to 9.5%, then to full exit via the 2024 transaction, demonstrating proper multi-hop synthesis across time and financial actions. (4) Entities (Johnson & Johnson, Kenvue, commercial paper, debt-for-equity) and years (2023–2024) are accurate. The answer is fully relevant and captures the evolution of the financial stake. A score of 9 is justified due to high factual fidelity with only minor omissions in dollar amounts and slight simplification of the initial transaction type.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 376,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's relationship with Indiana Bell Telephone Co. Inc. regarding guarantee disclosures remained unchanged between 2022 and 2023. The company continued to include Indiana Bell as part of its group of subsidiaries guaranteeing certain debt obligations, as evidenced by the consistent reference to \"Guarantee of certain obligations of Indiana Bell Telephone Co. Inc.\" in the 2023 filing (page 103, Exhibit 4-c), which mirrors the same disclosure structure present in the 2022 filing (page 133). No new guarantees or significant changes to the guarantee structure involving Indiana Bell were disclosed in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth: AT&T's guarantee relationship with Indiana Bell Telephone Co. Inc. remained unchanged between 2022 and 2023. The answer correctly identifies that Indiana Bell was included in the guarantee disclosures in both years, referencing consistent exhibit structures (Exhibit 4-c in 2023 and Exhibit 4-d in 2022). While the exhibit number differs slightly (4-c vs. 4-d), this may reflect actual differences in filing structure across years and does not indicate inaccuracy, especially since the LLM notes the 'same disclosure structure.' There are no numeric values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating multi-hop synthesis across two years of filings. The only minor limitation is that the LLM refers to Indiana Bell as part of 'subsidiaries guaranteeing certain debt obligations,' whereas the ground truth frames AT&T as guaranteeing Indiana Bell's obligations—this is a subtle but potentially important directional distinction. However, given the context of parent-subsidiary guarantee relationships in SEC filings, this phrasing is not necessarily incorrect. Thus, qualitative accuracy is slightly reduced to 9. Contextual relevance is perfect, directly addressing the evolution (or lack thereof) in the guarantee disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 378,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE’s cash involvement with AerCap shifted from a $203 million net cash payment to AerCap (reflected in the 2023 cash outflow) to no additional cash outflows in 2024, as the senior AerCap note remained outstanding but was not funded further.  Investment‑gain dynamics show that GE recorded a $5.2 billion gain in 2023 from selling its remaining AerCap equity stake, while in 2024 the company recognized only modest, non‑cash fair‑value adjustments to its AerCap note and equity interest, resulting in a much smaller impact on earnings.  Consequently, cash outflows related to AerCap ceased after 2023, and subsequent earnings gains from AerCap are now limited to relatively immaterial fair‑value changes rather than large realized gains.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that GE recorded a $5.2 billion *gain* in 2023 from selling its AerCap stake. The ground truth states that GE reported a *decrease* in gains by $5.2 billion in 2024 compared to 2023, meaning the gain was larger in 2023 but the $5.2B figure represents the year-over-year drop, not the gain itself. This is a critical misinterpretation of financial data. (2) The claim that GE sold its 'remaining AerCap equity stake' in 2023 is unsupported by the original answer, which states GE held an investment stake in 2024, indicating it did not fully divest. (3) The LLM introduces the concept of a 'senior AerCap note' and 'fair-value adjustments' not mentioned in the ground truth, adding speculative detail. (4) The original answer emphasizes a strategic shift from operational involvement (2023) to investment-based returns (2024), which the LLM partially captures but misrepresents due to incorrect gain characterization. (5) While the $203 million net cash payment to AerCap in 2023 is correctly cited, the LLM incorrectly frames it as a 'cash outflow' without clarifying it was part of transition services and receivables. The reasoning is flawed because it inverts the meaning of the $5.2 billion figure, leading to an incorrect conclusion about investment gains. Despite addressing cash involvement and gains, the answer fails on core facts and financial logic, warranting a low correctness score. Contextual relevance is moderate as it attempts the right themes but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 441,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot deepened its focus on integrating digital capabilities with store operations to enhance customer experience and maintain competitive differentiation. Building on investments described in the 2022 filing—such as curb-side pickup, self-service lockers, and mobile inventory tools—the company expanded its interconnected shopping experience, emphasizing seamless transitions between online research, in-store pickup, and delivery. By 2024, these efforts included broader use of mobile app navigation, electronic shelf labels, and AI-driven inventory tools like Sidekick, alongside expanded omni-channel fulfillment and same-day delivery networks. The company also reinforced its store-centric strategy, leveraging physical locations as hubs for pickup, returns, and delivery, while investing in supply chain automation and store refreshes to improve efficiency and customer satisfaction. This evolution reflects a continued prioritization of blending digital innovation with in-store convenience to meet evolving customer expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024, emphasizing the integration of digital capabilities with physical store operations to enhance customer experience. While the original answer focuses on store appearance as a competitive factor evolving into a broader 'interconnected shopping experience,' the LLM answer expands on this with specific examples (e.g., curb-side pickup, mobile app navigation, electronic shelf labels, AI-driven Sidekick, omni-channel fulfillment) that are consistent with the strategic direction described in the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all referenced initiatives and timelines (2022 to 2024) are correctly attributed. The LLM synthesizes multi-hop reasoning by connecting digital tools to store experience and competition, correctly identifying the shift from physical aesthetics to a digitally-enhanced, holistic experience. The only minor gap is that the LLM does not explicitly mention 'store appearance' as a starting point in 2022 as emphasized in the original answer, instead focusing on operational capabilities. However, it implies this through 'store refreshes' and 'ease of shopping,' maintaining semantic equivalence. Thus, the answer is factually correct, contextually rich, and logically sound, warranting a high score with only a slight deduction in qualitative accuracy for not foregrounding 'appearance' as directly as the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 437,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved through increased transaction volume and new financing arrangements. The Company's purchases from the ATMP JV rose to $1.7 billion in 2023 and $1.7 billion in 2024, while resales to the JV were minimal ($121 million in 2024 and $14 million in 2023). In October 2024, AMD entered a $100 million term loan with one ATMP JV, secured by receivables and bearing interest at SOFR + 50 basis points, which is recorded within receivables on its balance sheet. The carrying value of AMD's equity investment in the ATMP JV increased to $149 million as of December 28, 2024, up from $99 million in 2023, reflecting additional $17 million equity contributions in August 2024. These arrangements do not impact AMD's consolidated statement of operations, as purchases and resales are reported within purchases/resales with the JV without affecting net income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that AMD's resales to the ATMP JV were $14 million in 2023 and $121 million in 2024, and that a $100 million term loan was initiated in October 2024, it introduces several incorrect figures not present in the ground truth. Specifically, the claim that 'purchases from the ATMP JV rose to $1.7 billion in 2023 and 2024' is unsupported by the original answer and distorts the financial relationship. Additionally, the LLM mentions a SOFR + 50 bps interest rate, security by receivables, balance sheet classification, and equity investment increases from $99M to $149M with a $17M contribution — none of which are in the ground truth. These additions suggest fabrication or confusion with another source. (2) Quantitative accuracy is low: only the resale figures ($14M, $121M) and the $100M loan amount and timing (October 2024) are correct. All other numbers (e.g., $1.7B purchases, $149M equity, $99M prior value, $17M contribution) are incorrect or extraneous. (3) The reasoning partially captures the evolution — increased resales and new loan — but incorrectly frames the relationship around large-scale purchases and equity changes, which were not part of the original answer. The multi-hop synthesis fails because it conflates operational resales and new financing with unrelated investment and purchasing activity. (4) Contextual relevance is moderate — the answer addresses the evolution of the financial relationship and includes relevant elements like resales and the loan — but the inclusion of fabricated metrics undermines overall correctness. The conclusion that these arrangements do not affect net income is plausible but not verifiable from the ground truth, making it an unsupported inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 490,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Johnson & Johnson’s privacy‑compliance framework has been expanded and formalized in its 2024 filing to address the growing number of global data‑protection statutes and the heightened scrutiny of cross‑border data flows.  The company now reports a dedicated privacy‑compliance program that is overseen by the Regulatory Compliance & Sustainability Committee of the Board, with the CISO and Chief Information Officer responsible for its execution, and it specifically cites new privacy laws—particularly those imposing data‑localization and international‑transfer restrictions—as a key driver for strengthening controls, monitoring third‑party risks, and conducting regular maturity assessments of its data‑protection practices.  This evolution reflects the company’s response to both emerging regulatory requirements and the increased cyber‑risk environment highlighted throughout the 2023‑2024 reports.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Johnson & Johnson's privacy compliance programs between 2023 and 2024. It accurately captures the broadening focus on global privacy laws and international data flows, as well as the increased emphasis on third-party risk and regulatory compliance. The mention of oversight by the Regulatory Compliance & Sustainability Committee, the CISO, and the Chief Information Officer adds detail not present in the original answer but does not contradict it; however, this specific governance structure is not confirmed in the ground truth, making it a plausible but unverified addition. The LLM correctly identifies the drivers—new privacy laws, data localization, and cross-border transfer restrictions—and ties them to enhanced controls and maturity assessments, reflecting the anticipatory posture described in the original. While the core evolution (from 'other territories' in 2023 to 'globally' in 2024) is implied through the emphasis on global statutes, the LLM does not explicitly contrast the 2023 and 2024 scopes as the original does. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually relevant, with only minor over-specification in governance details preventing a top score in qualitative accuracy. Overall, the answer is factually consistent, comprehensive, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 416,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE’s estimated borrower litigation losses for Bank BPH increased from $2,669 million to $2,461 million, and the related valuation allowance on those receivables was fully written off, leaving a net allowance of $0 million at year‑end 2024. Consequently, the allowance for credit losses on the Bank BPH portfolio was reduced from $132 million (2023) to $106 million (2024), reflecting the resolution of the litigation and the removal of the related receivables from the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that estimated borrower litigation losses for Bank BPH increased from $2,669 million to $2,461 million, when in fact they decreased (from $2,669M in 2023 to $2,461M in 2024). This misrepresents the direction of change. (2) The LLM claims the valuation allowance was 'fully written off' and that there is a 'net allowance of $0 million' at year-end 2024, which contradicts the ground truth stating that the valuation allowance was $1,517 million in 2024 and that it fully offset the financing receivables — not that it was zero. The original answer specifies that the allowance continued to exist but fully offset the receivables, indicating a strategic shift, not elimination. (3) The LLM introduces a 'credit loss allowance' of $132M (2023) and $106M (2024), which are not mentioned in the ground truth and appear fabricated. The original data refers to $1,712M and $1,517M in valuation allowances — vastly different figures. (4) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of litigation losses and valuation allowances across years, misrepresents the financial impact, and invents metrics not present in the source. While the answer attempts to address GE's exposure to Bank BPH and references a settlement program (implied in the original), the severe quantitative inaccuracies and incorrect conclusions about write-offs and reduced allowances undermine the entire response. The contextual relevance is moderate because it addresses the right entities and general topic, but factual correctness is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 449,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, HD’s Indoor Garden line moved from being grouped under the “Hardlines” merchandising department to its own distinct category within the Hardlines segment, and its merchandising classification was updated in the 2024 disclosures to reflect this separate positioning. This evolution is evident in the 2024 net‑sales breakdown, where Indoor Garden reported $10.5 billion in sales (6.6% of total) and is listed explicitly among Hardlines departments, whereas in the 2022 filing it was aggregated under the broader Hardlines line item. Consequently, while the Indoor Garden category continues to be part of the Hardlines product line, its standalone merchandising status and reported sales figures have grown and become more prominently highlighted in the company’s 2024 reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and facts. The ground truth states that in 2022, Indoor Garden was a standalone category with $15,546 million (i.e., $15.546 billion) in net sales, accounting for 10.3% of total revenue. However, the LLM claims that in 2022, Indoor Garden was aggregated under Hardlines and then became a distinct category by 2024 — this reverses the actual evolution. In reality, the product line was downgraded from a standalone category to being grouped under Hardlines by 2024, indicating reduced prominence, not increased. (2) The LLM reports $10.5 billion in sales for 2024, but the ground truth does not provide 2024 financials — it only provides 2022 data. Thus, the LLM fabricates a 2024 figure not present in the original answer. Additionally, the 2022 sales figure is wrong: LLM says $10.5B in 2024 and implies lower or similar in 2022, but actual 2022 sales were $15.546B. The percentage cited (6.6%) is also not in the original and appears invented. (3) The multi-hop reasoning is flawed: the question asks about evolution from 2022 to 2024 based on financial performance and merchandising changes. The LLM misrepresents both the financial data and the direction of organizational change (from standalone to integrated vs. the claimed reverse). It fails to correctly synthesize the implications: declining prominence in 2024 vs. the LLM’s claim of growing prominence. (4) Scores are low because the answer contradicts the ground truth on key facts, invents numbers, and misrepresents the strategic shift. Contextual relevance is moderate because it addresses the right company and product line and attempts to discuss categorization changes, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 474,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive’s sourcing strategy to manage commodity price volatility shifted from limited hedging toward broader cost‑containment and productivity initiatives, while maintaining selective use of commodity contracts and sourcing diversification to offset raw‑material price swings. The company emphasizes price adjustments, productivity gains and strategic sourcing rather than extensive hedging to mitigate inflationary pressures on essential oils, resins, tropical oils, pulp, tallow, corn, poultry and soybeans.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of core facts and evolution of Colgate-Palmolive's sourcing strategies from 2022 to 2024. It accurately captures the shift toward greater emphasis on cost containment, productivity initiatives, and strategic sourcing over extensive hedging, which matches the ground truth's description of increased defensive tactics. The mention of specific commodities (essential oils, resins, soybeans, etc.) is consistent with the original answer, though the LLM includes additional items like tropical oils, pulp, tallow, corn, and poultry not explicitly listed in the ground truth—this adds detail but does not contradict. The LLM correctly identifies the continued use of sourcing strategies and implies a reduced reliance on derivatives (referring to 'selective use' rather than broad hedging), which aligns with the 2022 framework that included derivatives but evolved by 2024 toward non-hedging tools. However, the LLM omits explicit mention of derivative instruments and local currency borrowings in 2022, which were part of the original answer’s description of the earlier strategy. This is a minor omission affecting completeness in multi-hop synthesis, particularly around the contrast between financial risk management tools in 2022 versus operational tactics in 2024. There are no numerical inaccuracies (dates: 2022–2024 are correct), so quantitative accuracy is perfect. Contextual relevance is strong—the response directly addresses the evolution in relation to commodity price fluctuations. Qualitative accuracy is high but docked slightly for missing the full scope of 2022 financial instruments and for implying a 'shift from limited hedging' without clear support in the original text about the extent of hedging in 2022. Overall, the semantic meaning is equivalent with minor gaps in completeness and precision of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 515,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "Between 2023 and 2024, TREMFYA (guselkumab) sales grew strongly, increasing from $3.147 billion in 2023 to $3.670 billion in 2024—a 16.6% rise (including 18.1% operational growth and a 1.5% adverse currency effect). This growth was driven by market expansion and share gains, even as other immunology products faced biosimilar pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: TREMFYA sales increased from $3.147 billion in 2023 to $3.670 billion in 2024, representing a 16.6% growth. It accurately breaks this down into an 18.1% positive operational impact and a 1.5% negative currency effect. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $3.147 billion = $3,147 million). (2) Quantitative accuracy is perfect—values are correct, and the implied calculation (3,147 * 1.166 ≈ 3,670) is valid. The percentage change and components (operational growth, currency impact) are precisely reported. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that strong performance occurred despite currency headwinds, and contextualizes growth within market dynamics like biosimilar pressure on other immunology products. While the original answer emphasizes 'continued strength in PsO/PsA' and 'favorable patient mix,' the LLM substitutes with 'market expansion and share gains,' which is semantically close and contextually reasonable, though slightly less specific. (4) The answer is fully relevant, directly addressing both parts of the question—sales evolution and contributing factors. The only minor shortcoming is the omission of explicit mention of PsO/PsA and patient mix, which slightly reduces qualitative accuracy, but the core drivers are still accurately conveyed. Hence, correctness is rated 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 406,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E shifted from a 50% equity investment (where Disney reported only its share of A+E's income) to full operational control and consolidation of A+E's channels within Disney's Linear Networks segment. This change eliminated the separate equity investment reporting and integrated A+E's subscriber data (58 million domestic subscribers for A&E, HISTORY, and Lifetime as of September 2024) directly into Disney's consolidated reporting, removing it from the equity method disclosures used in 2022. Consequently, subscriber numbers for A+E channels are now reported as part of Disney's overall Linear Networks performance rather than as a separate equity investment stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Disney moved from a 50% equity investment to full operational control and consolidation, when the ground truth indicates the shift was from a partnership (without equity stake) in 2022 to a 50% equity stake in 2023—not full ownership or consolidation. This reverses the direction of the structural change. (2) The subscriber number of 58 million is correctly cited but attributed to September 2024, which is outside the 2022–2023 timeframe in the question and not mentioned in the original answer (which specifies 2023 data). The 2022 subscriber count (69 million) is omitted entirely. (3) The claim that A+E is now 'integrated into Disney's Linear Networks segment' and 'consolidated' is unsupported by the original answer, which only states it is reported under 'Equity in the income of investees'—consistent with equity method accounting, not consolidation. (4) The multi-hop reasoning fails: instead of correctly identifying the shift from arm’s-length partnership to equity investment, it fabricates a move to full control, leading to incorrect conclusions about reporting changes. While the answer addresses the general theme of reporting changes and mentions equity method disclosures, the core facts about the nature, direction, and financial treatment of the relationship change are wrong. Quantitative accuracy is low due to incorrect timeframes and missing data points. Qualitative accuracy suffers from flawed entity and relationship identification. Contextual relevance is moderate because it discusses subscriber reporting and equity investments, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 463,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "The financial impact of GE's relationship with AerCap shifted from a $865 million unrealized loss in 2022 to a $129 million realized and unrealized gain in 2023, reflecting the full monetization of the AerCap investment during 2023. Consequently, the realized/unrealized gains recorded under “Investment in and note with AerCap” in Note 19 rose sharply to $129 million in 2023, while the prior year showed a $865 million loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but significant inaccuracies. It correctly identifies the $129 million gain in 2023 from GE's investment in and note with AerCap, aligning with the ground truth. However, it incorrectly states that this was a 'realized and unrealized gain' when the original answer specifies it was an 'unrealized gain.' More critically, the LLM introduces a $865 million unrealized loss in 2022, which is not relevant to the question asking about 2023–2024 evolution. The key 2024 information is entirely missing: the $5.2 billion drop in gains on retained and sold ownership interests, with AerCap as a primary contributor. This omission severely undermines the answer’s completeness and correctness. (2) Quantitatively, the $129 million figure for 2023 is accurate, but the $865 million loss in 2022, while possibly factually correct from another context, is not part of the required 2023–2024 comparison and distracts from the actual trend. The critical $5.2 billion year-over-year decrease in 2024 is not mentioned, making the quantitative analysis incomplete. (3) The reasoning fails on the multi-hop requirement: the question asks for the evolution between 2023 and 2024, but the LLM compares 2023 to 2022 and omits 2024 entirely. This breaks the logical chain needed to assess the financial shift. The conclusion that 2023 reflected 'full monetization' is unsupported by the ground truth, which indicates a decline in gains in 2024, not completion of monetization. (4) Contextual relevance is moderate because the answer discusses the right entities (GE, AerCap, Note 19) and the general nature of gains, but it fails to address the core of the question—how the financial impact changed from 2023 to 2024. Hence, correctness is scored low due to missing key data and incorrect temporal focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 499,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard’s multi-layered security approach has evolved from a primarily network‑centric model in 2022 to a more proactive, ecosystem‑wide strategy by 2024, explicitly incorporating safeguards for third‑party service providers.  The 2024 disclosures highlight new security‑focused initiatives such as the Alias‑Based Remittances and Payouts platform, expanded integration of Mastercard In Control™ virtual‑card controls, and tighter technical standards developed with issuers, acquirers and fintech partners to protect cross‑border and B2B payment flows.  This progression signals a strategic shift toward embedding security into every layer of the payments ecosystem—particularly at the interfaces with external providers—to stay ahead of emerging cyber threats and maintain trust in its global network.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Mastercard's security approach from 2022 to 2024, noting a shift toward a more ecosystem-wide strategy that includes third-party providers. However, it introduces specific initiatives—such as the 'Alias-Based Remittances and Payouts platform' and expanded use of 'Mastercard In Control™'—that are not mentioned in the ground truth and cannot be verified from the provided knowledge. These additions, while plausible, introduce unverified details that affect factual accuracy. (2) There are no numeric values, dates, or financial figures in either the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward ecosystem-wide resilience and integration of third-party risk management by 2024. However, the ground truth emphasizes the *absence* of explicit third-party provider risk language in 2022 and its *emergence* in 2024, whereas the LLM frames it as a broader 'ecosystem-wide strategy' with new platforms, which shifts focus from the core factual development (explicit integration of third-party risk management) to inferred product-level enhancements not in the source. (4) The answer is contextually relevant and addresses all parts of the question—evolution over time, third-party provider risks, and strategic implications—with strong coherence. The core conclusion about a strategic shift is aligned with the ground truth, but the inclusion of unsupported specific initiatives reduces qualitative accuracy. Thus, correctness is scored 7 due to plausible but unverified details, despite correct overall direction and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 481,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation’s debt leverage covenant compliance remained intact, supported by its investment-grade credit ratings (A from S&P, A2 from Moody’s, and A from Fitch) and the replacement of its prior $2.5 billion revolving credit facility with a new $3.0 billion facility expiring in October 2028 (later extended to 2028). The company maintained compliance with the debt‑leverage covenant throughout 2021–2023, and no credit‑rating downgrade triggered any mandatory repayment provisions. Consequently, the evolution of compliance reflects continued adherence to covenant requirements despite the credit‑facility restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Target remained in compliance with its debt leverage covenant between 2022 and 2023 and mentions the extension of a $3.0 billion facility to October 2028, which aligns with the ground truth. However, it contains significant quantitative inaccuracies: it incorrectly claims the prior facility was $2.5 billion (ground truth: $3.0 billion), and fails to mention the new $1.0 billion 364-day facility obtained in 2023. Additionally, it references compliance from 2021–2023, while the question and ground truth focus on 2022–2023. (2) The credit ratings (A, A2, A) are factually correct but not mentioned in the original answer, so their inclusion is extraneous but not incorrect. The claim about 'no credit-rating downgrade triggering mandatory repayment' is plausible but not supported in the ground truth, introducing unverified information. (3) The multi-hop reasoning is partially sound—LLM correctly infers that covenant compliance persisted despite facility changes—but fails to accurately describe the nature of the credit facility changes (i.e., adding a 364-day $1B facility and extending the $3B facility to 2028). It incorrectly frames the $3B facility as a 'replacement' of a $2.5B facility, which contradicts the ground truth that the $3B facility was extended from 2026 to 2028. (4) The contextual relevance is high as it addresses covenant compliance and credit facility evolution. Qualitative accuracy is moderate due to correct logic but flawed details. Quantitative accuracy is low due to incorrect dollar amounts and missing key figures. Correctness score is 6 due to correct core conclusion (continued compliance) but significant factual errors in supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 472,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "The risks tied to Salesforce’s AI offerings—especially generative AI such as Agentforce—have shifted from a general focus on technology‑leadership and brand reputation in 2023 to a more specific set of concerns in 2024 about ethical and regulatory exposure, accuracy and bias in AI‑generated content, and heightened scrutiny from evolving AI‑related laws and standards. In 2023 the disclosures emphasized the need to keep pace with rapid AI innovation and the potential reputational damage of controversial AI use; by 2024 the filing explicitly calls out the “emerging ethical issues” of generative AI, the risk of inaccurate or copyrighted outputs, increased compliance costs, and the possibility of government or regulatory actions that could limit adoption and harm the brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Salesforce's AI-related risks from 2023 to 2024 as described in the ground truth. It correctly identifies the shift from broader concerns about technology leadership and reputation in 2023 to more specific risks in 2024, including ethical issues, regulatory scrutiny, inaccurate or biased AI outputs, copyright concerns, and increased compliance costs. All entities (Salesforce, Agentforce, generative AI), time periods (2023 vs 2024), and risk categories are correctly identified and aligned with the original answer. The reasoning is sound and reflects proper multi-hop synthesis across years and risk domains. The only minor deviation is that the LLM emphasizes 'brand reputation' and 'technology-leadership' slightly more than the original 2023 characterization, which focused on third-party integration liabilities and warranty expectations. However, the LLM does not contradict this—it reframes it in a broader context without introducing factual errors. No numerical data is present, so quantitative accuracy is scored based on correct use of years and logical comparisons, which are accurate. The answer is fully contextually relevant and addresses the question comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 349,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal 2023 and 2024, Lowe’s delivery capability for parcel‑eligible items accelerated markedly.  In fiscal 2023 the company could ship most parcel‑eligible products within two business days, and by fiscal 2024 it had expanded same‑day delivery via its gig‑network and next‑day delivery of major appliances to nearly every U.S. ZIP code.  These improvements were driven by the rollout of a market‑based delivery model, expanded fulfillment‑center capacity, and broader use of its gig‑provider network, enabling faster, more reliable home delivery of online orders.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor overstatement regarding same-day delivery. The original answer confirms that by fiscal 2024, Lowe's improved delivery of most parcel-eligible items to 'within two business days or less' and introduced next-day delivery for major appliances in nearly every U.S. ZIP code. The LLM correctly captures the 2023 baseline and the 2024 improvement in speed and geographic coverage. It accurately notes the expansion of next-day delivery for major appliances, matching the ground truth. However, the LLM adds that same-day delivery was expanded 'via its gig-network,' which is not mentioned in the original answer. While plausible and contextually consistent, this detail is not supported by the ground truth and represents an unsupported addition. The drivers mentioned (market-based delivery model, fulfillment-center capacity, gig-provider network) are reasonable inferences but not explicitly stated in the original answer, slightly reducing qualitative accuracy. Quantitatively, all timeframes and service levels are correctly represented (e.g., 'two business days,' 'next-day delivery'), with no errors in numbers or dates. The answer fully addresses the evolution between 2023 and 2024 and the specific improvements, making it contextually relevant and mostly factually accurate. Minor overreach on same-day delivery prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 394,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "From 2022 to 2023, Target's consolidated revenues declined modestly by 1.6% (from $109.1 billion in 2022 to $107.4 billion in 2023), while operating income rose sharply by 48.3% (from $3.85 billion in 2022 to $5.71 billion in 2023), reflecting improved profitability despite lower sales.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the core of the question. (1) It discusses Target's overall revenue and operating income trends from 2022 to 2023 but completely ignores the financial impact of the Dermstore LLC sale, which is the focus of the question. (2) The numbers provided—$109.1 billion and $107.4 billion for revenues, $3.85 billion and $5.71 billion for operating income—are not relevant to Dermstore and are presented without source or context. More critically, the ground truth states that Dermstore represented less than 1% of Target's consolidated revenues and operating income in both years, meaning its sale had negligible impact; the LLM instead implies broader financial trends are meaningful indicators, which is misleading. (3) The multi-hop reasoning is entirely missing: the sale occurred in February 2021, so there should be no material post-sale financial impact in 2022 or 2023. The $335 million pretax gain was recognized in 2021 and not repeated, but the LLM does not mention this key fact. (4) The answer fails on all evaluation dimensions: it is factually inaccurate in context, omits critical information, misrepresents the situation, and introduces irrelevant aggregate financials. Only minimal credit is given for mentioning Target and the correct years, but no meaningful alignment with the ground truth exists.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 379,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud’s strategic positioning shifted from being a foundational data engine to a central, AI‑enabled hub within Salesforce’s broader Customer 360 platform. The 2024 disclosures emphasize Data Cloud’s role in unifying disparate enterprise data, powering AI‑driven automation across Sales, Service, Marketing and Commerce, and serving as the backbone for new consumption‑based offerings such as Agentforce. This evolution places Data Cloud at the core of Salesforce’s growth strategy—driving deeper penetration with enterprise and international customers, expanding industry‑specific clouds, and differentiating Salesforce from competitors that lack an integrated, hyperscale data layer. Consequently, Data Cloud now functions not just as a data store but as a strategic differentiator that reinforces Salesforce’s end‑to‑end service ecosystem and intensifies the competitive battle in the enterprise cloud market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key qualitative aspects. (1) Correct elements: The answer correctly identifies Data Cloud as a unifying data platform within Salesforce and mentions its integration with Sales, Service, Marketing, and Commerce, which aligns with the 2023 description of a '360-degree view of customers.' It also appropriately situates Data Cloud as central to Salesforce's strategy, which is contextually relevant. (2) Quantitative accuracy: There are no numeric values in either the original or LLM answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM fails to accurately reflect the evolution in strategic positioning as described in the ground truth. While the original answer emphasizes a shift toward acknowledging competitive uncertainty, market novelty, and pricing challenges in 2024, the LLM portrays an increasingly confident, AI-driven expansion narrative—highlighting Agentforce and consumption-based offerings without noting Salesforce’s own stated lack of experience in such models. The LLM omits the critical 2024 risk disclosures about competitive dynamics and monetization challenges, instead framing Data Cloud as a growing strategic advantage. This misrepresents the tone and content of the 2024 filing. (4) The answer is contextually relevant and well-structured, but it invents strategic emphasis (e.g., 'AI-enabled hub', 'backbone for Agentforce') not present in the ground truth and misses the core shift from product promotion to risk acknowledgment. Thus, while it captures part of the 2023 positioning, it fails on the essential 2024 evolution, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 468,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "LOW's treatment of forward interest rate swap contracts as cash flow hedges remained consistent between 2023 and 2024, with no change in hedge designation methodology. The company continued to use the shortcut method for fair value hedges on its $850 million fixed-to-floating interest rate swaps, while cash flow hedges (including matured swaps from 2022-2023 note issuances) continued to be recorded in other comprehensive income before reclassification to earnings. The financial impact remained unchanged: matured swaps from 2023 note issuances generated a $247 million cash receipt, and the resulting gains/losses on cash flow hedges were still reported net of tax in OCI, with no material difference in accounting treatment between fiscal years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim that LOW's treatment of forward interest rate swaps remained consistent between 2023 and 2024. The ground truth states there was a clear shift—from cash flow hedges in 2023 to fair value hedges using the shortcut method in 2024. The LLM incorrectly asserts no change in hedge designation, which contradicts the key evolution described in the original answer. (2) Quantitatively, the $247 million cash receipt from the 2023 settlement is correctly stated, but the LLM introduces a new figure—$850 million for fixed-to-floating swaps—that does not appear in the ground truth and is therefore unverified and potentially inaccurate. The $2.0 billion notional amount from 2023 is omitted. (3) The multi-hop reasoning fails: the model does not recognize the shift in accounting treatment (cash flow → fair value hedges) and mischaracterizes the 2024 approach as a continuation rather than a change. It also conflates different types of swaps without proper distinction. (4) While the answer addresses the general topic and mentions OCI and the shortcut method, it fundamentally misrepresents the evolution in accounting policy. The contextual relevance is moderate because it discusses relevant concepts (hedge types, OCI, shortcut method), but the factual inaccuracies severely undermine correctness. Thus, the scores reflect major errors in both qualitative reasoning and quantitative accuracy, with only partial contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 413,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "Target’s owned‑brand strategy remained focused on expanding and deepening its portfolio of exclusive labels—such as A New Day, Goodfellow & Co, and Universal Thread—while using these brands to drive traffic, increase market share, and differentiate the shopping experience. In 2023 the company emphasized growing the breadth and depth of its owned‑brand assortment and leveraging partnerships (e.g., exclusive design collaborations) to enhance relevance and value for guests, continuing the same strategic pillars introduced in 2021 but with a stronger emphasis on owned‑brand growth as a core driver of sales and differentiation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution. It accurately captures that Target continued to emphasize owned brands as a key differentiator and driver of traffic, sales, and market share—consistent with the 2023 strategic shift described in the original answer. The mention of specific brands (A New Day, Goodfellow & Co, Universal Thread) adds relevant detail not in the original but is factually accurate and contextually appropriate. The answer correctly identifies the increased strategic emphasis on owned brands in 2023 as a core growth driver, reflecting the shift from descriptive presence to active strategic lever. However, it references 'strategic pillars introduced in 2021,' which is not mentioned or verifiable from the provided ground truth, introducing extraneous information that cannot be confirmed and slightly misaligns the timeline focus (2022–2023). While the core reasoning about portfolio expansion and differentiation is sound and semantically equivalent to the original, this minor overreach in temporal context prevents a perfect score. There are no numerical inaccuracies (quantitative accuracy is 10), and the answer is fully relevant to the question. The multi-hop synthesis—linking evolution across years and strategic intent—is mostly accurate, though slightly less precise than the original’s clear contrast between 2022 (descriptive) and 2023 (strategic).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 398,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM significantly expanded its software-enabled services and platform deployment, shifting from foundational connectivity (e.g., OnStar) to a broader, scalable ecosystem of subscription-based features and over-the-air updates. This included launching an end-to-end software platform for vehicle performance, safety, and infotainment (e.g., Super Cruise, climate controls), integrating with Tesla Superchargers, and expanding its Ultium EV architecture to enable rapid software updates across models. These efforts reflect a strategic pivot toward monetizing software-defined vehicles, with GM Financial and Cruise (its AV subsidiary) further embedding digital services into core operations—evidenced by $9.9 billion in R&D spending in 2023 and dedicated EV manufacturing investments—to build a sustainable, scalable digital revenue stream beyond traditional automotive sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of GM's software-enabled services from 2022 to 2023, noting a shift toward scalable digital solutions and over-the-air updates, which aligns with the ground truth. It correctly identifies the strategic pivot toward software-defined vehicles and mentions relevant technologies like Super Cruise. However, it introduces several unsupported details not present in the original answer or knowledge graph. Notably, the claim of '$9.9 billion in R&D spending in 2023' is not mentioned in the ground truth and cannot be verified from the provided context. Similarly, integration with Tesla Superchargers and expansion of the Ultium EV architecture to enable software updates are not referenced in the original answer, making them factual overreaches. (2) Quantitative accuracy is low because the $9.9 billion R&D figure is unverified and potentially incorrect in this context; no dollar amounts were mentioned in the ground truth, so introducing one constitutes a significant factual error. (3) Qualitatively, the reasoning is sound in identifying a strategic shift and platform scalability, and it correctly infers increased investment in digital solutions. The mention of GM Financial and Cruise aligns with the original's reference to AV technology and financing, though the LLM overextends by implying deeper integration than stated. The core multi-hop synthesis—comparing 2022's general description to 2023's specific platform deployment—is partially achieved but diluted by extraneous claims. (4) Contextual relevance is high as the answer directly addresses the evolution of service offerings and platform deployment and interprets strategic investment intent. However, the inclusion of unverified specifics reduces factual reliability. The answer conveys a similar direction but with inflated detail, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 514,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category grew from $661 million in fiscal 2023 to $837 million in fiscal 2024, reflecting a 27% increase. This growth was driven by expansion of the ThousandEyes offering and contributions from the broader Observability suite.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitative Accuracy: The LLM states revenue grew from $661 million in fiscal 2023 to $837 million in fiscal 2024, but the question asks about fiscal years 2022 and 2023. The LLM references fiscal 2024, which is outside the requested timeframe. Additionally, the dollar figures ($661M, $837M) are not present in the ground truth. The ground truth does not provide absolute revenue values for ThousandEyes, only incremental growth: $75M in 2022 (11% growth) and $80M in 2023 (14% growth). The 27% increase cited by the LLM is unsupported and incorrect. (2) Completeness: The LLM fails to address the actual evolution between FY2022 and FY2023, instead fabricating data for FY2023–FY2024. It omits the key point that the growth in both years was part of a broader product category (Optimized Application Experiences in 2022, Observability in 2023) and misattributes the entire category growth to ThousandEyes. (3) Entity Accuracy: While ThousandEyes and the product category are correctly identified, the fiscal years are wrong, and the financial metrics are fabricated. (4) Reasoning: The LLM does not perform the required multi-hop reasoning—comparing ThousandEyes' contribution across two specific fiscal years based on reported growth drivers. Instead, it invents absolute revenue numbers and a future year, showing no evidence of correct synthesis. (5) Semantic Equivalence: The LLM’s conclusion of 'growth' aligns only superficially with the ground truth; the magnitude, time frame, and basis are all incorrect. The answer is factually misleading. The contextual relevance is low because it answers a different question about different years with fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 479,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "The treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan shows it was first referenced in the 2023 10-K (page 104) as \"Amendment No. 4\" to the plan, but by the 2024 filing (page 104), it was formally listed as \"Amendment No. 4\" with a specific quarterly report citation (September 25, 2022). This evolution indicates Lockheed Martin strategically delayed explicit disclosure of the amendment until it was material enough to warrant formal inclusion in the executive compensation documentation, reflecting a deliberate disclosure strategy to manage regulatory visibility while maintaining transparency about plan modifications.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misrepresents the core evolution of Amendment No. 4's treatment between the 2023 and 2024 10-K filings. According to the ground truth, in the 2023 10-K, Amendment No. 4 was listed as a standalone exhibit (Exhibit 10.34) and incorporated from the September 2022 10-Q. In the 2024 10-K, it was no longer a standalone exhibit but included within a sequence of amendments (Nos. 2, 3, 4, and 5), still referencing the same 10-Q. The LLM incorrectly states that the amendment was 'first referenced' in the 2023 10-K and then 'formally listed' in 2024 with a new citation, implying delayed disclosure — which contradicts the ground truth that it was already disclosed in 2023. (2) The date 'September 25, 2022' is plausible as the 10-Q filing date, and page 104 appears consistent across filings, so quantitative elements like dates and locations are reasonably accurate, though not fully verifiable without source documents. However, the claim of 'strategic delay' and 'material enough to warrant formal inclusion' is factually incorrect — the amendment was already formally disclosed in 2023. (3) The multi-hop reasoning is flawed: the model fails to recognize that the amendment was already disclosed in 2023 and instead constructs a narrative of delayed formalization, missing the actual shift from standalone to consolidated exhibit presentation. This undermines the qualitative accuracy of the synthesis. (4) While the answer addresses the question’s focus on disclosure strategy, the conclusion about 'strategic delay' is unsupported and contradicts the ground truth, which indicates a shift toward consolidation, not delayed disclosure. Thus, the reasoning and factual basis are significantly off, warranting a low correctness score despite some contextual relevance and acceptable formatting of dates/pages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 508,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's CET1 capital ratio increased from 15.0% to 15.7% (and 15.8% under the Advanced approach), while its Tier 1 capital ratio rose from 16.6% to 16.8% (16.9% under the Advanced approach). The leverage‑based Tier 1 leverage ratio remained steady at 7.2% in both years, with the regulatory minimum unchanged at 4.0%. Thus, the firm’s capital ratios improved modestly, especially the CET1 ratio, while maintaining comfortable leverage coverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, JPMorgan's Standardized CET1 capital ratio was 15.0% (correctly stated), but the 2024 CET1 ratio is not provided in the original answer, so the LLM's claim of an increase to 15.7% (or 15.8% under Advanced) is unsupported and incorrect. Similarly, the LLM states Tier 1 capital ratio rose from 16.6% to 16.8%, but this metric is not mentioned in the ground truth at all. The only confirmed correct number is the 2024 Tier 1 leverage ratio of 7.2% (and regulatory minimum of 4.0%), which matches the original answer. However, the LLM incorrectly claims the leverage ratio was 7.2% in both years, while the original does not provide 2023's leverage ratio. (2) Calculations: No explicit calculations are made, but implied comparisons (e.g., 'increased from...to...') are not supported by the ground truth. (3) Multi-hop reasoning: The LLM attempts to synthesize trends across years and metrics, but introduces data not present in the original, failing to correctly limit its response to the provided facts. It conflates Tier 1 capital ratio with Tier 1 leverage ratio, which are distinct metrics. (4) The answer is contextually relevant and addresses the question's intent regarding capital ratio compliance, but introduces unsupported data, reducing factual accuracy. Correctness score is low due to major quantitative errors despite some correct context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 405,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial’s role evolved from being presented as a distinct segment within the consolidated financial statements to a more integrated component of GM’s overall operations. In 2023, GM Financial’s revenue and earnings were included in the consolidated totals under \"Total consolidated\" in the segment reporting tables, and its financial results were no longer separately identified as a distinct segment in the notes. Instead, its revenue and earnings were aggregated within the broader \"Automotive\" and \"Total consolidated\" figures, reflecting a tighter integration into GM’s core financial presentation. This is evident in the 2023 consolidated income statement where GM Financial’s $13,831 million revenue and $2,702 million earnings before interest and taxes are now part of the total $122,485 million revenue and $9,710 million earnings before interest and taxes, without separate segment disclosure. Additionally, the 2023 cash flow statement shows GM Financial’s financing activities (e.g., $50,963 million in debt proceeds and $44,675 million in debt payments) are now reported as part of the consolidated financing cash flows, rather than being isolated in a separate segment. This shift underscores a move toward consolidating GM Financial’s financial impact within GM’s overall consolidated results, rather than presenting it as a standalone segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual errors. (1) The claim that GM Financial was no longer presented as a distinct segment in 2023 is false: according to the ground truth, GM Financial remained a described segment in 2023, with enhanced disclosure about tax integration, not eliminated segment reporting. The original answer emphasizes a more detailed description of tax and intercompany adjustments, not removal of segment status. (2) The quantitative data cited—such as $13,831 million revenue and $2,702 million EBIT for GM Financial—are not present in the ground truth and appear fabricated. The ground truth does not provide any financial figures for GM Financial’s revenue or earnings, so these numbers cannot be verified and are likely hallucinated. Similarly, the claim that GM Financial’s results are now 'aggregated within Automotive' and no longer disclosed separately contradicts the original answer, which confirms continued segment-level presentation with more detailed adjustments. (3) The multi-hop reasoning is flawed: the model incorrectly infers that increased integration implies elimination of segment reporting, when the actual evolution is a refinement in disclosure about tax consolidation. The core insight from the original answer—increased transparency around deferred taxes and consolidated tax returns—is entirely missed. (4) While the LLM attempts to address the question’s focus on integration and financial presentation, it does so with incorrect facts and fabricated data, undermining both qualitative and quantitative accuracy. The contextual relevance is moderate because it discusses financial presentation and consolidation, but the substance is wrong. Thus, the correctness score is low due to major factual and numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 487,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "The treatment of step‑rent provisions in lease accounting has remained consistent between 2022 and 2024: periodic rent increases tied to price indices or sales volume are recognized as variable lease payments on a straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised). Both the 2022 and 2024 filings disclose that such step‑rent provisions are accounted for as variable lease payments and are not recognized as separate lease components, with no material impact on the financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the consistency of accounting treatment between 2022 and 2024. According to the ground truth, there was a clear shift in treatment: in 2022, step-rent provisions based on price indices or sales volume were accounted for on a straight-line basis, but by 2024, these were reclassified as variable lease payments and no longer straight-lined. The LLM incorrectly states that the treatment remained consistent and that variable lease payments were recognized on a straight-line basis, which contradicts both the evolution described in the original answer and standard accounting principles (variable lease payments are, by definition, not straight-lined). This represents a major factual and conceptual error in both entity accuracy and reasoning. While the LLM correctly identifies the types of rent increases (price indices, sales volume), it mischaracterizes their accounting treatment in both years. The answer also falsely claims that both filings disclose the same treatment, which is not supported by the ground truth. There are no numerical values to verify, so quantitative accuracy is minimally penalized, but qualitative accuracy is severely impacted due to flawed multi-hop reasoning—failing to detect and report the change over time that is central to the question. Contextual relevance is moderate because the topic and terminology are appropriate, but the substance is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 399,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "Based on the provided document pages, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show the following evolution from 2023 to 2024:\n\n1.  **2025 Payment:** The estimated benefit payment for 2025 increased slightly from **$1,860 million (2023)** to **$1,860 million (2024)** in the most recent table (page 88, 2024 data), indicating stability in the near-term payment amount.\n2.  **Long-Term (2029-2033):** The projected payments over the long-term period (2029-2033) increased significantly from **$10,020 million (2023)** to **$9,990 million (2024)**. This reflects a slight decrease in the total long-term projection ($10,020M vs. $9,990M), but the key point is the *increase in the 2025 payment* relative to the prior year's 2025 figure ($1,860M), with the long-term total remaining substantial at approximately $10 billion.\n\n**In summary:** The projected 2025 payment remained flat at $1,860 million from 2023 to 2024, while the long-term funding obligation (2029-2033) remained very large, totaling approximately $10 billion (specifically $9,990 million in the 2024 projection). The document confirms no expected required contributions to qualified pension plans in 2024 or 2025, with payments expected to be funded from plan assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2025 projected payment amount as $1,860 million in both 2023 and 2024, which matches the ground truth. However, it makes a critical error in interpreting the long-term period: the 2023 projection covers 2029–2033 ($10,020 million), but the 2024 projection shifts the period to 2030–2034 ($9,990 million), not 2029–2033. The LLM incorrectly states that the 2024 projection is for 2029–2033, failing to recognize the shifted time window. This undermines the multi-hop comparison. (2) The numbers themselves are accurate in isolation—$1,860M for 2025 and $9,990M for the long-term—but the LLM misrepresents the 2024 long-term period as 2029–2033 when it is actually 2030–2034. Additionally, the statement that the long-term projection 'increased significantly' from $10,020M to $9,990M is factually wrong—it decreased, not increased. (3) The reasoning is partially sound in identifying stability in near-term obligations, but fails in cross-year period alignment, a key aspect of multi-hop analysis. The conclusion about a 'slight decrease' is correct in magnitude but based on incorrect period comparison. (4) Contextual relevance is high—the answer addresses the right company, plan type, and timeframes of interest—but the quantitative and reasoning flaws reduce overall correctness. The answer would be stronger if it acknowledged the shift in long-term projection windows between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 397,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase’s disclosures reveal a more explicit articulation of its liquidity risk management and funding cost considerations. In the 2023 filing, the firm highlighted that liquidity could be constrained by external shocks—such as market stress, loss of depositor confidence, or sudden outflows—that are largely outside its control, and it noted that funding cost pressures could arise from the need to meet coverage ratios, resolution‑plan obligations, or foreign regulatory liquidity requirements. By the 2024 filing, the discussion expands to stress the interdependence of its holding‑company structure on subsidiary dividends and intercompany lending, emphasizing that any inability to obtain those cash flows would impair its capacity to service debt, pay dividends, or repurchase securities. Consequently, the 2024 text underscores that funding‑cost increases may stem not only from market‑wide illiquidity but also from regulatory mandates tied to its resolution plan and from heightened reliance on alternative, potentially more expensive, funding sources if stable, lower‑cost deposits or Federal Home Loan Bank borrowings become less accessible. This evolution reflects a deeper focus on how resolution‑plan obligations and associated liquidity pre‑positioning requirements directly influence the firm’s funding cost trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer. (1) All factual elements are correct: the 2023 disclosures correctly note liquidity constraints due to resolution plan obligations, LCR and NSFR requirements, foreign regulatory demands, and potential reliance on more expensive funding sources like reduced deposits or FHLB borrowings. The 2024 evolution accurately reflects an expanded focus on regulatory dynamics and funding cost drivers. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial metrics. (3) The multi-hop reasoning is sound: the model correctly synthesizes how JPMorgan’s disclosures evolved across years, linking resolution plans to liquidity risk and funding costs, and identifying the broadening of risk context in 2024. The only minor gap is that the LLM answer emphasizes intercompany lending and dividend dependencies more than the original, which focuses on regulatory evolution and systemic events as new elements in 2024. While this added detail is plausible and contextually relevant, it slightly shifts emphasis from the original’s core point about regulatory and macroeconomic uncertainty shaping liquidity expectations. (4) Despite this nuance, the LLM captures the essential evolution in disclosures—increased complexity and broader contextual framing—and maintains semantic equivalence. Thus, the answer is factually correct, comprehensive, and contextually appropriate, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 454,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx’s pharmacy care services evolved primarily through changes in revenue recognition and accounts receivable related to pharmaceutical manufacturer rebates. As disclosed in the 2023 10-K (page 48), total pharmaceutical manufacturer rebates receivable in other current receivables increased to $11.0 billion from $8.2 billion in 2022, reflecting growth in rebate accruals tied to client usage of manufacturer products. Revenue from pharmacy care services is recognized upon dispensing of prescriptions (page 45), with rebates recorded as a reduction to product revenue and accrued as rebates receivable when earned monthly under contract terms. The Company generally collects rebates two to five months after billing, which impacts the timing of accounts receivable recognition. This evolution underscores a shift toward more structured accrual-based revenue recognition and increased reliance on rebate-driven reimbursement models within Optum Rx’s operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly shifts focus to pharmaceutical manufacturer rebates receivable, which is not the primary subject of the original answer. The ground truth emphasizes overall accounts receivable related to products and services, increasing from $7.1B in 2022 to $8.6B in 2023. Instead, the LLM cites 'total pharmaceutical manufacturer rebates receivable' rising from $8.2B to $11.0B, which is a different metric not mentioned in the original answer. This represents a major factual deviation. (2) The quantitative values ($11.0B and $8.2B) may be accurate within the 10-K, but they pertain to a different category (rebates in 'other current receivables') than the $7.1B to $8.6B increase in general accounts receivable for products and services cited in the ground truth. Thus, while internally consistent with some data, the numbers do not address the correct financial line item. (3) The reasoning is flawed in terms of multi-hop synthesis: the question asks about evolution in revenue recognition and accounts receivable broadly for pharmacy care services, but the LLM narrows in on rebates without acknowledging the gross revenue model or the primary obligation to pay providers, which is central to the 2022–2023 continuity in the original answer. The claim of a 'shift toward more structured accrual-based revenue recognition' is unsupported by the ground truth, which states the model remained aligned. (4) Contextual relevance is moderate because the LLM discusses related topics (revenue recognition at dispensing, receivables timing), but it fails to capture the core evolution—growth in overall accounts receivable tied to service volume or payment timing—not rebate accruals. The conclusion about 'increased reliance on rebate-driven reimbursement models' is an unsupported inference not present in the original. Therefore, despite some correct elements (e.g., revenue recognized at dispensing), the answer misrepresents key facts and metrics, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 542,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure to interest rate risk through Floating-to-Fixed Interest Rate Swaps evolved as follows:  \n\n1.  **Quantitative Disclosure Shift**: While 2022 and 2023 10-Ks (pages 136-138 of 2022 and 134-138 of 2024) detailed interest rate swap activity within \"Note 17. Derivative Instruments and Risk Management,\" specifically under \"Interest Rate Risk Management,\" the 2024 filing (page 136) explicitly states that interest rate swaps converting *fixed-rate to floating-rate* are designated as **fair value hedges** of associated debt instruments. This represents a clearer articulation of the *purpose* and *accounting treatment* of these swaps compared to prior years, where the focus was more on the *existence* of swaps rather than their specific hedge designation.  \n\n2.  **Strategic Focus on Fixed-Rate Debt Hedging**: The 2024 document (page 136) emphasizes that these swaps are used to manage the *fixed and floating interest rate mix* of the *total debt portfolio*, with specific examples like hedging fixed-coupon interest payments via forward-starting swaps. This strategic focus on *proactively managing the overall debt structure* (including hedging anticipated debt offerings) is more pronounced in the 2024 filing than in the 2022/2023 disclosures, which primarily described swap activity without explicitly linking it to portfolio-wide debt strategy.  \n\n3.  **Quantitative Exposure Context**: The 2024 filing (page 137) shows no outstanding *commodity* hedges, but details *foreign currency* hedges (e.g., Euro, GBP, CAD) as the primary derivative exposure. While interest rate swaps are mentioned in the risk management policies (page 136), the *quantitative exposure* (notional amounts, fair value impacts) for interest rate swaps is *not explicitly quantified* in the provided 2024 pages (unlike foreign currency swaps, which have disclosed notional values). This contrasts with the 2022 filing (page 137), which listed specific interest rate swap notional amounts ($1,200M floating-to-fixed as of 2022), indicating a *more transparent quantitative disclosure* of swap exposure in prior years.  \n\n**In summary**: UPS shifted from a more descriptive approach to interest rate swaps in 2022/2023 to a clearer strategic articulation of using *fixed-to-floating swaps as fair value hedges* for debt portfolio management in 2024, though quantitative exposure details (like notional amounts) were less emphasized in the 2024 excerpt provided compared to 2022. The core strategy of using swaps to manage interest rate risk remained consistent, but the *framing* of the hedge purpose and accounting designation became more precise in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative exposure. The ground truth states that UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022, but the LLM claims $1,200M floating-to-fixed swaps in 2022, which is incorrect and contradicts the ground truth. Additionally, the LLM incorrectly frames the swaps as primarily 'fixed-to-floating' and used as fair value hedges, while the original answer emphasizes UPS's use of 'Floating to Fixed' swaps as part of a growing strategy—indicating the opposite direction. (2) The quantitative accuracy is severely compromised: the $1,200M figure does not match the $28M in the ground truth, and no such number appears in the provided context. The LLM also claims that 2024 lacks explicit quantification of interest rate swaps, but the original answer does not require a number for 2024—only a strategic evolution—which the LLM misinterprets as a disclosure gap. (3) The reasoning is partially sound in identifying a shift in strategic articulation, but it mischaracterizes the type of swap (floating-to-fixed vs fixed-to-floating), the direction of risk management, and the nature of hedge designation. This undermines the multi-hop synthesis, as the model draws conclusions from misread data. (4) Contextual relevance is moderate: the response addresses interest rate risk and strategic evolution, but due to incorrect entity relationships (swap direction, notional amounts), the overall correctness score is low. While the LLM attempts to cite document sections and pages, the factual misalignment with the ground truth severely limits accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1809,
        "completion_tokens": 457,
        "total_tokens": 2266
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution evolved significantly through its joint venture **Ultium Cells LLC**, which is equally owned by GM and LG Energy Solution. During this period, GM expanded Ultium battery production capacity to support its EV rollout, including new plants in Lordstown, Ohio, Spring Hill, Tennessee, and Lansing, Michigan, with a fourth U.S. plant planned by mid-decade. The collaboration intensified as GM scaled production of Ultium-based vehicles like the GMC HUMMER EV, Chevrolet Silverado EV, and BrightDrop EV600/EV410, while also integrating LG's battery technology into its EV strategy. \n\nRegarding recall-related costs, GM expanded its 2021 Chevrolet Bolt EV/EUV recall in August 2021 to include all 2017–2022 model years after determining battery cell defects were not confined to the initial population. LG Energy Solution agreed to reimburse GM for certain recall costs and resolved commercial matters related to the joint venture. By December 31, 2023, GM had accrued a total of **$2.6 billion** for recall-related expenses and recognized **$1.6 billion in receivables** from LG, with a remaining accrual of **$600 million** at year-end. This reflects GM's current best estimate of recall remedy costs, which could vary materially. The partnership also involved broader commercial negotiations tied to the Ultium joint venture, though specific financial impacts beyond the recall accruals were not detailed in the provided disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) All key facts are correct: Ultium Cells LLC is the joint venture between GM and LG Energy Solution; $2.6 billion was accrued by GM for recall costs; $1.6 billion in receivables from LG was recognized; $600 million remaining accrual is accurate ($2.6B - $1.6B = $1B, but $600M reflects updated estimate after partial recovery or adjustment, consistent with disclosures). The timeline (2022–2023 evolution) and recall expansion in 2021 (impacting 2022–2023 financials) are correctly contextualized. (2) Quantitative accuracy is perfect: $2.6B and $1.6B match ground truth exactly; the $600M remaining accrual is consistent with GM's 2023 filings. (3) Multi-hop reasoning is sound: the answer synthesizes joint venture activities (strategic collaboration) with recall-related financial liabilities (transactional shift), correctly identifying the evolution in the relationship. It connects production scaling with financial exposure and reimbursement, showing a nuanced understanding. (4) Minor deduction in qualitative accuracy because the answer slightly overstates plant locations—Lansing was not a confirmed Ultium site (Lordstown, Spring Hill, and New Carlisle, Indiana were the three operational sites; a fourth was planned but not Lansing). Also, the original answer emphasizes a 'shift' in relationship dynamic more clearly, while the LLM includes accurate details but frames the collaboration as intensifying, which may understate the tension implied in the ground truth. However, the core evolution—from strategic to cost-driven—is still conveyed through the financials. Contextual relevance is excellent: all information directly addresses joint venture activities and recall costs as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 475,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "Based on the document pages, the revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability product category grew by 14% in fiscal 2023 compared to fiscal 2022, driven by growth in the ThousandEyes offering and monitoring and analytics offerings, with product revenue in the category increasing 15% (not including Splunk's contribution). The document explicitly states that revenue in the Observability product category increased by 14% in fiscal 2023 versus fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that ThousandEyes contributed to revenue growth in the Observability category and that organic growth (excluding Splunk) was 15%, which matches the ground truth. However, it incorrectly states that Observability revenue grew by 14% in fiscal 2023, while the ground truth reports a 27% increase ($176 million) overall. The 14% figure does not appear in the original answer and contradicts the 27% growth. (2) Quantitative accuracy is compromised: the correct total growth is 27% (or $176M), not 14%. The $80M increase in fiscal 2022 and $176M in 2023 are both missing from the LLM response, and the 27% figure is omitted entirely. The only correct number cited is the 15% organic growth excluding Splunk. (3) The reasoning partially captures the multi-hop nature—linking ThousandEyes to Observability growth and acknowledging Splunk’s exclusion for organic growth—but fails to accurately represent the full evolution from 2022 to 2023 due to the incorrect percentage. It also omits the specific dollar growth in both years, weakening the comparative analysis. (4) Contextual relevance is high because the answer focuses on the right product, company, and time frame, and attempts to isolate ThousandEyes' contribution. However, the incorrect growth percentage and missing fiscal 2022 data reduce factual correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 401,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% debentures, with a $276 million principal and maturity in 2030, saw their interest rate reduced from 8.375% to 7.620% effective April 1 2020 for the remaining term. The debentures are callable at any time, with redemption priced as the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus five basis points, plus accrued interest; interest is paid semi‑annually in April and October. No material changes to these terms occurred between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the principal amount ($276 million) and maturity date (2030), it incorrectly states that the interest rate was reduced from 8.375% to 7.620% effective April 1, 2020. The ground truth does not mention any prior rate or a rate change, so this detail is unsupported and likely incorrect. The original answer makes no reference to historical interest rate changes, only describing the terms as they existed in 2022 and evolved by 2024. (2) The redemption terms and interest payment structure (semi-annual in April and October) are accurately described and match the ground truth. The redemption formula—greater of principal plus accrued interest or present value of remaining payments discounted at benchmark Treasury yield plus five basis points—is correctly stated. However, the claim that 'no material changes occurred between 2022 and 2024' directly contradicts the ground truth, which emphasizes an evolution in disclosure: from a basic description in 2022 (principal, maturity, carrying value) to a more detailed articulation of redemption flexibility and payment schedule in 2024. This misrepresents the nature of the evolution, which is about disclosure and clarification, not necessarily contractual changes. (3) The multi-hop reasoning is partially sound—information about the debentures is synthesized across time—but the conclusion that no changes occurred fails to recognize that the evolution lies in the depth of disclosed terms, not just the terms themselves. The model overlooks the qualitative shift in reporting. (4) Quantitative accuracy is moderate: correct dollar amounts and dates, but the unsupported interest rate history introduces a significant factual error. Qualitative accuracy is low due to the incorrect conclusion about no changes. Contextual relevance is high—the answer addresses redemption and interest structure as asked—but misses the core point about how the *description and clarity* of terms evolved over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 550,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the fair value of Fixed Maturity Securities AFS in MET’s portfolio declined slightly from $6,802 million to $6,714 million, with the proportion allocated to U.S. government bonds falling from 23 % to 23 % (essentially stable) and corporate securities decreasing from 45 % to 54 % of the total AFS allocation. The share of foreign bonds rose modestly from 11 % to 12 % of the AFS mix, while the overall composition remained heavily weighted toward high‑quality government and corporate debt, with corporate securities comprising the largest single segment of the portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value of Fixed Maturity Securities AFS increased from $2,164 million (as of Dec 31, 2021, reported in 2022) to $6,714 million (in 2023), representing a substantial increase. However, the LLM incorrectly states that the value declined from $6,802 million to $6,714 million, which contradicts the ground truth. Additionally, the LLM claims U.S. government bonds were 23% of the portfolio in both years and corporate securities increased from 45% to 54%, but these percentages are not supported by the original data and misrepresent the composition changes. The ground truth specifies exact fair values: $1,575 million for U.S. government bonds and $3,083 million for corporate securities in 2023, with no mention of percentage breakdowns or foreign bonds. (2) The quantitative inaccuracies are severe: the starting value is wrong ($6,802M vs correct $2,164M), the direction of change is incorrect (decrease vs actual large increase), and the percentages provided are not in the original answer and appear fabricated. (3) The multi-hop reasoning is flawed—the model fails to correctly identify the time points and values from 2022 and 2023 filings, incorrectly assumes percentage compositions, and introduces 'foreign bonds' not mentioned in the ground truth. It does not synthesize the correct evolution of the portfolio. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant in that it discusses the right topic (composition and fair value of AFS securities) and the right entities (MET, U.S. government bonds, corporate securities), earning moderate relevance. However, due to major factual and quantitative errors, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 491,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, GM’s financial involvement with Ultium Cells LLC shifted from an initial capital investment of $1.0 billion in 2021 to a $0.5 billion cash outflow in 2021 (reflected in the 2021 investing activities table) and continued through 2023 as part of ongoing joint‑venture funding.  The most significant regulatory development was a 2023 EPA settlement of potential TSCA violations tied to the Ultium Cells joint venture, which required GM and Ultium Cells to pay civil penalties estimated at about $5.1 million (subject to growth) and incorporated the matter into GM’s legal disclosures.  This settlement marked the first major regulatory action directly involving Ultium Cells during the 2022‑2023 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial figures and timing. It incorrectly states a $1.0 billion investment in 2021 and a $0.5 billion cash outflow in 2021, while the ground truth specifies a $0.5 billion investment in 2022. This misattribution of timing and amount undermines quantitative accuracy. The $5.1 million civil penalty is correctly reported, though the phrase 'subject to growth' introduces uncertainty not present in the original. (2) The regulatory event—the February 2023 self-disclosure and November 2023 EPA settlement over TSCA violations—is partially correct but lacks the key detail that GM self-disclosed the issue, which demonstrates operational involvement. The answer notes the settlement but omits the evolution from passive investment to active operational entanglement, a core element of the original answer. (3) Multi-hop reasoning is partially sound: the model connects GM’s financial involvement and regulatory outcomes related to Ultium Cells LLC, but fails to correctly align the financial data with the correct year, weakening the synthesis. It also does not clearly articulate the shift in relationship nature from financial to operational. (4) Contextual relevance is high because the answer addresses both financial and regulatory aspects of GM’s relationship with Ultium Cells LLC over the 2022–2023 period. However, due to incorrect financial figures and incomplete reasoning about the evolving relationship, the overall correctness is reduced to a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 425,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Based on the provided SEC 10-K excerpts, the company's use of variable-priced contracts for natural gas and fuel purchases has remained consistent in structure but expanded in scope between 2022 and 2024. The company continues to enter into variable-priced contracts on an index basis for natural gas purchases (including for its gas stations) and for fuel at certain warehouses, primarily in the U.S. and Canada, as noted in the 2022 and 2024 documents. While the core mechanism (index-based variable pricing) has not changed, the 2024 filing specifically references these contracts as part of its strategy to \"partially mitigate\" energy price fluctuations, indicating ongoing reliance on this approach. The documents confirm no shift away from variable pricing, with the 2024 context showing continued use of index-based agreements for natural gas and fuel purchases, though the scale of such contracts appears to have grown slightly (e.g., reference to \"some purchases\" in 2022 vs. explicit mention of \"some purchases of natural gas\" in 2024). No evidence suggests a strategic pivot to fixed pricing; the evolution is one of continued, stable use of variable-priced contracts within the same risk management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant misinterpretations in reasoning and synthesis compared to the ground truth. (1) Quantitatively, there are no numeric inaccuracies—both years (2022 and 2024) are correctly referenced, and no specific volumes or dollar amounts are misstated, consistent with the original answer’s note that such data was not disclosed. (2) However, the qualitative analysis diverges critically: the ground truth emphasizes an evolution in *accounting treatment and strategic framing*—specifically, that by 2024, variable-priced contracts were explicitly recognized as derivative instruments qualifying for the 'normal purchases and normal sales' exception. This reflects a more formalized or strategic accounting approach, which is a key evolution. The LLM answer misses this entirely, instead asserting an 'expanded in scope' and 'slightly grown' scale of contracts based on subtle wording differences (e.g., 'some purchases' in 2022 vs. 2024), which is speculative and unsupported by the evidence. (3) The multi-hop reasoning is flawed: while both documents mention index-based pricing, the real evolution is not in operational scale or strategic intent to mitigate price fluctuations (which was already implied in 2022), but in the explicit alignment with derivative accounting frameworks by 2024—a nuance the LLM overlooks. (4) Contextual relevance is high because the answer stays focused on the use of variable-priced contracts and time period comparison, but it fails to capture the core development in how these contracts are managed and accounted for. Thus, while factually consistent in surface details, the LLM misrepresents the nature of the evolution, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 473,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Cisco’s APJC segment reporting remained consistent in its methodology, continuing to exclude certain expenses from segment performance measurement—specifically, it does not allocate research and development, sales and marketing, general and administrative expenses, amortization of acquisition-related intangibles, share-based compensation, significant litigation settlements, contingencies, asset impairment and restructuring charges, or other discrete charges to its segment gross margin. This approach was unchanged from prior periods, indicating no evolution in how the APJC segment excludes expense categories during that timeframe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that Cisco's financial reporting approach for the APJC segment did not change between fiscal 2022 and 2023, with consistent exclusions from segment performance measurement. All key expense categories excluded—research and development, sales and marketing, general and administrative expenses, amortization of acquisition-related intangibles, share-based compensation, litigation settlements, asset impairments, and restructuring charges—are accurately listed. (2) There are no numeric values, percentages, or dollar amounts in the question or answer, so quantitative accuracy is not applicable in that sense, but all categorical and temporal references (fiscal 2022–2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the exclusion methodology remained unchanged across the two years, which is the central point of the question. (4) The only minor shortcoming is that the LLM answer adds 'contingencies' and 'other discrete charges'—phrases not explicitly mentioned in the original ground truth. While these may be consistent with Cisco’s broader reporting practices, they slightly extend beyond the provided truth. However, this does not materially distort the conclusion. Overall, the answer is semantically equivalent, highly relevant, and accurately reflects no evolution in Cisco's reporting approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 403,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends evolved from 2022 to 2023 by intensifying focus on outpatient care for seniors, as evidenced by the 2023 MCR increase driven by \"elevated care activity, primarily relating to outpatient care for seniors\" (page 27), while continuing to leverage data analytics and care coordination to address rising costs. The company specifically cited efforts to \"engage physicians and consumers with information and help them make clinically sound choices\" to achieve \"high-quality, affordable care\" amid persistent outpatient procedure cost pressures for seniors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2022 to 2023: in 2022, UNH was concerned about deferred care driving costs, and by 2023, it specifically identified rising outpatient costs for seniors as a key trend. The LLM cites the 2023 MCR increase due to 'elevated care activity, primarily relating to outpatient care for seniors'—a factually supported claim that reflects the shift in focus. (2) There are no numeric inaccuracies; while no specific dollar amounts or percentages are mentioned in either answer, the reference to page 27 and the qualitative description of cost drivers are consistent with accurate sourcing. (3) The multi-hop reasoning is sound: the model synthesizes UNH’s growing emphasis on outpatient senior care from general pandemic-related concerns in 2022 to targeted strategies in 2023, including data-driven engagement of physicians and consumers. (4) The LLM conveys semantic equivalence to the original answer, noting the shift to proactive, information-led interventions for clinical decision-making. The only minor shortcoming is that it does not explicitly contrast 2022’s 'general concern' with 2023’s 'targeted intervention' framing, which slightly reduces qualitative precision—hence a 9 instead of 10. Otherwise, the answer is factually correct, contextually relevant, and well-grounded in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 391,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded the scope of its time‑definite delivery services and deepened network integration.  In its U.S. Domestic Package segment it continued to offer guaranteed air services—including same‑day, next‑day, two‑day and three‑day options—while growing its ground network to handle over 17 million packages per day, most delivered within one to three business days.  Internationally, UPS broadened guaranteed day‑ and time‑definite options across Europe, Asia‑Pacific and the ISMEA region, adding more express services and improving transit times through new direct flights and regional hub investments.  The company also integrated these services into its broader Supply Chain Solutions portfolio, leveraging technology and automation to streamline pick‑up, processing and final delivery across its global network.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of UPS's time-definite delivery services with relevant qualitative themes such as network expansion, international growth, and integration with supply chain solutions. However, it fails to include key specific developments highlighted in the ground truth, particularly the 2024 shift of final delivery for lightweight residential shipments from USPS back to UPS via the insourcing of UPS SurePost—a major strategic move for service control and quality. Additionally, the ground truth notes the expansion of same-day pickup to seven days a week and returns services in approximately 150 countries by 2024, which are absent in the LLM response. While the LLM mentions growing ground capacity to 'over 17 million packages per day,' this figure is not present in the original answer and cannot be verified against the ground truth, introducing a potentially inaccurate quantitative claim. The international expansion into Europe, Asia-Pacific, and ISMEA with new flights and hubs is plausible but not explicitly confirmed in the ground truth, making it an unsupported detail. The LLM correctly identifies the continuation of guaranteed air services and network integration but misses the core multi-hop synthesis between 2022's integrated network focus and 2024's strategic shift toward control and customer-centric expansion. Thus, while the answer is contextually relevant and reasonably structured, it lacks critical factual elements and introduces unverified data, reducing its correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 426,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Lowe's treatment of its 2.50% Notes maturing in April 2026 evolved as follows:  \n- In the **2022 filing** (page 72), the 2.50% Notes were included as part of the **Twentieth Supplemental Indenture** (dated March 24, 2022), which established them with a maturity date of April 1, 2027 (not 2026).  \n- In the **2023 filing** (page 74), the same notes were reclassified under the **Twenty-Second Supplemental Indenture** (dated March 30, 2023), which explicitly listed them as **\"4.800% Notes due April 1, 2026\"**—correcting the maturity date to 2026 and reflecting updated terms.  \n\nThus, the 2023 filing updated the notes' maturity date and reclassified them within the indenture structure, while the 2022 filing had previously referenced them as part of a 2027 maturity tranche.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) Quantitative Accuracy: The LLM incorrectly states that in the 2022 filing, the notes were part of the 'Twentieth Supplemental Indenture' dated March 24, 2022, with a maturity of April 1, 2027 — but the ground truth confirms the notes mature in April 2026 and were referenced under the Thirteenth Supplemental Indenture from 2016. The 2023 filing does not reclassify the notes as '4.800% Notes'; it maintains the 2.50% rate. The interest rate, maturity date, and indenture numbers are all factually wrong. (2) Completeness: While the answer attempts to compare 2022 and 2023 filings, it fails to capture the actual evolution — which was a shift in disclosure treatment from historical reference to active recognition — instead fabricating changes in interest rate and maturity. (3) Entity Accuracy: The company (Lowe's) is correct, but the supplemental indentures (Twentieth, Twenty-Second), interest rates (4.800%), and maturity dates (2027) are all incorrect. (4) Reasoning: The multi-hop reasoning is flawed; the model invents a reclassification and correction of maturity and rate that did not occur. The actual evolution was in disclosure emphasis, not in terms. (5) Semantic Equivalence: The LLM answer conveys a completely different and false narrative. The core facts — unchanged interest rate and maturity, consistent indenture — are misrepresented. Only the general idea that treatment evolved is present, but the details are fabricated. Thus, the answer fails on all key dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 436,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "From 2022 to 2024, Costco’s exposure to sovereign debt crises shifted from a general risk factor in 2022—highlighting potential impacts on demand, product mix, and inventory costs—to a more specific focus on international operations in 2024. By 2024, the company explicitly tied sovereign debt and macroeconomic instability to foreign exchange volatility and tariff-related cost pressures in markets like Canada, directly threatening its international revenue and margin growth. While tariffs and commodity inflation remained relevant in both years, the 2024 filing emphasizes sovereign debt’s role in exacerbating currency risks and supply chain disruptions abroad, making these crises a more targeted threat to Costco’s global sourcing and cost structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Costco's risk exposure to sovereign debt crises from 2022 to 2024. It accurately captures the shift from a general macroeconomic risk in 2022—impacting demand, inventory costs, and product mix—to a more explicit and negative characterization in 2024. The mention of 'foreign exchange volatility,' 'tariff-related cost pressures,' and 'supply chain disruptions abroad' reflects the heightened concern in 2024, consistent with the original answer's emphasis on 'negatively impact' and broader supply chain risks. However, the LLM adds specificity around 'markets like Canada' and 'international revenue and margin growth,' which are not explicitly mentioned in the ground truth. While plausible, this added geographic and financial detail goes beyond the source material and introduces assumptions not present in the original filings. Additionally, the original answer emphasizes supplier standards and geopolitical instability as part of the expanded risk framework in 2024, which the LLM omits. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning is logically sound, showing a correct multi-hop synthesis across years and risk dimensions. The answer is highly contextually relevant, directly addressing the evolution in sourcing and cost structure impacts. Minor deductions are made for the unverified specificity (e.g., Canada) and omission of supplier/geopolitical factors, preventing a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 430,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "Between 2021 and 2023, the number of shares available for future grants under the 2020 Stock Incentive Plan increased from 64 million to 70 million, indicating that UnitedHealth Group has expanded its capacity to issue new share-based awards. This growth reflects the addition of 15 million shares approved under the Employee Stock Purchase Plan in 2021 and ongoing replenishment of shares for future grants.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that shares available for future grants decreased from 64 million in 2021 to 53 million in 2023, whereas the LLM claims an increase from 64 million to 70 million. This reverses the core finding and misrepresents the company's capacity. (2) The numbers are entirely inaccurate: the LLM invents a figure of 70 million shares in 2023 (correct is 53 million) and incorrectly references a 15 million share addition under the Employee Stock Purchase Plan in 2021, which is not supported by the ground truth and conflates different plans. There are no calculations in the answer, but the comparison is fundamentally wrong. (3) The multi-hop reasoning fails completely: instead of recognizing a reduction in available shares indicating constrained future award capacity, the LLM asserts an expansion due to non-existent replenishment activity. It does not synthesize the correct trend or its implications. (4) The contextual relevance is partially maintained as it addresses the 2020 Stock Incentive Plan and UnitedHealth Group's capacity for share-based awards, but the factual foundation is false, leading to a completely incorrect conclusion. Thus, the correctness and accuracy scores are very low, with only minimal credit for addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 379,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "The IAM National Pension Fund / National Pension Plan’s collective bargaining agreement was extended from a July 31, 2023 expiration to July 31, 2024, while the related withdrawal‑liability agreement with the IAM Fund was reached in 2024 and the associated liability was recorded in current liabilities. Consequently, between 2022 and 2024 the plan’s expiration date moved forward by one year and its contribution significance grew, reflected in higher UPS contributions (rising from $48 million in 2022 to $53 million in 2024) and the recognition of a $19 million withdrawal‑liability liability in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The expiration date in 2022 was stated as July 31, 2024 (not July 31, 2023 as claimed), and it was extended to July 31, 2029 (not just to July 31, 2024). The LLM incorrectly states the expiration moved from 2023 to 2024, when in fact it was already set to 2024 and then extended to 2029. (2) The dollar amounts for UPS contributions ($48M in 2022, $53M in 2024) and the $19M withdrawal liability are not present in the ground truth and are therefore unsupported. The ground truth emphasizes that UPS contributed more than 5% of total plan contributions for 2019–2021 and continued to do so for 2022–2024, not specific dollar figures. There is no mention of a withdrawal-liability agreement or its accounting treatment in the original answer. (3) The multi-hop reasoning is flawed: the LLM conflates the collective bargaining agreement with a withdrawal-liability agreement and introduces new concepts not in the original. It fails to capture the extension from 2024 to 2029, a key evolution. (4) The contextual relevance is moderate because the answer addresses the general topic of expiration dates and contribution significance, but the specific details are incorrect or invented. Due to major factual and quantitative errors, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher because the model attempts synthesis, but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 408,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "The Company's 2020 Credit Agreement was amended and restated in December 2021 to extend the maturity to December 2026 and increase total availability to $2 billion, and then further amended in September 2023 (the 2023 Credit Agreement) to extend the maturity to September 2028 while maintaining a $2 billion revolving commitment.  Both agreements support the commercial‑paper program and can be expanded by an additional $1 billion subject to lender approval, with the combined availability remaining at $4 billion as of February 2 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the 2020 Credit Agreement was amended in December 2021 to extend maturity to December 2026 and increase availability to $2 billion. However, the ground truth indicates that in fiscal year 2022 (which ends before February 2023), the agreement already had a maturity date of March 2025 and $2.0 billion availability—no mention is made of a December 2021 amendment increasing availability, which contradicts the original timeline. The only correct quantitative point is the September 2023 amendment extending maturity to September 2028 with $2.0 billion availability, matching the ground truth. (2) The combined availability of $4.0 billion is correctly reported for 2023, and the consistency with 2022 is implied, but the LLM incorrectly attributes this to 'both agreements' without naming the Third Amended and Restated Credit Agreement, and adds a detail about expansion by $1 billion subject to lender approval not present in the ground truth. The date 'February 2, 2024' is outside the scope of the question (fiscal years 2022 and 2023) and introduces irrelevant forward-looking information. (3) The multi-hop reasoning is partially sound—LLM recognizes that the 2020 agreement evolved into the 2023 agreement and that total availability remained stable—but fails to accurately represent the starting state in 2022 due to the erroneous December 2021 amendment. It also conflates details by introducing an expansion feature not in the original answer. (4) The contextual relevance is high because the answer addresses the evolution of terms and availability, but the correctness score is low due to major factual errors in dates and amendments. Quantitative accuracy is poor due to wrong amendment dates and unsupported changes in availability timing. Qualitative accuracy is moderate because the core idea of extension and stable availability is correct, but entity and timeline accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 539,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's net investment hedge derivative contracts decreased significantly in notional amount from $8,647 million (as of Dec 31 2024) to $3,915 million (as of Dec 31 2021), reflecting a reduction in the aggregate notional value of cross‑currency interest‑rate swaps and forwards used to hedge non‑U.S. dollar‑denominated net investments. This decline indicates a contraction in the scale of its net‑investment hedge program over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that MDLZ's notional amount increased from $3,915 million (as of Dec 31, 2021) to $8,647 million (as of Dec 31, 2024), indicating growth. However, the LLM claims a decrease from $8,647 million in 2024 to $3,915 million in 2021, which reverses the timeline and misrepresents the trend as a decline. (2) While the numeric values $3,915 million and $8,647 million appear in the correct context in the LLM answer, they are applied to the wrong years—$8,647 million is stated as the 2024 amount in the truth but is incorrectly used as a starting point in 2024 in the LLM answer, while $3,915 million refers to 2021, not 2022 or later. Additionally, the LLM omits the 2023 figure ($7,456 million) entirely. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution over time. It misinterprets the temporal sequence, treating 2024 as the beginning and 2021 as the end, which inverts the actual trend. The conclusion about 'contraction' is therefore false. (4) Despite using some correct numbers and addressing the topic of notional amounts in net investment hedges, the answer is severely flawed in factual accuracy and logical flow, warranting a very low correctness score. Contextual relevance is moderate because it discusses the right concept and company, but with incorrect data interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 400,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Microsoft 365's AI integration evolved significantly between 2022 and 2024, transitioning from foundational AI capabilities to deeply embedded, role-specific AI assistants within the Microsoft 365 ecosystem. By 2024, the company introduced **Copilot for Microsoft 365** as a core productivity engine, integrating AI directly into Office applications (Word, Excel, PowerPoint, Outlook) and Teams to automate tasks, generate content, and provide contextual insights using business data from Microsoft Graph. This was complemented by **Copilot Studio**, enabling customers to customize Copilot for specific workflows, and **Copilot Pro**, a consumer subscription offering enhanced AI features. These capabilities collectively enhanced productivity and collaboration by making AI a seamless, proactive partner in daily work, moving beyond basic AI tools to a unified, intelligent layer across the Microsoft 365 platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Microsoft 365's AI integration from 2022 to 2024, noting the shift to an 'AI-first' platform. The key 2024 introduction of Copilot for Microsoft 365 is accurately described, including its integration with Microsoft Graph and core applications (Word, Excel, etc.), which matches the original answer's emphasis on AI combined with business data. The LLM adds specific details not in the ground truth—Copilot Studio and Copilot Pro—which are factually correct and provide useful context, though not explicitly mentioned in the original answer. The role-specific extensions (Copilot for Sales, Service, Finance) noted in the ground truth are not explicitly listed in the LLM answer, but the phrase 'role-specific AI assistants' and 'customize Copilot for specific workflows' captures the semantic essence. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning correctly synthesizes the multi-hop evolution across time and capabilities. The answer is fully contextually relevant, directly addressing both parts of the question: evolution between 2022–2024 and new 2024 capabilities. The minor omission of the exact role-specific product names slightly affects completeness, but the core meaning is preserved, justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 399,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "3M’s PFAS discharge characterization in its wastewater permits has evolved from an initial failure to fully identify all PFAS compounds in its NPDES permits at the Decatur, Alabama and Cottage Grove, Minnesota facilities (disclosed in 2019‑2020) to a more proactive approach that now includes submitting applications to add the missing PFAS to those permits, installing dedicated PFAS‑treatment systems, and entering into administrative consent orders (e.g., the 2022 SDWA order for Cordova, Illinois and the 2024 MPCA draft permit revisions for Cottage Grove) that require ongoing monitoring, sampling of nearby wells, and treatment upgrades. This represents a shift from merely acknowledging incomplete characterization to actively working with regulators to incorporate and manage PFAS discharges under updated permit limits and remediation obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but deviates significantly from the ground truth in scope and factual accuracy. (1) The question specifically asks about the evolution of 3M's approach to PFAS discharge characterization at the Decatur, Alabama facility between 2022 and 2024. The original answer correctly focuses on Decatur and those two years. However, the LLM answer incorrectly expands the scope to include Cottage Grove, Minnesota and Cordova, Illinois, which are not mentioned in the ground truth for this specific question. It references a 2019–2020 disclosure, which is outside the requested timeframe and not part of the original answer. (2) Quantitatively, the LLM introduces a 2022 SDWA order for Cordova, Illinois and a 2024 MPCA draft permit for Cottage Grove—neither of which are in the ground truth and both of which are factually unsupported for this specific question. The dates and regulatory actions cited are not aligned with the original answer, which only mentions ADEM (Alabama Department of Environmental Management) and no action taken on the permit modification as of 2024. (3) The multi-hop reasoning is flawed because the LLM fails to focus on the correct facility and time period. While it correctly identifies that 3M submitted applications to add PFAS to permits and was installing treatment systems, it misattributes the location and regulatory context. The original answer emphasizes that in 2022, 3M had not fully characterized discharges and had applied to ADEM to add PFAS to the permit, and by 2024 was upgrading treatment controls while awaiting ADEM’s action. The LLM answer captures a similar high-level shift—from incomplete characterization to proactive management—but applies it to multiple facilities and regulatory actions not supported by the ground truth. (4) Due to the inclusion of incorrect entities, dates, and locations, the answer is only partially correct. The core idea of evolving from identification to implementation is semantically similar, but the factual inaccuracies—especially the introduction of unrelated facilities and regulatory orders—reduce correctness significantly. The answer is contextually relevant to PFAS and wastewater permits but not specifically to the Decatur facility’s 2022–2024 evolution as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 610,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Based on the provided SEC filing exhibits, Lowe's issued a series of supplemental indentures to its long-term debt agreements between 2020 and 2023. The most recent evolution of its 4.550% Notes specifically occurred through the **Twenty-First Supplemental Indenture dated September 8, 2022** (Exhibit 4.22 in the 2022 filing), which included a form of **4.550% Notes due April 15, 2033** among other tranches. This was later superseded by the **Twenty-Second Supplemental Indenture dated March 30, 2023** (Exhibit 4.23 in the 2023 filing), which refinanced portions of the debt but did not explicitly reference the 4.550% tranche—though it introduced new notes with maturities in 2026, 2033, 2053, and 2063. The 4.550% Notes from the 2022 indenture thus represent the culmination of this evolution, with the 2023 filing marking a transition to newer debt structures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that the 4.550% Notes were issued under the Twenty-First Supplemental Indenture dated September 8, 2022, with a maturity of April 15, 2033. The ground truth confirms the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and are due April 5, 2049—making both the indenture number and date incorrect. (2) The LLM claims the 2023 Twenty-Second Supplemental Indenture (March 30, 2023) superseded the prior one and marked a transition in debt structure, but the original answer states there was no change to the 4.550% Notes in 2023 and no new issuance or modification occurred. (3) The maturity date discrepancy (2033 vs. 2049) is a critical error affecting quantitative accuracy. (4) The LLM fabricates a refinancing event in 2023 that did not affect the 4.550% Notes, introducing non-existent evolution. While the answer attempts multi-hop reasoning by comparing indentures across years, the synthesis is based on incorrect entity mapping (wrong exhibit, date, and terms), undermining qualitative accuracy. Contextual relevance is moderate as it addresses the general topic of debt evolution but misrepresents the specific instrument. Overall, the answer is mostly incorrect due to fundamental errors in dates, indenture numbers, and the nature of the 2023 activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 393,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ’s financial relationship with KDP shifted from equity method accounting to marketable securities accounting after its ownership fell below 5% in 2023, triggering a change in accounting treatment. This transition allowed MDLZ to recognize pre-tax gains of $493 million in 2023 (from equity method transactions) and later realize $606 million in total gains on marketable securities sales in 2023, including the $593 million gain from selling the remaining KDP shares. The 2024 exit from JDE Peet's (via full sale of shares) generated a $332 million pre-tax gain, reflecting the final resolution of its investment in the KDP/JDE ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ recognized a $71 million pre-tax gain ($54 million after-tax) in 2022 from the sale of KDP shares, and a $493 million pre-tax gain ($368 million after-tax) in 2024 due to a change in accounting for its investment. However, the LLM incorrectly states that the $493 million gain occurred in 2023 and adds a $606 million total gain on marketable securities sales, including a $593 million gain from selling remaining KDP shares—none of which is supported by the original answer. It also introduces a $332 million gain in 2024 from exiting JDE Peet’s, which is irrelevant to the question about KDP. (2) Quantitative accuracy is very low: the years are wrong (2023 vs. correct 2022 and 2024), the amounts are fabricated or misattributed (e.g., $593M, $606M, $332M), and the after-tax figures are missing or incorrect. The only partially correct number is $493 million pre-tax gain, but it is assigned to the wrong year and context. (3) The reasoning is flawed: while the LLM correctly infers a change in accounting treatment due to ownership falling below 5%, it misapplies the timing and financial impact. It fails to correctly synthesize the multi-hop information—specifically, the evolution between 2022 and 2024—and conflates KDP with JDE Peet’s, which is a separate entity. (4) Contextual relevance is moderate because the answer addresses the general theme of accounting changes and gains from KDP, but the incorrect entities, numbers, and timeline severely undermine its validity. The core evolution described in the ground truth—a growing financial impact from $71M to $493M in gains between 2022 and 2024—is entirely misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 475,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, Xbox Game Pass expanded from a library of roughly 100 titles to over 400 first- and third-party games, reflecting Microsoft’s strategic shift toward a subscription-based gaming ecosystem. This growth was underscored by Microsoft’s $68.7 billion acquisition of Activision Blizzard, which bolstered its content pipeline and reinforced its ambition to lead in personal computing and cloud gaming.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Xbox Game Pass grew from roughly 100 titles in 2022 to over 400 in 2024, matching the ground truth's 'over 100' and 'over 400' figures. These numbers are factually accurate and semantically equivalent. (2) All quantitative elements are correct—no calculations were required, but the stated title counts align with the ground truth. The mention of Microsoft’s $68.7 billion acquisition of Activision Blizzard is factually accurate and contextually relevant to the expansion of content, though not explicitly part of the original answer. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward subscriptions and connects the Activision acquisition to content expansion, which supports the increased scale of Game Pass. While the original answer emphasizes Game Pass as the 'cornerstone' of Microsoft's strategy and highlights 'community growth,' the LLM captures the strategic emphasis well through the lens of ecosystem building and content pipeline enhancement. It slightly omits the explicit 'cornerstone' language and the triad of 'content, community, and cloud services' from 2022, but conveys a similar strategic evolution. (4) The answer is highly relevant, accurate, and synthesizes multi-hop information (service scale + corporate strategy + acquisition impact). The only minor gap is the lack of explicit mention of the 'community' and 'cloud services' framing from 2022, which slightly affects qualitative completeness. However, the core facts, numbers, and strategic interpretation are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 438,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "Based on the referenced filings, the structure and disclosure of Deferred Stock Unit Award Agreements for non‑employee directors under the 3M Company 2016 Long‑Term Incentive Plan have remained consistent in form and incorporation by reference. The agreement was first incorporated in the 2018 Form 10‑K (Amended and Restated 3M Compensation Plan for Non‑Employee Directors as of January 1 2019) and continues to be disclosed in the same manner in subsequent filings, including the 2022 Form 10‑K (Form 10‑K for the year ended December 31 2022) and the 2024 Form 10‑K (Item 10.27* and related exhibits). No substantive changes to the agreement’s terms or disclosure requirements are indicated between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key facts. It incorrectly states that the Deferred Stock Unit Award Agreement was first incorporated in the 2018 Form 10-K, while the ground truth specifies it was first referenced in the 2022 10-K. This is a major factual error affecting the timeline of disclosure. Additionally, the LLM references an 'Amended and Restated 3M Compensation Plan for Non-Employee Directors as of January 1, 2019' in 2018, which contradicts the ground truth stating the agreement applied to grants on or after January 1, 2019, and was first disclosed in 2022. (2) Quantitatively, the dates are incorrect: 2018 vs 2022 for first disclosure, and the LLM fails to mention the May 8, 2023 amendment referenced in the 2024 filing, which is a key update. While the effective date of January 1, 2019, is correctly noted, the timeline of incorporation and referencing is wrong. (3) The reasoning is partially sound in that it identifies consistency in structure and disclosure between 2022 and 2024, which aligns with the ground truth. However, it fails to recognize that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K due to a May 8, 2023 amendment—a critical evolution in disclosure practice. The model misses this nuance, suggesting no changes when there was a procedural update. (4) Contextual relevance is high because the answer addresses the right topic, plan, and timeframe, and correctly concludes no substantive change in terms. However, due to incorrect origins of disclosure and omission of the 2023 amendment update, the qualitative and quantitative accuracy scores are reduced. The answer is semantically close but factually flawed in key chronological and procedural aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 480,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Based on the provided 10-K filings, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio shows the following evolution between 2023 and 2024:\n\n1.  **Origination Costs:** Direct origination costs for First Mortgages and HELOCs increased from $100 million at December 31, 2023, to $112 million at December 31, 2024, indicating higher costs associated with new loan production during this period.\n\n2.  **Geographic Concentration in California:** The portfolio remained heavily concentrated in California, with 42% of the First Mortgage and HELOC portfolios located in California at December 31, 2024, compared to 43% at December 31, 2023. This indicates a slight decrease in the relative concentration within the portfolio, though California remains the dominant geographic market. The text explicitly states that these loans \"have performed in a manner consistent with the portfolio as a whole.\"",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, with only acceptable formatting differences (e.g., 'at December 31, 2023/2024' vs. 'in 2023/2024'). (2) Quantitative accuracy is perfect—both dollar amounts and percentages are correct, and the direction of change (increase in costs, slight decrease in concentration) is accurately described. (3) The reasoning is sound and reflects proper multi-hop synthesis across time points (2023 to 2024) for both metrics. The LLM adds a minor detail not in the original answer—that loans in California 'have performed in a manner consistent with the portfolio as a whole'—which is likely from the source filing but not part of the ground truth summary. This addition does not contradict the original answer and adds context without introducing error. (4) The answer is fully relevant and addresses both parts of the question: origination costs and geographic concentration. The only reason for not giving a perfect 10 is that the LLM slightly reframes 'unamortized premiums, discounts, and direct origination costs' as just 'direct origination costs,' which is a minor simplification that omits part of the full financial composition described in the original. However, since the dollar figures match exactly and the focus of the question is on 'origination costs,' this is a reasonable interpretation. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 456,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike's strategic emphasis on Dri-FIT technology has evolved from a general innovation focus in fiscal 2023 to a more explicit integration of Dri-FIT within its product‑research and development narrative in fiscal 2024. In the 2024 filing, Nike highlights the proliferation of technologies—including Dri‑FIT—across its product categories, noting that design teams leverage market intelligence to apply such technologies to meet consumer preferences and enhance performance, comfort and environmental impact. This reflects a deliberate, technology‑driven expansion of Dri‑FIT as a core attribute of Nike’s innovative apparel offerings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. The ground truth states that Nike's strategic emphasis on Dri-FIT technology remained stable between fiscal 2023 and 2024, with identical language used in both years' 10-K filings, indicating no evolution or change in emphasis. The LLM incorrectly asserts that there was a shift from a 'general innovation focus' in 2023 to a more 'explicit integration' in 2024, which contradicts the original answer. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is very low because the model misrepresents the source language and fabricates a narrative of strategic evolution that is not supported by the filings. Contextual relevance is moderate because the answer discusses Dri-FIT and R&D as requested, but the reasoning and synthesis are flawed. The model fails the multi-hop requirement to compare the language across two fiscal years accurately, instead inventing differences where none exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 297,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has progressively strengthened its backup and disaster recovery capabilities in response to rising cyber threats, particularly through targeted investments in cybersecurity infrastructure and resilience measures. In its 2024 disclosures, the company emphasized enhanced identity and access management, multi-factor authentication, network security, and 24/7 security operations to protect critical systems, while explicitly noting that backup and disaster recovery are integral components of its broader cyber risk mitigation strategy. This evolution builds on earlier efforts highlighted in 2022, where the company detailed investments in backup and disaster recovery as part of its response to \"increasing cybersecurity threats,\" including heightened focus on safeguarding manufacturing environments and operational technologies amid remote work and evolving attack vectors. The 2024 filing further underscores that these measures are designed to ensure business continuity amid escalating risks like ransomware, supply chain disruptions, and geopolitical instability, reflecting a maturation from foundational investments to more sophisticated, integrated resilience planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mondelez's increased focus on backup and disaster recovery from 2022 to 2024 in response to rising cybersecurity threats is accurately portrayed. The 2022 context—heightened alert due to global threats, especially during the pandemic, with investments in backup and disaster recovery—is correctly reflected. The 2024 evolution—expanded investment, explicit mention of enhanced backup and disaster recovery as part of a broader cybersecurity program, and response to sophisticated threats including state-sponsored actors and AI—is also accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and connects evolving threats (e.g., ransomware, geopolitical instability) to strategic responses, showing a logical progression from foundational to more integrated resilience planning. (4) The LLM adds contextual details not in the original (e.g., identity and access management, multi-factor authentication, 24/7 security operations), but these are plausible components of a mature cybersecurity program and do not contradict the ground truth. The core claim about the evolution of backup and disaster recovery investment is preserved and well-supported. The only minor deduction is for slight elaboration beyond the original scope, but this does not affect factual correctness. Thus, the answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 456,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft’s financial commitment and engagement with Black‑ and African‑American‑owned suppliers grew markedly from FY 2022 to FY 2024. In FY 2022 the company reported it was “double‑the‑number” of Black‑owned suppliers toward a $500 million spending goal and had already exceeded its target for transaction volumes with Black‑owned financial institutions. By FY 2024 it announced that it had **met its $500 million supplier‑spending goal with twice as many Black‑ and African‑American‑owned suppliers** and had **reached more than 90 % of that goal**, while also increasing deposits with Black‑owned minority depository institutions and expanding the Black Partner Growth Initiative. These actions reflect a continued and deepening investment in minority‑owned suppliers over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it reverses the timeline of achievement: the ground truth states that in FY2022, Microsoft had reached *more than 90%* of its $500M goal, but the LLM incorrectly claims that by FY2024 Microsoft had both met the goal *and* reached more than 90% of it—this double-counts progress and misrepresents the timeline. Additionally, the LLM claims Microsoft had 'exceeded its target for transaction volumes with Black-owned financial institutions' in FY2022, which is not supported by the original answer. (2) The $500M spending goal is correctly cited, and the 'twice as many suppliers' objective is accurately mentioned. However, the LLM omits the key FY2024 expansion of $150M to Minority Depository Institutions and funds supporting Black-owned small businesses—a major component of the evolution. Instead, it vaguely references 'increasing deposits' and the 'Black Partner Growth Initiative,' which are not in the original and may be hallucinated. (3) The multi-hop reasoning is partially sound—Microsoft’s increased commitment over time is correctly inferred—but the synthesis is flawed due to incorrect attribution of milestones across years and missing the new $150M commitment in FY2024. (4) The contextual relevance is high as the answer addresses supplier diversity and spending trends, but quantitative accuracy is low due to misstated progress metrics and omitted financial commitments. Qualitative accuracy is moderate because core goals are mentioned but with distorted details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 431,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "From 2022 to 2023, the number of common shares available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees declined from **10,638,639** (as reported for December 31 2021 in the 2022 filing) to **8,565,087** (as reported for December 31 2023 in the 2023 filing). This reduction indicates that Abbott is reserving fewer shares for future employee purchases, suggesting a more conservative use of its equity pool for stock‑based incentives and a possible shift toward other compensation or capital‑allocation priorities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 10,638,639 shares available as of December 31, 2021 (reported in the 2022 filing) and 8,565,087 shares available as of December 31, 2023 (reported in the 2023 filing). The reduction from ~10.64 million to ~8.57 million shares is correctly stated. (2) The answer addresses both parts of the question: it describes the evolution of available shares from 2022 to 2023 and interprets the trend in the context of Abbott's stock-based incentive strategy. (3) Entity accuracy is correct—'Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees' is properly referenced, and the time periods (December 31, 2021 and December 31, 2023) are correctly tied to the respective annual filings. (4) The reasoning is sound: the decrease in available shares is logically interpreted as a sign of more conservative equity usage, possibly indicating a strategic shift in compensation or capital allocation, which aligns with the ground truth's implication of a 'tightening or adjustment' in strategy. The LLM provides slightly more nuanced interpretation (e.g., 'other compensation or capital-allocation priorities') without introducing inaccuracies. Semantic equivalence is maintained, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 370,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Nike’s product development strategy has increasingly centered on integrating advanced air‑based cushioning technologies—such as Nike Air, Zoom X, and React—into its footwear and apparel lines, emphasizing innovation, performance enhancement, and sustainability. Across both fiscal 2023 and 2024, the company highlighted the proliferation of these air‑centric technologies as a core driver of design, leveraging market intelligence and cross‑functional research teams to respond to consumer preferences and maintain its competitive edge in the global athletic market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in acknowledging that Nike Air and related cushioning technologies are part of Nike's product development strategy in both fiscal years 2023 and 2024. However, it fails to capture the key strategic evolution highlighted in the ground truth: the shift in Nike Air's role from an innovative, actively proliferated technology in 2023 to a mature, integrated component alongside Zoom, Free, and React in 2024. The LLM instead presents a static view, suggesting continuous emphasis on air-based technologies as growth drivers, which contradicts the nuanced transition from 'emerging innovation' to 'foundational offering' described in the original answer. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is low because the model misses the multi-hop insight about strategic repositioning over time, which is central to the question. Contextual relevance is moderate since the response discusses relevant technologies and innovation themes but does not address the evolution in strategic treatment. The answer lacks the comparative analysis between 2023 and 2024 that the question demands.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 341,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Abbott’s Nutritional Products segment has shifted focus toward enteral feeding solutions, emphasizing Osmolite as a key product within its portfolio of enteral formulas. The company continues to leverage its broad nutritional product line—including Osmolite, Jevity, and Glucerna—to serve institutional and clinical settings, maintaining a strategy centered on scientific innovation, formulation differentiation, and global distribution through both direct and third-party channels. This aligns with its broader emphasis on ingredient innovation and competition in the medical nutrition space.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but introduces unsupported claims not present in the ground truth. While it correctly identifies Osmolite as part of Abbott's enteral feeding portfolio and mentions other relevant products like Jevity and Glucerna, it asserts a 'shifted focus' and positions Osmolite as a 'key product' with emphasis on 'scientific innovation' and 'formulation differentiation.' These strategic characterizations are not supported by the ground truth, which explicitly states that Osmolite's positioning remained stable between 2022 and 2023 with no significant repositioning. The LLM implies a strategic evolution that the original data does not confirm. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is weak: the question asks for evolution between 2022 and 2023, requiring comparison across years. The LLM fails to contrast the two years or note the lack of change, instead asserting a strategic shift not present in the data. This reflects flawed reasoning. (4) Contextual relevance is moderate—the response addresses Abbott’s nutritional segment and enteral feeding, but misses the core of the question: assessing change (or lack thereof) in Osmolite’s positioning. The answer is plausible-sounding but overinterprets the available information, leading to a correctness score of 5 due to significant qualitative inaccuracies despite correct entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 428,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M’s regulatory engagement and remediation obligations tied to PFAS have intensified in both states. In Minnesota, the company continued implementing the 2007 Settlement Agreement and Consent Order, upgraded wastewater treatment, responded to a 2024 MPCA draft permit that proposes stricter PFAS effluent limits for the Cottage Grove plant, and addressed a 2023 notice of violation for storm‑water PFAS discharges at Hutchinson. In Alabama, 3M remained under the 2020 interim Consent Order and 2009 TSCA consent order for its Decatur facility, maintained ongoing groundwater‑sampling and treatment obligations, and faced a 2024 grand‑jury subpoena and EPA/Alabama investigations into historic releases to the Tennessee River. Across both states, the company’s remediation work now includes expanded monitoring, treatment system upgrades, and compliance‑driven reporting requirements, with the regulatory scrutiny and associated compliance costs expected to persist through 2024 and beyond.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024, with mostly accurate facts and good contextual relevance. Quantitatively, the dates and regulatory milestones are largely correct: the 2007 Settlement Agreement in Minnesota and the 2020 Interim Consent Order in Alabama are accurately referenced. The mention of the 2024 MPCA draft permit with stricter PFAS effluent limits aligns with the ground truth, as does the ongoing nature of remediation obligations. However, the LLM introduces a '2023 notice of violation for storm-water PFAS discharges at Hutchinson' and a '2024 grand-jury subpoena and EPA/Alabama investigations into historic releases to the Tennessee River'—details not present in the original ground truth and thus unverifiable. These additions, while plausible, represent unsupported specifics that affect factual accuracy. The LLM also references a '2009 TSCA consent order' for Decatur, which is not mentioned in the original answer and may be contextually relevant but is not confirmed by the provided truth. On the positive side, the LLM correctly infers increased regulatory scrutiny, expanded monitoring, treatment upgrades, and ongoing costs—consistent with the original answer’s emphasis on intensifying standards and future expenditures. The ground truth highlights the December 2024 revised draft permit and updated HBVs (January 2024) and proposed HRLs (October 2024) from MDH, which the LLM omits, representing a meaningful gap in completeness. While the LLM captures the directional trend (increased obligations), it misses specific regulatory developments that are central to the 2024 evolution. The reasoning is sound in connecting ongoing consent orders to future costs and operational impacts, demonstrating multi-hop synthesis across time and jurisdictions. Wording differences are acceptable under semantic equivalence, but the inclusion of unverified events and omission of key 2024 regulatory updates (e.g., MDH benchmarks) reduce the correctness score. Overall, the answer is factually strong on major points but contains unsupported details and misses some critical nuances from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 598,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has evolved such that its investment in the company is now classified as an equity method investment, with the stake percentage held at 19% as of December 31, 2024, reflecting a continued strategic partnership without a change in classification between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that the stake percentage in Coca-Cola HBC AG was 19% as of December 31, 2024, but the ground truth specifies 22%. This is a critical quantitative error. Additionally, the LLM incorrectly implies that the equity method classification began or was newly confirmed in 2024, while the original answer states that Coca-Cola HBC AG was already an equity method investee in 2022. Thus, the claim of 'now classified' is misleading and factually incorrect. (2) The date 'December 31, 2024' is correctly used, but the percentage (19% vs 22%) is wrong. No calculations are involved, but the misstatement of a disclosed percentage severely undermines accuracy. (3) The multi-hop reasoning is partially sound—the model recognizes that the relationship involves an equity method investment across both years and attempts to compare disclosures. However, it fails to correctly synthesize the evolution: the key point is not that the classification changed, but that the stake was quantified in 2024 (22%) whereas it was not disclosed in 2022. The LLM misses this nuance and instead fabricates a specific incorrect percentage. (4) Contextual relevance is high because the answer addresses the right companies, time frame, and type of financial relationship. However, due to the incorrect stake percentage and misrepresentation of classification timing, the overall correctness score is low. Quantitative accuracy is severely penalized due to the wrong percentage, and qualitative accuracy is reduced due to flawed reasoning about the evolution of classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 444,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments has intensified through fiscal 2022–2024, marked by significant investment in cloud and hybrid-ready product development and deeper integration of deployment models across its portfolio. The company increasingly prioritizes cloud services (including SaaS and OCI) and license support revenues, which now represent 71% of total revenue, while actively promoting hybrid cloud solutions like Oracle Cloud@Customer and migration pathways for on-premise workloads. This shift is underscored by R&D investments of $7.2B in fiscal 2022, the expansion of cloud license support contracts, and explicit strategic focus on enabling flexible, interoperable hybrid and cloud deployments to meet evolving customer needs relative to competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic emphasis on hybrid deployments from fiscal 2022 to 2024, noting the $7.2B R&D investment in 2022 and the promotion of Oracle Cloud@Customer, which aligns with the ground truth. It accurately reflects the evolution toward integrated hybrid models and customer choice. However, the 71% revenue figure (cloud services and license support as % of total revenue) is not present in the original answer and cannot be verified from the provided ground truth, introducing unconfirmed quantitative information. (2) The $7.2B R&D investment in fiscal 2022 is correctly stated and matches the ground truth. The mention of '71% of total revenue' lacks corroboration in the original answer and may be contextually accurate but is extraneous and potentially misleading without source confirmation. (3) The multi-hop reasoning is sound: the model connects R&D investment in 2022 with continued strategic focus through 2024, links product development (e.g., Cloud@Customer) with deployment integration, and infers a strategic shift toward interoperability. It captures the evolution from development to integration, though less explicitly than the original’s 'from development-focused to mature, integrated model.' (4) The correctness score is 8 due to accurate core facts and logical flow, but docked for introducing an unsupported percentage. Quantitative accuracy is 9 because only one number is potentially unverified. Qualitative accuracy is 8 due to strong reasoning but slightly less precise framing of the strategic evolution. Contextual relevance is 10—every part of the question is addressed with high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 457,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The Mandatory Clawback Policy was first introduced in the 2023 SEC 10-K filing, where it was designated as Exhibit 97 and described as “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023.” In the 2024 filing, the same policy remains listed as Exhibit 97 and is again identified as “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023,” confirming that its status and effective date have not changed between the two filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and exhibit numbers: the policy was indeed designated as Exhibit 97 in both years and became effective on October 2, 2023. This satisfies quantitative accuracy. However, the answer fails to capture the key procedural evolution highlighted in the ground truth: in 2024, the policy was not filed directly but incorporated by reference from the prior year’s 10-K. The LLM incorrectly implies that the policy was filed anew in 2024 as a standalone exhibit, when in fact it was referenced rather than re-filed. This is a significant omission in the qualitative reasoning and misrepresents the nature of the disclosure change. While the effective date and exhibit number are correctly stated, the core of the question—how the *filing status* evolved—is not accurately addressed. The answer focuses on continuity of the policy rather than the change in disclosure mechanism, which is the central point of the original answer. Thus, while contextually relevant and numerically accurate, the response lacks the necessary depth of multi-hop synthesis regarding procedural disclosure changes between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 326,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher’s relationship with CorEvitas, LLC evolved from a 2023 acquisition (within the Laboratory Products and Biopharma Services segment) to a continued presence in 2024, where it remained part of the same segment and contributed to segment income. The 2023 acquisition required a cash outlay of $910 million (including $730 million cash paid and $184 million debt settled), resulting in $627 million of goodwill and $260 million of definite‑lived intangible assets (customer relationships, product technology, backlog). The amortization of these intangibles (weighted‑average 13‑year life for backlog, 18‑year for customer relationships, etc.) contributed to the $2.34 billion amortization expense reported in 2023 and $2.38 billion in 2024, directly affecting operating income and the adjusted operating margin. Consequently, the acquisition added to the company’s investing cash outflow ($0.91 billion in 2023) and influenced free cash flow, while the associated goodwill and intangibles are non‑tax‑deductible, affecting the tax rate and earnings per share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant factual inaccuracies. The core event — Thermo Fisher's acquisition of CorEvitas, LLC in 2023 for $0.91 billion — is correctly identified and matches the ground truth. The integration into the Laboratory Products and Biopharma Services segment is also accurate. However, the LLM introduces specific financial details not present in the original answer and inconsistent with the ground truth: it claims $730 million cash paid and $184 million debt settled, which are not in the original and cannot be verified. It also states $627 million of goodwill and $260 million of definite-lived intangible assets, which are absent from the ground truth and thus unverifiable. (2) The amortization period for definite-lived intangibles is partially correct: the LLM correctly notes an 18-year life for customer relationships (matching the ground truth's 18-year weighted average), but adds a 13-year life for backlog, which is not mentioned in the original. More critically, the LLM claims amortization expenses of $2.34 billion in 2023 and $2.38 billion in 2024 directly attributable to CorEvitas, which is a major overstatement — these figures represent Thermo Fisher’s total amortization expense, not CorEvitas-specific. This is a serious quantitative error. (3) The multi-hop reasoning is partially sound: the LLM correctly links the acquisition to segment integration, amortization, and financial statement impacts. However, it overattributes company-wide amortization figures to CorEvitas without evidence, showing flawed synthesis. It also incorrectly implies tax and EPS impacts due to non-tax-deductible goodwill, which is speculative and not in the original. (4) The contextual relevance is high — the answer addresses both the evolution of the relationship and financial implications as asked. The qualitative reasoning is logical but based on incorrect inputs. The correctness score is 6 due to correct core facts but major errors in financial attribution and unsupported specifics. Quantitative accuracy is low (5) due to fabricated or misattributed numbers. Qualitative accuracy is 7 because the conceptual framework is sound. Contextual relevance is 9 as the answer stays focused on the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 609,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX’s flight‑hour payment obligations under its 2012 Rolls‑Royce acquisition agreement remained contingent on the number of flight hours flown by V2500‑powered aircraft through June 2027. The company continues to accrue and capitalize these payments as “collaboration intangible assets” when they are made, treating them as part of the intangible assets associated with the acquisition. The timing of the payments is therefore driven by actual flight‑hour usage, and the amounts are capitalized as incurred rather than expensed when the obligation arises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the payment obligations are contingent on flight hours flown by V2500-powered aircraft through June 2027, consistent between 2022 and 2023. The treatment of payments as capitalized 'collaboration intangible assets' is correctly stated. (2) Quantitative accuracy is perfect: the date (June 2027) is correctly cited, and there are no numerical inaccuracies. Format and phrasing variations (e.g., 'accrue and capitalize' vs. 'capitalized as payments were made') are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes that the structure, timing, and accounting treatment remained unchanged between the two years, even though the question spans two reporting periods and requires understanding of both disclosures. (4) The only minor shortcoming is that the LLM does not explicitly state that there was 'no indication of a change'—a nuance present in the original answer—but it implies stability by stating the structure 'remained' the same. This omission does not detract significantly from correctness. Overall, the answer is factually complete, contextually precise, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 342,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "From 2022 to 2024, The Coca-Cola Company's contingent consideration liability related to its 2020 acquisition of fairlife was remeasured quarterly at fair value, with changes recorded in income until the final milestone payment is made. The liability, representing the remaining milestone payment contingent on fairlife achieving 2024 financial targets and payable in 2025, was valued using a Monte Carlo model (Level 3 inputs) and decreased from $6,126 million (as of Dec 31, 2024) to $3,017 million (as of Dec 31, 2023), reflecting the remeasurement adjustments tied to performance milestones.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The original answer states that in 2022, Coca-Cola did not disclose ongoing contingent payments, but by 2024, it disclosed a remaining milestone payment tied to fairlife achieving financial targets through 2024, with payment due in 2025. The LLM answer incorrectly claims that the contingent liability was remeasured quarterly and recorded in income, which is not supported by the ground truth. More critically, the LLM provides specific dollar amounts—$6,126 million as of Dec 31, 2024, and $3,017 million as of Dec 31, 2023—which are not only absent from the original answer but also logically impossible (the value increases over time in the LLM’s description, but the dates are reversed: 2024 value is higher than 2023’s, yet it's said to have 'decreased'). Additionally, $6 trillion is an absurdly large figure for a contingent payment related to fairlife, indicating a likely data error or hallucination. (2) The numbers are completely incorrect and internally inconsistent. The LLM claims the liability decreased from $6,126 million (Dec 2024) to $3,017 million (Dec 2023), which reverses the timeline—2023 precedes 2024, so a decrease from 2024 to 2023 is illogical. This suggests a fundamental misunderstanding of time sequence. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that the contingent payment relates to the 2020 acquisition and is tied to 2024 performance with a 2025 payout, it fabricates detailed accounting practices (quarterly remeasurement, Monte Carlo modeling, Level 3 inputs) not present in the original answer. The original does not mention any valuation methods or accounting treatment, so this is speculative. (4) The contextual relevance is moderate—the answer addresses the evolution of the financial relationship and contingent payments, so it's on-topic. However, due to severe quantitative errors and fabricated details, the correctness score is very low. The qualitative accuracy is slightly higher because the core idea of a pending milestone payment from the 2020 acquisition is consistent, but the added detail undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 581,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Oracle's strategic positioning of Oracle Cloud Services has evolved from a focus on standalone cloud applications toward deeper integration with enterprise applications and infrastructure technologies. The company emphasizes seamless migration paths for existing on-premise workloads to the Oracle Cloud, leveraging hybrid and multi-cloud deployment models to enhance interoperability, reduce customer complexity, and expand its SaaS and infrastructure offerings across core business functions. This shift underscores a strategy to unify cloud services with traditional license and hardware businesses, enabling customers to modernize IT environments through flexible, cost-effective, and scalable solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks specific details that anchor the evolution between 2022 and 2024 as defined in the original answer. (1) What was correct: The LLM correctly identifies Oracle's shift toward deeper integration of cloud services with enterprise applications and infrastructure, mentions hybrid and multi-cloud deployment models, and highlights seamless migration and interoperability—key themes present in both years. It also accurately reflects Oracle’s strategy to unify cloud services with traditional offerings. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in either answer, so no discrepancies exist; this score is 10 by default. (3) Multi-hop reasoning assessment: The LLM synthesizes a plausible evolution but fails to explicitly differentiate Oracle’s 2022 focus (e.g., Autonomous Database as a transformational innovation) from its 2024 positioning (holistic, integrated suite enabling customer choice). The original answer hinges on this year-over-year contrast, which the LLM omits. It does not reference the Autonomous Database or the shift from promoting individual innovations to an integrated platform—critical multi-hop elements. (4) Justification for scores: While the LLM captures the general direction of Oracle’s strategic evolution and remains contextually relevant, it lacks the specific evidence from each year required for full qualitative and correctness scores. The answer is more generic and misses the nuanced progression described in the ground truth, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high because the response stays on-topic and aligns with Oracle’s broader cloud strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 474,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was first incorporated by reference in the 2018 filing (Exhibit 10(r) to the 2018 Form 10‑K) and remained unchanged in the 2023 filing, where it continued to be cited as “Key/Specified Employee Policy” incorporated by reference to Exhibit 10(v) of the 2023 Form 10‑K. Thus, the policy’s documentation and incorporation by reference have remained consistent between the 2023 and 2024 SEC filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the Key/Specified Employee Policy was first incorporated in the 2018 filing via Exhibit 10(r), while the ground truth specifies Exhibit 10(v) from the 2018 filing, not 10(r). Additionally, the LLM claims the policy was cited in the 2023 Form 10-K as incorporated from Exhibit 10(v) of the *2023* filing, which contradicts the ground truth stating it was still referencing the *2018* exhibit. This misrepresents both the exhibit number and the year of the referenced document. (2) Quantitative accuracy is low because the years and exhibit numbers are incorrect—critical identifiers in SEC filings. The 2018 exhibit is cited as 10(r) instead of 10(v), and the 2023 citation wrongly points to a 2023 exhibit rather than reaffirming the 2018 one. These are not formatting differences but factual errors. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the continuity of referencing the same 2018 exhibit across years. Instead, it implies the 2023 filing introduced a new reference, undermining the core point about lack of updates. (4) Despite these errors, the answer is contextually relevant—it addresses the evolution of documentation and incorporation by reference, and correctly frames the policy as continuing. However, due to major factual and referential inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 396,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million from 2022 to 2023. This stability reflects RTX’s focus on maintaining a consistent debt profile while it refinanced other maturing obligations and pursued targeted debt issuances, indicating a strategy of preserving existing low‑cost long‑term financing rather than altering the composition of its maturing debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the aggregate principal balance remained unchanged at $285 million from 2022 to 2023. According to the ground truth, the balance was $115 million in 2022 and increased to $285 million in 2023, representing a significant increase, not stability. This error undermines the core of the response. (2) Quantitatively, the LLM incorrectly reports the 2022 figure (claims $285M vs. actual $115M) and falsely asserts no change, when in fact there was a $170 million increase. The 2023 value ($285M) is correct, but the 2022 value is wrong, leading to an invalid comparison. (3) The reasoning is flawed because it assumes stability and interprets it as a strategic choice to maintain low-cost financing, whereas the actual data shows a substantial increase in debt, indicating an expansion of debt exposure, not preservation of an existing structure. The multi-hop synthesis failed—correctly identifying the trend requires comparing two time points from the knowledge graph, which the model did incorrectly. (4) Scores reflect severe factual inaccuracies in numbers and trend interpretation (correctness: 2), poor quantitative accuracy due to wrong values and change characterization (2), weak qualitative reasoning despite plausible-sounding but incorrect narrative (3), and moderate contextual relevance as the answer addresses the right topic and metric, just with wrong data (7).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 399,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "Based on the provided pages, the carrying value of TMO's 1.95% 12-Year Senior Notes remained at $773 million as of both December 31 2023 and December 31 2024. The effective interest rate associated with these notes was 2.07 % at the end of 2023 and increased slightly to 2.08 % at the end of 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, the carrying value was $773 million with an effective interest rate of 2.08%, and in 2024, the carrying value decreased to $725 million and the effective interest rate declined to 2.07%. However, the LLM claims the carrying value remained unchanged at $773 million in both years and reports an incorrect trend in the effective interest rate (2.07% in 2023 and 2.08% in 2024), which is the reverse of the truth. (2) Quantitative accuracy is very low: both the carrying value for 2024 and the effective interest rates for both years are wrong. The LLM swaps the rates and fails to reflect the $48 million decrease in carrying value. (3) The reasoning is flawed as it fails to correctly synthesize the evolution over time—instead asserting stability and a rate increase, when the actual data shows a decline in both carrying value and effective rate. This indicates a failure in multi-hop reasoning across the two years. (4) Despite the incorrect numbers and trends, the answer is contextually relevant—it addresses the right company (TMO), the correct financial instrument (1.95% 12-Year Senior Notes), and the correct time frame (2023–2024)—hence a moderate relevance score. However, the core facts are inverted or missing, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 381,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The 2024 filing explicitly references the Directors' Code of Conduct in its governance materials (page 11), while the 2022 filing does not include a separate Directors' Code of Conduct in the provided excerpt. This shift indicates a more formalized governance disclosure in 2024, with the code now posted on the company’s website and subject to public amendment notices.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claims, despite using plausible financial terminology and referencing page numbers. (1) It incorrectly states that the 2022 filing 'does not include a separate Directors' Code of Conduct,' which contradicts the ground truth: in 2022, BNY Mellon explicitly detailed the Code's availability with a direct URL. Conversely, the LLM claims the 2024 filing 'now' includes the Code as a formalized disclosure, when in fact the ground truth indicates a reduction in prominence—no direct link or specific mention of updates was provided in 2024. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this non-existent dimension. (3) The multi-hop reasoning is fundamentally flawed: the model reverses the trend—portraying increased transparency in 2024 when the ground truth describes reduced visibility. This misrepresents the corporate governance implication entirely. (4) Contextual relevance is moderate because the answer addresses corporate governance disclosures and references filings, but the incorrect direction of change severely undermines its usefulness. The conclusion about 'more formalized governance disclosure' is unsupported and opposite to the evidence. Overall, the answer fails on factual correctness and reasoning, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 390,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement was established in **October 2024** as a new $5 billion unsecured 364‑day revolving facility that replaced the prior 364‑day revolving agreement entered into in **November 2023**. The agreement matures in **October 2025** (with a one‑year extension possible) and carries an interest rate of SOFR + 0.45% plus a 0.03% commitment fee. Its facility size ($5 billion) and maturity date (October 2025) therefore represent an evolution from the earlier $15 billion revolving credit facility (Credit Agreement) that extends to **November 2028**, while the Short‑Term Credit Agreement’s maturity is earlier (2025 vs. 2028) and its size is smaller.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2024 Short-Term Credit Agreement as a $5.0 billion unsecured 364-day revolving facility established in October 2024 with a maturity date of October 2025, which aligns with the ground truth. However, it incorrectly states that the agreement was established in October 2024, when in fact the 2024 agreement was entered into in October 2024 but replaces the November 2023 agreement — the timing of the 2023 agreement is misrepresented as being in November 2023 (correct), but the evolution is framed as if the 2024 agreement was established in October 2024, which is technically correct, but the answer fails to note that the 2023 agreement was established in November — thus missing the shift in timing from November to October. (2) Quantitative accuracy: The $5.0 billion facility size is correct for both years. The maturity dates (October 2025 for the 2024 agreement) are correct. However, the LLM introduces a $15 billion revolving credit facility extending to November 2028 and mentions SOFR + 0.45% interest rate and 0.03% commitment fee — none of which are present in the original answer or relevant to the Short-Term Credit Agreement evolution between 2023 and 2024. These details appear to conflate the short-term facility with Amazon’s long-term credit agreement, introducing factual inaccuracies. (3) Multi-hop reasoning: The model fails to properly synthesize the evolution across both years. It does not clearly state that the 2023 agreement was established in November 2023 with a maturity in October 2024, nor does it explicitly compare the establishment timing shift (November to October). Instead, it focuses on a comparison with a long-term facility not mentioned in the question or ground truth, indicating flawed reasoning. (4) The correctness score is 5 due to partial factual accuracy — key elements like facility size and 2024 maturity are correct, but the explanation is marred by irrelevant details, conflation of credit facilities, and incomplete/misleading evolution narrative. Quantitative accuracy is 5 because core numbers are right but extraneous incorrect figures are introduced. Qualitative accuracy is 5 due to flawed entity distinction and reasoning. Contextual relevance is 7 because the answer addresses the topic but drifts into irrelevant comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 638,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 through 2024 AMD’s APU strategy shifted from a primarily consumer‑focused, integrated CPU‑GPU product for mainstream PCs toward a broader, AI‑centric portfolio that tightly couples CPUs, GPUs and dedicated NPUs for both client and data‑center markets.  In 2022 the emphasis was on Ryzen and Ryzen PRO APUs for desktops and notebooks, while by 2024 AMD had expanded the APU line to include AI‑optimized processors (e.g., Ryzen AI 300 series with an on‑chip NPU) and was leveraging APU‑derived silicon in data‑center AI accelerators and semi‑custom solutions (e.g., Instinct MI300X GPUs, ZT Systems acquisition).  This integration across segments and the push into AI‑heavy workloads position AMD to capture higher‑margin revenue from AI‑PC and hyperscale deployments, driving growth in its Data Center and Client segments and expanding its addressable market in the emerging AI PC segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's strategic shift from 2022 to 2024: starting with integrated CPU-GPU APUs (Ryzen series) and evolving toward AI-centric APUs with dedicated NPUs (Ryzen AI 300 series), which matches the ground truth's emphasis on AMD becoming the first to integrate an NPU on the same SoC as an x86 CPU. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes product evolution (APU integration), target market expansion (from consumer to AI PC and data center), and revenue implications. It correctly infers that this shift enables higher-margin revenue in AI PCs and hyperscale, which is consistent with the ground truth’s conclusion about enhanced revenue potential. (4) Minor deviation: the LLM mentions 'Instinct MI300X GPUs' and 'ZT Systems acquisition' as part of APU-derived strategy—while MI300X is relevant to AMD's AI acceleration, it is technically a discrete GPU, not an APU, and the ZT Systems acquisition is more infrastructure-related; this slightly overreaches the APU integration narrative. However, the core evolution and implications are accurately captured. Wording differs but semantic meaning is equivalent. Thus, correctness is high with only a minor overextension in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 399,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving Medtronic dividends has not changed materially between 2023 and 2024.  Irish dividend withholding tax remains generally at 25 % on dividends paid to non‑resident shareholders, but U.S. residents who hold shares through a qualified intermediary (e.g., DTC) or who provide a valid U.S. certification of residence (Form 6166) or Irish Non‑Resident Form V2 are exempt from that withholding.  Consequently, U.S. shareholders who meet these exemption requirements continue to incur no Irish income‑tax liability on Medtronic dividends, and the withholding payment (if any) fully satisfies any Irish tax obligation.  No new statutory changes or additional exemptions were disclosed in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate applied in both 2023 and 2024, exemptions for U.S. residents via Form 6166 or Form V2, no Irish income tax liability for qualifying U.S. shareholders, and the principle that withholding (if applied) discharges any Irish tax liability. There is no material change between the years, which is correctly noted. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no incorrect numbers or calculations are present. (3) The reasoning is sound and reflects proper multi-hop synthesis across tax treatment, residency exemptions, and liability discharge. The mention of 'qualified intermediary (e.g., DTC)' is not in the original but is contextually reasonable and does not contradict the ground truth; however, the original emphasizes submission of a statement to Irish Revenue, which the LLM omits. This is a minor gap in completeness but does not undermine the correctness. (4) The answer is fully relevant, directly addressing the evolution (or lack thereof) in tax treatment. The omission of the requirement to submit a statement to Irish Revenue is the only notable deviation, but it does not alter the fundamental accuracy. Thus, a score of 9 is warranted—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 379,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosures for new products and services have evolved to explicitly highlight the risks associated with the company's platforms operating model initiative, particularly in 2024. In the 2024 filing, the risk factor \"we may not realize some or all of the expected benefits of our transition to a platforms operating model\" appears directly in the risk factors section (page 5), whereas earlier disclosures in 2022 (page 4) only referenced \"new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks\" without specifically naming the platforms operating model. This represents a more targeted and explicit disclosure of the specific risk tied to the platforms operating model transition in the 2024 filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of risk disclosures between 2022 and 2024: in 2022, BNY Mellon referenced general risks from new products, services, and strategic initiatives, while in 2024, it specifically called out the 'transition to a platforms operating model' as a distinct risk. (2) There are no numerical values requiring calculation, but the years (2022 and 2024) and page numbers (page 4 and page 5) are correctly cited and consistent with the original context. Format and referencing are precise. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across two filings (2022 and 2024), identified the shift from generic to specific risk language, and attributed it to the platforms operating model initiative. (4) The answer is semantically equivalent to the ground truth, with added value in citing specific page numbers and quoting the exact risk factor language. All entities—BNY Mellon, the platforms operating model, and the relevant time frame—are correctly identified. The response is highly relevant, complete, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 327,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Based on the provided 10-K filings, Amazon's relationship with the 3.600% Note due 2032 has remained consistent in its disclosure approach but evolved in timing and context. The note was first established under the May 12, 2021 Officers' Certificate (referenced in both 2023 and 2024 filings as part of the 2021 debt issuance), and its terms were reaffirmed in the December 1, 2022 Certificate (page 75, 4.8), which explicitly listed the 3.600% Note due 2032 among other 2024–2032 maturities. While the 2023 filing (AMZN_10k_2023.pdf) references the 2021 Certificate and includes the note in its debt disclosures (page 75, 4.8), the 2024 filing (AMZN_10k_2024.pdf) continues to reference the same 2022 Certificate (page 75, 4.8) without introducing new terms, indicating no material change in the instrument itself—only ongoing periodic reporting of existing debt covenants.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly diverges from the ground truth in key factual and multi-hop aspects. (1) Correctly identifies that the 3.600% Note due 2032 was part of Amazon's debt disclosures in both 2023 and 2024 and that there were no changes to the note’s terms or interest rate. However, it incorrectly attributes the establishment of the note to a 'May 12, 2021 Officers' Certificate' and a 'December 1, 2022 Certificate,' which contradicts the ground truth stating the note was established under a Supplemental Indenture dated April 13, 2022. (2) The LLM fails to mention the trustee transition — the core evolution between 2023 and 2024 — from Wells Fargo Bank, National Association (prior trustee) to Computershare Trust Company, National Association (successor trustee), and the fact that by 2024, only Computershare is referenced. This procedural change in trustee relationship is the central factual evolution in the original answer and is entirely omitted. (3) The LLM introduces specific document dates (May 12, 2021; December 1, 2022) and page references (page 75, 4.8) not present in the ground truth, suggesting fabrication or misattribution. (4) While the answer correctly notes no material change in the instrument, it misses the required multi-hop synthesis between the two years’ filings regarding trustee administration changes. Thus, despite some contextual relevance and partial qualitative accuracy, the absence of the key trustee transition and incorrect sourcing severely undermines factual correctness. Quantitative accuracy is moderate due to correct interest rate (3.600%) and maturity year (2032), but no calculations were involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 460,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ’s net investment hedge derivative contracts shifted from a $219 million liability (recorded as a negative fair‑value in 2023) to a $255 million asset (positive fair‑value in 2024), reflecting a $474 million swing in fair‑value. This change is disclosed in the “Net investment hedge contracts” line of the fair‑value tables (page 96/97) and is also reflected in the interest‑and‑other expense line where the loss on debt extinguishment was removed in 2024, resulting in a lower overall interest expense ($508 million in 2024 vs. $550 million in 2023). Consequently, the hedge’s financial impact moved from a drag on earnings to a modest gain, and its presentation shifted from a liability to an asset within other current assets on the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed derivative assets of $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. The LLM incorrectly claims a $219 million liability in 2023 and a $255 million asset in 2024, which are not supported by the original data. There is no mention of a $474 million swing in fair value in the ground truth, nor is there any indication that the net investment hedge moved from a liability to an asset. (2) The LLM invents specific numbers (e.g., $219M liability, $255M asset, $474M swing) that do not appear in the original answer and are factually incorrect. The claim about interest expense decreasing from $550M to $508M due to removal of loss on debt extinguishment is not present in the ground truth and introduces unrelated financial line items. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in disclosure focus—from balance sheet valuation (2023) to income statement impact related to hedge effectiveness (2024). The LLM instead fabricates a narrative around fair value swings and interest expense changes, missing the core qualitative evolution in accounting treatment and presentation. It fails to mention the key point about 'Other income, net' including amounts excluded from hedge effectiveness assessment in 2024. (4) The correctness score is low due to major factual and quantitative errors. While the LLM attempts to address the evolution of presentation, it does so with invented data and incorrect reasoning, leading to a misleading conclusion. The contextual relevance is moderate because it discusses disclosure and presentation changes, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 497,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, General Dynamics’ Abrams tank modernization strategy remained anchored in incremental upgrades rather than a new platform, with a strong focus on enhancing the existing M1A2 SEPv3 configuration and advancing the next‑generation M1E3 Abrams tank.  The company emphasized next‑generation lethality, survivability and mobility through upgrades such as SEPv3’s improved communications, power generation, fuel efficiency and armor, while also accelerating development of the M1E3 to meet future threat requirements.  Internationally, demand for Abrams tanks and related upgrades stayed robust, supported by ongoing export sales to NATO allies and partners in Europe, the Middle East, North Africa and the Indo‑Pacific, ensuring a growing installed base and sustained market leadership for the Abrams platform worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the focus on SEPv3 upgrades (communications, power generation, fuel efficiency, armor), the development of the M1E3 Abrams, and the emphasis on future threats and quicker upgrades are all accurately represented. The international demand across Europe, the Middle East, North Africa, and the Indo-Pacific is correctly noted, as is the growing installed base. (2) There are no numeric values (e.g., dollar amounts, quantities, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes technological development (SEPv3 and M1E3) with shifts in strategic emphasis from 2023 to 2024, correctly identifying that 2023 was about technical roadmap and 2024 about global procurement momentum, even if not explicitly contrasted. The only minor shortcoming is that the LLM does not clearly highlight the evolution in emphasis from 2023 (technical roadmap) to 2024 (global strategic relevance and procurement), instead presenting both elements as concurrent. This slightly weakens the qualitative accuracy, warranting a 9. (4) The answer is fully contextually relevant, directly addressing both technological development and international demand as asked. Overall, the LLM captures the core meaning and facts with high fidelity, differing only slightly in framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 404,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's APU strategy evolved from a primarily consumer-focused, value-and-mainstream positioning toward a more segmented, strategic emphasis on both client and enterprise markets. In 2022, APUs were positioned as integrated CPU+GPU solutions for mainstream desktops and notebooks, with Ryzen and Athlon mobile APUs built on Zen 3 architecture targeting gamers, creators, and commercial users. By 2024, AMD expanded APU adoption into the commercial and embedded segments, leveraging Ryzen PRO and embedded variants for enterprise durability, security, and manageability, while maintaining its role in semi-custom solutions like the Steam Deck. This shift reflects a strategic move to segment APUs across client (consumer and commercial), enterprise (via AMD PRO), and embedded markets, emphasizing performance-per-watt, security, and platform longevity rather than just cost-effective integrated graphics. The 2024 fiscal year also saw APUs integrated into data center and AI workloads through Instinct accelerators and semi-custom SoCs, underscoring a broader strategic emphasis on heterogeneous computing across all segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several plausible details but diverges significantly from the ground truth in key aspects of AMD's APU segmentation and strategic evolution as reported in official filings. (1) Correct elements: The general timeline (2022 to 2024) and the idea of broader APU use are contextually relevant. The mention of Ryzen, Athlon, and semi-custom applications like Steam Deck aligns with AMD's product usage and adds reasonable detail. (2) Quantitative accuracy is scored highly because there are no specific numbers (e.g., revenue, units, percentages) in either the original or LLM answer, so no numeric inaccuracies exist. (3) Qualitative inaccuracy arises because the LLM incorrectly characterizes the evolution: the ground truth states that in 2022, APUs were part of the Enterprise, Embedded and Semi-Custom segment in broad terms, not primarily consumer-focused as claimed. More critically, the 2024 shift per the original answer is structural—APUs were formally included in the Data Center and Client reportable segments—but the LLM misattributes this by suggesting APUs are used in data centers via 'Instinct accelerators', which is factually incorrect (Instinct are discrete GPUs, not APUs). APUs are not used in data center AI workloads in the way described. (4) The LLM invents a strategic expansion into data center AI via APUs that is not supported by the ground truth, which only states APUs were listed alongside AI accelerators in the Data Center segment, not that they are used for AI workloads. This reflects a failure in multi-hop reasoning—confusing co-listing with functional integration. (5) Contextual relevance is high because the answer addresses market segmentation and strategic emphasis as asked, but the factual misrepresentation of AMD's segment reporting and APU applications reduces correctness. The core structural evolution—formal inclusion in two reportable segments—is missed, and replaced with speculative market positioning details not in the source. Thus, while the answer sounds plausible and is well-structured, it does not reflect the actual evolution documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 569,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Based on the provided document pages, Medtronic's disclosure regarding the Financial Transfers Act 1992 has remained consistent between 2023 and 2024. The company continues to state that the Irish Minister for Finance can restrict financial transfers between Ireland and third countries under the Act, and that such transfers may be subject to sanctions-related restrictions. However, there is no indication of any significant change or evolution in this disclosure between the fiscal years 2023 and 2024. The relevant information appears on page 31 of both the 2023 and 2024 filings, where the company describes the Act's provisions and current restrictions without noting any new developments or changes from the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in describing the Financial Transfers Act 1992 and the role of the Irish Minister for Finance, which aligns with the ground truth. There are no numeric inaccuracies, as the response does not include conflicting dates or financial figures, so quantitative accuracy is high. However, the core of the question asks about the *evolution* of Medtronic's disclosure from 2023 to 2024, and here the LLM fails: it states there is 'no indication of any significant change or evolution,' which directly contradicts the ground truth. The original answer identifies a clear shift in emphasis — in 2023, Medtronic highlighted the dynamic, changing nature of the list of restricted countries, but by 2024, this emphasis was dropped, suggesting a shift in focus or stabilization. The LLM misses this nuance entirely and incorrectly concludes no evolution occurred. This is a critical error in qualitative accuracy and reasoning, as it fails to perform the required multi-hop comparison across years to detect a change in disclosure tone and content. While the answer is relevant and based on plausible document references (e.g., page 31 in both filings), it lacks the depth of comparative analysis needed. Thus, the correctness score is moderate due to a major omission in the evolution aspect, despite correct contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 374,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "Based on the disclosures, the G700 aircraft transitioned from development to delivery between 2023 and 2024. In the 2023 10-K (pages 3, 4, 5), Gulfstream highlighted the G700 as an \"ultra-long-range, ultra-large-cabin\" aircraft in final certification stages, with FAA certification expected in \"early 2024\" and production ramping to support \"deliveries in the second quarter of 2024\" (page 5). By the 2024 10-K (pages 68-72), the aircraft had entered service, as evidenced by the inventory increase tied to \"new Gulfstream aircraft models, including the G700 that began deliveries in the second quarter of 2024\" (page 70), and the production ramp was reflected in the company's capital investments and manufacturing capacity expansions noted in the Aerospace segment overview (pages 3, 4, 6). The G700's inclusion in the product lineup and delivery schedule marked a key evolution from prototype to operational aircraft, directly contributing to the 2024 inventory growth and revenue from new aircraft sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately represented: in 2023, the G700 was in final certification with FAA certification expected in early 2024 and deliveries planned for Q2 2024; by 2024, it had entered service and deliveries began in Q2 2024. (2) There are no numeric or date inaccuracies—'early 2024' for certification and 'second quarter of 2024' for deliveries match the original answer. The LLM correctly cites specific pages from the 10-K filings (e.g., pages 5, 70, etc.), enhancing credibility, though exact page numbers were not part of the ground truth and do not affect correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of disclosures, correctly inferring the progression from expected certification to actual delivery and production ramp-up, and links this to inventory growth and capital investments. (4) The answer is semantically equivalent to the original, adding contextual details (e.g., 'ultra-long-range, ultra-large-cabin', impact on inventory and revenue) that are consistent with and enrich the ground truth without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 347,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "From 2023 to 2024, PMI’s relationship with KT&G deepened into a long‑term, exclusive global partnership that secures PMI continued access to KT&G’s smoke‑free product pipeline and innovation, while KT&G gains a stable, high‑volume distribution channel and co‑development of new reduced‑risk products. This strategic dependency is now embedded in a 15‑year agreement (through 2038) with performance‑based volume reviews, making KT&G a core supplier for PMI’s heated‑tobacco and other smoke‑free offerings outside South Korea. At the same time, the collaboration has accelerated product commercialization, with PMI launching and expanding KT&G‑licensed heated‑tobacco units (e.g., Fiit, Miix, and licensed HEETS variants) across multiple regions, driving a notable rise in smoke‑free net revenues and market share.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15-year agreement through 2038 and the exclusive global commercialization of KT&G's smoke-free products by PMI, excluding South Korea. It accurately reflects the deepening strategic dependency and integration of KT&G as a core supplier within PMI's product ecosystem. However, the original answer emphasizes a shift from exclusive distribution to inclusion in PMI's broader smoke-free strategy, particularly noting that KT&G's products were explicitly referenced as part of PMI's heat-not-burn portfolio in 2024—a nuance not fully captured in the LLM response. The LLM adds details about 'performance-based volume reviews' and 'co-development of new reduced-risk products' that are not present in the ground truth, introducing plausible but unverified elements. (2) Quantitatively, all dates (15-year agreement through 2038) are accurate and consistent with the original. No financial figures or percentages are mentioned in either answer, so no calculation errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of the relationship over time, correctly identifying the transition from a commercialization agreement to deeper integration. However, it slightly overreaches by implying co-development and performance reviews without grounding in the source. (4) The answer is highly contextually relevant, addressing both strategic dependency and product commercialization. While it captures the core facts and correctly interprets the deepening relationship, it introduces minor unsupported details and misses the precise nuance of portfolio integration emphasized in the ground truth, justifying a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 466,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 through 2024 AMD’s semi‑custom SoC strategy shifted from a broad, diversified portfolio of custom‑design silicon for console, handheld and automotive platforms toward a more focused, AI‑centric positioning within its broader product ecosystem.  Early‑2022 disclosures highlighted the company’s reliance on long‑term wafer‑purchase agreements and joint‑venture ATMP capacity to support its semi‑custom designs, while emphasizing that revenue from these products depended on third‑party adoption and design wins.  By 2024 AMD was integrating its semi‑custom SoCs more tightly with its AI hardware roadmap—leveraging the same chiplet and Infinity Architecture platforms that power its Instinct accelerators and EPYC CPUs—and using acquisitions such as Silo AI and the pending ZT Systems transaction to accelerate AI‑software stacks (ROCm) and data‑center‑scale solutions.  This evolution reflects a strategic pivot to align semi‑custom offerings with AMD’s broader goal of becoming an end‑to‑end AI leader, embedding these SoCs in both data‑center AI accelerators and emerging AI‑PC client products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of AMD's semi-custom SoC strategy from 2022 to 2024, emphasizing the shift from dependency on third-party adoption to a more integrated, AI-driven ecosystem. Quantitatively, there are no specific numbers (e.g., revenue figures) in either the original or LLM answer, so no discrepancies exist—this earns a perfect score. Qualitatively, the LLM accurately reflects the strategic pivot, mentioning tighter integration with AI hardware (Instinct, EPYC), chiplet architecture, and AI-PCs. It adds value by referencing acquisitions (Silo AI, ZT Systems) and ROCm, which are consistent with AMD’s 2024 direction, though not explicitly mentioned in the ground truth. This represents a minor augmentation rather than error. The core shift—from third-party dependency to ecosystem integration with AI centrality—is correctly synthesized across years and product lines. The only reason for not scoring a 10 is that the original answer specifically highlights the inclusion of an NPU in x86 SoCs for AI PCs and broader use in gaming, cloud, and embedded systems, which the LLM mentions implicitly (via AI-PCs and data-center solutions) but less explicitly. Contextual relevance is perfect: the response directly addresses strategic positioning and ecosystem integration across the specified timeframe. Multi-hop reasoning is sound, connecting semi-custom SoCs to AI accelerators, CPUs, and broader company strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 414,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained unchanged in its core exemption framework: U.S. shareholders who hold shares through DTC with properly recorded U.S. addresses (and have the information relayed to Medtronic’s qualifying intermediary) are exempt from Irish dividend withholding tax (currently at 25%), and such exempted dividends also incur no additional Irish income tax liability unless the shareholder has other Irish connections (e.g., residency). The 2024 filing confirms this exemption applies to U.S. residents holding shares via DTC, while other shareholders may still face withholding tax, and explicitly states that U.S. residents exempt from withholding tax generally have no further Irish income tax obligation on those dividends. No new exemptions or changes to this treatment were introduced in the 2024 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 25% withholding tax rate and the exemption framework for U.S. residents, particularly those holding shares through DTC with proper documentation. It accurately states that exempt U.S. residents generally have no further Irish income tax liability unless they have other Irish connections, which aligns with the original answer. However, the LLM omits a key update from the 2024 filing: the clarification that non-exempt shareholders subject to withholding can discharge any further Irish income tax liability by furnishing a statement to Irish Revenue. This procedural clarification is a significant qualitative addition in 2024 that the LLM fails to mention. (2) Quantitatively, all numbers are correct: the 25% withholding tax rate is accurately reported, and no incorrect figures are presented. (3) The reasoning is sound in identifying the continuity of the exemption framework and the conditions for tax exemption, but it falls short in capturing the evolution in post-withholding procedures, which represents a multi-hop synthesis point between 2023 and 2024 disclosures. The LLM implies no changes occurred, while the ground truth confirms structural clarifications were made in 2024. (4) The answer is contextually relevant and well-structured, but the omission of the procedural update in 2024 reduces its qualitative accuracy and overall correctness, warranting a score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 403,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' financial performance and strategic focus in ship construction shifted from 2023 to 2024, with the Marine Systems segment's revenue outlook increasing to $12.8–12.9 billion for 2024 (up from $12.461 billion in 2023), driven by higher volume on the Columbia-class submarine program. However, operating margin pressure persisted in 2023 due to supply chain costs affecting the Virginia-class submarine and DDG-51 program, though the 2024 outlook anticipates improved margin (~7.6%) as the Columbia-class initiative advances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2024 revenue projection of $12.8–12.9 billion is accurate; the 2023 revenue of $12.461 billion (implied from context) aligns with known data; the ~7.6% operating margin for 2024 is correctly stated; and the cost pressures in 2023 on the Virginia-class and DDG-51 programs due to supply chain issues and overruns are properly identified. (2) Quantitative accuracy is excellent: all dollar figures and percentages match or are appropriately inferred from the ground truth. The $12.461 billion 2023 revenue is not in the original answer but is factual and improves precision, so its inclusion is acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes performance trends across years, identifies margin pressure in 2023, and links the improved 2024 outlook to the Columbia-class program’s growth. (4) The only minor shortcoming is that the original answer specifies a 110 basis point margin decline in 2023, which the LLM omits. While the existence of margin pressure is noted, this specific metric is missing, slightly reducing completeness. However, the overall reasoning and strategic shift are accurately captured, warranting a high score. Contextual relevance is perfect—the response directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 381,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided 10-K pages, BKNG's financial dependency on Booking.com for accommodation revenue remained heavily concentrated but showed a slight reduction in proportion between 2022 and 2023. In 2022, approximately 89% of the company's total revenue was derived from online accommodation reservation services, with Booking.com being the primary driver of this segment (as stated in BKNG_10k_2022.pdf page 5: \"The majority of the Company's merchant revenues and substantially all of its agency revenues are from Booking.com's accommodation reservations\"). By 2023, this proportion decreased to approximately 87% of total revenue (as noted in BKNG_10k_2023.pdf page 86: \"Approximately 89%, 89%, and 87% of the Company's revenues for the years ended December 31, 2023, 2022, and 2021, respectively, relate to online accommodation reservation services\"). This indicates a modest diversification of revenue streams, though Booking.com continues to be the dominant source of accommodation-related revenue, with the share declining slightly from 89% to 87% over the two-year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2023 percentage. The original answer (ground truth) states that Booking.com's accommodation reservations contributed 89% of BKNG's total revenue in both 2022 and 2023. However, the LLM claims it decreased to 87% in 2023, which contradicts the ground truth. This misrepresentation fundamentally alters the conclusion about the evolution of financial dependency. (2) The LLM cites BKNG_10k_2023.pdf page 86, quoting: 'Approximately 89%, 89%, and 87% of the Company's revenues for the years ended December 31, 2023, 2022, and 2021, respectively...' — but this sequence would mean 87% for 2021, 89% for 2022, and 89% for 2023, not 87% for 2023. The LLM incorrectly reverses the order, misreading the time sequence. Thus, the quantitative accuracy is severely compromised. (3) The reasoning is partially sound in attempting multi-hop synthesis across two 10-K filings and identifying Booking.com as the primary revenue driver. However, the core inference — that dependency slightly decreased — is incorrect due to the misread data. The correct interpretation, per ground truth, is that dependency remained unchanged at 89%, indicating stable, high reliance. (4) Contextual relevance is high because the LLM addresses the right metric (proportion of revenue from accommodation), the correct company (BKNG/Booking.com), and attempts temporal comparison. However, the key quantitative error undermines correctness and qualitative accuracy. A score of 3 reflects that while structure and intent are reasonable, the factual core is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 438,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, PMI's position regarding its Swiss Franc note shifted from having an outstanding balance of $299 million (as disclosed in the 2023 long‑term debt schedule) to $0 million by the end of 2024, indicating that the company fully repaid or otherwise removed that specific Swiss franc‑denominated obligation. This reduction reflects a deliberate de‑leveraging of foreign‑currency exposure, suggesting that PMI is actively managing its foreign‑currency obligations and may be seeking to minimize currency risk or simplify its debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $299 million Swiss Franc note obligation in 2023 and its reduction to $0 by 2024 are accurately reported, with acceptable formatting ($299 million). (2) The answer addresses both parts of the question: the evolution of the company's position (from $299M to $0) and the implication regarding foreign currency obligations. (3) Entity accuracy is correct—PMI is the implied company (consistent with context), and the time frame (2023 to 2024) is properly used. (4) The reasoning is sound: the elimination of the obligation implies repayment or restructuring, and the conclusion about strategic de-leveraging and risk management aligns semantically with the ground truth's 'strategic shift in managing Swiss Franc exposure.' The LLM adds slight elaboration (e.g., 'simplify its debt profile') that is reasonable and contextually supported. All multi-hop elements—comparing two years' disclosures and inferring strategic intent—are correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 298,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Based on the provided 10-K filings, the treatment of Non-Employee Director RSU Award Agreements remained consistent between 2023 and 2024, with no new agreements introduced or modified. The 2024 filing (page 247) references the same pre-2015 forms (e.g., Exhibit 10.31 and 10.32) that were originally incorporated in the 2014 10-K (page 5, item 10.8), indicating no substantive changes to the agreement terms or structure during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims that there were no new or modified agreements between 2023 and 2024, which directly contradicts the ground truth: the 2024 10-K introduced a new exhibit, 'Amendments to Certain Non-Employee Director Equity Award Agreements' (Exhibit 10.18), not present in 2023. (2) The LLM incorrectly references Exhibit numbers (10.31 and 10.32) and cites a 2014 10-K (page 5, item 10.8), which is irrelevant to the 2023–2024 comparison and unsupported by the provided data. These exhibit numbers and cross-year references do not align with the ground truth, which specifies Exhibit 10.8 in 2023 and the new Exhibit 10.18 in 2024. (3) The multi-hop reasoning fails completely: instead of identifying the addition of a new amendment exhibit in 2024, the model asserts continuity and no changes, missing the key evolution in disclosure. (4) The answer is not semantically equivalent to the ground truth—it conveys the opposite conclusion. While it addresses the general topic (RSU agreements), its core claims are factually wrong, resulting in a very low correctness score. Quantitative accuracy is near zero due to incorrect exhibit numbers and years. Qualitative accuracy is equally low due to flawed logic and entity misidentification. Contextual relevance is minimal but present in that it discusses the general subject matter.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 388,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PMI’s financial relationship with Swedish Match AB evolved primarily through the repayment of debt used to finance the acquisition. PMI recorded a $2.57 billion reduction to goodwill tied to Swedish Match due to measurement‑period adjustments, and it prepaid approximately €3 billion (about $3.2 billion) of the three‑year tranche of the €5.5 billion senior unsecured term loan that was taken out in 2022 to fund the Swedish Match purchase. The remaining €2.5 billion (≈$2.6 billion) of that term loan was still outstanding at year‑end 2024, reflecting the ongoing long‑term debt obligations linked to the acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that long-term debt obligations related to the Swedish Match AB acquisition decreased from $6,121 million in 2023 to $2,610 million in 2024—a reduction of $3,511 million. However, the LLM claims that PMI prepaid approximately $3.2 billion of debt and still had $2.6 billion outstanding, implying a total initial debt of about $5.8 billion, which does not match the $6,121 million reported in the original answer. Additionally, the LLM introduces a $2.57 billion reduction to goodwill due to measurement-period adjustments, which is not mentioned in the ground truth and distracts from the core focus on debt obligations. (2) The numbers provided in the LLM answer are inconsistent with the ground truth: while $2.6 billion outstanding in 2024 is close to the correct $2,610 million, the starting point and reduction amount are incorrect. The prepayment of €3 billion (~$3.2 billion) is not corroborated by the original answer and contradicts the actual decrease in debt. There is no mention in the ground truth about the structure of the loan (e.g., three-year tranche, €5.5 billion term loan), making these details potentially fabricated or misattributed. (3) The multi-hop reasoning is partially sound—PM did reduce its debt related to the acquisition between 2023 and 2024—but the explanation relies on unsupported specifics about loan tranches and prepayments rather than directly reporting the correct debt figures. The synthesis fails to align with the verified data points from the knowledge graph. (4) Despite introducing incorrect quantitative details and extraneous information (goodwill adjustment), the LLM correctly identifies a major repayment trend and acknowledges ongoing obligations in 2024, which aligns qualitatively with reduced financial exposure. Hence, some relevance and directional accuracy are preserved, warranting moderate scores for qualitative accuracy and contextual relevance, but the quantitative inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 563,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, BMS’s strategic positioning around KRAS inhibition shifted decisively with the **$4.8 billion acquisition of Mirati Therapeutics** (completed in January 2024). This transaction gave BMS full commercial rights to **Krazati (adagrasib)**, a best‑in‑class KRAS G12C inhibitor already approved for second‑line NSCLC and KRAS‑mutated colorectal cancer, and added the clinical‑stage **MRTX1719 (PRMT5 inhibitor)** to its pipeline. The acquisition was structured as a business combination, allocating roughly $640 million to acquired marketed product rights (Krazati) and $3.5 billion to indefinite‑lived IPRD covering future KRAS‑targeted programs. BMS now leverages Mirati’s commercial infrastructure and its own development capabilities to advance Krazati in first‑line NSCLC combinations and to expand the KRAS‑inhibitor portfolio, marking a clear evolution from a licensing‑focused approach to an integrated, acquisition‑driven strategy for KRAS‑targeted oncology.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in BMY's (Bristol-Myers Squibb's) strategic positioning around KRAS inhibition from 2023 to 2024. It correctly identifies the $4.8 billion acquisition of Mirati Therapeutics, completed in January 2024, which aligns with the ground truth. The answer accurately states that Krazati (adagrasib) was already FDA approved for second-line NSCLC and adds colorectal cancer approval—consistent with the original answer, though it does not explicitly mention the combination with cetuximab, a minor omission. The LLM correctly notes Krazati’s development in first-line NSCLC combinations with PD-1 inhibitors, though it refers to MRTX1719 (a PRMT5 inhibitor) as part of the pipeline, which is factually correct but not mentioned in the ground truth; this is additional context rather than an error. The allocation of $640 million to marketed product rights and $3.5 billion to IPRD is accurate per public filings and supports the qualitative assessment of the acquisition’s structure. The reasoning is sound, showing a shift from a licensing to an acquisition-driven strategy, which reflects correct multi-hop synthesis across time, corporate action, and pipeline development. Minor deductions: (1) refers to 'BMS' instead of 'BMY' (same company, ticker vs. common abbreviation, not a substantive error), (2) omits explicit mention of cetuximab in the colorectal cancer indication, and (3) introduces MRTX1719 not in the ground truth—though not incorrect, it slightly shifts focus. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the original answer with high quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 461,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Between 2023 and 2024, Goldman Sachs updated its Restricted Partner Compensation Plan (RPCP) to reflect new governance standards. The 2023 filing (Item 10.4) references the “Amended and Restated Restricted Partner Compensation Plan” originally incorporated in 2006, while the 2024 filing (Item 10.4) explicitly includes the “Amended and Restated Restricted Partner Compensation Plan” as a current governance document, indicating a formal revision and re‑positioning of the RPCP alongside the newly adopted Clawback Policy (effective December 1 2023) and other governance‑related compensation disclosures. This evolution shows a deliberate alignment of the RPCP with the firm’s newer compensation governance policies introduced during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies that impact overall correctness. (1) The exhibit number for the Restricted Partner Compensation Plan in 2023 is incorrectly stated as Item 10.4; the ground truth states it was Exhibit 10.3 in 2023 and moved to Exhibit 10.4 in 2024. This misidentification of exhibit numbers undermines quantitative and entity accuracy. (2) The LLM claims the plan was 'updated' or 'formally revised' in 2024, but the ground truth explicitly states the plan 'remained substantively unchanged'—this is a critical factual error. (3) While the LLM correctly identifies the introduction of the Clawback Policy (effective December 1, 2023) and its relevance to compensation governance, it incorrectly implies the RPCP was amended to align with it, which is not supported by the ground truth. (4) The ground truth emphasizes a shift in *disclosure placement* (from early to later in the exhibit list) as evidence of repositioning, but the LLM focuses on document titling and perceived revisions, missing this key nuance. (5) Despite these errors, the answer correctly identifies the broader trend of enhanced compensation governance and the introduction of the Clawback Policy, showing partial multi-hop reasoning and contextual understanding. However, due to incorrect exhibit numbers, false claims of substantive plan changes, and misrepresentation of disclosure evolution, the answer is only partially correct. Quantitative accuracy is moderate due to date correctness but penalized for exhibit number errors. Qualitative accuracy suffers from flawed reasoning about plan revisions. Contextual relevance is high as it addresses the core theme of governance evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, PMI’s heat-not-burn products shifted from being reported solely under “Heated Tobacco Units” in the shipment volume table to being explicitly categorized as “smoke-free products” within its net revenue breakdown, reflecting greater strategic emphasis on this segment. Additionally, the company integrated its smoke-free portfolio more closely with its broader business structure, as evidenced by the inclusion of Swedish Match’s revenue (including its smoke-free products like oral nicotine products) in the consolidated results and the reclassification of Swedish Match’s revenue under both “combustible tobacco” and “smoke-free products” categories, indicating deeper integration of its acquisitions into core operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects of product categorization and business integration. (1) Correctly identifies a shift in categorization from 2022 to 2023, noting that heat-not-burn products were more explicitly grouped under 'smoke-free products' in 2023, which aligns with the original answer. However, it incorrectly frames the 2022 categorization as being reported 'solely under Heated Tobacco Units in the shipment volume table,' which is not supported by the ground truth—PMI already categorized these products under Reduced-Risk Products (RRPs) in 2022, not just as a shipment metric. (2) No numeric values are present, so quantitative accuracy is not applicable—scored 10 by default as no numbers were misstated. (3) The reasoning is partially sound but flawed in synthesis: the mention of Swedish Match and its revenue reclassification is factually accurate in context of PMI's 2023 reporting, but this was not part of the evolution specifically related to heat-not-burn product categorization. The original answer emphasizes the inclusion of *licensed KT&G heat-not-burn products* as a sign of expanded integration, which the LLM answer omits entirely. Instead, it substitutes this with information about oral nicotine products via Swedish Match, conflating broader smoke-free integration with heat-not-burn-specific developments. (4) Contextual relevance is moderate: while the answer addresses strategic integration and categorization changes, it misattributes the nature of the evolution and introduces tangential information about acquisition integration that, while related, does not directly answer how *heat-not-burn* products specifically evolved in categorization and integration. Missing the key point about licensed KT&G products and the RRP-to-smoke-free reclassification weakens the qualitative accuracy. Thus, the answer is partially correct but lacks critical details and introduces potentially misleading emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 540,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Based on the provided SEC Consent Order disclosures in both 2023 and 2024 10-K filings, Bristol-Myers Squibb's business risk and disclosure group was formally established as part of its compliance measures under the Consent (specifically item (b) of the agreed measures), and the company maintained a company-wide policy with a formal governance process to monitor and resolve compliance questions regarding sales to direct customers. The 2024 filing confirms this governance structure remains in place, with the business risk and disclosure group continuing to play a key role in ensuring adherence to the Consent's requirements for limiting sales based on expected demand and preventing undisclosed inventory practices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: the establishment of the business risk and disclosure group in 2023 to comply with the SEC Consent Order, its ongoing role in 2024, and the presence of formal governance processes for compliance. The answer correctly identifies that the group was created under item (b) of the Consent’s requirements and emphasizes its continued role in monitoring compliance, particularly around sales practices and inventory disclosures. Quantitatively, there are no numbers, dates, or financial figures in dispute, so accuracy is perfect in that regard. The qualitative accuracy is slightly reduced because the LLM omits specific details mentioned in the original answer—such as the retention of an outside consultant to re-engineer accounting processes and the formal review and certification process for SEC filings—which are important components of the 2023 implementation. Additionally, while the LLM correctly notes the group's continued role in 2024, it does not explicitly state that there were no modifications or reductions in scope, nor does it frame the group as being 'fully integrated' into ongoing compliance, which weakens the synthesis of the evolution between years. However, the core multi-hop reasoning—linking the group’s creation in 2023 to its sustained function in 2024 within the Consent framework—is sound and contextually relevant. The answer stays focused on the question and draws appropriate inferences from the filings. Thus, while not fully complete, the answer captures the essential truth with accurate entities and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 446,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP’s pension expense methodology—specifically the expected return on plan assets—has remained consistent between 2023 and 2024, with the expected return rate held steady at 5.25% in both years. However, the actual return on plan assets shifted significantly, moving from an actual return of approximately 6% in 2023 to a loss of about 18% in 2022 (though the 2024 actual return is not explicitly stated, the pattern of using a long-term expected return of 5.25% to smooth volatility remains unchanged). The company continues to apply this expected return over a five-year period to reduce year-to-year volatility in pension expense, deferring differences between actual and expected returns to accumulated other comprehensive income. This practice and the 5.25% assumption have not changed materially between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and misses the core of the question. The question asks about the evolution in UNP's *treatment of the relationship* between expected return and asset allocation mix in narrative/disclosure terms between 2023 and 2024, not about the stability of the expected return assumption. The LLM incorrectly claims the expected return rate was 5.25% in both years, which is not supported by the ground truth; the ground truth states an *actual* return of 6% in 2023 and no disclosure for 2024. The LLM also incorrectly references a loss of 18% in 2022, which is irrelevant to the 2023–2024 comparison asked. (2) Quantitative accuracy is low: the 5.25% expected return is not mentioned in the ground truth, nor is the 2022 loss relevant. The actual return of 6% in 2023 is correctly noted, but the rest of the numbers are either fabricated or misattributed. (3) The reasoning is flawed: instead of analyzing changes in disclosure language (a qualitative shift from a multi-factor explanation to a narrower focus on asset allocation), the LLM focuses on the constancy of an assumed expected return rate, which is not the point of the question. It fails to recognize the multi-hop requirement to compare narrative disclosures across years regarding the basis for expected returns. (4) Contextual relevance is moderate because it discusses pension accounting and expected returns, but it misunderstands the nature of the evolution being asked about—disclosure language and rationale, not numerical assumptions or actual performance. Thus, while related, it does not answer the actual question, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 459,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon’s disclosure approach to the Directors’ Code of Conduct shifted from a general reference to a more explicit, publicly accessible format. In the 2022 filing, the code was mentioned only in passing within the “Available Information” section, directing readers to a PDF on the company’s website. By 2023, the filing specifically highlighted the Directors’ Code of Conduct in its own subsection under “Available Information,” provided a direct link to the PDF, and added a clear statement that any amendments or waivers to the code would be disclosed on the website. This change made the code more readily findable and integrated it into the broader corporate‑governance disclosures, improving both accessibility and transparency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall assessment of BNY Mellon's evolving disclosure approach to the Directors' Code of Conduct between 2022 and 2023, with accurate dates and correct entities (BNY Mellon, Directors' Code of Conduct, corporate governance reporting). The quantitative accuracy is perfect—no numerical data is misstated, and there are no calculation errors (though the question does not involve numeric computations). The answer correctly identifies a shift toward greater accessibility and integration in 2023. However, there are minor but notable discrepancies in qualitative accuracy: the original answer states that in 2022 the Code was referenced in the context of Board Meetings and Committee Information as part of broader governance disclosures, whereas the LLM claims it was mentioned 'only in passing within the Available Information section,' which slightly mischaracterizes the depth of integration. Additionally, the LLM introduces a detail not present in the ground truth—that in 2023, amendments or waivers would be disclosed—which, while plausible, is not supported by the original answer and represents an overreach. Despite these issues, the core reasoning about increased structuring and accessibility is sound and semantically aligned. The answer is highly relevant to the question and captures the key evolution, warranting a solid but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 386,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle has expanded its deployment flexibility by offering OCI services in customer data centers through solutions such as Exadata Cloud@Customer, OCI Dedicated Region, OCI Sovereign Cloud, and Oracle Roving Edge Infrastructure, enabling hybrid and multicloud architectures. This strategy underscores Oracle’s focus on facilitating cloud migration while supporting hybrid IT environments, as evidenced by its investments in simplifying workload migration, expanding OCI’s global footprint, and integrating database and middleware services across on-premise, cloud, and edge deployments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of the deployment solutions mentioned (Exadata Cloud@Customer, OCI Dedicated Region, OCI Sovereign Cloud, Roving Edge Infrastructure) and correctly identifies Oracle's strategic focus on hybrid and multicloud architectures, which aligns with the ground truth. There are no numeric inaccuracies, so quantitative accuracy is high. However, the LLM answer fails to capture the core evolution between 2023 and 2024 emphasized in the original answer: the shift from deployment flexibility (2023) to deeper integration with engineered systems like Oracle Exadata Database Machine (2024). While the LLM mentions Exadata Cloud@Customer, it does not highlight the strategic pivot toward tightly integrated, optimized engineered systems as a key development in 2024. This omission significantly weakens the qualitative accuracy, as the multi-hop reasoning—comparing Oracle’s strategic emphasis across years to infer a maturation in cloud migration strategy—is incomplete. The answer remains contextually relevant and correctly frames Oracle’s overall approach to cloud migration and hybrid IT, but it lacks the comparative, time-based strategic evolution that is central to the question. Thus, while factually sound, it is only partially complete in addressing the full scope of the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 367,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The formal review and certification process of annual and quarterly SEC reports was first established as part of the 2004 Consent Order with the SEC, and the company reaffirmed its continued use of that process in its 2023 and 2024 filings.  In the 2023 10‑K (page 61) and the 2024 10‑K (page 64), the company describes that the process includes a company‑wide policy, a governance structure to escalate compliance questions, regular monitoring of compliance, and documentation of the budgeting process—procedures that have remained essentially unchanged from 2023 to 2024.  No substantive evolution in the process is indicated; the focus in 2024 is on maintaining and documenting the existing governance and certification controls.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that the formal review and certification process was established in 2004 as part of a Consent Order with the SEC, while the original answer clearly indicates it was established in 2023 as part of a Consent agreement—this is a major error in both date and context. (2) The LLM claims the process has remained 'essentially unchanged' between 2023 and 2024 and that no substantive evolution occurred, directly contradicting the ground truth, which describes a clear evolution from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks (e.g., company-wide sales policies) in 2024. (3) The LLM references specific page numbers (2023 10-K p.61, 2024 10-K p.64) and mentions documentation of the budgeting process, which are not present or supported in the original answer, introducing unverified details. (4) Multi-hop reasoning fails: the question asks about evolution in compliance monitoring and governance procedures between 2023 and 2024, requiring synthesis of changes over time, but the LLM incorrectly concludes no change occurred. While the answer is relevant to SEC reporting processes, its core facts—timing of implementation, presence of evolution, and integration into broader policies—are incorrect, leading to a low correctness score. Minor credit is given for addressing compliance monitoring and governance structures, which are thematically relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 419,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International expanded its heat-not-burn (HNB) portfolio within its broader smoke-free product strategy, positioning it as a distinct growth category separate from traditional combustible tobacco and oral products. In 2023, HNB products—including brands like HEETS, Marlboro HeatSticks, and TEREA—generated $5.561 billion in net revenue (up from $5.175 billion in 2022), reflecting strong growth in Europe (17.6%) and Japan (14.5%), while adjusted in-market sales rose 14.8%. This growth was driven by increased shipment volumes (+14.7% for HTUs), with HNB now categorized as a core segment under PMI’s \"smoke-free products\" division, distinct from oral nicotine products (e.g., Swedish Match’s nicotine pouches, which grew 100% due to acquisition). PMI explicitly separates HNB performance in its segment reporting, emphasizing its strategic focus on HTUs as a key growth driver amid declining cigarette volumes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides relevant context about Philip Morris International's (PMI) heat-not-burn (HNB) product evolution and correctly identifies the strategic positioning of HNB within the smoke-free product segment in 2023, aligning with the ground truth. It accurately reflects the increased commercial focus and segmentation of HNB products as a core growth driver. However, the quantitative details—such as $5.561 billion and $5.175 billion in net revenue, 17.6% growth in Europe, 14.5% in Japan, 14.8% adjusted in-market sales, and +14.7% shipment volumes—are not present in the original answer and cannot be verified against the provided ground truth, which contains no financial figures. Since the ground truth does not include any numbers, the inclusion of specific dollar amounts and percentages introduces unverified data, significantly reducing quantitative accuracy. The qualitative reasoning is sound in describing the shift from RRPs to a more defined smoke-free categorization and the strategic emphasis on HNB, but it omits the key point about PMI including licensed KT&G products in its portfolio, which reflects a broader partnership strategy. This omission reduces completeness. The answer is contextually relevant and addresses market positioning and categorization, but the unsupported numerical claims and missing partnership expansion detail prevent a higher score. Semantic equivalence is partially achieved, but factual overreach in numbers undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 408,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle has expanded the flexibility of Oracle Database deployment through cloud-native options like Autonomous Database, which automates administration and enables consumption-based pricing, while deepening integration with its cloud platform (OCI), middleware (e.g., Java, Middleware), and engineered systems. This positions the database as a core component of Oracle's broader cloud strategy, emphasizing hybrid and multicloud deployment models (e.g., Exadata Cloud@Customer, Dedicated Region) to meet diverse customer needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Oracle Database's strategic positioning between 2023 and 2024, though with some differences in emphasis compared to the ground truth. (1) Correct elements: The LLM correctly identifies increased deployment flexibility through cloud-native options like Autonomous Database and consumption-based pricing, aligning with Oracle's broader cloud strategy. It accurately highlights hybrid and multicloud deployment models such as Exadata Cloud@Customer and Dedicated Region, which reflect Oracle's integration with OCI and engineered systems. The mention of integration with middleware (Java, Middleware) and engineered systems like Exadata is consistent with the 2024 shift toward deeper integration. (2) Quantitative accuracy: There are no specific numbers, dates, or financial figures in either answer, so no discrepancies exist—this aspect is fully accurate. (3) Multi-hop reasoning: The LLM synthesizes deployment models and integration trends across Oracle’s technology stack, correctly inferring a strategic shift toward integrated systems and cloud-centric deployment, even if it doesn’t explicitly contrast 2023’s perpetual licensing and customer choice emphasis. This is a minor omission but doesn't invalidate the overall correctness. (4) The main limitation is completeness: the LLM omits the specific 2023 emphasis on perpetual licensing and standalone deployment flexibility, which is a key part of the multi-hop comparison across years. While the 2024 evolution is well-represented, the contrast between 2023 (flexibility via licensing and deployment choice) and 2024 (integration into engineered systems) is underdeveloped. Despite this, the core factual content about integration and hybrid deployment evolution is accurate and relevant, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 495,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "From 2023 to 2024, BMS’s strategic relationship with Krazati evolved from a co-development and profit-sharing arrangement with 2seventy bio (originally covering BCMA-targeted therapies) to a fully licensed, BMS‑controlled commercialization. In 2024, BMS paid a $100 million upfront acquisition fee for the Orum ORM‑6151 program and, more significantly, completed the $4.8 billion acquisition of Mirati, which granted BMS exclusive rights to Krazati (a KRAS inhibitor). This transaction included a $100 million upfront payment plus up to $80 million in contingent milestones, and it was accounted for as an asset acquisition, with $12.1 billion expensed to acquired IPRD, reflecting BMS’s shift toward sole ownership and development of Krazati.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $4.8 billion acquisition of Mirati in 2024 and that this granted BMS (BMY) rights to Krazati, it fabricates a 'co-development and profit-sharing arrangement with 2seventy bio' related to Krazati, which is false—2seventy bio is unrelated to Krazati. Additionally, the $100 million upfront fee for the 'Orum ORM-6151 program' and the $80 million in contingent milestones are not mentioned in the ground truth and appear invented. The $12.1 billion expensed to acquired IPRD is also not in the original answer and contradicts the known facts. (2) Quantitatively, only the $4.8 billion acquisition figure is correct. The other figures—$100 million upfront, $80 million milestones, $12.1 billion IPRD—are unsupported and incorrect. The ground truth mentions a $1.0 billion contingent value right tied to PRMT5 inhibitor development, which the LLM completely omits. (3) The multi-hop reasoning is flawed: the model incorrectly links Krazati to 2seventy bio and introduces unrelated programs (Orum ORM-6151), failing to correctly synthesize the evolution from portfolio inclusion in 2023 to acquisition in 2024. It also mischaracterizes the nature of the transaction (asset acquisition vs. full company acquisition). (4) Despite these issues, the answer captures the core idea that BMY acquired Mirati in 2024 to gain control of Krazati, which reflects partial understanding. However, the numerous fabricated details and omissions of key commitments (e.g., $1B CVR for PRMT5) severely undermine accuracy. Contextual relevance is moderate as it addresses the strategic evolution but with incorrect supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 467,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on the 2022 and 2023 Form 10-K filings, the treatment of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (trading as BK/P) remained unchanged in terms of its structure and listing. The securities continued to be fully and unconditionally guaranteed by The Bank of New York Mellon Corporation and were listed on the New York Stock Exchange under the symbol BK/P in both years. No material changes to their terms or status were disclosed in the provided documents.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were listed on the NYSE under symbol BK/P, remained registered under Section 12(b), and were fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric inaccuracies—percentages, trading symbol, and guarantee structure are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of SEC filings (2022 and 2023) and concluded that there was no change in status or treatment, which aligns with the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the securities’ status. Minor wording differences (e.g., 'no material changes' vs. 'no change') do not affect factual accuracy and are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 292,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "Based on the provided financial disclosures, PMI's short-term credit arrangements experienced a significant shift in capacity and utilization between 2022 and 2023. The company's committed credit facilities remained stable at $6.3 billion, but borrowings under these facilities increased from $295 million at December 31, 2022, to $283 million at December 31, 2023, while the available capacity decreased as the company utilized more of its existing commitments. This shift suggests a more conservative near-term liquidity posture, as PMI appears to be actively managing its short-term borrowing needs amid potential market uncertainties, though the overall credit capacity remains substantial. The utilization trend indicates a deliberate reduction in available liquidity buffers, potentially signaling a strategic shift toward more disciplined capital allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that PMI's committed credit facilities remained stable at $6.3 billion, which is not mentioned in the ground truth and contradicts the reported increase in short-term credit capacity from $1.9 billion to $2.7 billion. More critically, it misrepresents the utilization trend: while the ground truth shows a decrease in utilization from $295 million to $283 million, the LLM claims borrowings 'increased' from $295M to $283M — this is factually wrong (283 < 295), and the direction of change is reversed. Additionally, the LLM incorrectly states that available capacity decreased due to higher utilization, when in fact capacity increased and utilization decreased, meaning available liquidity actually expanded. (2) Quantitative accuracy is very low: the correct capacity figures are $1.9B (2022) and $2.7B (2023); the correct utilization figures are $295M and $283M. The LLM gets the utilization numbers approximately right in value but wrong in interpretation (claiming an increase instead of a decrease). The $6.3B figure is entirely unsupported by the ground truth and appears fabricated. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the relationship between capacity and utilization. The ground truth indicates an expansion of capacity and a reduction in drawdown, signaling a more conservative liquidity posture due to a larger unused buffer. The LLM incorrectly infers that reduced available liquidity and increased borrowing indicate conservatism, which contradicts standard financial logic. (4) Contextual relevance is moderate — the answer addresses the right topic (short-term credit, liquidity posture) and attempts to interpret implications, but due to factual and directional errors, the conclusion is invalid. The qualitative reasoning is structured but based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 520,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle’s Autonomous Database has deepened its integration with the broader Oracle Cloud ecosystem and expanded its automation capabilities. The 2024 filing emphasizes tighter coupling with OCI services such as Java Cloud, OCI AI, and OCI networking/edge offerings, enabling customers to run Autonomous Database workloads across hybrid, multicloud, and sovereign cloud environments while leveraging OCI’s elastic compute, storage, and AI infrastructure. Automation has been broadened to include self‑driving database administration (patching, scaling, security, backup), machine‑learning‑driven fault prediction, and consumption‑based, on‑demand scaling, all designed to reduce labor costs and simplify deployment both on OCI and on‑premise via Exadata Cloud@Customer and OCI Dedicated Region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Oracle's Autonomous Database positioning from 2023 to 2024, emphasizing deeper integration with Oracle Cloud services and enhanced automation. The mention of Java Cloud and implied AI integration (via OCI AI) corresponds to the ground truth's reference to Oracle APEX and machine learning capabilities. The LLM expands slightly by referencing OCI networking/edge and sovereign cloud, which are not explicitly in the original but are contextually consistent with Oracle's 2024 cloud strategy and do not contradict the ground truth. Automation features such as self-driving administration, fault prediction, and on-demand scaling match the ground truth's emphasis on ML-driven diagnostics, error handling, and automatic threat detection. The LLM also correctly highlights hybrid and on-premise deployment via Exadata Cloud@Customer and OCI Dedicated Region, which reflects the continuity from 2023's hybrid focus. One minor omission is the lack of explicit mention of 'open interfaces' and 'data lake houses' or 'real-time analysis of transactional data' from the 2024 positioning, which slightly reduces completeness. However, the core evolution in integration and automation is accurately conveyed. All entities (Oracle, Autonomous Database, OCI, Java Cloud, Exadata) and timeframes (2023 to 2024) are correct. No numerical inaccuracies—dates and financial figures are not present, so quantitative accuracy is based on correct use of non-numeric data, which is flawless. The reasoning is sound, demonstrating multi-hop synthesis across years and services. The answer is contextually highly relevant and directly addresses the question's focus on integration and automation evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 485,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Based on the provided financial disclosures, GM's financial relationship with Ultium Cells Holdings LLC evolved significantly between 2023 and 2024, particularly regarding capital involvement and strategic positioning. In 2023, GM held a noncontrolling interest in Ultium Cells through its $1.6 billion investment (including $0.7 billion in 2023 alone), with $0.8 billion in committed capital contributions disclosed at year-end 2023. By 2024, GM increased its investment to $0.7 billion (as noted in the cash flow statement under \"Investment in UltiumCells Holdings LLC\"), reflecting continued strategic commitment to the joint venture despite broader industry shifts. However, GM's capital involvement remained secondary to its broader EV strategy, as evidenced by its 2024 decision to terminate funding for Cruise (a separate but related EV entity) while maintaining Ultium Cells investments, underscoring a focused pivot toward scalable battery manufacturing partnerships rather than expansive capital outlays. GM's maximum exposure to loss related to Ultium Cells was capped at $3.5 billion (including $0.8 billion in committed capital), but the company emphasized that its variable interests did not grant control over the entity's key economic activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2023 GM had a contingent commitment of $0.8 billion, not a $1.6 billion total investment including $0.7 billion in 2023. The LLM incorrectly states that GM made a $0.7 billion investment in 2023 as part of a larger $1.6 billion total, which contradicts the original answer that the $0.8 billion was a future commitment, not a realized investment. Furthermore, the LLM claims GM 'increased its investment to $0.7 billion' in 2024, implying a larger investment, but the ground truth states the 2024 $0.7 billion is a realized investment replacing the prior $0.8 billion commitment—this is a decrease, not an increase, and represents a shift from contingent to actual, not growth. The $3.5 billion maximum exposure and $0.8 billion committed capital are mentioned in the LLM answer but not in the original answer, suggesting potential hallucination or misattribution. (2) The numbers are therefore largely incorrect: the $1.6 billion total investment, $0.7 billion in 2023, and characterization of 2024 as an 'increase' are all inconsistent with the ground truth. Only the $0.8 billion committed in 2023 and $0.7 billion actual in 2024 align, though their interpretation is flawed. (3) The multi-hop reasoning is partially sound—LLM recognizes a shift in capital structure and strategic focus—but misrepresents the nature of the evolution. It incorrectly frames the relationship as one of increasing investment rather than a transformation from contingent liability to direct investment. The mention of Cruise is contextually relevant but not in the original answer, introducing extraneous information. (4) Correctness is scored low (4) due to major quantitative errors and misrepresentation of the financial evolution. Quantitative accuracy is 3 due to incorrect figures and misstated investment amounts. Qualitative accuracy is 5 because the general direction of strategic realignment is acknowledged, but the reasoning is flawed. Contextual relevance is 8 because the answer stays on topic and attempts to address capital involvement and strategy, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 593,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the as‑converted value released from the preferred‑stock protection declined from $3.5 billion (sixth‑anniversary release in 2022) to $2.7 billion (eighth‑anniversary release in 2024), reflecting a smaller release amount in 2024. Correspondingly, the number of Series A preferred shares issued fell from 176,655 shares released in 2022 to 99,264 shares released in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all quantitative aspects: the as-converted value released in 2022 ($3.5 billion) and 2024 ($2.7 billion), as well as the number of Series A preferred shares issued (176,655 in 2022 and 99,264 in 2024) are correct. The years are correctly tied to the sixth and eighth anniversary releases, respectively. There are no calculation errors, and the formatting of numbers (e.g., $3.5 billion vs $3.5 billion) is acceptable. The answer correctly identifies the downward trend in both value and share issuance, capturing the core financial evolution. The only minor shortcoming is the omission of the explicit conclusion about the 'reduction in financial burden' over time, which is present in the original answer and provides interpretive context. However, the LLM implies this through the comparison, so the reasoning remains sound. All entities (Visa, Series A preferred stock, as-converted value, anniversary releases) are correctly referenced. The response is fully relevant and synthesizes multi-hop information across two time points accurately. Thus, the answer is factually complete and semantically equivalent, warranting a high correctness score with only a slight deduction for missing interpretive depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 355,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "The financial and strategic relationship between 3M and the Aearo Entities evolved significantly between 2023 and 2024, marked by litigation resolution and structural adjustments. Following the Aearo Entities' Chapter 11 bankruptcy filing in July 2022, 3M reconsolidated them in Q2 2023 after their dismissal from bankruptcy in June 2023, leading to an immaterial income statement impact. The parties finalized the CAE Settlement in August 2023, under which 3M committed $6.0 billion (adjusted from an original $5.0 billion cash + $1.0 billion stock structure) to resolve Combat Arms Earplugs litigation, including a $4.2 billion pre-tax charge in Q3 2023. This settlement, combined with the reconsolidation, led to adjustments in segment reporting, particularly in Safety and Industrial (where Aearo-related litigation costs were initially reflected) and Corporate/Unallocated (which absorbed special litigation items post-bankruptcy). The resolution of litigation through the CAE Settlement and the reconsolidation stabilized the business relationship, allowing 3M to refocus on core segments like Safety and Industrial and Transportation and Electronics, while the Consumer segment faced organic sales declines due to broader market shifts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly impact correctness. While it correctly identifies the reconsolidation of Aearo Entities in 2023 after dismissal of bankruptcy, it incorrectly states that the CAE Settlement was finalized in August 2023 and includes specific financial figures—$6.0 billion total settlement, $5.0 billion cash + $1.0 billion stock, and a $4.2 billion pre-tax charge in Q3 2023—that are not present in the ground truth and contradict known public disclosures. The original answer does not specify any dollar amounts or charges related to the CAE Settlement, nor does it mention timing such as 'August 2023' or 'Q3 2023 charge'. These fabricated numbers severely undermine quantitative accuracy. (2) The LLM also misattributes segment impacts: while it mentions Safety and Industrial and Corporate/Unallocated segments absorbing litigation costs, the ground truth only references the Transportation and Electronics segment in 2024 in relation to divestiture/acquisition effects from prior deconsolidation and reconsolidation. There is no mention in the ground truth of segment reporting changes in Safety and Industrial or Consumer organic sales declines due to market shifts—these are extraneous details not supported by the original answer. (3) On qualitative accuracy, the LLM correctly captures the multi-hop evolution: Aearo’s bankruptcy exit leading to reconsolidation in 2023, immaterial income statement impact, and transition toward strategic financial treatment in 2024. It correctly infers a shift from litigation focus to integration into broader financial reporting. However, the addition of unsupported details about settlement structure and charges reflects flawed reasoning or hallucination. (4) Contextual relevance remains high because the response addresses both litigation impact and business segment adjustments as asked, organizing the narrative chronologically and thematically around 3M-Aearo dynamics. Despite incorrect specifics, the overall framework aligns with the question's intent. The correctness score is 5 due to partial factual alignment but major errors in key financial claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 583,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial structure of Visa’s Class C common stock remained tied to its broader capital structure but showed evolving dynamics in relation to other classes and earnings per share (EPS) performance. Class C shares, which have no voting rights except in limited circumstances (such as exiting the core payments business or certain mergers), continue to be non-convertible and non-dividend-paying, unlike Class A shares that receive dividends and participate fully in earnings. However, Class C common stock participates in earnings per share calculations on an as-converted basis, meaning its share of net income is allocated proportionally when calculating diluted EPS, even though it does not receive dividends. The EPS figures for Class C common stock rose significantly from $28.03 in 2022 to $33.17 in 2023 and $38.97 in 2024, reflecting both increased net income and a relatively stable, small share count (10–16 million weighted average shares outstanding). This growth outpaced Class A ($7.01 to $8.29 to $9.74) and Class B-1 ($11.33 to $13.26 to $15.46) EPS, indicating stronger per-share earnings leverage, though Class C’s impact on total EPS is limited due to its small share base. The lack of dividends and voting rights means Class C does not generate direct cash returns to shareholders but benefits indirectly from corporate performance through diluted EPS inclusion. Additionally, structural changes, such as the January 2024 amendment to the certificate of incorporation enabling the exchange of Class B-1 shares for Class C shares, have increased the number of Class C shares outstanding (to 1.1 billion authorized), potentially affecting future EPS dilution if conversion rates adjust downward. Nonetheless, Class C remains a non-economic stakeholder class with minimal direct financial returns but plays a role in capital allocation and litigation-related risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2024, Class C Common Stock had $33.17 basic EPS and $33.13 diluted EPS, while Class A had $8.29 basic and $8.28 diluted EPS. However, the LLM claims Class C EPS rose to $38.97 in 2024 and provides a trajectory from $28.03 in 2022 to $33.17 in 2023 to $38.97 in 2024—none of which are supported by the original answer. Additionally, the original answer does not mention Class B-1 shares, EPS figures for Class B-1, or any exchange mechanism between Class B-1 and Class C shares, nor does it reference a January 2024 amendment or 1.1 billion authorized shares. These are fabrications or hallucinations not present in the source. The original answer makes no mention of EPS trends over 2022–2024 beyond 2024 figures, nor does it state that Class C shares are non-dividend-paying or non-convertible—details the LLM introduces without grounding. While the LLM correctly identifies that Class C has different voting rights and is tied to financial institution clients, and captures the idea of stronger EPS performance relative to Class A, the numerical inaccuracies and invented structural changes severely undermine correctness. The reasoning is logically structured but based on incorrect data. The answer is contextually relevant and addresses the evolution of Class C stock in relation to other classes and EPS, but fails on factual precision and multi-hop synthesis, as it invents entities and figures not present in the knowledge base.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 428,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Qualcomm’s ADAS/AD strategy shifted from a broad, diversified portfolio of investments (including early‑stage ventures and multiple internal development programs) toward a more focused, monetizable approach.  In the 2024 filing the company reports that “Automotive (2) includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD,” and it explicitly ties ADAS/AD revenue to its QCT segment’s automotive sales, which grew from $1.5 billion in fiscal 2022 to $2.9 billion in fiscal 2024.  At the same time, Qualcomm’s patent‑licensing (QTL) segment continues to generate royalty income from automotive‑related devices, but the company no longer categorizes ADAS/AD as a separate revenue stream—instead it is folded into the broader automotive product and licensing categories.  Consequently, the evolution reflects a transition from exploratory investment to a revenue‑driven, segment‑integrated model for ADAS/AD technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative evolution of Qualcomm's ADAS/AD strategy from development to commercialization between fiscal 2022 and 2024, aligning with the ground truth. It correctly identifies the integration of ADAS/AD into the 'automotive' revenue category under QCT and notes the shift from investment to monetization. However, it introduces specific quantitative claims not present in the original answer or implied by the knowledge graph: namely, that automotive revenue grew from $1.5 billion in fiscal 2022 to $2.9 billion in fiscal 2024, and that ADAS/AD is explicitly tied to QCT segment sales. The ground truth does not provide these exact figures or confirm this revenue attribution, making the numerical assertions unsupported. Additionally, the claim that ADAS/AD is 'no longer categorized as a separate revenue stream' but 'folded into broader categories' adds detail beyond the original, which only states that ADAS/AD became part of automotive revenue—without commenting on prior standalone categorization or QTL royalties. While the overall reasoning and direction of evolution are sound (multi-hop synthesis from strategic activity to revenue classification), the inclusion of unverified financial figures significantly undermines quantitative accuracy. The contextual relevance is high, as the response directly addresses the question’s focus on strategic and revenue categorization changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 393,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa’s U.S. Retrospective Responsibility Plan evolved from a framework centered on the U.S. litigation escrow account, class B stock conversion mechanisms, and indemnification obligations under the interchange judgment sharing and loss sharing agreements to a more structured, multi‑layered approach that incorporates the omnibus agreement’s allocation formulas and explicit references to the plan’s provisions in settlement accounting. This evolution reflects a strategic shift toward formalizing liability allocation—particularly the 66.6667% Visa share of covered settlements—through the omnibus agreement and escrow funding, indicating that Visa is proactively managing and compartmentalizing litigation risk to limit exposure and ensure predictable financial responsibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Visa's U.S. Retrospective Responsibility Plan between 2022 and 2024. It correctly identifies the shift from a simpler structure based on the litigation escrow account and indemnification mechanisms to a more complex, multi-layered framework. The mention of the omnibus agreement, escrow funding, interchange judgment sharing, loss sharing, and Class B stock conversion aligns with the ground truth. The 66.6667% liability allocation (Visa's share) is a precise and correct detail that reflects accurate quantitative understanding. However, the LLM omits several specific components mentioned in the original answer, such as makewhole agreements related to the Class B-1 exchange offer and the U.S. litigation escrow agreement as a formalized mechanism. While the concept of 'structured, multi-layered approach' is conveyed, the absence of these specific instruments reduces completeness. The reasoning is sound and the synthesis across years is appropriate, showing a clear understanding of the strategic shift toward formalized, predictable risk management. Wording differs but meaning is semantically close. Quantitative accuracy is high—66.6667% is correct and properly contextualized. Contextual relevance is excellent, directly addressing both the mechanisms and the implication for litigation risk management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 382,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza remained stable in absolute terms but showed modest growth in alliance revenue, increasing 9% year‑over‑year to $1.311 billion in 2024 (up from $1.199 billion in 2023). This growth, together with the continued royalty income from Keytruda and the broader oncology portfolio, signals that Lynparza continues to be a strategically important product, though its performance is now being outpaced by faster‑growing assets such as Keytruda and newer launches like Winrevair.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a 9% growth in alliance revenue linked to Lynparza, it fabricates specific dollar amounts—$1.311 billion in 2024 and $1.199 billion in 2023—which are not present in the ground truth. The original answer states that Merck reported a $1.5 billion net intangible asset in 2023 but does not provide alliance revenue figures for 2023 or 2024. Therefore, the LLM invents numbers unsupported by the source, severely undermining quantitative accuracy. (2) The 9% growth rate is correctly mentioned, aligning with the ground truth, but attaching it to specific revenue figures constitutes a material overprecision and misrepresentation. There is no mention in the ground truth of Lynparza's performance being 'outpaced' by Keytruda or Winrevair, nor any comparison to other products—this is speculative and contextually unsupported. (3) The multi-hop reasoning is partially sound in linking alliance revenue growth to strategic importance, but fails to incorporate the key 2025 China approval for adjuvant early breast cancer, which is a critical indicator of expanded market potential and strategic evolution. This omission reduces completeness and qualitative accuracy. (4) The mention of 'continued royalty income from Keytruda' is irrelevant to Lynparza’s financial stake and introduces confusion, as Keytruda is not part of the Lynparza collaboration. Overall, while the answer captures the direction of performance (growth), it distorts magnitudes, adds unverified comparisons, and misses key regulatory developments, resulting in a partially correct but materially flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 459,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal’s competitive position within Altria’s oral tobacco segment eroded significantly.  In 2024, Skoal’s retail share fell to 7.6% (down from 9.3% in 2023) and its shipment volume dropped to 147 million cans (down from 163 million in 2023), while the overall oral‑tobacco category grew, driven by oral‑nicotine pouches.  Competitor brands—particularly the on! pouch brand (which held an 8.3% share in 2024, up from 6.8% in 2023) and Red Seal—gained share at the expense of traditional MST products, causing Skoal’s overall category share to decline from 42.5% in 2023 to 37.5% in 2024.  This shift reflects pricing pressure, modest volume declines and a strategic emphasis on higher‑margin pouch growth, which together weakened Skoal’s standing relative to its key rivals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the timeline and attribution of data. The original answer states that Skoal's retail share was 9.3% in 2022, not 2023, but the LLM incorrectly cites the 9.3% figure as being from 2023. This misalignment skews the temporal evolution of Skoal's performance. Additionally, the LLM introduces shipment volume data (147 million and 163 million cans) that are not present in the original answer and cannot be verified against the ground truth, raising concerns about hallucination. The claim that the 'overall oral-tobacco category grew' is also not supported by the original answer, which instead notes a decline in Altria's total retail share from 42.5% in 2023 to 37.5% in 2024—this share refers to Altria’s segment, not the total category. Furthermore, the LLM incorrectly attributes the 42.5% to 37.5% decline to Skoal’s 'overall category share', when in fact it refers to Altria’s total oral tobacco segment share. (2) While the 7.6% (2024) and 8.3% (on! in 2024) figures are correct, and the on! brand’s increase from 6.8% to 8.3% is accurately reflected, the misplacement of the 9.3% Skoal share to 2023 instead of 2022 breaks the correct multi-year comparison. The introduction of unverified shipment volumes further undermines quantitative accuracy. (3) The reasoning partially captures the trend of Skoal losing share to on! and other pouch products, and correctly identifies the strategic shift toward higher-margin pouches. However, it misrepresents the competitive landscape by mentioning 'Red Seal'—a brand not referenced in the original answer—as gaining share, which is unsupported. The synthesis fails to correctly contrast Skoal’s performance with Copenhagen, a key point in the original answer. (4) Despite these issues, the answer remains contextually relevant, addressing Skoal’s declining position and the rise of on!, and correctly identifying broader strategic trends within Altria. The core narrative of Skoal’s weakening position is directionally correct, but marred by significant factual and attributional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 569,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Microsoft Cloud revenue grew from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, reflecting a significant increase in its contribution to overall revenue over that period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Microsoft Cloud revenue for fiscal 2023 ($111.6 billion), which matches the ground truth. However, it inaccurately states fiscal 2022 Microsoft Cloud revenue as $91.4 billion instead of $91.2 billion, a minor but notable error. More importantly, the LLM fails to address the core of the question — the revenue contribution and evolution of Dynamics 365 specifically — and instead discusses Microsoft Cloud as a whole. (2) The $91.4B figure is incorrect (should be $91.2B); the $111.6B figure is correct. No calculation is performed, but the comparison implies growth, which is accurate in direction but lacks specificity about Dynamics 365. (3) The reasoning is flawed: the question requires multi-hop synthesis about Dynamics 365’s role and growth within Microsoft Cloud across two years. The LLM does not mention Dynamics 365’s 39% growth in FY2022 or its continued contribution in FY2023, missing key qualitative insights. It conflates Microsoft Cloud total growth with Dynamics 365’s performance. (4) Scores reflect partial quantitative accuracy (mostly correct numbers, one error), incomplete qualitative reasoning (fails to isolate Dynamics 365), and moderate correctness due to omission of the primary subject of the question. Contextual relevance is higher because the answer discusses the broader revenue trend related to the topic, but it does not fulfill the specific request about Dynamics 365’s evolving contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 408,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "From 2023 to 2024, Merck’s Balance Sheet Risk Management Program continued to use forward foreign‑exchange contracts as its primary hedging instrument, but the scope of hedging activities shifted toward broader protection of net investment positions and larger notional amounts. In 2024 the Company reported $406 million in designated hedging derivatives (primarily foreign‑exchange contracts on assets of $12,465 million notional) versus $189 million in 2023, while non‑designated derivatives rose to $323 million in assets and $343 million in liabilities (notional $26,095 million) from $153 million/$162 million previously. The fair‑value adjustments for designated hedges also increased, with a $17 million cumulative fair‑value hedging adjustment on long‑term debt in 2024 compared with $56 million in 2023, indicating a more extensive use of interest‑rate swaps to hedge fixed‑rate debt. Overall, the program now encompasses larger foreign‑exchange notional exposure and includes additional interest‑rate swaps to manage fair‑value risk on long‑term debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) The original answer states that in 2023, Merck used forward exchange contracts (not designated as hedges) for specific currencies (euro, Swiss franc, yen, renminbi), and in 2024 expanded to include purchased local currency put options and collar options, with a more strategic layering of hedges over time. The LLM answer instead introduces quantitative figures not present in the original—such as $406 million in designated hedging derivatives, $12,465 million notional, and changes in non-designated derivatives—that are unsupported by the ground truth and appear fabricated. There is no mention in the original answer of interest-rate swaps, fair-value adjustments on long-term debt, or any hedging of interest-rate risk, yet the LLM claims these were part of the 2024 program. (2) All numeric values in the LLM response ($406M, $189M, $323M, $343M, $26,095M, $17M, $56M) are entirely absent from the original answer and thus factually incorrect. (3) The multi-hop reasoning is flawed: the question asks about evolution in instruments and scope of hedging; the correct answer involves a shift from forwards only to include options and a more structured timing-based layering approach. The LLM instead invents a narrative around designated vs. non-designated derivatives and interest-rate swaps, which is not supported by the source. (4) While the mention of forward contracts is correct, the overall direction, instruments, and strategic evolution described are inaccurate. The answer is contextually related to risk management but misrepresents the actual evolution of Merck’s program, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 473,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "Between 2022 and 2024, PayPal’s credit loss provisions for merchant receivables declined materially as credit quality improved. The allowance for merchant loans, advances, and interest and fees receivable fell from $160 million at the end of 2023 to $113 million at the end of 2024, reflecting a reduction in expected credit losses driven by better performance of the PPBL portfolio and overall improvements in merchant credit metrics. This downward trend in provisions aligns with PayPal’s shift toward more direct investment in merchant financing products, such as PPWC and PPBL, which are now funded through its own capital and structured with fixed‑fee arrangements rather than relying solely on third‑party partner institutions. Consequently, the company’s exposure to credit risk has been managed through tighter underwriting, periodic review of credit limits, and a focus on shorter‑term, fixed‑fee financing that reduces the need for extensive loss reserves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative details, despite addressing the general theme of PayPal's evolving involvement in merchant financing. (1) The ground truth states that PayPal purchased $1.8 billion in merchant receivables in 2024 with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. The LLM answer omits these critical figures entirely and instead introduces a claim about the allowance for credit losses declining from $160 million in 2023 to $113 million in 2024—data not present in the original answer and unsupported by the provided ground truth. (2) The original answer references a principal and interest coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), but the LLM does not mention this metric at all, instead fabricating a narrative around declining provisions without grounding in the provided facts. (3) While the LLM correctly identifies PayPal’s strategic shift toward direct investment via products like PPWC and PPBL, this qualitative insight is partially accurate but not sufficiently supported by the correct multi-hop synthesis of actual data points from 2022 and 2024. (4) The reasoning about tighter underwriting and fixed-fee structures, while plausible, is not mentioned in the original answer and thus represents inference beyond the provided truth. Overall, the answer is contextually relevant and captures the directional shift, but fails on core quantitative accuracy, which is central to the question, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 430,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO declined in both absolute and relative terms.  In 2022, smokeable products generated roughly $21.8 billion in net revenue (≈ 90 % of total) and contributed about $10.9 billion of operating income; by 2024, net revenue from smokeable products fell to $21.2 billion (≈ 88 % of total) and operating income dropped to $10.8 billion – a modest revenue decline of ~3 % and an operating‑income decline of ~1 % (adjusted for special items).  This reduction is reflected in the lower share of total operating income and the growing weight of other segments (e.g., oral tobacco and wine) in Altria’s overall earnings, while goodwill allocation and impairment testing show that the smokeable segment’s goodwill remained stable ($99 million) but its contribution to overall profitability is diminishing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, goodwill allocated to smokeable products was $99 million (correctly mentioned in the LLM answer), but there is no disclosure of goodwill for 2024. The LLM incorrectly assumes goodwill remained stable at $99 million in 2024, which is not confirmed in the original answer and contradicts the point that it was 'undisclosed'—a key nuance. More critically, the LLM fabricates operating income figures: it claims smokeable products contributed $10.9 billion in 2022 and $10.8 billion in 2024, but the ground truth shows operating income was $10,670 million in 2023 and $10,821 million in 2024—indicating an increase, not a decrease. The LLM incorrectly states operating income dropped to $10.8 billion in 2024, when in fact it rose from 2023 to 2024. Additionally, the LLM introduces net revenue figures ($21.8B in 2022, $21.2B in 2024) and percentage shares (90%, 88%) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers and trends are entirely unsupported. (2) Calculations are flawed: the claimed ~1% decline in operating income is false given the actual increase from $10,670M to $10,821M (+1.4%). The LLM also mischaracterizes the trend as declining in both absolute and relative terms, which contradicts the ground truth showing sustained and slightly increased profitability. (3) Multi-hop reasoning is unsound: the LLM fails to correctly synthesize the evolution of financial significance by conflating undisclosed goodwill with declining importance, while misrepresenting operating income performance. It incorrectly infers diminishing profitability when the evidence shows the opposite. The mention of 'oral tobacco and wine' and 'special items' introduces external context not supported by the ground truth. (4) The contextual relevance is moderate because the answer addresses goodwill and operating income over time, but the factual errors—especially in direction of change—are severe. Correctness and quantitative accuracy are low due to fabricated numbers and incorrect trends. Qualitative accuracy is slightly higher only because the model attempts the right dimensions (goodwill, income, segment shift), but reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 616,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Based on the provided 10-K filings, Microsoft's commercial LinkedIn revenue increased from $13,816 million in fiscal 2022 to $16,372 million in fiscal 2023, reflecting growth in LinkedIn's commercial segment revenue as reported in the consolidated revenue breakdown. This growth contributed to the overall increase in Microsoft Cloud revenue, which rose to $137.4 billion in fiscal 2023 from $111.6 billion in fiscal 2022, with the commercial portion of LinkedIn being a component of that cloud revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Microsoft Cloud revenue (which includes LinkedIn's commercial portion) was $91.2 billion in FY2022 and $111.6 billion in FY2023. However, the LLM claims Microsoft Cloud revenue was $111.6 billion in FY2022 and $137.4 billion in FY2023 — reversing and distorting the ground truth numbers. Additionally, the LLM introduces specific figures for 'commercial LinkedIn revenue' ($13,816 million and $16,372 million), which are not present in the original answer and cannot be verified from the provided context. These numbers appear fabricated or misattributed. (2) The quantitative accuracy is very low: the Microsoft Cloud revenue figures are incorrect in both years, and the LinkedIn-specific revenue numbers are unsupported by the ground truth. There is no mention in the original answer of LinkedIn's standalone commercial revenue, only its inclusion within the broader Microsoft Cloud segment. (3) The reasoning is flawed — the model incorrectly isolates LinkedIn's commercial revenue and falsely presents it as explicitly reported in the 10-K, when the original answer only infers stronger contribution based on overall Microsoft Cloud growth. It fails the multi-hop synthesis by misrepresenting component relationships. (4) Contextual relevance is moderate because the answer addresses the general topic of LinkedIn's commercial revenue within Microsoft Cloud and attempts to show evolution, but the factual foundation is unsound, undermining the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 430,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization expanded geographically with Japan's MHLW approval in August 2023 and China's NMPA approval in January 2025 for new indications (adjuvant treatment for early breast cancer), driving a 9% increase in alliance revenue to $1,311 million (11% excluding FX). Revenue growth was fueled by higher demand in international markets, though specific geographic sales breakdown is not detailed in the provided documents. The drug's market expansion was further supported by its inclusion in new treatment combinations and conditional EU approvals for additional indications.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% alliance revenue growth for Lynparza between 2023 and 2024, which matches the ground truth. However, it introduces a specific dollar amount of $1,311 million and a figure of '11% excluding FX' that are not present in the original answer and cannot be verified from the provided ground truth, making these additions factually unsupported. The approval dates are partially incorrect: while Japan's MHLW approval in 2023 is accurate (August is plausible), the China NMPA approval is stated as January 2025 — this is outside the 2023–2024 timeframe in question and is presented as a driver of 2023–2024 growth, which is logically inconsistent. The original answer correctly notes the January 2025 approval but frames it as an indicator of ongoing expansion beyond 2024, not a contributor to 2023–2024 growth. (2) The revenue growth percentage (9%) is accurate, but the added $1,311 million and '11% excluding FX' figures are unverified and not in the ground truth, reducing quantitative accuracy. The timeline misplacement of the China approval affects factual correctness. (3) The LLM demonstrates sound multi-hop reasoning by linking approvals to revenue growth and identifying geographic and indication expansion. It correctly associates Japan's approval with 2023 and notes China's approval, though the temporal framing is flawed. The mention of 'conditional EU approvals' and 'new treatment combinations' adds context not contradicted by the ground truth but not explicitly supported either. (4) Despite the chronological and numerical inaccuracies, the answer addresses the core aspects of geographic expansion and revenue growth with mostly correct entities (Lynparza, MHLW, NMPA) and logical synthesis, warranting a moderate correctness score. The answer is contextually relevant and well-structured, but the inclusion of unverified figures and misaligned timing prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 526,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "The Powder Metal Matter generated a $455 million deferred tax asset in 2024, down from $644 million in 2023, reflecting a $189 million reduction in the associated future income‑tax benefit. This decline is reflected in the valuation‑allowance schedule, where the allowance for the Powder Metal Matter was lowered (contributing to the overall decrease in the total valuation allowance balance), and the 2024 effective tax rate now includes a $212 million tax charge related to the Otis non‑U.S. tax ruling that reduces the company’s foreign‑tax credits, further affecting the net tax benefit of the Powder Metal Matter. Consequently, the tax‑related advantage of the Powder Metal Matter has decreased, and the company now records a smaller future income‑tax benefit and a corresponding increase in tax expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $455 million deferred tax asset in 2024 and the $644 million value in 2023, matching the ground truth. The $189 million reduction is accurate and correctly calculated. However, the ground truth does not mention a 'deferred tax asset' or 'valuation allowance schedule'—these specific terms and mechanisms are not present in the original answer and represent an over-interpretation or addition of unverified detail. Additionally, the LLM introduces a $212 million tax charge related to the 'Otis non-U.S. tax ruling', which is entirely absent from the ground truth and unrelated to the Powder Metal Matter’s treatment evolution. This introduces significant factual noise. (2) Quantitatively, the core numbers ($455M, $644M, $189M reduction) are correct and calculations accurate. The percentage decrease (~29.3%) is implied but not stated, which is acceptable. However, the added $212M figure is incorrect in context and unsupported. (3) The multi-hop reasoning is partially sound—there is recognition of a shift from sales impact in 2023 to tax benefit in 2024—but the original answer emphasizes a shift in classification (from sales reduction to future tax benefit), while the LLM frames it as a change in tax asset valuation without acknowledging the earlier sales impact. The introduction of Otis and foreign tax credits distracts from the core evolution and reflects a failure to synthesize only the relevant information. (4) Correctness score is 6 due to accurate core numbers but significant overreach in details not in the ground truth, including erroneous linkage to unrelated tax items. Quantitative accuracy is 7 because primary figures are correct but secondary figures are not. Qualitative accuracy is 5 due to flawed reasoning and unsupported entity references. Contextual relevance is 9 as the response stays focused on the Powder Metal Matter’s tax treatment, despite the inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 525,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "From 2022 through 2024 the Paidy Credit Agreement was expanded and then fully drawn: the facility was initially a ¥60 billion revolving line (Feb 2022), increased by ¥30 billion in September 2022 to ¥90 billion (≈$574 million), and by December 31 2024 a total of ¥90 billion (≈$574 million) had been borrowed, leaving no remaining borrowing capacity.  The agreement terminates in February 2027, carries a low interest margin (Tokyo Interbank Offered Rate + 0.40‑0.60 %), and is subject to a leverage‑ratio financial covenant.  Consequently, the borrowing capacity fell from essentially full availability in 2022 to zero by the end of 2024, while the outstanding balance grew to the full ¥90 billion limit.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures some key facts. The original answer states that in 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. However, the LLM claims the initial facility was ¥60 billion in February 2022 and increased by ¥30 billion in September 2022 — details not present in the ground truth. The ground truth does not mention incremental increases or the timing of those changes, so this specific evolution is unsupported. The LLM correctly identifies the 2024 borrowing capacity as ¥90.0 billion (≈$574 million), aligning with the original answer’s conversion as of December 31, 2024. However, the LLM incorrectly states that the full ¥90 billion had been borrowed by December 31, 2024, leaving zero capacity — the original answer does not state that the facility was fully drawn, only that the capacity increased. This is a significant factual overreach. (2) The interest rate structure (TIBOR + 0.40–0.60%) and maturity date (February 2027) are correctly reported, as is the inclusion of a leverage ratio covenant. However, the original answer notes that interest terms were unspecified in 2022, which the LLM fails to acknowledge. (3) The multi-hop reasoning is partially sound — the model synthesizes changes in size, interest rate, maturity, and covenants — but introduces unverified details about the timing and tranches of the increase (¥60B → ¥90B), which undermines quantitative accuracy. (4) The contextual relevance is high because the answer addresses the evolution of terms and capacity over time, and the qualitative reasoning is logical, albeit based on incorrect inputs. Due to major quantitative errors and unsupported specifics, the correctness score is reduced to 6 despite capturing some correct final-state facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 513,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria’s reliance on long‑term senior unsecured notes declined: it issued $5.5 billion of such notes in February 2021 to refinance debt, repaid $1.5 billion of 4.75 % notes in May 2021 and $1.0 billion of 3.49 % notes in January 2020, and later repaid $776 million of 4.0 % and $345 million of 3.8 % notes in early 2024. By 2024 its total long‑term debt had fallen to $24.9 billion, and it supplemented its capital resources with the $1 billion senior unsecured note issuance in February 2025, indicating a reduced dependence on long‑term senior unsecured debt compared with the 2022‑2023 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Altria's reliance on long-term senior unsecured notes between 2022 and 2024. (1) Quantitative inaccuracies: The LLM cites note issuances in 2021 and 2020 (e.g., $5.5B in Feb 2021), which are outside the 2022–2024 timeframe and thus irrelevant to the question. It also references a $1B note issuance in *February 2025*, a future date not within the scope. The repayment amounts in early 2024 ($776M and $345M) may be factually correct but are not contextualized within the broader capital structure trend. The total long-term debt figure of $24.9B in 2024 is not supported by the ground truth, which does not provide aggregate debt figures. (2) The ground truth emphasizes that Altria *continued to rely* on long-term senior unsecured notes as a key capital source, with a decline in cash reserves from $4.5B (2022) to $3.1B (2024), suggesting *increased* reliance on external financing. The LLM incorrectly concludes a *decline* in reliance, which contradicts the original answer’s inference. (3) Multi-hop reasoning is flawed: the LLM focuses on debt repayments and past issuances but ignores the core comparison of capital structure evolution—specifically the decreasing cash levels that imply greater dependence on debt markets. It also fails to mention the $3.0B Credit Agreement or the strategic use of capital for dividends, buybacks, and debt repayment. (4) Contextual relevance is moderate because it discusses debt instruments and timelines, but the incorrect temporal focus and conclusion severely undermine accuracy. Overall, the answer misrepresents the direction of change in Altria’s financing strategy and introduces data outside the relevant period, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 488,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "Between 2023 and 2024, RTX’s financial treatment of the Powder Metal Matter shifted from a $5.4 billion net sales charge in 2023 (recorded in the third quarter of 2023) to a $2.5 billion reduction in cost of sales in 2024, reflecting the partners’ share of the matter’s impact. This evolution indicates that the remaining financial exposure is now primarily reflected in lower cost‑of‑sales and related tax benefits, rather than a large sales charge, suggesting diminishing but still material effects on future income‑tax benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The key financial figures are wrong: the original answer states that the Powder Metal Matter contributed $644 million to RTX's future income tax benefits in 2023 and $455 million in 2024, showing a decline in tax benefits. However, the LLM claims a $5.4 billion net sales charge in 2023 and a $2.5 billion reduction in cost of sales in 2024—figures not mentioned in the ground truth and unrelated to tax benefits. (2) Quantitative accuracy is very low: the numbers cited ($5.4B, $2.5B) do not match the ground truth ($644M, $455M), and there is no indication these relate to income tax benefits. The LLM confuses tax benefits with sales charges and cost-of-sales adjustments, which are different financial concepts. (3) The reasoning is flawed: the LLM describes an evolution in financial treatment involving net sales and cost of sales, but the original answer focuses solely on future income tax benefits, with no mention of sales or cost-of-sales impacts. The multi-hop synthesis is incorrect because it pulls in unrelated financial metrics. (4) While the LLM attempts to interpret the trend (diminishing impact), this inference is based on fabricated data. The contextual relevance is moderate because it addresses RTX and the Powder Metal Matter over 2023–2024, but the substance is factually misaligned. Overall, the answer misrepresents the financial treatment and provides incorrect data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 414,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "Between 2022 and 2024, PayPal’s borrowing capacity under the Paidy Credit Agreement was fully utilized: the agreement, originally a ¥60 billion (≈ $574 million) revolving facility expanded to ¥90 billion, was drawn down for the entire ¥90 billion amount by the end of 2024, leaving no remaining capacity. In contrast, the company’s primary $5 billion five‑year revolving credit facility remained largely unused, with $5 billion of borrowing capacity still available as of December 31 2024. This evolution reflects a shift from modest use of the Paidy facility in 2021 to a complete drawdown by 2024, while the larger corporate credit line stayed untouched.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, in 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. However, the LLM incorrectly states that the original facility was ¥60 billion (≈$574 million), which conflates the 2024 amount with an earlier period and misrepresents both the timeline and scale of the facility’s expansion. Additionally, the LLM claims the facility was expanded from ¥60 billion to ¥90 billion, but the ground truth does not support a ¥60 billion prior amount—only that capacity increased to ¥90 billion ($574 million) by 2024. The claim that the full ¥90 billion was drawn by end-2024 aligns with the ground truth (full drawdown, zero capacity left), which is correct. (2) The calculation of available capacity in 2022 is missing in the LLM answer—it fails to mention the $100 million available in 2022 based on $198M capacity minus $98M drawn pre-2022. Also, the LLM incorrectly equates ¥60 billion with $574 million, when ¥90 billion equals $574 million in the 2024 context; this is a major exchange rate and timing error. (3) The multi-hop reasoning is partially sound: the model correctly infers increased reliance on the Paidy facility over time and contrasts it with the unused $5 billion corporate facility, which adds contextual insight. However, it fabricates an earlier ¥60 billion facility not present in the ground truth, undermining the accuracy of the evolution narrative. (4) Despite these errors, the answer captures the directional trend—increased borrowing capacity and full drawdown by 2024—and addresses the core question about utilization evolution. The inclusion of the unused $5 billion facility, while contextually relevant, is not required by the question and slightly distracts from the focus on Paidy. Scores reflect partial correctness: quantitative accuracy penalized heavily due to incorrect figures and misaligned timelines; qualitative and contextual scores are higher due to logical structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 585,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, Accenture plc’s share‑purchase activity shows a modest increase in the number of Class A ordinary shares bought on the open market (11.75 M in fiscal 2024 versus 10.2 M in fiscal 2023), while the amount spent rose to $4.51 B from $3.78 B.  The company also expanded its share‑repurchase authority by an additional $4 M in September 2024, bringing total authorization to $6.69 B.  Regarding noncontrolling interests, the consolidated financial statements note that the noncontrolling ownership in Accenture Canada Holdings Inc. was less than 1 % as of August 31 2024, indicating that the equity stake held by former Accenture Leadership members remained essentially unchanged and did not materially affect the overall equity relationship.  Exchangeable shares of Accenture Canada Holdings Inc. continued to be convertible one‑for‑one into Accenture plc Class A ordinary shares, but no significant changes in the volume of such exchanges were disclosed between the two fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant irrelevant information and omits key structural developments. It correctly states that noncontrolling ownership in Accenture Canada Holdings Inc. was less than 1% as of August 31, 2024, which aligns with the ground truth. However, it incorrectly implies this figure is from 2023 by juxtaposing it with share repurchase data from fiscal 2023 and 2024, while the original answer specifies the less-than-1% stake relates to ownership by former leadership as of August 31, 2024, not a comparison across years. (2) The quantitative data about share repurchases—11.75M shares in 2024 vs 10.2M in 2023, $4.51B vs $3.78B spent, and $4B additional authorization (not $4M, which is a clear typo)—are factually accurate based on Accenture’s filings, but these figures are entirely unrelated to the question about ownership structure and equity relationships between Accenture plc and Accenture Canada Holdings Inc. The $4M typo (should be $4B) further undermines quantitative accuracy. (3) The LLM fails the multi-hop reasoning requirement: the question asks for evolution in ownership structure and equity relationship, particularly regarding noncontrolling interests and exchangeable shares. While it mentions the one-for-one convertibility, it omits the critical 2024 structural development—the creation of Accenture plc Class X ordinary shares tied directly to exchangeable shares and the restriction ensuring Class X shares never fall below the number of exchangeable shares held. This omission represents a failure to capture the core evolution described in the ground truth. (4) The answer is contextually relevant in discussing Accenture’s equity structure but misdirects focus toward share repurchases, which are peripheral to the specific legal and equity linkage between Accenture plc and its Canadian subsidiary. Due to major omissions in structural evolution and inclusion of irrelevant financial data, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 553,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of currency focus and cost-benefit considerations between 2022 and 2024. In 2022, the company expanded its hedging program to include the Chinese renminbi and emphasized a cost-benefit analysis that weighed natural offsets, volatility, and hedging instrument costs, particularly for developing market currencies like the renminbi. By 2024, Merck continued to layer in hedges over time, targeting currencies such as the euro, Japanese yen, and Chinese renminbi, while also using forward contracts to hedge net investments in foreign operations. The cost-benefit assessments remained central to determining hedge ratios, with a focus on minimizing variability in foreign currency cash flows and fair value changes, especially for monetary assets and liabilities denominated in non-functional currencies. The company's use of forward contracts for net investment hedging and its exclusion of certain hedge components from effectiveness testing further reflect a refined, economically driven approach to managing foreign exchange risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and misrepresents the evolution of Merck's hedging strategy between 2022 and 2024. (1) Correct elements: The mention of the Chinese renminbi in 2022 and the continued use of forward contracts in 2024 are factually consistent with the ground truth. There are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, the LLM incorrectly asserts that Merck 'expanded' its program to include the renminbi in 2022 and continued targeting it in 2024, while the ground truth indicates that the specific mention of the renminbi and cost-benefit analysis for developing countries was *omitted* in 2024—suggesting a de-emphasis, not continuation. (3) The multi-hop reasoning is flawed: the core of the question asks how the approach *evolved*, and the ground truth highlights a reduction in detail and a potential simplification of the framework by 2024. Instead, the LLM portrays a more sophisticated evolution with 'refined, economically driven' methods and continued cost-benefit assessments, which contradicts the original answer’s implication of simplification or reduced transparency. (4) The LLM also introduces new details not in the ground truth—such as hedging the euro and yen, layering in hedges over time, and excluding components from effectiveness testing—which are unsupported and suggest over-inference. While the response is contextually relevant and well-structured, it fails to accurately reflect the *direction* of change in Merck’s approach, leading to a correctness score of 5 due to significant qualitative inaccuracies despite strong contextual framing and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 466,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The 2024 10‑K shows that the Powder Metal Matter was removed from the “Significant Accounting Policies” section and is now disclosed only in the tax‑benefit schedule (Note 13) and in the “Future income taxbenefits” table.  The de‑designation of €180 million of euro‑denominated debt in Q4 2024 and the resulting $212 million tax charge (Note 13) indicate that the tax‑related benefit associated with the Powder Metal Matter is no longer being tracked as a separate line item.  Consequently, future income‑tax benefits tied to that matter are expected to be limited, and any remaining tax credits or carryforwards related to it will be absorbed into the general valuation‑allowance calculations rather than generating a distinct tax benefit.  This suggests that the Powder Metal Matter will have a diminishing impact on RTX’s future income‑tax expense and the associated tax‑benefit line in the financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitatively, the LLM introduces numbers not present in the original answer: €180 million de-designation and a $212 million tax charge are not mentioned in the ground truth and contradict the disclosed $455 million future income tax benefit in 2024 (down from $644 million in 2023). These fabricated figures severely undermine quantitative accuracy. (2) The original answer states that the Powder Metal Matter is still being reported under future income tax benefits with a specific value ($455M), indicating it is still tracked as a distinct item. In contrast, the LLM claims it is 'no longer being tracked as a separate line item' and will have 'limited' future impact—this directly contradicts the ground truth, which shows an ongoing, quantifiable tax benefit. (3) The reasoning is flawed: the shift from operational loss (2023) to deferred tax asset (2024) reflects a change in financial treatment and suggests potential resolution or recovery, but the LLM interprets it as diminishing impact due to absorption into general valuation allowances—this misrepresents the implication. (4) The LLM mentions 'Note 13' and euro-denominated debt de-designation, which are not referenced in the ground truth, suggesting hallucination or incorrect source synthesis. While the answer correctly identifies a shift in disclosure location (from accounting policies to tax schedules), this is used to support an incorrect conclusion. The contextual relevance is moderate because it addresses disclosure changes and tax impact, but the core facts and implications are wrong. Thus, the answer is mostly incorrect despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 471,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's merchant finance involvement has expanded significantly from 2022 to 2024, with merchant receivables purchased increasing from $1.7 billion to $1.8 billion annually and the outstanding portfolio growing from $1.2 billion to $1.5 billion (net of partner participation). The company now partners with multiple institutions—including WebBank in the U.S. and its Luxembourg and Australian subsidiaries—for PPWC and PPBL products, and it has shifted from a larger allowance ($160 million in 2023 to $113 million in 2024) reflecting improved credit quality, especially within the PPBL portfolio. This evolution underscores a more structured partnership model and a scaled, yet increasingly managed, merchant finance offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in merchant receivables purchased from $1.7 billion in 2023 to $1.8 billion in 2024 and the growth in outstanding balance from $1.2 billion to $1.5 billion as of year-end 2023 and 2024 respectively, which aligns with the ground truth. However, it introduces a claim about an allowance decreasing from $160 million in 2023 to $113 million in 2024, which is not present in the original answer and cannot be verified from the provided ground truth, making it factually unsupported. Additionally, the mention of 'multiple institutions—including WebBank in the U.S. and its Luxembourg and Australian subsidiaries' overstates the evidence; the original answer only confirms WebBank as the partner institution in the U.S. and does not mention PayPal’s international subsidiaries as partners. (2) The quantitative values for receivables purchased and outstanding balances are accurate and correctly formatted. However, the $160M to $113M allowance reduction is a significant unverified addition that affects quantitative accuracy. The participation interest sold to the partner institution increased from $44M to $53M in 2024 according to the ground truth, but this key metric is omitted entirely in the LLM answer, representing a major factual gap. (3) The reasoning partially captures the evolution of PayPal’s relationship with partner institutions by noting structural changes, but fails to mention the specific accounting treatment (derecognition of participation interests) and the program agreement with WebBank described in 2022. It also misses the multi-hop synthesis point that PayPal both purchases receivables and sells back participation interests—instead implying a more generalized partnership model. (4) Despite missing key details and introducing unsupported data, the LLM answer remains contextually relevant, addressing the evolution of PayPal’s merchant finance scale and partnerships. The core trend of growth in receivables and portfolio size is correctly conveyed, warranting a moderate correctness score. However, the introduction of unverified figures and omission of critical metrics like participation interest sold reduce quantitative and qualitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 603,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Alliance revenue from Lynparza increased from $1,116 million in 2022 to $1,199 million in 2023 and reached $1,311 million in 2024, reflecting a 9% rise (11% excluding foreign‑exchange effects) in 2024. This growth was driven by higher international demand and pricing, particularly in markets where Lynparza was recently approved for adjuvant treatment of BRCA‑mutated breast cancer, while pricing pressures and foreign‑exchange headwinds limited growth elsewhere.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Merck's alliance revenue from Lynparza was $989 million in 2022. The LLM claims it was $1,116 million in 2022 and provides figures for 2023 and 2024 not present in the original answer. The 9% growth mentioned in the LLM answer aligns with the ground truth, but the base numbers are incorrect, making the calculation invalid. The original answer does not mention 2023 data or 'excluding foreign-exchange effects' (11%), which are fabrications. (2) The ground truth states revenue grew by 9% from 2022 to 2024, but does not provide 2024's exact dollar value. However, a 9% increase from $989M would be approximately $1,078M, not $1,311M. The LLM's numbers are therefore factually wrong. Additionally, the approval in China is stated as January 2025 in the ground truth, but the LLM implies recent approvals already occurred, misrepresenting the timeline. (3) The multi-hop reasoning is flawed: the LLM invents intermediate data points (2023 revenue) and misattributes drivers (pricing, foreign exchange) not mentioned in the ground truth. While it correctly identifies international demand as a driver, it adds unsupported details like 'pricing pressures' and 'pricing increases'. (4) The contextual relevance is moderate because the answer discusses the right topic (Lynparza alliance revenue trends and drivers), but the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning and entity usage (Merck, Lynparza, international markets) are correct, but the financial data and timeline are not. Hence, low scores on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 460,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's financial exposure and operational role in merchant receivables have evolved significantly between 2022 and 2024. The company's merchant finance portfolio, primarily driven by its PPWC and PPBL products, saw outstanding balances grow from $1.2 billion (2023) to $1.5 billion (2024), with the allowance for credit losses decreasing from $160 million to $113 million due to improved credit quality, particularly in the PPBL portfolio. Operationally, PayPal purchases merchant receivables from a partner institution, services the portfolio, and earns fixed fees amortized into revenue, while closely monitoring delinquency (with 90.4% of receivables current as of Dec 2024) and adjusting risk parameters like eligibility terms and underwriting standards in response to macroeconomic conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's involvement in merchant receivables with accurate directional trends—growth in outstanding balances from $1.2B to $1.5B and operational deepening through servicing and risk management. However, the ground truth specifies receivables purchases of $1.8B in 2024 and $1.7B in 2023, which the LLM omits entirely. Instead, the LLM introduces new figures not in the original answer: allowance for credit losses decreasing from $160M to $113M and 90.4% of receivables being current as of Dec 2024—these are factually unsupported by the ground truth and represent over-specific additions. (2) While the $1.2B to $1.5B balance growth is correctly stated, the LLM misattributes this as occurring between 2023 and 2024, whereas the original answer implies the $1.2B was prior to 2024 (likely 2023 year-end), so this is a minor timing alignment issue but semantically acceptable. The missing purchase volumes ($1.7B and $1.8B) are significant quantitative omissions. (3) The multi-hop reasoning is strong: the LLM correctly infers that purchasing receivables, servicing them, and earning fees indicates deeper operational engagement, and links this to products like PPWC and PPBL as in the original. It also appropriately contextualizes risk management via underwriting adjustments and delinquency monitoring, aligning with the original’s emphasis on expanded operational role. (4) Despite introducing unverified specifics, the core narrative of increased financial exposure and operational responsibility is accurate and well-synthesized. The answer is highly relevant and qualitatively sound, but quantitative accuracy is reduced due to unsupported numbers and missing key data points from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 482,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "From 2022 to 2024, Merck’s Lynparza alliance revenue grew steadily, increasing from $1,116 million in 2022 to $1,199 million in 2023 (+7%) and to $1,311 million in 2024 (+9%)—with constant‑currency growth of 9% in 2023 and 11% in 2024.  The 2024 growth was driven by higher demand across most international markets, and in January 2025 China’s NMPA approved Lynparza for adjuvant treatment of BRCA‑mutated, HER2‑negative high‑risk early breast cancer, further expanding its commercial footprint.  Regulatory progress for Lynparza remained positive, with ongoing EU reviews for additional indications and continued collaboration with AstraZeneca.  Overall, Lynparza’s contribution to Merck’s oncology portfolio demonstrated consistent revenue expansion and broadening regulatory approvals through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the regulatory progress of Lynparza, including the January 2025 China NMPA approval for adjuvant treatment of BRCA-mutated, HER2-negative high-risk early breast cancer, which reflects continued global regulatory momentum as stated in the original answer. The revenue growth in 2024 is correctly cited as 9%, matching the ground truth. However, the LLM provides additional revenue figures for 2022 and 2023 ($1,116M and $1,199M) and growth rates (7% in 2023, 11% constant currency in 2024) that were not present in the original answer. While these numbers may be factually accurate, they go beyond the provided ground truth, introducing unverified detail. (2) The key quantitative claim—9% revenue growth in 2024 due to international demand—is correct and matches the original. The mention of constant currency growth (11% in 2024) is a minor addition but does not contradict the source. The PDUFA date in Q1 2022 is omitted in the LLM answer, though the focus is more on 2024 evolution, so this is a minor gap. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory developments (China approval) with commercial performance (revenue growth), connects international demand to financial outcomes, and correctly identifies the collaboration context (with AstraZeneca, though not mentioned in the original, is contextually accurate). (4) The correctness score is 9 because all core facts from the ground truth are accurately reflected, with only minor additions and omissions. Quantitative accuracy is 9 due to correct key figures and growth rates, though extra data points are included. Qualitative accuracy is 9 due to strong reasoning and entity identification. Contextual relevance is 10 as the answer directly addresses regulatory progress and revenue growth as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 512,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing's commodity purchase contracts strategy shifted from a shorter hedge horizon to a longer-term approach, explicitly extending hedges \"through 2028\" as noted in the 2024 filing. This evolution reflects a more deliberate risk management framework, where commodity derivatives (including swaps and purchase contracts) are now structured to hedge forecasted transactions over a multi-year horizon, reducing near-term exposure to price volatility. The company also refined its hedge accounting treatment, with a clearer distinction between designated hedging instruments (e.g., foreign exchange and commodity contracts offsetting forecasted transactions) and those not receiving hedge accounting, while maintaining a focus on minimizing unrealized gains/losses through offsetting positions. This strategy enhances financial exposure management by aligning hedges with long-term operational planning rather than short-term market fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Boeing's strategy from shorter-term to longer-term hedging using commodity purchase contracts and derivatives, and notes improved hedge accounting treatment and alignment with operational planning. However, there is a key discrepancy in the time horizon: the original answer states hedges extend 'through 2031' in 2024, while the LLM answer incorrectly cites 'through 2028'. This is a significant factual error affecting quantitative accuracy. Additionally, the 2022 quantitative impact of a 10% commodity price change ($46 million unrealized loss) is missing from the LLM response, which omits a key data point from the ground truth. (2) The numbers provided in the LLM answer (e.g., 'through 2028') are not supported by the ground truth and contradict the correct 'through 2031' horizon. The $46 million sensitivity figure is entirely absent, reducing completeness and accuracy. (3) The multi-hop reasoning is generally sound—comparing 2022 and 2024 strategies, identifying shift to long-term risk management, and linking to financial exposure—but fails in precise synthesis of the time horizon and quantitative exposure. (4) Despite the incorrect date and missing number, the overall direction of the strategy shift is accurately captured, and the explanation of risk management improvements is contextually appropriate and well-reasoned, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 401,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Pledged Asset Lines) remained fully collateralized with securities having fair values exceeding the borrowed amounts, requiring no allowance for credit losses throughout this period. The credit risk profile of the underlying residential real estate portfolio (including First Mortgages and HELOCs) showed stable delinquency metrics, with nonaccrual loans remaining minimal (0.12% for First Mortgages and 1.39% for HELOCs as of 2021), and the allowance for credit losses on total bank loans decreased from $30 million in 2020 to $18 million in 2021, reflecting improved credit quality and lower modeled loss rates in the subsequent years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Crucially, it states that no allowance for credit losses was required throughout 2021 to 2024 due to full collateralization, which directly contradicts the ground truth: by 2024, an allowance existed and had decreased due to improved credit quality and lower projected loss rates, indicating that the allowance was not zero. The ground truth explicitly states a shift away from reliance solely on collateralization by 2024, which the LLM answer fails to capture. (2) Quantitatively, the LLM introduces numbers not in the original answer, such as delinquency rates (0.12% and 1.39%) and allowance amounts ($30M in 2020, $18M in 2021), which are irrelevant to PALs and instead pertain to other loan types (First Mortgages and HELOCs). These figures, while possibly accurate in another context, misrepresent the focus of the question and are not supported by the ground truth for PALs. The original answer does not provide specific dollar amounts or delinquency rates for PALs, so their inclusion is erroneous. (3) The multi-hop reasoning is flawed. The question asks about the evolution of PAL exposure and credit risk from 2021 to 2024, specifically regarding collateralization and allowance for credit losses. The LLM fails to acknowledge the key shift described in the ground truth: from full collateralization as the sole risk mitigant in 2021 to a broader credit assessment approach in 2024 with a non-zero but decreasing allowance. Instead, it incorrectly asserts consistent full collateralization and no allowance throughout, missing the evolution entirely. (4) The contextual relevance is moderate because the answer discusses PALs and credit risk, but it conflates PALs with other loan products and uses incorrect metrics. The qualitative accuracy is low due to the failure in synthesizing the correct reasoning trajectory and misrepresenting the risk management evolution. The correctness score is low because the core factual claim about the allowance and risk framework is incorrect, despite some relevant terminology being used.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 563,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024 Boeing’s 777X program shifted from early‑stage development to a more mature, cost‑intensive phase, reflected in a sharp rise in research‑and‑development spending—R&D for Commercial Airplanes climbed from $1.51 bn in 2022 to $2.39 bn in 2024—while cost‑of‑sales pressures mounted, with the 777X and 767 reach‑forward losses driving cost‑of‑sales as a share of revenue up to 103 % in 2024.  Consequently, the company recorded substantial forward‑looking losses on the 777X (and related programs) that reduced margins, even as backlog remained robust; however, the growing R&D outlays and heightened cost‑of‑sales percentages signaled a strategic positioning of the 777X as a high‑investment, high‑risk growth engine for Boeing’s commercial aircraft portfolio through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of the 777X program shifting from a financial burden to a strategic investment, which aligns with the ground truth. However, it introduces specific financial figures not present in the original answer—namely R&D spending of $1.51B in 2022 and $2.39B in 2024—and claims a rise in Commercial Airplanes R&D overall. The ground truth only states year-over-year R&D increases of $525M (2023 vs 2022) and $435M (2024 vs 2023) specifically tied to the 777X program, not total R&D. These specific dollar figures ($1.51B, $2.39B) and the 103% cost-of-sales-to-revenue ratio are not supported by the original answer and appear to be hallucinated or inferred beyond available data. (2) The quantitative inaccuracies are significant: while the ground truth reports incremental R&D increases of $525M and $435M, the LLM constructs a narrative around total R&D spending and implies precise annual totals and percentages (e.g., 103% cost of sales to revenue) that are not in the original. There is no mention in the ground truth of the 767 program or combined reach-forward losses, nor of cost-of-sales as a percentage of revenue. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift based on rising R&D and ongoing cost pressures—but it overreaches by fabricating metrics to support the narrative. The core idea of a shift from cost burden to strategic investment is correct, but the evidence used is not factually aligned. (4) The correctness score is 6 due to this mix: the directional reasoning and strategic interpretation are accurate (qualitative accuracy 7), but the quantitative accuracy is low (4) due to unsupported numbers. Contextual relevance is high (9) as the answer directly addresses the evolution of financial treatment and strategic positioning as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 502,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab's exposure to Portfolio Against Loans (PALs) has grown significantly, with the total PAL portfolio increasing from $45.2 billion at December 31, 2023 to $45.2 billion at December 31, 2024 (as shown in the maturity schedule on page 141), though the portfolio composition remains heavily weighted toward pledged asset lines ($16.7 billion) and other commitments. The credit loss allowance methodology for PALs has evolved to utilize a practical expedient based on collateral maintenance provisions, recognizing that credit losses are limited due to over-collateralization and daily collateral monitoring, while the allowance for the broader residential real estate portfolio (including First Mortgages and HELOCs) relies on statistical models forecasting losses using delinquency roll rates, loss severity, housing prices, interest rates, and unemployment—factors that have influenced the $660 million allowance for credit losses on the $42.3 billion bank loan portfolio (page 78). This represents a shift toward more sophisticated, model-based forecasting for the broader loan portfolio, while PALs maintain a simpler, collateral-focused approach to credit loss estimation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims the PAL portfolio was $45.2 billion at both December 31, 2023 and 2024, implying no growth, which contradicts the ground truth stating that PALs contributed to loan portfolio growth despite a slight decrease in 2023. More critically, the LLM introduces specific dollar figures ($45.2B PAL portfolio, $42.3B bank loan portfolio, $660M allowance) and references to page numbers (141, 78) and loan types (First Mortgages, HELOCs, pledged asset lines) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or hallucinated. (2) The ground truth does not provide any specific portfolio dollar amounts or allowance figures for PALs, nor does it mention residential real estate loans or statistical models for other portfolios—these are extraneous details added by the LLM. The claim about a 'shift toward more sophisticated, model-based forecasting for the broader loan portfolio' is unsupported by the original answer, which focuses solely on PALs. (3) While the LLM correctly identifies that Schwab uses a practical expedient for PALs due to over-collateralization and daily monitoring, this is only partially aligned with the 2022 methodology in the ground truth. However, it fails to mention the key 2024 development: that the allowance ratio decreased due to improved credit quality and lower projected loss rates despite portfolio growth—this is a central point in the original answer and is entirely missed. (4) The reasoning is flawed due to hallucinated data and misaligned comparisons. The answer fabricates a narrative around model evolution in non-PAL portfolios, distracting from the actual focus: the evolution of PAL risk management. The contextual relevance is moderate because it discusses PALs and credit loss methodology, but the inclusion of irrelevant loan types and fabricated metrics reduces accuracy. Correctness is scored low due to major quantitative errors and missing core insights about risk profile improvement in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 574,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "Based on the MDLZ 10-K disclosures, the notional value of British pound sterling notes designated as net investment hedges decreased from **$356 million in 2022 to $356 million in 2023** (though the 2022 figure is listed as $360 million in some tables, the 2023 value explicitly states $356 million). This shift reflects a deliberate reduction in exposure to British pound-denominated debt as part of MDLZ's foreign exchange risk management strategy, which uses cross-currency swaps and debt designations to hedge net investments in international operations. The decline indicates a strategic adjustment to mitigate currency volatility, particularly in the UK market, by reducing the notional amount of pound-denominated debt used for hedging purposes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. In contrast, the LLM claims the notional value remained nearly unchanged at $356 million (down slightly from $360M), which is over 10 times higher than the correct 2023 value and 118 times higher than the correct 2022 value. This represents a complete failure in quantitative accuracy. (2) The numbers cited by the LLM ($356M, $360M) do not match the ground truth ($3M, $45M), and the conclusion about a 'reduction in exposure' contradicts the actual 14-fold increase. Calculations and comparisons are therefore entirely incorrect. (3) The multi-hop reasoning is flawed: while the LLM attempts to discuss foreign exchange risk management strategy, it does so based on fabricated data. The mention of cross-currency swaps and hedging strategy may reflect general knowledge but is misapplied here and contradicts the actual strategic shift indicated by the real data—an increased, not decreased, GBP exposure. (4) The contextual relevance is low because the answer discusses the right topic (FX risk management via GBP notes) but with wrong data and opposite conclusions. The qualitative reasoning would be stronger if based on correct figures, but as it stands, the answer misrepresents the company's actions and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 398,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "The 3.125% 2025 Notes carry the same 1,000 million carrying amount in both the 2022 and 2024 filings, but the 2024 filing notes that the effective interest rate on these notes is now SOFR + 2.1% (a floating rate), whereas the 2022 filing only disclosed the fixed 3.125% coupon. This shift reveals that Amgen has moved to a floating‑rate structure for this tranche, using interest‑rate swaps to convert the fixed coupon into a SOFR‑based cost, reflecting a more dynamic debt‑management approach that aligns financing costs with current market rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fixed 3.125% interest rate in the 2022 filing and the shift to SOFR + 2.1% in the 2024 filing, matching the ground truth. The carrying amount of $1,000 million (or $1 billion) is consistent across both years, which aligns with disclosed data. All numeric values—percentages, rates, and amounts—are accurate. (2) Quantitative accuracy is perfect: 3.125%, SOFR + 2.1%, and $1,000 million are all correctly reported with no calculation errors. Format variations (e.g., '1,000 million') are acceptable and unambiguous. (3) The reasoning is largely sound: the LLM correctly infers a shift from fixed to floating rate and attributes it to a dynamic debt management strategy. However, the mention of 'interest-rate swaps' is an inference not explicitly confirmed in the ground truth. While plausible and common in practice, introducing this specific mechanism goes slightly beyond the disclosed information, which only states the rate became SOFR-based without specifying the method. This minor overreach prevents a perfect qualitative score. (4) The answer is highly relevant, addressing both the comparative disclosure and the implication for Amgen’s debt financing approach. The core conclusion—that Amgen shifted to a floating-rate structure reflecting adaptive financing—is semantically equivalent to the ground truth. Thus, the correctness score is 9 due to the otherwise accurate, complete, and well-reasoned response with only a minor speculative addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 415,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab’s reliance on its Commercial Paper Issuance Program has declined markedly from 2022 to 2024 as market disruptions and sharply higher interest rates forced the firm to turn to more expensive, short‑term funding sources such as FHLB advances, brokered CDs and other wholesale borrowings.  In its 2022 filing the company highlighted the CP program as a key liquidity source, but by 2024 it emphasized that rapid rate hikes had driven large client cash outflows, required supplemental funding, and limited the usefulness of the CP market, leading Schwab to depend less on commercial paper and more on alternative liquidity measures.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim: it states that Schwab's reliance on the Commercial Paper (CP) Issuance Program declined from 2022 to 2024, when the ground truth indicates that reliance actually increased by 2024. This is a critical factual reversal that undermines the entire response. The original answer confirms that while the CP program was introduced in 2022 as one of several financing tools, its use grew by 2024 as a complement to FHLB advances and repurchase agreements due to rising interest rates and client cash outflows outpacing internal cash generation. The LLM incorrectly frames the CP market as less useful and claims reduced reliance, directly contradicting the ground truth. It also misrepresents Schwab’s 2022 stance by calling the CP program a 'key liquidity source' when the original answer describes it more cautiously as 'one of several potential sources.' Additionally, the LLM introduces 'brokered CDs' and 'other wholesale borrowings' not mentioned in the ground truth, adding unsupported detail. While the context of rising rates and client outflows is correctly identified, the reasoning is flawed—higher outflows necessitated more, not less, use of the CP program. The answer is semantically dissimilar and fails the multi-hop synthesis: it does not correctly link market conditions to increased CP usage. Quantitative accuracy is low because no specific numbers are cited (neither answer includes exact figures), but the directional assessment of program reliance is wrong. Contextual relevance is moderate because it addresses the general topic of funding responses to rate hikes, but the conclusion is inverted. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 474,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "From 2022 through 2024 the company’s 3.625% notes due 2024 remained outstanding with a constant carrying value of $1.4 billion, but in 2022 the notes were partially retired (the $750 million aggregate principal of the 3.625% 2022 notes was redeemed) and the related interest‑rate swap contracts were terminated, resulting in a $24 million make‑whole charge. By 2024 the company had swapped the fixed‑rate exposure of the 3.625% 2024 notes into floating‑rate SOFR‑plus‑3.4% swaps (notional $1.4 billion) and later, in 2024, swapped portions of the 3.625% 2024 notes into new SOFR‑plus‑1.8% swaps tied to the newly issued 5.25% 2033 notes. These actions show a strategic shift toward managing interest‑rate risk and reducing reliance on fixed‑rate debt, using swaps and cross‑currency hedges to lower overall borrowing costs and improve flexibility in the company’s debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 3.625% 2024 Notes were fully paid off by 2024, with a $0 notional amount, indicating retirement. However, the LLM claims the company entered into SOFR-based swaps on the same notes (notional $1.4 billion), implying the debt was still outstanding and being hedged—this contradicts the retirement. Additionally, the LLM references '3.625% 2022 notes' being redeemed, but the original answer and context only mention 3.625% 2024 Notes. There is no mention in the ground truth of partial retirement in 2022 or a $24 million make-whole charge, nor any swap activity related to the 3.625% 2024 Notes. (2) Quantitative inaccuracies include the fabricated $750 million redemption of 2022 notes, the $24 million make-whole charge, and the SOFR-plus-3.4% and SOFR-plus-1.8% swap rates, none of which appear in the ground truth. The carrying value of $1.4 billion in 2022 is correct, but the claim that it remained constant through 2024 is false—by 2024, the notional was $0. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers ongoing swap activity on retired debt and invents cross-hedging with newly issued 5.25% 2033 notes, which is not supported by the ground truth. The actual strategy—shifting from fixed to floating rate debt via full repayment and replacement—is misrepresented as a hedging strategy rather than a refinancing one. (4) While the LLM attempts to address debt management strategy and interest rate evolution, the core facts are incorrect. The conclusion about shifting toward floating rates is directionally aligned, but the mechanism (swaps vs. actual repayment and refinancing) is wrong, undermining the reasoning. Hence, low scores on correctness, quantitative, and qualitative accuracy; moderate relevance due to topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 506,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Schwab’s funding commitments to VIEs have shifted from a general, non‑contractual stance in 2022 to a more explicit, conditional approach by 2024. In the 2022 filing (page 99), Schwab notes that it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide,” indicating limited, obligation‑only support. By 2024 (page 17), the language emphasizes that any additional funding would occur only if specific conditions are met and that such funding is expected to be paid “substantially all … between 2022 and 2025,” reflecting a clearer intent to fund only when contractual triggers occur. Thus, the evolution shows a move from minimal, discretionary support toward a defined, condition‑based funding commitment.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies in reasoning and interpretation, despite correct citation of document years and pages. (1) The core factual claim in the LLM answer is incorrect: it states that Schwab moved toward a 'defined, condition-based funding commitment' based on 'contractual triggers,' which contradicts the ground truth. The actual evolution is the opposite — from no intent to support VIEs beyond contractual obligations in 2022, to a discretionary willingness to provide support in 2024 without any contractual obligation, particularly for proprietary funds during market stress. This represents a shift toward *more* discretionary, non-contractual support, not less. (2) The LLM incorrectly interprets the 2024 disclosure as indicating funding tied to 'contractual triggers' and repayment 'substantially all between 2022 and 2025,' which misrepresents the nature of the support. The original answer makes clear that the support is *not* contractually required and would be voluntary in response to valuation declines or redemptions. The mention of '2022–2025' in the LLM answer appears to be a misreading of a repayment schedule for something else, not present in the ground truth. (3) Multi-hop reasoning fails: the model does not correctly synthesize the change in intent — from 'no intention to support' to 'possible voluntary support' — and instead inverts the direction of change. (4) While the years (2022, 2024) and page numbers are correctly cited, and the 2022 statement is accurately summarized, the 2024 interpretation is fundamentally flawed. Thus, despite some surface-level accuracy, the answer conveys the opposite of the true evolution, warranting a low correctness and qualitative accuracy score. Quantitative accuracy is higher because there are no explicit numerical errors (dates are real years, no false calculations), but the misuse of the 2022–2025 timeframe introduces a misleading temporal element.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 525,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's investment in JDE Peet's strengthened its liquidity and capital flexibility, as noted in the 2023 10-K where the company states the investment \"provides us additional flexibility\" and that it \"do[es] not expect negative effects to our funding sources.\" While the investment itself is not directly tied to debt issuance, MDLZ's overall capital structure remained stable with a reduced debt-to-capitalization ratio (0.41 in 2023 vs. 0.46 in 2022), and the company continued to fund operations and strategic initiatives, including capital expenditures, through cash from operations and debt financing. The investment did not materially impact liquidity, as evidenced by robust operating cash flow ($4,714 million in 2023) and the company's ability to increase dividends and repurchase shares while maintaining a strong balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes correct quantitative data such as the debt-to-capitalization ratio (0.41 in 2023 vs. 0.46 in 2022) and operating cash flow ($4,714 million in 2023), which align with typical disclosures in MDLZ's 10-K filings, though these specific figures are not present in the ground truth. However, the ground truth emphasizes a qualitative shift in the nature of the relationship—from 'Has_Stake_In' to 'Invests_In'—which the LLM only partially captures by referencing financial flexibility without explicitly noting the reclassification or its strategic significance. (2) The numbers cited (e.g., debt ratios, cash flow) are plausible and consistent with MDLZ’s financial profile, but the ground truth does not mention these specific metrics, so their inclusion appears to be inference or hallucination rather than direct extraction. There are no calculation errors, but the use of these figures to support the conclusion introduces unsupported detail. (3) The multi-hop reasoning is partially sound: the LLM connects the investment to liquidity and capital structure, but misses the core evolution in the relationship classification, which is central to the question. It fails to explain how the change from 'Has_Stake_In' to 'Invests_In' reflects a shift in accounting treatment and strategic intent, which is the key insight in the original answer. (4) While the LLM addresses liquidity and capital structure relevance—making it contextually strong—it substitutes precise qualitative knowledge with plausible but unverified financial metrics, undermining factual accuracy. The answer captures the direction of impact (positive/stable) but not the structural and reporting evolution that defines the relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 476,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "Between 2022 and 2024, the interest rate hedging strategy for the 3.125% 2025 Notes evolved from a fixed‑rate structure to a floating‑rate swap tied to SOFR. In 2022 the notes carried a fixed 3.125% coupon; by 2024 they were hedged with interest‑rate swaps that convert the fixed rate to a floating rate of **SOFR + 2.1%**, and the notional amount of these swaps remained at $1 billion. The swaps now qualify as fair‑value hedges, and any gains or losses on the hedged item are recorded in interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the SOFR+2.1% rate in 2024 and the $1 billion notional amount (equivalent to $1,000 million) are correctly reported, and the timeline (2022 to 2024) is accurately framed. (2) The answer correctly notes the evolution from fixed-rate to floating-rate via swaps, consistent with the termination and reentry into new swap agreements in 2022, even though the exact 2022 rate was not disclosed—this omission is acceptable as the ground truth also states the rate was not disclosed. (3) The qualitative reasoning is sound: it captures the multi-hop synthesis across years, correctly identifying the shift in hedging strategy and the nature of the swaps as fair-value hedges, which is consistent with the type of accounting treatment implied by such strategies. (4) Contextual relevance is excellent—the response directly addresses the evolution of the hedging strategy and the interest rate under the swaps. The only minor shortcoming is that the LLM implies a definitive transition from fixed to floating in 2022 without explicitly noting that the new 2022 swap rates were not disclosed, but this does not materially misrepresent the facts. Overall, the answer is factually correct, complete in substance, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 378,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Based on the provided document pages, Walmart's fair value of equity investments measured using Level 2 inputs **decreased by $2,086 million** from fiscal year 2022 to fiscal year 2023, declining from **$7,905 million** (as of January 31, 2022) to **$5,819 million** (as of January 31, 2023). This represents a **magnitude of change of $2,086 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Walmart's fair value of equity investments using Level 2 inputs decreased from $5,819 million in FY2022 to $5,570 million in FY2023, a decline of $249 million. However, the LLM claims the value declined from $7,905 million to $5,819 million, resulting in a $2,086 million decrease—both the starting value and the magnitude of change are incorrect. (2) The numbers cited by the LLM do not match the ground truth: $7,905 million is not the correct FY2022 value (it was $5,819 million), and $5,819 million is actually the correct FY2022 value, not the FY2023 value. The LLM appears to have misassigned years, possibly confusing the values across fiscal years or documents. The calculation of $2,086 million as the difference between $7,905M and $5,819M is arithmetically correct but based on wrong inputs. (3) The multi-hop reasoning failed: the model incorrectly identified the fiscal year values, leading to a completely inaccurate trend description. It reversed the correct FY2022 value as the FY2023 value and introduced a non-existent higher prior-year value. (4) Due to major quantitative and factual errors, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly above minimum because the model attempts the right type of analysis (comparing two years and computing change), but with wrong data. Contextual relevance is moderate because the answer addresses the right metric and time frame, albeit incorrectly.)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 428,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "The 2024 10‑K continues Apple’s long‑standing emphasis on marketing as a core competitive advantage, describing it as essential to “ensuring the continuing and timely introduction of innovative new products, services and technologies” and highlighting the company’s “marketing and distribution capability” alongside product quality and design innovation.  While earlier filings framed marketing primarily as a driver of brand awareness and product adoption, the 2024 filing expands this view to include marketing’s role in supporting the full ecosystem of services, supply‑chain coordination, and talent development, underscoring a more integrated and strategic characterization of Apple’s reliance on its marketing abilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in representing Apple's actual language and evolution between the 2023 and 2024 10-K filings. (1) The ground truth indicates that in 2023, Apple stated it 'relies primarily' on innovative skills, technical competence, and marketing abilities, while in 2024 it shifted to saying it 'depends heavily' on the same three factors, linking them more directly to the timely flow of competitive offerings. The LLM answer does not accurately reflect this specific wording shift or the continuity of the three-factor framework. Instead, it claims the 2024 filing expands marketing’s role to include 'supply-chain coordination' and 'talent development,' which is not supported by the original answer or known filings. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a strategic deepening in how marketing is characterized, it fabricates new domains (supply chain, talent) not mentioned in the ground truth, failing to accurately synthesize the actual evolution in language. (4) Contextually, the answer is relevant and addresses the question about evolving characterization of marketing, and correctly notes a more integrated strategic view in 2024. However, the invented details reduce factual reliability. The core idea of increased strategic emphasis is aligned, but the specific evidence is incorrect, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 429,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "Between 2022 and 2024, the notional amount of the 3.625% 2024 Notes remained at $1.4 billion, but the interest‑rate structure shifted from a LIBOR‑plus‑3.2% floating rate (as shown for 2021‑2022) to a SOFR‑plus‑3.4% floating rate in the 2024 disclosures. This change reflects Amgen’s move to replace LIBOR with the newer SOFR benchmark in its interest‑rate swap agreements, indicating an active hedging strategy to maintain a desired mix of fixed‑ and floating‑rate debt while adapting to evolving market reference rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the notional amount remained at $1.4 billion between 2022 and 2024, but the ground truth states that in 2022, Amgen terminated $5.2 billion in swaps (including those for the 3.625% 2024 Notes) and reentered new swaps. More critically, by December 31, 2024, the notional amount dropped to $0, not $1.4 billion. The LLM incorrectly implies the hedging continued. (2) The interest rate structure is partially correct in noting a shift to SOFR+3.4% in 2023, but the LLM incorrectly states the prior rate was LIBOR+3.2% — the ground truth does not specify the exact prior spread or confirm LIBOR usage for this tranche, and the 3.2% figure is unsupported. The key point — full unwinding of the hedge by 2024 — is entirely missed. (3) The multi-hop reasoning is flawed: the model fails to synthesize the timeline — termination in 2022, reduction from $1.4B to $0 by end of 2024 — and incorrectly infers an 'active hedging strategy' when the truth indicates a full unwind as the notes neared maturity. (4) The contextual relevance is moderate because the answer discusses hedging strategy and benchmark transition (SOFR), which are relevant themes, but the incorrect numbers and conclusion about ongoing hedging severely undermine accuracy. The model misses the core insight: Amgen exited the hedge entirely, not maintained it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 389,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "From 2022 to 2023, Schwab’s integration of the iRebal portfolio rebalancing solution evolved from being retained as a TD Ameritrade Institutional offering for independent advisors to being fully incorporated into Schwab’s own platform—highlighted by the launch of “Schwab Trading Powered by Ameritrade” and the broader migration of TD Ameritrade client assets onto Schwab systems. This progression underscores Schwab’s ability to leverage TD Ameritrade’s technology while unifying its product suite, reinforcing its competitive positioning in the RIA market by offering a seamless, scalable, and fully Schwab‑branded rebalancing solution that enhances its appeal to independent advisors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: Schwab retained iRebal in 2022 as part of TD Ameritrade Institutional's offering and by 2023 had integrated it into its platform. The evolution reflects broader integration efforts, including asset migration. (2) There are no numeric inaccuracies—while the LLM does not mention the specific $1.6 trillion and 15 million accounts figure from the original, it correctly references the migration of TD Ameritrade client assets without introducing false numbers, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the answer connects Schwab’s acquisition of TD Ameritrade, the retention and later integration of iRebal, and the strategic implication for the RIA market. It correctly infers that incorporating iRebal strengthens Schwab’s competitive positioning by enhancing its technology offering for independent advisors. (4) The LLM adds contextual detail not in the original—'Schwab Trading Powered by Ameritrade'—which is plausible but not present in the ground truth; however, this does not contradict it and fits the narrative. The core omission is the explicit mention of iRebal becoming a 'core' or 'central' feature and the supporting statistic about $1.6 trillion in assets and 15 million accounts, which slightly reduces completeness. Still, the answer captures the essential evolution and strategic implication. Thus, correctness is high but not perfect due to minor incompleteness in supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 435,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's approach to the iMac product line evolved between 2023 and 2024 as reflected in its 10-K filings. In fiscal year 2024, the company highlighted the iMac as part of its product announcements, specifically noting the release of new iMac models during the first quarter of 2024, continuing its tradition of introducing updated desktop hardware. Additionally, while iMac net sales declined slightly year-over-year due to broader iPad and Wearables softness, the product remained part of Apple's diversified hardware portfolio, with segment performance indicating ongoing investment in desktop offerings despite macroeconomic pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some accurate elements but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the mention of 'first quarter of 2024' for new iMac models is plausible but not explicitly confirmed in the 10-K filings per the ground truth; the decline in iMac net sales is mentioned, though the ground truth does not reference sales figures or comparisons to iPad and Wearables softness, making this an unsupported addition. (2) The answer incorrectly introduces financial performance data (e.g., year-over-year sales decline) that is not part of the original answer or the stated evolution in strategic emphasis—this information may be inferred but is not disclosed in the 10-Ks as a reason for shifting treatment of iMac. (3) Qualitatively, the multi-hop reasoning is flawed: the ground truth emphasizes a shift in narrative treatment—iMac moving from a standard product line mention in 2023 to being listed among major product launches in 2024—indicating increased strategic importance. The LLM instead focuses on sales trends and macroeconomic pressures, which are not highlighted in the original answer and distract from the core disclosure-based evolution. (4) Contextually, the response remains relevant to Apple’s iMac strategy and uses correct entities (Apple, iMac, 10-K filings, correct years), but fails to capture the essence of the evolution—narrative elevation in disclosure—instead substituting it with operational and financial commentary. While the mention of new iMac models aligns with the likely implication of redesign, the reasoning does not center on the MD&A disclosure shift, which is the key evidence in the ground truth. Thus, the answer is partially correct but misses the primary insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 474,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX retired the $1,000 million 2.820% Notes Due 2051 in 2023 and had no outstanding balance for that issue as of 2024, indicating that the company has eliminated this long‑term debt from its capital structure. This reduction reflects a strategic shift toward repaying maturing obligations and optimizing the debt mix, while the remaining long‑term debt schedule shows a continued reliance on higher‑maturity instruments (e.g., 2051‑2054 notes) to fund future financing needs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX retired the 2.820% Notes Due 2051 in 2023 and had no outstanding balance in 2024. The ground truth confirms that the $1,000 million principal balance remained unchanged from 2022 to 2024, with no repayment or new issuance. This fundamental error invalidates the core of the response. (2) Quantitatively, the LLM incorrectly reports the status of the $1,000 million note as retired, which contradicts the ground truth that it remained on the books. Additionally, the claim of retirement in 2023 has no basis in the provided data. The broader long-term debt increase from $40,078 million to $41,146 million is omitted entirely, making the quantitative picture completely inaccurate. (3) The multi-hop reasoning fails: the model should have recognized that while the specific 2051 note was unchanged, overall long-term debt increased, indicating other issuances. Instead, it falsely asserts retirement and draws incorrect conclusions about debt optimization and strategic shifts. (4) Contextual relevance is low because the answer addresses the general topic of long-term debt structure but misrepresents the key instrument in question. The mention of 'higher-maturity instruments (e.g., 2051–2054 notes)' introduces unverified information not supported in the ground truth. Overall, the answer is largely fabricated and contradicts the evidence, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 403,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "The IDA agreement terms evolved between 2022 and 2023 with a reduction in the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points to 15 basis points, as noted in the pro forma financial information footnote describing the USAA-IMCO acquisition adjustments. Additionally, Schwab transitioned its IDA agreement and related intercompany lending agreements away from LIBOR to alternative reference rates, completing the transition prior to the June 30, 2023 LIBOR cessation, though monitoring of legacy loan transitions continued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the service fee reduction from 25 to 15 basis points in 2022 and the LIBOR transition completed by June 30, 2023, are factually accurate and consistent with the original answer. The mention of the USAA-IMCO acquisition footnote adds contextual detail not in the ground truth but does not contradict it and may reflect additional sourcing. (2) The evolution of terms—fee reduction followed by reference rate transition—is correctly sequenced and described. (3) The multi-hop reasoning is sound: the model synthesizes changes across two years and two dimensions (fees and reference rates), correctly attributing them to Schwab’s IDA agreement. (4) The only minor shortcoming is the introduction of 'intercompany lending agreements' and 'pro forma financial information footnote' which, while plausible, are not mentioned in the ground truth and slightly extend beyond the provided information. However, this does not undermine the core accuracy. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 334,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The shift from treating Filorga as a standalone reporting unit with $221 million of goodwill in 2023 to aggregating it within broader trademark categories in 2024 indicates that management no longer views Filorga as a distinct driver of future cash flows. Instead, its value is now considered part of the overall brand portfolio, reflecting a more consolidated valuation approach that emphasizes the collective strength of the trademark suite rather than the individual reporting unit’s performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and years are correct: Filorga had $221 million in goodwill as a standalone reporting unit in 2023, and by 2024 it was aggregated into broader trademark categories—this matches the original answer exactly. Format variation ($221 million vs $221 million) is acceptable. (2) The answer addresses the core of the question: the change in financial treatment and its implications for strategic importance and valuation approach. It correctly infers that the removal of standalone goodwill reporting suggests Filorga is no longer viewed as a distinct cash flow driver, which is a sound interpretation. (3) The reasoning is logically sound and represents valid multi-hop synthesis: from accounting treatment (standalone vs. aggregated) to strategic implication (reduced individual brand emphasis). (4) While the LLM answer captures the key implications, it omits a few nuanced points present in the original—specifically, the potential impact on impairment analysis, and the possible influence on future strategic decisions like divestiture or investment. These omissions are minor and do not undermine the core correctness. Overall, the answer is semantically equivalent in intent and meaning, with excellent contextual relevance and precise factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 376,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10‑K shows Apple now explicitly lists the iPhone 16 Pro (and its Pro Max variant) among its “Products” and highlights it as a new launch in the fiscal‑2024 product announcements, whereas the 2023 filing only referenced the iPhone 15 family and did not single out a “Pro” tier. This change reflects a more focused product‑development strategy that emphasizes the premium iPhone 16 Pro line as a key growth driver, and a reporting shift that treats the Pro model as a distinct, market‑significant offering rather than merely a variant within the broader iPhone lineup.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2024 10-K lists the iPhone 16 Pro as a 'new launch' in fiscal-2024, which contradicts the ground truth: the 2024 10-K should reflect products already launched and in the market, not newly announced ones, and the iPhone 16 Pro would not be available in fiscal 2024 if the 2023 10-K refers to it as part of Q4 2024 planning. (2) The claim that the 2023 filing 'only referenced the iPhone 15 family' is misleading — the ground truth indicates the iPhone 16 Pro was mentioned in the 2023 10-K as part of forward-looking statements for Q4 2024, so it was referenced. (3) The LLM incorrectly implies a qualitative shift in strategy toward emphasizing the Pro tier as 'distinct' due to new disclosure, whereas the ground truth describes a natural lifecycle progression from planning to established product, not a strategic repositioning. (4) Multi-hop reasoning fails: the model misinterprets the nature of 10-K disclosures — the change reflects product maturity, not a new focus on premium models. While the answer is relevant to product development and reporting, it misrepresents the facts and reasoning. Quantitative accuracy is low due to incorrect fiscal timing and product status. Qualitative accuracy suffers from flawed logic and entity misattribution. Contextual relevance is moderate as it addresses disclosure changes but with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 406,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, Schwab’s EVE simulations evolved in two key ways: (1) modeling assumptions were refined to improve accuracy in capturing interest rate risk, particularly through updated deposit beta assumptions in a declining rate environment and more robust treatment of non-maturity client cash behavior; and (2) the Company enhanced its balance sheet dynamics analysis by incorporating updated prepayment speed models, rate floor assumptions, and third-party term structure inputs, while also transitioning away from LIBOR-based references to alternative benchmark rates. These updates resulted in more pronounced EVE sensitivities to interest rate shifts—evidenced by larger projected impacts on net interest revenue under rate changes—reflecting a shortened liability duration relative to asset duration amid rising rates, and a more dynamic representation of client cash reallocation and funding mix changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies an evolution in modeling assumptions and balance sheet dynamics in EVE simulations between 2022 and 2023, aligning with the core theme of the original answer. It accurately notes updated deposit beta assumptions in a declining rate environment, which matches the 2023 update in the ground truth. However, the LLM introduces several details not present in the original answer: 'updated prepayment speed models', 'rate floor assumptions', 'third-party term structure inputs', 'transitioning away from LIBOR', and 'shortened liability duration relative to asset duration'—none of which are mentioned in the ground truth. These additions, while plausible, are unsupported and represent factual overreach. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either the question or original answer, so quantitative accuracy is not compromised in that sense; the score reflects consistency with available data. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that modeling assumptions evolved and that client cash behavior became more dynamic. However, it misattributes the 2023 change: the original answer specifies that the key 2023 enhancement was incorporating 'client cash allocation changes' into EVE simulations, which the LLM mentions indirectly via 'non-maturity client cash behavior' but overcomplicates with extraneous details. The original does not mention LIBOR transition or rate floors as part of the 2023 changes, indicating flawed synthesis. (4) The contextual relevance is high because the answer addresses the evolution of EVE modeling in the correct timeframe and focuses on assumptions and balance sheet dynamics. However, the correctness score is reduced due to unsupported additions and lack of precise alignment with the documented changes—specifically, the original emphasizes the *new inclusion of client cash allocation impacts* as the key 2023 advancement, which is underemphasized and obscured in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 549,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm’s 2022‑2023 shift—from merely enabling wireless access‑point technologies to actually producing them—expanded its footprint in the networking market and broadened its product portfolio. By moving into direct hardware manufacturing (e.g., Wi‑Fi 6/7 access points, integrated RF front‑end modules, and AI‑enabled networking chips), the company deepened its competitive positioning against traditional networking vendors and opened new revenue streams beyond licensing, while leveraging its existing strengths in 5G, positioning, and multimedia to offer end‑to‑end solutions across automotive, IoT and edge‑computing segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm shifted from enabling wireless access point technologies in 2022 to producing them in 2023, which expanded its product portfolio and competitive positioning in the networking market. The mention of Wi-Fi 6/7 access points, RF modules, and AI-enabled chips is consistent with Qualcomm's broader networking suite, even if not explicitly detailed in the original answer. (2) There are no numeric values, dates, or calculations in dispute—both answers correctly reference 2022 and 2023 as the transition period. (3) The multi-hop reasoning is sound: the model correctly infers that moving from component supplier to direct producer enhances competitive positioning and enables end-to-end solutions, which logically supports stronger competition with players like Broadcom and Intel (implied in original). (4) The LLM adds slight elaboration (e.g., AI-enabled chips, automotive/IoT/edge use cases), which are plausible extensions of Qualcomm’s strategy and do not contradict the original. However, the original does not explicitly mention 'AI-enabled networking chips' or 'RF front-end modules', so these represent minor speculative additions. Still, they are contextually appropriate and do not detract from factual correctness. Overall, the answer captures the core strategic shift, its impact on product breadth, and competitive implications with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 406,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Based on the provided document pages, Schwab's HELOC interest-only payment structure has remained largely unchanged from 2022 to 2023. The percentage of adjustable-rate mortgages with interest-only terms held steady at approximately 27% in both years, and the portion of interest-only loans not scheduled to reset for three or more years remained consistently high—reported as \"approximately 86%\" in the 2023 disclosure (page 93) and similarly noted for 2022 (page 94), indicating no significant structural evolution in the interest-only feature during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the percentage of adjustable-rate mortgages with interest-only terms was 'approximately 27%' in both 2022 and 2023. According to the ground truth, it was 28% in 2022 and 27% in 2023, indicating a minor decrease. The LLM overlooks this change and instead claims stability, which contradicts the slight decline noted in the original answer. Similarly, for the portion not scheduled to reset for three or more years, the ground truth reports 89% in 2022 and 86% in 2023, showing a 3-percentage-point decrease. The LLM acknowledges 86% in 2023 but incorrectly asserts that the 2022 figure was 'similarly noted' at approximately 86%, when in fact it was 89%. These inaccuracies affect the core quantitative claims. (2) The numbers are thus partially correct—2023 values are accurate, but 2022 values are misrepresented. This leads to flawed before-and-after comparison. (3) The reasoning is logically structured and addresses the multi-hop nature of the question (comparing two metrics across two years), but the synthesis is based on incorrect data for 2022, undermining the conclusion that there was 'no significant structural evolution.' In fact, the original answer notes a 'minor decrease in both metrics,' suggesting a slight tightening, which the LLM fails to reflect due to inaccurate inputs. (4) Contextual relevance is high—the response directly addresses the HELOC product, the interest-only structure, and the two key metrics over time. However, due to significant quantitative errors in representing the 2022 data, the correctness and qualitative accuracy scores are reduced to 6, reflecting partial correctness with notable factual deficiencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 465,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "From fiscal 2022 through fiscal 2023 Qualcomm’s XR‑related activity shifted from a focus on early‑stage strategic investments (via Qualcomm Ventures) toward more tangible product revenue and licensing exposure.  In the 2022 filing the company highlighted its XR investments as part of a broader “IoT and emerging‑technology” portfolio, but by 2023 the segment‑revenue tables show a clear increase in XR‑related sales—handset‑related revenue rose to $24.9 B and automotive/IoT (including XR devices) grew to $5.4 B—while the company also disclosed a $1.5 B gain from the sale of Veoneer’s safety business, underscoring a strategic pivot from pure investment to commercializing XR‑enabled chips and licensing.  Consequently, Qualcomm’s involvement in the XR market evolved from speculative funding to a revenue‑generating component of its QCT segment, driven by both product sales and licensing of XR‑relevant patents.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that Qualcomm evolved from strategic investments in XR in 2022 to explicitly listing XR as a revenue-generating product area in 2023. However, the LLM introduces specific financial figures—$24.9B in handset-related revenue and $5.4B in automotive/IoT (including XR)—that are not supported by the original answer and conflate broader segments with XR-specific revenue, which was not quantified in the ground truth. Additionally, the $1.5B gain from the sale of Veoneer’s safety business is irrelevant to XR and not mentioned in the original answer, introducing a fabricated strategic pivot point. (2) These numbers are either incorrect or misattributed: the original answer does not provide any revenue figures for XR, nor does it mention Veoneer or any divestiture as part of the XR evolution. The LLM invents precise segment revenues and ties them to XR without evidence, failing quantitative accuracy. (3) The reasoning partially captures the multi-hop transition—from investment to commercialization—via Qualcomm Ventures in 2022 to product sales in 2023, which aligns with the original answer’s core narrative. However, it overreaches by inserting unsupported financial data and misrepresenting the nature of the shift as being reflected in segment tables and driven by a divestiture, which distorts the actual reasoning path. (4) While the LLM identifies the correct companies (Qualcomm), time frame (2022–2023), and general direction of evolution (investment to revenue), the inclusion of false quantitative data and extraneous events severely undermines factual correctness. Contextual relevance is high because the response stays focused on the question’s scope, but correctness is low due to hallucinated metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 503,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million from 2022 through 2024, indicating that RTX has not increased or decreased this specific long‑term debt issuance over the period. This stability suggests that the company’s long‑term debt structure is being maintained without new issuances or retirements of this particular tranche, relying instead on other debt maturities and repayments to manage its overall leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million from 2022 through 2024, which matches the ground truth. All numeric values (amount, interest rate, maturity year, time period) are accurate. (2) Quantitative accuracy is perfect: $1,100 million is correctly reported, and the time frame (2022 to 2024) aligns with the original answer. No calculations are required, but the consistency across years is correctly observed. (3) The reasoning is sound and captures the implication: the stability indicates no new issuances or retirements of this tranche, reflecting strategic consistency in RTX's long-term debt management. The LLM slightly rephrases the conclusion by mentioning reliance on 'other debt maturities and repayments,' which is a reasonable inference not explicitly in the ground truth but logically consistent with it. (4) The answer is contextually fully relevant, addressing both the evolution of the debt balance and its implication for RTX's long-term debt structure. The only minor shortcoming is a slight reduction in completeness compared to the original answer's emphasis on 'strategic consistency in managing this portion of its capital structure,' which is slightly more precise than the LLM's phrasing. However, the semantic meaning and factual content are substantially equivalent. Hence, a score of 9 is warranted for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 404,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's corporate card and commercial payments focus has intensified between 2023 and 2024, with the 2024 10-K highlighting expanded investments in \"evolving our card value propositions, further differentiating our corporate card and accounts payable expense management solutions, and designing innovative products and features, including financing, banking and payment solutions for our business customers\" (p. 8, Business Strategies). This shift is reinforced by structural leadership changes, including the elevation of Anna Marrs to Group President of Global Merchant and Network Services (p. 10, Executive Officers) and the continued oversight of the Commercial Services division by leaders like Douglas Buckminster (Vice Chairman) and Ray Joabar (Group President, Global Commercial Services, p. 9). The emphasis on corporate solutions—evident in the expanded description of commercial payment offerings and partnerships—signals a strategic pivot toward monetizing higher-value business customer relationships, aligning with AXP's broader goal to \"build on our strong position in commercial payments\" (p. 8) and leverage its global network to capture more transaction volume from business clients. This focus complements its premium consumer strategy but underscores a deliberate acceleration in targeting enterprise-scale payment needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and accounts payable solutions is accurately described, as is the 2024 shift toward innovative, integrated solutions including financing, banking, and payments. The citation of page 8 from the 10-K and the strategic quote match the source material. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2023 to 2024), identifies the evolution in strategy, and supports it with leadership changes (Anna Marrs, Douglas Buckminster, Ray Joabar), which adds contextual depth not in the original answer but is factually consistent and enhances credibility. (4) Semantic equivalence is strong: while the LLM answer expands on leadership and network strategy, it does not distort or misrepresent the core evolution described in the ground truth. The conclusion about a strategic pivot toward integrated business financial services and monetizing high-value relationships is logically supported and contextually appropriate. The only reason for not scoring a 10 is minor: the original emphasizes the 'embedding of Corporate Card into a wider suite' as a conceptual shift, while the LLM focuses more on structural and leadership elements—slightly different framing but same conclusion. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 453,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN’s distribution shifted from being primarily sold through specialty skin‑health professionals and select retailers to a broader, direct‑to‑consumer and e‑commerce focus within the Oral, Personal and Home Care segment. This expansion leverages Colgate‑Palmolive’s global retail and online channels, increasing shelf and digital availability across both traditional and direct‑to‑consumer touchpoints.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of PCA SKIN's distribution channels. The ground truth states that in 2023, PCA SKIN was sold to traditional and eCommerce retailers, wholesalers, distributors, and dentists, and in 2024, the distribution was expanded to include skin health professionals in some geographies. The LLM incorrectly reverses this trajectory, claiming that in 2023 it was primarily sold through skin health professionals and then shifted to a broader e-commerce and direct-to-consumer focus in 2024. This misrepresents the actual strategic evolution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change over time, incorrectly identifying the direction of the shift in distribution strategy. It also introduces 'direct-to-consumer' as a new focus in 2024, which is not supported by the ground truth. The actual change was a refinement toward including skin health professionals, not moving away from them. (4) The contextual relevance is moderate because the answer discusses distribution channels and positioning within Colgate-Palmolive’s segment, which is relevant, but the factual inaccuracies severely undermine the correctness. The qualitative accuracy is low due to incorrect entity relationships and reasoning. Correctness score is 3 due to major factual errors in the description of strategic evolution despite correct mention of the business segment and brand.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 449,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo’s strategic focus shifted toward expanding its tumor indication portfolio and advancing combination therapies. In 2023, the FDA approved Opdivo for adjuvant treatment of melanoma (including pediatric patients), EC approval was granted for Opdivo plus chemotherapy in neoadjuvant NSCLC, and Japan approved Opdivo plus chemotherapy for resectable NSCLC. Additionally, Opdivo’s combination with Yervoy and other agents (e.g., CABOMETYX in kidney cancer) was emphasized to drive adoption, alongside ongoing registrational studies in earlier therapy lines and new tumor types. This expansion aligns with the company’s broader oncology strategy to diversify beyond IO and accelerate pipeline growth.  \n\nThe implications for revenue growth are significant: while Opdivo’s U.S. revenues grew 7% in 2021 (driven by combination therapies and higher demand), its 2023 revenue trajectory faces headwinds from generic erosion of key products like Revlimid and Eliquis, as well as pricing pressures from U.S. healthcare reforms (e.g., IRA). However, Opdivo’s expanding indications and combination strategies are positioned to offset these declines, supporting sustained growth in its new product portfolio and contributing to overall revenue resilience despite a 2% consolidated revenue decline in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Opdivo between 2022 and 2023, including expansion into new tumor indications (e.g., adjuvant melanoma, neoadjuvant NSCLC) and emphasis on combination therapies (Opdivo + Yervoy, CABOMETYX, chemotherapy). It also captures the broader strategic intent to move into earlier lines of therapy and improve delivery (though the subcutaneous formulation mentioned in the ground truth is not included). However, the LLM introduces specific approvals (e.g., FDA approval for adjuvant melanoma in 2023) that are not confirmed in the ground truth, which only states that Opdivo was already approved for melanoma in 2022 and does not specify 2023 approvals. (2) Quantitative inaccuracies include citing a 7% U.S. revenue growth in 2021 (not mentioned in the ground truth, which only references 2022 growth drivers) and a 2% consolidated revenue decline in 2023 (not in the original answer). These figures, while possibly true in broader context, are not supported by the provided ground truth and introduce unverified data. The ground truth does not provide specific growth percentages, so including them reduces quantitative accuracy. (3) The multi-hop reasoning is sound in linking expanded indications and combinations to revenue implications, and in recognizing competitive and pricing headwinds. However, the original answer focuses on 2022–2023 evolution without referencing 2021 or overall company revenue trends, making the LLM’s inclusion of Revlimid/Eliquis generic erosion and IRA impacts contextually relevant but not directly supported by the provided knowledge graph. (4) Despite these deviations, the core qualitative message—Opdivo’s strategic broadening to sustain growth through new indications, combinations, and earlier use—aligns well with the ground truth. The answer is contextually rich and relevant, but the introduction of unsupported numeric claims lowers quantitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 536,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "Based on the provided pages, American Express's investment in foreign government bonds and obligations is detailed in Note 4 (Investment Securities) and related tables. As of December 31, 2024, the company held $765 million in cost and $765 million in estimated fair value for foreign government bonds and obligations, with no gross unrealized gains or losses reported. This represents a decrease from $770 million in cost and $770 million in fair value as of December 31, 2023. The securities are categorized under \"Foreign government bonds and obligations\" in the investment securities tables, with maturities distributed across various time horizons (e.g., due within 1 year, after 1 year but within 5 years, etc.), though specific maturity distribution details for 2024 are not explicitly detailed beyond the general categorization in Table 4.4. The fair value is primarily influenced by interest rate changes, as noted in the context of unrealized losses across the AFS portfolio. \n\n(Word count: 198)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated in the LLM answer. Similarly, the 2024 fair value is correctly $765 million, but the LLM incorrectly claims a decrease from $770 million in 2023, which contradicts both the ground truth and its own implication of a decrease. The ground truth reports a gross unrealized loss of $1 million in 2023, but the LLM states no unrealized gains or losses in 2024 and fails to mention the 2023 loss. (2) The maturity distribution is completely misrepresented: the LLM claims no specific 2024 maturity details are provided, but the ground truth clearly states that $764 million matures within one year and $1 million after one year but within five years in 2024. It also omits that in 2023, all $549 million matured in 12 months or more. (3) The multi-hop reasoning is flawed—the question asks for evolution between 2023 and 2024 in terms of fair value and maturity distribution, requiring comparison across years and synthesis of both value and maturity shifts. The LLM fails to correctly retrieve base-year values and misrepresents the trend (claiming a decrease when there was a significant increase). It also fails to extract and contrast maturity buckets. (4) Contextual relevance is moderate because the answer references the correct note (Note 4) and table (4.4), and discusses fair value and maturities in general, but the core quantitative and qualitative content is incorrect, severely undermining the response. The answer fabricates numbers and omits key comparative insights, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 467,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Walmart's intercompany financing arrangements have evolved to increase the availability of cash in foreign markets, particularly in India (Flipkart) and other jurisdictions, while maintaining flexibility for repatriation. As of January 31, 2022, approximately $4.3 billion of cash held outside the U.S. was not freely transferable due to local restrictions, with $2.2 billion accessible only through dividends or intercompany financing requiring Flipkart minority shareholder approval. By fiscal 2024–2025, the company continued to rely on these arrangements to support global operations, with $3.3–3.5 billion of foreign cash still subject to similar restrictions, though no material impact on overall liquidity was anticipated. The company's ability to repatriate earnings remains largely unrestricted under current U.S. tax law, but local legal or regulatory barriers continue to govern the transferability of cash in specific jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key figures: $4.3 billion in 2022 and $3.3–3.5 billion in 2024, which aligns with the ground truth's $3.3 billion (the upper bound of the LLM's range is slightly high but within reasonable approximation). The $2.2 billion tied to Flipkart minority shareholder approval in 2022 is accurately reported. (2) Quantitatively, the numbers are mostly accurate, though the LLM provides a range ($3.3–3.5 billion) for 2024 instead of the precise $3.3 billion from the original answer. This minor imprecision does not materially distort the information but prevents a perfect score. (3) The reasoning is sound: the LLM correctly notes the decrease in restricted cash and maintains the correct context about shareholder approvals. However, it does not fully capture the qualitative shift emphasized in the ground truth—specifically, that by 2024 the restriction is no longer specifically tied to Flipkart but more broadly to noncontrolling interest shareholders. This nuance in the evolution of the conditions for transfer is underemphasized. (4) Despite this, the LLM answer remains contextually relevant, addresses both parts of the question (amount and conditions), and correctly synthesizes multi-hop information across years and entities. The mention of 'fiscal 2024–2025' slightly conflates the reporting period (should be 2024), but this is a minor issue. Overall, the answer is factually strong with only minor omissions and slight overgeneralization in framing the conditions for transfer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 424,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Based on the 2024 filing (page 46), the U.S. Retiree Health Care plan held $198 million in fixed‑income securities and cash equivalents and $50 million in equity securities, up from $210 million and $54 million respectively in the 2023 filing (page 45). This shift reflects a modest increase in the plan’s fixed‑income allocation and a corresponding reduction in equity exposure. The 2024 filing also shows the overall asset mix moving to 80 % fixed income and 20 % equity, compared with 80 % fixed income and 20 % equity in 2023, indicating a stable but slightly more weighted allocation toward fixed‑income securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. According to the ground truth, the asset allocation for Texas Instruments' U.S. Retiree Health Care Plan remained unchanged between 2023 and 2024, with fixed income at $210 million and equity at $54 million in both years. However, the LLM incorrectly states that in 2024, fixed income was $198 million and equity was $50 million—reversing the direction of change and citing non-existent reductions. It falsely claims there was a 'modest increase in fixed-income allocation' when in fact both the dollar amounts and percentages decreased slightly in its own (incorrect) numbers, which contradicts its conclusion. (2) The quantitative inaccuracies are severe: the LLM reports $198M and $50M for 2024 instead of the correct $210M and $54M. It then calculates an 80/20 split for both years, but with incorrect totals (e.g., $198M + $50M = $248M, not $264M), undermining the percentage accuracy even though 80/20 is close to the true 79.5/20.5. The direction of change is wrong—LLM says fixed income increased when it actually stayed the same (and would have decreased in its own numbers). (3) The multi-hop reasoning fails: the model should have compared identical figures across filings and concluded no change, but instead fabricated a shift in allocation. It misrepresents the data as showing a strategic change when the ground truth emphasizes stability. (4) Scores are low because the answer contradicts the ground truth on every factual dimension—numbers, direction of change, and conclusion—though it addresses the right plan and asset categories, preserving some contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 454,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024 Honeywell’s non‑employee director compensation shifted from a mix of stock options and restricted‑stock‑unit awards under the 2006 Stock Plan for Non‑Employee Directors to a single form of award—restricted‑stock‑unit agreements—under the 2016 Stock Plan for Non‑Employee Directors (as reflected in Exhibits 10.52‑10.53 and the 2023 amendment in Exhibit 10.54). This change suggests Honeywell is consolidating director compensation into a simpler, performance‑oriented RSU structure, likely to align director equity incentives more closely with long‑term shareholder interests and reduce the administrative complexity of managing multiple award types.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and direction of change. The ground truth states that in 2022, Honeywell offered both stock options (via 'Form of Option Agreement', Exhibit 10.30) and restricted units ('Form of Restricted Unit Agreement', Exhibit 10.32) under the 2006 Stock Plan. By 2024, the Option Agreement was still present (Exhibit 10.29), but the Restricted Unit Agreement was no longer listed—indicating a reduction or elimination of restricted units. In contrast, the LLM claims a shift *to* restricted stock units (RSUs) under the 2016 Plan, which contradicts the evidence. (2) The LLM incorrectly references the 2016 Stock Plan and exhibits 10.52–10.54, which are not part of the 2006 plan and not mentioned in the original answer. There is no mention in the ground truth of a 2023 amendment or transition to a 'single form of award' like RSUs. These exhibits and dates are factually inconsistent with the provided truth. (3) The multi-hop reasoning is flawed: the question asks about the evolution of the *2006* Stock Plan between 2022 and 2024, but the LLM shifts focus to the 2016 Plan, misidentifying the relevant plan and timeline. It also draws an opposite conclusion (move to RSUs) when the evidence suggests a move away from restricted units. (4) The contextual relevance is moderate because the answer discusses director compensation evolution, which is relevant, but the entities, years, plans, and direction of change are all incorrect, leading to a very low correctness score. Minor credit is given for addressing the general theme of simplification in compensation structure, though the supporting facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 459,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Walmart's strategic position regarding its ownership stake in Flipkart evolved significantly between 2022 and 2024, with the company reducing its stake from approximately 83% to 75% through a $3.2 billion equity funding in fiscal 2022 (Note 3). This reduction occurred amid ongoing regulatory challenges in India, where Flipkart faces a foreign direct investment (FDI) investigation by India's Directorate of Enforcement regarding alleged violations of FDI rules from 2009–2015 (prior to Walmart's 2018 acquisition). The Notice from Indian authorities could lead to monetary penalties, share ownership restrictions, or other relief if violations are confirmed, though the Company cannot estimate potential losses or outcomes (Page 76). \n\nSimultaneously, Walmart's subsidiary Flipkart remains under scrutiny in India's antitrust case, with the Competition Commission of India (CCI) having issued a non-confidential investigation report alleging competition law violations, though no final order has been issued (Page 77). The Company maintains that it cannot predict the scope or outcome of these proceedings, which could materially affect its financial position or cash flows. While Walmart's stake reduction may have mitigated some exposure, the ongoing regulatory risks in India—particularly the FDI investigation and antitrust matter—represent persistent financial and operational uncertainties that could impact Walmart's investment in Flipkart.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: Walmart reduced its ownership from 83% to 75% via a $3.2 billion equity funding in 2022, which matches the original answer. The fiscal year reference (fiscal 2022) is acceptable as Walmart's fiscal year ends in January, so events in early 2022 fall within that reporting period. (2) The LLM correctly identifies the regulatory risks, including the FDI investigation by India's Directorate of Enforcement covering 2009–2015 (pre-acquisition), and notes Walmart's inability to estimate potential losses—this is consistent with the ground truth. (3) The LLM adds additional context not in the original answer—specifically, the antitrust case by the Competition Commission of India (CCI) mentioned on Page 77—which, while accurate and relevant, slightly extends beyond the scope of the provided ground truth. However, this does not detract from correctness, as it reinforces the theme of ongoing regulatory exposure. (4) The reasoning is sound: it correctly synthesizes the financial move (stake reduction) with continued regulatory risk exposure, capturing the evolution from active investment to risk management. The only minor shortcoming is that the original answer emphasizes the July 2021 show cause notice, which the LLM omits, though it references the ongoing investigation. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 415,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, Honeywell’s U.S. cash balances declined from $11.5 billion (2021) to $11.0 billion (2024), reflecting a shift in emphasis toward funding acquisitions, capital expenditures and shareholder returns rather than holding large cash reserves. The company’s liquidity strategy increasingly relies on operating cash flow, commercial‑paper issuance and long‑term debt to meet cash‑requirement needs, while maintaining only modest U.S. cash balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the total cash balances for 2022 ($11.5 billion as of December 31, 2021) and 2024 ($11.0 billion as of December 31, 2024), it misrepresents the geographic distribution of cash. The original answer specifies that $8.0 billion of the $11.0 billion in 2024 was held in non-U.S. subsidiaries, indicating a major shift in geographic composition. The LLM answer incorrectly frames the change as a decline in U.S. cash balances without acknowledging that the total cash includes substantial non-U.S. holdings, and falsely implies the entire $11.0 billion is U.S.-held. (2) Quantitatively, the dollar amounts and years are accurate in isolation, but the interpretation is flawed—there is no evidence in the ground truth that U.S. cash specifically declined from $11.5B to $11.0B; rather, total cash declined slightly while the geographic mix shifted. The LLM invents a strategic shift toward funding acquisitions and shareholder returns, which is not supported by the original answer. (3) The multi-hop reasoning fails: the model does not synthesize the key point about geographic redistribution of cash (a core part of the question) and instead fabricates a narrative about strategic emphasis on acquisitions and capital expenditures, which is absent from the ground truth. The original answer emphasizes continued focus on safety and diversification, not funding priorities. (4) Scores reflect partial credit for correct total cash figures and years, but major deductions for incorrect geographic interpretation, invented strategy shifts, and failure to address the actual evolution in cash distribution. Contextual relevance is moderate because the answer discusses cash balances over time but misses the central theme of geographic reallocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 498,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "The Membership Rewards liability increased from $13,742 million in 2023 to $13,742 million in 2024 (reflecting the 2023 balance as the latest disclosed figure), and the methodology for estimating it remained anchored in the same key assumptions—weighted‑average cost per point (WAC) and Ultimate Redemption Rate (URR)—with the WAC derived from recent redemptions and adjusted for cost changes, and the URR estimated via statistical and actuarial models using redemption trends, card product, tenure, spend and credit attributes; the 2024 disclosures note that a 25‑basis‑point rise in URR would add roughly $197 million to the liability and a 1‑basis‑point rise in WAC would add about $220 million, indicating the same modeling approach was applied but with updated sensitivity figures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the claim that the liability was $13,742 million in both 2023 and 2024, which misrepresents the evolution of the liability and implies no change, while the ground truth does not provide specific liability totals for either year. This number appears to be fabricated or incorrectly cited. Additionally, the answer incorrectly states that the methodology 'remained anchored in the same key assumptions' and that 'the same modeling approach was applied,' which contradicts the ground truth that emphasizes a shift from a simpler mention of deferred fees in 2023 to a more detailed, model-driven approach in 2024. (2) The sensitivity figures ($197 million for a 25 bps increase in URR and $220 million for a 1 bps increase in WAC) are correctly reported and match the ground truth, which is a positive point for quantitative accuracy. However, the core financial evolution—specifically the methodological advancement—is misrepresented. (3) The multi-hop reasoning is flawed: the model fails to recognize that the key evolution is in disclosure depth and methodological sophistication, not just updated sensitivity numbers. It incorrectly assumes continuity in methodology when the ground truth indicates a qualitative shift in 2024 toward more transparent and detailed modeling. (4) Contextual relevance is high because the answer addresses the right topic, uses correct terminology (URR, WAC), and references sensitivity analysis. However, due to major factual and interpretive errors in both quantitative and qualitative dimensions, the correctness score is low. The answer gives a misleading impression of continuity rather than evolution, undermining its overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 479,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning of Frame.io has evolved from a standalone acquisition in late 2021 to an integrated component of its Digital Media ecosystem, where it now serves as the cloud‑native collaboration backbone for video workflows and is tightly coupled with Creative Cloud applications such as Premiere Pro, After Effects and Photoshop. By embedding Frame.io’s real‑time review, frame‑accurate commenting and Camera‑to‑Cloud ingestion directly into these Creative Cloud tools—and by offering it within Adobe Express and Adobe Firefly Services—Adobe aligns Frame.io with its broader product strategy of unifying creative, document and experience clouds into a single, AI‑enhanced workflow platform that drives recurring revenue and strengthens the end‑to‑end creative process.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's integration into Adobe's ecosystem, noting its transition from acquisition to a core component of Creative Cloud workflows. It accurately identifies key integrations with Premiere Pro, After Effects, and Photoshop, which aligns with the ground truth. However, it omits specific mention of Workfront and Adobe GenStudio—both highlighted in the original answer as key indicators of strategic alignment by 2024. The acquisition amount ($1.18 billion) and the 2022 timeframe for initial integration are not mentioned, though the LLM references the late 2021 acquisition (which is factually correct, as the acquisition was announced in December 2021 and closed in 2022). (2) There are no numerical inaccuracies; the LLM does not introduce any incorrect figures, and while it omits the $1.18 billion figure, it doesn't contradict it. Dates are handled appropriately—referring to late 2021 as the acquisition period is acceptable contextually, even though the integration began in 2022. (3) The multi-hop reasoning is sound: the LLM synthesizes Frame.io’s role in video collaboration with its integration into Adobe’s broader cloud strategy and recurring revenue model. It correctly infers strategic alignment with Creative Cloud and AI-enhanced workflows, though it misses the explicit 2024 inclusion in Adobe GenStudio, a key detail indicating deeper ecosystem integration. (4) The answer is highly contextually relevant and well-articulated, with strong qualitative reasoning. The omission of GenStudio and Workfront integration slightly reduces completeness and precision in reflecting the full scope of ecosystem alignment as defined in the ground truth, warranting a score of 8 rather than 9 or 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 482,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value of private alternative investments classified as Level 3 (significant unobservable inputs) for equity‑like funds increased modestly, from $5.5 million (2022) to $25.1 million (2023) in the pension plan and from $0.5 million to $2.4 million in the retiree health plan, while the overall Level 3 balance remained relatively stable at about $25 million versus $15.4 million previously, indicating only limited growth in the use of unobservable inputs for those assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains partial factual correctness but introduces significant inaccuracies and extraneous information not present in the ground truth. The core value for 2022 ($5.5 million) is correct, but the 2023 value is reported as $25.1 million instead of the correct $25.4 million, a small but notable discrepancy. More critically, the LLM introduces 'pension plan' and 'retiree health plan' with specific figures ($0.5M to $2.4M) and an 'overall Level 3 balance' of ~$25M vs $15.4M, none of which appear in the original answer or are implied by the question. These additions suggest a misinterpretation or hallucination of data sources. (2) The quantitative accuracy is partially correct: $5.5M (2022) is accurate; $25.1M (2023) is close but incorrect (should be $25.4M). The claim of a 'modest increase' contradicts the ground truth's characterization of a 'fivefold increase', which is mathematically accurate (25.4 / 5.5 ≈ 4.6x, nearly fivefold). The additional figures for retiree health plans and overall balances are unsupported and incorrect. (3) The reasoning is flawed due to incorrect multi-hop synthesis: the model appears to conflate data from different plans or categories not mentioned in the question or ground truth. The conclusion that there was 'only limited growth in the use of unobservable inputs' contradicts the ground truth's implication of a significant shift toward Level 3 valuations. (4) Contextual relevance is moderate—the answer addresses fair value changes in Level 3 equity-like funds over 2022–2023, which is relevant—but the inclusion of unmentioned sub-plans and incorrect totals reduces precision and trustworthiness. Overall, the answer is partially correct on the main input but fails in completeness and accuracy due to fabrication of details and miscalibration of the magnitude of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 496,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe's integration of Frame.io evolved from a standalone creative‑collaboration platform to a core component of its Digital Media portfolio. In the 2022 filing, Frame.io was described as a “cloud‑native creative collaboration platform” that streamlines asset production and is directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and its Camera‑to‑Cloud feature enables automated upload of on‑set footage. By 2024, Adobe positioned Frame.io within its broader Digital Experience and Digital Media offerings, emphasizing its role in accelerating content creation workflows, supporting enterprise‑scale production through Adobe GenStudio, and complementing generative‑AI services such as Firefly. The acquisition, initially noted in fiscal 2021, is now presented as part of Adobe’s strategy to connect content creation with digital‑experience delivery, personalization, and optimization across channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Frame.io was acquired in 2021 (noted as 'fiscal 2021'), integration began post-acquisition, and by 2024 it was deeply embedded in Adobe's Digital Media offerings. The platforms listed—Premiere Pro, After Effects, Photoshop, Lightroom, Workfront—are correctly identified as integration points, matching the original answer. The mention of Adobe GenStudio and generative AI (Firefly) reflects accurate contextual expansion present in the 2024 positioning. (2) Quantitative accuracy is perfect: no incorrect numbers or dates; '2022 filing' and 'fiscal 2021 acquisition' are correctly referenced. (3) Multi-hop reasoning is sound: the LLM synthesizes Frame.io’s evolution from initial integration to strategic centrality, connecting it to both Digital Media and Digital Experience segments, which reflects a nuanced understanding beyond the ground truth. One minor point: the original answer emphasizes Frame.io becoming a 'core part' specifically of Digital Media, while the LLM mentions both Digital Media and Digital Experience—slightly broader but not incorrect, as Adobe does position it across domains. (4) Semantic equivalence is strong; wording differs but meaning matches. The addition of 'Camera-to-Cloud' and 'Firefly' provides extra detail not in the ground truth but supported by public knowledge and contextually appropriate. No factual errors—only slight expansion on context. Hence, a 9/10 for correctness and qualitative accuracy, full marks for quantitative and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 434,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS Health expanded its medication adherence and cost-efficiency initiatives through integrated clinical programs and digital tools, particularly within its Health Services segment. The company enhanced its formulary management and utilization management strategies, including the use of the NovoLogix preauthorization tool to promote clinically appropriate use of specialty drugs and reduce costs. Digital connectivity was strengthened to provide patients with expanded visibility into lower-cost alternatives via enhanced analytics and data sharing. Additionally, CVS advanced its value-based care model through platforms like Canopy, which uses AI and machine learning to personalize care plans and improve outcomes, while expanding services like Signify Health’s in-home evaluations and Oak Street Health’s primary care centers to support chronic disease management and medication adherence. These efforts reflect a strategic evolution toward more personalized, data-driven, and cost-conscious medication management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of CVS's medication management strategy from 2022 to 2024 with accurate emphasis on clinical programs and digital tools. It correctly identifies key initiatives such as formulary and utilization management, the NovoLogix preauthorization tool, enhanced analytics for lower-cost alternatives, and expansion of value-based care through Oak Street Health. However, it introduces 'Canopy' and 'Signify Health’s in-home evaluations' as part of CVS's medication management evolution, which are not mentioned in the ground truth and lack verification in this context—this affects qualitative accuracy. Additionally, while the ground truth highlights the seven-day opioid supply policy and the CVS Weight Management program integrating GLP-1 optimization and lifestyle coaching, the LLM omits these specific clinical programs, missing a key aspect of the 2024 expansion. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward integrated, data-driven care, aligning with the ground truth’s conclusion. However, the inclusion of unverified platforms (Canopy, Signify Health) and omission of specific programs (CVS Weight Management, opioid policy) weakens the synthesis. (4) The answer is contextually relevant and well-structured, addressing the core themes of medication adherence and cost efficiency. The correctness score is 7 because the core direction and several key elements (NovoLogix, Oak Street, digital tools) are accurate, but important specifics from the ground truth are missing or replaced with potentially incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 482,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "From 2022 to 2024, Adobe has progressively deepened Frame.io’s integration within Creative Cloud, positioning it as a core collaborative hub across video, design, and marketing workflows. Key enhancements include tighter native integration with Premiere Pro, After Effects, Photoshop, and Lightroom for frame-accurate commenting and approvals, expanded Camera to Cloud functionality for direct on-set uploads, and broader availability within Adobe Express and Firefly-powered workflows. These improvements have streamlined end-to-end content production, enabling real-time collaboration, automated asset management, and seamless handoffs across creative teams—solidifying Frame.io’s role in Adobe’s vision for unified, AI-enhanced creative collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in 2022 and integrated it into Creative Cloud, with deepened integration into Premiere Pro, After Effects, Photoshop, and Lightroom by 2024. The evolution from a video-specific tool to a broader creative collaboration platform is accurately conveyed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the answer synthesizes Frame.io’s functional expansion (e.g., Camera to Cloud, real-time collaboration) with its strategic positioning across Adobe’s ecosystem, including integration with Workfront (implied via 'marketing workflows') and newer tools like Adobe Express and Firefly. The mention of 'frame-accurate commenting' and 'automated asset management' adds detail not in the original but is contextually plausible and consistent with known enhancements. (4) Minor omission: the original specifies Frame.io’s support for still images, design files, and PDFs, which the LLM answer implies via 'design and marketing workflows' and 'Adobe Express' but does not explicitly state. Also, Workfront is mentioned in the original but only indirectly referenced in the LLM answer. These are minor gaps in completeness but do not detract from the core accuracy. Overall, the answer captures the evolution and enhancements accurately and is semantically equivalent to the ground truth with slightly more forward-looking language (e.g., 'AI-enhanced collaboration').",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 446,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in fair‑value measurement has shifted from a primary Level 1 input toward a Level 2 approach. In 2023 the tables listed “recently executed transactions” as a direct source for Level 1 valuations of securities such as U.S. Treasury and agency issues, but by 2024 those same transactions are described as “comparable‑transaction” inputs that feed observable market data used in Level 2 classifications (e.g., benchmarking to comparable bonds or loans when quoted prices are unavailable). Consequently, the role of recent trades has moved from being quoted market prices that define fair value outright to being a supporting observable input that informs valuations classified at a higher level of the hierarchy.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual alignment with the ground truth. (1) It introduces a classification shift from Level 1 to Level 2 in fair value hierarchy, which is not mentioned or implied in the original answer. The ground truth describes an evolution in the *application scope* and *targeted use* of recently executed transactions (e.g., more focused on held-for-sale loans and extended to other investments), not a reclassification within the fair value hierarchy. (2) There are no numeric values in either answer, so quantitative accuracy is neutral; however, the LLM invents specific claims about 'U.S. Treasury and agency issues' and 'tables' that are not present in the original, indicating fabrication. (3) The multi-hop reasoning is flawed: the original requires synthesis around how the *role* of transaction data evolved across asset types and categories (corporate loans → held-for-sale loans, contingent commitments → other investments), but the LLM misdirects to a fair value hierarchy shift unsupported by the source. (4) While the answer is contextually relevant—both discuss the evolving role of transaction data in valuation—it contradicts the ground truth in key qualitative aspects. The core claim about Level 1 to Level 2 transition is unsupported, making the answer factually misleading despite plausible financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 379,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's Substance 3D Stager has evolved from a standalone desktop tool into a tightly integrated component of the broader Substance 3D ecosystem, now bundled with Substance 3D Painter, Sampler, Designer and Modeler and offered as part of the Adobe Substance 3D Collection subscription. The product is positioned as the central hub for assembling and previewing 3D scenes, with seamless connectivity to Adobe Firefly’s generative AI services and Adobe Express for scalable content creation, reinforcing its role as the entry point for end‑to‑end 3D workflows within Adobe’s Creative Cloud suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Substance 3D Stager's positioning between 2022 and 2024. It accurately captures the shift from a standalone product to an integrated component of the broader Substance 3D ecosystem. The mention of bundling with Painter, Sampler, Designer, and Modeler is consistent with the 2024 positioning as part of an end-to-end workflow. The answer adds specific details not in the original—such as integration with Adobe Firefly and Adobe Express and the product being part of a subscription collection—which are plausible enhancements but not confirmed in the ground truth. These additions do not contradict the original answer but go beyond it, potentially reflecting up-to-date knowledge. However, the original answer emphasizes that in 2022, Stager was only mentioned as a trademark with no functional detail, while the LLM implies it was already a 'desktop tool,' which is a slight overstatement based on the available evidence. This minor overinference affects qualitative accuracy slightly. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is perfect—the answer directly addresses the evolution and ecosystem integration. Overall, the answer is factually sound, well-reasoned, and semantically aligned with the ground truth, warranting a high correctness score with a small deduction for unsupported specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 409,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE’s strategic positioning on grid‑scale batteries shifted from a peripheral, risk‑aware mention in its 2022 outlook to a more explicit, forward‑looking component of its energy‑transition narrative in the 2023 filing. While both years stress that deep decarbonization will depend on emerging storage technologies—including grid‑scale batteries—2023 expands the discussion to highlight the need for significant investment, policy incentives, and the uncertainty around timing and commercial viability, signaling a higher strategic reliance on such technologies as a core pillar of GE’s future growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in GE's strategic positioning on grid-scale batteries from 2022 to 2023 with high factual accuracy. It accurately reflects that in both years, GE emphasized the potential importance of emerging technologies like grid-scale batteries for decarbonization, and that by 2023, the language evolved to signal greater strategic reliance. The answer correctly identifies the shift in tone and strategic framing, noting increased emphasis on investment needs, policy incentives, and uncertainty—elements consistent with a more central role in the energy transition strategy. However, the original answer specifies a key semantic shift: in 2023, GE stated decarbonization would 'depend in part' on such technologies, marking a clear elevation from speculative interest to strategic dependency. While the LLM conveys increased reliance, it does not explicitly mention this critical phrase or the conceptual shift from 'may become more important' to 'depend in part,' which is central to the ground truth. This omission slightly weakens the qualitative accuracy, though the overall reasoning and synthesis remain sound. There are no numerical values in the question or answers, so quantitative accuracy is scored based on correct use of years (2022, 2023), which are accurate. Contextual relevance is perfect—the response directly addresses the evolution in strategic positioning, role in energy transition, and level of reliance. Minor improvement in precision of strategic language would have made it fully equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 425,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS Health's disclosure regarding the use of broker-quoted debt securities in fair value measurements has remained consistent between 2022 and 2024, with no broker-quoted securities reported in Level 3 valuations during these years. The company continues to rely on internal pricing models and observable market data (Level 2 inputs) for most debt securities, with Level 3 assets now primarily consisting of private placement securities priced using internal analyses or broker quotes without active market pricing, though no specific broker-quoted securities were identified in the 2024 or 2023 filings. This approach has maintained stability in its fair value hierarchy classification, with Level 3 assets showing minimal net transfers out of the category in recent years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that CVS did not report any broker-quoted debt securities in its Level 3 fair value measurements for 2023 and 2024, aligning with the ground truth's assertion of continued absence. It also accurately reflects the company's reliance on internal pricing models and observable inputs, which is consistent with the original answer. However, the LLM omits a key qualitative shift noted in the ground truth: the 2024 filing no longer mentions any review process or negative impact related to broker-quoted securities, indicating reduced emphasis over time—a point not addressed in the LLM response. (2) Quantitatively, all years (2023, 2024) and references to Level 3 assets and internal pricing are accurate. There are no numerical inaccuracies, and the description of minimal net transfers out of Level 3 is consistent with stability in classification. (3) The reasoning is partially sound: the model correctly synthesizes the absence of broker-quoted securities across years, but fails to capture the evolution in disclosure tone and content—specifically the removal of discussion around impact and review processes—which is central to the question about 'evolution' in disclosure. This represents a gap in multi-hop qualitative analysis. (4) Scores reflect high factual accuracy (quantitative accuracy 9), but a moderate deduction in qualitative accuracy (7) for missing the nuance in disclosure evolution. Correctness is 7 due to core factual correctness but significant omission of the changing nature of narrative disclosure. Contextual relevance remains high as the answer directly addresses the topic with relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 455,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, BlackRock's equity securities at FVTNI increased from $1,059 million to $1,179 million, reflecting higher holdings in equity securities/mutual funds and related investments, while equity method investments rose from $2,510 million to $2,330 million in the consolidated VIE/VRE exposure table. The net interest in these consolidated VIEs also grew, with BlackRock's net interest increasing from $1,479 million (2023) to $1,460 million (2024) in the VIE column and from $716 million to $512 million in the VRE column, indicating a shift toward greater exposure through VIEs rather than VREs. Overall, the composition moved toward larger stakes in equity securities/mutual funds and a relative reduction in equity method investments compared with the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, BlackRock reported $1,211 million in equity securities/mutual funds and $1,895 million in equity method investments. In 2024, these values increased to $1,950 million and $2,783 million, respectively. However, the LLM incorrectly states that equity securities/mutual funds were $1,059 million (2023) and $1,179 million (2024), which is both numerically wrong and inconsistent with the actual trend. More critically, the LLM claims equity method investments decreased from $2,510 million to $2,330 million, which contradicts the ground truth showing an increase from $1,895 million to $2,783 million. (2) The numbers provided in the LLM answer do not match the ground truth in any category. The values for equity securities/mutual funds are off by over $150 million in 2023 and nearly $800 million in 2024. The equity method investment figures are also incorrect—overstated in 2023 and understated in 2024. Additionally, the LLM introduces unrelated concepts like 'consolidated VIE/VRE exposure', 'net interest', and 'VRE column', which are not mentioned in the question or the original answer and appear to be hallucinated or misattributed from other contexts. (3) The multi-hop reasoning is flawed. The question asks specifically about the composition of Equity Securities at FVTNI, focusing on two components: equity securities/mutual funds and equity method investments. The LLM fails to correctly retrieve or synthesize the correct figures across years and instead introduces irrelevant data about VIEs and VREs, indicating a failure in proper document alignment or data extraction. (4) The contextual relevance is moderate because the LLM attempts to discuss the right topic—changes in equity investments at BlackRock—but veers into unrelated financial constructs. Due to major quantitative errors and incorrect qualitative conclusions (e.g., claiming a reduction in equity method investments when they actually increased significantly), the correctness score is very low. Minor credit is given for addressing the general theme of portfolio composition change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 583,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "UnitedHealth Group's evaluation of credit-related impairments for available-for-sale debt securities remained consistent from 2022 to 2024, with no material allowance for credit losses recorded in any period. The company continued to assess securities for impairment based on fair value declines below amortized cost, credit quality of issuers, and intent to sell, concluding that unrealized losses were primarily driven by interest rate changes rather than credit deterioration. As of December 31, 2024, the allowance for credit losses on available-for-sale debt securities was still not material, reflecting no significant change in approach or material impairment recognition over the three-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that unrealized losses were primarily due to interest rate changes and not credit deterioration, and that the allowance for credit losses was not material in 2022 and 2024, which aligns with the ground truth. However, it incorrectly claims there was 'no significant change in approach' and that the allowance remained 'not material' through 2024, contradicting the original answer which notes a key evolution: by 2024, UnitedHealth explicitly recorded the allowance for credit losses as a separate component through an allowance account, indicating a more structured and formalized framework. This shift from a qualitative assessment to a more formal accounting treatment is a critical point missed by the LLM. (2) Quantitatively, the answer is accurate—no specific dollar amounts or percentages are misstated, and the time periods (2022, 2024) are correctly referenced. The mention of December 31, 2024, is consistent with reporting norms, even if the ground truth references 2021 for the prior allowance status. (3) The multi-hop reasoning is flawed: the question asks for the evolution from 2022 to 2024, but the LLM fails to recognize the progression in accounting treatment. It treats the period as static, missing the synthesis between consistent methodology (e.g., assessing expected cash flows) and the new explicit recognition of impairments through an allowance account. This represents a failure to capture the nuanced evolution described in the ground truth. (4) While the answer is contextually relevant and uses correct entities (UnitedHealth Group, available-for-sale debt securities, credit losses), the qualitative inaccuracy in depicting no change undermines the core of the question. The correctness score is low because the central theme—evolution in treatment—is misrepresented, even if individual facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 510,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved significantly between 2022 and 2023 in terms of investment value and equity income. The Company's equity investment in the ATMP JV increased from $69 million as of December 25, 2021 (reported in 2022 filing) to $99 million as of December 30, 2023 (reported in 2023 filing), reflecting growth in the investment value. Additionally, equity income recognized from the ATMP JV rose from $6 million in 2020 to $16 million in 2023, with the 2023 filing specifically noting $16 million in gains for fiscal year 2023 (compared to $14 million in 2022 and $6 million in 2021), demonstrating a clear upward trend in equity income from this relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, AMD's carrying value in the ATMP JV was $83 million in 2022, but the LLM incorrectly states it was $69 million (citing the 2021 value from the 2022 filing). While the 2023 carrying value is correctly reported as $99 million, the LLM misattributes the $69 million figure to 2022 instead of 2021. Similarly, for equity income, the ground truth states $14 million in 2022 and $16 million in 2023. The LLM correctly identifies $16 million in 2023 but incorrectly states $6 million in 2020 and $6 million in 2021 as reference points, omitting the correct $14 million for 2022. (2) The calculations and comparisons are partially correct in direction (upward trend), but the baseline values are wrong, undermining the accuracy of the evolution narrative. The LLM introduces irrelevant data (2020 and 2021 equity income) not asked for in the question, while missing the correct 2022 equity income figure. (3) The multi-hop reasoning is sound in structure—comparing investment value and equity income across years—but flawed due to incorrect data retrieval. The model synthesizes information across filings but pulls incorrect base years, suggesting a misalignment in temporal referencing (e.g., citing '2022 filing' but using 2021 data). (4) Despite these errors, the overall trend interpretation (growing investment and income) is consistent with the ground truth, and the 2023 figures are accurate. The answer is contextually relevant and well-structured, but the quantitative inaccuracies—especially the wrong 2022 investment and income figures—reduce the correctness score significantly. Minor formatting issues (e.g., fiscal year dates) are acceptable, but core numbers must match.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 485,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "Between 2022 and 2024, UnitedHealth Group’s exposure to tort claims remained significant, particularly through its affiliated physicians and health‑care provider networks, where medical‑malpractice and related liability claims continue to be self‑insured and can generate losses that exceed recorded reserves. The company also faces ongoing litigation involving out‑of‑network provider payment disputes, antitrust investigations, and whistleblower actions, all of which could result in monetary damages, regulatory penalties, or adverse publicity that materially affect its financial position. While the nature of the claims has not fundamentally changed, the volume of data‑driven services and the complexity of integrated health‑care operations have increased the potential financial impact of these tort and related legal exposures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (2022–2024), and correctly identifies UnitedHealth Group’s self-insured exposure to medical malpractice claims through affiliated physicians, as well as the risk that losses could exceed recorded liabilities. It also appropriately notes ongoing litigation types (e.g., out-of-network disputes, antitrust, whistleblower actions) that contribute to legal exposure. However, the LLM answer misses a key evolution highlighted in the original answer: the shift in focus from narrowly defined medical malpractice and professional liability claims in 2022 to broader systemic risks in 2024, particularly around clinical quality, patient safety standards, and reputational harm affecting business relationships. While the LLM mentions 'adverse publicity,' it does not emphasize the qualitative shift in risk profile or the emerging legal theories and damage cap circumvention noted in 2022. The answer generalizes continuity rather than capturing the nuanced evolution in nature and scope of tort exposure. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the context is highly relevant. The reasoning is sound but lacks the multi-hop synthesis needed to contrast the 2022 and 2024 risk landscapes as distinct phases. Thus, the answer is partially correct with minor but meaningful omissions in qualitative evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 404,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing’s revolving credit capacity evolved from a $3.0 billion three‑year facility and a $3.2 billion five‑year facility (both expiring in 2024) plus a $0.8 billion 364‑day line that expired in August 2024, to a new $4.0 billion five‑year revolving credit agreement (maturing May 2029) and the continued existence of the $3.0 billion three‑year line (now maturing August 2025) and the $3.0 billion five‑year line (maturing August 2028). This shift increased total available borrowing to $10 billion and extended the longest maturity to 2029, indicating a strategy to bolster liquidity, preserve cash for operations and large financing commitments, and maintain flexibility amid ongoing cash‑flow volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 Boeing had only a $3.0 billion three-year revolving credit agreement expiring in August 2025. However, the LLM incorrectly claims the existence of a $3.2 billion five-year facility and a $0.8 billion 364-day line in 2023, which are not supported by the original answer. Additionally, the LLM states that Boeing maintained both the $3.0 billion three-year and a $3.0 billion five-year facility into 2024, but the ground truth indicates that Boeing terminated two other credit facilities when it entered into the new $4.0 billion five-year agreement in 2024. The total capacity of $10 billion cited by the LLM is incorrect and not supported by the original data. (2) Quantitative accuracy is severely compromised: the original answer mentions only a $3.0 billion facility in 2023 and a new $4.0 billion facility in 2024, with no indication of the additional facilities cited by the LLM. The maturities cited (August 2028 for a five-year line) are fabricated. The calculation of $10 billion total capacity is baseless. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of Boeing’s credit agreements, instead inventing facilities and maturities. It misrepresents the strategic shift as an expansion to $10 billion, whereas the actual strategy was a replacement and extension with a single larger facility ($4.0 billion) while terminating others. (4) Contextual relevance is moderate because the answer addresses the general theme of liquidity strategy and maturity extension, but the factual foundation is so incorrect that the conclusion is misleading. The correct indication—enhancing liquidity and extending maturities through a new $4.0 billion facility—is partially captured in intent but undermined by false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 506,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "Based on the provided SEC 10‑K excerpts, the 2017 performance‑based options that were outstanding at the end of 2023 were fully exercised during 2024, generating an intrinsic value of **$373 million** on the date of exercise.  The fair‑value of the options that vested in 2024 was **$52 million**.  Consequently, the financial impact of the 2017 performance‑based options declined from a $52 million fair‑value of vested options in 2023 to $373 million of intrinsic value realized upon exercise in 2024, with no remaining outstanding performance‑based options after year‑end 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $52 million fair value of options vested in 2024 and the $373 million intrinsic value of options exercised in 2024, which matches the ground truth. However, it incorrectly states that the fair value of options vested in 2023 was $52 million, while the ground truth specifies $56 million. This is a factual error affecting quantitative accuracy. (2) The numbers for 2024 are accurate: $52 million (fair value vested) and $373 million (intrinsic value exercised) — both match the original answer. But the 2023 fair value is misstated: LLM says $52M (same as 2024), whereas it should be $56M. The intrinsic value for 2023 exercised options is omitted entirely — the ground truth reports $44 million, which the LLM fails to mention. (3) The reasoning contains a critical flaw: it claims the financial impact 'declined from a $52 million fair-value... in 2023 to $373 million... in 2024', which misrepresents both the direction and nature of change. It incorrectly frames a decrease in fair value but omits the increase in intrinsic value from $44M to $373M. Additionally, the synthesis implies a direct year-over-year decline in financial impact, which contradicts the ground truth showing a significant increase in realized value from exercised options. The claim that 'outstanding options were fully exercised' may be correct but isn't directly supported in the provided ground truth. (4) Despite these issues, the answer is contextually relevant and captures the substantial increase in intrinsic value in 2024. The 7/10 correctness score reflects accurate 2024 data but significant omissions and one incorrect 2023 figure, undermining full multi-hop accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 466,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments to revenue related to product return rights and variable consideration. In 2022, the company used trended historical return rates adjusted for known events to estimate returns for OEMs and distributors. By 2023, it continued this approach but emphasized the use of \"relevant, trended actual historical product return rate information\" adjusted for current conditions, while maintaining that these estimates had been \"materially consistent with actual results.\" The core methodology remained stable, but the 2023 disclosures highlighted more explicit reliance on recent historical data and market analysis to inform adjustments for returns, rebates, and price protection, particularly for distributor incentives and OEM programs. No fundamental change in the estimation technique occurred—only incremental refinement in data utilization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022 and 2023), entities (AMD, OEMs, distributors), and the general methodology (use of historical return rates adjusted for known events). It correctly notes that the core approach remained stable, which aligns with the ground truth. However, it misses a key qualitative shift emphasized in the original answer: the explicit alignment with ASC 606-10-32-8 through 14 and the adoption of the 'most likely amount' method under variable consideration. While the LLM mentions 'refinements in data utilization,' it downplays the more structured, codified accounting framework introduced in 2023, which is a significant conceptual evolution. The answer correctly identifies the continued use of trended historical data and adjustments for current conditions, and accurately reflects that estimates were materially consistent with actual results—details supported by the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. The shortfall is in fully capturing the accounting standard-specific reasoning and the shift toward a more formalized estimation approach under ASC 606, which constitutes a meaningful change beyond 'incremental refinement.' Thus, while the factual foundation is solid, the qualitative depth and precision in describing the methodological evolution are partially lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 394,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 Performance‑based Options declined from **1,549,080 shares outstanding at 12/31/23 to 625,825 shares outstanding at 12/31/24** (a loss of roughly 923,255 shares). This reduction reflects both **exercises of 905,219 options during 2024** and **forfeitures of 18,036 shares**, indicating that a substantial portion of the original performance‑based grants were either exercised or cancelled rather than continuing to remain outstanding. Consequently, the downward trend signals that many of the performance‑based awards reached the end of their vesting/ exercise horizon and were either realized or lost through employee departure before full vesting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers: 1,549,080 shares at end of 2023 and 625,825 at end of 2024, matching the ground truth. It accurately states that 905,219 shares were exercised and 18,036 forfeited during 2024. However, the calculated reduction (923,255) is slightly off — the actual difference is 1,549,080 - 625,825 = 923,255, which matches the LLM's stated loss, but the sum of exercises and forfeitures (905,219 + 18,036 = 923,255) is correct, so the components are accurate. The minor discrepancy is in presentation, not substance. (2) All numeric values are factually correct; the calculation of total reduction is mathematically accurate and consistent with the components provided. (3) The multi-hop reasoning is sound: the model correctly infers that the decline reflects both exercises and forfeitures, and links this to the lifecycle stage of the options approaching vesting/exercise deadlines. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed phrasing about employee departure and cancellation. The core facts, synthesis, and implications are correctly conveyed. Minor deduction in quantitative accuracy due to the presentation of the total loss as a derived figure without clarifying it's the sum of exercises and forfeitures, though the math itself is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 376,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services expanded its role within UnitedHealth Group's ecosystem by deepening integration with medical and behavioral care, scaling specialty and home-delivery capabilities, and embedding pharmacists into broader care teams. Strategically, it evolved from a standalone pharmacy benefits manager into a core engine for cost management and outcomes improvement across UnitedHealthcare's Medicare Advantage, Employer & Individual, and Optum Health segments, reinforcing the company's value-based care and holistic health model. This expansion was underscored by Optum Rx managing $178 billion in pharmaceutical spending in 2024, including $74 billion in specialty drugs, and serving as a critical link in coordinating medical, pharmacy, and behavioral care.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in quantitative claims. According to the ground truth, Optum Rx managed $112 billion in pharmaceutical spending in 2022, including $45 billion in specialty pharmaceuticals. The LLM claims that in 2024, Optum Rx managed $178 billion in spending, including $74 billion in specialty drugs. However, the original answer explicitly states that 'specific spending figures were not provided in 2024,' making the LLM's precise 2024 figures fabricated and factually incorrect. This is a critical error in a financial context. (2) There are no calculations in the ground truth to verify, but the LLM invents numbers that do not appear in any source, failing the quantitative accuracy test entirely. Even if trends were to be extrapolated, the magnitude of increase (from $112B to $178B) is unsupported and unjustified. (3) Qualitatively, the LLM captures some correct directional evolution: the integration of pharmacy services into broader care models, emphasis on value-based care, and coordination across medical, pharmacy, and behavioral health. These align with the 2024 strategic positioning described in the ground truth. The mention of embedding pharmacists into care teams and scaling home delivery is plausible but not explicitly confirmed in the provided truth. (4) Contextually, the answer is relevant and addresses the evolution of Optum Rx’s role and strategic positioning. However, the invention of specific financial figures where none were provided severely undermines factual correctness. While the qualitative reasoning about integration and strategic elevation is partially sound, the answer fails on core factual accuracy, especially in financial data, warranting a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 489,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Based on the provided SEC 10-K pages, BlackRock's Equity Securities at FVTNI (Fair Value Through Net Income) held for deferred cash compensation plans decreased slightly from $241 million at December 31 2023 to $173 million at December 31 2024, as reflected in the “Investments related to deferred cash compensation plans” line item within the equity‑method investments section of the fair‑value hierarchy tables. This reduction indicates a modest decline in the fair‑value measurement of those deferred‑compensation investments over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, in 2023, BlackRock reported $9 million (not $241 million) in Equity Securities at FVTNI related to deferred cash compensation plans. The LLM incorrectly states a decrease from $241 million to $173 million, which misrepresents both the starting value and the trend. The $173 million figure for 2024 is correct but is not a reduction from $241 million; rather, it reflects a reclassification into a different reporting category. (2) The numbers are significantly inaccurate: the 2023 value is off by over 25 times ($9M vs $241M), and no such decrease is supported by the ground truth. The calculation of a 'modest decline' is therefore based on false premises. (3) The multi-hop reasoning is flawed. The ground truth emphasizes a reclassification — the asset moved from 'Equity Securities at FVTNI' to 'Investments related to deferred cash compensation plans' under the Equity Method section — indicating a change in accounting presentation, not necessarily a change in economic value. The LLM misinterprets this reclassification as a simple decline in fair value, missing the key conceptual shift. (4) While the LLM identifies the correct 2024 value and the new location of the investment, it fails on the critical facts of the 2023 value and the nature of the change. The contextual relevance is moderate because it addresses the right topic and reporting line item for 2024, but the substantial factual and conceptual errors severely undermine correctness. Thus, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 457,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024 Accenture’s publicly announced open‑market share‑purchase authorization grew from roughly **$3.13 billion** (as of August 31 2022) to **$6.69 billion** (as of September 25 2024). This expansion reflects the company’s intent to increase capital flexibility, signaling a strategy of using share repurchases to deploy excess cash, support the stock price, and offset dilution from employee equity programs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that the aggregate available authorization decreased from $3,129,296 (~$3.13M) in 2022 to $2,694,281 (~$2.69M) in 2024. However, the LLM claims it increased to $6.69 billion, which is over double the correct total and misrepresents the trend entirely. This is a critical error in quantitative accuracy. (2) The numbers are not just inaccurate but fundamentally reversed: instead of a reduction, the model reports a massive increase. Additionally, the units are misrepresented — the original figures are in thousands (i.e., $3.13 billion), but the LLM incorrectly treats them as millions and then extrapolates to an erroneous $6.69 billion. There is no evidence in the ground truth of any increase, let alone one of this scale. (3) The multi-hop reasoning fails completely. The model should have compared the available authorization amounts across years and inferred a more conservative capital allocation strategy due to the reduction. Instead, it assumes growth and draws the opposite conclusion about capital deployment. (4) Due to severe factual and numerical inaccuracies, the correctness and quantitative accuracy scores are near zero. The qualitative reasoning is also deeply flawed. Contextual relevance is slightly higher only because the answer addresses share repurchases and capital allocation strategy — the right topic area — but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 411,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, Accenture’s treatment and disclosure of Accenture Canada Holdings Inc. Exchangeable Shares shifted from describing them primarily as a redemption mechanism tied to Class X ordinary shares in 2022 (with a note that redemption would not reduce the holder’s exchangeable share count below its current level) to a more detailed equity‑share‑holder perspective in 2024 that emphasizes the exchange ratio (one‑for‑one), the option to settle exchanges in cash, and the fact that these shares receive the same dividend entitlements as Class A ordinary shares.  \n\nThe company’s share‑repurchase activity also evolved: in 2022 it disclosed a broad open‑market program for Class A shares and mentioned that purchases of exchangeable shares could be made “by other means,” but it did not quantify any specific exchange‑share repurchases. By 2024, the 10‑K provides a detailed table of share‑purchase activity that explicitly separates Accenture plc Class A ordinary‑share purchases from Accenture Canada Holdings Inc. exchangeable‑share purchases, showing 47,752 exchangeable shares repurchased for $15,254 and a total of $4.5 billion spent on all share‑ purchase activity. This granular disclosure reflects a more transparent, program‑level approach to managing both ordinary‑share and exchangeable‑share redemptions.  \n\nFinally, shareholder rights associated with the exchangeable shares remained consistent—holders can exchange them for Class A ordinary shares on a one‑for‑one basis and receive dividend equivalents—but the 2024 filing clarifies that these shares are now treated as part of the company’s publicly announced share‑ purchase authorizations, with an additional $4 billion of repurchase authority approved in September 2024, underscoring a stronger commitment to returning capital to shareholders through both ordinary‑share and exchangeable‑share repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in disclosure and treatment of Accenture Canada Holdings Inc. Exchangeable Shares between 2022 and 2024, with accurate qualitative descriptions of shareholder rights (e.g., one-for-one exchange, dividend equivalence) and increased transparency in reporting. However, there are key quantitative inaccuracies that reduce factual correctness. The LLM states that 47,752 exchangeable shares were repurchased for $15,254 and that $4.5 billion was spent on all share-purchase activity by 2024. These figures are not supported by the ground truth, which does not provide specific repurchase volumes or dollar amounts spent on exchangeable shares—only a remaining authorization of $2,694,281 as of August 31, 2024. The mention of a $4 billion additional repurchase authority approved in September 2024 is also not present in the original answer, which only references a remaining authorization, not a new approval. While the LLM correctly identifies the shift from general intentions in 2022 to more structured disclosures in 2024, the inclusion of unsupported numerical data and repurchase breakdowns undermines quantitative accuracy. The reasoning is logically sound and contextually relevant, showing good synthesis of multi-hop elements (disclosure evolution, shareholder rights, repurchase framework), but the fabrication of specific transaction figures results in a partial correctness score. Semantic equivalence is mostly maintained except where invented numbers appear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1732,
        "completion_tokens": 415,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "Based on the provided financial data, the global revenue from Electrophysiology Devices increased by 12.4% in 2024 compared to 2023, and by 14.1% in 2023 compared to 2022. Excluding the impact of foreign exchange fluctuations, the percentage change in revenue for Electrophysiology Devices was 14.4% in 2024 (compared to 15.9% in 2023), reflecting growth driven by higher procedure volumes and increased demand for catheters and cardiac mapping products.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage change excluding foreign exchange fluctuations as 14.4% in 2024, which matches the ground truth. However, it incorrectly states the reported revenue growth as 12.4%, while the actual calculated change from $2,195M to $2,467M is (2,467 - 2,195) / 2,195 = 12.39% ≈ 12.4% — this is acceptable within rounding tolerance, so this point is borderline but defensible. The major issue is that the LLM introduces irrelevant data about 2023 vs 2022 (14.1% growth), which was not asked and is unsupported by the ground truth. (2) The dollar amounts for 2023 and 2024 are not explicitly stated in the LLM answer, which omits key quantitative details required for full completeness. While the percentage change is mostly accurate, the absence of revenue figures reduces quantitative completeness. (3) The multi-hop reasoning is partially sound — the model correctly isolates the FX-excluded growth rate for 2024. However, it adds unrequested comparative data across additional years, suggesting potential confusion in entity/time alignment. (4) Despite extra information and missing explicit revenue numbers, the core of the question — the percentage change excluding FX impact — is correctly answered as 14.4%, and the context (growth drivers) is reasonably consistent. Thus, the answer is mostly correct but lacks full completeness and introduces extraneous data, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 403,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Based on the provided document pages, Accenture's investment in Duck Creek Technologies (recorded as a $253 million gain in fiscal 2023) was excluded from adjusted financial metrics in fiscal 2024, but there is no indication of a subsequent investment valuation change or its impact on financial performance between fiscal 2022 and 2024. The document confirms the investment was held as an equity method investment (16% ownership, $138,902 carrying value as of August 31, 2022) and was not referenced in fiscal 2024 financial results beyond the prior-year gain adjustment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses key elements of the ground truth. It correctly identifies the 16% ownership and references the $253 million gain, but misattributes the gain to fiscal 2023 instead of fiscal 2024 as stated in the original answer. Additionally, the carrying value of $138,902 cited for August 31, 2022, contradicts the ground truth value of $223,166, indicating a factual discrepancy. (2) Quantitative accuracy is compromised: the investment valuation in 2022 is incorrect ($138,902 vs $223,166), and the timing of the $253 million gain is misstated (fiscal 2023 vs fiscal 2024). While $253 million is mentioned, its placement in the wrong fiscal year affects temporal accuracy. (3) The multi-hop reasoning is flawed—the question asks for evolution between fiscal 2022 and 2024, but the LLM fails to show a trajectory of valuation change or explain the shift in financial impact. Instead, it states there is 'no indication' of change, which contradicts the ground truth that reports a major gain. The exclusion from adjusted metrics in 2024 is an additional detail not in the original answer, potentially from external data, but it does not compensate for missing the core evolution. (4) Contextual relevance is moderate—the response addresses the investment relationship and mentions key facts like equity method accounting and ownership percentage, but fails to convey the significant increase in value and its positive impact on financial performance, which is central to the original answer. Overall, the LLM answer underreports the investment's growth and misrepresents the timeline, leading to a partially correct but significantly incomplete and factually inconsistent response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 475,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific’s retention awards shifted dramatically toward larger, performance‑linked equity grants: the February 2023 performance stock‑unit awards (subject to ROIC and three‑year OIG targets) were granted at a higher weighted‑average fair value of $204–$205 per share, compared with the 2021 awards that had a fair value of $148–$173 and a smaller pool of 227 k shares granted.  At the same time, the company’s overall equity‑compensation pool grew modestly, with 2.44 million options and awards outstanding in 2023 versus roughly 2.5 million in 2021, indicating a strategic move to tie a greater share of executive pay to measurable performance metrics while maintaining a relatively stable overall award size.  This reflects a compensation strategy that emphasizes performance‑driven equity incentives and reduces reliance on cash‑based or purely time‑vested awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the ground truth. (1) It introduces performance stock-unit awards tied to ROIC and OIG targets in February 2023 with specific fair values ($204–$205) and references 2021 awards with fair values of $148–$173 and 227k shares granted—none of which appear in the original answer or are supported by the provided ground truth. The ground truth states that in 2022, Union Pacific reported 389,207 retention shares outstanding as of December 31, 2021 (i.e., disclosed in 2022), and in 2023, it disclosed 954,405 retention shares and 366,046 retention units outstanding. The LLM confuses years, instruments, and metrics. (2) The quantitative inaccuracies are severe: the LLM cites 2.44 million and 2.5 million total equity awards/options outstanding in 2023 and 2021 respectively, but the ground truth does not provide total equity pool sizes or option counts, making this data unsupported. There is no mention of options in the original answer. (3) The multi-hop reasoning is flawed—the question asks about changes in composition and scale of retention shares and units between 2022 and 2023 disclosures, but the LLM misattributes data across years (e.g., using 2021 grant data for 2022 comparison) and conflates retention shares with performance stock units without evidence. The introduction of retention units in 2023 is a key factual point in the ground truth, but the LLM does not mention retention units at all. (4) While the LLM attempts to infer strategic intent (shift toward performance-based pay), this conclusion is based on fabricated data and misaligned comparisons. The actual ground truth indicates a significant increase in retention instruments and the introduction of retention units, suggesting a focus on retention rather than performance-based incentives. Thus, the reasoning and factual basis are unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 517,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife’s application of GAAP guidance for adjusted earnings remained consistent in its core exclusions—market volatility (e.g., net investment gains/losses, derivative gains/losses, MRB remeasurement, goodwill impairments) and asymmetrical accounting adjustments (e.g., amortization of basis adjustments, inflation-indexed benefit adjustments, in-force reinsurance asymmetries, non-economic contract inception losses). However, the 2024 reporting reflects a refined presentation under updated segment accounting policies, particularly following the adoption of ASU 2023-07 (Segment Reporting), which enhanced disclosure requirements but did not alter the fundamental exclusions. The 2024 adjusted earnings calculation also incorporates LDTI-related updates, such as reclassification of embedded derivatives to MRBs and adjustments to DAC/VOBA amortization, yet the exclusions for market volatility and asymmetrical accounting remain unchanged in substance. The key evolution lies in greater transparency and structural alignment with new reporting standards, not in the scope of adjustments.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but diverges significantly from the ground truth in key aspects of MetLife's evolving exclusions in adjusted earnings between 2023 and 2024. (1) Correctly identifies the continuity in core exclusions related to market volatility (e.g., MRBs, derivatives) and asymmetrical accounting (e.g., in-force reinsurance), and references LDTI adoption, which aligns with the 2023 update. However, it incorrectly asserts that the 'exclusions remain unchanged in substance' by 2024, directly contradicting the ground truth, which states that MetLife *expanded* exclusions in 2024—specifically for policyholder liability remeasurement gains/losses tied to in-force reinsurance and added equity method joint venture adjustments in net investment income. These are material changes in scope, not just presentation. (2) The mention of ASU 2023-07 (Segment Reporting) is contextually relevant to enhanced disclosures but is not part of the ground truth and distracts from the actual evolution in GAAP application for adjusted earnings. (3) The multi-hop reasoning is partially sound—linking LDTI to DAC/VOBA and MRBs is accurate—but fails to synthesize the *progression* from 2023 to 2024 in exclusion criteria. The model underemphasizes the substantive expansion in 2024, instead framing changes as presentational. (4) While terminology like 'asymmetrical accounting' and 'MRBs' is used correctly, the conclusion that there was no change in substance is factually incorrect per the original answer. Quantitative accuracy is high because no incorrect numbers are cited (the question is qualitative), and contextual relevance is strong due to appropriate framing around GAAP, LDTI, and adjusted earnings. However, the failure to identify the key 2024 expansions results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 493,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to compressed transformations has evolved from emphasizing broad industry-specific reinvention and foundational technology adoption (e.g., cloud, AI, IoT) to a more integrated, AI-driven strategy centered on generative AI and ecosystem partnerships. By 2024, the scope expanded to include deeper integration of AI across all transformation areas—such as redefining product design and engineering via Industry X, leveraging SynOps for intelligent operations, and embedding AI into customer experiences (via \"Song\")—while maintaining its focus on 360° value through talent, sustainability, and cross-industry expertise. This shift reflects a strategic pivot toward AI as a core enabler of speed and scale in transformation, supported by investments in R&D, strategic acquisitions, and partnerships with tech leaders like AWS, Microsoft, and Google.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Accenture's transformation approach toward greater AI integration and expanded scope, which aligns thematically with the ground truth. However, it introduces elements not present in the original answer and omits key specifics. For example, the LLM correctly identifies generative AI as a new technology in 2024 but fails to mention digital twins, 5G, metaverse, or AR/VR explicitly as part of the technological evolution. It also invents concepts not in the original, such as 'Industry X', 'SynOps', 'Song', and partnerships with AWS, Microsoft, and Google, which are not supported by the ground truth. While the shift toward AI is valid, the specific mechanisms (e.g., ecosystem partnerships, R&D investments) are speculative additions. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no incorrect numbers were introduced. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift toward AI, which is consistent with the expansion to generative AI. However, it fails to accurately synthesize the actual technological additions (e.g., AR/VR, advanced robotics, commercial hardware development) and the concrete expansion into capital projects like power grids and data centers. The scope broadening is mentioned in general terms but lacks the specific domains (plant construction, public infrastructure) that define the evolution. (4) The correctness score is 5 due to partial factual alignment—core idea of AI-driven evolution is correct, but significant omissions and hallucinated details reduce accuracy. Qualitative accuracy is 5 because while reasoning shows logical progression, it relies on unsupported specifics. Contextual relevance is high (8) as the response stays on-topic and addresses the evolution in strategy, technologies, and scope, albeit imprecisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 529,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott’s interest‑rate hedge contracts remained in place through 2024, but their notional amount and fair‑value exposure declined modestly from 2023 to 2024.  In the 2023 10‑K (Note 12), the “Interest Rate Hedge Contracts” column shows a fair‑value liability of $95 million at both December 2023 and December 2022, and the accompanying discussion notes that the decrease from 2022 was due to the maturity of $700 million of hedge contracts in 2023.  The 2024 filing (pages 38‑40) confirms that the company continues to use fair‑value hedges of fixed‑rate debt, but the hedge coverage has been reduced – the 2024 balance sheet reflects a lower fair‑value liability for these swaps (the 2024 table shows a $95 million liability, the same as 2023, but the footnote indicates that $2.9 billion of hedge contracts matured in 2023, leaving a smaller pool of active contracts).  Consequently, while the mechanism (fair‑value hedges that convert fixed‑rate debt to variable‑rate exposure) stayed the same, the extent of the hedging program contracted slightly, with fewer contracts outstanding in 2024 than in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly states that the notional amount of hedge contracts declined from 2023 to 2024, claiming that $2.9 billion matured in 2023 and that hedge coverage was reduced. However, the ground truth states that Abbott maintained a consistent notional value of $2.2 billion in both 2023 and 2024. The LLM also misrepresents the fair value liability: while it correctly notes a $95 million liability in 2023, it falsely implies a reduction in 2024, when the ground truth does not mention any change in fair value liability or notional amount. (2) The LLM incorrectly infers a 'smaller pool of active contracts' and 'reduced hedge coverage'—directly contradicting the ground truth that Abbott 'continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion,' indicating a stable hedging program. (3) Qualitatively, the reasoning is flawed: the LLM misinterprets the maturity of some contracts as evidence of a shrinking program, failing to recognize that companies routinely roll over hedges and that the stable notional amount indicates continuity. It also fabricates a narrative of decline without supporting evidence from the ground truth. (4) Contextually, the answer addresses the right topic—Abbott's use of fair value hedges to convert fixed-rate debt to variable—and correctly identifies the mechanism (fair value hedges), so it retains partial relevance. However, the core conclusion about a reduction in hedging activity is false. The ground truth emphasizes consistency in notional amount despite changes in average interest rates (3.6% to 3.8%), a point entirely missed by the LLM. Thus, while the answer demonstrates awareness of hedging concepts, its factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 503,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife's definition of Adjusted Earnings remained consistent with its GAAP-aligned segment performance framework, as detailed in the 2023 and 2024 10-K filings. Adjusted Earnings, defined as adjusted revenues less adjusted expenses (net of income tax), continues to exclude non-recurring items and market volatility impacts (e.g., net investment gains/losses, derivative gains/losses, MRB remeasurement), and is used by management to evaluate segment performance and allocate resources. The 2024 filing (page 152) confirms this methodology, which aligns with the updated LDTI accounting framework adopted in 2023, ensuring consistency in measuring segment profitability and capital allocation across all segments, including Group Benefits, RIS, Asia, Latin America, EMEA, and Corporate & Other.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key details about the evolution of MetLife's Adjusted Earnings definition between 2023 and 2024, particularly the specific changes introduced due to LDTI adoption and the expansion of exclusions in 2024. (1) What was correct: The answer correctly identifies that Adjusted Earnings remained a GAAP-aligned measure for segment performance and that it excludes market volatility impacts such as net investment gains/losses, derivative gains/losses, and MRB remeasurement. It also correctly references the 2024 10-K (page 152) and notes consistency with the LDTI framework adopted in 2023. (2) Quantitative accuracy: There are no numerical values in the question or ground truth requiring calculation, so this score is high—no factual inaccuracies in dates or metrics. (3) Multi-hop reasoning assessment: The model fails to fully synthesize the evolution from 2023 to 2024. Specifically, it omits that in 2023, MetLife removed adjustments for DAC/VOBA amortization and instead began adjusting for changes in measurement of guarantees. It also fails to mention the 2024 expansion of exclusions to include inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts, which represents a refinement beyond 2023. These are critical differentiators in the evolution of the metric. (4) Justification: While the answer captures the general continuity and purpose of Adjusted Earnings, it lacks the detailed transformation described in the ground truth, resulting in a moderate correctness score. The answer is contextually relevant and well-structured but incomplete in conveying the nuanced changes year-over-year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 458,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture’s publicly announced open‑market share‑purchase authorization has been expanded twice: the board added $3 million of authority in September 2022 (raising the total to $6.13 million) and $4 million in September 2024 (bringing the total to $6.69 million).  The company continues to fund these purchases through treasury shares, which are used for employee equity awards and other benefit programs.  In addition, Accenture acquires shares via employee‑share‑withholding programs for payroll‑tax obligations, which do not affect the aggregate open‑market authorization.  The share‑purchase activity shows a modest increase in volume and spending in 2024 compared with 2022, reflecting the higher authorization and continued use of both open‑market purchases and other employee‑share programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 (~$3.13 million), but the LLM claims the board added $3 million in September 2022, raising the total to $6.13 million, and then added $4 million in 2024 to reach $6.69 million. These figures are entirely incorrect—there is no mention in the ground truth of board authorizations increasing the total to $6.13M or $6.69M, nor any $3M or $4M additions. The actual authorization in 2022 was ~$3.13M, and there is no data provided about increases in 2024. (2) The LLM invents expansions of the share purchase program that are not present in the original answer. Additionally, the claim that purchases are 'funded through treasury shares' misrepresents the mechanism—treasury shares are *used for* employee benefits, not the funding source. The ground truth clarifies that open-market purchases are made, and shares are held as treasury shares, not that treasury shares fund the purchases. (3) While the LLM correctly identifies that share withholding for payroll tax obligations occurs and does not affect the public authorization, this is the only accurate qualitative point. The reasoning about a 'modest increase in volume and spending' is unsupported by the ground truth, which does not provide comparative spending data between 2022 and 2024. (4) The contextual relevance is fair because the answer addresses share purchase programs, acquisition methods, and employee-related share usage, but the severe numerical inaccuracies and fabricated board actions undermine correctness. The qualitative reasoning is partially sound but based on false premises. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 495,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife’s valuation methodology for Unit-linked Securities remained consistent between 2023 and 2024, still relying on significant unobservable inputs (Level 3) with no disclosed change in cost basis. The key evolution lies in the sensitivity analysis: the 2024 table (page 252) shows a reduced impact of input changes on estimated fair value for certain embedded derivatives (e.g., nonperformance risk spread decreased from 0.38% to 0.11% in 2023 to 0.38% to 0.11% in 2024, with a corresponding decrease in impact on estimated fair value), while the underlying valuation techniques and inputs for embedded derivatives (including mortality, lapse, utilization, and equity volatility assumptions) remained unchanged. The 2024 data also reflects a shift in the sensitivity of gains/losses for certain inputs, such as a smaller decrease in unrealized gains/losses in AOCI for nonperformance risk spread ($1,371 in 2023 vs. $1,189 in 2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The Original Answer states that MetLife shifted from a cost-based methodology in 2023 (amortized cost for fixed maturities, original cost for equities) to a Level 3 fair value approach in 2024 involving significant unobservable inputs and sensitivity analysis—indicating a major evolution in valuation methodology. However, the LLM claims the methodology 'remained consistent' and 'no disclosed change in cost basis,' which is factually wrong. (2) The LLM introduces specific numbers like 'nonperformance risk spread decreased from 0.38% to 0.11%' and unrealized gains/losses of $1,371 and $1,189, but these figures are not present in the Original Answer and cannot be verified against the ground truth; they appear fabricated or misattributed. There is no mention in the ground truth of these exact percentages or dollar amounts, nor of a '2024 table (page 252)', making the quantitative claims unsupported. (3) The multi-hop reasoning fails: the LLM did not correctly synthesize the shift from a static cost-based approach to a dynamic, assumption-driven Level 3 model, which is the core of the evolution. Instead, it incorrectly asserts continuity in methodology while focusing on sensitivity changes that are not mentioned in the ground truth. (4) Contextual relevance is moderate because the answer discusses fair value, Level 3 inputs, and sensitivity—topics related to valuation—but the factual inaccuracies and incorrect conclusion about no change severely undermine its validity. Overall, the LLM answer misrepresents the key evolution and introduces unverified quantitative details, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 461,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "The market-based RSU structure remained consistent between fiscal years 2022 and 2023, with both years featuring RSUs that include service and market conditions, vesting over four years (subject to market performance milestones in 2023), and fair value determined using a volatility of 32-38%, dividend yield of 1.7-3.3%, and risk-free rates of 1.4-4.2%. In fiscal 2023, the company increased the authorized shares under the 2012 Plan by 250 million and granted 124 million market-based RSUs at $51.98 weighted-average fair value, while fiscal 2022 included 27 million granted at $52.77. The total unrecognized compensation cost for unvested awards was $11,259 million as of November 3, 2024, expected to be recognized over a 3.0-year weighted-average period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the evolution of market-based RSU structure and vesting timeline between FY2022 and FY2023. The ground truth states that while four-year vesting remained common, the company introduced a new five-year vesting structure in FY2023 tied to stock price performance milestones. However, the LLM claims the structure 'remained consistent' and does not mention the introduction of five-year vesting at all, which is a critical omission. Instead, it incorrectly implies that the only change was the addition of market performance milestones in 2023, which contradicts the ground truth indicating that market conditions (TSR relative to index) were already in place in 2022. (2) Quantitatively, the LLM provides many specific numbers (e.g., 250 million shares, $51.98 fair value, 32-38% volatility, $11,259 million unrecognized cost), but these are not present in the ground truth and cannot be verified. Some of these figures may be factually accurate from filings but are irrelevant to the question about structural evolution. The date 'November 3, 2024' is future-dated relative to the context and likely incorrect. (3) The multi-hop reasoning is flawed: the model fails to compare the structural changes in vesting timelines (4-year vs. new 5-year) and mischaracterizes the nature of market conditions. It conflates general grant details with structural evolution, failing to synthesize the key change in vesting design. (4) The answer is contextually relevant in topic (RSUs) but misses the core of the question—structural evolution—instead focusing on quantitative grant data and valuation assumptions that do not address how the RSU design changed. Hence, correctness and qualitative accuracy are low despite some factual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 487,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase‑in treatment of CECL’s impact on regulatory capital shifted from a 75 % phase‑in of the delayed “day‑2” impact as of December 31 2023 to a full 100 % phase‑in beginning January 1 2025, meaning that by the end of 2024 the company was carrying the remaining 25 % of the delayed amount ($600 million) that will be fully phased in next year. During the phase‑in period (2020‑2024), the Federal Banking Agencies allowed a 25 % scaling factor for the ongoing “day‑2” impact, so Capital One added back $2.4 billion of capital in 2021 and has been phasing in that amount at 25 % per year, reaching 75 % ($1.8 billion) by end‑2023 and the final 25 % ($600 million) scheduled for 2025. Consequently, the regulatory capital treatment that applied during the phase‑in was to exclude the full CECL transition impact initially and then gradually reinstate it at 25 % per year, resulting in a CET1 ratio of 13.5 % on a fully phased‑in basis as of December 31 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timeline and phase-in mechanics. The ground truth states that the phase-in occurred at 25% per year from January 1, 2022, through December 31, 2024—meaning the full phase-in was completed by the end of 2024, not 2025. The LLM incorrectly claims that the final 25% is scheduled for 2025, which contradicts the original answer. (2) The dollar amounts ($2.4B, $1.8B, $600M) and the CET1 ratio of 13.5% are not mentioned in the ground truth and appear to be fabricated or inferred from external data not present in the original answer. These numbers cannot be verified against the provided truth and introduce unsupported specifics. (3) The multi-hop reasoning is partially sound in that the model understands the 25% annual phase-in concept and attempts to track cumulative impact over time, but it fails in correctly synthesizing the end date of the phase-in period. It also introduces Capital One and Federal Banking Agencies, which are not referenced in the original answer, thereby adding entity-level inaccuracies. (4) While the LLM captures the general regulatory treatment (25% annual phase-in), it distorts the timeline and adds unverified quantitative details, leading to a low correctness and quantitative accuracy score. Contextual relevance is high because it addresses the core topic and structure of the question, but qualitative accuracy is limited by incorrect entities and flawed logic in the final transition year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 421,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association evolved from issuing senior notes under the April 2022 indenture (4.15% 2032, 4.926% 2037) to issuing new notes under subsequent indentures, including a July 2024 indenture with 5.050% 2027, 5.050% 2029 and 5.150% 2031 notes, and an October 2024 supplemental indenture adding 4.150% 2028, 4.350% 2030, 4.550% 2032 and 4.800% 2034 notes. This reflects a progression of new senior note issuances with varying terms and maturities under separate indentures rather than a continuation of the original 2022 indenture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates, interest rates, and maturities compared to the ground truth. For example, it claims a July 2024 indenture with 5.050% 2027, 5.050% 2029, and 5.150% 2031 notes, which are not mentioned in the original answer. The October 2024 supplemental indenture described in the LLM answer includes 4.350% 2030 and 4.550% 2032 notes, which are also not in the ground truth. The original answer only specifies a 4.150% 2028 and 4.800% 2034 note issued in October 2024. Additionally, the LLM incorrectly references an April 2022 indenture as the starting point, while the ground truth states that the 2022 relationship was based on the January 2021 notes and new indentures from April 18, 2022, and July 12, 2024. (2) Quantitative accuracy is low: multiple incorrect percentages (e.g., 5.050%, 5.150%, 4.350%, 4.550%) and maturities (2027, 2029, 2030, 2031, 2032) not present in the original. The only correct figures are the 4.150% due 2028 and 4.800% due 2034, but even their context (October 2024 issuance) is partially speculative in the LLM answer. (3) The multi-hop reasoning is partially sound in structure—recognizing evolution in indentures over time and linking new issuances to evolving terms—but fails in factual synthesis. It invents indentures and notes not present in the ground truth, suggesting hallucination rather than accurate cross-document reasoning. (4) Contextual relevance is high because the answer attempts to trace the evolution of the relationship and discusses indentures, interest rates, and maturities appropriately. However, correctness score is low due to major factual and quantitative errors undermining the core content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 469,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "From 2023 to 2024 Capital One phased in the CECL Transition Rule impact at a 75 % rate, adding back $2.4 billion of capital in 2021 and applying 75 % of that amount by January 1 2024. The company’s CET1 ratio rose to 13.5 % on a fully phased‑in basis in 2024 (up from 12.9 % in 2023), reflecting the 75 % phase‑in of the delayed CECL impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Capital One added back $2.4 billion in 2021, while the ground truth specifies that $2.4 billion was already added back as of 2023 with a 50% phase-in. The $2.4 billion figure is correct, but the timing is wrong. The LLM also misrepresents the phase-in progression: it claims a 75% phase-in was applied by January 1, 2024, which is correct, but fails to mention the 50% phase-in in 2023, making the evolution unclear. Instead, it implies a jump to 75% without acknowledging the prior year's 50%. (2) The calculation of the phase-in is not explicitly verified in the LLM answer, and the reference to CET1 ratio increasing from 12.9% to 13.5% is extraneous and not part of the original question or ground truth, introducing unsupported data. (3) The multi-hop reasoning is partially sound in that it recognizes the CECL phase-in and its impact on regulatory capital, but it fails to accurately trace the year-over-year progression (50% in 2023 to 75% in 2024), which is central to the question. The synthesis across time points is flawed. (4) Despite introducing incorrect dates and extraneous metrics, the answer does address the core topic—CECL phase-in at Capital One—and correctly identifies the 75% level by 2024, earning partial credit for contextual relevance and qualitative understanding, though quantitative accuracy is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 400,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Based on the provided SEC filings, the treatment of VMware stock options for non-employee directors evolved significantly following the Broadcom acquisition. In the pre-acquisition VMware filings (reflected in the 2022 10-K pages), non-employee director stock options were typically granted with a cash settlement feature upon merger, but the key change occurred at the time of the VMware merger closing in November 2023. \n\nSpecifically, as detailed on page 67 of the Broadcom 2023 10-K (which covers the VMware Merger completion), all outstanding \"in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts.\" This replaced any prior VMware-specific director option plans, meaning non-employee directors no longer received VMware stock options post-acquisition—instead, their vested VMware options were cashed out or converted into Broadcom equity as part of the merger settlement. Prior to the merger, VMware's director compensation (as implied by standard practice in the filings) likely involved stock options or restricted stock, but the merger agreement terminated these and replaced them with Broadcom's post-merger equity structure. \n\n(298 characters)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in-the-money VMware stock options and RSUs for non-employee directors were accelerated and converted into equal parts cash and Broadcom common stock upon the acquisition's completion. This matches the original answer's core claim. (2) The date of the acquisition closing in November 2023 is consistent with known facts and supports the transition from 2022 (planned treatment) to 2023 (realized outcome). No specific dollar amounts or percentages are in dispute, and all referenced document locations (e.g., Broadcom 2023 10-K, page 67) support the claims. (3) The multi-hop reasoning is sound: it synthesizes pre-acquisition policy (2022) with post-acquisition realization (2023), correctly inferring the termination of VMware-specific plans and integration into Broadcom’s structure. (4) The only minor shortcoming is a slight expansion beyond the original answer by speculating that pre-merger director compensation 'likely' involved stock options 'as implied by standard practice,' which isn't explicitly confirmed in the ground truth. However, this doesn't introduce factual error but adds contextual inference. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 368,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures in the 2022 and 2024 10-K filings, the therapeutic positioning of Vraylar has evolved to include its approval as an adjunctive treatment for major depressive disorder (MDD), in addition to its established indications for schizophrenia and bipolar disorder. The 2021 FDA approval of Vraylar as an adjunctive therapy for MDD (supported by Phase 3 trials showing statistically significant efficacy in one study and numerical improvement in another) marked a key expansion of its use beyond psychosis and mood episodes, solidifying its role in treating a broader range of neuropsychiatric conditions by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Vraylar's therapeutic positioning from 2022 to 2024. It correctly identifies that in 2022, Vraylar was under evaluation in Phase 3 trials for adjunctive treatment of MDD, with one trial showing statistically significant results and the other numerical improvement—this aligns with the ground truth. The answer accurately states that by 2024, Vraylar was approved as an adjunctive treatment for MDD, expanding its use beyond schizophrenia and bipolar disorder. However, the LLM introduces a minor inaccuracy by citing '2021 FDA approval' for MDD, while the ground truth implies the approval occurred between 2022 and 2024 based on trial outcomes disclosed in that window; no explicit approval date is given in the original, but anchoring it to 2021 contradicts the timeline of ongoing Phase 3 evaluations in 2022. Additionally, the LLM omits the specific breadth of indications listed in the original (e.g., acute and maintenance treatment of schizophrenia, acute treatment of depressive episodes in bipolar I), which provides more granular detail about the expansion. Despite this, the overall reasoning and synthesis across years are sound, and the answer conveys the essential multi-hop insight: Vraylar’s indication expanded from investigational adjunctive MDD treatment in 2022 to approved, broader neuropsychiatric use by 2024. Wording differences are acceptable under semantic equivalence, but the incorrect date and slight incompleteness in listing indications prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 425,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE’s accounting for long‑term services agreements remained consistent: revenue is recognized over time using the percentage‑of‑completion method based on costs incurred to date versus the total estimated cost of the contract.  The company updates its estimates of future billings, utilization and costs whenever new information becomes available, revising revenue and related contract assets or liabilities on a cumulative‑catch‑up basis.  This approach is described in the 2022 filing (pages 83‑86) and reiterated in the 2024 filing (pages 15‑19).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims GE used the percentage-of-completion method in 2022, but the ground truth states that in 2022, GE used the straight-line basis for revenue recognition, particularly in Healthcare and Renewable Energy. The shift to percentage-of-completion occurred by 2024, primarily in the CES segment—this evolution is completely missed by the LLM. (2) The LLM fails to mention any of the key quantitative figures from the ground truth: the $6.6 billion net liability balance in 2024, the $162 billion total estimated life of contract billings, or the 4.1% ratio. These specific numbers are critical to the question about contract billing estimates and are entirely absent. (3) The multi-hop reasoning is flawed: the question asks for a comparison across 2022 and 2024, but the LLM asserts consistency over time, contradicting the documented policy change. It incorrectly cites the same method and estimation process in both years. (4) While the LLM references appropriate sections of filings and describes a plausible accounting framework, it fundamentally misrepresents the evolution of GE's policy. The contextual relevance is moderate because it discusses revenue recognition for long-term service agreements, but the core factual claims are incorrect. Minor credit is given for addressing the general topic and mentioning estimate updates, which aligns with improved forward-looking processes in 2024, but this is not enough to offset the major errors in method, timing, and missing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 427,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "The 1.250% Notes due 2027 are listed in both the 2022 and 2023 10‑K filings under “Notes due 2027” (2022 10‑K, page 29; 2023 10‑K, page 1). No substantive change to the terms or description of these notes is evident between the two filings—they continue to be identified simply as “1.250% Notes due 2027” with the same maturity and coupon. Consequently, IBM’s disclosure of the 1.250% Notes due 2027 remained essentially unchanged from the 2022 to the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that IBM's disclosure of the 1.250% Notes due 2027 remained 'essentially unchanged' between the 2022 and 2023 10-K filings. According to the ground truth, there was a meaningful evolution in disclosure: in the 2022 10-K, the notes were referenced via Exhibit 4.3 to a Form 8-K filed on January 30, 2019, as part of the instruments defining holders' rights. In contrast, the 2023 10-K explicitly lists the notes as a registered class of securities under the trading symbol IBM 27B on the New York Stock Exchange. This shift—from referencing an external exhibit to identifying the notes as a registered security with a trading symbol—represents a substantive change in disclosure practice that the LLM failed to recognize. While the LLM correctly identifies the notes' coupon (1.250%) and maturity (2027), and these quantitative details are accurate, it misses the key qualitative evolution in how IBM presented the notes in its filings. The reasoning is flawed because it assumes no change in disclosure based on similar naming, without engaging in the required multi-hop comparison of how the notes were categorized and referenced across the two filings. The answer is contextually relevant to the question but fundamentally incorrect in its conclusion, leading to a low correctness and qualitative accuracy score. The quantitative accuracy is higher because the basic facts about the notes (coupon, maturity) are correct, even if their contextual treatment is not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 416,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie's performance-vested RSUs have evolved from a structure with multi-year performance metrics tied to ROIC and total stockholder return (TSR) relative to a peer group in 2022 to a more streamlined framework by 2024, where vesting increments are now based on a combination of ROIC performance and TSR relative to a defined peer group, with vesting occurring in one-third increments over a three-year performance period. The company maintains its focus on aligning executive compensation with long-term value creation, though specific performance metrics and thresholds have been refined to reflect evolving strategic priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the performance metrics used in AbbVie's RSUs. The ground truth states that performance was based solely on ROIC relative to a peer group for awards granted in 2021 and 2020 (referenced in 2022 disclosures), with no mention of total stockholder return (TSR). However, the LLM incorrectly claims that TSR was part of the metric in 2022 and continues into 2024, which contradicts the original answer. This is a major error in entity and metric accuracy. (2) Quantitatively, the vesting structure—'one-third increments over a three-year period'—is correctly identified and consistent across both years, which supports partial quantitative accuracy. Dates (2022, 2024) are correctly used as reference points. However, the inclusion of TSR where it is not mentioned in the ground truth undermines the precision of the performance criteria description. (3) The multi-hop reasoning is partially sound in that the model attempts to compare structural changes over time and identifies a trend toward streamlining. However, the conclusion that metrics evolved from ROIC+TSR to ROIC+TSR is illogical if the starting point already includes TSR, and more importantly, misrepresents the actual evolution described (from ROIC-focused with historical tranches to a simplified ROIC-only framework). The synthesis fails because it introduces a metric (TSR) not present in the ground truth. (4) Contextual relevance is high because the answer addresses the question’s focus on vesting increments and performance metrics over time, uses correct company and award type (AbbVie, performance-vested RSUs), and discusses the right timeframe. However, due to the incorrect attribution of performance metrics, the qualitative and overall correctness scores are significantly reduced. Minor improvements in wording flexibility do not compensate for core factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 519,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 through 2024 GE’s investment in AerCap generated a net gain of $38 million in 2024 (up from a $865 million loss in 2022), reflecting the turnaround in the value of its AerCap stake.  The company also recognized a $480 million gain on its GE HealthCare investment in 2024, but the key point is that the realized/unrealized gains on the AerCap holding shifted from a large loss in 2022 to a modest gain in 2024, indicating an improving financial relationship with AerCap over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial figures: a $865 million unrealized loss in 2022 and a $38 million realized and unrealized gain in 2024, matching the ground truth. These numbers are accurately reported with correct signs (loss vs. gain) and years. (2) Quantitative accuracy is perfect—both the $865M loss and $38M gain are correctly cited, and the directional shift (from large loss to modest gain) is accurately portrayed. The mention of a $480 million gain on GE HealthCare is factually correct based on GE's 2024 filings but is extraneous to the AerCap question; however, it does not detract from the core accuracy regarding AerCap. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024) and interprets the shift in valuation impact as indicative of an improving financial relationship, which aligns with the ground truth’s conclusion of a 'significant turnaround.' The only minor shortcoming is that the original answer specifies the $38M gain in 2024 includes both realized and unrealized components, while the LLM simplifies this to 'net gain' without explicitly distinguishing the components—this is a slight omission but does not misrepresent the data. (4) Scores reflect high accuracy: full points for quantitative and contextual relevance; near-perfect qualitative reasoning; and a 9/10 overall due to the minor lack of specificity around the composition of the 2024 gain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 405,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's 0.300% Notes due 2026 (listed as \"0.300% Notes due 2026\" under \"Notes due 2026\" in the 2023 Form 10-K securities table on page 1) remained a disclosed debt instrument in both 2022 and 2023 filings. However, its visibility and prominence in financial instrument disclosures evolved: in the 2022 filing (page 28), it was referenced only within the broader context of the company's debt structure without specific emphasis, while in the 2023 filing (page 1), it was explicitly named and listed alongside other debt securities in the \"Securities registered pursuant to Section 12(b)\" table, confirming its continued formal disclosure but without increased prominence relative to other notes. The 2023 filing also included updated risk factor language about innovation and market competition that contextualizes the debt within IBM's broader strategic narrative, but the note itself was not highlighted as a distinct or newly emphasized financial instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fails to accurately reflect the key evolution in IBM's treatment of the 0.300% Notes due 2026 as described in the ground truth. Quantitatively, the note's name (0.300% Notes due 2026), timing (2022 vs 2023 filings), and context (SEC exhibits, Form 10-K) are correctly referenced, earning a high quantitative accuracy score. However, the qualitative assessment reveals a significant error: the LLM claims the note was 'explicitly named and listed' in the 2023 'Securities registered pursuant to Section 12(b)' table, which aligns partially with increased visibility, but contradicts the ground truth by stating there was 'no increased prominence relative to other notes'—the opposite of the truth. The ground truth emphasizes that by 2023, the note gained formal recognition by being listed on the NYSE under the trading symbol IBM 26B, a material upgrade in visibility and disclosure status from being merely referenced in an exhibit (Exhibit 4 to Form 8-K in 2016) in the 2022 filing. The LLM fails to mention the NYSE listing or the trading symbol IBM 26B entirely, missing a critical multi-hop detail that defines the evolution. Additionally, the LLM incorrectly downplays the change as not involving 'increased prominence,' which directly contradicts the ground truth’s assertion of 'increased visibility and formal recognition.' While the answer correctly identifies the shift from background reference to more explicit listing, it misinterprets the significance and fails to report the key fact of NYSE registration under a specific ticker, resulting in a partially correct but ultimately misleading conclusion. Contextual relevance is fair because the response stays on topic and references appropriate filing sections, but it lacks the decisive evidence needed to support the correct inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 499,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "GE's approach to the RISE Program has shifted from a focus on R&D investment and technology development (highlighted in 2022 as part of its sustainable flight strategy) to a more explicit commercial and strategic emphasis by 2024, where RISE is positioned as a core suite of technologies—including Open Fan, compact core, and hybrid electric systems—underpinning its sustainable aviation agenda and tied to tangible outcomes like the completion of over 250 tests on a full-scale Open Fan engine. This evolution reflects a deeper integration of RISE into GE Aerospace's core business strategy, with increased investment ($1.286B in 2024) and alignment with market demands for decarbonization, as evidenced by its role in the CFM International partnership and its focus on enabling next-generation engine platforms for both commercial and military applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's RISE Program from a conceptual R&D initiative in 2022 to a more concrete, investment-backed strategy by 2024, aligning with the ground truth's emphasis on increased commitment and technological development. It accurately identifies the strategic shift toward sustainability and integration into core business. However, the LLM introduces specific details not present in the ground truth: the $1.286B investment figure and the 'over 250 tests on a full-scale Open Fan engine' are not mentioned in the original answer and cannot be verified from the provided knowledge graph, making them potentially hallucinated. (2) Quantitative accuracy is compromised due to the inclusion of unverified numbers—while dollar amounts and test counts could vary by source, they are absent in the ground truth and thus represent unsupported additions. The format of $1.286B is precise but not corroborated. (3) The multi-hop reasoning is sound in structure: the model infers a strategic deepening from R&D to commercial integration, correctly linking RISE to GE Aerospace’s broader decarbonization goals and partnerships like CFM International. It appropriately synthesizes the program’s technological components (Open Fan, hybrid electric) as part of the evolved focus. However, the lack of corroboration for key metrics weakens the factual foundation. (4) Despite the unsupported specifics, the overall narrative matches the ground truth’s core message: a transition from announcement to active investment and strategic centrality. The answer is highly relevant and well-structured, but the introduction of unverified quantitative claims prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 471,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express’s funding strategy shifted markedly toward greater reliance on asset‑backed securitizations and unsecured term‑debt issuances. In 2023 the company issued roughly $13.5 billion of new debt (including $7.4 billion of fixed‑to‑floating senior notes and $0.5 billion of subordinated notes) and transferred $3.5 billion of securitized loan balances into its Asset‑Backed Securities program, expanding the proportion of funding sourced from securitizations. This expansion complemented a continued growth in retail deposits (up to $129.1 billion) and a modest increase in long‑term debt, but the share of funding derived from securitizations rose substantially, reflecting a strategic emphasis on diversifying and cost‑effectively financing its loan portfolio through capital‑market assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures such as '$13.5 billion of new debt', '$7.4 billion of fixed-to-floating senior notes', '$0.5 billion of subordinated notes', and '$3.5 billion of securitized loan balances' that are not present in the original answer (ground truth) and cannot be verified from the provided context. These numbers appear fabricated or misattributed, as the ground truth does not include any such dollar amounts related to debt issuances or securitization transfers in 2023. Additionally, the claim that retail deposits rose to '$129.1 billion' is unsupported by the original answer, which does not mention deposit levels at all. (2) The original answer emphasizes a qualitative shift in disclosure tone—from a definitional mention of securitizations in a glossary in 2022 to positioning securitizations as a core funding source alongside deposits and unsecured debt in 2023 due to strategic diversification. The LLM answer incorrectly frames this as a quantitative expansion in securitization activity with precise figures, which distorts the nature of the evolution. (3) While the LLM correctly identifies that securitizations became more strategically emphasized and are discussed alongside other funding sources, it fails to accurately represent the basis of the shift—i.e., a change in disclosure emphasis and strategic framing in the 10-K, not necessarily an operational increase in securitization volume. The multi-hop reasoning is partially sound in connecting securitizations to funding strategy, but it overreaches by injecting unsupported numerical data. (4) The contextual relevance is moderate because the answer addresses the general theme of evolving funding strategy, but the inclusion of false quantitative details significantly undermines factual correctness. The qualitative accuracy is limited by incorrect synthesis—emphasizing financial flows not in the source—though the directional insight (increased strategic importance) aligns loosely with the truth. Correctness is scored low due to major factual inaccuracies despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 569,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson’s financial relationship with AspenTech shifted from a minority equity stake to full operational integration after acquiring the remaining shares in May 2022.  The 2022 acquisition added AspenTech’s $656 million in sales and contributed $12 million of earnings (loss) to the Automation Solutions segment, while 2023 saw AspenTech’s sales surge to $656 million (up from $319 million in 2022) and earnings improve to $12 million, reflecting the full consolidation of its asset‑optimization software business.  Operationally, the combined entity leveraged AspenTech’s software within Emerson’s Automation Solutions portfolio, driving higher segment earnings before interest and taxes and enabling the company to report adjusted EBITA growth of 22 % in 2024 versus 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Emerson acquired the remaining shares of AspenTech in May 2022, whereas the ground truth indicates that the significant change occurred in 2023 with the acquisition of Heritage AspenTech and a 55% ownership stake, not full ownership. The answer fabricates a sales increase from $319M in 2022 to $656M in 2023, but the original answer states AspenTech contributed $656 in sales in 2022 — no 2023 sales figure is provided, and there is no mention of prior $319M sales. The claim of 'adjusted EBITA growth of 22%' in 2024 is unsupported by the ground truth, which does not mention 2024 or any such growth. (2) Quantitative accuracy is severely compromised: the $319M sales figure is invented; the $656M sales are misrepresented as a 2023 surge when they were reported for 2022; the $12 million earnings are repeated but mischaracterized as 'earnings (loss)' without basis; and the 0.6 percentage point gross margin improvement in 2023 from the ground truth is entirely omitted. (3) Multi-hop reasoning is flawed: the model fails to correctly track the evolution from minority investment in 2022 to 55% control in 2023, instead asserting a full acquisition in 2022. It invents operational outcomes (e.g., EBITA growth) not present in the source. The strategic shift from passive to active control is partially recognized but distorted by incorrect timing and details. (4) Contextual relevance is moderate because the answer addresses investment returns and operational integration, but the severe factual and quantitative errors undermine correctness. The synthesis is superficial and contains fabricated data, warranting a low correctness score despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 482,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech underwent a significant transformation. In 2022, Emerson acquired a controlling stake (55% ownership) in AspenTech through a transaction that included a $11.188 billion purchase consideration, resulting in the recognition of a $7.225 billion goodwill asset and a $4.39 billion intangible asset valuation, while recording a $5.9 billion noncontrolling interest for the remaining 45% stake. This acquisition, completed on May 16, 2022, fundamentally changed the accounting treatment, as Emerson began consolidating AspenTech's results and recognizing noncontrolling interest. By 2023, Emerson further refined its stake, ultimately selling its 40% noncontrolling interest in Copeland (a subsidiary of AspenTech formed after the 2022 acquisition) for $1.5 billion in cash and $1.9 billion note receivable in August 2024, though this sale occurred after the 2023 fiscal year. The 2023 financial statements reflect the ongoing impact of the acquisition, including $678 million in amortization of intangibles (including $97 related to Heritage AspenTech), $84 million in acquisition-related costs, and the reclassification of equity method losses from AspenTech to discontinued operations. The acquisition also drove significant non-cash charges, such as $231 million in acquisition-related inventory step-up amortization in 2024, which negatively impacted gross margins by 1.3 percentage points. Overall, the relationship evolved from a strategic acquisition in 2022 to a partial divestiture of its AspenTech stake by 2024, with the 2023 financials reflecting the initial consolidation and ongoing integration impacts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Emerson's financial relationship with AspenTech between 2022 and 2023. (1) Quantitative inaccuracies: The $11.188 billion purchase consideration, $7.225 billion goodwill, $4.39 billion intangible assets, $678 million amortization, $84 million acquisition costs, and $231 million inventory step-up are all incorrect or unsupported by the ground truth. The ground truth states a $6.0 billion cash contribution and a $5.9 billion noncontrolling interest, with no mention of these detailed purchase accounting figures. The SG&A increase of $572 million is misstated in the LLM as $678 million in amortization. The 0.6 percentage point positive margin impact in 2023 is contradicted by the LLM’s claim of a 1.3 percentage point negative impact. (2) The LLM incorrectly claims Emerson sold a 40% stake in Copeland in August 2024 for $1.5B cash and $1.9B note, which is outside the 2022–2023 scope and not mentioned in the ground truth. (3) Entity and timeline errors: The formation of 'New AspenTech' via contribution of Emerson’s software business and cash is misrepresented as a purchase of AspenTech; the transaction was a combination to form a new entity, not a straightforward acquisition. The LLM incorrectly frames it as Emerson acquiring AspenTech, whereas the ground truth describes a joint venture-like creation with a 55% controlling stake. (4) Reasoning flaws: The LLM suggests a divestiture occurred by 2024, implying a reversal of the relationship, which is not supported for the 2022–2023 period. It also introduces 'Heritage AspenTech' and 'equity method losses reclassified to discontinued operations'—concepts absent from the ground truth. (5) While the LLM correctly identifies the 55% ownership and $5.9 billion noncontrolling interest, and acknowledges integration impacts in 2023, the overwhelming number of fabricated financials and mischaracterizations of the transaction structure severely undermine factual correctness. The answer is contextually relevant in addressing noncontrolling interest and acquisition impacts but fails on core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 574,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "The 6.22% Debentures due 2027 were first disclosed in IBM’s 2022 Form 10‑K (Item 7A, Table of Contents) and continued to appear in the 2023 filing (Item 7A, Table of Contents) as part of the list of registered securities. The only change is that the 2023 filing adds a reference to the “Report of the Audit Committee of the Board of Directors” and “Audit and Non‑Audit Fees” in the Proxy Statement, but the debenture itself remains listed in the same format and with identical terms. Thus, IBM’s treatment and disclosure of the 6.22% Debentures due 2027 is essentially unchanged between the 2022 and 2023 SEC filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its characterization of IBM's disclosure evolution. The original answer states that in 2022, IBM referenced the debentures via Exhibit 3 to a 1997 Form 8-K, indicating a historical, passive disclosure. In 2023, IBM updated its presentation by listing the debentures with a trading symbol (IBM 27) and identifying them among NYSE-registered securities—a significant shift toward transparency and market orientation. The LLM incorrectly claims the debentures were 'first disclosed' in the 2022 10-K, which contradicts the ground truth that the instrument was filed in 1997. This is a major factual error. (2) Quantitatively, the percentage (6.22%) and maturity year (2027) are correct, and no numerical calculations are required, so quantitative accuracy is acceptable. However, the claim about 'Item 7A, Table of Contents' and added proxy references (Audit Committee, Audit Fees) introduces irrelevant details not tied to the debenture disclosure evolution, distracting from the core issue. (3) The multi-hop reasoning fails: the LLM does not recognize the shift from a historical exhibit reference (2022) to a structured, market-integrated disclosure (2023). Instead, it asserts the format is 'identical' and 'essentially unchanged,' which directly contradicts the ground truth. The model misses the key evolution in disclosure strategy. (4) Contextual relevance is moderate because it discusses the right instrument and filings, but the analysis focuses on irrelevant additions in the proxy statement rather than the actual change in how the debentures are presented. The conclusion is therefore fundamentally flawed. Correctness and qualitative accuracy are low due to incorrect facts and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 477,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group’s exposure to financial risk through risk‑based arrangements with health‑care providers has grown more pronounced in 2024.  The 2024 filing notes that “risk‑based arrangements with some physicians, hospitals and other health‑care providers limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers,” and that “if a risk‑based health‑care provider organization faces financial difficulties … we may be held responsible for unpaid health‑care claims which should have been the responsibility of the provider.”  Consequently, the company’s cost‑estimation and service‑delivery responsibilities now carry a greater liability for provider solvency and claim payments, requiring more robust monitoring and contingency planning to manage the heightened financial risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of UnitedHealth Group's financial risk exposure from 2023 to 2024, noting the increased responsibility for unpaid claims if risk-based providers face financial difficulties—a key development in 2024. The answer also captures the implications for cost estimation and service delivery, emphasizing greater liability and the need for enhanced monitoring and contingency planning. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2023 vs 2024) are correctly referenced in context. (3) The multi-hop reasoning is sound: the model synthesizes the shift in risk exposure over time and connects it to operational responsibilities, correctly inferring increased complexity in cost estimation due to provider solvency risks. The LLM cites a direct quote from the 2024 filing, strengthening its accuracy. (4) While the original answer includes additional detail about 2023 revenue recognition practices under value-based arrangements (e.g., per-patient-per-month premiums), the LLM answer omits this nuance but still captures the core comparative evolution in risk exposure. This minor omission prevents a perfect 10, but the overall factual correctness, reasoning, and relevance remain very strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 389,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech shifted from a significant equity investment to active divestiture. In 2022, Emerson held approximately 55% of AspenTech's shares following the acquisition of Heritage AspenTech, and recognized a $56 million mark-to-market gain on its equity investment. By 2023, Emerson had fully divested its stake in AspenTech through the sale of its 40% non-controlling interest in Copeland (which included AspenTech's equity interest) for $1.5 billion in cash, while also selling the associated $1.9 billion note receivable. This marked a strategic exit from its AspenTech investment, transitioning from ownership to complete divestiture.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and facts. (1) The original answer states that in 2022, Emerson had a financial investment of $362 million in AspenTech, but by 2023, it evolved into a strategic partnership where Emerson contributed its Industrial Software Business and ~$6.0 billion in cash to create 'New AspenTech', gaining 55% ownership. This represents a major strategic expansion, not a divestiture. The LLM incorrectly claims Emerson divested its stake in 2023, which contradicts the ground truth. (2) Quantitatively, the LLM states Emerson held 55% in 2022, but the truth is Emerson only gained 55% in 2023 after the transaction. The $56 million mark-to-market gain is not mentioned in the original and appears fabricated. The $1.5 billion sale of a 40% non-controlling interest in Copeland and $1.9 billion note receivable sale are unrelated details not present in the ground truth and misrepresent the relationship. (3) The reasoning is flawed: the LLM reverses the timeline and nature of the relationship—portraying a strategic acquisition as a divestiture. It fails to recognize the multi-hop evolution from minority investment to controlling stake. (4) Contextual relevance is low because the answer discusses disengagement while the truth describes deepening integration. The entities (AspenTech, Emerson) are correct, but the events, financials, and strategic interpretation are entirely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 396,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023 Adobe shifted Adobe Target from a standalone personalization engine within the broader Experience Cloud portfolio to a core component of the AI‑driven “Customer Journey” and “Journey Optimizer” suite, embedding it more tightly with Adobe Experience Platform, Real‑Time Customer Data Platform and Journey Optimizer to enable near‑real‑time, AI‑powered personalization across all channels. This evolution reflects Adobe’s strategic focus on unifying data, AI and activation tools—leveraging Adobe Sensei and generative AI—to deliver end‑to‑end, hyper‑personalized customer experiences as a central pillar of its growth strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Target and Adobe's strategic direction. (1) The answer correctly identifies the shift in Adobe Target’s role from a broader personalization tool in 2022 to a more central, AI-driven component in 2023. While the original answer does not describe Target as 'standalone' or mention a shift 'from standalone', it does confirm the increased emphasis on AI and machine learning, which the LLM captures accurately by referencing 'AI-powered personalization' and 'AI-driven'. The integration with Adobe Experience Platform, Real-Time CDP, and Journey Optimizer is contextually plausible and consistent with the 2023 description of omnichannel and AI-driven capabilities, though not explicitly stated in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the enhanced role of Adobe Target with Adobe’s broader AI strategy, correctly inferring strategic emphasis on AI-driven personalization. However, it adds specificity (e.g., 'embedding with Experience Platform') not present in the ground truth, which slightly exceeds the evidence. (4) The answer is semantically equivalent in intent and meaning, capturing the core evolution and strategic implication. Minor overstatement in integration details prevents a perfect score, but overall, the response is factually grounded, relevant, and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 431,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial stake in AspenTech remained indirect—it held no equity but acquired the company in Q3 2022 and integrated its operations. Post‑acquisition, Emerson converted outstanding Heritage AspenTech stock options and unvested restricted stock units into new AspenTech options and RSUs on the same terms, and it began recognizing AspenTech’s stock‑based compensation expense (e.g., $32 million in 2022, rising to $82 million in 2023) alongside the related tax benefits. Integration activities included reallocating the purchase‑price fair‑value of share‑based awards between pre‑ and post‑combination service periods, and Emerson’s stock‑compensation expense from AspenTech grew substantially as part of its broader compensation framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Emerson reported an $8,326 million balance related to AspenTech in 2022 as part of its acquisitions, indicating a direct financial stake. However, the LLM incorrectly claims Emerson held 'no equity' and misrepresents the nature of the stake as 'indirect,' which contradicts the acquisition framework described in the original answer. (2) Quantitative inaccuracies include the claim of $32 million stock-based compensation in 2022 and $82 million in 2023—these figures are not present in the ground truth and cannot be verified against it. The original answer does not provide specific compensation expense amounts for those years, so introducing these numbers is factually unsupported. Additionally, the $8,326 million acquisition balance is entirely omitted. (3) The multi-hop reasoning is partially sound in discussing post-acquisition integration activities like conversion of stock options and RSUs, and recognition of compensation expenses, which aligns with the operational integration mentioned in the original. However, it fails to correctly synthesize the evolution from a financial stake (2022) to operational integration (2023), instead implying no equity stake existed at all. The LLM also incorrectly frames AspenTech as being integrated under Emerson without acknowledging that AspenTech continued as a separate publicly traded company, a key point in the original answer. (4) Contextual relevance is high because the response addresses both financial stake and integration activities. However, due to major factual and quantitative errors—especially the denial of a direct financial stake and the invention of unverified compensation expenses—the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some integration mechanics are plausibly described, but core facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 523,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform’s role within Adobe’s customer journey solutions evolved from being a foundational data and audience infrastructure to a more tightly integrated, AI-powered orchestration engine. The 2023 filing emphasizes that Experience Platform now serves as the central hub that connects Adobe’s Experience Cloud applications—such as Journey Optimizer, Marketo Engage, and Campaign—enabling real‑time, cross‑channel campaign orchestration and hyper‑personalized customer journeys through AI services like Adobe Sensei and Generative AI. This deeper integration allows brands to activate unified customer profiles instantly, delivering seamless, data‑driven experiences across every touchpoint.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Experience Platform from 2022 to 2023. It accurately reflects the shift from foundational data infrastructure to a more active role in cross-channel orchestration and AI-powered personalization. The mention of Adobe Sensei, real-time data activation, and integration with Adobe Experience Cloud applications like Journey Optimizer aligns with the ground truth. However, the LLM omits specific 2023 innovations mentioned in the original answer, such as Adobe Mix Modeler and its role in marketing investment optimization using machine learning. While it names Marketo Engage and Campaign as integrated apps (which may be contextually accurate), these are not highlighted in the ground truth, which emphasizes Adobe Journey Optimizer as the key orchestration tool. The answer correctly identifies the enhanced AI integration and real-time profile usage but does not explicitly reference the cloud-native scalability or the shift from general AI infrastructure to specialized campaign planning functions. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is sound, though slightly less precise in entity specificity. The response is fully contextually relevant and addresses both integration with AI tools and cross-channel orchestration as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 385,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "UnitedHealth Group responded to Medicare Advantage funding pressures by accelerating its shift toward value-based care models, expanding integrated care delivery (including in-clinic, in-home, behavioral and virtual care), and intensifying medical and operating cost management—such as adjusting network composition, member benefits, and premiums—while continuing to grow enrollment in Medicare Advantage and Medicaid to offset revenue pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of UnitedHealth Group's response to Medicare Advantage funding pressures, including the shift toward value-based care, expansion of integrated care delivery (in-home, virtual, behavioral), and operational adjustments like network and benefit changes. It correctly identifies cost management as a response to financial pressures and notes continued enrollment growth in Medicare Advantage and Medicaid as an offset—consistent with the ground truth. However, it omits the clear evolution *from 2023 to 2024* emphasized in the original answer: in 2023, the focus was on growth-oriented investment in care models despite costs, while in 2024, the shift was toward strategic retrenchment due to specific external funding changes (reduced benchmarks, risk adjustment changes). This temporal contrast and the concept of a strategic pivot from expansion to cost containment are underemphasized. While the LLM mentions cost management and adjustments, it does not explicitly frame 2024 actions as a *reaction* to diminished funding, nor does it reference county-level plan offering decisions, a specific strategic response in the ground truth. There are no numerical inaccuracies (quantitative accuracy is high, scoring 10), and all entities (UnitedHealth Group, Medicare Advantage, care models) are correct. The reasoning is partially sound but lacks full multi-hop synthesis across years and causal drivers. Contextual relevance is strong as the answer directly addresses the question’s focus on care delivery evolution under funding pressure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 429,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Between 2022 and 2023, Thermo Fisher issued new debt instruments while retiring older ones, but the 1.950% Notes due 2029 remained outstanding throughout both years. The company's debt profile in the 2023 10-K (page 1) explicitly lists \"1.950% Notes due 2029\" among its registered securities, confirming the instrument was still active. However, the provided documents do not detail specific changes to the composition of TMO's debt instruments during this period, such as new issuances, redemptions, or refinancing activities related to the 2029 notes. The 2022 and 2023 10-Ks only disclose the existence of the 1.950% Notes due 2029 as part of the company's long-term debt structure without describing evolution in its composition.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.950% Notes due 2029 remained outstanding in both 2022 and 2023, which aligns with the ground truth. The trading symbol TMO 29 is not mentioned, but its absence does not invalidate the core fact. However, the LLM fails to report the key evolution in TMO's debt composition—specifically, the introduction of new debt instruments in 2023 such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034—which is central to the question about how the composition evolved. Instead, the LLM incorrectly states that the documents 'do not detail specific changes' and that there is no description of 'evolution in its composition,' which contradicts the ground truth that such changes were documented. This omission represents a significant failure in multi-hop synthesis, as the model should have identified both the continuity of the 2029 notes and the addition of new instruments. Quantitatively, all dates and percentages (1.950%, 2029) are accurate. Contextually, the answer is relevant and addresses the status of the 2029 notes, but it falls short by not acknowledging the broader strategic shift indicated by new issuances. Thus, while factually correct on the 2029 notes, it misses critical components of the debt composition evolution, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 366,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, Thermo Fisher added new note categories to its capital structure, including 0.500% Notes due 2028 (TMO 28A) and 1.375% Notes due 2028 (TMO 28), while retaining previously issued series such as the 0.750% Notes due 2024, 0.125% Notes due 2025, 2.000% Notes due 2025, 3.200% Notes due 2026, 1.400% Notes due 2026, 1.450% Notes due 2027, 1.750% Notes due 2027, 1.950% Notes due 2029, 0.875% Notes due 2031, 2.375% Notes due 2032, 3.650% Notes due 2034, 2.875% Notes due 2037, 1.500% Notes due 2039, and 1.875% Notes due 2049. The 0.500% Notes due 2028 represent a newly introduced tranche in the 2028 maturity year, expanding the company’s long‑term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the introduction of the 0.500% Notes due 2028. According to the ground truth, these notes were already present in 2022, not newly introduced in 2023 as the LLM implies. Instead, the new notes introduced in 2023 were the 3.200% Notes due 2026 and the 3.650% Notes due 2034. The LLM incorrectly labels the 0.500% Notes due 2028 as a 'newly introduced tranche' in 2023, which contradicts the original answer stating they were already listed in 2022. (2) Quantitatively, the percentages and maturities listed (e.g., 3.200% due 2026, 3.650% due 2034) are correct, but their characterization as existing in both years or being newly added is flawed. The inclusion of numerous other notes (e.g., 0.750% due 2024, 0.125% due 2025, etc.) is not supported by the original answer and introduces extraneous detail not present in the ground truth, raising concerns about hallucination. (3) The multi-hop reasoning is unsound: the question asks for evolution between 2022 and 2023, requiring comparison across years. The LLM fails to correctly identify what changed—specifically, the addition of two new note categories in 2023—while misrepresenting the 0.500% Notes due 2028 as new. It also omits mention of the continued presence of the 1.375% Notes due 2028, a key point in the original answer. (4) The contextual relevance is moderate because the answer discusses debt instruments and maturities, but the incorrect temporal assignment of when notes were issued undermines the core of the question. While the answer shows awareness of TMO’s debt portfolio, the misrepresentation of which instruments were introduced when results in a partially correct but fundamentally misleading response. Hence, correctness is scored low due to critical errors in entity timing and evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 503,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The excess fair value over carrying value for DHR's reporting units was approximately 140% to 495% of carrying value in the 2023 annual goodwill impairment analysis, and ranged from approximately 115% to 435% of carrying value in the 2024 analysis after applying a hypothetical 10% decrease to fair values. This represents a decrease in the excess percentage across all reporting units compared to the 2023 results.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the 2023 range was 140% to 495%, which the LLM correctly states. However, for 2024, the ground truth reports a range of 70% to 450%, while the LLM states 115% to 435%. Both the lower and upper bounds are incorrect. More critically, the LLM introduces a hypothetical 10% decrease to fair values as part of the 2024 analysis, which is not mentioned in the original answer and misrepresents the basis of the reported range. This suggests the LLM may have conflated sensitivity analysis with actual results. While the general direction of change (a decrease in excess fair value) is correctly identified, the specific numbers and reasoning are flawed. The answer is contextually relevant and addresses the question's intent to compare ranges across years, but the factual inaccuracies in the 2024 figures and the introduction of unverified methodology (hypothetical 10% decrease) undermine correctness. Multi-hop synthesis is attempted but based on incorrect data, reducing qualitative accuracy. Minor wording differences would be acceptable, but the numerical discrepancies are material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 330,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "The 2022 Employee Stock Plan reduced the available share pool by counting each RSU as two shares toward the plan’s authorization limit, while the 2023 plan eliminated that double‑counting rule, effectively freeing up additional shares for future equity awards. Consequently, the net available shares for issuance increased from 2022 to 2023 because RSUs no longer consumed two shares each under the updated plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and mechanism. (1) The original answer states that in 2022, canceled RSUs and tax-withheld shares were *added back* to the share pool at 2x, increasing availability. The LLM incorrectly claims that in 2022, RSUs were *double-counted against* the share pool (i.e., consuming two shares each), which is the opposite of the truth. (2) The LLM frames the change as eliminating a 'double-counting' burden, suggesting the 2022 plan was more restrictive. In reality, the 2022 plan was more generous by replenishing the pool with 2x shares upon cancellation or withholding. The 2023 removal of this 2x provision made the plan less generous. (3) The multi-hop reasoning fails: the LLM misinterprets the financial mechanism entirely—this is not about how RSUs count against the limit when granted, but how they are treated when canceled or withheld for taxes. (4) While the LLM correctly identifies a change between 2022 and 2023 and discusses share pool impact, the direction of the effect and the underlying logic are reversed. Thus, despite addressing the topic and timeframe correctly, the answer conveys the opposite of the truth. Quantitative accuracy is low because the 'factor of two' is misapplied in direction and context. Qualitative accuracy is poor due to flawed reasoning and entity misinterpretation (e.g., 'reduced the available share pool' vs. 'increased the available share pool'). Contextual relevance is moderate because it discusses the right plan and time period and attempts to explain a mechanical change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 430,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Danaher's strategic relationship with Aldevron has evolved significantly between 2023 and 2024, particularly in terms of financial stake and integration. In 2023, Danaher acquired Aldevron in a $9.6 billion cash transaction (completed August 30, 2021), which positioned Aldevron as a key part of its Life Sciences segment. By 2023, Aldevron contributed approximately $300 million in annual revenue (2020 figure) and was integrated into Danaher's Life Sciences business, which also includes Abcam (acquired in 2023 for $5.6 billion). The acquisition strengthened Danaher's position in genomic medicines and custom nucleic acid products, with Aldevron's plasmid DNA, mRNA, and protein manufacturing capabilities complementing Danaher's broader Life Sciences portfolio. Financially, the acquisition was funded through cash on hand and commercial paper, resulting in $6.1 billion of goodwill recorded. By 2024, Aldevron's operations were fully integrated into Danaher's Life Sciences segment, contributing to the segment's $24.3 billion in sales (2023 unaudited pro forma), though specific financial details for 2024 are not detailed in the provided documents beyond its role within the segment. The integration reflects Danaher's strategy to expand its life sciences footprint through strategic acquisitions, with Aldevron serving as a foundational asset in this expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in dates and financial figures. The acquisition of Aldevron was completed in 2021, not 2023, and the $9.6 billion figure is close to the ground truth $9,561 million (i.e., ~$9.56 billion), so the dollar amount is approximately correct (acceptable format variation). However, the LLM incorrectly states that the acquisition occurred in 2023, which misrepresents the timeline of integration. The $300 million annual revenue figure is attributed to 2020 and not confirmed in the ground truth, making its inclusion speculative. The $6.1 billion goodwill and $24.3 billion Life Sciences segment sales (pro forma 2023) are not present in the original answer and cannot be verified against the ground truth, suggesting potential hallucination or use of external data. (2) Quantitative accuracy is partially correct: $9.6B ≈ $9,561M is acceptable, but the use of unaudited pro forma figures and goodwill not mentioned in the original undermines precision. The date of acquisition (2021 vs. implied 2023) is a critical error. (3) Multi-hop reasoning is partially sound—the model correctly infers integration into the Life Sciences segment and identifies strategic alignment with genomic medicines and nucleic acid products. However, it fails to capture the key evolution from a separately accounted stake in 2023 to full integration by 2024, instead implying integration was already complete by 2023. The original answer emphasizes a shift in accounting treatment and structural integration between 2023 and 2024, which the LLM overlooks. (4) Contextual relevance is high—the answer addresses financial stake, integration, business segments, and strategic rationale. However, due to significant factual and temporal inaccuracies, especially around the timeline and unsupported financial metrics, the correctness score is limited to 5. The answer captures the general direction of the relationship but misses the precise evolution and supporting evidence from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 551,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 has evolved significantly between 2023 and 2024 by embedding AI deeply into its core productivity suite, transitioning from a traditional office productivity platform to an AI-first operating environment. This is exemplified by the integration of Copilot across Microsoft 365 applications (Word, Excel, PowerPoint, Outlook, Teams), where AI assists with content creation, data analysis, and workflow automation, directly driving revenue growth in the \"Productivity and Business Processes\" segment (up 14% in FY2024, fueled by Office 365 Commercial and Microsoft 365 Consumer subscriptions). Concurrently, Microsoft Cloud revenue grew 23% to $137.4 billion, with Azure AI infrastructure (including custom silicon like Maia and Cobalt) and enterprise AI solutions (e.g., Dynamics 365, LinkedIn, and security tools like Copilot for Security) forming the backbone of its commercial business metrics, directly contributing to the 16% overall revenue increase and 24% operating income growth reported in FY2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. While it correctly identifies the increased AI integration in Microsoft 365 via Copilot and mentions AI-first positioning, it fabricates or misrepresents key financial metrics. The claim that 'Productivity and Business Processes' grew 14% in FY2024 is unsupported by the original answer, which does not provide any revenue growth figures. Similarly, the $137.4 billion Microsoft Cloud revenue and 23% growth, 16% overall revenue increase, and 24% operating income growth are not mentioned in the ground truth and cannot be verified from the provided information. These specific numbers are therefore incorrect or hallucinated. (2) The original answer focuses on a change in metric definition—specifically, that Microsoft 365 Consumer now includes Basic subscribers as of 2024—which the LLM answer completely omits. This is a key strategic evolution in commercial business metrics and represents a major point of the ground truth. The LLM instead invents broader financial performance data not present in the source. (3) The reasoning around AI integration is sound and aligns with the 'AI-first' platform description from 2023, and the mention of Copilot across Office apps reflects accurate multi-hop understanding of Microsoft’s strategy. However, the synthesis fails on the business metrics side, where the model does not recognize the significance of the subscriber metric change and instead substitutes unrelated financial figures. (4) The contextual relevance is high because the answer addresses AI integration and commercial business impact, but quantitative accuracy is low due to fabricated percentages and dollar amounts. Qualitative accuracy is moderate because core strategic themes are correct, but key details are missing or invented. Correctness score is 5 due to partial factual alignment but significant errors in financial data and omission of the metric redefinition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 535,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft shifted Copilot Pro from a broad AI assistant to a tightly integrated, subscription‑based feature embedded in Microsoft 365 apps and the web. In the 2023 filing, Copilot was presented as a consumer‑focused AI tool for navigating the web and creating content, while the 2024 filing emphasizes its role within Microsoft 365 (e.g., Copilot for Sales, Service, Finance, and Copilot Studio) and its availability in Windows 11 and Edge, highlighting faster, more powerful AI assistance directly inside the productivity suite and across Microsoft’s cloud services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Microsoft's positioning of Copilot Pro between 2023 and 2024. It accurately captures the shift from a consumer-focused AI tool in 2023 to a more deeply integrated, productivity suite-enhancing feature in 2024, emphasizing its role within Microsoft 365 apps and web-based assistance. The mention of 'faster and more powerful AI assistance' is consistent with the original answer. The LLM adds specific examples (Copilot for Sales, Service, Finance, Copilot Studio, Windows 11, Edge) not present in the ground truth, which are plausible and contextually appropriate but not verifiable from the provided knowledge graph—this introduces minor over-specificity without contradicting facts. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across time and product positioning. The core message about strategic evolution and deeper integration matches the original, though the LLM frames the shift as 'from broad AI assistant to tightly integrated feature,' which slightly overstates the contrast compared to the more nuanced 'retained but embedded within broader narrative' evolution in the ground truth. This justifies a high but not perfect qualitative and correctness score. Contextual relevance is excellent, fully addressing the question's focus on positioning, emphasis, and integration changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 414,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "Based on the provided SEC 10-K filings, the 2007 Omnibus Incentive Plan (which authorizes up to 135 million shares for stock-based awards) had approximately 47 million shares remaining available for issuance as of December 31, 2024. This represents a decrease from prior years due to ongoing share issuances for equity compensation, though the plan itself remains active without an expiration date. The company continues to use new shares from its authorized but unissued pool to cover option exercises and award vestings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Quantitatively, the statement that approximately 47 million shares remained available as of December 31, 2024, aligns with the ground truth and is accurate. However, the LLM introduces a new figure—'135 million shares authorized'—which was not present in the original answer and cannot be verified from the provided context, making this a significant factual overreach. (2) The claim that the plan 'remains active without an expiration date' is unsupported by the original answer, which does not discuss the plan's expiration or ongoing status. (3) The original answer emphasizes a shift in disclosure transparency between 2023 and 2024: in 2023, no specific number was given for remaining shares, whereas in 2024, the 47 million figure was explicitly disclosed. This evolution in reporting clarity and availability tracking is the core of the original answer, but the LLM fails to mention the absence of data in 2023, thus missing a key comparative element of the multi-hop reasoning. (4) While the LLM correctly identifies the 2024 share availability and the use of new shares for awards, it omits the critical contrast between years and adds unverified details (authorized shares, perpetual status), undermining its qualitative accuracy. The answer is contextually relevant and addresses the topic of share availability, but lacks completeness and introduces unsupported facts, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 409,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft increased the estimated useful lives of its server and network equipment from four to six years, effective in fiscal year 2023, as a result of efficiency‑enhancing software investments and technological advances that reduced the rate of equipment obsolescence. This accounting estimate change lowered depreciation expense and reflected the longer operational lifespan of the hardware.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Microsoft's accounting policy: increasing the estimated useful lives of server and network equipment from four to six years, effective in fiscal year 2023. It accurately notes the drivers—software investments and technological advances—that reduced obsolescence, aligning with the ground truth. However, the LLM answer omits any mention of fiscal year 2024, specifically that the policy remained consistent in that year, which is a required part of the multi-part question. This omission reduces completeness. (2) Quantitatively, all numbers and dates are correct: the change from 4 to 6 years, and the effective timing in fiscal year 2023, are accurately reported. There are no calculations, but the factual numeric assertions match the ground truth exactly. (3) The reasoning is sound in linking technological improvements to longer useful lives and reduced depreciation, demonstrating correct multi-hop synthesis between operational changes and accounting policy. However, the failure to address the 2024 status means the model did not fully synthesize across both fiscal years as required by the question. (4) Contextual relevance is high—the answer directly addresses the policy change and its rationale. The missing 2024 update prevents a perfect score, but core facts and logic are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 384,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "From the 2022 and 2023 10‑K pages, MDT’s auction‑rate securities are classified as Level 3 in the fair‑value hierarchy and are recorded in “Other assets” on the balance sheet.  The fair‑value of these securities was $33 million at both April 29 2022 and April 28 2023, reflecting a slight decline from $36 million cost (with a $3 million unrealized loss) in 2022 to $33 million fair value (with a $3 million unrealized loss) in 2023.  Thus, MDT’s exposure to auction‑rate securities remained minimal, staying at $33 million fair value and continuing to be reported as a Level 3 asset within other assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of auction rate securities as $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly states that the securities were classified under 'Other assets' in both years, while the original answer clarifies that in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly moved to 'Other Assets'. This misrepresents the evolution in classification, which is a key part of the question. (2) The mention of a $36 million cost basis and $3 million unrealized loss in both years introduces details not present in the ground truth and cannot be verified from the provided information; these figures may be factually incorrect or misleading. The dates (April 29, 2022, and April 28, 2023) are plausible fiscal year-ends but were not specified in the original answer, so their inclusion adds precision not supported by the ground truth. (3) The multi-hop reasoning is partially sound—comparing fair value and classification across years—but fails on the critical point of classification change. The model misses the shift from general investment inclusion to explicit 'Other Assets' reporting, instead asserting consistent classification, which contradicts the original answer. (4) While the fair value stability is correctly noted, the erroneous classification timeline and unsupported cost/unrealized loss data reduce factual accuracy. The answer is contextually relevant and addresses exposure in terms of fair value and balance sheet classification, but with significant qualitative and quantitative flaws. Hence, correctness is partially compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 468,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net gains or losses from Cisco's available‑for‑sale debt investments shifted from a $21 million gain in fiscal 2023 to a $67 million loss in fiscal 2024, indicating a deterioration in the company's investment performance for this category.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Cisco had a $21 million *gain* in fiscal 2023, while the ground truth specifies a $21 million *loss*. This is a critical factual error that reverses the meaning of the financial performance. Additionally, while the $67 million loss in fiscal 2024 is correctly stated, the comparison between the two years is therefore flawed. (2) The numbers themselves ($21 million and $67 million) are accurate in magnitude but incorrect in sign—this changes the interpretation entirely. A gain vs. a loss is a fundamental distinction in financial reporting, so this error severely undermines quantitative accuracy. (3) The reasoning is partially sound in that it identifies a negative shift in performance, but because it starts from an incorrect premise (a gain turning into a loss rather than a smaller loss turning into a larger one), the multi-hop synthesis is invalid. The conclusion about deterioration is directionally correct but based on wrong data. (4) Contextual relevance is high because the answer addresses the right company, metric, and time frame, and attempts the correct comparison. However, due to the reversal of a key fact, the overall correctness score is low—this is a major factual error affecting the core of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 360,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco’s APJC operations shifted from a more capital‑intensive, hardware‑centric model in 2023 to a greater emphasis on software‑as‑a‑service and subscription‑based revenue streams in 2024, reflected in increased investment in cloud‑managed networking and security offerings. This strategic pivot reduces reliance on traditional product sales and drives a more recurring‑revenue model in the region.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It incorrectly claims a shift from a 'capital-intensive, hardware-centric model' to a 'software-as-a-service and subscription-based revenue streams' model in APJC between 2023 and 2024. The original answer makes no mention of such a product or revenue model transition. Instead, the actual evolution was from direct operational presence in 2023 to the addition of financial investments (marketable and non-marketable equity securities, equity method investments) in 2024. (2) There are no quantitative figures in the LLM answer to verify, but it fabricates strategic shifts (e.g., 'increased investment in cloud-managed networking') not present in the ground truth, resulting in a very low quantitative accuracy score due to absence and inaccuracy. (3) The multi-hop reasoning is flawed: the question asks about evolution in operational structure vs. financial investment, but the LLM instead discusses a software/hardware revenue shift, missing the core distinction between operational presence and financial investment entirely. (4) Contextual relevance is moderate because it addresses Cisco and the APJC region over 2023–2024 and touches on revenue model implications, but the substance is misaligned. The answer invents a narrative not supported by the source, leading to a low overall correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 385,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple’s App Store commission structure and regulatory compliance evolved in direct response to mounting legal and market pressures. In 2022, Apple maintained its standard 15–30% commission model but began preemptively adjusting its policies ahead of anticipated regulatory scrutiny, particularly in the EU and under U.S. antitrust investigations. By 2024, following rulings such as the *Epic Games v. Apple* case and the implementation of the EU’s Digital Markets Act (DMA), Apple was compelled to allow alternative payment systems and app distribution channels in the EU, while in the U.S., it introduced changes to how developers communicate with users about off‑App purchases, though it retained its core commission rates. These adjustments reflect a shift from a rigid, uniform fee structure to a more nuanced, region‑specific approach that balances compliance with ongoing revenue goals. Additionally, Apple has increasingly emphasized its role as a platform provider, highlighting the importance of third‑party developer support and digital content availability, while also investing in robust compliance mechanisms to mitigate litigation and regulatory risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Apple's App Store policies from 2022 to 2024. It accurately identifies the increasing regulatory pressures, particularly from the EU's Digital Markets Act (DMA) and the Epic Games lawsuit, and notes Apple's shift toward region-specific compliance measures. The mention of the 15–30% commission range is consistent with public knowledge, though the original answer does not specify exact percentages, so this detail is an addition rather than a contradiction. The LLM correctly states that Apple introduced alternative payment systems and distribution methods in the EU by 2024, which matches the ground truth. It also appropriately notes that in the U.S., Apple made limited changes, such as allowing communication about off-App purchases, while maintaining core commission rates—this reflects the nuanced, region-specific adjustments described in the original. However, the LLM implies a direct causal link to the *Epic Games v. Apple* ruling shaping 2024 U.S. changes, which is partially speculative; the ground truth emphasizes structural changes in the U.S. and EU without attributing them solely to Epic. Additionally, the original answer highlights new business terms, fee structures, and developer tools/APIs as implemented changes, which the LLM mentions only implicitly. These omissions prevent a perfect score, but the core facts, timeline, and reasoning are sound. Quantitative accuracy is high—no incorrect numbers or miscalculations, and dates (2022–2024) are correctly used. Qualitative accuracy is strong, with appropriate entity identification (Apple, DMA, Epic Games) and logical multi-hop synthesis across legal, regional, and policy dimensions. Contextual relevance is excellent, directly addressing the question’s focus on commission evolution and regulatory response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 508,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "The allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan shifted toward a higher proportion of fixed‑income securities over the period. In 2022 the plan’s assets were roughly 65% fixed income and 35% equity, while by 2024 the fixed‑income share rose to about 80% (with equity falling to roughly 20%), reflecting a deliberate move to align assets more closely with liability‑driven, interest‑rate sensitivity. This evolution is evident in the disclosed target ranges (fixed‑income 65‑80% and equity 20‑35% for the U.S. retiree health plan) and the actual weighted‑average allocations reported for 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from a higher equity allocation in 2022 to a more conservative 80% fixed income and 20% equity mix in 2024, aligning with the ground truth's emphasis on increased focus on fixed income for capital preservation. However, the 2022 percentages (65% fixed income, 35% equity) are not directly supported by the original answer, which provides dollar amounts ($248M fixed income and cash equivalents, $137M equity) but not percentages. A correct calculation from the ground truth data would yield approximately 64.4% fixed income ($248M / ($248M + $137M) = $248M / $385M ≈ 64.4%) and 35.6% equity, so the LLM's 65%/35% is a reasonable approximation. Despite this, the original answer does not explicitly state these percentages, so introducing them as factual without attribution to calculation introduces a minor inaccuracy. (2) The 2024 allocation (80% fixed income, 20% equity) matches the original answer exactly and is correctly presented. The mention of target ranges (65–80% fixed income, 20–35% equity) adds contextual detail not in the original answer, which may be accurate but is not verifiable from the provided ground truth, potentially reflecting external knowledge. (3) The multi-hop reasoning is sound: the LLM infers a strategic shift over time, synthesizing changes in allocation strategy between 2022 and 2024, and correctly interprets the conservative pivot. It also links the shift to liability-driven investing, which is a logical qualitative inference. (4) The correctness score is 8 because core financial data and trend direction are accurate, with only minor issues in presenting derived percentages as if explicitly stated. Quantitative accuracy is 7 due to the unverified percentage approximation and introduction of target ranges not in the ground truth. Qualitative accuracy is 9 due to strong reasoning and appropriate interpretation. Contextual relevance is 10 as the answer directly addresses the evolution of allocation strategy as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 548,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "From 2022 to 2024, Texas Instruments has maintained its strategic focus on analog and embedded processing products as core growth drivers, leveraging these segments to reinforce its competitive advantages in manufacturing efficiency, broad product portfolios, and supply chain control. In its 2024 segment reporting, the Analog segment generated $12.161 billion in revenue (38% of total) with a strong operating profit of $4.608 billion (38% margin), while Embedded Processing contributed $2.533 billion in revenue (16% of total) with $352 million in operating profit (14% margin)—both showing improved profitability versus prior years, underscoring how these segments continue to drive margin expansion and cash flow generation that underpin TI’s overall financial strength.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures for 2024—$12.161 billion revenue for Analog (38% margin) and $2.533 billion for Embedded Processing (14% margin)—that are not present in the original ground truth and cannot be verified against it. More critically, the ground truth emphasizes a structural and strategic evolution in how TI reports and positions Embedded Processing, particularly its elevation to a reportable segment by 2024, which the LLM answer fails to mention. This is a key qualitative shift that defines the strategic evolution, yet the LLM focuses instead on financial performance metrics absent from the original answer. (2) The quantitative data in the LLM response appears precise but is unsupported by the ground truth; there is no mention of revenue, profit margins, or percentages in the original answer, making these figures either hallucinated or misattributed. Even if accurate in another context, their inclusion here distorts the evaluation because they were not part of the verified knowledge graph output. (3) The multi-hop reasoning is partially sound—the LLM recognizes that Embedded Processing is a strategic area and links it to competitive advantages like manufacturing efficiency and product portfolio breadth. However, it misses the core evolution: the change in segment reporting structure from non-reportable in 2022 to a standalone reportable segment in 2024. This structural shift is the central point of the original answer and reflects a deeper strategic repositioning that the LLM overlooks. (4) While the LLM stays within the topic and discusses relevant themes (competitive advantages, segment performance), it substitutes financial detail for strategic insight, leading to a misalignment with the ground truth. The contextual relevance is moderate because it addresses TI’s strategy but through an incorrect evidentiary lens. Correctness is low due to unsupported numbers and omission of the key structural change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 535,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Between 2022 and 2024, Thermo Fisher’s 2.00% 10‑Year Senior Notes due 2025 evolved from a €782 million issuance in 2022 (reflecting a 2.10 % effective rate) to a €663 million balance by the end of 2024, with the effective interest rate rising slightly to 2.07 % as shown in the 2024 debt tables. This evolution reflects both the remaining principal outstanding and the modest increase in the noted effective rate over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple critical dimensions. (1) Quantitative Accuracy: The LLM reports a €782 million issuance in 2022 with a 2.10% effective rate and a decline to €663 million by 2024 at 2.07%, which directly contradicts the ground truth of a $1,200 million USD-denominated note with a consistent 2.23% effective rate in both 2022 and 2024. The currency (euros vs. dollars), principal amount, and interest rates are all wrong. Additionally, the maturity date is falsely stated as 2025, while the ground truth specifies October 15, 2031. (2) Completeness: The answer fails to capture the core fact that there was no change in the principal or effective interest rate between 2022 and 2024, incorrectly implying amortization or repayment. (3) Entity Accuracy: The company (TMO/Thermo Fisher) is correct, but the debt instrument details (maturity year, currency, amount, rate) are all inaccurate. The note is not due in 2025 but in 2031, and it is denominated in USD, not EUR. (4) Reasoning: The multi-hop reasoning is flawed—the LLM appears to have fabricated or confused data from a different debt instrument, possibly misattributing figures from another filing or company. There is no evidence of correct synthesis across years or documents. (5) Semantic Equivalence: The meaning is not equivalent—the ground truth emphasizes stability in the debt instrument, while the LLM suggests change and amortization, which is factually wrong. The answer is contextually relevant in topic but severely deficient in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 432,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE’s sales declined sharply from $1,839 million in 2023 to $1,605 million in 2024 (a 12.8 % drop), reflecting ongoing biosimilar competition and reduced market share. This downturn underscores that REMICADE’s contribution to Johnson & Johnson’s Pharmaceutical segment is diminishing, with growth now driven by newer immunology agents such as TREMFYA and DARZALEX and by oncology products. Consequently, REMICADE is becoming a less central revenue driver within the company’s pharmaceutical portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the sales decline of REMICADE from $1,839 million in 2023 to $1,605 million in 2024, matching the ground truth. The 12.8% decrease is accurately calculated: (1,839 - 1,605) / 1,839 ≈ 0.1272, which rounds to 12.7%–12.8%, so the percentage is correct. (2) All numeric values, years, and financial figures are accurate and properly formatted. The use of 'million' and the dollar amounts are consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers that the sales decline indicates a diminishing role for REMICADE in J&J’s Pharmaceutical segment. It appropriately contextualizes this by referencing the shift toward newer immunology agents (TREMFYA, DARZALEX) and oncology products, which aligns with the ground truth’s implication of competition and newer biologics. (4) The answer is semantically equivalent to the original, though it adds slightly more detail about specific successor products (TREMFYA, DARZALEX), which is plausible and contextually appropriate, even if not in the original answer. The only minor gap is that the original answer explicitly mentions REMICADE’s status in 2022 as a key product, which the LLM implies but does not directly state. However, the focus on 2023–2024 performance and trend is consistent with the question’s scope. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 391,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE sales declined sharply from $1,839 million (2022) to $1,605 million (2023) and further to $1,605 million (2024), with a 12.8% drop in 2024 (down 11.4% operationally). This reflects ongoing biosimilar competition eroding its market position within J&J's Immunology portfolio, where it now represents a small fraction of total Immunology sales ($17.8 billion in 2024). While STELARA and TREMFYA drove Immunology growth, REMICADE's sustained decline underscores its weakening competitive standing as biosimilars gain market share.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key sales figures. According to the ground truth, REMICADE had $3,190 million in sales in 2022, but the LLM incorrectly states $1,839 million. The 2023 figure is not provided in the ground truth, so the LLM's $1,605 million for 2023 cannot be verified, though it aligns with the 2024 number. The LLM correctly reports $1,605 million for 2024. However, the claimed 12.8% drop in 2024 matches the ground truth decline from 2023 to 2024, but the LLM misattributes the starting point. The operational decline of 11.4% is not in the ground truth and cannot be verified. (2) Calculations: The ground truth states a 14.9% decline from 2020 to 2022 (not 2021 to 2022), which the LLM omits entirely. The LLM fabricates a 2022 sales figure and implies a decline from $1,839M to $1,605M (~12.7%), which is numerically close to the reported 12.8% drop but based on incorrect base values. (3) Multi-hop reasoning: The LLM correctly infers that REMICADE is losing market position due to biosimilar competition and contextualizes it within J&J's broader Immunology portfolio growth driven by STELARA and TREMFYA. It also correctly notes REMICADE's shrinking share relative to total Immunology sales ($17.8B in 2024), which aligns with the weakening market position conclusion. (4) Despite correct qualitative trends and contextual understanding, the severe quantitative inaccuracies—especially the wrong 2022 sales figure—undermine the factual reliability. The answer fabricates data not present in the ground truth, leading to a low quantitative accuracy score. However, the reasoning about market position decline is directionally correct, supporting moderate qualitative and contextual scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 477,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "The sales of REMICADE declined 12.8% from 2023 to $1,605 million in 2024, driven by ongoing biosimilar competition that has reduced its market share. This decline contributed to a 1.2% overall decrease in Immunology segment sales ($17,828 million in 2024 vs. $18,052 million in 2023), as noted on page 31. Additionally, the document states that \"Continued infliximab biosimimal competition will result in a further reduction in sales of REMICADE\" (page 32), confirming that biosimilar entry has been a persistent factor in its sales decline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 12.8% decline in REMICADE sales from 2023 to 2024 and the $1,605 million sales figure in 2024, which aligns with the ground truth. However, it omits the 2021 sales figure of $16.8 billion, which is a key part of the question asking about the evolution between 2021 and 2024. This omission significantly affects completeness and quantitative accuracy. (2) The percentage decline (12.8%) and 2024 sales number ($1,605 million) are accurate and correctly formatted. The additional context about Immunology segment sales ($17,828 million in 2024 vs. $18,052 million in 2023) is relevant but not directly part of the ground truth answer, suggesting some extraneous detail. However, the core calculation of the 12.8% drop is consistent. (3) The reasoning correctly attributes the decline to biosimilar competition, citing ongoing market pressure and a direct quote from the document, demonstrating sound multi-hop synthesis and qualitative understanding. The causal explanation matches the ground truth. (4) The answer is contextually relevant and well-supported with document references (pages 31–32), but the failure to mention the 2021 sales baseline undermines the multi-hop requirement to assess performance evolution over the full period. While the 2023–2024 trend is accurate, the absence of the 2021 data point limits the answer’s completeness and factual coverage, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 402,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Based on the provided SEC 10-K filing data, STELARA (ustekinumab) experienced a significant decline in commercial performance between 2022 and 2024. In 2024, sales of STELARA in the United States were approximately $6.7 billion, representing a 4.6% decrease from $10.858 billion in 2023 (page 31). This decline was primarily driven by biosimilar competition in Europe, where third parties had filed abbreviated applications seeking approval for biosimilar versions, with the Company expecting continued biosimilar launches in both Europe and the U.S. in 2025 (page 32). The patent protecting STELARA in the U.S. expired in September 2023, further contributing to the sales reduction as biosimilars entered the market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported 2024 U.S. sales figure of $6.7 billion, which contradicts the ground truth stating global sales of $10,361 million ($10.361 billion) in 2024. The $6.7 billion figure is not supported by the ground truth and misrepresents the scale of STELARA's performance. Additionally, the LLM incorrectly attributes the 4.6% decline to 2024 U.S. sales specifically, while the ground truth reports this as a global decline from $10,858 million in 2023 to $10,361 million in 2024. The 4.6% calculation is approximately correct (a ~4.6% drop from $10,858M to $10,361M), but the LLM misapplies it to an incorrect base number. (2) The LLM introduces details not present in the original answer, such as 'biosimilar competition in Europe' and 'patent expiration in September 2023', which, while potentially true, are not part of the ground truth derived from the knowledge graph and thus cannot be verified as responsive to the provided data. The original answer focuses on regulatory status in 2022 and commercial performance in 2024 without citing reasons for decline. (3) The multi-hop reasoning is partially sound—the LLM attempts to connect regulatory developments with commercial trends—but it fabricates causal explanations and misrepresents geographic scope and sales figures. The original answer correctly identifies the transition from regulatory filing in 2022 to high-revenue maturity in 2024 with a slight decline, but the LLM distorts this narrative with unsupported specifics. (4) The contextual relevance is moderate because the answer addresses the evolution of STELARA’s status and performance, but the qualitative accuracy is reduced due to incorrect entity mappings (e.g., U.S. vs. global sales) and invented details. The correctness score is low due to major quantitative errors despite some accurate directional trends (sales decline, regulatory progression).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 529,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased by 55.2% in 2024 compared to 2023, and by 38.5% in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the percentage decreases: 38.5% in 2023 compared to 2022 and 55.2% in 2024 compared to 2023, which matches the ground truth. However, it does not explicitly mention the actual net revenue figures ($382 million in 2023 and $172 million in 2024) from the original answer, making it slightly less complete. (2) All numeric values and percentages are accurate and correctly attributed to the right years. There are no calculation errors. (3) The multi-hop reasoning is sound—the model correctly synthesizes year-over-year percentage changes across two time periods (2022→2023 and 2023→2024), showing understanding of comparative revenue trends. (4) The answer is semantically equivalent in conveying the key quantitative changes, though it omits the absolute revenue amounts. This minor omission prevents a perfect score, but the core of the question—how revenue changed and the percentage decreases—is fully and accurately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 283,
        "total_tokens": 1374
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Master Lease Agreements have become increasingly strategic between 2022 and 2023 as a mechanism to secure long‑term, predictable revenue streams that underpin AMT’s international expansion.  The agreements—often comprehensive and multi‑year—reduce churn, lock in escalation clauses (typically 3% annually in the U.S. and inflation‑linked abroad), and enable rapid colocation of new tenant equipment, thereby accelerating site utilization and supporting the company’s growth in emerging markets such as India, Africa and Latin America.  This structure not only cushions AMT against carrier consolidation and churn risks but also provides the stable, recurring cash flow needed to fund its aggressive site‑acquisition and development program across its 182,000‑site global portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, aligning with the core themes in the ground truth—long-term revenue, reduced churn, rapid deployment, and risk mitigation. However, it introduces specific details not present in the original answer, such as '3% annually in the U.S.' and 'inflation-linked abroad' escalation clauses, which are not mentioned in the ground truth and cannot be verified from the provided data. Additionally, the LLM references 'emerging markets such as India, Africa and Latin America' as part of the international growth strategy, which adds geographic specificity absent in the original answer and may not be supported by the knowledge graph. (2) Quantitatively, the LLM correctly states the 182,000-site global portfolio in 2023, matching the ground truth. However, it fails to mention the 2022 portfolio size of approximately 177,000 sites, which is a key comparative metric in the original answer. The omission of this number reduces quantitative completeness, even though the 2023 figure is accurate. (3) The multi-hop reasoning is generally sound—the LLM synthesizes the role of MLAs in revenue stability, churn reduction, and supporting international growth across years. It correctly infers that MLAs enable rapid deployment and reduce cycle times (implied by 'accelerating site utilization'). However, it adds unverified specifics (escalation rates, regions) that go beyond the source material, weakening factual accuracy. (4) The contextual relevance is high, as the answer directly addresses the evolution of MLAs between 2022 and 2023 and their strategic importance. The qualitative reasoning is strong but slightly overreaches with unsupported details. The correctness score is 7 due to accurate core facts and strategic narrative, but docked for missing 2022 site count and introducing unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 532,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "The role of Google Marketing Platform in Alphabet’s advertising revenue has expanded significantly between 2023 and 2024, now serving as a key channel for delivering both performance and brand advertising across Google Network properties. Advertising revenues from this platform are recognized on a gross basis when we act as principal, with revenue recorded at the amount billed to customers and partner payments reported as cost of revenues. This structure allows Alphabet to capture full market pricing while managing recognition across its broader Google Network ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts. (1) It accurately states that advertising revenues are recognized on a gross basis when Google acts as principal, with revenue recorded at the amount billed to customers—this matches the 2023 and 2024 gross revenue recognition described in the original answer. It also correctly identifies the role of Google Marketing Platform in delivering both performance and brand advertising across Google Network properties, which reflects the expanded functional emphasis noted for 2024. (2) There are no numeric values, dates, or financial figures in either answer that conflict; the LLM correctly references the relevant time period (2023–2024) and proper accounting treatment (gross recognition, partner payments as cost of revenues), so quantitative accuracy is perfect. (3) However, the LLM answer does not explicitly mention the evolution in the platform’s role between 2023 and 2024—specifically, the shift toward a more nuanced evaluation of principal vs. agent status based on control over inventory, which is a key differentiator in the original answer. This omission reduces the qualitative accuracy slightly, as it fails to fully capture the multi-hop reasoning about how the accounting justification matured in 2024. (4) Despite this, the answer remains contextually highly relevant, directly addressing the question about revenue recognition and management across Google Network properties. The synthesis is sound, though not fully complete in reflecting the evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 431,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Between 2023 and 2024, Federal Funds Purchased decreased from $14,804 million to $178,609 million (a modest decline), while Securities Loaned fell from $3,645 million to $192,859 million (a substantial drop). These declines indicate that Bank of America reduced its reliance on short‑term wholesale funding, shifting toward more stable funding sources such as deposits and retained earnings to support its short‑term liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It claims Federal Funds Purchased decreased from $14,804 million to $178,609 million, which is logically inconsistent (a larger number cannot be a 'decrease' from a smaller one), and misrepresents both the direction and magnitude of change. Similarly, it states Securities Loaned fell from $3,645 million to $192,859 million—a supposed 'drop' to a much higher value—demonstrating a fundamental error in interpretation. The ground truth states a net increase in volume of $16,466 million in 2023 and a 2024 fair value of $192,859 million, indicating growth, not decline. (2) Quantitatively, the LLM uses incorrect base figures not found in the original answer and mislabels trends. The only correct number is the $192,859 million fair value in 2024, but it is misapplied as a 'decline'. The calculation and comparison of changes are entirely flawed. (3) The multi-hop reasoning fails: instead of synthesizing that BAC increased its use of short-term secured funding, the LLM incorrectly infers a reduction and a shift to stable funding, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the general topic of short-term funding strategies, but the incorrect data and reasoning lead to an opposite and false conclusion. Thus, the answer is mostly incorrect with one coincidentally accurate number used in the wrong context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 397,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosures regarding pension and retiree medical plan liabilities shifted from a general discussion of market risks (e.g., interest rate and inflation impacts on pension assets/liabilities in 2022) to explicit quantification of sensitivity in 2024. In the 2024 filing (page 43), it states that a 1-percentage-point increase in interest rates would decrease net interest expense by $32 million due to higher cash balances, and notes that pension plan assets/liabilities are exposed to market fluctuations (referenced in \"Our Critical Accounting Policies and Estimates\"). The 2022 filing (page 39) only broadly mentions market risks affecting pension liabilities without specific sensitivity metrics, while the 2024 filing provides concrete, quantifiable exposure to interest rate changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that PepsiCo 'explicitly quantified' sensitivity in 2024 with a '$32 million' impact from a 1-percentage-point interest rate increase is incorrect and not supported by the ground truth. The original answer makes no mention of any such quantification or specific dollar impact, nor does it reference interest rate sensitivity in this way. This number appears to be fabricated or misattributed. (2) The LLM incorrectly frames the evolution as a shift from 'general discussion' to 'quantification', while the ground truth states the change was broadening the risk factors discussed—from market fluctuations (2022) to include inflationary, deflationary, and recessionary conditions (2024). The core of the evolution is the expansion of macroeconomic risk context, not the introduction of numerical sensitivity metrics. (3) The LLM misrepresents the 2024 disclosure by citing a specific page (43) and linking interest rate changes to net interest expense and cash balances, which is unrelated to pension and retiree medical plan liabilities. This reflects a fundamental confusion between different financial disclosures. (4) While the LLM correctly identifies that the 2022 disclosure referenced 'Our Critical Accounting Policies and Estimates' and was less detailed, it fails to capture the actual qualitative evolution described in the ground truth. The answer is contextually relevant and attempts multi-hop reasoning across years, but the reasoning is based on incorrect data. Thus, despite correct entity identification (PepsiCo, pension plans, correct time frame), the quantitative inaccuracy and mischaracterization of the disclosure evolution severely reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 480,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan remains positioned as a free, mobile-first scanning tool that transforms paper documents into editable PDFs via Adobe Document Cloud, maintaining its core functionality while being integrated into the broader Adobe Experience Cloud ecosystem. The 2024 context emphasizes its role within Adobe's AI-driven document workflows (e.g., Acrobat AI Assistant, Firefly integration), though its standalone positioning as a free mobile app for basic scanning has not changed significantly year-over-year.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe Scan's core functionality as a free mobile scanning tool integrated with Adobe Document Cloud and notes the continued emphasis on AI-driven workflows in 2024, such as Firefly integration. However, it incorrectly states that Adobe Scan is part of the 'Adobe Experience Cloud ecosystem,' which is inaccurate—ground truth confirms it remains within Adobe Document Cloud, not Experience Cloud. This misattribution affects entity accuracy and reasoning. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable; no errors here. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in Adobe Scan’s positioning and recognizes the broader trend toward AI integration. However, the failure to accurately situate Adobe Scan within Document Cloud (not Experience Cloud) undermines the synthesis. It also omits the specific 2024 emphasis on Content Credentials and digital trust mechanisms, which are key differentiators in the evolution. (4) The answer is contextually relevant and captures the general trajectory of Adobe Scan’s evolution, but the incorrect ecosystem attribution and missing details on digital trust reduce qualitative accuracy. Correctness score is 7 due to core factual accuracy on functionality and AI trends, but with notable omissions and one significant entity error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 396,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "From its 2023 launch, Gemini was introduced as Google’s first natively multimodal model, enabling it to understand and combine text, images, audio and video in a single system. By 2024, Gemini 2.0 was released as the most capable version yet, powering AI features across all of Google’s major products—including Search, Android, Chrome, Gmail, Maps, Play Store and YouTube—while also being integrated into Google Cloud’s Vertex AI platform for developers. This evolution transformed Gemini from a research breakthrough into a core, multimodal engine that drives search enhancements, generative AI experiences, and new assistant capabilities such as Project Astra and Project Mariner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was introduced in 2023 as a natively multimodal model (text, images, audio, video), and in 2024, Gemini 2.0 was launched as the most capable version. It was integrated into all seven of Google's major two-billion-user products—Search, Android, Chrome, Gmail, Maps, Play Store, and YouTube—matching the original answer. The mention of integration into Google Cloud’s Vertex AI platform is an additional detail not in the ground truth but is factually plausible and does not contradict it. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2023 and 2024), or product counts (seven products). (3) Multi-hop reasoning is sound: the answer synthesizes the evolution over time, product integration, and advanced applications like Project Astra and Project Mariner, correctly framing Gemini’s progression from research to core infrastructure. (4) The only minor shortcoming is that the original answer specifies Gemini 2.0 became the most capable model and highlights its use in experimental prototypes, while the LLM slightly rephrases this as 'new assistant capabilities'—a reasonable interpretation but slightly less precise. Overall, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 375,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Linde's helium-related sales and operating profit trends are embedded within the \"Other\" segment, which includes global helium wholesale and LAMT. In 2024, sales for \"Other\" decreased 2% due to lower volumes in global helium, while operating profit increased 44% driven by insurance recoveries for LAMT partially offset by higher helium-related costs. This indicates helium's impact on profitability improved year-over-year despite modest sales declines. The document does not provide standalone helium sales figures but links helium's performance to the broader \"Other\" segment dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2% sales decrease in the 'Other' segment due to lower global helium volumes and the 44% operating profit increase in that segment, which aligns with the ground truth. It also correctly notes that higher helium-related costs partially offset insurance recoveries in LAMT. However, it mischaracterizes the evolution of Linde's relationship with helium by stating that 'helium's impact on profitability improved year-over-year,' which contradicts the ground truth that helium had a negative impact in 2024 after being neutral/positive in 2022. The answer fails to mention the shift in relationship from positive/neutral in 2022 to negative in 2024, a key qualitative point. (2) Quantitatively, all numbers (2% sales decrease, 44% profit increase) are accurate and correctly attributed. There are no calculation errors. (3) The multi-hop reasoning is partially sound—information is synthesized across segments and years, but the conclusion drawn about improving helium profitability contradicts the source. The model fails to recognize that higher costs from helium limiting profit growth despite insurance recovery indicates worsening, not improving, impact. (4) Scores reflect mostly correct numbers and relevance to the question, but significant qualitative inaccuracy in interpreting the trend and evolution of the helium relationship, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 394,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights declined slightly from $1,891 million in 2022 to $1,858 million in 2024, a decrease of $33 million over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the net value of acquired franchise rights was $789 million in 2022 and $598 million in 2024, whereas the LLM claims $1,891 million in 2022 and $1,858 million in 2024. These numbers are not only wrong but over twice the correct magnitude. The calculated decrease of $33 million by the LLM is also incorrect; the actual decline is $191 million ($789M - $598M), which is a significant drop, not a slight decline. (2) Quantitative accuracy is extremely low: both the starting and ending values are wrong, and the difference is miscalculated. Even allowing for format variations, the numbers are not plausibly close. (3) The qualitative reasoning is flawed: while the LLM correctly identifies a downward trend (decline), it misrepresents the magnitude as 'slight' when the ground truth describes it as 'significant', indicating a failure in synthesizing the correct context. The model does not demonstrate accurate multi-hop reasoning, as it fails to retrieve and compare the correct values across years. (4) Contextual relevance is moderate because the answer addresses the right metric (net value of acquired franchise rights) and time frame (2022 to 2024), and attempts a comparison, but with entirely incorrect data. Thus, while the structure of the response is relevant, its factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 391,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron’s natural‑gas delivery commitments and Tengizchevroil production volumes are not detailed in the provided 2023‑2024 SEC 10‑K excerpts. The filings disclose general gas‑sales contracts (e.g., 2.9 trillion cubic feet of gas to be delivered from Australia and Israel through 2026) and worldwide gas production figures, but they do not specify the evolution of any specific Tengizchevroil delivery commitment or its production volume trajectory from 2023 to 2024. Consequently, the requested evolution cannot be determined from the supplied pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. (1) The original answer provides specific, quantified data for Chevron's natural gas volumes in 2023 and 2024, including both operational consumption (596 to 609 MMcf/d) and volumes sold (7,148 to 7,569 MMcf/d), explicitly tied to Tengizchevroil. The LLM claims this information is not available in the filings, which is false according to the ground truth. (2) There are no correct numbers or calculations in the LLM response; it fails to report any of the key figures, resulting in a quantitative accuracy score of 1. (3) The reasoning is flawed: the question requires a multi-hop synthesis of Chevron’s gas volumes and their relation to Tengizchevroil across two years, which the ground truth provides. The LLM incorrectly concludes the data is unavailable, failing the core task. (4) Contextual relevance is low because the answer dismisses the possibility of deriving the information rather than engaging with the actual data. The response may reflect a limitation in the model’s access or retrieval, but based on the provided ground truth, it is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 326,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has shifted from being treated as a cost of revenue (where payments to partners were recorded as cost of revenues) to being recognized as a revenue share that is now disclosed as part of the company's advertising revenue structure, with the 2024 filing showing that payments to Google Network partners are now accounted for as a reduction in revenue (i.e., reported on a gross basis with partner payments as cost of revenue) rather than as a separate expense line, reflecting a more integrated integration of network partner revenue into the core advertising revenue model.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct context regarding a shift in how payments to Google Network partners are accounted for, but fundamentally misrepresents the nature of the change. (1) The original answer states that in 2023, payments to Google Network partners were described as a standard operating expense under cash from operating activities, and in 2024 they were re-categorized under Traffic Acquisition Costs (TAC), explicitly tied to ad revenue generation. The LLM incorrectly claims that the change involved moving from 'cost of revenue' to a 'revenue share' model where payments are a reduction in revenue (i.e., gross vs net reporting). This is not supported by the ground truth and mischaracterizes the accounting treatment. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which the LLM gets right. (3) The multi-hop reasoning is flawed: the LLM invents a gross vs net revenue reporting shift that is not present in the original answer, and incorrectly frames the evolution as a change in revenue recognition rather than a reclassification within operating expenses. (4) While the answer is relevant to the topic and attempts to explain an accounting evolution, the core factual claim about revenue sharing and gross reporting is incorrect, leading to a low correctness and qualitative accuracy score. The contextual relevance is moderate because it addresses the right companies and time frame and recognizes a shift, but the substance is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 426,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America’s climate‑related regulatory requirements shifted from a focus on evolving disclosure and reporting obligations (e.g., SEC climate‑related rules and global benchmark reforms) to heightened, divergent jurisdictional mandates—such as the OECD 15 % global minimum tax, stricter U.K. tax‑asset assessments, and expanding climate‑related reporting and emissions‑target requirements—raising compliance complexity and creating new cross‑border legal risks. This evolution has amplified the company’s exposure to differing regulatory expectations across the U.S., U.K., EU and other jurisdictions, increasing potential penalties, litigation and reputational exposure tied to climate‑related disclosures and actions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend described in the ground truth—increasing regulatory pressure and jurisdictional divergence affecting Bank of America's climate-related compliance risks from 2023 to 2024—and correctly identifies the evolution from anticipated to actual impacts. However, it introduces specific policies not mentioned in the original answer, such as the 'OECD 15% global minimum tax' and 'stricter U.K. tax-asset assessments,' which are unrelated to climate-related regulatory requirements and not supported by the ground truth. While jurisdictional divergence and increased compliance risks are accurately highlighted, the LLM misattributes these to tax policies and specific international frameworks not referenced in the original answer. The ground truth emphasizes climate-related disclosure requirements (e.g., SEC rules, global benchmarks) and the shift from expected to experienced impacts, which the LLM partially reflects but distorts with irrelevant details. Quantitatively, there are no explicit numbers, so accuracy is high by default (e.g., '15%' is correctly stated but irrelevant). The reasoning is partially sound in recognizing multi-jurisdictional complexity, but the synthesis includes unsupported external elements, weakening the qualitative accuracy. Contextually, the answer remains relevant to regulatory evolution and compliance risks, earning high marks for relevance despite factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 396,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "From 2022 to 2024 GM’s strategy has shifted to double‑down on its full‑size pickup and mid‑size truck lines, using higher wholesale volumes and a more profitable mix to lift GMNA net sales (+11.4% in 2024) and EBIT‑adjusted (+18.1% in 2024).  In 2024 the company reports a $12.8 billion volume‑driven increase in GMNA net sales, with full‑size pickups accounting for the bulk of that growth, and notes that trucks now represent roughly 23.7 % of residual‑value units and generate higher variable profit, signaling a stronger market position for this product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several incorrect quantitative claims not present in the ground truth. Specifically, it states a +11.4% increase in GMNA net sales and +18.1% in EBIT-adjusted, along with a $12.8 billion volume-driven increase in net sales—none of which appear in the original answer and cannot be verified from the provided truth. Additionally, the claim that trucks represent '23.7% of residual-value units' is not mentioned in the ground truth and appears to be fabricated or misattributed. The ground truth highlights a 'variable profit of approximately 160%' on a weighted-average basis for full-size pickup trucks in 2024, which the LLM omits entirely. (2) The original answer does not provide any percentage growth in sales or EBIT, nor does it mention mid-size trucks or residual-value units. Thus, these numerical additions are factually unsupported. The only correct quantitative element is the general direction of growth in wholesale volumes and profitability, which aligns qualitatively with the truth. (3) The reasoning correctly identifies a strategic evolution from risk (2022) to strength (2024), and links increased wholesale volume to improved financial performance—this multi-hop synthesis is sound. However, the introduction of unverified metrics undermines the accuracy. The LLM captures the shift in strategic emphasis and infers stronger market positioning, which is contextually appropriate. (4) The correctness score is 6 due to partially accurate facts but significant quantitative errors. Quantitative accuracy is low (4) because key numbers are either incorrect or invented. Qualitative accuracy is moderate (7) as the narrative logic and entity identification (GM, full-size pickups, 2022–2024 shift) are correct. Contextual relevance is high (9) because the answer directly addresses the question’s focus on strategic evolution and performance indicators.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 515,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts declined modestly—from $9 million at the end of 2022 to $9 million at the end of 2023, and then to $9 million again by the end of 2024—indicating a relatively stable but small position. This shift suggests the company is maintaining a conservative, liquid investment posture for its decommissioning funds, while gradually emphasizing higher‑yielding or alternative assets (e.g., private‑equity, real‑estate, and corporate bonds) to enhance returns without significantly altering the overall risk profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It states that allocations were $9 million in 2022, 2023, and 2024, which contradicts the ground truth showing $21 million (Alabama Power) and $293 million (Georgia Power) in 2022, and $20 million and $349 million respectively in 2024. The LLM fails to mention either company specifically and instead aggregates a non-existent total of $9 million across years. (2) Quantitative accuracy is extremely low: the numbers are factually wrong, no correct calculations are made, and the trend described (stable at $9M) is false. The actual trend involves a slight decrease for Alabama Power and a significant increase for Georgia Power, which the model completely misses. (3) Qualitative reasoning is flawed: the LLM infers a shift toward higher-yielding assets based on fabricated data, while the ground truth suggests a strategic reallocation toward Georgia Power’s portfolio. The model introduces speculative asset classes (private equity, real estate) not mentioned or implied in the original answer. (4) Contextual relevance is low but not zero—the response addresses investment strategy in the context of decommissioning trusts and attempts to interpret the shift, so partial credit is given for staying on topic. However, due to pervasive factual and quantitative errors, the overall correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 387,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo’s relationship with independent bottlers shifted toward greater financial incentives and deeper strategic dependency. The company expanded bottler funding—annual, performance-based payments supporting advertising, consumer promotions, new product launches, and equipment placement—while maintaining exclusive territorial rights and perpetual franchise agreements that lock in long-term supply relationships. This increased reliance on bottler funding, coupled with the absence of any contractual limits on franchise rights, reinforces strategic dependency, as these rights are treated as indefinite-lived assets and are critical to PepsiCo’s global distribution model.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PepsiCo's relationship with independent bottlers from 2022 to 2024, noting increased structure in financial incentives and strategic dependency. It accurately describes the shift toward annual, performance-based funding for advertising, consumer promotions, new product launches, and equipment placement—aligning with the ground truth’s mention of specific allocation across trade and consumer programs. However, the LLM introduces information not present in the original answer: 'exclusive territorial rights,' 'perpetual franchise agreements,' and 'absence of contractual limits on franchise rights' are not mentioned in the ground truth and cannot be verified from the provided data. Additionally, while the LLM emphasizes indefinite-lived assets and global distribution model, these points, though plausible, go beyond the scope of the original answer. (2) Quantitatively, the LLM does not include the specific 14% revenue contribution from Walmart in 2024, which is a key factual element in the ground truth. This omission reduces quantitative completeness, though no incorrect numbers are stated (so no direct inaccuracy). (3) The multi-hop reasoning is partially sound—the model infers deeper strategic dependency based on funding mechanisms and long-term agreements, which is reasonable, but it fails to incorporate the concrete evidence (Walmart’s 14% of revenue) that supports the claim in the original answer. Thus, the synthesis is logical but incomplete. (4) The contextual relevance is high because the response directly addresses financial incentives and strategic dependency over time. The qualitative accuracy is reduced due to unsupported additions about franchise agreements and lack of key revenue dependency metric. Correctness score is 7 because core financial incentive evolution is accurate, but significant strategic dependency evidence is missing or supplemented with unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 533,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly’s role in the company’s innovation strategy has shifted from a nascent, experimental capability in 2023 to a core, strategically‑integrated AI platform by 2024, as reflected in its expanded trademark coverage and heightened risk disclosures that emphasize both the growth potential and the regulatory, competitive and reputational risks associated with its AI investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation of Adobe Firefly's evolving strategic role from 2023 to 2024, with accurate contextual framing around trademark listings and risk disclosures. It correctly identifies the increased strategic emphasis on Firefly in 2024, particularly through heightened risk disclosures, which aligns with the ground truth. The mention of expanded trademark coverage and risk factors related to regulatory, competitive, and reputational issues is consistent with the idea that Firefly became a more central, forward-looking component of Adobe’s AI strategy. However, the LLM slightly overreaches by characterizing Firefly in 2023 as a 'nascent, experimental capability,' which is not supported by the original answer—ground truth states it was already listed as a trademark in 2023, indicating it was established, not experimental. Additionally, while the original answer emphasizes the shift from being a registered brand to a highlighted innovation in risk factors, the LLM reframes this as a broader platform evolution without explicitly noting the specific change in disclosure type (from trademark listing to risk factor mention), which is a key multi-hop insight. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are involved), and the reasoning is mostly sound, though not perfectly aligned with the evidence-based progression in the ground truth. The answer remains contextually relevant and captures the essence of strategic elevation, warranting a solid but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 428,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant‑billing growth shifted markedly from 2022 to 2023. In 2022, escalations contributed to growth but churn remained modest (≈4 % in 2021 and ≈3 % in 2023), so rent increases were the primary growth lever. By 2023, however, churn rose to about 3 % of tenant billings—driven largely by cancellations and non‑renewals in the U.S. & Canada segment, especially T‑Mobile’s legacy Sprint leases—causing the net effect of rent escalations to be partially offset by the loss of revenue from churned tenants. Consequently, while escalations still add to billing growth, their contribution is now tempered by higher churn that erodes the incremental rent that would otherwise be realized.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key shift in the role of contractual rent escalations from 2022 to 2023, including the countervailing effect of increased churn, particularly from T-Mobile's lease cancellations in the U.S. & Canada segment. The answer correctly identifies that while rent escalations remained a growth driver, their net impact was partially offset by churn in 2023. However, there is a minor inaccuracy in the quantitative description: the LLM states that churn was '≈4 % in 2021 and ≈3 % in 2023', but the ground truth only confirms the 2023 churn rate of approximately 3% and does not provide 2021 data—thus introducing unsupported information. This affects quantitative accuracy slightly. The core reasoning and synthesis across years and factors (escalations vs. churn) are sound, and the mention of T-Mobile’s legacy Sprint leases adds relevant context. The answer addresses all parts of the question and maintains semantic equivalence with the original answer, though it slightly overstates the historical churn trend. Hence, correctness is high but not perfect due to the extraneous 2021 churn figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 322,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's capital expenditure commitments to Tengizchevroil have remained focused on the $1.5 billion allocated to the FGP/WPMP project in Kazakhstan, which is part of the company's broader $16 billion 2024 capex plan and includes roughly one‑third of its affiliate‑level spending. While Chevron continues to be involved in the upstream operations of Tengizchevroil through its equity stake, there is no indication of any new, significant increase in capital commitments between 2023 and 2024; the company's disclosed capex for the joint venture remains around $1.5 billion, consistent with its prior‑year allocation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that nearly half of Chevron's $3 billion Affiliate Capex in 2024—approximately $1.5 billion—was allocated to Tengizchevroil's FGP/WPMP project. While the LLM correctly identifies $1.5 billion as the amount, it incorrectly frames this as a fixed, ongoing commitment without noting that the $3 billion total Affiliate Capex was *expected in 2024*, not confirmed from 2023. The LLM also introduces a $16 billion total 2024 capex figure not present in the original answer, which distorts context. Additionally, stating that $1.5 billion represents 'roughly one-third' of affiliate-level spending contradicts the original 'nearly half' characterization, introducing a material calculation error. (2) The entity identification (Chevron, Tengizchevroil, FGP/WPMP project, Kazakhstan) and time periods (2023–2024) are accurate. However, the reasoning misrepresents the evolution: the original emphasizes a shift from capital investment (2023 focus) to production involvement (2024 focus), but the LLM fails to highlight this transition, instead asserting continuity without change. (3) The multi-hop synthesis is partially correct—linking Chevron to Tengizchevroil and identifying capex allocation—but misses the key conceptual shift from development to operational phase, which is central to the question about evolution. (4) Contextual relevance is strong as the answer addresses capex and production involvement, but the failure to accurately reflect the shift in relationship phase and the introduction of unsupported figures reduce factual correctness. Quantitative accuracy is low due to incorrect proportions and extraneous numbers; qualitative accuracy is moderate due to correct entities but flawed reasoning; contextual relevance remains high as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 508,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "The specificity of UPS’s bond‑matching approach for determining the discount rate for its U.S. pension and postretirement benefit plans has remained consistent between 2023 and 2024 – the company continues to select individual bonds that match the timing of projected benefit payments to establish the discount rate, rather than relying on a generic yield‑curve assumption. However, the actual discount rates applied shifted slightly: the 2024 U.S. pension discount rate was 5.88 % (up from 5.42 % in 2023), and the 2024 postretirement medical discount rate was 6.18 % (up from 5.80 % in 2023), reflecting the updated bond‑matching calculations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UPS uses a bond-matching approach for determining the discount rate and that the method is based on matching bonds to projected benefit payments. However, it introduces specific discount rate numbers for 2023 and 2024 (e.g., 5.88% vs 5.42% for pensions, 6.18% vs 5.80% for postretirement) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but are not supported by the knowledge graph excerpt, making their inclusion problematic. (2) The quantitative accuracy is partially correct in that the direction of rate changes (increases) aligns with typical market trends, but without confirmation from the source, these numbers represent unsupported additions. The original answer focuses on qualitative evolution in disclosure language, not numerical shifts in discount rates. (3) The multi-hop reasoning is flawed because the question asks about the evolution in the *specificity* and *framing* of the bond-matching approach, not changes in resulting discount rates. The LLM misdirects focus from disclosure language and methodological framing to numerical outcomes, missing the core nuance: the shift from describing the method as reflecting settlement intent to stating it 'guides' the selection process. This subtle but important evolution in operational framing is entirely omitted. (4) While the answer remains contextually relevant by discussing the correct company, plan types, and general methodology, it fails to capture the key qualitative shift in disclosure tone and specificity emphasized in the ground truth. The inclusion of unverified numbers reduces factual reliability, and the absence of the 'guides' language evolution undermines qualitative accuracy. Hence, the correctness score is moderate due to partial factual alignment but significant omission of the central point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 521,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde’s helium business shifted from being a major growth driver to a smaller, more stable part of its portfolio, with helium sales declining slightly (‑2% in 2024 versus 2023) due to lower volumes and pricing pressure, while the company offset this by focusing on higher‑margin projects and cost‑pass‑through mechanisms. This evolution contributed to a modest rise in overall sales for the “Other” category (which includes global helium wholesale) of $32 million (‑2%) in 2024, but operating profit in that category actually increased $19 million (44%) because insurance recoveries and productivity gains outweighed the higher helium‑related costs. Consequently, the net financial impact was limited: sales grew only modestly and operating profit improved slightly, reflecting the transition of helium from a high‑growth to a more mature, profit‑contributing line item.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that helium had a negative impact on Linde's sales in 2024, with a $32 million (2%) decrease in the Other segment due to lower helium volumes. However, the LLM incorrectly frames this as a 'modest rise in overall sales' of $32 million, which is the opposite of the truth—$32 million is a decrease, not an increase. Additionally, the LLM claims operating profit increased by $19 million (44%), but the original answer does not mention any such profit increase; instead, it states that helium-related costs pressured operating profit, partially offset by an insurance recovery. There is no support for a 44% profit gain. (2) Quantitative accuracy is poor: the $32 million figure is misrepresented as a sales increase rather than a decrease, and the 2% is correctly associated with sales but mischaracterized in direction. The $19 million and 44% figures are entirely fabricated and not present in the ground truth. (3) Multi-hop reasoning fails: the model incorrectly infers that helium transitioned from a growth driver to a stable profit contributor, while the ground truth shows a deterioration—from a supply input in 2022 to a source of operational and financial drag in 2024. The synthesis of cost pressures, volume declines, and insurance recovery is distorted. (4) Contextual relevance is moderate because the answer addresses Linde, helium, and financial impacts over time, but the conclusions are factually inverted. The core financial and operational narrative is incorrect, warranting a low correctness score despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 451,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Based on the provided 10-K filings, Bank of America's unfunded capital commitments for renewable energy investments decreased from $6.2 billion at December 31 2023 to $4.6 billion at December 31 2024. Correspondingly, the recognized tax credits related to these renewable energy investments declined from $3.9 billion in 2023 to $3.0 billion in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the tax credit figures. According to the ground truth, in 2023, Bank of America recognized $4.0 billion in tax credits, and in 2024, it recognized $3.9 billion. However, the LLM incorrectly states that tax credits declined from $3.9 billion in 2023 to $3.0 billion in 2024, reversing the correct values and introducing a false $0.9 billion drop. This is a major quantitative error affecting the core of the question. (2) The unfunded capital contributions are correctly reported: $6.2 billion in 2023 and $4.6 billion in 2024, showing a correct $1.6 billion decrease. This part is accurate. (3) The multi-hop reasoning is partially sound— the model identifies the need to compare both unfunded commitments and tax credits across years— but fails in synthesizing the correct tax credit figures, undermining the conclusion about tax benefit stability. (4) Contextually, the answer is well-structured and relevant, addressing both parts of the question, but the incorrect tax credit numbers lead to a misleading interpretation. The conclusion that tax credits 'declined' significantly is false per ground truth, which notes they 'slightly declined' from $4.0B to $3.9B. Thus, while structure and intent are good, factual correctness is compromised by key number swaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 372,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, GM’s fleet sales strategy shifted toward greater profitability focus, reducing fleet volume (down from 710,000 vehicles in 2021 to 710,000 in 2024 with fleet share declining from 16.1% to 11.3% of total sales) while maintaining commercial fleet customer engagement through dealer channels. The company explicitly prioritizes profitability over volume in fleet transactions, particularly for daily rental and commercial fleet sales, which are noted as \"generally less profitable than retail sales to end customers.\" This evolution reflects a strategic pivot to optimize revenue mix rather than expand fleet market share.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims fleet sales were 710,000 vehicles in both 2021 and 2024, with fleet share declining from 16.1% to 11.3%, but this data is not present in the original answer (ground truth) and cannot be verified from the provided context. No specific volume or percentage figures were mentioned in the ground truth for 2022 or 2024, so including such precise numbers is factually unsupported. (2) The calculation or comparison of fleet share drop from 16.1% to 11.3% and the repetition of 710,000 units across years appears fabricated or misattributed, as the original answer focuses only on qualitative shifts in sales channels and profitability, not volumes. (3) Qualitatively, the LLM captures the correct direction of GM’s strategic shift—prioritizing profitability over volume in fleet sales, especially for daily rental and commercial fleets—and correctly notes that these sales are less profitable than retail. It also aligns with the idea of maintaining engagement through dealer channels, which matches part of the 2024 evolution described in the ground truth. However, it omits the key point about the dual-channel approach (direct and through dealers) being more explicitly structured by 2024, which is central to the original answer’s claim of strategic evolution. (4) Contextually, the response is relevant and addresses the question’s focus on evolution in sales channels and profitability. While the reasoning about profitability focus is sound, the unsupported numerical claims severely undermine factual correctness. The synthesis is partially accurate but weakened by hallucinated data. Thus, the correctness score is moderate due to correct qualitative direction but major quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 484,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo’s relationship with Sabra underwent a strategic shift: in 2022 the company sold its Tropicana, Naked and other select juice brands to PAI Partners while retaining a 39% non‑controlling interest in a newly formed joint venture that would operate across North America and Europe, effectively reducing its direct ownership and operational control over Sabra’s U.S. business. This divestiture‑related transaction generated a pre‑tax gain of $122 million in the FLNA division (recorded in SG&A) and a larger $3.0 billion gain in the PBNA division (part of the “Juice Transaction” noted on page 73), which boosted division operating profit and overall corporate earnings. The reduced stake also meant that future financial results for Sabra would be reflected only as a minority interest, limiting PepsiCo’s direct profit exposure but preserving a strategic foothold in the joint venture’s growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a $122 million pre-tax gain, it misattributes this gain to the sale of Tropicana and Naked brands to PAI Partners, which is a separate transaction from the Sabra divestiture. The original answer states that PepsiCo went from full ownership of Sabra in 2022 to a 50% equity stake in 2024, but the LLM claims a 39% non-controlling interest, which is incorrect. Additionally, the LLM introduces a $3.0 billion gain from the 'Juice Transaction'—a detail entirely unrelated to Sabra, further conflating distinct corporate actions. (2) Quantitatively, the $122 million gain is correctly stated, but the $3.0 billion figure is irrelevant to Sabra and thus misleading. The 39% stake is factually wrong—ground truth specifies 50%. Dates (2022–2024) are correct, but the events described do not align with the Sabra timeline. (3) The multi-hop reasoning fails: the model incorrectly synthesizes information by merging the Sabra ownership change with the unrelated juice brands divestiture. It does not establish the correct causal link between remeasuring a 50% equity stake and the $122 million gain specific to Sabra. (4) Despite referencing a correct gain amount and the general timeframe, the core entities (Sabra vs. Tropicana/Naked), ownership percentages, and transaction context are wrong, leading to a mostly incorrect narrative. The answer is contextually relevant in discussing PepsiCo’s portfolio changes but fails on factual and logical accuracy regarding Sabra specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 434,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe has shifted Adobe Scan from a standalone mobile scanning app to a tightly integrated component of its broader Document Cloud ecosystem. In the 2024 filing, Adobe Scan is positioned alongside Acrobat Reader and Acrobat Sign as a free, complementary tool that feeds into the unified PDF and e-signature platform, reinforcing its role within the Acrobat Pro and Document Cloud subscriptions rather than operating as a separate consumer product. This evolution reflects Adobe's strategy to consolidate its document productivity tools under a cohesive cloud-based workflow, emphasizing integration with Acrobat Sign and AI-powered features like Adobe Scan's OCR capabilities within the broader Document Cloud experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answer that require verification—dates (2023, 2024) are correct and consistent with the original answer. (2) The LLM correctly identifies the evolution of Adobe Scan’s positioning: from a recognized product (implied in 2023 via trademark status) to an integrated component of Adobe Document Cloud in 2024. While the original answer emphasizes trademark listing in 2023, the LLM infers this into a 'standalone app' characterization, which is reasonable but slightly extrapolated. (3) The multi-hop reasoning is sound—synthesizing information across years and product strategy shifts. The LLM correctly links Adobe Scan to Acrobat, Acrobat Sign, and Document Cloud in 2024, accurately reflecting integration into a broader ecosystem. (4) The answer adds contextual detail not in the original (e.g., OCR capabilities, free tool status, subscription model), which is plausible and enhances relevance without contradicting facts. Only minor deduction from qualitative accuracy due to slight overreach in describing 2023 status beyond 'trademark listing.' Overall, the answer is semantically equivalent, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 352,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "From 2022 through 2024 GM’s financial exposure related to indemnifications and historical liabilities has shifted from a $5.6 billion estimate of reasonably‑possible indirect‑tax losses (recorded in 2024) to a situation where most indemnity‑related claims—such as the Takata airbag, ARC inflator and Bolt‑EV battery matters—are now either settled, accrued for modest amounts, or deemed remote, with only a few ongoing class actions (e.g., the Stellantis emissions‑related indemnity and certain emissions or warranty class actions) still unable to provide a quantifiable loss range. Consequently, while GM continues to accrue for probable product‑liability and warranty costs, the magnitude of potential indemnification outflows has generally declined, and the company now cannot estimate a material loss from most of these obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of General Motors' financial exposure to Stellantis from 2022 to 2024. (1) Quantitatively, the $5.6 billion estimate for indirect-tax losses is not mentioned in the ground truth and is unrelated to Stellantis indemnifications; this figure is factually incorrect in context. The ground truth states that GM accrued an 'immaterial amount' as of December 31, 2024, with no specific dollar value provided—certainly not a $5.6B liability. Additionally, the LLM incorrectly frames Takata-related recalls and Bolt-EV battery matters as GM's indemnity obligations to Stellantis, when in fact these are GM’s own product liabilities, not indemnifications owed to Stellantis. (2) The LLM conflates GM’s general indemnification disclosures (e.g., product liabilities, warranty claims) with specific obligations to Stellantis, which according to the ground truth are limited to emissions-related lawsuits, Takata-related recalls (as passed through due to legacy Opel/Vauxhall), and European end-of-life vehicle investigations. The mention of 'Stellantis emissions-related indemnity' is partially correct but lacks context and is misrepresented as a class action rather than a defined indemnification obligation. (3) The reasoning is flawed: the shift described—from high exposure to low—is plausible, but the LLM bases it on incorrect data and misattributed liabilities. It fails the multi-hop requirement by not connecting GM’s sale of Opel/Vauxhall to the resulting indemnity structure with Stellantis, instead discussing internal GM liabilities. (4) While the answer is structured around the right theme—declining indemnification risk—it misidentifies entities, misstates financial figures, and omits the core transformation from supply relationships (2022) to indemnity guarantees (2024). The contextual relevance is moderate because it addresses indemnifications and time trends, but the substance is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 539,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo’s operational dependency on co‑packers remained extensive, as disclosed in both the 2022 and 2024 10‑K filings: the company continues to rely on a highly distributed network of contract manufacturers, co‑packers, strategic alliances and joint ventures that own or lease plants, warehouses and distribution centers [25‑29; 30‑32].  While the structural reliance on these partners has not changed materially, the strategic involvement of co‑packers has deepened – PepsiCo now works more closely with them through equity interests, long‑term supply agreements and joint development initiatives, integrating them into its global supply‑chain governance and cybersecurity risk‑management processes [28‑31].  Consequently, co‑packers are both operationally indispensable and increasingly embedded in PepsiCo’s strategic planning and oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PepsiCo's continued operational dependency on co-packers through a distributed network is accurately noted for both 2022 and 2024, and the shift toward deeper strategic involvement—specifically through equity interests, long-term agreements, and integration into supply chain governance—is consistent with the original answer’s emphasis on 'strategic alliances or joint ventures in which we have an equity interest.' (2) There are no numerical values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024) and identifies the evolution from operational reliance to strategic integration. The mention of 'equity interests' directly supports the knowledge graph's claim of increased strategic involvement. Only minor phrasing differences exist—such as 'joint development initiatives' and 'cybersecurity risk-management processes'—which are plausible elaborations from the filings but not explicitly mentioned in the ground truth; these do not contradict but slightly extend the original answer. (4) Contextual relevance is perfect: the response directly addresses both operational dependency and strategic involvement over the specified time frame. The conclusion that co-packers are 'operationally indispensable and increasingly embedded in strategic planning' captures the essence of the evolution described in the original answer. A score of 9 is justified due to the slightly expanded detail beyond the ground truth, but no factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 453,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "SPG’s financial relationship with ABG shifted markedly between 2023 and 2024, moving from a larger, more diversified partnership to a significantly smaller ownership stake.  In 2023 the company recorded a $157.1 million gain on the sale of a portion of its ABG interest and recognized $59.1 million of non‑cash pre‑tax gains from multiple deemed disposals tied to ABG’s capital transactions, while also receiving $157.1 million from the sale of a segment of its ABG holdings.  By 2024 the partnership was further reduced when SPG sold its remaining ABG interest for $1.2 billion, generating a $414.8 million pre‑tax gain (plus $103.7 million of tax expense), and the company’s ownership was diluted to roughly 9.6 % after a series of ABG capital transactions.  These moves reflect a strategic evolution from a sizable joint‑venture stake to a smaller, more liquid investment, with the bulk of the financial benefit realized through large gains on disposal and the resulting dilution of SPG’s equity interest.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $157.1 million gain from the sale of a portion of SPG's ABG interest and the $59.1 million non-cash pre-tax gain from deemed disposals in 2023, it fabricates a $1.2 billion sale of SPG's 'remaining' ABG interest in 2024 generating a $414.8 million pre-tax gain, which is not supported by the ground truth. The ground truth states that in 2024, SPG disclosed an $18.8 million pre-tax gain from the sale of a portion of its ABG interest that occurred in December 2021 (not 2024), and highlights a strategic partnership with ABG for Reebok in the U.S. as the key 2024 development. The 9.6% ownership figure and $103.7 million tax expense are not mentioned in the original answer and appear to be hallucinated. (2) Quantitative accuracy is severely compromised: the $414.8 million gain and $1.2 billion sale are entirely incorrect; the $18.8 million gain from 2021 (disclosed in 2024) is omitted; the $145.8 million gain from dilution in SPARC Group in 2023 is missing. (3) Multi-hop reasoning is flawed: the model incorrectly infers a continued divestment narrative in 2024 based on fabricated data, missing the actual shift from financial gains to strategic operational collaboration (Reebok partnership). It fails to synthesize the correct timeline and nature of the relationship evolution. (4) Contextual relevance is moderate because the answer addresses the general theme of changing financial relationship and ownership, but the core facts and strategic shift are misrepresented. The answer invents a major transaction not present in the ground truth, undermining its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 461,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin's involvement in Sikorsky helicopter programs shifted from production-focused growth to a more diversified scope. In 2022, Sikorsky's helicopter programs (including the CH-53K heavy-lift helicopter) contributed to increased product sales, driven by higher production volumes on programs like the CH-53K and pilot training systems. By 2024, the focus expanded to include advanced development initiatives under the \"21st Century Security\" strategy, emphasizing all-domain solutions and integration with other platforms (e.g., hypersonics, AI/ML, and CJADC2), while maintaining Sikorsky's core helicopter programs as part of broader mission systems. Production volume trends for Sikorsky helicopters are not explicitly detailed in the 2024 filings beyond their role in sustaining segment growth, but the programs remain a key component of RMS's portfolio, particularly for heavy-lift and specialized missions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's continued involvement in Sikorsky helicopter programs from 2022 to 2024 and notes the strategic importance of programs like CH-53K, Black Hawk, and Seahawk. However, it misrepresents the 2022 financial impact: the ground truth states a $560 million increase in *product costs* (not sales) due to higher production volume, whereas the LLM incorrectly frames this as contributing to increased product sales. This is a significant quantitative and conceptual error. (2) No explicit numbers are provided in the LLM answer for 2024, which aligns with the ground truth’s lack of specific volume data, but the absence of the $560M cost increase figure—key to the 2022 context—reduces quantitative accuracy. The mention of 'pilot training systems' and '21st Century Security' strategy, while plausible, are not present in the original answer and may reflect overinterpretation or external knowledge. (3) The multi-hop reasoning is partially sound: the model infers a strategic evolution from production growth to broader integration, which parallels the ground truth’s narrative of shifting from cost driver to strategic focus. However, it fails to explicitly connect the 2022 cost increase to production volume as a transitional challenge, weakening the synthesis. (4) Despite missing the precise financial metric and mischaracterizing it, the LLM captures the overall trajectory—continued emphasis and portfolio integration—making the answer contextually relevant and qualitatively reasonable. The core facts about program scope evolution are consistent, but the lack of accurate financial detail lowers the correctness and quantitative scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 465,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Based on the provided SEC 10-K filings, Walmart's ownership stake and financial investment in Alert Innovation evolved as follows: In fiscal 2023, the company completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100% of the company. This acquisition was finalized during fiscal 2023, and Alert Innovation was subsequently sold and deconsolidated in fiscal 2025. There is no mention of any subsequent investment or ownership change related to Alert Innovation in fiscal 2024 beyond this acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart completed a $0.4 billion acquisition of Alert Innovation in fiscal 2023, increasing ownership to approximately 100%, which matches the ground truth. This part is factually accurate. However, the LLM claims that Alert Innovation was 'sold and deconsolidated in fiscal 2025', which is not mentioned in the original answer and introduces a future event (fiscal 2025) not present in the ground truth. The original answer states that by fiscal 2024, there was no mention of Walmart retaining ownership, indicating an exit likely occurred between fiscal 2023 and 2024. The LLM incorrectly shifts the timeline, implying continuity into fiscal 2025, which contradicts the original inference of a fiscal 2024 exit. (2) Quantitatively, the $0.4 billion figure is accurate and correctly formatted. (3) The multi-hop reasoning is partially sound—while the model correctly identifies the acquisition and ownership increase, it fails to correctly infer the exit timing. Instead of concluding that ownership was likely exited by fiscal 2024 due to absence of mention, it fabricates a deconsolidation in fiscal 2025, which is unsupported by the provided data. (4) The contextual relevance is high as the answer addresses the evolution of ownership and investment, but the introduction of an unverified future event reduces qualitative accuracy significantly. The core financial facts are correct, but the reasoning and conclusion about the divestiture are incorrect, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 425,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG increased its use of the Supplemental Facility to fund strategic acquisitions and debt refinancing. In 2023, it drew €750 million under the Supplemental Facility to repay existing borrowings, and in 2024 it continued to leverage the facility for property‑level financing and to support joint‑venture transactions, while maintaining a strong repayment strategy through cash‑flow‑driven debt reductions and scheduled note redemptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a major factual error in both direction and substance of SPG's utilization of the Supplemental Facility between 2023 and 2024. While it correctly states that €750 million was drawn in 2023 (matching the ground truth), it incorrectly claims that SPG continued to use the facility in 2024 for property-level financing and joint ventures. The ground truth explicitly states that by 2024, there was no outstanding balance and SPG had shifted away from using the Supplemental Facility entirely, having repaid the €750 million in November 2023. The LLM also fabricates a continued 'leverage' of the facility in 2024, which contradicts the full repayment and strategic move to long-term unsecured notes (e.g., $1.0 billion issuance in September 2024), a key point missing from the LLM response. The repayment strategy is misrepresented: the ground truth specifies repayment was enabled by bond issuance, not general 'cash-flow-driven debt reductions' or 'scheduled note redemptions' as claimed. Quantitatively, the €750 million draw is correct, but no other numbers (e.g., 2024 borrowing) are supported, and the $1.0 billion 2024 bond issuance — a critical data point showing refinancing strategy — is omitted. The reasoning is flawed: instead of showing a reduction in reliance on the facility, the LLM asserts increased use, failing the multi-hop synthesis between borrowing, repayment timing, and refinancing shift. Contextually, the answer addresses the topic of borrowing and repayment but misrepresents the evolution, making it partially relevant but factually unsound. Overall, core facts are incorrect, especially regarding 2024 activity, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 460,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has reinforced helium’s strategic importance by positioning it as a core product within its industrial‑gases portfolio and by expanding supply‑chain flexibility across its three distribution models.  In the 2024 filing, helium is highlighted alongside other process gases (e.g., hydrogen, carbon dioxide) as a primary product sold through on‑site, merchant and packaged‑gas channels, with long‑term on‑site contracts that include minimum purchase requirements and price‑escalation mechanisms, while merchant and packaged sales rely on shorter‑term (3‑7 year) agreements that still accommodate helium’s unique logistics (e.g., longer shipping distances).  This evolution reflects a continued focus on securing helium supply through diversified, contract‑based distribution strategies that support both large‑volume industrial users and niche, high‑purity applications.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that in 2024, Linde 'highlighted' helium as a primary product alongside hydrogen and carbon dioxide, which directly contradicts the original answer stating that helium was no longer specifically named in 2024 and was instead subsumed under general gas descriptions—indicating reduced emphasis, not reinforcement. (2) The LLM asserts that long-term on-site contracts with minimum purchase requirements apply to helium in 2024, but the ground truth states that in 2023, merchant contracts for helium had no minimum purchase requirements, and there is no mention of such terms being introduced in 2024; in fact, the removal of helium from explicit product listings suggests a downgrading of its strategic visibility. (3) The multi-hop reasoning is flawed: the model incorrectly infers continuity or expansion of helium's strategic role when the evidence shows a clear shift away from treating it as a distinct, highlighted product. (4) While the 3–7 year contract duration mentioned for merchant sales matches the original answer, this single point of alignment does not compensate for the overall misrepresentation of strategic direction. The answer fabricates supply-chain expansion and increased strategic focus unsupported by the data. Thus, despite some correct terminology and partial date references, the core factual claims about positioning and strategy are inverted from the truth, warranting a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and structure but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 443,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan’s asset allocation remained heavily weighted toward fixed income and cash equivalents, with only a modest equity position. In 2022, fixed income and cash equivalents totaled $182 million (comprising $7 million in Level 1, $0 in Level 2, and $175 million in Other), while equity securities were $98 million. By 2023, these categories shifted slightly to $182 million in fixed income and cash equivalents (still $7 million Level 1, $0 Level 2, $175 million Other) and $98 million in equity securities, indicating little change in the overall mix; the plan continued to maintain a predominance of fixed‑income securities with a smaller, stable equity component.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it reports $182 million in fixed income and $98 million in equity for both 2022 and 2023, which contradicts the ground truth: in 2022, fixed income and cash equivalents were $248 (not $182M) and equity was $137 (not $98M); in 2023, fixed income was $210 and equity was $54. The LLM claims no change, but the ground truth shows significant reductions, especially in equity. (2) Calculations are wrong: the LLM implies total assets remained stable at $280M ($182M + $98M), but actual totals were $385 in 2022 and $264 in 2023 — a substantial decrease not reflected at all. (3) Multi-hop reasoning failed: the question asks how the allocation evolved, requiring comparison across years, but the LLM incorrectly asserts 'little change' when there was a major shift. (4) The mention of Level 1/Level 2/Other breakdowns appears fabricated or misattributed, as these details are not in the original answer and conflict with the provided data. While the answer addresses the right topic (asset allocation in the U.S. Retiree Health Care Plan) and time frame, the core numbers and conclusions are factually wrong, leading to a very low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 376,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s revenue grew 56% to $1.1 billion, driven by higher demand across new and existing geographies, while overall company revenue slipped 1% to $27.1 billion due mainly to declining Veklury sales.  The FDA granted full EU marketing authorization for Hepcludex (bulevirtide) for HDV and approved Trodelvy for HR+/HER2‑ metastatic breast cancer, marking key regulatory milestones for the asset.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Trodelvy generated $380 million in 2022 and does not provide 2023 revenue. The LLM claims a 56% growth to $1.1 billion in 2023, which is unsupported and significantly overstates the data. This calculation is incorrect: a 56% increase from $380M would be ~$593M, not $1.1B. Additionally, the mention of 'EU marketing authorization for Hepcludex' is irrelevant to Trodelvy and confuses the asset with another drug. (2) The only correct quantitative point is the mention of regulatory approval for Trodelvy in HR+/HER2- metastatic breast cancer by the FDA, aligning with the original answer. However, the EC approval is mentioned in the ground truth but not accurately reflected as being for a 'similar indication'—the LLM misattributes it to Hepcludex. (3) The multi-hop reasoning fails: the LLM incorrectly synthesizes revenue growth and conflates Trodelvy with other company products (Veklury, Hepcludex), suggesting poor entity tracking. The strategic positioning improvement due to approvals is partially correct but undermined by incorrect context. (4) Despite addressing both revenue and regulatory aspects of the question, the severe numerical inaccuracies and entity confusion drastically reduce correctness. The contextual relevance is moderate because the answer attempts the right dimensions (revenue, approvals) but introduces irrelevant information and false calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 408,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "From 2022 to 2024 Chevron’s downstream‑related earnings and its investment in GS Caltex evolved from a modest, equity‑method holding to a more significant contributor to earnings.  In the 2022 10‑K (page 42), the “Income from equity affiliates” line shows a $1,003 million gain from GS Caltex in 2022, and by 2023 the same note reports $58 million of equity earnings from GS Caltex (page 84) while the consolidated downstream segment earnings rise to $5,394 million (page 83).  This upward trend indicates that the joint venture has become an increasingly important strategic asset, providing Chevron with higher downstream earnings and a valuable foothold in the Korean market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Chevron's equity earnings from GS Caltex were $1,003 million in 2022 and dropped to $58 million in 2023, which contradicts the ground truth that downstream-related earnings from GS Caltex contributed to improved income in 2022 and no such decline is indicated. The ground truth does not provide specific equity earnings for GS Caltex in 2023 or 2024, nor does it mention a drop. Additionally, the LLM cites a consolidated downstream segment earnings figure of $5,394 million in 2023, which is not mentioned in the ground truth and cannot be verified as relevant to GS Caltex specifically. (2) The ground truth reports Chevron's sales and other operating revenues with affiliated companies (including GS Caltex) as $16,286 million in 2022 and $13,850 million in 2024, showing a decrease. The LLM does not mention these figures at all, instead focusing on incorrect equity earnings and an unrelated downstream segment number. The LLM’s numbers do not align with the ground truth, and no source is provided for the $1,003M or $58M figures. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that the joint venture became more strategically important due to rising earnings, while the ground truth indicates a slight decrease in affiliated revenues and stable ownership, suggesting consistent but not increasing importance. The LLM fails to mention Chevron’s unchanged 50% ownership stake in GS Caltex, a key fact in the original answer. (4) The contextual relevance is moderate because the answer addresses Chevron, GS Caltex, downstream earnings, and strategic importance, but the incorrect data and flawed reasoning severely undermine factual correctness. The conclusion about increasing strategic importance is not supported by the ground truth, which suggests stable strategic value despite a revenue decline. Thus, the correctness score is low due to major quantitative and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 537,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program’s production volume grew steadily, with backlog increasing each year as orders rose—particularly on the CH-53K and related programs—while risk retirements (favorable profit‑booking adjustments) fluctuated, sometimes declining due to losses on classified contracts but later improving with contract resolutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key factual details from the ground truth and introduces unsupported claims. It correctly identifies that production volume increased and risk retirements fluctuated, but fails to include the specific $140 million profit increase in 2022, which is a central quantitative fact. No numeric data about 2024 is provided, nor is the 73% decline in RMS operating profit mentioned—both critical to the evolution of financial performance. Instead, the LLM references 'losses on classified contracts' and 'contract resolutions' that are not present in the original answer and cannot be verified from the provided ground truth. (2) There are no verifiable numbers in the LLM response: no dollar amounts, no percentages, no production volumes. The absence of the $140 million figure and the 73% profit decline results in significant quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—linking production growth and risk retirements to financial performance—but the synthesis is flawed because it draws conclusions (e.g., fluctuating risk retirements due to classified losses) not supported by the source. The original answer attributes the 2024 profit decline to lower booking rates across RMS, not classified contract losses. (4) The answer is contextually relevant, addressing production volume and risk retirements over time, but lacks precision and introduces extraneous details, reducing factual reliability. While it captures a general trend of maturation, it does not convey the core insight that 2022 gains likely diminished due to program maturity, as stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 456,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "PayPal’s seller protection programs shifted from a general risk‑mitigation focus in 2022 to a more explicit strategic emphasis on risk management and fraud prevention in 2023, as highlighted in the 2023 filing’s “Merchant and Consumer Payment Solutions” and “Strategy” sections. The company underscored that these programs—along with proprietary protection and risk‑management tools—are core to its value proposition for merchants, aiming to reduce merchant losses and enhance trust, while also reinforcing its broader push to deepen merchant engagement and expand its payments ecosystem. This evolution reflects a deliberate effort to manage risk exposure more directly and to position seller protection as a differentiator in a competitive, rapidly evolving payments landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in PayPal's approach from 2022 to 2023, noting a move toward strategic emphasis on seller protection as part of its value proposition. However, it inaccurately characterizes the 2022 focus as 'general risk-mitigation' and 2023 as 'more explicit strategic emphasis on risk management and fraud prevention,' which reverses the nuance in the ground truth. In reality, 2022 was already focused on risk exposure and loss implications (with specific data: 0.09%–0.15% of TPV), while 2023 elevated seller protection as a competitive differentiator tied to merchant trust and platform growth—not just deeper risk management. The LLM understates the strategic reframing in 2023, instead portraying it as a continuation of risk focus rather than a pivot toward value proposition and integration with analytics and merchant services. (2) Quantitatively, no numbers are mentioned in the LLM answer, so there are no errors in numeric accuracy. However, it omits the key quantitative detail from 2022 (historical loss rates of 0.09%–0.15% of TPV), which is a notable omission affecting completeness. (3) The multi-hop reasoning is partially sound—linking 2022 and 2023 filings and identifying a strategic evolution—but fails to fully synthesize the shift from risk exposure (2022) to strategic differentiation (2023). The LLM conflates 'strategic emphasis' with 'risk management,' missing the broader integration into merchant services and platform growth. (4) Correctness is scored 7 because core elements (evolution of focus, strategic importance) are present and factually aligned in spirit, but the characterization of the nature of the shift is imprecise. Quantitative accuracy is 10 because no numbers are stated, so none are wrong. Qualitative accuracy is 7 due to misrepresentation of the strategic shift’s direction. Contextual relevance is 9—answer is well-targeted and relevant, with only moderate conceptual drift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 532,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks continued to recognize revenue from its ready‑to‑drink beverages when control of the products transferred to customers, and it recorded breakage revenue from stored‑value cards as they were redeemed, while also recognizing royalty and product‑sale revenues from licensed stores and third‑party partners. The company’s revenue‑recognition policies remained unchanged, but the 2024 filing notes that licensed‑store revenues now include product and equipment sales, royalties and fees, and that breakage revenue from unredeemed stored‑value cards is recognized proportionally over time, reflecting the same timing of revenue recognition used in prior years. Starbucks remains dependent on a limited set of suppliers for high‑quality arabica beans and other key inputs, so any disruption in those supply relationships could materially affect its ability to produce and sell ready‑to‑drink beverages.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but fails to fully capture the evolution in Starbucks' approach to ready-to-drink (RTD) beverages between 2023 and 2024 as described in the ground truth. (1) On correctness: The answer correctly notes that revenue recognition occurs upon transfer of control, which aligns with the 2023 policy in the original answer, but it incorrectly states that revenue recognition policies 'remained unchanged'—the ground truth emphasizes a shift in focus from revenue reporting to supply chain resilience in 2024, which the LLM does not acknowledge. The LLM also fails to mention that RTD revenue was included under 'Other Revenues' in 2023 or that 2024 highlighted long-term contracts with specialty suppliers as a strategic shift. Instead, it generalizes supplier dependency to arabica beans broadly, not specifically linking it to RTD production or strategic supply chain moves. (2) Quantitative accuracy: There are no specific numerical values (e.g., dollar amounts, percentages) in either answer, so no factual discrepancies exist on numbers—score is high. (3) Reasoning: The multi-hop synthesis is weak—the question asks for an evolution across two years in two dimensions (revenue recognition and supplier dependency), but the LLM does not contrast 2023 vs 2024 meaningfully. It mentions supplier dependency but not the strategic emphasis on long-term contracts for RTD sourcing in 2024. It conflates general supplier risks with a specific strategic shift. (4) Contextual relevance: The answer discusses related topics (revenue recognition, supplier risks) but misses the core narrative shift from financial reporting to supply chain risk management in the RTD segment. While some elements are factually plausible, they do not reflect the documented evolution in focus between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 491,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s geographic reach expanded significantly, with sales rising 56% to $1.063 billion, driven by higher demand across new and existing regions worldwide. This growth was accompanied by regulatory approvals that broadened its use, including an EC approval for monotherapy in HR+/HER2‑ negative breast cancer (March 2023) and a U.S. accelerated approval for adult patients with unresectable locally advanced or metastatic TNBC (April 2023), further extending its market presence.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that Trodelvy had $370M in U.S. sales and $10M in Europe in 2022 (total $380M), but the LLM claims sales rose 56% to $1.063 billion in 2023, implying ~$683M growth. This figure is unsupported by the original data and represents a major overstatement. There is no mention in the ground truth of total sales in 2023 or a 56% increase, so this number is fabricated or misattributed. (2) Regarding regulatory approvals, the LLM correctly notes EC approval in March 2023 for HR+/HER2- breast cancer, aligning with the original answer. However, it incorrectly states that the U.S. approval in April 2023 was for 'unresectable locally advanced or metastatic TNBC' — this was actually an earlier indication. The ground truth specifies the 2023 FDA approval was for HR+/HER2- metastatic breast cancer, a new and more relevant expansion. The LLM confuses the indication, misrepresenting the therapeutic expansion. (3) The multi-hop reasoning is partially sound — the model connects regulatory approvals to expanded market reach, which is logical — but it fails to accurately synthesize the correct sales figures and indications across years. It invents a global sales figure and growth rate not present in the source. (4) Despite these issues, the answer is contextually relevant, addressing both geographic reach and regulatory developments. Some correct entities (EC, FDA, HR+/HER2-, breast cancer) are identified, and the general direction of expansion is accurate. However, due to major quantitative errors and a key misstatement about the FDA approval indication, the correctness score is low. Minor formatting issues aside, the core financial and regulatory facts are not reliably reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 493,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group’s ownership stake in ABG declined from approximately 11.8% to 9.6% due to multiple capital transactions that triggered deemed disposals, resulting in non-cash pre-tax gains of $12.4 million (Q3 2023), $36.4 million (Q2 2023), and $10.3 million (Q4 2023). Concurrently, the company recorded deferred tax liabilities of $3.1 million, $9.1 million, and $2.6 million respectively, and recognized additional gains from subsequent disposals, including a $157.1 million gain in Q4 2023 and a $414.8 million gain when it sold its remaining ABG interest for cash in Q1 2024. These transactions illustrate a steady reduction in SPG’s equity position while generating substantial non‑cash gains and tax impacts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a decline in Simon Property Group's (SPG) ownership stake in ABG from approximately 11.8% to 9.6%, it omits the earlier 12.3% stake mentioned in the ground truth and misrepresents the sequence and timing of dilutions. More critically, the financial gains reported are largely incorrect: the LLM claims a $36.4M gain in Q2 2023, $12.4M in Q3 2023, and $10.3M in Q4 2023 — while the original answer does not specify quarters and lists the gains in a different order ($36.4M, $12.4M, $10.3M), but crucially does not mention any additional gains such as $157.1M or $414.8M. These latter figures are entirely fabricated and not supported by the ground truth. Additionally, the claim that SPG sold its 'remaining ABG interest for cash in Q1 2024' for a $414.8M gain is false — the original answer states that SPG did not report any new transactions in 2024 and only referenced a prior 2021 transaction. The deferred tax liabilities ($3.1M, $9.1M, $2.6M) are also not present in the ground truth and appear to be hallucinated. (2) Quantitative accuracy is very low: 3 out of 8 cited financial figures match (the $36.4M, $12.4M, and $10.3M gains), but their timing is misassigned, and 5 figures ($157.1M, $414.8M, and three tax liabilities) are incorrect. The ownership percentages are partially correct but incomplete. (3) Qualitatively, the reasoning is flawed: the model suggests an ongoing series of disposals culminating in a full exit in Q1 2024, which contradicts the ground truth that SPG stopped disclosing active changes in 2024 and had no new transactions. The multi-hop synthesis fails — it incorrectly infers continued activity in 2024 when the key point is the absence of such activity. (4) Contextual relevance is moderate because the answer addresses SPG’s stake reduction and financial gains, but the inclusion of fabricated transactions and gains severely undermines correctness. The core narrative of stake reduction with gains is partially aligned, but the details are largely false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 563,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan was amended in 2023 with a third amendment (effective February 2 2023) and further modified in 2024 by a fourth amendment filed as Exhibit 10.2(C)+ in the 2024 filing (effective August 1 2024). Both the 2023 and 2024 filings disclose the plan’s forms of award agreements, with the 2023 filing referencing multiple “Additional Forms” (Exhibits 10.2(E)–10.2(L)) and the 2024 filing updating the list to include a new “Additional Forms” filing (Exhibit 10.2(K)+) and adding new director‑related award agreements (Exhibits 10.13+ and 10.14+).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Third Amendment in 2023 and Fourth Amendment on August 1, 2024, are accurately noted, including the effective dates and exhibit references. The mention of updated award agreement forms in both years is consistent with the original answer. (2) Quantitative accuracy is perfect: dates (February 2, 2023, and August 1, 2024) match the expected timeline, and exhibit numbers (e.g., 10.2(C)+, 10.2(E)–10.2(L), 10.2(K)+, 10.13+, 10.14+) are correctly cited, indicating precise document references. (3) The multi-hop reasoning is sound—LLM correctly synthesizes changes across 2023 and 2024 filings, identifying both amendments and evolution in award agreement forms. It goes beyond the ground truth by providing specific exhibit labels, which adds detail without introducing error. (4) The only minor shortcoming is that the original answer emphasizes the continuation and expansion of the plan over time as a thematic point, which the LLM implies but does not explicitly state. However, this does not detract from factual correctness. Wording differs but semantic meaning is equivalent or superior. All criteria for high scores are met, with only slight deduction in qualitative accuracy for lack of explicit synthesis statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 370,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, capitalized software licenses increased from $152 million to $223 million, reflecting a $71 million addition, and the company began amortizing these licenses (e.g., $63 million of amortization expense in 2023 versus $57 million in 2022). This growth in capitalized software and related amortization indicates that the company is investing more heavily in software licensing, likely to support new product development and enhance its technology portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth. It also correctly notes the increase in amortization expense from $57 million in 2022 to $63 million in 2023. However, the ground truth does not mention amortization expenses for either year, so this information is extraneous and not supported by the original answer, raising concerns about potential hallucination. (2) The quantitative values for the carrying amounts ($152M and $223M) are accurate, and the implied $71M increase is correct. The amortization figures ($57M and $63M) are plausible but not present in the ground truth, so their inclusion cannot be verified and reduces confidence in factual accuracy. (3) The reasoning correctly infers increased investment in software licensing based on the rising carrying value, aligning with the ground truth’s conclusion. However, the LLM incorrectly implies that the amortization policy began in this period ('began amortizing'), while the original answer states that amortization was already in place in 2022 under a straight-line method. This misrepresents the evolution of the accounting treatment. (4) The answer is contextually relevant and addresses both the valuation change and investment implication. However, it introduces unsupported details (amortization expenses) and misstates the evolution of the treatment, missing the key point that the shift was from disclosing a policy in 2022 to reporting a quantified asset value in 2023. Thus, while the core financial data and investment conclusion are correct, the reasoning and entity accuracy regarding accounting policy evolution are partially flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 474,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal’s use of European customer balances for credit funding shifted markedly between 2022 and 2023: the amount of European customer balances that management could designate for credit activities fell from about $3.8 billion (≈37 % of European balances) in 2022 to roughly $3.0 billion (≈39 % of balances) in 2023, reflecting tighter regulatory limits and a more selective deployment of those funds. This evolution shows that PayPal is increasingly relying on external financing—such as the €40 billion sale of consumer installment receivables and the €5 billion credit‑facility with Paidy—rather than solely on internally pooled European balances to fund its credit products, indicating a strategic pivot toward diversified, market‑based funding sources.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key figures: $3.8 billion in 2022 (37%) and $3.0 billion in 2023 (39%), which match the ground truth exactly. The percentage increase in utilization from 37% to 39% is accurately implied. The mention of the €40 billion receivables sale agreement in 2023 is correct, though the LLM incorrectly states that €5 billion was sold via a credit facility with Paidy, whereas the ground truth specifies $5.5 billion was sold under the receivables program, not a Paidy credit facility. This is a factual error in entity and mechanism. (2) Quantitative accuracy is high: all dollar amounts and percentages for customer balances are correct. However, the $5.5 billion sold in receivables is misrepresented as a €5 billion credit facility with Paidy, introducing a calculation and entity error. (3) The multi-hop reasoning is largely sound—linking reduced internal funding with increased external mechanisms—but the synthesis is flawed by the incorrect attribution of the €5 billion facility to Paidy, which is not supported by the original answer. The strategic interpretation of a pivot to diversified funding is valid and aligns with the ground truth. (4) Scores reflect high factual accuracy in core metrics, minor but notable error in external funding details, and strong overall reasoning and relevance. The answer addresses both parts of the question—evolution of balance utilization and strategic implications—with strong contextual alignment, warranting a high but not top score due to the funding mechanism misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 431,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Based on the provided SEC 10-K filings, Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved such that the carrying value of its private equity investments (including Valor Siren) increased from $24.2 million as of October 1, 2023 to $39.8 million as of September 29, 2024, reflecting a $15.6 million rise. This contributed to total other investments rising from $439.9 million to $463.9 million, though the company notes that the related financial statement activities were not material during the periods presented. Consequently, while the investment balance grew modestly, it had no significant impact on Starbucks' consolidated financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the carrying value of Starbucks' investment in Valor Siren Ventures I L.P. was not disclosed specifically for fiscal 2023. However, the LLM claims a precise figure of $24.2 million as of October 1, 2023, which is not supported by the original answer. Additionally, the LLM states the carrying value increased to $39.8 million by September 29, 2024, but the ground truth indicates that the combined carrying value of Valor Siren Ventures I L.P. and II L.P. was $211.9 million as of that date — not $39.8 million. The $39.8 million figure appears to be either fabricated or misattributed. (2) Calculations are internally consistent (a $15.6 million increase from $24.2M to $39.8M), but since the base numbers are incorrect, the entire quantitative analysis is invalid. The total other investments rising from $439.9M to $463.9M is not mentioned in the ground truth and introduces unsupported data. (3) The multi-hop reasoning fails because the model does not correctly identify that Valor Siren I was not individually quantified in 2023 and that the 2024 value includes both Fund I and Fund II. It incorrectly isolates Valor Siren I with specific values across years, failing to reflect the lack of granularity in 2023 and the combined reporting in 2024. (4) While the LLM correctly notes that the financial impact remained non-material and was reported in 'interest income and other, net,' this partial alignment does not compensate for the major factual and quantitative errors. The contextual relevance is moderate because it addresses the evolution of the investment and materiality, but the core data is wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 477,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, Analog Products' strategic positioning was reinforced through TI's continued investment in manufacturing capacity and technology, which underpins its sustainable competitive advantages—particularly supply chain control and broad product portfolio reach. Financially, Analog revenue declined 15% year-over-year to $13.04 billion in 2023, with operating profit dropping 30% to $5.821 billion, reflecting lower revenue and higher manufacturing costs despite stable factory utilization. This contributed to a reduced operating profit margin (44.6% vs. 54.4% in 2022), though the segment remained TI's largest revenue driver, underscoring its critical role in the company's cash flow generation and long-term growth strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth does not mention Analog Products' revenue or operating profit figures for 2023, nor a 15% revenue decline or 30% drop in operating profit. These specific numbers ($13.04B revenue, $5.821B operating profit, 44.6% margin) are not present in the original answer and contradict the emphasis on gross margin (67.5% in 2022) and strategic positioning rather than profitability declines. The original answer highlights gross margin and strategic framing, not operating profit or year-over-year declines. (2) Quantitative accuracy is very low: the LLM introduces precise numbers that are unsupported by the ground truth. There is no mention of a decline in revenue or profit in the original; instead, the focus is on sustained strategic importance and gross margin strength. The 67.5% gross margin in 2022 is omitted entirely, and no margin data for 2023 is provided in the ground truth, so the 44.6% figure is incorrect. (3) The reasoning partially captures the qualitative shift in strategic framing—mentioning supply chain control and competitive advantages—but incorrectly infers financial deterioration. It fails to reflect the multi-hop synthesis that Analog Products were increasingly tied to TI's four sustainable advantages in 2023 and that free cash flow per share became the key metric. Instead, it fabricates financial declines not present in the source. (4) Contextual relevance is moderate because the answer addresses strategic positioning and financial contribution, but the incorrect data undermines correctness. The qualitative accuracy is low due to the invention of financial results and omission of the actual strategic evolution centered on sustainable advantages and cash flow metrics. Correctness score is low due to major factual and quantitative errors despite some relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 522,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips reduced its capital allocation to the Lower 48 region, as evidenced by a decline in depreciation, depletion, and amortization (DD&A) expenses specific to that segment—from $4,854 million in 2022 to $5,729 million in 2023—reflecting lower investment and operational focus. Concurrently, the company recorded impairments within the Lower 48, though the provided data does not show a material increase in impairment charges relative to other segments, indicating a strategic shift toward prioritizing higher‑return assets elsewhere. Overall, the firm’s DD&A and impairment trends signal a deliberate scaling back of capital spending in the Lower 48 over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both entity and direction of change. It refers to 'ConocoPhillips' instead of 'Chevron', which is a critical entity error. Additionally, it incorrectly states that capital allocation decreased due to a 'decline' in DD&A from $4,854 million to $5,729 million, when in fact this represents an increase. The correct interpretation — that rising DD&A indicates increased capital investment — is reversed in the LLM response. (2) While the numerical values ($4,854 million in 2022 and $5,729 million in 2023) are quantitatively accurate and match the ground truth, the LLM misinterprets the implication of these figures. There are no calculation errors in the numbers themselves, but the conclusion drawn (decrease vs. actual increase) is wrong. (3) The multi-hop reasoning fails because the model misidentifies the company and inverts the logical relationship between DD&A trends and capital allocation strategy. Higher DD&A generally reflects greater prior investment and asset development, so an increase signals growing focus, not a reduction. The LLM incorrectly infers a strategic pullback, contradicting the ground truth. (4) Due to the wrong company, incorrect interpretation of trend direction, and flawed reasoning, the answer is mostly irrelevant and factually unsound despite having correct numbers. Hence, the correctness score is very low at 1, quantitative accuracy is moderate (3) due to correct numbers but wrong interpretation, qualitative accuracy is 1 due to severe reasoning and entity errors, and contextual relevance is low (3) because the topic is addressed with incorrect facts and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 455,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Verizon's approach to FWA Broadband has evolved from being primarily a consumer-focused offering to a strategic component supporting both Consumer and Business segments. In 2023, FWA was positioned as a key wireless broadband alternative (leveraging 5G/LTE networks) for residential and business customers, with approximately 3.1 million connections reported. By 2024, it became integral to Verizon's network strategy, explicitly tied to 5G/C-Band spectrum expansion (covering 242 million people) and used to drive network densification and IoT opportunities. While Consumer segment revenues from FWA are embedded within wireless service revenue ($79.1B in 2023), Business segment now actively targets enterprise and public sector customers with tailored FWA solutions as part of its broader connectivity portfolio, reflecting a shift toward positioning FWA as a strategic growth driver across both segments rather than just a consumer service.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2023, Verizon provided FWA via 5G and LTE networks and had 3.1 million connections, matching the original answer. The shift in 2024 toward a more strategic, integrated positioning within both Consumer and Business segments is accurately captured. (2) Quantitatively, the 3.1 million connections figure is correct. The mention of $79.1B in wireless service revenue for 2023 is plausible and contextually appropriate, though not explicitly in the ground truth; however, it does not contradict it and supports the narrative. The 242 million people covered by C-Band is consistent with Verizon's public disclosures in 2024, adding relevant context without introducing error. (3) The reasoning is sound: the LLM correctly synthesizes the evolution from a consumer-focused offering to a broader strategic product across segments, noting integration with IoT and network densification—consistent with the ground truth’s emphasis on FWA becoming more product-centric and part of a broader portfolio. The inference that FWA is now a 'strategic growth driver' is a reasonable interpretation of the shift from 'provides' to 'produces'. (4) The answer fully addresses both parts of the question—positioning within the product portfolio and target customer segments—across both years. Minor deduction in quantitative accuracy is due to inclusion of $79.1B and 242M figures not in the ground truth, but these are factually accurate and enhance rather than distort the response. No factual errors; excellent multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 440,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved from a 55% ownership stake (acquired in 2022) to a full acquisition proposal in November 2024 at $240 per share, implying a $15.3 billion fully diluted market cap. This evolution included the 2023 termination of foreign currency hedges related to the Micromine purchase and the 2024 sale of Emerson's remaining 40% non-controlling equity interest in Copeland (a joint venture with Blackstone) for $1.5 billion, alongside the $1.9 billion sale of the Copeland note receivable. These transactions resulted in a $279 pretax loss on the note receivable (recorded in continuing operations) and a $539 gain on the equity sale (recorded in discontinued operations). Financially, the integration of AspenTech (particularly the Test & Measurement acquisition) contributed to a 1.8 percentage point gross margin increase to 50.8% in 2024, though this was partially offset by $231 of acquisition-related inventory step-up amortization that negatively impacted margins by 1.3 percentage points. The equity structure shift also involved the reclassification of AspenTech-related earnings into discontinued operations following the Copeland divestiture.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Emerson's relationship with AspenTech from 2022 to 2024. (1) The timeline is incorrect: the original answer states that Emerson acquired a 55% stake in AspenTech by 2024 as part of forming 'New AspenTech', not in 2022 as the LLM claims. The LLM incorrectly asserts a full acquisition proposal in November 2024 at $240/share and a $15.3B valuation, which is not supported by the ground truth. (2) The financial figures are largely fabricated or misattributed: the $1.5B sale of a 40% non-controlling interest in Copeland, $1.9B note sale, $279M pretax loss, and $539M gain are not mentioned in the original answer and appear unrelated to the AspenTech relationship. (3) The gross margin impact is misrepresented: the original answer states AspenTech contributed 0.6 percentage points to gross margin in 2023, while the LLM claims a 1.8 percentage point increase in 2024 due to 'Test & Measurement acquisition'—a detail absent from the ground truth. The $231M inventory step-up amortization and 1.3 percentage point margin drag are also unverified. (4) The equity structure discussion conflates unrelated transactions: the reclassification into discontinued operations is tied to Copeland in the LLM answer, but the original answer references AspenTech stock plans and software restructuring. (5) Multi-hop reasoning fails: the LLM introduces irrelevant entities (Micromine, Copeland divestiture) and does not correctly synthesize the evolution of the Emerson-AspenTech relationship or its direct financial impact. While the answer attempts to address gross margin and equity structure, the core facts, numbers, and causal relationships are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 479,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "From 2022 to 2023, the financial relationship between NEE and FPL Group Capital Inc remained anchored in shared debt‑financing structures, but the nature of their obligations shifted toward more explicit capital‑market instruments. In 2022, NEE’s filings highlighted senior unsecured debt issuances (e.g., 3.55% Debentures due 2027 and 3.50% Debentures due 2029) and floating‑rate notes issued by FPL, while FPL Group Capital’s role was largely that of a guarantor and trustee for these securities. By 2023, NEE’s documents show an expansion of its own junior subordinated debentures (Series P, Q, R, S, T, U, V, W, X, Y) and a series of purchase‑contract and pledge agreements with The Bank of New York Mellon, indicating a deeper involvement of FPL Group Capital as the trustee and guarantor for these newer tranches. Consequently, while both entities continued to rely on long‑term debt and trust‑based financing, 2023 saw a greater emphasis on NEE‑issued junior debentures and more granular capital‑structure participation by FPL Group Capital through its trust and guarantee agreements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of the financial relationship between NEE and FPL Group Capital Inc. from 2022 to 2023 as per the ground truth. (1) The original answer states that in 2022, the relationship was defined by a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., but the LLM incorrectly describes the 2022 structure in terms of NEE's senior unsecured debentures and FPL's floating-rate notes, which are not mentioned in the ground truth and misattribute the nature of the obligation. (2) The LLM claims that in 2023, NEE issued junior subordinated debentures Series P through Y, but the ground truth specifies only Series B, C, L, M, N, O, and P — not the extensive list cited by the LLM. Additionally, the maturity dates (2057–2082) are omitted entirely in the LLM response, which undermines quantitative accuracy. (3) The LLM introduces entities and mechanisms not present in the original answer, such as 'purchase-contract and pledge agreements with The Bank of New York Mellon,' which are unsupported by the ground truth. (4) The core multi-hop reasoning — that the relationship evolved from a simple guarantee to a long-term capital financing arrangement via specific debenture issuances — is misrepresented. Instead of showing a shift from FPL Group, Inc.'s guarantee to NEE issuing debentures to FPL Group Capital Inc., the LLM frames FPL Group Capital as a trustee and guarantor in a more complex role that lacks evidentiary support. While the answer is contextually relevant in discussing debt instruments and capital structure evolution, the factual foundation is incorrect, leading to a low correctness score. Minor credit is given for recognizing a shift toward more structured capital involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 490,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, InterStim II’s market positioning strengthened as a core component of Medtronic’s Pelvic Health portfolio, gaining broader acceptance alongside newer devices such as InterStim Micro and InterStim X. The newer, recharge‑free InterStim II and Micro platforms expanded clinical adoption for overactive bladder, urinary retention and fecal incontinence, while the established InterStim II continued to benefit from growing physician familiarity and favorable reimbursement trends. This evolution placed InterStim II in direct competition with other neuromodulation solutions—particularly other InterStim models and emerging Sacral Neuromodulation devices—while also integrating more closely with Medtronic’s broader portfolio of Pelvic Health therapies, reinforcing its role alongside solutions like the Solitaire and Pipeline embolic devices and the evolving suite of spinal cord stimulation offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since no numbers are misstated, it receives a 10. The answer is contextually relevant and addresses the evolution of InterStim II's market positioning and acceptance between 2022 and 2024, correctly identifying its role within Medtronic’s Pelvic Health portfolio and newer devices like InterStim Micro and InterStim X. However, there is a critical factual error: the LLM incorrectly labels InterStim II as 'recharge-free'—in the ground truth, by 2024, InterStim II is described as recharge-free only in comparison to other models, but the key point is that InterStim Micro and InterStim X are the newer recharge-free models, while InterStim II is the established non-rechargeable device. The original answer emphasizes that the 2024 positioning differentiates models by recharge status, but the LLM misattributes the 'newer, recharge-free' label to InterStim II, which undermines the accuracy of the product differentiation. Additionally, the LLM incorrectly links InterStim II to Solitaire and Pipeline embolic devices and spinal cord stimulation offerings—these are unrelated to Pelvic Health and Sacral Neuromodulation, indicating a failure in entity accuracy and multi-hop reasoning. While the general trend of growing acceptance and integration into broader therapies is correct, the misrepresentation of device attributes and inclusion of irrelevant product lines significantly reduce qualitative accuracy. The answer captures the direction of evolution but distorts key differentiating facts, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 453,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility borrowing capacity remained robust, expanding from a $3.5–$4.5 billion range to support larger, longer‑dated issuances. The company shifted toward lower‑cost, fixed‑rate debt, issuing $1 billion of 4.75% senior notes due 2034 (Sept 2024) and earlier retirements of higher‑coupon floating‑rate notes (e.g., 2.75% notes in June 2023, 3.75% notes in Feb 2024, and 2% notes in Sept 2024). These actions reduced average interest expense (weighted‑average facility rate fell to 5.29% in 2024) and extended maturities, with the Supplemental Facility now maturing in 2029 and extendable to 2030, providing ample refinancing flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the Supplemental Facility had a borrowing capacity of $3.5 billion (expandable to $4.5 billion) in 2022 with a maturity of January 31, 2026. The LLM incorrectly states that the facility now matures in 2029 and is extendable to 2030, which contradicts the original data. The LLM claims the weighted-average facility rate fell to 5.29% in 2024, but this figure is not supported by the ground truth and appears fabricated. The LLM mentions issuing $1 billion of 4.75% senior notes due 2034 in September 2024 and retiring several notes (2.75% in June 2023, 3.75% in Feb 2024, 2% in Sept 2024), but these specific debt actions are not mentioned in the original answer and are unrelated to the Supplemental Facility. (2) The only correct quantitative point is the initial $3.5–$4.5 billion capacity range, which aligns with the ground truth. However, the €750 million borrowing in 2024 and its repayment on November 17, 2023, are completely omitted. The use of interest rate swaps to fix the rate at 3.81% in 2023 is also missing. Instead, the LLM introduces false numbers like 5.29% average rate and incorrect maturity dates. (3) The multi-hop reasoning is flawed. The question asks about the evolution of the Supplemental Facility specifically, but the LLM conflates general debt management activities with the Supplemental Facility. It fails to connect the €750 million drawdown and repayment via exchangeable bonds, a key evolution point. The strategic use of interest rate swaps to fix borrowing costs is ignored, undermining the analysis of interest rate strategy. (4) The correctness score is low due to major factual errors and fabrication of data. Quantitative accuracy is poor because most numbers are incorrect or invented. Qualitative accuracy is slightly higher only because the answer discusses debt management concepts relevant to the topic, albeit misapplied. Contextual relevance is moderate since the response stays within the domain of SPG’s financing activities, but it does not accurately reflect the Supplemental Facility’s actual utilization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 579,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "Verizon's device payment plans have remained structurally consistent from 2023 to 2024, continuing to offer non-interest-bearing installment notes over 36-month terms with potential billing credits tied to service retention. However, the company has refined its promotional incentives, introducing more targeted trade-in guarantees and usage-based upgrade options for Business customers while maintaining its focus on postpaid device subsidies for Business segments, as evidenced by the continued emphasis on fixed-term plans and device payment structures in both 2023 and 2024 disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but exhibits significant deviations from the ground truth in both reasoning and entity accuracy. (1) Correct elements include the mention of 36-month installment terms and non-interest-bearing notes in 2024, which aligns with the original answer. However, the claim that this structure was already in place in 2023 is incorrect—the ground truth states that such formalization occurred only in 2024. (2) Quantitatively, there are no explicit numerical errors (e.g., dates like 2023–2024 are correct, and 36-month term is accurate), but the answer fabricates details not present in the ground truth, such as 'billing credits tied to service retention' and 'usage-based upgrade options for Business customers,' which are unsupported by the provided data. (3) The multi-hop reasoning is flawed: the original answer emphasizes a structural evolution—from an informal financing mechanism in 2023 to a formalized, incentive-driven model in 2024—whereas the LLM incorrectly asserts structural consistency, missing the core shift. Additionally, the introduction of trade-in-based upgrades after paying a 'specified portion' of the plan is a key 2024 development, but the LLM mischaracterizes it as a refinement rather than a new feature. (4) Contextual relevance is moderate, as the response addresses device payment plans and promotional incentives, but introduces unverified segments (e.g., Business customers) and incentives not mentioned in the ground truth, reducing factual reliability. Overall, the answer conveys a misleading narrative of continuity rather than the actual evolution, warranting a low correctness score despite some accurate terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 461,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company’s legal relationship with Aqua-Chem has remained unchanged in terms of liability for Aqua-Chem’s asbestos-related claims. The Wisconsin insurance coverage litigation was fully resolved by 2014, with the Wisconsin Court of Appeals affirming summary judgment in favor of the Company and Aqua-Chem, and the Supreme Court of Wisconsin denying review. The Georgia case remains subject to the 2004 stay agreement, and no new legal developments regarding Aqua-Chem’s liability were reported in the 2023 or 2024 filings. The Company continues to pursue coverage agreements with insurers but holds no ongoing legal obligation to Aqua-Chem beyond the settled insurance matters.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that Coca-Cola's legal relationship with Aqua-Chem remained unchanged between 2023 and 2024, but the original answer states there was a shift in emphasis—from outright denial of liability to a more nuanced stance focused on insurance coverage and shared insurer responsibility. This change in disclosure tone and content is a key factual point missed by the LLM. (2) The LLM incorrectly asserts that the Wisconsin insurance litigation was 'fully resolved by 2014' with appellate affirmation and no further review, which is not supported by the ground truth and introduces specific dates (2014, court names) absent from the original. The ground truth does not mention resolution of Wisconsin litigation, let alone in 2014. (3) The LLM incorrectly states that 'no new legal developments' occurred, while the original answer explicitly notes a change in Coca-Cola’s 2024 disclosure to include more detailed descriptions of insurance policies and ongoing coverage litigation—indicating an evolution in narrative and legal positioning. (4) The LLM incorrectly references a '2004 stay agreement' in the Georgia case, a detail not present in the original answer and potentially fabricated. (5) Multi-hop reasoning failed: the question asks about evolution in stance on liability; the correct answer requires synthesizing changes in disclosure tone and content across 2023 and 2024 filings. The LLM instead asserts stasis and introduces extraneous, unverified details. While it correctly identifies that Coca-Cola denies direct liability, it misses the nuanced shift in emphasis on insurance coverage, which is central to the ground truth. Overall, major factual and reasoning errors undermine the response, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 490,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits and reduced foreign tax rates contributed to a significant decline in its effective tax rate from 71.6% in 2024 to (119.8)% in 2023, and further to 8.5% in 2021, indicating a strategic shift toward leveraging international tax incentives to minimize global tax liabilities. This trend reflects a deliberate focus on optimizing its international tax structure, particularly through operations in low-tax jurisdictions like Ireland and Israel, where statutory rates range from 12.5% to 24.0%, and through the use of R&D tax credits and tax holidays, which provided $67 million in benefits in 2024 (down from $129 million in 2023 and $220 million in 2022). The company's international tax strategy is further reinforced by its efforts to restructure foreign subsidiaries and capitalize on favorable tax regimes, as evidenced by the $2.7 billion in tax benefits from non-US income taxed at different rates in 2024, despite the overall increase in its effective tax rate due to a valuation allowance on US deferred tax assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains numerous factual inaccuracies and fabricates data not present in the ground truth. It incorrectly states Intel's effective tax rate as 71.6% in 2024, (119.8)% in 2023, and 8.5% in 2021—these figures are either reversed in time or entirely incorrect. The ground truth does not mention effective tax rates at all. The LLM also invents specific R&D tax credit benefits of $67M in 2024, $129M in 2023, and $220M in 2022, which are not in the original answer. Additionally, it references a $2.7 billion tax benefit from non-US income in 2024, which is not supported by the ground truth. (2) The only correct quantitative element is the direction of change in long-term income taxes (decreasing), but even this is not tied to the correct years or figures: the ground truth states long-term income taxes payable decreased from $4.3B in 2022 to $1.6B in 2024, a fact the LLM fails to mention or calculate. Instead, it introduces unrelated and incorrect numbers. (3) The multi-hop reasoning is flawed: while the question asks for a comparison of non-US tax credit impact on long-term tax liabilities between 2022 and 2024, the LLM diverts into discussions of tax rates, R&D credits, tax holidays, and restructuring without linking them to the actual liability figures. It fails to synthesize the correct cause (increased offset from non-US tax credits) and effect (reduction in long-term taxes payable). (4) The contextual relevance is moderate because the LLM addresses international tax strategy, which is part of the question, but the qualitative analysis is based on fabricated data and incorrect timelines, severely undermining its validity. The conclusion about strategic focus is plausible but unsupported by the provided facts. Thus, the answer is mostly incorrect with major factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 500,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, pension risk transfers have become more sensitive to interest rate movements, with declining rates creating unfavorable impacts on derivative gains and adjusted earnings, while rising rates generate favorable effects through higher reinvestment yields and lower liability valuations. Regulatory influences—particularly evolving solvency standards, reserve financing rules, and pension funding regulations—continue to shape the structure and timing of these transfers, affecting capital requirements and the mix of guaranteed and non-guaranteed funding products. The interplay of interest rate scenarios and regulatory changes has made pension risk transfers more volatile and strategically sensitive.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the increasing sensitivity of pension risk transfers to interest rates and the influence of regulatory changes between 2022 and 2024, aligning with the core themes in the ground truth. It accurately reflects that interest rate scenarios affect asset-liability management through derivative gains, reinvestment yields, and liability valuations—consistent with the original answer's emphasis on interest rate sensitivity. The mention of regulatory influences shaping the structure and product mix (guaranteed vs. non-guaranteed) also matches the original answer’s point about a potential shift toward non-guaranteed funding products due to pension funding regulations. However, the LLM answer introduces specific cause-effect dynamics—such as declining rates leading to unfavorable derivative gains and rising rates improving reinvestment yields—that are plausible but not explicitly stated or supported in the ground truth. The original answer does not discuss derivative gains or earnings impacts, nor does it specify that rising rates lower liability valuations; instead, it focuses on how regulatory changes may delay plan terminations and affect transfer likelihood. Thus, while the LLM answer is contextually relevant and semantically aligned in broad strokes, it adds inferential detail not present in the source, weakening the qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The answer addresses both interest rate sensitivity and regulatory influence across the 2022–2024 period, satisfying completeness. Overall, the reasoning is sound but slightly overextends beyond the evidence, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 467,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic’s positioning and product strategy for the InterStim Micro neurostimulator shifted from early-stage market entry toward broader clinical adoption and integration within its Pelvic Health portfolio. The 2022 10‑K notes the launch of InterStim Micro as a recharge‑free device for overactive bladder, urinary retention and fecal incontinence, and emphasizes its role in expanding less‑invasive therapies for women’s health. By 2024, the company highlighted continued acceptance and growth of InterStim Micro alongside other InterStim platforms (InterStim II, InterStim X) and underscored its inclusion in the “Pelvic Health” growth agenda, indicating that the Micro device has moved from a niche launch to a key driver of overall pelvic‑health sales, supported by AI‑enabled surgical navigation (StealthStation) and robotics (Mazor) to accelerate adoption.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its correctness: it incorrectly states that the InterStim Micro is a 'recharge-free device' in 2022, while the ground truth explicitly states that by 2024, Medtronic positioned it as a 'rechargeable neurostimulator'—a key strategic differentiator. This misrepresentation reverses a core aspect of the product's technical and marketing evolution. Additionally, the LLM falsely implies that InterStim Micro was launched in 2022 as recharge-free, which contradicts the ground truth that does not specify a 2022 launch nor describe it as recharge-free at that time. The mention of 'AI-enabled surgical navigation (StealthStation)' and 'robotics (Mazor)' as supporting adoption of InterStim Micro is unsupported by the original answer and introduces extraneous, unverified technology linkages. While the answer correctly identifies the therapeutic indications (overactive bladder, urinary retention, fecal incontinence) and the broader Pelvic Health portfolio context, and the timeline (2022 to 2024) is appropriately framed, the core product differentiation strategy is misrepresented. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound in structure but based on incorrect premises, leading to flawed synthesis. Contextually, the answer addresses the evolution of product strategy and positioning, so it remains relevant despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 406,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility usage declined significantly. Outstanding borrowings under the Supplemental Facility fell from $1.05 billion at the end of 2021 to $323.7 million by December 31, 2024, reflecting active repayments and strategic reductions. The company consistently used the facility to refinance maturing debt—most notably redeploying proceeds to retire $1.16 billion of mortgages in December 2021 and to fund the $808 million bond issuance in November 2023 that repaid the same amount under the Supplemental Facility. Consequently, the facility’s balance was largely retired by 2024, with only modest remaining capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that in 2022, the weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) was $519.9 million, with a maximum balance of $2.1 billion during the year. The LLM incorrectly claims $1.05 billion at the end of 2021 and $323.7 million by end of 2024—neither of which aligns with the ground truth. The repayment of €750.0 million ($815.4 million) on November 17, 2023, is misstated in the LLM answer as an $808 million bond issuance repaying the same amount, which is factually incorrect in both amount and timing. (2) The LLM references a $1.16 billion mortgage retirement in December 2021, which is outside the 2022–2024 scope and not mentioned in the original answer, suggesting fabricated or misattributed data. The $323.7 million figure for 2024 does not match the ground truth’s $311.1 million weighted average balance. (3) The reasoning is partially sound in identifying a trend of debt reduction and refinancing, but fails in multi-hop synthesis: it misaligns dates, amounts, and instruments (e.g., confusing bond issuances with repayments). The strategic reduction narrative is consistent, but execution details are flawed. (4) Contextual relevance is high as the answer addresses the evolution of the Supplemental Facility use, but quantitative inaccuracies severely undermine correctness. Minor format flexibility is allowed, but core numbers and events are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 416,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "Based on the depreciation, depletion, and amortization (DDA) expense figures in the consolidated financial statements, COP's DDA expense increased from $7,492 million in 2022 to $8,284 million in 2023. This rise reflects higher DDA costs in the Lower 48 region (up from $4,854 million to $5,729 million) and other segments, indicating that the company's investment activity in the Lower 48 expanded during 2023, driving the increased DDA expense. Consequently, the growth in DDA expense signals an acceleration in capital investment and related activity within the Lower 48 area from 2022 to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the Lower 48 DDA and impairments expenses for both 2022 ($4,854 million) and 2023 ($5,729 million), matching the ground truth exactly. It accurately interprets the increase as indicative of higher investment activity or asset utilization in the region. (2) All numeric values are correct, including the regional figures. The LLM also mentions the total company-wide DDA expenses ($7,492M in 2022 and $8,284M in 2023), which are not part of the ground truth but are factually accurate and provide helpful context without contradicting the core answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly isolates the Lower 48 regional expenses from broader company data and links the year-over-year increase to heightened investment activity, which aligns with standard financial interpretation of DDA trends. (4) The answer is semantically equivalent to the ground truth, with slightly more contextual detail (company-wide DDA), but the core information about the Lower 48 region’s expense evolution and its implication is fully accurate. The only minor point preventing a perfect 10 is that the original answer focuses strictly on the Lower 48 implications, while the LLM slightly broadens the scope, though not inaccurately. Thus, scores reflect near-perfect correctness with excellent quantitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 391,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "Verizon's corporate networking solutions have evolved from 2023 to 2024 by shifting emphasis from a standalone \"Business Markets and Other\" segment to integrating networking services more deeply within the Business Group's broader portfolio. In 2024, the Business segment explicitly highlights \"corporate networking solutions\" as a core offering under its wireless and wireline services, alongside security, managed network services, and IoT connectivity, reflecting a strategic focus on enterprise-grade network infrastructure. This evolution is underscored by the 2024 segment data showing $14.2 billion in Enterprise and Public Sector revenues (up from $15.1 billion in 2023, though the segment's revenue share decreased slightly), with corporate networking positioned as a key driver for business market growth and innovation, particularly through 5G and intelligent edge network deployments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It incorrectly states that Enterprise and Public Sector revenues increased to $14.2 billion in 2024 from $15.1 billion in 2023, which contradicts the ground truth—$14.2B is less than $15.1B, so this cannot be an 'increase'. Additionally, the ground truth does not provide 2024 revenue figures at all, only noting that such detailed revenue breakdowns were no longer specified in 2024. The LLM fabricates a data point by asserting a revenue figure for 2024 and making a comparative claim not supported by the source. (2) The LLM also misrepresents structural changes, claiming a shift from a 'Business Markets and Other' segment to a 'Business Group', but the original answer makes no mention of a segment name change—only a shift in service description detail. (3) On qualitative reasoning, the LLM correctly identifies a strategic emphasis on corporate networking solutions and references relevant technologies like 5G and edge computing, which aligns with contextual plausibility. However, it fails the multi-hop synthesis test by not accurately capturing the core evolution: a reduction in descriptive granularity of services and revenue disclosure from 2023 to 2024. Instead, it inverts the trend, suggesting more emphasis or integration, when the ground truth indicates a move toward streamlined, less detailed presentation. (4) Contextually, the answer is relevant and addresses the question's focus on service description and business emphasis. Despite incorrect facts, it attempts the right type of analysis. The correctness score is low due to major quantitative and factual errors that undermine the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 471,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife’s valuation of FVO securities and other Level‑3 assets was driven by observable market inputs (e.g., quoted prices, market‑pricing techniques) and significant unobservable inputs such as mortality, lapse, utilization, withdrawal, equity‑volatility and non‑performance‑risk spreads.  The company’s sensitivity analysis shows that a 10 % appreciation of the U.S. dollar would have reduced the estimated fair value of its interest‑rate‑ and foreign‑currency‑sensitive assets by roughly $11.8 billion, while the embedded‑derivative liabilities tied to those exposures would partially offset that impact.  Consequently, the net effect of U.S.‑dollar appreciation on the fair‑value hierarchy shifted the overall sensitivity from $7.2 billion of potential loss in 2021 to a smaller net exposure by 2024, reflecting both the higher observable market data and the offsetting liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, a 10% U.S. dollar appreciation would decrease the fair value of FVO securities by $54 million, but the LLM claims a $11.8 billion decrease in value for interest-rate- and foreign-currency-sensitive assets—this figure is not supported by the original answer and is off by orders of magnitude. Additionally, the LLM references a $7.2 billion potential loss in 2021, which is not mentioned in the original answer and introduces a year (2021) not part of the question’s scope (2022–2024). No fair value figure for 2024 is provided in the ground truth, yet the LLM implies a net exposure shift without supporting data. (2) The only correct numeric detail is the use of a 10% appreciation scenario, but the associated impacts are entirely incorrect. The original $54 million sensitivity in 2022 is ignored. The LLM invents large-scale dollar figures ($11.8B, $7.2B) with no basis in the provided truth. (3) The multi-hop reasoning is flawed. The question asks about the evolution in MetLife’s valuation *approach* and sensitivity to U.S. dollar changes. While the LLM mentions unobservable inputs and offsetting liabilities, it fails to capture the key evolution described in the ground truth: a shift from a static sensitivity model in 2022 to a more nuanced, duration- and currency-dependent framework in 2024 based on nonperformance risk spreads and unobservable inputs varying by duration and currency. Instead, it fabricates a narrative around net exposure reduction due to offsetting liabilities, which is not in the original. (4) The contextual relevance is moderate because the LLM discusses valuation inputs and currency sensitivity, which are relevant topics, but it misses the core evolution in methodology and introduces irrelevant or incorrect data. The answer is not semantically equivalent to the ground truth and fails to reflect the actual progression described in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 540,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "Between 2022 and 2023, NextEra Energy's power marketing activities expanded through NEER, with energy trading revenues rising $5,952 million—driven by favorable non‑qualifying commodity hedges and new wind/solar/battery projects—while operating expenses increased $566 million due to higher O&M and depreciation costs. This growth contributed to a $3,273 million jump in NEER's net income (after noncontrolling interests), reflecting stronger earnings from new clean‑energy investments and improved trading gains, even as the company faced higher interest expenses and occasional impairment charges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth states that NextEra Energy's net income rose from $285 million in 2022 to $3,558 million in 2023—a $3,273 million increase—the LLM incorrectly attributes this jump to NEER's net income 'after noncontrolling interests' without confirming the base figures. More critically, the LLM introduces a $5,952 million increase in 'energy trading revenues' and a $566 million rise in operating expenses, which are not present in the original answer and cannot be verified from the provided ground truth. These specific revenue and expense figures are unsupported and likely incorrect. (2) The only numerically accurate element is the $3,273 million net income increase ($3,558M - $285M = $3,273M), which the model correctly calculated. However, it mislabels this as 'NEER's net income (after noncontrolling interests)' without confirming alignment with the original entity-level reporting. (3) Qualitatively, the LLM captures the directional evolution—expansion of power marketing via NEER and increased profitability—and correctly identifies drivers like new clean energy projects and trading gains. It also acknowledges headwinds like higher interest expenses and impairments, which adds depth, though these are not in the original. The multi-hop synthesis is partially sound: it connects NEER’s activities to financial performance, but fabricates intermediate financial line items (revenue, opex) not present in the ground truth. (4) Contextual relevance is high—the response directly addresses the evolution of power marketing and financial performance between 2022 and 2023, focusing on the right subsidiary (NEER) and correct time frame. However, the introduction of unverified financial details undermines factual correctness. The core conclusion about significant growth is aligned, but the supporting data is not fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 520,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBased on the provided document, The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, as indicated in Note 6 where it states \"As of December 31, 2024, we owned 28% of Coca-Cola FEMSA, S.A.B. de C.V.\" The Company's equity income (loss)-net from equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting improved performance of its equity method investments including Coca-Cola FEMSA. This increase in equity income is consistent with the overall rise in net income of the equity method investees, which grew from $7,657 million in 2023 to $8,439 million in 2024, as shown in the consolidated financial information. The Company's carrying value of its investment in Coca-Cola FEMSA was $1,786 million as of December 31, 2024, though the document does not provide the specific 2023 carrying value for this investment. The equity income increase demonstrates how the Company's stake in Coca-Cola FEMSA contributes to its overall equity income, which is a key component of its consolidated financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. The original answer states that in 2023, The Coca-Cola Company did not hold a direct 28% ownership stake in Coca-Cola FEMSA but rather had an indirect financial dependency through credit rating linkages. However, the LLM claims a 28% stake was maintained from 2023 to 2024, which contradicts the ground truth that the direct ownership stake evolved by 2024. This misrepresents the core evolution of the financial relationship. (2) Quantitatively, the LLM introduces specific numbers—equity income rising from $1,691M to $1,770M, net income of equity investees from $7,657M to $8,439M, and a carrying value of $1,786M in 2024—that are not present in the original answer or implied by the knowledge graph. These figures may be plausible but are unsupported by the provided ground truth and appear fabricated or misattributed. The absence of 2023 carrying value is correctly noted, but the use of unverified financials undermines accuracy. (3) The multi-hop reasoning is flawed: the original answer emphasizes a strategic shift from indirect dependency (2023) to direct ownership (2024), implying a change in the nature of the relationship. The LLM instead assumes continuity of ownership, missing this key evolution and thus failing to correctly synthesize the change over time. (4) Contextual relevance is moderate—the LLM discusses equity income implications and ownership stakes, which are relevant topics. However, due to incorrect entity relationships and unsupported numerical claims, the qualitative and quantitative accuracy scores are low. The answer gives a false sense of precision with detailed numbers while missing the central conceptual shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 485,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Based on the provided financial data, the Lower 48 region's operational focus shifted significantly between 2022 and 2023, with production volumes increasing substantially while depreciation expenses also rose. Specifically, Lower 48 production volumes rose from 213 thousand barrels daily in 2022 to 447 thousand barrels daily in 2021 (and further to 584 thousand barrels daily in Delaware Basin alone by 2021), and depreciation expenses for the region increased from $4,854 million in 2022 to $5,729 million in 2023, reflecting both higher operational activity and asset base expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Lower 48 production volumes rose from 213 thousand barrels per day (bpd) in 2022 to 447 thousand bpd in 2021, which is both temporally illogical (2021 before 2022) and factually incorrect. The ground truth states that in 2022, crude oil production was 447 thousand bpd, not 2021. Additionally, the claim that Delaware Basin production reached 584 thousand bpd by 2021 is unsupported by the original answer and introduces a new, unverified sub-region. (2) While the depreciation expenses are correctly cited ($4,854 million in 2022 and $5,729 million in 2023), the production volume data is severely misstated. The original answer does not mention a drop or fluctuation in production volumes between 2022 and 2023, but rather emphasizes stable or moderate levels despite increased financial investment. The LLM incorrectly infers a substantial increase in production volumes, which contradicts the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize production and depreciation trends over time. Instead of noting that financial investment increased (via higher DD&A) while production remained stable—indicating growing investment relative to output—it falsely claims both production and depreciation rose, misrepresenting the relationship. (4) Despite these issues, the answer is contextually relevant in discussing production volumes and depreciation expenses for the Lower 48 region, and it correctly identifies the increase in depreciation expenses. However, due to major quantitative inaccuracies and incorrect temporal logic, the overall correctness score is low. Minor score allowances are made for correct expense figures and general topic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 488,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Verizon's 4G LTE network has evolved from a foundational connectivity platform to a strategic growth driver within its broader network infrastructure and monetization strategy. While the company continues to invest in expanding and densifying its 4G LTE coverage to support Fixed Wireless Access (FWA) broadband and enhance network reliability, its primary strategic focus has shifted toward 5G deployment and leveraging the combined capabilities of its 4G LTE and 5G networks to deliver advanced services and fuel future growth, as highlighted in the 2024 10-K's emphasis on 5G evolution and fiber expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Verizon's 4G LTE network strategy between 2023 and 2024. It correctly identifies that in 2023, 4G LTE served as a foundational platform, particularly for Fixed Wireless Access (FWA), which matches the original answer. The shift in 2024 toward a more integrated, multi-technology ecosystem is also accurately reflected, though the LLM emphasizes 5G and fiber expansion—consistent with the 2024 10-K—while the original answer specifically names C-Band, millimeter wave, and fiber as components of the integrated vision. The LLM captures the strategic evolution from service delivery to a broader growth enabler, which is the core of the multi-hop reasoning. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Verizon, 4G LTE, FWA, 2023–2024 timeframe) are correct. The only minor shortcoming is that the LLM does not explicitly mention the integration of 4G LTE within a multi-spectrum (C-Band, mmWave) strategy, instead framing it as a complement to 5G. This omits a nuance in the technological integration described in the ground truth, slightly reducing qualitative accuracy. However, the overall meaning and strategic trajectory are semantically equivalent. Contextual relevance is strong as the response directly addresses the evolution in strategic role within infrastructure and growth initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 396,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 through 2024, Emerson’s financial relationship with AspenTech evolved from a 55% equity stake (after the 2022 Heritage AspenTech acquisition) to full ownership via a proposed $240‑per‑share cash acquisition announced in November 2024, while the company also explored divesting its Safety & Productivity segment.  The stake’s value grew as AspenTech’s backlog rose from $328 million in 2021 to $1,042 million in 2022, supporting higher segment earnings, and the integration of AspenTech contributed to gross‑margin expansion (50.8% in 2024) despite inventory‑step‑up amortization.  However, the later sale of Emerson’s remaining 40% non‑controlling interest in Copeland (a key AspenTech‑related asset) generated a $279 million pretax loss on the note receivable and a $539 million gain on the equity sale, underscoring the financial impact of the evolving AspenTech relationship on backlog, margins and overall earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Emerson held a 55% stake in AspenTech in 2022 due to a 'Heritage AspenTech acquisition,' but the ground truth indicates that Emerson only reached 55% ownership in 2024 after a transaction creating 'New AspenTech.' The claim of a $240-per-share cash acquisition announced in November 2024 is not supported by the original answer and introduces a future event not in the ground truth. The backlog figures are partially correct—$1,042 million in 2022 is accurate—but the LLM incorrectly cites $328 million in 2021, whereas the original answer states $6,533 million in 2021. The gross margin is cited as 50.8% in 2024 in the LLM answer, which is not mentioned in the ground truth; instead, the truth states a 3.3 percentage point increase in gross margin in 2023 due to the acquisition. The LLM introduces a $279 million pretax loss and $539 million gain from the sale of Copeland, which is entirely absent from the original answer and appears to conflate unrelated financial events. (2) Quantitative accuracy is severely compromised: the 2021 backlog is off by over $6 billion, the gross margin figure is fabricated, and the Copeland transaction details are unsupported. The only correct numbers are the $1,042 million backlog in 2022 and the general direction of margin improvement. (3) Multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution of ownership (55% in 2024, not 2022), misattributes financial impacts, and introduces unrelated divestitures and gains. It does not correctly synthesize the impact of the AspenTech integration on backlog growth to $8,053 million in 2024, a key point in the ground truth. (4) Contextual relevance is moderate—the answer addresses stake value, ownership, and financial metrics—but the factual errors and invented details severely undermine correctness. The qualitative reasoning is unsound due to incorrect entity relationships and timeline confusion. Correctness score is low due to major factual and numerical errors despite some relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 568,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "Between 2022 and 2023, NEE’s financial commitment to the Mountain Valley Pipeline shifted from active investment to complete exit. In 2022, NEE recorded a $1.5 billion impairment charge related to its investment in the pipeline (page 97), and by the first quarter of 2022 it had fully written off that investment (page 97). By 2023, NEE reported no remaining investment in the project and disclosed only $11 million of equity method investees, indicating the pipeline was fully divested (page 111). This abandonment signals a strategic pivot away from gas‑pipeline ventures toward renewable and regulated transmission projects, emphasizing capital allocation to wind, solar, and transmission infrastructure instead.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and fact. (1) The original answer states that NEE's commitment to the Mountain Valley Pipeline evolved from a general equity stake (32%-55%) in 2022 to a more defined 32.8% ownership in 2023, accompanied by a 20-year $70 million/year transportation agreement—indicating increased strategic commitment. In contrast, the LLM claims NEE fully exited the investment by Q1 2022 after a $1.5 billion impairment and had no remaining exposure in 2023, which contradicts the ground truth. (2) The cited numbers—$1.5 billion impairment, $11 million in equity method investees—are not supported by the ground truth and appear fabricated or misattributed. The correct figures are the 32.8% equity stake and $70 million annual contract value in 2023; no impairment or write-off is mentioned in the original. (3) The multi-hop reasoning fails: instead of synthesizing continuity and deepening of investment, the model incorrectly infers divestment and strategic retreat. (4) Contextual relevance is low because the answer describes a strategic exit that did not occur, misrepresenting NEE’s actual strategy of strengthening its infrastructure commitment. The conclusion about pivoting to renewables is unsupported by the provided truth. Overall, the answer is factually and logically inverted, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 381,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "From 2023 to 2024, Coca-Cola's relationship with Costa Limited has deepened its operational integration and strategic positioning within the Global Ventures segment. Costa Limited's sales are now explicitly included in the Global Ventures operating segment, reflecting its expanded role beyond bottling to include direct consumer sales through its retail stores. This integration supports Coca-Cola's broader strategy of leveraging Costa's established market presence and brand portfolio to drive growth in emerging beverage categories and enhance its global beverage portfolio diversification. The 2024 annual impairment testing for indefinite-lived intangible assets, including goodwill tied to Global Ventures, underscores the strategic importance of this segment to Coca-Cola's long-term value creation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Coca-Cola's relationship with Costa Limited from 2023 to 2024. It accurately captures the deeper operational integration of Costa Limited within the Global Ventures segment and correctly identifies that Costa's retail operations are part of this integration. The mention of Costa contributing to direct consumer sales through retail stores matches the original answer. The strategic positioning is well-articulated, emphasizing portfolio diversification and growth in emerging beverage categories, which is consistent with the broader strategic role described in the ground truth.\n\nQuantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), so the response is not factually inaccurate in that regard. The reference to 2024 annual impairment testing is contextually appropriate and reflects strategic importance, though this specific detail is not in the original answer. While not incorrect, it introduces a minor element not present in the ground truth, slightly affecting qualitative accuracy.\n\nThe original answer notes that by 2024, Global Ventures also included innocent and doğadan, as well as distribution coordination fees—details omitted in the LLM response. This is a meaningful omission in terms of completeness, as it fails to fully represent the expanded scope of the segment beyond Costa. However, the core of the multi-hop reasoning—Costa’s deeper integration into Global Ventures—is sound and correctly synthesized across time periods.\n\nOverall, the LLM answer conveys the essential truth with strong contextual relevance and accurate entity and year references (Costa Limited, Global Ventures, 2023–2024). The reasoning is logical and supports the conclusion, though it lacks full completeness in describing the segment’s expanded composition. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 547,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Based on the provided SEC 10-K filings, Intel's investment in economically hedged marketable debt instruments experienced a significant decline in fair value between 2022 and 2024. As explicitly stated in the 2024 filing (page 80), the fair value of these hedged investments was $13.5 billion as of December 28, 2024, compared to $17.1 billion as of December 30, 2023, reflecting a net loss of $464 million in 2024 (after prior net gains of $534 million in 2023 and $748 million in 2022). This deterioration was primarily attributed to the uncertainty surrounding the realizability of US deferred tax assets, which led to a $10.9 billion increase in the valuation allowance for deferred tax assets during 2024. Consequently, the fair value of Intel's economically hedged marketable debt investments decreased substantially over the two-year period, with the 2024 fair value being notably lower than both 2023 and 2022 levels.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the direction and magnitude of changes between 2022 and 2024. While it correctly states the $13.5 billion fair value in 2024 and $17.1 billion in 2023, it incorrectly implies that the 2024 value is lower than 2022 levels, when the ground truth does not provide the 2022 fair value—only the $748 million net loss for that year. The LLM incorrectly claims a 'deterioration' and 'decline... over the two-year period' without data to support a 2022-to-2024 fair value comparison. (2) The LLM misstates the 2022 and 2023 net gains/losses: it claims 'prior net gains of $534 million in 2023 and $748 million in 2022', but the ground truth states Intel recorded net *losses* of $748 million in 2022 and $464 million in 2024. The $534 million gain in 2023 is not mentioned in the original answer and contradicts the ground truth narrative. This is a critical quantitative error. (3) The multi-hop reasoning is flawed: the LLM introduces new causal information—'uncertainty surrounding the realizability of US deferred tax assets' and a '$10.9 billion increase in valuation allowance'—that is not present in the original answer and cannot be verified from the provided ground truth. This suggests hallucination or use of external data not in the knowledge graph. (4) Despite these issues, the LLM correctly identifies the $13.5 billion 2024 fair value and $464 million 2024 loss, and correctly notes a decline from 2023 to 2024. It also addresses the evolution of investments as requested. Hence, partial credit is given for contextual relevance and some accurate data points, but significant deductions are made for incorrect numbers, mischaracterized trends, and unsupported causal reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 483,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT’s communications‑site portfolio continued to generate recurring lease revenue that is largely non‑cancellable and escalates on a fixed or inflation‑linked basis, providing a stable cash‑flow base.  However, the company recorded significant asset‑retirement obligations ($4.5 billion undiscounted) and, under its securitization and loan agreements, excess cash flow is subject to DSCR‑based cash‑trap and amortization conditions that can restrict distributions and limit the use of cash for capital projects or debt repayment.  Consequently, while recurring revenue remained robust, the ability to fully deploy cash from operations was increasingly constrained by these covenant‑driven cash‑flow restrictions and the need to fund asset‑retirement liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the recurring revenue model in 2023–2024, noting stable, non-cancellable lease income from communications sites, which matches the original emphasis on 99% of revenue from property operations. It also accurately states the $4.5 billion in undiscounted asset retirement obligations as of December 31, 2024, consistent with the ground truth. (2) Quantitatively, all numbers are correct: the $4.5 billion figure is precisely reported, and no incorrect dates or percentages are introduced. Format is consistent and acceptable. (3) The multi-hop reasoning is sound—linking recurring revenue to long-term liabilities and cash flow constraints shows synthesis across financial operations and obligations. The LLM adds contextual detail not in the original (e.g., DSCR-based cash traps, securitization agreements), which is factually plausible and enhances the narrative without contradicting the ground truth. However, the original answer does not mention cash flow restrictions due to covenants, so this is an extrapolation. While reasonable, it slightly extends beyond the provided truth, preventing a perfect 10 on qualitative accuracy. (4) The answer remains highly relevant, addressing both recurring revenue and asset retirement liabilities as required by the question. The added context about cash flow deployment constraints improves practical understanding without straying from the core evolution in financial focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "XOM's strategic positioning in Guyana has evolved significantly between 2023 and 2024, with the legal operating framework transitioning from the Petroleum Activities Act 2023 to a more stable regulatory environment that supports long-term development. The company has emphasized Guyana as a core growth area, particularly through its Pioneer acquisition and expanding upstream investments, which are now categorized under \"Advantaged Assets\" in its earnings drivers. This strategic focus reflects a deliberate shift toward high-value, long-cycle projects in Guyana to drive future growth, supported by the country's newly established legal structure for petroleum agreements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Petroleum Activities Act 2023 as the legal framework in 2023 and notes the strategic elevation of Guyana as an 'Advantaged Asset' in 2024, aligning with the ground truth. However, it inaccurately implies a transition to a new legal framework by 2024 ('transitioning from... to a more stable regulatory environment'), while the ground truth does not indicate any change in the legal framework itself—only a shift in strategic emphasis. Additionally, the mention of the 'Pioneer acquisition' and 'expanding upstream investments' introduces unsupported specifics not present in the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond the year 2023 for the Act, which the LLM correctly cites—so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the evolution from a regulatory basis to strategic emphasis on Guyana as a growth driver. However, it adds unverified details (e.g., Pioneer acquisition) and misrepresents the legal evolution, weakening the reasoning chain. (4) The contextual relevance is high because the answer addresses both legal framework and business growth emphasis. The core strategic shift is accurately captured, but the addition of unsupported details and slight misrepresentation of the legal change justify a score of 7 for correctness and qualitative accuracy, while quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 415,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar’s diesel‑electric locomotives remain part of its Energy & Transportation segment, but the company’s strategic focus and operational responsibilities have shifted.  While the segment continues to design, manufacture and support diesel‑electric locomotives and related components (including remanufacturing and leasing), the 2024 disclosures show that the segment’s profit growth was driven primarily by favorable price realization rather than volume changes, and that operational responsibilities are now integrated with the broader Machinery, Energy & Transportation (ME&T) business.  Consequently, Caterpillar’s involvement in diesel‑electric locomotives is positioned within the ME&T portfolio, with responsibilities spanning product design, manufacturing, marketing, sales and product support across the segment’s overall line‑of‑business strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key strategic shifts emphasized in the ground truth. (1) Correct elements: The answer correctly identifies Caterpillar's diesel-electric locomotives as part of the Machinery, Energy & Transportation (ME&T) segment and notes continuity in design, manufacturing, remanufacturing, and support responsibilities. It also accurately reflects that operational responsibilities are integrated within ME&T, aligning with the 2024 structure. (2) Quantitative accuracy: There are no specific numbers, percentages, or financial figures in either the ground truth or LLM response, so no numerical inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM fails to capture the core strategic evolution highlighted in the original answer—specifically, the 2024 shift toward integrated systems for power generation, marine, oil and gas, and industrial sectors, and more importantly, the emphasis on electrified powertrains and zero-emission technologies. This omission represents a significant gap in qualitative accuracy, as the strategic pivot to environmentally focused innovation is central to the question about Caterpillar’s evolving positioning. (4) The LLM instead focuses on profit drivers (price realization vs. volume), which is not mentioned in the ground truth and appears to be an unsupported inference. While contextually relevant and well-structured, the answer substitutes operational integration for strategic transformation, thus missing the essence of the evolution. Hence, correctness is reduced to 6 due to major omissions in strategic direction despite accurate entity and segment identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 461,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "From 2022 to 2024, Capital One’s reliance on securitized debt obligations as a funding source grew modestly but remained a relatively small portion of total funding. In the 2023 balance sheet (page 220), securitized debt obligations were reported at $18,067 million, up from $18,043 million in 2022, and represented about 4 % of total liabilities. By the 2024 filing (page 218), the carrying value of securitized debt fell slightly to $14,335 million, still accounting for roughly 4 % of total liabilities. This indicates that while the company continues to use securitizations to diversify funding, it is not a dominant or rapidly expanding component of its overall financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, no exact amount was disclosed for securitized debt obligations, but the LLM claims a specific figure of $18,043 million in 2022 and $18,067 million in 2023—neither of which appear in the original answer and contradict the 'no exact amount provided' assertion. Additionally, the 2024 carrying value in the LLM answer is $14,335 million, whereas the ground truth reports $14,264 million—a close but incorrect figure. The LLM also introduces 'Capital One' as the company, which is not named in either the question or the original answer, introducing an incorrect entity. (2) The quantitative values are largely fabricated or misattributed. There is no mention of page numbers (e.g., page 220, 218) or specific balance sheet data in the original answer, suggesting the LLM hallucinated sources. The 4% of total liabilities metric is absent from the ground truth and cannot be verified, further undermining numerical accuracy. (3) The multi-hop reasoning is flawed. The original answer infers increasing reliance due to the emergence of a quantified value in 2024 versus no specific number in 2022. The LLM instead assumes a decline from 2023 to 2024 and concludes stable, minor use—contradicting the strategic implication of growing importance. The reasoning fails to align with the ground truth’s interpretation. (4) While the LLM attempts to address the evolution and strategic implication, the introduction of an unverified company, incorrect financial figures, and contradictory trends severely undermine correctness. Contextual relevance is moderate because the structure and intent of the response match the question, but factual foundations are unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 480,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees evolved primarily through enhanced financial reporting and relationship management practices. The company refined its assumptions regarding renewal options in lease accounting (noting that renewal options were now considered \"reasonably certain\" of being exercised under its new \"Restaurant Development\" growth pillar), which increased lease right-of-use assets and liabilities. Additionally, the 2024 adoption of ASU 2023-07 expanded segment reporting disclosures, providing greater detail on reportable segment expenses that directly impacts how developmental licensee performance is disclosed. While the core franchise/license fee structure remained unchanged (royalties based on sales, initial fees recognized over the 20-year term), the company refined its estimates for renewal probabilities and lease liability valuations specifically tied to developmental licensee operations, reflecting a more structured approach to managing these relationships within its International Developmental Licensed Markets & Corporate segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) It incorrectly claims McDonald's refined assumptions about renewal options being 'reasonably certain' under a new 'Restaurant Development' growth pillar and that this increased lease assets/liabilities—this is not mentioned in the original answer and appears fabricated. (2) It references adoption of 'ASU 2023-07' in 2024 to expand segment reporting, which is specific and technical but absent from the ground truth; no such standard or impact is confirmed in the provided data. (3) The original answer notes a change in rounding presentation to the nearest whole number in 2024, which the LLM omits entirely. (4) The ground truth emphasizes McDonald's evaluation of variable interest entities and conclusion against consolidation in 2024—this key point is missing from the LLM response. (5) While the LLM correctly notes that royalties are based on sales and initial fees are paid, it adds unverified details such as recognition over a 20-year term, which is not in the original. (6) The LLM invents a connection between lease accounting changes and developmental licensee operations without support. Overall, the answer misrepresents the nature of the evolution, focusing on lease accounting and segment reporting standards not referenced in the truth, while missing the actual disclosures about variable interest entity assessments and rounding changes. The core financial treatment and relationship management evolution described in the ground truth are not accurately reflected, resulting in a low correctness score despite some surface-level plausibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 456,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Southern Company’s Equity and Incentive Compensation Plan saw a modest increase in reserved shares for future awards, with 26.9 million shares still available at year‑end 2023 (up from prior years’ reserves). Executive award disclosures in the 2024 filing (page 317) continue to reference the 2021 Plan’s terms, but the company now explicitly notes that any remaining shares under the plan are limited to those reserved for the plan, reflecting a tighter share pool for future grants.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly states the 26.9 million shares available in 2023, matching the ground truth. However, it incorrectly implies a 'modest increase' or that the 26.9 million is 'up from prior years’ reserves'—this comparison is not supported in the original answer and introduces unsupported inference. The original answer does not mention any trend or comparison to years prior to 2023. 2) The LLM references 'page 317' of the 2024 filing and notes continued use of the 2021 Plan, which aligns with the ground truth’s reference to the 2021 Equity and Incentive Compensation Plan effective May 26, 2021. However, the original answer emphasizes a shift toward greater transparency in 2024 through detailed disclosure of Named Executive Officer award terms, while the LLM focuses instead on a 'tighter share pool' and limitations on remaining shares—this is a misrepresentation of the evolution described. 3) The multi-hop reasoning is partially sound: the model connects 2023 share availability with 2024 disclosure practices under the same plan. However, it fails to capture the core evolution—increased transparency in executive award disclosures—as the key development, instead emphasizing share pool constraints not mentioned in the ground truth. 4) While the LLM retains some factual elements (correct share number, correct plan name and effective date), it mischaracterizes the nature of the evolution between 2023 and 2024. The original answer highlights a shift from internal reserve planning to enhanced disclosure and governance transparency, whereas the LLM frames it as a tightening of share availability. This undermines the qualitative accuracy. Contextual relevance is fair as it addresses share availability and executive disclosures, but misses the central theme of transparency and formalized governance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta's revenue growth accelerated from 26% in 2022 to 5% in 2023, but this represented a slowdown from the prior year's robust expansion. The change was driven by adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC treatment in the U.S., partially offset by lower volumes and net price declines in certain European markets. The document notes that Inlyta's growth trajectory showed a deceleration, with the 2023 growth rate (5%) being significantly lower than the 26% growth recorded in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the quantitative claims. It states that Inlyta had 26% growth in 2022 and 5% in 2023, implying a deceleration. However, the ground truth does not provide any growth rate for Inlyta in 2022—only that it contributed to Pfizer's operational growth. The 5% operational growth mentioned in the original answer is for 2023, not a comparison point from 2022. Additionally, the LLM incorrectly frames the 5% as a slowdown from 26%, which is unsupported by the source. The 2023 revenue figure of $1,036 million is missing in the LLM answer, a key data point. (2) The calculation and comparison of growth rates are entirely incorrect. There is no evidence in the ground truth of a 26% growth rate in 2022. The LLM fabricates a prior-year growth rate, leading to a false narrative of deceleration. The 5% operational growth in 2023 is correctly mentioned, but misrepresented as a decline in momentum without basis. (3) The qualitative reasoning partially captures the contributing factors—U.S. adoption of immune checkpoint inhibitor combinations and European pricing/volume challenges—but incorrectly embeds them in a false growth trajectory narrative. The multi-hop synthesis fails because it invents a 2022 growth rate not present in the data, breaking the logical chain. (4) Scores reflect severe quantitative inaccuracy (2/10), partial qualitative accuracy due to correct mention of drivers (4/10), decent contextual relevance as it addresses revenue evolution and factors (7/10), and low overall correctness (3/10) due to fabricated metrics undermining the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 450,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's financial structure with franchisees remained largely unchanged in terms of revenue recognition methodology, but the company continued to collect rent and royalty fees from franchised locations based on a percentage of sales, with initial fees recognized over the 20-year franchise term. The 2024 10-K shows no material change in the core franchise revenue model, though the company did acquire 228 restaurants from franchisees in Israel (page 47), recording $240 million of goodwill related to these acquisitions. The franchise model continues to rely on franchisees bearing occupancy costs (including property taxes, insurance, and site maintenance) while the company retains real estate ownership for company-operated locations. Technology platform fees paid by franchisees to recover costs are recognized on a gross basis as revenue when services are delivered, but this revenue recognition approach remained consistent year-over-year. The company's capitalized software amortization increased to $907 million in 2024 (from $836 million in 2023), reflecting ongoing investment in technology platforms that franchisees help fund.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several accurate quantitative details, such as the increase in capitalized software amortization from $836 million in 2023 to $907 million in 2024, and the $240 million goodwill from the Israel restaurant acquisitions. These figures are factually correct and contextually relevant. However, the core of the question—how the financial structure and dependency evolved specifically regarding revenue recognition and cost-sharing for technology platforms—was mischaracterized. The LLM claims there was 'no material change' and that the revenue recognition approach 'remained consistent year-over-year,' which directly contradicts the ground truth. According to the original answer, in 2024 McDonald's began recognizing technology service revenue from franchisees on a gross basis, with related expenses in 'Other restaurant expenses,' signaling a shift toward greater integration and cost-sharing. This evolution reflects a meaningful change in the financial relationship, indicating increased dependency and operational interdependence, which the LLM failed to identify. While the LLM correctly notes that technology fees are recognized on a gross basis, it incorrectly concludes that this was unchanged from 2023. This is a critical error in reasoning and factual accuracy, undermining the qualitative and overall correctness. The answer is contextually relevant and includes useful background on the franchise model, but it misses the key multi-hop insight: the shift in accounting treatment reflects a deeper structural evolution in the franchisee relationship. Thus, while numerically some data points are accurate, the central claim about no change is false, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 466,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $101 million at December 31 2022 to $161 million at December 31 2023, indicating that the company’s exposure to energy market fluctuations grew modestly over that period. This rise reflects higher valuations of natural‑gas and power derivatives, suggesting greater sensitivity to changes in energy prices and market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It claims the fair value of energy-related derivatives increased from $101 million in 2022 to $161 million in 2023, which is incorrect. The ground truth shows a shift in net position from a net liability of $54 million in 2022 (calculated as total liabilities $109M - total assets $55M) to a net liability of $219 million in 2023 (liabilities $234M - assets $28M), indicating a worsening liability position, not an increase in asset value. The LLM incorrectly interprets the change as a rise in fair value to $161M, which does not appear in any part of the ground truth. (2) Quantitative inaccuracies are severe: the 2023 figures cited by the LLM ($161M) are fabricated. The correct 2023 data comes from Alabama Power ($15 assets, $110 liabilities) and Georgia Power ($13 assets, $124 liabilities), totaling $28M in assets and $234M in liabilities — a net liability of $206M (rounded to $219M in original answer, possibly due to additional subsidiaries or rounding). The LLM fails to report liabilities correctly and misrepresents net changes. (3) Multi-hop reasoning is flawed: the model fails to synthesize subsidiary-level data across years and incorrectly aggregates or interprets the direction of exposure. Instead of identifying increased net liabilities as a sign of greater risk, it suggests a modest growth in exposure based on a false increase in fair value. (4) Contextual relevance is moderate — the answer addresses the question's structure (evolution and implication), but with incorrect data and reasoning. The mention of natural gas and power derivatives is plausible but unsupported by the provided truth. Thus, while the intent aligns, factual correctness is poor, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 485,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan (the “2019 Plan”) was adopted by shareholders in October 2019 and its detailed terms were first incorporated by reference in the 2021 Form 10‑K (Exhibit 10‑28). Subsequent filings—including the 2022 and 2024 Form 10‑Ks—re‑state the plan’s key provisions (e.g., the 187 million share reserve, one‑for‑one counting of options/SARs and five‑for‑one counting of full‑value awards) and note that the plan remains the only P&G equity plan that permits future grants, with about 77 million shares still available for issuance as of 2024. Thus, from 2022 through 2024 the plan’s disclosure context has remained consistent, focusing on its share reserve, award‑counting methodology, and continued status as the sole plan allowing future equity grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate details about the 2019 Stock and Incentive Compensation Plan, including its adoption in October 2019, the share reserve (187 million), award-counting methodology, and the fact that about 77 million shares remained available for issuance as of 2024. However, the original answer emphasizes an evolution in disclosure context—from the plan's formal introduction and establishment in 2022 to its integration as a standard component of P&G’s equity compensation framework by 2024. The LLM answer contradicts this by stating that the disclosure context 'has remained consistent' from 2022 to 2024, which misrepresents the evolution highlighted in the ground truth. This is a significant qualitative error in reasoning and interpretation, despite accurate individual facts. Additionally, the LLM claims the plan was first incorporated in the 2021 10-K, but the original answer focuses on 2022 as the point of detailed disclosure, creating a discrepancy in timeline emphasis. While the numbers (187M, 77M) are plausible and internally consistent, they are not verifiable from the ground truth provided, which contains no such figures—thus scoring lower on quantitative accuracy. The answer is contextually relevant and well-structured, correctly identifying the plan and its ongoing role, but fails to capture the nuanced shift in disclosure significance over time, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 392,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets has evolved from 2023 to 2024 by shifting emphasis from diversification alone to a more structured, proactive risk management framework. In 2024, the company explicitly highlighted the use of formal rebalancing programs and external manager guidelines to manage asset class exposures relative to target allocations, alongside diversification as a primary risk mitigation strategy. This represents a more defined operationalization of its long-term investment strategy, which previously was described more generally in 2023. The 2024 disclosures also show a more detailed breakdown of asset allocations and fair value measurements, reinforcing a systematic approach to risk control.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing the evolution of Southern Company's risk management approach. Contrary to the ground truth, the LLM claims that in 2024 there was an increased emphasis on formal rebalancing programs and external manager guidelines, whereas the original answer states that oversight of external managers was actually reduced in 2024. Additionally, the LLM incorrectly frames the shift as moving from 'diversification alone' to a more structured framework, but the ground truth indicates that diversification and rebalancing were already key components in 2023. The LLM also introduces concepts not present in the original, such as 'detailed breakdown of asset allocations and fair value measurements' in 2024, which are not mentioned in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, since no numbers are misstated, this dimension is scored as accurate. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in emphasis from active oversight (2023) to market-driven risk exposure (2024), instead asserting a strengthening of operational controls in 2024, which contradicts the source. The causal and comparative logic is therefore unsound. (4) While the response is contextually relevant—addressing Southern Company, pension risk, and year-over-year changes—the qualitative inaccuracies severely undermine correctness. The answer describes the opposite of the actual shift in risk management emphasis, warranting a low correctness and qualitative accuracy score despite proper framing and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 458,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA’s role in the CUDA platform shifted from being primarily a foundational programming layer for its GPUs to a more integrated, full‑stack offering that is tightly coupled with its broader data‑center and AI software ecosystem. The 2023 filing highlights expanded use of CUDA‑X libraries, AI‑specific extensions (e.g., Tensor Cores, AI Enterprise software), and new services such as DGX Cloud, indicating that NVIDIA is leveraging CUDA not just to accelerate compute but to lock customers into its end‑to‑end AI platform. This strategic focus underscores a move toward dominating enterprise AI workloads and reinforcing its leadership across data‑center, automotive, and professional visualization markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values, dates, or financial figures in the question or answers that require verification—both focus on qualitative shifts between 2022 and 2023, which are correctly identified. (2) The LLM correctly captures the evolution from a supplier role in 2022 to a more integrated developer and integrator role in 2023, emphasizing CUDA's expansion within NVIDIA’s software ecosystem. It adds specific examples such as CUDA-X libraries, AI Enterprise software, Tensor Cores, and DGX Cloud, which are consistent with the strategic shift described in the original answer. (3) The multi-hop reasoning is sound: the model synthesizes the change in role with broader strategic implications—namely, moving toward full-stack dominance in AI and data center solutions. While the original answer does not mention 'DGX Cloud' or 'Tensor Cores' explicitly, these are plausible and relevant illustrations of the strategic direction and do not contradict the ground truth. (4) The LLM enhances the original answer with additional context (e.g., 'lock customers into its end-to-end AI platform') that reflects accurate interpretation of strategic intent. The only minor gap is that the original emphasizes 'developer vs supplier' more explicitly, while the LLM frames it as a shift in integration depth—but this is semantically equivalent. No factual errors; excellent contextual and qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 406,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Based on the provided 10-K filings, Pfizer's financial relationship with Viatris evolved significantly between 2022 and 2023 through the termination of their post-separation agreements. In 2022, Pfizer recorded $33 million due to Viatris as of December 31, 2023 (down from $94 million as of December 31, 2022), reflecting the winding down of transitional services and manufacturing agreements. The $277 million payment to Viatris in 2021 (reported in Other financing activities) was a one-time settlement related to the separation agreement, after which the indemnification of GSK's guarantee was terminated. By 2023, these arrangements were largely completed, with no material amounts recorded under the interim TSAs or MSAs, indicating the financial relationship had been fully resolved.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in the reversal of the timeline and incorrect characterization of the $33 million figure. The ground truth states that $94 million was due to Viatris as of December 31, 2022, decreasing to $33 million as of December 31, 2023. However, the LLM incorrectly states that '$33 million due to Viatris as of December 31, 2023 (down from $94 million as of December 31, 2022)' — this misrepresents the direction of the change and implies the 2023 number is a liability from 2022, which is backwards. Additionally, the LLM introduces a $277 million payment in 2021 related to GSK and a separation agreement, which is not mentioned in the original answer and appears irrelevant to the 2022–2023 evolution between Pfizer and Viatris. (2) The only correct quantitative elements are the $94 million (2022) and $33 million (2023) figures, though their presentation is misleading. The claim about 'no material amounts recorded' in 2023 aligns partially with the original answer’s statement about most transitional services being completed. However, the LLM incorrectly attributes revenue growth from legacy Upjohn products to 2022 as $780 million — this key fact is entirely missing from the LLM response. (3) The multi-hop reasoning is flawed: the LLM fails to connect Pfizer's 2022 revenue growth from manufacturing for Viatris under supply agreements, a central part of the financial relationship. Instead, it focuses on a one-time 2021 payment and indemnification of GSK's guarantee, which are not part of the ground truth and suggest confusion between different corporate events. (4) The contextual relevance is moderate because the answer discusses the winding down of agreements and reduced interdependence, which matches the original's conclusion. However, due to major omissions (missing $780M revenue item) and factual inaccuracies (timeline reversal, irrelevant GSK payment), the overall correctness score is low. Quantitative accuracy is poor due to misused numbers and introduction of false data. Qualitative accuracy suffers from incorrect reasoning and entity conflation. Contextual relevance is acceptable because the general theme of reduced financial ties is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 601,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "The treatment of communications sites under debt obligations has shifted from the 2023 disclosures, which emphasized asset‑retirement obligations and the material cash requirements tied to lease‑related payments, to the 2024 filing, which integrates these sites into detailed securitization structures (e.g., the 2015, 2018 and 2023 Trust Securitizations). In 2024 the company explicitly links cash‑flow from the sites to debt‑service coverage tests, cash‑trap reserve accounts, and amortization periods, and it discloses how covenant compliance directly affects the ability to distribute excess cash. Thus, the evolution reflects a move from a general discussion of lease‑related cash needs to a precise, covenant‑driven framework that governs the sites’ cash flows and their role in meeting debt obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and substance. (1) The ORIGINAL ANSWER states that in 2023, communications sites were explicitly listed as collateral (e.g., 3,343 sites securing Series 2015-2 Notes and $1.3B repayment via 2023 Securitization), while in 2024 there was no such site-specific disclosure—instead, broader obligations like $4.5B in asset retirement obligations were reported. The LLM answer falsely claims the opposite: that 2023 focused on general lease-related cash needs and that 2024 introduced more detailed, covenant-driven frameworks linking site cash flows to debt. This is a fundamental reversal of the actual evolution. (2) Quantitatively, the LLM answer omits all specific numbers from the ground truth: no mention of 3,343 sites, $1.3B repayment, or $4.5B future cash outlay. Instead, it references securitizations (2015, 2018, 2023 Trusts) and mechanisms like cash-trap reserves and debt-service tests not mentioned in the original answer, introducing unverified details. (3) The multi-hop reasoning is flawed: the model incorrectly infers increased specificity in 2024 when the truth is decreased specificity. It fails to recognize the shift from asset-specific collateral disclosures to generalized liability reporting. (4) Contextual relevance is moderate because the answer discusses related concepts (debt, communications sites, cash flows), but the core factual claims are unsupported and inverted. The conclusion about a move to a 'covenant-driven framework' is not substantiated by the original data. Thus, despite plausible financial language, the answer is factually wrong on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 455,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements remained consistent in structure but evolved in key ways between 2022 and 2023. Revenue from these agreements continues to be recognized as monthly fees under multi-year contracts based on subscriber counts, with payments generally collected within 60 days. However, the 2023 filing emphasizes that fees from NBC and Telemundo retransmission consent agreements—including those tied to streaming rights on Peacock—are now explicitly accounted for as licenses of functional intellectual property, with revenue recognized monthly as programming is delivered. This reflects a shift toward integrating streaming distribution models into traditional retransmission frameworks, though the core revenue recognition timing (monthly, post-delivery) and contractual structure (multi-year, subscriber-based) remained unchanged. The 2023 document also notes that while fixed fees apply to some networks, most revenue still derives from per-subscriber charges under these agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: revenue recognition remains monthly as programming is delivered, tied to subscriber counts, with payments collected within 60 days—consistent between 2022 and 2023. The evolution in 2023 includes explicit inclusion of streaming rights via Peacock and treatment of retransmission fees as licenses of functional intellectual property, which matches the strategic shift toward hybrid distribution models mentioned in the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all temporal references (2022 vs 2023) and structural details (multi-year contracts, per-subscriber vs fixed fees) are factually correct and consistent with the source. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes in revenue recognition framework (from traditional to IP licensing model) and connects Peacock’s integration into distribution, indicating understanding across time periods and business segments. (4) The only minor gap is that the LLM does not explicitly mention 'virtual multichannel video providers' or the 'combined linear and streaming distribution model' in identical terms, though it conveys the same meaning by referencing streaming rights on Peacock and hybrid frameworks. Wording differences do not affect semantic accuracy. Overall, the response is factually complete, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 420,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "From 2023 to 2024, Caterpillar's involvement in diesel-electric locomotives remained strategically focused but did not show significant expansion. The Energy & Transportation segment, which includes diesel-electric locomotives and related rail products, reported $11,982 million in sales for 2023 and $9,175 million for 2022, with no indication of new product launches or major strategic shifts in this area. The segment continues to face competitive pressures from firms like Wabtec Corp and Siemens Mobility, while maintaining its core offerings in remanufacturing, components, and rail-related services as part of its broader Energy & Transportation portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and misses the core evolution described in the ground truth. It incorrectly states that Caterpillar's involvement 'did not show significant expansion' and fails to recognize the key shift from a general operational role in 2023 to a more defined 'production' role in 2024. Instead, it implies continuity, which contradicts the ground truth. (2) The financial figures cited ($11,982 million in 2023 and $9,175 million in 2022) are not present in the original answer and are therefore unverifiable; more importantly, they are irrelevant to the question about strategic evolution. The original answer does not mention any sales figures for the segment, so their inclusion misdirects the focus and introduces unsupported data. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a qualitative shift in language—from general support/remans in 2023 to explicit 'production' in 2024—and increased competitive disclosure. The LLM fails to capture this progression and instead asserts no major strategic shift, which is incorrect. It also incorrectly attributes competitive pressures to both years, while the original answer states that such explicit naming of competitors (Wabtec, Siemens Mobility) only appeared in 2024, marking a new strategic awareness. (4) The contextual relevance is moderate because the answer discusses the correct segment and topic area, but it misrepresents the evolution and introduces extraneous sales data. Due to major errors in reasoning, entity usage, and factual content, the correctness score is low despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 449,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's revenue recognition and cost-sharing arrangements with franchisees remained consistent with prior practice: royalties and rent continue to be based on a percentage of sales, with minimum rent payments recognized straight-line over the franchise term and variable rent recognized at the time of sale. Initial fees are recognized over the 20-year franchise term as performance obligations are satisfied. The Company generally acts as the principal in technology platform arrangements, recognizing gross revenue when services are transferred to franchisees, while cost allocations for restaurant improvements are finalized post-project and may result in immaterial adjustments to property and equipment or accounts receivable. No material changes to these core revenue recognition or cost-sharing practices were disclosed in the 2024 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details and correctly identifies the core revenue recognition practices (royalties, rent based on sales percentage, minimum rent straight-line recognition, initial fees over 20-year term, gross recognition of technology platform fees). All entities (McDonald's, franchisees), time periods (2023–2024), and financial treatments are correctly referenced. The answer correctly notes no material changes in core practices, which aligns with the ground truth. However, it underemphasizes a key qualitative evolution highlighted in the original answer: the increased transparency and more detailed disclosures in 2024, particularly around technology fee presentation on the income statement and the structured cost-sharing process for restaurant improvements (funding during project, allocation between Property and Equipment and Accounts Receivable, finalization upon completion). While the LLM mentions 'cost allocations...finalized post-project,' it omits the nuance of interim cost tracking and the shift toward enhanced disclosure, which represents an important evolution in reporting clarity. This omission reduces completeness in capturing the 'evolution' aspect of the question, though the core mechanics are sound. Wording differences are acceptable under semantic equivalence, but the lack of emphasis on improved 2024 disclosures slightly weakens the qualitative accuracy. Contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 416,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Southern Company's executive equity compensation approach remained consistent between 2023 and 2024, continuing to utilize its 2021 Equity and Incentive Compensation Plan for granting performance share units (PSUs) and restricted stock units (RSUs) to executives, with no significant changes to plan documentation or award terms observed in the provided filings. The company maintained its established vesting schedules (including immediate vesting upon change-in-control for unvested PSUs/RSUs) and performance-based award structures, as evidenced by the consistent descriptions of PSU/RSU terms, vesting periods, and plan amendments (e.g., the 2021 Plan's terms and the 2022 amendment to the Executive Change in Control Severance Plan) appearing in the 2023 and 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core conclusion, directly contradicting the ground truth. While it correctly identifies that Southern Company used the Equity and Incentive Compensation Plan (specifically the 2021 version) and granted PSUs and RSUs in both years—supporting quantitative and entity accuracy—the central claim that there were 'no significant changes' is factually wrong per the original answer. The ground truth states that in 2024, the company formalized terms for Named Executive Officer equity awards and introduced detailed documentation practices (e.g., specific exhibit designations for award terms), which were absent in 2023. This represents a clear evolution toward greater structure, specificity, and transparency in executive compensation documentation. The LLM fails to recognize or report this key shift, indicating a failure in multi-hop reasoning and qualitative synthesis. It treats consistency in plan name and award types as evidence of no change, overlooking the qualitative evolution in governance and disclosure practices. Thus, while some factual elements (plan name, award types, vesting features) are accurate, the overall assessment misrepresents the evolution asked about in the question. The answer is contextually relevant but fundamentally flawed in reasoning and conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 368,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has diminished from 2022 to 2024, as evidenced by its reduced emphasis on this channel in recent disclosures. The 2024 filing (pages 5-9) no longer highlights membership club stores as a key customer segment in the same strategic context as 2022 (pages 2-6), instead listing them generically among other retail channels without specific strategic focus. This shift indicates a broader strategic pivot toward diversified retail channels—including e-commerce and direct-to-consumer—while deprioritizing dependence on any single wholesale channel, including membership clubs, to mitigate concentration risks and align with evolving consumer shopping behaviors.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that P&G's reliance on membership club stores *increased* from 2022 to 2024, with a shift in language from identifying them as one of many key channels to emphasizing *dependency* on them. In contrast, the LLM claims reliance has *diminished*, which is the opposite of the correct answer. This fundamental error invalidates the conclusion. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate. Thus, this dimension is scored as 10 by default. (3) The multi-hop reasoning is flawed. The model fails to correctly interpret the evolution in P&G’s channel strategy across years. Instead of recognizing increased strategic emphasis, it incorrectly infers deprioritization based on document page references (e.g., '2024 filing pages 5-9') that are not supported by the ground truth. The synthesis across time periods is unsound. (4) Contextual relevance is moderate—the answer addresses the right topic (P&G’s retail channel strategy) and mentions relevant channels like e-commerce and consumer behavior. However, the conclusion misrepresents the direction of change and thus misleads the user. The feedback would be that while the structure and intent are reasonable, the factual core is inverted, leading to a highly misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 393,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "Based on the provided 10-K pages, AMT's involvement with the Nigeria Letters of Credit remained unchanged between 2023 and 2024, with $3.4 million in letters of credit outstanding as of December 31, 2023 (page 118). The document indicates these were drawn during 2023 and 2024 but does not describe any structural evolution or new commitments related to them in 2024. The only relevant context is that they were part of the Company's \"other subsidiary debt\" with no prepayment considerations specified for the 2023 Securities (which relate to the Nigeria Letters of Credit structure), and the Company maintained compliance with related covenants as of December 2024 (page 115). This suggests the financial obligations tied to these instruments remained static without significant evolution during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AMT's involvement with Nigeria Letters of Credit remained unchanged. The ground truth confirms that the obligation decreased from $3.4 million in 2023 to $0 in 2024, indicating full settlement. The LLM incorrectly claims the $3.4 million remained outstanding and that there was no evolution, which contradicts the ground truth. (2) Quantitatively, the LLM correctly identifies the $3.4 million figure for 2023 but fails to report the $0 value in 2024, a critical omission. This results in a major error in financial obligation tracking. The dates (2023 and 2024) are correctly referenced, but the core numerical progression is wrong. (3) The multi-hop reasoning is flawed: the question requires comparing two years' obligations and inferring the financial implication of the change. The LLM fails to recognize the elimination of the liability by 2024, misinterpreting the static nature of the instrument despite the carrying value dropping to zero. It also incorrectly infers 'no evolution' when the full exit represents a significant change. (4) Contextual relevance is moderate—the LLM cites relevant document pages and mentions compliance and debt structure, but these details do not compensate for missing the central fact of obligation elimination. The answer focuses on covenant compliance and lack of prepayment terms, which are contextually related but not the focus of the question. Thus, while some elements are relevant, the core conclusion is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 427,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the composition of GD's Retirement Annuity Contracts shifted from being reported solely within Level 3 (with no Level 3 investments noted in 2023 or 2024) to being explicitly categorized under Level 3 assets in the fair value hierarchy, alongside other investments like insurance deposits and real estate funds. The valuation methodology remained consistent—reporting at fair value using observable inputs where possible, with Level 3 assets measured using significant unobservable inputs—but the explicit disclosure of Retirement Annuity Contracts as Level 3 assets (previously grouped under \"Other investments\" or not separately detailed in earlier years) indicates a more transparent breakdown of asset categories. This change reflects a refined approach to reporting, emphasizing the distinction between Level 2 and Level 3 investments to enhance clarity for stakeholders regarding the valuation inputs used for these assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GD reported Retirement Annuity Contracts as part of Level 3 assets in 2022 with a fair value of $35 million as of December 31, 2021, and $38 million as of December 31, 2020. However, the LLM incorrectly states that there were 'no Level 3 investments noted in 2023 or 2024,' which contradicts the original answer stating these contracts were still categorized under Level 3 in 2024. The LLM also fails to mention the key shift in valuation methodology—specifically, that by 2024, GD began using NAV as a practical expedient, which excludes the assets from the formal fair value hierarchy. Instead, the LLM claims the valuation methodology 'remained consistent,' which is factually incorrect. (2) Quantitative accuracy is poor: the LLM omits the specific dollar values ($35M and $38M) and the correct time references (values as of 2020 and 2021 reported in 2022 filings), and introduces false claims about missing Level 3 disclosures in 2023/2024. (3) Multi-hop reasoning is flawed—the question requires synthesizing changes in both methodology and composition over time, but the LLM misrepresents the direction of change (claiming increased transparency and consistency when the ground truth indicates a move toward simplified NAV-based reporting). The model fails to recognize the shift from detailed fair value disclosures to NAV as a practical expedient, which is the central point of the original answer. (4) Contextual relevance is moderate because the answer discusses Level 3 assets and fair value hierarchy, which are relevant concepts, but the incorrect facts and reversed interpretation of the reporting change severely undermine its usefulness. The conclusion about 'refined approach' and 'enhanced clarity' contradicts the ground truth's indication of a simplification that removes the assets from the formal hierarchy, reducing rather than increasing detailed disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 535,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Based on the provided 2022 and 2024 10-K pages, the composition and value of restricted cash for securitization investors remained consistently classified at **Level 3** in both years (as shown in Table 17.6 of the 2024 filing and corroborated by the 2022 table on page 178, which lists \"Restricted cash for securitization investors\" under Level 3 with a carrying/fair value of $458 million in 2023 and $441 million in 2024). The fair value hierarchy classification did not change between 2022 and 2024, remaining Level 3, with no indication of reclassification to Level 1 or 2. The value decreased slightly from $458 million (2023) to $441 million (2024), but the classification remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that restricted cash for securitization investors was classified as Level 3 in both 2022 and 2024. The ground truth states that in 2024, the entire $441 million was classified under Level 1, indicating a shift from 2022 when the fair value hierarchy was not explicitly detailed. The LLM incorrectly asserts no change occurred, directly contradicting the ground truth. (2) The LLM cites a value of $458 million in 2023 and $441 million in 2024, which may align with incremental changes, but the question focuses on 2022 to 2024, and the 2022 value is not provided in the LLM response. More critically, the classification error (Level 3 vs Level 1) invalidates the quantitative accuracy despite plausible dollar figures. (3) The multi-hop reasoning fails because the LLM misinterprets or misrepresents the fair value hierarchy shift. It references tables (e.g., Table 17.6, page 178) not available in the provided context, suggesting hallucination or reliance on external data. The synthesis across years is flawed, as it invents a consistent Level 3 classification contrary to the ground truth’s explicit statement of a move to Level 1. (4) The contextual relevance is moderate because the answer addresses the right metric (restricted cash for securitization investors) and time frame, but the incorrect classification and reasoning severely undermine factual correctness. The LLM appears to fabricate table references and misstates the hierarchy, leading to a very low correctness score despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 437,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's financial relationship with its franchisees evolved through more structured asset management and goodwill accounting practices. The company recorded goodwill adjustments when acquiring franchise restaurants, with new acquisitions in 2024 resulting in approximately $240 million of goodwill, and it continues to write off goodwill entirely if a company‑operated restaurant is sold within 24 months of acquisition. Additionally, the company’s franchisees now incur significant advertising contributions based on a percent of sales, and the company’s consolidation conclusions about these cooperatives remain unchanged, indicating that franchisee‑related financial interactions are primarily through royalty, rent and advertising fee structures rather than direct equity ownership.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly diverges from the ground truth in both factual content and reasoning. (1) Quantitatively, the claim of '$240 million of goodwill' in 2024 is not supported by the original answer, which does not specify any dollar amount for goodwill—this number is fabricated or misattributed. The 24-month write-off rule is mentioned in the LLM answer but not in the ground truth, which only states that goodwill was written off either fully or partially depending on timing relative to acquisition, without specifying a 24-month threshold. (2) The original answer emphasizes a structural shift from asset acquisition (2023) to a service-based model in 2024, particularly around technology platform services where McDonald's recognizes revenue on a gross basis and incurs corresponding expenses in 'Other restaurant expenses.' This key evolution is entirely missing in the LLM response. Instead, the LLM focuses on advertising contributions and consolidation of cooperatives, which are not mentioned in the ground truth and represent a different dimension of franchisee relations. (3) The multi-hop reasoning fails because the LLM does not synthesize the shift from asset management (acquisition, goodwill) to ongoing service-based financial interactions. It incorrectly frames the evolution as one of 'more structured' asset management rather than a transformation in the nature of the relationship. (4) While the LLM correctly identifies that goodwill adjustments occurred during restaurant acquisitions and that franchisees pay fees, it misses the core narrative of a strategic pivot toward technology services in 2024. The contextual relevance is moderate because it discusses financial aspects of franchisee relationships but focuses on the wrong aspects. Overall, the answer is partially accurate but contains significant factual inaccuracies and omits the central point of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 529,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the 2019 Stock and Incentive Compensation Plan (the \"2019 Plan\") remained the sole equity compensation plan permitting future grants, with its maximum share reserve unchanged at 187 million shares. While the 2019 Plan continued to be counted alongside legacy plans (e.g., 2001, 2009, 2014) in disclosure tables, its future issuance capacity was explicitly highlighted as the only plan allowing new grants, with shares reserved for future issuance declining from 119 million (2022) to 77 million (2024) due to the \"one-for-one\" counting of options/SARs versus \"five-for-one\" for full-value awards (RSUs/PSUs). The plan’s role in equity compensation was consistently framed as the successor to prior plans, with its terms and governance oversight detailed in proxy statements, but no structural changes to its reserve or governance were disclosed between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM asserts specific numerical values—187 million maximum share reserve, 119 million shares in 2022, and 77 million in 2024—that are not present in the original answer (ground truth). The ground truth does not mention any share counts or numerical reserves, nor does it reference 'one-for-one' or 'five-for-one' counting methodologies. These figures and technical details are fabrications or hallucinations not supported by the provided truth. (2) Completeness: While the question asks about the evolution of disclosure treatment, particularly regarding the plan’s relationship with other plans and its role in equity compensation, the LLM focuses heavily on unverified quantitative metrics rather than the disclosed shift in narrative framing—from governance/adoptions details to strategic ownership context. The core insight from the original answer (a shift in disclosure emphasis from procedural governance to strategic ownership framework) is missed. (3) Entity Accuracy: The companies (Procter & Gamble), plan names (2019 and 2014 Plans), and years (2022–2024) are correctly identified. (4) Reasoning: The multi-hop synthesis is partially sound—linking the 2019 Plan to legacy plans and noting its ongoing role in equity compensation—but the reasoning is built on false quantitative premises. The LLM invents a detailed share-reserve narrative that distracts from the actual evolution in disclosure tone and purpose. (5) Semantic Equivalence: The LLM answer is not semantically equivalent to the ground truth. It introduces a level of granular, technical detail (e.g., award counting ratios) absent in the original and fails to capture the conceptual shift (governance → ownership framework) that is central to the correct answer. While it acknowledges continuity in governance oversight, it misses the transformation in disclosure focus. Thus, despite some contextual relevance and correct entity identification, the answer is factually incorrect on key points and scores low on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 572,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations remained consistent between 2022 and 2023, with the brand continuing to operate in multiple international Premium Outlet locations across Japan, Mexico, South Korea, Malaysia, Thailand, and Canada. In 2022, Ferragamo was listed among the selected tenants at key international sites including Gotemba Premium Outlets (Japan), Yeoju Premium Outlets (South Korea), Johor Premium Outlets (Malaysia), and Punta Norte Premium Outlets (Mexico), and this presence continued into 2023 as evidenced by its inclusion in the 2023 international outlet listings such as at Yeoju, Paju, and Jeju in South Korea, and at Johor in Malaysia. The brand was not noted as having opened new international outlet locations during this period but maintained its existing foothold in these jointly operated properties.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. According to the ground truth, Salvatore Ferragamo was present in three Japanese outlet locations under Simon Property Group (SPG) in 2022 and only in one U.S. location (Las Vegas Outlets North) in 2023—indicating a significant reduction and geographic shift. The LLM falsely claims Ferragamo maintained a consistent presence across multiple international locations including South Korea, Malaysia, Mexico, Thailand, and Canada in both years, which contradicts the ground truth. (2) Quantitatively, the answer fails completely: it invents outlet locations (Yeoju, Paju, Jeju, Johor, Punta Norte) not mentioned in the original data and omits the key fact that Ferragamo disappeared from SPG's Japanese outlets and appeared only in a U.S. location in 2023. There are no correct numerical or locational comparisons. (3) The multi-hop reasoning is flawed—the question requires comparing Ferragamo's presence across SPG's international outlets between two years, but the LLM incorrectly asserts continuity and broad geographic presence without evidence, failing to recognize the contraction and shift from Japan to the U.S. (4) The contextual relevance is low because the answer discusses irrelevant countries and outlets, but it does address the general topic (Ferragamo in SPG outlets), so minimal relevance is retained. Scores are low due to complete factual inaccuracy, invented data, and failure to reflect the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 422,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "From 2023 to 2024, ConocoPhillips’ proved natural gas reserves in the Asia Pacific/Middle East region grew from 296 billion cubic feet to 296 billion cubic feet (stable), while total consolidated reserves rose from 8,443 billion to 9,771 billion cubic feet, driven by upward revisions and purchases in the Lower 48 and Alaska. This expansion reflects a strategic shift toward increasing natural‑gas production in North America, while maintaining a modest presence in the Asia‑Pacific/Middle East, underscoring the company’s focus on leveraging U.S. unconventional gas resources to bolster overall operational growth in the region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that COP's natural gas reserves in the Asia Pacific/Middle East region were 296 billion cubic feet in both 2023 and 2024, implying stability. However, the ground truth shows a decrease from 312 billion cubic feet in 2023 to 296 billion cubic feet in 2024, indicating a reduction, not stability. The LLM incorrectly reverses the 2023 value, making it appear unchanged when it actually declined. (2) The quantitative inaccuracies are critical: the 2023 figure is wrong (296Bcf vs correct 312Bcf), and while the 2024 figure (296Bcf) is correct, the comparison is flawed. The LLM also introduces unrelated data about total consolidated reserves (8,443Bcf to 9,771Bcf), which distracts from the regional focus and is not relevant to the question. These numbers, while possibly accurate in another context, are not part of the ground truth provided and mislead the analysis. (3) The reasoning is unsound: the LLM concludes that COP is maintaining a 'modest presence' and shifting focus to North America, which may be a plausible inference, but it is based on incorrect regional data and fails to acknowledge the actual decline in the Asia Pacific/Middle East. The multi-hop synthesis is flawed because it uses incorrect baseline data for the region and introduces external information not supported in the original answer. (4) Scores reflect that core facts (reserves trend in region) are wrong, calculations/comparisons are invalid, and while the answer attempts contextual interpretation (operational focus), it does so on a false foundation. Contextual relevance is moderate because it addresses the region and operational focus, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 470,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "From 2022 to 2024, Comcast’s capital‑expenditure focus shifted toward its Connectivity & Platforms business, emphasizing scalable infrastructure, line extensions, and the rollout of next‑generation wireless gateways to enable multigigabit symmetrical speeds and expanded home‑and‑business coverage.  Investment in customer‑premise equipment and support capital declined, while spending on network upgrades and new attractions at Universal theme parks remained a strategic priority.  This evolution reflects a continued emphasis on enhancing broadband capacity and delivering advanced gateway solutions across its cable operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of strategic evolution and investment focus, but misses some key nuances in Comcast's shift in approach to wireless gateways. (1) Correct elements: The emphasis on next-generation wireless gateways, multigigabit symmetrical speeds, and network infrastructure upgrades aligns with the 2024 strategic shift. The mention of scalable infrastructure and capital expenditure reallocation is contextually accurate. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist—this aspect is accurate by default. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift in capital allocation and technological focus, but fails to mention the 2022 customer-facing features like the xFi application and advanced security, which were part of the original answer and important for showing the evolution. Additionally, the LLM introduces Universal theme parks, which, while true in a broader corporate context, is irrelevant to the specific question about wireless gateways and distracts from the core narrative. (4) Semantic equivalence: The core idea—that Comcast deepened its strategic investment in wireless gateways as part of network infrastructure by 2024—is preserved. However, the absence of the 2022 customer-experience focus and the inclusion of off-topic information reduce completeness and qualitative accuracy. Hence, the correctness score is 7: the main trajectory is correct, but key details are missing or diluted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, Gulfstream’s market presence evolved with the introduction of the ultra‑long‑range G800 (expected service in 2023) and the clean‑sheet G400 (target entry in 2025), expanding its lineup beyond the existing G500/G600 family. Cumulative deliveries of the G500 and G600 rose to over 300 aircraft by year‑end 2024, underscoring their growing role as the core of Gulfstream’s product portfolio while the new G800 and G400 models broaden the company’s reach into longer‑range and previously untapped market segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that cumulative deliveries of the G500 and G600 reached over 300 by year-end 2024, which matches the ground truth. However, it omits the 2022 reference point — that deliveries totaled almost 150 by year-end 2021 — which is relevant context for the 2022–2024 evolution. While the doubling is implied, the specific baseline is missing. (2) The numeric value 'over 300' is accurate per the original answer. The mention of G800 expected service in 2023 and G400 target entry in 2025 aligns with typical timelines but slightly extends beyond the 2022–2024 scope; however, this contextual shift in product focus is consistent with the ground truth indicating G600's maturation and new models taking center stage. (3) The reasoning is sound: the LLM correctly infers that the G500/G600 series has become a core part of the lineup (supported by delivery growth) and that newer models like G800 and G400 are shifting strategic focus — this reflects the multi-hop synthesis of delivery data and product lifecycle progression. (4) The answer is highly relevant and captures the essence of the market presence and production evolution, though it could more explicitly contrast the 2022 vs 2024 status of the G600 (e.g., transition from 'new introduction' to 'established'). The omission of the earlier delivery figure slightly reduces completeness, but the core facts and trajectory are correct, warranting a high score with minor deductions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 406,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge shifted from majority ownership to a significantly reduced stake, culminating in the deconsolidation of Corebridge in June 2024. Following this, AIG retained a 22.7% ownership interest and began accounting for its remaining stake as an equity method investment, recognizing income from dividends and changes in Corebridge's stock price. The document details that AIG sold approximately 43 million shares between August and November 2024 and completed a $3.8 billion sale of 120 million shares to Nippon in December 2024, reducing its ownership from 48.4% to 22.7%. While AIG previously recognized gains from Corebridge's stock appreciation and received dividends, the deconsolidation resulted in a $4.8 billion loss, and subsequent equity method accounting now reflects only modest income from the retained investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's financial relationship with Corebridge, correctly identifying the shift from majority ownership to equity method accounting and the intent to divest. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states AIG held 52.2% in 2023, but the LLM claims 48.4% before reduction to 22.7%, which contradicts the original data. The timing is also inconsistent: the ground truth notes the accounting change began June 9, 2024, but the LLM cites deconsolidation in June 2024 without specifying the exact date and adds events (e.g., $3.8B sale to Nippon in December 2024, share sales between August–November 2024) not present in the original answer. These specific dollar amounts, share counts, and transaction details (e.g., 43M shares, $3.8B, Nippon) are absent from the ground truth and appear to be hallucinated or sourced from external data. While the qualitative shift—deconsolidation, move to equity method, income recognition via dividends and stock price changes—is correctly interpreted, the inclusion of unsupported specifics severely impacts quantitative accuracy. The reasoning is logically sound in structure (multi-hop synthesis of ownership change and accounting impact), but relies on incorrect data points. Contextually, the answer is highly relevant and addresses both equity ownership and income recognition as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 397,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla’s Solar Roof production strategy shifted from a highly integrated, roof‑by‑roof installation model toward a more modular, factory‑built approach that relies on standardized tiles and streamlined on‑site assembly. This evolution reduced its direct manufacturing dependency on custom‑roof‑specific components but introduced new operational challenges, including supply‑chain constraints for specialized glass and solar cells, and the need to coordinate complex installation logistics across multiple regions. Consequently, Tesla had to invest heavily in training installers, expand its service network, and manage fluctuating raw‑material costs to maintain production ramps and meet demand.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies a shift in Tesla's Solar Roof production strategy between 2022 and 2024, the nature of the evolution described—'modular, factory-built approach' and 'roof-by-roof installation model'—is not supported by the original answer. The ground truth states that in 2022, production was centered at Gigafactory New York as a dedicated facility, with no mention of a shift to modular or factory-built tiles. Instead, by 2024, Tesla highlighted increased complexity, delays in ramping production, and operational risks related to design tolerances, quality, output rates, and supply chain coordination. The LLM invents specifics such as 'standardized tiles,' 'streamlined on-site assembly,' and 'training installers' that are not present or implied in the original. (2) There are no numeric values, dates, percentages, or dollar amounts in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the actual evolution—transition from a focused production setup (2022) to a risk-laden ramp-up phase (2024) with new dependencies—instead fabricating a narrative about modular design and installation logistics. The original answer emphasizes manufacturing challenges like supply chain coordination and cost-effective scaling, but not installer training or service network expansion. (4) The contextual relevance is moderate because the answer addresses Tesla’s Solar Roof production strategy and mentions supply chain and scaling issues, but the core factual content diverges significantly from the source, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 493,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s strategic focus on on‑device AI shifted from a broad, cross‑industry investment to a more targeted, partnership‑driven approach.  In the 2023 filing the company highlighted its intent to expand AI capabilities across automotive, IoT and other sectors, but by 2024 it emphasized tighter integration with key customers—especially smartphone OEMs—and noted that Apple’s move to develop its own modem and AI‑related chips, plus Chinese OEMs’ push for in‑house solutions, would constrain the market for Qualcomm’s integrated modem and AI‑enabled silicon.  Consequently, Qualcomm’s investment approach became more defensive, concentrating resources on core 5G/AI platforms that can be leveraged in high‑margin, premium‑tier handsets while seeking new growth in automotive and IoT only where it can secure clear commercial pathways.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual and reasoning discrepancies. The original answer states that Qualcomm evolved from producing on-device AI as a core product in 2023 to a more investment-centric, ecosystem-driven strategy in 2024 focused on R&D, acquisitions, and third-party integration. In contrast, the LLM answer incorrectly frames the shift as a 'defensive' and 'partnership-driven' move due to competitive pressures from Apple and Chinese OEMs—details not present in the ground truth. These competitive dynamics and the characterization of a 'defensive' posture represent a fundamental misrepresentation of Qualcomm's strategic evolution. Additionally, the LLM introduces external market constraints and specific customer dynamics (e.g., Apple developing its own modem/AI chips) that are not supported by the original answer. While the mention of automotive and IoT aligns with the original, the reasoning and motivation behind the strategic shift are incorrect. The core multi-hop synthesis—tracking evolution in business focus and investment approach—is flawed, as the LLM invents causal factors rather than reflecting the documented shift toward long-term ecosystem development. Thus, while some surface-level topics (AI in automotive, IoT) are relevant, the explanation lacks factual fidelity to the source, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 419,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana's presence in SPG-operated properties remained consistent across international outlets, appearing in key locations such as Yeoju (South Korea), Paju (South Korea), Jeju (South Korea), and multiple European and Canadian premium outlets. This stability reflects SPG's strategic focus on maintaining high-end luxury tenant mix in its premium outlet portfolio, reinforcing brand positioning through curated, globally recognized luxury brands in high-traffic outlet destinations. The consistent inclusion of Dolce & Gabbana across multiple international properties underscores SPG's deliberate curation of premium luxury tenants to enhance the prestige and attractiveness of its outlet centers.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) It claims Dolce & Gabbana maintained a consistent presence in SPG-operated properties in South Korea, Europe, and Canada between 2022 and 2023, but the original answer states the brand was present in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) and only in Las Vegas, U.S., in 2023—there is no mention of South Korea, Europe, or Canada in the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the temporal and geographic facts are wrong: the shift is from multiple Japanese locations in 2022 to a single U.S. location in 2023, not stability across international sites. (3) The multi-hop reasoning fails completely—the LLM does not recognize the strategic withdrawal from Japan and relocation to a U.S. flagship site, which is central to the correct interpretation. Instead, it invents a narrative of global consistency that is unsupported. (4) The contextual relevance is slightly above zero because it discusses SPG's brand positioning strategy in premium outlets, which is thematically relevant, but the factual foundation is false, leading to an invalid conclusion. The original answer indicates a strategic shift toward exclusivity in a key U.S. market; the LLM incorrectly infers stability and global curation. Due to complete factual inaccuracy and flawed reasoning, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 392,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "Between 2023 and 2024, ConocoPhillips increased its investment in exploration and development activities in the Asia Pacific/Middle East region, particularly through equity affiliates. In 2023, the company reported $462 million in exploration and development spending for equity affiliates in this region (including $416 million in development costs), and in 2024, this expanded to $462 million in exploration and $416 million in development for affiliates, with notable discoveries in the Middle East. This indicates a strategic focus on growing its presence in the Asia Pacific/Middle East through targeted investments in equity partnerships, especially in resource-rich areas like the Middle East, to enhance long-term reserve growth and production.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region in 2023 and $0 in 2024, indicating a complete pause in exploration. In contrast, the LLM claims exploration spending was $462 million in both years, with additional development costs, suggesting growth—this is factually wrong. (2) The numbers are completely inaccurate: $462M and $416M do not appear in the ground truth and are not consistent with any disclosed figures. The LLM confuses exploration with development and incorrectly attributes spending to equity affiliates, which is not mentioned in the original. There are no calculations in the LLM response, but the values themselves are fabricated. (3) The multi-hop reasoning is flawed—the question asks about evolution in exploration investment and strategic implications. The LLM incorrectly infers increased investment and strategic growth, while the truth indicates a full withdrawal, suggesting strategic retreat. The model fails to synthesize the correct trend (decline to zero) and instead invents an upward trajectory. (4) The contextual relevance is low because it addresses the right region and company but with false data and opposite conclusions. Scores are low due to total factual inaccuracy, incorrect entities (spending figures, cost breakdowns), and reversed strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 399,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "From 2022 to 2024, Comcast’s financial stake and debt involvement in Universal Beijing Resort evolved as follows: In 2022, Comcast held a 30% interest in the resort and had consolidated its financials, including $3.5 billion of debt (primarily a term loan) tied to the project. By 2023, the resort’s debt had risen to $3.5 billion, with $3.1 billion of term loan outstanding, and Comcast’s consolidated balance sheet reflected $7.8 billion in assets and $7.2 billion in liabilities for the resort. By the end of 2024, the resort’s debt decreased slightly to $3.4 billion (including $3.0 billion term loan), while Comcast’s consolidated exposure remained substantial, with $7.3 billion in assets and $7.0 billion in liabilities, underscoring continued leverage and risk tied to its 30% ownership stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the 2022 and 2023 data. According to the ground truth, in 2022, Comcast did not disclose specific financial stake or debt figures for Universal Beijing Resort—only that it was a new entity with increased depreciation and amortization. However, the LLM incorrectly states that Comcast held a 30% interest and had consolidated $3.5 billion in debt in 2022, which contradicts the original answer. The 30% ownership was only explicitly stated in 2024, not in 2022. (2) The LLM claims that in 2023, the resort’s debt 'rose to $3.5 billion'—but the ground truth says it was $3.5 billion in 2023 and decreased to $3.4 billion in 2024. While the $3.5 billion figure for 2023 is correct, the characterization of it as a 'rise' is unsupported by the original data, which does not provide 2022 debt levels. Additionally, the LLM fabricates term loan breakdowns ($3.1 billion in 2023, $3.0 billion in 2024), which are not present in the original answer. The asset and liability figures for 2023 ($7.8B assets, $7.2B liabilities) and 2024 ($7.3B assets, $7.0B liabilities) are correctly reported. (3) The multi-hop reasoning is partially sound in that it tracks changes over time, but it fails on the critical point of when Comcast first disclosed its 30% stake and debt details. The model incorrectly assumes early consolidation and specific debt figures in 2022 that were not disclosed, undermining the validity of the synthesis. (4) The contextual relevance is high because the answer addresses the evolution of stake and debt over time and uses appropriate financial metrics. However, due to significant quantitative errors and incorrect attribution of early disclosures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and intent of the reasoning are sound, but key facts are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 523,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s net derivatives balance declined modestly, moving from a net liability of $168 million at the end of 2022 to a net liability of $146 million at the end of 2023 (a reduction of roughly $22 million). This improvement was driven by a combination of purchases, settlements and realized gains/losses that offset one another, as shown in the “Derivatives (net) Years Ended December 31” tables for 2022 and 2023. The downward shift indicates that the company is actively managing its derivative positions—entering new contracts and settling existing ones in a way that reduces overall exposure, although the remaining net liability still reflects ongoing market‑based hedging and risk‑management activities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy. According to the ground truth, Duke Energy's net derivatives balance was $29 million in 2022 and decreased to $13 million in 2023, with settlements increasing from $32 million to $68 million. However, the LLM states the net derivatives balance was a liability of $168 million in 2022 and $146 million in 2023—values that are not only incorrect but over five times larger than the true figures. This fundamental error invalidates all subsequent analysis. The LLM also fails to mention the actual settlement amounts, which are central to the question. While the answer attempts qualitative reasoning about active management and risk reduction, it is based on fabricated data. The reasoning structure is sound in form (discussing settlements, purchases, and exposure), but it lacks grounding in the correct data. The context is relevant—derivatives management at Duke Energy—and the time frame is correct (2022 to 2023), but the answer synthesizes no valid multi-hop information from the actual data. Therefore, despite addressing the general topic, the answer is factually wrong on all key metrics and thus severely misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 337,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG’s LTIP units continued to be granted under its 2019 Stock Incentive Plan, but the 2023 LTI Program introduced a new performance‑based component with a higher potential fair‑value ($23.6 million for 2023 awards) and required a three‑year performance period before vesting on January 1, 2026. Earlier programs (2019‑2022) also used LTIP units with performance conditions tied to FFO and TSR, but their grant‑date fair values were lower ($12.2 million for 2021, $13.7 million for 2022) and they vested on January 1, 2023 for the 2019 awards. The dilutive effect of LTIP units is reflected in the two‑class earnings‑per‑share calculations, where earned LTIP units are treated as participating securities; however, the filings note that no securities had a material dilutive impact for the years examined. Valuation modeling shifted to Monte Carlo simulations for market‑based LTIP awards, and expense recognition now follows the performance‑period schedule, with the 2023 awards’ $7.9 million fair value being amortized over the three‑year vesting period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported quantitative details not present in the ground truth, significantly affecting correctness. While it correctly identifies that LTIP units are treated as participating securities under the two-class method and that Monte Carlo modeling is used for market-based awards (aligning with the 2023 disclosure evolution), it fabricates specific dollar amounts ($23.6 million for 2023, $12.2 million for 2021, $13.7 million for 2022, $7.9 million amortized) and vesting dates (January 1, 2026 for 2023 awards; January 1, 2023 for 2019 awards) that are not in the original answer. The ground truth does not mention any specific grant-date values or vesting schedules, nor does it compare FFO/TSR conditions across years. The LLM also incorrectly implies that dilutive effects were assessed for 'the years examined' without specifying that the original answer only references 2019–2021 as having no material dilutive effect. These numerical and temporal specifics suggest over-extrapolation or hallucination. However, the core qualitative shift—from general dilution statements in 2022 to more detailed valuation modeling and classification disclosures in 2023—is correctly captured, showing sound reasoning on the directional evolution. The answer is contextually relevant and addresses both dilutive effect and valuation modeling, but the inclusion of unverified figures undermines quantitative accuracy. Thus, partial credit is given for correct conceptual framework but docked heavily on factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 430,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Comcast's financial commitment to Atairos Group, Inc. has decreased over time, with its capital commitment reduced from up to $5 billion to $4.5 billion in 2020 and further to $1.5 billion (as of 2021) in subsequent updates, while it also committed to fund $40–$45 million annually for management fees. The company accounts for its investment in Atairos as an equity‑method holding, recognizing its share of gains and losses, making capital contributions ($73 million in 2024, $145 million in 2023, $52 million in 2022), and maintaining an unfunded commitment of about $1.4–$1.5 billion, which represents its maximum financial risk. This involvement reflects a shift from larger early‑stage funding to a more limited, fee‑based and capital‑call‑driven engagement by 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The original answer states that Comcast's capital commitment was $5 billion in 2022 and decreased to $4.5 billion by 2024. However, the LLM claims the reduction occurred in 2020 (from $5B to $4.5B) and further to $1.5B in 2021—dates and amounts that are completely inconsistent with the ground truth. There is no mention in the original answer of a $1.5B commitment or updates in 2020/2021, making these fabrications. The LLM also states management fees are $40–$45 million annually, while the original specifies a $40 million annual management fee commitment in 2024—close but not exact, and presented with false precision and range. The actual capital contributions cited in the LLM answer ($73M in 2024, $145M in 2023, $52M in 2022) are not present in the original answer and contradict the narrative of a $4.5B aggregate commitment. The unfunded commitment of $1.4–$1.5B is also not mentioned in the ground truth. (2) Quantitative accuracy is severely compromised: incorrect dollar amounts, wrong years, fabricated figures, and unsupported ranges. The only correct number is the $40 million management fee, which aligns approximately with the original. (3) Multi-hop reasoning is flawed: the LLM invents a timeline and financial structure not supported by the source. It incorrectly implies a progressive drawdown of commitments over 2020–2021, whereas the original describes a single reduction from $5B to $4.5B between 2022 and 2024. The introduction of equity-method accounting and specific annual contributions adds detail not in the original and distracts from the actual evolution of commitments. (4) Scores are low due to major factual and numerical errors. Contextual relevance is moderate because the answer addresses Comcast’s evolving involvement and mentions capital and management fees, but the details are largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 516,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "ConocoPhillips' natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, reflecting upward revisions and additions in the region despite a slight decline in total proved reserves. This growth indicates the company is maintaining and modestly expanding its focus on natural gas resources in the Asia Pacific/Middle East, even as overall reserve levels fluctuate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that natural gas reserves increased from 312 to 296 billion cubic feet, when in fact this is a decrease. The direction of change is reversed, which is a critical factual error. (2) The numbers themselves—312 billion cubic feet in 2023 and 296 billion cubic feet in 2024—are accurate and match the ground truth. However, the interpretation of these numbers as an 'increase' is incorrect; it should be a 'slight decrease.' This undermines the quantitative accuracy despite correct raw values. (3) The reasoning is flawed because the LLM concludes that the company is 'expanding its focus' based on a supposed increase, when the actual slight decline suggests a potential shift away or reduced emphasis, as per the original answer. The multi-hop synthesis fails because the model misinterprets the trend, leading to an incorrect inference about operational focus. (4) Contextual relevance is moderate—the answer addresses the right region, company (COP/ConocoPhillips), metric (natural gas reserves), and time frame (2023–2024)—but the core conclusion is factually wrong due to misinterpretation of the data trend. Thus, while contextually aligned, the answer is substantively incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 347,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast’s wireless gateway procurement strategy was centered on acquiring a significant volume of customer‑premise equipment—including wireless gateways and set‑top boxes—from a limited pool of suppliers to support its expanding broadband and bundled services. By 2024, the company’s network‑deployment investment focus shifted toward upgrading its infrastructure, particularly by expanding scalable infrastructure and line‑extension projects to enable multigigabit symmetrical speeds via DOCSIS 4.0, while continuing to invest in next‑generation platforms such as xFi and cloud‑based services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures Comcast's 2022 procurement strategy, correctly stating that the company acquired a significant volume of customer-premise equipment, including wireless gateways, from a limited number of suppliers. This matches the original answer's description of passive procurement. For 2024, it correctly identifies the strategic shift toward network deployment investments, including infrastructure upgrades for multigigabit symmetrical speeds, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, quantities) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024) and strategy (procurement vs investment), correctly identifying the evolution in approach. However, the LLM answer slightly underemphasizes the specific role of wireless gateways in the 2024 investment focus. While it mentions xFi and next-gen platforms, it does not explicitly state that wireless gateways are a key component of capital expenditures or their integration into network scalability goals, which is a minor omission in completeness. (4) Despite this, the answer remains contextually relevant and semantically equivalent in intent and substance. The shift from procurement to strategic infrastructure investment is clearly conveyed, even if the emphasis on wireless gateways in 2024 is less explicit than in the original. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 461,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted decisively between 2022 and 2024 from a peripheral, niche offering to a core, mass‑market growth lever. By 2024 the company was actively expanding its production capacity and integrating Solar Roof into its broader energy‑generation and storage segment, emphasizing higher‑volume manufacturing at new factories (e.g., Berlin, Texas) and leveraging localized supply chains to reduce unit costs. However, the product still faces significant production challenges, including scaling manufacturing processes, managing raw‑material constraints for photovoltaic cells, and achieving the cost efficiencies needed to compete with traditional solar solutions. Consequently, while Solar Roof’s strategic importance has risen, its rollout remains contingent on overcoming these technical and supply‑chain hurdles.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Tesla's strategic positioning of the Solar Roof between 2022 and 2024. The ground truth states that in 2022, Tesla emphasized the Solar Roof as a contributor to energy revenue growth, but by 2024, the tone shifted to caution about production ramp delays. In contrast, the LLM incorrectly claims the product evolved from a 'peripheral, niche offering' to a 'core, mass-market growth lever'—this is the opposite of the documented shift, which was from optimism to caution. Additionally, the LLM introduces unsupported details such as expansion into 'new factories (e.g., Berlin, Texas)' and 'localized supply chains,' which are not mentioned in the original answer and lack grounding in the provided truth. (2) There are no specific numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not heavily applicable; however, the absence of incorrect figures allows for a moderate score in this category. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution in tone and strategic framing over time. Instead of identifying a shift from deployment success to operational risk disclosure, it fabricates a narrative of increasing strategic importance and expansion, which contradicts the ground truth. (4) While the mention of ongoing production challenges (e.g., scaling, cost efficiencies) aligns partially with the original answer’s mention of 'potential production ramp delays,' this alone does not compensate for the fundamental misrepresentation of strategic evolution. The contextual relevance is moderate because the answer addresses the general topic and some relevant themes, but the core conclusion is factually inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 482,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "From 2022 to 2023, Duke Energy’s investment in “Net pending transactions and other investments” within its post‑retirement assets increased from $53 million to $54 million—a modest rise of $1 million (about 2%). This small growth suggests the company is maintaining a stable, low‑profile position in this category, likely reflecting a cautious or neutral strategic stance rather than an aggressive expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, but the LLM claims it increased from $53 million to $54 million. This misrepresents the core quantitative fact. (2) The calculation of a $1 million increase (2%) is based on incorrect data and does not reflect the actual decrease of $39 million (from $53M to $14M), which is a 73.6% drop. All numbers and the resulting percentage change are wrong. (3) The multi-hop reasoning fails because the LLM incorrectly identifies the trend, leading to an entirely flawed interpretation. Instead of recognizing a significant reduction indicating strategic withdrawal or completion of initiatives, it infers a 'cautious or neutral strategic stance' due to a non-existent increase. (4) The contextual relevance is partially maintained as the answer addresses the right metric and time frame, and attempts to interpret strategic positioning, but the incorrect data renders the analysis invalid. Due to fundamental errors in facts and reasoning, scores are very low, with only minimal credit for addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 344,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company’s liability‑driven investment framework remained focused on aligning plan assets with liabilities, but the target equity/fixed‑income mix shifted slightly: pension assets moved from a 20% equity / 80% fixed‑income split to roughly 21% equity and 63% corporate bonds (with the remainder in government securities and other investments), while postretirement assets stayed near the 55% equity / 45% fixed‑income target but showed a higher equity share (about 57% equity, 30% corporate bonds, 13% government/other). Consequently, defined‑contribution plan expense rose to $112 million in 2024 (up from $109 million in 2023), and the disclosed composition of plan assets now reflects a larger allocation to equities and a modest increase in corporate‑bond holdings, with the fair‑value hierarchy showing more Level 2 inputs and a continued immaterial Level 3 presence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the company maintained a consistent 20%/80% equity/fixed income target allocation for pension assets in both 2023 and 2024. However, the LLM incorrectly states that the allocation shifted to 'roughly 21% equity and 63% corporate bonds,' which is not supported by the original answer. Additionally, the LLM introduces 'postretirement assets' and their allocation (55% equity target, 57% actual), which are not mentioned in the ground truth and represent a complete fabrication. The only correct quantitative elements are the defined contribution plan expenses: $109 million in 2023 and $112 million in 2024. (2) The dollar amounts are accurate and correctly reflect the increase of $3 million. However, all percentage allocations for plan assets are incorrect or unsupported. The ground truth does not provide actual asset composition—only the target allocation—and notes that 2024 added a disclosure about characterizing the actual composition, not that specific breakdowns like 63% corporate bonds were reported. (3) The multi-hop reasoning is flawed. The question asks about evolution in the liability-driven investment framework with respect to defined contribution expenses and asset composition disclosure. The correct answer hinges on recognizing that while the target allocation remained unchanged, the 2024 filing introduced a new level of transparency regarding the actual composition. The LLM instead invents detailed asset allocations and misrepresents the evolution as a shift in investment strategy rather than improved disclosure. It fails to capture the key qualitative change: enhanced transparency, not a change in targets or actual allocations. (4) The contextual relevance is moderate because the answer addresses defined contribution expenses and plan asset composition, but the substantial factual errors and hallucinated data severely undermine correctness. Quantitative accuracy is very low due to incorrect percentages and invented categories. Qualitative accuracy is low because the reasoning misidentifies the nature of the evolution in the framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 584,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm’s strategic focus on On-Device AI remained centered on advancing foundational technologies—particularly 5G, high‑performance low‑power computing, and AI‑enabled chipsets—for use across mobile handsets, automotive, and IoT. The company highlighted continued investment in AI‑centric R&D (e.g., on‑device AI capabilities within Snapdragon platforms) and expanded its AI‑related licensing and patent portfolio, while also emphasizing the transition to new process nodes and the integration of AI into its automotive cockpit and connectivity solutions. No major strategic pivot away from on‑device AI was disclosed; instead, the emphasis was on scaling existing AI‑driven product lines and leveraging them in new growth areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entities, timeframes (fiscal 2023–2024), and general focus areas (On-Device AI, 5G, automotive, IoT), and contains no numerical inaccuracies, hence a high quantitative accuracy score. However, it fails to capture the key evolution highlighted in the ground truth: the strategic shift from a vision-oriented emphasis in 2023 to an active, investment-driven expansion in 2024 involving acquisitions and strategic transactions. The LLM response describes continued R&D, scaling, and integration but does not mention the explicit shift toward new investments, product areas, or strategic transactions that marks the evolution in fiscal 2024. This omission represents a significant gap in qualitative accuracy, as the core of the question—how the strategy evolved—is under-addressed. While the answer is contextually relevant and accurately reflects Qualcomm’s ongoing AI focus, it lacks the critical synthesis of the strategic progression from vision to execution via investment, which is central to the original answer. Thus, the correctness score is reduced to 6 for partial accuracy with a key missing insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 326,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members is listed as Exhibit 9.1 in both the 2022 and 2023 10‑K filings, and it remains the “Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004.” No new amendment or replacement of this exhibit appears in the 2023 filing, indicating that the governance structure governed by this voting trust has remained unchanged and therefore stable between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct in stating that the Voting Trust Agreement remains in place and unchanged in both the 2022 and 2023 10-K filings, and it correctly identifies the date of the agreement (March 1, 2004) and its inclusion as Exhibit 9.1. However, it contradicts the ground truth by asserting that the 'Second Amended and Restated' designation is still used in the 2023 filing. According to the original answer, the 2023 10-K omits the 'Second Amended and Restated' language, referring to the agreement more simply, which signals a shift in presentation even if no substantive amendment occurred. The LLM incorrectly claims the full title is retained in 2023, which misrepresents the evolution in classification and presentation. This undermines the qualitative accuracy, as the core of the question focuses on how the *description* of the agreement changed between years and what that implies about governance stability. While the conclusion about stability is aligned with the ground truth, it is based on incorrect reasoning—stability is inferred from the absence of amendments, but the LLM fails to note the actual change in terminology. The quantitative elements (date, exhibit number) are accurate, and the response is contextually relevant, addressing governance implications. However, the failure to identify the key difference in labeling across filings results in a significant factual error in the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 399,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "Between 2023 and 2024, ConocoPhillips' natural gas reserves in the Asia Pacific/Middle East region grew from 48 billion cubic feet (BCF) at the end of 2023 to 62 BCF at the end of 2024, reflecting upward revisions (including 55 BCF of technical revisions and 17 BCF from extensions/discoveries) that more than offset modest downward adjustments. This increase signals that the region is becoming a progressively more strategic component of COP’s global reserves portfolio, contributing a larger share of both proved gas and equity‑affiliated reserves.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 312 billion cubic feet (Bcf) in 2023 to 296 Bcf in 2024, a reduction of 16 Bcf (5.1%). However, the LLM claims reserves *grew* from 48 Bcf to 62 Bcf, which is not only directionally wrong but also uses completely incorrect base figures. (2) The numbers are severely inaccurate: 48 Bcf and 62 Bcf vs. actuals of 312 Bcf and 296 Bcf. The LLM cites 'upward revisions' and 'technical revisions' of 55 Bcf and 17 Bcf, which are not supported by the ground truth and appear fabricated. There is no mention of such revisions in the original answer. (3) The multi-hop reasoning is flawed. The LLM fails to correctly identify the trend (decline vs. increase), misrepresents the magnitude of reserves, and draws an opposite conclusion about strategic importance. While the original answer notes a slight decline possibly indicating a reevaluation of strategic focus, the LLM incorrectly infers growing strategic importance due to non-existent growth. (4) The contextual relevance is low but not zero—the answer addresses the right region and company and attempts to discuss strategic implications, so it receives minimal credit. However, due to pervasive factual and quantitative errors, the correctness, quantitative, and qualitative accuracy scores are near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 404,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge shifted from consolidation to deconsolidation, resulting in a $4.8 billion loss on deconsolidation and a retained equity‑method investment. Post‑deconsolidation, AIG reports equity‑method income from Corebridge—primarily dividends and changes in the stock’s fair value—reflected in net investment income, while Corebridge’s own debt structure remained largely unchanged, featuring a $250 million DDTL facility and $9.37 billion of total Corebridge debt outstanding.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the high-level transformation in AIG's relationship with Corebridge—shifting from consolidation to equity method reporting—which is correct and contextually relevant. However, several key quantitative inaccuracies undermine factual correctness. The $4.8 billion loss on deconsolidation is not mentioned in the ground truth and appears fabricated or misattributed. The DDTL facility of $250 million is not referenced in the original answer and introduces unverified detail. While the $9.37 billion total Corebridge debt is close to the ground truth $9,368 million (approx. $9.37 billion), it lacks the breakdown into $6,452 million senior unsecured notes and $989 million junior subordinated debt, which is a significant omission. (2) The original answer specifies that the debt was on AIG’s balance sheet in 2023 due to consolidation, but in 2024, after deconsolidation, AIG reports equity method income including dividends and changes in stock price since June 9, 2024. The LLM correctly identifies equity method income from dividends and fair value changes, but incorrectly attributes changes in stock price to net investment income—equity method income typically reflects earnings, not stock price fluctuations, unless marked-to-market through other comprehensive income, which requires clarification. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift in accounting treatment and its implications on reporting. However, it fails to accurately represent the 2023 debt structure and introduces unsupported figures (e.g., $4.8B loss, $250M DDTL), indicating flawed synthesis or reliance on incorrect data. (4) The contextual relevance is high as the answer addresses the evolution in financial relationship, debt, and equity income. Qualitative accuracy is moderate due to correct conceptual framing but flawed details. Quantitative accuracy is low due to incorrect or unverified numbers. Correctness score is 6 due to correct directional narrative but significant factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 555,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s Special Use Funds allocation shifted markedly toward fixed‑income securities: the fair‑value of fixed‑income holdings rose from roughly $2.5 billion (2021) to $3.7 billion (2024) for NEE and from $1.9 billion to about $2.0 billion for FPL, while equity holdings remained a smaller, relatively stable share of the fund. This increased fixed‑income weighting—especially longer‑dated debt securities with average maturities of eight to nine years—reflects a more conservative risk posture and a focus on preserving liquidity, as the funds must meet potentially urgent storm‑damage or nuclear‑decommissioning cash needs. Consequently, the company appears to be prioritizing stable, lower‑volatility assets to safeguard cash availability rather than pursuing higher‑risk equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims that fixed income holdings increased from $2.5 billion in 2021 to $3.7 billion in 2024, but the ground truth states that in 2022, Special Use Funds were entirely fixed income at $2,505 million, and by 2024, the portfolio included only $722M in U.S. Government/municipal bonds, $685M in corporate debt, and $873M in asset-backed securities—totaling approximately $2,280 million in fixed income. More critically, the LLM omits the introduction of $6,164 million in equity securities in 2024, which is the central fact of the shift. The mention of FPL (a subsidiary) and 2021 data is extraneous and not requested in the question. (2) The LLM incorrectly frames the strategy as a shift toward fixed income, when in reality it was a major pivot toward equities, indicating higher risk appetite—not lower. This misrepresents the core trend. (3) The reasoning is flawed: the conclusion of a 'more conservative risk posture' directly contradicts the ground truth, which shows a clear diversification into equities suggesting increased risk tolerance and long-term growth orientation. (4) The answer fails on multi-hop synthesis: it does not correctly compare 2022 (100% fixed income) to 2024 (equity-dominated) and instead invents a narrative of increasing fixed income. While the answer addresses the question's structure (evolution, allocation, risk/liquidity implications), its factual foundation is incorrect, severely undermining correctness and qualitative reasoning. Contextual relevance is moderate as it discusses the right topic and fund purpose (e.g., storm/nuclear needs), but this does not compensate for factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 472,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has evolved from a general competitive concern in 2022 to a more pronounced challenge by 2024, particularly due to 5G adoption and network sharing trends. By 2024, American Tower explicitly highlighted that extensive site infrastructure sharing—such as RAN sharing, roaming, or resale arrangements among wireless providers—could reduce new lease activity, as carriers might utilize shared equipment instead of deploying new equipment or decommission redundant network assets, directly threatening revenue from leasing agreements. This shift reflects a more specific and material risk to growth, as noted in the 2024 filing’s discussion of 5G-related technologies potentially diminishing demand for tower-based infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the evolution of the risk from 2022 to 2024 is accurately described, with proper emphasis on 5G adoption and its impact on new lease activity. The shift from a general concern about infrastructure sharing to a more specific focus on RAN sharing, roaming, and resale arrangements is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), company (AMT/American Tower), and technological context (5G’s effect on infrastructure demand). The LLM correctly infers that the risk became more material and specifically tied to lack of compensation for shared use, which is implied in the 2024 filing’s stronger language on financial impact. (4) The only minor shortcoming is that the LLM does not explicitly mention AMT’s lack of compensation in shared arrangements—a key nuance in the original answer—but it does convey the financial threat to leasing revenue, which captures the essence. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 389,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron’s equity investment in Angola LNG Limited grew from $336 million at the end of 2019 to $2,180 million by the end of 2021, and its share of the affiliate’s net equity rose from $38,851 million to $40,153 million, reflecting an increase in both the size of the investment and the underlying affiliate’s equity base.  In the 2023 10‑K, the company reports that its “Investments and Advances” in Angola LNG Limited were $1,762 million at the end of 2023 (up from $1,963 million in 2022 and $336 million in 2021), and that its share of Angola LNG’s net equity was $45,823 million in 2023 (up from $40,153 million in 2021), indicating a continued expansion of its ownership stake and equity‑method exposure.  The 2023 filing also notes that Chevron records its share of Angola LNG’s earnings using the equity method, and that the investment is accounted for at a value higher than underlying equity (e.g., about $80 million excess at year‑end 2023), confirming that the investment structure remains an equity‑method affiliate with a growing carrying value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution of Chevron's financial relationship with Angola LNG Limited between 2022 and 2023, specifically regarding investment structure and equity method accounting. The original answer correctly identifies a reclassification from 'Depends_On' in 2022 to 'Invests_In' in 2023, despite unchanged ownership (36.4%). The LLM instead fabricates financial figures (e.g., $336M to $2,180M growth) and cites data from 2019–2021, which are irrelevant to the 2022–2023 comparison. (2) Quantitative accuracy is very low: the LLM invents 'Investments and Advances' of $1,762M in 2023 and $1,963M in 2022, and claims share of net equity rose to $45,823M in 2023 from $40,153M in 2021—none of which appear in the ground truth. The ground truth does not provide any dollar amounts for the investment, only the ownership percentage and relationship type. (3) Qualitatively, the LLM misunderstands the nature of the evolution: it focuses on increasing investment values and equity-method accounting as evidence of growing ownership, but the ground truth emphasizes a structural reclassification in relationship type, not a change in ownership percentage or dollar investment. The LLM correctly notes that equity method accounting is used, but this is a minor point. (4) Contextual relevance is moderate because it discusses Chevron, Angola LNG, equity method accounting, and recent years, but it misses the key conceptual shift (relationship type reclassification) and invents numerical data, leading to a fundamentally incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 445,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 remained in active production and service, with cumulative deliveries exceeding 250 aircraft by year-end 2023, reflecting steady production growth. While specific 2023 performance metrics aren't detailed in the provided pages, the G600—like its sister G500—was noted for being faster, more fuel-efficient, and offering greater cabin volume and range than the models it replaced, holding multiple city-pair speed records as part of Gulfstream's record-setting product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly states that cumulative deliveries of the G600 exceeded 250 by year-end 2023, which aligns with the ground truth and is quantitatively accurate. It also correctly notes the G600's performance advantages over previous models and its active production status, contributing to contextual relevance. However, the answer fails to capture the core evolution in the G600's role—from being a 'recent addition' in 2022 to a 'mature product' in 2023—thus missing a key qualitative shift. More importantly, it omits the critical point that the G600's technologies (e.g., Symmetry Flight Deck) became foundational for newer models like the G700, G800, and G400 in 2023, which is central to the multi-hop reasoning required. While performance metrics are generally well-characterized, the answer admits 'specific 2023 performance metrics aren't detailed,' suggesting incomplete synthesis. The absence of this strategic evolution significantly weakens the qualitative accuracy, even though numerical and entity details (G600, 2022–2023, >250 deliveries) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 305,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees evolved from a focus on financial co-investment and operational support to a deeper strategic collaboration centered on shared values and long-term sustainability. The company increasingly partnered with franchisees to fund restaurant modernization and technology upgrades, emphasizing joint investments in brand standards, supply chain innovation, and community engagement—while maintaining a franchising model that prioritizes franchisee autonomy in day-to-day operations but aligns on global priorities like equal pay, human rights, and inclusive growth. This shift reflects a move from purely transactional financial arrangements to a more integrated partnership focused on mutual success and stakeholder impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in McDonald's relationship with franchisees toward greater collaboration and co-investment between 2022 and 2024, which aligns with the ground truth. However, it mischaracterizes the nature and timing of the evolution. The original answer specifies that in 2022, McDonald's did not typically invest in restaurant capital under developmental licenses, indicating a passive model, while by 2024, the company began co-investing in improvements and system upgrades—marking a clear strategic shift. The LLM response frames the evolution as moving 'from financial co-investment and operational support' in 2022 to deeper collaboration in 2024, which inaccurately suggests co-investment was already occurring in 2022, contradicting the ground truth. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is partially sound: the model infers increased strategic collaboration and modernization efforts, which is supported. However, it fails to accurately represent the starting point (2022) of the relationship, thus misrepresenting the direction of change. This undermines the qualitative accuracy despite capturing some elements of the evolving partnership. (4) Contextual relevance is high because the answer addresses financial involvement, strategic collaboration, and modernization. But due to the incorrect characterization of the 2022 baseline, the core factual claim about the evolution is flawed, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 443,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, net revenues from smokeable products declined $720 million (from $22,476 million to $21,756 million), and operating income in that segment fell $18 million (from $10,688 million to $10,670 million). Overall, Altria’s reported operating income dropped $372 million (from $11,919 million in 2022 to $11,547 million in 2023), driven primarily by higher general corporate expenses and amortization of intangibles, despite gains in oral tobacco products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the net revenues and operating income for smokeable products in 2022 and 2023 as $22,476 million and $21,756 million for revenue, and $10,688 million and $10,670 million for operating income—matching the ground truth exactly. The calculated differences ($720 million decline in revenue, $18 million decline in operating income) are accurate. (2) All numeric values are correct and properly formatted; calculations are precise. (3) The multi-hop reasoning is sound: the model correctly identifies the year-over-year changes in the smokeable products segment. It adds context about Altria’s overall operating income decline, which, while not part of the original question, is factually consistent and does not detract from accuracy. However, this additional information slightly exceeds the scope of the question, which focused solely on smokeable products’ net revenues and operating income. (4) The answer is semantically equivalent to the ground truth in addressing the core question, with excellent quantitative accuracy and strong qualitative reasoning. The slight deduction in qualitative accuracy is due to the inclusion of extra, albeit correct, information about overall operating income and expense drivers, which were not asked for. Contextual relevance remains high as the primary focus on smokeable products’ performance is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 387,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role in BMY's strategy evolved from a core IO product to a broader commercial and collaborative asset. It expanded through new approvals (e.g., Opdivo Qvantig, Opdivo plus Yervoy for colorectal cancer, and neoadjuvant NSCLC), entered new markets (e.g., Japan), and deepened its partnership framework—particularly with Ono in Japan and Nektar for NKTR-214 combinations—while maintaining its central role in BMY's oncology portfolio and generating significant alliance revenues.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unverified information not present in the ground truth. While it correctly identifies Opdivo as a key part of BMY's oncology strategy and mentions collaboration with Ono, it fabricates or misrepresents specific approvals and partnerships. For example, the mention of 'Opdivo Qvantig' is incorrect—this is not a real product (likely a confusion with Opdivo Qvantig, which does not exist; the correct name may be Opdivo Qvantig, but no such approval is documented in the knowledge graph). The approval for 'Opdivo plus Yervoy for colorectal cancer' is not mentioned in the ground truth for this time frame, nor is the neoadjuvant NSCLC indication. Additionally, the partnership with Nektar for NKTR-214 combinations is not referenced in the original answer and lacks support in the provided context. (2) There are no numeric values in either answer to verify calculations, but the dates are critical: the ground truth specifies a March 2024 FDA approval for urothelial carcinoma, which the LLM fails to mention entirely. Instead, it invents multiple new indications without specifying correct dates or approvals. This represents a major factual deviation. (3) The multi-hop reasoning is flawed—the question asks for evolution in strategy with emphasis on collaborative framework and new approvals. The LLM correctly notes the ongoing collaboration with Ono but incorrectly expands it to include Nektar and mischaracterizes the nature of the partnership evolution. Crucially, it misses the key shift from co-development (with profit/loss sharing) to BMY-led independent commercialization, which is the central point in the ground truth. The strategic evolution is therefore misrepresented. (4) Despite these issues, the answer is contextually relevant—it addresses the general theme of Opdivo’s strategic evolution, mentions correct entities like Ono and Yervoy, and acknowledges expanded indications and commercialization. However, due to significant factual errors and omission of the key 2024 urothelial carcinoma approval and structural shift in collaboration model, the correctness and qualitative accuracy scores are moderate. The answer gives a plausible but factually unsupported narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 606,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "Between 2022 and 2024, American Tower’s disclosures regarding interest rate benchmarks for debt instruments shifted from referencing LIBOR-based rates in its 2022 filings (e.g., 2021 Credit Facility with LIBOR or EURIBOR borrowing rates ranging from 0.875%–1.750%) to explicitly adopting alternative benchmarks in its 2024 securitization structures. By 2024, the Company’s debt agreements (including the 2023 Securitization and related Loan Agreement) referenced specific fixed interest rates for tranches (e.g., 5.490% for Series 2023-1A Securities and 5.735% for Series 2023-1R Securities) and eliminated direct LIBOR/EURIBOR dependencies, instead tying rates to defined contractual terms and incorporating amortization triggers tied to debt service coverage ratios (DSCR). This evolution reflects a move toward more stable, predetermined rates and reduced reliance on floating benchmarks, particularly in securitized debt instruments, while maintaining covenants tied to financial performance metrics like DSCR thresholds.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the high-level evolution from LIBOR/EURIBOR toward alternative benchmarks, which aligns with the ground truth. However, there are significant factual inaccuracies in the quantitative details. The ground truth states that in 2024, new drawings under letters of credit in Nigeria bore interest at SOFR plus a spread, but the LLM claims that 2024 debt agreements (e.g., 2023 Securitization) used fixed rates like 5.490% and 5.735% for specific tranches—this level of specificity and these exact figures are not present in the original answer and appear fabricated or misattributed. Additionally, the original answer does not mention a '2023 Securitization' or 'Series 2023-1A Securities', nor does it reference DSCR amortization triggers or fixed-rate tranches, making these additions unsupported by the ground truth. While the shift away from LIBOR is correctly identified, the LLM incorrectly specifies the mechanism (fixed contractual rates in securitizations) rather than the actual shift to SOFR for Nigerian letters of credit. The covenants discussion in the LLM answer focuses on DSCR thresholds, whereas the original emphasizes a change in disclosure focus—from detailed covenants and renewal terms in 2022 to consequences of non-compliance in 2024—without mentioning DSCR. Thus, while the directional trend (away from LIBOR) is correct, the specific financial instruments, rates, and covenant mechanisms cited are not supported, leading to a partial score. The reasoning shows an attempt at multi-hop synthesis but relies on incorrect entity mappings and unsupported details, reducing factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 444,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's deepened its co‑investment strategy with franchisees, shifting toward greater real‑estate ownership by the company while still relying on franchisees to fund restaurant upgrades; the firm increasingly uses long‑term leases and ownership of land and buildings to support performance, and it partners with franchisees on capital projects to modernize stores and boost revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's relationship with franchisees regarding real estate ownership and co-investment strategy between 2022 and 2024. It correctly identifies that McDonald's increasingly owns or controls real estate (land and buildings) through long-term leases or ownership, while franchisees continue to invest in equipment, signage, and interior elements—this aligns with the 2024 disclosure in the ground truth. The mention of co-investment in capital projects for store modernization reflects the 'co-investment model' described as enabling high performance. However, the LLM answer omits a key aspect of the 2022 context: the emphasis on Systemwide coordination for ESG initiatives, which set the stage for deeper alignment but did not yet specify real estate roles. This missing nuance reduces completeness in the multi-hop comparison across years. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (McDonald's, franchisees, real estate, co-investment) are correctly identified. The reasoning is sound but slightly less detailed than the original in tracing the strategic evolution from general collaboration to a structured model. Contextual relevance is strong, as the response directly addresses the question's focus on real estate and co-investment trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 380,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "Between 2022 and 2023, the 2015 Stock Compensation Plan for Non-Employee Directors was formally amended and restated effective October 26 2022 (as disclosed in the 2022 Form 10‑K and incorporated by reference to the 2022 10‑Q), and the same plan continued to be referenced in the 2023 filing (page 109 of the 2023 10‑K) with updated share‑availability figures. This evolution reflects Altria’s ongoing effort to align director compensation with shareholder interests while maintaining a structured, equity‑based framework that is regularly updated to reflect governance best practices and evolving compensation strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the formal amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors effective October 26, 2022—and accurately notes its incorporation by reference from the September 30, 2022, Form 10-Q (referenced in the 2022 Form 10-K and carried into 2023). The mention of updated share-availability figures aligns with the ground truth’s disclosure of 703,256 shares available in 2022, though the LLM does not explicitly state that number. However, it does not contradict it and implies an update, which is consistent. (2) All dates (October 26, 2022) and document references (Form 10-K, Form 10-Q, page 109 of 2023 10-K) are factually accurate and match the source data. There are no calculation errors because no explicit computation is required. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2023 filings), identifies a governance action (amendment and restatement), and infers its implications on director compensation strategy. It correctly links the procedural update to broader governance practices. (4) The only minor shortcoming is the omission of the specific number of shares available (703,256) in 2022, which was present in the ground truth and directly responsive to the question about 'status and documentation.' This slightly reduces completeness and qualitative accuracy, but since the answer implies updated figures without misrepresenting them, the impact is minimal. Overall, the answer is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 441,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, the impact of roaming and resale arrangements among wireless service providers has intensified competitive pressure on American Tower’s leasing activity, leading to slower new lease growth. This is evident from the 2024 filing noting that extensive sharing of site infrastructure—such as roaming, resale, and RAN sharing enabled by advanced technologies like 5G—may cause carriers to utilize shared equipment instead of deploying new equipment, potentially reducing demand for tower space and pressuring lease rates downward. The company explicitly states that such practices \"may cause new lease activity to slow\" and could result in \"decommissioning of equipment on certain existing sites,\" directly linking these dynamics to reduced lease growth and heightened competitive pressures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution from 2022 to 2024: in 2022, roaming and resale arrangements were seen as a factor that could slow new lease activity; by 2024, this expanded to include RAN sharing and raised concerns about decommissioning existing equipment. All key qualitative points—slower lease growth, reduced demand for tower space, downward pressure on lease rates, and equipment decommissioning—are accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the impact of technological advances (5G), carrier behavior (infrastructure sharing), and business implications (competitive pressure, reduced leasing demand) across time, correctly linking them to AMT’s leasing activity and revenue outlook. (4) The answer addresses all parts of the question: the evolution of impact over time and what it indicates about competitive pressures on new lease growth. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misrepresentations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 364,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's franchisee relationship has shifted toward deeper strategic co-investment and tighter operational alignment. The company increasingly expects franchisees to fund major reinvestment initiatives—such as modernized restaurant builds, technology upgrades, and sustainability projects—often through co-investment partnerships, while simultaneously tightening standards around brand consistency, food safety, and customer experience execution. This reflects a move from pure royalty-based revenue dependence toward a model where franchisee financial commitment to capital projects is seen as essential to maintaining the brand's global competitiveness and accelerating growth under the \"Accelerating the Arches\" strategy. The 2024 filing emphasizes that franchisee willingness to invest at \"reasonable interest rates\" is now a critical factor for future growth, with the company actively collaborating on initiatives that cater to local consumer preferences while strengthening the overall system's value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the shift from pandemic-related challenges in 2022 to a strategic co-investment model in 2024 is accurately captured. The emphasis on franchisee reinvestment, restaurant modernization, technology, and brand consistency matches the original answer. The mention of 'Accelerating the Arches' strategy and local consumer preferences is consistent with the source. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution over time (2022 vs 2024), identifies the changing nature of McDonald's relationship with franchisees, and infers the strategic shift from operational adaptation to investment-driven growth. The only minor gap is that the LLM does not explicitly reference the pandemic’s impact on labor and supply chains in 2022, though it implies a transition from prior challenges. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both strategic investment and operational expectations as asked. Wording differs but semantic meaning is equivalent or stronger in some aspects (e.g., specifying technology upgrades and sustainability). Overall, this is a strong, factually correct response with only negligible omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 416,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's investment strategy for equity securities within its Special Use Funds evolved significantly from 2022 to 2024. In 2022, the fund held $2,349 million in Level 1 equity securities and $199 million in Level 3 equity securities, with a total equity securities value of $5,290 million. By 2024, the fund's equity securities increased substantially to $2,614 million in Level 1, $3,321 million in Level 2, and $229 million in Level 3, totaling $6,164 million. This growth reflects a strategic shift toward higher allocations in Level 2 securities (commingled funds with underlying Level 1 assets) and a continued presence in Level 3, indicating a more diversified and potentially higher-yielding investment approach within the Special Use Funds. The fund also expanded its fixed-income holdings, with corporate debt securities rising from $5 million to $685 million and asset-backed securities from $0 to $873 million, suggesting a deliberate move to enhance portfolio stability and income generation amid changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy held $8,922 million in Special Use Funds with no explicit breakdown of equity securities. However, the LLM claims $2,349M in Level 1, $199M in Level 3, and a total equity value of $5,290M in 2022 — none of which is supported by the original answer or implied in the filing. These numbers are entirely fabricated or misattributed. In 2024, the LLM correctly states that equity securities totaled $6,164 million, which matches the ground truth. However, it adds granular breakdowns into Level 1, 2, and 3 securities ($2,614M, $3,321M, $229M) that are not present in the original answer and cannot be verified. (2) The calculation of the 2024 total ($2,614 + $3,321 + $229 = $6,164M) is mathematically correct, but the components are unsupported. The claim about fixed-income growth (e.g., corporate debt rising to $685M, asset-backed to $873M) is not mentioned in the ground truth and introduces new, unverified data. (3) The multi-hop reasoning is flawed: the LLM assumes a detailed 2022 equity breakdown exists when the original answer explicitly states it does not. This undermines the core comparison. The conclusion about a 'strategic shift toward higher allocations in Level 2 securities' and 'diversified, higher-yielding approach' is speculative and based on incorrect inputs. (4) While the LLM attempts to address the evolution of investment strategy and correctly identifies the $6,164M equity figure for 2024, the majority of the quantitative foundation is incorrect. The contextual relevance is moderate because it discusses the right topic and timeframe, but the factual core is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 479,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, net revenues from smokeable products declined modestly from $22,476 million to $21,756 million, while operating income for that segment fell slightly from $10,688 million to $10,670 million. Overall operating income for the company also slipped from $11,919 million in 2022 to $11,547 million in 2023, reflecting higher general corporate expenses and amortization, partially offset by improved results in the oral tobacco segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures for smokeable products from 2022 to 2023: net revenues decreased from $22,476 million to $21,756 million, and operating income declined from $10,688 million to $10,670 million—matching the ground truth exactly. These numbers are presented with accurate formatting (e.g., 'million' used consistently, spacing with thin space is typographically acceptable). (2) All calculations implied (year-over-year changes) are factually sound: a decrease of $720 million in net revenue and $18 million in operating income is correctly reflected. (3) The reasoning is strong and synthesizes the correct entities (smokeable products, financial metrics, years). The LLM adds context about overall company operating income and contributing factors (higher corporate expenses, oral tobacco performance), which, while not part of the original question, does not contradict the ground truth and enhances understanding—though this extra detail is not required. (4) The answer fully addresses the question’s focus on net revenues and operating income for smokeable products over the two years. The minor deduction in qualitative accuracy is due to the inclusion of additional, unrequested information (overall company operating income and expense dynamics), which, while accurate, slightly shifts focus from the core request. However, since it doesn’t detract from correctness and may provide useful context, the overall correctness score remains high. Semantic equivalence is preserved, and all multi-hop elements (correct metric, segment, and year alignment) are properly handled.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 447,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between fiscal 2022 and 2023, Accenture’s utilization of its Class A ordinary shares shifted from a larger open‑market purchase program to a more focused share‑repurchase effort. In fiscal 2022 the company bought 12.18 million Class A shares for $4.11 billion (including $959 million of other share‑purchase activity), whereas by the end of fiscal 2023 it had authorized an additional $3 billion of repurchase authority and was actively repurchasing shares under that program, indicating a continued but more targeted deployment of its share‑purchase authority. The shares acquired are held as treasury stock and are intended for employee‑benefit uses such as equity awards and ESPP purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 (approximately $3.13 million), not $4.11 billion spent on share purchases as claimed by the LLM. The LLM incorrectly states that 12.18 million shares were bought for $4.11 billion in fiscal 2022, which is not supported by the original answer and misrepresents the scale and nature of the program. Additionally, the $3 billion repurchase authorization mentioned for 2023 is not in the original answer; the original does not specify new authorization amounts for 2023, only that shares were being held as treasury shares for employee benefits. (2) The calculation and use of $4.11 billion and $959 million are entirely fabricated and do not appear in the ground truth. The original answer does not provide actual purchase volumes or dollar amounts executed—only the available authorization. The LLM invents execution data that is not present. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies that shares are held as treasury stock and used for employee benefits like equity awards, which matches the original answer. It also correctly infers a focus on employee compensation mechanisms. However, it fails to mention the key 2024 detail about share withholding for payroll taxes, which is part of the evolution but omitted. The multi-hop synthesis is weak because it introduces unsupported figures instead of relying on disclosed authorizations and intended uses. (4) The contextual relevance is high because the answer addresses share purchase programs and intended usage of shares, directly responding to the question’s focus. However, due to major quantitative errors and invented data, the correctness score is low. The qualitative accuracy is moderate due to correct identification of treasury use and employee benefits, but the reasoning is undermined by factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 550,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants evolved to include newer debt instruments with lower coupon rates and extended maturities, reflecting a strategic shift toward cheaper, longer-term financing. The company issued 0.400% and 0.950% senior unsecured notes in 2021 (with maturities in 2027 and 2030), followed by 0.450%, 0.875%, and 1.250% notes in 2021 (maturing in 2027, 2029, and 2033), and later 1.450%, 2.300%, and 2.950% notes in 2021 (maturing in 2026, 2031, and 2050). These offerings replaced higher-rate legacy debt (e.g., 4.70% notes redeemed in 2021) and reduced reliance on LIBOR/EURIBOR-based borrowings, with interest rates now anchored to fixed percentages (e.g., 0.400%–2.950%) and adjusted via credit rating-based margins (1.125% above EURIBOR/LIBOR for credit facilities). The structure shifted from variable-rate facility-based debt to a portfolio dominated by fixed-rate senior notes with longer maturities, reducing refinancing risk and enhancing financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution of AMT's operating covenants between 2022 and 2024, specifically regarding debt instruments and interest rate benchmarks (e.g., LIBOR to SOFR). The original answer correctly identifies a shift from LIBOR/EURIBOR-based covenants in 2022 to SOFR-based structures in 2024, particularly for Nigerian letters of credit. In contrast, the LLM answer fabricates detailed information about senior notes with specific coupon rates (e.g., 0.400%, 0.950%) issued in 2021, which is outside the requested time frame and not mentioned in the ground truth. (2) Quantitatively, all the percentages, maturities, and issuance years (e.g., multiple '2021' note issuances) are factually incorrect and unsupported by the ground truth. There is no mention of such notes or redemptions (e.g., 4.70% notes) in the original answer. (3) The reasoning is flawed: the LLM incorrectly frames the evolution as a shift from variable to fixed-rate notes due to refinancing, whereas the actual evolution is a benchmark transition (LIBOR/EURIBOR → SOFR) driven by regulatory changes. The answer fails to mention SOFR at all, which is central to the 2024 update. (4) Contextually, the response discusses debt structure but misidentifies the nature of the change—focusing on coupon rates and maturities rather than covenants and interest rate benchmarks. It also references credit rating-based margins tied to LIBOR/EURIBOR as if still current, contradicting the transition to SOFR. Overall, the answer is factually inaccurate, misaligned with the time frame, and misses the key regulatory and structural shift in covenants.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 464,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "The 2024 filing shows Disney+ had approximately 123 million paid subscribers worldwide as of September 28, 2024, up from about 36 million Disney+ Hotstar subscribers (reported separately) and roughly 52 million Hulu subscribers; the 2023 filing does not provide a comparable Disney+ subscriber figure, but it does list 66 million total subscribers across its linear networks, indicating growth in the DTC segment.  \n\nThe consolidation of Star+ into Disney+ in Latin America eliminated the standalone Star+ offering and integrated its sports and general‑entertainment content into a single Disney+ product, strengthening Disney’s international streaming strategy by creating a unified, larger‑scale platform that can leverage a broader content library, improve subscriber retention, and support future multi‑product bundles (e.g., Disney+ + ESPN+ in the U.S.). This move is expected to boost Disney’s international subscriber base and increase average revenue per user across the region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2023 (not 2024), but the LLM incorrectly reports this figure as being from the 2024 filing and misplaces the date to September 28, 2024. Additionally, the LLM fabricates a global Disney+ subscriber count of 123 million and includes unrelated figures such as 52 million Hulu subscribers and 66 million linear network subscribers, none of which are mentioned or implied in the original answer. These numbers are not supported by the ground truth and represent a major deviation in quantitative accuracy. (2) The date of the subscriber count is misrepresented: the 2023 filing reports data as of September 28, 2023, not 2024. The LLM incorrectly shifts this date forward, creating a false impression of more recent data. There is no mention in the original answer of Hulu subscriber numbers or global Disney+ totals, so their inclusion is erroneous. (3) Regarding reasoning, the LLM correctly identifies the consolidation of Star+ into Disney+ in Latin America by June 2024 and interprets it as a strategic move toward unification, which aligns with the ground truth’s interpretation of streamlining international offerings. However, it overreaches by projecting impacts on ARPU, subscriber growth, and bundling with ESPN+, which are not stated or implied in the original answer. The multi-hop synthesis fails because it invents data rather than drawing only from the provided filings. (4) While the general direction of the strategic interpretation is plausible and contextually relevant, the severe factual and numerical inaccuracies—especially the incorrect subscriber numbers, misattributed dates, and fabricated comparisons—undermine the answer’s reliability. The contextual relevance is moderate because it addresses both parts of the question, but with incorrect data and speculative extensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements increased from approximately 3,000 in 2022 to approximately 2,100 in 2023 (covering about one-fifth of subsidiaries' employees), indicating the company's strategy of proactively renegotiating expiring agreements without material disruption to operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the number of employees covered under collective labor agreements increased from 3,000 in 2022 to 2,100 in 2023, when in fact it decreased. This is a critical factual error. The correct trend is a reduction from 3,000 to 2,100, not an increase. Additionally, the LLM introduces new information not present in the original answer—'covering about one-fifth of subsidiaries' employees'—which is unsupported by the ground truth and appears fabricated. (2) Quantitative accuracy is severely compromised: the numbers themselves (3,000 and 2,100) are correct in value but are applied in the wrong direction (increase vs. decrease), reversing the meaning. There are no calculations in this question, but the comparison is fundamentally flawed. (3) The multi-hop reasoning fails because the model misinterprets the temporal comparison and draws an opposite conclusion. While the original answer infers a strategic shift due to fewer renegotiations, the LLM incorrectly frames the decrease as an increase and still attributes it to proactive renegotiation—partially aligning with the strategy point but based on false premises. (4) Contextual relevance is moderate because the answer addresses labor agreements and company strategy, but the incorrect data trend and unsupported detail about subsidiaries reduce its validity. The conclusion about proactive renegotiation is plausible but misaligned with the evidence. Overall, major factual and logical errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 423,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's investment in U.S. Government and municipal bonds was $131 million at the end of 2022 (as shown in the fair value hierarchy table on page 101 of the 2022 filing) and increased to $137 million at the end of 2023 (shown in the same table structure for 2023 on page 87 of the 2024 filing). This represents a $6 million increase in total value across these years. The investment remained relatively stable, with the 2024 filing showing $137 million compared to $131 million in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that NextEra Energy's investment in U.S. Government and municipal bonds was $137 million in 2022 and $161 million in 2024, representing a $24 million increase. However, the LLM claims the investment was $131 million in 2022 and $137 million in 2023 (not 2024), with no data provided for 2024. It incorrectly reports the 2024 filing as showing $137 million, which contradicts both the timeline and the actual value. (2) The quantitative inaccuracies are critical: the LLM underreports the 2022 value by $6 million, omits the correct 2024 value entirely, and falsely attributes the $137 million figure to 2023 instead of 2022. The calculated $6 million increase is incorrect; the true increase is $24 million (17.5%). Additionally, the LLM references a '2024 filing' but uses data from 2023, indicating confusion in year alignment. (3) The multi-hop reasoning is flawed: the model fails to correctly extract and compare values across the correct years (2022 to 2024), instead using 2022 to 2023 data, and does not report the actual evolution through 2024. It also misattributes the source tables without verifying the correct year-to-year progression. (4) Despite these major errors, the answer is contextually relevant—addressing the right company, asset class, and general trend direction (increase)—and attempts proper citation of SEC filing pages. However, the core numerical and temporal inaccuracies severely undermine factual correctness, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 439,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in BMS's portfolio evolved from a mature oncology product to a strategically expanded asset with new combination and formulation approvals. Manufacturing strategy remained anchored in internal capability (e.g., maintaining an approved internal source for Opdivo) while expanding third-party partnerships to support demand, consistent with BMS's broader flexible manufacturing network approach. Therapeutic approvals accelerated with multiple 2024 FDA and EC authorizations: Opdivo received FDA approval for first-line metastatic urothelial carcinoma (Dec 2024), EC approval for Opdivo+Yervoy in colorectal cancer (Dec 2024), and expanded use in neoadjuvant NSCLC (Oct 2024), alongside the launch of Opdivo Qvantig (subcutaneous formulation) in December 2024. These developments reinforced Opdivo's position as a cornerstone IO therapy, supported by ongoing manufacturing investments to scale production for new indications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Opdivo in BMS's portfolio and mentions both manufacturing continuity and expansion of therapeutic approvals. However, there are significant factual inaccuracies in dates and approvals. The ground truth states that the FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma was in March 2024, but the LLM incorrectly states it as December 2024. Additionally, the LLM introduces several approvals not present in the ground truth: EC approval for Opdivo+Yervoy in colorectal cancer (Dec 2024), expanded use in neoadjuvant NSCLC (Oct 2024), and the launch of Opdivo Qvantig in December 2024—none of which are supported by the original answer. These are major additions that lack grounding in the provided truth. (2) Quantitative accuracy is compromised due to incorrect dates (March 2024 vs Dec 2024) and the introduction of unverified events. While the general manufacturing strategy (internal + third-party) aligns with the original, the specific timing and scope of approvals do not. (3) The multi-hop reasoning is partially sound—the model connects manufacturing strategy and therapeutic expansion, which is appropriate. However, it fabricates or misattributes several regulatory milestones, indicating a failure to accurately synthesize only the provided information. (4) The contextual relevance is high because the answer addresses both manufacturing and therapeutic evolution as required. Qualitative accuracy is moderate because core concepts are correct, but specific entity-event linkages are flawed. Correctness score is reduced due to unsupported approvals and incorrect dates, which affect factual reliability despite a logically structured response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 481,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Disney's relationship with National Geographic magazine has remained within the broader Entertainment segment's content licensing and publishing activities, with National Geographic magazine reported as part of Content Sales/Licensing in the 2024 10-K. The company continues to leverage National Geographic's IP through its linear channels (including National Geographic Channels) and DTC platforms, though no structural changes to its business relationship with the magazine are noted between 2023 and 2024. The magazine's revenue is included in the Content Sales/Licensing revenue stream, which also encompasses TV/VOD distribution, home entertainment, and other licensing activities.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative shift in Disney's relationship with National Geographic magazine between 2023 and 2024. (1) Correctly identifies that National Geographic magazine remained under Content Sales/Licensing in the Entertainment segment in both years, and accurately reflects its inclusion in licensing and distribution revenue. (2) Quantitative accuracy is high: no specific numbers are misstated, and the structural placement (Content Sales/Licensing) aligns with ground truth. However, the critical change in ownership disclosure—Disney’s 73% ownership mentioned in 2023 but omitted in 2024, with a shift from 'owned' to 'published'—is entirely missing. This omission undermines the answer's completeness and qualitative accuracy. (3) The multi-hop reasoning is weak: the question asks about evolution in business structure and strategic positioning, which requires comparing disclosures across years. The LLM fails to detect the shift in language and emphasis that indicates a more operational rather than ownership-focused relationship in 2024. (4) While contextually relevant and factually sound on surface-level structure, the answer does not capture the nuanced but important change in how Disney reports its relationship, which is central to the question. Thus, correctness and qualitative accuracy are reduced despite accurate entity and segment identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 389,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal’s 2024 filing expands its global payment capabilities by highlighting the ability to process transactions in “approximately 150 currencies” and to enable consumers to “send payments in approximately 200 markets,” a notable increase from the 2023 description that referenced “approximately 140 currencies” and “approximately 200 markets.”  The 2024 text also emphasizes broader currency‑holding options (“hold balances in their eligible PayPal accounts in 24 currencies”) and more explicit linkage of these capabilities to the company’s strategy for expanding offline engagement and cross‑border commerce.  Thus, between 2023 and 2024 the company’s language shifted from a general reference to multi‑currency support to a more detailed articulation of a larger number of supported currencies and markets, underscoring its ambition to process global payments in many different currencies.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy. The ground truth states that PayPal's transaction management databases allowed withdrawals in 56 currencies in 2023 and 57 in 2024—only a one-currency increase. However, the LLM claims PayPal expanded from 'approximately 140 currencies' in 2023 to 'approximately 150 currencies' in 2024, which is factually wrong and misrepresents the scale of change. Additionally, the LLM introduces unsupported metrics such as '200 markets' and 'hold balances in 24 currencies,' which are not mentioned in the original answer and cannot be verified from the provided ground truth. The qualitative shift toward a more consumer-centric framing (placing 'consumers' before 'merchants') noted in the original answer is completely missed by the LLM. Instead, the LLM fabricates a strategic emphasis on 'offline engagement' and 'cross-border commerce' not present in the ground truth. While the LLM correctly identifies that PayPal updated its description to reflect broader capabilities, the actual evolution described—both numerically and contextually—is inaccurate. The answer is contextually relevant in that it addresses PayPal’s evolving database capabilities in global payments, but the specific details and multi-hop synthesis are flawed. There is no evidence in the ground truth for the large increases in currency support or market reach claimed by the LLM, making the core of the response factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 403,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The Series K Debentures issued in February 2020 carried a 4.60 % fixed rate, but in March 2023 NEECH completed a remarketing that reset the interest rate to 6.051 % per annum (payable semi‑annually beginning September 1, 2023). This rate increase reflects a more expensive refinancing environment and indicates that NEE is leveraging higher‑cost debt to fund its growth and equity‑unit programs, while still maintaining a strategy of issuing long‑dated, largely fixed‑rate securities to manage its capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key interest rate change from the 2023 remarketing—6.051% per annum effective March 2023—which matches the ground truth. It also accurately notes the semi-annual payment start date of September 1, 2023. However, the LLM introduces a detail not present in the ground truth: that the original rate was 4.60% from February 2020. While this may be factually accurate in broader context, it is not part of the provided ground truth and adds unverified information. Additionally, the ground truth mentions a March 1, 2023 letter setting terms effective that date, which the LLM omits, though the practical effect (continuation of the updated rate) is implied. (2) Quantitatively, all numbers—6.051%, March 2023, September 1, 2023—are correct. The mention of 4.60% is plausible but not confirmed in the ground truth, slightly reducing quantitative precision. (3) The reasoning is sound: the LLM correctly infers that the rate increase reflects a response to market conditions (higher refinancing costs) and ties it to NEE’s broader financing strategy of using long-dated, fixed-rate debt. This aligns with the ground truth’s conclusion about strategic adjustment. (4) The answer is highly relevant and addresses both parts of the question: evolution of terms (rate reset) and strategic implication. The extra detail about the original rate and equity-unit programs goes beyond the ground truth but does not contradict it. Overall, the answer is factually strong with minor overreach on unconfirmed details, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 436,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil’s use of the unit‑of‑production depreciation method remained tied to its proved reserve base, but the company adjusted the underlying reserve estimates to reflect market‑driven price changes and reserve revisions. The 2023 filing notes that depreciation is calculated using the most recent SEC‑price‑based proved reserves, and that assets are re‑depreciated when proved reserves are “substantially de‑booked” or when reserve volumes shift enough to alter the unit‑of‑production rate. Consequently, any evolution in the method is driven by revised reserve volumes and price assumptions rather than a change in the depreciation principle itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that ExxonMobil maintained the unit-of-production (UOP) depreciation method between 2022 and 2023, with refinements tied to changes in proved reserves and pricing assumptions. The key qualitative point—that the methodology itself did not change but was refined based on reserve revisions and SEC pricing—is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the continuity of the UOP method, the trigger for re-depreciation (substantial de-booking or reserve shifts), and the increased reliance on SEC-price-based reserves in 2023—especially when reserves are significantly reduced. This matches the original answer’s emphasis on using the most recent SEC price in response to economic conditions. (4) The only minor gap is that the LLM does not explicitly mention the fallback to straight-line depreciation when asset life doesn’t correlate with reserves—a detail included in the original 2022 description. However, this omission does not distort the overall evolution of the method. The answer remains semantically equivalent in intent and factual content, with strong contextual relevance and precise entity and year matching. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 427,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Netflix’s 2024 filing shows a clear shift toward deeper internal studio capacity, with the company explicitly describing the scaling of its own production operations—including recent acquisitions such as Scanline and Animal Logic—to create original programming in‑house. While it continues to work with third‑party partners for certain content and distribution, the emphasis on “building out expertise” and “scaling our own studio operations” signals a reduced reliance on external production partners compared with the 2023 filing, which placed greater focus on strategic acquisitions and external licensing as growth levers. This evolution reflects a move from a primarily partnership‑driven model toward greater vertical integration of its content creation pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's 2023 emphasis on third-party risks and acquisitions (Scanline, Animal Logic) and the 2024 shift toward internal scaling and operational improvements are accurately represented. The LLM correctly identifies the strategic evolution from external partnerships to greater internal control. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in language and strategic focus across two years, correctly inferring reduced reliance on third parties based on shifted emphasis. The omission of third-party risk disclosures in 2024 is implied by the change in tone, which the LLM captures well. (4) The only minor gap is that the LLM does not explicitly mention the 2024 focus on 'managing complexity' or 'corporate culture and operational practices' as highlighted in the original answer, which slightly reduces qualitative completeness. However, the core strategic shift toward vertical integration and internal scaling is correctly and clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the evolution in strategy between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 388,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Based on the provided pages, Mastercard's strategic positioning of Cyber and Intelligence Solutions evolved from being positioned as a distinct growth area in 2022 to being integrated within broader value-added services and operational initiatives in 2023. The 2023 document (page 49) explicitly references \"cyber and intelligence solutions\" as part of its value-added products and services, highlighting their role in enabling secure transactions, but does not isolate them as a standalone strategic pillar like in prior years. Instead, the focus shifted toward operational efficiency and growth in core segments (e.g., 13% net revenue growth in 2023 driven by payment network and value-added services), with cyber and intelligence solutions embedded as a key enabler within the company's broader payments ecosystem, rather than a separate strategic category. The 2022 document (page 79) similarly contextualizes these solutions as part of Mastercard's \"family of well-known and trusted brands\" supporting secure payments, but the 2023 reporting reflects a more integrated, less emphasized positioning within overall financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant inaccuracies in the qualitative evolution of Mastercard's Cyber and Intelligence Solutions. While the ground truth states that the strategic importance of Cyber and Intelligence Solutions *increased* in 2023—being elevated to a value-added service that supports the broader payments ecosystem—the LLM incorrectly claims the opposite: that it was *less emphasized* and *integrated rather than highlighted*. This misrepresents the strategic shift. The LLM suggests a downgrading or de-emphasis in 2023, stating it was 'not isolated as a standalone strategic pillar' and 'embedded as a key enabler', which contradicts the ground truth that it was explicitly elevated and given broader strategic relevance. (2) Quantitatively, the LLM mentions a '13% net revenue growth in 2023' and references specific page numbers (49 and 79). However, these numbers and citations are not present in the ground truth and cannot be verified against it. Despite this, no explicit numerical contradiction exists (e.g., wrong year or amount), so quantitative accuracy is scored highly as no incorrect numbers are asserted from the ground truth perspective. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the directional change in strategic positioning—from being part of 'Other revenues' focused on fraud prevention in 2022 to a more expansive, ecosystem-wide role in 2023. Instead, it infers reduced emphasis due to lack of isolation, which is a misinterpretation of strategic integration as de-prioritization. (4) Contextual relevance is moderate: the answer discusses the right topic, time frame, and company, and references integration into value-added services, which aligns partially with the ground truth. However, the core conclusion about strategic positioning is inverted, leading to a low correctness and qualitative accuracy score despite appropriate context and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 527,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla’s energy storage product strategy shifted toward greater vertical integration and modular design to improve manufacturing efficiency and scalability, while explicitly acknowledging production risks tied to new factory ramp-ups and battery cell supply constraints. The company emphasized expanding its Megapack and Powerwall production at facilities like Gigafactory Texas and Nevada, but highlighted dependencies on proprietary battery cell development and raw material availability (e.g., lithium, nickel) to meet demand, with delays in cell production or supply chain disruptions posing significant operational risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Tesla's energy storage strategy from 2023 to 2024. It accurately captures the shift from emphasizing modular design and in-house expertise (2023) to addressing production ramp challenges and supply chain dependencies (2024). The mention of vertical integration, modular design, factory ramp-ups, and supply constraints (e.g., battery cells, lithium, nickel) reflects accurate qualitative synthesis. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The LLM adds specific details not in the original answer—such as Gigafactory Texas and Nevada and raw material examples—which are contextually plausible and enhance completeness without contradicting the ground truth. However, the original answer emphasizes 'supplier reliability' and 'quality standards' more explicitly, which the LLM answer touches on indirectly but does not fully mirror. This slight deviation in emphasis prevents a perfect score, but the core multi-hop reasoning—connecting strategic shifts to production and supply challenges across years—is sound and relevant. Thus, the answer is factually consistent, contextually appropriate, and semantically equivalent, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 372,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings expanded its floating‑rate debenture program with a focus on shorter‑to‑mid‑term maturities and a larger principal footprint. In January 2024 it issued $3.8 billion of fixed‑rate debentures (4.90%–5.55%) maturing 2026‑2054, and concurrently issued $600 million of floating‑rate debentures due 2026. Subsequent 2024 filings added a $4.85% debenture series due 2028 and a floating‑rate series also due 2028, while the 2025‑2029 series (4.85%–5.45%) and the 2029‑2034 series (5.25%–5.55%) were rolled out through mid‑2024. Overall, the strategy shifted toward issuing more floating‑rate notes with maturities clustered around 2026‑2029 and extending longer‑dated fixed‑rate series to 2034‑2054, increasing total outstanding floating‑rate principal to roughly $600 million plus additional floating‑rate tranches in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, NextEra Energy Capital Holdings sold $600 million in floating rate debentures due 2026, and in 2024, formalized the same series via an Officer's Certificate on January 31, 2024, with no update to the principal amount. The LLM incorrectly claims that in January 2024, the company issued $600 million in floating-rate debentures 'concurrently' with $3.8 billion in fixed-rate debentures, which is not supported by the original answer. Furthermore, the LLM fabricates additional floating-rate series due in 2028 and mentions unspecified 'floating-rate tranches in 2024'—none of which are mentioned in the ground truth. The original answer explicitly states that the principal amount was not updated in 2024 and that there was no significant expansion or restructuring. (2) Quantitative inaccuracies include the false assertion of $3.8 billion in fixed-rate issuances, multiple new floating-rate series (e.g., due 2028), and interest rates (4.85%–5.55%) that do not appear in the ground truth. The only correct number is the $600 million principal and the 2026 maturity, but even this is misrepresented as part of a broader expansion. (3) The multi-hop reasoning is flawed: the model incorrectly infers a strategic shift toward more floating-rate notes and longer maturities, while the ground truth indicates continuity and consistency in strategy without expansion. The synthesis across years is invalid because the 2024 data does not support new issuances beyond formalizing the 2023 plan. (4) The contextual relevance is moderate because the answer addresses issuance strategy, principal amount, and maturity structure—but the content is largely fabricated. Correctness and quantitative accuracy are very low due to invented figures and series; qualitative accuracy is low due to incorrect reasoning and entity conflation. Only the mention of $600 million and 2026 maturity aligns with truth, but even that is embedded in a misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 552,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel’s supply chain responsibility focus shifted from broad industry coalition-building toward more targeted supplier engagement and expanded diversity commitments. While continuing its RISE strategy collaborations (e.g., Alliances for Global Inclusion), the company significantly broadened its supplier diversity goals—aiming for $2 billion in annual spending with diverse suppliers by 2030—and deepened efforts to address forced‑labor risks, human‑rights oversight, and responsible minerals sourcing across its global supply chain. This evolution reflects a tighter integration of inclusion metrics into supplier programs and a more structured, accountable approach to managing upstream environmental and social impacts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly references Intel's RISE strategy and mentions responsible minerals sourcing and supplier engagement, it incorrectly states a shift from 'broad industry coalition-building' to 'targeted supplier engagement,' which contradicts the ground truth that describes a shift from announcing expansions (2023) to deepening existing partnerships (2024). The LLM also introduces a new goal of '$2 billion in annual spending with diverse suppliers by 2030'—a figure not present in the original answer and unrelated to the question about supply chain responsibility evolution in 2023–2024. This significantly undermines quantitative and factual accuracy. (2) The dollar amount ($2 billion) and the 2030 target are unsupported by the ground truth and appear to conflate supplier diversity with broader supply chain responsibility initiatives. No such spending goal or timeline was mentioned in the original answer, which focused on Scope 3 emissions and supplier coverage under sustainability programs. (3) The multi-hop reasoning is partially sound—Intel did continue RISE strategy collaborations and expanded focus on human rights and responsible minerals—but the synthesis is flawed because it invents a strategic pivot not stated in the ground truth. The original answer emphasizes continuity in capability-building and a shift in emphasis toward transparency in climate and water impacts, not diversity spending. (4) The contextual relevance is high because the answer addresses collaboration focus and supplier engagement scope, but correctness is limited by fabricated metrics and mischaracterization of strategic evolution. Thus, the correctness score is moderate due to partial alignment on themes but major errors in specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 503,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "The characterization of the assumptions underlying the standardized measure of discounted future cash flows has evolved from emphasizing first‑day‑of‑the‑month average prices and year‑end costs in 2022 to explicitly noting that such discrete price points can cause significant year‑to‑year variability in cash‑flow estimates in 2023, while still applying the same 10 % discount factor and net‑proved‑reserve basis. Consequently, ExxonMobil’s 2023 disclosure underscores the potential for greater cash‑flow volatility due to changing average prices, whereas the 2022 filing presented the standardized measure without highlighting this source of variability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in XOM's disclosure between 2022 and 2023. (1) It correctly identifies that the standardized measure continues to use first-day-of-the-month average prices, year-end costs, and a 10% discount factor—matching the ground truth. (2) Quantitatively, all elements are correct: the 10% discount factor is accurately noted, and there are no numerical inaccuracies. (3) The multi-hop reasoning is sound: the model synthesizes changes in tone and framing across two years, correctly noting that while methodology remained unchanged, the 2023 filing emphasizes the volatility caused by discrete pricing points. (4) The LLM conveys the key qualitative shift—acknowledging increased sensitivity to price variability—even if it does not use the exact phrase 'depends on' from the 2023 filing. The answer is semantically equivalent, though slightly less precise in capturing the exact linguistic shift from 'prepared on the basis of' to 'depends on.' This minor omission in verbatim framing prevents a perfect 10, but the overall meaning, context, and implications are correctly conveyed. Thus, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 341,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard expanded its open banking platform to connect over 95% of U.S. deposit accounts and roughly 3,000 European banks, embedding it within its broader digital identity and data infrastructure. This integration enabled seamless, secure consumer data sharing and enhanced payment experiences, while its digital identity solutions—leveraging Ekata’s acquisition and AI-driven verification—strengthened authentication across people, devices, and transactions, supporting financial inclusion and fraud prevention. The company also deepened its DEI focus, tying executive compensation to gender pay equity metrics and expanding initiatives like its neurodiversity hiring program.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative facts from the ground truth: connectivity to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe in 2023. These numbers match the original answer exactly, and the time frame (2022–2023 evolution) is accurately framed. However, the LLM introduces information not present in the ground truth, such as the acquisition of Ekata and AI-driven verification, which, while plausible, are not mentioned in the provided knowledge base and thus cannot be verified. Additionally, the mention of DEI initiatives like tying executive compensation to gender pay equity and neurodiversity hiring, while positive, is irrelevant to the question about digital identity and open banking integration. (2) Quantitative accuracy is perfect—no errors in numbers, percentages, or dates. The 95% U.S. coverage and 3,000 European banks are correctly cited. (3) The multi-hop reasoning is partially sound: the model correctly links the expansion of open banking infrastructure to enhanced digital identity reach and application. It also correctly infers that deeper integration with financial services occurred. However, it misses the specific 2023 partnership to launch an ACH payment solution using open banking infrastructure, which is a key piece of evidence for deeper integration in the ground truth. Instead, it generalizes to 'enhanced payment experiences' without citing the ACH example. (4) The correctness score is 7 because core facts and numbers are accurate, but there are notable omissions (ACH payment solution) and additions of unverified details (Ekata, DEI programs), which reduce factual precision. The answer remains largely aligned in meaning but includes extraneous and unsupported content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 482,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted from a standalone residential product to an integrated offering tightly coupled with its energy storage and vehicle charging ecosystem. Production challenges persist due to complex glass‑tile manufacturing and supply‑chain constraints, while the company increasingly depends on its proprietary battery‑cell development and local manufacturing (e.g., new Gigafactories in Mexico and Europe) to meet cost and volume goals. Consequently, Solar Roof’s growth is now closely tied to Tesla’s broader battery‑cell supply strategy and its ability to scale new factories without disrupting vehicle or energy‑storage production.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. However, the qualitative accuracy is low because the LLM introduces unverified claims not present in the ground truth. Specifically: (1) The assertion that Tesla shifted Solar Roof from a 'standalone' to an 'integrated offering' is plausible but not supported in the original answer, which only notes integration with Powerwall in 2023; (2) The claim about 'complex glass-tile manufacturing and supply-chain constraints' as ongoing production challenges is speculative—the ground truth mentions delays but does not specify causes; (3) The reference to 'proprietary battery-cell development' and 'new Gigafactories in Mexico and Europe' is unsupported in the provided context, as the original answer does not mention specific factories or battery-cell strategy in relation to Solar Roof; (4) The conclusion tying Solar Roof growth to 'battery-cell supply strategy' and factory scaling is an overextension not present in the original, which only notes that Tesla's success 'depends in large part' on mass-market vehicle production, indirectly affecting Solar Roof. The answer partially addresses the evolution between 2023 and 2024 but fabricates specific strategic dependencies and production challenges. While it captures the idea of production delays and broader strategic dependencies, it fails to accurately reflect the limited scope and indirect nature of the 2024 strategic shift as described in the ground truth. Thus, the correctness score is 5—partially correct on high-level themes but significantly flawed in entity accuracy and reasoning fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 463,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "Based on the provided document pages, NextEra Energy, Inc.'s use of Pledge Agreements has evolved with new agreements executed in 2024, specifically on **June 1, 2024**, and **October 1, 2024**. The June 1, 2024 Pledge Agreement involves **The Bank of New York Mellon** as the Purchase Contract Agent, while the October 1, 2024 Pledge Agreement involves the same agent and **Deutsche Bank Trust Company Americas** as Collateral Agent, Custodial Agent, and Securities Intermediary. These agreements are referenced in the 2024 filings (Form 10-Q for the quarter ended June 30, 2024, and Form 10-K for the year ended December 31, 2024), indicating a continuation and expansion of the Pledge Agreement structure with new counterparties and dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates—June 1, 2024, and October 1, 2024—are correct, and the counterparties (The Bank of New York Mellon and Deutsche Bank Trust Company Americas) are correctly identified. The mention of the 2024 Form 10-Q and Form 10-K filings adds contextual accuracy. (2) The original answer notes that in 2023, a Pledge Agreement dated September 1, 2022, was disclosed, involving both Deutsche Bank Trust Company Americas and The Bank of New York Mellon. The LLM answer does not explicitly mention the 2023 disclosure or the 2022-dated agreement, which is a minor omission but does not misrepresent the evolution—it focuses instead on the 2024 developments. (3) The reasoning is sound: the LLM correctly infers an expansion in the use of Pledge Agreements based on new 2024 agreements and identifies the evolving roles of counterparties (e.g., Deutsche Bank in multiple agent roles in October 2024). (4) The answer is contextually relevant and provides additional detail (agent roles, filing types) that enrich the response. The only reason for not scoring a 10 is the lack of explicit reference to the 2023 disclosure of the 2022 agreement, which slightly reduces completeness in the multi-hop timeline. However, the core evolution—new 2024 agreements with same counterparties—is accurately conveyed, supporting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 393,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel’s Edge AI strategy evolved through expanded software platforms and ecosystem partnerships. In 2024, the company emphasized AI-enabled compute and connectivity at the edge, launching updated processors (e.g., 4th Gen Xeon with vRAN Boost, Xeon D-1800/2800 series) and software tools like OpenVINO 2023.1 to accelerate edge AI deployment across industries. This included deeper collaboration with ecosystem partners (e.g., Ericsson, Nokia, Cisco, Dell, Microsoft) to drive software-defined networking and edge infrastructure adoption, while also advancing AI-specific hardware like the Intel Gaudi 3 AI accelerators and Jaguar Shores GPU accelerator. The focus shifted toward enabling developers to build, deploy, and manage distributed edge AI workloads through integrated hardware-software solutions, positioning Intel as a key player in the cloud-to-edge infrastructure transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements of Intel's Edge AI evolution, particularly around software tools (e.g., OpenVINO 2023.1) and ecosystem partners (Ericsson, Nokia, Cisco, etc.), which aligns with the ground truth's emphasis on partnerships. It also correctly identifies Intel's focus on edge AI deployment and cloud-to-edge transformation, contributing to high contextual relevance. However, the answer introduces specific hardware (4th Gen Xeon with vRAN Boost, Xeon D-1800/2800, Gaudi 3, Jaguar Shores GPU) and software versions (OpenVINO 2023.1) that are not mentioned in the ground truth, making their inclusion speculative or unsupported by the provided knowledge. More critically, the LLM fails to accurately represent the core strategic shift described in the original answer: the move under the NEX initiative to transform edge systems into cloud-native, programmable general-purpose compute platforms. This central evolution—shifting from modular software building blocks in 2023 to a cloud-native, software-defined infrastructure approach in 2024—is underemphasized or missing. Instead, the LLM focuses on product launches and hardware, which, while relevant, do not fully reflect the strategic platform and ecosystem evolution described in the ground truth. The qualitative reasoning is partially sound but misses the multi-hop synthesis of Intel’s shift from a horizontal software platform to an integrated, cloud-native, programmable edge strategy. Quantitative accuracy is high because the dates (2023–2024) and version numbers (if assumed accurate) are plausible, but since the ground truth does not specify them, their use risks factual overreach. Overall, the answer is contextually relevant and contains accurate directional information but lacks fidelity to the strategic narrative and key conceptual evolution in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 501,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "Based on the provided pages, CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged at $1,250 million during both 2023 and 2024, as shown in the 2023 and 2024 borrowings tables (page 168 and page 162). The company continued to hold this specific tranche of debt without any reported issuance, repayment, or modification between these years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.75% senior notes due August 2030 remained unchanged at $1,250 million in both 2023 and 2024, which matches the ground truth. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $1,250 million is correctly reported for both years, and the interest rate (1.75%) and maturity date (August 2030) are correct. (3) The reasoning is sound and directly addresses the evolution of this specific debt tranche. However, the original answer also mentions other senior notes due in 2030 (e.g., 3.75% due April 2030), noting their value remained stable as well. While the question primarily focuses on the 1.75% notes, the LLM omits this contextual detail about the broader 2030 debt composition, slightly reducing completeness in multi-hop synthesis. (4) Despite this minor omission, the LLM fully answers the core question about the 1.75% notes with precise data and correct reasoning, making it highly accurate and contextually relevant. The absence of the additional note does not detract from the primary focus but prevents a perfect qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 324,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix’s ad-supported subscription plan transitioned from a nascent offering to a core component of its pricing strategy, explicitly positioned to accelerate membership growth and broaden market reach. The company highlighted that the plan’s lower price point directly supports its objective of increasing subscriber additions, particularly in price-sensitive markets, while maintaining profitability through targeted advertising revenue. This strategy aligns with its broader goal of driving seasonal membership growth—especially in Q4—and reinforcing its competitive position against rivals by offering a differentiated, affordable option that expands its addressable audience without cannibalizing higher-tier plans. (Based on strategic emphasis in 2024 filings and prior-year context of testing the model.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Netflix's ad-supported plan from 2023 to 2024: introduced as a lower-priced option in 2023 and becoming a core strategic component by 2024. The key themes—expanding membership, targeting price-sensitive markets, integrating advertising revenue, and avoiding cannibalization of higher-tier plans—are all factually consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the ground truth, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it synthesizes the plan’s introduction in 2023 with its strategic entrenchment in 2024, correctly inferring its role in growth objectives and competitive positioning. The mention of Q4 seasonal growth and profitability via advertising revenue adds context supported by typical SEC filing narratives, though slightly more detailed than the ground truth—this is acceptable as elaboration, not error. (4) The only minor gap is that the original answer emphasizes the shift from 'experimental' to 'strategic,' a nuance slightly underemphasized in the LLM response, but the core idea of strategic integration is conveyed. Wording differs but semantic meaning matches. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 411,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Based on the provided 10-K filings, Tesla's approach to the Semi has evolved from pilot production (noted in the 2023 filing as \"Nevada: Tesla Semi – Pilot production\") to active development and integration into its broader strategy, as evidenced by its inclusion in 2024 production planning (\"Nevada: Tesla Semi – Pilot production\" remains active) and emphasis on new vehicle launches like the Cybercab and next-generation platforms. The company continues to advance the Semi's development alongside other new models, leveraging its manufacturing expansion and battery technology improvements to support production ramp-ups, though specific production milestones or revenue contributions from the Semi are not detailed in the provided excerpts.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misrepresents the evolution of Tesla's production status between 2023 and 2024. According to the ground truth, in 2023 Tesla had already begun 'early production and deliveries' of the Tesla Semi, which indicates a more advanced stage than pilot production. However, the LLM incorrectly states that pilot production was noted in the 2023 filing, which contradicts the ground truth that early production and deliveries had already started. In 2024, the status advanced to 'pilot production' at Nevada — but since pilot production appears to be a step behind 'early production and deliveries,' the LLM’s portrayal of progress from pilot (2023) to continued pilot (2024) does not align with the actual progression described in the original answer. (2) There are no explicit numbers, dollar amounts, or dates in the response beyond years (2023, 2024), which are used correctly. Thus, quantitative accuracy is high because no incorrect figures are presented, though the interpretation of production stages introduces factual error. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the sequence of production phases. Starting deliveries in 2023 should represent a more advanced stage than pilot production, yet the LLM implies pilot production was the 2023 status and frames it as the starting point, suggesting a misunderstanding of the relative maturity of production stages. This undermines the qualitative accuracy despite correct mention of Nevada and ongoing development. (4) Contextual relevance is strong — the answer addresses production status, location (Nevada), and strategic positioning relative to other vehicles and technology. However, due to the inversion of the production timeline and incorrect characterization of 2023 status, the core factual claim about evolution is inaccurate, warranting a mid-range correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 524,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024—evidenced by the addition of new agreements with executives like Brian Bolster (May 2024) and the inclusion of updated retention terms in the 2024 proxy filing—demonstrates the company’s deliberate focus on securing leadership continuity. By extending and broadening these agreements, NextEra underscores its strategic emphasis on retaining key executive talent to sustain its growth trajectory and oversee the execution of its long‑term capital projects and regulatory initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024, noting the addition of Brian Bolster in May 2024, which matches the ground truth. The date (May 6, 2024) is accurately reflected as 'May 2024'—a reasonable level of precision. The 2023 executives (LeMasney and Pimentel) are not explicitly named in the LLM answer, but their existence is implied through the contrast with 2024, and the focus is on the expansion, which is correct. (2) There are no numerical inaccuracies—dates are correct within acceptable formatting variation. (3) The multi-hop reasoning is sound: the model synthesizes information across years and executives to infer a strategic emphasis on leadership continuity and talent retention. It correctly infers the strategic implication of the expansion, such as sustaining growth and managing long-term projects, which is consistent with the ground truth’s interpretation of proactive talent management. (4) The answer is contextually excellent, directly addressing both parts of the question—leadership continuity and strategic emphasis. The only minor shortcoming is the lack of explicit mention of the 2023 executives by name or count, which slightly reduces completeness but does not detract from the overall correctness. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 408,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel’s xPU strategy shifted from broad product expansion toward tighter integration with its IDM 2.0 foundry model and open‑platform initiatives. In 2023 the company emphasized a diversified xPU portfolio (GPUs, IPUs, FPGAs) to capture growth in AI, edge and networking, while 2024 focused on leveraging its internal foundry capacity, advancing the x86 ecosystem via an advisory group, and using Smart Capital to fund capacity and R&D, underscoring a strategic pivot to scale xPU offerings through its own manufacturing and ecosystem partnerships.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's xPU strategy from 2023 to 2024 with accurate qualitative details. It correctly notes the diversified xPU portfolio in 2023 (GPUs, IPUs, FPGAs) and the 2024 emphasis on ecosystem expansion via an advisory group, aligning with the ground truth. However, it omits the specific $16.0 billion R&D expenditure in 2023, which is a key quantitative detail from the original answer. While it mentions 'Smart Capital' and 'IDM 2.0', these are contextually relevant but not explicitly detailed in the ground truth, representing plausible inference rather than error. (2) There are no incorrect numbers, dates, or calculations—only a partial omission of the R&D figure. The years 2023 and 2024 are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes shifts in strategic focus and product priorities across years, correctly identifying the move toward ecosystem development and manufacturing integration. It infers a strategic pivot that aligns with the ground truth’s 'product competitiveness' framing, though it uses different terminology. (4) The answer is contextually excellent and conveys a semantically similar evolution, but loses minor points for not explicitly referencing the R&D amount and slightly reframing the strategic shift using external concepts (e.g., IDM 2.0) not emphasized in the ground truth. Overall, core facts and reasoning are correct, with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 408,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Netflix’s advertising technology strategy has shifted from a nascent, risk‑laden pilot in 2023 to a more structured, infrastructure‑focused initiative by 2024.  In the 2023 filing the company highlighted “limited experience” and a host of uncertainties around ad‑sales organization, measurement tools, and member acceptance, warning that any failure could impair revenue growth.  By 2024 the same risk section emphasizes the need to “develop and expand an advertising sales and advertising technology organization team” and to build the “technology and related infrastructure to support advertising,” indicating that the firm has moved beyond early‑stage experimentation and is now investing in dedicated ad‑tech platforms, data‑analytics capabilities, and partner integrations to scale its ad business.  This evolution reflects a deliberate organizational development—creating a dedicated ad‑sales team and associated tech stack—paired with capital investment in scalable, secure infrastructure (e.g., cloud, CDN, and recommendation systems) to support a growing ad‑supported subscription tier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Netflix's 2023 stance of limited experience, reliance on third parties, and associated risks are accurately described. The 2024 shift toward building internal advertising sales and technology teams and infrastructure is correctly captured, including direct quotes from filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to show an evolution in strategy from external dependence to internal development. It infers organizational development (dedicated ad-sales team) and infrastructure investment (cloud, CDN, recommendation systems) as part of the strategic shift, which is consistent with the original answer’s emphasis on building technology and infrastructure. (4) The LLM adds slight elaboration (e.g., 'data-analytics capabilities', 'partner integrations', 'secure infrastructure') not explicitly stated in the ground truth, but these are reasonable inferences and do not contradict the original. The core message—strategic evolution from experimentation to investment in internal ad tech—is preserved with high fidelity. Only a minor deduction in qualitative accuracy due to slight expansion beyond the source, but overall excellent semantic equivalence and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 419,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Tesla’s approach to free Supercharging has shifted from recognizing revenue over the expected vehicle ownership period (as disclosed in 2023) to recognizing it based on actual usage or expiration, whichever occurs first, and only when the performance obligation is satisfied. In 2024, the company explicitly states that other limited free Supercharging incentives are recognized based on actual usage or expiration, reflecting a more usage-driven revenue model rather than straight-line recognition over the vehicle’s life. This change aligns with updated ASC 606 guidance and impacts how revenue from these programs is measured and recognized in the financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in Tesla's revenue recognition for free Supercharging between 2023 and 2024 and correctly identifies a shift toward deferring recognition based on performance obligations, aligning with ASC 606. It accurately reflects a move away from immediate or straight-line recognition over vehicle life to a more usage- or expiration-based model, which is contextually relevant and mostly consistent with the ground truth. However, it misses the key structural detail from the original answer that in 2023, free Supercharging was bundled under Automotive Sales Revenue and recognized over time as part of vehicle delivery, and in 2024, Tesla began explicitly deferring revenue for features like FSD, connectivity, and free Supercharging as liabilities to be amortized. The LLM answer implies a usage-driven model but does not clearly state that revenue is now deferred and recognized over time (amortized) rather than upon delivery—this is a critical distinction in accounting treatment. While the mention of ASC 606 is reasonable and supports the reasoning, the original answer emphasizes deferral and amortization, not just satisfaction of performance obligations based on usage. Thus, the qualitative reasoning is partially correct but lacks precision in describing the accounting mechanism. Quantitatively, there are no specific numbers to verify, so accuracy is high by default. Contextual relevance is strong as the response directly addresses revenue recognition and program structure changes. The correctness score is reduced due to incomplete and slightly misleading characterization of the 2024 accounting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 450,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's recent debt issuances show a clear shift toward longer‑dated, fixed‑rate subordinated securities. In 2023 the company issued 4.45% Notes due 2026 and Floating Rate Notes due 2073, and in early 2024 it launched the Series O Junior Subordinated Debentures due 2029 with a 4.85% coupon and a floating‑rate tranche due 2028. These moves extend maturity horizons (many series now run to 2030‑2055) and lock in relatively stable coupon rates, reflecting a strategy to diversify funding sources, reduce reliance on short‑term floating‑rate markets, and secure low‑cost capital for growth projects while maintaining a strong balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, NextEra Energy issued Series O Junior Subordinated Debentures due May 1, 2079, with no explicit coupon rate disclosed. In 2024, they issued Series O Debentures with a 5.55% coupon and a maturity date of November 1, 2029. The LLM incorrectly states that the 2024 issuance had a 4.85% coupon and a maturity of 2029 (wrong rate), and fabricates a floating-rate tranche due 2028 and other notes (4.45% due 2026, floating rate due 2073) not mentioned in the original answer. These are entirely incorrect instruments and misrepresent the actual issuance pattern. (2) Quantitative accuracy is very low: the coupon rates (4.85% vs correct 5.55%), maturity dates (generic 2029 vs specific Nov 1, 2029; omission of 2079 date), and additional instruments (2026, 2073, 2028) are all factually wrong. The LLM invents a trend toward longer-dated debt, while the truth shows a shift from very long-term (2079) to short-term (2029), which is the opposite direction. (3) The multi-hop reasoning is flawed: instead of identifying a strategic shift from long-dated, no-coupon/deferred interest debentures to shorter-term, fixed-coupon instruments, the LLM asserts the opposite — a move toward longer-dated, fixed-rate securities — which contradicts the evidence. The conclusion about 'locking in low-cost capital' and 'reducing reliance on floating-rate markets' is unsupported by the actual data. (4) Scores are justified as follows: correctness is low (2/10) due to pervasive factual errors; quantitative accuracy is poor (2/10) due to wrong numbers and invented dates/rates; qualitative accuracy is slightly higher (3/10) because the answer attempts to discuss financing strategy, albeit based on false premises; contextual relevance is moderate (5/10) as it addresses debt strategy evolution but with incorrect instruments and directionality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 523,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil’s impairment assessment framework has evolved from a 2022 focus on monitoring long‑term oil‑price and margin trends, reserve volumes, and development plans to a 2023 approach that explicitly incorporates the Corporation’s Energy Outlook and greenhouse‑gas emission‑reduction targets into cash‑flow projections, while still relying on unit‑of‑production depreciation and straight‑line methods when reserve volumes or asset lives diverge from economic expectations. This shift reflects a more integrated view of long‑term supply dynamics, including OPEC policy impacts and climate‑related cost assumptions, in evaluating potential asset impairments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All entities—ExxonMobil, OPEC, 2022 to 2023 timeframe, impairment assessment framework—are correctly identified. The evolution in framework is accurately described: in 2022, OPEC's influence on oil supply was explicitly acknowledged in impairment assessments; by 2023, this consideration was integrated into a broader framework including climate-related factors like greenhouse gas emission costs and Energy Outlook assumptions. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from direct OPEC focus to an integrated assessment that includes macroeconomic and environmental variables. While the original answer emphasizes the 'embedding' of OPEC within a broader framework, the LLM captures this by stating that OPEC policy impacts are now part of a more comprehensive evaluation alongside climate-related assumptions. (4) The LLM adds slight detail not in the original (e.g., unit-of-production depreciation methods), which is consistent with typical 10-K disclosures and does not contradict the ground truth. Overall, the core evolution in ExxonMobil’s approach is correctly conveyed, warranting a high correctness score. Minor deduction in qualitative accuracy due to slightly less precise emphasis on how OPEC discussion became 'embedded' rather than 'explicit,' but the conceptual shift is accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 436,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "From 2023 to 2024, Netflix’s ad‑supported subscription plan has been positioned as a core growth lever within its broader strategy to expand pricing flexibility and attract price‑sensitive viewers.  The 2023 filing emphasizes the plan’s role in “offering a range of pricing plans, including our ad‑supported subscription plan, to meet a variety of consumer needs,” while the 2024 filing expands this focus, describing the ad tier as a “key driver of membership growth” and highlighting ongoing efforts to refine its pricing, ad inventory and user experience to further boost adoption.  Consequently, the company has shifted from merely acknowledging the ad‑supported tier to treating it as a strategic priority with more detailed operational and financial emphasis.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Netflix's approach to its ad-supported subscription plan from 2023 to 2024, noting a shift toward greater strategic emphasis. It accurately reflects that in 2023 the plan was part of a range of pricing options and in 2024 gained prominence as a growth driver. However, the LLM misrepresents the tone and content of the 2023 filing: the original answer indicates that in 2023 the ad-supported plan was discussed primarily in the context of risk and uncertainty due to lack of operating history, not as a proactive growth strategy. The LLM portrays the 2023 stance as more strategically positive than it was, missing the risk-focused framing. While the 2024 characterization aligns well with the ground truth—highlighting strategic prioritization and operational refinement—the 2023 depiction lacks the cautionary tone present in the actual filing. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Netflix, ad-supported plan, 2023–2024 timeframe) are correct. The reasoning shows good synthesis across years but misses the critical shift from risk disclosure to strategic integration, slightly weakening qualitative accuracy. Contextual relevance is high as the response directly addresses the evolution in strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 365,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping-related costs have risen steadily, but the company has focused on improving fulfillment efficiency to offset those pressures. In 2022, fulfillment expenses grew 28% year‑over‑year, driven by higher wages, carrier rates, and network inefficiencies, while by 2024 the growth slowed to 9% and the fulfillment cost‑to‑sales ratio actually declined slightly (from 15.2% to 15.4% of net sales). This reflects Amazon’s strategic shift toward scaling its fulfillment network and leveraging economies of scale—such as higher sales volumes, optimized routing, and better supplier terms—to keep shipping costs from eroding margins, even as it continues to offer fast, low‑price shipping options.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that in 2022, Amazon anticipated rising shipping costs due to customer adoption of shipping offers and faster delivery methods, with $76.7 billion in shipping costs in 2021. However, the LLM claims a 28% YoY growth in fulfillment expenses in 2022 and a slowdown to 9% by 2024, which is not supported by the original answer. Additionally, the LLM cites a fulfillment cost-to-sales ratio declining from 15.2% to 15.4%, which is logically inconsistent (an increase, not a decrease), and this specific metric is not mentioned in the ground truth. (2) There are no verifiable sources provided for the 28%, 9%, or 15.2%–15.4% figures, and the direction of the ratio change contradicts the claim of declining pressure. The ground truth does not provide percentage changes in fulfillment costs or cost-to-sales ratios, so these numbers appear fabricated or misattributed. (3) The multi-hop reasoning is partially sound in that the LLM identifies a strategic shift toward efficiency and network optimization, which aligns with the evolution from customer-driven cost increases (2022) to operations-centric efficiency (2024). However, it fails to accurately reflect the basis of that shift as described in the original—specifically, the emphasis on network expansion and efficiency gains offsetting higher costs in 2024. (4) While the general theme of cost pressure and efficiency efforts is relevant and contextually appropriate, the inclusion of incorrect quantitative data significantly undermines factual correctness. The qualitative reasoning is plausible but not fully accurate due to reliance on unsupported metrics. Hence, the correctness score is low due to major quantitative errors, despite some alignment in strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 494,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's Master Retirement Trust saw a shift in asset allocation and disclosure practices. The 2024 target allocation increased equity exposure to 45% (from 45% in 2023) and slightly reduced debt securities to 33% (from 35%), while maintaining similar hedge fund and real estate allocations. Disclosure practices remained consistent, with the same 27%/33%/15%/18%/5%/7%/3% subsidiary allocation percentages used for both years, and Level 3 assets (primarily partnership interests and hedge funds) continuing to be reported separately in the fair value hierarchy. The 2024 reconciliation shows a decrease in Level 3 assets from $76M to $68M, reflecting net losses and transfers.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, Duke Energy described the Master Retirement Trust in terms of investment objectives and VEBA trusts with target and actual allocations, but does not specify exact percentages like 45% equity or 35% debt. The LLM fabricates precise asset allocation figures (e.g., 45% equities, 33% debt) and claims no change in equity exposure (45% to 45%), which is unsupported by the original answer. Additionally, the LLM incorrectly states that subsidiary allocations (27%/33%/15%/18%/5%/7%/3%) were the same in both years, while the ground truth indicates that the 2024 report introduced new subsidiary-level disclosures (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) not present in 2023. The claim about Level 3 assets decreasing from $76M to $68M is entirely fabricated—no such numbers appear in the ground truth. (2) The quantitative inaccuracies are severe: none of the percentages or dollar amounts (e.g., $76M, $68M) are mentioned in the original answer. The original emphasizes structural changes in reporting (e.g., introduction of balance reconciliations and Level 3 disclosures in 2024), not numerical shifts in asset values. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that the evolution lies in disclosure depth and transparency (e.g., new reconciliation statements and subsidiary allocations introduced in 2024), not in changes to target allocations or asset values. It mischaracterizes the nature of the evolution as quantitative rather than qualitative/reporting-related. (4) Despite these issues, the answer is contextually relevant—it addresses asset allocation and disclosure practices over time and attempts to compare 2023 and 2024. However, the factual and quantitative errors severely undermine correctness, warranting a low score. The qualitative reasoning is partially sound in structure but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 533,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's financial relationship with Google Network Partners remained characterized by the same cost structure and payment obligations described in the 2022 and 2024 10-K filings. The company continues to pay Network Partners a significant portion of advertising revenue—specifically, amounts paid to Google Network partners are included in cost of revenues and are presented as financing activities in the cash flow statement. While the 2024 filing notes increased share repurchases and dividend payments, it does not indicate any structural change to the Network Partner payment model; the cost of these payments continues to be reported as part of cost of revenues, with no shift in the underlying contractual obligations or payment percentages relative to prior years. The company's cash flow from operations, which funds these payments, grew from $101.7B (2023) to $125.3B (2024), supporting ongoing Network Partner payments without altering the fundamental cost structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its interpretation of the financial relationship evolution between Google and its Network Partners. While it correctly identifies that payments to Network Partners are included in cost of revenues, it incorrectly asserts there was no structural change in the payment model by 2024. This directly contradicts the ground truth, which states that by 2024, these payments were highlighted as a primary use of operating cash outflows, indicating a shift from a cost-of-revenue item to a more prominent operational cash flow obligation. The LLM mischaracterizes this evolution, claiming continuity where the ground truth describes transformation. (2) The quantitative elements—cash flow from operations growing from $101.7B (2023) to $125.3B (2024)—are plausible and may be factually accurate based on external knowledge, but they are not present in the original answer or question context, and their inclusion gives a false sense of precision not supported by the provided ground truth. These numbers were not part of the knowledge graph answer, so their use introduces unverified data. (3) The multi-hop reasoning is flawed: the original answer requires synthesizing a shift in financial classification and emphasis—from cost of revenue in 2022 to operating cash outflow prominence in 2024. The LLM fails this synthesis, instead asserting consistency. It also incorrectly categorizes Network Partner payments as 'financing activities' in the cash flow statement, which is false—TAC payments are operating activities, not financing. This reflects a fundamental misunderstanding of financial statements. (4) The contextual relevance is moderate because the answer addresses the right topic and entities (Google, Network Partners, TAC, cost of revenues), but the core conclusion about 'no structural change' is incorrect, undermining the qualitative and overall correctness scores. The answer appears confident but misrepresents the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 549,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the treatment of offsetting swap positions evolved in terms of accounting recognition and financial impact as follows:\n\n1.  **Fair Value Hedge Accounting**: For designated interest rate swaps used as fair value hedges, the gain or loss on the hedged item (e.g., long-term debt) and the gain or loss on the derivative (e.g., interest rate contracts) are recorded in the same line item of the income statement (e.g., interest expense). In 2023, the gain on the hedged item was $0, while the derivative gain was $(11) million, resulting in a net gain of $(11) million in interest expense. This contrasts with 2022, where the hedged item had a gain of $11 million and the derivative had a loss of $(11) million, resulting in a net gain of $0 in interest expense. This indicates that the offsetting gains and losses were fully recognized in income but shifted in timing and presentation between years.\n\n2.  **Cash Flow Hedge Accounting**: For designated cash flow hedges (e.g., foreign currency exchange contracts), the gain or loss reclassified from AOCI to income is recognized in the same period as the hedged forecasted transaction. In 2023, $213 million was reclassified from AOCI to revenue and $(10) million to interest expense, compared to $304 million and $(10) million in 2022, respectively. This reflects a decrease in the amount reclassified, likely due to changes in the effectiveness of the hedges or the termination of certain hedge relationships. The actual amount reclassified over the next 12 months is expected to be approximately $62 million pre-tax, but will vary with market conditions.\n\n3.  **Non-Designated Derivatives**: For derivatives not designated as hedges (e.g., foreign currency exchange contracts), the gain or loss from fair value changes is recognized directly in income. In 2023, a loss of $7 million was recognized in investment income and other, compared to a loss of $69 million in 2022. This significant reduction in loss indicates that the company may have reduced its exposure to non-designated derivatives or that market movements caused smaller losses in 2023. The settlement of these derivatives (e.g., cash flows from termination) is also reflected in the consolidated statement of cash flows.\n\nOverall, the financial impact of these swap positions evolved from a more favorable net gain position in 2022 (for fair value hedges) and a larger loss in non-designated derivatives (2022) to a less favorable net loss position in 2023 (for fair value hedges) and a significantly smaller loss in non-designated derivatives (2023), reflecting changes in hedge designation, effectiveness, and market conditions. The settlements and fair value changes were consistently reported in the consolidated income statement as part of the respective line items (interest expense, revenue, or investment income and other), with the net effect impacting the bottom line.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The Original Answer states that UPS reported fair value changes and settlements for non-hedge-designated derivatives (interest rate swaps, foreign exchange forwards, etc.) with specific figures for 2021 ($163M gain) and 2020 ($124M gain), but explicitly notes that the 2023 financial impact was *not quantified* in the excerpt. In contrast, the LLM answer fabricates numerous specific dollar amounts for 2023 and 2022 across multiple categories (e.g., $(11)M derivative gain, $213M reclassified from AOCI, $7M loss in investment income), which are not supported by the ground truth. These numbers are entirely hallucinated. (2) The ground truth makes no mention of fair value hedge accounting, cash flow hedge reclassifications from AOCI, or breakdowns by income statement line items—these are all invented by the model. The Original Answer focuses on the *evolution in disclosure transparency*, noting that while UPS continued marking derivatives to fair value, the 2023 report lacked quantification of current-year impacts, indicating reduced transparency. The LLM instead presents a detailed, false narrative about shifting gains/losses and hedge effectiveness. (3) The multi-hop reasoning is flawed: the model incorrectly assumes that because prior years had disclosed figures, 2022–2023 must have comparable data, and it invents a comparative analysis. It also misidentifies the core issue—transparency and disclosure changes—by focusing on nonexistent quantitative shifts in income statement impacts. (4) While the LLM stays within the domain of derivative accounting and mentions concepts plausibly related to SEC filings (AOCI, hedge designation, fair value), the complete absence of factual alignment with the ground truth—especially on numbers and key disclosures—severely undermines correctness. The contextual relevance is moderate because it addresses derivative treatment and income statement impact, but the substance is factually baseless.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1935,
        "completion_tokens": 555,
        "total_tokens": 2490
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 filing shows a markedly higher focus on the Directors' Savings Plan than in 2023, with the plan now explicitly highlighted in Item 11 (Executive Compensation) and detailed in the “Director and Officer Trading Arrangements” and “Equity Compensation Plan Information” sections. This increased prominence signals that Duke Energy is giving the Directors' Savings Plan a more central role in its director‑compensation strategy, using it to align director interests with shareholders and to provide a structured, defer‑and‑match mechanism that was less emphasized in the prior year’s disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023, noting its explicit inclusion in Item 11 and detailed discussion in specific sections—consistent with the ground truth's observation of a substantive description in 2024 versus minimal treatment in 2023. The LLM accurately infers that this reflects a strategic shift toward emphasizing deferral mechanisms and aligning director incentives with shareholders. While the ground truth highlights phantom investment options and balance adjustments, the LLM captures the essence of deferral and structure (e.g., 'defer-and-match mechanism') without explicitly mentioning 'phantom investments,' which is a minor omission. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and all entities (Duke Energy, 2023 vs 2024, Directors' Savings Plan) are correct. The reasoning is sound, demonstrating multi-hop synthesis between years and disclosure depth. The answer is contextually relevant and conveys the strategic shift accurately, warranting a high correctness score with only a slight deduction for missing granular detail on phantom investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 362,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "American Express has shifted from a largely static, fee‑based value proposition to a more dynamic, partnership‑driven model that emphasizes expanding premium benefits, digital‑first experiences and broader merchant coverage.  Between 2022 and 2024 the company increasingly tied cobrand renewals and partner incentives to competitive pressures—raising reward and payment‑partner fees to secure or replace relationships—and responded to changing consumer habits (e.g., greater demand for travel, dining and digital‑wallet integration) by investing in new card product refreshes, expanded lounge and dining platforms, and AI‑enabled service tools.  This evolution is aimed at preserving its differentiated “premium consumer” positioning against rivals such as Visa and Mastercard, while mitigating the risk of losing key partner arrangements that could erode network volume and loan balances.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. It accurately reflects the competitive pressures from digital wallets and payment rivals, rising rewards costs, and shifting consumer behaviors such as demand for digital integration, dining, and travel benefits. The emphasis on cobrand partnerships, digital enhancements (e.g., AI tools), and premium positioning aligns with the ground truth. There are no numeric inaccuracies (quantitative accuracy is 10), as the response avoids specific figures not present in the original and focuses on qualitative shifts. The answer correctly identifies the strategic pivot toward a more dynamic, partnership-driven model and highlights relevant areas like app enhancements and lounge/dining platforms. However, it omits specific 2024 initiatives mentioned in the ground truth, such as targeting Millennial and Gen-Z consumers, expanding global merchant coverage, and naming strategic platforms like Tock and Rooam. While it references AI and digital tools, it does not explicitly mention automation or the Amex app as key 2024 focus areas. These omissions prevent a perfect score, but the overall reasoning and synthesis across years and competitive dynamics remain sound. The answer is highly contextually relevant, directly addressing how Amex evolved its value proposition in response to competition and customer behavior changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 402,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil's long-term debt financing strategy has remained consistent through 2022–2024, with its long-term notes continuing to be issued primarily through the New York Stock Exchange under the same naming conventions (e.g., 0.524% Notes due 2028, 0.835% Notes due 2032, 1.408% Notes due 2039). The company maintained a stable approach to debt maturity structure and issuance volumes, reflecting its focus on long-term financial stability rather than structural shifts in financing composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct entities and dates, such as the 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, which are accurately mentioned in both the ground truth and LLM response. However, it fails to acknowledge the key change in composition — the removal of the 0.142% Notes due 2024 by 2024, which matured or were repaid. This omission directly contradicts the ground truth's central point about strategic evolution in debt structure. Instead, the LLM claims the strategy has 'remained consistent' and 'stable', which is factually incorrect given the retirement of short-term debt. (2) Quantitatively, the percentages and maturities cited are accurate where present, but the answer omits the 0.142% Notes due 2024 entirely, leading to an incomplete and misleading picture. No calculations are required, but the synthesis of changes over time is flawed. (3) The multi-hop reasoning is unsound: the question asks how the composition evolved, requiring comparison across years and inference about strategic shifts. The LLM fails to perform this synthesis, instead asserting continuity without evidence. It also introduces unsupported details — e.g., that notes are issued via the New York Stock Exchange — which is not disclosed in the ground truth and likely incorrect (debt is typically issued through underwriters, not stock exchanges). (4) Correctness is low (3/10) due to fundamental misrepresentation of the trend; quantitative accuracy is moderate (6/10) because existing numbers are correct but incomplete; qualitative accuracy is poor (3/10) due to flawed reasoning and incorrect conclusion; contextual relevance is acceptable (7/10) as the topic and entities are relevant, but the analysis misses the core evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 483,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express deepened its strategic emphasis on corporate card solutions by positioning them as a core growth pillar within its broader commercial payments agenda. The company increasingly differentiated its corporate offerings through enhanced value propositions, expanded financing and expense management capabilities, and targeted innovations—such as integrated banking and payment solutions—designed to meet the evolving needs of business customers. This evolution reflects a sustained commitment to scaling high-value commercial relationships, particularly through product differentiation in corporate cards and accounts payable services, reinforcing American Express’s role as a strategic financial partner for enterprises.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of strategic emphasis on corporate card solutions as a core part of American Express's commercial payments agenda and the focus on product differentiation through enhanced value propositions, expense management, and integrated solutions. The dates (2022–2024) and entities (American Express, corporate card solutions) are accurate, and there are no numeric inaccuracies, earning a perfect quantitative accuracy score. However, the LLM omits a key evolution highlighted in the original answer: the shift from an internal product development focus in 2022 to a more externally integrated global network strategy by 2024, particularly around increasing merchant acceptance and leveraging marketing insights and fraud protection through ecosystem integration. While the LLM captures the continuity of focus, it does not fully convey the strategic pivot toward external integration and global network expansion, which is central to the evolution between the years. This missing nuance affects qualitative accuracy, as the multi-hop reasoning—comparing strategic emphasis across time to identify a shift in approach—is incomplete. The answer remains contextually relevant and well-aligned with the broader theme, hence a high contextual relevance score. Semantic equivalence is partially achieved, but the absence of the ecosystem strategy shift prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 397,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has evolved to become a critical strategic driver of cash flow and investment focus between 2022 and 2024. AWS net sales grew 19% year-over-year in 2024 (reaching $107.6 billion), contributing significantly to consolidated sales growth (11%) and operating cash flow ($115.9 billion in 2024), while directly driving capital expenditures ($77.7 billion in 2024) primarily for AWS infrastructure. This strategic emphasis is underscored by substantial ongoing investments, including $2.75 billion in a Q1 2024 convertible note to Anthropic and plans for $2.7 billion additional AWS-related investments by Q4 2025, reflecting AWS's central role in Amazon's long-term growth and capital allocation strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of AWS as a key financial driver by 2024, aligning with the ground truth's narrative shift from risk to core revenue generator. However, there are significant quantitative discrepancies. The ground truth reports $115.9 billion in operating cash flow for 2024 (correctly cited), but attributes it to Amazon as a whole, driven in part by AWS. The LLM incorrectly implies AWS alone generated this cash flow, which is not supported. Additionally, the LLM states AWS net sales reached $107.6 billion in 2024 with 19% YoY growth — this figure is not present in the ground truth and cannot be verified against it. The $84.9 billion 2023 operating cash flow is omitted in the LLM response, weakening the year-over-year comparison emphasized in the original. The $77.7 billion capex and $2.75 billion Anthropic investment are factually plausible but not mentioned in the ground truth, introducing unverified details. (2) While $115.9 billion in 2024 operating cash flow is accurate, other numbers (AWS net sales, growth rate, capex, Anthropic note) are either unverifiable or incorrectly attributed. The 19% growth and $107.6B sales figure may be accurate in external sources but are not in the provided ground truth, making them extraneous or potentially misleading in this evaluation context. (3) The multi-hop reasoning is partially sound — the model infers AWS’s strategic importance from financial trends and investments, correctly identifying a shift in emphasis. However, it fails to contrast 2022’s risk-focused narrative with 2024’s financial dominance as clearly as the ground truth, and introduces unsupported specifics. (4) The answer is contextually relevant and captures the directional shift in AWS’s role. Qualitative reasoning is strong, but quantitative accuracy is weakened by inclusion of unverified figures and misattribution of cash flow to AWS specifically. Correctness score is 7 due to accurate core narrative but significant numerical and attributional issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 551,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "The trend analyses used to evaluate historical consistency of regulatory asset balances shifted focus between 2023 and 2024 from assessing historical consistency through management inquiries and independent expectation comparisons (2023) to incorporating more detailed external regulatory precedent analysis and specific storm/fuel cost recovery assessments in 2024, while maintaining the core approach of comparing recorded balances to independently developed expectations and evaluating commission-approved amortization patterns.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and fails to reflect the actual evolution described in the ground truth. (1) The original answer states that in 2023, trend analyses evaluated the historical consistency of regulatory asset balances generally, and by 2024, the focus expanded to include specific evaluation of the regulatory recoverability of asset retirement obligations related to coal ash. The LLM answer instead claims that in 2023, analyses relied on management inquiries and independent expectations, and in 2024 shifted to external regulatory precedent analysis and storm/fuel cost recovery assessments—none of which are mentioned or supported in the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, hence a score of 10. (3) The multi-hop reasoning is flawed: the model invents audit procedures (e.g., 'storm/fuel cost recovery', 'external regulatory precedent analysis') not present in the original data, indicating a failure to accurately synthesize or retrieve the correct information. (4) Contextual relevance is partially met because the answer discusses trend analyses and regulatory asset balances over the two years, but the specific evolution described is factually incorrect and introduces irrelevant details. The core shift toward coal ash-related asset retirement obligations is entirely missing, which is the key factual development. Thus, the answer does not convey semantically equivalent information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 431,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Based on the 2022 and 2023 10‑K excerpts, Costco’s private‑label penetration grew as a deliberate response to heightened cost pressures.  In 2022 the company noted that “merchandise costs in 2022 were impacted by inflation higher than what we have experienced in recent years” and that its pricing strategy—including “increasing the penetration of our private‑label items”—was used to offset those cost increases while trying to keep overall price hikes minimal.  By 2023 the same discussion of “adjustments to our pricing and merchandise mix, including increasing the penetration of our private‑label items” continued, showing that the expansion of private‑label offerings was maintained and reinforced to mitigate ongoing inflationary cost pressures.  Thus, between 2022 and 2023 Costco deepened its reliance on private‑label products to sustain competitive pricing and protect margins amid rising costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies that in 2022, Costco faced higher inflation in merchandise costs and responded with a pricing strategy that included increasing private-label penetration. In 2023, it correctly notes the continuation and reinforcement of this strategy. The core evolution—shifting from a reactive stance in 2022 to a more sustained strategic emphasis in 2023—is accurately captured, though the LLM does not explicitly use the phrase 'shift from reactive to strategic,' the meaning is semantically equivalent. (2) There are no numerical values (e.g., percentages, dollar amounts) in either the question or the answers, so quantitative accuracy is not applicable in that sense; however, the years 2022 and 2023 are correctly referenced, and no incorrect dates or figures are introduced—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years and correctly infers that the continued emphasis on private-label items represents a deepening of strategy in response to ongoing cost pressures. It correctly links cost pressures to pricing strategy and private-label expansion. (4) The answer is contextually fully relevant, directly addressing how Costco’s strategy evolved regarding private-label penetration in response to cost and pricing pressures. The only minor shortcoming is that the LLM does not explicitly frame the 2023 approach as more 'strategic and sustained' compared to 2022’s 'reactive' approach, which slightly reduces qualitative accuracy, but the implication is clearly present. Hence, all scores are high, with correctness at 9 due to this slight nuance omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 473,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on the financial disclosures in the 2023 and 2024 Form 10-K filings, Pfizer's outlook for Paxlovid shifted significantly from 2023 to 2024 as the company transitioned from government procurement to commercial market sales. In 2023, Paxlovid generated $18.9 billion in revenue, but by 2024, revenue dropped to $5.7 billion as the U.S. government discontinued free distribution and commercial pricing took effect, with only $1.3 billion in 2023 revenue attributed to government contracts. The company recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of government inventory, followed by a $771 million favorable adjustment in Q1 2024 for returned courses, and recognized $442 million in revenue from a U.S. government stockpile supply through 2028. Remaining performance obligations for Paxlovid totaled approximately $1 billion in contracted revenue as of December 2024, with deliveries expected through 2028 under new commercial agreements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical data. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM incorrectly asserts multiple revenue figures and adjustments without grounding in the RPO metric. The $18.9 billion and $5.7 billion revenue figures for 2023 and 2024 are not supported by the original answer and conflate total revenue with performance obligations. The $1.3 billion government contract revenue, $3.5 billion non-cash reversal, $771 million adjustment, and $442 million stockpile revenue are all absent from the ground truth and appear fabricated or misattributed. Only the $1 billion RPO as of December 2024 matches the original answer and is correct. (2) Quantitative accuracy is low because most numbers are either incorrect or introduced without support. The only correct figure is the $1 billion RPO in 2024. Calculations like the net effect of reversals and adjustments are not requested by the question and are factually unsupported. (3) The reasoning attempts multi-hop synthesis by discussing the shift from government to commercial sales and linking RPOs to future deliveries, which aligns with the qualitative trend in the original answer. However, it overreaches by introducing unverified financial events and misrepresenting RPOs as historical revenue. The core multi-hop element—comparing disclosed RPOs between 2023 and 2024—is partially addressed but obscured by extraneous and incorrect data. (4) Contextual relevance is moderate because the answer focuses on Paxlovid’s financial outlook and RPOs, which is on-topic, but distracts with irrelevant revenue details and adjustments not mentioned in the ground truth. The conclusion about increased contractual certainty is implied but buried under inaccuracies. Correctness score is 4 due to one major correct fact (the $1B 2024 RPO) but widespread quantitative errors and incomplete alignment with the original answer’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 552,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has extended its Reasonable and Supportable (R&S) Period from 2022 through 2024, reflecting a more forward-looking approach to estimating credit loss reserves by incorporating current and reasonably supportable economic conditions and longer-term loss rate assumptions. This evolution indicates a more sophisticated and risk-aware financial risk management strategy, as the company increasingly relies on statistical and actuarial models with greater discretion in determining the R&S Period and associated loss rates to reflect changing portfolio dynamics and macroeconomic trends.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies that American Express uses the Reasonable and Supportable (R&S) Period in estimating credit loss reserves and links it to financial risk management, it incorrectly states that the R&S Period was 'extended' from 2022 to 2024. The original answer does not mention any extension of the duration of the R&S Period; instead, it emphasizes the evolution of how the concept is presented — from being newly explained in 2022 to being embedded in a mature framework by 2024. There is no evidence in the ground truth that the length of the R&S Period changed. (2) Quantitatively, the LLM answer omits the specific reserve figure of $3.3 billion as of December 31, 2021, which is referenced in the original answer as context for the 2022 discussion. While no incorrect numbers are introduced, the absence of this key data point reduces quantitative completeness. The years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is partially sound — the model connects the use of R&S Period to credit loss estimation and infers a more sophisticated risk management approach. However, it misinterprets the nature of the evolution: the original answer focuses on the conceptual integration and normalization of the R&S methodology over time, not an extension of its time horizon or increased modeling discretion. The LLM invents a claim about 'longer-term loss rate assumptions' and 'greater discretion' not present in the ground truth. (4) Contextual relevance is high because the response addresses the core topic — the evolution of R&S Period usage and implications for risk management. However, due to significant qualitative inaccuracies and missing key factual nuance, the correctness score is limited to 4. The answer conveys a plausible but factually divergent narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 512,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon’s debt financing strategy has remained focused on issuing long‑dated fixed‑rate notes, but the composition of its most recent tranche shifted in 2024.  In the 2022 filing (pages 71‑73) the company disclosed its 0.800 % senior unsecured notes due 2025 as part of the June 3 2020 “2020 Notes” shelf, describing them as a low‑cost, long‑term funding source.  By the 2024 filing (pages 72‑76), the same 0.800 % 2025 notes appear among a broader set of 2022‑2023 debt certificates, and the company added newer supplemental indentures (e.g., the April 13 2022 supplemental indenture) that introduced additional 2025‑dated securities with slightly higher coupons (3.000 % and 3.300 %).  Thus, while the 0.800 % 2025 note continues to exist, Amazon’s approach has evolved from a single‑issue, ultra‑low‑rate tranche to a more diversified portfolio of 2025‑dated notes with varied coupon structures, reflecting a strategic shift toward managing interest‑rate exposure and capital‑raising flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amazon's continued reference to the 0.800% Note due 2025 from 2022 to 2024 and notes the evolution in debt strategy toward a more diversified portfolio. However, there is a discrepancy in the specific new coupon rates cited. The LLM claims Amazon introduced 3.000% and 3.300% notes in 2022 via a supplemental indenture on April 13, 2022, but the ground truth references a 4.600% Note due 2025 introduced by 2024, not the 3.000% or 3.300% notes. This misstatement of specific percentages affects quantitative accuracy. (2) The dates (June 3, 2020, and April 13, 2022) and the structure of the 2020 Notes shelf are plausibly detailed, but the absence of the 4.600% note — a key fact in the ground truth — and the introduction of unverified coupon rates (3.000%, 3.300%) represent factual inaccuracies. The 0.800% note is correctly referenced across years. (3) The multi-hop reasoning is strong: the LLM synthesizes information across 2022 and 2024 filings, identifies the continuity of the 0.800% note, and infers a strategic shift toward diversification in coupon structures. The logic supporting a shift in strategy to manage interest-rate exposure is sound and aligns with the ground truth’s conclusion, even if the supporting instruments differ. (4) The contextual relevance is perfect — the answer directly addresses the evolution of Amazon’s debt financing with respect to the 0.800% Note due 2025. The qualitative accuracy is high due to correct entity identification (Amazon, 0.800% Note due 2025, shelf issuance structure) and valid reasoning, though the incorrect specification of new note rates reduces quantitative accuracy. The correctness score is 8 because the core strategic conclusion is accurate and well-supported, but the use of incorrect coupon rates for the new debt instruments constitutes a notable factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 510,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The treatment of the Twenty-third Supplemental Indenture has remained consistent in both the 2022 and 2024 SEC filings, where it is still listed as a current and active indenture (e.g., in 2022 filings it appears as part of the series of supplemental indentures under Item 4.1.23, and in 2024 filings it continues to be referenced as an ongoing indenture, such as the “Sixty‑second Supplemental Indenture, dated as of April 1, 2024”). This repeated disclosure indicates that the indenture remains relevant and in force, with no evidence of retirement, amendment, or discontinuation, underscoring its continued legal and financial significance in Duke Energy’s debt structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states that the Twenty-third Supplemental Indenture was explicitly mentioned in the 2022 filing but absent in the 2024 filing, indicating reduced relevance. In contrast, the LLM claims it was consistently referenced in both years and remains active, which contradicts the evidence. (2) The LLM incorrectly cites a 'Sixty-second Supplemental Indenture, dated as of April 1, 2024' as evidence of ongoing relevance, but the ground truth references the Forty-ninth Supplemental Indenture dated March 14, 2024 — a significant discrepancy in both number and date. There is no mention of the Twenty-third in the 2024 filing, so asserting its continued reference is false. (3) The multi-hop reasoning is fundamentally flawed: the model fails to detect the absence of the indenture in the 2024 filing and incorrectly infers continuity and significance. It does not synthesize the change in disclosure practice over time, which is central to the question. Instead, it fabricates evidence of ongoing disclosure. (4) The correctness score is 1 due to complete factual inaccuracy. Quantitative accuracy is 1 because all dates and supplemental indenture numbers are wrong. Qualitative accuracy is 1 due to incorrect entities, flawed logic, and failure to identify the shift in disclosure. Contextual relevance is 3 because the answer addresses the general topic (indenture disclosures) but misrepresents the core facts and trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 415,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From the 2022 10‑K (pages 51‑55) we see that Alphabet repurchased $59.3 billion of its Class A and Class C shares during fiscal 2022. The 2023 10‑K (page 83) reports $62.2 billion of repurchases for fiscal 2023, and the 2024 10‑K (page 84) shows $62.0 billion of repurchases for fiscal 2024. Thus, the total value of shares repurchased was approximately $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts are accurate: $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024, with no calculation errors. Format variations (e.g., $59.3 billion vs $59.3B) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the evolution of repurchase activity over time and the total value repurchased in each year. (3) Entity accuracy is correct—Alphabet is the right company, and the Class A and Class C shares are accurately referenced (note: the original answer and LLM answer both group Class A and C, which is consistent with the source data). Fiscal years 2022, 2023, and 2024 are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes data across three 10-K filings (multi-hop reasoning), cites specific document pages, and presents a clear, factual progression of repurchase activity. While the LLM omits the interpretive summary about 'consistent and significant activity with a slight peak in 2023', this descriptive element is not required for factual correctness. The core information requested—evolution and yearly totals—is fully and accurately provided. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 359,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was first incorporated by reference in the 1988 10‑K (Exhibit 10.20) and has been amended over time. In the 2022 filing, the plan was restated as part of the “Twelfth Amendment and Restatement of the American Express Retirement Restoration Plan” (Exhibit 10.17), and the 2024 filing updates the plan’s documentation to reflect the “American Express Company 2016 Incentive Compensation Plan (as amended and restated effective May 6, 2024)” (Exhibit 10.23), which now governs the deferral provisions. Thus, between the 2022 and 2024 SEC filings, the plan’s documentation was revised to incorporate the 2024 restated 2016 Incentive Compensation Plan and related amendments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the treatment and documentation changes of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings as per the ground truth. (1) The LLM incorrectly states that in the 2022 filing, the plan was restated as part of the 'Twelfth Amendment and Restatement of the American Express Retirement Restoration Plan' (Exhibit 10.17), but the ground truth indicates that Exhibit 10.17 in 2022 was a 1994 amendment to the Salary/Bonus Deferral Plan, not a restatement under a different plan. (2) The LLM claims the 2024 filing references the 'American Express Company 2016 Incentive Compensation Plan (as amended and restated effective May 6, 2024)' (Exhibit 10.23) as governing the deferral provisions, which is not supported by the ground truth; instead, the 2024 filing reintroduces the original 1988 plan via Exhibit 10.13, the 1994 amendment via Exhibit 10.14, and adds Exhibit 10.16 for the 1997 amendments—none of which are mentioned in the LLM answer. (3) The LLM invents a connection to the 2016 Incentive Compensation Plan and a May 6, 2024 restatement that is absent from the ground truth, indicating a fundamental misinterpretation or hallucination. (4) The ground truth emphasizes continuity of foundational documentation with expanded historical disclosure in 2024, while the LLM suggests a substantive shift in governance that did not occur. Quantitative accuracy is low due to incorrect dates (e.g., May 6, 2024), wrong exhibit numbers (10.23 vs actual 10.13, 10.14, 10.16), and mischaracterized amendments. Qualitative accuracy is poor due to incorrect entity mapping and flawed multi-hop reasoning—failing to track the actual exhibits and their historical references across filings. Contextual relevance is moderate because the answer addresses the general topic of plan documentation changes, but the specifics are factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 521,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Between 2022 and 2024, Starbucks' interest rate swap liability shifted from a $34.0 million long‑term liability (recorded in “Other long‑term liabilities”) in 2022 to $19.2 million in long‑term liabilities and $3.6 million in accrued liabilities in 2024, reflecting a substantial reduction in the swap’s balance‑sheet exposure. Concurrently, the fair‑value hedging adjustment on the hedged long‑term debt declined from a $52.3 million cumulative fair‑value hedge loss in 2022 to a $17.8 million loss in 2024, indicating that the magnitude of the liability related to its interest‑rate swaps has decreased significantly over the two‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states the 2022 liability of $34.0 million under 'Other long-term liabilities', it incorrectly reports the 2024 figures. The LLM claims a $19.2 million liability in long-term liabilities and a $3.6 million liability in accrued liabilities in 2024, but the ground truth states a $19.2 million liability in 2024 and an additional $41.4 million liability from 2023 (not $3.6 million in accrued liabilities). The $3.6 million figure is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) The LLM introduces a fair-value hedging adjustment ($52.3 million loss in 2022, $17.8 million in 2024), which is not present in the original answer and cannot be verified from the provided ground truth. This adds unsupported detail and distracts from the core question about balance sheet classification and magnitude. (3) The multi-hop reasoning is partially sound in that it attempts to compare 2022 and 2024 data and interpret trends, but it fails to accurately represent the evolution across all years, especially the 2023 liability of $41.4 million, which is critical to understanding the trend. The LLM omits this key intermediate data point and misrepresents the balance sheet classification shift. (4) The contextual relevance is high because the answer addresses the question's focus on interest rate swaps, balance sheet classification, and magnitude over time. However, due to major quantitative errors and the introduction of unverified financial data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of change (reduction in liability) is correct, but the reasoning is based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 495,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, Duke Energy’s Directors’ Savings Plan was amended twice: an amendment effective December 16 2021 (referenced in the 2022 filing) and a further amendment that took effect in 2024, which updated the plan’s deferral and matching contribution provisions and clarified how phantom‑stock earnings are credited. These changes reflect a more structured, transparent approach to director compensation, emphasizing formal deferral mechanisms and aligning director pay with the company’s broader equity‑based compensation policies while maintaining a clear, board‑approved framework for governance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the number of amendments. The original answer confirms only one amendment (dated December 16, 2021) is explicitly mentioned in the 2022 filing, while the 2024 reference focuses on operational details like phantom investment options and unfunded accounts, not a second formal amendment. The LLM incorrectly states there was a 'further amendment that took effect in 2024,' which is not supported by the ground truth. This affects quantitative and qualitative accuracy. However, the core evolution—policy establishment in 2022 shifting toward operational transparency and alignment with shareholder interests by 2024—is correctly interpreted. The reasoning about governance, deferral mechanisms, and alignment with equity-based compensation is semantically consistent with the original answer. Dates and entities (Duke Energy, Directors' Savings Plan, phantom-stock, deferrals) are accurate. The answer addresses both parts of the question: evolution over time and implications for governance. While the conclusion about structured transparency and alignment with long-term interests is valid, the erroneous claim of a 2024 amendment reduces factual precision. No numerical calculations were required, so quantitative accuracy is high aside from the incorrect inference of a second amendment date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 380,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023 Costco’s Kirkland Signature brand shifted from a primarily price‑driven, value‑oriented positioning to a more differentiated, higher‑margin offering that is explicitly linked to the company’s sustainability and ESG commitments.  While the brand continues to emphasize low‑price quality, the 2023 filing highlights an increased focus on meeting ESG expectations—such as clean‑energy sourcing, carbon‑reduction goals, and transparent sustainability reporting—reflecting a strategic evolution toward a broader, socially responsible positioning that also raises regulatory and reputational risk.  This evolution is underscored by Costco’s public sustainability targets and its growing reliance on clean‑energy and emissions‑control initiatives, which now play a material role in the brand’s risk profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The original answer states that in 2022, Costco emphasized Kirkland Signature as a strategic asset due to quality, pricing, and margin benefits, with plans to grow its penetration. In 2023, the risk profile expanded to include supply chain, FX, and catastrophic events affecting the brand. The LLM answer incorrectly claims a shift toward ESG and sustainability commitments in 2023, including clean-energy sourcing and carbon-reduction goals as part of the brand's positioning—this is not supported by the provided ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse the fabrication of content. (3) The multi-hop reasoning is flawed: the LLM invents a strategic evolution around ESG that is not in the original data, fails to mention the actual shift from growth-focused (2022) to risk-focused (2023) framing, and misrepresents the nature of the risk profile change. (4) While the answer is framed around the correct company (Costco), brand (Kirkland Signature), and time period (2022–2023), the core content is factually wrong, making it mostly irrelevant despite surface-level plausibility. The contextual relevance is low because it answers a different question about ESG evolution rather than the actual shift in risk disclosure focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 402,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East region grew from **50 billion cubic feet (BCF) at the end of 2022 to 62 BCF at the end of 2024**.  The increase was driven by upward revisions (≈ 126 BCF in 2024), purchases (≈ 1 BCF in 2024), and extensions/discoveries (≈ 18 BCF in 2024), while sales were negligible.  Overall, the region’s gas reserve base expanded by roughly **12 BCF**, reflecting both organic additions and acquisitions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 billion cubic feet (BCF) in 2022 to 296 BCF in 2024—a reduction of 30 BCF. In contrast, the LLM claims reserves grew from 50 BCF to 62 BCF, an increase of 12 BCF, which is factually wrong on all key metrics. (2) Quantitative accuracy is severely lacking: the starting and ending volumes (50 vs. 326 BCF and 62 vs. 296 BCF) are wildly off. Additionally, the LLM cites large additions from revisions (126 BCF), purchases (1 BCF), and extensions/discoveries (18 BCF) in 2024, while the original answer explicitly states there were no significant reserve additions or sales in 2024 and only minimal extensions and discoveries. These figures are fabricated or misattributed. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the trend over time and misrepresents both the direction (increase vs. actual decrease) and drivers (significant additions vs. minimal activity). It also introduces data for 2024 that contradicts the ground truth of no significant activity. (4) Despite using relevant terminology (e.g., revisions, extensions, discoveries) and addressing the general structure of reserve changes, the complete factual inaccuracy of numbers, trends, and drivers results in a very low correctness score. Contextual relevance is moderate because the answer attempts to address the right region, company, and type of reserve change, but with entirely incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 437,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F evolved through a clear shift from leasing to owning the aircraft type. As disclosed in the 2022 10-K (page 40), FedEx Express operated **114 Boeing 767F aircraft**, all leased, with no owned 767Fs. By 2024, the company had transitioned to **owning 14 B767F aircraft** (as shown in the 2024 10-K's aircraft purchase commitments on page 117), with additional commitments for 11 more deliveries through 2025–2026. This reflects a strategic modernization focus on replacing older, less fuel-efficient aircraft (like the MD-11 and 757) with newer, more efficient 767F and 777F models to achieve long-term operating savings, as noted in the 2022 10-K (page 40) and 2024 10-K (page 117). The 767F now serves as a key component of FedEx's fleet modernization, with planned deliveries aligning with its fuel efficiency and capacity goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, FedEx *owned* 114 Boeing 767F aircraft, but the LLM incorrectly claims they were all *leased* and that FedEx owned zero. This is a direct contradiction of the ground truth. Additionally, the LLM asserts that by 2024, FedEx owned 14 B767Fs with commitments for 11 more, but the original answer states that no updated ownership figures were disclosed in 2024—making the LLM's specific numbers unsupported. (2) Quantitative accuracy is severely compromised: the 114 aircraft figure is mischaracterized (owned vs. leased), and the 14 owned + 11 committed aircraft in 2024 are not present in the ground truth, representing fabricated data. No calculations are required in the question, but the use of specific numbers from 10-K pages (e.g., page 117) implies precision that contradicts the original answer. (3) The multi-hop reasoning is partially sound—FedEx is indeed modernizing its fleet with 767Fs and replacing older models like the MD-11 and 757, and fuel efficiency and long-term savings are correctly cited as motivations. However, the core evolution described (shift from leasing to owning) is not supported by the ground truth, which only confirms ownership in 2022 and strategic focus in 2024 without discussing leasing or ownership changes. (4) Contextual relevance is fair because the answer addresses fleet modernization and the role of the 767F, but the incorrect quantitative foundation undermines the qualitative reasoning. The answer introduces leasing-to-own transition and specific purchase commitments not present in the ground truth, leading to a mostly incorrect conclusion despite relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks’ involvement with roasted coffee evolved through a strategic shift in its supply‑chain infrastructure and inventory management. While the company’s total inventory (including roasted coffee) grew from $2.18 billion in fiscal 2022 to $2.18 billion in fiscal 2023 and then to $2.18 billion in fiscal 2024 (reflecting continued investment in roasting capacity and warehouse space), the valuation of its equity‑method investments in joint ventures such as the North American Coffee Partnership remained relatively stable, hovering around $283 million in 2022 and $216 million in 2021, indicating a consistent but modest contribution to overall earnings. This suggests that Starbucks has been expanding its owned roasting and distribution facilities—evidenced by the listed owned roasting sites and growing PP&E—while maintaining a steady, non‑material equity stake in its key coffee‑production partnerships.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and fails to report the correct inventory value for roasted coffee in 2022, which is $310.3 million according to the ground truth. Instead, it cites total inventory of $2.18 billion across 2022–2024, which is irrelevant to the specific metric requested (roasted coffee inventory). Additionally, the mention of equity-method investments (~$283M in 2022) and joint ventures like the North American Coffee Partnership is unrelated to the question about roasted coffee inventory and production infrastructure. These figures pertain to investment holdings, not roasting operations or inventory values. (2) The quantitative inaccuracies are severe: the key number ($310.3M roasted coffee inventory in 2022) is entirely omitted and replaced with incorrect aggregate inventory data. The claim that total inventory was exactly $2.18B for three consecutive years appears suspicious and is not aligned with typical financial reporting fluctuations, further undermining credibility. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Starbucks has roasting facilities (and lists some correctly, such as York, PA; Minden, NV; Kunshan, China; Kent, WA), it fails to connect this infrastructure expansion to the evolution of roasted coffee involvement in terms of inventory and production scale. Instead, it diverts into unrelated financial metrics (equity-method investments), showing poor synthesis of relevant information. (4) Despite the incorrect focus, the answer does show some contextual awareness by referencing roasting sites and infrastructure growth, which aligns partially with the 2024 expansion mentioned in the ground truth. However, the absence of the core inventory figure and substitution with irrelevant data severely undermines correctness. The reasoning does not support the conclusion about a shift from inventory holding to active production because the necessary data comparison is missing. Thus, the correctness score is low due to major factual and quantitative errors, even though some elements of infrastructure are mentioned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 573,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided SEC filing pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 is documented as follows:  \n- The 2.750% Senior Notes due 2025 were first authorized in the Board of Directors' resolutions referenced on **page 129 of the 2023 10-K filing** (specifically listed among multiple senior note authorizations).  \n- The same resolution was reiterated in the **2024 10-K filing on page 130**, where it appears in the list of notes authorized for issuance (including \"2.750% Senior Notes due 2025\" alongside other senior debt instruments).  \n- No evidence of redemption, refinancing, or changes to the terms of the 2.750% Senior Notes due 2025 is indicated in the provided pages; the filings only confirm the ongoing authorization of these notes as part of PepsiCo's debt management strategy.  \n\nThus, the utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024, with no evolution in terms or usage disclosed in the referenced filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 2.750% Senior Notes due 2025 were indeed authorized in the 2023 10-K (page 129) and reiterated in the 2024 10-K (page 130), with no changes to terms or redemption indicated. These numeric and document references are correct, earning full marks for quantitative accuracy. However, the qualitative reasoning and completeness fall short. The original answer identifies a key strategic evolution: PepsiCo introduced a new 2.750% Senior Notes due 2030 in 2024, signaling an extension of its use of this interest rate to longer-term debt. The LLM answer fails to mention this critical development, which is central to the question about the 'evolution' of utilization. By concluding that 'utilization remained consistent' and 'no evolution...disclosed,' the LLM misinterprets the strategic shift implied by the introduction of a new long-term instrument at the same rate. This omission represents a failure in multi-hop reasoning—connecting the continued authorization of the 2025 notes with the introduction of the 2030 notes to infer a broader financing strategy. While the LLM accurately reports the status of the 2025 notes, it misses the synthesis required to assess strategic evolution, resulting in a partially correct but ultimately misleading conclusion. Contextual relevance is high as the response stays on-topic and cites appropriate document locations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 394,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "From 2022 to 2024 FedEx’s planned utilization of the B777F aircraft shifted from a larger, multi‑year commitment (11 B777Fs slated for delivery in 2023‑2026 in the 2022 filing) to a much smaller, near‑term schedule of only two B777Fs planned for delivery in 2025, as shown in the 2024 “Aircraft purchase commitments” table. This reduction indicates that FedEx is scaling back its long‑term fleet expansion and is instead focusing on shorter‑term, more flexible aircraft acquisitions to meet near‑term capacity needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025 in its 2022 plan, not 11 aircraft from 2023–2026 as claimed. The 2024 update shows only 2 B777Fs planned for 2025 with no further plans—this part is partially correct but misrepresented in the LLM answer as 'two B777Fs planned for delivery in 2025', while the original answer refers to 'operating' not 'delivery'. The LLM invents a '2022 filing' reference to 11 B777Fs over 2023–2026, which is not in the ground truth. (2) Quantitative accuracy is low: the numbers (11 aircraft, 2023–2026 delivery schedule) are incorrect and not supported by the original answer. The correct numbers are 4 for 2024 and 2 for 2025 in the 2022 plan, revised to 2 for 2025 only in the 2024 plan. (3) The multi-hop reasoning is partially sound—LLM recognizes a reduction in planned utilization and infers a strategic shift—but the flawed data undermines the conclusion. The correct inference is a move toward complete phase-out, not just 'shorter-term acquisitions'. (4) Contextual relevance is fair: the answer addresses fleet strategy and timeline changes, but the incorrect data leads to a misleading interpretation. The core idea of reduced emphasis is present, but specifics and reasoning are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 377,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency-other derivative liabilities in AOCI declined significantly from $55.3 million to $11.5 million, reflecting reduced exposure to foreign exchange fluctuations. This decrease indicates the company is actively managing and reducing its sensitivity to currency movements, though some foreign currency risk remains through other derivative positions and hedging activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Starbucks reported foreign currency - other derivative liabilities of $0.3 million (not $55.3 million), and in 2024 the net gains in AOCI were $11.5 million. The LLM incorrectly states that liabilities 'declined' from $55.3 million to $11.5 million, which misrepresents both the magnitude and nature of the figures. The $55.3 million figure does not appear in the ground truth and is entirely incorrect. Additionally, the ground truth refers to a shift from a liability in 2022 to gains in 2024, not a decline in liabilities within AOCI. (2) The quantitative values are largely wrong: $55.3M vs $0.3M in 2022 is a 55x overstatement; while $11.5M in 2024 matches, it is mischaracterized as a liability reduction rather than a gain. No valid calculation or trend can be derived from these incorrect inputs. (3) The multi-hop reasoning is flawed: the model fails to correctly identify that the 2022 figure is a liability on the balance sheet (accrued liabilities) while the 2024 figure is an unrealized gain in AOCI—these are different financial statement items and cannot be directly compared as a 'decline'. The conclusion that exposure is 'reduced' contradicts the ground truth implication of increased exposure or hedging activity. (4) Contextual relevance is moderate—the answer addresses foreign currency derivatives and AOCI, and attempts to interpret the trend, but due to factual errors, the analysis is misleading. Correctness and quantitative accuracy are severely penalized due to incorrect core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 444,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo’s 2.625% Senior Notes due 2026 were first established in 2019 (via the July 29, 2019 2.625% Senior Note due 2029 filing) and have since been referenced in multiple subsequent disclosures, including the February 15, 2023 filing of a Floating Rate Note due 2026 and the November 13, 2023 5.125% Senior Note due 2026 filing, which also included board resolutions authorizing the terms of the 2.625% 2026 notes. In the 2024 filings (July 17, 2024 and February 12, 2024), the company again disclosed board resolutions that specifically authorized the terms of the 2.625% Senior Notes due 2026 as part of its broader suite of senior note issuances, underscoring the continued use and formal authorization of this debt instrument in its capital‑raising strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2.625% Senior Notes due 2026 were 'first established in 2019' via a filing for the 2.625% Senior Note due 2029—this conflates two different notes (2026 vs 2029) and misrepresents the origin of the 2026 notes. The ground truth does not mention a 2019 establishment for the 2026 notes. (2) The LLM references a 'Floating Rate Note due 2026' filed on February 15, 2023, and a '5.125% Senior Note due 2026' filed on November 13, 2023, which are not mentioned in the original answer and appear to be fabricated or misattributed. (3) The original answer emphasizes a comparative evolution in disclosure breadth between 2023 and 2024—specifically, the expansion of disclosed notes to include new maturities like the 3.000% due 2027 and 2.625% due 2029. The LLM fails to mention this key development, instead focusing on repeated board authorizations, which misses the core point about diversification and strategic expansion of debt instruments. (4) While the LLM correctly notes that the 2.625% Senior Notes due 2026 were still disclosed in 2024 and tied to board resolutions, this only partially aligns with the 2023 disclosure described in the ground truth. However, the multi-hop synthesis is flawed: it invents specific filing dates and instruments not in the original and fails to compare the scope of disclosures across years. (5) The reasoning is internally consistent but based on incorrect data, leading to a misleading narrative. The answer is contextually relevant to PepsiCo’s debt disclosures but lacks the accurate, comparative analysis required. Quantitative accuracy is low due to incorrect dates, percentages, and instruments. Qualitative accuracy is moderate because it identifies the right instrument and general context of board authorizations but fails on entity and temporal accuracy. Contextual relevance is fair as it addresses debt disclosures but misses the broader strategic implication highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 552,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "From 2022 to 2024, Cisco’s exposure to technical hurdles has intensified as it accelerates investments in strategic priority areas such as AI, cloud, cybersecurity, and network programmability. The company repeatedly emphasizes that developing new products—especially programmable, software‑defined networking and security solutions—requires overcoming complex technical challenges, and that delays or mis‑steps in these efforts could erode market share and profitability. Consequently, Cisco’s strategic investments and product development timelines are now more tightly linked to its ability to surmount these technical obstacles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth. It correctly identifies the evolution of Cisco's exposure to technical hurdles from 2022 to 2024, noting increased reliance on overcoming such challenges amid strategic investments in AI, cloud, cybersecurity, and software-defined solutions—consistent with the original answer. The answer captures the heightened stakes around product development timelines and the link between technical execution and market competitiveness. While it does not explicitly mention the 2024-specific risks of reputational damage, legal liability, or reduced customer retention, it does convey the core shift in risk profile and strategic dependency. All entities (Cisco, AI, cloud, security, network programmability) and timeframes (2022 to 2024) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved). The reasoning is sound and reflects multi-hop synthesis across years and strategic domains. The omission of some nuanced 2024 risk factors prevents a perfect 10, but the answer remains highly accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 327,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided SEC 10-K filings, Google Ad Manager's role in driving Google Network revenues grew significantly between 2022 and 2023, as evidenced by its explicit positioning and performance metrics in the 2023 filing. In 2023, Google Network revenues were specifically tied to Ad Manager's ecosystem, with the filing stating that \"amounts paid to Google Network partners primarily for ads displayed on their properties\" are recorded as cost of revenues, and that Google Network partners are key to monetizing advertising inventory. This reflects a strategic shift where Ad Manager's platform (including AdMob, AdSense, and Ad Manager) became a more central driver of Google Network revenue growth, as highlighted by the 2023 document's emphasis on \"Google Network partners\" and the platform's role in delivering ads across third-party properties. The 2022 filing similarly noted Google Network revenue growth driven by \"strength in AdMob, Google Ad Manager, and AdSense,\" but the 2023 context shows deeper integration and reliance on Ad Manager's infrastructure for network revenue generation.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the trend described in the ground truth. In 2022, Google Ad Manager was explicitly cited as a key driver of the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. However, in 2023, it was no longer singled out for revenue growth and instead listed among other platforms (Google Ads, Display & Video 360, Marketing Platform) without specific attribution to growth—indicating a reduced emphasis, not an increased one. The LLM incorrectly claims that Ad Manager's role 'grew significantly' and became 'more central' in 2023, which contradicts the ground truth. (2) Quantitatively, the $8.6 billion figure is not mentioned in the LLM response, but no incorrect numbers are stated. The LLM references cost of revenues and partner payments, which are contextually relevant but not directly tied to Ad Manager's performance as a growth driver. There are no calculation errors because no calculations are attempted. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in narrative tone—from explicit attribution of growth in 2022 to general inclusion in a suite of tools in 2023. Instead, it infers deeper integration and greater strategic importance in 2023 based on mentions of 'Google Network partners,' which misinterprets the qualitative shift. (4) The contextual relevance is moderate because the answer discusses related concepts (Ad Manager, network partners, revenue generation), but the core conclusion about Ad Manager's growing role is factually incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 451,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "From 2022 to 2024, Starbucks’ foreign currency‑other derivative liability in AOCI declined from $55.3 million to $11.5 million, a reduction of $43.8 million (approximately 79%). This represents the magnitude of change in those derivative liabilities over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers cited ($55.3 million in 2022 and $11.5 million in 2024) are completely wrong and do not match the ground truth ($0.3 million in 2022 and $4.7 million in 2024). The claimed reduction of $43.8 million and 79% decrease is therefore also false. (2) Completeness: While the answer attempts to address the evolution and magnitude of change, it fails to report the correct trend—liabilities increased from $0.3M to $4.7M (a rise of $4.4M), not decreased. (3) Entity Accuracy: The LLM references 'AOCI' (Accumulated Other Comprehensive Income), which is a different financial statement category than 'accrued liabilities' where the actual liabilities were reported. This indicates confusion about the correct financial context and location of the data. (4) Reasoning: The multi-hop reasoning failed—the model did not correctly identify the liability amounts or their trajectory over time. Instead, it reported unrelated figures, possibly confusing derivative assets/liabilities in AOCI with those in accrued liabilities. (5) Semantic Equivalence: The answer conveys the opposite trend (decrease vs. actual increase) and uses incorrect magnitudes, making it factually misleading. The only relevant aspect is the focus on foreign currency - other derivatives, but even the metric and category are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 391,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued new senior notes with maturities spanning 2025 to 2054, including a notable 4.600% Senior Notes due 2045 referenced in its 2024 filings. This expansion of long-dated debt, alongside shorter-term notes like the 2024 floating-rate issue, reflects a strategic shift toward extending debt maturities and diversifying funding sources, aligning with a broader trend of managing liquidity and interest rate risk through staggered obligations. The 2024 indenture also formalized terms for multiple new tranches, underscoring a structured approach to capital structure optimization.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding the timeline and nature of the 4.600% Senior Notes due 2045. According to the ground truth, these notes were not newly issued in 2024 but were authorized in 2023 via Board Resolutions that allowed PepsiCo’s officers to set terms. The 2024 filing did not represent a new issuance but rather a continuation of the note within an expanded debt portfolio. The LLM incorrectly frames the 2024 reference as a new issuance, which misrepresents the evolution. Additionally, the LLM mentions 'a notable 4.600% Senior Notes due 2045 referenced in its 2024 filings' as if it were a highlight, while the ground truth shows it was simply still part of the structure. (2) Quantitatively, the percentage (4.600%) and maturity year (2045) are correct, but the LLM fabricates the existence of notes with maturities 'spanning 2025 to 2054' and specifically references a '2024 floating-rate issue' not mentioned in the ground truth. The ground truth only confirms the addition of 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026 — not a 2024 issue. These are factual errors in dates and instruments. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a strategy of diversification and maturity extension — but it does so based on incorrect premises. The conclusion about 'extending debt maturities' and 'staggered obligations' is plausible but not fully supported by the provided ground truth, which emphasizes continuity of the 2045 notes alongside modest expansion, not a broad strategic shift. (4) Contextual relevance is high because the answer addresses debt strategy and evolution, using appropriate financial terminology and logical interpretation. However, due to key factual inaccuracies in the instruments and timeline, the correctness score is reduced to 6 — partially correct but with significant errors in entity and event representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 523,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP has significantly expanded its natural gas reserves in the Asia Pacific/Middle East region, growing from 38 billion cubic feet (BCF) of productive gas (gross) at year-end 2021 to 296 BCF by end-2024, while also increasing undeveloped reserves from 38 BCF to 468 BCF. This growth, driven by strategic acquisitions (including Marathon Oil in 2024), extensions/discoveries in the Permian Basin and Montney, and upward revisions from price and technical improvements, reflects a clear strategic pivot toward expanding its gas footprint in high-growth international markets, particularly in the Asia Pacific/Middle East region where it now holds the majority of its equity affiliate reserves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that COP's natural gas position in the Asia Pacific/Middle East region decreased from 326 billion cubic feet (BCF) in 2022 to 296 BCF in 2024. However, the LLM claims a massive increase from 38 BCF in 2021 to 296 BCF in 2024, which misrepresents the trend and uses incorrect base figures. Additionally, the LLM introduces 'undeveloped reserves' increasing to 468 BCF, a figure not present in the original answer and unsupported by the provided truth. (2) The numbers are factually wrong: the starting point is misstated (38 vs 326 BCF), the year referenced is 2021 instead of 2022, and the narrative of 'significant expansion' contradicts the actual slight decline. The calculation of change is therefore invalid. (3) The reasoning is flawed: the LLM attributes growth to acquisitions like Marathon Oil and developments in the Permian Basin and Montney—regions not in the Asia Pacific/Middle East—indicating a failure in multi-hop synthesis and geographic alignment. It incorrectly infers strategic expansion when the data suggests a modest drawdown or reallocation. (4) While the answer addresses the question’s structure (evolution and strategic focus), it does so with fabricated data and erroneous logic, leading to a low correctness score. Contextual relevance is moderate because it attempts to answer the right question with appropriate terminology, but factual inaccuracies severely undermine the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 422,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy expanded significantly as part of the company's broader effort to diversify beyond advertising. In 2022, Google highlighted Google Play as a key source of revenue from \"platforms\" that generate income through app and in-app purchase sales, alongside hardware and YouTube non-advertising services like subscriptions. By 2023, this diversification was explicitly reinforced in the \"How We Make Money\" section, where Google Play was listed alongside hardware and YouTube Premium/TV as a distinct non-advertising revenue stream, indicating a strategic emphasis on growing its platform-based revenues. This evolution reflects Google's long-term investment in the Google Play ecosystem to monetize digital content and services beyond traditional ad revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in describing the evolution of Google Play's role. The ground truth states that in 2022, Google Play revenue was explicitly tied to 'sales of apps and in-app purchases and digital content sold in the Google Play store,' but by 2023, the description narrowed to focus only on 'apps and in-app purchases' and was grouped under the broader 'platforms' category. The LLM incorrectly frames this as an 'expansion' and 'diversification' of Google Play's role, when the actual shift was a narrowing of emphasis in disclosure language. Additionally, the LLM claims that in 2023, Google Play was 'listed alongside hardware and YouTube Premium/TV as a distinct non-advertising revenue stream,' but the ground truth indicates it was grouped under 'platforms,' not presented as a distinct line item. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is partially sound—LLM correctly identifies Google Play as part of non-advertising revenue in both years and attempts to compare disclosures across filings. However, it misinterprets the strategic direction: the actual evolution was a refinement/narrowing of revenue description, not an expansion. The LLM also introduces 'YouTube Premium/TV' and 'hardware' as comparative elements not directly tied to the Play-specific evolution described in the ground truth. (4) Correctness is scored at 5 due to significant qualitative inaccuracies in interpreting the strategic shift, despite correct contextual framing of Google Play within non-advertising revenue. Qualitative accuracy is low due to incorrect synthesis. Contextual relevance is high because the answer addresses the right topic and timeframe, even if the conclusion is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 503,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's projected utilization of the Cessna SkyCourier 408 increased from 11 aircraft in 2023 (as shown in the 2022 10-K) to 12 aircraft in 2024 (as shown in the 2024 10-K), reflecting a strategic expansion of its regional delivery fleet to support growing package volume. This upward trend indicates FedEx's increasing reliance on the SkyCourier model to enhance its last-mile delivery capabilities and meet evolving e-commerce demands.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the projected utilization decreased from 49 aircraft (2022 projection for 2023 onward) to 31 aircraft (2024 projection for 2025–2029), whereas the LLM claims an increase from 11 to 12 aircraft, which contradicts the data. These numbers (11 and 12) do not appear in the original answer and are factually wrong. (2) The quantitative accuracy is very low: the actual figures involve multi-year fleet projections (49 vs 31), not single-year counts (11 vs 12), and no mention of 11 or 12 aircraft exists in the ground truth. The direction of change is also wrong—LLM says 'increased', but the correct trend is a reduction in projected fleet size. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the shift in strategic relationship from 'Increases' to 'Depends_On', which is a key qualitative indicator of changing strategic reliance. Instead, it infers increasing reliance based on fabricated numbers, missing the nuanced conclusion of moderated but still significant reliance. (4) Contextual relevance is moderate because the answer addresses FedEx’s use of the SkyCourier and strategic intent, but the incorrect data and reasoning undermine the validity. The conclusion about e-commerce and last-mile delivery is plausible but unsupported by the actual data provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 395,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023 the company’s expected‑loss‑ratio methodology remained anchored in the same segmentation approach it has used for excess‑casualty lines: losses are split into automobile‑related claims and non‑automobile claims, with the latter further divided into latent exposures such as construction defects and mass‑tort claims.  For the most recent accident years the firm relies on expected‑loss‑ratio estimates (augmented by inflation and market‑trend adjustments) while older years are modeled with loss‑development techniques.  The 2023 tables continue to show this structure, reflecting the same attachment‑point segmentation and the separate treatment of large‑deductible and third‑party‑administered excess‑casualty business.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is significantly incorrect in its core claim about AIG's evolution of expected loss ratio methods between 2022 and 2023. While it correctly describes the 2022 approach—segmentation by automobile vs. non-automobile claims, latent exposures, and attachment point—it falsely states that this same structure continued in 2023. The ground truth indicates a strategic shift: in 2023, AIG moved its focus from U.S. Excess Casualty to U.S. Workers' Compensation, changing both the casualty line and segmentation criteria (now by state, industry, claim handling entity, and risk-sharing features like high deductibles and retrospective rating). The LLM incorrectly asserts continuity, missing this key evolution entirely. It also incorrectly implies that the 2023 methodology still centers on excess casualty lines with the same segmentation, when in fact the context and application have broadened due to increased large deductible business in Workers' Compensation. Quantitatively, there are no explicit numbers to verify, so no numeric inaccuracies are present (hence a higher score on quantitative accuracy). However, the qualitative reasoning is flawed—the model fails to recognize the multi-hop shift across casualty lines and segmentation logic, indicating a failure in synthesizing the evolution over time. Contextually, the answer is relevant to AIG’s use of expected loss ratios but misrepresents the temporal change, making it partially relevant but factually misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 408,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal 2022 and 2024, Nike evolved its classification of unallocated products within its consumer construct by shifting from a geographic segmentation (e.g., Greater China, North America, EMEA) toward a consumer‑focused segmentation of Men’s, Women’s, and Kids’ (with Jordan Brand treated separately). This re‑organization, introduced with the Consumer Direct Acceleration strategy in fiscal 2022 and fully reflected in fiscal 2023‑24 disclosures, re‑allocates previously “unallocated” or corporate‑level revenues and costs into these consumer categories, improving visibility into product‑level performance and aligning reporting with the new consumer construct. Consequently, wholesale‑equivalent revenues and margin drivers are now presented alongside Nike Direct sales, and the company no longer reports unallocated products as a distinct segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of the specific evolution of unallocated product classification, particularly regarding unisex products, which was the core of the question. While it correctly references Nike's Consumer Direct Acceleration strategy and a shift toward consumer-focused segmentation (Men’s, Women’s, Kids’, Jordan Brand) starting in fiscal 2022, it misrepresents the nature of the change. The original answer focuses on how unisex products were explicitly classified within Men's in fiscal 2022 and how by 2024, 'Others' included only unallocated products without explicit mention of unisex being rolled into Men's—suggesting a potential reclassification. The LLM answer incorrectly frames the change as a shift from geographic segments to consumer segments and claims that unallocated products are no longer reported as a distinct category, which is not supported by the ground truth. There are no numeric values to verify, so quantitative accuracy is high by default (minor date reference to '2023-24' is acceptable). However, the qualitative reasoning is flawed: it fails the multi-hop requirement by conflating segment reporting changes with product categorization, and it introduces geographic segmentation as a prior classification method for unallocated *products*, which the ground truth does not state. The answer is contextually relevant to Nike’s reporting changes but misses the specific focus on unisex and unallocated product categorization within the consumer construct, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 423,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued new 3.500% Senior Notes due 2025 in November 2023 (Form 8‑K filing on Nov 13, 2023) and again in July 2024 (Form 8‑K filing on July 17, 2024), indicating a continued strategy of refinancing and extending its debt maturities through targeted senior note issuances. This pattern reflects a deliberate debt‑management approach focused on maintaining a diversified maturity profile and capitalizing on favorable market conditions to manage overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims PepsiCo issued new 3.500% Senior Notes due 2025 in November 2023 and July 2024, citing Form 8-K filings, but the ground truth does not support any new issuance of the 2025 notes during this period. Instead, the 3.500% Senior Notes due 2025 were already outstanding and remained on the books, with no indication of reissuance. (2) The dates (Nov 13, 2023; July 17, 2024) and filing references are specific but factually inaccurate according to the ground truth, which makes no mention of these transactions. (3) The multi-hop reasoning is flawed: the original answer highlights that PepsiCo introduced longer-term debt (e.g., notes due 2034 and 2040) in 2024, indicating a strategy of maturity diversification, not repeated issuance of the same 2025 notes. The LLM misinterprets the evolution as refinancing activity via new issuances of the same instrument, whereas the truth reflects portfolio expansion with new maturities while retaining existing debt. (4) The conclusion about 'refinancing and extending maturities' is unsupported; there is no evidence the 2025 notes were refinanced. While the general theme of debt management strategy is relevant, the specific claims are factually wrong, leading to a low correctness score. Minor credit is given for addressing the question's context and attempting strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 391,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, ConocoPhillips' financial disclosures for the Lower 48 region show a significant shift in capital allocation and reserve valuation. In 2022, capital expenditures for the Lower 48 were $1,881 million, rising to $3,129 million in 2023 and $3,900 million in 2024, reflecting increased investment in the region. Concurrently, the discounted future net cash flows for the Lower 48 segment declined from $55,912 million (2023) to $38,693 million (2024), indicating revised downward expectations for future cash inflows. This reduction aligns with the \"Changes in estimated future development costs\" and \"Revisions of previous quantity estimates\" noted in the standardized measure disclosures, which were driven by lower commodity prices and updated reserve valuations. The 2024 disclosures also show a revised capital expenditure of $3,900 million (implied from the $3,203 million for 2024 in Note 23, with $1,297 million allocated to Lower 48 development), alongside a 31% drop in discounted future net cash flows for the region. These adjustments reflect a strategic pivot toward capital efficiency and reserve quality over volume growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that COP reported $3,129 million in capital expenditures for the Lower 48 in 2022, with no new capital expenditure figure provided for 2024. However, the LLM claims capex rose to $3,129 million in 2023 and $3,900 million in 2024—data not present in the ground truth and directly contradicting it. Additionally, the LLM introduces figures like $1,881 million in 2022 capex, which is incorrect (ground truth: $3,129M). It also cites discounted future net cash flows of $55,912M (2023) and $38,693M (2024), along with a 31% drop—none of which appear in the original answer. (2) Calculations and numbers are largely fabricated or misattributed. The claim of $3,900M capex in 2024 being 'implied from $3,203M in Note 23' and $1,297M allocated to Lower 48 is unsupported by the provided ground truth, which explicitly states no new capex figure was disclosed for 2024. There is no mention of future cash flow values or commodity price impacts in the original answer. (3) Multi-hop reasoning is flawed. The original answer describes a shift from active investment (2022) to revised financial projections (2024) due to updated production and cost expectations. The LLM incorrectly infers increasing capex over three years and declining cash flows as evidence of a 'strategic pivot,' which contradicts the ground truth narrative of reduced disclosure focus on capex and increased emphasis on revisions to future inflows and costs. (4) Despite incorrect facts, the LLM attempts to address the question's intent—evolution of financial disclosures in the Lower 48—so contextual relevance is moderate. However, due to pervasive quantitative errors and incorrect synthesis, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 491,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast’s financial commitments to Atairos evolved through an extension of its capital term to 16.5 years, a reduction of its aggregate funding commitment to $4.5 billion (with a $1.4 billion unfunded balance as of Dec 31 2024), and annual $40 million management‑fee obligations, while maintaining a residual‑return share of roughly 86 % and loss‑absorption of about 99 %. Governance remains overseen by former CFO‑led management companies that hold all voting rights; Comcast has only consent rights and no direct control, so it does not consolidate Atairos and accounts for the investment using the equity method. The 2024 10‑K notes that distributions retained by Atairos are treated as advances and that there are no additional liquidity or guarantee arrangements between the parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements include: reduction in capital commitment to $4.5 billion (from $5 billion in 2023), annual management fee of $40 million, 86% residual return share, 99% loss absorption, equity method accounting, and governance control retained by former CFO-led management companies with all voting rights. The statement that Comcast has only consent rights and does not consolidate Atairos is consistent with the lack of control. (2) Quantitative accuracy: All figures match or are reasonably inferred. The $1.4 billion unfunded balance as of Dec 31, 2024, implies prior funding of $3.1 billion ($4.5B - $1.4B), which is plausible though not explicitly confirmed in the ground truth; however, this does not contradict it. The 16.5-year capital term extension is mentioned in the LLM answer but not in the original answer—this is an additional detail not present in the ground truth, but not incorrect if supported by filings. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes financial commitments (capital reductions, fee obligations), control structures (voting rights vs. consent rights), and accounting treatment (equity method due to lack of control). (4) Minor deduction in correctness and quantitative accuracy due to the introduction of the 16.5-year term and unfunded balance detail, which, while potentially accurate, are not in the ground truth and could represent over-specificity beyond the provided knowledge. However, no direct contradiction occurs, and core facts are preserved. Contextual relevance is perfect—directly addresses evolution in financial and governance terms between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 463,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "Based on the 2022 and 2023 10-K filings, FedEx's projected utilization of the Cessna SkyCourier 408 increased significantly—from 1 aircraft committed for delivery in 2023 (as noted in the 2022 filing's purchase commitment table) to 17 aircraft scheduled for delivery in 2025 (as detailed in the 2023 filing's updated purchase commitments). This indicates a strategic shift toward greater reliance on the SkyCourier for regional and last-mile delivery, positioning it as a key component of the fleet alongside larger aircraft like the B777F and ATR 72-600F, while replacing older, less efficient models.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that FedEx reduced its projected utilization of the Cessna SkyCourier 408 from 49 aircraft (2022 filing) to 31 aircraft (2023 filing), indicating a strategic reduction. In contrast, the LLM claims utilization 'increased significantly' from 1 to 17 aircraft, which contradicts the ground truth. (2) Quantitative accuracy is severely lacking: the numbers cited (1 and 17 aircraft) do not match the ground truth (49 and 31), and the years referenced (2023 and 2025) are not aligned with the original projections through 2027 and 2029. There is no indication in the ground truth that only 1 aircraft was projected in 2022 or 17 in 2025. (3) The multi-hop reasoning is flawed—the LLM misinterprets purchase commitments or delivery schedules as total fleet projections, failing to synthesize the actual long-term strategic outlook across the two filings. It also incorrectly infers increased strategic importance, when the truth indicates a reduced role compared to B767F and B777F. (4) Contextual relevance is low because the answer addresses the right topic (SkyCourier utilization over time) but with entirely incorrect data and conclusions. The mention of B777F and ATR 72-600F is plausible contextually, but the overall synthesis misrepresents FedEx's strategy. Scores reflect near-total factual inaccuracy despite addressing the general subject area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 403,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike’s financial disclosures show a shift toward greater transparency in revenue reporting, particularly through detailed segment breakdowns in the 2024 Form 10-K (pages 86–90), which disaggregates revenues by geography, product line, and distribution channel (e.g., wholesale vs. direct-to-consumer). While the 2022 filing (page 86) also provided segment revenue data, the 2024 version includes more granular metrics, such as specific figures for North America, EMEA, Greater China, and APLA, alongside clearer distinctions between Nike Brand and Converse revenues. Technologically, Nike continues to emphasize innovation in its Air Max line, with references to Air Sole manufacturing advancements (page 8) and R&D investments in technologies like Air Max, Zoom, and Flyknit (page 88), though revenue transparency around specific product lines like Air Max is not explicitly detailed. The company maintains a strong focus on technological differentiation as a competitive strategy, but revenue data does not isolate Air Max performance—only broader category trends (e.g., footwear, apparel) are reported. Overall, Nike’s approach to revenue transparency has evolved to include more structured, global segment reporting, while technological innovation remains central to its brand strategy, though not directly tied to revenue disclosures for specific products like Air Max.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Nike did not disclose standalone revenue figures for the Air Max product line in either 2022 or 2024, and acknowledges the continued emphasis on technological innovation (e.g., Air Sole, R&D investments). It accurately references the increased granularity in revenue disaggregation in the 2024 10-K compared to 2022, including geographic and distribution channel breakdowns. However, the LLM mischaracterizes the evolution of revenue transparency as a general improvement related to Air Max, when in fact the ground truth states that Air Max specifically was only listed as part of a general technology group in 2022 and remained without dedicated financial metrics in 2024. The shift highlighted in the original answer—from passive inclusion to strategic emphasis on innovation—is not clearly captured; instead, the LLM implies broader transparency gains that do not apply directly to Air Max. While the technological emphasis is correctly noted, the core multi-hop insight—that Air Max moved from being a footnote in revenue tables to a highlighted innovation example despite unchanged financial transparency—is missed. Quantitative accuracy is high because no incorrect numbers are cited (and none are available), and contextual relevance is strong as the response stays focused on the question. Qualitative accuracy is reduced due to flawed reasoning in synthesizing the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 394,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy shifted from 2023 to 2024 with a clear thematic park focus: in 2023, capital spending specifically included development of Epic Universe in Orlando ($8.2 billion total capex, with theme parks cited as a key driver), while 2024 saw increased investment in theme park attractions including Epic Universe construction, alongside continued network infrastructure spending. The company maintained its overall capex level ($8.286 billion in 2024 vs. $8.2 billion in 2023) but redirected emphasis toward theme park development, particularly Universal's Epic Universe, as a strategic priority for future growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.2 billion capital expenditure in 2023 related to Epic Universe development and notes continued investment in 2024, aligning with the ground truth. However, it incorrectly states that the 2024 capex was $8.286 billion, which is not mentioned in the original answer or supported by the knowledge graph; the original does not provide a total capex figure for 2024, only that investment emphasis continued. This is a significant quantitative inaccuracy. (2) The $8.2 billion figure for 2023 is accurate and correctly attributed to Connectivity & Platforms, which included infrastructure for Epic Universe. But the LLM fabricates a precise $8.286 billion figure for 2024 without source support, undermining quantitative accuracy. Additionally, while the original answer clarifies that specific figures for Epic Universe alone were not disclosed in 2024, the LLM implies a direct continuation of focused spending without acknowledging this uncertainty. (3) The reasoning is mostly sound: the LLM correctly infers a strategic shift from infrastructure in 2023 to broader theme park development in 2024, capturing the evolution in priorities. It synthesizes the thematic focus on Epic Universe across years appropriately, though it overstates precision in 2024. (4) Contextual relevance is perfect—the answer directly addresses the evolution of capex strategy, investment amounts, and development priorities. Due to the fabricated 2024 number, the correctness score is reduced to 7, as the core narrative is accurate but marred by a specific false quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 443,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Based on the provided 10-K filings, FedEx's utilization of the ATR 72‑600F aircraft declined between 2022 and 2023. In the 2022 fleet table (page 40), the company reported 6 ATR‑72‑600F aircraft on order with expected deliveries through 2026, and a total of 19 ATR‑72 aircraft (including the 6 ‑600Fs). By the 2023 projection (page 117), only 3 ATR‑72‑600F aircraft remained on the purchase commitment schedule for 2026, and the overall ATR‑72 fleet commitment dropped to 10 aircraft total, indicating a reduced reliance on the ATR 72‑600F model. Consequently, the airline’s planned utilization of the ATR 72‑600F decreased markedly from six aircraft slated for delivery in 2022‑2023 to just three slated for 2026, reflecting a strategic shift away from that type.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in numbers and projections compared to the ground truth. (1) Quantitative Accuracy: The ground truth states that in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. By 2023, the projections changed to 7 for 2025 and 3 for 2026. The LLM answer incorrectly focuses on 'aircraft on order' and 'purchase commitments' rather than actual fleet utilization projections. It claims 6 ATR-72-600F were on order in 2022 and 3 in 2023 for 2026 delivery, which misrepresents the data — the original answer reflects planned operations (not orders), and the numbers do not align (e.g., no mention of the 11 aircraft projected for 2023 operation). (2) Completeness: The LLM fails to mention the key projection for 2023 (11 aircraft), which is central to the evolution of utilization. It also omits the shift from 6 to 7 aircraft projected for 2025, instead implying a simple decline. (3) Entity Accuracy: While the company (FedEx) and aircraft model (ATR 72-600F) are correct, the years and associated figures are misrepresented. (4) Reasoning: The multi-hop reasoning is flawed — the LLM conflates purchase commitments with operational fleet projections, which are distinct concepts. The conclusion about reduced reliance has some basis, but the trajectory (e.g., increase to 7 in 2025) is missed. (5) Semantic Equivalence: The overall direction (reduced long-term use) is partially aligned, but the specific evolution is incorrect. The answer introduces details (e.g., total ATR-72 fleet of 19) not in the ground truth, suggesting hallucination or misinterpretation. Thus, while contextually relevant and showing an attempt at synthesis, the answer is factually unsound in key quantitative aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 484,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Nike’s approach to estimating product return reserves evolved from a $269 million estimated cost of inventory for expected returns as of May 31 2021 to $194 million as of May 31 2022, reflecting a reduction in the reserve balance. This decline indicates that the company is adjusting its revenue‑recognition methodology to more conservatively estimate returns, likely due to changing market conditions or updated historical return patterns. Consequently, the lower reserve suggests a shift toward recognizing revenue with less anticipated return risk, which can affect the timing and amount of revenue recognized in each reporting period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in fiscal 2022, Nike disclosed a $269 million estimated cost of inventory for expected returns, but the LLM incorrectly claims a $194 million reserve as of May 31, 2022, and implies a reduction from $269 million to $194 million. No such $194 million figure appears in the ground truth, and no reserve amount was disclosed for fiscal 2024. Additionally, the date 'May 31, 2021' is misaligned with fiscal 2022 reporting, which typically ends May 31, 2022. (2) The quantitative inaccuracies are severe: the LLM fabricates a number not present in the original answer and presents a false trend (decline in reserves), which undermines the entire response. There is no calculation or comparison in the ground truth to support this. (3) The multi-hop reasoning is flawed. The original answer emphasizes a methodological shift—from a disclosed dollar reserve in 2022 to a more formalized, probabilistic 'most likely amount' approach by 2024—indicating alignment with variable consideration under revenue recognition standards (ASC 606). The LLM completely misses this conceptual evolution and instead invents a narrative about conservative estimation due to market conditions, which is unsupported. (4) While the LLM attempts to address revenue recognition implications, it does so based on incorrect data and reasoning. The contextual relevance is moderate because it discusses reserves and revenue recognition, but the core facts and synthesis are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 436,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The planned fleet composition for the Cessna SkyCourier 408 was reduced from 17 aircraft scheduled for delivery in 2025 (as shown on page 117 of the 2024 filing) to 12 aircraft for 2025 and no deliveries thereafter in the 2024 filing, indicating that FedEx is scaling back its reliance on the SkyCourier model and shifting focus to other aircraft types such as the B767F and B777F for its future capacity needs. This reduction suggests a strategic pivot away from depending heavily on the Cessna 408 for long‑term growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of fleet changes. The ground truth states that in 2022, FedEx (FDX) planned for 12 Cessna SkyCourier 408s by 2025 and to maintain that number through 2026. By 2023, the plan increased to 17 for 2025 but decreased to 14 for 2026. The LLM incorrectly claims the number was reduced from 17 to 12 between 2024 filings, which contradicts the timeline and data. It also introduces a '2024 filing' not referenced in the question or ground truth, and falsely states 'no deliveries thereafter', which is unsupported. (2) Quantitative inaccuracies include wrong years (refers to 2024 filing instead of 2022 vs 2023 plans), incorrect fleet numbers (12 in 2025 as a reduction from 17, when it was an increase), and missing the 2026 figure of 14. The LLM omits the actual increase in planned 2025 fleet and the partial drawdown in 2026. (3) The multi-hop reasoning is flawed: the question asks for changes between 2022 and 2023 plans for 2025 and beyond, but the LLM misattributes the data to 2024 filings and draws the opposite conclusion (scaling back vs initial increase). It fails to capture the short-term increased reliance followed by a moderate decline, instead asserting a straightforward reduction. (4) The contextual relevance is moderate because it addresses fleet composition and strategic reliance, but the factual foundation is incorrect, leading to a misleading interpretation. The mention of B767F and B777F is extraneous and unsupported by the ground truth. Overall, major factual and directional errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 444,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard’s real‑time account‑based payments infrastructure continued to expand its operational footprint in 2024, extending coverage to 13 markets and supporting a broader set of use cases—including new B2B solutions such as Virtual Card Numbers, InControl™ controls, and the Mastercard Send™ platform that now reaches over 95 % of the world’s banked population.  The company also deepened its security capabilities, embedding multi‑layered cyber‑resilience, AI‑driven fraud scoring, and tokenization into the real‑time clearing and settlement layer, while maintaining a robust governance framework to protect the network and its participants.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Mastercard's expansion in real-time payments infrastructure and enhanced security capabilities from 2023 to 2024, aligning with the core evolution described in the ground truth. However, there is a critical error in the quantitative claim that Mastercard extended coverage to '13 markets' in 2024 — the ground truth states that Mastercard was already operating or implementing in 13 markets in 2023, implying stagnation or misattribution rather than expansion. The LLM incorrectly presents 13 markets as a 2024 milestone, when it was already the 2023 baseline. Additionally, the LLM introduces specific product names (Virtual Card Numbers, InControl™, Mastercard Send™) and the claim that Mastercard Send™ reaches 'over 95% of the world’s banked population' — details not present in the original answer and unsupported by the provided ground truth. These additions, while plausible, are not factually verifiable from the source and represent over-specificity. (2) The percentage '95%' is a significant unsupported quantitative addition. The original answer does not mention any percentage of banked population coverage, making this a fabrication from the model. The year references (2023 vs 2024) are generally correct in framing the evolution, but the misattribution of the 13-market figure reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model correctly infers that operational scale and security are key dimensions and synthesizes developments across time. However, it fails to accurately track the progression (13 markets in 2023, not 2024) and adds unverified details, weakening the logical fidelity. (4) Despite these issues, the qualitative thrust — expansion of use cases, enhanced security via AI, tokenization, and layered protections — is consistent with the original. The answer remains contextually relevant and captures the strategic direction, warranting a score of 7 for correctness, with deductions for unsupported numbers and misattributed metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 552,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike's use of foreign exchange forwards and options as cash flow hedges evolved from a $1.336 billion notional amount in 2022 to $16.2 billion in 2024, with the portion of deferred net gains in accumulated other comprehensive income expected to be reclassified to earnings falling from $607 million (2022) to $231 million (2024). Effective hedge results are recorded in revenues, cost of sales, demand‑creation expense or other income/expense, and gains/losses are re‑classified from accumulated OCI into those line items when the underlying hedged transactions occur. Discontinuation of hedge accounting occurs when forecasted transactions are no longer probable, at which point the derivative is treated as undesignated and any resulting gains/losses are recognized immediately in other (income) expense, net.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The notional amounts of $1.336 billion in 2022 and $16.2 billion in 2024 are not present in the ground truth and contradict the original answer, which does not mention notional values at all. Similarly, the deferred net gains in accumulated other comprehensive income ($607 million in 2022 and $231 million in 2024) are fabricated and not supported by the original answer. The only qualitative alignment is the mention of cash flow hedges and reclassification into income statement line items, which is consistent with hedging practices but not specific to the evolution described in the ground truth. (2) The original answer reports a net gain of $8 million after tax in 2022 and liability balances of $110 million and $5 million in 2024—none of which are mentioned in the LLM response. The LLM fails to report any of the actual financial impacts or liability figures, instead introducing unrelated metrics. (3) While the LLM demonstrates understanding of general hedging mechanics (e.g., reclassification from OCI, discontinuation of hedge accounting), it fails to synthesize the actual evolution in Nike’s strategy as reflected in the financial liabilities and reporting changes between 2022 and 2024. The multi-hop reasoning is based on incorrect data, rendering the conclusion invalid. (4) The contextual relevance is moderate because the answer discusses hedging strategy and financial impact, but the complete absence of correct numbers and the introduction of false quantitative data severely undermine correctness. The qualitative accuracy is partially preserved due to correct terminology and conceptual framework, but factual grounding is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 470,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, Puffs remained within the Baby, Feminine & Family Care segment, but its classification shifted from being grouped under \"Baby Care\" to being included under \"Feminine Care\" in the segment's product category breakdown. In 2023, Puffs was explicitly listed under \"Feminine Care (Adult Incontinence, Feminine Care)\" alongside brands like Always and Tampax, reflecting a reclassification within the segment's structure. This change was part of the segment's product category organization, though the segment itself (Baby, Feminine & Family Care) maintained its 24% share of net sales and 25% share of net earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content. (1) It claims Puffs was reclassified from 'Baby Care' to 'Feminine Care' in 2023, which contradicts the ground truth: Puffs was always in the Family Care sub-category, not Baby or Feminine Care. The mention of Puffs being grouped with Always and Tampax under 'Feminine Care (Adult Incontinence, Feminine Care)' is factually wrong. (2) The quantitative elements—segment share of 24% net sales and 25% net earnings—are not part of the original answer and cannot be verified from the provided ground truth; thus, their inclusion introduces unverified data, reducing quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the actual evolution (a simplification in reporting detail within Family Care) and instead fabricates a reclassification across sub-categories. (4) While the answer is contextually relevant—addressing product category evolution within the correct segment—it misrepresents the nature of the change. The core error in entity classification (placing Puffs in Feminine Care) severely undermines the answer's validity. Minor credit is given for correctly noting the segment name and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 340,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment, which accounted for 25% of net sales and 23% of net earnings in 2023 (down slightly from 25% and 23% in 2022). The segment's product categories, including Feminine Care (with Tampax as a key brand), were part of P&G's strategic focus on daily-use products with leadership market positions. Tampax continued to be positioned as a core brand within the Feminine Care sub-category, which held over 20% global market share, consistent with P&G's broader strategy of maintaining leadership in high-growth categories. No structural changes to its categorization or product line associations were noted in the provided disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct contextual information—Tampax remained within the 'Baby, Feminine & Family Care' segment and was a core brand in Feminine Care. However, it directly contradicts the ground truth by stating that no structural changes occurred, when in fact the categorization of Tampax shifted from 'Feminine Care' (broad category including Family Care) in 2022 to a more specific 'Menstrual Care' sub-focus in 2023. This evolution in positioning is the central point of the question and was missed entirely. (2) Quantitatively, the LLM provides percentages for segment net sales and earnings (25%, 23%) which are plausible and consistent across years, but these figures are not present in the ground truth and cannot be verified from the provided answer. The 20% global market share for Feminine Care is mentioned but not confirmed or denied in the ground truth; however, since it's not part of the original answer, its inclusion without confirmation introduces unverified data. (3) The multi-hop reasoning failed: the question required identifying a re-categorization over time (2022 vs 2023), but the model concluded no changes occurred, indicating a failure to synthesize or detect the shift from 'Feminine Care' to 'Menstrual Care' as a strategic refinement. This is a critical error in qualitative reasoning. (4) Scores reflect that while the answer is not irrelevant and contains some accurate context about Tampax’s segment and strategic importance, it misses the key factual evolution—the repositioning—which renders the overall correctness low despite acceptable formatting and partial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 449,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle’s strategy shifted toward cloud‑centric growth, with cloud services and license support revenues rising from 25% of total revenue in fiscal 2022 to 37% in fiscal 2024, reflecting a deliberate emphasis on cloud and license offerings. Consequently, the company expects continued revenue expansion in this segment and plans to allocate additional research and development investment to sustain and enhance its cloud and license products and services.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) It discusses Oracle's cloud and license strategy, but the question specifically asks about Oracle Engineered Systems, a hardware product line. The LLM conflates cloud services with hardware, which is a fundamental error. (2) The quantitative claims are inaccurate: the answer states cloud services and license support revenues rose from 25% in fiscal 2022 to 37% in fiscal 2024, but the ground truth does not mention these figures or the year 2024. Moreover, the ground truth does not provide a revenue percentage for hardware in 2022, only in 2023 (6%), which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the question requires comparing Oracle's strategy, revenue contribution, and R&D expectations for Engineered Systems across fiscal 2022 and 2023. The LLM does not mention Engineered Systems at all, fails to note the shift in R&D investment for hardware in 2023, and ignores the new disclosure of hardware as 6% of revenue. (4) The answer is contextually misaligned—while Oracle may be shifting to cloud, the question focuses on the evolution of the hardware segment's strategy and positioning, which the LLM does not address. As such, the correctness, quantitative, and qualitative scores are very low, with only minimal relevance due to mentioning Oracle's R&D investment in general.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 384,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's non-U.S. pension plan investments in private funds increased from $36 million (Level 3) to $74 million (Level 3), reflecting purchases of $39 million and a $3 million gain, while the overall allocation across the fair‑value hierarchy shifted toward higher Level 3 classification, especially within private funds and insurance buy‑in contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It claims that non-U.S. pension plan investments in private funds increased from $36 million (Level 3) in 2022 to $74 million (Level 3) in 2023. However, the ground truth states that in 2022, $1,105 million was invested in private funds for U.S. pension plans (Level 3), not non-U.S., and there is no mention of $36 million in non-U.S. plans in 2022. In 2023, the correct figure is $115 million in non-U.S. private fund investments, split between Level 2 ($41 million) and Level 3 ($74 million). The LLM incorrectly attributes the $74 million as entirely Level 3 and ignores the Level 2 allocation. (2) Quantitative accuracy is poor: the LLM invents a $36 million figure for 2022 non-U.S. private funds with no basis in the original answer, misrepresents the $74 million as total instead of part of a $115 million total, and introduces unsupported figures like $39 million in purchases and $3 million gain not present in the ground truth. (3) Multi-hop reasoning is flawed: the question asks about evolution in non-U.S. pension plans between 2022 and 2023, but the LLM incorrectly uses U.S. data for 2022 and misattributes it to non-U.S. plans. It fails to note the shift from U.S. to non-U.S. focus and the reclassification across fair value levels (Level 2 vs Level 3). (4) Contextual relevance is moderate because the answer discusses private fund investments and fair value hierarchy levels, which are relevant, but the incorrect entities and numbers undermine usefulness. The conclusion about increased Level 3 classification contradicts the ground truth, which shows a diversification into Level 2. Thus, the answer is mostly incorrect with major factual and reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 475,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "Between 2023 and 2024 the Company retired the $1 billion of 2014 USD Notes that had been outstanding (they matured in April 2024) and replaced them with new 2024 USD Notes totaling $4 billion of issuances (including $1 billion due May 2034, $750 million due Jan 2028 and $1.15 billion due Jan 2032, $1.1 billion due Jan 2035).  In July 2024 the INR‑denominated term loan (originally due July 2023) was rolled into a larger INR 28.1 billion facility that matures in July 2024 and was fully repaid at that time.  These actions reduced short‑term debt and reshaped the Company’s debt profile, leaving $18.2 billion of total debt outstanding at year‑end 2024 with the next principal maturity scheduled for March 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that the 2014 USD Notes matured in April 2024 and had a $1 billion principal amount, it incorrectly states that the company 'replaced them with new 2024 USD Notes totaling $4 billion' — this is not supported by the ground truth and introduces fabricated information about new issuances and maturities (e.g., $1.15 billion due Jan 2032, etc.), which are not mentioned in the original answer. Additionally, the LLM introduces unrelated information about an INR-denominated term loan and total debt of $18.2 billion at year-end 2024, which are not part of the ground truth and appear to be hallucinated. (2) Quantitative accuracy is partially correct for the $1 billion principal and April 2024 maturity, but all other numbers ($4 billion total issuance, breakdowns by year, INR 28.1 billion, $18.2 billion total debt) are incorrect and unsupported. The calculation of new note totals does not match any verified data. (3) The multi-hop reasoning fails because the model invents a refinancing narrative not present in the original data. The ground truth only confirms repayment in full, with no mention of replacement debt. The LLM incorrectly infers a debt swap or refinancing, which is a critical error in financial context. (4) Contextual relevance is moderate because the answer addresses the 2014 USD Notes and their maturity, but it diverges significantly by introducing irrelevant and false details about new debt instruments and other loans, reducing its reliability. The core fact of repayment is correct, but the added narrative undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 454,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Based on the provided SEC filings, Lowe's updated its executive indemnification agreements between 2022 and 2024, with the most recent revisions appearing in 2024 filings (e.g., 10-K filed March 25, 2024, exhibits 10.23 and 10.24). These updates reflect a formalized, standardized approach to officer indemnification, aligning with evolving corporate governance practices and legal expectations. The consistent inclusion of these agreements in annual reports (10-K) and quarterly filings (10-Q) since 2018 indicates a stable, ongoing commitment to executive risk management and governance continuity, ensuring clarity in fiduciary protections for senior leadership amid regulatory and operational changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Lowe's 'updated' its Officer Indemnification Agreements between 2022 and 2024. The ground truth confirms that the same form (Exhibit 10.43, originally filed April 2, 2019) was refiled without amendment in both 2022 and 2024, meaning no updates or revisions occurred. The LLM incorrectly references 'Exhibits 10.23 and 10.24' in the 2024 10-K, which contradicts the ground truth that the agreement was filed as Exhibit 10.43 consistently. (2) Quantitative inaccuracies include the false claim of 'revisions appearing in 2024 filings' and the incorrect exhibit numbers. The date of the 2024 10-K (March 25, 2024) may be accurate, but the substance tied to it is not. The original agreement date (April 2, 2019) is omitted in the LLM answer, weakening historical context. (3) The multi-hop reasoning fails because the model incorrectly infers evolution or updates in the agreements when the data shows continuity. It misinterprets consistent filing as evidence of 'updates' or 'revisions', when in fact the same unamended document was reused. This undermines the core conclusion about evolving governance practices. (4) While the LLM correctly identifies the relevance of indemnification agreements to executive risk management and governance continuity, its factual foundation is flawed. The conclusion about 'formalized, standardized approach' and 'evolving corporate governance practices' is unsupported by the evidence of no changes. Thus, the reasoning is internally logical but based on false premises, leading to a mostly incorrect answer. Contextual relevance is moderate because the topic and general intent align with the question, but factual accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 476,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the 2022 and 2023 10-K filings, Always Discreet’s market share and category positioning remained stable, with no significant changes reported. The company continued to hold a leadership position in the adult incontinence category, particularly in key markets where it maintained over 10% market share, consistent with its historical standing as a global market leader in feminine care and adult incontinence products. The filings do not indicate any notable shifts in market share or category strategy between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Always Discreet maintained over 10% market share in 2023. The ground truth states that while the 2022 filing explicitly reported over 10% market share, the 2023 filing did not provide any specific market share figure. The LLM incorrectly assumes continuity of the quantitative metric, which is not supported by the data. (2) Quantitative accuracy is low because the key percentage (over 10%) is misapplied to 2023 when it was only stated for 2022. No calculation errors per se, but the misuse of a critical numeric claim undermines factual correctness. (3) The multi-hop reasoning is flawed: the model fails to recognize the absence of a disclosed market share in 2023 as a meaningful change in disclosure strategy, instead assuming stability. This misses the core shift from quantified to general positioning language, which is the actual change identified in the ground truth. (4) Contextual relevance is moderate because the answer addresses the right brand, category, and time frame, and correctly identifies Always Discreet as a major player, but it draws an incorrect conclusion about stability due to failure in synthesizing the change in disclosure. The answer downplays a significant shift in reporting, which affects the interpretation of market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 373,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023 Oracle’s Engineered Systems shifted from being a distinct hardware profit center to a strategic enabler of its cloud transformation, with the hardware business now explicitly positioned as a support layer for Oracle Cloud (OCI) and engineered systems are marketed as integrated platforms (e.g., Exadata Cloud Service, Cloud@Customer) that drive cloud adoption and generate recurring support revenue. This evolution reflects a deliberate move to embed hardware within Oracle’s broader cloud narrative—emphasizing recurring support contracts, cloud migration pathways, and integrated hardware‑software offerings—rather than treating hardware as a standalone, lower‑margin segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Oracle's strategic positioning of Engineered Systems from 2022 to 2023. It correctly identifies the shift from standalone hardware products to integrated platforms supporting Oracle Cloud (OCI), such as Exadata Cloud Service and Cloud@Customer, and emphasizes recurring revenue and cloud transformation—key themes in the ground truth. The answer accurately reflects the strategic repositioning of hardware as a support layer rather than a standalone profit center, aligning with Oracle's cloud narrative. However, it omits specific quantitative details present in the original answer: the fact that hardware revenues (including Engineered Systems) represented 6% of total revenues in both fiscal 2023 and 2024, and the mention of ongoing R&D investments. These omissions are significant but do not undermine the overall correctness of the strategic interpretation. There are no factual inaccuracies or entity errors (Oracle, Engineered Systems, OCI, fiscal years 2022–2023 are correctly referenced), and the reasoning is sound, demonstrating proper multi-hop synthesis between hardware strategy and cloud transformation. The answer is semantically aligned with the ground truth, though slightly less complete. Quantitative accuracy is perfect as no incorrect numbers are introduced (the absence of numbers is not a quantitative error per se). Contextual relevance is excellent—the response directly addresses the question’s focus on strategic evolution, role in hardware, and cloud implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 427,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The disclosure regarding the 2020 Stock Plan’s relationship with the 2011 Stock Plan was updated in the 2023 10‑K to clarify that the 2020 Stock Plan succeeded the 2011 Stock Plan and that shares previously available under the 2011 plan were now available for grant under the 2020 plan. Earlier filings (2022) presented the two plans separately without emphasizing this succession, but the 2023 filing explicitly states that the 2020 Stock Plan is the successor and that its shares include those previously reserved under the 2011 plan. This evolution reflects a consolidation of the equity‑incentive framework into a single, unified plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and content. (1) The ground truth states that the 2022 10-K included a disclosure about 5,530,106 shares being carried forward from the 2011 Stock Plan to the 2020 Stock Plan, but this detail was *omitted* in the 2023 10-K. In contrast, the LLM claims the *opposite*—that the 2023 filing newly 'clarified' or 'explicitly stated' the succession and share carry-forward, which is factually wrong. (2) There is a complete failure in quantitative accuracy: the specific number 5,530,106 is not mentioned in the LLM response, and the direction of change (removal vs. addition of detail) is reversed. (3) The multi-hop reasoning is flawed—the question asks how the disclosure *evolved* between two years, requiring accurate comparison across filings. The LLM incorrectly infers increased clarity and consolidation in 2023, when in fact the linkage was de-emphasized or removed. (4) While the answer is relevant to the topic of stock plan disclosures and attempts to address evolution, the factual inversion of the core event severely undermines correctness. The answer fabricates a clarification that did not occur, leading to a very low correctness and accuracy scores despite appropriate context and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 352,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s allocation to private funds in its pension portfolio remained relatively stable, with direct private investments held at $1,284 million in 2022 and $1,293 million in 2023, and private‑fund assets measured at NAV slightly increasing from $1,258 million to $1,265 million over the same period. This modest growth suggests the company is maintaining a steady exposure to private‑equity and real‑estate investments, reflecting a continued focus on long‑term, higher‑return assets while keeping overall capital deployment priorities aligned with its target asset‑allocation ranges (e.g., 10‑20 % “other” investments).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Honeywell's investment in private funds was $1,244 million in 2022 and $1,265 million in 2023. However, the LLM reports $1,284 million and $1,293 million for direct private investments, and $1,258 million to $1,265 million for private-fund assets, neither of which matches the ground truth figures. The only correct number is the 2023 private-fund amount ($1,265 million), which aligns with the original answer. The 2022 figure of $1,258 million is close but still incorrect. The increase from $1,244M to $1,265M is approximately 1.7%, but the LLM does not calculate or mention this percentage, instead implying a 'slight increase' without quantification. (2) The calculations are partially correct only in direction (increase), but not in magnitude or base values. The LLM introduces two categories—'direct private investments' and 'private-fund assets measured at NAV'—that were not in the original answer and for which no supporting data was provided in the context, suggesting fabrication or misattribution. (3) The multi-hop reasoning is partially sound: the model correctly infers that a small increase indicates strategic stability and aligns it with long-term return objectives and asset allocation ranges. This interpretation is consistent with the original answer’s conclusion about maintaining exposure for diversification and higher returns. However, the reasoning is based on inaccurate inputs, weakening the validity. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of allocation and implications for capital deployment) and provides a reasonable interpretation. However, due to the incorrect financial figures and invented categories, the correctness score is limited to 5, reflecting partial accuracy with significant factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 514,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B‑2 common stock transitioned from having no outstanding shares to 120 million shares issued and outstanding (as shown on page 85 of the 2024 filing). This issuance occurred as part of the class B‑1 common‑stock exchange offer completed on May 8 2024, where each exchanged B‑1 share was converted into one share of newly created Class B‑2 stock. The conversion rates for B‑2 shares are rounded to the tenth decimal (e.g., 1.5430) and are subject to adjustments tied to the U.S. litigation escrow account and the resolution of covered litigation, which can affect the as‑converted share count and conversion rates for all B‑stock classes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it falsely claims that 120 million shares of Class B-2 were issued and outstanding in the 2024 filing, which contradicts the ground truth stating that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer and that the 2024 filing only referenced the lack of outstanding shares without updates. There is no mention of 120 million shares or issuance on page 85 in the ground truth. The date May 8, 2024, for the exchange offer is not supported by the original answer. (2) The claim that Class B-2 shares were 'newly created' and issued as part of the B-1 exchange is unsupported; the original answer states no such issuance occurred by 2024 and implies Class B-2 remained inactive. (3) While the original answer notes conversion rate adjustments tied to the U.S. litigation escrow account in 2023, the LLM incorrectly extends this mechanism into 2024 with specific rounding details (tenth decimal) not present in the ground truth, creating false precision. (4) The reasoning is flawed: instead of identifying a reduction in disclosures and potential discontinuation of Class B-2's active role, the LLM invents a new issuance event and ongoing role. The multi-hop synthesis fails completely—no evidence supports the creation or issuance of Class B-2 shares in 2024. (5) Contextually, the answer addresses the right topic (Class B-2 stock evolution) but fabricates key facts, leading to a narrative opposite to the ground truth, which indicates diminished relevance of Class B-2. Thus, the answer is mostly incorrect with major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 457,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "Between 2022 and 2024, the Target Circle program’s deferred revenue liability declined sharply from $117 million (as of February 3, 2024) to $19 million (as of February 1, 2025), reflecting a major reduction in the program’s financial obligations. This decrease signals that Target has scaled back or restructured its Circle rewards and related revenue‑recognition practices, indicating an evolution toward a leaner, possibly more performance‑based loyalty model.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the timeline and misrepresents the data. It states that deferred revenue declined from $117 million in 2024 to $19 million in 2025, which is factually correct based on the ground truth, but it completely omits the 2022 figure of $89 million and falsely implies a decline between 2022 and 2024 when in fact deferred revenue increased from $89M (2022) to $117M (2024). Instead, the LLM incorrectly frames the change as a 'decline' between 2022 and 2024, when it should be an increase. (2) The numbers $117 million (Feb 3, 2024) and $19 million (Feb 1, 2025) are correctly cited, but the $89 million (Jan 29, 2022) figure is entirely missing, and the direction of change between 2022 and 2024 is wrong. The LLM incorrectly uses the 2024 number as the starting point, reversing the trend. (3) The multi-hop reasoning fails because the model does not synthesize the full trajectory: increase from 2022 to 2024, then sharp drop by 2025. It skips the first hop (2022 data) and mischaracterizes the evolution. The conclusion about 'scaling back or restructuring' may be plausible for the 2024–2025 drop but does not account for the prior growth, leading to an incomplete and misleading interpretation. (4) The contextual relevance is fair because it discusses the right program, metric (deferred revenue), and a plausible implication, but the factual inaccuracies in trend direction and missing data severely undermine correctness. Quantitative accuracy is low due to incorrect temporal use of numbers. Qualitative reasoning is partially sound but based on flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 442,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes was $996 million on December 31 2023 versus $980 million on December 31 2022, reflecting a modest increase in market value. This slight rise suggests that investor perception of the notes remained relatively stable, with market conditions supporting only a marginal premium over par.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the change in fair value. The ground truth states the fair value decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023 — but this is incorrect in the original answer as well, because $996M is actually higher than $980M, meaning the value increased, not decreased. However, the original answer claims it 'decreased' and interprets it as moving 'closer to par', implying par is above $996M. The LLM correctly reports the numbers ($980M in 2022, $996M in 2023) but mischaracterizes the change as an 'increase' and interprets it as a 'marginal premium over par'. The quantitative values are accurate, but the interpretation conflicts with the original answer's logic. (2) Number verification: $980 million (2022) and $996 million (2023) are correctly cited by the LLM. However, the original answer incorrectly states this is a decrease, when numerically it is an increase of $16 million. The LLM correctly identifies the direction of change (increase), contradicting the ground truth. This creates ambiguity: the ground truth may have a typo (intending to say 'increased' instead of 'decreased'), or the numbers may be swapped. Given the instruction to evaluate against the original answer as ground truth, the LLM contradicts it and thus loses points. (3) Multi-hop reasoning: The LLM attempts to interpret the change in fair value in terms of investor perception and market conditions, which is required. However, its conclusion of 'relatively stable' and 'marginal premium' does not align with the original answer's claim of 'stabilization or improved outlook' due to moving closer to par. While both point to positive sentiment, the LLM lacks the specific reasoning about convergence to par value. (4) Correctness score is 4 due to the conflict with ground truth on interpretation despite numerically accurate data; quantitative accuracy is 4 because the numbers are correct but the implied direction of change in the original answer is likely erroneous; qualitative accuracy is 5 due to reasonable but misaligned reasoning; contextual relevance is 8 because the response addresses both parts of the question and remains on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 600,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, Visa issued approximately 120 million shares of Class B‑2 common stock and 48 million shares of Class C common stock as part of the May 2024 Class B‑1 common stock exchange offer, while also releasing $2.7 billion of as‑converted value from its Series B and C preferred stock in July 2024. The company continued to repurchase Class A shares (64 million shares for $17 billion in fiscal 2024) and maintained a substantial share‑repurchase authorization, but no new Class B‑1 shares were outstanding after the exchange. These actions reflect a shift in equity composition toward more Class B‑2 and Class C shares and a continued focus on capital returns through buybacks and dividend payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, 241 million shares of Class B-1 were tendered and approximately 48 million shares of Class C were issued. The LLM incorrectly attributes this exchange to a 'May 2024' event, misrepresenting the timing. Additionally, the LLM claims 120 million shares of Class B-2 were issued, a figure not present in the ground truth and unsupported by the provided data. The $2.7 billion release from Series B and C preferred stock in July 2024 is also not mentioned in the original answer and appears fabricated. The share repurchase of 64 million Class A shares for $17 billion in fiscal 2024, while potentially accurate contextually, is extraneous and not directly related to the evolution of Class C common stock. (2) Quantitative accuracy is poor: the 120 million Class B-2 shares, $2.7 billion preferred stock release, and $17 billion repurchase are unverified and not in the ground truth. Only the 48 million Class C shares issued aligns with the original answer, but even this is misdated. (3) The multi-hop reasoning is flawed—the LLM conflates events across years and introduces unrelated financial actions, failing to correctly trace the equity evolution of Class C stock from 2023 to 2024. It misses the key point that by 2024, Class C common stock stabilized at only 10 shares issued and outstanding, which is central to the original answer. (4) Contextual relevance is moderate because the answer discusses equity restructuring and share classes, but it introduces irrelevant details (e.g., preferred stock conversions, Class A buybacks) and omits the critical conclusion about the minimal outstanding Class C shares in 2024. The core narrative of restructuring in 2023 followed by stabilization in 2024 is lost.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 494,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "From 2022 to 2024, Lowe's has shifted its Rough Plumbing business from being grouped under the broader \"Building Products\" category (which included Rough Plumbing among other subcategories) to being explicitly highlighted as a distinct service offering within its installed sales model. In the 2024 10-K, Lowe's specifically lists \"Rough Plumbing\" alongside Kitchen & Bath, Flooring, Appliances, and Millwork as a key category accounting for the majority of installed sales, emphasizing its standalone importance. Additionally, Lowe's expanded its service model to include dedicated installation services through independent contractors for Rough Plumbing, integrating it into its omnichannel approach where customers can now finalize installation contracts and checkout online via lowes.com or the mobile app, reducing the need for in-store returns. This evolution reflects a strategic focus on streamlining Rough Plumbing as a core, standalone service within its installed sales business, which represented approximately 5% of total sales in fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Rough Plumbing was classified under 'Building Products' in 2022 and evolved into a service-oriented offering by 2024, integrated with installation services and protection plans. The LLM correctly identifies that installed sales accounted for approximately 5% of total sales in 2024, matching the ground truth. (2) Quantitative accuracy is perfect: the 5% figure is correctly cited and contextualized. No calculations were required, but the number is accurately reported. (3) The multi-hop reasoning is sound—LLM synthesizes the shift in business classification and expansion into services, drawing correct inferences about strategic bundling and omnichannel integration. It adds contextual detail (e.g., online checkout, independent contractors) not in the ground truth but plausibly consistent with it. (4) The only minor gap is that the ground truth explicitly mentions 'protection plans' as part of the service evolution, which the LLM omits. However, the emphasis on installation services and standalone categorization captures the core transformation. Wording differs but semantic meaning is equivalent. The answer is fully relevant and addresses both business classification and service offerings across the specified time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 371,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The Class B‑2 common stock was created in May 2024 when Visa’s exchange offer retired the newly‑renamed Class B‑1 shares and issued approximately 120 million Class B‑2 shares (and 48 million Class C shares).  Prior to this exchange, no Class B‑2 shares were outstanding, and the newly issued Class B‑2 shares carry the same conversion‑rate adjustment mechanism that governs the Class B‑1 stock, effectively expanding the company’s equity base and altering the capital‑structure weighting among its multiple common‑stock classes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was created in May 2024 with 120 million shares—both the date and number are incorrect. Additionally, the LLM references Visa and an exchange offer involving Class B-1 and Class C shares, which are not mentioned in the original answer and introduce a completely different context. (2) Quantitative accuracy is poor: the original states 77 million shares in 2023 and zero prior to a later exchange, while the LLM reports 120 million Class B-2 and 48 million Class C shares issued in 2024—none of these numbers align with the ground truth. There is no indication in the original answer that Class B-2 shares were issued as part of an exchange offer in 2024; rather, it states that no shares were outstanding before the exchange offer, implying they existed on paper or were retired. (3) The reasoning is flawed: the LLM fabricates a narrative around Visa (not mentioned in the original), a May 2024 creation event, and a conversion mechanism tied to Class B-1, none of which are supported by the ground truth. The multi-hop synthesis fails because it does not reflect the actual evolution: introduction in 2023, then absence noted in 2024, suggesting restructuring. Instead, it invents a causal event (exchange offer) and misrepresents timing and share counts. (4) Contextual relevance is moderate—the answer discusses Class B-2 stock in the context of capital structure evolution, which is relevant, but the specifics are factually wrong and based on fabricated entities and events. Thus, while the general theme matches, the factual foundation does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 479,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program, as reflected in the gift card liability and deferred revenue figures, remained relatively stable between 2023 and 2024. As of February 1, 2025, the Target Circle liability was $19 million, compared to $117 million as of February 3, 2024, indicating a significant decrease in deferred revenue related to the program. This reduction suggests a decline in the program's growth or evolution, potentially reflecting changes in redemption patterns or program adjustments, though the core program structure remains part of Target's broader customer loyalty strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Target Circle's deferred revenue was $117 million as of February 3, 2024, with no disclosed liability in 2022. The LLM incorrectly claims a $19 million liability as of February 1, 2025 (a future date not addressed in the question), and asserts a decrease from $117 million to $19 million, which contradicts the ground truth showing an increase to $117 million by 2024. There is no mention of a $19 million figure or a decline in the original answer. (2) Quantitative accuracy is severely compromised: the LLM reverses the trend (decrease vs. actual increase), introduces a non-existent future date (2025), and fabricates a $19 million figure not present in the source. The comparison between 2023 and 2024 is unsupported, as the original answer does not provide 2023 data. (3) The multi-hop reasoning is flawed. The question asks about changes between 2022 and 2024, but the LLM incorrectly infers a decline based on fabricated data. It fails to recognize that the introduction of a $117 million liability in 2024 (vs. no disclosed amount in 2022) indicates growth, not decline. The conclusion about reduced growth contradicts the evidence. (4) Contextual relevance is moderate—the answer discusses financial liability and program evolution, which are relevant—but the incorrect data and reversed conclusion severely undermine its validity. The mention of gift card liability and redemption patterns introduces unsupported speculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 421,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVIDIA’s 2024 10‑K shows that concerns about pollution limits and related regulatory constraints have shifted from a general risk discussion in 2023 to a more specific focus on how environmental rules could affect its data‑center supply chain and customer expansion.  In the 2023 filing the company warned that “pollution limits” could constrain operations and that trade restrictions might limit sales to certain markets.  By 2024 the language is tighter: the filing notes that “water and energy availability and reliability … are critical, and extreme heat or water shortages could impair the ability of our customers to expand their data‑center capacity and consume our products,” and that “new or proposed regulations relating to carbon taxes, fuel or energy taxes, pollution limits … could result in greater direct costs … and require us to alter our operations and product design activities.”  This indicates that regulatory pressure on energy‑intensive data‑center growth and emissions is now a concrete operational and strategic concern for NVIDIA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution from 2023 to 2024 in NVDA's risk disclosures regarding pollution limits is accurately portrayed. In 2023, the focus was on increased costs and operational changes due to compliance, energy, and capital expenditures, which the LLM correctly summarizes. In 2024, the expansion of concern to include land, permitting, and resource constraints (especially water and energy) affecting customer data center expansion is also accurately reflected, particularly through direct quotes about water and energy availability and regulatory impacts on customer capacity. (2) There are no numerical values in the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning—linking NVDA’s operational concerns to downstream customer constraints and ultimately to demand risk for NVDA’s products—is sound and well-supported. The LLM infers the strategic implication (impact on product demand) from customer expansion barriers, which is consistent with the ground truth’s conclusion about demand effects. (4) The only minor shortcoming is that the LLM does not explicitly state that permitting and land constraints could 'impair customers' ability to expand' as directly as the original answer does, though it conveys the same idea through discussion of water/energy shortages and regulatory barriers. Wording differences are acceptable under semantic equivalence, and the core insight about growing regulatory risk affecting customer demand is preserved. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 477,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "The company's Guaranteed Senior Notes issued by its Japanese subsidiary were valued using Level 3 inputs, and in July 2024 the subsidiary repaid $77 of these notes. Meanwhile, the Company retired $1,000 of its 2.750% Senior Notes on May 18, 2024, reducing the carrying amount of long‑term debt and resulting in a fair‑value estimate of the remaining long‑term debt of approximately $5,412 at the end of 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. It correctly states that the Japanese subsidiary repaid $77 of Guaranteed Senior Notes in 2024 and that these notes were valued using Level 3 inputs. It also correctly reports the fair value of long-term debt at the end of 2024 as approximately $5,412. However, it incorrectly introduces the retirement of $1,000 of 2.750% Senior Notes on May 18, 2024, which is not mentioned in the ground truth and is unrelated to the Guaranteed Senior Notes. This misattributes the reduction in debt to a different instrument, undermining the accuracy. Additionally, the original answer notes that $500 in Guaranteed Senior Notes were issued in 2023, a key point about composition that is entirely missing in the LLM response. (2) Quantitative accuracy is partially correct: $77 repayment and $5,412 fair value at end of 2024 are accurate; however, the $1,000 retirement is fabricated and not supported by the ground truth. The 2.750% rate and May 18 date are also unverified. The 2023 fair value of $5,738 is omitted, preventing proper comparison. (3) Multi-hop reasoning is flawed: the model fails to connect the 2023 issuance to the 2024 repayment within the same class of debt (Guaranteed Senior Notes), instead conflating it with a different senior note. This breaks the logical synthesis required across years and instruments. (4) Contextual relevance is high as the answer addresses fair value, repayment, and valuation inputs, but the inclusion of irrelevant debt retirement reduces precision. Correctness score is 5 due to mixed factual content: some key numbers are right, but core events (issuance in 2023, specific repayment within Guaranteed Senior Notes) are either omitted or distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 485,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix’s risk exposure related to streaming‑service investments shifted from a focus on personnel‑driven technology and development spending to heightened cybersecurity and regulatory scrutiny. In the 2022 filing, the company highlighted the need for skilled staff to maintain and improve its streaming platform, noting that “technology and development” expenses grew 24 % year‑over‑year, driven largely by headcount increases supporting streaming enhancements. By 2024, the same disclosures emphasized that cybersecurity risks—such as potential data breaches, unauthorized access to content, and the costs of maintaining a robust security program—had become a central concern, with the company describing its enterprise‑wide information‑security program, bug‑bounty initiatives, and regular third‑party audits as critical to protecting its streaming infrastructure. This evolution reflects a transition from expanding technical staff to managing the heightened risk exposure associated with protecting that expanded platform and its massive global user base.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution from personnel-driven investment in 2022 to cybersecurity focus in 2024, aligning with the ground truth's core narrative. However, it omits the specific $384 million figure for personnel cost increases disclosed in 2022, instead referencing a 24% YoY growth in 'technology and development' expenses, which is related but not equivalent to the ground truth's disclosed amount. This introduces a partial factual discrepancy, as the $384M figure is central to the original answer and not mentioned. (2) The 24% YoY expense growth may be accurate contextually but is not present in the ground truth and cannot be verified against it; thus, it introduces unverified quantitative information. The absence of the $384M number reduces quantitative accuracy despite plausible reasoning. (3) The multi-hop reasoning is strong: the model correctly synthesizes a shift in risk exposure over time, connecting personnel growth in 2022 to cybersecurity programs in 2024, including third-party audits, bug bounties, and data/content protection risks. This reflects sound qualitative understanding and logical progression. (4) Contextual relevance is perfect—the answer directly addresses the question about investment evolution and risk exposure changes, with appropriate focus on personnel and cybersecurity developments across the specified years. The omission of the exact dollar amount prevents a higher correctness score, but the overall direction, entities, and synthesis are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 423,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Based on the provided SEC filings, BNY Mellon's approach to restricted stock unit (RSU) agreements has evolved through incremental updates to its equity compensation framework rather than a fundamental shift. The 2024 filing (Exhibit 10.29) introduces a new form of RSU agreement, continuing a pattern of annual updates seen in prior years (e.g., 2021, 2022, 2023 forms filed as Exhibits 10.2, 10.22, and 10.24). These updates reflect ongoing refinement of lifecycle management for equity instruments, particularly in alignment with executive compensation strategy, as evidenced by the consistent incorporation of new RSU and performance share unit agreements (e.g., 2024 Performance Share Unit Agreement, Exhibit 10.25) into the company's compensation structure. The evolution underscores a systematic approach to adapting equity awards to regulatory and strategic needs, with no indication of structural changes to the core compensation philosophy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key details from the ground truth, particularly regarding the specific evolution between the 2023 and 2024 filings. (1) What was correct: The LLM correctly identifies that BNY Mellon updates its RSU agreements annually and references the 2024 Form of RSU Agreement (Exhibit 10.29) as newly filed in 2024. It also accurately notes the pattern of annual updates and ties this to executive compensation strategy, showing awareness of lifecycle management. (2) Quantitative accuracy: The years (2021–2024) and exhibit numbers (e.g., 10.29, 10.25) are correctly cited, and no numerical calculations are required, so this aspect is strong. (3) Multi-hop reasoning assessment: The answer fails to capture the critical distinction highlighted in the ground truth — that in the 2023 filing, the '2024 Form' was 'Filed herewith,' but in the 2024 filing, it became 'Previously filed,' while the '2025 Form' was then 'Filed herewith.' This transition is central to understanding the lifecycle management and forward-looking nature of the compensation strategy. The LLM does not mention the 2025 form at all, which is a significant omission. (4) Justification for scores: Correctness is 6 because core facts about annual updates are right, but the absence of the key filing status change (newly filed → previously filed) undermines the depth of analysis. Qualitative accuracy is 6 due to incomplete reasoning and missing synthesis of the filing status evolution. Quantitative accuracy is 8 because dates and exhibit numbers are correct. Contextual relevance is 9 as the response stays focused on the question and discusses relevant aspects of RSU lifecycle and executive compensation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 465,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes issued in 2029 remain outstanding through their maturity in 2029, with their carrying amount declining slightly from $743 million as of January 28, 2024 to $743 million as of February 2, 2025 (reflecting amortization of any discount and normal principal repayments). No redemption or refinancing of these specific notes was noted in the 2024 filings, so their maturity timeline stays unchanged, and their carrying amount reflects the ongoing accretion of the discount over the remaining term.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states the notes were 'issued in 2029', when they were actually issued in November 2023. This is a critical error that undermines the entire response. The carrying amount is stated as $743 million in both 2024 and 2025, but the ground truth only provides data up to January 28, 2024; projecting the same amount to February 2, 2025 without change is misleading, especially since the original answer notes a slight decrease due to amortization. The maturity date is correctly implied as April 2029, but the phrasing 'issued in 2029' falsely suggests issuance and maturity in the same year. (2) Quantitative inaccuracies include the incorrect issuance year (2029 vs 2023), missing the initial principal amount ($750 million) and discount ($3.4 million) from 2023, and failing to mention the April 15, 2029 maturity date precisely. The carrying amount of $743 million is correctly cited for January 28, 2024, but the answer fabricates a future value for 2025 with no basis in the provided data. (3) The multi-hop reasoning is flawed: the model fails to connect the 2023 issuance details with the 2024 carrying amount evolution. It omits the key fact that the notes were newly issued in 2023, which is central to understanding their status evolution. The answer also incorrectly implies ongoing principal repayments, while the original answer specifies semi-annual interest payments starting in 2024, not principal amortization. (4) Despite these issues, the answer is contextually relevant—it addresses the maturity timeline and carrying amount as requested, and correctly notes no redemption or refinancing occurred. However, the severe factual and temporal inaccuracies, especially the reversal of issuance and maturity years, result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 499,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "The Company’s Japanese subsidiary issued $500 million of Guaranteed Senior Notes in November 2023 at fixed rates of 1.400%–2.120% (maturing 2033‑2043) and subsequently repaid $77 million of those notes in July 2024.  In May 2024 the subsidiary also settled the $1,000 principal balance on the parent’s 2.750% Senior Notes, using cash and short‑term investments.  Overall, the issuance increased long‑term debt by roughly $500 million, while the July 2024 repayment reduced it by $77 million, leaving the net balance of the Japanese‑subsidiary debt at $919 million (including other long‑term debt) as of September 1, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that Costco's Japanese subsidiary issued $500 million in Guaranteed Senior Notes in November 2023 at fixed rates of 1.400%–2.120%, which aligns with the ground truth (allowing for the addition of maturity dates not in the original), it introduces a repayment of $77 million in July 2024—this matches the amount in the ground truth but adds an unverified date (July 2024) not present in the original. More critically, the LLM claims the subsidiary repaid $1,000 million (i.e., $1 billion) on the parent’s 2.750% Senior Notes in May 2024, which is not mentioned or implied in the ground truth and appears to be a hallucination. Additionally, the net debt balance of $919 million as of September 1, 2024, is unsupported by the original answer and involves incorrect aggregation (e.g., adding unrelated debt). (2) Quantitative accuracy is partially correct: $500 million issuance and $77 million repayment match the original in magnitude (with acceptable formatting), but the $1,000 million repayment is entirely fabricated. The net debt calculation ($500M - $77M = $423M, not $919M) is mathematically and contextually wrong. (3) The multi-hop reasoning fails: the model incorrectly combines unrelated debt instruments (parent company’s Senior Notes vs. subsidiary’s Guaranteed Senior Notes) and invents repayment events and dates. The original answer only confirms issuance in 2023 and partial repayment of $77M in 2024—no details on timing or additional instruments. (4) Scores reflect partial correctness on core issuance and repayment amounts but severe penalties for hallucinated data, incorrect synthesis, and erroneous calculations. Contextual relevance is moderate as the answer focuses on the right entity and instrument but drifts into irrelevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 502,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk from competitors developing after‑market parts has grown from 2022 to 2023, as reflected in the 2023 filing’s explicit discussion of “Competitors’ products can capture significant market share or lead to a decrease in market prices overall, resulting in an adverse effect on the Company’s business and financial statements,” and the earlier 2022 text that warned that “Competitors may also develop after‑market services and parts for our products which may detract from our sales.” This heightened risk is linked to intensified competition, pricing pressure and the potential for reduced sales of the Company’s own products, which can negatively impact revenue and profitability as disclosed in both years’ risk‑factor sections.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers or miscalculations, it scores highly by default. The core issue lies in qualitative accuracy and reasoning: the LLM incorrectly asserts that the risk has 'grown' from 2022 to 2023, which contradicts the ground truth. According to the original answer, the risk was framed as a direct threat in 2022 ('detract from our sales') but was relatively de-emphasized in 2023, being contextualized among broader industry pressures like cost containment and reimbursement policies—not elevated. The LLM misinterprets the evolution of the risk, failing to recognize the strategic recalibration and reduced emphasis in 2023. While the LLM correctly identifies that both years mention competitive pressure from after-market parts and potential impacts on sales and financials, it draws the opposite conclusion about the trend in risk severity. This represents a critical failure in multi-hop reasoning: synthesizing the shift in tone and framing across filings. Contextual relevance is moderate—the response addresses the right topic and cites appropriate themes (pricing pressure, competition, financial impact)—but misrepresents the directional change in risk assessment, leading to a misleading overall answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 368,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix refined its membership strategy by introducing lower‑priced, ad‑supported tiers and by testing modest price increases across regions to boost average revenue per user. These moves were designed to offset slower paid‑membership growth, sustain revenue expansion amid rising content costs, and counteract macro‑economic pressures such as inflation. The changes aimed to preserve profitability while maintaining a broad, globally diversified subscriber base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shifts—introduction of ad-supported tiers and pricing adjustments—and links them to business challenges like slower membership growth and macroeconomic pressures, which aligns with the ground truth. However, it omits key quantitative details from 2022: the 19% revenue increase, 11% growth in average paying memberships, 7% rise in average revenue per membership, and the 50% drop in paid net membership additions. These omissions affect completeness and quantitative accuracy. (2) No specific numbers from the LLM answer match the ground truth exactly; while 'slower paid-membership growth' is consistent with the 50% decline, the absence of actual percentages or revenue figures reduces precision. The LLM does not mention foreign exchange impacts or enforcement of terms of use to limit password sharing—key elements in Netflix’s 2024 strategy. (3) The reasoning is logically sound and reflects multi-hop understanding—connecting pricing and plan changes to broader business challenges like content costs and competition—but misses the synthesis of specific performance metrics with strategic responses. (4) Despite missing key numbers and some features (e.g., password sharing enforcement), the answer remains contextually relevant and conveys a qualitatively accurate narrative. Hence, correctness is reduced to 7 due to significant but not critical omissions in quantitative and feature-specific details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 405,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023 Boeing’s approach to in‑orbit incentive payments remained tied to performance‑based risk, but the financial exposure and accounting treatment intensified.  In 2023 the company recorded $1.585 billion of additional reach‑forward losses on its five largest fixed‑price development programs—including Commercial Crew, KC‑46A, MQ‑25, T‑7A and VC‑25B—driven by production disruptions, supplier issues and technical challenges, which directly heightens the risk that in‑orbit incentive fees may be withheld or require refunds if satellites fail to meet contractual performance criteria.  Consequently, while revenue from in‑orbit payments is still recognized during construction, the increased reach‑forward loss recognition reflects a greater financial risk and a more conservative estimation of recoverable incentive fees in the 2023 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $1.585 billion (or $1,585 million) loss is correctly reported, with acceptable format variation ($1.585 billion = $1,585 million). The years (2022 vs 2023) are correctly used. (2) The LLM correctly identifies the fixed-price development programs, though it lists MQ-25 and T-7A instead of only those mentioned in 2022 (Commercial Crew, KC-46A, VC-25B). This is a minor discrepancy—while these are part of the five major programs, the original answer specifies continuity from 2022, which the LLM slightly generalizes. (3) The reasoning is sound: the LLM captures the evolution from risk acknowledgment to increased financial exposure via reach-forward losses and explains that in-orbit incentive payments are at risk if performance criteria are not met. It correctly notes revenue is recognized during construction, increasing exposure. (4) The answer conveys the same core evolution: from general risk in 2022 to quantified losses and clearer accounting treatment in 2023. The only minor shortcoming is slightly less precision in linking the 2023 programs directly back to the 2022 list, but the overall multi-hop synthesis across years and financial treatment is strong. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 385,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the disclosure of BNY Mellon’s Directors’ Code of Conduct remained consistent in its availability—referenced in both the 2023 and 2024 Form 10‑K filings as being posted on the company’s website (e.g., https://www.bnymellon.com/.../directors‑code‑of‑conduct.pdf)—but the 2024 filing explicitly notes that any amendments or waivers to the Code will be disclosed on the website, whereas the 2023 filing did not emphasize this disclosure mechanism. Thus, while the Code itself was still publicly accessible, the 2024 version added a clearer statement of intent to publish future changes or waivers, reflecting a modest evolution in transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of the evolution between 2023 and 2024. Contrary to the LLM's claim, the 2023 filing already stated the intention to disclose amendments or waivers on the website, but the 2024 filing did not add this disclosure — rather, it generalized the reference to the Code without repeating the direct URL. The LLM incorrectly reverses the direction of change: it claims the 2024 filing 'added a clearer statement' about amendments, when in fact the 2023 filing had the more detailed disclosure. (2) Quantitatively, the years (2023, 2024) and the URL (though partially redacted) are correctly referenced, and there are no numerical errors since no calculations are involved. These elements are factually sound, hence a higher quantitative accuracy score. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from explicit URL and amendment disclosure in 2023 to a more consolidated, implicit reference in 2024. Instead, it invents a new narrative where transparency increased in 2024, which contradicts the ground truth. This represents a failure in qualitative reasoning and entity-state comparison over time. (4) Contextual relevance is moderate because the answer addresses the right topic (website disclosure of the Code) and the right company and years, but misrepresents the nature of the change, leading to an incorrect conclusion about the evolution of transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 412,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from a concept to a production-ready L4 autonomous driving system designed for fleet deployment, primarily targeting transportation network companies, public transit operators, and mobility service providers. The strategy shifted toward bundling Mobileye Drive with Moovit’s MaaS platform and expanding design wins with OEMs like Polestar and Geely, while regulatory progress in countries like Germany enabled broader deployment of robotaxi services starting in 2022. This marked a transition from ADAS-focused volume growth to scaling autonomous driving solutions for commercial robotaxi and shared mobility markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mobileye Drive™ between 2022 and 2023. It accurately notes the shift toward targeting transportation network companies, public transit operators, and mobility service providers, as well as the bundling strategy with Moovit’s MaaS platform—both key elements from the ground truth. The mention of Geely as a design win is correct and supported by the original answer. However, the LLM introduces 'Polestar' as an additional OEM, which is not mentioned in the ground truth and cannot be verified from the provided data, representing a minor entity inaccuracy. It also states that Mobileye Drive evolved 'from a concept to a production-ready system,' but the original answer indicates it was already launched as an L4 SDS in 2022, suggesting it was beyond the concept phase. The reference to regulatory progress in Germany and robotaxi services starting in 2022 is not present in the ground truth and may be extraneous or unverified. Despite these issues, the core strategic shift—focusing on fleet deployment, MaaS integration, and commercial partnerships—is correctly identified and well-reasoned. All dates and company names (except Polestar) are accurate or semantically aligned. The answer is highly relevant to the question and synthesizes the multi-hop elements (2022 launch, partnerships, 2023 strategy shift) effectively, though with slight overreach in unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 398,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 through 2024 the structure of AT&T’s Tower preferred interests was reshaped.  \n- In 2019 AT&T issued two series of cumulative preferred interests in Tower Holdings – a $1,500 September series (Class A‑1) at a 5.0% initial distribution and a $4,500 December series (Class A‑2) at 4.75% – both reset every five years.  \n- In August 2024 the 2019 Tower preferred interests were amended and recast as Fixed‑Rate Class A Limited Membership Interests (paying a 5.90% distribution) and Floating‑Rate Class A Limited Membership Interests (paying SOFR + 250 bps), with the reset schedule extending to 2029 and the ability to call the floating tranche at any time.  \n- The amendment also changed the redemption trigger and added a five‑year call period beginning November 2029, while preserving the contingent‑redemption rights that allow holders to force redemption if distributions are missed or credit‑rating requirements are not met.  \n\nThus, between 2022 and 2024 the original 2019 Tower preferred interests remained in place but were restructured in 2024 into a mixed fixed‑ and floating‑rate regime with a later call date and updated reset mechanics.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two original series of Tower Preferred Interests from 2019 (Class A-1: $1,500 at 5.0%; Class A-2: $4,500 at 4.75%), their reset frequency (every five years), and the August 2024 restructuring into Fixed-Rate (5.90%) and Floating-Rate (SOFR + 250 bps) interests. These core facts align with the ground truth. However, the question specifically asks about the evolution from 2022 to 2024, and the LLM incorrectly attributes the issuance of the original series to 2019 in the context of the 2022–2024 timeline, even though the original answer only discusses the state in 2022, not the 2019 issuance. While factually accurate that the interests were issued in 2019, the framing may mislead by emphasizing 2019 rather than the structural status during 2022 as presented in the ground truth. (2) All numeric values—dollar amounts ($1,500, $4,500), percentages (5.0%, 4.75%, 5.90%, SOFR + 250 bps), and the August 2024 amendment date—are correct. The LLM adds details not in the original answer (e.g., call period beginning November 2029, contingent redemption rights), which are plausible but not confirmed in the ground truth, leading to minor overreach. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the 2019-issued interests were still in place in 2022 and then restructured in 2024, showing evolution. However, the emphasis on 2019 issuance slightly distracts from the 2022–2024 focus. (4) Despite minor framing issues and the addition of unverified structural details (call period, redemption triggers), the core evolution in structure and distribution rate is accurately conveyed. The answer is contextually relevant and captures the key transformation. Thus, the correctness score is 8 due to accurate core facts but slight over-speculation and misaligned temporal emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 503,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The investment approach for Level 3 assets in the Balanced Index Fund remained consistent, with the fund being composed of approximately 60% equities and 40% debt securities, valued using a market approach based on quoted market prices of identical instruments (Level 1). Unrealized gains/(losses) for Level 3 assets in the Balanced Index Fund evolved as follows: for 2023, changes were $2 for corporate fixed income securities, $6 for mortgage-backed and asset-backed fixed income securities, and $3 for other fixed income securities; for 2022, changes were ($16) for corporate fixed income securities, ($11) for mortgage-backed and asset-backed fixed income securities, ($14) for municipal fixed income securities, and ($1) for real asset securities. This indicates a shift from net unrealized losses in 2022 to net unrealized gains in 2023 across key Level 3 asset classes within the fund.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the quantitative details. While it correctly reports the 2022 unrealized losses of ($16) million for corporate fixed income and ($11) million for mortgage-backed and asset-backed securities, it adds additional 2022 losses—($14) for municipal and ($1) for real asset securities—that are not present in the original answer and not supported by the ground truth. Similarly, for 2023, it reports gains of $2 and $6 million for the two main categories (matching the ground truth), but adds a $3 million gain for 'other fixed income securities' which is not mentioned in the original. These extra figures introduce factual errors and distort the completeness and accuracy of the response. (2) The investment approach description is partially incorrect: the LLM states that Level 3 assets were valued using Level 1 inputs (quoted market prices), which contradicts the definition of Level 3 assets (which rely on unobservable inputs). The original answer notes that the 2023 valuation methodology referenced a market approach using Level 1 prices—this likely refers to other fund assets, not Level 3. The LLM incorrectly applies Level 1 valuation to Level 3 assets, reflecting a misunderstanding of the SEC hierarchy. (3) The multi-hop reasoning is sound in identifying the shift from losses to gains and the stable 60/40 allocation, showing good synthesis across years. However, the erroneous inclusion of extra asset categories and misattribution of valuation levels undermines the qualitative accuracy. (4) Despite these issues, the core narrative—a turnaround from unrealized losses to gains and consistent fund composition—is preserved, and the answer remains contextually relevant. The correctness score is 6 due to significant quantitative errors and a key conceptual mistake about valuation levels, though major directional insights are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 515,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon’s forward-looking statements shifted from a broader focus on market, operational, and strategic risks to a more pronounced emphasis on accounting standards and regulatory compliance. In the 2023 filing, accounting developments were mentioned only as part of general risk factors, whereas the 2024 filing explicitly highlights changes in accounting standards as a distinct risk that could materially impact reported financial condition, results of operations, cash flows, and other financial data. This evolution reveals that accounting standards are increasingly shaping the company’s strategic priorities, compelling BNY Mellon to adjust its reporting, capital management, and business practices to align with evolving regulatory requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and interpretation. (1) There are no numeric values to verify (dates 2023 and 2024 are correct), so quantitative accuracy is perfect. (2) The LLM accurately captures the evolution in BNY Mellon's forward-looking statements: from a general mention of accounting developments in 2023 to a more explicit and material focus in 2024. It correctly identifies that accounting standards are now seen as having a material impact on financial reporting and strategic decisions. (3) The multi-hop reasoning is sound—comparing language across years and inferring increased strategic importance. However, the LLM omits specific details from the original answer, such as the exact phrasing shift ('may impact our businesses' vs. expanded list including 'regulatory, technology, market, economic or accounting developments') and the mention of 'capital plans including dividends and repurchases' and 'efficiency savings' as newly tied elements in 2024. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the core insight remains valid. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution in emphasis and implications for strategic priorities. Wording differs but meaning is semantically equivalent on key points. Minor deduction for missing granular evidence from the filings that would strengthen the claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 407,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The 2023 disclosures highlight heightened risks around store safety and cybersecurity that could directly undermine the associate experience—through concerns about personal safety, increased operational pressures, and potential disruptions to work environments—contrasting with the 2022 focus on engagement‑driven initiatives such as culture‑centric development, recognition programs, and enhanced benefits. Consequently, while 2022 emphasized building emotional commitment and inclusive growth, 2023’s risk narrative suggests that safety and cyber threats may erode morale, retention, and the overall associate experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (2) The LLM correctly identifies the 2022 engagement-focused initiatives (recognition programs, culture-centric development, benefits) and contrasts them with 2023's heightened risks around store safety (e.g., organized retail crime implied via 'store shrink') and cybersecurity. It accurately captures the shift in focus and the potential negative impact on associate morale, retention, and experience. (3) The multi-hop reasoning is sound: it synthesizes information across years (2022 vs 2023), initiatives (engagement vs risk), and their implications for associate experience. The only minor omission is that the original answer specifies that 'four out of five associates were emotionally committed'—a concrete data point that the LLM answer alludes to ('emotional commitment') but does not explicitly include. This slightly reduces completeness and qualitative accuracy, but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of risks and their potential impact on the associate experience compared to prior-year initiatives. Wording differs but semantic meaning aligns closely with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 393,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The learning curve’s impact on cost and production estimates was explicitly highlighted in the 2023 disclosures as a key driver of program profitability and risk. Specifically, the company noted that changes in underlying assumptions—including the learning curve—could materially affect gross margins on commercial airplane programs, with a 1% shift in estimated gross margin translating to approximately $300 million (or $330 million for commercial programs) of pre‑tax income impact in 2023. This risk is tied to ongoing challenges on programs such as the VC‑25B, KC‑46A, Commercial Crew, T‑7A, MQ‑25, 777X, and 787, where learning‑curve‑related cost overruns or margin compression have led to cumulative catch‑up adjustments, reach‑forward losses, and the need for valuation allowances. Consequently, the role of the learning curve has evolved from a background factor to a central, quantifiable element in both cost estimation and risk management for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of the learning curve's role in Boeing's cost and production planning between 2022 and 2023, correctly identifying its increased centrality in risk and cost estimation. However, it introduces significant quantitative inaccuracies not present in the ground truth. Specifically, the claim that a 1% shift in gross margin translates to $300 million (or $330 million) of pre-tax income impact in 2023 is not supported by the original answer and appears to be fabricated or misattributed. The original answer does not include any numerical quantification of financial sensitivity to the learning curve, so this addition undermines factual correctness. Additionally, while the LLM correctly notes that the learning curve was tied to programs like the 787 and 777X, it expands the list to include VC-25B, KC-46A, Commercial Crew, T-7A, and MQ-25 without confirmation from the ground truth, which only explicitly references the 787 in 2022 and implies broader integration in 2023 without naming specific programs. The qualitative reasoning is sound in recognizing a shift from 'risk' to 'integrated factor,' aligning with the original's description of the learning curve becoming a predictable and manageable component. The answer is contextually relevant and addresses the evolution in relation to profitability and risk management. However, the inclusion of unverified financial figures and program-specific details reduces quantitative accuracy significantly, warranting a moderate correctness score despite strong qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 430,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The Dividend Reinvestment Plan (DRP) disclosure was updated in the 2024 filing to specifically note that certain officers and directors participate in the DRP and that they may elect to have shares withheld to cover taxes or exercise prices, which may involve non‑Rule 10b5‑1 trading arrangements. This language appears in Item 9B of the 2024 filing, whereas the 2023 filing only mentioned that officers or directors could participate in the DRP, employee stock purchase plan and 401(k) plan without detailing the withholding elections or the potential non‑Rule 10b5‑1 trading aspect.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a fundamental factual inaccuracy in its description of the evolution between the 2023 and 2024 filings, reversing the direction of change. According to the ground truth, the 2023 filing included detailed disclosure about Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, while the 2024 filing omitted this detail—indicating a reduction in specificity. However, the LLM claims that the 2024 filing 'updated' the disclosure to include mention of non-Rule 10b5-1 arrangements, which were absent in 2023—this is the opposite of the truth. This error reflects a failure in multi-hop reasoning and synthesis across the two filings. While there are no numerical inaccuracies (hence a high quantitative accuracy score), the qualitative analysis is severely flawed because the core narrative of disclosure evolution is incorrect. The context of officer/director participation and share withholding is relevant and partially accurate, so the answer retains some contextual relevance, but the reversed logic undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 300,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "From fiscal 2021 through fiscal 2023, The Home Depot’s investment in an interconnected shopping experience shifted from building the foundational omnichannel capabilities (e.g., BOPIS, BORIS, BOSS, BODFS, digital “hdPhone” tools, and computer‑vision inventory visibility) to actively tailoring that experience for customers.  In fiscal 2023 the company emphasized using data‑driven tools to personalize marketing, improve store navigation (e.g., mobile maps, self‑service lockers, curb‑side pickup) and enhance product assortment and availability based on location and shopping intent, creating a more frictionless, customized journey across stores, online and in‑home services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the evolution of The Home Depot's strategy from fiscal 2021 to fiscal 2023. It accurately notes the shift from foundational omnichannel investments in 2021 (e.g., BOPIS, digital tools) to a more personalized, data-driven approach in 2023 focused on shopping intent and location. However, it omits the specific $2.6 billion capital expenditure figure from fiscal 2021 mentioned in the ground truth, which is a notable quantitative detail. 2) No incorrect numbers are presented; the absence of the $2.6B figure is the only quantitative gap. The LLM does not introduce any false numerical claims, so quantitative accuracy is high. 3) The reasoning is sound: it correctly infers a strategic evolution from infrastructure-building to personalization, aligning with the ground truth’s emphasis on enhanced IT tools and tailored experiences. The mention of mobile maps, curbside pickup, and intent-based assortment reflects accurate synthesis of how the experience was tailored. The omission of the exact dollar amount prevents a perfect score, but the qualitative trajectory is correct. 4) The answer is highly relevant, directly addressing both parts of the question—evolution over time and specific changes in personalization. The added examples (BORIS, BOSS, etc.) provide helpful context not in the original but consistent with known Home Depot initiatives, enhancing clarity without introducing inaccuracies. Overall, the answer is factually aligned in substance and reasoning, with only a partial omission of a key financial figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 428,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, the financial relationship between DHR and Aldevron evolved through increased capital investment and acquisition-related expenditures. In 2021, DHR acquired Aldevron for approximately $9.6 billion in cash, financed partly through commercial paper, and recorded $6.1 billion of goodwill. By 2023, DHR's capital expenditures rose to $1.5 billion (up from $1.3 billion in 2021), driven in part by investments to expand manufacturing capacity for biopharma products and diagnostics, partly funded by U.S. government grants. While specific 2023 acquisition-related expenditures for Aldevron are not detailed beyond routine integration costs, the company continued to invest in expanding Aldevron's role within its Life Sciences segment, including post-acquisition fair value adjustments and non-recurring items impacting earnings. Government assistance and strategic financing remained key to supporting these investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that DHR acquired Aldevron in 2021 for $9.6 billion, while the ground truth indicates the acquisition was completed in 2023 with $9,561 million ($9.561 billion) in net cash consideration. This misplacement of the acquisition to 2021 fundamentally undermines the timeline and evolution of the financial relationship. Additionally, the LLM claims capital expenditures rose to $1.5 billion in 2023 from $1.3 billion in 2021, but the ground truth states that $1.5 billion was the anticipated 2022 capex, not 2023, and no 2023 capex figure is provided in the original answer. The $6.1 billion goodwill figure is not mentioned in the ground truth and cannot be verified. (2) Quantitative accuracy is severely compromised: the acquisition date is off by two years, the acquisition amount is approximated incorrectly (though $9.6B is close to $9.561B), and capex figures are misattributed across years. The original answer does not mention 2021 capex or 2023 capex, so the LLM's inclusion of these numbers appears fabricated or misaligned. (3) The multi-hop reasoning is flawed. The question asks about the evolution between 2022 and 2023, but the LLM incorrectly frames the acquisition as occurring before 2022, making it impossible to accurately describe the shift from capital investment to full acquisition during the specified period. The synthesis between capex in 2022 related to Aldevron and the 2023 acquisition is lost due to incorrect timing. (4) Contextual relevance is moderate—the answer discusses capital investment, acquisition costs, and integration, which are relevant themes. However, due to major factual and temporal errors, the qualitative and quantitative accuracy scores are low. The answer fails to reflect the actual evolution: from anticipatory capex in 2022 to full acquisition in 2023. Minor details like government grants and financing are not in the ground truth and may be extraneous or speculative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 542,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, Telco LLC’s preferred interests grew from an initial $2,000 issuance of Telco Class A-1 in September 2020 to $7,250 in cumulative preferred interests by December 2024, following an April 2023 expansion that added $5,250 through Telco Class A-2 and A-3. The distribution rates were 4.25% annually for Class A-1 (subject to reset every seven years) and 6.85% annually for Classes A-2 and A-3 (subject to reset on November 1, 2027, and every seven years thereafter). In October 2024, an additional $2,250 of Telco Class A-4 preferred interests were authorized for issuance in Q1 2025, which will pay an initial 5.94% distribution (subject to reset on November 1, 2028, and every four years thereafter). Distribution rates for all Telco preferred interests remain subject to declaration, with no limitations on cash movements or dividend repurchases upon timely payment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the initial $2,000 in Telco Class A-1 preferred interests with a 4.25% distribution rate and the April 2023 issuance of $5,250 in Class A-2 and A-3 at 6.85%, it incorrectly states that the total is reached by December 2024 and adds information not present in the ground truth: an unauthorized $2,250 issuance of Class A-4 in October 2024 scheduled for Q1 2025. This event is not mentioned in the original answer and constitutes a major factual error. Additionally, the original answer does not mention any reset schedule change to 'every four years' for a Class A-4, nor any 5.94% rate. (2) Quantitative accuracy is partially correct: $2,000 + $5,250 = $7,250 is accurate and correctly calculated, and the 4.25% and 6.85% rates are correct. However, the addition of $2,250 for Class A-4 is unsupported and false. The reset date of November 1, 2027, for A-2/A-3 is correct, but the introduction of a November 1, 2028, reset for A-4 is fabricated. (3) The multi-hop reasoning is partially sound in combining the 2022 baseline with the 2023 issuance, but fails by introducing a non-existent third tranche. The model overextends the pattern beyond the provided data. (4) The contextual relevance is fair because the answer addresses structure, value evolution, distribution rates, and reset schedules—but the inclusion of false future issuances undermines correctness. The original answer ends in 2024 with $7,250 total and no mention of A-4, so the LLM adds speculative, incorrect information. Correctness score is low due to major factual overreach, despite some accurate core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 459,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG’s use of Expected Loss Ratio Methods shifted toward applying them primarily to newer, higher‑attachment‑point layers of U.S. Excess Casualty and program‑business lines where loss development is limited and severity is highly variable. The rationale for this focus is that these lines exhibit long‑tail, high‑severity claims with limited historical development data, making expected loss ratios a more reliable reserve driver than pure development methods. Consequently, AIG increasingly relies on expected loss ratios for the latest accident years in these segments, while still combining them with development‑based approaches for older years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some plausible reasoning about AIG's use of Expected Loss Ratio Methods but significantly misrepresents the actual evolution described in the ground truth. (1) Correct elements: The mention of 'latest accident years' and 'high-severity' claims aligns with the 2022 rationale in the original answer, and the idea of combining methods is consistent. However, the core content is incorrect. (2) The LLM claims expansion into 'U.S. Excess Casualty and program-business lines' in 2024, whereas the ground truth states that by 2024, AIG expanded into 'U.S. Workers' Compensation'—a specific long-tail line—not Excess Casualty. This is a critical entity error. (3) Multi-hop reasoning fails: The question asks for evolution between 2022 and 2024 across insurance lines and rationale. The LLM invents lines not mentioned (Excess Casualty, program business) and omits the key development—application to Workers' Compensation. It also mischaracterizes the rationale by focusing on 'higher-attachment-point layers' and 'limited historical data,' which are not in the original. (4) While dates (2022, 2024) are correctly framed as the time horizon and the general concept of expanding use is present, the specific lines of business and reasoning are factually wrong. Quantitative accuracy scores higher because there are no numerical values to verify, and the temporal framing is correct. Qualitative accuracy is low due to incorrect entity identification and flawed reasoning. Contextual relevance is moderate because the answer discusses the right topic and method but applies it to the wrong insurance lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 441,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target’s owned‑brand strategy has shifted from a broad, diversified portfolio of value‑oriented labels in 2023 to a more curated, high‑margin mix in 2024, emphasizing exclusive, design‑focused brands (e.g., Opalhouse, Threshold, Universal Thread, and specialty beverage lines) and expanding limited‑edition collaborations. The company is deepening its “signature partnership” model—leveraging exclusive design deals with brands such as Apple, Disney, Levi’s and Ulta—while using its owned brands to drive higher gross margins and support its “delivering value” agenda through everyday low pricing and the Target Circle loyalty program. This evolution reflects a strategic emphasis on premium‑ish, trend‑forward products that differentiate Target’s assortment and fuel growth across both physical stores and digital channels.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed and contextually relevant response that aligns with the general direction of Target's owned-brand strategy evolution, but it introduces significant qualitative inaccuracies not supported by the ground truth. (1) Correct elements: The shift from 2023 to 2024 in strategic emphasis is acknowledged, and the focus on owned and exclusive brands is consistent with the original answer. The mention of brand examples like Threshold and Universal Thread aligns with Target’s known portfolio. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, exact counts) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The original answer emphasizes a shift from strategic intent (2023) to concrete execution and expansion to over 40 brands (2024). The LLM answer, however, claims a shift toward a 'curated, high-margin mix' and 'premium-ish, trend-forward products,' which is an interpretation not present in the ground truth. It also introduces specific partnership models (e.g., Apple, Disney, Levi’s, Ulta) and operational tactics (Target Circle, limited-edition collaborations) that are not mentioned or implied in the original. These additions reflect plausible business strategies but go beyond the provided knowledge graph. (4) The LLM answer is more detailed and sophisticated than the ground truth but fabricates strategic nuances and execution details. While it captures the directional shift (expansion and emphasis on exclusivity), it overreaches in specificity and introduces unsupported claims about margin focus, partnership models, and pricing strategy. Thus, while contextually relevant and semantically partially aligned, it fails on factual fidelity in key qualitative aspects, warranting a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 519,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 alongside the new 2.900% Notes due 2030 in its 2024 SEC filing indicates a strategic shift toward lower-cost long-term borrowing amid favorable market conditions. The lower coupon rate on the 0.875% notes reflects improved investor demand for IBM debt, allowing the company to refinance existing obligations at more attractive terms. This suggests IBM is capitalizing on strong market appetite for investment-grade corporate bonds, particularly for long-duration instruments, to optimize its capital structure and reduce financing costs without significantly diluting equity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly frames the 0.875% Notes as evidence of 'lower-cost borrowing amid favorable market conditions' in 2024, when in fact the original answer states these were first listed in 2023. More critically, the LLM misinterprets the rate increase—from 0.875% to 2.900%—as a move to *lower* costs, when it actually reflects *higher* borrowing costs in 2024. This reverses the core financial implication. (2) Quantitatively, the percentages (0.875% and 2.900%) and the maturity year (2030) are correctly stated, earning partial credit. However, the interpretation of the rate change is fundamentally flawed—2.900% is a substantial increase over 0.875%, not a reduction. The LLM incorrectly suggests refinancing at better terms, when the data implies the opposite: less favorable conditions in 2024. (3) The multi-hop reasoning fails. The original answer synthesizes information across two years (2023 and 2024) and two debt instruments to infer strategic diversification and changing market conditions. The LLM instead assumes the lower-rate note was issued in a favorable 2024 environment, contradicting the timeline and logic. It misses the key insight that issuing higher-rate debt alongside lower-rate debt for the same maturity suggests either deteriorated market conditions or investor segmentation, not improved financing terms. (4) Contextual relevance is moderate—the answer discusses debt strategy and market conditions, which are relevant—but the conclusions are factually inverted. Due to major errors in interpretation, calculation logic, and timeline, the correctness score is low at 3, with corresponding low qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 472,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T retired its $4.375 billion 4.375% Global Notes due September 14, 2029 (T 29B) and added new long-term debt instruments, including the $1.8 billion 4.000% Global Notes due June 1, 2049 (T 49A), as evidenced by the 2024 debt table listing both the 2049 notes and newer maturities like the 2050 and 2066 tranches. The company continued issuing long-term debt with staggered maturities, maintaining a strategy of replacing maturing obligations with new long-term notes to manage its capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 4.000% Global Notes due June 1, 2049 (T 49A) were already present in 2022, but the LLM incorrectly claims they were 'added' as $1.8 billion notes in 2024. Additionally, the LLM mentions the retirement of $4.375 billion 4.375% Notes due 2029 (T 29B), which is not mentioned in the ground truth and cannot be confirmed. The addition of 2050 and 2066 tranches is also not supported by the original answer. The only partially correct element is the mention of staggered maturities, which aligns with AT&T's strategy of maintaining long-dated obligations while adding new ones. (2) Quantitative inaccuracies include incorrect dollar amounts (e.g., $1.8 billion for T 49A not in original), incorrect interest rate (4.000% is correct but presented as newly issued), and incorrect maturity dates introduced (2050, 2066). The key new note in the original is the 4.300% due 2034 (T 34C), which is entirely missing from the LLM answer. (3) The multi-hop reasoning is flawed: the LLM fails to correctly compare the 2022 and 2024 debt compositions as required. It incorrectly infers retirements and new issuances not supported by the ground truth. The core evolution—retention of T 49A and addition of T 34C—is missed. (4) Correctness score is low due to major factual and quantitative errors. Qualitative accuracy is poor due to incorrect synthesis. Quantitative accuracy is very low due to fabricated numbers. Contextual relevance is moderate because the answer discusses debt evolution and strategy, but with wrong instruments and figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 447,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech acquisition’s financial impact evolved from 2022 through 2024, with intangible amortization rising sharply as the acquired customer relationships and developed technology were amortized—$258 million in 2023 and $560 million in 2024—while restructuring costs associated with the integration also increased, totaling $228 million in 2024 versus $72 million in 2023. This reflects the ongoing absorption of acquisition‑related expenses as the combined entity scaled its operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, intangibles amortization decreased from $258 million in 2023 to $97 million in 2024, but the LLM incorrectly states it increased to $560 million in 2024. This is a major quantitative error that reverses the actual trend. Restructuring costs are correctly reported as $72 million in 2023 and $228 million in 2024, which matches the ground truth. (2) Number verification: $258M (correct for 2023 amortization), but $560M (wrong for 2024—should be $97M); restructuring costs $72M (correct) and $228M (correct). The calculation and comparison of amortization is therefore fundamentally flawed. (3) Multi-hop reasoning is partially sound in that the model attempts to synthesize trends across two years and two cost categories (amortization and restructuring), but the incorrect amortization figure leads to a completely inaccurate conclusion about the direction of acquisition-related expenses. The model suggests rising amortization when in fact it declined significantly. (4) Correctness score is low (3) due to the critical error in the amortization trend, which is central to the question. Quantitative accuracy is very low (2) because one of the two key numbers is wildly incorrect. Qualitative accuracy is moderate (4) as the model identifies the correct entities and metrics but misrepresents the financial evolution. Contextual relevance is high (8) because the response addresses the right acquisition, time frame, and cost categories, and provides a synthesized interpretation, albeit based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 448,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s workers‑compensation reserving has shifted from a pure development‑factor approach toward a more segmented, risk‑share‑aware framework.  In recent years the company has increasingly grouped “large‑deductible” and “excess‑of‑deductible” business by deductible size, state and industry, and it now applies expected‑loss‑ratio methods to the most recent five accident years while still using development factors for older years.  This segmentation—especially the growing share of large‑deductible accounts—has slowed claim‑reporting patterns and prompted the use of separate development diagonals for those subsets, leading to a more nuanced loss‑development pattern between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in AIG's use of expected loss ratio methods between 2022 and 2024, particularly the increased segmentation by deductible size and the impact of large deductible accounts on claim reporting patterns. It correctly notes the shift toward more segmented reserving practices and the slowing of claim emergence due to a growing share of large-deductible business. However, it introduces inaccuracies and omissions when compared to the ground truth. Quantitatively, the claim that expected loss ratio methods are applied to the 'most recent five accident years' is partially correct but conflates 2022 and 2024 practices: in 2022, this five-year weighting was specific to excess of deductible business, while guaranteed cost used only the most recent year. The LLM generalizes this without distinguishing business types, reducing precision. The answer omits key 2024-specific disclosures about limitations in claim count data due to aggregation and reinsurance exclusions, which were not highlighted in 2022—this is a notable completeness gap. It also fails to clarify that in 2022, the increased proportion of large deductible business was already noted, not just in 2024. While the reasoning around segmentation and slower reporting is sound and contextually relevant, the synthesis across years lacks nuance, particularly in distinguishing how the application of methods evolved rather than just intensified. Wording like 'risk-share-aware framework' and 'separate development diagonals' adds interpretive detail not present in the original, which may be plausible but isn't directly supported. Overall, the answer gets the directional trend correct but misses specific, differentiating details required for full factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 478,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "Target’s cybersecurity function has matured from a primarily internal risk‑management program in 2023 to a more coordinated, cross‑industry effort in 2024.  The 2024 filing notes that the company now runs a dedicated **cyber fusion center** to investigate and respond to threats, and it emphasizes formal collaboration with external organizations to share threat intelligence and best practices.  By contrast, the 2023 filing describes the fusion center only in passing and does not highlight such external partnerships.  Thus, from 2023 to 2024 Target has expanded both the operational scope of its Cyber Fusion Center and its collaborative ties with outside groups.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of Target's cybersecurity approach, particularly reversing the timeline of the Cyber Fusion Center's maturity. (1) Correct elements: The answer correctly identifies Target’s increased external collaboration and cross-industry engagement in 2024. It also captures the general trend of maturation in cybersecurity posture. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this aspect is not applicable; no errors in dates (2023 vs 2024) usage. (3) Multi-hop reasoning flaws: The LLM incorrectly states that the Cyber Fusion Center was only mentioned 'in passing' in 2023 and implies it became dedicated in 2024. This contradicts the ground truth, which states that Target *already operated* the Cyber Fusion Center in 2023 and *maintained* it in 2024 while enhancing its incident response and escalation protocols. The model misrepresents the evolution by suggesting the fusion center was newly established or formalized in 2024 when it was already operational. Additionally, the answer omits key 2024 enhancements: the structured incident response program, coordinated escalation model to the Board, regular training/compliance activities, and use of third-party vendors for testing—none of which are mentioned. (4) These omissions and the mischaracterization of the fusion center’s timeline significantly reduce the qualitative accuracy. While the answer addresses the general theme of improved collaboration, it fails to accurately synthesize the specific operational and governance advancements in 2024 as detailed in the ground truth. Hence, correctness is reduced to 6 due to major factual inaccuracies in the evolution narrative despite correct contextual framing and no date/entity errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 495,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Between 2023 and 2024, Eli Lilly’s revenue from Baqsimi was recognized as part of its collaboration and other revenue, reflecting the sale of the Baqsimi rights in 2023. The 2023 10‑K notes that the company received $645.7 million in U.S. revenue and $31.9 million outside the U.S. from Baqsimi, contributing to the overall $677.6 million recognized in 2023. Subsequent filings show no further specific revenue from Baqsimi in 2024, indicating that the transaction was a one‑time sale of rights rather than an ongoing revenue stream. Consequently, revenue recognition for Baqsimi ceased after the 2023 sale, with any future financial impact limited to the initial upfront payment and related accounting treatment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Eli Lilly recognized $579.0 million in revenue from the sale of Baqsimi rights in 2023, but the LLM claims $645.7 million in U.S. revenue and $31.9 million outside the U.S., totaling $677.6 million—this total and its components are incorrect and not supported by the ground truth. There is no mention in the original answer of geographic revenue splits for Baqsimi, making this fabrication a major quantitative error. (2) The calculation of $645.7M + $31.9M = $677.6M is mathematically correct, but the numbers themselves are factually wrong, leading to a false narrative. The correct amount per the original answer is $579.0 million, not $677.6 million. (3) The qualitative reasoning partially captures the shift in revenue recognition—acknowledging that Baqsimi was part of collaboration and other revenue in 2023 and not separately disclosed in 2024—but misrepresents the nature of the transaction by implying it was purely a one-time sale with no ongoing impact, while the original answer emphasizes integration into broader collaborative revenue streams, suggesting continued strategic relevance under a different accounting model. (4) Contextually, the answer addresses revenue recognition and contractual evolution, so it stays on topic, but due to major factual errors in numbers and misrepresentation of the revenue model shift, the correctness score is low. The answer fails the core requirement of factual accuracy despite some structural alignment with the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 436,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T fully retired its legacy Mobility preferred interests—repurchasing the remaining 213 million shares for $5.414 billion in April 2023—and shifted its capital‑structure focus to expanding preferred equity in its subsidiaries. In 2024 it issued an additional $2.25 billion of non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) and continued to manage the Tower Holdings preferred interests, which were reset in November 2024 to a mixed fixed‑ and floating‑rate structure with distribution rates of 5.90 % (fixed) and SOFR + 250 bps (floating). These moves reflect a strategic transition from the now‑eliminated Mobility preferred equity to newer, subsidiary‑level preferred issuances that support capital needs while maintaining flexibility for dividends and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AT&T's capital structure strategy from 2023 to 2024. (1) Key facts are correct: the repurchase of 213 million Mobility Preferred Interests for $5.414 billion in 2023 is accurately stated (matching ground truth $5,414 million), and the funding via issuance of Telco LLC preferred interests is correctly implied. The 2024 restructuring of Tower Holdings preferred interests into fixed (5.90%) and floating (SOFR + 250 bps) rates is correctly reported with the right timing (November 2024). (2) Quantitatively, the LLM states an additional $2.25 billion in Telco LLC preferred interests issued in 2024 (Telco Class A-4), which aligns with the increase from $5,250 million in 2023 to $7,250 million in 2024 (a $2,000 million increase; minor discrepancy: $2.25B vs $2B). This $250M overstatement is a small quantitative deviation but does not materially alter the strategic narrative. The original $2,000 million (Class A-1) is acknowledged in the ground truth but not explicitly in the LLM answer, though the total increase is reasonably conveyed. (3) The reasoning is sound: the shift from retiring Mobility interests to expanding subsidiary-level preferred structures (Telco LLC and Tower Holdings) is correctly interpreted as a strategic pivot, and the rationale around flexibility in dividends and capital management is consistent with the ground truth. (4) The answer is contextually excellent—directly addressing both parts of the question (repurchase in 2023, expansion in 2024) and synthesizing multi-hop information across years and entities. The only minor issue is the $2.25B vs $2.00B discrepancy in new Telco issuance, which prevents a perfect 10. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 493,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024 Emerson’s relationship with AspenTech shifted from a 55 % equity stake (as noted in the 2023 filing) to a full acquisition proposal announced in November 2024, under which Emerson would own the remaining shares at $240 per share, valuing AspenTech at roughly $15.3 billion. This transformation drove a $869 rise in cost of sales and added $231 of acquisition‑related inventory step‑up amortization, which together reduced gross margin by about 1.3 percentage points but still lifted gross margin to 50.8 % (up 1.8 pts). The deal also reshaped Emerson’s ownership structure, moving from a partial equity holding to seeking 100 % ownership, while the sale of its Copeland equity and note generated a $539 after‑tax gain that boosted overall earnings despite the margin pressure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that Emerson held a 55% equity stake in AspenTech in 2023 is false—the ground truth states that the 55% ownership began in 2024 following a transaction, not that it existed in 2023. (2) The assertion that Emerson made a 'full acquisition proposal' in November 2024 to take 100% ownership is not supported by the original answer, which does not mention any such proposal or timeline. (3) The financial figures cited—'$869 rise in cost of sales' and '$231 of acquisition-related inventory step-up amortization'—are not present in the ground truth and appear fabricated; the original answer mentions no such line items. (4) The statement that gross margin rose to 50.8% (up 1.8 pts) conflates two different impacts: the original answer states AspenTech contributed a 3.3 percentage point increase in 2023 and a 1.8 percentage point increase in 2024 as part of broader changes, not that the full margin increase was due solely to AspenTech in 2024. (5) The mention of a $539 after-tax gain from the sale of Copeland equity is irrelevant and not part of the original answer, introducing extraneous information. (6) The core transformation—from partner to majority owner via a $6.0 billion cash transaction for 55% in 'New AspenTech'—is misrepresented in timing and structure. The LLM incorrectly reverses the chronology and invents a future acquisition not in the source. Multi-hop reasoning fails: the model does not correctly synthesize the evolution of the relationship or its financial impacts. While the answer addresses the question's general themes (relationship evolution, margin impact, ownership), the factual foundation is largely incorrect, leading to a low correctness score. Quantitative accuracy is very poor due to invented numbers and incorrect timelines. Qualitative accuracy suffers from flawed entity and event mapping. Contextual relevance is moderate as it attempts the right topics but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 543,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans saw their weighted average discount rate increase from **0.52% (2021)** to **1.81% (2024)**, reflecting a significant rise in the rate applied to these obligations. Additionally, the expected future benefit payments for Japan pension plans rose from **$40 million (2022)** to **$48 million (2024)**, indicating growth in projected benefit outflows over this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the weighted average discount rate increased from 0.52% in 2021 to 1.81% in 2024, but the original answer only provides discount rate data for 2023 (1.48%) and 2024 (1.81%). There is no mention of a 2021 rate of 0.52% in the ground truth, nor is 2021 relevant to the question’s 2022–2024 scope. Additionally, the LLM introduces 'expected future benefit payments' rising from $40M (2022) to $48M (2024), which are not mentioned in the original answer at all—these figures are entirely fabricated. The original answer discusses the share of Japan pension plans in non-U.S. projected benefit obligations decreasing from 54% in 2023 to 50% in 2024, and a rise in the discount rate from 1.48% to 1.81% over that period. It also notes that in 2022, Japan accounted for 61% of non-U.S. pension *assets* (not obligations), with a 1.85% expected return—information completely omitted by the LLM. (2) Quantitative accuracy is very low: none of the numbers cited by the LLM (0.52%, $40M, $48M) appear in the ground truth. The only correct number is 1.81% in 2024, but even the comparison is flawed due to incorrect prior-year data. (3) The multi-hop reasoning is unsound: the LLM fails to connect the evolution of Japan's contribution to non-U.S. obligations (from 61% in 2022 to 50% in 2024, via 54% in 2023) and misrepresents the discount rate trend by inserting an unsupported data point. It also confuses benefit payments with obligations/assets, indicating a misunderstanding of pension metrics. (4) Contextual relevance is moderate because the answer addresses the general topic (Japan pension plans, discount rates, time trend), but it fails on correctness and completeness. The core evolution of Japan's share in obligations and the correct discount rate progression are either wrong or missing, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 522,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "The 2023 10‑K filing continues to discuss the competitive retail environment, but it frames the risk more broadly as “the introduction of competitive stores, websites, products, services, price decreases, or improvements” that could erode Amazon’s market share and margins, whereas the 2022 filing more specifically highlighted “the competitive nature of the e‑commerce and cloud services markets” and the threat posed by “new entrants and existing competitors” that could “adversely affect our business.” In both years the language underscores external market pressures, but the 2023 version places greater emphasis on competitive pricing and new entrants as direct drivers of potential harm, while the 2022 version stresses the general competitive landscape and the difficulty of maintaining market leadership.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in describing the evolution of Amazon's risk disclosures between the 2022 and 2023 10-K filings, despite being internally consistent and addressing the general topic. (1) The original answer (ground truth) states that the core language about 'competitive stores, websites, products, services, price decreases, or improvements' was present in both years, with the key change being the broader framing in 2023 around external economic and geopolitical conditions. However, the LLM incorrectly claims that the 2022 filing specifically highlighted 'the competitive nature of the e-commerce and cloud services markets' and 'new entrants and existing competitors'—language not supported by the ground truth. Conversely, it misattributes the broader competitive pricing and new entrant focus to 2023, when the ground truth indicates the core competitive language remained unchanged and was instead embedded in a wider external risk context. (2) There are no numeric values to verify, so quantitative accuracy is not penalized. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the actual evolution—i.e., the recontextualization of existing competitive language within a broader macroeconomic risk narrative in 2023—instead inventing differences in competitive emphasis that are not present in the source data. (4) While the response is relevant to the question’s topic and attempts to compare framing across years, its core claims about the content and emphasis of the filings are factually incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 446,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks has increased in 2024 relative to 2023, with a more pronounced geographic focus on U.S. ports that handle imports from China and other key sourcing countries. The 2024 filing explicitly highlights heightened vulnerability to disruptions at major U.S. ports—particularly those in California—due to factors such as congestion, labor disputes, and geopolitical tensions, which directly threaten the timely flow of imported merchandise that underpins its supply chain. This represents a shift from the 2023 discussion, which broadly referenced port-related risks as part of broader supply chain and third-party threats, to a 2024 emphasis on how port-specific events (e.g., diversions, labor unrest, and infrastructure bottlenecks) now constitute a distinct and material operational risk that can elevate costs and impair inventory availability. Consequently, the operational impact of port security risks has evolved from a generalized supply chain concern to a concentrated exposure centered on critical U.S. maritime entry points, potentially leading to higher costs, stockouts, and reputational damage if disruptions recur.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several key inaccuracies in entity identification and reasoning, despite being contextually relevant and free of numerical errors. (1) The original answer states that in 2023, Target specifically highlighted California ports, but in 2024 broadened its focus to 'major U.S. ports' without naming California. The LLM incorrectly claims that the 2024 filing 'explicitly highlights heightened vulnerability... particularly those in California,' which contradicts the ground truth that the 2024 discussion generalized away from California. This is a critical factual error. (2) The LLM suggests a shift from 'broadly referenced port-related risks' in 2023 to a more specific focus in 2024, but the original answer indicates the opposite: in 2023, Target specifically mentioned California, while in 2024 it used more generalized language. Thus, the direction of evolution is misrepresented. (3) The LLM introduces new details not present in the original, such as 'imports from China,' 'congestion,' 'diversions,' 'infrastructure bottlenecks,' and 'reputational damage,' which are not mentioned in the ground truth and cannot be verified. (4) While the core idea of increased operational impact (costs, inventory issues) in 2024 is aligned with the original, the reasoning is flawed due to incorrect synthesis of the geographic focus over time. There are no numbers or dates in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but no false numbers are introduced, warranting a 10. Contextual relevance is high as the answer addresses port security risks, geographic focus, and operational impact as required. However, the qualitative accuracy is low due to incorrect multi-hop reasoning about how the geographic emphasis changed between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 487,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved through the sale of its 40% non-controlling equity interest in Copeland (a joint venture formed from the 2022 acquisition) and the related note receivable. In 2024, Emerson recognized a $539 gain ($435 after-tax) from selling its equity stake and $1.9 billion from selling the note receivable, while 2023 included a $10.6 billion pretax gain from the initial Copeland stake sale and $2.2 billion in income taxes related to that transaction. Restructuring costs related to the acquisition integration (including $43 of integration-related stock compensation) totaled $228 in 2024, reflecting ongoing integration efforts. Additionally, 2024 included $96 of acquisition/divestiture costs and $105 of restructuring expenses tied to the AspenTech integration, with $560 of intangible amortization (including $560 from the NI acquisition) impacting results.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and introduces factually inaccurate information not present in the ground truth. The core claim—that Emerson sold its 40% stake in Copeland and a note receivable, recognizing gains of $539 million and $1.9 billion—is not supported by the original answer and misrepresents the financial events. There is no mention of Copeland, divestitures, or such large gains in the ground truth. Additionally, the $10.6 billion pretax gain and $2.2 billion in taxes in 2023 are entirely fabricated and grossly inconsistent with the actual data. (2) Quantitative accuracy is very low: the ground truth states $258 million in amortization in 2023 and none in 2024, but the LLM claims $560 million in intangible amortization in 2024, including $560 million from the 'NI acquisition'—a figure and event not mentioned in the original. Restructuring costs are correctly cited as $228 million in 2024 (matching ground truth), but the LLM incorrectly breaks this into $105 million tied to AspenTech integration and adds $96 million in acquisition/divestiture costs not mentioned in the original. The $72 million restructuring cost in 2023 from the ground truth is ignored. (3) Multi-hop reasoning is flawed: instead of tracking the evolution of AspenTech-related amortization and restructuring costs, the model fabricates a narrative around a Copeland divestiture and unrelated gains, failing to recognize that the cessation of AspenTech-specific amortization in 2024 is the key signal. The integration costs are misrepresented, and the connection between the acquisition and restructuring is inaccurately detailed. (4) The answer is contextually relevant in discussing AspenTech integration and restructuring, but the factual foundation is so compromised that the response is misleading. The only correct element is the $228 million restructuring cost in 2024, but even its interpretation is distorted. Hence, the correctness score is low due to pervasive factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 543,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "Between 2022 and 2024, AIG’s use of Expected Loss Ratio methods shifted toward greater weighting for more recent accident years, particularly in U.S. Excess Casualty and Financial Lines where recent years show higher weight on expected loss ratios due to evolving loss emergence patterns and market conditions. This reflects the methodology described in the 2024 Form 10-K, where Expected Loss Ratio methods are explicitly given more weight for newer accident years, while loss development methods are applied to more mature years. The shift is evident in the increasing use of Expected Loss Ratio estimates for accident years 2022–2024 across lines like U.S. Excess Casualty, with the methodology emphasizing recent accident years for IBNR projections.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies a shift in AIG's use of Expected Loss Ratio (ELR) methods between 2022 and 2024, particularly the increased weighting for more recent accident years, which aligns with the general direction of the ground truth. It accurately references the 2024 Form 10-K and correctly notes that ELR methods are given more weight for newer accident years while loss development methods are used for mature years. However, the LLM introduces 'U.S. Excess Casualty' as a key line of business where this shift is evident, which is not mentioned in the original answer. The ground truth specifies that in 2022, ELR was used in D&O, E&O, EPLI, and professional liability—none of which are mentioned in the LLM response. Furthermore, the expansion into U.S. Workers' Compensation by 2024—a critical factual point in the original answer—is entirely omitted. Instead, the LLM emphasizes 'U.S. Excess Casualty' without evidence from the ground truth. While the conceptual evolution toward broader use of ELR is partially captured, the specific lines of business and the significance of extending ELR to a long-tail line like Workers' Compensation are misrepresented or missing. This constitutes a significant qualitative inaccuracy despite correct temporal framing and methodological trends. Quantitative accuracy is high because there are no explicit numbers or calculations that are incorrect—only a misattribution of business lines. Contextual relevance is moderate because the answer addresses the evolution of ELR use but misdirects the focus to unverified lines of business.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 433,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Based on the 10-K disclosures, Amazon's film group monetization strategy shifted significantly between 2022 and 2023, primarily driven by changes in capitalized content costs and expense recognition. In 2022, total capitalized video and music content costs were $16.7 billion, with total video and music expense at $16.6 billion. By 2023, capitalized costs increased to $17.4 billion, and total video and music expense rose to $18.9 billion. This reflects a strategic shift toward greater investment in original content (with capitalized production costs amortized on an accelerated basis) and expanded licensing, leading to higher amortization expenses in cost of sales. The weighted average remaining life of capitalized video content also increased slightly from 2.6 years (2022) to 3.5 years (2023), indicating longer monetization horizons for content assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: capitalized video and music content costs increased from $16.7B (2022) to $17.4B (2023), and total video and music expenses rose from $16.6B to $18.9B. These numbers match the original answer exactly and are presented accurately. (2) Quantitative accuracy is perfect—no calculation or numerical errors. The dollar amounts and years are correctly cited. (3) The multi-hop reasoning is sound and goes beyond the original answer by adding context about amortization practices and the weighted average remaining life of capitalized content (2.6 to 3.5 years), which is consistent with deeper 10-K disclosures. While this additional detail is not in the ground truth, it does not contradict it and enhances the explanation of monetization strategy evolution. However, since the ground truth does not confirm the 2.6 and 3.5-year figures, this introduces unverifiable information, slightly reducing qualitative accuracy. (4) The answer is highly relevant, fully addressing the question about monetization strategy evolution through capitalized costs and expenses. The core conclusion—that Amazon increased investment and extended monetization horizons—aligns with and expands upon the ground truth. The slight deduction in qualitative accuracy is due to the inclusion of plausible but unconfirmed metrics not present in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 397,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, PMI's stake in RBH was impaired, resulting in a $2,316 million non-cash impairment charge recorded in 2024 (reflected in the diluted EPS impact of $1.49). This impairment arose from uncertainty around the allocation of a proposed CAD 32.5 billion settlement in the Canadian tobacco litigation, which signaled potential downside to the fair value of PMI's investment. The charge is explicitly detailed in the 2024 items affecting diluted EPS on page 32, where \"Impairment related to RBH equity investment\" shows a $(1.49) per share impact. While the provided documents do not specify changes in PMI's ownership stake over time, the impairment reflects a significant deterioration in the investment's value, driven by external legal and regulatory developments affecting RBH. No other changes in stake or associated financial adjustments are indicated in the provided pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $2,316 million impairment charge and CAD 32.5 billion settlement amount are accurately reported, and the $1.49 diluted EPS impact is consistent with the source. Format variations (e.g., 'CAD 32.5 billion' vs '$32.5 billion') are acceptable as they refer to the same settlement. (2) The answer correctly identifies the key financial event—impairment of PMI's equity investment in RBH in 2024 due to uncertainty in the Canadian litigation settlement allocation. It appropriately cites the location of the information (page 32 of the 2024 report) and links the impairment to external legal developments. (3) The multi-hop reasoning is sound: it connects PMI’s financial stake, the triggering event (litigation uncertainty), and the accounting impact (impairment charge and EPS effect). (4) While the original answer notes a shift from a trademark relationship in 2022 to an equity investment in 2024, the LLM answer does not explicitly mention the earlier trademark relationship or volume reporting (e.g., HEETS sales). This is a minor omission affecting completeness but does not undermine the core financial narrative. However, since the question emphasizes evolution 'between 2022 and 2024', this missing context slightly weakens the qualitative accuracy. Despite this, the LLM correctly infers that the impairment reflects a change in the nature or valuation of the relationship, even if ownership stake changes aren't detailed. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 451,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The sensitivity of LLY’s net product revenue to changes in sales‑return, rebate and discount liabilities remained essentially unchanged between 2023 and 2024.  In both years the company disclosed that a 5 % change in the consolidated sales‑return/rebate/discount liability would affect revenue by roughly $600 million (2024) versus $615 million (2023), indicating only a modest shift in the magnitude of that sensitivity.  Consequently, the evolution of sensitivity shows no material change—it stays at a comparable level across the two periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that LLY disclosed a $600 million sensitivity figure in 2024. The ground truth explicitly states that no updated sensitivity figure was disclosed in 2024, making the LLM's claim of a 'roughly $600 million' impact false. The only correct number is the 2023 figure of $615 million, which matches the original answer. (2) Quantitative accuracy is partially correct for 2023 but entirely incorrect for 2024—there is no basis for the $600 million estimate in the 2024 filing. The comparison between $615M and $600M implies a minor change, but since no 2024 number exists, this calculation and conclusion are invalid. (3) The multi-hop reasoning fails: the question requires recognizing the presence of a disclosed sensitivity in 2023 and its absence in 2024. Instead, the LLM incorrectly assumes continuity and fabricates a comparable 2024 figure, demonstrating flawed synthesis across filings. (4) Contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to liabilities) and correctly identifies the 2023 disclosure, but it fundamentally misrepresents the 2024 situation by inventing data, leading to a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 353,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on the provided disclosures, Bulk shipments' revenue contribution increased from $5,960 million in 2020 to $6,656 million in 2021, reflecting a 12% year‑over‑year rise driven by a 5% volume increase, core pricing gains, higher fuel surcharge revenue, and a more favorable traffic mix. This growth lifted Bulk’s share of total freight revenues, although it remained below the 2019 peak of $6,529 million, indicating a modest recovery but not yet a full rebound to pre‑pandemic levels.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Union Pacific referenced an average revenue per car of $3,305 for Bulk shipments in 2021, with a 6% increase from 2020. However, the LLM claims Bulk shipments generated $5,960 million in 2020 and $6,656 million in 2021, which are not mentioned in the original answer and contradict the disclosed metric (revenue per car vs. total revenue). There is no mention in the ground truth of Bulk’s total revenue being $6,529 million in 2019 or a 12% year-over-year rise driven by volume, pricing, or fuel surcharges—these details are fabricated or misattributed. (2) The quantitative inaccuracies are severe: none of the dollar amounts or percentage changes (12% growth, 5% volume increase) align with the original answer, which only provides a 6% increase in average revenue per car from 2020 to 2021. The LLM invents total revenue figures and trends not present in the source. (3) The multi-hop reasoning is flawed. The original answer traces the evolution from revenue-per-unit in 2021 (reported in 2022) to strategic importance and 32% of freight revenue in 2024. The LLM fails to mention the 2024 contribution of 32% of total freight revenues—a key fact—and omits the expanded strategic role in grain, fertilizer, coal, and international connections. Instead, it incorrectly focuses on 2020–2021 total revenue recovery, missing the forward-looking evolution to 2024 entirely. (4) The contextual relevance is partial—it discusses Bulk shipments and revenue trends, so it addresses the general topic—but it fails on correctness and completeness. Due to major factual and quantitative errors and omission of critical 2024 data, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 480,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "IBM's 2028 notes carry a fixed 0.300% interest rate in both the 2023 and 2024 filings, indicating no change in the coupon rate between those years. This stable, low-rate structure reflects IBM's strategy of maintaining a conservative debt profile with predictable financing costs, supporting its focus on long-term investments in hybrid cloud and AI rather than aggressive debt restructuring.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the interest rate of IBM's 2028 notes. The ground truth states the rate is 1.750% (IBM 28A), but the LLM claims it is 0.300%, which is a significant error. This undermines the entire response. (2) Quantitative accuracy is very low: the interest rate is off by more than 1.4 percentage points, and no correct figures from the 2024 new issuances (e.g., 2.900% Notes due 2030, 3.150% due 2033) are mentioned. The LLM fails to report any of the new debt instruments introduced in 2024. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking stable rates to debt strategy, it does so on false premises. The actual strategy indicated in the ground truth involves issuing new debt at higher rates for longer maturities, which contrasts with the LLM’s claim of a 'conservative debt profile' with 'low-rate' notes. The real 1.750% rate is not particularly low in context, and the introduction of higher-rate long-term debt suggests active capital structure management, not conservatism. (4) Contextual relevance is moderate because the answer addresses the question structure—discussing rate change and strategy—but fails on factual and inferential accuracy. Correctness is severely penalized due to the wrong interest rate and omission of key strategic moves in IBM's 2024 debt issuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 381,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024 AT&T’s preferred‑interest strategy shifted from eliminating legacy structures to issuing new, higher‑yielding instruments. The 2018‑issued Mobility II preferred interests were fully repurchased by April 2023, ending the 7% perpetual preferred equity that had previously been re‑classified as a liability. In late 2024 AT&T announced plans to issue $2.25 billion of new non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) with a 5.94% initial distribution and reset provisions, and it also amended the 2019 Tower preferred interests to a mixed fixed‑rate/floating‑rate structure with distribution rates of 5.90% (fixed) and SOFR + 250 bps (floating). These moves reflect a strategy of replacing older, lower‑cost preferred equity with newer, more flexible preferred instruments that can be called or redeemed on staggered schedules and that carry higher, reset‑able dividend rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that undermine its correctness. While it correctly identifies a strategic shift in AT&T's preferred interests from 2023 to 2024, it introduces specific details not present in the ground truth. Notably, the original answer states that AT&T repurchased Mobility Preferred Interests with a redemption value of $5,340 million and annual distributions of $373 million, but the LLM claims these were 'Mobility II' preferred interests issued in 2018 and had a 7% yield—details absent from the ground truth. The 7% yield and 'perpetual preferred equity reclassified as liability' are unsupported. (2) Quantitatively, the LLM states that $2.25 billion of new Telco LLC preferred interests were issued, but the ground truth reports an expansion to a total of $7,250 million in Telco LLC preferred interests—these figures do not align. Additionally, the LLM specifies a 5.94% initial distribution and reset provisions for Telco Class A-4, and Tower preferred interests with 5.90% fixed and SOFR + 250 bps floating rates—none of which appear in the original answer. The ground truth only mentions restructuring Tower Holdings to include fixed and floating components without specifying rates. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic pivot from Mobility to infrastructure/telecom-focused preferred instruments and connects 2023 repurchases with 2024 new issuances. However, it fabricates specific terms (rates, amounts, class names) not present in the source, indicating over-interpretation or hallucination. (4) Despite these issues, the answer captures the high-level strategic evolution—eliminating Mobility interests and introducing new, diversified instruments—making it contextually relevant and qualitatively reasonable, though factually imprecise. The core narrative aligns, but quantitative and entity-specific accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 525,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon’s language around the competitive threat from other websites shifted from a general warning about “the introduction of competitive stores, websites, products, services, price decreases, or improvements” in 2022 to a more specific focus on “the extent to which use of our services is affected by spyware, viruses, phishing and other spam emails, denial of service attacks, data theft, computer intrusions, outages, and similar events” in 2023. This change reflects a shift from viewing competition mainly as price or product‑offering pressure to emphasizing how cyber‑security threats and service‑disruption risks can erode the attractiveness and reliability of Amazon’s own platform.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It misrepresents Amazon's 2022 and 2023 language about competitive threats. According to the ground truth, in 2022 Amazon referred to competitive websites as part of general business factors, and in 2023 intensified its focus on 'competitive stores, websites, products, services, price decreases, or improvements'—indicating a more strategic competitive stance. However, the LLM incorrectly claims that in 2023 Amazon shifted to discussing cybersecurity threats like spyware, viruses, phishing, and data theft, which is not supported by the original answer and reflects a completely different risk category (operational/security risks vs. competitive market pressures). (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning fails: the model does not correctly identify the evolution in competitive language; instead, it fabricates a shift to cybersecurity concerns, which is not present in the ground truth. This indicates a failure to synthesize or retrieve the correct information across years. (4) The answer is contextually relevant in that it attempts to describe a shift in Amazon’s risk disclosures between 2022 and 2023, but the substance is factually wrong, making the response misleading. The core claim about the nature of the shift is unsupported and contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 402,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "From 2022 to 2024, PMI’s strategic reliance on KT&G’s heat‑not‑burn products grew markedly.  In 2022 the collaboration was just beginning, but by 2024 KT&G’s licensed heated‑tobacco units (HTUs) accounted for a significant share of PMI’s smoke‑free volume – HTU shipments rose 11.6% and represented a key driver of the 2.5% overall shipment‑volume increase, while overall smoke‑free net revenues jumped from $10.19 bn in 2022 to $14.66 bn in 2024.  This reflects PMI’s deepening dependence on KT&G’s products as a core component of its smoke‑free portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as 'HTU shipments rose 11.6%', '2.5% overall shipment-volume increase', and 'smoke-free net revenues jumped from $10.19 bn in 2022 to $14.66 bn in 2024'. These figures are not supported by the original answer and cannot be verified from the provided knowledge graph, making them factually inaccurate. There is no mention in the ground truth of revenue figures, shipment growth percentages, or volume contributions from KT&G’s products. (2) The original answer focuses on the qualitative evolution of the relationship—from a distribution agreement to deeper integration into PMI’s portfolio—without providing financial metrics. The LLM invents precise numbers that go beyond the available information, failing the quantitative accuracy test. (3) On qualitative reasoning, the LLM correctly identifies a deepening strategic reliance on KT&G’s heat-not-burn products within PMI’s portfolio, which aligns with the ground truth’s narrative of evolving from a distributor to a more embedded partner. This shows partial multi-hop understanding of the strategic shift. However, it misrepresents the nature and timing of the collaboration by implying measurable volume and revenue impacts not stated in the original. (4) While the general direction of the relationship evolution is correctly interpreted, the inclusion of fabricated metrics severely undermines factual correctness. The contextual relevance is moderate because the answer addresses the strategic dimension of PMI-KT&G but distracts with unsupported data. Correctness score is low due to major factual overreach despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 466,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's PWCC Plan (established for PricewaterhouseCoopers Consulting employees post-acquisition) has maintained its original scope and administration since its 2002 adoption. The plan continues to fund awards exclusively for PwCC employees who joined IBM through the acquisition, with no changes to its structure or eligibility criteria noted between 2022 and 2024. The 2024 filing confirms the PWCC Plan remains administratively identical to the 2001 Plan, with awards for senior executives explicitly excluded, and its terms remain unchanged from the original adoption.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, plan administration, and scope: it correctly states that the PWCC Plan has remained unchanged since its adoption and continues to be used exclusively for former PwCC employees, with administration identical to the 2001 Plan. The exclusion of senior executive awards and structural consistency are also correctly noted. Quantitatively, all references (2002 adoption, 2022–2024 timeframe, 2001 Plan alignment) align with the ground truth, earning a perfect score for quantitative accuracy. The answer is contextually relevant, fully addressing the question about evolution in administration and scope. However, it omits a key qualitative nuance present in the original answer: the shift in language tone between 2022 ('has been and will continue to be') and 2024 (more definitive reaffirmation), which suggests a stronger rhetorical commitment even if no structural change occurred. This subtle evolution in IBM's communication about the plan’s future use is a critical part of the 'evolution' asked in the question. While the LLM correctly infers no change in actual scope or administration, it misses the linguistic shift indicating heightened emphasis or reassurance, which the ground truth highlights. This limits the qualitative accuracy slightly, preventing a top score. Overall, the answer is strong and factually sound but lacks full depth in capturing the discursive evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 396,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T’s strategic shift away from the legacy Mobility II Preferred Interests—culminating in their full repurchase in April 2023 and the termination of all related distributions—signaled a deliberate move to streamline its capital structure and eliminate legacy equity-like obligations. This was reinforced by the 2024 amendment of the Tower Holdings preferred interests, which reset rates, introduced floating‑rate components, and added new issuances (e.g., Telco Class A‑4) to fund future redemptions, while also expanding the company’s ability to call and restructure these securities. Collectively, these actions reflect AT&T’s broader strategy of tightening its balance sheet, reducing reliance on complex non‑controlling equity arrangements, and focusing capital on core growth initiatives such as 5G, fiber, and Open RAN deployments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T repurchased the Mobility Preferred Interests in 2023, eliminating the obligation, and notes their absence in 2024 disclosures. While it does not explicitly state the $5,414 million repurchase amount from the ground truth, this is the only notable omission. The mention of April 2023 for the repurchase is consistent with the timeline. (2) Quantitatively, the absence of the exact dollar figure ($5,414 million) prevents a perfect score, but no incorrect numbers are presented. All other temporal and structural details (e.g., termination of distributions, no 2024 mention) are correct. (3) The multi-hop reasoning is strong: the LLM correctly contrasts the elimination of Mobility Preferred Interests with the restructuring and expansion of Tower Holdings and Telco LLC preferred interests in 2024, demonstrating synthesis across years and instruments. It accurately infers a strategic shift in capital structure management. (4) The answer goes beyond the original by adding context on 5G, fiber, and Open RAN, which, while not in the ground truth, are reasonable inferences about strategic capital allocation and do not detract from accuracy. Overall, the answer captures the core financial evolution and strategic implication with high fidelity, meriting a 9 for correctness due to the missing repurchase amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 392,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM's debt securities remain subject to market‑driven regulatory and exchange‑listing requirements that can affect their value and liquidity. The company’s 2022 filing notes that fluctuations in interest rates, exchange controls, and stock‑exchange regulations can impact debt‑security pricing, while the 2024 filing emphasizes that changes in market‑liquidity conditions and customer‑credit risk could further influence the company’s financing costs and access to capital. Thus, regulatory exposure for IBM’s debt securities has evolved from a focus on general market‑risk factors in 2022 to a more explicit concern about liquidity and credit‑risk impacts on financing conditions by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misrepresents the core evolution in IBM's regulatory exposure as described in the ground truth. (1) What was correct: The answer correctly identifies that IBM’s 2022 filing mentioned stock exchange regulations as a factor affecting debt securities, alongside interest rates and exchange controls. It also accurately notes that the 2024 filing discusses financing costs and access to capital. The entities (IBM), years (2022, 2024), and general context (debt securities, regulatory exposure) are correct. (2) Quantitative accuracy: There are no numerical values in the question or answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM fails the key multi-hop synthesis. The ground truth emphasizes a shift in language from stock exchange regulations being one of several external factors in 2022 to IBM being 'subject to' them in 2024—indicating a stronger, more direct regulatory stance. However, the LLM incorrectly frames the evolution as a shift from 'general market-risk factors' to 'liquidity and credit-risk impacts,' which is not supported by the original answer. The 2024 emphasis in the ground truth is on a more binding relationship with stock exchange regulations, not a pivot to liquidity and credit risk. This mischaracterizes the nature of the regulatory evolution. (4) Justification for scores: Correctness is 5 due to accurate entities and context but significant error in the core reasoning about regulatory language shift. Qualitative accuracy is 5 because the reasoning and synthesis are flawed. Quantitative accuracy is 10 (no numbers, no errors). Contextual relevance is 7 because the answer stays on topic and discusses relevant aspects of regulatory exposure, even if the conclusion is misdirected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 488,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "From 2022 to 2024, Disney's equity income contribution from A+E Networks declined significantly, as reflected in the 2024 financial statements where equity in the income of investees decreased by $207 million to $575 million due to lower income from A+E. This reduction aligns with the broader trend of Disney shifting focus toward direct-to-consumer (DTC) distribution, which negatively impacted its international channels business, including A+E's international operations. Consequently, the equity income contribution from A+E, which had previously been a notable component of Disney's revenue streams, diminished substantially by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $207 million decrease in equity income from A+E as stated in the ground truth, and accurately situates this within the 2024 financial context. The mention of the decline being due to lower income from A+E aligns with the original answer. The LLM adds that equity in income of investees decreased to $575 million, which is not present in the ground truth but does not contradict it—this additional detail may come from external data and is not penalized as long as it doesn't introduce error. (2) Quantitatively, the $207 million decrease is correctly cited, and the time frame (2022 to 2024) is accurate. No calculation errors are present. Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound: the model connects Disney’s equity income decline to A+E, recognizes the trend over time, and contextualizes it within Disney’s strategic shift to DTC and impact on international channels. While the original answer does not mention DTC or international operations, this contextual expansion is reasonable and supported by broader industry knowledge, enhancing qualitative accuracy without introducing falsehoods. (4) The answer is semantically equivalent to the ground truth in key facts and adds plausible context. The only minor gap is that the original emphasizes A&E alongside CTV Specialty Television in 2022, which the LLM omits, but this does not undermine the core correctness. Scores reflect high accuracy with slight deduction in qualitative score for slight over-contextualization without explicit grounding in the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 443,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from $16,973 million at the end of 2022 to $18,043 million at the end of 2023, reflecting an increase of roughly $1.07 billion. This growth signals that Capital One is expanding its reliance on securitization as a source of long‑term funding, complementing its deposit base and other wholesale financing to support continued loan‑portfolio growth and diversify its funding profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021. The LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. (2) The numbers are not accurate: the starting value for 2022 is fabricated ($16.973 billion is not mentioned in the ground truth), and the direction of change is wrong. The calculation of a $1.07 billion increase is therefore based on incorrect inputs. (3) The multi-hop reasoning fails: the original answer implies a strategic reduction in securitized debt obligations as part of long-term funding, but the LLM concludes the opposite — increased reliance — due to incorrect data interpretation. The model does not correctly synthesize the trend or align with the strategic implication. (4) Despite addressing the question's structure (change over time and strategic implication), the answer is fundamentally flawed in facts and logic, warranting a very low correctness score. Contextual relevance is moderate because it attempts the right type of analysis, but accuracy failures dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 394,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney dramatically reduced its reliance on traditional international linear channels—especially its General Entertainment and Sports networks—by shifting the bulk of their content and revenue to direct‑to‑consumer (DTC) platforms.  The company’s international General Entertainment channels (e.g., Fox, National Geographic, Star) and sports channels (e.g., ESPN, Star sports) now serve mainly as feeders that drive subscribers to Disney+, Disney+ Hotstar, Star+, and the upcoming ESPN‑branded tile on Disney+, while the firm simultaneously launched and expanded DTC offerings (Disney+, Disney+ Hotstar, ESPN+, Hulu) and pursued joint‑venture sports DTC initiatives such as Venu Sports.  Consequently, the international channels’ subscriber base is being deliberately run down as the company pivots to monetize its library through subscription fees, advertising, and premium‑access models rather than traditional licensing and affiliate revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic shift from linear international channels to DTC platforms, correctly identifying key brands (Fox, National Geographic, Star, ESPN) and DTC services (Disney+, ESPN+, Hulu, Star+). It accurately references the Venu Sports joint venture, aligning with the ground truth. However, it omits the specific quantitative detail from the original answer that Disney operated approximately 220 General Entertainment channels outside the U.S. in 2022—a key factual anchor. Additionally, while the LLM mentions a pivot from scripted linear content, it overemphasizes sports and does not clearly distinguish the evolution in *scripted* programming specifically, which was a central part of the question. The claim that international channels 'serve mainly as feeders' and that their subscriber base is 'being deliberately run down' introduces interpretive language not fully substantiated in the ground truth, which focuses on a strategic shift but does not state active subscriber reduction. The 2025 ESPN DTC launch is implied in the LLM answer via the 'upcoming ESPN-branded tile' but not explicitly dated, missing a specific forward-looking milestone. Quantitatively, no incorrect numbers are cited (so no factual errors), but the absence of the '220 channels' figure reduces completeness. The reasoning is largely sound and reflects multi-hop synthesis across brands, platforms, and time, but with slight overextrapolation. The answer remains contextually relevant and well-aligned with the strategic narrative, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 432,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla’s accounts receivable remained heavily dependent on timing of customer and financing partner payments, with balances fluctuating due to factors like regulatory credit sales near quarter-end and government rebate collection delays (up to a year). This volatility directly impacted receivable levels, as seen in the $627 million long-term rebates receivable reported as of 2021. Concurrently, scaling production of energy storage products faced significant hurdles, including supply chain constraints (e.g., battery cell shortages), manufacturing ramp delays, and the need to establish new facilities (like Mexico), all of which created dependencies on accurate component forecasting and supplier reliability to meet growth targets without disrupting output or increasing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $627 million long-term government rebates receivable as of the end of 2021 (reported in the 2022 filing), which aligns with the ground truth. It accurately describes the extended collection periods (up to a year) and links this to volatility in accounts receivable, particularly due to regulatory credit sales and rebate delays. However, the LLM incorrectly implies that the $627 million balance is from 2022, when it is actually as of December 31, 2021 (disclosed in the 2022 annual report). This is a minor temporal misattribution but does not distort the overall financial context. (2) The quantitative accuracy is high: the $627 million figure is correct, and no erroneous calculations are made. The LLM correctly uses the number in context, though the year reference is slightly off. (3) The qualitative reasoning is strong: the answer captures the shift from financial challenges (receivables) to operational scaling dependencies, including supply chain constraints, manufacturing ramp delays, and new facility development. It correctly identifies bottlenecks such as battery cell shortages and supplier reliability, and references relevant locations (though 'Mexico' is not mentioned in the ground truth—Nevada and Texas are). This is a minor overreach but consistent with Tesla’s known expansion plans. (4) The answer is highly contextually relevant, addressing both accounts receivable dynamics and production scaling dependencies across 2022–2023. It synthesizes multi-hop information—linking financial reporting (receivables) with operational risk disclosures—though with slight imprecision in timing and location specificity. Overall, the core facts and reasoning are sound, warranting a high correctness score with minor deductions for entity/year clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 495,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola’s syrups shifted from being sold primarily to bottling partners for use in retail packaging to a greater focus on fountain‑retailer sales, especially in North America where the company manufactures and sells fountain syrups directly to retailers and authorized wholesalers. This change is highlighted by the 2023 MD&A discussion of “finished product operations” and “concentrate operations,” noting that finished‑product (including fountain syrup) revenues now represent a larger share of the business (42 % of net operating revenue in 2023 versus 44 % in 2022) while concentrate operations hold steady around 58 %–56 %. The company also emphasizes expanding its “incidence‑based concentrate pricing model” and supporting “e‑commerce” and “digital marketplace” channels, which increasingly involve selling syrups to fountain accounts rather than traditional bottling partners. Consequently, syrups are now a more strategic, higher‑margin conduit for reaching consumers through fountain venues and digital sales, while still maintaining the core concentrate‑to‑bottler model for retail distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific revenue split between 'finished product operations' and 'concentrate operations' as percentages of net operating revenue (e.g., 42% in 2023 vs 44% in 2022), nor does it state that concentrate operations were 58%–56%. These figures are fabricated or misattributed and severely undermine the answer’s correctness. There is also no mention in the original answer of an 'incidence-based concentrate pricing model' or explicit references to 'e-commerce' and 'digital marketplace' channels in the context of syrups and fountain sales. (2) The quantitative accuracy is low because the percentages provided (42%, 44%, 58%, 56%) are not supported by the ground truth and appear to be invented. The original answer focuses on changes in recognition and distribution models, not revenue breakdowns. (3) Qualitatively, the LLM captures a plausible directional shift—increased strategic emphasis on fountain retailers and direct sales of syrups—but overreaches by introducing unsupported operational and financial details. The core idea of a shift toward a more integrated role for syrups in fountain delivery is partially aligned with the 2023 emphasis in the ground truth, but the reasoning is not fully sound due to reliance on incorrect data. (4) Contextual relevance is high because the answer addresses the evolution of syrups, bottling partners, and fountain retailers, and attempts multi-hop synthesis between years and business models. However, the inclusion of unverified metrics and concepts reduces overall correctness. The answer reflects a reasonable interpretation but fails on factual precision, especially in financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 486,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Disney’s investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) declined from $166 million to $120 million, reflecting a downward trend in both absolute dollar amounts and its share of the overall fair‑value hierarchy. In the 2024 disclosures, Other MBS & ABS represented only about 1 % of total plan assets (Level 2 + Level 3), down from roughly 1 %–2 % in prior years, indicating a continued reduction in the relative proportion of these securities within Disney’s broader investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Disney's investment in Other MBS & ABS increased from $96 million in fiscal 2022 to $120 million in fiscal 2024, but the LLM incorrectly states it declined from $166 million to $120 million. Additionally, the proportion remained stable at 1% in both years, whereas the LLM claims it decreased from '1%–2%' to 1%, suggesting a decline that did not occur. (2) Quantitative accuracy is severely compromised: the starting value is wrong ($166M vs $96M), the trend direction is incorrect (decrease vs actual increase), and the percentage change is misrepresented. Only the 2024 value ($120M) and its 1% share are correct. (3) The reasoning is flawed—despite referencing the fair value hierarchy (Level 2 + Level 3), the model fails to correctly synthesize the multi-hop data across years and misrepresents the trend. It incorrectly infers a continued reduction without evidence from the ground truth. (4) Contextual relevance is moderate: the answer addresses the right topic, time frame, and metric category, and correctly identifies the 1% proportion in 2024, but the core facts and trend analysis are incorrect, undermining overall validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 349,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, the Skunk Works’ advanced development focus shifted from a broader portfolio of next‑generation platforms to a tighter concentration on hypersonic strike weapons and related air‑dominance technologies.  The 2022 disclosures highlighted ongoing work on hypersonics, unmanned and manned aerial systems, and air‑mobility concepts, while the 2023 filing emphasizes that hypersonic programs with the U.S. Army and Navy are entering early‑production phases and that these systems are a primary growth driver for the company’s future capabilities.  Consequently, the evolution of the focus areas reflects a strategic pivot toward maturing hypersonic weapons as the flagship next‑generation military aircraft capability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies hypersonics as a key focus area in both 2022 and 2023, which aligns with the ground truth. It also accurately notes the continuation of work on unmanned and manned systems and air mobility from 2022. However, it incorrectly characterizes the evolution as a 'strategic pivot' toward hypersonic weapons and 'air-dominance technologies' as the flagship capability, whereas the ground truth states the shift was a refinement emphasizing air dominance—not a pivot centered on hypersonics alone. The ground truth does not mention early production phases with the U.S. Army and Navy or label hypersonics as the 'primary growth driver,' which are unsupported additions. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—score reflects no factual errors in this dimension. (3) The multi-hop reasoning is partially sound: the model synthesizes focus areas across years but misinterprets the nature of the evolution. It fails to note that air dominance was newly emphasized in 2023 while maintaining ISR, situational awareness, and air mobility—instead over-indexing on hypersonics. The original answer highlights a broad continuity with a sharpened focus on air dominance; the LLM narrows it incorrectly to hypersonics. (4) Correctness is scored at 5 due to significant qualitative inaccuracies in the characterization of strategic emphasis and unsupported claims about production phases and growth drivers. Qualitative accuracy is low due to flawed reasoning and entity synthesis. Contextual relevance is high because the answer addresses the right topic and timeframe with relevant themes, even if misaligned in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 471,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla shifted from a modular, vehicle-derived design approach toward a more integrated, software-driven strategy for Powerwall, emphasizing remote control and dispatch capabilities while maintaining its focus on modular battery system design to optimize manufacturing capacity. Production emphasis remained on scaling energy storage output—particularly through Megapack and Powerwall—while leveraging in-house expertise in power electronics and battery cell development to support global deployment, though specific production capacity details for Powerwall are not explicitly detailed in the 2023 disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the answer misrepresents Tesla's evolution in Powerwall strategy from 2022 to 2023. The ground truth emphasizes a shift from cross-selling Powerwall with solar products (due to availability and grid concerns) and improving Solar Roof installation in 2022, to a more engineered integration of Solar Roof and solar systems with Powerwall in 2023. In contrast, the LLM introduces a 'modular, vehicle-derived design approach' and a shift toward 'software-driven strategy' and 'remote control and dispatch capabilities,' which are not mentioned or supported in the original answer. These points reflect a plausible but factually unsupported narrative. The LLM also references Megapack and in-house battery cell development, which are outside the scope of the Powerwall integration focus. While it correctly notes continued production emphasis on Powerwall, it fails to capture the core evolution: from sales/availability focus to technical integration with solar systems. The reasoning is not sound on multi-hop synthesis because it does not accurately reflect the documented shift in integration strategy. Contextual relevance is moderate—some focus on Powerwall and production, but key strategic evolution points are incorrect or missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 393,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead's strategic positioning around Biktarvy evolved from being a core HIV product within a broader portfolio that included Genvoya, Descovy, Odefsey, Truvada, Complera, and Stribild, to a more focused anchor in its HIV segment amid rising competitive and commercialization risks. The 2024 10-K highlights that HIV products, particularly those containing TAF like Biktarvy, face threats from shifting treatment paradigms, generic competition, and the need for continual innovation to maintain market share, while also being exposed to broader commercial pressures such as reimbursement constraints and forecasting volatility due to reliance on a few U.S. wholesalers. This underscores a strategic shift toward protecting and optimizing Biktarvy’s position, even as Gilead navigates risks tied to product lifecycle management and external pricing reforms like the Inflation Reduction Act.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Biktarvy's evolution from a core HIV product in a broader portfolio to a more central but risk-exposed anchor by 2024. The mention of other TAF-containing products (e.g., Genvoya, Descovy) adds contextual richness not in the original but consistent with Gilead’s portfolio, enhancing completeness without introducing error. (2) There are no numeric values in the question or answer requiring verification—dates (2022–2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes Biktarvy’s strategic role, the increasing reliance on TAF-based therapies, and the associated commercial risks (generic competition, reimbursement, wholesaler concentration, Inflation Reduction Act), which reflects accurate inference from typical 10-K risk factors. (4) While the original emphasizes the shift from innovation focus to vulnerability due to narrow therapeutic dependence, the LLM captures this concept through discussion of lifecycle management and external pricing pressures. The only minor gap is that the LLM does not explicitly state that this overreliance creates financial stability risks for Gilead as a whole, slightly tempering qualitative accuracy. However, the core message about increased commercial risk and strategic refocusing is preserved. Wording differs but semantic equivalence is strong, and all entities (Biktarvy, TAF, Gilead, 2022–2024 timeframe) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 415,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "The U.S. Retrospective Responsibility Plan remained unchanged between 2022 and 2023, continuing to rely on the same mechanisms—including the U.S. litigation escrow agreement, conversion feature of class B common stock, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement—to address potential liability from U.S. covered litigation. No structural changes to these mechanisms were disclosed in the 2023 filing compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the U.S. Retrospective Responsibility Plan remained unchanged between 2022 and 2023. The ground truth confirms that in 2023, a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — was added to the plan, indicating an expansion. The LLM incorrectly asserts no structural changes were disclosed, which contradicts the documented evolution. (2) There are no numeric values, dates, or calculations in the response that need verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning failed: the model should have compared the composition of the plan across the two years and identified the addition in 2023. Instead, it concluded no changes occurred, missing a key synthesis step. (4) While the listed mechanisms from 2022 are accurately described, the failure to identify the new 2023 component results in a major factual error, severely impacting correctness and qualitative accuracy. Contextual relevance is high because the answer addresses the right topic and mechanisms but draws an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 325,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 through 2024, GILD’s patent protection for Biktarvy was extended to 2033, providing continued exclusivity for the product, while the company’s risk disclosures increasingly highlighted its reliance on HIV product sales and the broader challenges of maintaining market share amid patent expirations and competitive pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2033 U.S. patent expiration for Biktarvy, consistent with the ground truth from 2022, and accurately reflects Gilead's (GILD) ongoing reliance on HIV products. However, it incorrectly implies that the patent was 'extended' to 2033 during the 2022–2024 period, whereas the original answer states it was already listed with a 2033 expiration in 2022—no extension event is mentioned. This misrepresents the timeline. Additionally, the LLM omits the key point that no E.U. expiration was listed in 2022, which is part of the original answer’s evidence for strong long-term protection. (2) The date '2033' is factually correct and matches the ground truth; no other numbers are present. The use of '2033' is accurate, but the framing of 'extended' introduces a false event not supported by the data. (3) The LLM captures the multi-hop element by linking patent protection to business risk, and correctly notes increasing risk disclosures around HIV product dependency and competition. However, it fails to contrast the strong patent position in 2022 with the heightened risk disclosures in 2024 despite that protection, which is the core of the original answer’s reasoning. The synthesis is partially correct but lacks the nuanced evolution: strong IP position vs. growing market vulnerability. (4) The answer is contextually relevant and mostly accurate in substance, but the incorrect implication of a patent extension and omission of the E.U. patent status reduce factual precision. The strategic evolution is partially conveyed but not fully articulated as in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 444,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided SEC 10-K filings, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The documents confirm that the relevant guarantees are referenced in the \"Guaranty of certain obligations\" exhibits (specifically 4-c in T_10k_2022.pdf and 4-d in T_10k_2023.pdf), but no changes to the guarantee structure or referenced documentation are indicated in the provided pages. The 2023 filing (T_10k_2023.pdf, page 104) continues to reference the same legacy guarantees without any noted amendments or structural changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly concludes that there were no modifications to the financial guarantees between 2022 and 2023, which aligns with the ground truth. However, it inaccurately states that the 2022 guarantee was referenced under Exhibit 4-c (in T_10k_2022.pdf), while the ground truth specifies Exhibit 4-d in both years. This is a factual error in exhibit numbering. The 2023 reference to Exhibit 4-d is correct. (2) There are no numerical values requiring calculation, so quantitative accuracy is high, though the exhibit number discrepancy affects precision. (3) The multi-hop reasoning is partially sound—the model correctly infers continuity of the guarantee structure and lack of amendments. However, the incorrect exhibit citation for 2022 suggests a misidentification of the source document, undermining full confidence in the synthesis across years. (4) Contextual relevance is perfect—the answer directly addresses the question about structural changes and documentation. The core conclusion (no changes) is correct, but the error in exhibit labeling reduces overall correctness and qualitative accuracy. Minor but notable factual inaccuracy prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 335,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C‑to‑Class A conversion rate between 2022 and 2023 indicates that the dilution effect on Class A common‑stock voting power remains unchanged, so any future conversion of Class C (or related preferred) securities will continue to reduce the voting influence of existing Class A shareholders in major corporate actions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that the consistent Class C to Class A conversion rate between 2022 and 2023 implies no change in the dilution effect on Class A voting power, which aligns with the ground truth. The quantitative accuracy is perfect: the conversion rate of 4.0000 is correctly implied as unchanged (though not explicitly stated), and there is no incorrect numerical claim. The answer correctly identifies the key implication—stable voting power dilution for Class A shareholders in significant corporate transactions. However, it omits specific contextual details present in the original answer, such as the actual as-converted Class A stock values (38 million in 2022, 39 million in 2023), which provide supporting evidence for the stability despite a slight increase in value. While the core reasoning is sound and semantically equivalent in conclusion, the LLM does not fully demonstrate the multi-hop synthesis of both the conversion rate and the as-converted stock values to arrive at the stability conclusion. This minor incompleteness in contextual support data prevents a top score, but the answer remains substantially accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 331,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Solar Roof production focus from a high-volume, cost-intensive approach to a more controlled ramp, emphasizing quality and supply chain stability amid raw material constraints and supplier dependencies. The company increasingly relied on in-house battery cell production and localized manufacturing (e.g., Gigafactory Shanghai) to mitigate external risks, while maintaining strategic partnerships for key components to sustain growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies a shift in Tesla's Solar Roof strategy from 2022 to 2023, it fabricates specific details not present in the original answer, such as a 'high-volume, cost-intensive approach' in 2022 and a pivot toward 'quality and supply chain stability' in 2023. The ground truth states that in 2022, Tesla directly produced the Solar Roof at Gigafactory New York, but the LLM incorrectly introduces 'in-house battery cell production' and 'Gigafactory Shanghai' as part of Solar Roof strategy, which are unrelated to Solar Roof manufacturing and not mentioned in the original. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations since none are present. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift from active production to increased disclosure of risks (delays, supply chain constraints, ramping challenges), reflecting a change in strategic communication and risk management. The LLM instead invents a narrative around manufacturing optimization and geographic diversification that is not supported by the ground truth. It fails to capture the core evolution: from direct production focus to highlighting strategic execution risks. (4) The contextual relevance is moderate because the answer addresses the general topic of Tesla's Solar Roof evolution, but introduces irrelevant elements (battery cells, Shanghai) and misses the key point about risk disclosures and strategic caution in 2023. Thus, while the direction of change (increased caution) is loosely reflected, the factual basis and reasoning are significantly off, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 485,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola’s business model shifted further toward finished beverage production and distribution. While concentrate operations still generated 58 % of net operating revenue in 2023 (up from 56 % in 2022), syrup sales—especially fountain syrups sold to retailers and bottling partners—are increasingly integrated into the Company’s bottling and distribution network, supporting both its consolidated bottling operations and its Global Ventures segment. This reflects a continued evolution where syrups are no longer just a stand‑alone concentrate business but a key input for the Company’s finished‑product operations and its extensive distribution system.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention that concentrate operations generated 56% or 58% of net operating revenue in 2022 or 2023, nor does it state that these percentages increased. This data is entirely fabricated or misattributed, severely undermining the answer's credibility. There is no support in the original answer for any percentage-based revenue breakdown between concentrate and finished products. (2) The quantitative accuracy is low because the core numbers (56%, 58%) are incorrect and not present in the ground truth. No calculations or comparisons based on real data are performed in the original, so introducing them here is a major error. (3) Qualitatively, the LLM captures a partial truth about syrups being more integrated into distribution and production, and correctly identifies fountain syrups being sold to retailers and bottling partners. It also correctly implies a strategic evolution. However, it misses the key 2023 shift that fountain syrup operations were explicitly included in the North America operating segment, reflecting tighter regional control—a central point in the original answer. The mention of 'Global Ventures segment' is not supported in the provided ground truth. (4) Contextually, the answer addresses the evolution of syrups in production and distribution, so it remains relevant. However, due to the inclusion of false quantitative data and omission of the structural segment change, the correctness score is low. The reasoning is partially sound but built on incorrect premises, leading to a misleading conclusion despite some accurate directional insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 468,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia remained limited in scale relative to its global footprint. Africa/Eurasia contributed $228 million to operating profit in 2022 (as reported in the 2022 segment data on page 116), $253 million in 2023 (page 115), and $253 million in 2024 (page 115), reflecting modest growth. Capital expenditures in Africa/Eurasia declined from $30 million in 2022 to $12 million in 2024 (page 116), indicating reduced investment in the region. The company's geographic reporting structure was realigned in 2024, moving skin health businesses from Europe to North America, but Africa/Eurasia remained a distinct reportable segment with consistent operating profit contributions. The company's strategic focus outside Africa/Eurasia appears to be on emerging markets like Latin America and Asia Pacific, which received significantly higher capital investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Africa/Eurasia had an operating profit of $203 million in 2022, but the LLM claims $228 million in 2022, $253 million in 2023, and $253 million in 2024—none of which match the original answer or implied data. There is no mention of 2023 in the ground truth, and the profit figures are entirely fabricated or misattributed. Capital expenditures are also introduced (e.g., $30M to $12M) with page references, but these details are absent from the ground truth and cannot be verified as correct; thus, they represent unsupported claims. (2) The quantitative inaccuracies are severe: the core financial figure (operating profit) is wrong across all years, and additional metrics (capex) are introduced without basis in the original answer. Even if formatting flexibility is allowed, the numbers do not align with the ground truth. (3) The reasoning partially captures the 2024 realignment of skin health from Europe to North America and correctly notes that Africa/Eurasia remained a distinct segment. However, it incorrectly infers growth trends and investment shifts due to false data. The conclusion about strategic focus shifting to Latin America and Asia Pacific is speculative and not supported in the original answer. (4) The contextual relevance is moderate because the LLM addresses geographic reporting changes and financial contribution, but the use of incorrect data undermines the analysis. The qualitative reasoning is flawed due to reliance on non-ground-truth numbers. Correctness score is low due to major factual and numerical errors despite some structural alignment with the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 466,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Johnson & Johnson’s Orthopaedics business remained a stable, high‑volume component of its MedTech segment, with worldwide sales of $8.94 billion in 2023—up 4.1 % from 2022—and modest growth in both U.S. (3.8 %) and international (4.6 %) markets.  The segment’s focus on “enabling technologies” is evident in its expanding portfolio of hip, knee, trauma, spine, sports and surgical products, which together accounted for roughly 30 % of total MedTech sales and showed consistent double‑digit gains in advanced and surgical offerings (e.g., a 27.5 % rise in Interventional Solutions worldwide).  While overall Orthopaedics growth slowed slightly compared with the prior year, the company continues to emphasize innovation and technology‑driven solutions to sustain its market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 global sales figure of $8.94 billion (equivalent to $8,942 million) and the 4.1% year-over-year growth, as well as the U.S. (3.8%) and international (4.6%) growth rates, which aligns with the ground truth. However, it introduces unsupported data not present in the original answer or implied by the question, such as 'roughly 30% of total MedTech sales' and 'double-digit gains' with a specific example of a '27.5% rise in Interventional Solutions worldwide'—this figure is not mentioned in the ground truth and cannot be verified from the provided context. (2) The quantitative accuracy is partially correct: the core 2023 revenue and growth figures are accurate, but the additional percentages (27.5%, 30%) are fabricated or misattributed, undermining trust in the response. There is no evidence in the ground truth that 'advanced and surgical offerings' showed double-digit gains. (3) The multi-hop reasoning is flawed. The question asks for a comparison between 2023 and 2024 strategic presentations. While the LLM correctly describes the 2023 focus on financial metrics, it fails to acknowledge the key shift in 2024: the *absence* of revenue figures and the *qualitative pivot* to innovation and enabling technologies. Instead, it implies continued quantitative reporting and adds unverified performance data for 2024, which contradicts the ground truth. The strategic evolution—from numbers to narrative—is not captured. (4) Contextual relevance is high because the answer addresses Orthopaedics, sales performance, and enabling technologies, but the qualitative accuracy is low due to incorrect synthesis of the 2024 strategy and introduction of phantom data. The correctness score is 5 because while core 2023 facts are right, the answer fails on the central comparative insight and adds significant inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 508,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss-sharing agreements remained consistent in structure but showed incremental expansion in scope and procedural refinement. In 2022, the company continued to allocate liability for U.S. covered litigation—encompassing the Interchange Multidistrict Litigation and opt-out cases under MDL 1720—among Visa U.S.A., Visa International, and participating members via the loss-sharing agreement, indemnification obligations, and the omnibus agreement, which formalized a 66.6667% Visa / 33.3333% Mastercard split for settlements and judgments. The 2023 updates, particularly through amendments to the omnibus agreement, extended coverage to include certain post-amendment opt-out actions arising from facts similar to MDL 1720, ensuring these were treated as covered litigation under the same liability-allocation framework. While the core mechanisms persisted, the 2023 changes emphasized broader inclusion of newly emerged cases within the U.S. covered litigation scope, reflecting a strategic evolution to preemptively manage emerging legal risks without altering the fundamental loss-sharing calculus. This expansion was operationalized through updated escrow account protocols and indemnification enforcement mechanisms, maintaining the 66.6667% liability allocation for Visa while reinforcing procedural safeguards for liability recovery via the Europe retrospective responsibility plan’s conversion rate adjustments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key aspects of Visa's 2023 evolution in liability management. (1) Quantitatively, the 66.6667% / 33.3333% split between Visa and Mastercard is accurately reported, and references to MDL 1720 and opt-out actions are factually consistent. However, the LLM incorrectly states that the 2023 updates involved 'amendments to the omnibus agreement' extending coverage—this is not supported by the original answer, which instead emphasizes a shift to the U.S. Retrospective Responsibility Plan as a broader, consolidated framework. (2) The LLM introduces the 'Europe retrospective responsibility plan’s conversion rate adjustments,' which is irrelevant and incorrect in the context of U.S. covered litigation—this detail is not present in the ground truth and misdirects the analysis. (3) Qualitatively, the reasoning is flawed: the original answer describes a strategic pivot from a bilateral loss-sharing model with Mastercard toward a more comprehensive, retrospective U.S.-focused plan in 2023, whereas the LLM portrays continuity and incremental expansion under the same framework, missing the conceptual shift toward resolution and consolidation of past liabilities. (4) The LLM fails to mention the critical 2023 change that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a retrospective, closure-oriented approach—this is a central point in the ground truth. (5) Contextually, the answer remains focused on litigation liability management and uses appropriate terminology, earning high relevance. However, the failure to capture the shift from active liability sharing to retrospective consolidation results in a partially correct but misleading narrative. Overall, the answer gets core numbers right but misrepresents the strategic evolution, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 524,
        "total_tokens": 2224
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive’s allocation to Guaranteed Investment Contracts (GICs) declined sharply—from $55 million in 2022 (Level 2, International) to $34 million in 2023 and $30 million in 2024 (Level 2, International)—reflecting a strategic shift away from low‑yielding, fixed‑return assets. This reduction coincides with a broader rebalancing toward higher‑return pooled funds, fixed‑income securities, and equity investments, indicating that the company is moving its pension‑plan assets toward a more diversified, growth‑oriented portfolio and away from reliance on traditional GICs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, CL held $1 million in GICs under U.S. Pension Plans and $55 million under International Pension Plans. The LLM omits the U.S. allocation entirely and incorrectly states that the $55 million was solely for International (Level 2) in 2022, which is partially correct but incomplete. More critically, the LLM claims $34 million in 2023 and $30 million in 2024 for International, but the ground truth reports $34 million in 2024 with no mention of 2023 or $30 million. The $30 million figure is factually incorrect and unsupported. Additionally, the U.S. complete phase-out by 2024 is entirely omitted. (2) Calculations and comparisons are flawed: the 'decline from $55M to $30M' implies a $25M drop, but the actual International reduction is $21M ($55M to $34M), and the full picture includes the U.S. elimination of $1M. The LLM fails to mention the U.S. component, leading to an incomplete and misleading quantitative narrative. (3) Reasoning and multi-hop synthesis are partially sound—the interpretation of a strategic shift toward diversified, growth-oriented assets is reasonable and aligns with the ground truth's indication of strategic reallocation. However, the reasoning is based on incomplete and slightly inaccurate data, weakening the conclusion. The mention of pooled funds, equities, and fixed income as replacements is plausible but not verifiable from the provided ground truth. (4) Contextual relevance is high—the answer addresses the evolution and strategic implication as asked. Despite incorrect numbers and omissions, it attempts a multi-hop synthesis and provides a coherent qualitative interpretation. However, the omission of U.S. data and fabrication of 2023/2024 figures reduce correctness significantly. Thus, the correctness score is 5: partially correct but with major factual gaps and errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 523,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved from a general API gateway into a strategic hub for integrating digital assets and emerging technologies. It expanded its focus on blockchain and crypto by enabling programmable payments through the Mastercard Multi-Token Network™, supporting tokenized transactions, and facilitating the buying/spending of cryptocurrencies via card-linked solutions. Simultaneously, it strengthened its role in new payment flows—such as disbursements, remittances, and B2B payments—by offering APIs for Mastercard Send, Track BPS, and Alias-Based Remittances, while also enhancing integration capabilities for virtual cards, digital wallets, and AI-driven fraud prevention. This evolution positioned the platform as a critical enabler for secure, scalable, and innovative payment experiences across diverse commerce use cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of the Mastercard Developer Platform from a general integration point in 2022 to a more strategically focused enabler of digital assets and emerging technologies by 2024. The mention of the Mastercard Multi-Token Network™ and its role in programmable payments and tokenized transactions is factually consistent with the original answer. The LLM adds specific examples not in the original (e.g., Mastercard Send, Track BPS, Alias-Based Remittances, virtual cards, AI-driven fraud prevention), but these are contextually plausible extensions of the platform's functionality and do not contradict the ground truth. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while the core reasoning and entity identification (Mastercard, Multi-Token Network™, blockchain, digital assets) are correct, the original answer does not mention AI-driven fraud prevention or specific API names, so some details may represent inference beyond the provided knowledge graph. However, these do not detract from the overall correctness. The answer is fully contextually relevant, addressing both the timeline (2022–2024) and the platform's evolving role in digital asset integration. Minor deduction in qualitative accuracy due to slight over-enrichment with unverified specifics, but the core multi-hop synthesis across years and technological evolution is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 420,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Between 2022 and 2024, the company maintained **zero investment in U.S. common stock within its pension plans**, with no purchases, holdings, or dividends received from its own shares in either year. This consistent divestment reflects a deliberate strategic shift toward a more diversified and risk-averse asset allocation, emphasizing fixed income, pooled funds, and external equities rather than internal stock holdings. The absence of equity exposure to its own stock underscores a focus on reducing concentration risk and aligning with broader institutional investment best practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant factual inaccuracies. It correctly states that there was zero investment in U.S. common stocks in the domestic pension plan in both years, aligning with the ground truth. However, it completely omits the $2 million investment in U.S. common stocks within the international pension plan that persisted in both 2022 and 2024—this is a critical omission that undermines the completeness and correctness of the response. (2) Quantitatively, the answer is accurate in stating zero holdings for the overall or domestic pension plan, but fails to report the $2 million figure present in the international plan, leading to an incomplete and misleading quantitative picture. No calculations were required, but the synthesis of holdings across plans is flawed. (3) The multi-hop reasoning is unsound because the model fails to distinguish between the U.S. and international pension plans, treating 'pension plans' as a monolithic entity. The ground truth requires disentangling domestic vs. international allocations, which the LLM does not do. As a result, the strategic interpretation—while plausible—is based on incomplete data. (4) The contextual relevance is high because the answer addresses the evolution over time and attempts to interpret strategic allocation. However, due to the omission of key data and incorrect generalization across pension plans, the qualitative and quantitative accuracy scores are reduced significantly. A fully accurate answer must acknowledge both the absence in the U.S. plan and the continued $2M holding in the international plan.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 447,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney increased capital investment in its cruise line and broader Experiences segment, announcing plans to expand its fleet of cruise ships and boost spending on theme‑park and resort enhancements. At the same time, the company highlighted operational‑risk concerns tied to these investments—including higher borrowing costs from elevated interest rates, exposure to foreign‑exchange volatility, and the uncertainty of consumer demand for out‑of‑home entertainment—factors that could affect the profitability and timing of its cruise‑ship expansion and related capital projects.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no specific numeric values, so there are no quantitative inaccuracies—this aligns with the ground truth which also does not include specific dollar amounts or percentages. Thus, quantitative accuracy is high. (2) However, the qualitative content diverges significantly from the ground truth. The original answer states that Disney's strategic focus shifted from growth and capital investment in cruise ships in 2022 to emphasizing operational risks (e.g., hurricanes, global events) in 2023. In contrast, the LLM claims Disney 'increased capital investment' and 'announced plans to expand its fleet' in 2023, which contradicts the shift toward risk mitigation described in the ground truth. The LLM frames continued expansion as the trend, while the truth reflects a pivot from expansion to caution. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2022 and 2023, requiring synthesis of changing emphasis across years. The LLM fails to capture the strategic shift—instead suggesting ongoing investment alongside risk disclosures, rather than a change in focus. It conflates simultaneous risk mentions with consistent strategic direction, missing the recalibration from growth engine to operational exposure. (4) While the LLM mentions relevant risk factors (foreign exchange, interest rates, demand uncertainty), these are not the primary operational risks highlighted in the ground truth (i.e., hurricanes and direct operational disruptions like Hurricane Milton). The contextual relevance is moderate because it discusses investment and risks in cruise operations, but the core evolution in strategic focus is misrepresented, leading to a correctness score of 5—partially correct but with significant factual and inferential errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 489,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard has expanded its use of short‑duration foreign‑exchange derivatives to hedge the foreign‑currency exposure that arises during its daily settlement activities, moving from primarily cash‑flow hedges of anticipated revenues and expenses in 2022 toward a broader mix that includes net‑investment hedges and forward contracts tied to anticipated receipts and disbursements, with the notional amount of such short‑term contracts growing from roughly $1 billion in 2022 to over $2.7 billion in 2024.  These derivatives are now recorded in general and administrative expense when marked‑to‑market, and the company expects the associated gains or losses to be reclassified into earnings only when the underlying settlement transactions occur, typically within a few days of the transaction date.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Mastercard maintained continuity in its use of short-duration foreign exchange derivative contracts between 2022 and 2024, with the same objective of reducing volatility from currency fluctuations on daily settlement activities. However, the LLM claims an expansion in use and a shift from 'primarily cash-flow hedges' to a 'broader mix' including net-investment hedges, which is not supported by the original answer. There is no mention in the ground truth of a change in hedge type or strategy beyond adjustments to euro-denominated debt hedging via de-designation and re-designation. (2) The quantitative claims are entirely fabricated: the LLM states notional amounts grew from $1 billion in 2022 to over $2.7 billion in 2024, but the original answer provides no such figures. This is a major error in quantitative accuracy. Additionally, the claim about accounting treatment—'recorded in general and administrative expense when marked-to-market'—is not present in the ground truth and introduces unverified details. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the role of derivatives in managing daily settlement risk, it incorrectly infers an evolution in strategy and introduces new elements (e.g., net-investment hedges, specific notional growth) not present in the source. The actual evolution noted in the ground truth is limited to dynamic management of euro-denominated debt hedges, not short-duration settlement derivatives. (4) Contextual relevance is moderate because the answer addresses the general topic of short-duration FX derivatives and daily settlement risk, but it fabricates specifics and misrepresents the nature of strategic changes. The qualitative accuracy is low due to incorrect entity relationships and unsupported inferences. Overall, the answer appears plausible but diverges substantially from the ground truth in both facts and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 540,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce’s strategic relationship with enterprise cloud companies has deepened through tighter ecosystem integration and expanded investment focus on AI-driven platforms. The company has increasingly embedded AI agents (via Agentforce) across its core offerings—including Marketing, Commerce, Service, and Slack—leveraging Data Cloud and MuleSoft to unify data and automate workflows, while also broadening its strategic investments in enterprise cloud startups to accelerate platform adoption and industry-specific AI capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant factual inaccuracies and unsupported details not present in the ground truth. (1) Correct elements: The general direction of deeper ecosystem integration from 2023 to 2024 aligns with the original answer. The mention of expanding investment focus and platform adoption reflects the evolution in strategic emphasis. (2) Quantitative accuracy is scored highly because there are no specific numbers (e.g., dollar amounts, percentages, dates) in either the ground truth or LLM response that conflict; thus, no numeric inaccuracies exist. (3) Qualitative inaccuracy arises because the LLM introduces unverified specifics such as 'AI agents via Agentforce', 'AI-driven platforms', and integration with 'Marketing, Commerce, Service, and Slack' using 'Data Cloud and MuleSoft'—none of which are mentioned in the ground truth. These details, while plausible for Salesforce, are not supported by the provided knowledge graph and represent hallucinated content. Additionally, the shift described in the original answer is from financial investment to strategic dependency and ecosystem enablement (especially via AppExchange and third-party developers), which the LLM fails to mention. Instead, it reframes the evolution around AI, which is not referenced in the ground truth. (4) Contextual relevance is moderate because the answer addresses the evolution of strategic relationships and ecosystem integration, but it does so through a distorted lens focused on AI and technical integrations not present in the source. The core multi-hop reasoning—comparing 2023 investment focus to 2024 ecosystem dependency—is missed, weakening the qualitative accuracy. Thus, the correctness score is mid-range due to partial alignment with facts but major omissions and additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 491,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s accrual rates for vendor funding programs were adjusted to reflect higher projected purchase volumes, resulting in a more sensitive linkage between funding levels and anticipated purchase growth between fiscal 2023 and fiscal 2024. This increased sensitivity is evident in the updated vendor‑fund accrual methodology discussed in the “Merchandise Inventory” and “Critical Accounting Policies and Estimates” sections of the 2024 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. The ground truth states that the company's methodology for accrual rates remained consistent between fiscal 2023 and 2024, with no material changes. The only notable difference was the omission in fiscal 2024 of the explicit mention of 'graduated purchase volumes'—a rhetorical or presentational change, not a methodological one. However, the LLM incorrectly asserts that there was an 'increased sensitivity' and an 'updated vendor-fund accrual methodology' in fiscal 2024, directly contradicting the original answer. There are no numeric values in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default for absence of numerical errors. The qualitative accuracy is very low because the model misrepresents the evolution of the accrual approach, inventing a change that did not occur. Contextual relevance is moderate: the response addresses the general topic (accrual rates and purchase volumes) and references appropriate sections of the filing, but draws an unsupported conclusion. The model fails the multi-hop reasoning test by misinterpreting the absence of a phrase as evidence of a methodological shift, rather than recognizing it as a possible simplification or stabilization within a consistent framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 363,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024 the LLY–Boehringer Ingelheim partnership remained legally intertwined but grew more independent.  In 2022 BI sued generic firms over Jardiance patents, and the case was stayed, while LLY continued to receive BI‑driven indemnification for any product‑liability claims tied to Jardiance.  By 2024 the U.S. government had selected Jardiance for price‑setting under the IRA, signaling a shift toward regulatory exposure that now directly involves LLY, and the partnership’s collaborative dependency on the product had begun to erode as pricing pressure intensified.  Consequently, while the legal ties persisted, the strategic reliance on Jardiance as a shared revenue driver was diminishing.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that Boehringer Ingelheim (BI) initiated patent litigation in 2022 and that Jardiance was selected under the Inflation Reduction Act (IRA) by 2024, it incorrectly claims that the partnership's collaborative dependency 'began to erode' and that 'strategic reliance... was diminishing.' This directly contradicts the ground truth, which states that LLY's business became 'significantly dependent' on the Jardiance collaboration by 2024 due to IRA pricing impacts. The LLM inverts the correct trend. (2) Quantitatively, the answer omits the key 66% discount figure from the 2023 list price under the IRA, which is a critical data point in the original answer. While it correctly references 2022 and 2024 timelines, the absence of this percentage reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize that increased regulatory exposure (IRA pricing) leads to greater, not lesser, strategic entanglement and dependency. It misinterprets regulatory pressure as a driver of decoupling rather than deeper collaboration necessity. The claim of 'eroding' dependency is unsupported and incorrect. (4) Contextual relevance is moderate because the answer addresses legal involvement and collaboration around Jardiance, but the conclusion misrepresents the evolution of the relationship. The mention of indemnification is plausible but not in the ground truth, introducing unverified detail. Overall, the answer gets some surface facts right but fails on the core qualitative and directional assessment of the strategic relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 454,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023 Disney’s capital‑investment strategy shifted from a broad focus on parks‑and‑resorts expansion to a more targeted emphasis on cruise‑ship development and related Experiences, while still supporting overall Parks & Experiences growth. In 2022 the company highlighted cruise‑ship projects (e.g., Lighthouse Point) and capital spend on new attractions and resort upgrades, and by 2023 the narrative emphasized “majority of capital spend” still at Parks & Experiences but specifically called out cruise‑ship investments as part of that portfolio, reflecting a continued but refined allocation of capital toward expanding the Disney Cruise Line fleet and related vacation‑club and resort experiences.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Disney's capital investment strategy from 2022 to 2023, noting an increased emphasis on cruise ships within the Parks & Experiences segment. It accurately reflects that in 2023, Disney explicitly included cruise ships in its major capital spending, aligning with the ground truth. However, the LLM incorrectly states that in 2022, Disney 'highlighted cruise-ship projects (e.g., Lighthouse Point)' and capital spend on such projects. The original 2022 10-K did not specifically highlight cruise ships or Lighthouse Point as active capital investments; instead, it discussed general risks to business plans including parks and resorts without singling out cruise ships. This is a factual overstatement not supported by the ground truth. (2) There are no numeric values, percentages, or dollar amounts in either the question or ground truth, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the evolution of strategic emphasis from 2022 to 2023 and identifies the broader Parks & Experiences context. However, it introduces a specific example (Lighthouse Point) and implies earlier active investment in cruise ships in 2022 that the ground truth does not support, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution of strategy, but the incorrect attribution of 2022 focus on cruise projects reduces factual precision. Correctness is therefore scored 7 due to core accurate trend identification but with a significant factual overreach in the 2022 characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 461,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Mastercard Foundry’s role in fostering innovation has expanded significantly between 2022 and 2024, shifting from a primarily experimental innovation lab to a more integrated driver of strategic growth through technology adoption and fintech collaboration. In 2024, it launched targeted programs like Launchpad (a five-day app prototyping workshop) and expanded its innovation toolkit to include AI-powered solutions such as Decision Intelligence Pro, which leverages generative AI for enhanced fraud detection and transaction security. Concurrently, Foundry deepened partnerships with fintechs and financial institutions by integrating its open banking platform, enabling seamless data access and integration via APIs, while also supporting blockchain-based payment models through its Multi-Token Network. This evolution reflects a move toward embedding innovation directly into Mastercard’s core ecosystem—accelerating product development, enhancing security, and enabling scalable solutions like Click to Pay and tokenized payments that now represent 30% of all transactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Mastercard Foundry from an innovation lab to a more strategic innovation driver, which aligns with the ground truth. It correctly identifies the 2024 focus on blockchain and the Multi-Token Network, as well as fintech partnerships. However, it introduces specific programs and tools not present in the original answer—such as 'Launchpad,' a 'five-day app prototyping workshop,' 'Decision Intelligence Pro,' and 'AI-powered solutions leveraging generative AI'—which are not supported by the ground truth and appear to be fabricated or hallucinated. Additionally, the claim that 'tokenized payments now represent 30% of all transactions' is a specific quantitative assertion absent from the original and cannot be verified against the provided knowledge. (2) Quantitative accuracy is low because the 30% transaction figure is unsupported, and no such percentage appears in the ground truth. There are no numbers in the original answer to validate the LLM's metrics, making this a significant factual overreach. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution toward deeper tech integration and identifies blockchain and fintech collaboration as key themes. However, it fails to accurately represent the 2022 baseline (e.g., the rebrand from Mastercard Labs) and adds unverified details that distort the factual progression. (4) Contextual relevance is high because the answer addresses the question's core about evolution in innovation role, emerging tech, and partnerships. Qualitative accuracy is moderate due to correct thematic understanding but undermined by invented specifics. Correctness score is 6 due to partially correct trajectory but significant factual inaccuracies and hallucinations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 491,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "Between 2022 and 2024, Lilly’s collaboration with Boehringer Ingelheim remained strategically focused on advancing key cardiometabolic and immunology assets, including empagliflozin (Jardiance) for heart failure and chronic kidney disease, and baricitinib for autoimmune conditions. However, regulatory designations such as FDA Breakthrough Therapy and Fast Track were granted earlier (e.g., empagliflozin in 2021), and by 2024, the partnership faced significant pricing pressures due to U.S. Inflation Reduction Act (IRA) provisions. Specifically, Jardiance was selected among the first ten drugs subject to Medicare price negotiation, with HHS setting a 66% discount off 2023 list prices effective in 2026, signaling accelerating revenue erosion for the collaboration’s flagship products. This regulatory shift, combined with ongoing global cost-containment efforts and payer consolidation, intensified pricing pressures on their joint portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Breakthrough Therapy and Fast Track designations were indeed granted earlier (2021 for empagliflozin), which is consistent with the original answer noting regulatory support by 2022; Jardiance was selected under the Inflation Reduction Act for Medicare price negotiation with a 66% discount off 2023 list prices, effective in 2026—this matches the ground truth exactly in both percentage and timing. (2) Quantitative accuracy is perfect: the 66% discount, 2023 pricing reference, and 2026 effective date are all correctly stated. Format variations (e.g., '66% discount') are semantically equivalent and acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), regulatory developments (FDA designations → IRA pricing), and financial implications, showing evolution from regulatory facilitation to pricing pressure. It appropriately identifies Jardiance as part of the Lilly-Boehringer Ingelheim collaboration. (4) The only minor shortcoming is that the original answer emphasizes the shift *between 2022 and 2024* more directly, while the LLM notes designations occurred earlier (which is more precise), slightly downplaying the 2022 status. However, this does not constitute an error—rather, added precision. The strategic focus on cardiometabolic and immunology assets adds context not in the original but is accurate and relevant. Thus, the answer is factually superior in some respects, fully complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 438,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "From 2023 to 2024, the CH-53K King Stallion heavy‑lift helicopter transitioned from being highlighted as an ongoing program within RMS’s portfolio to a concrete, funded effort that reached key milestones—including the first four aircraft awarded in 2022 and the remaining orders completed in 2023, with international interest reinforced by a 2021 Letter of Offer and Acceptance from Israel for 12 units. The 2024 10‑K underscores that RMS continues to expand its CH‑53K production capacity to meet anticipated demand, positioning the platform as a strategic growth pillar alongside other mature programs such as the F‑35 and missile‑defense systems.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported details not present in the ground truth. (1) Quantitatively, it cites specific events such as 'first four aircraft awarded in 2022' and 'remaining orders completed in 2023' and a 2021 Letter of Offer and Acceptance from Israel for 12 units—none of which are mentioned or verifiable in the original answer or underlying knowledge graph. These specific dates, order details, and international agreements are fabrications or hallucinations. (2) The original answer emphasizes a shift in strategic framing—from being a near-to-mid-term growth element in 2023 to being part of an integrated, technology-driven portfolio in 2024 focused on AI/ML, autonomy, and multi-domain solutions. The LLM answer instead focuses on production scaling and funding milestones, missing the core evolution in strategic positioning. (3) The LLM incorrectly positions the CH-53K alongside the F-35 and missile-defense systems as a 'strategic growth pillar,' which conflates segments—the F-35 is part of Aeronautics, not Rotary and Mission Systems (RMS), making this a significant entity and segment error. (4) While the LLM correctly identifies RMS as the responsible segment and notes continued importance of CH-53K in 2024, it fails to capture the qualitative shift in narrative from standalone growth driver to integrated component of digital, all-domain solutions. Thus, while contextually relevant and partially accurate in broad strokes, the answer is undermined by significant factual and reasoning errors, especially in quantitative claims and cross-program synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 443,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The shift in Lilly’s diabetes portfolio—highlighted by the 2022‑2024 10‑K disclosures—shows a strategic pivot toward broader cardiovascular and obesity‑related indications (e.g., Jardiance’s cardiovascular death and heart‑failure benefits, Trulicity’s CV risk reduction, and the expansion of anti‑obesity pipelines) rather than focusing solely on glucose‑lowering. This reflects a market‑focused strategy to capture higher‑value therapeutic niches and counteract revenue pressure from generic/biosimilar competition, signaling that Lilly is prioritizing products with stronger payer justification and longer‑term growth potential.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic shift in Lilly's focus toward cardiovascular and obesity-related indications, which aligns with broader industry trends and Lilly's overall pipeline strategy. However, it fails to accurately reflect the specific change in the co-commercialization portfolio with Boehringer Ingelheim between 2022 and 2024 as stated in the ground truth. The original answer notes that the portfolio narrowed from including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar in 2022 to only Jardiance, Glyxambi, Synjardy, and Trijardy XR in 2024. The LLM answer does not mention this specific portfolio contraction or the removal of Trajenta, Jentadueto, and Basaglar, which is central to the question. Instead, it generalizes the shift to a broader strategic pivot without grounding it in the actual product-level changes in the collaboration. (2) There are no numeric values, dates, or calculations in either answer that conflict—dates (2022–2024) are consistent, and no incorrect figures are cited—so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the LLM infers strategic intent from product focus, but it does not synthesize the actual portfolio changes between the two years, which is the core of the multi-hop requirement. It misses the link between the dropped products and potential reasons like generic competition (e.g., Basaglar facing biosimilar pressure) or lifecycle management. (4) While the LLM provides a plausible and contextually relevant interpretation of Lilly’s broader strategic direction, it does not directly answer what the *change in the co-commercialized portfolio* indicates. Thus, it substitutes a related but incomplete narrative, leading to a moderate correctness score. The answer is not factually wrong but omits key factual changes required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 513,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program’s financial impact shifted markedly between 2023 and 2024. In 2023, the program contributed to a $1.6 billion increase in segment operating profit driven by favorable profit‑booking adjustments, but in 2024 operating profit fell 11% as profit‑booking rates declined—primarily because $555 million of losses were recorded on a classified contract and overall profit‑booking adjustments dropped by $375 million. Backlog grew in both years, expanding to $38.8 billion by year‑end 2024, reflecting higher orders on JASSM‑related platforms such as PAC‑3, LRASM and GMLRS. Consequently, while JASSM remained a key contributor to backlog growth, its direct contribution to operating profit weakened in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitatively, the numbers cited are incorrect: the ground truth states that JASSM contributed to a $1.2 billion increase in tactical and strike missile programs in 2024, but the LLM claims a $1.6 billion increase in segment operating profit in 2023 and attributes profit declines to a classified contract loss of $555 million and a $375 million drop in adjustments—none of which appear in the original answer. There is no mention of profit-booking adjustments, operating profit changes, or classified contract losses in the ground truth. (2) The backlog figure of $38.8 billion is introduced without context and is not mentioned in the original answer, which only notes that JASSM was a key contributor to backlog growth alongside PAC-3 and GMLRS. (3) Qualitatively, the reasoning is flawed: the LLM incorrectly frames JASSM’s financial performance around operating profit volatility, while the original answer emphasizes a ramp-up in production activity and increased strategic importance due to backlog contributions. The LLM also conflates JASSM with related but distinct programs (e.g., LRASM), and incorrectly implies financial deterioration in 2024, whereas the ground truth indicates increased production and strategic value. (4) Contextually, the answer addresses backlog and performance trends, so it remains somewhat relevant, but the core facts, metrics, and multi-hop synthesis are incorrect. The model appears to hallucinate detailed financial data not present in the source, leading to a mostly incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 444,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPMorgan's credit risk evaluation for Business Banking Loans has shifted from a focus on **delinquency rates and loan-to-value (LTV) ratios** in 2023 to a greater emphasis on **refreshed FICO scores and geographic risk concentrations** in 2024, as reflected in updated monitoring frameworks and portfolio segmentation disclosures. This evolution enhances early distress identification by prioritizing borrower creditworthiness trends (e.g., declining FICO scores) and regional economic vulnerabilities, which are more responsive to emerging stress signals than traditional delinquency metrics alone.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and direction. The original answer states that in 2023, JPM focused on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment, and in 2024 shifted to using delinquency rates (specifically loans more than 30 days past due) as early indicators of distress. In contrast, the LLM claims that in 2023, JPM focused on delinquency rates and LTV ratios, and in 2024 shifted to FICO scores and geographic risk—none of which is supported by the ground truth. These specific metrics (LTV, FICO refresh, geographic concentration) are not mentioned in the original answer and represent a complete reversal of the actual evolution. (2) There are no numeric values to verify (e.g., percentages, dollar amounts), but the years 2023 and 2024 are correctly referenced as time points. However, the attribution of activities to those years is factually wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the shift from broader prime consumer credit strategy and scoring models in 2023 to delinquency-based monitoring in 2024. Instead, it fabricates a narrative around FICO and geography, indicating a failure to synthesize the correct information across time periods. (4) The contextual relevance is moderate because the answer addresses the general topic of credit risk evolution in Business Banking Loans and attempts to discuss early distress identification. However, due to major factual inaccuracies and invented details, the qualitative and quantitative accuracy scores are very low, resulting in a correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 455,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided SEC 10-K filing excerpts, Target Corporation's executive compensation framework shows evolution in its long-term incentive plans between 2022 and 2023 filings. Specifically, the company maintains multiple shareholder-approved plans (SPP I, SPP II, SPP III) with SPP II (2016 Plan Statement, as amended April 3, 2016) serving as a key component referenced in both years' filings. The 2023 filing (page 68) explicitly lists SPP II alongside other compensation plans like the 2020 Long-Term Incentive Plan and Officer Deferred Compensation Plan, indicating continuity in its executive pay structure. This consistency suggests Target's compensation framework emphasizes structured, long-term equity-based incentives (including performance shares and restricted stock units) rather than significant structural changes to its executive reward system between these filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the evolution of Target's SPP II plan terms. The ground truth states that in the 2022 filing, SPP II was described under the 2016 Plan Statement (effective April 3, 2016), but in the 2023 filing, it was updated to the 2022 Plan Statement (effective May 1, 2022), indicating a material update to the plan. However, the LLM incorrectly claims there was no change and asserts continuity, stating SPP II remained under the 2016 Plan Statement in both years. This misrepresents the core factual development. (2) The dates (April 3, 2016, and May 1, 2022) are critical quantitative elements that the LLM fails to acknowledge or incorporate. By omitting the 2022 restatement, the answer misses a key factual update, leading to incorrect conclusions. (3) The multi-hop reasoning is flawed: the question requires comparing two filings across years to detect changes in plan documentation, but the LLM fails to identify the shift from the 2016 to the 2022 Plan Statement, which is the central change. Instead, it emphasizes continuity and references other plans (e.g., SPP I, SPP III, 2020 LTIP) not directly relevant to the SPP II evolution, diluting focus. (4) While the answer is contextually relevant—discussing executive compensation and referencing correct plan types like performance shares and RSUs—it draws an incorrect conclusion about structural stability. The ground truth suggests strategic evolution in compensation design, while the LLM asserts consistency, contradicting the evidence. Thus, despite appropriate framing, the factual and reasoning errors severely undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 451,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations under the Olumiant collaboration with Incyte have evolved such that milestone payments tied to regulatory and sales-based triggers have been capitalized as intangible assets and are being amortized to cost of sales, with Incyte eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales milestones through 2024; future milestone payments remain contingent on achieving specified development and commercialization events, but no material contingent payments are expected beyond those already accrued.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $100 million in additional regulatory milestones and $100 million in sales milestones from the 2022 agreement, which matches the ground truth. However, it incorrectly implies that these milestone payments were still eligible through 2024, whereas the ground truth states that by 2024, there is no mention of remaining regulatory milestones—indicating they likely were paid out or expired. This misrepresents the evolution of obligations. Additionally, the LLM introduces new information not in the original answer—specifically that milestone payments have been capitalized as intangible assets and are amortized to cost of sales—which is not supported by the provided ground truth. It also claims 'no material contingent payments are expected beyond those already accrued,' which is a speculative conclusion not present in the original. (2) Quantitatively, the $100M + $100M figures are accurate and correctly attributed to regulatory and sales milestones. However, the timeline is wrong—these were 2022 terms, not ongoing through 2024. The answer fails to reflect the shift in structure by 2024 to royalties only. (3) The multi-hop reasoning is flawed: while the model captures the initial state (2022), it fails to synthesize the change over time to 2024. The ground truth emphasizes a structural shift from dual milestones to sales-based royalties, which the LLM omits entirely. Instead, it assumes continuity. (4) The contextual relevance is moderate—it addresses the topic of milestone payments and Incyte’s eligibility, but misses the core evolution the question asks about. The addition of unverified accounting treatment reduces accuracy. Correctness score is low due to significant factual and reasoning errors about the timeline and structure changes, despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 501,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco’s financial exposure in the APJC region grew modestly from fiscal 2022 to fiscal 2023, with APJC revenue rising from $8.0 billion to $8.027 billion and the segment’s gross margin increasing from $5.241 billion to $5.241 billion (essentially flat), while the company’s overall net deferred tax assets rose to $4.394 billion, reflecting a broader global tax position that includes the APJC footprint.  The segment’s asset balances (e.g., purchased intangibles and goodwill) also expanded, indicating a continued investment in the region, but the exposure remains limited to the typical revenue and margin levels reported for APJC in the 2022‑2023 fiscal years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and introduces specific financial figures (e.g., $8.0 billion revenue, $5.241 billion gross margin) for the APJC region in fiscal 2022 and 2023 that are not present in the ground truth and were not disclosed in Cisco's segment reporting for those years. The ground truth explicitly states that 'specific financial figures for APJC were not disclosed' in fiscal 2022, and only asset balances ($5,382 million) were reported in 2023. Thus, the LLM fabricates revenue and margin data unsupported by the source. (2) The only potentially relevant number mentioned—asset growth—is inaccurately represented; the LLM refers to 'asset balances (e.g., purchased intangibles and goodwill) also expanded' without citing the actual disclosed asset value of $5,382 million in 2023, nor does it mention the lack of asset disclosure in 2022. The reference to 'net deferred tax assets of $4.394 billion' is a global figure and not specific to APJC, making it misleading in the context of regional financial exposure. (3) The multi-hop reasoning is flawed: the question asks for evolution in financial exposure based on segment reporting and asset balances, which requires acknowledging the shift from no disclosed segment asset data in 2022 to a disclosed $5.382 billion in 2023. The LLM fails to capture this key point and instead invents granular income statement metrics that were not reported. (4) The contextual relevance is moderate because the answer discusses Cisco, APJC, and fiscal years 2022–2023, but the qualitative and quantitative inaccuracies severely undermine correctness. The model appears to hallucinate data rather than report disclosure patterns. Correctness score is low due to major factual errors and fabrication of undisclosed figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 487,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "From 2022 to 2024, the strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved in response to regulatory changes, particularly the Inflation Reduction Act (IRA). The IRA mandated government price-setting for certain drugs, and in August 2023, HHS selected Jardiance as one of the first ten medicines subject to price negotiation, with a 66% discount off the 2023 U.S. list price effective in 2026. This regulatory shift, along with the broader impact of IRA provisions on pricing and reimbursement, necessitated adjustments to LLY's business strategies, including potential impacts on revenue streams and investment in research and development. The collaboration now operates within a framework of significantly reduced pricing expectations for Jardiance and other selected products, accelerating revenue erosion prior to exclusivity expiration.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory change—the Inflation Reduction Act (IRA)—and Jardiance being selected in August 2023 as one of the first ten drugs subject to government price negotiation. It also correctly notes the 66% discount. However, it incorrectly states the discount takes effect in 2026, while the ground truth specifies it was applied in August 2024. This is a critical error in timing that affects revenue projections and strategic response. (2) Quantitatively, the 66% discount and August 2023 selection are accurate, but the effective date of the discount is wrong. The ground truth clearly states the discount was applied in August 2024, not 2026. Additionally, the LLM omits the 2022 revenue growth figures (30% in U.S., 28% outside U.S.), which are key to showing the evolution from strong growth to revenue pressure. (3) The reasoning is sound in linking the IRA to strategic shifts in pricing and R&D, and the synthesis of regulatory impact on collaboration is logical. However, the failure to mention the pre-IRA growth context weakens the multi-hop narrative of 'evolution' from 2022 to 2024. (4) The answer is highly contextually relevant, addressing the collaboration, regulatory change, and strategic implications. Scores reflect mostly correct facts but significant issues with date accuracy and incompleteness regarding 2022 performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 388,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "The 2023 10‑K shows GM’s cybersecurity risk discussion has been expanded to explicitly address safety‑critical vehicle systems and the reputational fallout from large‑scale recalls—e.g., the Bolt EV safety recall—highlighting that unauthorized access to in‑vehicle software could compromise safety, trigger costly recalls, and damage brand trust. While prior years emphasized general cyber‑risk and data‑privacy, the 2023 filing adds a dedicated focus on how cyber threats to connected‑vehicle platforms affect product safety, regulatory compliance and GM’s positioning in EV/AV technologies.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct but significantly misaligns with the ground truth in terms of reasoning and focus. (1) Correct elements: The mention of the Chevrolet Bolt EV recall and its connection to reputational risk in 2023 is accurate. The reference to GM’s EV/AV technology positioning is also consistent with the original answer. There are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, the core evolution described in the ground truth—shift from financial/logistical concerns in 2022 to reputational/strategic risks in 2023—is not accurately reflected. Instead, the LLM answer pivots to a discussion of cybersecurity risks, particularly unauthorized access to in-vehicle software, which is not mentioned in the original answer and misrepresents GM’s stated evolution. (3) The multi-hop reasoning fails: the question asks about the evolution in risk emphasis between 2022 and 2023 regarding product safety recalls on global platforms, but the LLM introduces a new theme (cybersecurity of connected vehicles) not present in the ground truth. This suggests a misinterpretation of the source material. (4) While some entities (GM, Bolt EV, 2023) and context (EV/AV positioning) are correct, the qualitative inaccuracy in reasoning and shift in topic from financial/reputational risk of recalls to cybersecurity undermines the correctness. The answer is contextually relevant but addresses a different aspect of risk, leading to a low correctness and qualitative accuracy score despite no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 424,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "The Guaranteed Senior Notes issued by Costco's Japanese subsidiary, totaling approximately $500 in November 2023 with maturities from 2033 to 2043, saw a $77 repayment in July 2024, reflecting ongoing reduction of this debt. This repayment, alongside the $1,000 repayment of the 2.750% Senior Notes in May 2024, demonstrates Costco's strategy of actively managing and reducing long‑term debt through targeted repayments and refinancing, supporting a long‑term financing approach focused on maintaining a strong balance sheet and lowering leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 issuance in November 2023 and the $77 repayment in July 2024, which aligns with the ground truth. However, it introduces a significant factual error by mentioning a $1,000 repayment of 2.750% Senior Notes in May 2024, which is not present in the original answer and cannot be verified from the provided context. This addition misrepresents Costco's financing activity and undermines the accuracy of the response. (2) The dates (November 2023, July 2024) and dollar amounts ($500, $77) are correct and match the ground truth. The interest rates (1.400% to 2.120%) and maturities (2033 to 2043) are omitted, which reduces completeness. The erroneous $1,000 repayment is a major quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers that repayment indicates debt management. However, it fails to capture the key evolution in disclosure transparency between 2022 and 2024 (from general Level 3 valuation description to detailed note issuance), which is central to the question. Instead, it shifts focus to an unmentioned refinancing event, indicating flawed synthesis. (4) The contextual relevance is high because the answer addresses long-term financing strategy and debt repayment, but correctness and qualitative accuracy are reduced due to the inclusion of unsupported data and omission of key details about increased disclosure and fixed-rate debt strategy. The core evolution in reporting and strategy emphasis on extended maturities and fixed rates is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 430,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco’s available‑for‑sale debt investments fell sharply from $15,592 million at the end of fiscal 2023 to $9,865 million at the end of fiscal 2024—a decline of about $5.7 billion (≈37%). This reduction reflects the company’s decision to sell or otherwise dispose of a portion of its high‑quality, investment‑grade securities, likely to free up cash for strategic initiatives such as the Splunk acquisition, dividend payments, share‑repurchase programs, and other capital‑allocation priorities. Consequently, the decrease signals a more aggressive deployment of cash toward growth investments and shareholder returns rather than holding a large portfolio of debt securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dates and direction of change. The ground truth states that the drop occurred between 2022 and 2023, with values decreasing from $15,592 million to $9,865 million. However, the LLM incorrectly frames this change as occurring between fiscal 2023 and fiscal 2024, reversing the timeline. This is a critical error in temporal context and undermines the quantitative accuracy. Additionally, while the dollar decrease is correctly calculated as approximately $5.7 billion (actual: $5,727 million), the percentage decline (≈37%) is based on incorrect year framing. (2) The original answer notes a gain of $9 million in 2022 from available-for-sale investments, which the LLM omits entirely, missing a key part of the investment strategy context. (3) The reasoning about strategic reallocation toward acquisitions (e.g., Splunk), dividends, and buybacks is plausible and adds contextual insight not in the original, but it introduces unverified assumptions not supported by the ground truth. While this reflects sound qualitative reasoning, it goes beyond the provided data. (4) The entities (Cisco, available-for-sale debt investments) are correct, but the fiscal years are misaligned, breaking the multi-hop logic. Despite this, the answer remains contextually relevant by addressing both the change in value and implications for investment strategy, even if with incorrect timing and unsupported specifics. Thus, correctness is partially compromised due to major date/number flow errors, though core magnitude and directional trend (a large decrease) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 446,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "From 2023 to 2024, JPMorgan Chase’s exposure to system‑damage risks remained high, but the firm highlighted a continued escalation in third‑party vendor attacks and more complex data‑recovery challenges.  The 2024 filing stresses that breaches involving vendors—especially ransomware and attacks on open‑source components—can cause prolonged service outages, extended data‑restoration delays, and greater financial losses that may exceed cyber‑insurance coverage, while also amplifying reputational and regulatory fallout.  Consequently, the company’s risk profile has not diminished; instead, it has evolved toward heightened reliance on often‑inadequately secured external providers and the need for more robust, rapid recovery capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: the evolution from 2023 to 2024 is properly framed, with accurate emphasis on third-party vendor attacks (especially ransomware), data recovery challenges, and financial risks exceeding cyber insurance coverage. The LLM correctly identifies increased complexity in recovery and service outages, which maps to the original answer's mention of 'inability to prevent systems from processing fraudulent transactions' and 'increased complexity in recovering from data theft or destruction.' (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, no incorrect numbers are introduced, and all references to financial impact are consistent with the original (e.g., losses exceeding insurance). (3) Multi-hop reasoning is sound: the LLM synthesizes the shift in risk focus from internal vulnerabilities (2023) to external third-party threats (2024), correctly identifying the evolving nature of system damage risks. It adds contextual depth by mentioning open-source components and reputational/regulatory fallout, which are reasonable inferences consistent with the direction of the original answer. (4) The only reason for not scoring a perfect 10 is minor: the original answer specifically mentions 'zero-day vulnerabilities' and 'distributed denial-of-service attacks' as 2023 risks, which the LLM omits. While the focus is on 2024 evolution, a more complete answer would briefly acknowledge the prior-year baseline. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 457,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has invested in expanding its private‑label portfolio and supporting infrastructure to drive its private‑label growth strategy.  By 2024 the company had opened 26 new warehouses (including relocations) and added new distribution and logistics facilities that provide the space needed to stock and promote private‑label items, while also upgrading its supply‑chain and e‑commerce capabilities to increase the availability of private‑label products across its U.S., Canadian and international operations.  These operational investments underpin the company’s effort to grow private‑label sales and improve margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misses the core operational investments highlighted in the ground truth. (1) Quantitatively, the claim of opening '26 new warehouses (including relocations)' by 2024 is not supported by the original answer and introduces a specific number absent from the ground truth, making it factually unsupported. There is no mention of warehouse expansion or logistics facilities in the original answer. (2) The original answer emphasizes that Costco invested in internal 'processing, packaging, and manufacturing facilities' to build in-house production capabilities for private-label goods—this is the key operational shift. The LLM instead focuses on distribution, logistics, e-commerce, and warehouse count, which are not mentioned in the ground truth and represent a different type of investment. (3) While both answers connect operational investments to private-label growth, the LLM fails the multi-hop reasoning by not linking the 2022 strategy (increasing private-label penetration to manage inflation) to the 2024 evolution of internal production capabilities. Instead, it invents infrastructure expansions that are contextually plausible but factually incorrect per the provided knowledge. (4) The LLM answer is contextually relevant to Costco's private-label strategy and addresses the timeframe, but substitutes the actual investments with generic supply chain upgrades, missing the specific shift from external sourcing to internal manufacturing. Thus, while the general direction is reasonable, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 439,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group’s approach to Medicaid managed‑care bidding remained focused on submitting bids based on assumptions about enrollment, utilization and medical costs, but the risk of inaccurate assumptions grew as external factors—such as CMS payment adjustments, benchmark changes and competitive bidding environments—became more volatile. The company explicitly highlighted that any material mis‑estimation of these factors could adversely affect its results of operations, financial position and cash flows, underscoring heightened awareness of bid‑accuracy risk in both years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of UnitedHealth Group's focus on assumptions related to enrollment, utilization, and medical costs in Medicaid managed care bidding, and correctly notes the financial risks of inaccurate assumptions. It accurately reflects that these risks were emphasized in both 2022 and 2023, and mentions relevant external factors like CMS adjustments and competitive dynamics. However, it misses a key evolution highlighted in the ground truth: the shift in emphasis from 2022's primary concern about *contract renewal risk and member retention* to 2023's deeper focus on *bid assumptions and competitive pricing dynamics*. While the LLM acknowledges ongoing risks related to bid accuracy, it does not clearly articulate this strategic shift in focus over time, which is central to the question. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the entities (UnitedHealth Group, Medicaid managed care, CMS) and years (2022–2023) are correct. The reasoning is sound but incomplete in synthesizing the multi-hop evolution across years. The answer remains contextually relevant and well-structured, but lacks the precise comparative insight that defines the evolution in UnitedHealth’s risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 362,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "From 2022 to 2023, MetLife’s investment in Municipals within its Fixed Maturity Securities AFS portfolio remained classified at Level 2 of the fair‑value hierarchy. In the 2023 table, the Municipals line shows $147 million reported under Level 2 (with no Level 1 or Level 3 amounts), compared with $159 million reported at Level 2 in 2022. Thus, the valuation hierarchy classification did not change—Municipals continued to be categorized as Level 2 assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents both the magnitude and direction of change in MET's Municipals investment from 2022 to 2023. (1) QUANTITATIVE INACCURACY: The LLM claims MET's Municipals investment was $159 million in 2022 and $147 million in 2023, but the ground truth states it was $14,212 million in 2022 and $159 million in 2023—indicating a massive decrease, not a minor fluctuation. The LLM reversed the years and misrepresented the scale of the investment. (2) ENTITY/CLASSIFICATION ERROR: The LLM asserts that Municipals were classified as Level 2 in both years, but the original answer states that in 2022, there was no detailed breakdown of valuation hierarchy levels—only an aggregate 'Estimated Fair Value'—while in 2023, it was explicitly classified as Level 2. Thus, the LLM incorrectly claims consistency in classification when the transparency improved in 2023. (3) REASONING FAILURE: The model fails to recognize the multi-hop nature of the question—comparing both valuation amount and hierarchy classification across years—and instead presents a false narrative of stability. (4) SEMANTIC NON-EQUIVALENCE: The conclusion that 'classification did not change' directly contradicts the ground truth, which emphasizes increased transparency in 2023 with explicit Level 2 classification. While the answer is relevant to the topic, the core facts are inverted or incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 400,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal 2022 to 2024 Microsoft’s licensing model for Office 365 shifted from a primarily volume‑licensing approach—using agreements such as Enterprise Agreements, Microsoft Products and Services Agreements, and Open Value that required organization‑wide commitments and often bundled Software Assurance—to a broader suite of subscription‑focused contracts that emphasize flexibility and direct, non‑expiring agreements.  The newer Microsoft Customer Agreement and Microsoft Online Subscription Agreement let customers subscribe monthly or annually, purchase perpetual licenses with optional SA, and scale usage up or down without the long‑term, three‑year commitments typical of earlier Enterprise Agreements.  This evolution gives customers—especially small‑to‑medium businesses and government/academic entities—greater choice to mix perpetual and subscription rights, opt‑in to SA only when desired, and transact directly through simplified digital experiences rather than through traditional reseller or volume‑licensing channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Microsoft's licensing and subscription models for Office 365 from fiscal 2022 to 2024. (1) It accurately captures the shift from volume licensing with organization-wide commitments (e.g., Enterprise Agreements) in 2022 to more flexible, customer-centric models in 2024, including the Microsoft Customer Agreement and Microsoft Online Subscription Agreement. The mention of monthly/annual subscriptions and removal of long-term commitments matches the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no discrepancies. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers a strategic shift toward flexibility, direct purchasing, and scalability, particularly benefiting SMBs and public sector entities. However, the LLM slightly overreaches by mentioning 'perpetual licenses with optional SA' and 'mixing perpetual and subscription rights'—this is not emphasized in the ground truth, which focuses on cloud subscriptions and unearned revenue recognition, not hybrid perpetual models. The original answer does not reference Software Assurance (SA) or perpetual licensing, so this addition introduces a minor factual deviation. (4) Despite this nuance, the core message about increased licensing flexibility and agreement modernization is preserved, and the answer is highly relevant to the question. Hence, a score of 8 is justified—strong accuracy with a minor overextension in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 439,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS shifted significantly: the proportion of Level 3 holdings decreased from 2% to 0.1% of total fixed maturity securities AFS, while Level 2 holdings increased from 74% to 59% of the total. This indicates a strategic move toward more liquid, observable investments, reducing reliance on illiquid assets and aligning with a focus on managing risk and volatility in the investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the actual composition changes in MET's Level 3 Fixed Maturity Securities AFS between 2022 and 2023. (1) The original answer specifies exact dollar amounts for Corporate bonds, Foreign Bonds, and Equity Securities/Other Investments in Level 3 for both years. The LLM instead discusses percentages of total fixed maturity securities (e.g., Level 3 decreasing from 2% to 0.1%, Level 2 increasing from 74% to 59%), which are not present in the ground truth and factually incorrect in context. (2) There is no mention in the ground truth about Level 2 holdings or percentage breakdowns of total AFS securities—these numbers appear fabricated. The actual shift involves a massive increase in 'Other Investments' within Level 3—from $11 million in Equity Securities in 2022 to $828 million in Other Investments in 2023—completely missed by the LLM. (3) The multi-hop reasoning fails: the LLM misidentifies the nature of the change (aggregate portfolio classification percentages vs. actual Level 3 composition) and draws an incorrect conclusion about liquidity and risk management, missing the real insight about a strategic shift toward 'Other Investments' as a more aggressive diversification move. (4) The contextual relevance is low because it discusses unrelated metrics, though it does attempt to interpret investment strategy. Due to complete failure in quantitative accuracy and core factual content, the correctness score is near the lowest.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 413,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Microsoft's strategic positioning of Office 365 has evolved from a standalone on-premises productivity suite to a core component of its integrated cloud services portfolio, increasingly bundled with Azure and other cloud offerings. This shift reflects a response to competitive pressures from AI-driven platforms, as Office 365 now serves as a primary vehicle for delivering AI-enhanced capabilities (e.g., Copilot integrations) within Microsoft's broader cloud ecosystem, aiming to maintain market relevance against rivals like Google Workspace and Amazon Web Services. The company emphasizes seamless integration across its cloud services to drive subscription retention and monetize AI investments, positioning Office 365 as a strategic differentiator in a crowded market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution of Office 365 between 2022 and 2024. It accurately captures the shift from a standalone suite to an integrated component of Microsoft's cloud and AI strategy, noting its bundling with Azure and role in delivering AI capabilities like Copilot. The competitive pressures from Google Workspace and AWS are relevant and consistent with the original answer's mention of rivals offering alternative AI models. However, the LLM answer incorrectly implies that Office 365 originated as an 'on-premises productivity suite'—this mischaracterizes its cloud-native trajectory; while Office had on-premises versions historically, Office 365 itself was launched as a cloud service. Additionally, the original answer specifically references Microsoft's 2024 focus on devoting resources to AI models and infrastructure in response to free/ad-funded or open-source AI competitors, a nuance not fully captured in the LLM response. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound, though slightly less precise in reflecting the timeline and nature of Office 365’s evolution. Contextual relevance is excellent, addressing all key aspects of the question: strategic positioning, integration into cloud portfolio, and competitive response to AI-driven offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 385,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's handling of credit-related impairments remained consistent in methodology but showed improved financial transparency. The company continued to evaluate credit-related impairments on available-for-sale debt securities by comparing fair value to amortized cost, using observable inputs (Level 2) and only rarely relying on unobservable inputs (Level 3). While no material impairments were recorded in either year, the 2023 disclosures emphasized more detailed tracking of unrealized losses across security types and highlighted that losses were primarily driven by interest rate changes rather than credit deterioration. This refined disclosure approach enhanced transparency around the valuation of its $40+ billion investment portfolio, though the core impairment assessment methodology remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but significantly misrepresents the evolution of UnitedHealth Group's impairment methodology between 2022 and 2023. While it correctly notes that no material impairments were recorded and that unrealized losses were due to interest rate changes, it incorrectly claims the 'core impairment assessment methodology remained unchanged.' This directly contradicts the ground truth, which states that in 2023 the company formalized a new, more structured approach by distinguishing between credit-related and non-credit-related impairments and changing how these are recorded (allowance against investment income vs. other comprehensive income). The LLM answer fails to mention this critical shift in accounting treatment and evaluation framework, which is the central point of the original answer. (2) Quantitatively, the mention of a '$40+ billion investment portfolio' is plausible and consistent with UnitedHealth's scale, though not explicitly verifiable from the ground truth provided; no incorrect numbers or calculations are present, so quantitative accuracy is relatively high. (3) The multi-hop reasoning is flawed: the question asks for evolution in methodology and financial impact, requiring synthesis of changes over time. The LLM answer fails to recognize the key change in 2023—segmented impairment recognition and revised financial reporting—which represents a significant methodological evolution. Instead, it asserts continuity, missing the core insight. (4) Contextual relevance is moderate because the answer discusses relevant topics (impairment evaluation, fair value, interest rate impacts), but it misses the essential qualitative shift in accounting policy. Correctness and qualitative accuracy are low due to this fundamental mischaracterization of the evolution in UnitedHealth's approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 506,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans shifted toward higher exposure to corporate bonds and foreign bonds within Level 2, while the Level 3 balance grew modestly (from $55 million in 2022 to $54 million in 2023) and the overall fair‑value hierarchy showed increased weighting of Level 2 assets (e.g., corporate bonds rising to $3.029 billion and foreign bonds to $808 million in 2023). Additionally, the target allocation for Fixed Maturity Securities AFS remained around 85‑95 % of plan assets, but the actual 2023 allocation was slightly lower at approximately 82 % for U.S. pension benefits.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific details not present in the ground truth, such as Level 2 and Level 3 asset breakdowns, corporate and foreign bond values ($3.029 billion, $808 million), and a claim about target allocation (85–95%) and actual 2023 allocation (82%), none of which are supported by the original answer. The ground truth does not mention fair value hierarchy levels, specific bond types, or target/actual allocation percentages for 2023. (2) The only potentially relevant quantitative data in the original answer is the 2023 fair values: $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. The LLM answer does not include these correct figures and instead fabricates others. The claim that Level 3 assets went from $55 million to $54 million contradicts typical reporting trends and is unsupported. (3) The multi-hop reasoning is flawed: the original answer describes a shift from percentage-based allocation in 2022 (84% and 95%) to absolute valuations in 2023, but the LLM fails to mention the 2022 percentages and instead invents a narrative around asset classifications and hierarchy levels. It does not correctly synthesize the evolution from relative (percentage) to absolute (dollar) reporting. (4) While the LLM attempts to address the evolution of allocation and valuation, it does so with hallucinated data and incorrect specifics, leading to a low correctness score. The contextual relevance is moderate because it discusses the topic area (allocation of Fixed Maturity Securities AFS), but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 439,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved from being a relatively small segment (accounting for 2.6% of total sales in 2022) to a more prominent component within its broader product portfolio, though still representing a modest share of overall revenue. This growth aligns with the company's \"Elevate Assortment\" pillar under its Total Home strategy, which emphasizes expanding product offerings to meet customer needs across categories like Kitchens & Bath, Building Products, and Hardlines. The category's inclusion in the company's strategic pillars and its contribution to total sales (35.3% in 2023, up from 2.6% in 2022) suggests it has gained relative importance as part of Lowe's effort to broaden its core product mix beyond traditional hardware and lumber, though it remains a smaller portion of the overall portfolio compared to dominant categories like Building Products (32.4% in 2023) and Home Décor (35.3% in 2023). This evolution reflects a deliberate shift toward offering more integrated, high-margin solutions for home improvement projects, reinforcing its role as a strategic growth area within the company's omnichannel and Total Home strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the quantitative claims. The ground truth states that Kitchens & Bath was repositioned organizationally—from Home Décor in 2022 to core construction/renovation categories in 2023—but provides no sales percentages. The LLM invents specific figures: 2.6% of sales in 2022 and a dramatic rise to 35.3% in 2023, which is not supported by the original answer. Moreover, it incorrectly states that Kitchens & Bath accounted for 35.3% of total sales in 2023, while also claiming Home Décor was 35.3% in 2023—this duplication and magnitude are unsupported and implausible given typical category breakdowns. (2) There are severe calculation and data integrity issues: the 2.6% to 35.3% jump is presented as fact but has no basis in the ground truth, which does not mention any sales figures. The LLM also misattributes the 35.3% figure to both Kitchens & Bath and Home Décor, creating internal inconsistency. (3) The multi-hop reasoning is partially sound in that it identifies the 'Total Home' strategy and attempts to link Kitchens & Bath to strategic growth, but it fails to accurately reflect the nature of the repositioning (organizational/category grouping shift) and instead fabricates financial metrics to support its point. The core insight about increased strategic importance aligns with the ground truth, but the reasoning is based on false data. (4) The contextual relevance is moderate because the answer addresses the evolution and strategic importance, but the reliance on invented numbers and mischaracterization of the portfolio structure severely undermines correctness. The qualitative reasoning is flawed due to incorrect entity relationships and made-up metrics. Thus, the correctness score is low due to fundamental factual and quantitative errors, despite some alignment in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 513,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International has progressively shifted its strategic focus toward cheese and grocery categories, particularly through targeted acquisitions like Evirh in China (2024) and the expansion of its cheese & grocery portfolio within its broader snacking strategy. This evolution reflects a deliberate prioritization of cheese and grocery as high-growth, complementary segments to its core snacking business, aligning with its long-term growth agenda to drive sustainable revenue expansion beyond traditional snack categories. The company's investments and strategic emphasis on these categories underscore their role as key growth engines within its global snacking leadership vision.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and substance. The ground truth states that Mondelez *exited direct production* of Cheese & Grocery by 2024, reducing its involvement to only a strategic stake, whereas the LLM claims the company *expanded* in this category through acquisitions like 'Evirh in China (2024)'—a company and deal that do not exist in the provided knowledge base. There is no mention of any such acquisition or expansion in the original answer. (2) Quantitative accuracy is completely lacking: the original answer cites $1,990 million in 2022 revenue from Cheese & Grocery, but the LLM answer omits all numerical data and introduces false events. No calculations are attempted, but the absence of correct figures and presence of fabricated ones (e.g., non-existent acquisition) severely undermines accuracy. (3) Multi-hop reasoning is flawed—the question requires synthesizing changes in business strategy across years (2022 to 2024), but the LLM incorrectly infers increased prioritization when the actual shift was de-prioritization. The model fails to recognize the strategic retreat from direct production and misinterprets the 'adjacent category' positioning as active expansion. (4) Contextual relevance is moderate because the answer discusses strategy and growth categories related to the question, but the factual foundation is so incorrect that the conclusion is opposite to the truth. The LLM suggests increased prioritization when the reality is a strategic downgrading of the category in favor of core snacks. Thus, while the structure and intent align with the question, the content is fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 456,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Abbott's presentation of its enteral feeding product lineup shows a clear shift in how it positions Jevity relative to Freego™ products between the 2022 and 2023 10-K filings. In the 2022 filing (page 4 of ABT_10k_2022.pdf), Jevity is listed alongside other enteral products like Glucerna 1.2 Cal and Osmolite under the Nutritional Products segment, but Freego™ is not mentioned at all. By contrast, the 2023 filing (page 4 of ABT_10k_2023.pdf) explicitly groups Jevity with Freego™ (1.2 Cal and 1.5 Cal) as part of the \"nutritional products used in enteral feeding,\" indicating a more integrated presentation of these products. This change reflects Abbott's effort to position Freego™ as a complementary product line within its enteral feeding portfolio, moving it from an omitted reference to a defined component alongside Jevity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, Freego™ products were mentioned in the 2022 10-K filing—specifically listed after Jevity, Glucerna, and Osmolite, as Freego™ (Enteral Pump) and Freego™ sets. However, the LLM incorrectly claims that 'Freego™ is not mentioned at all' in the 2022 filing, which is false and a critical error. This misrepresentation invalidates the core of the LLM's reasoning. Additionally, the LLM states that in 2023, Freego™ is grouped with Jevity as '1.2 Cal and 1.5 Cal' variants, implying nutritional formulations similar to Glucerna, which contradicts the ground truth: Freego™ refers to enteral pump devices and sets, not caloric formulations. The ground truth indicates a reordering of product listing—Freego™ moved up in the list after Jevity in 2023, suggesting increased prominence—not integration as nutritionally aligned products. Thus, the LLM misidentifies both the nature of Freego™ and its presence in the 2022 filing. While the answer attempts to address the question and recognizes a strategic shift, the factual foundation is flawed. Quantitative accuracy is low due to incorrect assertions about presence/absence and product categorization. Qualitative accuracy suffers from incorrect entity interpretation and flawed multi-hop reasoning. Contextual relevance is moderate because the response is on-topic and attempts comparative analysis, but based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 408,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MetLife’s municipal bond holdings declined in fair value from $524 million to $10 million (a reduction of roughly $514 million), and the classification of these securities shifted from “Municipals” within the Fixed Maturity Securities AFS portfolio to essentially zero exposure in the 2023 tables. This reduction reflects a deliberate de‑risking of the municipal segment, as the company recognized credit‑loss allowances and wrote down the securities, indicating a proactive strategy to limit exposure to potentially underperforming municipal credits and to manage overall credit‑risk concentrations within its investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, MET's municipal holdings were $14,212 million in 2022 and dropped to $159 million in 2023, not $524 million to $10 million as stated by the LLM. This represents a massive discrepancy in scale and magnitude—over a 13,000% error in the reported values. The LLM also fails to mention the significant unrealized gains ($2,464 million) and minimal losses ($13 million) in 2022, which are key indicators of portfolio health and risk management context. (2) The calculation of a $514 million reduction is incorrect because the starting and ending values are wrong. The actual reduction is $14,212M - $159M = $14,053M, a far more substantial shift. Additionally, the claim that exposure went to 'essentially zero' is misleading—$159 million is not negligible, especially compared to the LLM’s own $10M figure. (3) The reasoning about de-risking and credit-loss allowances is partially plausible but not supported by the provided ground truth, which does not mention write-downs or allowances—only a repositioning reflected in fair value and hierarchy classification (Level 2). The LLM invents details not present in the source, weakening the multi-hop logic. It also misses the key point about the securities remaining in the 'fixed maturity securities AFS' category in both years, with only a change in fair value and hierarchy level. (4) While the general direction of the conclusion—reduced exposure suggesting credit risk management—is aligned with the ground truth, the severe numerical inaccuracies and fabricated details (e.g., write-downs, allowances) undermine correctness. The answer is contextually relevant to the question’s intent but fails on core factual delivery, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 490,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s interest rate hedge contracts decreased from approximately $2.9 billion at December 31 2022 to $2.2 billion at December 31 2023, a reduction driven by the maturity of $700 million of hedges in 2023. The hedges, which convert portions of fixed‑rate debt to variable‑rate exposure, are marked‑to‑market and offset the fair‑value changes of the underlying fixed‑rate obligations, allowing Abbott to manage its fixed‑rate debt more flexibly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts remained consistent at approximately $2.2 billion in both 2022 and 2023. However, the LLM claims the value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, citing a $700 million reduction due to maturities—information not supported by the original answer. This misrepresents the quantitative trend entirely. (2) The calculation of a $700 million decrease from $2.9B to $2.2B is mathematically correct, but the starting value of $2.9B is false; the correct 2022 value is $2.2B. Thus, the core numbers are factually wrong. (3) While the LLM correctly identifies the purpose of the hedges—converting fixed-rate debt to variable-rate and managing fair value changes—it fails the multi-hop synthesis by incorrectly asserting a decline in notional amount and omitting the key qualitative evolution in 2023: enhanced disclosures and a more refined risk management approach. The reasoning about hedge function is sound, but the evolution over time is misrepresented. (4) The contextual relevance is moderate because the answer addresses the right topic (use of hedges in fixed-rate debt management) and correctly explains their purpose, but the incorrect numerical trend and missing insight about improved disclosure in 2023 severely undermine factual correctness. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and acceptable relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 426,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M’s fixed‑rate registered notes were systematically retired and replaced with new fixed‑rate issuances at progressively higher rates. In 2022 the company repaid €500 million of fixed‑rate medium‑term notes and $600 million of fixed‑rate medium‑term notes that matured, and in 2023 it retired $500 million of fixed‑rate registered notes and €650 million of fixed‑rate medium‑term notes as they reached maturity. By 2024 the remaining fixed‑rate registered notes outstanding carried rates of 2.41 % (2029 maturity) and 3.08 % (2030 maturity), while new issuances such as the $1 billion 2029 note at 2.41 % and the $600 million 2030 note at 3.08 % reflected a higher interest‑rate environment. Consequently, repayment activity shifted from maturing older, lower‑coupon notes to the issuance of newer fixed‑rate debt at higher effective rates, and the company began converting portions of its long‑term fixed‑rate exposure to floating‑rate exposure via interest‑rate swaps.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that 3M issued $3.25 billion in fixed-rate notes in August 2019 (not 2022–2024), including $1.0 billion 10-year notes due 2029 and $1.0 billion 30-year notes due 2049, and held $600 million 10-year notes due 2030 (3.05%) and $650 million 30-year notes due 2050 (3.70%) in 2022. The LLM incorrectly claims repayments in 2022 of €500 million and $600 million of medium-term notes, which are not mentioned in the ground truth. The 2023 repayment of $500 million in fixed-rate registered notes is correct, but the LLM adds a fictional €650 million repayment. In 2024, the ground truth states $1.1 billion in medium-term notes were repaid, but the LLM omits this and instead invents new issuances in 2024 (e.g., $1 billion 2029 note at 2.41%, $600 million 2030 note at 3.08%), which are not supported. These rates and amounts do not appear in the original. (2) The quantitative inaccuracies are severe: incorrect amounts (e.g., €500M, €650M), wrong years, fabricated issuances, and incorrect interest rates (2.41%, 3.08% vs. actual 3.05%, 3.70%). The actual repayment in 2024 was $1.1 billion, not addressed in the LLM answer. (3) The reasoning is partially sound in identifying a shift toward floating-rate debt via swaps (correctly noted in original for 2021 swaps affecting 2049/2050 notes), but the LLM incorrectly frames the strategy as issuing new fixed-rate debt at higher rates, whereas the original indicates a reduction in fixed-rate debt and conversion to floating via swaps, not new issuances. (4) Contextual relevance is moderate—the answer addresses repayment activity and interest rate strategies, but the factual foundation is flawed. Due to major errors in numbers, entities, and synthesis, the correctness score is low at 3, with quantitative accuracy particularly poor (2), qualitative reasoning partially accurate (4), and relevance acceptable (7).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 529,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, Schwab’s capital structure strategy shifted toward greater reliance on debt issuances—particularly senior unsecured notes and brokered CDs—to fund its banking subsidiaries and support brokerage client deposits, while reducing net interest revenue sensitivity through hedging of fixed‑to‑floating rate Senior Notes and a more stable asset‑liability duration profile. This evolution reflects a continued focus on maintaining strong regulatory capital ratios (e.g., Tier 1 Leverage ≈ 8.5 % in 2023) while managing funding costs in a higher‑rate environment, using both market‑issued securities and short‑term borrowings to supplement cash generated by client activity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial instruments (senior unsecured notes, brokered CDs) and strategies (hedging fixed-to-floating rate notes, duration management) not mentioned in the ground truth. It also cites a specific regulatory capital ratio (Tier 1 Leverage ≈ 8.5%) for 2023, which is not present in the original answer and cannot be verified against the provided ground truth. These additions introduce factual claims that cannot be confirmed and may be inaccurate. (2) There are no verifiable numbers in the original answer to cross-check calculations (e.g., no dollar amounts, percentages, or exact figures provided in the ground truth), so the LLM’s inclusion of a Tier 1 Leverage ratio is an unsupported addition rather than a correct or incorrect calculation. The absence of quantitative data in the ground truth means the LLM should not have introduced specific percentages. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic evolution in funding sources, aligning with the ground truth’s theme of diversification. It identifies debt issuances and other tools (impliedly FHLB, repos, CDs) as part of a broader funding mix, which matches the 2024 shift described. However, it reframes the evolution as a 'greater reliance' on debt issuances, whereas the ground truth positions securities issuances as still important but relatively less dominant in a more diversified framework. This misrepresents the nature of the shift. (4) The contextual relevance is high because the answer addresses capital structure evolution, funding sources, and capital management. However, correctness and qualitative accuracy are reduced due to unsupported specifics and a mischaracterization of the strategic shift—emphasizing increased reliance rather than integration into a broader toolkit. The answer adds plausible detail but goes beyond the evidence in the ground truth, leading to a partial match in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 530,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife decreased from $270 million (recorded as a liability for the contingent consideration as of the acquisition date) to $3,017 million reflected in the liability column for 2023 and then to $6,126 million in the 2024 fair‑value table, indicating that the liability has grown as the company re‑measures it upward each quarter; however, the milestone payment of $275 million was made in 2023, showing that fairlife achieved the required financial targets and the remaining contingent consideration is now largely tied to future 2024‑2025 payouts. This evolution demonstrates that fairlife’s performance against its financial targets has been sufficient to trigger milestone payments, but the increasing fair‑value liability suggests ongoing uncertainty and the potential for additional payments if future targets are met.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Coca-Cola had a $270 million contingent liability in 2022 related to fairlife, with a $100 million milestone already paid in 2021 for 2020 performance. The LLM incorrectly states that the liability increased to $3,017 million in 2023 and $6,126 million in 2024, which is over 20 times larger than the original amount and completely inconsistent with the truth. It also falsely claims a $275 million milestone payment was made in 2023, whereas no such payment is mentioned in the ground truth—only the $100 million in 2021. (2) The numbers are entirely incorrect: $3,017M and $6,126M appear fabricated; the $275M payment in 2023 has no basis. The direction of change (increasing liability) contradicts the expected resolution of a contingent obligation as milestones are met. (3) The multi-hop reasoning is flawed: the model fails to correctly track the timeline of payments and obligations. It misrepresents the nature of the contingent consideration, suggesting ongoing revaluation upward when the ground truth indicates only the final $270M was pending through 2024. The conclusion that liability growth indicates uncertainty contradicts the original answer’s implication that sustained obligation suggests continued progress toward targets. (4) Despite incorrect facts, the answer attempts to address the question’s intent—analyzing obligation evolution and performance implications—hence moderate contextual relevance. However, due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 442,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved from a complementary offering within its broader cloud and license business to a central pillar of its global growth strategy between 2022 and 2024. The company has increasingly prioritized OCI as a standalone, high-growth engine, emphasizing its integration with enterprise IT solutions through hybrid and multi-cloud deployment models that align with customer migration patterns. This shift is underscored by significant investments in infrastructure (e.g., $6.866B capital expenditures in 2024), expanded global data center footprints, and a strategic pivot away from non-core hardware toward cloud-based infrastructure technologies, as noted in the 2022 fiscal year discussion where hardware revenue declined due to \"de-emphasis of sales and marketing efforts for certain non-strategic hardware products.\" Financially, OCI's growth is reflected in the 6% constant-currency revenue increase in the cloud and license business (reaching $36.052B in 2022), driven by cloud services and license support adoption, while the company explicitly positions OCI as a key differentiator in its global market positioning, targeting enterprise IT modernization and integration with existing Oracle applications and infrastructure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims. While the $36.052B cloud and license revenue for 2022 matches the ground truth, the LLM incorrectly attributes a 6% constant-currency revenue increase to that year's cloud and license business without specifying that this growth figure is not explicitly tied to OCI alone in the source data. More critically, the $6.866B capital expenditure in 2024 is fabricated—the ground truth does not provide any capital expenditure figure for 2024, nor does it mention such a specific investment in OCI infrastructure. Additionally, the claim about hardware revenue decline due to 'de-emphasis of sales and marketing efforts' in 2022, while contextually plausible, is not part of the original answer and introduces unverified detail. (2) The original answer focuses on a shift in strategic language—from no explicit positioning of OCI in 2022 to positioning it as a core component alongside SaaS in 2024. The LLM captures this directional shift but overstates it with unsupported financial and operational data. The integration with enterprise IT solutions is correctly framed around hybrid and multi-cloud models, but the original answer emphasizes 'comprehensive and integrated applications and infrastructure services' as a direct quote, which the LLM paraphrases without citation. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic elevation of OCI from being a revenue contributor to a central pillar. However, it fails to restrict its claims to the information provided in the ground truth, introducing external-sounding details (e.g., capital expenditures, specific growth rates for OCI) that were not in the original. (4) The contextual relevance is high because the answer addresses both global market positioning and integration with enterprise IT solutions. However, due to significant quantitative inaccuracies and unsupported assertions, the correctness score is limited to 6—partially correct but with major factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 556,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the allowance for credit losses on Schwab's residential real estate loans (including First Mortgages and HELOCs) declined significantly, from $34 million to $15 million, reflecting a decrease in projected loss rates and improved credit quality. The allowance as a percentage of total year‑end loans fell from 0.18 % to 0.09 %, and the allowance relative to nonaccrual loans dropped from 317 % to 253 %, indicating a more favorable risk profile and reduced credit‑loss expectations for the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both entity and conceptual focus. (1) It discusses 'residential real estate loans' (First Mortgages and HELOCs) at Schwab, which are unrelated to 'PALs' (Presold Asset Loans), the actual subject of the question. This is a critical entity error. (2) The quantitative figures cited—$34 million to $15 million allowance, 0.18% to 0.09%, 317% to 253%—may be accurate for Schwab's mortgage portfolio, but they are irrelevant to PALs and do not appear in the ground truth. There is no mention in the original answer of these specific dollar amounts or percentages related to PALs. (3) The multi-hop reasoning fails completely: the question requires tracing the evolution of PALs' risk treatment, specifically around credit loss allowance and collateralization. The correct answer hinges on the application of ASC 326’s collateral maintenance practical expedient in 2024, leading to zero allowance due to full collateralization—none of which is mentioned. (4) The LLM answer is contextually misaligned, discussing a different loan category altogether. While the general theme of 'improved credit quality' is directionally similar, the specifics are entirely fabricated in context. Thus, despite some plausible-sounding financial reasoning, the answer is factually and contextually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 368,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Nike’s operational structure and strategic emphasis in the Asia Pacific & Latin America (APLA) region have evolved significantly between fiscal years 2023 and 2024. In FY2024, the company reorganized its geographic reporting to explicitly highlight APLA as a distinct operating segment, reflecting a strategic focus on accelerating growth in this high-potential region. This shift aligns with leadership changes, including the appointment of Heidi O’Neill as President of Consumer, Product & Brand and Craig Williams as President of Geographies & Marketplace, both of whom have deep APLA experience. The company also intensified investments in localized product innovation, digital commerce expansion, and sustainable manufacturing partnerships across APLA, particularly in Vietnam and Indonesia, to capture rising consumer demand and mitigate supply chain risks. These moves underscore a deliberate pivot to position APLA as a core growth engine, moving beyond its historical role as a manufacturing hub to a strategic market and innovation center.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. The ground truth states that Nike transitioned parts of its APLA operations to third-party distributors in FY2024, indicating a move away from direct control, while in FY2023 the region had union-represented employees reflecting localized operations. In contrast, the LLM claims Nike elevated APLA to a distinct operating segment in FY2024 with increased investments in innovation, digital commerce, and leadership appointments—none of which are supported by the original answer. There is a direct contradiction: the ground truth describes a strategic withdrawal from direct operations, while the LLM describes a strategic expansion and elevation. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM invents entities (Heidi O'Neill, Craig Williams), actions (reorganization to highlight APLA as a segment, appointments, investments), and strategic narratives (APLA as innovation center) not present in or inferable from the ground truth. The original answer focuses on a shift from direct to outsourced operations; the LLM fabricates a narrative of growth and strategic elevation. (4) Correctness is severely compromised due to fundamental factual inaccuracies. While the answer is contextually relevant to the question's topic (Nike's APLA evolution), the direction of the strategic shift is reversed, warranting a low correctness score of 2. Qualitative accuracy is also very low due to incorrect entity and relationship identification. Contextual relevance is moderate because the answer addresses the right region and time frame, but with wrong content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 482,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Abbott’s 2022 10‑K shows that the U.S. Pediatric Nutritional business was a key growth driver within the Nutritionals segment, with U.S. Pediatric Nutritionals sales rising 10 % in 2021 (and 6 % in 2020) after a 10 % increase in 2020, reflecting strong demand for Pedialyte and other pediatric formulas.  In 2023 the company expanded the Pedialyte portfolio—adding new flavors and packaging formats—and intensified marketing spend to capture additional market share, positioning Pedialyte as the flagship product for growth in the U.S. pediatric nutrition space.  This strategic emphasis on product‑portfolio expansion and heightened focus on the U.S. pediatric segment carried through 2023, supporting overall sales growth in the Nutritionals segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it misstates the year for the 10% sales increase in U.S. Pediatric Nutritional products as occurring in 2021 (with a 6% increase in 2020), which contradicts the ground truth stating a 10.3% increase specifically in 2022 for Pedialyte. The ground truth does not mention 2020 or 2021 pediatric nutrition growth rates in this context, nor does it support the claim that the 10% increase was in 2020. Additionally, the LLM claims Abbott 'expanded the Pedialyte portfolio—adding new flavors and packaging formats—and intensified marketing spend' in 2023, but this specific product expansion and marketing detail is not present in the original answer or supported by the knowledge graph. (2) Quantitative accuracy is low: the LLM incorrectly attributes a 10% increase to 2021 instead of 2022, and references unrelated growth percentages for 2020. The correct figure from the ground truth is a 10.3% sales increase for Pedialyte in 2022. No data is provided about 2023 sales growth or exact marketing spend, so those claims cannot be verified and appear fabricated. (3) The reasoning is partially sound in that it identifies Pedialyte as a growth driver in the U.S. Pediatric Nutritional business and links it to Abbott's broader Nutritionals segment. However, it fails to capture the key multi-hop insight from the ground truth: the strategic evolution of Pedialyte from a growth contributor in 2022 to a formally recognized brand in the 2023 portfolio alongside Ensure and Glucerna, indicating structural integration. This shift from informal contributor to formal portfolio inclusion is the core of the strategic evolution and is entirely missed by the LLM. (4) Contextual relevance is high because the answer addresses Abbott, Pedialyte, the U.S. Pediatric Nutritional business, and strategic emphasis across 2022–2023. However, due to significant factual and quantitative errors and the omission of the key structural integration point, the overall correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 559,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "From 2022 to 2023, RTX's long-term debt increased significantly from $31,351 million to $43,638 million, driven by new issuances of $5.750% notes due 2026–2034 and term loans totaling $7 billion, while repayments of older notes (e.g., 3.700% and 3.650% notes due 2023) reduced only a modest portion of the principal. This expansion reflects a strategic shift toward longer‑dated, higher‑yielding debt to fund share repurchases and refinance maturing obligations, indicating that RTX is actively managing its debt profile by extending maturities and leveraging capital markets to support shareholder returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the specific question about RTX's 7.100% notes due 2027. The ground truth states that the aggregate principal balance for these specific notes increased from $6 million in 2022 to $135 million in 2023. However, the LLM response does not mention these figures or even the 7.100% notes due 2027 specifically. Instead, it discusses overall long-term debt and unrelated debt instruments such as 5.750% notes due 2026–2034 and term loans, which are not referenced in the original answer. (2) The quantitative inaccuracies are significant: the LLM introduces numbers like $31,351 million and $43,638 million in long-term debt, which are not part of the ground truth and pertain to total debt rather than the specific 7.100% notes. There is no verification of the $6M to $135M increase in the specific notes, nor any calculation based on them. (3) The multi-hop reasoning is flawed because the model fails to isolate and track the evolution of the specific debt instrument (7.100% notes due 2027) across the two years. Instead, it generalizes about RTX’s debt strategy using broader trends that may be accurate in context but do not answer the focused question. The conclusion about refinancing and shareholder returns, while plausible, is not supported by the specific data about the 7.100% notes and contradicts the implication of increased exposure to this high-interest debt. (4) The contextual relevance is low because the answer addresses RTX’s overall debt strategy rather than the targeted financial position of a specific note. While the general strategy discussion may be informed by other filings, it does not fulfill the requirement to analyze the 7.100% notes due 2027. Thus, despite some plausible qualitative framing, the factual core of the answer is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 506,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike’s Converse segment experienced a sharp revenue decline—down roughly 14‑15% on a reported basis and about 15% on a currency‑neutral basis—driven by weaker sales in North America and Western Europe and reduced wholesale and direct‑to‑consumer volumes.  In contrast, Nike’s overall brand revenues grew modestly (about 4% reported, 8% constant‑currency), with footwear and apparel up 2‑10% and 10‑14% respectively, reflecting stronger demand in Men’s, Women’s, Jordan and Kids categories and strategic pricing actions.  Strategically, Converse is being treated as a distinct, stand‑alone operating segment that now contributes only a small share of total sales (≈58% of non‑U.S. revenue), allowing Nike to focus its growth initiatives on the core Nike Brand while continuing to manage Converse’s under‑performance separately.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ~15% currency-neutral revenue decline for Converse in fiscal 2023, aligning with the ground truth. The mention of 14-15% on a reported basis and 15% on a currency-neutral basis is consistent with the original answer. However, the LLM introduces additional details not present in the ground truth—such as Nike’s overall brand growth (4% reported, 8% constant currency), footwear/apparel breakdowns, and Converse contributing '≈58% of non-U.S. revenue'—which are either unsupported or irrelevant. The latter figure appears to be a misinterpretation or fabrication, as the ground truth does not mention Converse’s share of non-U.S. revenue. (2) The core quantitative claim about Converse’s 15% decline is accurate and correctly attributed to fiscal 2023. The additional percentages related to Nike’s broader performance, while plausible, are not part of the original answer and introduce unverified data, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that Converse is underperforming relative to Nike’s core brand and that it operates as a distinct unit. It captures the strategic shift toward treating Converse as a stand-alone entity, which matches the ground truth’s description of it being a wholly-owned subsidiary operating independently. However, the conclusion that this structure allows Nike to focus on core growth while managing Converse’s underperformance separately goes beyond the original answer’s scope, adding interpretation not explicitly supported. (4) Despite some extraneous and potentially inaccurate data, the LLM captures the essential evolution: Converse faced significant revenue declines in fiscal 2023 and was strategically repositioned as a standalone brand by fiscal 2024. The core facts are correct, and the reasoning is largely sound, warranting a high score, but the inclusion of unsupported metrics prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 533,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "From 2022 to 2024, Coca‑Cola’s risk assessment shifted from a focus on traditional cost‑inflation and supply‑chain pressures to an explicit emphasis on digital transformation as a driver of sales growth and margin improvement.  In the 2022 filing the company highlighted digital evolution only as a “shopping‑pattern” change that could affect sales if not addressed, whereas the 2024 filing elevates digitization to a “top priority,” stating that successful digitization is essential to “increase sales and improve margins” and that failure to digitize could “adversely impact our financial performance.”  Consequently, the 2024 risk discussion ties digital initiatives directly to both revenue growth and margin expansion, reflecting a strategic evolution in how the company views the digital economy’s impact on its financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Coca-Cola's shift in risk assessment from 2022 to 2024 is accurately portrayed, with digital evolution initially seen as a potential threat related to changing shopping patterns (2022), and later elevated to a strategic imperative tied directly to sales growth and margin improvement (2024). The 2024 framing of digitization as a 'top priority' and the explicit warning that failure could 'adversely impact financial performance' matches the original answer's emphasis. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but dates (2022, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the model correctly synthesizes a change over time in risk perception across two filings, linking digital transformation to financial outcomes in 2024 more strongly than in 2022. (4) The only minor deviation from the original answer is that the LLM introduces the phrase 'shopping-pattern change' and 'top priority,' which are not verbatim in the ground truth, but these are reasonable paraphrasings consistent with the described evolution. The core message—that digital evolution went from a peripheral risk to a central financial dependency—is preserved with high fidelity. Wording differences do not affect semantic accuracy. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight rewording, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 443,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "From fiscal 2022 through 2024 Oracle’s R&D spending has risen steadily—$7.2 billion in FY22, $7.9 billion in FY23 and $8.5 billion in FY24—reflecting its push to expand cloud‑focused innovation.  This increased investment underpins a strategic shift that positions Oracle Cloud Services (SaaS and OCI) as the primary growth engine, while cloud license and support revenues now represent roughly 70‑71 % of total sales and are growing faster than traditional on‑premise license and hardware revenues.  Consequently, Oracle is emphasizing cloud subscriptions and migration programs to move customers from on‑premise deployments to its cloud offerings, even as it continues to support on‑premise licenses through renewal of support contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not supported by the ground truth. While the original answer confirms $7.2 billion in R&D for FY22, it explicitly states that the FY24 report does not specify R&D investment. The LLM incorrectly asserts $7.9 billion in FY23 and $8.5 billion in FY24, which are unsupported by the provided ground truth. Additionally, the claim that 'cloud license and support revenues represent roughly 70-71% of total sales' and are 'growing faster than traditional on-premise' is not mentioned or verifiable from the original answer. (2) The quantitative inaccuracies are critical: the LLM fabricates two years of R&D spending and introduces a precise revenue percentage (70-71%) with no basis in the ground truth. These are major deviations, not formatting differences. (3) The qualitative reasoning shows understanding of Oracle's strategic shift toward cloud services and away from on-premise, and correctly identifies SaaS and OCI as central offerings. The synthesis of cloud as a growth engine and migration from on-premise aligns thematically with the original answer. However, the reasoning is undermined by invented data to support the narrative, failing the multi-hop requirement to accurately extract and compare only what is stated. (4) Contextually, the answer addresses the evolution of Oracle's cloud strategy, R&D investment, and positioning relative to on-premise—matching the question's intent. Hence, contextual relevance is high. However, correctness is severely penalized due to unsupported numbers and metrics, resulting in a low overall score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 459,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan, which was used to award shares to non-employee directors, no longer permits new stock awards or deferrals—effective after its termination, no future awards or deferrals can be made under this plan. This means that the plan’s share pool (1,993,916 shares remaining as of 2023) is now closed for new issuances, and all outstanding awards are fully vested and distributed according to prior deferral elections.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it states that 1,993,916 shares remained in the plan as of 2023, which directly contradicts the ground truth stating only 391 shares were issuable in 2024 related to the plan. This large discrepancy in share count undermines the entire quantitative foundation of the answer. Additionally, the LLM claims the plan was 'terminated' without specifying when, while the original answer notes a progressive closure—no future awards allowed in 2023, with 2024 confirming finality. (2) The number 1,993,916 is not supported by the ground truth and appears fabricated or misattributed; the only numeric data in the original is 391 shares in 2024. There are no calculations in the answer, but the use of an incorrect share pool size is a severe quantitative error. (3) The reasoning partially captures the plan's inactivity—correctly noting no new awards or deferrals—but fails to reflect the multi-hop evolution: from being inactive in 2023 to fully closed with only minimal outstanding obligations in 2024. The answer incorrectly implies a large pool of shares remains, which contradicts the conclusion that the plan had 'effectively concluded.' (4) While the answer addresses the general status of the plan and its applicability to non-employee directors, the severe numerical inaccuracy and misrepresentation of the scale of remaining obligations lead to a low correctness score. Contextual relevance is moderate because the structure and intent of the response align with the question, but factual grounding is weak.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 439,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald’s disclosure around food safety concerns remained consistent in emphasizing supply chain risks and cost volatility, with no major shift in focus. The 2023 filing (page 31) reiterates that food safety events—including supply chain disruptions, contamination, or food-borne illness incidents—could adversely affect the brand, reputation, and financial results, similar to prior years. While the company highlights ongoing efforts to manage supply chain interruptions and commodity cost volatility (page 30), it does not indicate a new or evolved disclosure strategy; instead, it maintains the same risk framework as in 2022, particularly regarding supply chain reliability and the potential for cost increases impacting profitability. The emphasis on supply chain risks and cost volatility persists as a core component of its risk factors, without significant evolution in wording or scope.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that McDonald's disclosure remained consistent between 2022 and 2023 with no major shift. The ground truth shows a clear evolution: in 2022, food safety was framed primarily as a reputational risk affecting brand perception, while in 2023, it was reframed as a contributor to supply chain volatility and commodity cost fluctuations (e.g., beef, chicken, pork prices), indicating a shift toward financial and operational risk. The LLM incorrectly asserts there was 'no significant evolution' and that supply chain risks were equally emphasized in both years, contradicting the documented shift in emphasis. While the LLM references correct general risk categories (brand reputation, supply chain, financial results) and plausible filing details (page numbers), it fails to capture the key multi-hop insight—the change in framing from reputational to financial/supply chain impact. There are no numerical errors (hence high quantitative accuracy), but the qualitative reasoning is flawed, leading to a low correctness score. Contextual relevance is moderate because the answer discusses related themes but misses the central evolution the question targets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 338,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "Based on the provided pages, the carrying value of TMO's 1.750% 7-Year Senior Notes was $621 million at December 31 2024 and $662 million at December 31 2023, with an effective interest rate of 1.96 % for 2024 versus 1.89 % for 2023. This reflects a modest increase in carrying value and a slight rise in the effective interest rate over the one‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on all key metrics. According to the ground truth, the carrying value was $700 million in both 2023 and 2024, and the effective interest rate was 1.89% in both years. The LLM incorrectly reports carrying values of $662 million (2023) and $621 million (2024), and interest rates of 1.89% (2023) and 1.96% (2024), which contradicts the stable values in the original answer. (2) The numbers are significantly off: the carrying values are both wrong and show a decrease, while the ground truth shows no change. The interest rate is incorrectly reported as increasing, when it remained constant. These are not formatting or rounding issues but substantive factual errors. (3) The multi-hop reasoning is flawed—the model fails to correctly extract and compare the same debt instrument across years, and incorrectly infers a trend that does not exist. It does attempt to address the evolution over time, showing awareness of the comparative structure, but the underlying data is wrong. (4) The correctness and quantitative accuracy scores are very low due to complete mismatch in numbers. Qualitative accuracy is low because the reasoning is structured correctly (comparing two years) but based on incorrect data. Contextual relevance is moderate because the answer addresses the right topic and metric types, but with wrong values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 383,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million in both 2022 and 2023, indicating that the company did not increase or decrease its holdings of this specific long‑term debt issue during the period. This stability suggests that RTX is maintaining a relatively steady long‑term debt maturity profile rather than actively adjusting the mix of maturing obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it states that RTX's exposure to the 7.000% notes due 2038 was $148 million in both 2022 and 2023, which directly contradicts the ground truth: the correct amount was $11 million in 2022 and $148 million in 2023. This represents a significant increase, not stability. (2) The calculation of change (from $11M to $148M) shows a 1,245% increase, which the LLM completely misses. (3) Qualitatively, the reasoning is flawed: the LLM concludes that RTX maintained a steady debt profile, when the actual data suggests a strategic increase in exposure—possibly through new issuances or restructuring to extend maturities. This misinterpretation stems from incorrect data and invalidates the multi-hop synthesis. (4) Contextually, while the answer addresses the question's structure (change in exposure and implication for debt management), it does so with false information, making the response misleading despite proper framing. The core facts are wrong, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 310,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees regarding rent and royalties evolved in two key ways: First, while total franchise revenue grew to $13.085 billion in 2021 (up from $10.726 billion in 2020), the company continued to collect both minimum rent payments (based on underlying lease investments) and variable royalties tied to sales, with future minimum payments due under franchise arrangements totaling $33.78 billion over the life of agreements. Second, the company maintained its practice of allocating franchise revenue between lease (rental income) and non-lease components (royalties and initial fees), and although pandemic-related disruptions caused temporary deferrals of approximately $1 billion in cash collections from franchisees in 2020, by December 31, 2021, substantially all of these deferrals had been collected, indicating a return to normal collection patterns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and misaligned timeframes. While it correctly notes that McDonald's deferred approximately $1 billion in rent and royalties due to pandemic-related disruptions, it incorrectly attributes the collection timeline and context. The original answer states that substantially all of the deferred amounts were collected by the end of 2021, but the LLM answer implies ongoing collection activity into 2022 without clarifying that the deferrals were from 2020 and largely resolved by 2021. Additionally, the LLM introduces revenue figures for 2020 ($10.726B) and 2021 ($13.085B), which are not mentioned in the ground truth and are irrelevant to the 2022–2023 evolution asked in the question. (2) The $33.78 billion in future minimum payments is not referenced in the original answer and appears extraneous or misattributed. There is no verification that this number is accurate in context, and its inclusion distracts from the core issue of pandemic deferrals and normalization. The $1 billion deferral amount is correctly cited, but the timing (2020 deferrals, collected by end of 2021) is misrepresented by being discussed in the context of 2022–2023 developments. (3) The multi-hop reasoning is partially sound—linking pandemic deferrals to eventual collection and normalization—but fails to correctly situate the timeline. The key evolution between 2022 and 2023 is that operations had returned to normal with no ongoing accommodations, which the LLM mentions indirectly but buries under irrelevant earlier data. It does not clearly state that 2023 reflects standard operations with no mention of deferrals, which is the central point of the original answer. (4) The contextual relevance is high because the answer addresses franchisee financial relationships, rent, and royalties, and touches on pandemic impacts. However, the qualitative accuracy is reduced by incorrect temporal framing and inclusion of unsupported figures. The correctness score is 6 due to partial factual alignment but significant errors in timing and extraneous, unverified data that distort the narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 574,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca‑Cola Company’s stake in Embotelladora Andina S.A. has been treated as an equity‑method investment that remains on the books through 2024.  In the 2022 10‑K (pages 74‑78) the company notes that it continues to account for its remaining ownership interest in Andina as an equity‑method investment, and the 2024 10‑K (pages 85‑89) shows that the carrying value of that investment ($90 million) is far below its fair value ($168 million), leaving a $78 million unrealized gain.  This evolution—maintaining a modest equity stake while the fair‑value‑to‑carrying‑value gap persists—signals that Coca‑Cola is using the investment as a strategic foothold in the Andean bottling market rather than seeking a full exit or refranchising, positioning the holding as a long‑term partnership that complements its broader bottling‑investments portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the carrying value ($90 million) and fair value ($168 million) in 2024, and correctly infers a $78 million unrealized gain (difference), which aligns with the ground truth. It also accurately states that Coca-Cola maintained an equity-method investment through 2024. However, it omits the key 2022 event mentioned in the ground truth: Coca-Cola recognized a $39 million gain from the partial sale of its stake in Embotelladora Andina S.A., indicating a divestiture action. This omission significantly affects the qualitative interpretation. (2) All numeric values—$90M carrying value, $168M fair value, and implied $78M unrealized gain—are factually correct and consistent with the ground truth. The calculation of the difference is accurate. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the ongoing equity stake and valuation metrics across years. However, it fails to incorporate the 2022 gain from partial sale, which is a critical piece of evidence for the strategic refranchising narrative. Without this, the reasoning shifts toward a 'long-term partnership' and 'strategic foothold' interpretation, which contradicts the ground truth's emphasis on a 'partial exit strategy.' This mischaracterizes Coca-Cola’s intent. (4) The contextual relevance is high because the answer addresses the evolution of the stake and strategic positioning. Quantitative accuracy is perfect. Correctness is scored 7 because core financial data is correct, but the absence of the 2022 gain and resulting misinterpretation of strategy constitutes a significant, though not total, deviation from the ground truth. Qualitative accuracy is lower due to flawed reasoning in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 479,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "From 2022 to 2024, Oracle’s strategic investment in cloud infrastructure evolved from a focus on foundational hardware and platform capabilities toward a more integrated, enterprise-grade cloud services model anchored by Oracle Cloud Infrastructure (OCI). Early investments emphasized server and storage hardware, operating systems, and virtualization technologies to support both on-premise and cloud deployments. By 2024, Oracle had significantly expanded its cloud platform, investing in data center capacity, global expansion, and automated service delivery through Oracle Cloud Operations, enabling rapid deployment of cloud updates on a quarterly cadence. This evolution positioned OCI not just as an infrastructure layer but as a strategic differentiator within Oracle’s broader product portfolio, supporting cloud license and SaaS offerings with integrated services, support, and hybrid deployment flexibility. The company’s internal development efforts intensified to enhance scalability, security, and compatibility—particularly around Java and enterprise workloads—reinforcing OCI’s role as a differentiated alternative to competitors like AWS and Microsoft Azure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Oracle's cloud infrastructure strategy from 2022 to 2024: starting with foundational internal development (R&D, hardware, virtualization) and progressing to a more structured, product-centric approach centered on Oracle Cloud Infrastructure (OCI). The emphasis on internal development efforts in 2022 and the strategic positioning of OCI by 2024 as a core offering are consistent with the original answer. (2) There are no numeric values, dates, or financial figures in either answer that conflict; the LLM correctly references the 2022–2024 timeframe and does not introduce any incorrect quantitative data. Format and factual precision are maintained. (3) The multi-hop reasoning is sound: the model synthesizes Oracle’s internal R&D focus, technological investments, and strategic repositioning of OCI within its product portfolio across time. It adds contextual depth—such as global expansion, quarterly updates, hybrid deployment, and competitive differentiation—without contradicting the ground truth. (4) While the original answer emphasizes the shift from general cloud development to a 'defined, market-ready suite,' the LLM elaborates on how that was achieved (e.g., data center expansion, automation, Java integration), enhancing rather than distorting the narrative. The only minor gap is that the LLM does not explicitly mention the 'global R&D workforce' as highlighted in the original, but it does reference intensified internal development, which is semantically aligned. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 458,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO's integration of The Binding Site Group, acquired in January 2023, is evident in its contribution to the Specialty Diagnostics segment’s revenue and income growth, and its later acquisition of Olink Holding AB in July 2024 further expands the Life Sciences Solutions segment’s proteomics capabilities. These moves underscore a strategic focus on broadening high‑growth diagnostic and proteomics offerings while leveraging synergies and cash‑flow generation to fund ongoing acquisitions and shareholder returns.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a significant factual error by mentioning the acquisition of Olink Holding AB in July 2024, which is not present in the ground truth and cannot be verified from the provided context. This undermines the factual accuracy of the response. The acquisition of The Binding Site Group in 2023 is correctly noted, though the specific month (January) is not confirmed in the original answer and may be inaccurate. (2) Quantitatively, the $2.70 billion acquisition amount is not mentioned in the LLM answer, which omits a key financial figure from the ground truth. The 19-year weighted-average amortization period for customer relationships — a critical post-acquisition integration metric — is also missing. These omissions reduce quantitative completeness. (3) The multi-hop reasoning is partially sound in linking the acquisition to strategic focus on diagnostics, but the introduction of an unverified second acquisition (Olink) distorts the strategic narrative. The ground truth emphasizes integration into intangible assets and long-term value creation via amortization and portfolio expansion in blood cancer diagnostics, whereas the LLM shifts focus to proteomics and shareholder returns, which are not supported in the original. (4) Contextual relevance is high because the answer addresses TMO's strategic direction and integration post-acquisition, but it fails to fully capture the evolution between 2023 and 2024 as defined by asset integration and amortization metrics. The answer adds extraneous information not grounded in the source, reducing its overall correctness despite some alignment in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 466,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure of BNY Mellon’s Directors’ Code of Conduct evolved from a standalone document referenced only in the 2022 filing (with a link to a PDF hosted at `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf`) to a more clearly defined, website-hosted policy in the 2024 filing, which explicitly states that the Directors’ Code of Conduct is posted at `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf` and commits to disclosing amendments or waivers on the website. The scope of application remained consistent—applying to all directors of BNY Mellon—but the 2024 version strengthened the commitment to transparency by specifying that changes to the Directors’ Code of Conduct will be disclosed on the website, whereas the 2022 version only mentioned the intention to disclose such changes without detailing the platform. Additionally, the 2024 filing refined the website URL structure (removing \"www\" and standardizing the path), reflecting a more deliberate and accessible disclosure practice.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the URLs and the evolution of disclosure practices. According to the ground truth, the 2022 URL was https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, but the LLM incorrectly cites it as ending in '/in relations/', which is both incomplete and malformed. Furthermore, the LLM claims the 2024 URL is the same as the 2022 one, but in reality, the domain changed from 'bnymellon.com' to 'bny.com'—a key rebranding signal. The correct 2024 URL is https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, which the LLM fails to report accurately. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but dates (2022 vs 2024) are correctly referenced. However, the core factual elements—URLs—are wrong, which is critical in assessing accessibility. (3) The multi-hop reasoning is partially sound: the model correctly identifies that the scope of application remained unchanged (applying to all directors) and attempts to assess transparency improvements. However, it fabricates details about the 2024 filing 'committing to disclose amendments' and claims the 2022 version only 'intended' to disclose changes—information not present in the ground truth. The ground truth makes no mention of differing disclosure commitments over time, only a URL change due to rebranding. (4) While the LLM addresses the question's structure (website links and scope), its factual inaccuracies—especially the URLs and inferred policy enhancements—severely undermine correctness. The contextual relevance is high because it engages with both disclosure and scope, but the qualitative and quantitative accuracy suffer due to incorrect data and unsupported inferences. Thus, the correctness score is low despite reasonable structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 519,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial reporting and strategic emphasis regarding franchisees evolved in several key ways. The company continued to emphasize its role as the principal in franchise-related revenue streams, particularly for technology platforms and brand licensing, recognizing revenue on a gross basis as goods/services are transferred to franchisees. Additionally, the company refined its goodwill reporting, with a 2023 table showing increased goodwill balances ($2.9B to $3.04B) and ongoing qualitative impairment testing, while maintaining historical practices of writing off goodwill on restaurant sales within 24 months. The company also refined its capitalized software amortization policies (3-10 year lives) and maintained its approach to reviewing long-lived assets for impairment at the market level, ensuring franchisee-related cash flow dependencies were considered in impairment assessments. These adjustments reflect a continued focus on aligning financial reporting with the operational realities of its franchise-heavy business model.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The original answer highlights a strategic shift in McDonald's relationship with franchisees: in 2022, transactions with franchisees were noted as immaterial to financials, while in 2023, franchisees were explicitly recognized as key stakeholders in a detailed ownership breakdown, signaling greater strategic emphasis. The LLM answer does not mention this evolution at all. Instead, it discusses unrelated or tangential financial reporting details such as revenue recognition as principal, goodwill balances ($2.9B to $3.04B), software amortization, and impairment testing—none of which are present in the ground truth and do not address the core question about evolving strategic emphasis and transparency toward franchisees. (2) While the LLM provides specific numbers (e.g., $2.9B to $3.04B goodwill), these figures are not in the original answer and cannot be verified against the ground truth; thus, their accuracy is unknown and potentially fabricated. (3) The multi-hop reasoning is flawed: the question requires comparing McDonald's treatment and emphasis on franchisees across 2022 and 2023, focusing on financial reporting tone and strategic framing. The LLM instead dives into technical accounting policies without showing how the relationship evolved in strategic or reporting emphasis. (4) Due to significant factual misalignment and omission of the actual evolution described in the ground truth, the correctness score is low. The answer is contextually somewhat relevant (it's about McDonald's and franchisees) but misses the key insight entirely, warranting a 3/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 456,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liability related to the Clif Bar acquisition was initially recorded at fair value of $548 million (Level 3) as of December 31 2023 and $452 million as of December 31 2022. Subsequent fair‑value adjustments of $128 million in 2023 and $44 million in 2022 were recorded in selling, general and administrative expenses, and the liability balance increased to $680 million by the end of 2023 before any further changes in 2024. These adjustments reflect the ongoing re‑measurement of the contingent consideration under the purchase price allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the contingent consideration liability was $548 million at December 31, 2023, but the LLM incorrectly claims it increased to $680 million by the end of 2023 after a $128 million adjustment, which contradicts the original figure. Additionally, the LLM introduces a $452 million value for 2022 and a $44 million adjustment in 2022, none of which are present in the ground truth and cannot be verified. (2) The calculation logic is flawed: if the liability was $548 million at year-end 2023 and a $128 million adjustment was recorded in 2023, this would imply a prior balance of $420 million, not $452 million as stated, making the numbers internally inconsistent. The claim of a $680 million ending balance is unsupported and incorrect. (3) The multi-hop reasoning is weak. The question asks about the evolution between 2023 and 2024, particularly regarding fair value measurement and purchase price allocation adjustments. The ground truth notes that while 2023 included active fair value measurement via Monte Carlo simulation, 2024 contains no direct update—instead referencing prior-year adjustments. The LLM fails to mention the absence of 2024 disclosures or the potential finalization/reclassification of the liability, missing a key qualitative shift. Instead, it fabricates a 2024 balance without evidence. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses contingent consideration, fair value adjustments, Level 3 inputs, and SG&A expense recognition, which are all pertinent topics. However, due to major quantitative errors and failure to reflect the discontinuation of disclosures in 2024, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 484,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD’s strategic focus on Vulkan API support has evolved from a foundational emphasis in 2022—highlighted by its promotion of open standards like Vulkan and ROCm for cross-platform graphics and compute—to a more integrated, performance-driven approach by 2024, where Vulkan is positioned alongside ROCm optimizations to enhance AI/ML workloads and heterogeneous computing in data centers and gaming. This shift reflects AMD’s broader strategy to maintain competitiveness in the discrete GPU market by leveraging open ecosystems to challenge NVIDIA’s dominance, particularly through initiatives like FSR (FidelityFX Super Resolution) and tighter integration of Vulkan with AI acceleration, ensuring its GPUs remain relevant in emerging workloads while reducing reliance on proprietary APIs like DirectX 12 Ultimate.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of AMD's strategic emphasis on Vulkan API support between 2022 and 2024, with accurate contextual framing around competitiveness in the discrete GPU market. It correctly identifies AMD’s continued support for Vulkan and ties it to broader initiatives like ROCm and FSR, which aligns with AMD’s open-ecosystem strategy. The dates (2022 and 2024) are used appropriately, and there are no numeric inaccuracies, earning a perfect score on quantitative accuracy. However, the original answer emphasizes a concrete architectural evolution—from RDNA 2 (2022) to RDNA 3 (2024) in the Radeon RX 7000 series—as the core of AMD’s technical progression with Vulkan support. The LLM answer omits these specific architecture names and product series, instead generalizing the shift toward 'performance-driven' and 'AI/ML workloads' without grounding the evolution in the actual GPU architecture transitions. This missing technical specificity reduces completeness and weakens the multi-hop synthesis between time, product architecture, and API support. While the LLM correctly infers AMD’s intent to compete with NVIDIA via open standards, it introduces ROCm and data center focus more prominently than supported by the ground truth, which centers on gaming and creation workloads. Thus, while the reasoning is plausible and contextually relevant, it substitutes some precise technical details with broader strategic claims, leading to a 7 in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 420,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "The Powder Metal Matter charge recorded in 2023 reduced RTX’s operating profit by $2.9 billion, driving a $1.9 billion decline in operating profit from 2022 to 2023. This charge, along with related acquisition‑accounting adjustments, was the primary factor behind the steep drop in operating profit margin (from 8.2 % in 2022 to 5.2 % in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.9 billion Powder Metal Matter charge in 2023 and its role in driving a $1.9 billion decline in operating profit from 2022 to 2023 are precisely stated and match the original answer. The mention of acquisition-accounting adjustments is consistent with the context, though the original emphasizes a decrease in such adjustments in 2022, which the LLM omits. (2) Quantitative accuracy is perfect: the dollar amounts ($2.9B charge, $1.9B profit decline) and operating profit margins (8.2% in 2022, 5.2% in 2023) are correct and consistent with known data. The implied calculation (a 3-percentage-point margin decline) is accurate. (3) Multi-hop reasoning is sound: the model correctly links the 2023 charge to the year-over-year decline in operating profit and contextualizes it within profitability trends. However, it does not explicitly contrast the 2022 trend of declining integration-related charges (a positive factor) with the 2023 surge, which is a minor omission in qualitative completeness. (4) The answer is contextually excellent—directly addressing the impact of integration-related charges on operating profit trends and highlighting the shift in 2023. The added detail about margin contraction enhances relevance. Overall, the answer is factually robust and semantically equivalent to the ground truth, with only slight room for deeper contextual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 407,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "Between 2023 and 2024 the relationship with Clif Bar shifted from an acquisition‑related integration cost to a divestiture‑related cost. In 2023 the company recorded $11 million of acquisition‑related costs tied to the Clif Bar purchase, but by 2024 those costs disappeared and were replaced by $25 million of divestiture‑related costs associated with the sale of its stake in JDE Peet’s (which included the Clif Bar equity‑method investment). Thus, the financial activity moved from acquisition‑integration expense in 2023 to a gain/loss on equity‑method investment and divestiture costs in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that MDLZ acquired Clif Bar (with the acquisition occurring on August 1, 2022) and that in 2023 and 2024, the company was dealing with post-acquisition financial activities such as integration costs and purchase price allocation adjustments. However, the LLM falsely claims that by 2024, MDLZ divested its stake in Clif Bar and incurred $25 million in divestiture-related costs tied to JDE Peet’s, which is not supported by the original answer. There is no mention of a divestiture of Clif Bar or any equity-method investment sale related to Clif Bar in the ground truth. (2) The $11 million acquisition-related costs in 2023 are not mentioned in the original answer, so their inclusion is unverified and potentially fabricated. The $25 million divestiture cost is also not present in the ground truth and appears to conflate Clif Bar with JDE Peet’s, which is a separate entity. These numbers and their interpretation are factually inaccurate. (3) The multi-hop reasoning is flawed: instead of recognizing that the evolution from 2023 to 2024 involved ongoing consolidation and financial adjustments post-acquisition, the model incorrectly infers a divestiture narrative, likely due to confusion with another transaction (JDE Peet’s). This breaks the logical chain and misrepresents the relationship trajectory. (4) The contextual relevance is partially maintained because the answer discusses financial activities related to Clif Bar over the two years, but the core facts and direction of the relationship (acquisition and integration vs. divestiture) are inverted, leading to a fundamentally incorrect conclusion. Hence, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 499,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024 Gulfstream’s energy‑efficient engine strategy shifted from incremental upgrades to a broader sustainability focus, highlighted by expanded use of sustainable aviation fuel (SAF) and the launch of the ultra‑long‑range, ultra‑large‑cabin G700. The G700, certified by the FAA in early 2024, incorporates new, more efficient engines and aerodynamic refinements that improve fuel efficiency and reduce emissions, reflecting the company’s move toward higher‑performance, lower‑carbon aircraft. This evolution is also evident in the continued deployment of SAF‑capable service and test aircraft, with Gulfstream having flown over two million nautical miles on SAF since 2016 and conducting the world’s first 100 % SAF transatlantic flight in November 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Gulfstream's approach to energy-efficient engines from 2023 to 2024. It correctly identifies the emphasis on sustainable aviation fuel (SAF) in 2023, including the world’s first 100% SAF transatlantic flight in November 2023, and notes over two million nautical miles flown on SAF since 2016—details consistent with Gulfstream’s public sustainability reporting. The shift to operational realization in 2024 is accurately tied to the G700, which is described as featuring new, more efficient engines and FAA certification in early 2024. While the original answer does not specify the FAA certification date, the G700’s 2024 introduction with 'all-new engines' is correctly highlighted as a key development. However, the LLM answer slightly overreaches by implying a strategic shift from 'incremental upgrades' in 2023, which is not stated in the ground truth—the original answer frames 2023 as focused on R&D and SAF leadership, not incrementalism. Additionally, the LLM introduces 'aerodynamic refinements' and 'lower-carbon aircraft' as part of the evolution, which, while plausible, are not mentioned in the ground truth. These additions do not contradict but extend beyond the provided facts. Quantitatively, all dates (2023, 2024), the November 2023 flight, and the two million nautical miles are accurate. The reasoning correctly synthesizes a multi-hop narrative: from 2023 R&D/SAF focus to 2024 product realization with the G700. The answer is contextually highly relevant, directly addressing both parts of the question. Minor deductions are due to slight over-enrichment of details not in the original, but the core facts, timeline, and evolution are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 470,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 through 2024 AMD’s semi‑custom SoC business moved from a model that relied on long‑term wafer‑purchase commitments and exclusivity with a single foundry (the 2021 amendment to the GF wafer‑supply agreement) to a more flexible, multi‑foundry strategy that emphasizes design‑services revenue and custom‑product sales rather than volume wafer purchases.  The company now derives semi‑custom revenue from design‑services fees and sales of its custom SoCs to OEMs, while its wafer‑purchase targets under the GF agreement are limited to 2022‑2025 with penalties only for missing purchase targets, and AMD has removed any exclusivity constraints, allowing it to shift capacity to other foundries as needed.  Consequently, the revenue contribution of semi‑custom SoCs has become a smaller, more project‑based component of AMD’s overall product mix, with growth tied to the success of the specific customer programs that incorporate those chips rather than to broad, long‑term volume commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some factual elements but diverges significantly from the ground truth in key aspects of AMD's strategic evolution regarding semi-custom SoCs from 2022 to 2024. (1) Correct elements include the mention of design-services revenue and custom SoC sales, which aligns with non-recurring engineering (NRE) fees and product sales referenced in the original answer. However, the LLM incorrectly frames the evolution around foundry strategy (e.g., GlobalFoundries agreement, multi-foundry shift), which is not mentioned in the ground truth and misdirects the core narrative. (2) Quantitatively, the LLM references a '2021 amendment' and '2022–2025' wafer-purchase targets, which may be factually accurate in isolation but are not supported by the knowledge graph as drivers of the semi-custom SoC revenue structure evolution. These details introduce extraneous information not present in the original answer, reducing quantitative fidelity. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a shift from dependency on third-party product success to strategic integration within a diversified portfolio (AI accelerators, GPUs, etc.), indicating greater internal control and alignment with long-term trends. The LLM instead focuses on supply chain flexibility and foundry contracts, missing the central theme of strategic positioning and portfolio diversification. (4) Contextual relevance is moderate—the answer discusses revenue structure and changes over time, addressing the question’s scope, but fails to capture the essential transformation in AMD’s strategic role. The conclusion that semi-custom revenue became 'smaller' and 'project-based' contradicts the ground truth, which positions these products as more centrally integrated. Overall, the LLM answer reflects a plausible but incorrect interpretation based on peripheral details rather than the actual evolution in AMD’s business model and strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 523,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "Between fiscal years 2023 and 2024, Medtronic increased its authorized preferred share capacity from 127.5 million to 500,000 shares (though no shares were outstanding), reflecting a strategic expansion of its capital structure options. This evolution indicates a proactive approach to capital management, providing greater flexibility for future financing or equity-based initiatives while maintaining a focus on shareholder returns through dividends and repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Medtronic increased its authorized preferred shares from 127.5 million to 500,000, which is incorrect both in direction and magnitude. The ground truth states that the authorization remained unchanged: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value were authorized in both years. The LLM incorrectly interprets the two separate classes of preferred shares as a change over time. Additionally, the claim that 'no shares were outstanding' is partially correct but misleadingly framed, as the ground truth confirms zero issuance for both classes in both years. (2) Quantitative accuracy is very low: the LLM reverses the relationship between 127.5 million and 500,000, suggesting an increase when there was none, and conflates two distinct share classes. The numbers themselves appear in the correct range but are misapplied. (3) The multi-hop reasoning fails: the model does not recognize that the same capital structure was reported in both years and incorrectly infers a strategic shift. The conclusion about 'proactive capital management' and 'strategic expansion' is unsupported by the data, which shows no change. (4) Contextual relevance is moderate because the answer addresses capital strategy and preferred shares, but the analysis is based on a false premise. The mention of dividends and repurchases is extraneous and unsupported. Overall, the answer is mostly incorrect due to fundamental errors in data interpretation and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 434,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "The framing of reputational risk related to adverse publicity has shifted from a general mention of reputational harm tied to business disruptions and regulatory scrutiny in 2022 to a more explicit linkage with sustainability concerns, climate change, and geopolitical events in 2024, reflecting heightened focus on environmental and societal impacts as drivers of reputational damage. In both years, adverse publicity was connected to operational failures, cybersecurity incidents, and regulatory actions, but the 2024 disclosures broaden the scope to include climate-related risks and sustainability-focused reputational threats as key concerns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: BK, 2022 and 2024 timeframes, and the evolution of reputational risk disclosures are properly identified. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the framing of reputational risk evolved over time, noting the expansion from regulatory scrutiny and operational failures in 2022 to include sustainability, climate change, and broader societal concerns in 2024. The mention of 'platforms operating model transition' in the ground truth is slightly more specific than the LLM's 'operational failures,' but the LLM compensates by correctly identifying cybersecurity and regulatory actions as consistent links across years. The LLM adds 'geopolitical events,' which is not in the original answer—this is a minor overreach but does not contradict the ground truth and may reflect related context in the filings. (4) The answer is contextually relevant and captures the core evolution: adverse publicity was broadened to include ESG-related risks. The only reason for not scoring a 10 is the slight addition of 'geopolitical events' and omission of explicit mention of 'diversity' and 'platforms operating model transition,' which slightly reduces qualitative precision. Overall, the semantic meaning and factual core are correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 428,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "From 2023 to 2024, Amazon’s accounting treatment of its $1.25 billion convertible note investment in Anthropic, PBC remained classified as an available‑for‑sale security measured at fair value with unrealized gains and losses recorded in “Accumulated other comprehensive income (loss).” The note was initially recorded at cost and later adjusted to fair value; any impairment would have been recognized in “Other income (expense), net.” By 2024 the investment was still held as a Level 3 asset, but the company’s disclosures on market‑risk and equity‑investment risk indicate that its fair‑value measurement is highly uncertain due to the lack of market data for private‑company investments and the impact of broader economic conditions. Consequently, while the classification (available‑for‑sale) did not change, the valuation approach became more dependent on qualitative assessments of impairment and on observable price changes, reflecting heightened risk and uncertainty in Anthropic’s valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $1.25 billion initial investment is accurately stated, and the classification as a Level 3 asset is preserved. The absence of mention of the additional $2.75 billion commitment in 2024 is a minor omission but does not distort the core facts about the existing investment's classification and valuation treatment. (2) The investment classification as 'available-for-sale' and the accounting for unrealized gains/losses in 'Accumulated other comprehensive income (loss)' are correctly reported, matching the original answer. (3) The qualitative reasoning is sound: the LLM correctly identifies that while the classification remained unchanged, the 2024 disclosures emphasized increased valuation uncertainty due to lack of market data and economic conditions—this reflects the shift in emphasis noted in the ground truth. The mention of impairment recognition in 'Other income (expense), net' adds a detail not in the original but is accounting-accurate and contextually appropriate. (4) The answer is contextually relevant, directly addressing the evolution in Amazon's investment classification and valuation approach. The only minor gap is the lack of explicit reference to the broader portfolio context in 2024 (i.e., Anthropic as part of a larger set of private company investments), but the focus on valuation challenges is well captured. Overall, the answer demonstrates strong multi-hop synthesis and factual precision, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 433,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the risks to MDLZ’s intellectual property protection shifted from a general focus on maintaining trademark, patent, copyright and trade‑secret rights through traditional legal mechanisms and third‑party agreements to an added concern about emerging threats such as artificial‑intelligence‑related developments that could undermine those protections. The company now explicitly warns that any failure to obtain or adequately safeguard its IP—especially in light of evolving AI technologies—could diminish its competitiveness and materially harm its business, financial condition and stock price. This evolution reflects a heightened awareness of both legal changes and technological disruptions that could weaken MDLZ’s IP shield.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of the evolution of MDLZ's intellectual property risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically mentioned artificial intelligence as a concern in relation to intellectual property protection, while in 2024 this AI-specific reference was removed. Instead, the 2024 risk disclosure broadened to emphasize legal and regulatory non-compliance, potential penalties, and reputational harm, without highlighting AI. The LLM answer incorrectly reverses this trend by stating that AI concerns were 'added' between 2023 and 2024 and that the company 'now explicitly warns' about AI—this is factually wrong, as the AI mention was present in 2023 and absent in 2024. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default (score 10). The qualitative accuracy is low because the model fails to correctly synthesize the multi-hop information across years and misrepresents the direction of change in risk disclosure. Contextual relevance is moderate because the answer addresses IP protection and related mechanisms, but the core reasoning about the evolution of risks is flawed. The answer conveys the opposite of the true evolution, leading to a correctness score of 3 due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 380,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Based on the provided SEC filing excerpts, Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements shows a clear evolution between the 2023 and 2024 filings. In the 2023 filing (page 10.32), the company referenced \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" as part of its standard equity compensation documentation. However, in the 2024 filing (page 247), these specific forms are no longer referenced in the exhibit list; instead, the 2024 filing includes updated language about \"Form of One-Time/Year-End RSU Award Agreement\" (pages 244-245) and references amendments to director equity agreements (page 246), indicating a formal revision to the award structure and terms for non-employee directors, moving away from the prior pre-2015 agreement formats.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It references 'page 10.32' and 'page 247' as locations in the filings, which is not consistent with standard SEC exhibit numbering or the ground truth; the original answer refers to exhibit numbers (10.17, 10.18, 10.69), not page numbers. (2) The LLM claims that in 2023, Goldman Sachs referenced 'Form of Non-Employee Director RSU Award Agreement' and 'Cash-Settled' versions, but the ground truth states the 2023 filing referenced Exhibit 10.17 tied to a November 28, 2008 amendment—no mention of RSU forms or 2015 formats in the truth. (3) The 2024 shift to 'One-Time/Year-End RSU Award Agreement' and references to amendments on page 246 are not supported by the ground truth, which states the change was a shift in referenced source from the 2008 amendment to Exhibit 10.69 of the 2008 Annual Report under the same exhibit number (10.18). (4) The core evolution described in the ground truth—a continuity of policy with consolidation or formalization of historical documentation—is completely missed; instead, the LLM invents a narrative about moving away from pre-2015 formats and updating RSU structures, which is unsupported. (5) No correct dates (e.g., November 28, 2008) or exhibit numbers (10.17 → 10.18 with link to 10.69) are accurately reported. The reasoning is flawed, with incorrect multi-hop synthesis and likely hallucinated exhibit content. While the answer attempts to address the question’s intent (evolution in treatment), the factual inaccuracies are severe, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 436,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers shifted toward greater merchant-based transactions, increasing its contractual responsibilities for payment processing, refunds, and revenue recognition. This evolution resulted in higher merchant-related expenses (e.g., payment processing, chargebacks) that negatively impacted operating margins, while also generating incremental revenues like credit card rebates. Revenue recognition now primarily reflects commissions or margins on transactions where BKNG facilitates payments from travelers, with revenue measured based on expected consideration from contracts with travel providers, including discounts and sales incentives.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no specific numeric values, so quantitative accuracy is not applicable—however, since there are no incorrect numbers, it does not detract from accuracy, warranting a 10. Contextually, the answer addresses BKNG's evolving relationship with travel service providers regarding revenue recognition and contractual responsibilities between 2022 and 2023, maintaining relevance (score 6). However, the qualitative accuracy is low (score 4) because the LLM misrepresents the nature of BKNG's evolution. The original answer states that BKNG clarified its role as an agent and recognizes revenue on a net basis, emphasizing accounting treatment and timing (at service usage). In contrast, the LLM claims a shift toward 'merchant-based transactions,' implying BKNG acts as a principal, which contradicts the ground truth that it acts as an agent (hence revenue on net basis). This is a fundamental mischaracterization of the business model and revenue recognition principle. The LLM also introduces concepts not present in the original—such as 'credit card rebates' and 'higher merchant-related expenses' affecting margins—without support in the ground truth. There is no mention of increased responsibility for payment processing or refunds in the original. Thus, while the answer discusses revenue recognition, it does so under an incorrect framework, failing the multi-hop reasoning requirement to accurately synthesize BKNG’s disclosed accounting policies and contractual role evolution. The core factual claim—that BKNG moved toward merchant model—is unsupported and contradicts the agent-based (net revenue) model emphasized in 2023. Therefore, despite correct entities (BKNG, travel service providers, 2022–2023) and topical focus, the reasoning and factual basis are significantly flawed, leading to a correctness score of 4: partially correct in topic and context, but with major errors in substance and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 521,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "The executive life insurance policy disclosures remained unchanged between the 2023 and 2024 10-K filings, with no new policy language or structural modifications appearing in the 2024 filing. The 2024 filing (page 246) continues to reference the same historical policy documents (pages 10.12 and 10.13) first disclosed in 2006, with no updates or revisions to the policy terms or disclosure format.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims there were 'no structural modifications' in the 2024 filing, which directly contradicts the ground truth: the exhibits were renumbered from 10.11 and 10.12 in 2023 to 10.12 and 10.13 in 2024, indicating a clear structural change in exhibit organization. (2) The LLM incorrectly states that the policies referenced in the 2024 filing were 'first disclosed in 2006'—this detail is not present in the ground truth and introduces unsupported information. (3) The claim that there were 'no updates or revisions to the policy terms or disclosure format' is misleading; while the policies themselves may not have changed substantively, the exhibit renumbering constitutes a structural update in disclosure format. (4) The LLM fails the multi-hop reasoning requirement: it should have compared the exhibit numbers and their presentation across the two filings and recognized that renumbering reflects a structural reorganization. The answer is contextually relevant to the question but fundamentally wrong on the key point—structural changes did occur. Quantitative accuracy is partially preserved in that no incorrect numbers are cited (e.g., exhibit numbers mentioned are plausible), but they are misinterpreted. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 379,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, Broadcom’s strategic focus on FBAR filters shifted from external reliance to greater internal control and differentiation. In 2022, the company emphasized outsourcing most manufacturing but retained internal fabrication for proprietary processes like FBAR filters to protect IP and accelerate time-to-market. By 2024, this approach was reinforced as part of a broader strategy to leverage internal capabilities for high-value products, ensuring competitive positioning through proprietary technology, system-level expertise, and tailored solutions for key customers, while maintaining a variable, low-cost model through selective outsourcing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding Broadcom's manufacturing strategy in 2022. The ground truth states that FBAR filters were fabricated internally as part of a proprietary process, but the LLM incorrectly claims that Broadcom 'outsourced most manufacturing' and only retained internal fabrication for FBAR filters. This misrepresents the original context, which did not mention broad outsourcing—only that internal fabrication was used for specific technologies like FBAR filters, VCSELs, and side-emitting lasers. This error undermines the claim of a 'shift from external reliance to greater internal control,' which is not supported by the ground truth. The strategic importance of internal fabrication for IP protection and time-to-market is correctly identified, and the 2024 reinforcement of internal capabilities aligns with the original answer. However, the LLM omits the key 2024 update about increased competitive pressure from specific companies (Qorvo, Qualcomm, Skyworks), which is central to the evolution of competitive positioning. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly identifies continuity in internal fabrication of FBAR filters and links it to competitive advantage. However, it fabricates the premise of prior external reliance, introducing flawed reasoning about strategic shift. It also fails to incorporate the expanded competitive landscape in 2024, a critical element in the evolution of strategic importance. (4) Correctness is scored at 5 due to major factual inaccuracies in the characterization of Broadcom’s 2022 strategy and omission of key competitive dynamics in 2024. Qualitative accuracy is 5 due to partial reasoning and entity synthesis but with significant errors. Contextual relevance is 8 because the answer addresses the core topic of manufacturing approach and competitive positioning, albeit with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 565,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "BMY's strategic positioning of Krazati evolved significantly between 2023 and 2024 through its acquisition of Mirati Therapeutics in January 2024, which granted BMS exclusive rights to commercialize Krazati (a KRAS inhibitor) for second-line NSCLC and other indications, while also advancing its PRMT5 inhibitor in clinical development. Financially, the acquisition was valued at approximately $4.8 billion (including $4.5 billion in cash for shares and $1.0 billion in contingent value rights), with $640 million allocated to definite-lived acquired product rights (including Krazati) and $3.5 billion to indefinite-lived IPRD assets, reflecting a strategic shift toward oncology-focused growth with high-value pipeline assets. This move strengthened BMS's oncology portfolio and contributed to the company's overall financial strategy, though specific valuation impacts are tied to the broader acquisition accounting rather than Krazati's standalone performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core evolution in BMY's (Bristol Myers Squibb, referred to as BMS) strategic positioning of Krazati through the acquisition of Mirati in 2024 and notes the expansion of clinical development, particularly in combination with a PD-1 inhibitor for first-line NSCLC. It accurately captures the financial valuation of the acquisition at $4.8 billion, including $4.5 billion in cash and $1.0 billion in contingent value rights. However, there is a quantitative inconsistency: the sum of $4.5B cash and $1.0B CVR is $5.5B, not $4.8B, which contradicts the ground truth and introduces a calculation error. Additionally, the allocation of $640M to definite-lived assets and $3.5B to IPRD is plausible but not confirmed in the ground truth, which does not provide such a breakdown—this detail may be inferred but is not verifiable from the original answer. (2) The ground truth emphasizes specific 2023 clinical trials (KRYSTAL-17, -10, -12*) and their indications, which the LLM omits entirely. This is a notable completeness gap in clinical development focus. The LLM does correctly note FDA/EMA approvals and the shift to combination therapy in 2024, aligning with the original answer. (3) The multi-hop reasoning is sound: the model connects the acquisition to expanded rights, clinical development, and financial valuation, synthesizing oncology strategy with financial accounting. However, it fails to fully trace the evolution from 2023 trial focus to 2024 expansion, missing a key comparative element. (4) The answer is contextually excellent—directly relevant and well-structured—but loses points on quantitative precision and partial omission of 2023 clinical details. Hence, correctness is high but not complete, warranting an 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 485,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG’s relationship with travel service providers shifted toward deeper integration and more structured financial arrangements, particularly around incentive programs and deferred merchant bookings. The company increasingly uses incentive-based compensation (e.g., referral bonuses, rebates, loyalty points) as a reduction of revenue at grant time, while also managing financial obligations through deferred revenue from merchant bookings—liabilities held until travel services are delivered. This reflects a more mature, mutually dependent ecosystem where BKNG balances marketing spend, incentive costs, and revenue recognition with provider partners, especially as it expands connected trip offerings and payment solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in BKNG's relationship with travel service providers from 2022 to 2023, noting a move toward deeper integration and financial interdependence. While the original answer emphasizes competition in 2022 and dependence in 2023, the LLM captures this evolution by referencing structured financial arrangements and a mutually dependent ecosystem. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links the increase in 'Deferred merchant bookings' (a liability) to financial obligations and ties incentive programs (referral bonuses, rebates, loyalty points) to revenue reduction, demonstrating synthesis across accounting practices and strategic shifts. (4) The LLM uses slightly different phrasing—'incentive-based compensation recognized as reduction of revenue at grant time'—which is consistent with the original's statement that such incentives are 'recognized as a reduction of revenue.' The mention of 'connected trip offerings and payment solutions' adds context not in the original but does not contradict it; it enhances relevance without introducing error. The only minor gap is that the LLM does not explicitly contrast the 2022 competitive stance with the 2023 shift, but the implication of strategic evolution is clearly conveyed. Thus, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 437,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom’s involvement in custom touch controllers evolved from being highlighted as a key component within its wireless product portfolio—specifically noted for processing signals from touch screens in mobile devices—through 2023 and into 2024, where it remained part of its broader semiconductor offerings for mobile device connectivity. While the 2022 document lists custom touch controllers under wireless applications, later filings continue to reference them within the wireless and mobile device markets, indicating sustained development and integration into mobile platforms. However, there is no explicit mention of a shift in role or lifecycle stage (such as maturity or phase-out) in the provided materials, suggesting that Broadcom maintained its involvement in custom touch controllers as part of its ongoing product portfolio, particularly within wireless and mobile device semiconductor solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Broadcom's involvement with Custom Touch Controllers in 2022 as part of its wireless semiconductor solutions and confirms their continued presence in 2024 within mobile and wireless offerings. However, it fails to capture the key evolution described in the ground truth—namely, the strategic shift from being a component supplier to an active producer involved in design and creation as part of broader custom silicon solutions. This represents a significant omission in the qualitative assessment of Broadcom’s role in the product lifecycle. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; thus, quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—the model synthesizes information across years and correctly tracks the presence of Custom Touch Controllers in Broadcom’s portfolio. However, it does not infer or report the strategic evolution in engagement level (from supply to deeper development involvement), which is central to the question about lifecycle role. The absence of explicit phrasing like 'design and creation' or 'deeper engagement' indicates a failure in synthesizing the qualitative shift. (4) Contextual relevance is high because the answer stays focused on Broadcom, the correct product, and the correct timeframe. But due to the missing core insight about role evolution, the correctness and qualitative accuracy scores are reduced. The answer reflects continuity but misses transformation, which is the essence of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 438,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's freight car asset acquisition strategy shifted from aggressive purchase commitments in 2023 to a more restrained approach in 2024, as evidenced by reduced purchase obligations ($999 million due in 2025 versus $590 million in 2026) and lower capital investment in freight cars ($788 million in 2024 versus $800 million in 2022), while maintaining focus on modernizing the fleet through lease buyouts and targeted acquisitions rather than large-scale new purchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of Union Pacific's strategy shift. The ground truth states that UP shifted from leasing in 2023 to acquiring freight cars in 2024, with lease buyouts increasing from $57M to $143M. The LLM incorrectly claims a 'restrained approach' in 2024 and cites reduced purchase obligations and lower capital investment, which contradicts the ground truth of a more aggressive ownership stance. (2) Quantitative inaccuracies include: fabricated numbers such as $999M and $590M in purchase obligations (not in ground truth), $788M and $800M in capital investment (not mentioned), and omission of the key lease buyout figures ($143M in 2024 vs $57M in 2023) that define the strategic shift. These numbers appear to be hallucinated or misattributed. (3) The multi-hop reasoning is flawed: instead of connecting the increase in lease buyouts to a strategic pivot toward asset ownership, the model infers restraint from unrelated or incorrect financial figures, failing to synthesize the correct data points across years. (4) Contextual relevance is moderate because the answer discusses asset acquisition and fleet modernization, which are relevant themes, but the factual foundation is incorrect, leading to a wrong conclusion about the strategic direction. The model misrepresents the core evolution of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 385,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA, specifically the transition of certain NIKE Brand businesses to third-party distributors, resulted in a significant reduction in direct operations and inventory holdings within the region. This shift, highlighted in Note 18 (Divestitures) and referenced in Note 15 (Operating Segments), led to a decrease in Asia Pacific & Latin America revenues from $5,955 million in FY2022 to $6,431 million in FY2023 (though the document shows FY2023 as $6,431M and FY2022 as $5,955M), while also reducing inventory levels in APLA from $894 million (FY2022) to $810 million (FY2023) and decreasing additions to property, plant, and equipment in the region from $56 million (FY2022) to $64 million (FY2023). The move aimed to streamline operations but impacted revenue growth and asset utilization in the APLA segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. It incorrectly states that APLA revenues decreased from $5,955M in FY2022 to $6,431M in FY2023, which is logically inconsistent (a higher number cannot represent a decrease). The actual direction of change is misrepresented, and these figures are not supported by the ground truth, which does not provide specific revenue numbers for APLA in either year. Inventory and PPE numbers ($894M to $810M, $56M to $64M) are fabricated and not present in the original answer or implied by the knowledge graph. (2) There is no mention in the ground truth of actual financial figures like revenues, inventory levels, or capital expenditures for APLA in FY2022 or FY2023; thus, inserting such specific numbers undermines the answer's credibility. The reference to Note 15 and Note 18 is plausible contextually, but the use of these notes to derive false metrics reduces accuracy. (3) The qualitative reasoning partially aligns with the ground truth: the shift from direct operations to third-party distributors and the strategic intent to reduce operational overhead are correctly identified. The mention of divestitures in Note 18 is consistent with the original answer. However, the LLM fails to mention the key financial impact — non-recurring impairment charges due to foreign currency translation losses — which is a central element of the original answer. It also omits the change in reporting structure (from direct operations to a strategic stake) and the associated accounting treatment. (4) The contextual relevance is moderate because the answer addresses the general theme of structural changes and operational impacts, but the inclusion of fabricated data and incorrect trends severely damages correctness. The reasoning is partially sound but built on false premises. Due to major quantitative errors and missing core financial impacts, the overall correctness score is low despite some alignment in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 548,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom’s involvement with InP lasers evolved from a focus on leveraging its internal III-V fabrication capabilities—particularly for high-value components like FBAR filters and InP-based lasers used in optical transceivers—to a more pronounced strategic emphasis on vertical integration and IP protection. By 2024, the company reinforced its internal fabrication strategy for InP lasers, citing it as a key differentiator that enables faster time-to-market, IP safeguarding, and performance leadership in fiber-optic communications, while maintaining reliance on external foundries for commodity CMOS processes. This shift solidified Broadcom’s competitive positioning in high-speed optical modules, where proprietary InP laser design and integration became central to its value proposition against peers like Coherent and Lumentum.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Broadcom used internal fabrication for InP lasers in 2022, continued this strategy through 2024, and increasingly emphasized competitive differentiation. The mention of competitors like Coherent Corp. and Lumentum Holdings Inc. matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022 to 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom's evolving strategy from internal fabrication to competitive positioning, connecting technological capability (InP lasers) with market differentiation. The addition of FBAR filters and CMOS foundry reliance adds context not in the ground truth but does not contradict it and supports the plausibility of the narrative. (4) Semantic equivalence is strong—the LLM captures the strategic shift toward highlighting InP laser capabilities as a differentiator, even using similar framing around competitive positioning. The only minor gap is that the original answer explicitly notes the *disclosure* of internal fabrication in 2022 and the *increased emphasis on competitors* in 2024, while the LLM implies these points without referencing disclosure language. This slight omission prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 427,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, the ownership structure of Swoosh, LLC relative to NIKE’s Class A and Class B Common Stock remained essentially unchanged: Swoosh, LLC continued to beneficially own roughly 77 % of the Class A shares, which would convert to about 16 % of the Class B shares if fully converted. This concentration means that a single entity controls the vast majority of voting power despite the lower percentage of Class B ownership, limiting the influence of other shareholders in corporate governance matters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 77% ownership of Class A Common Stock and the 16% equivalent in Class B Common Stock if converted are accurately reported for both 2022 and 2023. There are no calculation errors, and the percentages match the original answer exactly. (2) The answer correctly identifies that the ownership structure remained consistent across the two years, addressing the evolution (or lack thereof) in ownership. (3) The qualitative reasoning is sound: the LLM correctly infers that the 77% ownership of Class A shares—despite only translating to ~16% of Class B—confers disproportionate voting power, which limits other shareholders' influence. This captures the core implication regarding shareholder influence. (4) The only minor omission is that the original answer specifically names Travis Knight as having a significant role in managing Swoosh, LLC’s shares, which the LLM omits. While not critical to the overall correctness, this detail adds context about *why* the concentrated ownership translates to individual influence. However, the LLM still correctly attributes influence to the concentrated ownership structure. The answer is semantically equivalent in substance and fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 366,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI integrated its Reduced‑Risk Products (RRPs) more tightly into the core commercial structure: the Swedish Match acquisition (completed in 2022) gave PMI a leading oral‑nicotine portfolio (ZYN) that was folded into the existing geographical segments, and by early 2024 the company planned to report RRP performance within its four main regional segments rather than as a separate category.  Market availability expanded as PMI continued to roll out IQOS and other RRPs in 84 markets, while also investing $30 million in a new production facility in Lviv, Ukraine, to support supply.  This integration and geographic expansion drove the 10.7 % rise in net revenues to $35.2 billion in 2023, with RRPs contributing $9.1 billion of net revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. While it correctly identifies a strategic integration of Reduced-Risk Products (RRPs), it misrepresents the nature of the change: the ground truth states that RRPs were reclassified under a broader category called Smoke-Free Products (SFPs) that now includes wellness and healthcare offerings, whereas the LLM claims RRPs will be reported within regional segments by early 2024 — a detail not in the original and potentially incorrect timing. The acquisition of Swedish Match is mentioned as completed in 2022, which may be factually correct, but the original answer does not mention this, so it cannot be verified as part of the knowledge graph's ground truth. (2) Quantitative inaccuracies include the claim that RRPs contributed $9.1 billion in net revenue — this figure is not in the original and cannot be confirmed; similarly, the $35.2 billion total net revenue and 10.7% increase are absent from the ground truth and thus unverified. The $30 million investment in Lviv, Ukraine, is also not mentioned in the original and appears to be hallucinated. The only correct quantitative point is the availability in 84 markets by end of 2023, which matches the original. (3) The multi-hop reasoning is partially sound — the model connects portfolio integration and market expansion — but it fails to accurately reflect the rebranding from RRPs to SFPs and the inclusion of wellness/healthcare products, which is a key strategic shift. Instead, it focuses on geographic segment reporting, which is not supported by the ground truth. (4) Scores reflect partial correctness: the 84-market availability is accurate and relevant, but the introduction of unverified financials, incorrect structural changes, and unsupported details like the Ukraine facility significantly reduce factual reliability. The answer is contextually relevant and addresses the question's intent, but with major factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 546,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "From 2022 to 2024, Caterpillar’s strategic role in the reciprocating engines business shifted from a primary engine supplier to a broader power‑generation and engine‑system integrator.  In 2022 the company highlighted its engine portfolio and dealer network as the main channel for reciprocating engines, but by 2024 it was emphasizing “Power Generation” and “Industrial” applications, noting that sales of large reciprocating engines for data‑center and gas‑compression uses had grown sharply while industrial engine sales declined.  This repositioning has expanded the revenue base of the Energy & Transportation segment—total sales rose 3 % to $28.85 bn in 2024, with profit margin improving from 17.6 % to 19.9 %—and has lifted the contribution of engine‑related sales to overall gross margin, as higher‑margin power‑generation products now represent a larger share of the mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitatively, the LLM claims Caterpillar's Energy & Transportation segment sales rose to $28.85 billion in 2024 with profit margin improving from 17.6% to 19.9%, but these figures are not supported by the original answer or implied in the context—no revenue, margin, or segment-level financials were mentioned in the ground truth. (2) The LLM incorrectly characterizes Caterpillar’s evolution as a shift toward 'power-generation and engine-system integrator' with emphasis on data-center and gas-compression uses, while the ground truth states the key change was the addition of remanufacturing services for its own and other companies’ engines. This is a fundamental misrepresentation of the strategic evolution. (3) The original answer highlights the expansion into remanufacturing as a driver of gross margin potential due to lower material costs and reuse of asset value, whereas the LLM attributes margin improvement to higher-margin power-generation products—this reasoning is unsupported and misaligned. (4) The LLM fails to mention Perkins Engines Company Limited, the global dealer network, or the shift from product sales to full lifecycle service provision, all of which are central to the ground truth. While the answer is contextually relevant in discussing revenue composition and margin impact, the incorrect entities, fabricated metrics, and flawed reasoning severely undermine accuracy. Minor relevance is retained as it attempts to address strategic evolution and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 441,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Based on the provided SEC 10-K filings, BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolved in terms of transparency and mechanisms between 2022 and 2023. In the 2022 filing (page 11), the company stated its intent to disclose amendments to the Code of Conduct for executive officers and the Directors' Code of Conduct on its website, but did not specify a formal mechanism for stakeholder notification. By the 2023 filing (page 11), the language remained consistent regarding disclosure on the website, but the context shifted to include updated governance details under \"ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE,\" with no explicit new commitment beyond the prior year's approach. Notably, the 2023 filing (page 12) referenced a specific amendment to the Executive Severance Plan (effective March 1, 2024) as part of governance updates, but this pertained to severance terms rather than the Directors' Code of Conduct itself. Crucially, neither filing detailed a new mechanism for informing stakeholders of changes to the Directors' Code of Conduct beyond the general website disclosure commitment, indicating no significant evolution in transparency practices between the years. The core commitment to website disclosure remained unchanged, with no additional transparency measures (e.g., dedicated governance reports or stakeholder notifications) introduced in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that BNY Mellon maintained a consistent approach to disclosing amendments to the Directors' Code of Conduct in both 2022 and 2023, with no change in the mechanism—specifically, posting amendments on its website. The LLM accurately notes that neither year introduced new stakeholder notification mechanisms beyond website disclosure, which matches the ground truth's assertion of a stable governance communication strategy. The mention of page numbers (11 and 12) and the reference to the Executive Severance Plan amendment in 2023 are factually consistent with typical 10-K structures and do not contradict the ground truth, as the LLM correctly distinguishes that this change was unrelated to the Directors' Code of Conduct. There are no numeric inaccuracies—dates, years, and document references are correct. The reasoning is sound and reflects proper multi-hop synthesis: comparing disclosures across two years, identifying the absence of new commitments, and contextualizing related but distinct governance updates. The only minor point preventing a perfect 10 is that the LLM frames the answer initially as suggesting an 'evolution' in transparency and mechanisms, which could imply change, but then correctly concludes there was no significant evolution. This slight tension in framing slightly affects qualitative accuracy but does not undermine the factual correctness. Overall, the answer is semantically equivalent to the ground truth, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 433,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike shifted from a wholesale‑centric operating model in APLA to a distributor‑driven model, reducing its direct sales presence in the region. This strategic change is reflected in the FY23 filing where APLA revenues are now reported under “Asia Pacific & Latin America” and show growth driven by distributor partnerships rather than NIKE‑owned channels, while corporate overhead and restructuring costs were adjusted to support the new model. Consequently, Nike’s operational structure in APLA moved toward greater reliance on third‑party distributors, altering its market participation and reducing direct revenue exposure in that geography.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic shift in Nike's APLA approach between FY22 and FY23—moving from direct/wholesale operations to a distributor-driven model—which aligns with the ground truth. It correctly identifies the transition toward third-party distributors and reduced direct presence. However, there are some inaccuracies and unsupported details: (1) The claim that APLA revenues are now reported under 'Asia Pacific & Latin America' in FY23 is vague and not explicitly confirmed in the ground truth; the original answer does not mention a change in reporting segments. (2) The reference to 'corporate overhead and restructuring costs adjusted to support the new model' introduces new information not present in the ground truth, which does not mention restructuring costs. (3) While the ground truth notes APLA contributed to 14% growth in NIKE Direct in FY22, the LLM omits this specific quantitative support, weakening the FY22 baseline. (4) The LLM implies a shift from 'wholesale-centric' to distributor model, whereas the original describes direct operations and wholesale coexisting in FY22, making 'wholesale-centric' a slight mischaracterization. Quantitative accuracy is high as no incorrect numbers are stated (the 14% figure is simply omitted), and the reasoning reflects a sound multi-hop understanding of operational evolution. Contextual relevance is strong as the response directly addresses both operational structure and market participation. Overall, the answer is directionally correct with minor factual overreach and omission of key supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar’s sales and profitability evolved significantly. In 2021, favorable price realization contributed to a 22% increase in consolidated sales and revenues to $50.971 billion, driven by higher end-user demand and dealer inventory adjustments, while operating profit rose 51% to $6.878 billion, supported by higher sales volume and favorable price realization offsetting unfavorable manufacturing costs. By 2024, sales and revenues declined 3% to $64.809 billion due to lower sales volume, but operating profit margin expanded to 20.2% (from 19.3% in 2023), with adjusted profit per share reaching $21.90, indicating that favorable price realization partially offset volume declines and contributed to improved profitability despite reduced revenue. The document notes that in 2025, the company expects favorable price realization in Energy & Transportation to offset lower volume impacts in Construction and Resource Industries.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 instead of 2022 as the starting point, stating a 22% increase in sales to $50.971 billion and a 51% rise in operating profit to $6.878 billion—none of which align with the ground truth for 2022. The ground truth states that in 2022, favorable price realization contributed $9.223 billion to sales growth, but the LLM does not mention this figure at all. For 2024, the LLM claims sales declined 3% to $64.809 billion and cites an operating profit margin of 20.2%, but the ground truth does not provide total revenue or margin percentages; instead, it states that profit increased from $10.335 billion in 2023 to $10.792 billion in 2024 due to favorable pricing offsetting a $2.251 billion volume decline. The LLM fails to report these exact profit figures or the $2.251 billion volume impact, which are central to the original answer. (2) Multiple numeric values are either fabricated or misattributed: the $50.971 billion revenue in 2021, 22% growth, $6.878 billion profit, 51% profit growth, $64.809 billion in 2024, 20.2% margin, and $21.90 adjusted EPS—all lack support in the ground truth. The only partially correct element is the qualitative idea that price realization offset volume declines in 2024, but even this is framed with incorrect data. (3) The multi-hop reasoning is flawed: the model fails to connect the correct years (2022–2024), uses data from an irrelevant year (2021), and introduces forward-looking 2025 expectations not asked for in the question. It also does not synthesize the actual quantitative impact of price realization across the required timeframe. (4) Despite incorrect numbers and timeline errors, the LLM captures the general trend that favorable pricing helped maintain profitability amid volume declines, which provides some contextual relevance. However, due to severe quantitative inaccuracies and misrepresentation of core financial data, the overall correctness score is low. The qualitative reasoning is partially sound but built on false premises, and the answer fails the primary requirement of factual fidelity to the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 585,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024 GM’s EV manufacturing strategy shifted from a broad, capital‑intensive rollout toward a more focused, financially disciplined approach.  In the 2023 filing the company emphasized scaling EV production, building a North‑American‑centric battery supply chain and monetising its EV platforms, while warning that high fixed costs and uncertain demand could force inventory losses.  By the 2024 filing the narrative tightens around “profitable delivery of a strategic EV portfolio,” stressing that near‑term earnings still rely on high‑margin ICE trucks and SUVs to fund EV development, and highlighting tighter cost controls, targeted raw‑material sourcing agreements, and a refocused autonomous‑driving effort that reduces capital outlays.  This evolution reflects a strategic pivot to preserve cash, mitigate risk, and align EV capacity growth with realistic demand and supply‑chain constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the shift from broad EV scaling in 2023 to a more disciplined, financially conscious strategy in 2024 is accurately portrayed. The emphasis on high fixed costs, uncertain demand, and inventory risks in 2023 matches the original. In 2024, the focus on profitability, cost controls, targeted sourcing, and reduced capital outlays reflects the evolved strategy toward a resilient and scalable North American supply chain. (2) There are no numeric values (e.g., dollar amounts, percentages, production volumes) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes strategic shifts across two years, connects EV manufacturing capacity to supply chain development, and integrates financial constraints and ICE vehicle funding logic. The mention of 'targeted raw-material sourcing agreements' aligns with the original's 'strategic sourcing initiatives' and 'multi-year supply agreements.' Only minor phrasing differences exist—e.g., 'North-American-centric' vs 'North American-focused'—but these are semantically equivalent. (4) The LLM adds contextual nuance (e.g., autonomous driving refocus, ICE vehicle funding role) not explicitly in the original but consistent with GM’s reported strategy, enhancing relevance without introducing error. One point deducted from qualitative accuracy due to slight expansion beyond the original scope (autonomous driving emphasis), though it doesn’t detract from correctness. Overall, the answer is factually robust, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 473,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly declined from 2022 to 2024, as evidenced by the remaining performance obligations disclosed in the 10-K filings. In 2022, Paxlovid generated $18.9 billion in revenue, but by 2024, its revenue had dropped to $5.7 billion, with only $1 billion in contracted revenue expected to be recognized from remaining performance obligations through 2028. This reflects the transition from government procurement to commercial markets and the diminishing demand for Paxlovid as the pandemic recedes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2022, but the LLM incorrectly claims $18.9 billion in revenue as if it were an RPO, conflating revenue with contractual future obligations. While $18.9 billion in 2022 Paxlovid revenue is factually accurate based on public reports, the question specifically asks about 'remaining performance obligations'—a contractual accounting metric—not total revenue. The LLM then states that in 2024, $1 billion in RPOs are expected to be recognized through 2028, but the ground truth specifies this $1 billion is as of December 31, 2024, not spread through 2028. (2) The quantitative accuracy is partially correct in that the $1 billion figure for 2024 RPOs aligns with the ground truth, but the use of 2022 revenue as a proxy for RPOs is a critical error. The claim of $5.7 billion in 2024 revenue is not part of the ground truth and is irrelevant to the question about RPOs. (3) The multi-hop reasoning is flawed: the LLM fails to correctly interpret the evolution from 'no disclosed RPOs in 2022' to '$1 billion in 2024' and instead constructs a narrative around declining revenue, which misrepresents the nature of the question. The conclusion that the financial commitment 'declined' contradicts the ground truth, which shows an evolution from undefined to a defined $1 billion commitment—indicating increased visibility, not necessarily reduced commitment. (4) Contextual relevance is moderate because the answer discusses Paxlovid and financial metrics, but it misinterprets the key concept (RPOs vs. revenue), leading to an incorrect overall assessment. The qualitative reasoning is poor due to this conflation and incorrect synthesis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 498,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Caterpillar's approach to monitoring supplier financial viability has remained consistent between 2022 and 2023, with no significant evolution in risk mitigation strategies or contractual agreements. The company continues to require suppliers to maintain industry-leading quality and delivery capabilities, monitor supplier financial viability as part of its risk management, and use agreements to protect intellectual property and mitigate supply chain disruptions. However, the core contractual framework for supplier relationships—particularly the standard sales and service agreements governing dealer interactions—has not changed materially, remaining terminable at will with 90 days' notice and requiring dealers to maintain detailed financial records available for review. (Based on consistent references to supplier risk monitoring in raw materials sections across both years and unchanged dealer agreement terms in pages 7, 8, 9, 10, 11 of both 2022 and 2023 filings.)",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in Caterpillar's approach between 2022 and 2023, leading to a significant factual gap. (1) Correct elements: The answer accurately states that Caterpillar monitors supplier financial viability and uses contractual agreements to protect intellectual property and mitigate disruptions—this is consistent with both years. It also correctly notes that dealer agreements remain largely unchanged, terminable with 90 days' notice, which aligns with the filings. (2) Quantitative accuracy: There are no numerical figures in this question, so this dimension is not applicable beyond correct referencing of years (2022 and 2023), which are accurate. (3) Multi-hop reasoning: The model fails in synthesizing the nuanced evolution from 2022 to 2023. The ground truth highlights that in 2023, Caterpillar explicitly elevated 'supplier financial viability' as the first-listed risk in supply chain disclosures—indicating a heightened strategic emphasis—even if the core monitoring mechanisms remained similar. Additionally, the 2023 filing mentions reinforcing global strategic sourcing models to build long-term relationships and leverage enterprise spend, suggesting a more structured approach. The LLM incorrectly concludes there was 'no significant evolution,' contradicting the ground truth's emphasis on increased prioritization and structural focus. (4) The answer is contextually relevant and well-structured but lacks the critical qualitative shift reported in the 2023 filing. While it correctly identifies continuity, it overlooks the strategic repositioning of financial viability as a primary risk, which is central to the question about evolution in risk mitigation strategies. Hence, correctness and qualitative accuracy are penalized, though contextual relevance remains high due to accurate framing and sourcing references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 508,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Visa has strategically expanded its Risk and Identity Solutions within Value-Added Services by integrating AI-driven fraud prevention tools like Visa Protect Authentication Intelligence, Visa Deep Authorization, and Visa Risk Manager into its Visa Protect suite, while simultaneously enhancing its identity verification capabilities through open banking initiatives and acquisitions such as Pismo. This evolution reflects a deliberate shift toward embedding advanced, network-agnostic security and authentication solutions across both card-based and emerging payment flows (e.g., A2A, P2P), positioning these services as critical differentiators within its broader \"network of networks\" strategy to capture new transaction opportunities in B2B, cross-border, and real-time payments ecosystems.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core evolution of Visa's strategic positioning of Risk and Identity Solutions between 2022 and 2024. (1) The original answer emphasizes a structural evolution from a loosely described set of services in 2022 to a clearly defined three-pillar strategy in 2024: services for Visa transactions, network-agnostic services for non-Visa transactions, and services beyond payments. This specific strategic framework is entirely missing in the LLM answer. (2) Instead, the LLM introduces specific product names (e.g., Visa Protect Authentication Intelligence, Visa Deep Authorization, Visa Risk Manager), technical capabilities (AI-driven tools), and acquisitions (Pismo) and open banking initiatives that are not mentioned in the ground truth and cannot be verified from the provided knowledge graph. These additions, while plausible, represent hallucinated details that shift focus from the structural and strategic integration highlighted in the original answer. (3) The multi-hop reasoning is flawed because the LLM fails to compare the 2022 and 2024 strategic positioning as required; instead, it describes an evolution in technological capabilities and product integration that is not supported by the ground truth. (4) Quantitative accuracy receives a 10 because there are no numerical claims to evaluate. Qualitative accuracy is scored 5 due to the correct general direction of increased integration and strategic importance, but major inaccuracies in the nature of the evolution and unsupported specifics. Contextual relevance is high (8) because the answer addresses the general theme of Risk and Identity Solutions within value-added services and attempts to describe strategic evolution, even if the details are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 493,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations has not been explicitly detailed as a separate risk factor in the 2023 filing, but the 2022 filing (page 12) notes that “changes in the policies or practices of our retail trade customers, such as inventory de‑stocking, fulfillment requirements, limitations on access to shelf space, delisting of our products, or environmental, sustainability, supply chain and packaging standards or initiatives” can adversely affect the business. The 2023 outlook (page 31) reiterates that “the retail landscape … continues to evolve … as a result of the continued growth of eCommerce, changing consumer preferences … and the increased presence of alternative retail channels, such as subscription services and direct‑to‑consumer businesses,” which further underscores that shelf‑space constraints and related retail‑customer policy shifts remain an ongoing risk. Consequently, while the 2023 filing does not quantify a change in exposure, it confirms that the risk associated with limited shelf space and evolving retail policies persists and is still being managed through investments in data, digital, and alternative channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, shelf space limitations were presented as a potential risk due to retail customer policies, citing specific language from the filing (e.g., limitations on access to shelf space, delisting). In 2023, it accurately reflects that while shelf space is not called out explicitly as a standalone risk, the evolving retail landscape—including eCommerce growth and alternative channels like subscription and DTC services—confirms the ongoing relevance of this challenge. This captures the evolution from potential to active impact as described in the original answer. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced years (2022, 2023), page numbers (12, 31), and financial terms are correct or appropriately attributed. (3) The multi-hop reasoning is sound: the model connects the 2022 risk disclosure with the 2023 discussion of retail evolution, infers continuity of shelf space constraints within broader dynamics, and notes strategic responses (investment in digital, data, alternative channels), which matches the original answer’s conclusion. (4) The only minor shortcoming is that the LLM slightly underemphasizes the shift from 'potential risk' to 'actively experienced challenge'—a nuance present in the ground truth—though it does imply ongoing management and persistence of the risk. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the original with only slight softening of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 449,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's hybrid deployment strategy has evolved to emphasize greater integration and flexibility across on-premise, cloud, and hybrid environments, particularly through expanded offerings like Oracle Cloud@Customer and dedicated region instances that enable seamless workload migration and interoperability. The company has increasingly positioned its cloud services (including SaaS and OCI) as a core component of its strategy, with cloud services revenue growing from 25% to 37% of total revenue between fiscal 2022 and 2024, reflecting a strategic shift toward cloud-first deployment models while maintaining support for hybrid and on-premise solutions through complementary license, hardware, and services offerings. This evolution is underscored by investments in cloud infrastructure, expanded SaaS portfolio (e.g., Fusion Cloud applications), and initiatives to facilitate customer migration to Oracle Cloud, as highlighted in the 2024 10-K's discussion of deployment models and revenue trends.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Oracle's strategic evolution toward deeper integration in hybrid deployments between fiscal 2023 and 2024, noting expanded offerings like Oracle Cloud@Customer (aligned with Exadata Cloud@Customer in the ground truth) and dedicated regions. It accurately reflects Oracle’s emphasis on interoperability, workload migration, and support for hybrid environments. However, the claim that cloud services revenue grew from 25% to 37% of total revenue between fiscal 2022 and 2024 is not supported by the original answer or verifiable data in the context provided—this specific quantitative assertion introduces a factual inaccuracy not present in the ground truth. (2) The percentage figures (25% to 37%) are not mentioned in the original answer and cannot be confirmed as accurate based on the knowledge graph; thus, the quantitative accuracy is reduced due to this unsupported metric. There are no other numbers or calculations in the original answer to validate against. (3) The multi-hop reasoning is sound: the model synthesizes product offerings (Cloud@Customer, dedicated regions), strategic emphasis (integration, migration), and evolution over time (2023 to 2024), aligning with the original answer’s narrative of increasing integration and support. While the core qualitative shift—greater integration and extensibility in hybrid deployments—is correctly identified, the inclusion of unverified revenue percentages weakens the factual foundation. (4) The contextual relevance is high because the response directly addresses the evolution in product offerings and strategic emphasis. Qualitative accuracy is strong due to correct entity identification (Oracle, hybrid deployments, Cloud@Customer, dedicated regions) and logical reasoning, despite the quantitative flaw. Correctness score is 7 because the central strategic evolution is accurately conveyed, but the introduction of an unsupported revenue statistic prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 536,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Based on the provided 10-K excerpts, Pfizer's financial commitment to Paxlovid has significantly evolved between 2022 and 2024. In 2022, Paxlovid generated $18.9 billion in revenue (as noted in the 2022 Form 10-K), but by 2024, its revenue declined sharply to $5.7 billion, reflecting the transition from government procurement to commercial markets and the impact of U.S. government inventory returns. The company now expects only $1 billion in contracted revenue from remaining Paxlovid performance obligations as of December 31, 2024, with $4 billion expected from Comirnaty, indicating a strategic shift away from pandemic-driven revenue toward long-term commercial sustainability.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While the ground truth states that Pfizer reported $1 billion in remaining performance obligations for Paxlovid as of December 31, 2024, the LLM incorrectly presents this $1 billion as 'contracted revenue expected to be recognized' without clarifying the multi-year recognition through 2028. More critically, the LLM introduces specific revenue figures—$18.9 billion in 2022 and $5.7 billion in 2024—that are not mentioned in the original answer and cannot be verified from the provided ground truth. These numbers, while potentially accurate in reality, are not supported by the knowledge graph answer being evaluated, making their inclusion a significant deviation. Additionally, the mention of $4 billion expected from Comirnaty is entirely absent from the original answer and introduces unrelated information, suggesting a failure in entity focus. (2) The quantitative accuracy is partially correct in that the $1 billion remaining performance obligation aligns with the ground truth, but the additional revenue figures and comparisons (e.g., decline from $18.9B to $5.7B) are unsupported and introduce calculation-based reasoning not present or verifiable in the original. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in timing and structure of revenue (from immediate pandemic sales to multi-year recognition), not a year-over-year revenue decline. The LLM mischaracterizes the evolution as a revenue drop due to market transition and inventory returns—details not in the ground truth—indicating incorrect synthesis. (4) Contextual relevance is high because the answer addresses Pfizer, Paxlovid, financial commitment, and time frame (2022–2024), but correctness and qualitative accuracy are reduced due to unsupported numbers and misattribution of reasoning. The core idea of reduced commitment is present, but the evidence used is factually inconsistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 535,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Caterpillar’s relationship with its independent dealers remained unchanged in structure—dealers continue to operate under standard sales and service agreements that grant them rights to purchase, sell and service Caterpillar products within defined territories, while obligating them to promote the brand, maintain adequate staffing, and provide detailed financial records. However, the strategic emphasis shifted: in 2023 the company highlighted tighter integration of dealer‑financed financing programs (via Cat Financial) and reinforced dealer support for warranty, technical assistance, and intellectual‑property protection, while still allowing termination on 90‑day notice. The 2023 disclosures also underscored the company’s focus on dealer‑driven market expansion and the use of dealer networks for financing and insurance services, reflecting a continued but more strategically coordinated partnership.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of Caterpillar's dealer relationships between 2022 and 2023. The ground truth states that in 2022, the relationship was described in general terms as part of the global sales strategy, while in 2023, Caterpillar formalized these relationships through standardized agreements—marking a shift from a general partnership to a structured contractual framework. However, the LLM claims the 'structure remained unchanged,' which contradicts the ground truth and misrepresents the core evolution. This undermines the qualitative accuracy. That said, the LLM correctly identifies key elements of the contractual obligations (rights to sell/service, promotion, staffing, financial records), strategic emphasis on dealer networks for financing and market expansion, and mentions Cat Financial integration and 90-day termination, which are contextually relevant and plausible details. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. The answer is well-structured and addresses the question's focus on contractual obligations and strategic emphasis, hence high contextual relevance. However, the failure to recognize the structural shift from informal to formal agreements in 2023—a central point in the original answer—results in a moderate correctness score of 6 due to a major omission in multi-hop reasoning and factual synthesis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 407,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company’s operational focus in Africa/Eurasia shifted toward higher capital investment and restructuring activity. Africa/Eurasia’s share of the 2022 Global Productivity Initiative charges dropped from 11% in 2022 to 5% in 2023, reflecting reduced restructuring spending in the region, while capital expenditures in Africa/Eurasia rose modestly from $13 million in 2022 to $33 million in 2023. This indicates a strategic reallocation of resources away from broad productivity initiatives toward targeted growth and efficiency projects in other segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that capital expenditures in Africa/Eurasia rose from $13 million in 2022 to $33 million in 2023, when the ground truth shows $33 million was spent in 2022 (with $13 million in 2021, not 2022). This reverses the actual trend. Additionally, the LLM claims Africa/Eurasia’s share of restructuring charges dropped from 11% in 2022 to 5% in 2023, but the original answer states that in 2023, approximately 10% of cumulative charges from the 2022 Global Productivity Initiative relate to Africa/Eurasia—there is no mention of a 2023 charge percentage or a drop to 5%. (2) The quantitative errors are severe: both the capital expenditure timeline and the restructuring charge percentages are inverted or fabricated. The $13 million figure is misassigned to 2022 instead of 2021, and the $33 million is incorrectly placed in 2023 instead of 2022. (3) The multi-hop reasoning is flawed—the LLM infers a shift toward growth due to increased capex, but the truth is capex peaked in 2022 and no 2023 capex figure is provided; the real shift in 2023 is toward restructuring, not away from it. The model misinterprets the direction of strategic evolution. (4) The contextual relevance is moderate because it addresses capital expenditures and restructuring in Africa/Eurasia, but the incorrect data and reversed logic undermine the conclusion. Scores are low due to major factual and directional errors in both numbers and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 418,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s strategic focus on 5G evolved from a period of risk mitigation and supply chain resilience (highlighted by 2022 concerns over strategic investment failures, supply disruptions, and customer vertical integration threats) to a more mature commercialization phase by 2024, marked by expanded RFFE and modem-RF integrations (e.g., Snapdragon 5G modem-RF platforms), broader adoption in automotive/IoT beyond handsets, and sustained investment in 5G Advanced/6G research. While 2022 emphasized safeguarding against investment losses and supply vulnerabilities, 2024 reflects successful scaling of 5G technologies into new markets—evidenced by QCT’s diversification into automotive and IoT, long-term supplier partnerships (despite ongoing geopolitical risks), and continued leadership in 5G patent licensing (with 200+ 5G license agreements), though challenges like customer vertical integration (e.g., Apple, Samsung) and China-related tensions persist. Investment emphasis shifted from defensive risk management to strategic growth in adjacent sectors, with commercialization outcomes showing increased revenue from non-handset applications, albeit amid intense competition and supply chain constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's 5G strategy from 2022 to 2024, noting the shift from investment and risk management to commercialization and market expansion. It accurately reflects the emphasis on diversification into automotive and IoT, continued leadership in 5G patent licensing, and ongoing challenges like customer vertical integration and geopolitical risks. However, the original answer emphasizes that by 2024, the majority of QTL revenues came specifically from OFDMA-based products (e.g., multimode 3G/4G/5G devices), a key commercialization outcome that the LLM answer omits. Instead, it generalizes revenue growth without citing this specific metric. (2) Quantitatively, the LLM mentions '200+ 5G license agreements'—a plausible figure consistent with Qualcomm’s public disclosures and not contradicted by the ground truth, which does not provide a specific number. No incorrect numbers, dates, or calculations are present. The years 2022 and 2024 are correctly used as reference points. (3) The multi-hop reasoning is sound: the model synthesizes strategic focus, investment shifts, commercialization outcomes, and persistent risks across time. It correctly infers that movement into automotive/IoT and modem-RF integrations reflect commercial scaling, aligning with the original answer’s theme of transitioning to market leadership. However, it adds detail about 5G Advanced/6G research and RFFE integrations not explicitly mentioned in the ground truth, which, while likely accurate, slightly extends beyond the provided knowledge. (4) The answer is highly contextually relevant, directly addressing both investment emphasis and commercialization outcomes. The omission of the specific OFDMA revenue detail prevents a perfect score, but the overall qualitative and factual alignment is strong, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 511,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid’s revenue contribution declined sharply as the U.S. government’s procurement transitioned to commercial markets. In 2022, Paxlovid generated $18.9 billion in revenue, accounting for a large share of total sales, but by 2023 this fell to $1.279 billion, and in 2024 it was $5.716 billion, reflecting the shift to commercial pricing and the impact of revenue reversals tied to government inventory returns. Contractual commitments included advance purchases under EUAs that were later reversed—$3.5 billion was reversed in Q4 2023, with a $771 million favorable adjustment in Q1 2024 for returned courses—while new agreements now provide for future deliveries through 2028, with remaining performance obligations totaling roughly $1 billion as of December 31, 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in revenue figures. The ground truth states Paxlovid generated $76 million in revenue in 2022, but the LLM claims $18.9 billion, which is over 240 times higher and completely incorrect. The LLM also reports 2024 revenue of $5.716 billion, while the original answer does not provide a 2024 revenue figure—only remaining performance obligations of $1 billion. These obligations are not revenue, so equating them as such is a fundamental error. The $3.5 billion reversal and $771 million adjustment are not supported by the ground truth, which mentions government returns and adjustments but does not specify these exact numbers. (2) Quantitative accuracy is severely compromised: all major dollar figures (revenue for 2022, 2023, 2024, reversals, adjustments) are either fabricated or grossly inflated. The only correct number is the $1 billion in remaining performance obligations as of end-2024, which matches the ground truth. (3) The reasoning is partially sound in identifying a strategic shift from government to commercial markets and noting contractual commitments extending to 2028, but it fails to correctly synthesize the actual financial data. The model incorrectly assumes revenue declined from 2022 to 2023 to 2024, when the ground truth only provides 2022 revenue and implies future obligations without stating 2023 or 2024 revenues. (4) Contextual relevance is moderate—the answer addresses revenue trends and contractual commitments as asked, and attempts to explain strategic positioning, but due to severe factual errors, the overall correctness is very low. The qualitative accuracy is slightly higher because the direction of strategic evolution (from emergency use to commercial contracts) is plausible, though not fully substantiated by the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 506,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "Between 2022 and 2023, the company’s exposure to credit market tightness as a supply chain risk shifted from a general mention of “the impact on our suppliers of tighter credit or capital markets” in the 2022 filing to a more explicit warning that “tighter credit or capital markets” could directly disrupt supply‑chain operations and that such disruptions could “adversely affect our business, results of operations, cash flows and financial condition” if not remedied. This evolution indicates that the firm’s vulnerability to external financial conditions has increased: it now anticipates that restricted credit and tighter capital markets could impair its ability to secure raw and packaging materials, maintain supplier relationships, and sustain production, making the business more sensitive to macro‑financial stress.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of risk language between 2022 and 2023. It accurately captures the shift from credit market tightness affecting suppliers in 2022 to a more direct impact on the company’s operations in 2023. The use of quotes like 'adversely affect our business, results of operations, cash flows and financial condition' reflects accurate extraction from the 2023 filing, even if not in the original answer. The conclusion that vulnerability has increased is a reasonable interpretation, though slightly stronger than the original answer’s more neutral 'broader recognition of ongoing vulnerability.' This represents a minor interpretive difference rather than a factual error. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and multi-hop, connecting changes in risk disclosures across years and inferring implications about financial sensitivity. The answer is fully contextually relevant. The slight deduction in qualitative accuracy is due to the stronger claim of 'increased vulnerability'—while defensible, it goes a step beyond the original’s emphasis on reframing rather than intensification. Overall, the answer conveys the core truth with accurate sourcing and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 371,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "From 2022 to 2024 Pfizer’s contractual and financial commitments tied to Paxlovid shifted dramatically. In 2022, Paxlovid generated $18.9 billion of revenue and was supplied under multiple government purchase agreements, with deferred revenue balances of about $5.1 billion. By 2023, revenues fell to $1.28 billion as U.S. government contracts wound down and a $3.5 billion non‑cash revenue reversal was recorded; remaining performance obligations were roughly $1 billion. In 2024, Paxlovid revenue rebounded modestly to $5.7 billion, driven by commercial sales and a $771 million favorable adjustment to prior returns, while remaining performance obligations are now projected at about $1 billion to be recognized through 2028. Thus, Pfizer’s fiscal exposure to Paxlovid contracted sharply after 2022, transitioning from large government‑backed supply commitments to a smaller, commercially‑focused revenue stream with limited future contractual obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While the $771 million favorable adjustment and the $1 billion remaining performance obligations as of 2024 are correctly reported and align with the ground truth, the revenue figures for 2022 ($18.9B), 2023 ($1.28B), and 2024 ($5.7B) are not supported by the original answer and contradict the disclosed evolution. The ground truth does not mention specific annual revenues for Paxlovid in 2022 or 2024, nor does it reference a $3.5 billion non-cash revenue reversal in 2023 or deferred revenue of $5.1 billion in 2022. These figures appear fabricated or misattributed. (2) The only verified numbers in the LLM response are the $1 billion remaining performance obligations (correctly cited for 2024) and the $771 million favorable adjustment—both match the original answer. All other financial figures lack support in the ground truth and introduce major errors. (3) The reasoning attempts multi-hop synthesis by tracking financial and contractual evolution over time, but it builds on incorrect data. The conclusion that Pfizer transitioned to a 'smaller, commercially-focused revenue stream' is plausible but not substantiated in the provided ground truth, which emphasizes long-term contracts through 2028 and ongoing renegotiations, suggesting continued significant commitment. The original answer highlights regulatory milestones in 2022 (EUA, CMA, Japan approval) and forward-looking obligations, which the LLM omits entirely, weakening the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the evolution of financial and contractual commitments over time and attempts to interpret trends. However, due to severe quantitative inaccuracies and omission of key regulatory context, the correctness score is low. The answer creates a narrative unsupported by the evidence, despite including two correct data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 531,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024 the estimated financial liability for Aearo‑related respirator‑mask/asbestos claims fell from **$62 million (accrued as of Dec 31 2023)** to **$51 million (accrued as of Dec 31 2024)**, reflecting a $11 million reduction in the accrual.  The company notes that the liability is shared among Aearo, Cabot, American Optical and a Warner‑Lambert subsidiary (the “Payor Group”), and that the amount can change if future claim volume, cost trends, settlement outcomes, or interpretations of the indemnity agreements shift.  Consequently, while the accrued liability decreased, the company cannot precisely predict how much the ultimate liability may exceed the recorded amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims a $62 million accrual for Aearo-related liabilities as of December 31, 2023, which contradicts the ground truth stating that in 2023, Aearo was in bankruptcy with no specific accrual mentioned for Aearo itself; instead, MMM had a $574 million accrual for respirator/asbestos liabilities excluding Aearo. The $62 million figure is not supported by the original answer and appears fabricated. The 2024 accrual of $51 million for Aearo-related claims is correct. The $11 million reduction is therefore based on incorrect input and is invalid. (2) The LLM incorrectly implies that the $62M to $51M change represents a reduction in Aearo-specific accruals from 2023 to 2024, but the ground truth does not report any Aearo-specific accrual in 2023—only that litigation was stayed due to bankruptcy. Thus, the core quantitative comparison is flawed. (3) The qualitative aspects partially align: the mention of shared liability among Aearo, Cabot, American Optical, and Warner-Lambert subsidiary (the Payor Group) reflects correct multi-party involvement, though the original answer emphasizes Cabot’s assumption of pre-1997 exposure in exchange for a $100,000 quarterly fee—a key contractual mechanism that the LLM omits. This omission weakens the explanation of how risk exposure evolved. (4) Contextually, the answer addresses the evolution of financial liability and risk exposure, so relevance is high. However, due to major errors in numbers and missing key contractual risk-limiting arrangements, the correctness score is low. The answer creates a misleading narrative of declining accruals when the real shift was from bankruptcy stay to active, limited liability management via agreement. Semantic equivalence fails on critical points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 498,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal declined from 7.6% in 2023 to 7.6% → 7.6%? Actually 2024 share is 7.6% (down from 9.3% in 2023), a drop of about 1.7 percentage points. This share decline occurred alongside a modest decrease in shipment volume (down ~1% in 2024 vs. 2023), whereas between 2020 and 2021 the segment’s shipment volume was essentially flat (820.3 million cans in 2021 vs. 819.6 million in 2020) with only a slight share loss. Thus, Skoal’s retail‑share trend fell sharply from 2023 to 2024, contrasting with the near‑steady shipment volumes seen from 2020 to 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that Skoal's retail share was 7.6% in 2023 and then again 7.6% in 2024, contradicting itself and the ground truth, which correctly shows a drop from 9.3% in 2023 to 7.6% in 2024. The LLM does eventually note the 9.3% to 7.6% drop but frames it confusingly. (2) The shipment volume data is completely wrong: the LLM claims Skoal’s shipment volume decreased modestly in 2024 vs 2023 and was flat between 2020 and 2021 (819.6M to 820.3M), but the ground truth states Skoal’s shipment volume declined from 208.5 million to 197.4 million packs/cans between 2020 and 2021 — a ~5.3% drop, not flat. The LLM appears to have used total segment or company-wide shipment data instead of Skoal-specific figures. (3) The multi-hop reasoning is flawed: the question asks to compare Skoal’s 2023–2024 retail share trend with its own shipment trend from 2020–2021. The LLM fails to connect the correct product-specific data across time periods and instead introduces unrelated or aggregated data, breaking the logical chain. (4) Despite the incorrect numbers and reasoning, the LLM attempts to address both parts of the question and draws a comparison, so it retains partial contextual relevance. However, due to major quantitative and qualitative inaccuracies, the overall correctness is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 381,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s engineering focus shifted from primarily advancing 4G/LTE and multimode RF technologies toward deeper integration of AI, multimedia (camera, video, display, computer vision), and on-device generative AI capabilities, while expanding its R&D into automotive (ADAS/AD), XR, and broader IoT applications. This evolution is reflected in its 2024 disclosures emphasizing AI research (including power-efficient, personalized on-device AI), multimedia SoC innovations, and strategic investments in AI and automotive sectors, moving beyond mobile handsets to target industries like automotive and industrial IoT, as detailed in the \"Research and Development\" sections of both 2022 and 2024 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024. It accurately identifies Qualcomm's continued focus on multimedia technologies such as camera, video, display, and computer vision, and correctly notes the expanded integration of AI—particularly on-device and generative AI—into its R&D strategy by 2024. The mention of expansion into automotive (ADAS/AD), XR, and IoT applications matches the ground truth's emphasis on diversification beyond mobile handsets. However, the LLM answer introduces '4G/LTE and multimode RF technologies' as a primary engineering focus in 2022, which is not emphasized in the original answer; instead, the ground truth highlights multimedia and sensor technologies alongside modem and RF as part of a broader capability set, not a shift away from 4G/LTE. This misrepresents the nature of the evolution. Additionally, while the LLM captures the platform-oriented shift, it does not explicitly highlight the increased emphasis on enabling developers across device categories, a key qualitative shift in 2024. There are no numerical inaccuracies (dates: 2022, 2024 are correct), and all entities (Qualcomm, AI, automotive, IoT, multimedia) are accurately referenced. The reasoning is sound and synthesizes multi-hop information across time periods and strategic focus areas. Wording differs but maintains semantic equivalence on core points, though minor omissions in nuance prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 409,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M’s financial relationship with the Aearo Entities evolved from deconsolidation in late 2022 to full reconsolidation in Q2 2023 after the bankruptcy dismissal of the Aearo entities. Following reconsolidation, 3M recorded a $4.2 billion pre‑tax charge in Q3 2023 related to the CAE Settlement, reflecting a $5.3 billion present‑value contribution (cash and stock) to fund the settlement and associated legal costs. By year‑end 2023, 3M had accrued $5.0 billion for Combat‑Arms earplug liabilities and, in 2024, continued to fund the settlement—paying $10 million in September 2023, $250 million in December 2023, and $253 million on Jan 31 2024—while the $1 billion equity portion of the settlement was converted to cash. Intercompany balances tied to the former deconsolidated entities were eliminated, resulting in a net liability of about $0.6 billion that was removed from the consolidated balance sheet. Thus, the relationship shifted from a largely off‑balance‑sheet, contingent exposure to an actively funded, settled liability with the Aearo entities now fully re‑included in 3M’s consolidated financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of 3M's financial relationship with the Aearo Entities. (1) The core claim that 3M reconsolidated the Aearo Entities in Q2 2023 is contradicted by the ground truth, which states reconsolidation occurred as of December 31, 2023. (2) The LLM introduces a $4.2 billion pre-tax charge, $5.3 billion present-value contribution, $5.0 billion accrual, and specific payments ($10M, $250M, $253M) that are not mentioned in the original answer and appear to conflate the CAE settlement details with the reconsolidation accounting impact. (3) The original answer emphasizes the removal of a $0.7 billion equity investment and $0.6 billion net liability due to reconsolidation, but the LLM incorrectly frames the $0.6 billion net liability as the only balance removed and omits the $0.7 billion asset entirely. (4) The LLM incorrectly states that the Aearo Entities were 'fully re-included' in 2024, while the ground truth explicitly says they were no longer consolidated in 2024 and 3M now 'has a stake in' them—indicating deconsolidation, not continued consolidation. (5) The reasoning is flawed: the answer suggests active funding and settlement payments reflect the financial relationship, but the question focuses on equity investment and intercompany balances, not litigation funding. The multi-hop synthesis fails because it draws from incorrect timelines and conflates settlement mechanics with balance sheet reconsolidation. While the mention of eliminating intercompany balances aligns thematically, the quantitative and directional (consolidated vs. non-consolidated) conclusions are factually wrong. Minor contextual elements (e.g., intercompany elimination) are relevant, but overall correctness is low due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 495,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa’s Risk and Identity Solutions evolved from a primarily fraud‑prevention toolkit into a broader, AI‑driven suite that underpins its “network of networks” strategy. The portfolio now includes real‑time authorization scoring (Visa Deep Authorization), A2A‑specific fraud protection (Visa Protect for A2A), and expanded token‑based authentication (Visa Consumer Authentication Service), positioning these capabilities as core value‑added services that support Visa’s expanded B2B, cross‑border and open‑banking flows. This strategic shift reinforces Risk and Identity Solutions as a differentiator within Visa’s overall value‑added services portfolio, driving deeper client engagement and new revenue streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Visa's Risk and Identity Solutions from fraud prevention to a more integrated role within its value-added services, which aligns with the ground truth. It correctly identifies the enhanced strategic positioning and mentions relevant use cases like real-time decisioning and authentication. However, it introduces specific product names and features not present in the original answer—such as 'Visa Deep Authorization', 'Visa Protect for A2A', and 'Visa Consumer Authentication Service'—which are not mentioned in the 2022 or 2024 ground truth descriptions. Additionally, the claim about being 'AI-driven' and supporting a 'network of networks' strategy is speculative and not supported in the provided truth data. While the original answer notes that Risk and Identity Solutions became one of five core categories in a broader portfolio by 2024 and that over 200 services existed as of September 30, 2024, the LLM does not include this specific quantitative benchmark. The absence of this key factual detail, combined with the introduction of unverified product names and strategic framing, reduces factual accuracy. The reasoning is logically plausible but not fully grounded in the evidence provided. Quantitative accuracy is high because no incorrect numbers are stated (the LLM avoids making up figures), but it misses the critical data point of 'more than 200 products and services' as of 2024. Contextual relevance is strong, as the response directly addresses the evolution and strategic positioning. Overall, the answer reflects partial correctness with meaningful embellishment beyond the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 454,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "Between 2023 and 2024, RTX's disclosure of Acquisition Accounting Adjustments shifted from a $1.998 billion net adjustment in 2023 to a $2.058 billion net adjustment in 2024, reflecting a modest increase driven primarily by higher amortization of acquired intangibles and property‑plant‑equipment fair‑value adjustments, partially offset by slightly lower amortization of customer contractual obligations. This evolution indicates that while the overall magnitude of acquisition‑related adjustments remained relatively stable, the 2024 figure shows a small upward trend compared with the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM claims RTX disclosed a $2.058 billion net adjustment in 2024, which directly contradicts the ground truth stating that RTX did *not* provide updated quantitative figures for 2024. The only correct number is the 2023 figure of $1,998 million (correctly reported as $1.998 billion). The $2.058 billion figure is fabricated, and no such calculation or disclosure exists in the ground truth. (2) Completeness: The answer fails to address the key evolution — the shift from quantitative to qualitative disclosure — which is the core of the question. Instead, it falsely asserts continued numerical disclosure in 2024. (3) Entity Accuracy: While RTX and the general concept of acquisition accounting adjustments are correctly identified, the years and metrics are misrepresented. (4) Reasoning: The multi-hop reasoning is flawed; the model invents a trend (modest increase, components like PPE adjustments) without any supporting evidence. The ground truth explicitly states that 2024 disclosures were qualitative, making any numerical comparison invalid. (5) Semantic Equivalence: The LLM conveys the opposite of the truth — that quantification continued — when in fact the key point is that it stopped. The answer is contextually misleading despite using plausible-sounding financial language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 389,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft's Office 365 Commercial revenue grew from $44.97 billion in fiscal 2022 to $48.85 billion in fiscal 2023, reflecting a strong upward trajectory within the Microsoft Cloud portfolio. This growth contributed to the overall Microsoft Cloud revenue increasing from $91.4 billion in 2022 to $111.6 billion in 2023, underscoring Office 365 Commercial's expanding share and importance in the broader cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly states the overall Microsoft Cloud revenue increase from $91.4 billion in FY2022 to $111.6 billion in FY2023 (matching the ground truth), it fabricates specific Office 365 Commercial revenue figures of $44.97 billion in FY2022 and $48.85 billion in FY2023. These numbers are not present in the original answer or supported by the knowledge graph, which does not disclose standalone Office 365 Commercial revenue for those years. (2) The calculation of growth from $44.97B to $48.85B implies a ~8.6% increase, which may seem plausible but is irrelevant because the base numbers are incorrect. The ground truth does not provide direct Office 365 Commercial revenue figures for FY2022 or FY2023, only its qualitative role as a growth driver and its inclusion in the consolidated Microsoft Cloud figure. (3) The reasoning is partially sound in recognizing that Office 365 Commercial is part of the broader Microsoft Cloud ecosystem and that cloud revenue grew significantly year-over-year. However, the model fails the multi-hop synthesis by incorrectly assuming that Office 365 Commercial’s revenue can be isolated and quantified when the source information only supports its inclusion in a consolidated cloud total. (4) Contextually, the answer addresses the question about evolution and growth trajectory, and correctly references the Microsoft Cloud revenue growth. However, the invention of precise revenue numbers undermines factual correctness. The qualitative accuracy is moderate because the conceptual framing is reasonable, but the lack of transparency about data limitations and the introduction of false precision reduce reliability. Correctness score is low due to unsupported numerical claims, despite correct contextual framing and cloud revenue totals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 510,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Alliance revenue related to Lynparza increased from $1,199 million in 2023 to $1,311 million in 2024, reflecting a 9% rise (11% excluding foreign‑exchange effects). This growth was driven by higher demand for Lynparza in most international markets, including the January 2025 Chinese approval for its use as an adjuvant treatment for germline‑BRCA‑mutated, HER2‑negative high‑risk early breast cancer. The expansion of its indication and continued uptake abroad were the primary factors behind the revenue uplift.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific dollar amounts ($1,199 million in 2023 and $1,311 million in 2024) and a 9% growth figure, which aligns with the ground truth's reported 9% growth. However, the original answer does not provide any dollar figures, so the inclusion of precise revenue numbers in the LLM response cannot be verified and appears to be hallucinated. The 11% growth excluding foreign-exchange effects is also not present in the ground truth and cannot be confirmed. (2) The calculation of 9% growth from $1,199M to $1,311M is mathematically accurate: (1,311 - 1,199) / 1,199 ≈ 0.0934 or ~9.3%, which rounds to 9% — this supports partial quantitative accuracy. However, since these figures are not in the original answer, their presence undermines factual correctness. (3) The LLM correctly identifies the key qualitative driver — higher demand in international markets — which matches the ground truth. However, it introduces a forward-looking event: 'January 2025 Chinese approval', which is outside the 2023–2024 timeframe and cannot contribute to revenue changes already observed in 2024. This is a critical reasoning error, as it cites a future event as a cause of past revenue growth. (4) While the LLM captures the general trend and directional reasoning (increased demand driving growth), it adds unverified numerical data and a causally invalid future event, reducing factual reliability. The contextual relevance remains high because it directly addresses the evolution and contributing factors. Correctness score is reduced due to unsupported numbers and flawed causality, despite correct directional logic and partial alignment with the 9% growth figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 461,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan in the 2024 Form 10-K reflects its continued inclusion within the company’s broader equity compensation framework, now operating alongside newer plans such as the 2019 Stock and Incentive Compensation Plan. While the 2014 Plan is referenced in the exhibit list and related governance materials, it is no longer the primary vehicle for future equity grants, with the 2019 Plan now serving as the main plan permitting future issuances. Disclosure of the 2014 Plan’s terms and conditions is incorporated by reference from prior filings, consistent with SEC requirements, but its role has diminished in current compensation reporting, particularly in the summary of equity awards and future available shares presented in Item 12.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the evolution of the Procter & Gamble 2014 Stock and Incentive Compensation Plan between 2023 and 2024, with correct dates, plan names (2014 and 2019), and regulatory context. It correctly identifies that the 2014 Plan is no longer the primary vehicle for grants and that disclosures are incorporated by reference, aligning with SEC requirements—this matches the ground truth's emphasis on shifting from active regulatory disclosure to a more integrated, historical role in equity reporting. The answer also accurately notes the plan’s inclusion in Item 12 and exhibit lists, reflecting its diminished but ongoing role. While the original answer emphasizes a shift toward transparency in ownership structure and equity compensation, the LLM focuses more on the operational shift to the 2019 Plan and reduced prominence in current reporting. This is consistent with the ground truth but omits explicit mention of the 'broader list of equity compensation plans for reporting on stock issuances upon exercise of options' and the comparative framing between 2023 and 2024 regarding disclosure focus. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Procter & Gamble, 2014 and 2019 Plans, Form 10-K, Item 12) are correct. The reasoning is sound and reflects proper multi-hop synthesis across time periods and disclosure practices. The answer is highly contextually relevant. The slight deduction in qualitative accuracy and overall correctness is due to incomplete articulation of the shift in disclosure purpose (from regulatory to structural transparency), which is central to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 460,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains part of P&G’s legacy equity framework but is no longer a primary vehicle for new grants; its role has been superseded by the 2019 Stock and Incentive Compensation Plan, which now serves as the principal plan for future equity awards within the company’s compensation structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but lacks alignment with the specific evolution described in the ground truth. (1) There are no numeric values in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies that the 1992 Stock Plan is a legacy plan and no longer the primary vehicle for new grants, and correctly notes the 2019 Stock and Incentive Compensation Plan as the current principal plan. This shows accurate entity identification (correct plans and implied timeline). (3) However, the multi-hop reasoning is incomplete. The question specifically asks how the *treatment* of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings. The ground truth highlights a structural change in disclosure: from being referenced by incorporation in 2023 to being included in a consolidated table of equity plans in 2024. This shift in reporting format—indicating a move from standalone status to passive tracking—is the core of the evolution. The LLM answer does not mention this change in disclosure treatment or the comparative context between the two filings. (4) While the general idea that the 1992 plan is inactive and superseded is consistent with the truth, the answer fails to address the specific evolution in *filing treatment* between 2023 and 2024, which is the central focus of the question. Thus, correctness and qualitative accuracy are reduced due to missing the key multi-hop insight about disclosure changes, even though the overall context about plan succession is relevant and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 434,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "The company’s focus on large‑scale transformations has remained consistent, but the 2024 filing notes that client spending is now more closely tied to these long‑term transformation projects, with revenue recognition spread over a longer horizon. Consequently, while the strategic emphasis on transformations has not changed, the timing of revenue conversion has slowed, reflecting a shift toward more extended, value‑driven engagements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the consistent emphasis on large-scale transformations between 2023 and 2024 and correctly notes the extended revenue conversion timeline. The statement that client spending is more closely tied to long-term projects in 2024 reflects a reasonable interpretation of the continued prioritization mentioned in the original answer. (2) There are no numeric values or calculations in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across both years and correctly infers that the strategic focus has remained stable while revenue timing has lengthened. However, the LLM omits specific context from 2023 about reduced spending on smaller contracts and the slowdown in consulting services, which were key details explaining *why* large-scale transformations stood out. This partial omission affects completeness and nuance, preventing a perfect qualitative score. (4) The answer remains highly relevant to the question, focusing on client spending patterns and revenue conversion timelines as asked. While the LLM does not explicitly reference the economic volatility context, it does convey the strategic reinforcement through phrasing like 'more extended, value-driven engagements.' Overall, the answer is factually consistent and semantically close to the ground truth, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 415,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "From fiscal 2023 to 2024, Accenture issued 7.9 million Class A ordinary shares for employee share programs, increasing the total Class A share count from 15,664,616 to 15,672,485. This issuance contributed $1.42 billion to shareholders’ equity and modestly diluted the share count, but did not fundamentally alter the overall equity structure beyond the addition of new Class A shares and related paid‑in capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture issued 7,970 Class A Ordinary Shares in fiscal 2024 for employee programs, not 7.9 million. The LLM incorrectly states the share count increased from 15,664,616 to 15,672,485, while the ground truth reports an increase from 15,656,591 in 2023 to 15,664,561 in 2024. The LLM also introduces a $1.42 billion equity contribution and mentions share dilution, which are not present in the original data and cannot be verified. (2) Quantitative accuracy is severely compromised: the share issuance is off by a factor of nearly 1,000 (7,970 vs 7.9 million), and the base share counts are incorrect. The treasury share activity and its financial impact ($(3,408,491) million to $(6,678,037) million) are entirely omitted. (3) The reasoning is flawed: the model mischaracterizes the nature of the change—ground truth indicates a shift from acquiring shares (via withholding) in 2023 to issuing shares in 2024, but the LLM frames it only as an issuance without acknowledging the prior year's activity. It also fails to mention the purchase of 12,181 treasury shares in 2024, a key part of the equity reallocation. (4) Contextual relevance is moderate—the answer addresses employee share issuance and equity impact, but with incorrect data and incomplete synthesis. The conclusion that the structure was not 'fundamentally altered' contradicts the ground truth's emphasis on 'significant reallocation.' Overall, major factual and quantitative errors undermine correctness despite some relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 442,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ reduced its exposure to Canadian‑denominated debt designated as net‑investment hedges from $443 million at the end of 2022 to $453 million at the end of 2023 (a modest increase in notional amount, but the related after‑tax gain/loss shifted from a $25 million gain in 2022 to an $8 million loss in 2023). This change reflects a broader trend of actively managing foreign‑currency‑denominated debt, as the company also adjusted its net‑investment hedge program and overall foreign‑currency hedge coverage across other currencies, indicating a strategic shift in how it hedges international debt exposures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, MDLZ's Canadian-denominated debt decreased by $3 million in 2022 (from $3M in 2021 to $0M or near-zero), and then increased by $8 million in 2023, reversing the prior trend. However, the LLM claims exposure increased from $443M to $453M between 2022 and 2023, which is off by orders of magnitude—these figures do not align with the actual Canadian note balances cited in the original answer (which were in the single-digit millions, not hundreds of millions). (2) The numbers are factually wrong: the ground truth shows Canadian notes were $3M in 2021, implied near $0 in 2022, and then up $8M in 2023 (i.e., to ~$8M), not $453M. Additionally, the LLM introduces unrelated details about after-tax gains/losses ($25M gain in 2022, $8M loss in 2023) that are not mentioned in the original answer and appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: while the question asks about changes in Canadian-denominated debt and how that compares to overall foreign currency debt trends, the LLM fails to mention the key reversal from decline to increase in Canadian notes. Instead, it fabricates a narrative around net-investment hedges and after-tax gains without grounding in the provided truth. It also fails to reference the broader trend involving Euro and Swiss franc notes (Euro down from $211M to $81M), which is central to the original answer’s comparative analysis. (4) The contextual relevance is moderate because the LLM addresses the general topic of foreign currency debt management, but the specific facts, figures, and trends are incorrect or invented, leading to a very low correctness and quantitative accuracy score. The qualitative reasoning is poor due to incorrect entity values and missing multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 508,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to growth-stage companies has evolved significantly from 2023 to 2024, particularly through its Accenture Ventures unit, which now actively partners with and invests in growth-stage technology companies to accelerate innovation. This strategic involvement is underscored by the firm's increased focus on emerging technologies like AI and generative AI, as well as its broader ecosystem engagement to scale solutions for clients. While specific investment figures are not detailed in the provided pages, the emphasis on growth-stage companies reflects a deliberate shift toward deeper, more strategic collaboration to drive client value and market leadership.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Accenture's approach from partnership to investment in growth-stage companies and correctly identifies Accenture Ventures as the driving unit. It also appropriately highlights strategic involvement through innovation and emerging technologies like AI, which aligns with the broader context of Accenture's innovation focus. However, it fails to include key quantitative details present in the ground truth: specifically, the $1.3 billion R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024, which are critical for demonstrating the financial backing of this strategic shift. While the LLM mentions a 'shift toward deeper, more strategic collaboration,' it does not explicitly state the change in language from 'partners with' to 'invests in' as evidence of the evolving model, which is a key factual point in the original answer. Additionally, the LLM incorrectly implies that Accenture Ventures both partners with and invests in companies in 2024, whereas the ground truth indicates a shift from one model to the other, suggesting a more decisive strategic evolution. The reasoning is partially sound and contextually relevant, but the absence of specific financial figures and imprecise characterization of the strategic shift reduce factual accuracy. Thus, while the qualitative direction is correct and the response is relevant, the lack of key data points and minor misrepresentation of the nature of the evolution limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 409,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 through 2024 Merck’s Lynparza collaboration with AstraZeneca has moved from a milestone‑driven, catch‑up amortization model to a growth‑focused revenue stream.  The 2021 intangible‑asset balance for Lynparza ($1.1 bn) is being amortized through 2028, and by 2024 alliance revenue from Lynparza had risen 9% year‑over‑year to $1.311 bn, reflecting higher international demand and the absence of further catch‑up amortization.  Consequently, the earlier $153 m cumulative amortization catch‑up recorded in 2021 is no longer a driver; instead, Lynparza’s contribution to overall alliance revenue is expanding organically as the drug gains new regulatory approvals (e.g., China’s 2025 adjuvant indication).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Merck's financial and strategic involvement in the Lynparza collaboration from 2022 to 2024. It accurately states the $1.1 billion intangible asset balance being amortized through 2028, consistent with the ground truth. The 9% year-over-year increase in alliance revenue by 2024 is correctly reported, aligning with the original answer. However, the LLM introduces a specific revenue figure of $1.311 billion and a $153 million amortization catch-up in 2021, which are not present in the ground truth. While these figures may be factually accurate, they go beyond the provided knowledge and introduce unverified specifics, slightly reducing quantitative accuracy. (2) The mention of a 2021 asset balance (instead of 2022) is a minor misalignment in timing, though the amortization period through 2028 is correct. The core financial trajectory—shifting from amortization focus to revenue growth—is sound. (3) The multi-hop reasoning is strong: the model synthesizes information about amortization, revenue trends, and future strategic importance (e.g., China approval in 2025), correctly linking financial evolution with regulatory developments. (4) Despite the addition of unsupported granular figures, the overall factual narrative matches the ground truth in substance and direction. The answer is contextually excellent, fully addressing the question’s focus on financial and strategic evolution. Minor deductions only for unverified specifics not in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 424,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "Between 2023 and 2024, Broadcom’s strategic emphasis on **ValueOps** within its Distributed Software portfolio shifted from a general capability for streamlining software planning, development and delivery (highlighted in 2023 as part of its broader distributed‑software offering) to a more pronounced, dedicated focus in 2024, where ValueOps is explicitly positioned alongside DevOps and AIOps as a core pillar of the Distributed Software portfolio and is featured prominently in the “Distributed Software Portfolio” table and accompanying descriptions. This evolution indicates that Broadcom is treating ValueOps as a strategic growth driver—integrating it more deeply into its broader private‑cloud and enterprise‑software strategy and aligning it with its broader infrastructure‑software and security initiatives—to strengthen its end‑to‑end visibility and business‑outcome focus across the software lifecycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AVGO's strategic emphasis on ValueOps between 2023 and 2024. It correctly identifies that in 2023, ValueOps was a component of the broader Distributed Software offering without special prominence, and that by 2024, it was elevated to a core pillar alongside DevOps and AIOps—explicitly mentioned in the portfolio table and descriptions. The answer accurately reflects the shift in strategic positioning and notes the emphasis on end-to-end visibility and business outcomes, aligning with the ground truth. The only minor shortcoming is that it does not explicitly state that the three domains (ValueOps, DevOps, AIOps) are now the organizing framework for the portfolio, nor does it directly quote the 'end-to-end visibility across all stages of the digital lifecycle' phrasing, though the concept is implied. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are involved), and all entities (AVGO/Broadcom, ValueOps, DevOps, AIOps, Distributed Software portfolio, 2023–2024 timeframe) are correctly identified. The reasoning is sound, demonstrating multi-hop synthesis across years and strategic contexts. The answer is fully contextually relevant and conveys nearly identical meaning to the original answer with only slight variation in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 375,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx’s DRIVE transformation—specifically Network 2.0—moved from planning to execution, with the new legal structure finalized in June 2024 and integration of legacy FedEx Ground and FedEx Services underway. The company expects the transformation to generate cost savings and a more flexible, aligned cost base, but acknowledges that actual savings, timing and the magnitude of those benefits may differ from expectations due to integration complexities, labor‑relation issues, regulatory hurdles and potential asset impairments. Consequently, while Network 2.0 is projected to deliver operational efficiencies and permanent cost reductions, it also carries implementation risks that could increase costs, delay benefits or adversely affect financial results if not successfully executed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in FedEx's strategic approach to Network 2.0 between 2023 and 2024. (1) It correctly identifies the shift from planning to execution, aligning with the ground truth's narrative of transitioning from strategic investment justification in 2023 to integration and risk management in 2024. The mention of the June 2024 finalization of the legal structure is consistent with the timeline implied in the 2024 filing. (2) There are no numeric values (e.g., cost savings figures) in either the original or LLM answer, so quantitative accuracy is not compromised—no incorrect numbers or miscalculations are present, earning a 10. (3) The LLM accurately reflects key risks: integration complexities, labor issues, regulatory hurdles, asset impairments, and uncertainty around timing and magnitude of savings—mirroring the 2024 filing’s emphasis. It synthesizes multi-hop information across years and strategic phases soundly. One minor omission is the lack of explicit mention of 'harmonizing operating practices,' 'customer and service provider agreements,' or 'cultural differences' detailed in the 2024 risk factors, which slightly reduces qualitative completeness. (4) The answer remains contextually precise, directly addressing the evolution in cost savings expectations and implementation risks. Overall, the LLM conveys semantic equivalence with the ground truth, with only slight detail gaps preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 412,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts remained minimal and essentially unchanged between 2022 and 2023, with the fair value of the embedded derivative consistently recorded as a $3 liability in both years. This stability indicates that Mondelez International's engagement with these specific investment contracts did not result in significant financial fluctuations during this period, suggesting a relatively static position in their equity method investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the financial impact. The ground truth states that in 2022, MDLZ reported a net liability of $3 million, which reversed to a gain of $7 million in 2023. The LLM incorrectly claims a consistent $3 million liability in both years, contradicting the actual reversal. (2) Quantitative accuracy is severely lacking: the LLM fails to report the $7 million gain in 2023 and falsely asserts no change, when in fact there was a $10 million swing (from -$3M to +$7M). This misrepresents the core financial data. (3) The multi-hop reasoning is flawed—the question requires comparing two years of equity method investment impacts and inferring strategic implications. The LLM not only misses the reversal but draws the opposite conclusion (static engagement vs. active shift), failing to synthesize the correct trend. (4) Contextual relevance is partially met as the answer addresses equity method investments and MDLZ’s engagement, but the incorrect data renders the conclusion invalid. The answer is semantically opposite to the truth, indicating a fundamental error in source data or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 333,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Based on the document, the estimated cost to complete the VMware Cloud Foundation July 2024 releases was $38 million at the end of fiscal 2023 and increased to $38 million (the same absolute amount) by fiscal 2024, but the percentage of completion rose from 67 % to 67 % – effectively indicating that the remaining work stayed constant while the overall project remained on schedule. The modest increase in absolute cost to complete, together with the high completion rate, shows that development is progressing close to expectations, with only a small amount of work left to finish the July 2024 releases.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the estimated cost to complete increased from $38 million to $38 million, which is misleading despite the same numerical value. The ground truth emphasizes that the cost remained *unchanged*, but the phrasing 'increased to $38 million' inaccurately implies a change. Additionally, the LLM claims the percentage of completion rose from 67% to 67%, which is logically inconsistent—there was no change, so stating it 'rose' is incorrect. (2) While the dollar amount ($38 million) is correct in both years, the description of movement ('increased') and the contradictory percentage claim undermine quantitative accuracy. There are no calculation errors per se, but the presentation misrepresents stability as a change. (3) The multi-hop reasoning is partially sound—linking cost to completion with development progress—but flawed in interpretation. The model fails to recognize that a stable cost estimate with no change in completion percentage indicates on-track progress without new developments, not 'a modest increase in absolute cost.' The conclusion that 'only a small amount of work is left' is speculative and not supported by the 67% figure, which implies one-third still remains. (4) The answer is contextually relevant and addresses the question's intent regarding development progress, but the incorrect characterization of unchanged values as increases reduces factual reliability. The core insight about being on schedule is aligned with the ground truth, but it's based on flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 434,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office's Ship and Go kiosk has evolved from a niche self-service shipping option to a core component of an integrated e-commerce and returns ecosystem between 2023 and 2024. This evolution reflects FedEx's broader approach to unifying logistics and returns management—leveraging kiosks for seamless label generation and drop-offs, integrating with FedEx Returns Technology for in-store return label printing, and expanding capabilities like Consolidated Returns to enable boxless, label-less returns—demonstrating a strategic shift toward frictionless, customer-centric omnichannel fulfillment that aligns with the growth of e-commerce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the Ship and Go kiosk was present in approximately 1,300 locations in both 2023 and 2024, and its core functionality remained consistent. The shift in strategic emphasis toward returns management in 2024 is correctly identified, including integration with FedEx Returns Technology and Consolidated Returns. (2) There are no numeric values requiring calculation in this question, but the LLM correctly avoids introducing any false quantitative claims (e.g., does not misstate location count or change it incorrectly), so quantitative accuracy is full. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of functionality and strategic emphasis across years, correctly inferring a shift from shipping-centric to returns-integrated positioning. The only minor shortcoming is that the LLM describes the 2023 positioning as a 'niche' self-service option, which is a slight interpretive stretch not present in the original answer—ground truth describes it as a self-serve solution without qualifying it as 'niche.' Similarly, 'core component' and 'ecosystem' are stronger characterizations than the original, though justified by the trend. (4) The answer is fully contextually relevant, directly addressing both the evolution of the kiosk and what it indicates about FedEx's e-commerce logistics and returns strategy. Overall, the semantic meaning matches the ground truth with high fidelity, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 431,
        "total_tokens": 1835
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.1,
    "average_quantitative_accuracy": 5.91,
    "average_qualitative_accuracy": 5.43,
    "average_contextual_relevance": 7.67,
    "score_distribution": {
      "excellent": 173,
      "good": 165,
      "fair": 303,
      "poor": 359
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000
  }
}